Citrus Sinensis ID: 035998

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020
Protein Sequence
MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Secondary Structure (PSIPRED)
cccccHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccccccccccccccEEEcccccccccccccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccEEEcccccccccccHHHHHccccccEEEEEccccccccccccccccccccEEcccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccHHHHccccccEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccEEEEEccccccccccccEEEcccccccccccHHHHHcccccccEEEcccccccccccHHHHHccccccEEEccccccEEcccHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccEEccccccccccccHHHHHHHcccccccccccccccEEEccccccccccHHHHHccccccEEEcccccccccccHHHHccccccEEccccccccccccHHcccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHcccccccHHHHcccccEEEEccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHccccccccccEEEEEEEcccEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccEEEcccHHHHccccccccEEEEccccccccccccccccccccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHccccccEEcccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHEHHHHcccccccccHHccHHHHHHHHHHHHccccccccccccccccccccEEEEEcccccccccHHHcccccEEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEEccccccccccccccccccEEEEEccccccccccHHHHHccccccEEEEccccccccccHcHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHHccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccccHHHHcccccEEEEEEcccccccccHHHHcccccEEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccccccHHHccccccEEEccEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEcccccccccHHHHHHHHccccHHcEEEccccEEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHcHHHHHEEEEccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEEHHHEEEEccccHHHHcccccccccEEHHccccccccccHcEEEEEcccccEEHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccEEccHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHc
Coil and Loop (DISEMBL)
MGVQDLCLFIILAGFCFQAQLLHAQRqdltcnpndLAALEDFMKNFEsgidgwgtnasssdcchwvgitcnsssslglndsigsgrvTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHnllkgtvpvslvnlpnlevldlssndlsgplpqtinlpsiqvldissnslngsvptsicknssriRVINLSVNYfsgtlspglgncasLEHLCLGMndltggiaDDIFQLQKLRLLglqdnqlsgklspsiadlsnlvrldvssnnfsgnipdvfAGLGEFQYLVAHsnrftgriphslsnsptlnllnlrnnsldgslllncpaltnltsldlgtnkfngplptnlprcrklkninlarnnfsgqipetyknFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNfrneklptdprlhfanLKVLVIASCglrgsipqwlrgcsKLQLVDLswnqlsgtipvwfggfqdlfyldlsnntftgeipknltglpslitrnisleepspdfpffmrrnvsarglqynqiwsfpptidlslnrldgsiwpefgnlkklhvfdlkhnnlsgpipseltgmtslETLDLSYnnlsgaipislekLSFLSKFSvannhltgripsggqfqtfpnssfdgnnlcgehrysctidresgqvksakksrrnkYTIVGMAIGITFGSAFLLILIFMILLRAhsrgevdpekeeantndkdLEELGSKLVVLFHNKEKEISIDDIlestnnfdqaniigcgGFGLvyratlpdgrnVAIKRLSGDCGQMEREFRAEVEALSraqhpnlvhlqgycmhkndrLLIYSFMENGSLDYWLhekldgpssldwdsrLHIAQGAARGLAYLHqscephilhrdikssnilldgnfgahLADFGLARLilspydthvttdlvgtlgyippeygqasvatykgdvYSFGVVLLELltgkrpmdmckpkgsrDLISWVIRMRqenresevldpfiydkqhdKEMLRVLDIACLclsespkvrpttQQLVSWLDSII
Flexible Loop (DISEMBL)
MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSssslglndsiGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPtsicknssriRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEklptdprlhfANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYsctidresgqvksakksrrnkyTIVGMAIGITFGSAFLLILIFMILLRAHSRgevdpekeeantndkdleeLGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLtgkrpmdmckpkgsrDLISWVIRMRqenresevldpFIYDKQHDKEMLRVLDIACLCLsespkvrpttqqlvswldsii
Low Complexity Region (SEG)
MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHslsnsptlnllnlrnnsldgslllnCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFEslsylslsnssiynlssALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIsleklsflskfsVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFGSAfllilifmillRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Disordered region (IsUnstruct)
***QDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGIT***************GRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTI***************NKYTIVGMAIGITFGSAFLLILIFMILLRA************************SKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE**********LVSW*****
Disordered Region (DISOPRED)
***QDLCLFIILAGFCFQAQLLHAQRQ*****PNDLAALEDFMK************ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRY************************VGMAIGITFGSAFLLILIFMILLRAH************************KLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Disordered Region (DISEMBL)
MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTID*************RNKYTIVGMAIGITFGSAFLLILIFMILLRAHSR************NDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Disordered Region (DISPRO)
*GVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTI**************RNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRG********************SKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1020	2.2.26 [Sep-21-2011]
Q9ZVR7	1008	Phytosulfokine receptor 1	yes	no	0.983	0.995	0.664	0.0
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.991	0.990	0.657	0.0
Q9FN37	1036	Phytosulfokine receptor 2	no	no	0.951	0.937	0.496	0.0
Q9C7S5	1095	Tyrosine-sulfated glycope	no	no	0.976	0.909	0.437	0.0
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.857	0.734	0.356	1e-142
Q9LJF3	1164	Receptor-like protein kin	no	no	0.950	0.833	0.342	1e-137
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.874	0.739	0.354	1e-135
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.874	0.739	0.354	1e-134
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.912	0.798	0.327	1e-134
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.903	0.770	0.340	1e-130

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score = 1343 bits (3477), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 680/1024 (66%), Positives = 823/1024 (80%), Gaps = 21/1024 (2%)

Query: 1    MGVQDLCLFIILAG--FCFQAQLLHAQRQDLT-CNPNDLAALEDFMKNFESGIDGWGTNA 57
            M V   C+ +I      CF      ++ Q  + C+P+DL AL DF+ + E   DGW  ++
Sbjct: 1    MRVHRFCVIVIFLTELLCF---FYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSS 57

Query: 58   SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
            SS+DCC+W GITCNS+++         GRV  L L  ++L GKLSESLG L ++R LNLS
Sbjct: 58   SSTDCCNWTGITCNSNNT---------GRVIRLELGNKKLSGKLSESLGKLDEIRVLNLS 108

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
             N +K ++P+S+ NL NL+ LDLSSNDLSG +P +INLP++Q  D+SSN  NGS+P+ IC
Sbjct: 109  RNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGIPTSINLPALQSFDLSSNKFNGSLPSHIC 168

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
             NS++IRV+ L+VNYF+G  + G G C  LEHLCLGMNDLTG I +D+F L++L LLG+Q
Sbjct: 169  HNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQ 228

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            +N+LSG LS  I +LS+LVRLDVS N FSG IPDVF  L + ++ +  +N F G IP SL
Sbjct: 229  ENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFLGQTNGFIGGIPKSL 288

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            +NSP+LNLLNLRNNSL G L+LNC A+  L SLDLGTN+FNG LP NLP C++LKN+NLA
Sbjct: 289  ANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLA 348

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            RN F GQ+PE++KNFESLSY SLSNSS+ N+SSAL +LQ C+NLTTLVLTLNF  E LP 
Sbjct: 349  RNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPD 408

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
            D  LHF  LKVLV+A+C L GS+P+WL   ++LQL+DLSWN+L+G IP W G F+ LFYL
Sbjct: 409  DSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYL 468

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNN+FTGEIPK+LT L SL +RNIS+ EPSPDFPFFM+RN SAR LQYNQI+ FPPTI
Sbjct: 469  DLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTI 528

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
            +L  N L G IW EFGNLKKLHVFDLK N LSG IPS L+GMTSLE LDLS N LSG+IP
Sbjct: 529  ELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIP 588

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
            +SL++LSFLSKFSVA N+L+G IPSGGQFQTFPNSSF+ N+LCGEHR+ C+   ES  + 
Sbjct: 589  VSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALI- 647

Query: 658  SAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSR-GEVDPEKEEANT-NDKDLE 715
              K+SRR++   +GMAIGI FGS FLL L+ +I+LRA  R GEVDPE EE+ + N K+L 
Sbjct: 648  --KRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELG 705

Query: 716  ELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
            E+GSKLVVLF + +KE+S DD+L+STN+FDQANIIGCGGFG+VY+ATLPDG+ VAIK+LS
Sbjct: 706  EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS 765

Query: 776  GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            GDCGQ+EREF AEVE LSRAQHPNLV L+G+C +KNDRLLIYS+MENGSLDYWLHE+ DG
Sbjct: 766  GDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDG 825

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            P+ L W +RL IAQGAA+GL YLH+ C+PHILHRDIKSSNILLD NF +HLADFGLARL 
Sbjct: 826  PALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARL- 884

Query: 896  LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
            +SPY+THV+TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT KRP+DMCKPKG 
Sbjct: 885  MSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGC 944

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
            RDLISWV++M+ E+R SEV DP IY K++DKEM RVL+IACLCLSE+PK RPTTQQLVSW
Sbjct: 945  RDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSW 1004

Query: 1016 LDSI 1019
            LD +
Sbjct: 1005 LDDV 1008

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score = 1320 bits (3415), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 674/1025 (65%), Positives = 810/1025 (79%), Gaps = 14/1025 (1%)

Query: 1    MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSS 60
            MGV  + + +IL GFC Q  ++++Q  +LTCN NDL ALE FM+  ES IDGW  N SSS
Sbjct: 1    MGVLRVYVILILVGFCVQIVVVNSQ--NLTCNSNDLKALEGFMRGLESSIDGWKWNESSS 58

Query: 61   ---DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
               +CC WVGI+C SS SLGL+D   SGRV  L L +R+L GKLSES+  L QL+ LNL+
Sbjct: 59   FSSNCCDWVGISCKSSVSLGLDDVNESGRVVELELGRRKLSGKLSESVAKLDQLKVLNLT 118

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
            HN L G++  SL+NL NLEVLDLSSND SG  P  INLPS++VL++  NS +G +P S+C
Sbjct: 119  HNSLSGSIAASLLNLSNLEVLDLSSNDFSGLFPSLINLPSLRVLNVYENSFHGLIPASLC 178

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
             N  RIR I+L++NYF G++  G+GNC+S+E+L L  N+L+G I  ++FQL  L +L LQ
Sbjct: 179  NNLPRIREIDLAMNYFDGSIPVGIGNCSSVEYLGLASNNLSGSIPQELFQLSNLSVLALQ 238

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            +N+LSG LS  +  LSNL RLD+SSN FSG IPDVF  L +  Y  A SN F G +P SL
Sbjct: 239  NNRLSGALSSKLGKLSNLGRLDISSNKFSGKIPDVFLELNKLWYFSAQSNLFNGEMPRSL 298

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            SNS +++LL+LRNN+L G + LNC A+TNLTSLDL +N F+G +P+NLP C +LK IN A
Sbjct: 299  SNSRSISLLSLRNNTLSGQIYLNCSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFA 358

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            +  F  QIPE++KNF+SL+ LS SNSSI N+SSAL++LQ C+NL TLVLTLNF+ E+LP+
Sbjct: 359  KIKFIAQIPESFKNFQSLTSLSFSNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPS 418

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
             P L F NLKVL+IASC LRG++PQWL     LQL+DLSWNQLSGTIP W G    LFYL
Sbjct: 419  VPSLQFKNLKVLIIASCQLRGTVPQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYL 478

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNNTF GEIP +LT L SL+++  ++EEPSPDFPFF ++N +A GLQYNQ  SFPP I
Sbjct: 479  DLSNNTFIGEIPHSLTSLQSLVSKENAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFPPMI 538

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
            DLS N L+GSIWPEFG+L++LHV +LK+NNLSG IP+ L+GMTSLE LDLS+NNLSG IP
Sbjct: 539  DLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIP 598

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQV 656
             SL KLSFLS FSVA N L+G IP+G QFQTFPNSSF+GN  LCGEH   C I  +S   
Sbjct: 599  PSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSPH- 657

Query: 657  KSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEE 716
             SA KS++N   IV +A+G   G+ FLL +  +I+LR  SRGEVDPEK+     D D  E
Sbjct: 658  GSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKA----DADEIE 713

Query: 717  LGSKLVVLFHNKEK--EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL 774
            LGS+ VVLFHNK+   E+S+DDIL+ST++F+QANIIGCGGFGLVY+ATLPDG  VAIKRL
Sbjct: 714  LGSRSVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRL 773

Query: 775  SGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD 834
            SGD GQM+REF+AEVE LSRAQHPNLVHL GYC +KND+LLIYS+M+NGSLDYWLHEK+D
Sbjct: 774  SGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVD 833

Query: 835  GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
            GP SLDW +RL IA+GAA GLAYLHQSCEPHILHRDIKSSNILL   F AHLADFGLARL
Sbjct: 834  GPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARL 893

Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
            IL PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG+RPMD+CKP+G
Sbjct: 894  IL-PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDVCKPRG 952

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            SRDLISWV++M+ E RESE+ DPFIYDK H +EML VL+IAC CL E+PK RPTTQQLVS
Sbjct: 953  SRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQLVS 1012

Query: 1015 WLDSI 1019
            WL++I
Sbjct: 1013 WLENI 1017

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1

 Score =  942 bits (2434), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 510/1028 (49%), Positives = 688/1028 (66%), Gaps = 57/1028 (5%)

Query: 31   CNPNDLAALEDF---MKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRV 87
            C+PNDL+AL +    +KN +S  + W    + S CC W G+ C  S          SGRV
Sbjct: 19   CHPNDLSALRELAGALKN-KSVTESW---LNGSRCCEWDGVFCEGSDV--------SGRV 66

Query: 88   TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG 147
            T L L ++ L+G +S+SLG L +LR L+LS N LKG VP  +  L  L+VLDLS N LSG
Sbjct: 67   TKLVLPEKGLEGVISKSLGELTELRVLDLSRNQLKGEVPAEISKLEQLQVLDLSHNLLSG 126

Query: 148  PLPQTIN------------------------LPSIQVLDISSNSLNGSVPTSICKNSSRI 183
             +   ++                         P + +L++S+N   G +   +C +S  I
Sbjct: 127  SVLGVVSGLKLIQSLNISSNSLSGKLSDVGVFPGLVMLNVSNNLFEGEIHPELCSSSGGI 186

Query: 184  RVINLSVNYFSGTLSPGLGNCA-SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLS 242
            +V++LS+N   G L  GL NC+ S++ L +  N LTG + D ++ +++L  L L  N LS
Sbjct: 187  QVLDLSMNRLVGNLD-GLYNCSKSIQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLS 245

Query: 243  GKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT 302
            G+LS ++++LS L  L +S N FS  IPDVF  L + ++L   SN+F+GR P SLS    
Sbjct: 246  GELSKNLSNLSGLKSLLISENRFSDVIPDVFGNLTQLEHLDVSSNKFSGRFPPSLSQCSK 305

Query: 303  LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS 362
            L +L+LRNNSL GS+ LN    T+L  LDL +N F+GPLP +L  C K+K ++LA+N F 
Sbjct: 306  LRVLDLRNNSLSGSINLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFR 365

Query: 363  GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLH 422
            G+IP+T+KN +SL +LSLSN+S  + S  + VLQ CRNL+TL+L+ NF  E++P +    
Sbjct: 366  GKIPDTFKNLQSLLFLSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVT-G 424

Query: 423  FANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
            F NL +L + +CGLRG IP WL  C KL+++DLSWN   GTIP W G  + LFY+D SNN
Sbjct: 425  FDNLAILALGNCGLRGQIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKMESLFYIDFSNN 484

Query: 483  TFTGEIPKNLTGLPSLITRNISLEE--PSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLS 540
            T TG IP  +T L +LI  N +  +   S   P +++RN S+ GL YNQ+  FPP+I L+
Sbjct: 485  TLTGAIPVAITELKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSRFPPSIYLN 544

Query: 541  LNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISL 600
             NRL+G+I PE G LK+LH+ DL  NN +G IP  ++G+ +LE LDLSYN+L G+IP+S 
Sbjct: 545  NNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSF 604

Query: 601  EKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYSCTIDRESGQVKSA 659
            + L+FLS+FSVA N LTG IPSGGQF +FP+SSF+GN  LC      C +   S  +   
Sbjct: 605  QSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDV-LMSNMLNPK 663

Query: 660  KKSRRN-------KYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDK 712
              SRRN       + +IV + I +  G   LL +I + + R      ++   EE  +   
Sbjct: 664  GSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDEETISGVS 723

Query: 713  DLEELGSKLVVLFHNKE-KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAI 771
              + LG   +VLFH+   K++S++++L+STNNF QANIIGCGGFGLVY+A  PDG   A+
Sbjct: 724  --KALGPSKIVLFHSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAV 781

Query: 772  KRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE 831
            KRLSGDCGQMEREF+AEVEALSRA+H NLV LQGYC H NDRLLIYSFMENGSLDYWLHE
Sbjct: 782  KRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHE 841

Query: 832  KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL 891
            ++DG  +L WD RL IAQGAARGLAYLH+ CEP+++HRD+KSSNILLD  F AHLADFGL
Sbjct: 842  RVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGL 901

Query: 892  ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK 951
            ARL L PYDTHVTTDLVGTLGYIPPEY Q+ +AT +GDVYSFGVVLLEL+TG+RP+++CK
Sbjct: 902  ARL-LRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCK 960

Query: 952  PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
             K  RDL+S V +M+ E RE+E++D  I +  +++ +L +L+IAC C+   P+ RP  ++
Sbjct: 961  GKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCIDHEPRRRPLIEE 1020

Query: 1012 LVSWLDSI 1019
            +V+WL+ +
Sbjct: 1021 VVTWLEDL 1028

Phytosulfokine receptor with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1

 Score =  813 bits (2100), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 469/1071 (43%), Positives = 644/1071 (60%), Gaps = 75/1071 (7%)

Query: 6    LCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHW 65
            + LF++L  +     +      +  CN  D  +L  F  N  S +     N SS DCC W
Sbjct: 25   MVLFVLL--YVLSISVFFLTVSEAVCNLQDRDSLLWFSGNVSSPVSPLHWN-SSIDCCSW 81

Query: 66   VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTV 125
             GI+C+ S            RVT + L  R L G L  S+ +L +L  L+LSHN L G +
Sbjct: 82   EGISCDKSPE---------NRVTSIILSSRGLSGNLPSSVLDLQRLSRLDLSHNRLSGPL 132

Query: 126  PVSLVN-LPNLEVLDLSSNDLSGPLP---------------QTINLPS------------ 157
            P   ++ L  L VLDLS N   G LP               QT++L S            
Sbjct: 133  PPGFLSALDQLLVLDLSYNSFKGELPLQQSFGNGSNGIFPIQTVDLSSNLLEGEILSSSV 192

Query: 158  -------IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHL 210
                   +   ++S+NS  GS+P+ +C  S ++  ++ S N FSG LS  L  C+ L  L
Sbjct: 193  FLQGAFNLTSFNVSNNSFTGSIPSFMCTASPQLTKLDFSYNDFSGDLSQELSRCSRLSVL 252

Query: 211  CLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP 270
              G N+L+G I  +I+ L +L  L L  N+LSGK+   I  L+ L  L++ SN+  G IP
Sbjct: 253  RAGFNNLSGEIPKEIYNLPELEQLFLPVNRLSGKIDNGITRLTKLTLLELYSNHIEGEIP 312

Query: 271  DVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL-LLNCPALTNLTS 329
                 L +   L  H N   G IP SL+N   L  LNLR N L G+L  ++     +L+ 
Sbjct: 313  KDIGKLSKLSSLQLHVNNLMGSIPVSLANCTKLVKLNLRVNQLGGTLSAIDFSRFQSLSI 372

Query: 330  LDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLS 389
            LDLG N F G  P+ +  C+ +  +  A N  +GQI       ESLS+ + S++ + NL+
Sbjct: 373  LDLGNNSFTGEFPSTVYSCKMMTAMRFAGNKLTGQISPQVLELESLSFFTFSDNKMTNLT 432

Query: 390  SALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL----HFANLKVLVIASCGLRGSIPQWLR 445
             AL +LQ C+ L+TL++  NF +E +P++        F +L++  I +C L G IP WL 
Sbjct: 433  GALSILQGCKKLSTLIMAKNFYDETVPSNKDFLRSDGFPSLQIFGIGACRLTGEIPAWLI 492

Query: 446  GCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNI-- 503
               +++++DLS N+  GTIP W G   DLFYLDLS+N  TGE+PK L  L +L+++    
Sbjct: 493  KLQRVEVMDLSMNRFVGTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYD 552

Query: 504  SLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDL 563
            + E    + P F+  N      QYNQ+ S PPTI +  N L G+I  E G LK LH+ +L
Sbjct: 553  ATERNYLELPVFVNPNNVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILEL 612

Query: 564  KHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG 623
              NN SG IP EL+ +T+LE LDLS NNLSG IP SL  L FLS F+VANN L+G IP+G
Sbjct: 613  LGNNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTG 672

Query: 624  GQFQTFPNSSFDGNNLC--GEHRYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFGSA 681
             QF TFP ++F+GN L   G    SC   + S       K  R     + + +       
Sbjct: 673  TQFDTFPKANFEGNPLLCGGVLLTSCDPTQHSTTKMGKGKVNRTLVLGLVLGLFFGVSLI 732

Query: 682  FLLILIFMILLRAHSRGEVDPEKEEANTN----------DKDLEELGSKLVVLFHNKE-- 729
             +L+ + ++  R  + G+ +  + E N+N          DKD+      LV+LF N    
Sbjct: 733  LVLLALLVLSKRRVNPGDSENAELEINSNGSYSEVPPGSDKDI-----SLVLLFGNSRYE 787

Query: 730  -KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAE 788
             K+++I ++L++T+NF QANIIGCGGFGLVY+ATL +G  +A+K+L+GD G ME+EF+AE
Sbjct: 788  VKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKAE 847

Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            VE LSRA+H NLV LQGYC+H + R+LIYSFMENGSLDYWLHE  +GP+ LDW  RL+I 
Sbjct: 848  VEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIM 907

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
            +GA+ GLAY+HQ CEPHI+HRDIKSSNILLDGNF A++ADFGL+RLIL PY THVTT+LV
Sbjct: 908  RGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLIL-PYRTHVTTELV 966

Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            GTLGYIPPEYGQA VAT +GDVYSFGVV+LELLTGKRPM++ +PK SR+L++WV  M+++
Sbjct: 967  GTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKRD 1026

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             +  EV D  + +  +++ MLRVLDIAC+C++++P  RP  QQ+V WL +I
Sbjct: 1027 GKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQVVDWLKNI 1077

Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  508 bits (1308), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 351/985 (35%), Positives = 508/985 (51%), Gaps = 110/985 (11%)

Query: 90   LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNL-------------- 135
            L L    L G +   LGN   L+ L LS N L G +P+ L  +P L              
Sbjct: 263  LNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLSGSLP 322

Query: 136  ------EVLD---LSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRV 185
                  +VLD   L++N  SG +P  I + P ++ L ++SN L+GS+P  +C  S  +  
Sbjct: 323  SWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELC-GSGSLEA 381

Query: 186  INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKL 245
            I+LS N  SGT+      C+SL  L L  N + G I +D+++L  L  L L  N  +G++
Sbjct: 382  IDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDSNNFTGEI 440

Query: 246  SPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNL 305
              S+   +NL+    S N   G +P         + LV   N+ TG IP  +    +L++
Sbjct: 441  PKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSV 500

Query: 306  LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
            LNL  N   G + +     T+LT+LDLG+N   G +P  +    +L+ + L+ NN SG I
Sbjct: 501  LNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSI 560

Query: 366  PET----YKNFESLSYLSLSNSSIYNLS------SALQVLQQCRNLTTLVLTLNFRNEKL 415
            P      +   E      L +  I++LS         + L +C  L  + L+ N  + ++
Sbjct: 561  PSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEI 620

Query: 416  PTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF 475
            P        NL +L ++   L GSIP+ +    KLQ ++L+ NQL+G IP  FG    L 
Sbjct: 621  PASLS-RLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLV 679

Query: 476  YLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP 535
             L+L+ N   G +P +L  L  L                                     
Sbjct: 680  KLNLTKNKLDGPVPASLGNLKELTH----------------------------------- 704

Query: 536  TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGA 595
             +DLS N L G +  E   ++KL    ++ N  +G IPSEL  +T LE LD+S N LSG 
Sbjct: 705  -MDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGE 763

Query: 596  IPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYS-CTIDRES 653
            IP  +  L  L   ++A N+L G +PS G  Q    +   GN  LCG    S C I  E 
Sbjct: 764  IPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKI--EG 821

Query: 654  GQVKSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLR-----AHSRGEVDPEKEEAN 708
             +++SA       + I G+ +G T     +++ +F+  LR        +   DPE+ E +
Sbjct: 822  TKLRSA-------WGIAGLMLGFT-----IIVFVFVFSLRRWAMTKRVKQRDDPERMEES 869

Query: 709  T----NDKDLEEL-GSKL-------VVLFHNKEKEISIDDILESTNNFDQANIIGCGGFG 756
                  D++L  L GS+        + +F     ++ + DI+E+T++F + NIIG GGFG
Sbjct: 870  RLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFG 929

Query: 757  LVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI 816
             VY+A LP  + VA+K+LS    Q  REF AE+E L + +HPNLV L GYC    ++LL+
Sbjct: 930  TVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLV 989

Query: 817  YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNI 876
            Y +M NGSLD+WL  +      LDW  RL IA GAARGLA+LH    PHI+HRDIK+SNI
Sbjct: 990  YEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNI 1049

Query: 877  LLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVV 936
            LLDG+F   +ADFGLARLI S  ++HV+T + GT GYIPPEYGQ++ AT KGDVYSFGV+
Sbjct: 1050 LLDGDFEPKVADFGLARLI-SACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVI 1108

Query: 937  LLELLTGKRPM--DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDI 994
            LLEL+TGK P   D  + +G  +L+ W I+   + +  +V+DP +         LR+L I
Sbjct: 1109 LLELVTGKEPTGPDFKESEGG-NLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQI 1167

Query: 995  ACLCLSESPKVRPTTQQLVSWLDSI 1019
            A LCL+E+P  RP    ++  L  I
Sbjct: 1168 AMLCLAETPAKRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  489 bits (1260), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 390/1138 (34%), Positives = 570/1138 (50%), Gaps = 168/1138 (14%)

Query: 26   RQDLTCNPNDLAALEDF----MKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDS 81
            R+ L+ + ND A L  F    +K+  +   G     S  D C W G++C+S         
Sbjct: 24   RRLLSDDVNDTALLTAFKQTSIKSDPTNFLGNWRYGSGRDPCTWRGVSCSSD-------- 75

Query: 82   IGSGRVTGLFLYKRRLKGKLS-ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDL 140
               GRV GL L    L G L+  +L  L  LR L L  N    +   S  +  +LEVLDL
Sbjct: 76   ---GRVIGLDLRNGGLTGTLNLNNLTALSNLRSLYLQGNNFS-SGDSSSSSGCSLEVLDL 131

Query: 141  SSNDLSGP------LPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFS 194
            SSN L+            +NL S+   + S N L G + +S   ++ RI  ++LS N FS
Sbjct: 132  SSNSLTDSSIVDYVFSTCLNLVSV---NFSHNKLAGKLKSSPSASNKRITTVDLSNNRFS 188

Query: 195  G----TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQL-QKLRLLGLQDNQLSGKLSP-S 248
                 T      N  SL+HL L  N++TG  +   F L + L +  L  N +SG   P S
Sbjct: 189  DEIPETFIADFPN--SLKHLDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSISGDRFPVS 246

Query: 249  IADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYL----VAHS----------------- 286
            +++   L  L++S N+  G IP D +   G FQ L    +AH+                 
Sbjct: 247  LSNCKLLETLNLSRNSLIGKIPGDDY--WGNFQNLRQLSLAHNLYSGEIPPELSLLCRTL 304

Query: 287  -------NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA-LTNLTSLDLGTNKFN 338
                   N  TG++P S ++  +L  LNL NN L G  L    + L+ +T+L L  N  +
Sbjct: 305  EVLDLSGNSLTGQLPQSFTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNIS 364

Query: 339  GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQV-LQQ 397
            G +P +L  C  L+ ++L+ N F+G++P  + + +S S L     +   LS  + V L +
Sbjct: 365  GSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGK 424

Query: 398  CRNLTTLVLTLNFRNEKLPTD----PRLH--------------------FANLKVLVIAS 433
            C++L T+ L+ N     +P +    P+L                       NL+ L++ +
Sbjct: 425  CKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGGNLETLILNN 484

Query: 434  CGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPK--- 490
              L GS+P+ +  C+ +  + LS N L+G IPV  G  + L  L L NN+ TG IP    
Sbjct: 485  NLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSLTGNIPSELG 544

Query: 491  -------------NLTG-LPSLITRNISLEEPS----PDFPFFMRRN----------VSA 522
                         NLTG LP  +     L  P       F F               V  
Sbjct: 545  NCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEF 604

Query: 523  RGLQYNQIWSFPPT-------------------------IDLSLNRLDGSIWPEFGNLKK 557
             G++  ++  FP                           +DLS N + GSI   +G +  
Sbjct: 605  EGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGY 664

Query: 558  LHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
            L V +L HN L+G IP    G+ ++  LDLS+N+L G +P SL  LSFLS   V+NN+LT
Sbjct: 665  LQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSDLDVSNNNLT 724

Query: 618  GRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQVKSAKKSRRNKYTIV-GMAIG 675
            G IP GGQ  TFP + +  N+ LCG     C+    SG   +   +   K +I  GM+ G
Sbjct: 725  GPIPFGGQLTTFPLTRYANNSGLCGVPLPPCS----SGSRPTRSHAHPKKQSIATGMSAG 780

Query: 676  ITFGSAFLLILIFMILLRAHSRGEVDPEKEE----------ANTNDKDLEELGSKLVVLF 725
            I F S   ++++ M L RA    + + ++E+          ++     + E  S  V  F
Sbjct: 781  IVF-SFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPLSINVATF 839

Query: 726  HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREF 785
                ++++   +LE+TN F   ++IG GGFG VY+A L DG  VAIK+L    GQ +REF
Sbjct: 840  EKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGDREF 899

Query: 786  RAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSR 844
             AE+E + + +H NLV L GYC    +RLL+Y +M+ GSL+  LHEK   G   LDW +R
Sbjct: 900  MAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSAR 959

Query: 845  LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              IA GAARGLA+LH SC PHI+HRD+KSSN+LLD +F A ++DFG+ARL+ S  DTH++
Sbjct: 960  KKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLV-SALDTHLS 1018

Query: 905  -TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI 963
             + L GT GY+PPEY Q+   T KGDVYS+GV+LLELL+GK+P+D  +     +L+ W  
Sbjct: 1019 VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAK 1078

Query: 964  RMRQENRESEVLDP-FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            ++ +E R +E+LDP  + DK  D E+L  L IA  CL + P  RPT  Q+++    ++
Sbjct: 1079 QLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELV 1136

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  483 bits (1244), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 345/973 (35%), Positives = 515/973 (52%), Gaps = 81/973 (8%)

Query: 108  LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNS 167
             V+L F ++  N L G++P   ++  NL  LDLS+N+ S   P   +  ++Q LD+SSN 
Sbjct: 211  FVELEFFSIKGNKLAGSIPE--LDFKNLSYLDLSANNFSTVFPSFKDCSNLQHLDLSSNK 268

Query: 168  LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
              G + +S+  +  ++  +NL+ N F G L P L +  SL++L L  ND  G   + +  
Sbjct: 269  FYGDIGSSL-SSCGKLSFLNLTNNQFVG-LVPKLPS-ESLQYLYLRGNDFQGVYPNQLAD 325

Query: 228  LQKLRL-LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAH 285
            L K  + L L  N  SG +  S+ + S+L  +D+S+NNFSG +P D    L   + +V  
Sbjct: 326  LCKTVVELDLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTLLKLSNIKTMVLS 385

Query: 286  SNRFTGRIPHSLSNSPTLNLLNLRNNSLDG---SLLLNCPALTNLTSLDLGTNKFNGPLP 342
             N+F G +P S SN P L  L++ +N+L G   S +   P + NL  L L  N F GP+P
Sbjct: 386  FNKFVGGLPDSFSNLPKLETLDMSSNNLTGIIPSGICKDP-MNNLKVLYLQNNLFKGPIP 444

Query: 343  TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSAL-QVLQQCRNL 401
             +L  C +L +++L+ N  +G IP +  +   L  L L    +  LS  + Q L   + L
Sbjct: 445  DSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILW---LNQLSGEIPQELMYLQAL 501

Query: 402  TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
              L+L  N     +P     +   L  + +++  L G IP  L   S L ++ L  N +S
Sbjct: 502  ENLILDFNDLTGPIPASLS-NCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSIS 560

Query: 462  GTIPVWFGGFQDLFYLDLSNNTFTGEIP----------------------------KNLT 493
            G IP   G  Q L +LDL+ N   G IP                            K   
Sbjct: 561  GNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECH 620

Query: 494  GLPSLI----TRNISLEEPSPDFPF-FMR--RNVSARGLQYNQIWSFPPTIDLSLNRLDG 546
            G  +L+     R   L+  S   P  F R  R ++     +N    F   +DLS N+L+G
Sbjct: 621  GAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIF---LDLSYNKLEG 677

Query: 547  SIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
            SI  E G +  L + +L HN+LSG IP +L G+ ++  LDLSYN  +G IP SL  L+ L
Sbjct: 678  SIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLL 737

Query: 607  SKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSA---KKSR 663
             +  ++NN+L+G IP    F TFP+  F  N+LCG   Y   +   SG    A   +KS 
Sbjct: 738  GEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCG---YPLPLPCSSGPKSDANQHQKSH 794

Query: 664  RNKYTIVG-MAIGITFGSAFLLILIFMILLRAHSR---------GEVDPEKEEANTNDK- 712
            R + ++ G +A+G+ F S F +  + ++ +    R           +D     A  N   
Sbjct: 795  RRQASLAGSVAMGLLF-SLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAW 853

Query: 713  ---DLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV 769
                  E  S  +  F    ++++  D+LE+TN F   +++G GGFG VY+A L DG  V
Sbjct: 854  KFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVV 913

Query: 770  AIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL 829
            AIK+L    GQ +REF AE+E + + +H NLV L GYC    +RLL+Y +M+ GSL+  L
Sbjct: 914  AIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVL 973

Query: 830  HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF 889
            H++      L+W +R  IA GAARGLA+LH +C PHI+HRD+KSSN+LLD N  A ++DF
Sbjct: 974  HDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDF 1033

Query: 890  GLARLILSPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            G+ARL +S  DTH++ + L GT GY+PPEY Q+   + KGDVYS+GVVLLELLTGK+P D
Sbjct: 1034 GMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTD 1092

Query: 949  MCKPKGSRDLISWVIRMRQENRESEVLDPFIY--DKQHDKEMLRVLDIACLCLSESPKVR 1006
                 G  +L+ WV ++  + + ++V D  +   D   + E+L+ L +AC CL +    R
Sbjct: 1093 SAD-FGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKR 1150

Query: 1007 PTTQQLVSWLDSI 1019
            PT  Q+++    I
Sbjct: 1151 PTMIQVMAMFKEI 1163

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  481 bits (1238), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 345/973 (35%), Positives = 514/973 (52%), Gaps = 81/973 (8%)

Query: 108  LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNS 167
             V+L F +L  N L G++P   ++  NL  LDLS+N+ S   P   +  ++Q LD+SSN 
Sbjct: 211  FVELEFFSLKGNKLAGSIPE--LDFKNLSYLDLSANNFSTVFPSFKDCSNLQHLDLSSNK 268

Query: 168  LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
              G + +S+  +  ++  +NL+ N F G L P L +  SL++L L  ND  G   + +  
Sbjct: 269  FYGDIGSSL-SSCGKLSFLNLTNNQFVG-LVPKLPS-ESLQYLYLRGNDFQGVYPNQLAD 325

Query: 228  LQKLRL-LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAH 285
            L K  + L L  N  SG +  S+ + S+L  +D+S NNFSG +P D  + L   + +V  
Sbjct: 326  LCKTVVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKLPVDTLSKLSNIKTMVLS 385

Query: 286  SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL---LLNCPALTNLTSLDLGTNKFNGPLP 342
             N+F G +P S SN   L  L++ +N+L G +   +   P + NL  L L  N F GP+P
Sbjct: 386  FNKFVGGLPDSFSNLLKLETLDMSSNNLTGVIPSGICKDP-MNNLKVLYLQNNLFKGPIP 444

Query: 343  TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSAL-QVLQQCRNL 401
             +L  C +L +++L+ N  +G IP +  +   L  L L    +  LS  + Q L   + L
Sbjct: 445  DSLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILW---LNQLSGEIPQELMYLQAL 501

Query: 402  TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
              L+L  N     +P     +   L  + +++  L G IP  L   S L ++ L  N +S
Sbjct: 502  ENLILDFNDLTGPIPASLS-NCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSIS 560

Query: 462  GTIPVWFGGFQDLFYLDLSNNTFTGEIP----------------------------KNLT 493
            G IP   G  Q L +LDL+ N   G IP                            K   
Sbjct: 561  GNIPAELGNCQSLIWLDLNTNFLNGSIPPPLFKQSGNIAVALLTGKRYVYIKNDGSKECH 620

Query: 494  GLPSLI----TRNISLEEPSPDFPF-FMR--RNVSARGLQYNQIWSFPPTIDLSLNRLDG 546
            G  +L+     R   L+  S   P  F R  R ++     +N    F   +DLS N+L+G
Sbjct: 621  GAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIF---LDLSYNKLEG 677

Query: 547  SIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
            SI  E G +  L + +L HN+LSG IP +L G+ ++  LDLSYN  +G IP SL  L+ L
Sbjct: 678  SIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLL 737

Query: 607  SKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSA---KKSR 663
             +  ++NN+L+G IP    F TFP+  F  N+LCG   Y   I   SG    A   +KS 
Sbjct: 738  GEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCG---YPLPIPCSSGPKSDANQHQKSH 794

Query: 664  RNKYTIVG-MAIGITFGSAFLLILIFMILLRAHSR---------GEVDPEKEEANTNDK- 712
            R + ++ G +A+G+ F S F +  + ++ +    R           +D     A  N   
Sbjct: 795  RRQASLAGSVAMGLLF-SLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSATANSAW 853

Query: 713  ---DLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV 769
                  E  S  +  F    ++++  D+LE+TN F   +++G GGFG VY+A L DG  V
Sbjct: 854  KFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVV 913

Query: 770  AIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL 829
            AIK+L    GQ +REF AE+E + + +H NLV L GYC    +RLL+Y +M+ GSL+  L
Sbjct: 914  AIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVL 973

Query: 830  HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF 889
            H++      L+W +R  IA GAARGLA+LH +C PHI+HRD+KSSN+LLD N  A ++DF
Sbjct: 974  HDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDF 1033

Query: 890  GLARLILSPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            G+ARL +S  DTH++ + L GT GY+PPEY Q+   + KGDVYS+GVVLLELLTGK+P D
Sbjct: 1034 GMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTD 1092

Query: 949  MCKPKGSRDLISWVIRMRQENRESEVLDPFIY--DKQHDKEMLRVLDIACLCLSESPKVR 1006
                 G  +L+ WV ++  + + ++V D  +   D   + E+L+ L +AC CL +    R
Sbjct: 1093 SAD-FGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKR 1150

Query: 1007 PTTQQLVSWLDSI 1019
            PT  Q+++    I
Sbjct: 1151 PTMIQVMAMFKEI 1163

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  478 bits (1231), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 363/1108 (32%), Positives = 534/1108 (48%), Gaps = 177/1108 (15%)

Query: 58   SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLS----ESLGNLVQLRF 113
            S    C W G++C+             GR+ GL L    L G L+     +L NL  L  
Sbjct: 61   SGRGSCSWRGVSCSD-----------DGRIVGLDLRNSGLTGTLNLVNLTALPNLQNLYL 109

Query: 114  ----------------------------------------------LNLSHNLLKGTVPV 127
                                                          +N+S+N L G +  
Sbjct: 110  QGNYFSSGGDSSGSDCYLQVLDLSSNSISDYSMVDYVFSKCSNLVSVNISNNKLVGKLGF 169

Query: 128  SLVNLPNLEVLDLSSNDLSGPLPQTI--NLP-SIQVLDISSNSLNG---SVPTSICKNSS 181
            +  +L +L  +DLS N LS  +P++   + P S++ LD++ N+L+G    +   IC N  
Sbjct: 170  APSSLQSLTTVDLSYNILSDKIPESFISDFPASLKYLDLTHNNLSGDFSDLSFGICGN-- 227

Query: 182  RIRVINLSVNYFSGTLSP-GLGNCASLEHLCLGMNDLTGGIADDIF--QLQKLRLLGLQD 238
             +   +LS N  SG   P  L NC  LE L +  N+L G I +  +    Q L+ L L  
Sbjct: 228  -LTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAH 286

Query: 239  NQLSGKLSPSIADL-SNLVRLDVSSNNFSGNIPDVFAGL--------------GEF---- 279
            N+LSG++ P ++ L   LV LD+S N FSG +P  F                 G+F    
Sbjct: 287  NRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTV 346

Query: 280  -------QYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL------LLNCPALTN 326
                    YL    N  +G +P SL+N   L +L+L +N   G++      L + P L  
Sbjct: 347  VSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEK 406

Query: 327  LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY 386
            +    +  N  +G +P  L +C+ LK I+L+ N  +G IP+      +LS L +  +   
Sbjct: 407  IL---IANNYLSGTVPMELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSDLVMWAN--- 460

Query: 387  NLSSALQ--VLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL 444
            NL+  +   V  +  NL TL+L  N     +P        N+  + ++S  L G IP  +
Sbjct: 461  NLTGTIPEGVCVKGGNLETLILNNNLLTGSIPESIS-RCTNMIWISLSSNRLTGKIPSGI 519

Query: 445  RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS 504
               SKL ++ L  N LSG +P   G  + L +LDL++N  TG++P  L     L+     
Sbjct: 520  GNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTGDLPGELASQAGLVMPG-- 577

Query: 505  LEEPSPDFPFFMRRN----------VSARGLQYNQIWSFPPT------------------ 536
                   F F               V   G++  ++   P                    
Sbjct: 578  -SVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGMTMYTFS 636

Query: 537  -------IDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSY 589
                    D+S N + G I P +GN+  L V +L HN ++G IP    G+ ++  LDLS+
Sbjct: 637  ANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSH 696

Query: 590  NNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCT 648
            NNL G +P SL  LSFLS   V+NN+LTG IP GGQ  TFP S +  N+ LCG     C 
Sbjct: 697  NNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPC- 755

Query: 649  IDRESGQVKSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEAN 708
                 G       + R       +A  +  G AF  +   M+++  +   +V  ++++  
Sbjct: 756  -----GSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKRE 810

Query: 709  TNDKDLEELGS---KL----------VVLFHNKEKEISIDDILESTNNFDQANIIGCGGF 755
               + L   GS   KL          V  F    ++++   +LE+TN F    ++G GGF
Sbjct: 811  KYIESLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGF 870

Query: 756  GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL 815
            G VY+A L DG  VAIK+L    GQ +REF AE+E + + +H NLV L GYC    +RLL
Sbjct: 871  GEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLL 930

Query: 816  IYSFMENGSLDYWLHEK--LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKS 873
            +Y +M+ GSL+  LHEK    G   L+W +R  IA GAARGLA+LH SC PHI+HRD+KS
Sbjct: 931  VYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKS 990

Query: 874  SNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGDVYS 932
            SN+LLD +F A ++DFG+ARL+ S  DTH++ + L GT GY+PPEY Q+   T KGDVYS
Sbjct: 991  SNVLLDEDFEARVSDFGMARLV-SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS 1049

Query: 933  FGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP-FIYDKQHDKEMLRV 991
            +GV+LLELL+GK+P+D  +     +L+ W  ++ +E R +E+LDP  + DK  D E+   
Sbjct: 1050 YGVILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHY 1109

Query: 992  LDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            L IA  CL + P  RPT  QL++    +
Sbjct: 1110 LKIASQCLDDRPFKRPTMIQLMAMFKEM 1137

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  466 bits (1198), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 358/1052 (34%), Positives = 526/1052 (50%), Gaps = 130/1052 (12%)

Query: 84   SGRVTGLFLYKRRLKGKLSE--SLGNLVQLRFLNLSHNLLKGTVPVS-LVNLPNLEVLDL 140
            S  +T L L +  L G ++   SLG+   L+FLN+S N L     VS  + L +LEVLDL
Sbjct: 121  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 180

Query: 141  SSNDLSGP----LPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT 196
            S+N +SG        +     ++ L IS N ++G V  S C N   +  +++S N FS T
Sbjct: 181  SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVN---LEFLDVSSNNFS-T 236

Query: 197  LSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP--------- 247
              P LG+C++L+HL +  N L+G  +  I    +L+LL +  NQ  G + P         
Sbjct: 237  GIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYL 296

Query: 248  SIAD--------------LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI 293
            S+A+                 L  LD+S N+F G +P  F      + L   SN F+G +
Sbjct: 297  SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 356

Query: 294  P-HSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLT----SLDLGTNKFNGPLPTNLPRC 348
            P  +L     L +L+L  N   G L     +LTNL+    +LDL +N F+GP+  NL + 
Sbjct: 357  PMDTLLKMRGLKVLDLSFNEFSGEL---PESLTNLSASLLTLDLSSNNFSGPILPNLCQN 413

Query: 349  RK--LKNINLARNNFSGQIPETYKNFESLSYLSLS-NSSIYNLSSALQVLQQCRNLTTLV 405
             K  L+ + L  N F+G+IP T  N   L  L LS N     + S+L  L + R+L    
Sbjct: 414  PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK--- 470

Query: 406  LTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
            L LN    ++P +  ++   L+ L++    L G IP  L  C+ L  + LS N+L+G IP
Sbjct: 471  LWLNMLEGEIPQE-LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 529

Query: 466  VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRN------ 519
             W G  ++L  L LSNN+F+G IP  L    SLI  +++    +   P  M +       
Sbjct: 530  KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 589

Query: 520  --VSARGLQY-------------NQIWSFPPTIDLSLNRLD-------------GSIWPE 551
              ++ +   Y               +  F       LNRL              G   P 
Sbjct: 590  NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 649

Query: 552  FGNLKKLHVFDLK------------------------HNNLSGPIPSELTGMTSLETLDL 587
            F N   +   D+                         HN++SG IP E+  +  L  LDL
Sbjct: 650  FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 709

Query: 588  SYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYS 646
            S N L G IP ++  L+ L++  ++NN+L+G IP  GQF+TFP + F  N  LCG     
Sbjct: 710  SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPR 769

Query: 647  CTIDRESGQVKSAKKSRRNKYTIVG-MAIGITFGSAFLLILIFM------------ILLR 693
            C      G     +   R   ++ G +A+G+ F    +  LI +              L 
Sbjct: 770  CDPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELE 829

Query: 694  AHSRGEVDPEKEEANTNDKDLEELGSKLVV---LFHNKEKEISIDDILESTNNFDQANII 750
             ++ G  +     AN  +  L  +   L +    F    ++++  D+L++TN F   ++I
Sbjct: 830  MYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLI 889

Query: 751  GCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK 810
            G GGFG VY+A L DG  VAIK+L    GQ +REF AE+E + + +H NLV L GYC   
Sbjct: 890  GSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVG 949

Query: 811  NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRD 870
            ++RLL+Y FM+ GSL+  LH+       L+W +R  IA G+ARGLA+LH +C PHI+HRD
Sbjct: 950  DERLLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRD 1009

Query: 871  IKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGD 929
            +KSSN+LLD N  A ++DFG+ARL +S  DTH++ + L GT GY+PPEY Q+   + KGD
Sbjct: 1010 MKSSNVLLDENLEARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGD 1068

Query: 930  VYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY--DKQHDKE 987
            VYS+GVVLLELLTGKRP D     G  +L+ WV +   + R S+V DP +   D   + E
Sbjct: 1069 VYSYGVVLLELLTGKRPTD-SPDFGDNNLVGWV-KQHAKLRISDVFDPELMKEDPALEIE 1126

Query: 988  MLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            +L+ L +A  CL +    RPT  Q+++    I
Sbjct: 1127 LLQHLKVAVACLDDRAWRRPTMVQVMAMFKEI 1158

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1020
255555545	1010	Phytosulfokine receptor precursor, putat	0.982	0.992	0.735	0.0
224102001	1025	predicted protein [Populus trichocarpa]	0.996	0.991	0.742	0.0
224108147	1021	predicted protein [Populus trichocarpa]	0.992	0.991	0.723	0.0
225425114	1020	PREDICTED: phytosulfokine receptor 1 [Vi	0.972	0.972	0.703	0.0
297817842	1008	ATPSKR1 [Arabidopsis lyrata subsp. lyrat	0.984	0.996	0.667	0.0
15227264	1008	phytosulfokin receptor 1 [Arabidopsis th	0.983	0.995	0.664	0.0
29427830	1021	RecName: Full=Phytosulfokine receptor 1;	0.991	0.990	0.657	0.0
20197335	910	putative protein kinase [Arabidopsis tha	0.887	0.994	0.650	0.0
449445377	1007	PREDICTED: phytosulfokine receptor 1-lik	0.981	0.994	0.591	0.0
242065836	1054	hypothetical protein SORBIDRAFT_04g02666	0.956	0.925	0.552	0.0

>gi|255555545|ref|XP_002518809.1| Phytosulfokine receptor precursor, putative [Ricinus communis] gi|223542190|gb|EEF43734.1| Phytosulfokine receptor precursor, putative [Ricinus communis]

 Score = 1505 bits (3896), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 751/1021 (73%), Positives = 854/1021 (83%), Gaps = 19/1021 (1%)

Query: 1    MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSS 60
            M V+D  + +++ GFCFQA   H+  Q+LTCN ND  AL+ FM   +S I GWG    SS
Sbjct: 3    MDVRDFWVMVVIVGFCFQAHFFHSHSQNLTCNENDRRALQAFMNGLQSAIQGWG----SS 58

Query: 61   DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNL 120
            DCC+W GITC             S RV  L L  RRL G L ESLGNL QL  L+LS N 
Sbjct: 59   DCCNWPGITC------------ASFRVAKLQLPNRRLTGILEESLGNLDQLTALDLSSNF 106

Query: 121  LKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNS 180
            LK ++P SL +LP L++L+LS ND +G LP +INLPSI  LDISSN+LNGS+PT+IC+NS
Sbjct: 107  LKDSLPFSLFHLPKLQLLNLSFNDFTGSLPLSINLPSITTLDISSNNLNGSLPTAICQNS 166

Query: 181  SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQ 240
            ++I+ I L+VNYFSG L P LGNC SLEHLCLGMN+LTGG++D IF+L++L+LLGLQDN+
Sbjct: 167  TQIKAIRLAVNYFSGALLPDLGNCTSLEHLCLGMNNLTGGVSDGIFELKQLKLLGLQDNK 226

Query: 241  LSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNS 300
            LSGKL P I  L  L RLD+SSN FSGNIPDVF  L  F+Y + HSN F G IP SL+NS
Sbjct: 227  LSGKLGPGIGQLLALERLDISSNFFSGNIPDVFDKLPSFKYFLGHSNNFLGTIPLSLANS 286

Query: 301  PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNN 360
            P+L LLNLRNNSL G +LLNC A+T+L SLDLG+NKF GPLP NLP C+ LKNINLARNN
Sbjct: 287  PSLILLNLRNNSLHGDILLNCSAMTSLASLDLGSNKFRGPLPDNLPSCKNLKNINLARNN 346

Query: 361  FSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPR 420
            F+GQIPET+KNF+SLSY SLSNSSI+NLSSALQ+ QQC+NLTTLVL+LNFR E+LP  P 
Sbjct: 347  FTGQIPETFKNFQSLSYFSLSNSSIHNLSSALQIFQQCKNLTTLVLSLNFRGEELPALPS 406

Query: 421  LHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLS 480
            LHFANLKVLVIASC L GSIP WLR  + LQL+DLSWN L GTIP+WF  F +LFYLDLS
Sbjct: 407  LHFANLKVLVIASCRLTGSIPPWLRDSTNLQLLDLSWNHLDGTIPLWFSDFVNLFYLDLS 466

Query: 481  NNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLS 540
            NN+F GEIPKNLT LPSLI+RNISL EPSPDFPFFM+RN S R LQYNQ+WSFPPT+DLS
Sbjct: 467  NNSFVGEIPKNLTQLPSLISRNISLVEPSPDFPFFMKRNESTRALQYNQVWSFPPTLDLS 526

Query: 541  LNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISL 600
             N L G IWPEFGNLKKLH+ DLK+N+LSGPIP+EL+ MTSLE LDLS+NNLSG IP SL
Sbjct: 527  HNNLTGLIWPEFGNLKKLHILDLKYNHLSGPIPTELSEMTSLEMLDLSHNNLSGVIPSSL 586

Query: 601  EKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSAK 660
             +LSFLSKF+VA N L G+IP GGQF TFPNSSF+GNNLCG+H      + +   +++ K
Sbjct: 587  VRLSFLSKFNVAYNQLNGKIPVGGQFLTFPNSSFEGNNLCGDHGAPPCANSDQVPLEAPK 646

Query: 661  KSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSK 720
            KSRRNK  I+GM +GI FG++FLL+L+FMI+LRAHSRGEVDPEKE A+TNDKDLEELGSK
Sbjct: 647  KSRRNKDIIIGMVVGIVFGTSFLLVLMFMIVLRAHSRGEVDPEKEGADTNDKDLEELGSK 706

Query: 721  LVVLFHNKE--KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC 778
            LVVLF NKE  KE+S++D+L+STNNFDQANIIGCGGFGLVYRATLPDGR VAIKRLSGDC
Sbjct: 707  LVVLFQNKENYKELSLEDLLKSTNNFDQANIIGCGGFGLVYRATLPDGRKVAIKRLSGDC 766

Query: 779  GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS 838
            GQMEREFRAEVE LSRAQHPNLVHLQGYCM KNDRLLIYS+MEN SLDYWLHEK DGP+ 
Sbjct: 767  GQMEREFRAEVETLSRAQHPNLVHLQGYCMFKNDRLLIYSYMENSSLDYWLHEKTDGPTL 826

Query: 839  LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
            LDW +RL IAQGAARGLAYLHQSCEPHILHRDIKSSNILL+ NF AHLADFGLARLIL P
Sbjct: 827  LDWVTRLQIAQGAARGLAYLHQSCEPHILHRDIKSSNILLNENFEAHLADFGLARLIL-P 885

Query: 899  YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL 958
            YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL
Sbjct: 886  YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL 945

Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
            ISWVI+M++ENRESEV DPFIYDKQ+DK++L+VLDIACLCLSE PKVRP+T QLVSWLD 
Sbjct: 946  ISWVIQMKKENRESEVFDPFIYDKQNDKQLLQVLDIACLCLSEFPKVRPSTMQLVSWLDG 1005

Query: 1019 I 1019
            I
Sbjct: 1006 I 1006

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224102001|ref|XP_002312507.1| predicted protein [Populus trichocarpa] gi|222852327|gb|EEE89874.1| predicted protein [Populus trichocarpa]

 Score = 1504 bits (3895), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 760/1024 (74%), Positives = 874/1024 (85%), Gaps = 8/1024 (0%)

Query: 1    MGVQDL-CLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWG-TNAS 58
            MGVQDL  LF++L    F+AQ+L  Q Q+LTCN +DL AL+DFM+  +  I GWG TN+S
Sbjct: 1    MGVQDLWVLFLVLGFLMFRAQVL--QSQNLTCNQDDLKALQDFMRGLQLPIQGWGATNSS 58

Query: 59   SSDCCHWVGITCNSSSSLGL-NDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
            S DCC+W+GITCNSSSSLGL NDS+ SGRVT L L KRRL G+L ES+G+L QLR LNLS
Sbjct: 59   SPDCCNWLGITCNSSSSLGLVNDSVDSGRVTKLELPKRRLTGELVESIGSLDQLRTLNLS 118

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
            HN LK ++P SL +LP LEVLDLSSND +G +PQ+INLPSI  LD+SSN LNGS+PT IC
Sbjct: 119  HNFLKDSLPFSLFHLPKLEVLDLSSNDFTGSIPQSINLPSIIFLDMSSNFLNGSLPTHIC 178

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
            +NSS I+ + L+VNYFSG LSPGLGNC +LEHLCLGMN+LTGGI++DIFQLQKL+LLGLQ
Sbjct: 179  QNSSGIQALVLAVNYFSGILSPGLGNCTNLEHLCLGMNNLTGGISEDIFQLQKLKLLGLQ 238

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            DN+LSG LS  I  L +L RLD+SSN+FSG IPDVF  L +F + + HSN F G IPHSL
Sbjct: 239  DNKLSGNLSTGIGKLRSLERLDISSNSFSGTIPDVFHSLSKFNFFLGHSNDFVGTIPHSL 298

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            +NSP+LNL NLRNNS  G + LNC ALTNL+SLDL TN F+GP+P NLP C+ LKNINLA
Sbjct: 299  ANSPSLNLFNLRNNSFGGIIDLNCSALTNLSSLDLATNNFSGPVPDNLPSCKNLKNINLA 358

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            RN F+GQIPE++++FE LS+LS SN SI NLSSALQ+LQQC+NLTTLVLTLNF  E+LP 
Sbjct: 359  RNKFTGQIPESFQHFEGLSFLSFSNCSIANLSSALQILQQCKNLTTLVLTLNFHGEELPD 418

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
            +P LHF NLKVLV+A+C L GSIPQWL G SKLQLVDLSWN+L+G+IP WFGGF +LFYL
Sbjct: 419  NPVLHFENLKVLVMANCKLTGSIPQWLIGSSKLQLVDLSWNRLTGSIPSWFGGFVNLFYL 478

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNN+FTGEIPKNLT LPSLI R+IS+EEPSPDFPFF+ RN S RGLQYNQ+WSFP T+
Sbjct: 479  DLSNNSFTGEIPKNLTELPSLINRSISIEEPSPDFPFFLTRNESGRGLQYNQVWSFPSTL 538

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
             LS N L G IWPEFGNLKKLH+F L  NNLSGPIPSEL+GMTSLETLDLS+NNLSG IP
Sbjct: 539  ALSDNFLTGQIWPEFGNLKKLHIFALSSNNLSGPIPSELSGMTSLETLDLSHNNLSGTIP 598

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
             SL  LSFLSKFSVA N L G+IP+G QF TFPNSSF+GN+LCG+H        +    +
Sbjct: 599  WSLVNLSFLSKFSVAYNQLHGKIPTGSQFMTFPNSSFEGNHLCGDHGTPPCPRSDQVPPE 658

Query: 658  SAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEEL 717
            S+ KS RNK  I GMA+GI FG+AFLL L+ MI+LRAH+RGEVDPEK +A+TNDK+LEE 
Sbjct: 659  SSGKSGRNKVAITGMAVGIVFGTAFLLTLMIMIVLRAHNRGEVDPEKVDADTNDKELEEF 718

Query: 718  GSKLVVLFHNKE--KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
            GS+LVVL  NKE  K++S++D+L+ TNNFDQANIIGCGGFGLVYRATLPDGR +AIKRLS
Sbjct: 719  GSRLVVLLQNKESYKDLSLEDLLKFTNNFDQANIIGCGGFGLVYRATLPDGRKLAIKRLS 778

Query: 776  GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            GD GQM+REFRAEVEALSRAQHPNLVHLQG+CM KND+LLIYS+MEN SLDYWLHEKLDG
Sbjct: 779  GDSGQMDREFRAEVEALSRAQHPNLVHLQGFCMLKNDKLLIYSYMENSSLDYWLHEKLDG 838

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            PSSLDWD+RL IAQGAARGLAYLHQ+CEPHI+HRDIKSSNILLD NF AHLADFGLARLI
Sbjct: 839  PSSLDWDTRLQIAQGAARGLAYLHQACEPHIVHRDIKSSNILLDENFVAHLADFGLARLI 898

Query: 896  LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
            L PYDTHVTTDLVGTLGYIPPEYGQA+VATY GDVYSFGVVLLELLTGKRPMDMCKPKGS
Sbjct: 899  L-PYDTHVTTDLVGTLGYIPPEYGQAAVATYMGDVYSFGVVLLELLTGKRPMDMCKPKGS 957

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
            RDLISWVI+M++ENRESEV DPFIYDKQ+DKE+ RVL+IA LCLSE PK+RP+T+QLVSW
Sbjct: 958  RDLISWVIQMKKENRESEVFDPFIYDKQNDKELQRVLEIARLCLSEYPKLRPSTEQLVSW 1017

Query: 1016 LDSI 1019
            LD+I
Sbjct: 1018 LDNI 1021

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108147|ref|XP_002314737.1| predicted protein [Populus trichocarpa] gi|222863777|gb|EEF00908.1| predicted protein [Populus trichocarpa]

 Score = 1437 bits (3719), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 741/1024 (72%), Positives = 860/1024 (83%), Gaps = 12/1024 (1%)

Query: 1    MGVQDLCL-FIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGT-NAS 58
            MGVQ L + F++L    FQA +L  Q Q+L CN NDL AL++FM+  +S I GWGT N+S
Sbjct: 1    MGVQALWVAFLVLGFLMFQAHVL--QSQNLACNQNDLRALQEFMRGLQSSIQGWGTTNSS 58

Query: 59   SSDCCHWVGITCNSSSSLGL-NDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
            SSDCC+W GITC SSSSLGL NDS+ SGRVT L L ++RL GKL ES+G+L QL+ LNLS
Sbjct: 59   SSDCCNWSGITCYSSSSLGLVNDSVNSGRVTKLELVRQRLTGKLVESVGSLDQLKTLNLS 118

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
            HN LK ++P SL +LP LEVLDLSSND SG +PQ+INLPSI+ LDISSNSL+GS+PT IC
Sbjct: 119  HNFLKDSLPFSLFHLPKLEVLDLSSNDFSGSIPQSINLPSIKFLDISSNSLSGSLPTHIC 178

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
            +NSSRI+V+ L+VNYFSG LSPGLGNC +LEHLCLGMNDL GGI++DIFQLQKL+LLGLQ
Sbjct: 179  QNSSRIQVLVLAVNYFSGILSPGLGNCTTLEHLCLGMNDLIGGISEDIFQLQKLKLLGLQ 238

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            DN+LSG LS  I  L +L RLD+SSNNFSG IPDVF  L + ++ + HSN F GRIP SL
Sbjct: 239  DNKLSGNLSTGIGKLLSLERLDISSNNFSGTIPDVFRSLSKLKFFLGHSNYFVGRIPISL 298

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            +NSP+LNLLNLRNNS  G + LNC A+TNL+SLDL TN F+G +P+ LP C+ LKNINLA
Sbjct: 299  ANSPSLNLLNLRNNSFGGIVELNCSAMTNLSSLDLATNSFSGNVPSYLPACKNLKNINLA 358

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            +N F+G+IPE++KNF+ LSYLSLSN SI NLSS L++LQQC++LT LVLTLNF+ E LP 
Sbjct: 359  KNKFTGKIPESFKNFQGLSYLSLSNCSITNLSSTLRILQQCKSLTALVLTLNFQGEALPA 418

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
            DP LHF NLKVLVIA+C L GSIPQWL   SKLQLVDLSWN LSGTIP WFGGF +LFYL
Sbjct: 419  DPTLHFENLKVLVIANCRLTGSIPQWLSNSSKLQLVDLSWNNLSGTIPSWFGGFVNLFYL 478

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNN+FTGEIP+NLT LPSLI+R+IS+EEPSP FP FMRRN S RGLQYNQ+ SFPPT+
Sbjct: 479  DLSNNSFTGEIPRNLTELPSLISRSISIEEPSPYFPLFMRRNESGRGLQYNQVRSFPPTL 538

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
             LS N L G IWPEFGNL KLH+F+LK N LSG IP EL+GMTSLETLDLS+NNLSG IP
Sbjct: 539  ALSDNFLTGPIWPEFGNLTKLHIFELKSNFLSGTIPGELSGMTSLETLDLSHNNLSGVIP 598

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
             SL  LSFLSKFSVA N L G+IP+GGQF TFPNSSF+GN LCG+H        +   + 
Sbjct: 599  WSLVDLSFLSKFSVAYNQLRGKIPTGGQFMTFPNSSFEGNYLCGDHGTPPCPKSDGLPLD 658

Query: 658  SAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEEL 717
            S +KS  NKY I+GMA+GI FG+A LL+LI  I+LRAHSRG +   K    T+DK+ EEL
Sbjct: 659  SPRKSGINKYVIIGMAVGIVFGAASLLVLI--IVLRAHSRGLI--LKRWMLTHDKEAEEL 714

Query: 718  GSKLVVLFHNKE--KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
              +L+VL  + E  K++S++D+L+STNNFDQANIIGCGGFG+VYRATLPDGR +AIKRLS
Sbjct: 715  DPRLMVLLQSTENYKDLSLEDLLKSTNNFDQANIIGCGGFGIVYRATLPDGRKLAIKRLS 774

Query: 776  GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            GD GQM+REFRAEVEALSRAQHPNLVHLQGYCM KND+LL+Y +MEN SLDYWLHEK+DG
Sbjct: 775  GDSGQMDREFRAEVEALSRAQHPNLVHLQGYCMFKNDKLLVYPYMENSSLDYWLHEKIDG 834

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            PSSLDWDSRL IAQGAARGLAYLHQ+CEPHILHRDIKSSNILLD NF A+LADFGLARL+
Sbjct: 835  PSSLDWDSRLQIAQGAARGLAYLHQACEPHILHRDIKSSNILLDKNFKAYLADFGLARLM 894

Query: 896  LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
            L PYDTHVTTDLVGTLGYIPPEYGQA+VATYKGDVYSFGVVLLELLTG+RPMDMCKPKGS
Sbjct: 895  L-PYDTHVTTDLVGTLGYIPPEYGQAAVATYKGDVYSFGVVLLELLTGRRPMDMCKPKGS 953

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
            +DLISWVI+M++E+RESEV DPFIYDKQ+DKE+LR L IACLCLSE PK+RP+T+QLVSW
Sbjct: 954  QDLISWVIQMKKEDRESEVFDPFIYDKQNDKELLRALQIACLCLSEHPKLRPSTEQLVSW 1013

Query: 1016 LDSI 1019
            LDSI
Sbjct: 1014 LDSI 1017

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425114|ref|XP_002273186.1| PREDICTED: phytosulfokine receptor 1 [Vitis vinifera]

 Score = 1379 bits (3570), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 703/999 (70%), Positives = 817/999 (81%), Gaps = 7/999 (0%)

Query: 27   QDLTCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGR 86
            Q+ TC+ NDLA L +F+K  ESGI+GW  N+SS+ CC W G++CNSS+ LGL+D   S R
Sbjct: 23   QNQTCSSNDLAVLLEFLKGLESGIEGWSENSSSA-CCGWTGVSCNSSAFLGLSDEENSNR 81

Query: 87   VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
            V GL L   RL GK+ ESLG L QLR LNLS N  KG++P SL + P LE L L +N  +
Sbjct: 82   VVGLELGGMRLSGKVPESLGKLDQLRTLNLSSNFFKGSIPASLFHFPKLESLLLKANYFT 141

Query: 147  GPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCAS 206
            G +  +INLPSI+ LDIS NSL+GS+P  IC+NS+RI+ IN  +N+FSG++  G GNC+ 
Sbjct: 142  GSIAVSINLPSIKSLDISQNSLSGSLPGGICQNSTRIQEINFGLNHFSGSIPVGFGNCSW 201

Query: 207  LEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS 266
            LEHLCL  N LTG + +D+F+L++L  L L+DN LSG L   I +LS+LV  D+S N   
Sbjct: 202  LEHLCLASNLLTGALPEDLFELRRLGRLDLEDNSLSGVLDSRIGNLSSLVDFDISLNGLG 261

Query: 267  GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTN 326
            G +PDVF      Q   AHSN FTG+IP+SL+NSPT++LLNLRNNSL GS+ +NC  + N
Sbjct: 262  GVVPDVFHSFENLQSFSAHSNNFTGQIPYSLANSPTISLLNLRNNSLSGSININCSVMGN 321

Query: 327  LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY 386
            L+SL L +N+F G +P NLP CR+LK +NLARNNFSGQIPET+KNF SLSYLSLSNSS+Y
Sbjct: 322  LSSLSLASNQFTGSIPNNLPSCRRLKTVNLARNNFSGQIPETFKNFHSLSYLSLSNSSLY 381

Query: 387  NLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRG 446
            NLSSAL +LQQCRNL+TLVLTLNF  E+LP D  L F  LKVLVIA+C L GSIP WLR 
Sbjct: 382  NLSSALGILQQCRNLSTLVLTLNFHGEELPGDSSLQFEMLKVLVIANCHLSGSIPHWLRN 441

Query: 447  CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLE 506
             + LQL+DLSWN L+GTIP WFG F  LFYLDLSNN+FTGEIPKN+TGL  LI+R IS+E
Sbjct: 442  STGLQLLDLSWNHLNGTIPEWFGDFVFLFYLDLSNNSFTGEIPKNITGLQGLISREISME 501

Query: 507  EPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHN 566
            EPS DFP F++RNVS RGLQYNQ+ S PPT+DLS N L G+IWPEFGNLKKL+VF+LK N
Sbjct: 502  EPSSDFPLFIKRNVSGRGLQYNQVGSLPPTLDLSNNHLTGTIWPEFGNLKKLNVFELKCN 561

Query: 567  NLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQF 626
            N SG IPS L+GMTS+ET+DLS+NNLSG IP SL +LSFLSKFSVA N LTG+IPSGGQF
Sbjct: 562  NFSGTIPSSLSGMTSVETMDLSHNNLSGTIPDSLVELSFLSKFSVAYNQLTGKIPSGGQF 621

Query: 627  QTFPNSSFDGN-NLCGEHRYSCTIDRESGQVK--SAKKSRRNKYTIVGMAIGITFGSAFL 683
            QTF NSSF+GN  LCG+H   C  D    QV   S   S+R+K  I+GM++GI FG+ FL
Sbjct: 622  QTFSNSSFEGNAGLCGDHASPCPSDDADDQVPLGSPHGSKRSKGVIIGMSVGIGFGTTFL 681

Query: 684  LILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKE--KEISIDDILEST 741
            L L+ +I+LR   RGEVDPEKEEA+ NDK+LE+LGS+LVVLF NKE  KE+ IDD+L+ST
Sbjct: 682  LALMCLIVLRTTRRGEVDPEKEEADANDKELEQLGSRLVVLFQNKENNKELCIDDLLKST 741

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            NNFDQANIIGCGGFGLVYRATLPDGR VAIKRLSGDCGQMEREF+AEVEALSRAQHPNLV
Sbjct: 742  NNFDQANIIGCGGFGLVYRATLPDGRKVAIKRLSGDCGQMEREFQAEVEALSRAQHPNLV 801

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             LQGYC +KNDRLLIYS+MEN SLDYWLHEKLDGPSSLDWD+RL IAQGAA GLAYLHQS
Sbjct: 802  LLQGYCKYKNDRLLIYSYMENSSLDYWLHEKLDGPSSLDWDTRLQIAQGAAMGLAYLHQS 861

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
            CEPHILHRDIKSSNILLD  F AHLADFGLARLIL PYDTHVTTDLVGTLGYIPPEYGQA
Sbjct: 862  CEPHILHRDIKSSNILLDEKFEAHLADFGLARLIL-PYDTHVTTDLVGTLGYIPPEYGQA 920

Query: 922  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
            SVATYKGDVYSFGVVLLELLTGKRPMDMCKP+G RDLISWVI+M++E RESEV DPFIYD
Sbjct: 921  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPRGCRDLISWVIQMKKEKRESEVFDPFIYD 980

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            KQHDKE+LRVLDIACLCLSE PK+RP+T+QLVSWL++I+
Sbjct: 981  KQHDKELLRVLDIACLCLSECPKIRPSTEQLVSWLNNIL 1019

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297817842|ref|XP_002876804.1| ATPSKR1 [Arabidopsis lyrata subsp. lyrata] gi|297322642|gb|EFH53063.1| ATPSKR1 [Arabidopsis lyrata subsp. lyrata]

 Score = 1347 bits (3486), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 683/1023 (66%), Positives = 819/1023 (80%), Gaps = 19/1023 (1%)

Query: 1    MGVQDLCLFII--LAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNAS 58
            M V  LC+ +I  +   CF        +  +TC+ +DL AL DF+ N E   DGW  ++S
Sbjct: 1    MRVNRLCVIVIVLIELLCFFCS--SESQTTVTCHSHDLEALRDFIANLEPKPDGWINSSS 58

Query: 59   SSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSH 118
            S+DCC+W GITCN++++          RVT L L  ++L GKLSESLG L ++R LNLS 
Sbjct: 59   STDCCNWSGITCNTNNT---------RRVTKLELGNKKLSGKLSESLGKLDEIRVLNLSR 109

Query: 119  NLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICK 178
            N  K ++P+S+ NL NL+ LDLSSNDLSG + ++INLP++Q  D+SSN LNGS+P+ IC 
Sbjct: 110  NFFKDSIPLSIFNLKNLQTLDLSSNDLSGEISRSINLPALQSFDLSSNKLNGSLPSHICH 169

Query: 179  NSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQD 238
            NS++IRV+ L+VNYF+G  + G GNC  LEHLCLGMNDLTG I +D+F L+ L LLG+Q+
Sbjct: 170  NSTQIRVVKLAVNYFAGNFTSGFGNCVFLEHLCLGMNDLTGNIPEDLFHLKSLNLLGIQE 229

Query: 239  NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS 298
            N+LSG LS  I +LS+LVRLDVS N FSG IPDVF  + + ++ +  +N F G IP +L+
Sbjct: 230  NRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDEMPKLKFFLGQTNGFIGGIPKTLA 289

Query: 299  NSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLAR 358
            NSP+LNLLNLRNNSL G L LNC A+  L SLDLGTN+FNGPLP NLP C++LKN+NLAR
Sbjct: 290  NSPSLNLLNLRNNSLSGPLRLNCTAMIALNSLDLGTNRFNGPLPENLPDCKRLKNVNLAR 349

Query: 359  NNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTD 418
            N F GQ+PE++KNF+SLSY SLSNSS+ N+SSAL +LQ C+NLTTLVLTLNF  E LP D
Sbjct: 350  NVFHGQVPESFKNFQSLSYFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPDD 409

Query: 419  PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLD 478
              LHF  LKVLV+A+C L GS+P WL   ++LQL+DLSWN+L+G IP W G F+DLFYLD
Sbjct: 410  SSLHFEKLKVLVVANCKLTGSMPSWLSSSNELQLLDLSWNRLTGAIPSWIGSFKDLFYLD 469

Query: 479  LSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTID 538
            LSNN+FTGEIPK+LT LPSL +RNIS  EPSPDFPFFM+RN SAR LQYNQI+ FPPTI+
Sbjct: 470  LSNNSFTGEIPKSLTQLPSLASRNISFNEPSPDFPFFMKRNESARALQYNQIFGFPPTIE 529

Query: 539  LSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPI 598
            L  N L G IW EFGNLKKLHVFDLK N LSG IPS L+GMTSLE LDLS N LSG+IP 
Sbjct: 530  LGHNNLSGPIWEEFGNLKKLHVFDLKWNKLSGSIPSSLSGMTSLEALDLSNNRLSGSIPA 589

Query: 599  SLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKS 658
            SL+ LSFLSKFSVANN+L+G IPSGGQFQTFPNSSF+ N+LCGEHR+ C+   E      
Sbjct: 590  SLQTLSFLSKFSVANNNLSGVIPSGGQFQTFPNSSFESNSLCGEHRFPCS---EGTDRTL 646

Query: 659  AKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSR-GEVDPEKEEANT-NDKDLEE 716
             K+SRR+K   +GMAIGI FGS FLL L+ +I+LRA  R GEVDPE EE+ + N K+L E
Sbjct: 647  IKRSRRSKGADIGMAIGIAFGSVFLLTLLLLIVLRARRRSGEVDPEIEESESMNRKELGE 706

Query: 717  LGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSG 776
            +GSKLVVLF N +KE+S DD+L+STN+FDQANIIGCGGFG+VY+ATLPDG+ VAIK+LSG
Sbjct: 707  IGSKLVVLFQNNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSG 766

Query: 777  DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGP 836
            DCGQ+EREF AEVE LSRAQHPNLV L+G+C +KNDRLLIYS+MENGSLDYWLHE+ DGP
Sbjct: 767  DCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGP 826

Query: 837  SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
            + L W +RL IAQGAA+GL YLH+ C+PHILHRDIKSSNILLD NF +HLADFGLARL +
Sbjct: 827  ALLKWRTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARL-M 885

Query: 897  SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
            SPY+THV+TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT KRP+DMCKPKG R
Sbjct: 886  SPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCR 945

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            DLISWV++M+ ENR SEV DP IY K++DKEM RVL+I CLCLSE+PK RPTTQQLVSWL
Sbjct: 946  DLISWVVKMKHENRASEVFDPLIYSKENDKEMFRVLEITCLCLSENPKQRPTTQQLVSWL 1005

Query: 1017 DSI 1019
            D +
Sbjct: 1006 DDV 1008

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15227264|ref|NP_178330.1| phytosulfokin receptor 1 [Arabidopsis thaliana] gi|29428075|sp|Q9ZVR7.4|PSKR1_ARATH RecName: Full=Phytosulfokine receptor 1; Short=AtPSKR1; AltName: Full=Phytosulfokine LRR receptor kinase 1; Flags: Precursor gi|224589499|gb|ACN59283.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330250464|gb|AEC05558.1| phytosulfokin receptor 1 [Arabidopsis thaliana]

 Score = 1343 bits (3477), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 680/1024 (66%), Positives = 823/1024 (80%), Gaps = 21/1024 (2%)

Query: 1    MGVQDLCLFIILAG--FCFQAQLLHAQRQDLT-CNPNDLAALEDFMKNFESGIDGWGTNA 57
            M V   C+ +I      CF      ++ Q  + C+P+DL AL DF+ + E   DGW  ++
Sbjct: 1    MRVHRFCVIVIFLTELLCF---FYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSS 57

Query: 58   SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
            SS+DCC+W GITCNS+++         GRV  L L  ++L GKLSESLG L ++R LNLS
Sbjct: 58   SSTDCCNWTGITCNSNNT---------GRVIRLELGNKKLSGKLSESLGKLDEIRVLNLS 108

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
             N +K ++P+S+ NL NL+ LDLSSNDLSG +P +INLP++Q  D+SSN  NGS+P+ IC
Sbjct: 109  RNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGIPTSINLPALQSFDLSSNKFNGSLPSHIC 168

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
             NS++IRV+ L+VNYF+G  + G G C  LEHLCLGMNDLTG I +D+F L++L LLG+Q
Sbjct: 169  HNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQ 228

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            +N+LSG LS  I +LS+LVRLDVS N FSG IPDVF  L + ++ +  +N F G IP SL
Sbjct: 229  ENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFLGQTNGFIGGIPKSL 288

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            +NSP+LNLLNLRNNSL G L+LNC A+  L SLDLGTN+FNG LP NLP C++LKN+NLA
Sbjct: 289  ANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLA 348

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            RN F GQ+PE++KNFESLSY SLSNSS+ N+SSAL +LQ C+NLTTLVLTLNF  E LP 
Sbjct: 349  RNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPD 408

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
            D  LHF  LKVLV+A+C L GS+P+WL   ++LQL+DLSWN+L+G IP W G F+ LFYL
Sbjct: 409  DSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYL 468

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNN+FTGEIPK+LT L SL +RNIS+ EPSPDFPFFM+RN SAR LQYNQI+ FPPTI
Sbjct: 469  DLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTI 528

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
            +L  N L G IW EFGNLKKLHVFDLK N LSG IPS L+GMTSLE LDLS N LSG+IP
Sbjct: 529  ELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIP 588

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
            +SL++LSFLSKFSVA N+L+G IPSGGQFQTFPNSSF+ N+LCGEHR+ C+   ES  + 
Sbjct: 589  VSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALI- 647

Query: 658  SAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSR-GEVDPEKEEANT-NDKDLE 715
              K+SRR++   +GMAIGI FGS FLL L+ +I+LRA  R GEVDPE EE+ + N K+L 
Sbjct: 648  --KRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELG 705

Query: 716  ELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
            E+GSKLVVLF + +KE+S DD+L+STN+FDQANIIGCGGFG+VY+ATLPDG+ VAIK+LS
Sbjct: 706  EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS 765

Query: 776  GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            GDCGQ+EREF AEVE LSRAQHPNLV L+G+C +KNDRLLIYS+MENGSLDYWLHE+ DG
Sbjct: 766  GDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDG 825

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            P+ L W +RL IAQGAA+GL YLH+ C+PHILHRDIKSSNILLD NF +HLADFGLARL 
Sbjct: 826  PALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARL- 884

Query: 896  LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
            +SPY+THV+TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT KRP+DMCKPKG 
Sbjct: 885  MSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGC 944

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
            RDLISWV++M+ E+R SEV DP IY K++DKEM RVL+IACLCLSE+PK RPTTQQLVSW
Sbjct: 945  RDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSW 1004

Query: 1016 LDSI 1019
            LD +
Sbjct: 1005 LDDV 1008

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|29427830|sp|Q8LPB4.1|PSKR1_DAUCA RecName: Full=Phytosulfokine receptor 1; Short=DcPSKR1; AltName: Full=Phytosulfokine LRR receptor kinase 1; Flags: Precursor gi|21623969|dbj|BAC00995.1| phytosulfokine receptor [Daucus carota]

 Score = 1320 bits (3415), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 674/1025 (65%), Positives = 810/1025 (79%), Gaps = 14/1025 (1%)

Query: 1    MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSS 60
            MGV  + + +IL GFC Q  ++++Q  +LTCN NDL ALE FM+  ES IDGW  N SSS
Sbjct: 1    MGVLRVYVILILVGFCVQIVVVNSQ--NLTCNSNDLKALEGFMRGLESSIDGWKWNESSS 58

Query: 61   ---DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
               +CC WVGI+C SS SLGL+D   SGRV  L L +R+L GKLSES+  L QL+ LNL+
Sbjct: 59   FSSNCCDWVGISCKSSVSLGLDDVNESGRVVELELGRRKLSGKLSESVAKLDQLKVLNLT 118

Query: 118  HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
            HN L G++  SL+NL NLEVLDLSSND SG  P  INLPS++VL++  NS +G +P S+C
Sbjct: 119  HNSLSGSIAASLLNLSNLEVLDLSSNDFSGLFPSLINLPSLRVLNVYENSFHGLIPASLC 178

Query: 178  KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
             N  RIR I+L++NYF G++  G+GNC+S+E+L L  N+L+G I  ++FQL  L +L LQ
Sbjct: 179  NNLPRIREIDLAMNYFDGSIPVGIGNCSSVEYLGLASNNLSGSIPQELFQLSNLSVLALQ 238

Query: 238  DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
            +N+LSG LS  +  LSNL RLD+SSN FSG IPDVF  L +  Y  A SN F G +P SL
Sbjct: 239  NNRLSGALSSKLGKLSNLGRLDISSNKFSGKIPDVFLELNKLWYFSAQSNLFNGEMPRSL 298

Query: 298  SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
            SNS +++LL+LRNN+L G + LNC A+TNLTSLDL +N F+G +P+NLP C +LK IN A
Sbjct: 299  SNSRSISLLSLRNNTLSGQIYLNCSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFA 358

Query: 358  RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
            +  F  QIPE++KNF+SL+ LS SNSSI N+SSAL++LQ C+NL TLVLTLNF+ E+LP+
Sbjct: 359  KIKFIAQIPESFKNFQSLTSLSFSNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPS 418

Query: 418  DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
             P L F NLKVL+IASC LRG++PQWL     LQL+DLSWNQLSGTIP W G    LFYL
Sbjct: 419  VPSLQFKNLKVLIIASCQLRGTVPQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYL 478

Query: 478  DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            DLSNNTF GEIP +LT L SL+++  ++EEPSPDFPFF ++N +A GLQYNQ  SFPP I
Sbjct: 479  DLSNNTFIGEIPHSLTSLQSLVSKENAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFPPMI 538

Query: 538  DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
            DLS N L+GSIWPEFG+L++LHV +LK+NNLSG IP+ L+GMTSLE LDLS+NNLSG IP
Sbjct: 539  DLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIP 598

Query: 598  ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQV 656
             SL KLSFLS FSVA N L+G IP+G QFQTFPNSSF+GN  LCGEH   C I  +S   
Sbjct: 599  PSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSPH- 657

Query: 657  KSAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEE 716
             SA KS++N   IV +A+G   G+ FLL +  +I+LR  SRGEVDPEK+     D D  E
Sbjct: 658  GSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKA----DADEIE 713

Query: 717  LGSKLVVLFHNKEK--EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL 774
            LGS+ VVLFHNK+   E+S+DDIL+ST++F+QANIIGCGGFGLVY+ATLPDG  VAIKRL
Sbjct: 714  LGSRSVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRL 773

Query: 775  SGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD 834
            SGD GQM+REF+AEVE LSRAQHPNLVHL GYC +KND+LLIYS+M+NGSLDYWLHEK+D
Sbjct: 774  SGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVD 833

Query: 835  GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
            GP SLDW +RL IA+GAA GLAYLHQSCEPHILHRDIKSSNILL   F AHLADFGLARL
Sbjct: 834  GPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARL 893

Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
            IL PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG+RPMD+CKP+G
Sbjct: 894  IL-PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDVCKPRG 952

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            SRDLISWV++M+ E RESE+ DPFIYDK H +EML VL+IAC CL E+PK RPTTQQLVS
Sbjct: 953  SRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQLVS 1012

Query: 1015 WLDSI 1019
            WL++I
Sbjct: 1013 WLENI 1017

Source: Daucus carota

Species: Daucus carota

Genus: Daucus

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|20197335|gb|AAC78507.3| putative protein kinase [Arabidopsis thaliana]

 Score = 1173 bits (3034), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 602/926 (65%), Positives = 735/926 (79%), Gaps = 21/926 (2%)

Query: 1   MGVQDLCLFIILAG--FCFQAQLLHAQRQDLT-CNPNDLAALEDFMKNFESGIDGWGTNA 57
           M V   C+ +I      CF      ++ Q  + C+P+DL AL DF+ + E   DGW  ++
Sbjct: 1   MRVHRFCVIVIFLTELLCF---FYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSS 57

Query: 58  SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
           SS+DCC+W GITCNS+++         GRV  L L  ++L GKLSESLG L ++R LNLS
Sbjct: 58  SSTDCCNWTGITCNSNNT---------GRVIRLELGNKKLSGKLSESLGKLDEIRVLNLS 108

Query: 118 HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
            N +K ++P+S+ NL NL+ LDLSSNDLSG +P +INLP++Q  D+SSN  NGS+P+ IC
Sbjct: 109 RNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGIPTSINLPALQSFDLSSNKFNGSLPSHIC 168

Query: 178 KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
            NS++IRV+ L+VNYF+G  + G G C  LEHLCLGMNDLTG I +D+F L++L LLG+Q
Sbjct: 169 HNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQ 228

Query: 238 DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
           +N+LSG LS  I +LS+LVRLDVS N FSG IPDVF  L + ++ +  +N F G IP SL
Sbjct: 229 ENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFLGQTNGFIGGIPKSL 288

Query: 298 SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
           +NSP+LNLLNLRNNSL G L+LNC A+  L SLDLGTN+FNG LP NLP C++LKN+NLA
Sbjct: 289 ANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLA 348

Query: 358 RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
           RN F GQ+PE++KNFESLSY SLSNSS+ N+SSAL +LQ C+NLTTLVLTLNF  E LP 
Sbjct: 349 RNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPD 408

Query: 418 DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
           D  LHF  LKVLV+A+C L GS+P+WL   ++LQL+DLSWN+L+G IP W G F+ LFYL
Sbjct: 409 DSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYL 468

Query: 478 DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
           DLSNN+FTGEIPK+LT L SL +RNIS+ EPSPDFPFFM+RN SAR LQYNQI+ FPPTI
Sbjct: 469 DLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTI 528

Query: 538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
           +L  N L G IW EFGNLKKLHVFDLK N LSG IPS L+GMTSLE LDLS N LSG+IP
Sbjct: 529 ELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIP 588

Query: 598 ISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
           +SL++LSFLSKFSVA N+L+G IPSGGQFQTFPNSSF+ N+LCGEHR+ C+   ES  + 
Sbjct: 589 VSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALI- 647

Query: 658 SAKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSR-GEVDPEKEEANT-NDKDLE 715
             K+SRR++   +GMAIGI FGS FLL L+ +I+LRA  R GEVDPE EE+ + N K+L 
Sbjct: 648 --KRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELG 705

Query: 716 ELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
           E+GSKLVVLF + +KE+S DD+L+STN+FDQANIIGCGGFG+VY+ATLPDG+ VAIK+LS
Sbjct: 706 EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS 765

Query: 776 GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
           GDCGQ+EREF AEVE LSRAQHPNLV L+G+C +KNDRLLIYS+MENGSLDYWLHE+ DG
Sbjct: 766 GDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDG 825

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
           P+ L W +RL IAQGAA+GL YLH+ C+PHILHRDIKSSNILLD NF +HLADFGLARL 
Sbjct: 826 PALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARL- 884

Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQA 921
           +SPY+THV+TDLVGTLGYIPPEYGQA
Sbjct: 885 MSPYETHVSTDLVGTLGYIPPEYGQA 910

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445377|ref|XP_004140449.1| PREDICTED: phytosulfokine receptor 1-like [Cucumis sativus] gi|449498410|ref|XP_004160530.1| PREDICTED: phytosulfokine receptor 1-like [Cucumis sativus]

 Score = 1150 bits (2976), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 605/1023 (59%), Positives = 755/1023 (73%), Gaps = 22/1023 (2%)

Query: 1    MGVQDLCLFIILAGFCFQAQLLHAQRQDLTCNPNDLAALEDFMKNFESGIDGWGTNASSS 60
            MG+Q+    ++L    F    L   +  L C+ ND  A  DF + F S I     N SS 
Sbjct: 1    MGLQNFFSILLLLSAIFLRFHLSCSQTPLICHSNDSEAFHDFHRTFTSQIHSLHANCSS- 59

Query: 61   DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNL 120
            +CC   G+TC+SS           GRV  + L   +L G+L  S+     LR LNLS N 
Sbjct: 60   NCCSCTGLTCDSS-----------GRVVKIELVGIKLAGQLPNSIARFEHLRVLNLSSNC 108

Query: 121  LKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQ-TINLPSIQVLDISSNSLNGSVPTSICKN 179
            L G++P++L +LP+LEV DLS N   G     T++LPS+++L++S N  NG +P  IC N
Sbjct: 109  LTGSIPLALFHLPHLEVFDLSFNRFLGNFSTGTLHLPSLRILNVSRNLFNGVLPFHICIN 168

Query: 180  SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDN 239
            S+ I V+NLS N F G     L +C SL+ L L  N ++GGI ++I  L+KL  L +Q+N
Sbjct: 169  STFIEVLNLSFNDFLGVFPFQLADCVSLKRLHLESNFISGGIPNEISGLRKLTHLSVQNN 228

Query: 240  QLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSN 299
            +LSG L+  + +L +LVRLD+SSN F G IPDVF       + VA SNRF+GRIP SLSN
Sbjct: 229  KLSGSLNRIVGNLRSLVRLDLSSNEFFGEIPDVFYNSLNLSFFVAESNRFSGRIPKSLSN 288

Query: 300  SPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARN 359
            S +L++LNLRNNS+ G+L LNC A+ +L +LDLG+N+F G +P+NLP C +L++INLARN
Sbjct: 289  SASLSVLNLRNNSIGGNLDLNCSAMKSLVTLDLGSNRFQGFIPSNLPSCTQLRSINLARN 348

Query: 360  NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDP 419
            N  GQIPET++ F+SL+YLSL+N+SI N+SSAL +LQ C++L+T+VLT NF  E L  DP
Sbjct: 349  NLGGQIPETFRKFQSLTYLSLTNTSIVNVSSALNILQHCQSLSTVVLTFNFHGEVLGDDP 408

Query: 420  RLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDL 479
             LHF +L+V +IA+C L+G IPQWLR  +KLQ +DLSWN+L G IP WFG FQ +FYLDL
Sbjct: 409  NLHFKSLQVFIIANCRLKGVIPQWLRSSNKLQFLDLSWNRLGGNIPSWFGEFQFMFYLDL 468

Query: 480  SNNTFTGEIPKNLTGLPSLITRNISLEEP-SPDFPFFMRRNVSARGLQYNQIWSFPPTID 538
            SNN+F G IPK +T + S I RN  L+EP SPDF  F++RN    G QYNQ+W FPPT+D
Sbjct: 469  SNNSFVGGIPKEITQMKSYIDRNFLLDEPVSPDFSLFVKRN--GTGWQYNQVWRFPPTLD 526

Query: 539  LSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPI 598
            L  N L G IWPE GNLK++ V DLK N+LSG I S L+GM SLETLDLS+N LSG IP 
Sbjct: 527  LGFNNLSGPIWPELGNLKQIMVLDLKFNSLSGSISSSLSGMVSLETLDLSHNKLSGTIPP 586

Query: 599  SLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKS 658
            SL+KL+FLSKFSVA N L G IP GGQF +FPNSSF+GNN C +     + D ++  V  
Sbjct: 587  SLQKLNFLSKFSVAYNQLHGAIPKGGQFHSFPNSSFEGNNFCVQDDLCASSDGDALVV-- 644

Query: 659  AKKSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEV-DPEKEEANTNDKDLEEL 717
              KSR    +++G+ +G+ FG  FL   + + +LR   RG V DPE E +N ++KDLEE+
Sbjct: 645  THKSRMVTGSLIGIIVGVIFGIIFLATFVVVFMLRP-PRGRVGDPENEVSNIDNKDLEEV 703

Query: 718  GSKLVVLFHNKEK-EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSG 776
             + LVVLF N +   +S++DIL+STN+FDQ NIIGCGGFGLVY+ATLPDGR VAIKRLSG
Sbjct: 704  KTGLVVLFQNNDNGSLSLEDILKSTNDFDQENIIGCGGFGLVYKATLPDGRKVAIKRLSG 763

Query: 777  DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGP 836
            DCGQM+REF+AE+E LSRAQHPNLV LQGYCM+KNDRLLIYS+MENGSLDYWLHEK DG 
Sbjct: 764  DCGQMDREFQAEIETLSRAQHPNLVLLQGYCMYKNDRLLIYSYMENGSLDYWLHEKPDGS 823

Query: 837  SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
            S LDWD+RL IA+GAA GLAYLHQ CEPHILHRDIKSSNILLD NF AHLADFGLARLIL
Sbjct: 824  SCLDWDTRLQIARGAAGGLAYLHQFCEPHILHRDIKSSNILLDKNFKAHLADFGLARLIL 883

Query: 897  SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
             PYDTHVTTDLVGTLGYIPPEYGQ+S+ATY+GDVYSFGVVLLELLTGKRP+DMC+PKG R
Sbjct: 884  -PYDTHVTTDLVGTLGYIPPEYGQSSIATYRGDVYSFGVVLLELLTGKRPIDMCRPKGLR 942

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            DLISWV +MR++ + SEV DPF+YDK+++  M+ VLDIACLCL + PK RP+TQQLV+WL
Sbjct: 943  DLISWVFQMRKDKKVSEVFDPFVYDKKNEMAMVEVLDIACLCLCKVPKERPSTQQLVTWL 1002

Query: 1017 DSI 1019
            D +
Sbjct: 1003 DKV 1005

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242065836|ref|XP_002454207.1| hypothetical protein SORBIDRAFT_04g026660 [Sorghum bicolor] gi|241934038|gb|EES07183.1| hypothetical protein SORBIDRAFT_04g026660 [Sorghum bicolor]

 Score = 1067 bits (2759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 564/1020 (55%), Positives = 731/1020 (71%), Gaps = 44/1020 (4%)

Query: 30   TCNPNDLAALEDFMKNFESGIDGWGTNASSSD---CCHWVGITCNSSSSLGLNDSIGSGR 86
            +C+P DL ALE F K  + GI GW     +SD   CC W+G+TC+           GSG+
Sbjct: 41   SCDPGDLKALEGFYKGLDRGIAGWTFPNGTSDAASCCAWLGVTCD-----------GSGK 89

Query: 87   VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
            V GL L+ RRL+G+L  SL  L QL++LNLS N   G VP  L  L  L+ LDLS N+L+
Sbjct: 90   VIGLDLHGRRLRGQLPLSLTQLDQLQWLNLSDNNFGGAVPAPLFQLQRLQQLDLSYNELA 149

Query: 147  GPLPQTINLPSIQVLDISSNSLNGSVPT-----------------------SICKNSSRI 183
            G LP  ++LP +++ +IS N+ +GS PT                       SIC++S  I
Sbjct: 150  GILPDNMSLPLVELFNISYNNFSGSHPTLRGSERLIVFDAGYNSFAGQIDTSICESSGEI 209

Query: 184  RVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG 243
             V+  S N F+G    G GNC  LE L + +N ++  + +D+F+L  L++L LQ+NQLSG
Sbjct: 210  SVLRFSSNLFTGDFPAGFGNCTKLEELYVELNIISRRLPEDLFRLPSLKILSLQENQLSG 269

Query: 244  KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTL 303
             +SP   +LSNL RLD+S N+FSG+IP+VF  L + ++  A SN F G +P SL +SP+L
Sbjct: 270  GMSPRFGNLSNLDRLDISFNSFSGHIPNVFGSLRKLEFFSAQSNLFRGPLPPSLCHSPSL 329

Query: 304  NLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG 363
             +L LRNNSL+G + LNC A+T L+SLDLGTNKF G +  +L  CR LK++NLA NN SG
Sbjct: 330  KMLYLRNNSLNGEINLNCSAMTQLSSLDLGTNKFIGTI-YSLSDCRNLKSLNLATNNLSG 388

Query: 364  QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEK-LPTDPRLH 422
            +IP  ++  +SL+YLSLSN+S  ++ SAL VLQ C +LT+LVLT NF ++K LP      
Sbjct: 389  EIPAGFRKLQSLTYLSLSNNSFTDMPSALSVLQDCPSLTSLVLTKNFHDQKALPMTGIQG 448

Query: 423  FANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
            F +++V VIA+  L G +P WL   ++L+++DLSWNQL+G IP   G  + LFYLDLSNN
Sbjct: 449  FHSIQVFVIANSHLSGPVPPWLANFTQLKVLDLSWNQLTGNIPACIGDLEFLFYLDLSNN 508

Query: 483  TFTGEIPKNLTGLPSLITRNISLEEPSPD-FPFFMRRNVSARGLQYNQIWSFPPTIDLSL 541
            + +GEIP+NL+ + +L+TR IS E    D FPFF++RN + +GLQYNQ+ SFPP++ LS 
Sbjct: 509  SLSGEIPENLSNMKALVTRKISQESTETDYFPFFIKRNKTGKGLQYNQVSSFPPSLVLSH 568

Query: 542  NRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLE 601
            N+L G I   FG LK LHV DL +NN+SG IP +L+GM+SLE+LDLS+NNL+G IP SL 
Sbjct: 569  NKLTGPILSGFGILKHLHVLDLSNNNISGTIPDDLSGMSSLESLDLSHNNLTGGIPYSLT 628

Query: 602  KLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYSCTIDRESGQVKSAK 660
            KL+FLS FSVA N+L G IPSGGQF TF +S+++GN  LCG                +A 
Sbjct: 629  KLNFLSSFSVAYNNLNGTIPSGGQFSTFSSSAYEGNPKLCGIRLGLPRCHSTPAPTIAAT 688

Query: 661  KSRRNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSK 720
              R+NK  I G+A+GI  G+AF+L +  + +L++    +    K   +TN + LE   + 
Sbjct: 689  NKRKNKGIIFGIAMGIAVGAAFILSIAVIFVLKSSFNKQDHTVKAVKDTN-QALELAPAS 747

Query: 721  LVVLFHNK-EKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG 779
            LV+LF +K +K ++I DIL+STNNFDQANIIGCGGFGLVY+ATL DG  +AIKRLSGD G
Sbjct: 748  LVLLFQDKADKALTIADILKSTNNFDQANIIGCGGFGLVYKATLQDGAAIAIKRLSGDFG 807

Query: 780  QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
            QMEREF+AEVE LS+AQHPNLV LQGYC   +DRLLIYSFMENGSLD+WLHEK DGPS L
Sbjct: 808  QMEREFKAEVETLSKAQHPNLVLLQGYCRIGSDRLLIYSFMENGSLDHWLHEKPDGPSRL 867

Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
             W  RL IA+GAARGLAYLH SC+PHILHRD+KSSNILLD NF AHLADFGLARLI  PY
Sbjct: 868  IWPRRLQIAKGAARGLAYLHLSCQPHILHRDVKSSNILLDENFEAHLADFGLARLI-CPY 926

Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI 959
             THVTTDLVGTLGYIPPEYGQ+SVAT+KGDVYSFG+VLLELLTGKRP+DMCKPKG+R+L+
Sbjct: 927  ATHVTTDLVGTLGYIPPEYGQSSVATFKGDVYSFGIVLLELLTGKRPVDMCKPKGARELV 986

Query: 960  SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            SWV  M++ENRE++VLD  +YDK+ + +M++++D+ACLC+S+SPK+RP T QLV WLD+I
Sbjct: 987  SWVTHMKKENREADVLDRAMYDKKFETQMIQMIDVACLCISDSPKLRPLTHQLVLWLDNI 1046

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1020
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.983	0.995	0.616	0.0
TAIR|locus:2154709	1036	PSKR2 "phytosylfokine-alpha re	0.905	0.891	0.476	4.2e-230
TAIR|locus:2207056	1095	PSY1R "PSY1 receptor" [Arabido	0.677	0.631	0.481	2.1e-171
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.469	0.411	0.419	1.3e-130
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.466	0.408	0.413	3.4e-128
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.883	0.755	0.347	4e-122
TAIR|locus:2005498	1196	BRI1 "BRASSINOSTEROID INSENSIT	0.466	0.397	0.383	1.6e-114
TAIR|locus:2019255	1106	AT1G74360 [Arabidopsis thalian	0.462	0.426	0.343	2.7e-113
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.893	0.729	0.331	3.8e-110
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.579	0.589	0.315	1.5e-109

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 3265 (1154.4 bits), Expect = 0., P = 0.
 Identities = 631/1024 (61%), Positives = 764/1024 (74%)

Query:     1 MGVQDLCLFIILAG--FCFQAQLLHAQRQDLT-CNPNDLAALEDFMKNFESGIDGWGTNA 57
             M V   C+ +I      CF      ++ Q  + C+P+DL AL DF+ + E   DGW  ++
Sbjct:     1 MRVHRFCVIVIFLTELLCF---FYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINSS 57

Query:    58 SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
             SS+DCC+W GITCNS+++         GRV  L L  ++L GKLSESLG L ++R LNLS
Sbjct:    58 SSTDCCNWTGITCNSNNT---------GRVIRLELGNKKLSGKLSESLGKLDEIRVLNLS 108

Query:   118 HNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSIC 177
              N +K ++P+S+ NL NL+ LDLSSNDLSG +P +INLP++Q  D+SSN  NGS+P+ IC
Sbjct:   109 RNFIKDSIPLSIFNLKNLQTLDLSSNDLSGGIPTSINLPALQSFDLSSNKFNGSLPSHIC 168

Query:   178 KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ 237
              NS++IRV+ L+VNYF+G  + G G C  LEHLCLGMNDLTG I +D+F L++L LLG+Q
Sbjct:   169 HNSTQIRVVKLAVNYFAGNFTSGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQ 228

Query:   238 DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHXX 297
             +N+LSG LS  I +LS+LVRLDVS N FSG IPDVF  L + ++ +  +N F G IP   
Sbjct:   229 ENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFLGQTNGFIGGIPKSL 288

Query:   298 XXXXXXXXXXXXXXXXXXXXXXXCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
                                    C A+  L SLDLGTN+FNG LP NLP C++LKN+NLA
Sbjct:   289 ANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCKRLKNVNLA 348

Query:   358 RNNFSGQIPETYKNFEXXXXXXXXXXXXXXXXXALQVLQQCRNLTTLVLTLNFRNEKLPT 417
             RN F GQ+PE++KNFE                 AL +LQ C+NLTTLVLTLNF  E LP 
Sbjct:   349 RNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLTTLVLTLNFHGEALPD 408

Query:   418 DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYL 477
             D  LHF  LKVLV+A+C L GS+P+WL   ++LQL+DLSWN+L+G IP W G F+ LFYL
Sbjct:   409 DSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYL 468

Query:   478 DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
             DLSNN+FTGEIPK+LT L SL +RNIS+ EPSPDFPFFM+RN SAR LQYNQI+ FPPTI
Sbjct:   469 DLSNNSFTGEIPKSLTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTI 528

Query:   538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
             +L  N L G IW EFGNLKKLHVFDLK N LSG IPS L+GMTSLE LDLS N LSG+IP
Sbjct:   529 ELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIP 588

Query:   598 IXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVK 657
             +            VA N+L+G IPSGGQFQTFPNSSF+ N+LCGEHR+ C+   ES  +K
Sbjct:   589 VSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALIK 648

Query:   658 SAKKSRRNKYTIVGMAIGITFGSAXXXXXXXXXXXRAHSR-GEVDPEKEEANT-NDKDLE 715
                +SRR++   +GMAIGI FGS            RA  R GEVDPE EE+ + N K+L 
Sbjct:   649 ---RSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELG 705

Query:   716 ELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS 775
             E+GSKLVVLF + +KE+S DD+L+STN+FDQANIIGCGGFG+VY+ATLPDG+ VAIK+LS
Sbjct:   706 EIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLS 765

Query:   776 GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
             GDCGQ+EREF AEVE LSRAQHPNLV L+G+C +KNDRLLIYS+MENGSLDYWLHE+ DG
Sbjct:   766 GDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDG 825

Query:   836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
             P+ L W +RL IAQGAA+GL YLH+ C+PHILHRDIKSSNILLD NF +HLADFGLARL 
Sbjct:   826 PALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARL- 884

Query:   896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
             +SPY+THV+TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT KRP+DMCKPKG 
Sbjct:   885 MSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGC 944

Query:   956 RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
             RDLISWV++M+ E+R SEV DP IY K++DKEM RVL+IACLCLSE+PK RPTTQQLVSW
Sbjct:   945 RDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSW 1004

Query:  1016 LDSI 1019
             LD +
Sbjct:  1005 LDDV 1008

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 2220 (786.5 bits), Expect = 4.2e-230, P = 4.2e-230
 Identities = 449/942 (47%), Positives = 608/942 (64%)

Query:    90 LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
             L L + +LKG++   +  L QL+ L+LSHNLL G+V   +  L  ++ L++SSN LSG L
Sbjct:    93 LDLSRNQLKGEVPAEISKLEQLQVLDLSHNLLSGSVLGVVSGLKLIQSLNISSNSLSGKL 152

Query:   150 PQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA-SLE 208
                   P + +L++S+N   G +   +C +S  I+V++LS+N   G L  GL NC+ S++
Sbjct:   153 SDVGVFPGLVMLNVSNNLFEGEIHPELCSSSGGIQVLDLSMNRLVGNLD-GLYNCSKSIQ 211

Query:   209 HLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGN 268
              L +  N LTG + D ++ +++L  L L  N LSG+LS ++++LS L  L +S N FS  
Sbjct:   212 QLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLLISENRFSDV 271

Query:   269 IPDVFAGLGEFQYLVAHSNRFTGRIPHXXXXXXXXXXXXXXXXXXXXXXXXXCPALTNLT 328
             IPDVF  L + ++L   SN+F+GR P                              T+L 
Sbjct:   272 IPDVFGNLTQLEHLDVSSNKFSGRFPPSLSQCSKLRVLDLRNNSLSGSINLNFTGFTDLC 331

Query:   329 SLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFEXXXXXXXXXXXXXXX 388
              LDL +N F+GPLP +L  C K+K ++LA+N F G+IP+T+KN +               
Sbjct:   332 VLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLFLSLSNNSFVDF 391

Query:   389 XXALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCS 448
                + VLQ CRNL+TL+L+ NF  E++P +    F NL +L + +CGLRG IP WL  C 
Sbjct:   392 SETMNVLQHCRNLSTLILSKNFIGEEIPNNVT-GFDNLAILALGNCGLRGQIPSWLLNCK 450

Query:   449 KLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEE- 507
             KL+++DLSWN   GTIP W G  + LFY+D SNNT TG IP  +T L +LI  N +  + 
Sbjct:   451 KLEVLDLSWNHFYGTIPHWIGKMESLFYIDFSNNTLTGAIPVAITELKNLIRLNGTASQM 510

Query:   508 -PSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHN 566
               S   P +++RN S+ GL YNQ+  FPP+I L+ NRL+G+I PE G LK+LH+ DL  N
Sbjct:   511 TDSSGIPLYVKRNKSSNGLPYNQVSRFPPSIYLNNNRLNGTILPEIGRLKELHMLDLSRN 570

Query:   567 NLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXXXXXXXXXXXXVANNHLTGRIPSGGQF 626
             N +G IP  ++G+ +LE LDLSYN+L G+IP+            VA N LTG IPSGGQF
Sbjct:   571 NFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQF 630

Query:   627 QTFPNSSFDGN-NLCGEHRYSCTIDRESGQVKSAKKSRRN----KY---TIVGMAIGITF 678
              +FP+SSF+GN  LC      C +   S  +     SRRN    K+   +IV + I +  
Sbjct:   631 YSFPHSSFEGNLGLCRAIDSPCDV-LMSNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAI 689

Query:   679 GSAXXXXXXXXXXXRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKE-KEISIDDI 737
             G             R      ++   EE  +     + LG   +VLFH+   K++S++++
Sbjct:   690 GITLLLSVILLRISRKDVDDRINDVDEETISGVS--KALGPSKIVLFHSCGCKDLSVEEL 747

Query:   738 LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH 797
             L+STNNF QANIIGCGGFGLVY+A  PDG   A+KRLSGDCGQMEREF+AEVEALSRA+H
Sbjct:   748 LKSTNNFSQANIIGCGGFGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEH 807

Query:   798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
              NLV LQGYC H NDRLLIYSFMENGSLDYWLHE++DG  +L WD RL IAQGAARGLAY
Sbjct:   808 KNLVSLQGYCKHGNDRLLIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAY 867

Query:   858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
             LH+ CEP+++HRD+KSSNILLD  F AHLADFGLARL L PYDTHVTTDLVGTLGYIPPE
Sbjct:   868 LHKVCEPNVIHRDVKSSNILLDEKFEAHLADFGLARL-LRPYDTHVTTDLVGTLGYIPPE 926

Query:   918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
             Y Q+ +AT +GDVYSFGVVLLEL+TG+RP+++CK K  RDL+S V +M+ E RE+E++D 
Sbjct:   927 YSQSLIATCRGDVYSFGVVLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEKREAELIDT 986

Query:   978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
              I +  +++ +L +L+IAC C+   P+ RP  +++V+WL+ +
Sbjct:   987 TIRENVNERTVLEMLEIACKCIDHEPRRRPLIEEVVTWLEDL 1028

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1666 (591.5 bits), Expect = 2.1e-171, P = 2.1e-171
 Identities = 343/712 (48%), Positives = 461/712 (64%)

Query:   326 NLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFEXXXXXXXXXXXX 385
             +L+ LDLG N F G  P+ +  C+ +  +  A N  +GQI       E            
Sbjct:   369 SLSILDLGNNSFTGEFPSTVYSCKMMTAMRFAGNKLTGQISPQVLELESLSFFTFSDNKM 428

Query:   386 XXXXXALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL----HFANLKVLVIASCGLRGSIP 441
                  AL +LQ C+ L+TL++  NF +E +P++        F +L++  I +C L G IP
Sbjct:   429 TNLTGALSILQGCKKLSTLIMAKNFYDETVPSNKDFLRSDGFPSLQIFGIGACRLTGEIP 488

Query:   442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITR 501
              WL    +++++DLS N+  GTIP W G   DLFYLDLS+N  TGE+PK L  L +L+++
Sbjct:   489 AWLIKLQRVEVMDLSMNRFVGTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQ 548

Query:   502 NI--SLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLH 559
                 + E    + P F+  N      QYNQ+ S PPTI +  N L G+I  E G LK LH
Sbjct:   549 KAYDATERNYLELPVFVNPNNVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLH 608

Query:   560 VFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXXXXXXXXXXXXVANNHLTGR 619
             + +L  NN SG IP EL+ +T+LE LDLS NNLSG IP             VANN L+G 
Sbjct:   609 ILELLGNNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGP 668

Query:   620 IPSGGQFQTFPNSSFDGNNL-CGEHRY-SCTIDRESGQVKSAKKSRRNKYTIVGMAIGIT 677
             IP+G QF TFP ++F+GN L CG     SC  D          K + N+  ++G+ +G+ 
Sbjct:   669 IPTGTQFDTFPKANFEGNPLLCGGVLLTSC--DPTQHSTTKMGKGKVNRTLVLGLVLGLF 726

Query:   678 FGSAXXXXXXXXX--XXRAHSRGEVDPEKEEANTNDKDLE-ELGS----KLVVLFHNKE- 729
             FG +             R  + G+ +  + E N+N    E   GS     LV+LF N   
Sbjct:   727 FGVSLILVLLALLVLSKRRVNPGDSENAELEINSNGSYSEVPPGSDKDISLVLLFGNSRY 786

Query:   730 --KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRA 787
               K+++I ++L++T+NF QANIIGCGGFGLVY+ATL +G  +A+K+L+GD G ME+EF+A
Sbjct:   787 EVKDLTIFELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKA 846

Query:   788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
             EVE LSRA+H NLV LQGYC+H + R+LIYSFMENGSLDYWLHE  +GP+ LDW  RL+I
Sbjct:   847 EVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNI 906

Query:   848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
              +GA+ GLAY+HQ CEPHI+HRDIKSSNILLDGNF A++ADFGL+RLIL PY THVTT+L
Sbjct:   907 MRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLIL-PYRTHVTTEL 965

Query:   908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
             VGTLGYIPPEYGQA VAT +GDVYSFGVV+LELLTGKRPM++ +PK SR+L++WV  M++
Sbjct:   966 VGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKR 1025

Query:   968 ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             + +  EV D  + +  +++ MLRVLDIAC+C++++P  RP  QQ+V WL +I
Sbjct:  1026 DGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKRPNIQQVVDWLKNI 1077

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0004888 "transmembrane signaling receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 894 (319.8 bits), Expect = 1.3e-130, Sum P(2) = 1.3e-130
 Identities = 209/498 (41%), Positives = 289/498 (58%)

Query:   537 IDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAI 596
             +DLS N + GSI   +G +  L V +L HN L+G IP    G+ ++  LDLS+N+L G +
Sbjct:   644 LDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFL 703

Query:   597 PIXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQ 655
             P             V+NN+LTG IP GGQ  TFP + +  N+ LCG     C+    SG 
Sbjct:   704 PGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCS----SGS 759

Query:   656 VKSAKKSRRNKYTIV-GMAIGITFG-SAXXXXXXXXXXXRAHSRGEVDPEK--EEANTND 711
               +   +   K +I  GM+ GI F               R   + E   EK  E   T+ 
Sbjct:   760 RPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSG 819

Query:   712 KDLEELGS---KL---VVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD 765
                 +L S    L   V  F    ++++   +LE+TN F   ++IG GGFG VY+A L D
Sbjct:   820 SSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLAD 879

Query:   766 GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL 825
             G  VAIK+L    GQ +REF AE+E + + +H NLV L GYC    +RLL+Y +M+ GSL
Sbjct:   880 GSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSL 939

Query:   826 DYWLHEKLD-GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA 884
             +  LHEK   G   LDW +R  IA GAARGLA+LH SC PHI+HRD+KSSN+LLD +F A
Sbjct:   940 ETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVA 999

Query:   885 HLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
              ++DFG+ARL+ S  DTH++   L GT GY+PPEY Q+   T KGDVYS+GV+LLELL+G
Sbjct:  1000 RVSDFGMARLV-SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSG 1058

Query:   944 KRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP-FIYDKQHDKEMLRVLDIACLCLSES 1002
             K+P+D  +     +L+ W  ++ +E R +E+LDP  + DK  D E+L  L IA  CL + 
Sbjct:  1059 KKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDR 1118

Query:  1003 PKVRPTTQQLVSWLDSII 1020
             P  RPT  Q+++    ++
Sbjct:  1119 PFKRPTMIQVMTMFKELV 1136

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 3.4e-128, Sum P(2) = 3.4e-128
 Identities = 202/489 (41%), Positives = 281/489 (57%)

Query:   538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
             D+S N + G I P +GN+  L V +L HN ++G IP    G+ ++  LDLS+NNL G +P
Sbjct:   645 DISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLP 704

Query:   598 IXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSC-TIDRESGQ 655
                          V+NN+LTG IP GGQ  TFP S +  N+ LCG     C +  R    
Sbjct:   705 GSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPRRPIT 764

Query:   656 VK-SAKKSRRNKYTIVGMAIG-ITFGSAXXXXXXXXXXXRAHSRGE--VD--PEKEEANT 709
              +  AKK       I G+A   + F              +   + E  ++  P     + 
Sbjct:   765 SRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSW 824

Query:   710 NDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV 769
                 + E  S  V  F    ++++   +LE+TN F    ++G GGFG VY+A L DG  V
Sbjct:   825 KLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVV 884

Query:   770 AIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL 829
             AIK+L    GQ +REF AE+E + + +H NLV L GYC    +RLL+Y +M+ GSL+  L
Sbjct:   885 AIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVL 944

Query:   830 HEKLD--GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA 887
             HEK    G   L+W +R  IA GAARGLA+LH SC PHI+HRD+KSSN+LLD +F A ++
Sbjct:   945 HEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVS 1004

Query:   888 DFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             DFG+ARL+ S  DTH++   L GT GY+PPEY Q+   T KGDVYS+GV+LLELL+GK+P
Sbjct:  1005 DFGMARLV-SALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKP 1063

Query:   947 MDMCKPKGSRDLISWVIRMRQENRESEVLDP-FIYDKQHDKEMLRVLDIACLCLSESPKV 1005
             +D  +     +L+ W  ++ +E R +E+LDP  + DK  D E+   L IA  CL + P  
Sbjct:  1064 IDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFK 1123

Query:  1006 RPTTQQLVS 1014
             RPT  QL++
Sbjct:  1124 RPTMIQLMA 1132

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
 Identities = 333/959 (34%), Positives = 481/959 (50%)

Query:    90 LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
             L L    L G +   LGN   L+ L LS N L G +P+ L  +P L       N LSG L
Sbjct:   263 LNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLL-TFSAERNQLSGSL 321

Query:   150 PQTINLPSIQVLD---ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCAS 206
             P  +     +VLD   +++N  +G +P  I ++   ++ ++L+ N  SG++   L    S
Sbjct:   322 PSWMG--KWKVLDSLLLANNRFSGEIPHEI-EDCPMLKHLSLASNLLSGSIPRELCGSGS 378

Query:   207 LEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF 265
             LE + L  N L+G I +++F     L  L L +NQ++G +   +  L  L+ LD+ SNNF
Sbjct:   379 LEAIDLSGNLLSGTI-EEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNF 436

Query:   266 SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHXXXXXXXXXXXXXXXXXXXXXXXXXCPALT 325
             +G IP             A  NR  G +P                             LT
Sbjct:   437 TGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLT 496

Query:   326 NLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE---TYKNFEXXXXXXXXX 382
             +L+ L+L  N F G +P  L  C  L  ++L  NN  GQIP+        +         
Sbjct:   497 SLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNL 556

Query:   383 XXXXXXXXALQVLQ-QCRNLTTL----VLTLNFRNEKLPTDPRLHFANLKVLV-IASCGL 436
                     +    Q +  +L+ L    +  L++     P    L    + V + +++  L
Sbjct:   557 SGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHL 616

Query:   437 RGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLP 496
              G IP  L   + L ++DLS N L+G+IP   G    L  L+L+NN   G IP++   L 
Sbjct:   617 SGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLG 676

Query:   497 SLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLK 556
             SL+  N++  +     P  +  N+  + L +         +DLS N L G +  E   ++
Sbjct:   677 SLVKLNLTKNKLDGPVPASLG-NL--KELTH---------MDLSFNNLSGELSSELSTME 724

Query:   557 KLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXXXXXXXXXXXXVANNHL 616
             KL    ++ N  +G IPSEL  +T LE LD+S N LSG IP             +A N+L
Sbjct:   725 KLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNL 784

Query:   617 TGRIPSGGQFQTFPNSSFDGNN-LCGEHRYS-CTIDRESGQVKSAKKSRRNKYTIVGMAI 674
              G +PS G  Q    +   GN  LCG    S C I  E  +++SA       + I G+ +
Sbjct:   785 RGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKI--EGTKLRSA-------WGIAGLML 835

Query:   675 GITFGSAXXXXXXXXXXXRAHSRGEVDPEK-EEANTN---DKDLEEL-GSKL-------V 722
             G T                   +   DPE+ EE+      D++L  L GS+        +
Sbjct:   836 GFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINI 895

Query:   723 VLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME 782
              +F     ++ + DI+E+T++F + NIIG GGFG VY+A LP  + VA+K+LS    Q  
Sbjct:   896 AMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGN 955

Query:   783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
             REF AE+E L + +HPNLV L GYC    ++LL+Y +M NGSLD+WL  +      LDW 
Sbjct:   956 REFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWS 1015

Query:   843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              RL IA GAARGLA+LH    PHI+HRDIK+SNILLDG+F   +ADFGLARLI S  ++H
Sbjct:  1016 KRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI-SACESH 1074

Query:   903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM--DMCKPKGSRDLIS 960
             V+T + GT GYIPPEYGQ++ AT KGDVYSFGV+LLEL+TGK P   D  + +G  +L+ 
Sbjct:  1075 VSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGG-NLVG 1133

Query:   961 WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             W I+   + +  +V+DP +         LR+L IA LCL+E+P  RP    ++  L  I
Sbjct:  1134 WAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 1.6e-114, Sum P(2) = 1.6e-114
 Identities = 192/501 (38%), Positives = 274/501 (54%)

Query:   529 QIWSFPPTIDLSL--NRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLD 586
             +I S P    L+L  N + GSI  E G+L+ L++ DL  N L G IP  ++ +T L  +D
Sbjct:   673 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 732

Query:   587 LSYNNLSGAIPIXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYS 646
             LS NNLSG IP             + N  L G          +P    D +N  G   + 
Sbjct:   733 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----------YPLPRCDPSNADGYAHHQ 782

Query:   647 CTIDRESGQVKSAKKSRRNKYTIVGMAIGITFG-SAXXXXXXXXXXXRAHSRGEVDPEKE 705
              +  R    + +   +    ++ V +   I  G                ++ G  +    
Sbjct:   783 RSHGRRPASL-AGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDR 841

Query:   706 EAN-TNDK--DLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT 762
              AN TN K   ++E  S  +  F    ++++  D+L++TN F   ++IG GGFG VY+A 
Sbjct:   842 TANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAI 901

Query:   763 LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN 822
             L DG  VAIK+L    GQ +REF AE+E + + +H NLV L GYC   ++RLL+Y FM+ 
Sbjct:   902 LKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKY 961

Query:   823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
             GSL+  LH+       L+W +R  IA G+ARGLA+LH +C PHI+HRD+KSSN+LLD N 
Sbjct:   962 GSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENL 1021

Query:   883 GAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
              A ++DFG+ARL +S  DTH++   L GT GY+PPEY Q+   + KGDVYS+GVVLLELL
Sbjct:  1022 EARVSDFGMARL-MSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELL 1080

Query:   942 TGKRPMDMCKPK-GSRDLISWVIRMRQENRESEVLDPFIY--DKQHDKEMLRVLDIACLC 998
             TGKRP D   P  G  +L+ WV +   + R S+V DP +   D   + E+L+ L +A  C
Sbjct:  1081 TGKRPTD--SPDFGDNNLVGWV-KQHAKLRISDVFDPELMKEDPALEIELLQHLKVAVAC 1137

Query:   999 LSESPKVRPTTQQLVSWLDSI 1019
             L +    RPT  Q+++    I
Sbjct:  1138 LDDRAWRRPTMVQVMAMFKEI 1158

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

GO:0010224 "response to UV-B" evidence=IGI

GO:0005768 "endosome" evidence=IDA

GO:0046982 "protein heterodimerization activity" evidence=IPI

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0010268 "brassinosteroid homeostasis" evidence=IEP

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0043234 "protein complex" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0009911 "positive regulation of flower development" evidence=IGI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IEP;IMP

GO:0010584 "pollen exine formation" evidence=IMP

GO:0048657 "tapetal cell differentiation" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0005496 "steroid binding" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

TAIR|locus:2019255 AT1G74360 [Arabidopsis thaliana (taxid:3702)]

 Score = 731 (262.4 bits), Expect = 2.7e-113, Sum P(2) = 2.7e-113
 Identities = 173/503 (34%), Positives = 267/503 (53%)

Query:   536 TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGA 595
             T+ L  N  +G + PE G L  L   +L  NN SG IP E+  +  L+ LDLS+NN SG 
Sbjct:   598 TLHLGFNEFEGKLPPEIGQLP-LAFLNLTRNNFSGEIPQEIGNLKCLQNLDLSFNNFSGN 656

Query:   596 IPIXXXXXXXXXXXXVANN-HLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESG 654
              P             ++ N  ++G IP+ GQ  TF   SF GN L     +       + 
Sbjct:   657 FPTSLNDLNELSKFNISYNPFISGAIPTTGQVATFDKDSFLGNPLLRFPSFFNQSGNNTR 716

Query:   655 QVKSAKKSRRNKYTI---VGMAIGITFGSAXXXXXXXXXXXRAHSRGEVDPEKEEANTND 711
             ++ +     R +  +   + +A+ + F +            +A    E+D        +D
Sbjct:   717 KISNQVLGNRPRTLLLIWISLALALAFIACLVVSGIVLMVVKASREAEIDLLDGSKTRHD 776

Query:   712 KDLEELGS------KLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD 765
                   GS      K+ V+  +K    +  DIL++T+NF +  ++G GG+G VYR  LPD
Sbjct:   777 MTSSSGGSSPWLSGKIKVIRLDKST-FTYADILKATSNFSEERVVGRGGYGTVYRGVLPD 835

Query:   766 GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-----HPNLVHLQGYCMHKNDRLLIYSFM 820
             GR VA+K+L  +  + E+EFRAE+E LS        HPNLV L G+C+  ++++L++ +M
Sbjct:   836 GREVAVKKLQREGTEAEKEFRAEMEVLSANAFGDWAHPNLVRLYGWCLDGSEKILVHEYM 895

Query:   821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
               GSL+  + +K    + L W  R+ IA   ARGL +LH  C P I+HRD+K+SN+LLD 
Sbjct:   896 GGGSLEELITDK----TKLQWKKRIDIATDVARGLVFLHHECYPSIVHRDVKASNVLLDK 951

Query:   881 NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLEL 940
             +  A + DFGLARL L+  D+HV+T + GT+GY+ PEYGQ   AT +GDVYS+GV+ +EL
Sbjct:   952 HGNARVTDFGLARL-LNVGDSHVSTVIAGTIGYVAPEYGQTWQATTRGDVYSYGVLTMEL 1010

Query:   941 LTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD--KQHD--KEMLRVLDIAC 996
              TG+R +D     G   L+ W  R+   N  ++   P      K  +  ++M  +L I  
Sbjct:  1011 ATGRRAVD----GGEECLVEWARRVMTGNMTAKG-SPITLSGTKPGNGAEQMTELLKIGV 1065

Query:   997 LCLSESPKVRPTTQQLVSWLDSI 1019
              C ++ P+ RP  +++++ L  I
Sbjct:  1066 KCTADHPQARPNMKEVLAMLVKI 1088

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
 Identities = 318/960 (33%), Positives = 462/960 (48%)

Query:    85 GRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV-NLPNLEVLDLSSN 143
             G +  L L    L G++ E   N+ QL  L L++N L G++P S+  N  NLE L LS  
Sbjct:   287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346

Query:   144 DLSGPLPQTIN-LPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLG 202
              LSG +P  ++   S++ LD+S+NSL GS+P ++ +    +  + L  N   GTLSP + 
Sbjct:   347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFE-LVELTDLYLHNNTLEGTLSPSIS 405

Query:   203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS 262
             N  +L+ L L  N+L G +  +I  L+KL +L L +N+ SG++   I + ++L  +D+  
Sbjct:   406 NLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFG 465

Query:   263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHXXXXXXXXXXXXXXXXXXXXXXXXXCP 322
             N+F G IP     L E   L    N   G +P                            
Sbjct:   466 NHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFG 525

Query:   323 ALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFEXXXXXXXXX 382
              L  L  L L  N   G LP +L   R L  INL+ N  +G I     +           
Sbjct:   526 FLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGS--SSYLSFDVT 583

Query:   383 XXXXXXXXALQVLQQCRNLTTLVLTLNFRNEKLP-TDPRLHFANLKVLVIASCGLRGSIP 441
                      L+ L   +NL  L L  N    K+P T  ++    L +L ++S  L G+IP
Sbjct:   584 NNGFEDEIPLE-LGNSQNLDRLRLGKNQLTGKIPWTLGKIR--ELSLLDMSSNALTGTIP 640

Query:   442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITR 501
               L  C KL  +DL+ N LSG IP W G    L  L LS+N F   +P  L     L+  
Sbjct:   641 LQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVL 700

Query:   502 NISLEEPSPDFPFFMRR--NVSARGLQYNQI-WSFPPTID---------LSLNRLDGSIW 549
             ++     +   P  +     ++   L  NQ   S P  +          LS N L G I 
Sbjct:   701 SLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIP 760

Query:   550 PEFGNLKKLH-VFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXXXXXXXXXX 608
              E G L+ L    DL +NN +G IPS +  ++ LETLDLS+N L+G +P           
Sbjct:   761 VEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGY 820

Query:   609 XXVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQVKSAKKSRRNKY 667
               V+ N+L G++    QF  +P  SF GN  LCG     C   R +   K    S R+  
Sbjct:   821 LNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNN--KQQGLSARS-- 874

Query:   668 TIVGMAIGITFGSAXXXXXXXXXXXRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHN 727
              ++  AI                  + H   +       A T+     +   K   LF N
Sbjct:   875 VVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHK--PLFRN 932

Query:   728 --KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKR-LSGDCGQMERE 784
                + +I  +DI+E+T+N  +  +IG GG G VY+A L +G  VA+K+ L  D     + 
Sbjct:   933 GASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS 992

Query:   785 FRAEVEALSRAQHPNLVHLQGYCMHKND--RLLIYSFMENGSLDYWLHEK---LDGPSSL 839
             F  EV+ L R +H +LV L GYC  K++   LLIY +M+NGS+  WLHE    L+    L
Sbjct:   993 FSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL 1052

Query:   840 -DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
              DW++RL IA G A+G+ YLH  C P I+HRDIKSSN+LLD N  AHL DFGLA+++   
Sbjct:  1053 LDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTEN 1112

Query:   899 YDTHVTTD--LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
              DT+  ++     + GYI PEY  +  AT K DVYS G+VL+E++TGK P D        
Sbjct:  1113 CDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFG-AEM 1171

Query:   957 DLISWV---IRMRQENRESEVLDPFIYDKQHDKE--MLRVLDIACLCLSESPKVRPTTQQ 1011
             D++ WV   + +    R+ +++DP +      +E    +VL+IA  C   SP+ RP+++Q
Sbjct:  1172 DMVRWVETHLEVAGSARD-KLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQ 1230

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 608 (219.1 bits), Expect = 1.5e-109, Sum P(2) = 1.5e-109
 Identities = 197/624 (31%), Positives = 280/624 (44%)

Query:    65 WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGT 124
             W  ++    S  G+   +    VT L L    L G LS  + +L  L+ L+L+ N + G 
Sbjct:    50 W-NLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGP 108

Query:   125 VPVSLVNLPNLEVLDLSSNDLSGPLPQTIN--LPSIQVLDISSNSLNGSVPTSICKNSSR 182
             +P  + NL  L  L+LS+N  +G  P  ++  L +++VLD+ +N+L G +P S+  N ++
Sbjct:   109 IPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLT-NLTQ 167

Query:   183 IRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGL-QDNQL 241
             +R ++L  NYFSG +    G    LE+L +  N+LTG I  +I  L  LR L +   N  
Sbjct:   168 LRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAF 227

Query:   242 SGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHXXXXXX 301
                L P I +LS LVR D ++   +G IP     L +   L    N FTG I        
Sbjct:   228 ENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLIS 287

Query:   302 XXXXXXXXXXXXXXXXXXXCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF 361
                                   L NLT L+L  NK  G +P  +    +L+ + L  NNF
Sbjct:   288 SLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNF 347

Query:   362 SGQIPETYKNFEXXXXXXXXXXXXXXXXXALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL 421
             +G IP+  K  E                     +     L TL+   NF    +P D   
Sbjct:   348 TGSIPQ--KLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIP-DSLG 404

Query:   422 HFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQ-DLFYLDLS 480
                +L  + +    L GSIP+ L G  KL  V+L  N L+G +P+  GG   DL  + LS
Sbjct:   405 KCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLS 464

Query:   481 NNTFTGEIPK---NLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
             NN  +G +P    NL+G+  L+          P  P   R       LQ  Q+      +
Sbjct:   465 NNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIP--PEIGR-------LQ--QL----SKL 509

Query:   538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
             D S N   G I PE    K L   DL  N LSG IP+ELTGM  L  L+LS N+L G+IP
Sbjct:   510 DFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIP 569

Query:   598 IXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQV 656
             +             + N+L+G +PS GQF  F  +SF GN+ LCG +   C        V
Sbjct:   570 VTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHV 629

Query:   657 KSAKKSRRNKYTIVGMAIGITFGS 680
             K    S   K  +V   +G+ F S
Sbjct:   630 KPL--SATTKLLLV---LGLLFCS 648

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8LPB4	PSKR1_DAUCA	2, ., 7, ., 1, 1, ., 1	0.6575	0.9911	0.9902	N/A	no
Q9ZVR7	PSKR1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6640	0.9833	0.9950	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00081354 hypothetical protein (1026 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1020
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-102
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-38
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.004
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	0.004
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  342 bits (880), Expect = e-102
 Identities = 297/1013 (29%), Positives = 452/1013 (44%), Gaps = 167/1013 (16%)

Query: 58   SSSDCCHWVGITCNSSS---SLGLNDSIGSGRVTGLF----------LYKRRLKGKL--- 101
            SS+D C W GITCN+SS   S+ L+    SG+++             L   +L G +   
Sbjct: 53   SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112

Query: 102  ----SESL----------------GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLS 141
                S SL                G++  L  L+LS+N+L G +P  + +  +L+VLDL 
Sbjct: 113  IFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172

Query: 142  SNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG 200
             N L G +P ++ NL S++ L ++SN L G +P  + +  S ++ I L  N  SG +   
Sbjct: 173  GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS-LKWIYLGYNNLSGEIPYE 231

Query: 201  LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV 260
            +G   SL HL L  N+LTG I   +  L+ L+ L L  N+LSG + PSI  L  L+ LD+
Sbjct: 232  IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291

Query: 261  SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLN 320
            S N+ SG IP++   L   + L   SN FTG+IP +L++ P L +L L +N   G +  N
Sbjct: 292  SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351

Query: 321  CPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL 380
                 NLT LDL TN                        N +G+IPE            L
Sbjct: 352  LGKHNNLTVLDLSTN------------------------NLTGEIPEG-----------L 376

Query: 381  SNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI 440
             +S                NL  L+L                F+N          L G I
Sbjct: 377  CSSG---------------NLFKLIL----------------FSN---------SLEGEI 396

Query: 441  PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLIT 500
            P+ L  C  L+ V L  N  SG +P  F     +++LD+SNN   G I      +PSL  
Sbjct: 397  PKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM 456

Query: 501  RNISLEEPSPDFP-FFMRRNVSARGLQYNQIWSFPPT----------IDLSLNRLDGSIW 549
             +++  +     P  F  + +    L  NQ     P           + LS N+L G I 
Sbjct: 457  LSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516

Query: 550  PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKF 609
             E  + KKL   DL HN LSG IP+  + M  L  LDLS N LSG IP +L  +  L + 
Sbjct: 517  DELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQV 576

Query: 610  SVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTIDRESGQVKSAKKSRRNKYT 668
            ++++NHL G +PS G F     S+  GN  LCG        D  SG +   K+ R+    
Sbjct: 577  NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG-------DTTSG-LPPCKRVRKTP-- 626

Query: 669  IVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNK 728
                 I  T G+  +L L+    +    R  ++ ++ E      +L+   SK+       
Sbjct: 627  SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVS------ 680

Query: 729  EKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRA 787
             K I+I+DIL S     + N+I  G  G  Y+  ++ +G    +K ++ D   +     A
Sbjct: 681  -KSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIA 735

Query: 788  EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
            ++  L   QHPN+V L G C  +    LI+ ++E  +L   L        +L W+ R  I
Sbjct: 736  DMGKL---QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKI 785

Query: 848  AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            A G A+ L +LH  C P ++  ++    I++DG    HL    L  L+ +     +++  
Sbjct: 786  AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-- 842

Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
                 Y+ PE  +    T K D+Y FG++L+ELLTGK P D  +      ++ W      
Sbjct: 843  ----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYS 897

Query: 968  ENRESEVLDPFIYDKQ--HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
            +      +DP I      +  E++ V+++A  C +  P  RP    ++  L+S
Sbjct: 898  DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (429), Expect = 5e-47
 Identities = 88/269 (32%), Positives = 123/269 (45%), Gaps = 23/269 (8%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRL--SGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
             +G G FG VY+A     G+ VA+K L    +  + ++  R E+  L R  HPN+V L  
Sbjct: 6    KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                K+   L+  + E G L  +L     GP  L  D    IA    RGL YLH      
Sbjct: 66   AFEDKDHLYLVMEYCEGGDLFDYLSRG--GP--LSEDEAKKIALQILRGLEYLH---SNG 118

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-YGQASVA 924
            I+HRD+K  NILLD N    +ADFGLA+ +L        T  VGT  Y+ PE     +  
Sbjct: 119  IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 925  TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
              K DV+S GV+L ELLTGK P      +   D +  +IR                + + 
Sbjct: 177  GPKVDVWSLGVILYELLTGKPP---FSGENILDQL-QLIRRILGP------PLEFDEPKW 226

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                    D+   CL++ P  RPT ++++
Sbjct: 227  SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 3e-46
 Identities = 74/195 (37%), Positives = 97/195 (49%), Gaps = 12/195 (6%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
           +G GGFG VY A     G+ VAIK +   D   +  E   E+E L +  HPN+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             +N   L+  + E GSL   L E       L  D  L I      GL YLH +    I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 868 HRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-YGQASVAT 925
           HRD+K  NILLD + G   LADFGL++L+ S         +VGT  Y+ PE        +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYS 172

Query: 926 YKGDVYSFGVVLLEL 940
            K D++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (418), Expect = 1e-45
 Identities = 79/273 (28%), Positives = 119/273 (43%), Gaps = 37/273 (13%)

Query: 748  NIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
              +G G FG VY A     G+ VAIK +      +       E++ L + +HPN+V L  
Sbjct: 5    EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                ++   L+  + E G L   L ++  G  S D ++R ++ Q     L YLH      
Sbjct: 65   VFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSED-EARFYLRQ-ILSALEYLHSK---G 117

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE------YG 919
            I+HRD+K  NILLD +    LADFGLAR +         T  VGT  Y+ PE      YG
Sbjct: 118  IVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYG 174

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
            +A       D++S GV+L ELLTGK P          D +  + +   + +       + 
Sbjct: 175  KAV------DIWSLGVILYELLTGKPPFP------GDDQLLELFKKIGKPKPPFPPPEWD 222

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               +         D+    L + P+ R T ++ 
Sbjct: 223  ISPE-------AKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  158 bits (402), Expect = 2e-43
 Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 36/278 (12%)

Query: 749  IIGCGGFGLVYRATL-----PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH 802
             +G G FG VY+  L          VA+K L  D   Q   EF  E   + +  HPN+V 
Sbjct: 6    KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G C  +    ++  +ME G L  +L +       L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
              + +HRD+ + N L+  N    ++DFGL+R +    D +        + ++ PE  +  
Sbjct: 122  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEG 178

Query: 923  VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI---RMRQENRESEVLDPF 978
              T K DV+SFGV+L E+ T G++P      +   +++ ++    R+ Q         P 
Sbjct: 179  KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLEYLKNGYRLPQPPNCP----PE 231

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            +Y            D+   C +E P+ RPT  +LV  L
Sbjct: 232  LY------------DLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  157 bits (399), Expect = 5e-43
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 35/278 (12%)

Query: 749  IIGCGGFGLVYRATL-----PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH 802
             +G G FG VY+ TL          VA+K L  D   Q   EF  E   + +  HPN+V 
Sbjct: 6    KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G C  +   +++  +M  G L  +L +    P  L     L  A   ARG+ YL    
Sbjct: 66   LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
              + +HRD+ + N L+  N    ++DFGL+R +    D +        + ++ PE  +  
Sbjct: 123  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLKEG 179

Query: 923  VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI---RMRQENRESEVLDPF 978
              T K DV+SFGV+L E+ T G+ P          +++ ++    R+ +         P 
Sbjct: 180  KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---EVLEYLKKGYRLPKPPNCP----PE 232

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            +Y             +   C +E P+ RPT  +LV  L
Sbjct: 233  LY------------KLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (388), Expect = 1e-41
 Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)

Query: 750  IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHL 803
            +G G FG VY+ TL  DG      VA+K L     + ER EF  E   + +  HPN+V L
Sbjct: 7    LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             G C       ++  +M  G L  +L +  +  +  D    L +A   A+G+ YL     
Sbjct: 67   LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGMEYLESK-- 121

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
             + +HRD+ + N L+  N    ++DFGL+R I               + ++ PE  +   
Sbjct: 122  -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 924  ATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI---RMRQENRESEVLDPFI 979
             T K DV+SFGV+L E+ T G++P      +   +++  +    R+ +     E     +
Sbjct: 181  FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLELLEDGYRLPR----PENCPDEL 233

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            Y            ++   C +  P+ RPT  +LV 
Sbjct: 234  Y------------ELMLQCWAYDPEDRPTFSELVE 256

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  148 bits (375), Expect = 7e-40
 Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 46/289 (15%)

Query: 748  NIIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
              +G G FG VY+  L         VA+K L  D  + ER +F  E   + +  HPN+V 
Sbjct: 1    KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEK-----LDGPSSLDWDSRLHIAQGAARGLAY 857
            L G C  +    L+  +ME G L  +L +          S+L     L  A   A+G+ Y
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-- 915
            L        +HRD+ + N L+  +    ++DFGL+R +    D +       T G +P  
Sbjct: 121  LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKK----TGGKLPIR 172

Query: 916  ---PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI---RMRQE 968
               PE  +  + T K DV+SFGV+L E+ T G  P      +   +++ ++    R+ + 
Sbjct: 173  WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRKGYRLPK- 228

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                E     +Y            ++   C    P+ RPT  +LV  L+
Sbjct: 229  ---PEYCPDELY------------ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (360), Expect = 8e-38
 Identities = 70/207 (33%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 748 NIIGCGGFGLVYRATLPD-GRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
            ++G G FG VY A   D G  +A+K   LSGD  +       E+  LS  QHPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 805 GYCMHKNDRLLIYSFME---NGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G      ++  +  F+E    GSL   L +  KL  P       R +  Q    GLAYLH
Sbjct: 66  G-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-----VIRKYTRQ-ILEGLAYLH 118

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
            +    I+HRDIK +NIL+D +    LADFG A+ +        T  + GT  ++ PE  
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 920 QASVATYKGDVYSFGVVLLELLTGKRP 946
           +        D++S G  ++E+ TGK P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 5e-31
 Identities = 86/285 (30%), Positives = 132/285 (46%), Gaps = 40/285 (14%)

Query: 748  NIIGCGGFGLVYRATL--PDGR--NVAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
             +IG G FG V R  L  P  +  +VAIK L +G   +   +F  E   + +  HPN++ 
Sbjct: 10   KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L+G        ++I  +MENGSLD +L E  DG         + + +G A G+ YL +  
Sbjct: 70   LEGVVTKSRPVMIITEYMENGSLDKFLREN-DG--KFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE 917
                +HRD+ + NIL++ N    ++DFGL+R +     T+ T       G IP     PE
Sbjct: 127  ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRWTAPE 178

Query: 918  YGQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVL 975
                   T   DV+SFG+V+ E+++ G+RP  DM     ++D+I              V 
Sbjct: 179  AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM----SNQDVI------------KAVE 222

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            D +      D     +  +   C  +    RPT  Q+VS LD +I
Sbjct: 223  DGYRLPPPMDCPSA-LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (308), Expect = 6e-31
 Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 30/267 (11%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            IG GGFG VY+A     G+ VAIK +  +  + + +   E++ L + +HPN+V   G   
Sbjct: 8    IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SY 66

Query: 809  HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             K D L ++  F   GSL   L    +   +    +  ++ +   +GL YLH      I+
Sbjct: 67   LKKDELWIVMEFCSGGSLKDLLKST-NQTLTESQIA--YVCKELLKGLEYLH---SNGII 120

Query: 868  HRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATY 926
            HRDIK++NILL  +    L DFGL+ +L  +         +VGT  ++ PE        Y
Sbjct: 121  HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMAPEVINGKPYDY 176

Query: 927  KGDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K D++S G+  +EL  GK P  ++   K          ++           P + + +  
Sbjct: 177  KADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGP------PGLRNPEKW 223

Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQL 1012
             +  +  D    CL ++P+ RPT +QL
Sbjct: 224  SDEFK--DFLKKCLQKNPEKRPTAEQL 248

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 3e-29
 Identities = 79/288 (27%), Positives = 118/288 (40%), Gaps = 55/288 (19%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA----EVEALSRAQHPNLVHLQ 804
            IG G FG VY      DG+   +K +  D   M  + R     EV+ L +  HPN++   
Sbjct: 8    IGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63

Query: 805  GYCMH--KNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHI-AQGAARGLAYL 858
             Y     +  +L I   ME    G L   + ++         +  L    Q     L YL
Sbjct: 64   -YYESFEEKGKLCI--VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-LCLALKYL 119

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
            H      ILHRDIK  NI L  N    L DFG+++++ S  D  +   +VGT  Y+ PE 
Sbjct: 120  H---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPEL 174

Query: 918  -----YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
                 Y       YK D++S G VL EL T K P +        +L+   +++ +     
Sbjct: 175  CQNKPY------NYKSDIWSLGCVLYELCTLKHPFE------GENLLELALKILKGQY-- 220

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                P     Q+  E+  ++      L + P+ RP+  Q+   L S  
Sbjct: 221  ---PPI--PSQYSSELRNLVSS---LLQKDPEERPSIAQI---LQSPF 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 3e-29
 Identities = 71/208 (34%), Positives = 110/208 (52%), Gaps = 14/208 (6%)

Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLS--GDCGQMEREFRAEVEALSRAQHPN 799
           N+   ++IG G FG+VY+   L  G  VAIK++S      +  +    E++ L   +HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 800 LVHLQGYCMHKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           +V   G  +  +D L I   + ENGSL   + +    P SL     +++ Q   +GLAYL
Sbjct: 61  IVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAVYVYQ-VLQGLAYL 115

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H+     ++HRDIK++NIL   +    LADFG+A   L+         +VGT  ++ PE 
Sbjct: 116 HEQ---GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVS-KDDASVVGTPYWMAPEV 170

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
            + S A+   D++S G  ++ELLTG  P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  120 bits (301), Expect = 3e-29
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 22/277 (7%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGD---CGQMEREFRAEVEALSRAQHP-NLVHLQG 805
            +G G FG VY A   D + VA+K L+       +    F  E++ L+   HP N+V L  
Sbjct: 8    LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
            +   +    L+  +++ GSL+  L +       L     L I       L YLH      
Sbjct: 66   FFQDEGSLYLVMEYVDGGSLEDLLKKIGR-KGPLSESEALFILAQILSALEYLHSK---G 121

Query: 866  ILHRDIKSSNILLDGN-FGAHLADFGLARLI----LSPYDTHVTTDLVGTLGYIPPEY-- 918
            I+HRDIK  NILLD +     L DFGLA+L+     +     + +  VGT GY+ PE   
Sbjct: 122  IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 919  -GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
                + A+   D++S G+ L ELLTG  P             +           +  L  
Sbjct: 182  GLSLAYASSSSDIWSLGITLYELLTGLPP----FEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             +     +       D+    L++ PK R ++   +S
Sbjct: 238  PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (295), Expect = 4e-29
 Identities = 75/277 (27%), Positives = 131/277 (47%), Gaps = 26/277 (9%)

Query: 742  NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRL-SGDCGQMEREFRAEVEALSRAQHPN 799
            ++ ++  ++G G  G+VY+    P G+  A+K++      +  ++   E++ L   + P 
Sbjct: 1    SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            +V   G    + +  ++  +M+ GSL   L    K+     L      +IA+   +GL Y
Sbjct: 61   VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKI-PEPVLA-----YIARQILKGLDY 114

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            LH   + HI+HRDIK SN+L++      +ADFG+++++ +  D   T   VGT+ Y+ PE
Sbjct: 115  LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              Q    +Y  D++S G+ LLE   GK P     P G     S+   M+          P
Sbjct: 171  RIQGESYSYAADIWSLGLTLLECALGKFP---FLPPGQ---PSFFELMQAICDGP---PP 221

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             +  ++   E     D    CL + PK RP+  +L+ 
Sbjct: 222  SLPAEEFSPEF---RDFISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (286), Expect = 5e-28
 Identities = 91/281 (32%), Positives = 124/281 (44%), Gaps = 40/281 (14%)

Query: 746  QANIIGCGGFGLVYRA-TLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            + N IG G FG VY A  L  G  +A+K  R+  +  +  +E   E++ L   +HPNLV 
Sbjct: 4    RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 803  LQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
              G  +H+     +Y FME    G+L+  L         +    R++  Q    GLAYLH
Sbjct: 64   YYGVEVHREK---VYIFMEYCSGGTLEELLEHGRILDEHV---IRVYTLQ-LLEGLAYLH 116

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT--DLVGTLGYIPPE 917
                  I+HRDIK +NI LD N    L DFG A  + +   T       L GT  Y+ PE
Sbjct: 117  SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 918  YGQASVATYKG-----DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
                +    KG     D++S G V+LE+ TGKRP        +   I + +    +    
Sbjct: 174  V--ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD---NEFQIMFHVGAGHK---- 224

Query: 973  EVLDPFIYDK-QHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                P I D  Q   E    LD    CL   PK RPT  +L
Sbjct: 225  ----PPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 1e-27
 Identities = 87/285 (30%), Positives = 123/285 (43%), Gaps = 40/285 (14%)

Query: 744  FDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            F     +G G FG V+     +   VAIK L  D    +++F+ EV+AL R +H +L+ L
Sbjct: 8    FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQS 861
               C       +I   ME GS    L   L  P    L   S + +A   A G+AYL   
Sbjct: 68   FAVCSVGEPVYIITELMEKGS----LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-- 121

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP-YDTHVTTDLVGTLGYIP----- 915
             E + +HRD+ + NIL+  +    +ADFGLARLI    Y +            IP     
Sbjct: 122  -EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--------IPYKWTA 172

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
            PE       + K DV+SFG++L E+ T G+ P          D I+   RM    +    
Sbjct: 173  PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK---- 228

Query: 975  LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                IY     K ML        C +  P+ RP+ + L   LD+I
Sbjct: 229  CPQEIY-----KIMLE-------CWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (283), Expect = 2e-27
 Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)

Query: 728  KEKEISIDDILES---TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER 783
            +E + ++ DI+        +     IG G  G VY+AT    G+ VAIK++       E 
Sbjct: 2    EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL 61

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
                E+  +   +HPN+V          D L ++  +M+ GSL   + +           
Sbjct: 62   IIN-EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQN---------F 110

Query: 843  SRLHIAQGAA------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
             R++  Q A       +GL YLH     +++HRDIKS NILL  +    LADFG A  + 
Sbjct: 111  VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167

Query: 897  SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP-MDMCKPKGS 955
                   +  +VGT  ++ PE  +      K D++S G++ +E+  G+ P +    P  +
Sbjct: 168  KEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRA 224

Query: 956  RDLIS--WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              LI+   +  ++   + S     F+                  CL + P+ RP+ ++L+
Sbjct: 225  LFLITTKGIPPLKNPEKWSPEFKDFLN----------------KCLVKDPEKRPSAEELL 268

Query: 1014 S 1014
             
Sbjct: 269  Q 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (278), Expect = 5e-27
 Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 37/274 (13%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG+V+        +VAIK +    G M E +F  E + + +  HPNLV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M NG L  +L E+      L  +  L +       + YL  +     +H
Sbjct: 70   KQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
            RD+ + N L+  +    ++DFGLAR +L   D + ++   GT   + + PPE    S  +
Sbjct: 124  RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSS--QGTKFPVKWAPPEVFDYSRFS 179

Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE--SEVLDPFIYDK 982
             K DV+SFGV++ E+ + GK P +                 R  N E    V   +   +
Sbjct: 180  SKSDVWSFGVLMWEVFSEGKMPYE-----------------RFSNSEVVESVSAGYRLYR 222

Query: 983  QHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                    V  I   C  E P+ RP  ++L+S L
Sbjct: 223  PKLAPT-EVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (271), Expect = 5e-26
 Identities = 84/280 (30%), Positives = 125/280 (44%), Gaps = 40/280 (14%)

Query: 748  NIIGCGGFGLVYRA-TLPDGRNVAIKRLSGD-CGQMEREFRAEVEALSRAQHPNLVHLQG 805
             +IG G   +VY A  LP+   VAIKR+  + C     E R EV+A+S+  HPN+V    
Sbjct: 7    EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 806  YCMHKNDRLLIYSFMENGS-LDYWLHE-KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
              +  ++  L+  ++  GS LD         G   LD      + +   +GL YLH    
Sbjct: 67   SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLKGLEYLHS--N 121

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD--THVTTDLVGTLGYIPPE-YGQ 920
              I HRDIK+ NILL  +    +ADFG++  +    D    V    VGT  ++ PE   Q
Sbjct: 122  GQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
                 +K D++SFG+  +EL TG  P     P         V+ +  +N      DP   
Sbjct: 181  VHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQN------DPPSL 227

Query: 981  DKQHD--------KEMLRVLDIACLCLSESPKVRPTTQQL 1012
            +   D        ++M+       LCL + P  RPT ++L
Sbjct: 228  ETGADYKKYSKSFRKMIS------LCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 8e-26
 Identities = 72/218 (33%), Positives = 106/218 (48%), Gaps = 36/218 (16%)

Query: 744 FDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMERE-F-----RAEVEALSRAQ 796
           +++   IG G +G VY+A     G  VA+K++  +    E+E F     R E++ L + +
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIR-EIKLLQKLR 56

Query: 797 HPNLVHLQGYC--MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL-HIAQGAAR 853
           HPN+V L+       K    +++ +M++   D  L   LD P     +S++    +    
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDH---D--LTGLLDSPEVKFTESQIKCYMKQLLE 111

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           GL YLH +    ILHRDIK SNIL++ +    LADFGLAR           T+ V TL Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWY 167

Query: 914 IPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PPE       YG         D++S G +L EL  GK
Sbjct: 168 RPPELLLGATRYGPEV------DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  106 bits (266), Expect = 1e-25
 Identities = 73/248 (29%), Positives = 115/248 (46%), Gaps = 37/248 (14%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G FGLV+     + R VAIK +    G M E +F  E + + +  HP LV L G C 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            ++   L++ FME+G L  +L  +         ++ L +      G+AYL  S    ++H
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
           RD+ + N L+  N    ++DFG+ R +L    T  T    GT   + +  PE    S  +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYS 179

Query: 926 YKGDVYSFGVVLLELLT-GKRPMD----------------MCKPK----GSRDLISWVIR 964
            K DV+SFGV++ E+ + GK P +                + KP+       +L+    +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239

Query: 965 MRQENRES 972
            R E+R S
Sbjct: 240 ERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (264), Expect = 4e-25
 Identities = 69/234 (29%), Positives = 98/234 (41%), Gaps = 20/234 (8%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLS-GDCGQME--REFRAEVEALSRAQHP 798
           +F+   +IG G FG V      D + + A+K ++   C +    R    E   L    HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 799 NLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            LV+L  Y     + + L+   +  G L Y L +K     S +   +  I +     L Y
Sbjct: 61  FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEE-QVKFWICE-IVLALEY 115

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I+HRDIK  NILLD     H+ DF +A  +    DT  TT   GT GY+ PE
Sbjct: 116 LH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTL-TTSTSGTPGYMAPE 169

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
                  +   D +S GV   E L GKRP        SR +   +   ++    
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPY----RGHSRTIRDQIRAKQETADV 219

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  104 bits (262), Expect = 8e-25
 Identities = 89/282 (31%), Positives = 142/282 (50%), Gaps = 33/282 (11%)

Query: 749  IIGCGGFGLVYRATL-PDGRN---VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            +IG G FG V R  L   G+    VAIK L SG   +  R+F +E   + +  HPN++HL
Sbjct: 11   VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            +G        ++I  FMENG+LD +L +  DG  ++     + + +G A G+ YL    E
Sbjct: 71   EGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTV--IQLVGMLRGIAAGMKYL---SE 124

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLG--YIPPEYGQ 920
             + +HRD+ + NIL++ N    ++DFGL+R +     D   T+ L G +   +  PE   
Sbjct: 125  MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
                T   DV+S+G+V+ E+++ G+RP  DM     ++D+I+ +    Q+ R    +D  
Sbjct: 185  YRKFTSASDVWSYGIVMWEVMSYGERPYWDM----SNQDVINAI---EQDYRLPPPMDCP 237

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                Q       +LD    C  +    RP   Q+VS LD +I
Sbjct: 238  TALHQ------LMLD----CWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 8e-25
 Identities = 74/224 (33%), Positives = 113/224 (50%), Gaps = 37/224 (16%)

Query: 750 IGCGGFGLVYRATL--PDGR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH 802
           +G G FG VY+  L  P+ R    +VAIK L  +   ++++EFR E E +S  QHPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKL----------------DGPSSLDWDSRLH 846
           L G C  +    +++ ++ +G     LHE L                   SSLD    LH
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGD----LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           IA   A G+ YL      H +HRD+ + N L+       ++DFGL+R I S     V + 
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 907 LVGTLGYIPPE---YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +  + ++PPE   YG+ +  +   D++SFGVVL E+ + G +P
Sbjct: 186 SLLPVRWMPPEAILYGKFTTES---DIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (261), Expect = 1e-24
 Identities = 76/285 (26%), Positives = 115/285 (40%), Gaps = 24/285 (8%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLV 801
              +G G FG V      P G N    VA+K L+     Q   +F  E+E L    H N+V
Sbjct: 10   KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 802  HLQGYC--MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
              +G C         LI  ++ +GSL  +L    D    ++    L  +    +G+ YL 
Sbjct: 70   KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLG 126

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP---- 915
                   +HRD+ + NIL++      ++DFGLA+++    D +     V   G  P    
Sbjct: 127  ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY----VKEPGESPIFWY 179

Query: 916  -PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
             PE  + S  +   DV+SFGV L EL T   P     P     +I          R  E+
Sbjct: 180  APECLRTSKFSSASDVWSFGVTLYELFTYGDP-SQSPPAEFLRMIGIAQGQMIVTRLLEL 238

Query: 975  LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            L       +       V D+  LC    P+ RP+   L+  +D +
Sbjct: 239  LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-24
 Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 25/205 (12%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLS------GDCGQMEREFRAEVEALSRAQHPNLVH 802
           IG G +G+VY+A     G  VAIK++       G      RE    ++ L    HPN++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS-LDWDSRLHIAQGAARGLAYLHQS 861
           L     HK D  L++ FM+       L++ +      L             +GLA+ H  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDTD-----LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YG 919
               ILHRD+K  N+L++      LADFGLAR   SP   +  T  V T  Y  PE   G
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPELLLG 172

Query: 920 QASVATYKGDVYSFGVVLLELLTGK 944
                +   D++S G +  ELL+ +
Sbjct: 173 -DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 43/278 (15%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            IG G FG V       G+ VA+K L  D     + F AE   ++  +HPNLV L G  + 
Sbjct: 14   IGKGEFGDVMLGDY-RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 810  KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
             N   ++  +M  GSL  +L  +  G + +    +L  A     G+ YL    E + +HR
Sbjct: 72   GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 870  DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQASVATYK 927
            D+ + N+L+  +  A ++DFGLA+      +     D  G L   +  PE  +    + K
Sbjct: 127  DLAARNVLVSEDLVAKVSDFGLAK------EASQGQD-SGKLPVKWTAPEALREKKFSTK 179

Query: 928  GDVYSFGVVLLELLT-GKRPMDMCKPK-GSRDLISWV---IRMRQENRES-EVLDPFIYD 981
             DV+SFG++L E+ + G+ P     P+   +D++  V    RM     E+ E   P +Y 
Sbjct: 180  SDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPHVEKGYRM-----EAPEGCPPEVYK 230

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
               D            C    P  RPT +QL   L  I
Sbjct: 231  VMKD------------CWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 4e-24
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 30/220 (13%)

Query: 744 FDQANIIGCGGFGLVYRAT-LPDGRN----VAIKRLSGDCG-QMEREFRAEVEALSRAQH 797
            ++  ++G G FG VY+   +P+G      VAIK L  +   +  +E   E   ++   H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARG 854
           P++V L G C+      LI   M  G L  ++      +     L+W  ++      A+G
Sbjct: 69  PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           ++YL    E  ++HRD+ + N+L+       + DFGLA+L L   +     +     G +
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LDVDEKEYHAEG----GKV 173

Query: 915 P-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
           P      E     + T+K DV+S+GV + EL+T G +P +
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (256), Expect = 5e-24
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 33/279 (11%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHP 798
            ++ +    +G G  G+V +    P G+ +A+K  RL  +   ++++   E++ L +   P
Sbjct: 1    DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSP 59

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
             +V   G   +  D  +   +M+ GSLD  L E + G        +  IA    +GL YL
Sbjct: 60   YIVGFYGAFYNNGDISICMEYMDGGSLDKILKE-VQGRIPERILGK--IAVAVLKGLTYL 116

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPE 917
            H+  +  I+HRD+K SNIL++      L DFG++ +L+ S     +    VGT  Y+ PE
Sbjct: 117  HE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-----LAKTFVGTSSYMAPE 169

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK--PKGSRDLISWVIRMRQENRESEVL 975
              Q +  + K D++S G+ L+EL TG+ P       P G  +L+ +++     N     L
Sbjct: 170  RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-----NEPPPRL 224

Query: 976  --DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                F  D Q             LCL + P+ RP+ ++L
Sbjct: 225  PSGKFSPDFQD---------FVNLCLIKDPRERPSYKEL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (255), Expect = 5e-24
 Identities = 85/276 (30%), Positives = 127/276 (46%), Gaps = 30/276 (10%)

Query: 743  NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEV--EA--LSRAQH 797
            +F+  N IG G FG+V++     D R  A+K++  D  +M R  R E   EA  L++   
Sbjct: 1    DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDS 58

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
              ++      + K    ++  + ENG L   L  +   P   D   R  I      GLA+
Sbjct: 59   SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILLGLAH 116

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            LH      ILHRDIKS N+ LD      + D G+A+ +LS  +T+    +VGT  Y+ PE
Sbjct: 117  LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSD-NTNFANTIVGTPYYLSPE 171

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              +      K DV++ GVVL E  TGK P D    +G+  LI  +IR             
Sbjct: 172  LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGA--LILKIIRGVFPPV------S 222

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
             +Y +Q       +  +   CL++  + RP T QL+
Sbjct: 223  QMYSQQ-------LAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 6e-24
 Identities = 63/208 (30%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLS-------GDCGQMEREFRAEVEALSRAQHPNLV 801
           +G G FG V      D G+  A+K L         +          E   LSR  HP +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT----LTERNILSRINHPFIV 56

Query: 802 HLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            L  Y     ++L L+  +   G L   L    +       +  +R + A+     L YL
Sbjct: 57  KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-----EERARFYAAE-IVLALEYL 109

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H      I++RD+K  NILLD +    L DFGLA+ + S  +   T    GT  Y+ PE 
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEV 164

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
                     D +S GV+L E+LTGK P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 7e-24
 Identities = 70/213 (32%), Positives = 98/213 (46%), Gaps = 39/213 (18%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE------FRAEVEALSRAQHPNLV 801
            +G G +G+VY+A     G  VA+K++  D    E E       R E+  L   +HPN+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALR-EISLLKELKHPNIV 61

Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            L      +    L++ + +    D  L    +K  GP S +      I     RGLAY 
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM---D--LKKYLDKRPGPLSPNL--IKSIMYQLLRGLAYC 114

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
           H      ILHRD+K  NIL++ +    LADFGLAR    P  T+  T  V TL Y  PE 
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEI 169

Query: 918 ------YGQASVATYKGDVYSFGVVLLELLTGK 944
                 Y   +V     D++S G +  E++TGK
Sbjct: 170 LLGSKHYS-TAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 31/220 (14%)

Query: 750 IGCGGFGLVYRATL----PDGRN--VAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH 802
           +G G FG V+        P+     VA+K L         ++F  E E L+  QH N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEK------LDGPSS----LDWDSRLHIAQGAA 852
             G C   +  ++++ +ME+G L+ +L         L  P S    L     L IA   A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGT 910
            G+ YL      H +HRD+ + N L+  +    + DFG++R + +   Y     T L   
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML--P 187

Query: 911 LGYIPPE---YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           + ++PPE   Y +    T + DV+SFGVVL E+ T GK+P
Sbjct: 188 IRWMPPESIMYRK---FTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 12/200 (6%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG V+     +   VA+K L    G M+ ++F AE + + + +HP L+ L   C 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    ++   M+ GSL  +L        +L     + +A   A G+AYL      + +H
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSP-YDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N+L+  N    +ADFGLAR+I    Y+          + +  PE    +  + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 928 GDVYSFGVVLLELLT-GKRP 946
            DV+SFG++L E++T G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  102 bits (256), Expect = 2e-23
 Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 33/276 (11%)

Query: 745  DQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVH 802
            ++ N IG G  G VY+    P GR  A+K + G+    + R+   E+E L    HPN+V 
Sbjct: 77   ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                  H  +  ++  FM+ GSL+        G    D      +A+    G+AYLH+  
Sbjct: 137  CHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLHRR- 187

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE----- 917
              HI+HRDIK SN+L++      +ADFG++R++    D   ++  VGT+ Y+ PE     
Sbjct: 188  --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTD 243

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
                +   Y GD++S GV +LE   G+ P  + + +G    +   I M Q          
Sbjct: 244  LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPPEAPATASR 302

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                            I+C CL   P  R +  QL+
Sbjct: 303  EFRHF-----------ISC-CLQREPAKRWSAMQLL 326

Length = 353

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 99.6 bits (248), Expect = 3e-23
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 33/270 (12%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG+V         +VAIK +    G M E EF  E + + +  H  LV L G C 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M NG L  +L E             L + +    G+AYL        +H
Sbjct: 70   KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIH 123

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
            RD+ + N L+D      ++DFGL+R +L   D + ++  VG+   + + PPE    S  +
Sbjct: 124  RDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSS--VGSKFPVRWSPPEVLLYSKFS 179

Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV++FGV++ E+ + GK P +      + + +S  +R+ + +  SE           
Sbjct: 180  SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE----------- 228

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                 +V  I   C  E  + RPT QQL+S
Sbjct: 229  -----KVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  100 bits (250), Expect = 4e-23
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 32/242 (13%)

Query: 781  MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
            + ++   E++ +   + P +V   G  +++N+  +   FM+ GSLD     K  GP  ++
Sbjct: 46   VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVE 103

Query: 841  WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPY 899
                  IA     GL YL+      I+HRDIK SNIL++      L DFG++  LI S  
Sbjct: 104  ILG--KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159

Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------- 951
            DT      VGT  Y+ PE  Q    T K DV+S G+ ++EL  GK P             
Sbjct: 160  DT-----FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD 214

Query: 952  PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
            P G  DL+  ++             P +      +++   +D    CL + P  RPT QQ
Sbjct: 215  PMGILDLLQQIV-----QEPP----PRLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQ 262

Query: 1012 LV 1013
            L 
Sbjct: 263  LC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 99.6 bits (248), Expect = 5e-23
 Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 21/209 (10%)

Query: 749 IIGCGGFGLVY--RATLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +IG G FG V   R  LP  R   VAIK L +G   +  R+F +E   + +  HPN++HL
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           +G        +++  +MENGSLD +L  K DG  ++     + + +G A G+ YL    +
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTV--IQLVGMLRGIASGMKYL---SD 124

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
              +HRD+ + NIL++ N    ++DFGL+R++    +   TT      G IP     PE 
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT----RGGKIPIRWTAPEA 180

Query: 919 GQASVATYKGDVYSFGVVLLELLT-GKRP 946
                 T   DV+S+G+V+ E+++ G+RP
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 73/211 (34%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 748 NIIGCGGFGLVYRATL--PDGRN----VAIKRLSGDC-GQMEREFRAEVEALSRAQHPNL 800
             +G G FG VY       DG      VA+K L   C  Q E +F  E   +S+  H N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 801 VHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARGLAY 857
           V L G    +  R ++   M  G L  +L E   + + PSSL     L  A+  A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFG----AHLADFGLARLIL--SPYDTHVTTDLVGTL 911
           L    E H +HRDI + N LL    G    A +ADFG+AR I   S Y       L   +
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAML--PI 185

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
            ++PPE     + T K DV+SFGV+L E+ +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 34/276 (12%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VA+K L    G M  E F  E + + + +H  LV L   C 
Sbjct: 14   LGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L         L     + +A   A G+AYL      + +H
Sbjct: 72   EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
            RD+ + NIL+  N    +ADFGLARLI    Y           + +  PE       T K
Sbjct: 127  RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184

Query: 928  GDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
             DV+SFG++L E++T G+ P   M       +R+++  V R  +  R     +  +Y   
Sbjct: 185  SDVWSFGILLTEIVTYGRVPYPGMT------NREVLEQVERGYRMPRPPNCPEE-LY--- 234

Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                     D+   C  + P+ RPT + L S+L+  
Sbjct: 235  ---------DLMLQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.7 bits (243), Expect = 2e-22
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 23/219 (10%)

Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRN---VAIKRLSGDCGQMER-EFRAEVEALSR 794
             ++  +  +IG G FG V+R  L   GR    VAIK L     + +R +F +E   + +
Sbjct: 3   HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQ 62

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             H N++ L+G        ++I  +MENG+LD +L +     SS      L   +G A G
Sbjct: 63  FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML---RGIAAG 119

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS-PYDTHVTTDLVGTLGY 913
           + YL    + + +HRD+ + NIL++ N    ++DFGL+R++   P  T+ T+      G 
Sbjct: 120 MKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG-----GK 171

Query: 914 IPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
           IP  +       Y+      DV+SFG+V+ E+++ G+RP
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 5e-22
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 30/227 (13%)

Query: 742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSR 794
           NN +    IG G FG V++A  P          VA+K L  +    M+ +F+ E   ++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD--------YWLHE----------KLDGP 836
             HPN+V L G C       L++ +M  G L+                           P
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
             L    +L IA+  A G+AYL    E   +HRD+ + N L+  N    +ADFGL+R I 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 897 SP-YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
           S  Y      D +  + ++PPE    +  T + DV+++GVVL E+ +
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.7 bits (240), Expect = 8e-22
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 750 IGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A         D   VA+K L        ++F  E E L+  QH ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLH---------EKLDGPSSLDWDSRLHIAQGAARG 854
            G C+  +  ++++ +M++G L+ +L           + + P+ L     LHIAQ  A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + YL      H +HRD+ + N L+  N    + DFG++R + S     V    +  + ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           PPE       T + DV+S GVVL E+ T GK+P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 83/272 (30%), Positives = 126/272 (46%), Gaps = 31/272 (11%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VAIK L    G M  E F AE   + + QHP LV L    +
Sbjct: 14   LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYA-VV 70

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    +I  +MENGSL  +L  K      L  +  + +A   A G+A++ +    + +H
Sbjct: 71   TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIH 125

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
            RD++++NIL+       +ADFGLARLI  + Y           + +  PE       T K
Sbjct: 126  RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIK 183

Query: 928  GDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
             DV+SFG++L E++T G+ P   M  P+  ++L     RM + +   E L          
Sbjct: 184  SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEEL---------- 232

Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   ++  LC  E P+ RPT + L S L+
Sbjct: 233  ------YELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 79/305 (25%), Positives = 120/305 (39%), Gaps = 53/305 (17%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLS---GDCGQMEREFRAEVEALSRAQH 797
            N ++   ++G G +G+V +      G  VAIK+      D    +   R EV+ L + +H
Sbjct: 1    NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRH 59

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS-RLHIAQGAARGLA 856
             N+V+L+     K    L++ ++E   L+  L      P  L  D+ R +I Q   + +A
Sbjct: 60   ENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEAS---PGGLPPDAVRSYIWQ-LLQAIA 114

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            Y H     +I+HRDIK  NIL+  +    L DFG AR + +   + + TD V T  Y  P
Sbjct: 115  YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAP 170

Query: 917  E-------YGQASVATYKGDVYSFGVVLLELLTGKRP--------------MDMCKPKGS 955
            E       YG+        DV++ G ++ ELL G  P                   P   
Sbjct: 171  ELLVGDTNYGKPV------DVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQ------HDKEMLRVLDIACLCLSESPKVRPTT 1009
                          R + V  P     +        K     LD    CL   PK R T 
Sbjct: 224  SH----QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279

Query: 1010 QQLVS 1014
             +L+ 
Sbjct: 280  DELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 93.6 bits (233), Expect = 9e-21
 Identities = 70/289 (24%), Positives = 120/289 (41%), Gaps = 25/289 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQM-EREFRAEVEALSRAQHPN 799
                + + +G G  G V +  L +   + A+K ++ D     +++   E+E     + P 
Sbjct: 1    EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 800  LVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            +V   G  + ++   +     + E GSLD    +       +       IA+   +GL+Y
Sbjct: 61   IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPP 916
            LH      I+HRDIK SNILL       L DFG++  L+ S   T       GT  Y+ P
Sbjct: 121  LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAP 172

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPM--DMCKPKGSRDLISWVIRMRQENRESEV 974
            E  Q    +   DV+S G+ LLE+   + P   +   P G  +L+S+++ M     + E 
Sbjct: 173  ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232

Query: 975  LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS---WLDSII 1020
             +   + ++         D    CL + P  RPT   ++        + 
Sbjct: 233  GNGIKWSEE-------FKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.0 bits (232), Expect = 9e-21
 Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 40/233 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRA-----EVEALSR- 794
           ++F    IIG G F  V  A      +  AIK L     Q+ +E +      E E L+R 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58

Query: 795 AQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDW-DSRLHIAQGAA 852
             HP ++ L  Y     + L  +  +  NG L  ++ +      SLD   +R + A+   
Sbjct: 59  NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAE-IL 112

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL----- 907
             L YLH      I+HRD+K  NILLD +    + DFG A+ +L P  +  +        
Sbjct: 113 LALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNI 168

Query: 908 --------------VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
                         VGT  Y+ PE      A    D+++ G ++ ++LTGK P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 77/279 (27%), Positives = 118/279 (42%), Gaps = 39/279 (13%)

Query: 748  NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM-ERE---FRAEVEALSRAQHPNLVH 802
              IG G FG V +     DG+ +  K +  D G M E+E     +EV  L   +HPN+V 
Sbjct: 6    ETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIV- 62

Query: 803  LQGYCMHKNDR--LLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
               Y     DR    +Y  ME    G L   + +       ++ +    I       L  
Sbjct: 63   --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 858  LH--QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
             H        +LHRD+K +NI LD N    L DFGLA+++   +D+      VGT  Y+ 
Sbjct: 121  CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMS 178

Query: 916  PEYGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            PE  Q +  +Y  K D++S G ++ EL     P      +    L S +    +E +   
Sbjct: 179  PE--QLNHMSYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKI----KEGKFRR 229

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            +  P+ Y  +     L  + I    L+  P  RP+T++L
Sbjct: 230  I--PYRYSSE-----LNEV-IK-SMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 29/271 (10%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG+V+         VAIK ++   G M E +F  E + + +  HP LV L G C 
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  FMENG L  +L ++      L  D  L + Q    G+ YL ++     +H
Sbjct: 70   QQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIH 123

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG-TLGYIPPEYGQASVATYK 927
            RD+ + N L+       ++DFG+ R +L   D + ++      + + PPE    S  + K
Sbjct: 124  RDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 928  GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
             DV+SFGV++ E+ T GK P +    K + +++  + R  +  R      P +      +
Sbjct: 182  SDVWSFGVLMWEVFTEGKMPFE---KKSNYEVVEMISRGFRLYR------PKLASMTVYE 232

Query: 987  EMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
             M         C  E P+ RPT  +L+  + 
Sbjct: 233  VMYS-------CWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 744  FDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            ++    IG G +G VY+A  +  G  VAIK +  + G      + E+  L   +HPN+V 
Sbjct: 5    YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 803  LQG-YCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
              G Y   + D+L I   ME    GSL         GP  L      ++ +   +GLAYL
Sbjct: 65   YFGSY--LRRDKLWI--VMEYCGGGSLQDIYQV-TRGP--LSELQIAYVCRETLKGLAYL 117

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
            H++     +HRDIK +NILL  +    LADFG++  + +      +   +GT  ++ PE 
Sbjct: 118  HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEV 172

Query: 919  GQ-ASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI----RMRQENRE 971
                    Y  K D+++ G+  +EL   + PM    P  +  LIS       +++ + + 
Sbjct: 173  AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232

Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            S V   FI  K+              CL++ PK RPT  +L+ 
Sbjct: 233  SPVFHDFI--KK--------------CLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 78/277 (28%), Positives = 119/277 (42%), Gaps = 35/277 (12%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS--GDCGQMEREFRAEVEALSRAQHPNL 800
            FD    +G G +G VY+A     G+ VAIK +    D  ++ +E    +  L +   P +
Sbjct: 5    FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYI 60

Query: 801  VHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            V   G    KN  L I   ME    GS+   +  K+    +L  +    I     +GL Y
Sbjct: 61   VKYYG-SYFKNTDLWI--VMEYCGAGSVSDIM--KITN-KTLTEEEIAAILYQTLKGLEY 114

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            LH +     +HRDIK+ NILL+    A LADFG++  +        T  ++GT  ++ PE
Sbjct: 115  LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              Q      K D++S G+  +E+  GK P     P   R      I M        + DP
Sbjct: 170  VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP--MR-----AIFMIPNKPPPTLSDP 222

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                ++   E    +     CL + P+ RP+  QL+ 
Sbjct: 223  ----EKWSPEFNDFVK---KCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 20/223 (8%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHP 798
           T  F+   +IG G +G VY+A     G+ VAIK +       E E + E   L + + HP
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHP 63

Query: 799 NLVHLQGYCMHKN-----DRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
           N+    G  + KN     D+L L+      GS+   +         L  +   +I +   
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGLAYLH++    ++HRDIK  NILL  N    L DFG++  + S          +GT  
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPY 178

Query: 913 YIPPE-----YGQASVATYKGDVYSFGVVLLELLTGKRPM-DM 949
           ++ PE         +    + DV+S G+  +EL  GK P+ DM
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 22/216 (10%)

Query: 750 IGCGGFGLVYRAT------LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A         D   VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLH------------EKLDGPSSLDWDSRLHIAQGA 851
            G C   +  ++++ +M++G L+ +L             +       L     LHIA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
           A G+ YL      H +HRD+ + N L+  N    + DFG++R + S     V    +  +
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            ++PPE       T + DV+SFGV+L E+ T GK+P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 81/295 (27%), Positives = 120/295 (40%), Gaps = 57/295 (19%)

Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++ +    ER EF  E   +      ++V
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGL 855
             L G        L++   M  G L  +L       E   G         + +A   A G+
Sbjct: 73   RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            AYL        +HRD+ + N ++  +    + DFG+ R I   Y+T       G  G +P
Sbjct: 133  AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI---YETDYYRK--GGKGLLP 184

Query: 916  -----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN 969
                 PE  +  V T K DV+SFGVVL E+ T  ++P                    Q  
Sbjct: 185  VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-------------------QGL 225

Query: 970  RESEVLDPFIYDKQHDK------EMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
               EVL  F+ D  H        + L  L++  +C   +PK+RPT  ++VS L  
Sbjct: 226  SNEEVLK-FVIDGGHLDLPENCPDKL--LELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 85/271 (31%), Positives = 121/271 (44%), Gaps = 34/271 (12%)

Query: 750  IGCGGFGLVYRA-TLPDGRNVAIKRLS-GDCGQMERE----FRAEVEALSRAQHPNLVHL 803
            +G G FG VY    L DG   A+K +S  D GQ  +E       E+  LS+ QHPN+V  
Sbjct: 8    LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 804  QGYCMHKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             G    + D L I+   +  GSL   L +    P  +    RL+  Q    GL YLH   
Sbjct: 68   LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV---IRLYTRQILL-GLEYLHDR- 121

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY-GQA 921
              + +HRDIK +NIL+D N    LADFG+A+ ++            G+  ++ PE   Q 
Sbjct: 122  --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEVIAQQ 176

Query: 922  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
                   D++S G  +LE+ TGK P    +          V  + +  R  E+  P I D
Sbjct: 177  GGYGLAADIWSLGCTVLEMATGKPPWSQLEG---------VAAVFKIGRSKEL--PPIPD 225

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               D+    +L     CL   P +RPT  +L
Sbjct: 226  HLSDEAKDFIL----KCLQRDPSLRPTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 750 IGCGGFGLVYRAT----LPDGRN--VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A     LP+     VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE-----------KLDGPSSLDWDSRLHIAQGAA 852
            G C      L+++ +M +G L+ +L             +   P  L     L IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ YL      H +HRD+ + N L+       + DFG++R I S     V    +  + 
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           ++PPE       T + D++SFGVVL E+ T GK+P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 748 NIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           + +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           C  +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + 
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125

Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           +HRD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS 183

Query: 926 YKGDVYSFGVVLLELLT 942
            K DV++FGV+L E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 91.2 bits (226), Expect = 8e-20
 Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 33/223 (14%)

Query: 742 NNFDQANIIGCGGFGLVYRATL-PDG--RNVAIKRLSGDCGQME-REFRAEVEALSR-AQ 796
           N+    ++IG G FG V +A +  DG   + AIKR+     + + R+F  E+E L +   
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKL-----------DGPSSLDWDSR 844
           HPN+++L G C H+    L   +  +G+L D+    ++              S+L     
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           LH A   ARG+ YL Q      +HRD+ + NIL+  N+ A +ADFGL+R      + +V 
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 179

Query: 905 TDLVGTLGYIPP-----EYGQASVATYKGDVYSFGVVLLELLT 942
                T+G +P      E    SV T   DV+S+GV+L E+++
Sbjct: 180 K----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 86/284 (30%), Positives = 135/284 (47%), Gaps = 37/284 (13%)

Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D  ++E +F  E   +    HPN++
Sbjct: 1    RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 802  HLQGYCMHKNDR-LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG--AARGLAYL 858
             L G C+      L++  +M++G L  ++  +   P+  D      I  G   A+G+ YL
Sbjct: 60   SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPP 916
                    +HRD+ + N +LD +F   +ADFGLAR I     Y  H  T     + ++  
Sbjct: 115  ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E  Q    T K DV+SFGV+L EL+T G  P          D+  ++++ R+  +     
Sbjct: 172  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRLLQPEYCP 228

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            DP +Y+      ML        C    P++RPT  +LVS ++ I
Sbjct: 229  DP-LYEV-----MLS-------CWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 71/232 (30%), Positives = 103/232 (44%), Gaps = 57/232 (24%)

Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMERE--------FRAEVE 790
           S   F++ N IG G +G+VYRA     G  VA+K++     +M+ E         R E+ 
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLR-EIT 58

Query: 791 ALSRAQHPNLVHLQ---------------GYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            L   +HPN+V L+                YC      LL               + +  
Sbjct: 59  LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL---------------DNMPT 103

Query: 836 PSSLDWDSRLH-IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
           P S   +S++  +     RGL YLH++    I+HRD+K SN+LL       +ADFGLAR 
Sbjct: 104 PFS---ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157

Query: 895 ILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
              P    +T  +V TL Y  PE   G  +  T   D+++ G +L ELL  K
Sbjct: 158 YGLP-AKPMTPKVV-TLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 749 IIGCGGFGLVYRA-TLPDGRNVAIK------RLSGDCGQMERE----FRAEVEALSRAQH 797
           +IG G +G VY A  +  G  +A+K       ++G     +++     R+E+E L    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+   +    +   ++  GS+   L          +        +    GLAY
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAY 123

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      ILHRD+K+ N+L+D +    ++DFG+++     YD      + G++ ++ PE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 918 YGQASVATY--KGDVYSFGVVLLELLTGKRP 946
              +    Y  K D++S G V+LE+  G+RP
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G FG VY+  L     VA+K   S     ++R+F  E E L +  HPN+V L G C+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            K    ++   +  GSL  +L +K +    L     L ++  AA G+ YL        +H
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQ 920
           RD+ + N L+  N    ++DFG++R      +  + T +   L  IP     PE   YG+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYT-VSDGLKQIPIKWTAPEALNYGR 171

Query: 921 ASVATYKGDVYSFGVVLLELLTG 943
            +  +   DV+S+G++L E  + 
Sbjct: 172 YTSES---DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 88.7 bits (221), Expect = 7e-19
 Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 50/223 (22%)

Query: 748 NIIGCGGFGLVYRAT-LPDGRNVAIKRLSG------DCGQMEREFRAEVEALSRAQHPNL 800
             IG G +G+V  A     GR VAIK++S       D    +R  R E++ L   +H N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA---KRILR-EIKLLRHLRHENI 61

Query: 801 VHL-------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA----Q 849
           + L              ND  ++   ME    D  LH+ +  P  L   +  HI     Q
Sbjct: 62  IGLLDILRPPSPEDF--NDVYIVTELME---TD--LHKVIKSPQPL---TDDHIQYFLYQ 111

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLV 908
              RGL YLH +   +++HRD+K SNIL++ N    + DFGLAR +    D     T+ V
Sbjct: 112 -ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 909 GTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            T  Y  PE       Y +A       D++S G +  ELLT K
Sbjct: 168 VTRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 33/281 (11%)

Query: 743  NFDQANIIGCGGFG--LVYRATLPDGRNVAIKRLS-GDCGQMEREF-RAEVEALSRAQHP 798
            ++    ++G G FG   +YR T  D   V  K ++     + ER     E+  LS  QHP
Sbjct: 1    HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA--QGAARGLA 856
            N++    + M  ++ LLI     NG     L++K+       ++  + +         ++
Sbjct: 60   NIIAYYNHFM-DDNTLLIEMEYANGGT---LYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            Y+H++    ILHRDIK+ NI L       L DFG+++++ S Y    T  +VGT  Y+ P
Sbjct: 116  YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSP 170

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
            E  Q     +K D+++ G VL ELLT KR  D      + + ++ V+++ Q N    V  
Sbjct: 171  ELCQGVKYNFKSDIWALGCVLYELLTLKRTFD------ATNPLNLVVKIVQGNYTPVV-- 222

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ-LVSWL 1016
                   +  E++ ++      L + P+ RPT  + L   L
Sbjct: 223  -----SVYSSELISLVH---SLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 87/302 (28%), Positives = 143/302 (47%), Gaps = 51/302 (16%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKR-LSGDCGQMERE--FRAEVEALSRAQH 797
              ++   ++G G +G+V +    + G+ VAIK+ L  +  +M ++   R E+  L + +H
Sbjct: 1    EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRH 59

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGLA 856
             NLV+L      K    L++ F+++  LD    +    P+ LD    R ++ Q   RG+ 
Sbjct: 60   ENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQ-ILRGIE 114

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            + H     +I+HRDIK  NIL+  +    L DFG AR + +P +  V TD V T  Y  P
Sbjct: 115  FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAP 169

Query: 917  E-------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-DLISWVIRM--- 965
            E       YG+A       D+++ G ++ E+LTG+ P+    P  S  D +  +I+    
Sbjct: 170  ELLVGDTKYGRAV------DIWAVGCLVTEMLTGE-PL---FPGDSDIDQLYHIIKCLGN 219

Query: 966  ---RQEN-----------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
               R +            R  EV +    +K+  K    VLD+A  CL   P  RP++ Q
Sbjct: 220  LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Query: 1012 LV 1013
            L+
Sbjct: 280  LL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.9 bits (215), Expect = 2e-18
 Identities = 79/279 (28%), Positives = 121/279 (43%), Gaps = 18/279 (6%)

Query: 750  IGCGGFGLV--YR---ATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
            +G G FG V  Y    A    G  VA+K L  +CGQ     ++ E+  L    H N+V  
Sbjct: 12   LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 804  QGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            +G C  +  +   LI  ++  GSL  +L +     + L     L  AQ    G+AYLH  
Sbjct: 72   KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQ 920
               H +HRD+ + N+LLD +    + DFGLA+ +   ++ + V  D    + +   E  +
Sbjct: 127  ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
             +  +Y  DV+SFGV L ELLT         PK   ++I          R  E+L+  + 
Sbjct: 184  ENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                      V  +   C     K RPT + L+  L  +
Sbjct: 243  LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 32/217 (14%)

Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRL------SGDCGQMEREFRAEVEALSRA 795
            +++   +G G + +VY+A     GR VAIK++          G      R E++ L   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59

Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW---DSRLHIAQGAA 852
           +HPN++ L     HK++  L++ FME   L     EK+    S+     D + ++     
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFME-TDL-----EKVIKDKSIVLTPADIKSYMLM-TL 112

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL YLH +    ILHRD+K +N+L+  +    LADFGLAR   SP +  +T  +V T  
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV-TRW 167

Query: 913 YIPPE--YGQASVATYKG---DVYSFGVVLLELLTGK 944
           Y  PE  +G    A + G   D++S G +  ELL   
Sbjct: 168 YRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 80/290 (27%), Positives = 125/290 (43%), Gaps = 33/290 (11%)

Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT            VA+K L       ERE   +E++ +S 
Sbjct: 35   NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
               H N+V+L G C      L+I  +   G L  +L  K +  S L  +  L  +   A+
Sbjct: 95   LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAK 152

Query: 854  GLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+A+L  ++C    +HRD+ + N+LL       + DFGLAR I++  +  V  +    + 
Sbjct: 153  GMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 913  YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENR 970
            ++ PE     V T++ DV+S+G++L E+ + G  P   M        LI    RM Q   
Sbjct: 209  WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ--- 265

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                  P     +       + DI   C    P  RPT +Q+V  +   +
Sbjct: 266  ------PEHAPAE-------IYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 43/288 (14%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS------GDCGQMEREFRAEVEALSRA 795
             + +   +G G F   Y+A  +  G  +A+K+++       +  ++    R E+  ++R 
Sbjct: 1    EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 796  QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             HP+++ + G     +   L   +M  GS+ + L +   G          +  Q   RGL
Sbjct: 61   NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIIN-YTEQ-LLRGL 116

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLA-RLILSPYDT-HVTTDLVGTL 911
            +YLH   E  I+HRD+K +N+L+D   G  L  ADFG A RL             L+GT+
Sbjct: 117  SYLH---ENQIIHRDVKGANLLIDST-GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 912  GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
             ++ PE      YG++       DV+S G V++E+ T K P +  K      LI  +   
Sbjct: 173  AFMAPEVLRGEQYGRSC------DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI--- 223

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                  S    P I   +H    LR  D+   CL   P+ RP +++L+
Sbjct: 224  -----ASATTAPSI--PEHLSPGLR--DVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 28/208 (13%)

Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGD---CGQMEREFRAEVEALSRAQHPNLVHLQG 805
           +G GGFG V    +    R  A+K +          +    +E E L    HP +V    
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV---- 56

Query: 806 YCMHKN--DRLLIYSFME---NGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARGLAYL 858
             +++   D+  IY  ME    G L   L +    D     ++ +R +IA        YL
Sbjct: 57  -KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIAC-VVLAFEYL 109

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H      I++RD+K  N+LLD N    L DFG A+ + S   T       GT  Y+ PE 
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEI 163

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
                  +  D +S G++L ELLTG+ P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 17/206 (8%)

Query: 750 IGCGGFGLVYRATL--PDGR--NVAIKRLSGD-CGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG+V R       G+   VA+K L  D    +  +F  E   +    H NL+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQGAARGLAYLHQSC 862
           G  +     +++      GSL   L +   G    S   D  + IA G    + YL    
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK- 116

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT-DLVGTLGYIPPEYGQA 921
               +HRD+ + NILL  +    + DFGL R +    D +V    L     +  PE  + 
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 922 SVATYKGDVYSFGVVLLELLT-GKRP 946
              ++  DV+ FGV L E+ T G+ P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 83/231 (35%), Positives = 111/231 (48%), Gaps = 49/231 (21%)

Query: 744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMERE------FRAEVEALSRAQ 796
           FD    IG G +G VY+A   D G  VA+K++  D    E+E       R E++ L +  
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIR-EIKILRQLN 64

Query: 797 HPNLVHLQGYCMHKNDRL----------LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
           H N+V+L+     K D L          L++ +M     D+ L   L+  S L   S  H
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLE--SGLVHFSEDH 117

Query: 847 IA---QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
           I    +    GL Y H+    + LHRDIK SNILL+      LADFGLARL  S  ++  
Sbjct: 118 IKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRP 173

Query: 904 TTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            T+ V TL Y PPE       YG A       DV+S G +L EL T K+P+
Sbjct: 174 YTNKVITLWYRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 69/221 (31%), Positives = 102/221 (46%), Gaps = 32/221 (14%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEAL-------S 793
            N+ +  ++G G FG VY     D GR +A+K++  D      E + EV AL        
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFD--PDSPETKKEVNALECEIQLLK 59

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             QH  +V   G C+  ++ L I+  +M  GS+   L  K  G  + +  +R +  Q   
Sbjct: 60  NLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALT-ETVTRKYTRQ-IL 114

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTL 911
            G+ YLH +    I+HRDIK +NIL D      L DFG + RL            + GT 
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            ++ PE      YG+      K DV+S G  ++E+LT K P
Sbjct: 172 YWMSPEVISGEGYGR------KADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 39/234 (16%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS----------GDCGQMEREFRAEV 789
             NF     IG G F +VY+A  L DGR VA+K++            DC +       E+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-------EI 53

Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL-HEKLDG---PSSLDWDSRL 845
           + L +  HPN++      +  N+  ++    + G L   + H K      P    W   +
Sbjct: 54  DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113

Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
            +       L ++H      I+HRDIK +N+ +       L D GL R   S   T    
Sbjct: 114 QLC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAH 164

Query: 906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP--------MDMCK 951
            LVGT  Y+ PE    +   +K D++S G +L E+   + P          +CK
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 78/277 (28%), Positives = 118/277 (42%), Gaps = 40/277 (14%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+     +   VA+K L    G M  + F  E   +   QH  LV L     
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 809  HKNDRLLIYSFMENGSLDYWLHE----KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             +    +I  +M  GSL  +L      K+  P  +D+ +++      A G+AY+ +    
Sbjct: 72   KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERK--- 122

Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQAS 922
            + +HRD++++N+L+  +    +ADFGLAR+I    D   T        + +  PE     
Sbjct: 123  NYIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 923  VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM-RQENRESEVLDPFIY 980
              T K DV+SFG++L E++T GK P            +    RM R EN   E       
Sbjct: 180  SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE------- 232

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                      + DI   C  E  + RPT   L S LD
Sbjct: 233  ----------LYDIMKTCWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 85.2 bits (211), Expect = 6e-18
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 48/297 (16%)

Query: 749  IIGCGGFGLVYRATL-----PDGR-NVAIKRLSGDCGQMEREFR---AEVEALSR-AQHP 798
             +G G FG V +A       P+    VA+K L  D    E++     +E+E +    +H 
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHK 76

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSL-DWDSRLHIAQ 849
            N+++L G C  +    ++  +  +G+L  +L        +   D P    +  ++  +  
Sbjct: 77   NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 850  GA---ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
             A   ARG+ +L        +HRD+ + N+L+  +    +ADFGLAR I        TT+
Sbjct: 137  FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 907  LVGTLGY--IPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
              G L    + PE     V T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 194  --GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 247

Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                  +E   ++      Q   E+  ++     C  E P  RPT +QLV  LD ++
Sbjct: 248  ------KEGYRMEKPQNCTQ---ELYHLM---RDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.5 bits (209), Expect = 7e-18
 Identities = 81/290 (27%), Positives = 124/290 (42%), Gaps = 40/290 (13%)

Query: 749  IIGCGGFGLVYRATL--PDGR--NVAIKRLSGD-CGQME-REFRAEVEALSRAQHPNLVH 802
            I+G G FG V    L   DG    VA+K +  D     E  EF +E   +    HPN++ 
Sbjct: 6    ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 803  LQGYCMHKNDR------LLIYSFMENGSL-DYWLHEKL-DGPSSLDWDSRLHIAQGAARG 854
            L G C   +        ++I  FM++G L  + L+ +L   P  L   + L      A G
Sbjct: 66   LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS-PY--DTHVTTDLVGTL 911
            + YL      + +HRD+ + N +L  +    +ADFGL++ I S  Y     +    V   
Sbjct: 126  MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180

Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR 970
             +I  E     V T K DV++FGV + E+ T G+ P    +     D       +R  NR
Sbjct: 181  -WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY------LRHGNR 233

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                       KQ +  +  + D+   C    PK RPT  +L   L++I+
Sbjct: 234  L----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.2 bits (208), Expect = 8e-18
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 17/212 (8%)

Query: 746 QANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM---EREFRA---EVEALSRAQHPN 799
           +  ++G G +G VY      G+ +A+K++  D   +   E+E+     EV+ L   +H N
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G C+  N   +   F+  GS+   L+     P  +       I  G    +AYLH
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG----VAYLH 119

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI----LSPYDTHVTTDLVGTLGYIP 915
            +C   ++HRDIK +N++L  N    L DFG AR +    L    +++   + GT  ++ 
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE    S    K D++S G  + E+ TGK P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.1 bits (210), Expect = 8e-18
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 21/241 (8%)

Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRLSGDCG-QMEREFRAEVE 790
           IL+ T    +  ++G G FG VY+   +P+G  V    AIK L+   G +   EF  E  
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   HP+LV L G C+    +L +   M +G L  ++HE  D   S   L+W  ++  
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI-- 118

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    E  ++HRD+ + N+L+       + DFGLARL+      +     
Sbjct: 119 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR 966
              + ++  E       T++ DV+S+GV + EL+T G +P D    +   DL+    R+ 
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231

Query: 967 Q 967
           Q
Sbjct: 232 Q 232

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 84/278 (30%), Positives = 129/278 (46%), Gaps = 43/278 (15%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+ AT      VA+K +    G M  E F AE   +   QH  LV L    +
Sbjct: 14   LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 809  HKNDRLLIYSFMENGSL-DYWLHE---KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             K    +I  FM  GSL D+   +   K   P  +D+ +++      A G+A++ Q    
Sbjct: 71   TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQR--- 121

Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQA 921
            + +HRD++++NIL+  +    +ADFGLAR+I    + +  T   G    + +  PE    
Sbjct: 122  NYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINF 177

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
               T K DV+SFG++L+E++T G+ P   M  P+  R L       R EN   E+ +   
Sbjct: 178  GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI-- 235

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    M+R       C    P+ RPT + + S LD
Sbjct: 236  --------MMR-------CWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 78/276 (28%), Positives = 131/276 (47%), Gaps = 41/276 (14%)

Query: 749  IIGCGGFG---LVYRATLPDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVH 802
            ++G G +G   LV   T  DG+   IK+L+       RE +A   E + LS+ +HPN+V 
Sbjct: 7    VVGKGSYGEVSLVRHRT--DGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVA 63

Query: 803  LQGYCMHKNDRL-LIYSFMENGSLDYWLHEK----LDGPSSLDWDSRLHIAQGAARGLAY 857
             +     ++  L ++  F E G L + L E+    L     ++W  ++ +A      L Y
Sbjct: 64   YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            LH   E HILHRD+K+ N+ L       + D G+AR++ +  D   T  L+GT  Y+ PE
Sbjct: 118  LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPE 172

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
                    YK DV++ G  + E+ T K   +      ++D+ S V R+ +       L P
Sbjct: 173  LFSNKPYNYKSDVWALGCCVYEMATLKHAFN------AKDMNSLVYRIIEGK-----LPP 221

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                K +  E+    ++    LS+ P+ RP+ + ++
Sbjct: 222  M--PKDYSPEL---GELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQME-REFRAEVEALSRAQH-PNLVHLQGY 806
           IG G FG V +      G  +A+KR+     + E +    +++ + R+   P +V   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 807 CMHKNDRLLIYSFMENGSLD--Y-WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
              + D  +    M+  SLD  Y +++E L   S +  +    IA    + L YL +  E
Sbjct: 72  LFREGDCWICMELMDI-SLDKFYKYVYEVLK--SVIPEEILGKIAVATVKALNYLKE--E 126

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             I+HRD+K SNILLD N    L DFG++ +L+ S   T    D  G   Y+ PE    S
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR---D-AGCRPYMAPERIDPS 182

Query: 923 VAT-Y--KGDVYSFGVVLLELLTGKRP 946
               Y  + DV+S G+ L E+ TGK P
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 30/221 (13%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE--------FRAEVE 790
           S + +++ N I  G +G+VYRA     G  VA+K+L     +ME+E         R E+ 
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLR-EIN 56

Query: 791 ALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            L + QHPN+V ++   +  N     ++  ++E+      L E +  P          + 
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKS--LMETMKQPFLQS--EVKCLM 112

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
                G+A+LH +    ILHRD+K+SN+LL+      + DFGLAR   SP      T LV
Sbjct: 113 LQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP--LKPYTQLV 167

Query: 909 GTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            TL Y  PE   G    +T   D++S G +  ELLT K+P+
Sbjct: 168 VTLWYRAPELLLGAKEYST-AIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 71/245 (28%), Positives = 102/245 (41%), Gaps = 65/245 (26%)

Query: 748 NIIGC---GGFGLVYRA---TLPDGRNVAIKRLSGDCGQME-------REFRAEVEALSR 794
            I GC   G +G VY+A      DG+  AIK+  GD  Q         RE      AL R
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI-----ALLR 57

Query: 795 A-QHPNLVHLQGYCMHKNDRL--LIYSFMENGSLDYW----LHEKLDGPS-------SLD 840
             +H N+V L    +   D+   L++ + E+   D W     H +    S       SL 
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH----LADFGLARLIL 896
           W   L+       G+ YLH +    +LHRD+K +NIL+ G         + D GLARL  
Sbjct: 115 W-QILN-------GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Query: 897 SPYDTHVTTD-LVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           +P       D +V T+ Y  PE       Y +A       D+++ G +  ELLT   P+ 
Sbjct: 164 APLKPLADLDPVVVTIWYRAPELLLGARHYTKAI------DIWAIGCIFAELLT-LEPIF 216

Query: 949 MCKPK 953
             +  
Sbjct: 217 KGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 45/215 (20%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA--------EVEALSRAQ-HPN 799
           +G G FG VY A     G  VAIK+       M+++F +        EV++L +   HPN
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK-------MKKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 800 LVHLQGYCMHK-NDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           +V L    + + ND L  ++ +ME G+L Y L +   G           I     +GLA+
Sbjct: 60  IVKL--KEVFRENDELYFVFEYME-GNL-YQLMKDRKG-KPFSESVIRSIIYQILQGLAH 114

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS--PYDTHVTTDLVGTLGYIP 915
           +H+       HRD+K  N+L+ G     +ADFGLAR I S  PY     TD V T  Y  
Sbjct: 115 IHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-----TDYVSTRWYRA 166

Query: 916 PE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           PE         + V     D+++ G ++ EL T +
Sbjct: 167 PEILLRSTSYSSPV-----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 41/277 (14%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 14   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 809  HKNDRLLIYS-FMENGSLDYWLHEK----LDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
               + + I + +M  GSL  +L  +    L  P  +D  +++      A G+AY+ +   
Sbjct: 70   VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMAYVERM-- 121

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQA 921
             + +HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE    
Sbjct: 122  -NYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 177

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               T K DV+SFG++L EL T G+ P      +   D +    RM       E L     
Sbjct: 178  GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 233

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                        D+ C C  + P+ RPT + L ++L+
Sbjct: 234  ------------DLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 74/280 (26%), Positives = 120/280 (42%), Gaps = 45/280 (16%)

Query: 749  IIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
             IG G FG V    YR     G  VA+K +  D     + F AE   +++ +H NLV L 
Sbjct: 13   TIGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLL 65

Query: 805  GYCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            G  + +   L I + +M  GSL  +L  +  G S L  D  L  +      + YL  +  
Sbjct: 66   GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
             + +HRD+ + N+L+  +  A ++DFGL +   S  DT         + +  PE  +   
Sbjct: 122  -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKK 175

Query: 924  ATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD---PFI 979
             + K DV+SFG++L E+ + G+ P         R  +  V+   ++  + +  D   P +
Sbjct: 176  FSTKSDVWSFGILLWEIYSFGRVPY-------PRIPLKDVVPRVEKGYKMDAPDGCPPVV 228

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            Y            D+   C       RP+  QL   L+ I
Sbjct: 229  Y------------DVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 57/291 (19%)

Query: 750  IGCGGFGLV----YRATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVH 802
            +G G FG V    Y   +  G+   VA+K L        ++EF  E   +++  HP +V 
Sbjct: 3    LGHGNFGSVVKGVYL--MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 803  LQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSS--LDWDSRLHIAQGAARGLAYLH 859
            L G C  K + L L+      G L  +L ++ + P S   +   ++      A G+AYL 
Sbjct: 61   LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE 112

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPE 917
                 H +HRD+ + N+LL     A ++DFG++R  L     +      G   L +  PE
Sbjct: 113  ---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 918  ---YGQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWV---IRMRQEN 969
               YG+ S    K DV+S+GV L E  + G +P  +M   KG+ ++I+ +    R+ +  
Sbjct: 169  CINYGKFS---SKSDVWSYGVTLWEAFSYGAKPYGEM---KGA-EVIAMLESGERLPRPE 221

Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                     IY             I   C    P+ RPT  +L S      
Sbjct: 222  ECP----QEIY------------SIMLSCWKYRPEDRPTFSELESTFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 36/276 (13%)

Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
            F +   IG G FG VY+    D R    VAIK +  +  + E E  + E+  LS+   P 
Sbjct: 6    FTKLERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +    G  +      +I  ++  GS LD      L  P  L+      I +   +GL YL
Sbjct: 64   ITRYYGSYLKGTKLWIIMEYLGGGSALD------LLKPGPLEETYIATILREILKGLDYL 117

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE 917
            H   +   +HRDIK++N+LL       LADFG+A  +    DT +  +  VGT  ++ PE
Sbjct: 118  HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPE 171

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              + S   +K D++S G+  +EL  G+ P     P         V+ +  +N       P
Sbjct: 172  VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKN------SP 218

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
               + Q+ K     ++    CL++ P+ RPT ++L+
Sbjct: 219  PTLEGQYSKPFKEFVEA---CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 20/216 (9%)

Query: 748 NIIGCGGFGLVYRATLPD-------GRNVAIKRL-SGDCGQMEREFRAEVEALSRAQHPN 799
           N +G G FG VY  T  D          VA+K L  G   Q ++EF  E   +S   HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARGLA 856
           +V L G C+    + +I   ME G L  +L +   +  GP  L     L I    A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGA-----HLADFGLARLILSPYDTHVTTDLVGTL 911
           YL Q    H +HRD+ + N L+            + DFGLAR I          + +  +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            ++ PE       T + DV+SFGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.4 bits (203), Expect = 7e-17
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 37/272 (13%)

Query: 750  IGCGGFGLVYRATLPDGRN-VAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLVHLQG 805
            IG G FG VY AT       VA+K++S    Q   +++    EV+ L + +HPN +  +G
Sbjct: 29   IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 806  YCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
              + ++   L+  +    + D   +H+K      L       I  GA +GLAYLH     
Sbjct: 89   CYLKEHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SV 923
             ++HRDIK+ NILL       LADFG A    SP ++      VGT  ++ PE   A   
Sbjct: 142  -MIHRDIKAGNILLTEPGQVKLADFGSAS-KSSPANS-----FVGTPYWMAPEVILAMDE 194

Query: 924  ATYKG--DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
              Y G  DV+S G+  +EL   K P+       + + +S +  + Q +       P +  
Sbjct: 195  GQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQND------SPTLQS 242

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
             +        +D    CL + P+ RP + +L+
Sbjct: 243  NEWTDSFRGFVD---YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 83.0 bits (206), Expect = 7e-17
 Identities = 71/210 (33%), Positives = 104/210 (49%), Gaps = 29/210 (13%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLS---GDCGQMEREFRAEVEALSR-AQHPNLVH 802
           +G G +G+V++A   D R    VA+K++     +    +R FR E+  L     HPN+V 
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 803 LQGYCMHK--NDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           L    + K  ND+   L++ +ME    D  LH  +      D   R  + Q   + L Y+
Sbjct: 72  L--LNVIKAENDKDIYLVFEYMET---D--LHAVIRANILEDVHKRYIMYQ-LLKALKYI 123

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIP 915
           H     +++HRD+K SNILL+ +    LADFGLAR +    +     V TD V T  Y  
Sbjct: 124 HSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 916 PEYGQASVATYKG-DVYSFGVVLLELLTGK 944
           PE    S    KG D++S G +L E+L GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 28/208 (13%)

Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 805 GYC--MHKNDRLLIYSFMENGSLDYWL---HEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C    + +  L+  ++  GSL  +L    E+LD    L + S++       +G+ YL 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYLG 125

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP---- 915
                  +HRD+ + NIL++      + DFGL +++  P D       V   G  P    
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYK--VREPGESPIFWY 178

Query: 916 -PEYGQASVATYKGDVYSFGVVLLELLT 942
            PE    S  +   DV+SFGVVL EL T
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 9e-17
 Identities = 81/267 (30%), Positives = 119/267 (44%), Gaps = 31/267 (11%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA-EVEALSRAQHPNLVHLQGYC 807
            IG G FG VY+A      + VAIK +  +  + E E    E++ LS+ + P +    G  
Sbjct: 9    IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67

Query: 808  MHKNDRL-LIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
              K  +L +I  +   GS LD      L  P  LD      I +    GL YLH   E  
Sbjct: 68   FLKGSKLWIIMEYCGGGSCLD------LLKPGKLDETYIAFILREVLLGLEYLH---EEG 118

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
             +HRDIK++NILL       LADFG++  + S      T   VGT  ++ PE  + S   
Sbjct: 119  KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVIKQSGYD 176

Query: 926  YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
             K D++S G+  +EL  G+ P+    P     LI               L+   + K   
Sbjct: 177  EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP--------KNNPPSLEGNKFSKPF- 227

Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQL 1012
            K+ +       LCL++ PK RP+ ++L
Sbjct: 228  KDFVS------LCLNKDPKERPSAKEL 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.1 bits (201), Expect = 9e-17
 Identities = 71/214 (33%), Positives = 98/214 (45%), Gaps = 31/214 (14%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFR-----AEVEALSRAQHPNLVHL 803
           I  G +G V+ A     G   AIK +      M R+ +      E + LS+AQ P +V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 804 QGYC--MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS-RLHIAQGAARGLAYLHQ 860
             Y     K +  L+  ++  G L   L   L+   SLD D  R++IA+     L YLH 
Sbjct: 59  --YYSFQGKKNLYLVMEYLPGGDL-ASL---LENVGSLDEDVARIYIAEIVL-ALEYLHS 111

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS------PYDTHVTTDLVGTLGYI 914
           +    I+HRD+K  NIL+D N    L DFGL+++ L         D      +VGT  YI
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 915 PPEY--GQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE   GQ    +   D +S G +L E L G  P
Sbjct: 169 APEVILGQGH--SKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 72/237 (30%), Positives = 109/237 (45%), Gaps = 20/237 (8%)

Query: 724 LFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQME 782
           LF      + ++ + + T+ ++    IG G +G VY+ T   DG   A+K L      ++
Sbjct: 4   LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVD 62

Query: 783 REFRAEVEAL-SRAQHPNLVHLQGYCMHKNDRL------LIYSFMENGSLDYWLHEKLDG 835
            E  AE   L S   HPN+V   G   +K D+L      L+      GS+   +   L  
Sbjct: 63  EEIEAEYNILQSLPNHPNVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
              LD     +I  GA  GL +LH +    I+HRD+K +NILL    G  L DFG++  +
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 896 LSPYDTHVTTDLVGTLGYIPPEY---GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
            S      T+  VGT  ++ PE     Q    +Y  + DV+S G+  +EL  G  P+
Sbjct: 179 TSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 42/213 (19%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSG----DCG--QMEREFRAEVEALSRAQHPNLVH 802
           IG G  G+V++A     G  VA+K+++          Q  RE    ++AL   QHP +V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA------RGLA 856
           L     H +  +L+  +M +      L E L      D +  L  AQ  +      +G+A
Sbjct: 64  LLDVFPHGSGFVLVMEYMPSD-----LSEVLR-----DEERPLPEAQVKSYMRMLLKGVA 113

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y+H +    I+HRD+K +N+L+  +    +ADFGLARL  S  +  + +  V T  Y  P
Sbjct: 114 YMHAN---GIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAP 169

Query: 917 E--YGQ----ASVATYKGDVYSFGVVLLELLTG 943
           E  YG       V     D+++ G +  ELL G
Sbjct: 170 ELLYGARKYDPGV-----DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 748 NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQG 805
            I+G G  G VY+A  L   R +A+K +  D   +++++  +E+E L +   P ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 806 YCMHKNDRLLIYSFMENGSLD-YW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
               +N   +   FM+ GSLD Y  + E + G           IA    +GL YL     
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAVVKGLTYLWSL-- 114

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
             ILHRD+K SN+L++      L DFG++  +++     +    VGT  Y+ PE      
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQ 169

Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
                DV+S G+  +EL  G+ P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 16/212 (7%)

Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFR----AEVEALSRAQH 797
            +++  ++G G FG+V+      D + V IK++  +  QM ++ R     E + L    H
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSH 58

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++      +     +++  +   G+L  ++ ++    S LD D+ LH        L +
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHH 116

Query: 858 LHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           +H      ILHRD+K+ NILLD +     + DFG+++ ILS      T  +VGT  YI P
Sbjct: 117 VHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT--VVGTPCYISP 170

Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           E  +      K D+++ G VL EL + KR  +
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG V+  T      VA+K L    G M  E F  E + + + +H  LV L    +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYA-VV 70

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    ++  +M  GSL  +L +  +G  +L   + + +A   A G+AY+ +    + +H
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDG-EG-RALKLPNLVDMAAQVAAGMAYIERM---NYIH 125

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
           RD++S+NIL+       +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 927 KGDVYSFGVVLLELLTGKR 945
           K DV+SFG++L EL+T  R
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 74/293 (25%), Positives = 131/293 (44%), Gaps = 38/293 (12%)

Query: 744  FDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQH 797
            F    ++G G FG V  A L       + VA+K L  D        EF  E   +    H
Sbjct: 1    FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 798  PNLVHLQGYCMHKNDR------LLIYSFMENGSLD-YWLHEKL-DGPSSLDWDSRLHIAQ 849
            PN++ L G  +    +      ++I  FM++G L  + L  ++ + P +L   + +    
Sbjct: 61   PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 850  GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDL 907
              A G+ YL      + +HRD+ + N +L+ N    +ADFGL++ I S   Y     + L
Sbjct: 121  DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR 966
               + ++  E    +V T   DV++FGV + E++T G+ P    +   + ++ +++I+  
Sbjct: 178  --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKGN 232

Query: 967  QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            +  +  + L+              V ++ C C S  PK RP+ Q L   L+ I
Sbjct: 233  RLKQPPDCLE-------------DVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY+A     G   A K +  +  +   +F  E++ LS  +HPN+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
           ++N   ++  F + G+LD  +  +L+    L      ++ +     L +LH      ++H
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERG--LTEPQIRYVCRQMLEALNFLH---SHKVIH 126

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT--- 925
           RD+K+ NILL  +    LADFG++    S      T   +GT  ++ PE     VA    
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEV----VACETF 180

Query: 926 ------YKGDVYSFGVVLLELLTGKRP 946
                 YK D++S G+ L+EL   + P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 33/276 (11%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQME-REFRAEVEALSR---AQHP 798
            + +  +IG G +G VYR   +P GR VA+K ++ D    +  + + EV  LS+   +Q P
Sbjct: 3    YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 799  NLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+    G    K  RL +I  + E GS+       L     +       I +     L Y
Sbjct: 63   NITKYYG-SYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            +H+     ++HRDIK++NIL+       L DFG+A L+        T   VGT  ++ PE
Sbjct: 117  IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPE 171

Query: 918  YGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
                      K D++S G+ + E+ TG  P        +  LI    + +          
Sbjct: 172  VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKSKP--------- 219

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            P + D  + K +    +    CL E PK R + ++L
Sbjct: 220  PRLEDNGYSKLL---REFVAACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.2 bits (200), Expect = 2e-16
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 21/222 (9%)

Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRN----VAIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G      VAIK L      +  +E   E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    E  ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 119 ----AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 33/217 (15%)

Query: 748 NIIGCGGFGLVYRATLP-DGR--NVAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVH 802
           ++IG G FG V RA +  DG   N AIK L     + + R+F  E+E L +   HPN+++
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 803 LQGYCMHKNDRLLIYSFMENGSL------------DYWLHEKLDGPSSLDWDSRLHIAQG 850
           L G C ++    +   +   G+L            D    ++    S+L     L  A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A G+ YL    E   +HRD+ + N+L+  N  + +ADFGL+R      + +V      T
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK----T 176

Query: 911 LGYIPP-----EYGQASVATYKGDVYSFGVVLLELLT 942
           +G +P      E    SV T K DV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.5 bits (196), Expect = 3e-16
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 46/216 (21%)

Query: 750 IGCGGFG---LVYRATLPDGRNVAIKRLS-GDCGQMER-EFRAEVEALSRAQHPNLVHLQ 804
           IG G FG   LV      DG+   IK ++       ER E R EV  LS  +HPN+V  Q
Sbjct: 8   IGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 805 GYCMHKNDRLLIYSFMENGSL----DYW----LHEKLDGPSS--------LDWDSRLHIA 848
                        SF ENG+L    DY     L++K++            LDW  ++ +A
Sbjct: 66  ------------ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
                 L ++H   +  ILHRDIKS NI L  +    L DFG+AR++ S  +   T   +
Sbjct: 114 ------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--I 162

Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           GT  Y+ PE  +      K D+++ G VL E+ T K
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 33/217 (15%)

Query: 748 NIIGCGGFGLVYRATLP-DG--RNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVH 802
           ++IG G FG V +A +  DG   + AIKR+     + + R+F  E+E L +   HPN+++
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 803 LQGYCMHKNDRLLIYSFMENGSL------------DYWLHEKLDGPSSLDWDSRLHIAQG 850
           L G C H+    L   +  +G+L            D          S+L     LH A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            ARG+ YL    +   +HRD+ + NIL+  N+ A +ADFGL+R      + +V      T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK----T 169

Query: 911 LGYIPP-----EYGQASVATYKGDVYSFGVVLLELLT 942
           +G +P      E    SV T   DV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 744 FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS---GDCG---QMEREFRAEVEALSRAQ 796
           +++   IG G +G VY+A  L  GR VA+K++     + G      RE  A ++ L   +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59

Query: 797 HPNLVHLQGYCM-HKNDR-LLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQGAA 852
           HPN+V L   C   + DR L +    E+   D  L   L       L  ++   + +   
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTL 911
           RG+ +LH      I+HRD+K  NIL+  +    +ADFGLAR+    Y   +  T +V TL
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI----YSFEMALTSVVVTL 170

Query: 912 GYIPPE-YGQASVATYKGDVYSFGVVLLEL 940
            Y  PE   Q+S AT   D++S G +  EL
Sbjct: 171 WYRAPEVLLQSSYAT-PVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 79/276 (28%), Positives = 120/276 (43%), Gaps = 36/276 (13%)

Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
            F +   IG G FG V++    D R    VAIK +  +  + E E  + E+  LS+   P 
Sbjct: 6    FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +    G  +      +I  ++  GS LD      L  P  LD      I +   +GL YL
Sbjct: 64   VTKYYGSYLKDTKLWIIMEYLGGGSALD------LLEPGPLDETQIATILREILKGLDYL 117

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE 917
            H   +   +HRDIK++N+LL  +    LADFG+A  +    DT +  +  VGT  ++ PE
Sbjct: 118  HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPE 171

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              + S    K D++S G+  +EL  G+ P     P     LI        E   S+ L  
Sbjct: 172  VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            F+                  CL++ P  RPT ++L+
Sbjct: 232  FVE----------------ACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 81/268 (30%), Positives = 114/268 (42%), Gaps = 59/268 (22%)

Query: 743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLS-GDCGQMEREF-RAEVEALSRAQHPN 799
            ++    IG G FG +Y A    D  +  IK +        E+E  + EV  L++ +HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA-------- 851
           +V                SF ENG L + + E  DG    D   R++  +G         
Sbjct: 61  IV------------TFFASFQENGRL-FIVMEYCDGG---DLMKRINRQRGVLFSEDQIL 104

Query: 852 ------ARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLILSPYDTHVT 904
                 + GL ++H   +  ILHRDIKS NI L  N   A L DFG+AR +       + 
Sbjct: 105 SWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELA 159

Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD----------MCK--- 951
              VGT  Y+ PE  Q      K D++S G VL EL T K P +          +C+   
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF 219

Query: 952 ----PKGSRD---LISWVIRMRQENRES 972
               P  SRD   LIS + ++   +R S
Sbjct: 220 APISPNFSRDLRSLISQLFKVSPRDRPS 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 32/276 (11%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRA-EVEALSRAQHPN 799
            +F     +G G +G VY+   L D +  A+K +  G   Q ERE    E+  L+   HPN
Sbjct: 1    DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            ++  +   +  N   ++  +   G L   + ++      +       I     RGL  LH
Sbjct: 61   IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
               E  ILHRD+KS+NILL  N    + D G+++++      ++    +GT  Y+ PE  
Sbjct: 121  ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVW 173

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR---MRQENRESEVLD 976
            +    +YK D++S G +L E+ T   P +    +  +DL   V R          S+ L 
Sbjct: 174  KGRPYSYKSDIWSLGCLLYEMATFAPPFE---ARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             FI      + ML+V           PK+RP   ++
Sbjct: 231  NFI------RSMLQV----------KPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 4e-16
 Identities = 76/237 (32%), Positives = 107/237 (45%), Gaps = 42/237 (17%)

Query: 724 LFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQ 780
           LF   + E    D+ E          IG G FG VY A   D R    VAIK++S    Q
Sbjct: 7   LFSKDDPEKLFTDLRE----------IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQ 54

Query: 781 MEREFR---AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGP 836
              +++    EV  L + +HPN +  +G  + ++   L+  +    + D   +H+K    
Sbjct: 55  SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK---- 110

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
             L       I  GA +GLAYLH       +HRDIK+ NILL       LADFG A L+ 
Sbjct: 111 -PLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV- 165

Query: 897 SPYDTHVTTDLVGTLGYIPPEY------GQASVATYKGDVYSFGVVLLELLTGKRPM 947
           SP ++      VGT  ++ PE       GQ      K DV+S G+  +EL   K P+
Sbjct: 166 SPANS-----FVGTPYWMAPEVILAMDEGQ---YDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 81/305 (26%), Positives = 127/305 (41%), Gaps = 57/305 (18%)

Query: 749  IIGCGGFGLVYRAT------LPDGRNVAIKRLSGDCGQME-REFRAEVEALSRAQHPNLV 801
             +G G FG V +AT            VA+K L  +    E R+  +E   L +  HP+++
Sbjct: 7    TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSR---------------- 844
             L G C      LLI  + + GSL  +L E    GPS L  D                  
Sbjct: 67   KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 845  ---LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT 901
               +  A   +RG+ YL    E  ++HRD+ + N+L+       ++DFGL+R +    D+
Sbjct: 127  GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-DS 182

Query: 902  HVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGS 955
            +V      + G IP      E     + T + DV+SFGV+L E++T G  P     P+  
Sbjct: 183  YVKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
             +L+    RM +    SE             EM  ++     C  + P  RPT   +   
Sbjct: 239  FNLLKTGYRMERPENCSE-------------EMYNLM---LTCWKQEPDKRPTFADISKE 282

Query: 1016 LDSII 1020
            L+ ++
Sbjct: 283  LEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.1 bits (197), Expect = 4e-16
 Identities = 82/274 (29%), Positives = 127/274 (46%), Gaps = 41/274 (14%)

Query: 750  IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLVHL 803
            IG G FG VY A   D R    VAIK++S    Q   +++    EV+ L R +HPN +  
Sbjct: 33   IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            +G  + ++   L+  +    + D   +H+K      L       I  GA +GLAYLH   
Sbjct: 91   KGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH- 144

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA- 921
              +++HRDIK+ NILL       LADFG A +  SP ++      VGT  ++ PE   A 
Sbjct: 145  --NMIHRDIKAGNILLTEPGQVKLADFGSASIA-SPANS-----FVGTPYWMAPEVILAM 196

Query: 922  SVATYKG--DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                Y G  DV+S G+  +EL   K P+       + + +S +  + Q         P +
Sbjct: 197  DEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQNE------SPTL 244

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
               +        +D    CL + P+ RPT+++L+
Sbjct: 245  QSNEWSDYFRNFVDS---CLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 35/227 (15%)

Query: 738 LESTNNFDQAN---IIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           LE    +D+     ++G G +G+VY A  L     +AIK +     +  +    E+   S
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMEN---GSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +H N+V   G    +N    I  FME    GSL   L  K  GP   +  + +   + 
Sbjct: 61  YLKHRNIVQYLGSDS-ENGFFKI--FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQ 116

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLI--LSPYDTHVTTDL 907
              GL YLH   +  I+HRDIK  N+L++   G   ++DFG ++ +  ++P     T   
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----CTETF 169

Query: 908 VGTLGYIPPE--------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            GTL Y+ PE        YG  +      D++S G  ++E+ TGK P
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPA------DIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLS--------GDCGQMEREFRAEVEALSRAQHPNL 800
           +G GGFG V    +   G+  A K+L         G+   +      E + L +     +
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL-----NEKKILEKVSSRFI 55

Query: 801 VHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           V L  Y     D L L+ + M  G L Y ++  +  P   +  +  + AQ    GL +LH
Sbjct: 56  VSL-AYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFPEARAIFYAAQ-IICGLEHLH 112

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           Q     I++RD+K  N+LLD +    ++D GLA  +             GT GY+ PE  
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVL 166

Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
           Q  V  +  D ++ G  L E++ G+ P    K K  +
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 78.2 bits (192), Expect = 8e-16
 Identities = 83/273 (30%), Positives = 125/273 (45%), Gaps = 33/273 (12%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 14   LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + FM  GSL  +L E  DG   L     + +A   A G+AY+ +    + +
Sbjct: 70   VSEEPIYIVTEFMGKGSLLDFLKEG-DG-KYLKLPQLVDMAAQIADGMAYIERM---NYI 124

Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 125  HRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL+T G+ P      +   + +    RM       E L         
Sbjct: 182  IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL--------- 232

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
              E+++      LC  + P  RPT + + S+L+
Sbjct: 233  -HELMK------LCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 66/235 (28%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMERE------FRAEVEALSRAQHPNLVH 802
           +G G FG VY+A  +  GR VA+K++       E++       R E++ L + +HPN+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR-EIKILKKLKHPNVVP 71

Query: 803 LQGYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR---- 853
           L    +      K  R  +Y  M    +D+ L   L+ P        + + +   +    
Sbjct: 72  LIDMAVERPDKSKRKRGSVY--MVTPYMDHDLSGLLENP-------SVKLTESQIKCYML 122

Query: 854 ----GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD--------- 900
               G+ YLH++   HILHRDIK++NIL+D      +ADFGLAR    PYD         
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR----PYDGPPPNPKGG 175

Query: 901 ----THVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               T   T+LV T  Y PPE       Y  A       D++  G V  E+ T +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV------DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 66/250 (26%), Positives = 104/250 (41%), Gaps = 51/250 (20%)

Query: 742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           ++F+    +G G FG V        G+  A+K LS        Q+E     E   L   +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59

Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           HP LV+L G     +  L L+  ++  G L   L  +  G       +R + AQ     L
Sbjct: 60  HPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQVVL-AL 114

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I++RD+K  N+LLD +    + DFG A+ +     T+    L GT  Y+ 
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYT---LCGTPEYLA 166

Query: 916 PE------YGQASVATYKGDVYSFGVVLLELLTG------KRPMDMCK---------PKG 954
           PE      YG+A       D ++ G+++ E+L G        P+ + +         P  
Sbjct: 167 PEIILSKGYGKAV------DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF 220

Query: 955 ----SRDLIS 960
               ++DLI 
Sbjct: 221 FSPDAKDLIR 230

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM--EREFRAEVEALSRAQHPN 799
            +   + IG G +G+V  AT  P G  VAIK++S    Q   +R  R E++ L R +H N
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64

Query: 800 LVHLQ------GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ +        +    ND  ++   ME       L+ KL     L  D   +      R
Sbjct: 65  IIGILDIIRPPSFESF-NDVYIVQELMETD-----LY-KLIKTQHLSNDHIQYFLYQILR 117

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLG 912
           GL Y+H +   ++LHRD+K SN+LL+ N    + DFGLAR+    +D T   T+ V T  
Sbjct: 118 GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 913 YIPPEYGQASVATYKG-----DVYSFGVVLLELLTGK 944
           Y  PE     +   KG     D++S G +L E+L+ +
Sbjct: 175 YRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 12/183 (6%)

Query: 769 VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY 827
           VA+K L  D  +  R +F  E++ +SR ++PN++ L G C+  +   +I  +MENG L+ 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 828 WLHE--------KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD 879
           +L +          +   S+   + L++A   A G+ YL      + +HRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLE 939
            ++   +ADFG++R + S     +    V  + ++  E       T   DV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 940 LLT 942
           + T
Sbjct: 224 MFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 2e-15
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 29/220 (13%)

Query: 750 IGCGGFGLVYRATL-----PDGRNVAIKRLSG-DCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G   FG +Y+  L        + VAIK L   +  Q   EF+ E   ++   HPN+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWL-----HEKL------DG--PSSLDWDSRLHIAQG 850
            G    +    +++ ++  G L  +L     H  +      DG   SSLD    LHIA  
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A G+ YL        +H+D+ + NIL+       ++D GL+R I S     V    +  
Sbjct: 133 IAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 911 LGYIPPE---YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           + ++PPE   YG+ S  +   D++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDS---DIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 25/204 (12%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRL--SGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G +G+V++    + G+ VAIK+   S D   +++    E+  L + +HPNLV+L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
              K    L++ + ++  L    +E    P  +       I     + + + H+    + 
Sbjct: 69  FRRKRKLHLVFEYCDHTVL----NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121

Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-------YG 919
           +HRD+K  NIL+       L DFG AR IL+       TD V T  Y  PE       YG
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDY-TDYVATRWYRAPELLVGDTQYG 179

Query: 920 QASVATYKGDVYSFGVVLLELLTG 943
              V     DV++ G V  ELLTG
Sbjct: 180 -PPV-----DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 72/211 (34%), Positives = 102/211 (48%), Gaps = 30/211 (14%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G +G+VY+      G+ VA+K++   S + G      R E+  L   QHPN+V LQ 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPNIVCLQD 66

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRL------HIAQGAARGLAYL 858
             M ++   LI+ F+   S+D  L + LD  P     D+ L       I QG    + + 
Sbjct: 67  VLMQESRLYLIFEFL---SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFC 117

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
           H      +LHRD+K  N+L+D      LADFGLAR    P    V T  V TL Y  PE 
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEV 172

Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             G    +T   D++S G +  E+ T K+P+
Sbjct: 173 LLGSPRYST-PVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IIG G FG V +     G+ VA+K +   C    + F  E   +++  H NLV L G  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
           H N   ++   M  G+L  +L  +  G + +     L  +   A G+ YL       ++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           RD+ + NIL+  +  A ++DFGLAR+     D          + +  PE  +    + K 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKHKKFSSKS 178

Query: 929 DVYSFGVVLLELLT-GKRP 946
           DV+S+GV+L E+ + G+ P
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 3e-15
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 21/216 (9%)

Query: 749 IIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFR---------AEVEALSRAQHP 798
           +IG G FG VY       G  +A+K++         + R          E+  L   QH 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           N+V   G  +  +   +   ++  GS+   L+       +L    R  + Q   +GL YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVRQ-ILKGLNYL 122

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL----ILSPYDTHVTTDLVGTLGYI 914
           H      I+HRDIK +NIL+D   G  ++DFG+++      LS         L G++ ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC 950
            PE  + +  T K D++S G +++E+LTGK P   C
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 83/275 (30%), Positives = 127/275 (46%), Gaps = 41/275 (14%)

Query: 750  IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLVHL 803
            IG G FG VY A   D RN   VAIK++S    Q   +++    EV  L + +HPN +  
Sbjct: 23   IGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            +G  + ++   L+  +    + D   +H+K      L       +  GA +GLAYLH   
Sbjct: 81   RGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH- 134

Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA- 921
              +++HRD+K+ NILL       L DFG A  I++P +       VGT  ++ PE   A 
Sbjct: 135  --NMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANX-----FVGTPYWMAPEVILAM 186

Query: 922  SVATYKG--DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                Y G  DV+S G+  +EL   K P+       + + +S +  + Q   ES  L    
Sbjct: 187  DEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQN--ESPAL---- 234

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                H  E  R  +    CL + P+ RPT++ L+ 
Sbjct: 235  -QSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 71/263 (26%), Positives = 113/263 (42%), Gaps = 28/263 (10%)

Query: 750  IGCGGFGLVYRATLPD-GRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            +G GGFG V    + + G+  A K     RL    G  E+    E E L +   P +V+L
Sbjct: 1    LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                  K    L+ S M  G L Y ++    G   L+ +  +H +     G+ +LH    
Sbjct: 59   AYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLH---S 113

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
              I++RD+K  N+LLD      L+D GLA   +   D    T   GT GY+ PE  +   
Sbjct: 114  MDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 924  ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
             +Y  D ++ G  + E++ G+ P    K K +++       +++   E EV        +
Sbjct: 171  YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE------ELKRRTLEDEV------KFE 218

Query: 984  HDKEMLRVLDIACLCLSESPKVR 1006
            H        DI  L L++ P+ R
Sbjct: 219  HQNFTEESKDICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G +G+VY+A     G  VA+K++   + D G      R E+  L    HPN+V L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 806 YCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRL---HIAQGAARGLAYLHQS 861
             +H  ++L L++ F     LD  L + +D       D  L   ++ Q   +G+AY H  
Sbjct: 66  -VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQ-LLQGIAYCHSH 118

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YG 919
               +LHRD+K  N+L+D      LADFGLAR    P  T+  T  V TL Y  PE   G
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLG 173

Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
               +T   D++S G +  E++  +RP+
Sbjct: 174 SRQYST-PVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)

Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRL--SGDCGQMEREFRA---EVEALSRAQ 796
           N+    ++G G FG VY     D GR +A+K++    D  +  +E  A   E++ L   +
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 797 HPNLVHLQGYCM--HKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           H  +V   G C+   +  +L I+  +M  GS+     ++L    +L  +      +   +
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV-TTDLVGTLG 912
           G++YLH +    I+HRDIK +NIL D      L DFG ++ I +   +      + GT  
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           ++ PE         K DV+S    ++E+LT K P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 36/283 (12%)

Query: 749  IIGCGGFGLVYRATLP------DGRNVAIKRLSG-DCGQMEREFRAEVEALSRAQHPNLV 801
             +G G FG V+ A             V +K L       ++ EFR E++   +  H N+V
Sbjct: 12   TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL-----HEKLDGPSSLDWDSRLHIAQGAARGLA 856
             L G C       +I  + + G L  +L      ++   P  L    ++ +    A G+ 
Sbjct: 72   RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY--DTHVTTDLVGTLGYI 914
            +L  +     +HRD+ + N L+       ++   L++     Y  + +   + +  L ++
Sbjct: 132  HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYNSEYYKLRNALIPLRWL 185

Query: 915  PPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
             PE  Q    + K DV+SFGV++ E+ T G+ P        S +    + R++    E  
Sbjct: 186  APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF----YGLSDE--EVLNRLQAGKLEL- 238

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                       +    R+  +   C + +PK RP+  +LVS L
Sbjct: 239  --------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 20/201 (9%)

Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYC 807
           ++G G FG V++ TL D   VA+K    D  Q ++ +F +E   L +  HPN+V L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-QSCEPHI 866
             +    ++   +  G    +L +K D    L     +  A  AA G+AYL  ++C    
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKNC---- 114

Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQA 921
           +HRD+ + N L+  N    ++DFG++R      D  + +     L  IP     PE    
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSS--SGLKQIPIKWTAPEALNY 168

Query: 922 SVATYKGDVYSFGVVLLELLT 942
              + + DV+S+G++L E  +
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.5 bits (188), Expect = 5e-15
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ--MEREFRAEVEALSRAQ---HPNLVHL 803
           IG G +G VY+A  P  G  VA+K +     +  +      EV  L R +   HPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 804 QGYCMH-KNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
              C   + DR     L++  ++     Y   +K+  P  L  ++   + +   RGL +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPG-LPAETIKDLMRQFLRGLDFL 124

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTLGYIPPE 917
           H +C   I+HRD+K  NIL+       LADFGLAR+    Y   +  T +V TL Y  PE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRAPE 177

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGK 944
               S      D++S G +  E+   K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.1 bits (187), Expect = 8e-15
 Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 19/189 (10%)

Query: 769 VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY 827
           VA+K L  D  +  R +F  EV+ LSR + PN++ L G C+ ++   +I  +MENG L+ 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 828 WL--HEKLDGPS-------------SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK 872
           +L  H   D                ++ + S LH+A   A G+ YL      + +HRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165

Query: 873 SSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYS 932
           + N L+  N    +ADFG++R + +     +    V  + ++  E       T   DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 933 FGVVLLELL 941
           FGV L E+L
Sbjct: 226 FGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 8e-15
 Identities = 69/244 (28%), Positives = 96/244 (39%), Gaps = 54/244 (22%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMERE----FRAEVEALSRAQ 796
           ++F+   +IG G FG V+     D   V A+K L      ++R      RAE + L+ A 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADAD 59

Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            P +V L  Y     + L L+  +M  G L   L  K   P      +R +IA+     L
Sbjct: 60  SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVL-AL 114

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA--------------RLILSPYDT 901
             +H+      +HRDIK  NIL+D +    LADFGL                     +  
Sbjct: 115 DSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 902 HVTTD-------------LVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLT 942
           +V                 VGT  YI PE      YG         D +S GV+L E+L 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------DWWSLGVILYEMLY 225

Query: 943 GKRP 946
           G  P
Sbjct: 226 GFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 1e-14
 Identities = 38/113 (33%), Positives = 67/113 (59%), Gaps = 7/113 (6%)

Query: 65  WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGT 124
           W G  C        + + G   + GL L  + L+G +   +  L  L+ +NLS N ++G 
Sbjct: 404 WSGADCQ------FDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN 457

Query: 125 VPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSI 176
           +P SL ++ +LEVLDLS N  +G +P+++  L S+++L+++ NSL+G VP ++
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 30/213 (14%)

Query: 749 IIGCGGFGLVYRATLPDGRNV-AIKRLSGD---------CGQMEREFRAEVEALSRAQHP 798
           ++G G FG V  A L     + A+K L  D         C   E+     V AL+  +HP
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAG-KHP 56

Query: 799 NLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARGL 855
            L  L   C    DRL  +  ++  G L + +    + D P +     R + A+    GL
Sbjct: 57  FLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-----RFYAAE-IVLGL 109

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            +LH   E  I++RD+K  N+LLD      +ADFG+ +  +    T  T+   GT  YI 
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIA 164

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE           D ++ GV+L E+L G+ P +
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 24/235 (10%)

Query: 744 FDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ--- 796
           F Q  ++G GGFG V     RAT   G+  A K+L     +  ++ + E  AL+  Q   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEK---KRIKKRKGESMALNEKQILE 55

Query: 797 --HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +   V    Y     D L L+ + M  G L + ++    G +  +    +  A     
Sbjct: 56  KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICC 113

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           GL  LHQ     I++RD+K  NILLD +    ++D GLA  +  P    +    VGT+GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGY 167

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           + PE  +    T+  D ++ G +L E++ G+ P    K K  R+ +  +++  QE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 69/262 (26%), Positives = 120/262 (45%), Gaps = 30/262 (11%)

Query: 769  VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY 827
            VA+K L  D  +  R +F  E++ +SR + PN++ L   C+  +   +I  +MENG L+ 
Sbjct: 49   VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 828  WL--HEKLDGP-----SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
            +L  HE  +        ++ + + + +A   A G+ YL      + +HRD+ + N L+  
Sbjct: 109  FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165

Query: 881  NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLEL 940
            N+   +ADFG++R + S     +    V  + ++  E       T   DV++FGV L E+
Sbjct: 166  NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 941  LTGKRPMDMCKPKGSRDLI-SWVIR-----MRQENRESEVLDPFIYDKQHDKEMLRVLDI 994
            LT      +CK +    L    VI       R + R+  +  P +      K ML     
Sbjct: 226  LT------LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS---- 275

Query: 995  ACLCLSESPKVRPTTQQLVSWL 1016
               C   + K RP+ Q++ + L
Sbjct: 276  ---CWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 59/234 (25%)

Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRA-------EVEALS 793
           + +++   IG G FG V++A      + VA+K++      ME E          E++ L 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITALREIKILQ 66

Query: 794 RAQHPNLVHLQGYC-----MHKNDRLLIYSFME-----------NGSLDYWLHEKLDGPS 837
             +H N+V+L   C      +   +   Y   E           N ++ + L E      
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--- 123

Query: 838 SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS 897
                    + +    GL Y+H++    ILHRD+K++NIL+  +    LADFGLAR    
Sbjct: 124 ---------VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 898 PY--DTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLT 942
                 +  T+ V TL Y PPE       YG         D++  G ++ E+ T
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI------DMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 40/220 (18%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALS-----RAQHPNLVHLQ 804
           I  G FG VY         +A KR +GD   ++   ++++ A +     +A+   +  +Q
Sbjct: 4   ISKGAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQ 53

Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-----------PSSLDWDSRLHIAQGAAR 853
           G         L YSF ++    Y + E L+G               DW ++ +IA+    
Sbjct: 54  GE--SPYVAKLYYSF-QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIAE-VVL 108

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           G+  LHQ     I+HRDIK  N+L+D      L DFGL+R  L           VGT  Y
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDY 159

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK 953
           + PE           D +S G V+ E L G  P     P 
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 30/238 (12%)

Query: 744 FDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALS------ 793
           F    ++G GGFG V     RAT   G+  A K+L     + +R  + + EA++      
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKL-----EKKRIKKRKGEAMALNEKQI 53

Query: 794 --RAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +     +V L  Y     D L L+ + M  G L + ++    G    D +  +  A  
Sbjct: 54  LEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAE 110

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
              GL  LH+     I++RD+K  NILLD      ++D GLA  I    +       VGT
Sbjct: 111 ITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRVGT 164

Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           +GY+ PE  +    T+  D +  G ++ E++ GK P    K K  R+ +   ++  QE
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE 222

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.2 bits (190), Expect = 3e-14
 Identities = 60/196 (30%), Positives = 88/196 (44%), Gaps = 23/196 (11%)

Query: 766 GRNVAIKRLSGDCGQMERE---FRAEVEALSRAQHPNLVHL--QGYCMHKNDRLL-IYSF 819
           G  VAIK L  D  + E +   FR E    +R  HPN+V L   G        L  ++ +
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA--PPGLLFAVFEY 60

Query: 820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL- 878
           +   +L   L    DG        RL + Q     LA  H      I+HRD+K  NI++ 
Sbjct: 61  VPGRTLREVLAA--DGALPAGETGRL-MLQ-VLDALACAHNQ---GIVHRDLKPQNIMVS 113

Query: 879 --DGNFGAHLADFGLARLILSPYDTHV-----TTDLVGTLGYIPPEYGQASVATYKGDVY 931
                  A + DFG+  L+    D  V     TT+++GT  Y  PE  +    T   D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 932 SFGVVLLELLTGKRPM 947
           ++G++ LE LTG+R +
Sbjct: 174 AWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 29/274 (10%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFR-AEVEALSRAQHPNL 800
              D    IG G  G+V  AT    GR VA+K++     Q  RE    EV  +   QHPN+
Sbjct: 20   YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNI 78

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            V +    +  ++  ++  F+E G+L D   H +++            +     + L++LH
Sbjct: 79   VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------TVCLAVLKALSFLH 132

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
                  ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE  
Sbjct: 133  AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVI 187

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                   + D++S G++++E++ G+ P     P         +  M+   R  + L P +
Sbjct: 188  SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---------LQAMK---RIRDNLPPKL 235

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              K   K   R+       L   P  R T  +L+
Sbjct: 236  --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 32/274 (11%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA----EVEALSRAQH 797
            NF     IG G F  VYRAT L DG  VA+K++      M+ + RA    E++ L +  H
Sbjct: 3    NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNH 61

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLD----YWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            PN++      +  N+  ++    + G L     ++  +K   P    W   + +      
Sbjct: 62   PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--- 118

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
             L ++H      ++HRDIK +N+ +       L D GL R   S   T     LVGT  Y
Sbjct: 119  -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 172

Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + PE    +   +K D++S G +L E+   + P    K     +L S   ++ Q +    
Sbjct: 173  MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCDY--- 225

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007
               P +    + +E+ ++++   +C++  P+ RP
Sbjct: 226  ---PPLPSDHYSEELRQLVN---MCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 26/213 (12%)

Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHP 798
           NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    HP
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           N+V L      +N   L++ F+      +     L G       S L       +GLA+ 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF---QLLQGLAF- 115

Query: 859 HQSCEPH-ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
              C  H +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  PE
Sbjct: 116 ---CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 170

Query: 918 ------YGQASVATYKGDVYSFGVVLLELLTGK 944
                 Y   +V     D++S G +  E++T +
Sbjct: 171 ILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 8e-14
 Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 31/278 (11%)

Query: 743  NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            +F+    IG G +G VY+A  +  G   AIK +  + G+     + E+  +   +H N+V
Sbjct: 10   DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL-HIAQGAARGLAYLHQ 860
               G  + ++   +   F   GSL    H  + GP S   +S++ ++++   +GL YLH 
Sbjct: 70   AYFGSYLRRDKLWICMEFCGGGSLQDIYH--VTGPLS---ESQIAYVSRETLQGLYYLHS 124

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
              +   +HRDIK +NILL  N    LADFG++  I +      +   +GT  ++ PE   
Sbjct: 125  KGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV-- 177

Query: 921  ASVATYKG-----DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            A+V    G     D+++ G+  +EL   + PM    P  +  L++          +S   
Sbjct: 178  AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT----------KSNFQ 227

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
             P + DK   K          + L+++PK RPT ++L+
Sbjct: 228  PPKLKDKM--KWSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRN------VAIK--RLSGDCGQMEREFRAEVEALSR 794
           NF Q   +G G +  VY+     GRN      VA+K   L  + G      R E+  +  
Sbjct: 1   NFKQLEKLGEGTYATVYK-----GRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKE 54

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +H N+V L      +N  +L++ +M+     Y   +      +LD ++         +G
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYM--DTHGVRGALDPNTVKSFTYQLLKG 112

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           +A+ H++    +LHRD+K  N+L++      LADFGLAR    P +T  + ++V TL Y 
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYR 167

Query: 915 PPEYGQASVATYKG--DVYSFGVVLLELLTGK 944
            P+    S  TY    D++S G ++ E++TG+
Sbjct: 168 APDVLLGS-RTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 9e-14
 Identities = 57/167 (34%), Positives = 79/167 (47%), Gaps = 33/167 (19%)

Query: 544 LDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKL 603
           L G I  +   L+ L   +L  N++ G IP  L  +TSLE LDLSYN+ +G+IP SL +L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 604 SFLSKFSVANNHLTGRIPSGGQFQTFPNSSF---DGNNLCGEHRYSCTID--RESGQVKS 658
           + L   ++  N L+GR+P+    +    +SF   D   LCG       I   R  G   S
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-------IPGLRACGPHLS 542

Query: 659 AKKSRRNKYTIVGMAIGITFGS--AFLLILIFMI--------LLRAH 695
                      VG  IGI FG   AFL ++I  +        +LRA 
Sbjct: 543 -----------VGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQ 578

Length = 623

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.6 bits (178), Expect = 9e-14
 Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 58/291 (19%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRA---EVEALSRAQHPNLVHL 803
            +G G +G VY+    P G  +A+K  RL  D    E +F     E++ L +A  P +V  
Sbjct: 9    LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKFNQIIMELDILHKAVSPYIVDF 64

Query: 804  QG---------YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             G          CM          +M+ GSLD  L+        +  D    I     +G
Sbjct: 65   YGAFFIEGAVYMCME---------YMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGY 913
            L +L +  E +I+HRD+K +N+L++GN    L DFG++  L+ S   T+     +G   Y
Sbjct: 115  LKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSY 167

Query: 914  IPPEY----GQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
            + PE     G     TY  + DV+S G+ +LE+  G+ P     P  +   I   +    
Sbjct: 168  MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIV 223

Query: 968  ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WL 1016
            +     +   +  D Q         D    CL++ P  RPT  QL+   WL
Sbjct: 224  DGDPPTLPSGYSDDAQ---------DFVAKCLNKIPNRRPTYAQLLEHPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 53/283 (18%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQH-PNLVHLQGY 806
            +G G +G+V +   +P G  +A+KR+      Q ++    +++   R+   P  V   G 
Sbjct: 9    LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 807  CMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
               + D   ++  ME  + SLD +  +  D   ++  D    IA    + L YLH     
Sbjct: 69   LFREGD---VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL-- 123

Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPEY--GQA 921
             ++HRD+K SN+L++ N    L DFG++  L+    D+   T   G   Y+ PE    + 
Sbjct: 124  SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV----DSVAKTIDAGCKPYMAPERINPEL 179

Query: 922  SVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
            +   Y  K DV+S G+ ++EL TG+ P D           SW               PF 
Sbjct: 180  NQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWK-------------TPFQ 215

Query: 980  YDKQ----------HDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
              KQ           +K      D    CL ++ K RP   +L
Sbjct: 216  QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.9 bits (184), Expect = 9e-14
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 22/162 (13%)

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
            L  +H     H++HRDIKS+NILL  N    L DFG +++  +     V     GT  Y+
Sbjct: 153  LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 915  PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
             PE  +    + K D++S GV+L ELLT KRP D                   EN E EV
Sbjct: 213  APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD------------------GENME-EV 253

Query: 975  LDPFI---YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            +   +   YD         + +I    LS  PK RP++ +L+
Sbjct: 254  MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 73/279 (26%), Positives = 112/279 (40%), Gaps = 34/279 (12%)

Query: 750  IGCGGFGLVYRATLPDGRNVA---IKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQG 805
            IG G FG V       G + A   +K L       E+  F  EV+      HPN++   G
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL--HIAQGAARGLAYLHQSCE 863
             C+     LL+  F   G L  +L     G  +      +   +A   A GL +LHQ+  
Sbjct: 63   QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE----Y 918
               +H D+   N  L  +    + D+GLA L   P D ++T D     L ++ PE     
Sbjct: 120  -DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 919  GQ---ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGS-RDLISWVIRMRQENRESE 973
            GQ       T K +++S GV + EL T   +P     P  S   ++  V+R +       
Sbjct: 178  GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----PDLSDEQVLKQVVREQDIKLPKP 233

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             LD    D+ ++      LD         P+ RPT +++
Sbjct: 234  QLDLKYSDRWYEVMQFCWLD---------PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 34/275 (12%)

Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
            F +   IG G FG V++    D R    VAIK +  +  + E E  + E+  LS+   P 
Sbjct: 6    FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +    G  +      +I  ++  GS    L     GP   D      + +   +GL YLH
Sbjct: 64   VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GP--FDEFQIATMLKEILKGLDYLH 118

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEY 918
               +   +HRDIK++N+LL       LADFG+A  +    DT +  +  VGT  ++ PE 
Sbjct: 119  SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEV 172

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q S    K D++S G+  +EL  G+ P     P         V+ +  +N    +   F
Sbjct: 173  IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKNNPPTLTGEF 225

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                +  KE +        CL++ P  RPT ++L+
Sbjct: 226  ---SKPFKEFIDA------CLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 58/172 (33%), Positives = 75/172 (43%), Gaps = 29/172 (16%)

Query: 786 RAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL----DW 841
           R E   L++ +HPN+V  +             SF  +G L Y + E  DG   +      
Sbjct: 46  RKEAVLLAKMKHPNIVAFK------------ESFEADGHL-YIVMEYCDGGDLMQKIKLQ 92

Query: 842 DSRLHIAQGAARGLAYLHQSC-------EPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
             +L         L +  Q C       E  +LHRDIKS NI L  N    L DFG ARL
Sbjct: 93  RGKLFPEDTI---LQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149

Query: 895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           + SP     T   VGT  Y+PPE  +      K D++S G +L EL T K P
Sbjct: 150 LTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 1e-13
 Identities = 77/284 (27%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLV 801
            F+   ++G G +G VY+   +  G+  AIK +    G  E E + E+  L + + H N+ 
Sbjct: 8    FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 802  HLQGYCMHKN-----DRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
               G  + KN     D+L L+  F   GS+   +          +W +  +I +   RGL
Sbjct: 67   TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGL 124

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            ++LHQ     ++HRDIK  N+LL  N    L DFG++  +        T   +GT  ++ 
Sbjct: 125  SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 179

Query: 916  PEY---GQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
            PE     +   ATY  K D++S G+  +E+  G  P+    P  +  LI      R +++
Sbjct: 180  PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK 239

Query: 971  E-SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            + S+    FI                  CL ++   RPTT+QL+
Sbjct: 240  KWSKKFQSFIES----------------CLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.2 bits (180), Expect = 2e-13
 Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 38/214 (17%)

Query: 750 IGCGGFGLVYRATLP-DGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHPNLVHL-- 803
           IG G FG+V+  T P DG+ VA+K++     +    +R FR E++ L   +H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 804 -----QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS-RLHIAQGAARGLAY 857
                      +     IY   E    D  LH+ +  P  L  D  ++ + Q   RGL Y
Sbjct: 67  ILQPPHIDPFEE-----IYVVTELMQSD--LHKIIVSPQPLSSDHVKVFLYQ-ILRGLKY 118

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH +    ILHRDIK  N+L++ N    + DFGLAR+       H+T ++V T  Y  PE
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174

Query: 918 -------YGQASVATYKGDVYSFGVVLLELLTGK 944
                  Y  A       D++S G +  ELL  +
Sbjct: 175 ILMGSRHYTSAV------DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 69/242 (28%), Positives = 115/242 (47%), Gaps = 23/242 (9%)

Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRN----VAIKRLSGDCG-QMEREFRAEVE 790
           IL+ T    +  ++G G FG VY+   +PDG N    VAIK L  +   +  +E   E  
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++    P +  L G C+    +L +   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI-- 118

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHVTTD 906
               A+G++YL    E  ++HRD+ + N+L+       + DFGLARL+ +   + H    
Sbjct: 119 ----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171

Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
            V  + ++  E       T++ DV+S+GV + EL+T G +P D    +   DL+    R+
Sbjct: 172 KV-PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL 230

Query: 966 RQ 967
            Q
Sbjct: 231 PQ 232

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSG--DCGQMEREFRAEVEALSRAQHPNLVHLQG 805
            IG G +G+V  A     G+ VAIK++    D   + +    E++ L   +H N++ ++ 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 806 YCMHK----NDRLLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIA----QGAARGL 855
                     D  ++   ME+      LH  +  D P + +     HI     Q   RGL
Sbjct: 72  ILRPPGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEE-----HIRYFLYQ-LLRGL 120

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH--VTTDLVGTLGY 913
            Y+H +    ++HRD+K SN+L++ +    + DFG+AR + S    H    T+ V T  Y
Sbjct: 121 KYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 914 IPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             PE       Y  A       D++S G +  E+L G+R +
Sbjct: 178 RAPELLLSLPEYTTAI------DMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 65/236 (27%)

Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS---GDCGQMEREFRAEVEAL 792
           + E TN +     +G G FGLV  A     G+NVAIK++          +R +R E++ L
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLL 63

Query: 793 SRAQHPNLV-----------------HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
              +H N++                  L G  +H   RLL    +E   + Y+L++ L  
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQFIQYFLYQIL-- 118

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
                            RGL Y+H +    ++HRD+K SNIL++ N    + DFGLAR  
Sbjct: 119 -----------------RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR-- 156

Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQAS--VATYKG-----DVYSFGVVLLELLTGK 944
               D  +T       GY+   Y +A   + T++      D++S G +  E+L GK
Sbjct: 157 --IQDPQMT-------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 73.1 bits (179), Expect = 2e-13
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 13/288 (4%)

Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN 187
           +L+NL  L  LDL+ N L   + + + L ++  LD+ +N++   +P  I    S ++ ++
Sbjct: 88  NLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELD 146

Query: 188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP 247
           LS N    +L   L N  +L++L L  NDL+  +   +  L  L  L L  N++S  L P
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP 203

Query: 248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN 307
            I  LS L  LD+S+N+    +    + L     L   +N+    +P S+ N   L  L+
Sbjct: 204 EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261

Query: 308 LRNNSL-DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP 366
           L NN +   S L +   LTNL  LDL  N  +  LP        L+ +            
Sbjct: 262 LSNNQISSISSLGS---LTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT---LKA 315

Query: 367 ETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEK 414
              K    L   ++ ++   +   AL +L+   NL TL   L+  N  
Sbjct: 316 LELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLN 363

Length = 394

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 14/209 (6%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V +    P G  +A K +  +     R +   E++ L     P 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L E    P  +    ++ IA    RGLAYL 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL--GKVSIA--VLRGLAYLR 120

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPEY 918
           +  +  I+HRD+K SNIL++      L DFG++ +LI S     +    VGT  Y+ PE 
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPER 173

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRPM 947
            Q +  + + D++S G+ L+EL  G+ P+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 41/299 (13%)

Query: 733  SIDDI-LESTNN----FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFR 786
            S+DDI L +  +    F+   ++G G +G VY+   +  G+  AIK +     + E E +
Sbjct: 2    SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIK 60

Query: 787  AEVEALSR-AQHPNLVHLQGYCMHK-----NDRL-LIYSFMENGSLDYWLHEKLDGPSSL 839
             E+  L + + H N+    G  + K     +D+L L+  F   GS+   +          
Sbjct: 61   LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120

Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
            DW +  +I +   RGLA+LH      ++HRDIK  N+LL  N    L DFG++  +    
Sbjct: 121  DWIA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Query: 900  DTHVTTDLVGTLGYIPPEY-----GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
                T   +GT  ++ PE         +   Y+ D++S G+  +E+  G  P+    P  
Sbjct: 176  GRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            +  LI          R      P +  K+  K+ +  ++    CL ++   RP+T+QL+
Sbjct: 234  ALFLIP---------RNPP---PKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 3e-13
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 24/208 (11%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGD---------CGQMEREFRAEVEALSRAQHP 798
           ++G G FG V  A L   G   A+K L  D         C  +E+     V AL+  ++P
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKR----VLALA-WENP 56

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            L HL      K     +  F+  G L + + +K       D       A     GL +L
Sbjct: 57  FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFL 112

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H      I++RD+K  N++LD +    +ADFG+ +   + +  +  +   GT  YI PE 
Sbjct: 113 HSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEI 167

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
            Q    T+  D +SFGV+L E+L G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 33/236 (13%)

Query: 755 FGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYC 807
           FG VY+  L         + VAIK L     G +  EF+ E    SR QHPN+V L G  
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 808 MHKNDRLLIYSFMENGSLDYWL-----HEKLDG-------PSSLDWDSRLHIAQGAARGL 855
             +    +I+S+  +  L  +L     H  +          S+L+    +HI    A G+
Sbjct: 78  TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            +L      H++H+D+ + N+L+       ++D GL R + +     +  + +  + ++ 
Sbjct: 138 EFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194

Query: 916 PE---YGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
           PE   YG+ S+ +   D++S+GVVL E+ + G +P   C    ++D+I  +IR RQ
Sbjct: 195 PEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQP--YCG-YSNQDVIE-MIRNRQ 243

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 77/282 (27%), Positives = 128/282 (45%), Gaps = 35/282 (12%)

Query: 742  NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
            ++++    +G G +G VY+A  L  G   A+K +  + G      + E+  +   +H N+
Sbjct: 9    HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA---QGAARGLAY 857
            V   G  + +    +   +   GSL    H  + GP S      L IA   +   +GLAY
Sbjct: 69   VAYFGSYLSREKLWICMEYCGGGSLQDIYH--VTGPLS-----ELQIAYVCRETLQGLAY 121

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            LH   +   +HRDIK +NILL  N    LADFG+A  I +      +   +GT  ++ PE
Sbjct: 122  LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPE 176

Query: 918  YGQASVATYKG-----DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
               A+V    G     D+++ G+  +EL   + PM    P  +  L+S          +S
Sbjct: 177  V--AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS----------KS 224

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                P + DK   K      +   + L+++PK RPT ++L++
Sbjct: 225  NFQPPKLKDKT--KWSSTFHNFVKISLTKNPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 30/227 (13%)

Query: 749 IIGCGGFGLVYRA--TLPDGRN--VAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHL 803
           I+G G FG + R    LP  R   VAI  L   C  +  R F AE   L +  H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
           +G     N  +++  +M NG+LD +L  HE       L     + +  G A G+ YL   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGLASGMKYL--- 123

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG-YIPPE--- 917
            E   +H+ + +  +L++ +    ++ F   RL     +   TT    +   +  PE   
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 918 YGQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWV 962
           Y   S A+   DV+SFG+V+ E+++ G+RP  DM      +D+I  V
Sbjct: 182 YHHFSSAS---DVWSFGIVMWEVMSYGERPYWDM----SGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 30/206 (14%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLS-------GDCGQMEREFRAEVEA--LSRAQHPNL 800
           +G G FG VY   + D + VA +RL        G+    E   +A  EA  LS+  HP +
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNE-TVQANQEAQLLSKLDHPAI 64

Query: 801 VHLQGYCMHKNDRLLIYSFMENGSLDYWLHE------KLDGPSSLDWDSRLHIAQGAARG 854
           V      + ++   +I  + E   LD  L E       L      +W  +L +      G
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + Y+HQ     ILHRD+K+ NI L  N    + DFG++RL++   D  + T   GT  Y+
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD--LATTFTGTPYYM 172

Query: 915 PPEYGQASVATYKGDVYSFGVVLLEL 940
            PE  +      K D++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 33/219 (15%)

Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHP 798
            +++   IG G +G V++A        VA+KR+     D G      R E+  L   +H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59

Query: 799 NLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA----R 853
           N+V L    +H + +L L++ + +       L +  D   S + D    I +       +
Sbjct: 60  NIVRLYD-VLHSDKKLTLVFEYCDQD-----LKKYFD---SCNGDIDPEIVKSFMFQLLK 110

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP---YDTHVTTDLVGT 910
           GLA+ H     ++LHRD+K  N+L++ N    LADFGLAR    P   Y   V      T
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----T 162

Query: 911 LGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           L Y PP+  +G A + +   D++S G +  EL    RP+
Sbjct: 163 LWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 22/207 (10%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFR---AEVEALSRA-QHPNLVHL 803
           ++G G FG V+ A L    +  AIK L  D   M+ +      E   LS A +HP L HL
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 804 QGYCMH--KNDRLLIYSFMENGSLDYWLH--EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
             YC    K +   +  ++  G L + +    K D P +  + + +        GL +LH
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC------GLQFLH 113

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
                 I++RD+K  NILLD +    +ADFG+ +   +      T    GT  YI PE  
Sbjct: 114 SK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDYIAPEIL 168

Query: 920 QASVATYKGDVYSFGVVLLELLTGKRP 946
                    D +SFGV+L E+L G+ P
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 38/223 (17%)

Query: 750 IGCGGFGLVY------------RATLPDGRN-----VAIKRLSGDCGQMER-EFRAEVEA 791
           +G G FG V+            +A   +        VA+K L  D     R +F  EV+ 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR------- 844
           LSR   PN+  L G C       +I  +MENG L+ +L + +   S L  +S+       
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDTHV 903
           L++A   A G+ YL      + +HRD+ + N L+  N+   +ADFG++R L  S Y   V
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRV 188

Query: 904 TTDLVGTLGYIPPEYGQASVA----TYKGDVYSFGVVLLELLT 942
                  + ++  E    SV     T K DV++FGV L E+LT
Sbjct: 189 QGRAPLPIRWMAWE----SVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 77/286 (26%), Positives = 123/286 (43%), Gaps = 47/286 (16%)

Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 14   LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGA---ARGL 855
             L G        L+I   M  G L  +L     +++        S   + Q A   A G+
Sbjct: 73   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G +P
Sbjct: 133  AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLP 184

Query: 916  -----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN 969
                 PE  +  V T   DV+SFGVVL E+ T  ++P                  M  E 
Sbjct: 185  VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GMSNEQ 229

Query: 970  RESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 230  VLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 32/274 (11%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFR----AEVEALSRAQH 797
            NF     IG G F  VYRAT L D + VA+K++      M+ + R     E++ L +  H
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLD----YWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            PN++      +  N+  ++    + G L     Y+  +K   P    W   + +      
Sbjct: 62   PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--- 118

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
             + ++H      ++HRDIK +N+ +       L D GL R   S   T     LVGT  Y
Sbjct: 119  -VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 172

Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + PE    +   +K D++S G +L E+   + P    K     +L S   ++ Q      
Sbjct: 173  MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQKIEQ------ 222

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007
              D      +H  E LR  ++  +C+   P  RP
Sbjct: 223  -CDYPPLPTEHYSEKLR--ELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 5e-13
 Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFR---AEVEALSR-AQHPNLVHL 803
           +IG G FG V  A    DG+  A+K L        +E +   AE   L +  +HP LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 804 QGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             Y     ++L  +  F+  G L + L  +   P      +R + A+  A  L YLH   
Sbjct: 62  H-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHSI- 115

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  NILLD      L DFGL +  ++  DT  TT   GT  Y+ PE  +  
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
                 D +  G VL E+L G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           +G G FG V    L    +   VA+K +    C + E E F +E   +    HPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 805 GYCMHKNDR------LLIYSFMENGSL-DYWLHEKL-DGPSSLDWDSRLHIAQGAARGLA 856
           G C+   +       ++I  FM++G L  + L+ +L D P  L     +      A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIP 915
           YL        +HRD+ + N +L+ N    +ADFGL++ I +  D +    +    + +I 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVKWIA 182

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            E     V T K DV+SFGV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.5 bits (173), Expect = 8e-13
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G +G+V  A   +    VAIK+++    +    +R  R E++ L    H N++ ++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 806 YCM--HK---NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
                H+   ND  ++Y  M     D  LH+ +    +L  D   +      RGL Y+H 
Sbjct: 72  IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--- 917
           +   ++LHRD+K SN+LL+ N    + DFGLAR      D    T+ V T  Y  PE   
Sbjct: 127 A---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLL 181

Query: 918 ----YGQASVATYKGDVYSFGVVLLELLTGK 944
               Y  A       DV+S G +  ELL  K
Sbjct: 182 NCSEYTTAI------DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 75/289 (25%), Positives = 111/289 (38%), Gaps = 54/289 (18%)

Query: 749  IIGCGGFGLVYRATL----PDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
             IG G FG VY+        +   VA+K          RE F  E   + +  HP++V L
Sbjct: 13   CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 804  QGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             G          ++  ME    G L  +L        SLD  S +  +   +  LAYL  
Sbjct: 73   IGVITENP----VWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES 125

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPE- 917
                  +HRDI + N+L+       L DFGL+R +    D        G L   ++ PE 
Sbjct: 126  K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMAPES 179

Query: 918  --YGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES-- 972
              + + + A+   DV+ FGV + E+L  G +P    K   + D+I      R EN E   
Sbjct: 180  INFRRFTSAS---DVWMFGVCMWEILMLGVKPFQGVK---NNDVI-----GRIENGERLP 228

Query: 973  --EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                  P +Y             +   C +  P  RP   +L + L  I
Sbjct: 229  MPPNCPPTLY------------SLMTKCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 22/213 (10%)

Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY+A   +   +A  ++     + E E +  E++ L+   HPN+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAYLHQSCEPHIL 867
           ++N+  ++  F   G++D  + E L+ P +   + ++ +  +     L YLH++    I+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLE-LERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT---DLVGTLGYIPPEYGQASVA 924
           HRD+K+ NIL   +    LADFG     +S  +T         +GT  ++ PE      +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG-----VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 925 T-----YKGDVYSFGVVLLELLTGKRPMDMCKP 952
                 YK DV+S G+ L+E+   + P     P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 69/229 (30%), Positives = 103/229 (44%), Gaps = 21/229 (9%)

Query: 749 IIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER------EFRAEVEALSRAQHPNLV 801
           IIG GGFG VY     D G+  A+K L     +M++        R  +  +S    P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 802 HLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            +  Y  H  D+L  I   M  G L Y L +   G  S + + R +  +    GL ++H 
Sbjct: 61  CMT-YAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFS-EKEMRFYATE-IILGLEHMHN 115

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
                +++RD+K +NILLD +    ++D GLA    S    H +   VGT GY+ PE  Q
Sbjct: 116 R---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQ 168

Query: 921 ASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
              A     D +S G +L +LL G  P    K K   ++    + +  E
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E++ L     P +V   G      +  +    M+ GSLD  L +    P ++    ++ I
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENIL--GKISI 106

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTD 906
           A    RGL YL +  +  I+HRD+K SNIL++      L DFG++ +LI S  ++     
Sbjct: 107 A--VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----- 157

Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            VGT  Y+ PE  Q +  T + D++S G+ L+E+  G+ P+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 69/239 (28%), Positives = 103/239 (43%), Gaps = 27/239 (11%)

Query: 744 FDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN 799
           F Q  ++G GGFG V     RAT   G+  A KRL     +  ++ + E  AL+  Q   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT---GKMYACKRLEK---KRIKKRKGESMALNEKQILE 55

Query: 800 LVHLQ-----GYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            V+ Q      Y     D L L+ + M  G L + ++    G    + +  L  A     
Sbjct: 56  KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILC 113

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           GL  LH+    + ++RD+K  NILLD      ++D GLA  I  P +       VGT+GY
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI--P-EGESIRGRVGTVGY 167

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
           + PE       T   D +  G ++ E++ G+ P    K K  R+ +    R   E  E 
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLETEEV 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G +G+VY+A        +A+K++     D G      R E+  L   QH N+V LQ 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 806 YCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRL---HIAQGAARGLAYLHQS 861
             +H   RL L++ +     LD  L + +D       + RL   ++ Q   RG+AY H  
Sbjct: 69  -VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQ-ILRGIAYCHSH 121

Query: 862 CEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--Y 918
               +LHRD+K  N+L+D    A  LADFGLAR    P  T   T  V TL Y  PE   
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILL 176

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRPM 947
           G    +T   D++S G +  E++  ++P+
Sbjct: 177 GSRHYST-PVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 71/221 (32%), Positives = 101/221 (45%), Gaps = 25/221 (11%)

Query: 749 IIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ--- 804
           IIG GGFG VY     D G+  A+K L     +M++    E  AL+     +LV      
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDCP 57

Query: 805 -----GYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
                 Y  H  D+L  I   M  G L Y L +   G  S + + R + A+    GL ++
Sbjct: 58  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFS-EAEMRFYAAE-IILGLEHM 113

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H      +++RD+K +NILLD +    ++D GLA    S    H +   VGT GY+ PE 
Sbjct: 114 HNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 919 GQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL 958
            Q  VA     D +S G +L +LL G  P    K K   ++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 14/164 (8%)

Query: 795 AQHPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + HP LV L   C     RL  +  ++  G L + +  +   P      +R + A+  + 
Sbjct: 53  SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAE-ISL 107

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L YLH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  Y
Sbjct: 108 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
           I PE  +     +  D ++ GV++ E++ G+ P D+    GS D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 73/273 (26%), Positives = 117/273 (42%), Gaps = 37/273 (13%)

Query: 744  FDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ--- 796
            F    ++G GGFG V     RAT   G+  A K+L     +  ++ + E  AL+  +   
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEK---KRIKKRKGEAMALNEKRILE 55

Query: 797  --HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
              +   V    Y     D L L+ + M  G L + ++    G    D    +  A     
Sbjct: 56   KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCC 113

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            GL  L +     I++RD+K  NILLD      ++D GLA  I  P +       VGT+GY
Sbjct: 114  GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI--P-EGETVRGRVGTVGY 167

Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + PE       T+  D +  G ++ E++ G+ P    K +  R+ +   ++  QE    E
Sbjct: 168  MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE----E 223

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR 1006
              + F  D    K + R+L      L+++PK R
Sbjct: 224  YSEKFSEDA---KSICRML------LTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 32/229 (13%)

Query: 749 IIGCGGFGLVYRATLPDGRNV-AIKRLSGD---------CGQMEREFRAEVEALSRAQHP 798
           ++G G FG V  A L       AIK L  D         C  +ER     V AL+  +HP
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERR----VLALA-WEHP 56

Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            L HL  +C  +    L +   ++  G L + +        +    +R + A+    GL 
Sbjct: 57  FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---RARFYAAE-IICGLQ 110

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           +LH+     I++RD+K  N+LLD +    +ADFG+ +  +        +   GT  YI P
Sbjct: 111 FLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM--NGEGKASTFCGTPDYIAP 165

Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
           E  +        D +SFGV+L E+L G+ P          D +   I  
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----DEDELFDSILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 11/219 (5%)

Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAIK+++      +     
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN 65

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 120

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +  +T +
Sbjct: 121 CRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRST-M 175

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 20/208 (9%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRA---EVEALSRA-QHPNLVHL 803
           ++G G FG V  A L   GR  A+K L  D    + +      E   LS A  HP L  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 804 QGYCMHKNDRLL-IYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              C    DRL  +  F+  G L + + +  + D   +     R + A+     L +LH 
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-----RFYAAE-ITSALMFLH- 113

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
             +  I++RD+K  N+LLD      LADFG+ +  +  ++   T+   GT  YI PE  Q
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--FNGKTTSTFCGTPDYIAPEILQ 169

Query: 921 ASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +     D ++ GV+L E+L G  P +
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 3e-12
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 11/219 (5%)

Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  +I  I +    + +   IG G  G V+ A  +  G+ VAIK+++      +     
Sbjct: 6   EKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN 65

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAV 120

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS N+LL  +    L DFG    I +P  +  +T +
Sbjct: 121 CRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRST-M 175

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 16/213 (7%)

Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD--CGQMEREFRA---EVEALSRAQ 796
           N+ +  ++G G FG VY     D GR +A K++  D    +  +E  A   E++ L   Q
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 797 HPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           H  +V   G    + ++ L     +M  GS+     ++L    +L         +    G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGY 913
           ++YLH +    I+HRDIK +NIL D      L DFG + RL            + GT  +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           + PE         K DV+S G  ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLS------GDCGQMEREFRAEVEALSRAQHPNLV 801
           +IG G +G+V  A     G  VAIK+++       D  ++ RE    ++ L   +HP++V
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDIV 62

Query: 802 HLQGYCMHKNDR-----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            ++   +  + R      +++  ME+      LH+ +     L  +          R L 
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTLGYIP 915
           Y+H +   ++ HRD+K  NIL + +    + DFGLAR+  +   T +  TD V T  Y  
Sbjct: 118 YIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 916 PEYGQASVATYKG--DVYSFGVVLLELLTGK 944
           PE   +  + Y    D++S G +  E+LTGK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 11/219 (5%)

Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +   + +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSK-RSTM 176

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 14/216 (6%)

Query: 732 ISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVE 790
           +S+ D  +    F++   IG G  G VY A  +  G+ VAIK+++      +     E+ 
Sbjct: 12  VSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL 68

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            +   +HPN+V+     +  ++  ++  ++  GSL   + E     + +D      + + 
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRE 123

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
             + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +  +T +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRST-MVGT 178

Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ PE         K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 14/226 (6%)

Query: 749 IIGCGGFGLVYRAT-LPDGRN----VAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVH 802
           ++G G FG V++   +P+G +    VAIK +    G+   +E    + A+    H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L G C   + +L +      GSL   + +  D   SLD    L+     A+G+ YL +  
Sbjct: 74  LLGICPGASLQL-VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
              ++HR++ + NILL  +    +ADFG+A L+      +  ++    + ++  E     
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
             T++ DV+S+GV + E+++ G  P    +P    DL+    R+ Q
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 42/293 (14%)

Query: 753  GGFGLVYRATLPDGRNVAIKRLSGDCGQMER--EFRAEVEALSRAQHPN-LVHLQGYCMH 809
                 + +   P    VA+K+++ D    E     + E+    + QHPN L ++  + + 
Sbjct: 13   LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IV 70

Query: 810  KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA---QGAARGLAYLHQSCEPHI 866
             ++  ++   M  GS +  L      P  L     L IA   +     L Y+H       
Sbjct: 71   DSELYVVSPLMAYGSCEDLLKTHF--PEGL---PELAIAFILKDVLNALDYIHSK---GF 122

Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-----LGYIPPEYGQA 921
            +HR +K+S+ILL G+    L+    +  ++                   L ++ PE  Q 
Sbjct: 123  IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 922  SVATY--KGDVYSFGVVLLELLTGKRP--------MDMCKPKGS-RDLISWVI----RMR 966
            ++  Y  K D+YS G+   EL  G  P        M + K +G+   L+           
Sbjct: 183  NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242

Query: 967  QENRESEVLDPFIYDKQHDKEMLRVL-----DIACLCLSESPKVRPTTQQLVS 1014
                 S    P   D        R           LCL   P+ RP+  QL++
Sbjct: 243  MSQSRSSNEHPNNRDSVDHPYT-RTFSEHFHQFVELCLQRDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 7e-12
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 16/210 (7%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 120

Query: 860 QSCEPH-ILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPPE 917
              E H I+HRD+K SNIL++      L DFG++ +LI S     +    VGT  Y+ PE
Sbjct: 121 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPE 172

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 67.4 bits (164), Expect = 8e-12
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           +G G +G VY+A   DG++    A+K++ G    M      E+  L   +HPN++ LQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66

Query: 807 CMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY-----LH 859
            +   DR   L++ + E+   D W   K    S  +    + + +G  + L Y     +H
Sbjct: 67  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIH 122

Query: 860 QSCEPHILHRDIKSSNILLDGNFG----AHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
                 +LHRD+K +NIL+ G         +AD G ARL  SP       D +V T  Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 915 PPEYGQASVATYKG-DVYSFGVVLLELLTGKRPMDMCK 951
            PE    +    K  D+++ G +  ELLT + P+  C+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 75/288 (26%), Positives = 122/288 (42%), Gaps = 32/288 (11%)

Query: 750  IGCGGFGLVYRATL-PDGRN----VAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHL 803
            +G G FG V      P+G N    VA+K L     G    + + E+E L    H N+V  
Sbjct: 12   LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 804  QGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            +G C         LI  F+ +GSL  +L       + ++   +L  A    +G+ YL   
Sbjct: 72   KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR 128

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQ 920
                 +HRD+ + N+L++      + DFGL + I +  + + V  DL   + +  PE   
Sbjct: 129  ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 921  ASVATYKGDVYSFGVVLLELLT----GKRPM----DMCKPKGSRDLISWVIRMRQENRES 972
             S      DV+SFGV L ELLT       PM     M  P   +  ++ ++R+ +E +  
Sbjct: 186  QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                P    ++  + M +       C    P  R T Q L+   ++I+
Sbjct: 246  PR--PPNCPEEVYQLMRK-------CWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHP 798
           +++++   +G G +  VY+  +  +G+ VA+K  RL  + G      R E   L   +H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDS-RLHIAQGAARGLA 856
           N+V L      K    L++ ++      Y     +D  P  L  ++ +L + Q   RGL+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQY-----MDKHPGGLHPENVKLFLFQ-LLRGLS 117

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y+HQ    +ILHRD+K  N+L+       LADFGLAR    P  +H  ++ V TL Y PP
Sbjct: 118 YIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPP 172

Query: 917 E--YGQASVATYKGDVYSFGVVLLELLTG 943
           +   G    +T   D++  G + +E++ G
Sbjct: 173 DVLLGSTEYSTCL-DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 25/227 (11%)

Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+   L  D   VA+K         ++ +F  E   L +  HPN+V L G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             K    ++   ++ G  D+    + +GP  L     + + + AA G+ YL      H +
Sbjct: 63  TQKQPIYIVMELVQGG--DFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESK---HCI 116

Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YG 919
           HRD+ + N L+       ++DFG++R      +        G +  IP     PE   YG
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 920 QASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
           + S  +   DV+SFG++L E  + G  P      + +R+ I   +R+
Sbjct: 172 RYSSES---DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL 215

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 13/112 (11%)

Query: 846 HIAQGAARGLAYLHQSCEPH-ILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHV 903
            +     + L YL    E H ++HRD+K SNILLD +    L DFG++ RL+    D+  
Sbjct: 118 KMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV----DSKA 170

Query: 904 TTDLVGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRPMDMCK 951
            T   G   Y+ PE          Y  + DV+S G+ L+EL TG+ P   CK
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.5 bits (162), Expect = 2e-11
 Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 38/238 (15%)

Query: 743 NFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRA--- 795
           NF+   ++G G +G   LV + T  D G+  A+K L      +++    E     R    
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ-KAALVQKAKTVEHTRTERNVLE 59

Query: 796 ---QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              Q P LV L  Y      +L LI  ++  G +   L++            R + ++  
Sbjct: 60  HVRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQ------------RDNFSEDE 106

Query: 852 AR--------GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
            R         L +LH+     I++RDIK  NILLD      L DFGL++  LS  +   
Sbjct: 107 VRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-EKER 162

Query: 904 TTDLVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
           T    GT+ Y+ PE  +      K  D +S G+++ ELLTG  P  +   + ++  +S
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 749 IIGCGGFGLVYRATLPDGRNV-AIKRLSGD---------CGQMEREFRAEVEALSRAQHP 798
           ++G G FG V  A L     V AIK L  D         C   E+     + AL+ A+HP
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALA-AKHP 56

Query: 799 NLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARGL 855
            L  L   C    DRL  +  ++  G L + +    K D P S     R + A+     L
Sbjct: 57  FLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-----RFYAAE-VTLAL 109

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            +LH+     +++RD+K  NILLD      LADFG+ +  +    T  TT   GT  YI 
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIA 164

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  Q        D ++ GV++ E++ G+ P +
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 70/270 (25%), Positives = 118/270 (43%), Gaps = 40/270 (14%)

Query: 769  VAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
            VA+K L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L 
Sbjct: 53   VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 827  YWLHEKLDGPSSLDW--------DSRLHI------AQGAARGLAYL-HQSCEPHILHRDI 871
             +L  +   P  +++        + +L        A   ARG+ YL  + C    +HRD+
Sbjct: 113  EYLRARR--PPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC----IHRDL 166

Query: 872  KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVY 931
             + N+L+  +    +ADFGLAR I        TT+    + ++ PE     + T++ DV+
Sbjct: 167  AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226

Query: 932  SFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLR 990
            SFGV+L E+ T G  P      +    L+    RM + +  +  L   + D         
Sbjct: 227  SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD--------- 277

Query: 991  VLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                   C    P  RPT +QLV  LD I+
Sbjct: 278  -------CWHAVPSQRPTFKQLVEDLDRIL 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)

Query: 749 IIGCGGFG---LVYRATLPD-GRNVAIKRLSGDC--------GQMEREFRAEVEALSRAQ 796
           ++G G FG   LV + T PD G+  A+K L             +MER+  AEV       
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56

Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           HP +V L  Y      +L LI  F+  G L   L +++      + D + ++A+  A  L
Sbjct: 57  HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALAL 111

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            +LH      I++RD+K  NILLD      L DFGL++  +            GT+ Y+ 
Sbjct: 112 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMA 166

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           PE       T   D +SFGV++ E+LTG  P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 63/218 (28%), Positives = 88/218 (40%), Gaps = 50/218 (22%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEA---------LSRAQHPN 799
           +G G +G V  A     GR VAIK+LS       R F++ + A         L    H N
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75

Query: 800 LVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ L              D  L+   M     +    +KL      D   +  + Q   R
Sbjct: 76  VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-----DDHIQFLVYQ-ILR 129

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           GL Y+H +    I+HRD+K SNI ++ +    + DFGLAR           T  V T  Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWY 181

Query: 914 IPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             PE       Y Q        D++S G ++ ELLTGK
Sbjct: 182 RAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 45/213 (21%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMER--EFRAEVEALSR-AQHPNLVHLQG 805
           IG G F  V +A +   G+  AIK +      +E+    R E++AL R + HPN++ L  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRL-- 63

Query: 806 YCMHKNDRL-----LIYSFMENGSLDYWLHEK--LDGPSSLDWDSRLHIAQGAARGLAYL 858
                 DR      L++  M+    +     K  L       +  +L       + L ++
Sbjct: 64  -IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHM 116

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS--PYDTHVTTDLVGTLGYIPP 916
           H++    I HRDIK  NIL+  +    LADFG  R I S  PY     T+ + T  Y  P
Sbjct: 117 HRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY-----TEYISTRWYRAP 167

Query: 917 E-------YGQASVATYKGDVYSFGVVLLELLT 942
           E       YG       K D+++ G V  E+L+
Sbjct: 168 ECLLTDGYYG------PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.0 bits (163), Expect = 2e-11
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 35/236 (14%)

Query: 786  RAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
            R+E+  L+   H  +V         +  LLI  +   G L+  + ++L           L
Sbjct: 113  RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK--------EHL 164

Query: 846  HIAQGAARGLAY--------LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS 897
               +     L Y        +H      ++HRD+KS+NI L       L DFG ++    
Sbjct: 165  PFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 898  PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
                 V +   GT  Y+ PE  +    + K D++S GV+L ELLT  RP    K    R+
Sbjct: 222  SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQRE 278

Query: 958  LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            ++  V+  +         DPF         M  +LD     LS++P +RPTTQQL+
Sbjct: 279  IMQQVLYGK--------YDPFPCPVS--SGMKALLDP---LLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 11/156 (7%)

Query: 795 AQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + +P LV L   C     RL L+  ++  G L + +  +   P      +R + A+    
Sbjct: 53  SSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEE---HARFYAAE-ICI 107

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L +LH   E  I++RD+K  N+LLD +    L D+G+ +  L P DT  T+   GT  Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDM 949
           I PE  +     +  D ++ GV++ E++ G+ P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 23/218 (10%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           +G G +G VY+A   DG++    A+K++ G    M      E+  L   +HPN++ LQ  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66

Query: 807 CMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY-----LH 859
            +  +DR   L++ + E+   D W   K    S  +    + + +   + L Y     +H
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIH 122

Query: 860 QSCEPHILHRDIKSSNILLDGNFG----AHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
                 +LHRD+K +NIL+ G         +AD G ARL  SP       D +V T  Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 915 PPEYGQASVATYKG-DVYSFGVVLLELLTGKRPMDMCK 951
            PE    +    K  D+++ G +  ELLT + P+  C+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 67/270 (24%), Positives = 109/270 (40%), Gaps = 28/270 (10%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG VY+A   +   +A  ++     + E E +  E+E L+   HP +V L G   
Sbjct: 20   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
                  ++  F   G++D  + E LD    L       I +     L YLH      I+H
Sbjct: 80   WDGKLWIMIEFCPGGAVDAIMLE-LD--RGLTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT--- 925
            RD+K+ N+LL  +    LADFG++   +           +GT  ++ PE           
Sbjct: 134  RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETMKDTP 191

Query: 926  --YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
              YK D++S G+ L+E+   + P     P          + ++    E   L       Q
Sbjct: 192  YDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSEPPTLS------Q 237

Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              K  +   D     L + P+ RP+  QL+
Sbjct: 238  PSKWSMEFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 15/204 (7%)

Query: 750 IGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVH 802
           +G GGFG V     RAT   G+  A K+L+    +  + +     E   L++     +V 
Sbjct: 1   LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L      K D  L+ + M  G L Y ++   +                   GL +LHQ  
Sbjct: 58  LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
              I++RD+K  N+LLD +    ++D GLA  +        T    GT G++ PE  Q  
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGE 172

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
              +  D ++ GV L E++  + P
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 45/287 (15%)

Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY            + R VA+K ++      ER EF  E   +      ++V
Sbjct: 14   LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGL 855
             L G        L++   M +G L  +L       E   G         + +A   A G+
Sbjct: 73   RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            AYL+       +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G +P
Sbjct: 133  AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLP 184

Query: 916  -----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN 969
                 PE  +  V T   D++SFGVVL E+ +  ++P                  +  E 
Sbjct: 185  VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ---------------GLSNEQ 229

Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                V+D    D+  +    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 230  VLKFVMDGGYLDQPDNCPE-RVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 42/225 (18%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGD---------CGQMEREFRAEVEAL 792
           +F+   ++G G FG V  A       + AIK L  D         C  +E+     V AL
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR----VLAL 56

Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQ 849
           S  + P L  L   C    DRL  +  ++  G L Y + +  +   P ++ + + + I  
Sbjct: 57  S-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-- 112

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               GL +LH      I++RD+K  N++LD      +ADFG+ +  +  +D   T    G
Sbjct: 113 ----GLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM--WDGVTTKTFCG 163

Query: 910 TLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           T  YI PE      YG++       D ++FGV+L E+L G+ P +
Sbjct: 164 TPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF------RAEVEALSRAQHPNLVH 802
           IG G FG VY+    D  R  A+K LS      ++E       R  +      + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L+      +D  L+  +M  G L +W H + +G  S D  ++ +IA+     L +LH   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL-FW-HLQKEGRFSED-RAKFYIAE-LVLALEHLH--- 113

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE----- 917
           +  I++RD+K  NILLD      L DFGL++  L+   T  T    GT  Y+ PE     
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDE 171

Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             Y +        D +S GV++ E+  G  P
Sbjct: 172 KGYTKHV------DFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.1 bits (158), Expect = 4e-11
 Identities = 66/265 (24%), Positives = 115/265 (43%), Gaps = 25/265 (9%)

Query: 750  IGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            IG G  G+V  A     GR VA+K +     Q       EV  +   QH N+V +    +
Sbjct: 29   IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
               +  ++  F++ G+L   + +     + L+ +    + +   + L YLH      ++H
Sbjct: 89   VGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIH 140

Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
            RDIKS +ILL  +    L+DFG    I    D      LVGT  ++ PE    +    + 
Sbjct: 141  RDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 929  DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEM 988
            D++S G++++E++ G+ P     P      +  + R+R          P + +      +
Sbjct: 199  DIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRDSP------PPKLKNAHKISPV 246

Query: 989  LRVLDIACLCLSESPKVRPTTQQLV 1013
            LR  D     L+  P+ R T Q+L+
Sbjct: 247  LR--DFLERMLTREPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 22/216 (10%)

Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD--CGQMEREFRA---EVEALSRAQ 796
           N+    ++G G FG VY     D GR +A+K++  D    +  +E  A   E++ L    
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 797 HPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           H  +V   G      +R L      M  GS+     ++L    +L  +      +    G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR----LILSPYDTHVTTDLVGT 910
           ++YLH +    I+HRDIK +NIL D      L DFG ++    + LS       T   GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GT 172

Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ PE         K D++S G  ++E+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.1 bits (164), Expect = 4e-11
 Identities = 64/241 (26%), Positives = 97/241 (40%), Gaps = 52/241 (21%)

Query: 744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER---EFRAEVEALSRAQHPN 799
           +D   +IG GG G VY A  P   R VA+K++  D  +       F  E +  +   HP 
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 800 LV-----------------HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
           +V                 +++GY +    + L+ S  +  SL   L EK    + L   
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTL----KSLLKSVWQKESLSKELAEKTSVGAFLS-- 117

Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDT 901
               I       + Y+H      +LHRD+K  NILL G FG   + D+G A       + 
Sbjct: 118 ----IFHKICATIEYVHSK---GVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEED 169

Query: 902 HVTTD----------------LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR 945
            +  D                +VGT  Y+ PE      A+   D+Y+ GV+L ++LT   
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229

Query: 946 P 946
           P
Sbjct: 230 P 230

Length = 932

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 5e-11
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 2/92 (2%)

Query: 212 LGMND--LTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNI 269
           LG+++  L G I +DI +L+ L+ + L  N + G + PS+  +++L  LD+S N+F+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 270 PDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSP 301
           P+    L   + L  + N  +GR+P +L    
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)

Query: 769  VAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
            VA+K L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L 
Sbjct: 50   VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 827  YWLHEKLDGPSSLDWD-SRLHIAQ-----------GAARGLAYL-HQSCEPHILHRDIKS 873
             +L  +        +D +R+   Q             ARG+ YL  Q C    +HRD+ +
Sbjct: 110  EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAA 165

Query: 874  SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSF 933
             N+L+  N    +ADFGLAR + +      TT+    + ++ PE     V T++ DV+SF
Sbjct: 166  RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225

Query: 934  GVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL 992
            GV++ E+ T G  P      +    L+    RM +    +  L   + D           
Sbjct: 226  GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD----------- 274

Query: 993  DIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 C    P  RPT +QLV  LD I+
Sbjct: 275  -----CWHAIPSHRPTFKQLVEDLDRIL 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 75/296 (25%), Positives = 126/296 (42%), Gaps = 46/296 (15%)

Query: 750  IGCGGFGLVYRA-------TLPD-GRNVAIKRLSGDCGQME-REFRAEVEALS-RAQHPN 799
            +G G FG V RA       + PD    VA+K L  +    +  +  +E+E +    +H N
Sbjct: 20   LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK--------LDGPSS----LDWDSRLHI 847
            +++L G C  +    +I  +   G+L  +L  +         D        L +   +  
Sbjct: 80   IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 848  AQGAARGLAYLH-QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR +        T++
Sbjct: 140  AYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFG+++ E+ T G  P      +    L+    RM
Sbjct: 196  GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM 255

Query: 966  -RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +  N   E     +Y    +            C    P  RPT +QLV  LD ++
Sbjct: 256  DKPSNCTHE-----LYMLMRE------------CWHAVPTQRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 33/277 (11%)

Query: 753  GGFGLVYRATLPDG-----RNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGY 806
            G FG ++   L D        V +K +     +++      E   L    H N++ +   
Sbjct: 17   GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 807  CMHKNDR-LLIYSFMENGSLDYWL----HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            C+   +   ++Y +M  G+L  +L      + + P +L     +H+A   A G++YLH+ 
Sbjct: 77   CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG-TLGYIPPEYGQ 920
                ++H+DI + N ++D      + D  L+R  L P D H   D     + ++  E   
Sbjct: 137  ---GVIHKDIAARNCVIDEELQVKITDNALSR-DLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                +   DV+SFGV+L EL+T G+ P     P      +    R+ Q     +      
Sbjct: 193  NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPD------ 246

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                   E+  V+  AC C +  P+ RP+  QLV  L
Sbjct: 247  -------ELFAVM--AC-CWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 69/267 (25%), Positives = 116/267 (43%), Gaps = 29/267 (10%)

Query: 750  IGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            IG G  G+V  AT    G+ VA+K++     Q       EV  +    H N+V +    +
Sbjct: 30   IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
              ++  ++  F+E G+L D   H +++       +    +     R L+YLH      ++
Sbjct: 90   VGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCLSVLRALSYLHNQ---GVI 140

Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
            HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE         +
Sbjct: 141  HRDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 928  GDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKE 987
             D++S G++++E++ G+ P     P            ++   R  + L P + D      
Sbjct: 199  VDIWSLGIMVIEMIDGEPPYFNEPP------------LQAMRRIRDNLPPRVKDSHKVSS 246

Query: 988  MLR-VLDIACLCLSESPKVRPTTQQLV 1013
            +LR  LD   L L   P  R T Q+L+
Sbjct: 247  VLRGFLD---LMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 70/232 (30%), Positives = 107/232 (46%), Gaps = 25/232 (10%)

Query: 743 NFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLS-------GDCGQMEREFRAEVEA 791
           NF+   ++G G +G   LV +    D G+  A+K L            +  R  R  +EA
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 792 LSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           + R   P LV L  Y    + +L LI  ++  G L   L+++     S   + R++IA+ 
Sbjct: 61  VRRC--PFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAE- 113

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
               L +LHQ     I++RDIK  NILLD      L DFGL++  L+  +        GT
Sbjct: 114 IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGT 169

Query: 911 LGYIPPEYGQASVATYKG--DVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
           + Y+ PE  +     +    D +S GV+  ELLTG  P  +   + S+  IS
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 8e-11
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 37/218 (16%)

Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
           +GCG  GLV+ A   D  + VA+K++   D   ++   R E++ + R  H N+V +    
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVYEVL 71

Query: 808 MHKNDRL--LIYSFMENGSLDYWLHEKLD---------GPSSLDWDSRLHIAQGAARGLA 856
                 L   + S  E  S+ Y + E ++         GP S +  +RL + Q   RGL 
Sbjct: 72  GPSGSDLTEDVGSLTELNSV-YIVQEYMETDLANVLEQGPLSEEH-ARLFMYQ-LLRGLK 128

Query: 857 YLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILSPYD--THVTTDLVGTLGY 913
           Y+H +   ++LHRD+K +N+ ++  +    + DFGLAR++   Y    +++  LV T  Y
Sbjct: 129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWY 184

Query: 914 IPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             P        Y +A       D+++ G +  E+LTGK
Sbjct: 185 RSPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 9e-11
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 26/205 (12%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMERE----FRAEVEA--LSRAQHPNLVH 802
           +G G +  VY+  +  +G+ VA+K +S     M+ E    F A  EA  L   +H N+V 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVIS-----MKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLHIAQGAARGLAYLHQS 861
           L      K     ++ +M      Y +      P  L  ++ RL + Q   RGLAY+H  
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQH----PGGLHPYNVRLFMFQ-LLRGLAYIHGQ 122

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YG 919
              HILHRD+K  N+L+       LADFGLAR    P  T+ +   V TL Y PP+   G
Sbjct: 123 ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--VVTLWYRPPDVLLG 177

Query: 920 QASVATYKGDVYSFGVVLLELLTGK 944
               ++   D++  G + +E+L G+
Sbjct: 178 ATDYSS-ALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 33/230 (14%)

Query: 733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMERE----FRA 787
            I  +     +FD   +IG G FG V        + V A+K LS     ++R     F  
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWE 92

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSL-----DYWLHEKLDGPSSLD 840
           E + ++ A    +V L      ++D+ L  +  +M  G L     +Y + EK        
Sbjct: 93  ERDIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-------- 142

Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
           W +R + A+     L  +H       +HRD+K  N+LLD +    LADFG    + +   
Sbjct: 143 W-ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197

Query: 901 THVTTDLVGTLGYIPPEY----GQASVATYKGDVYSFGVVLLELLTGKRP 946
               T  VGT  YI PE     G       + D +S GV L E+L G  P
Sbjct: 198 VRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 18/235 (7%)

Query: 730 KEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAE 788
           K I  D   + ++ ++    IG G +G V++     +G   A+K L      ++ E  AE
Sbjct: 6   KTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAE 64

Query: 789 VEAL-SRAQHPNLVHLQGYCMHKN----DRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
              L + + HPN+V   G    K+    D+L L+      GS+   +   L     ++  
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124

Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              +I   A  GL +LH +     +HRD+K +NILL    G  L DFG++  + S     
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 903 VTTDLVGTLGYIPPEY---GQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKP 952
            T+  VGT  ++ PE     Q   +TY  + DV+S G+  +EL  G  P+    P
Sbjct: 182 NTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 42/225 (18%)

Query: 743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD---------CGQMEREFRAEVEAL 792
           +F+   ++G G FG V  A         AIK L  D         C  +E+   A  +  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-- 58

Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQ 849
              + P L  L   C    DRL  +  ++  G L Y + +  K   P ++ + + + +  
Sbjct: 59  ---KPPFLTQLHS-CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-- 112

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               GL +LH      I++RD+K  N++LD      +ADFG+ +      D   T    G
Sbjct: 113 ----GLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCG 163

Query: 910 TLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           T  YI PE      YG++       D +++GV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSV------DWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 42/225 (18%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGD---------CGQMEREFRAEVEAL 792
           +F+   ++G G FG V  A       + AIK L  D         C  +E+     V AL
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR----VLAL 56

Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQ 849
              + P L  L   C    DRL  +  ++  G L Y + +  K   P ++ +      A 
Sbjct: 57  P-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AA 108

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A GL +LH      I++RD+K  N++LD      +ADFG+ +  +    T  T    G
Sbjct: 109 EIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCG 163

Query: 910 TLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           T  YI PE      YG++       D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 40/271 (14%)

Query: 768  NVAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSL 825
             VA+K L  D    +  +  +E+E +    +H N+++L G C       ++  +   G+L
Sbjct: 46   TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105

Query: 826  DYWLHEKLDGPSSLDWD--------------SRLHIAQGAARGLAYL-HQSCEPHILHRD 870
              +L  +   P  +D+                 +  A   ARG+ YL  Q C    +HRD
Sbjct: 106  REYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC----IHRD 159

Query: 871  IKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDV 930
            + + N+L+  +    +ADFGLAR + +      TT+    + ++ PE     V T++ DV
Sbjct: 160  LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219

Query: 931  YSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEML 989
            +SFGV+L E+ T G  P      +    L+    RM +    +           H+  M 
Sbjct: 220  WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCT-----------HELYM- 267

Query: 990  RVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                I   C    P  RPT +QLV  LD ++
Sbjct: 268  ----IMRECWHAVPSQRPTFKQLVEDLDRVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 11/156 (7%)

Query: 795 AQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + HP LV L   C     RL  +  F+  G L + +  +   P      +R + A+  + 
Sbjct: 53  SNHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEE---HARFYSAE-ISL 107

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L +LH   E  I++RD+K  N+LLD      L D+G+ +  + P DT  T+   GT  Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNY 162

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDM 949
           I PE  +     +  D ++ GV++ E++ G+ P D+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 29/221 (13%)

Query: 742 NNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMERE---FRAEVEALSR 794
            +FD  +++G G FG V     +AT   G   A+K +       +     F  E + LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 795 AQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAA 852
           +  P +  LQ Y     D L L+  +   G L   L  + +     D D ++ ++A+   
Sbjct: 58  SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQ--FDEDMAQFYLAE-LV 112

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-VGTL 911
             +  +HQ      +HRDIK  N+L+D      LADFG A  + +  +  V + L VGT 
Sbjct: 113 LAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA--NKMVNSKLPVGTP 167

Query: 912 GYIPPEYGQASVATYKG------DVYSFGVVLLELLTGKRP 946
            YI PE         KG      D +S GV+  E++ G+ P
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 16/204 (7%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFR---AEVEAL-SRAQHPNLVHL 803
           +IG G FG V  A    DG+  A+K L       ++E +   AE   L    +HP LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 804 QGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             Y     D+L  +  ++  G L + L  +   P      +R + A+  A  L YLH   
Sbjct: 62  H-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLH--- 113

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  NILLD      L DFGL +  +    T  T+   GT  Y+ PE  +  
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 750 IGCGGFGLVYRA-TLPDG-RNVAIKRL---SGDCGQMEREFR--AEVEALSRAQHPNLVH 802
           IG G +G V++A  L +G R VA+KR+   +G+ G      R  A +  L   +HPN+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 803 LQGYC-MHKNDR----LLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQGAARGL 855
           L   C + + DR     L++  ++   L  +L +  +   P+    D    +     RGL
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL----RGL 123

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-VTTDLVGTLGYI 914
            +LH      ++HRD+K  NIL+  +    LADFGLAR+    Y      T +V TL Y 
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQMALTSVVVTLWYR 176

Query: 915 PPE-YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            PE   Q+S AT   D++S G +  E+   ++P+
Sbjct: 177 APEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 24/198 (12%)

Query: 761 ATLPDGRN------VAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND 812
           AT+  GR+      VA+K  RL  + G      R EV  L   +H N+V L      +  
Sbjct: 19  ATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDIIHTERC 77

Query: 813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ-GAARGLAYLHQSCEPHILHRDI 871
             L++ ++++      L + LD   +L     + I      RGL+Y H+     ILHRD+
Sbjct: 78  LTLVFEYLDSD-----LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDL 129

Query: 872 KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGD 929
           K  N+L++      LADFGLAR    P  T+  ++ V TL Y PP+   G    +T   D
Sbjct: 130 KPQNLLINEKGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSTEYST-PID 186

Query: 930 VYSFGVVLLELLTGKRPM 947
           ++  G +L E+ TG RPM
Sbjct: 187 MWGVGCILYEMATG-RPM 203

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 31/211 (14%)

Query: 749 IIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLV 801
           ++G G FG V     +AT   G+  A+K L  +    + E      E   L   +HP L 
Sbjct: 2   LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L+ Y    +DRL       NG   ++ H   +   S D  +R + A+     L YLH S
Sbjct: 59  ALK-YSFQTHDRLCFVMEYANGGELFF-HLSRERVFSED-RARFYGAE-IVSALGYLH-S 113

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---- 917
           C+  +++RD+K  N++LD +    + DFGL +  +S   T       GT  Y+ PE    
Sbjct: 114 CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169

Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 NDYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 63/225 (28%), Positives = 90/225 (40%), Gaps = 57/225 (25%)

Query: 749 IIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREF---RAEVEAL----------SR 794
           ++G G FG V  A     G   AIK L       ++     R EVE+L          + 
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANS 58

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG---- 850
            +HP LV+L   C    D   +   ME  +                 D  +HI       
Sbjct: 59  ERHPFLVNLFA-CFQTEDH--VCFVMEYAA---------------GGDLMMHIHTDVFSE 100

Query: 851 ------AAR---GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT 901
                 AA    GL YLH   E  I++RD+K  N+LLD      +ADFGL +  +   D 
Sbjct: 101 PRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157

Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             T+   GT  ++ PE    +  T   D +  GV++ E+L G+ P
Sbjct: 158 --TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 11/191 (5%)

Query: 772 KRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE 831
           K+       +      E++ L R    N++ + G+ +   D L   S +       +L E
Sbjct: 52  KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 832 KLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-EPHILHRDIKSSNILLDGNFGAHLADFG 890
            LD    L + ++L +A    +GL  L++   +P+   +++ S + L+  N+   +   G
Sbjct: 112 VLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHG 168

Query: 891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMD 948
           L +++ SP   +V       + Y   +      S  T K D+YS GVVL E+ TGK P +
Sbjct: 169 LEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Query: 949 MCKPKGSRDLI 959
               K   DLI
Sbjct: 224 NLTTKEIYDLI 234

Length = 283

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 13/199 (6%)

Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 809 HKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             ++  ++  F+E G+L D   H +++       +    +     + L+ LH      ++
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNE------EQIAAVCLAVLKALSVLHAQ---GVI 138

Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE         +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 928 GDVYSFGVVLLELLTGKRP 946
            D++S G++++E++ G+ P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC---GQMEREFRAEVEALSR-AQHPNLVHL 803
           +IG G FG V  A    + +  A+K L        + E+   +E   L +  +HP LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 804 QGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             +     D+L  +  ++  G L Y L  +      L+  +R + A+  A  L YLH   
Sbjct: 62  H-FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAE-IASALGYLHSL- 115

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  NILLD      L DFGL +  +    T  T+   GT  Y+ PE     
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 750 IGCGGFGLVY--RATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           +G G +  VY  R+ L D   VA+K  RL  + G      R EV  L   +H N+V L  
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLD--GPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
               +    L++ +     LD  L + LD  G S    + +L + Q   RGL Y H+   
Sbjct: 72  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQ-LLRGLNYCHRR-- 123

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQA 921
             +LHRD+K  N+L++      LADFGLAR    P  T+  ++ V TL Y PP+   G  
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--SNEVVTLWYRPPDILLGST 180

Query: 922 SVATYKGDVYSFGVVLLELLTGKRPM 947
             +T + D++  G +  E+ TG RP+
Sbjct: 181 DYST-QIDMWGVGCIFYEMSTG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 9e-10
 Identities = 45/140 (32%), Positives = 61/140 (43%), Gaps = 5/140 (3%)

Query: 829 LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD 888
           L   +D    L  +  + I +     LAYLH      I+HRD+K+ NI LD    A L D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGD 228

Query: 889 FGLA-RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           FG A +L   P DT       GTL    PE         K D++S G+VL E+      +
Sbjct: 229 FGAACKLDAHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Query: 948 DMCKPKGSRDLISWVIRMRQ 967
              + K S   +  +IR  Q
Sbjct: 288 FGKQVKSSSSQLRSIIRCMQ 307

Length = 392

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMERE----FRA--EVEALSRAQHPNLVH 802
           +G G +  VY+  +   G+ VA+K +      +E E    F A  E   L   +H N+V 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIR-----LEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDS-RLHIAQGAARGLAYLHQ 860
           L      K    L++ +++       L + +D     L   + RL + Q   RGLAY HQ
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQ-LLRGLAYCHQ 121

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
                +LHRD+K  N+L+       LADFGLAR    P  +   ++ V TL Y PP+   
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SKTYSNEVVTLWYRPPDVLL 176

Query: 921 ASVA-TYKGDVYSFGVVLLELLTGKRPM 947
            S   +   D++  G +  E+ TG RP+
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRN-VAIKRLS-GDCGQMERE--FRAEVEALSRAQHP 798
           + ++   +G G FG V+        +  A+K ++  +  ++++E     E   L    HP
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 799 NLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            ++ L  +    + R L  +  ++  G L  +L    +    + L + S +  A      
Sbjct: 62  FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA------ 113

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH      I++RD+K  NILLD      L DFG A+ +        T  L GT  Y+
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYL 165

Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE  Q+       D ++ G+++ E+L G  P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 21/230 (9%)

Query: 743 NFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLSGDC----GQMEREFRAEVEALSR 794
           NF+   ++G G +G   LV + +  D G+  A+K L         +     R E + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 795 A-QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             Q P LV L  Y    + +L LI  ++  G L   L ++         + +++  +   
Sbjct: 61  IRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGE-IV 115

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L +LH+     I++RDIK  NILLD N    L DFGL++      +        GT+ 
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGTIE 171

Query: 913 YIPPEY--GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
           Y+ P+   G         D +S GV++ ELLTG  P  +   K S+  IS
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 21/232 (9%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G FG V    +  G     V +K L      Q + +F  E +     QH NL+   G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS-SLDWDSRLHIAQGAARGLAYLHQSCEP 864
            C      LL+  F   G L  +L         + D  +   +A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE-----Y 918
           + +H D+   N LL  +    + D+GL+       D +VT D L   L +I PE     +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-DYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 919 GQASVA--TYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
           G   V   T + +V+S GV + EL   G +P    +      ++++ +R +Q
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTVREQQ 227

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 18/220 (8%)

Query: 750 IGCGGFGLVYRATLPDGR---NVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQG 805
           +G G FG V +      +   +VAIK L  +  +  R E   E E + +  +P +V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
            C  +   +L+      G L+ +L  K D  +  +    +H     + G+ YL      +
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---QVSMGMKYLE---GKN 115

Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASV 923
            +HRD+ + N+LL     A ++DFGL++  L   D++      G   L +  PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 924 ATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV 962
            + + DV+S+G+ + E  + G++P    K KG  +++S++
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYK--KMKGP-EVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 32/161 (19%)

Query: 792 LSRAQHPNLVHLQGY-------CM---HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW 841
           L    HP+++ ++         CM   H +  L  Y+++               P  L  
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDL--YTYLTKR----------SRP--LPI 156

Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL-ILSPYD 900
           D  L I +    GL YLH      I+HRD+K+ NI ++      + D G A+  +++P  
Sbjct: 157 DQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213

Query: 901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
                 L GT+    PE         K D++S G+VL E+L
Sbjct: 214 ----LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 42/231 (18%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRLSGDC----GQMEREFRAEVEALSRAQ 796
            +F+   +I  G +G VY     + R   A+K+++        Q+++ F  E + L+ A+
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59

Query: 797 HPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           +P +V +  +C  +  R L  +  ++E G     L  K  G   +D  +R++ A+     
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDM-ARMYFAE-TVLA 113

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-----SPYDTHVTTD--- 906
           L YLH      I+HRD+K  N+L+       L DFGL+++ L     + Y+ H+  D   
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 907 -----LVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
                + GT  YI PE      YG+        D ++ G++L E L G  P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPV------DWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 9/160 (5%)

Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
           AE   L++   P +V L+          L+ +F+  G L +  H + +G   L   +R +
Sbjct: 42  AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH--HLQREGRFDL-SRARFY 98

Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+     L  LH   + ++++RD+K  NILLD      L DFGL +L +   D   T  
Sbjct: 99  TAE-LLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNT 152

Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             GT  Y+ PE       T   D ++ GV+L E+LTG  P
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.0 bits (145), Expect = 3e-09
 Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 20/243 (8%)

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF 226
                   ++  +S+ + ++  S++             +SL+     +N           
Sbjct: 43  ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLN----------- 91

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
            L  L  L L  N+L   +S  + +L+NL  LD+ +NN +   P +       + L    
Sbjct: 92  -LLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
           N+    +P  L N P L  L+L  N L   L      L+NL +LDL  NK +  LP  + 
Sbjct: 150 NKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE 206

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
               L+ ++L+ N+   ++  +  N ++LS L LSN+ + +L  ++  L    NL TL L
Sbjct: 207 LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLS---NLETLDL 262

Query: 407 TLN 409
           + N
Sbjct: 263 SNN 265

Length = 394

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMERE---FRAEVEALSRA-QHPNLVHL 803
           +IG G FG V  A    DG   A+K L       ++E     AE   L +  +HP LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 804 QGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             Y     ++L  +  ++  G L + L  +      L+  +R + A+  A  + YLH   
Sbjct: 62  H-YSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAE-VASAIGYLHSL- 115

Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  NILLD      L DFGL +  + P +T  T+   GT  Y+ PE  +  
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
                 D +  G VL E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 39/111 (35%), Positives = 55/111 (49%), Gaps = 5/111 (4%)

Query: 158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDL 217
           I  L + +  L G +P  I K    ++ INLS N   G + P LG+  SLE L L  N  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 218 TGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGN 268
            G I + + QL  LR+L L  N LSG++  ++        L  +S NF+ N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL----LHRASFNFTDN 525

Length = 623

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 4e-09
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQHP 798
           +F+   +IG G FG V    L +   V   ++      ++R     FR E + L    + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLAY 857
            +  L      +N+  L+  +   G L   L +  D  P  +   +R ++A+     +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAE-MVIAIDS 117

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           +HQ    H +HRDIK  NIL+D N    LADFG + L L    T  ++  VGT  YI PE
Sbjct: 118 VHQL---HYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 918 YGQASVATYKG------DVYSFGVVLLELLTGKRPM 947
             QA +   KG      D +S GV + E+L G+ P 
Sbjct: 174 ILQA-MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 43/283 (15%)

Query: 750  IGCGGFGLVY--RATLPDGRNVAIKRLS---GDCGQMEREFRAEVEAL--------SRAQ 796
            +G G FG VY  R        +A+K ++      G+ +RE    +  +         + +
Sbjct: 8    LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 797  HPNLVHLQGYCMHKNDRL-LIYSFMENGSL-DYWLHEKLDG---PSSLDWDSRLHIAQGA 851
            HPN+V      + +NDRL ++   +E   L +++   K           W+  + +    
Sbjct: 68   HPNIVRYYKTFL-ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125

Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
               L YLH+  E  I+HRD+  +NI+L  +    + DFGLA+           T +VGT+
Sbjct: 126  ---LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTI 177

Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
             Y  PE  +      K DV++FG +L ++ T      +  P  S +++S  +  +     
Sbjct: 178  LYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLS--LATKIVEAV 229

Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             E L   +Y +        V D+   CL+   + RP   Q+ +
Sbjct: 230  YEPLPEGMYSED-------VTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 750 IGCGGFGLVY--RATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           +G G +  V+  R+ L +   VA+K  RL  + G      R EV  L   +H N+V L  
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD--WDSRLHIAQGAARGLAYLHQSCE 863
                    L++ +     LD  L + +D   ++    + ++ + Q   RGLAY H+   
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRGLAYCHRR-- 123

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQA 921
             +LHRD+K  N+L++      LADFGLAR    P  T+  ++ V TL Y PP+   G +
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY--SNEVVTLWYRPPDVLLGSS 180

Query: 922 SVATYKGDVYSFGVVLLELLTGKRPM 947
             +T + D++  G +  E+ +G RP+
Sbjct: 181 EYST-QIDMWGVGCIFFEMASG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 8e-09
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 35/215 (16%)

Query: 749 IIGCGGFGLVYRATLPDGRN------------VAIKRLSGDCGQMEREFRAEVEALSRAQ 796
           ++G GG+G V++     G +              I R   D        +AE   L   +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHT----KAERNILEAVK 58

Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLD----WDSRLHIAQGA 851
           HP +V L  Y      +L LI  ++  G L  ++H + +G    D    + S + +A   
Sbjct: 59  HPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA--- 112

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L +LHQ     I++RD+K  NILLD      L DFGL +   S ++  VT    GT+
Sbjct: 113 ---LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTI 164

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE    S      D +S G ++ ++LTG  P
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 26/231 (11%)

Query: 727 NKEKEISID-DILESTN-NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER 783
           ++++E  ID DI  S N ++   NIIG G FG+VY A   D    VAIK++  D     R
Sbjct: 49  DEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR 108

Query: 784 EFRAEVEALSRAQHPNLVHLQGY----CMHKNDRLL----IYSFMENGSLDYWLHEKLDG 835
           E       +    H N++ L+ Y    C  KN++ +    +  F+      Y  H   + 
Sbjct: 109 ELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN 164

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARL 894
            +   +  +L+  Q   R LAY+H      I HRD+K  N+L+D N     L DFG A+ 
Sbjct: 165 HALPLFLVKLYSYQ-LCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 895 ILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTG 943
           +L+      +   + +  Y  PE   G  +  T+  D++S G ++ E++ G
Sbjct: 221 LLA---GQRSVSYICSRFYRAPELMLGATNYTTHI-DLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 58/232 (25%), Positives = 89/232 (38%), Gaps = 50/232 (21%)

Query: 748 NIIGCGGFGLVYRA-TLPDGRNVAIKRLS---------------GDCGQMEREFRAEVEA 791
             +G G +G V +A     G+ VAIK++                G CG      R E++ 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELKI 73

Query: 792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           ++  +H N++ L    +  +   L+   M        L + +D    L       I    
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL---- 907
             GL  LH+    + +HRD+  +NI ++      +ADFGLAR    P  +   +      
Sbjct: 129 LNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 908 --------VGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
                   V TL Y  PE       Y  A       D++S G +  ELLTGK
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAV------DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 18/215 (8%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQH 797
           ++F+   +IG G FG V    +     +   ++      ++R     FR E   L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
             +  L      +N   L+  +   G L   L +  D  P  +   +R +IA+     + 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYIAE-MVLAIH 116

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +HQ    H +HRDIK  N+LLD N    LADFG + L ++   T  ++  VGT  YI P
Sbjct: 117 SIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172

Query: 917 EYGQA---SVATY--KGDVYSFGVVLLELLTGKRP 946
           E  QA    +  Y  + D +S GV + E+L G+ P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 37/280 (13%)

Query: 750  IGCGGFGLVYRATLPDGRNVA---IKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQG 805
            IG G FG V  + +     VA   +K L  +    E+ EF  + +     QHPN++   G
Sbjct: 3    IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 806  YCMHKNDRLLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             C+     LL++ + E G L  +L   +     S L    R+  A   A G+ ++H+   
Sbjct: 63   QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKH-- 118

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY-DTHVTTD--LVGTLGYIPPE--- 917
             + LH D+   N  L  +    + D+G+     S Y + ++ T+      L ++ PE   
Sbjct: 119  -NFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 918  --YGQ--ASVATYKGDVYSFGVVLLELL-TGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
              +G    +  T   +V++ GV L EL     +P         R++++ VI+ +Q     
Sbjct: 175  EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVIKDQQ----V 227

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            ++  P + +  + +    VL    L    SP+ R T +++
Sbjct: 228  KLFKPQL-ELPYSERWYEVLQFCWL----SPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 749 IIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLV 801
           ++G G FG V     +AT   GR  A+K L  +    + E      E   L  ++HP L 
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L+ Y    +DRL       NG  + + H   +   S D  +R + A+     L YLH  
Sbjct: 59  ALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAE-IVSALDYLHS- 113

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---- 917
            E ++++RD+K  N++LD +    + DFGL +  +   D        GT  Y+ PE    
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLED 170

Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             YG+A       D +  GVV+ E++ G+ P
Sbjct: 171 NDYGRAV------DWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 71/229 (31%), Positives = 104/229 (45%), Gaps = 46/229 (20%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
           ++F+   +IG G FG V    + + G+  A+K L+    + E   RAE  A  R +   L
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN----KWEMLKRAET-ACFREERDVL 55

Query: 801 VHLQGYCMHKNDRLLI----YSFMENGSL----DYW-------LHEKLDG--PSSLDWDS 843
           V+         DR  I    Y+F +  +L    DY+       L  K +   P  +   +
Sbjct: 56  VN--------GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---A 104

Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
           R ++A+     +  +HQ      +HRDIK  N+LLD N    LADFG + L L    T  
Sbjct: 105 RFYLAE-MVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQ 159

Query: 904 TTDLVGTLGYIPPEYGQASVATYKG------DVYSFGVVLLELLTGKRP 946
           +   VGT  YI PE  QA +   KG      D +S GV + E+L G+ P
Sbjct: 160 SNVAVGTPDYISPEILQA-MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 6e-08
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFR---AEVEALSRAQH 797
            +F     +G GG+G V+ A   D G  VA+KR+         E R    E + L+  + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG---------PSSLDWDS-RLHI 847
             LV             L+Y+F ++  L Y   E + G            L  D  R ++
Sbjct: 61  EWLVK------------LLYAFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
           A+     +  LH+      +HRD+K  N L+D +    L DFGL++ I++         +
Sbjct: 108 AEMFE-AVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSV 158

Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           VG+  Y+ PE  +     +  D +S G +L E L G  P  
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 16/208 (7%)

Query: 743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSG-DCGQMER--EFRAEVEALSRAQHP 798
           +F+    +G G FG V  A     G   AIK L   +  +M++      E   L    HP
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +V++      +N    +  F+  G L   L +    P+ +   ++ + A+       YL
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV---AKFYHAE-LVLAFEYL 134

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
           H S +  I++RD+K  N+LLD      + DFG A+ +        T  L GT  Y+ PE 
Sbjct: 135 H-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEV 186

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
            Q+       D ++ GV+L E + G  P
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 23/234 (9%)

Query: 725 FHNKEKEI--SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME 782
           F N+ ++I   I  +     ++D   +IG G FG V        + V   +L      ++
Sbjct: 24  FLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK 83

Query: 783 RE----FRAEVEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGP 836
           R     F  E + ++ A  P +V L  +C  ++D+ L  +  +M  G L   L    D P
Sbjct: 84  RSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVP 140

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
               W ++ + A+     L  +H      ++HRD+K  N+LLD +    LADFG    + 
Sbjct: 141 EK--W-AKFYTAE-VVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193

Query: 897 SPYDTHVTTDLVGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRP 946
                   T  VGT  YI PE    Q     Y  + D +S GV L E+L G  P
Sbjct: 194 ETGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRL--SGDCGQMEREFRAEVEALSRAQHP 798
           N F+   ++G G +G+V +    + +  VAIK+   S +  +++     E++ L   +  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           N+V L+     +    L++ ++E   L+  L E  +G        R +I Q   + + + 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNG--VPPEKVRSYIYQ-LIKAIHWC 116

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
           H++    I+HRDIK  N+L+  N    L DFG AR +    + +  T+ V T  Y  PE 
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172

Query: 918 -----YGQASVATYKGDVYSFGVVLLELLTGK 944
                YG+A       D++S G +L EL  G+
Sbjct: 173 LLGAPYGKAV------DMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 38/238 (15%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGR--NVAIKRLSG----DCGQ 780
            ++ ++  +D       F+    +G G FG V  AT  +     VAIKR          Q
Sbjct: 22  KRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++  F +E + L+   HP  V+L G    ++   L+  F+  G    +L      P+   
Sbjct: 75  VDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN--- 130

Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
            D     A        YL QS   +I++RD+K  N+LLD +    + DFG A+++    D
Sbjct: 131 -DVGCFYAAQIVLIFEYL-QSL--NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----D 182

Query: 901 THVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           T   T L GT  YI PE      +G+A+      D ++ G+ + E+L G  P    +P
Sbjct: 183 TRTYT-LCGTPEYIAPEILLNVGHGKAA------DWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 9e-08
 Identities = 28/76 (36%), Positives = 46/76 (60%)

Query: 291 GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRK 350
           G IP+ +S    L  +NL  NS+ G++  +  ++T+L  LDL  N FNG +P +L +   
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 351 LKNINLARNNFSGQIP 366
           L+ +NL  N+ SG++P
Sbjct: 492 LRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 54/180 (30%), Positives = 73/180 (40%), Gaps = 39/180 (21%)

Query: 852  ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            ARG+ +L  + C    +HRD+ + NILL  N    + DFGLAR I    D          
Sbjct: 184  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPM-------DMCK--PKGSRDLIS 960
            L ++ PE     V T + DV+SFGV+L E+ + G  P        + C+    G+R    
Sbjct: 240  LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR---- 295

Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                     R  E   P IY             I   C    PK RPT   LV  L  ++
Sbjct: 296  --------MRAPENATPEIY------------RIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 25/173 (14%)

Query: 852  ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A+G+ +L  + C    +HRD+ + NILL  N    + DFGLAR I    D     D    
Sbjct: 189  AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN 969
            L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++  
Sbjct: 245  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGT 299

Query: 970  R--ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            R    +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 300  RMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 340

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 2e-07
 Identities = 29/64 (45%), Positives = 36/64 (56%)

Query: 435 GLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTG 494
           GLRG IP  +     LQ ++LS N + G IP   G    L  LDLS N+F G IP++L  
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488

Query: 495 LPSL 498
           L SL
Sbjct: 489 LTSL 492

Length = 623

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 65/286 (22%), Positives = 113/286 (39%), Gaps = 53/286 (18%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQH 797
           ++F+   +IG G FG V      D  ++   ++      +E+E     RAE + L  A  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
             +V +      K +  LI  F+  G +   L +K    +  +  ++ +IA+     +  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAE-TVLAIDA 116

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL---------- 907
           +HQ      +HRDIK  N+LLD      L+DFGL   +   + T    +L          
Sbjct: 117 IHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173

Query: 908 -----------------------VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
                                  VGT  YI PE    +      D +S GV++ E+L G 
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 945 RPMDMCKPKGS-RDLISWVIRMRQENRESEVLDPFIYDKQHDKEML 989
            P     P+ + R +++W        +E+ V  P +   +  K+++
Sbjct: 234 PPFCSETPQETYRKVMNW--------KETLVFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 39/180 (21%)

Query: 852  ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            ARG+ +L  + C    +HRD+ + NILL  N    + DFGLAR I    D     D    
Sbjct: 183  ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPM-------DMCK--PKGSRDLIS 960
            L ++ PE     V T + DV+SFGV+L E+ + G  P        + C+   +G+     
Sbjct: 239  LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT----- 293

Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               RMR      E   P IY             I   C   +P+ RPT  +LV  L  ++
Sbjct: 294  ---RMRA----PEYATPEIY------------SIMLDCWHNNPEDRPTFSELVEILGDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 53.3 bits (129), Expect = 2e-07
 Identities = 47/157 (29%), Positives = 69/157 (43%), Gaps = 22/157 (14%)

Query: 797 HPNLVHLQGYCMH-KNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           +PN + L  Y +      +LI  ++++G L D    E       L       I +     
Sbjct: 68  NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEA 121

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSP--YDTHVTTDLVGTL 911
           L  LH+    +I+H DIK  N+L D      +L D+GL ++I +P  YD        GTL
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTL 170

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            Y  PE  +        D ++ GV+  ELLTGK P  
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 6/110 (5%)

Query: 839 LDWDSRLHIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS 897
           LD D  L  +   A+G+ +L  ++C    +HRD+ + N+LL     A + DFGLAR I++
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
             +  V  +    + ++ PE     V T + DV+S+G++L E+ + GK P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 750 IGCGGFGLVYRA---TLPDGRNVAIKRLSGDCGQ--MEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V +         + VA+K L  D     ++ E   E   + +  +P +V + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G C  ++  +L+    E G L+ +L +       +   +   +    + G+ YL    E 
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE---ET 114

Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQAS 922
           + +HRD+ + N+LL     A ++DFGL++  L   + +      G   + +  PE     
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             + K DV+SFGV++ E  + G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 3e-07
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 23/167 (13%)

Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
           E   L   +HP L  L+ Y     DRL  +  ++  G L  + H   +   S D  +R +
Sbjct: 45  ESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSED-RTRFY 100

Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+     L YLH      I++RD+K  N++LD +    + DFGL +  ++  D      
Sbjct: 101 GAE-IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKT 154

Query: 907 LVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             GT  Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 61/257 (23%), Positives = 102/257 (39%), Gaps = 45/257 (17%)

Query: 743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQHP 798
           +F+   +IG G FG V      D  +V   ++      +E+E     RAE + L  A   
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +V +      K +  LI  F+  G +   L +K    +  + +++ +IA+     +  +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAE-TVLAIDSI 117

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL----------- 907
           HQ      +HRDIK  N+LLD      L+DFGL   +   + T    +L           
Sbjct: 118 HQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 908 ----------------------VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR 945
                                 VGT  YI PE    +      D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 946 PMDMCKPKGS-RDLISW 961
           P     P+ + + +++W
Sbjct: 235 PFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 62/220 (28%), Positives = 92/220 (41%), Gaps = 54/220 (24%)

Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFRAEVEA---------LSRAQH 797
           +G G +G V  A   D R    VAIK+L        R F++E+ A         L   +H
Sbjct: 23  VGSGAYGTVCSAL--DRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMKH 73

Query: 798 PNLVHLQGYCMHK------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            N++ L             +D  L+  FM         HEKL        D    +    
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE------DRIQFLVYQM 127

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +GL Y+H +    I+HRD+K  N+ ++ +    + DFGLAR      D+ +T  +V T 
Sbjct: 128 LKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV-TR 179

Query: 912 GYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            Y  PE       Y Q        D++S G ++ E+LTGK
Sbjct: 180 WYRAPEVILNWMHYTQTV------DIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 749 IIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEALSRAQHPNLV 801
           ++G G FG V     +AT   GR  A+K L  +    + E      E   L   +HP L 
Sbjct: 2   LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L+ Y    +DRL       NG  + + H   +   + +  +R + A+     L YLH  
Sbjct: 59  ALK-YAFQTHDRLCFVMEYANGG-ELFFHLSRERVFTEE-RARFYGAE-IVSALEYLHSR 114

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---- 917
               +++RDIK  N++LD +    + DFGL +  +S  D        GT  Y+ PE    
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLED 169

Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 NDYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 21/165 (12%)

Query: 792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           + +  H ++V L G C+   + +++  F+E G LD ++H K D   +  W  +  +A+  
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPW--KFKVAKQL 114

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILL-----DGNFGA--HLADFGLARLILSPYDTHVT 904
           A  L+YL    +  ++H ++ + NILL     DG  G    L+D G+   +LS       
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------R 165

Query: 905 TDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLEL-LTGKRPM 947
            + V  + +I PE  + S   +   D +SFG  L E+   G+ P+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 25/235 (10%)

Query: 725 FHNKEKEI--SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME 782
           F N+ K+    I D+     +++   +IG G FG V        R V   +L      ++
Sbjct: 24  FLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK 83

Query: 783 RE----FRAEVEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGP 836
           R     F  E + ++ A  P +V L  +   ++DR L  +  +M  G L   L    D P
Sbjct: 84  RSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVP 140

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
               W +R + A+     L  +H       +HRD+K  N+LLD +    LADFG    + 
Sbjct: 141 EK--W-ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193

Query: 897 SPYDTHVTTDL-VGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRP 946
              +  V  D  VGT  YI PE    Q     Y  + D +S GV L E+L G  P
Sbjct: 194 K--EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 40/227 (17%)

Query: 735 DDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           D        + Q   IG G  G+V  A     G NVA+K+LS       R F+ +  A  
Sbjct: 14  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHA-- 64

Query: 794 RAQHPNLVHLQGYCM-HKNDRLLIYSFMENGSLD-----YWLHEKLDGP------SSLDW 841
           +  +  LV L+  C+ HKN   L+  F    SL+     Y + E +D          LD 
Sbjct: 65  KRAYRELVLLK--CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH 122

Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LIL 896
           +   ++      G+ +LH +    I+HRD+K SNI++  +    + DFGLAR      ++
Sbjct: 123 ERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM 179

Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           +PY        V T  Y  PE           D++S G ++ EL+ G
Sbjct: 180 TPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 7e-07
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 61/223 (27%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEA---------LSRAQHPN 799
           +G G +G V  A     G  VAIK+LS       R F++E+ A         L   QH N
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 800 LVHL--------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           ++ L         G      D  L+  +M+         +K+ G   L  D   ++    
Sbjct: 76  VIGLLDVFTSAVSGDEFQ--DFYLVMPYMQTDL------QKIMG-HPLSEDKVQYLVYQM 126

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG-- 909
             GL Y+H +    I+HRD+K  N+ ++ +    + DFGLAR        H   ++ G  
Sbjct: 127 LCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYV 175

Query: 910 -TLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            T  Y  PE       Y Q        D++S G ++ E+LTGK
Sbjct: 176 VTRWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 44/157 (28%), Positives = 64/157 (40%), Gaps = 13/157 (8%)

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN+V L  Y + ++   L+    E G L   + + L+ P          + + AA  +  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC-------VKRWAAEMVVA 97

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           L       I+ RD+  +NILLD      L  F     +    D     ++     Y  PE
Sbjct: 98  LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPE 152

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
            G  S  T   D +S G +L ELLTGK  +  C P G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK-TLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.0 bits (124), Expect = 9e-07
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 44/215 (20%)

Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78

Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187

Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++ G 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 27/202 (13%)

Query: 764 PDGRNVAIKR--LSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME 821
           P G  V ++R  L     +M    + E+       HPN+V  +   +  N+  ++ SFM 
Sbjct: 23  PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 822 NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI--LHRDIKSSNILL 878
            GS  D      +DG S L   +  +I QG  + L Y+H     H+  +HR +K+S+IL+
Sbjct: 83  YGSAKDLICTHFMDGMSEL---AIAYILQGVLKALDYIH-----HMGYVHRSVKASHILI 134

Query: 879 DGNFGAHLADFGLARLILSPYD----THVTTDL----VGTLGYIPPEYGQASVATY--KG 928
             +   +L+  GL R  LS  +      V  D     V  L ++ PE  Q ++  Y  K 
Sbjct: 135 SVDGKVYLS--GL-RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191

Query: 929 DVYSFGVVLLELLTGKRPM-DM 949
           D+YS G+   EL  G  P  DM
Sbjct: 192 DIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 44/215 (20%)

Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 71

Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 132 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 180

Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 6/111 (5%)

Query: 838 SLDWDSRLHIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
           +LD +  L  +   A+G+++L  ++C    +HRD+ + NILL       + DFGLAR I 
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIR 265

Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           +  +  V  +    + ++ PE     V T++ DV+S+G++L E+ + G  P
Sbjct: 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 20/163 (12%)

Query: 788 EVEALSRAQHPNLVHLQ--------GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
           E+ AL R  H N++ ++         Y + +     +YSFM + + D+      D P  L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-----KDRP--L 265

Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
              +R  I +     + Y+H   +  ++HRDIK  NI L+ +    L DFG A       
Sbjct: 266 LKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
           +       VGT+    PE           D++S G++LL++L+
Sbjct: 322 EAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-06
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 408 LNFRNEKL----PTD-PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG 462
           L   N+ L    P D  +L   +L+ + ++   +RG+IP  L   + L+++DLS+N  +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLR--HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 463 TIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLP 496
           +IP   G    L  L+L+ N+ +G +P  L G  
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 75/297 (25%), Positives = 103/297 (34%), Gaps = 59/297 (19%)

Query: 225 IFQLQKLRLLGLQDNQLSGK-LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF---- 279
           +  LQ LRL G    + + K L+ ++    +L  L +S N  +G IP     L +     
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKG 80

Query: 280 ---QYLVAHSNRFTGRIPH---SLSNSPTLNLLNLRNNSL-DGSLLLNCPALT----NLT 328
              Q L    N           SL  S +L  L L NN L D  L L    L      L 
Sbjct: 81  CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140

Query: 329 SLDLGTNKFNG----PLPTNLPRCRKLKNINLARNNFSGQ----IPETYKNFESLSYLSL 380
            L LG N+  G     L   L   R LK +NLA N         + E  K   +L  L L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 381 SNSSIYNL-SSAL-QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG 438
           +N+ + +  +SAL + L   ++L  L L  N                     +   G   
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDN--------------------NLTDAGAAA 240

Query: 439 SIPQWLRGCSKLQLVDLSWN--------QLSGTIPVWFGGFQDLFYLDLSNNTFTGE 487
                L     L  + LS N         L+  +       + L  LDL  N F  E
Sbjct: 241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLA----EKESLLELDLRGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 38/104 (36%), Positives = 55/104 (52%), Gaps = 11/104 (10%)

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT---TDLVG 909
            GL Y+H +   ++LHRD+K  N+L++ +    + DFGLAR   S          T+ V 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF-SENPGENAGFMTEYVA 171

Query: 910 TLGYIPPEYGQASVATY-KG-DVYSFGVVLLELLTGKRPMDMCK 951
           T  Y  PE    S  +Y K  DV+S G +L ELL G++P+   K
Sbjct: 172 TRWYRAPEI-MLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.8 bits (107), Expect = 3e-06
 Identities = 26/60 (43%), Positives = 38/60 (63%), Gaps = 1/60 (1%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSL 168
            L+ L+LS+N L      +   LPNL+VLDLS N+L+   P+    LPS++ LD+S N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.0 bits (119), Expect = 4e-06
 Identities = 77/295 (26%), Positives = 119/295 (40%), Gaps = 48/295 (16%)

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
           LP++L R   L  ++ +  + S    E   N   L  L L+ + + +  S L  L    N
Sbjct: 62  LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELT---N 117

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
           LT+L L  N     +P    L  +NLK L ++   +  S+P  LR    L+ +DLS+N L
Sbjct: 118 LTSLDLDNN-NITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDL 175

Query: 461 SGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV 520
           S  +P       +L  LDLS N         ++ LP  I    +LEE             
Sbjct: 176 S-DLPKLLSNLSNLNNLDLSGN--------KISDLPPEIELLSALEELD----------- 215

Query: 521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMT 580
               L  N I     ++                NLK L   +L +N L   +P  +  ++
Sbjct: 216 ----LSNNSIIELLSSL---------------SNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 581 SLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFD 635
           +LETLDLS N +S     SL  L+ L +  ++ N L+  +P             +
Sbjct: 256 NLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308

Length = 394

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 4e-06
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 67/255 (26%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMERE----FRAEVEALSRAQ 796
           ++F+   +IG G FG V      D  ++ A+K+L      +E+E     RAE + L+ A 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59

Query: 797 HPNLVHLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAAR 853
           +P +V L  Y   +++    LI  ++  G +   L +K     +   + +R +IA+    
Sbjct: 60  NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAE-TIL 112

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA----RLILSPYDTHVTTDL-- 907
            +  +H+      +HRDIK  N+LLD      L+DFGL     +   + +   ++  L  
Sbjct: 113 AIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169

Query: 908 ------------------------------VGTLGYIPPE------YGQASVATYKGDVY 931
                                         VGT  YI PE      Y +        D +
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC------DWW 223

Query: 932 SFGVVLLELLTGKRP 946
           S GV++ E+L G  P
Sbjct: 224 SLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 21/99 (21%)

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR     +     T  V T  
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182

Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 183 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 49/231 (21%)

Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLH-EKLDGPSSLDWDSRLHIAQG 850
            +S+  H +L  + G C+  ++ +++  F+E+G LD  L  EK   P  + W  ++ +AQ 
Sbjct: 70   MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVP--VAW--KITVAQQ 125

Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILL------DGNFG-AHLADFGLARLILSPYDTHV 903
             A  L+YL    + +++H ++ + NILL      +G      L+D G++   LS      
Sbjct: 126  LASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------ 176

Query: 904  TTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLEL-LTGKRPMDMCKPKGSRDLIS 960
              + V  + +I PE   G  S++T   D +SFG  LLE+   G+ P+             
Sbjct: 177  REERVERIPWIAPECVPGGNSLST-AADKWSFGTTLLEICFDGEVPL------------- 222

Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACL---CLSESPKVRPT 1008
                  +E   SE      Y+K+H        ++A L   CL+  P  RP+
Sbjct: 223  ------KERTPSE--KERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 22/216 (10%)

Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIK--RLSGDCGQMEREFRAEVEAL-SRAQH 797
           + +++   IG G +G VY+A     G+ VA+K  RL  D   +      E+  L   ++ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 798 PNLVHLQG--YCMHKNDRLLIYSFMENGSLDYWLHEKLDG-----PSSLDWDSRLHIAQG 850
             +V L    +   KN +  +Y   E   LD  L + +D         L   +       
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFE--YLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVG 909
             +G+A+ H+     ++HRD+K  N+L+D   G   +AD GL R    P  ++ T ++V 
Sbjct: 119 LLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-THEIV- 173

Query: 910 TLGYIPPEYGQASVATYKG--DVYSFGVVLLELLTG 943
           TL Y  PE    S   Y    D++S G +  E+   
Sbjct: 174 TLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.3 bits (118), Expect = 6e-06
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 54/220 (24%)

Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y      G+NVAIK+LS       R F+    A  RA +  LV L   
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKLS-------RPFQNVTHA-KRA-YRELV-LMKL 71

Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARGL 855
             HKN   L+  F    SL+     Y + E +D          LD +   ++      G+
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGI 131

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VVT 180

Query: 911 LGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE      Y + +V     D++S G ++ E++ G 
Sbjct: 181 RYYRAPEVILGMGY-KENV-----DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 13/162 (8%)

Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++         +   +I  FM  GS +  L      P  +      +I  GA RGL
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGL 114

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG-LARLILSPYDTHVTTDL----VGT 910
            YLHQ+     +HR+IK+S+IL+ G+    L+    L  L+ +     V  D        
Sbjct: 115 NYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV 171

Query: 911 LGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRP-MDM 949
           L ++ PE  +  +  Y  K D+YS G+   EL TG+ P  DM
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 21/99 (21%)

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR      D  + T  V T  
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEM-TGYVATRW 180

Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE       Y Q        D++S G ++ ELL GK
Sbjct: 181 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.3 bits (115), Expect = 2e-05
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 17/154 (11%)

Query: 750 IGCGGFGLVYRA-TLPDGRNVAIKRLSGD---CGQMEREFRAEVEALSRAQHPNLVHLQG 805
           I  G FG VY      + +  A+K +         M  + +AE +AL+ ++ P +VHL  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLH--EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                N+  L+  ++  G +   LH     D   ++ + S + +A      L YLH+   
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLHR--- 122

Query: 864 PH-ILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
            H I+HRD+K  N+L+       L DFGL+++ L
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 18/149 (12%)

Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEV-EALSRAQH--PNLVHLQG 805
           ++  G    VY     D     +K         +RE    + + L+R     P ++    
Sbjct: 5   LLKGGLTNRVYLLGTKDED-YVLKINPSREKGADREREVAILQLLARKGLPVPKVLA--- 60

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                    L+  ++E  +LD            +  + +  IA+  A  LA LHQ     
Sbjct: 61  SGESDGWSYLLMEWIEGETLD-----------EVSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARL 894
           + H D+   NIL+D      + D+  A  
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 21/58 (36%), Positives = 29/58 (50%)

Query: 425 NLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
           NLK L +++  L        +G   L+++DLS N L+   P  F G   L  LDLS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 3e-05
 Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 40/236 (16%)

Query: 744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHPN 799
           F +  ++G G  G V+   L   G+  A+K L         +      E E L+   HP 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 800 LVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           L  L  Y   + +  L     +   G L + L ++  G    +  +R + A+     L Y
Sbjct: 63  LPTL--YASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLL-ALEY 118

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA---------------------RLIL 896
           LH      I++RD+K  NILL  +    L+DF L+                      +  
Sbjct: 119 LH--LL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 897 SPYDTHV------TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            P +T        +   VGT  YI PE           D ++ G++L E+L G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.1 bits (112), Expect = 4e-05
 Identities = 26/80 (32%), Positives = 44/80 (55%)

Query: 306 LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
           L L N  L G +  +   L +L S++L  N   G +P +L     L+ ++L+ N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 366 PETYKNFESLSYLSLSNSSI 385
           PE+     SL  L+L+ +S+
Sbjct: 483 PESLGQLTSLRILNLNGNSL 502

Length = 623

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 4e-05
 Identities = 60/240 (25%), Positives = 94/240 (39%), Gaps = 31/240 (12%)

Query: 735 DDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE---FRAEVEA 791
           DD     N ++    IG G FG V+       +     +     G  ERE      EV  
Sbjct: 6   DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNV 65

Query: 792 LSRAQHPNLV-HLQGYCMHKNDRLLI-YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
           +   +H N+V ++  +    N +L I   F + G L   + +       ++  + + I +
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 850 GAARGLAYLHQSCE----PHILHRDIKSSNILL-----------------DGNFGAHLAD 888
                LAY H   +      +LHRD+K  NI L                 +G   A + D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRP 946
           FGL++ I      H     VGT  Y  PE       +Y  K D+++ G ++ EL +GK P
Sbjct: 186 FGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 36/108 (33%), Positives = 48/108 (44%), Gaps = 20/108 (18%)

Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           L I +   R + YLH   E  I+HRDIK+ NI ++      L DFG A     P D +  
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA---CFPVDINAN 238

Query: 905 T--DLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
                 GT+    PE      YG A       D++S G+VL E+ T  
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAV------DIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 6e-05
 Identities = 74/235 (31%), Positives = 107/235 (45%), Gaps = 11/235 (4%)

Query: 100 KLSESLGNLV-QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSI 158
            +   +G L   L+ L+LS N ++ ++P  L NLPNL+ LDLS NDLS       NL ++
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNL 188

Query: 159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT 218
             LD+S N ++  +P  I +  S +  ++LS N     L   L N  +L  L L  N L 
Sbjct: 189 NNLDLSGNKIS-DLPPEI-ELLSALEELDLSNN-SIIELLSSLSNLKNLSGLELSNNKLE 245

Query: 219 GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE 278
               + I  L  L  L L +NQ+S     S+  L+NL  LD+S N+ S  +P     L  
Sbjct: 246 DLP-ESIGNLSNLETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPL--IALLL 300

Query: 279 FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD-GSLLLNCPALTNLTSLDL 332
               +  +   T +      NS  LN   L N        L    +L NL +LD 
Sbjct: 301 LLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 7e-05
 Identities = 28/88 (31%), Positives = 44/88 (50%)

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL 317
           L + +    G IP+  + L   Q +    N   G IP SL +  +L +L+L  NS +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 318 LLNCPALTNLTSLDLGTNKFNGPLPTNL 345
             +   LT+L  L+L  N  +G +P  L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 65/265 (24%), Positives = 98/265 (36%), Gaps = 55/265 (20%)

Query: 744 FDQANIIGCGGFGLVYRATLPDGRNV-AIKRL-SGDCGQMER--EFRAEVEALSRAQHPN 799
           F +   IG G FG V      D   + A+K L   D     +    +AE + L+ A +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 800 LVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           +V L  Y     D L  +  ++  G +   L         L   +R +IA+     +  +
Sbjct: 63  VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESV 117

Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-------------------LSPY 899
           H+      +HRDIK  NIL+D +    L DFGL                       + P 
Sbjct: 118 HKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 900 DTHVTTD----------------------LVGTLGYIPPEYGQASVATYKGDVYSFGVVL 937
           +     D                      LVGT  YI PE    +  T   D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 938 LELLTGKRPMDMCKPKGSR-DLISW 961
            E+L G+ P     P  ++  +I+W
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 1e-04
 Identities = 36/147 (24%), Positives = 53/147 (36%), Gaps = 41/147 (27%)

Query: 432 ASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN 491
           A C    +  +W      +  + L    L G IP      + L  ++LS N+  G IP +
Sbjct: 407 ADCQFDSTKGKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS 461

Query: 492 LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPE 551
           L  + SL                                      +DLS N  +GSI   
Sbjct: 462 LGSITSLEV------------------------------------LDLSYNSFNGSIPES 485

Query: 552 FGNLKKLHVFDLKHNNLSGPIPSELTG 578
            G L  L + +L  N+LSG +P+ L G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGG 512

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 26/57 (45%), Positives = 32/57 (56%)

Query: 536 TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNL 592
           ++DLS NRL       F  L  L V DL  NNL+   P   +G+ SL +LDLS NNL
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 27/187 (14%)

Query: 839  LDWDSRLHIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL- 896
            L +   +  +   A G+ +L  ++C    +HRD+ + N+L+       + DFGLAR I+ 
Sbjct: 236  LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291

Query: 897  -SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPK 953
             S Y +  +T L   L ++ PE    ++ T   DV+SFG++L E+ T G  P  ++   +
Sbjct: 292  DSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349

Query: 954  GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
               + I    RM +    S+                 + +I   C  E  ++RP   QLV
Sbjct: 350  QFYNAIKRGYRMAKPAHASD----------------EIYEIMQKCWEEKFEIRPDFSQLV 393

Query: 1014 SWLDSII 1020
              +  ++
Sbjct: 394  HLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 2e-04
 Identities = 19/50 (38%), Positives = 25/50 (50%)

Query: 96  RLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
           RL      +   L  L+ L+LS N L    P +   LP+L  LDLS N+L
Sbjct: 11  RLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 2e-04
 Identities = 19/60 (31%), Positives = 29/60 (48%)

Query: 557 KLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHL 616
            L   DL +N L+        G+ +L+ LDLS NNL+   P +   L  L    ++ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 11/134 (8%)

Query: 812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL-HQSCEPHILHRD 870
           DR   Y    +  +   L +  DG   L     L      ARG+ +L  ++C    +HRD
Sbjct: 209 DRPASYKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRD 262

Query: 871 IKSSNILLDGNFGAHLADFGLARLIL--SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           + + N+LL       + DFGLAR I+  S Y +  +T L   + ++ PE    ++ T   
Sbjct: 263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLS 320

Query: 929 DVYSFGVVLLELLT 942
           DV+S+G++L E+ +
Sbjct: 321 DVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 28/83 (33%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y+H   E  I+HRDIK+ N+L++G     L DFG A      + T     + GT+    P
Sbjct: 275 YIH--GE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 917 EYGQASVATYKGDVYSFGVVLLE 939
           E       T   D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 21/161 (13%)

Query: 792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           +S+  H +LV   G C+  ++ +++  +++ GSLD +L +K     ++ W  +L +A+  
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW--KLEVAKQL 109

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGA----HLADFGLARLILSPYDTHV 903
           A  L +L    +  + H ++ + N+LL    D   G      L+D G++  +L P +   
Sbjct: 110 AWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL-PKEI-- 163

Query: 904 TTDLVGTLGYIPPE-YGQASVATYKGDVYSFGVVLLELLTG 943
              L+  + ++PPE        +   D +SFG  L E+ +G
Sbjct: 164 ---LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 0.002
 Identities = 41/135 (30%), Positives = 55/135 (40%), Gaps = 32/135 (23%)

Query: 835 GPSSLDWD------SRLHIAQ-----GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG 883
           GP  LDW       S  H+AQ     G A  L Y H   E H++H D+K  NIL++    
Sbjct: 215 GPCLLDWIMKHGPFSHRHLAQIIFQTGVA--LDYFHT--ELHLMHTDLKPENILMET--S 268

Query: 884 AHLADFGLARLILSPY--------------DTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
             + D  +    L P               + H  T +V T  Y  PE        Y  D
Sbjct: 269 DTVVD-PVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTD 327

Query: 930 VYSFGVVLLELLTGK 944
           ++S G ++ EL TGK
Sbjct: 328 MWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 65/268 (24%), Positives = 103/268 (38%), Gaps = 57/268 (21%)

Query: 744 FDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMEREF---RAEVEALSRAQHPN 799
           F +   +G G FG V  A   D + + A+K L      +  +    +AE + L+ A +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V L      K++   +  ++  G +   L      P  L   +R +IA+     +  +H
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAELTC-AVESVH 118

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT-------HVTTD------ 906
           +      +HRDIK  NIL+D +    L DFGL       +D+       HV  D      
Sbjct: 119 KM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 907 --------------------------------LVGTLGYIPPEYGQASVATYKGDVYSFG 934
                                           LVGT  YI PE    +  T   D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 935 VVLLELLTGKRPMDMCKPKGSR-DLISW 961
           V+L E+L G+ P     P  ++  +I+W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.0 bits (94), Expect = 0.004
 Identities = 60/284 (21%), Positives = 99/284 (34%), Gaps = 53/284 (18%)

Query: 132 LPNLEVLDLSSNDLSGP----LPQTINL-PSIQVLDISSNSLNGSVPTSIC-----KNSS 181
           L  L+VL L  N L       L   +   PS++ L +S N                    
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 182 RIRVINLSVNYFSGTLSPGLGNC---ASLEHLCLGMNDLTGG----IADDIFQLQ-KLRL 233
            ++ ++LS N         L +    +SL+ L L  N L       +A  +  L   L  
Sbjct: 82  GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141

Query: 234 LGLQDNQLSGKLSPSIADL----SNLVRLDVSSNNFSGN-IPDVFAGLGEFQYLVA---H 285
           L L  N+L G    ++A       +L  L++++N      I  +  GL     L     +
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201

Query: 286 SNRFT----GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPL 341
           +N  T      +  +L++  +L +LNL +N+L                 D G        
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLT----------------DAGAAAL---A 242

Query: 342 PTNLPRCRKLKNINLARNNF----SGQIPETYKNFESLSYLSLS 381
              L     L  ++L+ N+     +  + E     ESL  L L 
Sbjct: 243 SALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLR 286

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 35.8 bits (83), Expect = 0.004
 Identities = 15/44 (34%), Positives = 20/44 (45%), Gaps = 6/44 (13%)

Query: 32 NPNDLAALEDFMKNFESG----IDGWGTNASSSDCCHWVGITCN 71
            +D  AL  F  +        +  W  N SSSD C W G+TC+
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSW--NPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 31/165 (18%)

Query: 742 NNFDQANIIGCGGFG---LVYRATLPDGRNVAIKRLSGDCGQMERE-----FRAEVEALS 793
            +F    +IG G FG   LV +     G+  A+K L     +M ++      +AE + L+
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKS--EMFKKDQLAHVKAERDVLA 56

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD------SRLHI 847
            +  P +V L           LI  F+  G L   L         + +D      +R ++
Sbjct: 57  ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYM 107

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA 892
           A+     +  +H+      +HRDIK  NIL+D      L+DFGL+
Sbjct: 108 AE-CVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1020
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.81
PRK12274	218	serine/threonine protein kinase; Provisional	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.73
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.72
PRK10345	210	hypothetical protein; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
PLN03150	623	hypothetical protein; Provisional	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.62
PLN03150	623	hypothetical protein; Provisional	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.38
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.38
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.11
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.09
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.02
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.99
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.98
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.97
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.96
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.89
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.86
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.77
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.76
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.74
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.51
PRK09902	216	hypothetical protein; Provisional	98.51
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.44
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.41
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.4
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.38
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.37

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.2e-112  Score=1084.36  Aligned_cols=914  Identities=30%  Similarity=0.492  Sum_probs=751.4

Q ss_pred             CHHHHHHHHHHHHHhccCCCCCCCCC-CCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCC
Q 035998           32 NPNDLAALEDFMKNFESGIDGWGTNA-SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQ  110 (1020)
Q Consensus        32 ~~~~~~aL~~~k~~~~~~~~~~~~~~-~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~  110 (1020)
                      .|+|++||++||+++.++. ++...| .+.|||.|.||+|++.           ++|++|+|++++++|.++.++..+++
T Consensus        27 ~~~~~~~l~~~~~~~~~~~-~~~~~w~~~~~~c~w~gv~c~~~-----------~~v~~L~L~~~~i~~~~~~~~~~l~~   94 (968)
T PLN00113         27 HAEELELLLSFKSSINDPL-KYLSNWNSSADVCLWQGITCNNS-----------SRVVSIDLSGKNISGKISSAIFRLPY   94 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCc-ccCCCCCCCCCCCcCcceecCCC-----------CcEEEEEecCCCccccCChHHhCCCC
Confidence            6799999999999996432 222223 4578999999999752           58999999999999999999999999


Q ss_pred             CcEEecCCCCCCCCCCcccc-CCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEcc
Q 035998          111 LRFLNLSHNLLKGTVPVSLV-NLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS  189 (1020)
Q Consensus       111 L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~  189 (1020)
                      |+.|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. ..+++|++|+|++|.+++.+|..+ ..+++|++|+|+
T Consensus        95 L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~L~~L~Ls~n~~~~~~p~~~-~~l~~L~~L~L~  172 (968)
T PLN00113         95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLG  172 (968)
T ss_pred             CCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc-cccCCCCEEECcCCcccccCChHH-hcCCCCCEEECc
Confidence            99999999999999998765 999999999999999998875 358999999999999998888876 579999999999


Q ss_pred             CCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccC
Q 035998          190 VNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNI  269 (1020)
Q Consensus       190 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  269 (1020)
                      +|.+.+.+|..++++++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+|..++++++|++|++++|++++.+
T Consensus       173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~  252 (968)
T PLN00113        173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI  252 (968)
T ss_pred             cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCC
Q 035998          270 PDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCR  349 (1020)
Q Consensus       270 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  349 (1020)
                      |..|+++++|++|++++|++++.+|..+.++++|+.|++++|.+.+.+|..+..+++|++|++++|.+++.+|..+..++
T Consensus       253 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~  332 (968)
T PLN00113        253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP  332 (968)
T ss_pred             ChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc-hhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceE
Q 035998          350 KLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN-LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKV  428 (1020)
Q Consensus       350 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~-l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~  428 (1020)
                      +|+.|++++|++++.+|..++.+++|+.|++++|++.. +|.   .+..+++|+.|+++.|.+...++. ....+++|+.
T Consensus       333 ~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~---~~~~~~~L~~L~l~~n~l~~~~p~-~~~~~~~L~~  408 (968)
T PLN00113        333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE---GLCSSGNLFKLILFSNSLEGEIPK-SLGACRSLRR  408 (968)
T ss_pred             CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCCh---hHhCcCCCCEEECcCCEecccCCH-HHhCCCCCCE
Confidence            99999999999999999999999999999999999874 443   456678899999999877666553 3456789999


Q ss_pred             EEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCC
Q 035998          429 LVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEP  508 (1020)
Q Consensus       429 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~  508 (1020)
                      |++++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..++ .++|+.++++.+..
T Consensus       409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l  487 (968)
T PLN00113        409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQF  487 (968)
T ss_pred             EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCcc
Confidence            99999999999999999999999999999999999999999999999999999999988888764 47788888877666


Q ss_pred             CCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEcc
Q 035998          509 SPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLS  588 (1020)
Q Consensus       509 ~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  588 (1020)
                      ....|.....           + .-...|+|++|++++.+|+.|+++++|++|+|++|+++|.+|..|+.+++|+.|||+
T Consensus       488 ~~~~~~~~~~-----------l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  555 (968)
T PLN00113        488 SGAVPRKLGS-----------L-SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS  555 (968)
T ss_pred             CCccChhhhh-----------h-hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence            5544421110           0 112579999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCccccccccccccccccccccccCCCCCCCCCcCCccccCCC-CCCCCC----CCCccCCcCCccccccccC
Q 035998          589 YNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHR----YSCTIDRESGQVKSAKKSR  663 (1020)
Q Consensus       589 ~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~-l~~~~~----~~c~~~~~~~~~~~~~~~~  663 (1020)
                      +|+++|.+|..+.++++|+.|++++|+++|.+|..+++.++...+|.||+ +||...    ++|...         +   
T Consensus       556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~---------~---  623 (968)
T PLN00113        556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV---------R---  623 (968)
T ss_pred             CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc---------c---
Confidence            99999999999999999999999999999999999999999999999998 998642    344210         0   


Q ss_pred             CCceEEEEEEehhhhhHHHHHHHHHHHhhhccccCCCCccccccCCCCchhhhhccceEEEecCCCccccHHHHHHhccC
Q 035998          664 RNKYTIVGMAIGITFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNN  743 (1020)
Q Consensus       664 ~~~~~i~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  743 (1020)
                      ....+.+.+++++++.+++++++++++++|++++.+..  +.+....  . .+    .........+.+.++++.   ..
T Consensus       624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~-~~----~~~~~~~~~~~~~~~~~~---~~  691 (968)
T PLN00113        624 KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK--RVENEDG--T-WE----LQFFDSKVSKSITINDIL---SS  691 (968)
T ss_pred             ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccc--ccccccc--c-cc----ccccccccchhhhHHHHH---hh
Confidence            11111222211111111112222222222222211111  1110000  0 00    000001112234455543   45


Q ss_pred             CCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |...++||+|+||.||+|+. .++..||||++......    ..+|++.+++++|||||+++++|.+.+..++||||+++
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            77788999999999999986 47899999998754322    23468889999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|.++++.       ++|.++..++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.......     
T Consensus       768 g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        768 KNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            999999863       6899999999999999999997666699999999999999999888875 665543211     


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC-
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD-  981 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-  981 (1020)
                       .....+++.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|..............|+.... 
T Consensus       835 -~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        835 -DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             -CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCC
Confidence             1223678999999999999999999999999999999999999964332 2334555655444333344445554432 


Q ss_pred             -ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          982 -KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       982 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       ....++..++.+++.+||+.||++||+|+|++++|+++
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence             23456677889999999999999999999999999976

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.5e-59  Score=597.44  Aligned_cols=514  Identities=32%  Similarity=0.513  Sum_probs=475.2

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc--CCCCcceeeeccCccCCCCCccccccCCcccEE
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI  186 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~--~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L  186 (1020)
                      .+++.|+|++|+++|.+|..|..+++|++|+|++|++++.+|..+  .+++|++|+|++|+++|.+|..   .+++|++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L  145 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL  145 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence            579999999999999999999999999999999999998887654  7999999999999999999874   47899999


Q ss_pred             EccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCc
Q 035998          187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       187 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                      +|++|.+++.+|..++++++|++|+|++|.+++.+|..+.++++|++|+|++|++++.+|..++++++|++|+|++|+++
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCC
Q 035998          267 GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP  346 (1020)
Q Consensus       267 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~  346 (1020)
                      +.+|..|+++++|++|++++|++++.+|..++++++|+.|++++|.+.+..|..+..+++|++|+|++|++.+.+|..+.
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~  305 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI  305 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc-hhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN-LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       347 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~-l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                      .+++|+.|++++|.+++..|..+..+++|+.|++++|.+.. +|.   .+..+++|+.|+++.|.+...++.. ...+++
T Consensus       306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~---~l~~~~~L~~L~Ls~n~l~~~~p~~-~~~~~~  381 (968)
T PLN00113        306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK---NLGKHNNLTVLDLSTNNLTGEIPEG-LCSSGN  381 (968)
T ss_pred             CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCCh---HHhCCCCCcEEECCCCeeEeeCChh-HhCcCC
Confidence            99999999999999999999999999999999999999974 444   4678899999999999876655543 345688


Q ss_pred             ceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcC
Q 035998          426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISL  505 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~  505 (1020)
                      |+.|++.+|++.+.+|..+..+++|+.|++++|++++.+|..|..+++|+.|+|++|.+++.+|..+..+++|+.++++.
T Consensus       382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  461 (968)
T PLN00113        382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR  461 (968)
T ss_pred             CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999987


Q ss_pred             CCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEE
Q 035998          506 EEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETL  585 (1020)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  585 (1020)
                      +......|.....             .-.+.||+++|++++..|..|+++++|+.|+|++|++++.+|..++++++|++|
T Consensus       462 n~~~~~~p~~~~~-------------~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  528 (968)
T PLN00113        462 NKFFGGLPDSFGS-------------KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL  528 (968)
T ss_pred             ceeeeecCccccc-------------ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEE
Confidence            7665544432210             112579999999999999999999999999999999999999999999999999


Q ss_pred             EccCCcccccCCccccccccccccccccccccccCCCC-CCCCCcCCccccCCCCCCC
Q 035998          586 DLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-GQFQTFPNSSFDGNNLCGE  642 (1020)
Q Consensus       586 ~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~l~~~  642 (1020)
                      +|++|+++|.+|..+..+++|+.|+|++|+++|.+|.. ..+..+....+.+|++.|.
T Consensus       529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  586 (968)
T PLN00113        529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS  586 (968)
T ss_pred             ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence            99999999999999999999999999999999999974 4566788888999998774

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-48  Score=432.43  Aligned_cols=288  Identities=51%  Similarity=0.871  Sum_probs=254.5

Q ss_pred             CCccccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEE
Q 035998          728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC  807 (1020)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  807 (1020)
                      ..+.++++++..||++|...+.||+|+||.||+|..++|+.||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45678999999999999999999999999999999999999999988765432156699999999999999999999999


Q ss_pred             eccC-ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          808 MHKN-DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       808 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      .+.+ +.++|||||++|+|.++++.....  .++|.+|++||.++|+||+|||+.+.++||||||||+|||+|.++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 499999999999999999976333  7899999999999999999999998889999999999999999999999


Q ss_pred             eeccccccccCCCCccccccc-ccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDL-VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||+|+..... ... .... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+...+......+.|....
T Consensus       219 sDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  219 SDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999654321 111 1112 7999999999999999999999999999999999999999876655566689998888


Q ss_pred             HhhcccccccCcccc-CccCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIY-DKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .......+++||.+. ..+.. .++.++..++.+|++.+|.+||+|.||+++|+.+
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            888889999999987 55554 6888999999999999999999999999999764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=375.89  Aligned_cols=249  Identities=27%  Similarity=0.471  Sum_probs=208.1

Q ss_pred             CcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-eEEEEEecc
Q 035998          745 DQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-RLLIYSFME  821 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~  821 (1020)
                      +..+.||+|..|+||+++++ +++.+|+|++.... ....+++.+|++++++.+||+||.+||.|..... ..++||||+
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            55788999999999999976 68889999995543 4566899999999999999999999999999884 999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      +|+|++++...    +.+++...-+|+.+|++||.|||+ +   +||||||||+|||++..|+|||||||.++.+.+.  
T Consensus       162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999875    568999999999999999999996 6   9999999999999999999999999999987543  


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                        ...+.+||..|||||-+.+..|+.++||||||+.++|+++|+.||....+ ...+..+....+..+ ..+...+    
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~-ppP~lP~----  304 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDE-PPPRLPE----  304 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcC-CCCCCCc----
Confidence              45678999999999999999999999999999999999999999976411 112222222222221 1111111    


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .   ....++.+++..|+++||.+||+++|+++
T Consensus       305 -~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  305 -G---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -c---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1   13346889999999999999999999987

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-45  Score=397.95  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=215.6

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          744 FDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +...+.||+|.||+||.|.++....||+|.++.. ....++|.+|+++|++++|++||+++++|..++..+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            3567889999999999999987789999999865 233578999999999999999999999999988999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      +|.+|++.  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...+. ....
T Consensus       287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~  360 (468)
T KOG0197|consen  287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA  360 (468)
T ss_pred             cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence            99999997  3456788999999999999999999999   9999999999999999999999999999954332 2333


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      .....-+..|+|||.+....++.|||||||||+||||+| |+.||..+...+....++...++.++.             
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~-------------  427 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE-------------  427 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC-------------
Confidence            333444678999999999999999999999999999999 999998776554444444433333322             


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         .++..++++|..||+.+|++||||+.+...|+++
T Consensus       428 ---~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  428 ---GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             ---CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence               2334799999999999999999999999998875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=389.43  Aligned_cols=253  Identities=35%  Similarity=0.519  Sum_probs=209.0

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh--hHHHHHHHHHHHHHcCCCccceEeeEEeccC-ceEEEEEecc
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ--MEREFRAEVEALSRAQHPNLVHLQGYCMHKN-DRLLIYSFME  821 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  821 (1020)
                      ...+.+|+|+||+||+|.++....||||++......  ..++|.+|+.++++++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            445669999999999999975444999999865422  2568999999999999999999999999887 7899999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eEecCCCCCCEEEcCCC-CeEEeeccccccccCCC
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH-ILHRDIKSSNILLDGNF-GAHLADFGLARLILSPY  899 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~  899 (1020)
                      +|+|..+++..  ....+++..++.|+.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999874  346899999999999999999999999   7 99999999999999997 99999999998764321


Q ss_pred             CcccccccccccCccCccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQ--ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                        ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||....+      .+.............+.. 
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~-  269 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPK-  269 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCc-
Confidence              2334478999999999999  66999999999999999999999999976543      222222222222111111 


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                              .+...+..++.+||+.||..||++.+++..|+.+
T Consensus       270 --------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  270 --------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             --------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                    1334688999999999999999999999999865

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=367.18  Aligned_cols=203  Identities=30%  Similarity=0.519  Sum_probs=182.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCC--chhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ..+|...+.||+|+||.||+|+++ ++..||||.+...  .....+-+..|+.++++++|||||++++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888999999999999999975 6889999999776  3445566889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC------CCeEEeeccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN------FGAHLADFGL  891 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~  891 (1020)
                      |||+||||.+|++.+    +.+++..+++++.|+|.||++||++   +||||||||.|||++..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999986    5789999999999999999999999   99999999999999764      4589999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK  953 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  953 (1020)
                      |+.+.   ........+|++-|||||++..+.|+.|+|+||+|+|+|||++|+.||+.....
T Consensus       162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            99884   344556689999999999999999999999999999999999999999865543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.8e-44  Score=407.29  Aligned_cols=259  Identities=31%  Similarity=0.484  Sum_probs=220.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      .+....+.||+|+||+||+|+..      +.+.||||.++..... ..++|++|++.+.+++|||||+++|+|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44566789999999999999743      3567999999987755 6789999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          815 LIYSFMENGSLDYWLHEKLD----------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      +|+|||+.|||.+||+-...          .+.+++..+.++||.|||.||+||-++   .+|||||.++|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999975321          134588999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||++|...+.+..+......-+.+|||||.+..+++|.+||||||||++||+++ |+.||.+....+..+.++   
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~---  719 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR---  719 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH---
Confidence            9999999999877665555545556789999999999999999999999999999999 999998766544333222   


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          .+..         -+.+..++.++++||..||+..|.+||+|+||-..|+..
T Consensus       720 ----~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  720 ----AGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ----cCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                2221         122344566899999999999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-44  Score=372.59  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchh-------hHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ-------MEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      .+.|.+.+.+|+|+||.|-+|. .++|+.||||++.+....       ....+.+|+++|++++|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3457888999999999999997 458999999999765311       12346799999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC---CCeEEeec
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADF  889 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  889 (1020)
                      .||||||++||+|.+++...    ..+.++....++.|++.|+.|||+.   ||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999988765    5677888899999999999999999   99999999999999765   77999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-cccHHHHHHHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV---ATYKGDVYSFGVVLLELLTGKRPMDMCKPKG-SRDLISWVIRM  965 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~  965 (1020)
                      |+|+..+   ....+.+.+||+.|.|||++.++.   +..++|+||+||++|-+++|.+||....... ..+++......
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            9999874   345667789999999999987654   3348899999999999999999997544322 22222111111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                               +.    ..+..+..++..++|.+|+..||++||+++|+++  |+.
T Consensus       401 ---------f~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  401 ---------FG----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             ---------cc----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence                     11    1223345567899999999999999999999997  554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-43  Score=385.18  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=211.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .+|...++||+|+|+.||.++. .+|..||+|++.+..   ....+.+.+|+++.+.++|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 789999999997642   334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+|+.++|..+++++    ..+++.+++.+++||+.|+.|||++   +|+|||||..|++++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999865    6899999999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      +.  ....+.+|||-|.|||++....++..+||||+|||||-|++|++||....-.+      ....++....    .-|
T Consensus       171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~Y----~~P  238 (592)
T KOG0575|consen  171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNEY----SMP  238 (592)
T ss_pred             cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcCc----ccc
Confidence            43  33456799999999999999999999999999999999999999997432222      2222222111    111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             .....+..+||.++|+.+|.+|||+++|++
T Consensus       239 -------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  239 -------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   122235789999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-43  Score=349.71  Aligned_cols=256  Identities=26%  Similarity=0.412  Sum_probs=209.5

Q ss_pred             CCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeE-EeccCc-eEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGY-CMHKND-RLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~  817 (1020)
                      +|++.++||+|.||+||+++ ..+|..||.|.+.-..  ....++...|+.++++++|||||+++++ +.++.. .+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            47888999999999999997 4689999999887443  2334578899999999999999999984 444444 78999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP-HILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      ||+++|||...++.....+..+++..+|+++.|++.||.++|....+ -|+||||||.||+++.+|.+|++|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999998888889999999999999999999999994322 38999999999999999999999999999885


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      +  ......+.+|||.||+||.+.+.+|++|+||||+||++|||+.-++||.+.      .+.+....+.+. ..+.+.+
T Consensus       180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg-d~~~~p~  250 (375)
T KOG0591|consen  180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG-DYPPLPD  250 (375)
T ss_pred             c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-CCCCCcH
Confidence            4  234556789999999999999999999999999999999999999999753      333333333332 1111111


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                              ......+.+++..|+..||+.||+...+++.
T Consensus       251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             --------HHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence                    2334568899999999999999985544443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=360.17  Aligned_cols=242  Identities=28%  Similarity=0.383  Sum_probs=202.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.++||+|+||+||.++.+ +++.+|+|++++..   ....+...+|..++.+++||+||+++-.|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            357899999999999999999865 68899999998754   22345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +||+.||.|..++.+.    ..++++.+..++..|+.||.|||++   +|||||+||+|||+|.+|+++|+|||+|+...
T Consensus       104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999865    5789999999999999999999999   99999999999999999999999999999653


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..  ...+...+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...+..      .+...+......   .-
T Consensus       177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~~---~~  245 (357)
T KOG0598|consen  177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKLP---LP  245 (357)
T ss_pred             cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcCC---CC
Confidence            32  23445579999999999999999999999999999999999999999754332      222222222200   00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1007 (1020)
                      |..       ...+..+++.+.++.||++|.
T Consensus       246 p~~-------ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  246 PGY-------LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             Ccc-------CCHHHHHHHHHHhccCHHHhc
Confidence            100       113578999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.6e-42  Score=342.25  Aligned_cols=264  Identities=25%  Similarity=0.338  Sum_probs=209.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      +.|+.+.++|+|+||.||+++.+ +|+.||||+|....  +...+-..+|++++++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788899999999999999976 59999999997654  3445667899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++.--|++ +.+.   +..++.+.+.+++.|++.|+.|+|++   ++|||||||+|||++.+|.+|+||||+|+....+
T Consensus        82 ~~dhTvL~e-Le~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDHTVLHE-LERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecchHHHHH-HHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            998754443 3333   45678899999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH--------HHH-h-
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI--------RMR-Q-  967 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~--------~~~-~-  967 (1020)
                      .  ...+.++.|..|+|||.+.+ ..|+.++||||+||++.||++|.+-|.+..+-+..-.+....        .+. . 
T Consensus       155 g--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  155 G--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             c--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            3  34567888999999998877 799999999999999999999999987544322111111110        000 0 


Q ss_pred             ----hcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ----ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ----~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .-..++..++...+...+.....+.+++..|++.||.+|++-+|++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                01122222233333333444557899999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.9e-45  Score=374.87  Aligned_cols=483  Identities=27%  Similarity=0.372  Sum_probs=332.3

Q ss_pred             cccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcc
Q 035998          104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRI  183 (1020)
Q Consensus       104 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L  183 (1020)
                      .+..-..|+.|++++|.++ .+-+.+.+|..|++|++++|+++..+|....+..++.|+.++|+++ .+|..+. .+.+|
T Consensus        40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~-s~~~l  116 (565)
T KOG0472|consen   40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIG-SLISL  116 (565)
T ss_pred             hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHh-hhhhh
Confidence            3445566777777777777 5556677777777777777777766666667777777777777777 7777664 46667


Q ss_pred             cEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCC
Q 035998          184 RVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSN  263 (1020)
Q Consensus       184 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  263 (1020)
                      ..+++++|.+. .+|+.++.+..|+.|+..+|+++ ..|.+++.+.+|..|++.+|+++...|..+ +++.|++||..+|
T Consensus       117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N  193 (565)
T KOG0472|consen  117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSN  193 (565)
T ss_pred             hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchh
Confidence            77788888777 67888899999999999999998 688899999999999999999995544444 4999999999999


Q ss_pred             cCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCC
Q 035998          264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT  343 (1020)
Q Consensus       264 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  343 (1020)
                      .++ .+|..++++.+|..|+|..|+|. ..| .|.+++.|.+|+++.|+|.........++.+|.+|||.+|+++ ..|+
T Consensus       194 ~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pd  269 (565)
T KOG0472|consen  194 LLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPD  269 (565)
T ss_pred             hhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCch
Confidence            997 78888999999999999999998 556 8999999999999999999766677779999999999999999 8999


Q ss_pred             CCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhh-----cccc---CCCC
Q 035998          344 NLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLT-----LNFR---NEKL  415 (1020)
Q Consensus       344 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~-----~n~~---~~~~  415 (1020)
                      .++-+++|.+||+|+|.|+ ..|..++++ +|+.|-+.+|+++.+...+-..+.-.-|++|.-.     .+.-   .+..
T Consensus       270 e~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~  347 (565)
T KOG0472|consen  270 EICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETA  347 (565)
T ss_pred             HHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccccc
Confidence            9999999999999999999 578889999 9999999999999998776554444455555431     1100   0111


Q ss_pred             CCCccc------cccCceEEEecccccccccchhhhcCCC---CcEEecccccccccccccccCcCcCcE-EeCCCCccc
Q 035998          416 PTDPRL------HFANLKVLVIASCGLRGSIPQWLRGCSK---LQLVDLSWNQLSGTIPVWFGGFQDLFY-LDLSNNTFT  485 (1020)
Q Consensus       416 ~~~~~~------~~~~L~~L~l~~n~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~  485 (1020)
                      ++.+..      ..-+.+.|.++.-+++ .+|.......+   ...++++.|++. .+|..+..+..+.+ +++++|.+.
T Consensus       348 ~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is  425 (565)
T KOG0472|consen  348 MTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS  425 (565)
T ss_pred             CCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc
Confidence            111111      2234566666666666 34444433333   667777777776 66666665555543 344444443


Q ss_pred             ccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecC
Q 035998          486 GEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH  565 (1020)
Q Consensus       486 ~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~  565 (1020)
                       .+|..++.+++|..+                                    +|++|-+. .+|.+++.+..|+.||+|.
T Consensus       426 -fv~~~l~~l~kLt~L------------------------------------~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~  467 (565)
T KOG0472|consen  426 -FVPLELSQLQKLTFL------------------------------------DLSNNLLN-DLPEEMGSLVRLQTLNLSF  467 (565)
T ss_pred             -cchHHHHhhhcceee------------------------------------ecccchhh-hcchhhhhhhhhheecccc
Confidence             666666666655433                                    33333332 3444445555555555555


Q ss_pred             CcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCCCCCCCcCCccccCCCC
Q 035998          566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNL  639 (1020)
Q Consensus       566 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~l  639 (1020)
                      |++. .+|..+..+.-|+++-.++|++....|..+.++.+|..|||.+|.+...+|..|.+.++..+...||++
T Consensus       468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            5443 444444444444444444444443323334444444444444444444444444444444444444443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=358.77  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=209.9

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      +..++|..++.||+|+|++|++|+. .+++.||||++.+.-   ....+.+..|-++|.+| +||.|++++..|+++...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3456789999999999999999985 468999999986542   12234577899999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      |+|+||+++|+|-++++..    +.+++..++.++.+|+.|++|||++   |||||||||+|||+|+||++||+|||.|+
T Consensus       150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999987    6899999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc---------c--cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 035998          894 LILSPYDT---------H--VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       894 ~~~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  962 (1020)
                      .+......         .  .....+||..|++||++.....++.+|+|+||||+|+|+.|++||.+.++     +....
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliFq  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIFQ  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHHH
Confidence            87532111         1  12458999999999999999999999999999999999999999976443     22222


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..+..+...++-+.            ..+.+|+.+.+..||.+|+|.++|.+
T Consensus       298 kI~~l~y~fp~~fp------------~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 KIQALDYEFPEGFP------------EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHhcccCCCCCC------------HHHHHHHHHHHccCccccccHHHHhh
Confidence            22222222222221            35789999999999999999999876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-42  Score=361.14  Aligned_cols=261  Identities=25%  Similarity=0.326  Sum_probs=208.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHH-HHHHHHHHHHHcC-CCccceEeeEEeccC-ceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQ-HPNLVHLQGYCMHKN-DRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  816 (1020)
                      .++|.++++||.|.||+||+|+. .+|..||||+++......++ .=.+|+..+++++ |||||++.+++.+.+ ..++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            35799999999999999999984 57899999998766544333 3368999999998 999999999999988 89999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      ||||+. +|.+.++++   ...+++..+..|+.||++||+|+|++   |+.|||+||+|||+.....+||+|||+||.+.
T Consensus        89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999976 899998876   46899999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCCcccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      +.   ...+.++.|..|+|||++ +.+.|+.++|+|++|||++|+.+-++-|.+..+-   |.+-.+..+..........
T Consensus       162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~---Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI---DQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH---HHHHHHHHHhCCCccccch
Confidence            42   334567889999999964 6789999999999999999999999988754332   3332222221111111111


Q ss_pred             C----------------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 D----------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .                +......-+.+..+..+++.+|+++||.+||||+|+++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            0                00011112235567889999999999999999999987

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.4e-44  Score=370.25  Aligned_cols=476  Identities=27%  Similarity=0.325  Sum_probs=352.2

Q ss_pred             eEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccC
Q 035998           87 VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN  166 (1020)
Q Consensus        87 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N  166 (1020)
                      ...+++++|.+. .+.+.+.+|..|.+|++++|+++ ..|++++.+..++.|+.++|+++..++...++.+|++|++++|
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n  124 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSN  124 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhcccc
Confidence            455778888887 45667899999999999999999 8999999999999999999999977777779999999999999


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCC
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS  246 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  246 (1020)
                      .+. .+|++++ .+..|..++..+|+++ ..|..++++.+|..|++.+|+++...|+ .-.++.|++||..+|-++ .+|
T Consensus       125 ~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tlP  199 (565)
T KOG0472|consen  125 ELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSNLLE-TLP  199 (565)
T ss_pred             cee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchhhhh-cCC
Confidence            998 8888885 4677899999999998 7888999999999999999999955444 445999999999999998 889


Q ss_pred             cccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCC
Q 035998          247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTN  326 (1020)
Q Consensus       247 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  326 (1020)
                      +.++.+.+|.-|+|.+|+|. ..| .|.++..|..|+++.|+|.-...+....++++.+|||.+|+++ ..|+.+.-+.+
T Consensus       200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrs  276 (565)
T KOG0472|consen  200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRS  276 (565)
T ss_pred             hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhh
Confidence            99999999999999999998 566 8999999999999999999544445569999999999999999 67778888999


Q ss_pred             cCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCC---CCCeee-------CCCCCC------cchhh
Q 035998          327 LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFE---SLSYLS-------LSNSSI------YNLSS  390 (1020)
Q Consensus       327 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~-------l~~N~i------~~l~~  390 (1020)
                      |++||+|+|.|+ ..|.+++++ .|+.|-+.+|++..+ -..+-+..   -|++|.       ++.-.-      +..+.
T Consensus       277 L~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~  353 (565)
T KOG0472|consen  277 LERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE  353 (565)
T ss_pred             hhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence            999999999999 688889999 999999999988521 11110000   011111       000000      00001


Q ss_pred             HHHHHhhhcccchhhhhccccCCCCCCCccccc--cCceEEEecccccccccchhhhcCCCCcE-Eeccccccccccccc
Q 035998          391 ALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF--ANLKVLVIASCGLRGSIPQWLRGCSKLQL-VDLSWNQLSGTIPVW  467 (1020)
Q Consensus       391 ~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~--~~L~~L~l~~n~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~p~~  467 (1020)
                      .......+.+.+.|+++.-.... +|...+..-  .-....+++.|++. ++|..+..++.+.+ +++++|+++ .+|..
T Consensus       354 ~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~  430 (565)
T KOG0472|consen  354 SFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLE  430 (565)
T ss_pred             cccchhhhhhhhhhccccccccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence            11122233344444444332211 111111111  12566777788777 67777777776544 566666665 88888


Q ss_pred             ccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccC
Q 035998          468 FGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGS  547 (1020)
Q Consensus       468 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~  547 (1020)
                      ++.+++|..|+|++|.+. .+|..++.+..|+.+                                    |+|.|+|. .
T Consensus       431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L------------------------------------nlS~NrFr-~  472 (565)
T KOG0472|consen  431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL------------------------------------NLSFNRFR-M  472 (565)
T ss_pred             HHhhhcceeeecccchhh-hcchhhhhhhhhhee------------------------------------cccccccc-c
Confidence            888888888888888887 788888887776544                                    34444443 2


Q ss_pred             CCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          548 IWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       548 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      +|...-.+..|+.+-.++|++....|+.+.+|.+|.+|||.+|.|. .||+.++++++|+.|.+++|++.
T Consensus       473 lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  473 LPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             chHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            4444455555666666667776444444777888888888888887 77778888888888888888877

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-40  Score=324.41  Aligned_cols=261  Identities=28%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .+|...+++|+|.||.||+|+. ++|+.||||+++...  ........+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688889999999999999985 579999999997543  2345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ||+. +|...++..   ...++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+++.++++
T Consensus        82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 888888764   45788999999999999999999999   9999999999999999999999999999998876


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH---hhcccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR---QENRESEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~  974 (1020)
                      ....  ...+-|..|+|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.+..+   .++....-+..   .+..+++.
T Consensus       155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCccc
Confidence            5432  33477889999997655 6799999999999999999999888765432   23333333322   22222221


Q ss_pred             cC----------cc-ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LD----------PF-IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d----------~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..          |. ......+.+.....+++.+|+.+||.+|++++|+++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            10          10 011123445566799999999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=340.08  Aligned_cols=262  Identities=28%  Similarity=0.454  Sum_probs=211.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .+.|+..+.||.|..+.||+|+. +.+..||||++.-+.. .....+++|++.|+.++||||++++..|..+...|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46789999999999999999985 5789999999976543 335789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ||.+|++.+.++..+.  ..+++..+..|.+++++||.|||.+   |.||||||+.|||++.+|.|||+|||.+..+.+.
T Consensus       105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999998754  4589999999999999999999999   9999999999999999999999999999887664


Q ss_pred             CCccc-c-cccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          899 YDTHV-T-TDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       899 ~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      +.... . ...+||+.|||||++..  ..|+.|+||||||++..|+.+|..||....+-..      .. +.-.+..+..
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll-~tLqn~pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LL-LTLQNDPPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HH-HHhcCCCCCc
Confidence            43221 1 45789999999998543  4799999999999999999999999987655321      11 1111111111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .......+........+.+++..|++.||.+|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1001111112222336889999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=373.24  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=214.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ...+.++||.|.||+|++|+++    ....||||.++.-. ....++|..|+.+|.++.||||+++.|+....+..+||+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            3456789999999999999875    23569999998654 345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |||++|+|+.||+..   .+.+++.+..-++++||.||.||-+.   ++|||||.++|||++.+-.+|++|||++|...+
T Consensus       710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999976   24589999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          898 PYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       898 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      +.... .+....-+.+|.|||.+..++++.++||||+||+|||.++ |.+||-.+...+....++.      ..      
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~------gy------  851 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ------GY------  851 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh------cc------
Confidence            43221 1111223578999999999999999999999999999988 9999987665433222221      11      


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                          .-+.+.+++..+++||..||++|-.+||.|.+|+..|.+++
T Consensus       852 ----RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  852 ----RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             ----CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                12234456678999999999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-40  Score=350.78  Aligned_cols=265  Identities=28%  Similarity=0.356  Sum_probs=204.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  816 (1020)
                      +.|+.+++||+|.||.||+|+. .+|+.||+|++..+.  .....-+.+||.++++++||||+++.+...+.  ...|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4577789999999999999984 579999999987664  34456678999999999999999999998876  688999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +|||+. ||.-++...   .-.++..++..++.|++.||+|+|.+   +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus       197 FeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999987 666555532   34689999999999999999999999   99999999999999999999999999999775


Q ss_pred             CCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc--c
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES--E  973 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~  973 (1020)
                      .. .....+..+.|..|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+..+-+..+.+-.......+..+.  .
T Consensus       270 ~~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PS-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CC-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            43 2333566788999999997765 589999999999999999999999998654433222222222222222222  1


Q ss_pred             ccCcccc---CccC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 VLDPFIY---DKQH-------DKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~---~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...-...   ..+.       .......++|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1100000   0110       111224678999999999999999999986

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=360.78  Aligned_cols=328  Identities=22%  Similarity=0.260  Sum_probs=182.6

Q ss_pred             CCCCCCCCCcCceEEcCCCCCCCC-----CCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccc
Q 035998           55 TNASSSDCCHWVGITCNSSSSLGL-----NDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL  129 (1020)
Q Consensus        55 ~~~~~~~~C~w~gv~C~~~~~~~~-----~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l  129 (1020)
                      ..++.++.|.-.-..|+......+     +... ...+..|++++|.+...-++.|-++++|+.++|..|.++ .||...
T Consensus        44 ~~cpa~c~c~~~lldcs~~~lea~~~~~l~g~l-p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~  121 (873)
T KOG4194|consen   44 SECPATCPCNTRLLDCSDRELEAIDKSRLKGFL-PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG  121 (873)
T ss_pred             ccCCCcCCCCceeeecCccccccccccccCCcC-ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence            345666778888888987654332     1121 134555666666666555555666666666666666666 566555


Q ss_pred             cCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccc
Q 035998          130 VNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLE  208 (1020)
Q Consensus       130 ~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~  208 (1020)
                      +...+|+.|+|.+|.|+..-.+.+ .++.|+.||||.|.|+ .+|..-|..-.++++|+|++|.|+...-..|.++.+|.
T Consensus       122 ~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~  200 (873)
T KOG4194|consen  122 HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLL  200 (873)
T ss_pred             ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchhe
Confidence            555556666666666665544444 4566666666666665 55555555555566666666666655555555555666


Q ss_pred             cccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccc
Q 035998          209 HLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNR  288 (1020)
Q Consensus       209 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  288 (1020)
                      .|.|++|+++...+..|.++++|+.|+|..|+|.-..--+|.+|++|+.|.|..|.++......|-++.++++|+|+.|+
T Consensus       201 tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~  280 (873)
T KOG4194|consen  201 TLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNR  280 (873)
T ss_pred             eeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccch
Confidence            66666666654444445555555555555555553333455555555555555555555444555555555555555555


Q ss_pred             ccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCccc
Q 035998          289 FTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPET  368 (1020)
Q Consensus       289 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  368 (1020)
                      ++..-..++.++++|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+...+.+|..+..|++|+|++|+++..-..+
T Consensus       281 l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~a  360 (873)
T KOG4194|consen  281 LQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGA  360 (873)
T ss_pred             hhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhH
Confidence            55444455555555555555555555444444444455555555555555444444544555555555555554444444


Q ss_pred             ccCCCCCCeeeCCCCCC
Q 035998          369 YKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       369 ~~~l~~L~~L~l~~N~i  385 (1020)
                      |..+++|+.|||++|.|
T Consensus       361 f~~lssL~~LdLr~N~l  377 (873)
T KOG4194|consen  361 FVGLSSLHKLDLRSNEL  377 (873)
T ss_pred             HHHhhhhhhhcCcCCeE
Confidence            44444444444444443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=359.71  Aligned_cols=265  Identities=29%  Similarity=0.456  Sum_probs=209.2

Q ss_pred             HHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          735 DDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      +++....+++.+.+.||+|.||+||+|+|.  ..||||++..+.  +...+.|+.|+.++++-+|.||+-+.|||.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344444455678899999999999999985  579999998665  3445789999999999999999999999998877


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                       .||+.||+|.+|+.+++...   ..++..+.+.|++|||+||.|||.+   +|||||||..||++++++.|||+|||++
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence             99999999999999998753   5688889999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      ..-.............|...|||||+++.   .+|++.+||||||+|+|||+||..||.. ...   +.+-|.  ..+..
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~---dqIifm--VGrG~  609 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNR---DQIIFM--VGRGY  609 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CCh---hheEEE--ecccc
Confidence            75432222222333567789999998754   4799999999999999999999999973 222   111111  11111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ...   |...   ....+.+++.+|+..||.+++++||.+.+|+..|++++
T Consensus       610 l~p---d~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  610 LMP---DLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             cCc---cchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            011   1100   12234557889999999999999999999999888764

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=390.21  Aligned_cols=260  Identities=30%  Similarity=0.463  Sum_probs=213.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC--CC----EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD--GR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      .+.+..+.||+|+||.||.|...+  |.    .||||.++... .+...+|.+|+.+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445677899999999999998642  33    49999998765 345578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      |++|||++|||..|+++.+.   ....++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999987532   245788999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      |+.+.+.+.........-...|||||.+..+.++.|+|||||||++||++| |..||......+....+      ...++
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~ggR  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGGR  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCCc
Confidence            997655443333333344578999999999999999999999999999999 99999765443322211      11111


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .          +++..++..++++|..||+.+|++||+|.++++.+..++
T Consensus       923 L----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  923 L----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             c----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence            1          112234456899999999999999999999999887763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=323.39  Aligned_cols=236  Identities=25%  Similarity=0.326  Sum_probs=199.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|+..+.+|.|+||.|.+++.+ +|..+|+|++.+..-   ...+...+|..+++.+.||+++++++.|.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            35788999999999999999865 588899999987642   22345778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++||-|..++++.    +.+++..++.++.||+.|++|||+.   +|++||+||+|||+|++|.+||+|||+|+... 
T Consensus       124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-  195 (355)
T ss_pred             eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence            999999999999975    5789999999999999999999999   99999999999999999999999999999873 


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-hhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-QENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d  976 (1020)
                          ..+.+.+|||.|+|||++..+.+..++|+|||||++|||+.|.+||...++.      .....+. ..-..+..+.
T Consensus       196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v~fP~~fs  265 (355)
T KOG0616|consen  196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKVKFPSYFS  265 (355)
T ss_pred             ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCcccCCcccC
Confidence                2356689999999999999999999999999999999999999999865541      1111111 1111122121


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1007 (1020)
                                  ..+.+|+...++.|-.+|.
T Consensus       266 ------------~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  266 ------------SDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             ------------HHHHHHHHHHHhhhhHhhh
Confidence                        2578899999999998883

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=356.20  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=210.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ...|+..++||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            3457778899999999999997 457889999999877666667789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |+||+|.+.+...     .+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||+|..+....
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999988764     589999999999999999999999   99999999999999999999999999999875432


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        ......+||+.|||||+.....|++|+||||||++++||+-|++||-...+      +...+.+...+ ..++-.+  
T Consensus       424 --~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng-~P~lk~~--  492 (550)
T KOG0578|consen  424 --SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPKLKNP--  492 (550)
T ss_pred             --CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcC-CCCcCCc--
Confidence              245667999999999999999999999999999999999999999964222      22222222221 1222221  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ......+.+++.+|++.||++|++++|+++
T Consensus       493 -----~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 -----EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -----cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                 222346889999999999999999999987

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.2e-39  Score=349.41  Aligned_cols=253  Identities=26%  Similarity=0.335  Sum_probs=208.1

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ..++|+.+++||+|+||+||+|+-+ +|..+|+|++++....   ..+.+..|..+|....+|+||+++-.|++.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999854 6999999999887532   23457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||++|||+..+|...    +.++++.+..++.+.+.|++.+|+.   |+|||||||+|+|||..|++||+|||+|.-.
T Consensus       219 iMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999999875    6899999999999999999999999   9999999999999999999999999998543


Q ss_pred             cC---------------------CCCcc-----c-------------------ccccccccCccCccccCCCCCCchhhH
Q 035998          896 LS---------------------PYDTH-----V-------------------TTDLVGTLGYIPPEYGQASVATYKGDV  930 (1020)
Q Consensus       896 ~~---------------------~~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  930 (1020)
                      ..                     +.+..     .                   ....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            21                     00000     0                   012589999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-
Q 035998          931 YSFGVVLLELLTGKRPMDMCKPKGSR-DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT- 1008 (1020)
Q Consensus       931 wSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 1008 (1020)
                      ||+|||||||+.|.+||....+.+.. ..+.|......+....              ...+..++|.+|+. ||++|.. 
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999877665543 3344443333322211              11367899999999 9999985 


Q ss_pred             --HHHHHH
Q 035998         1009 --TQQLVS 1014 (1020)
Q Consensus      1009 --~~evl~ 1014 (1020)
                        ++||.+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              666544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=343.19  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=202.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC--ceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN--DRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  818 (1020)
                      .++...+.||+|+||.||++... +|..+|||..........+.+.+|++++++++|||||+.+|......  ..++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            35677899999999999999865 48999999987653333567899999999999999999999855544  5889999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+++|+|.+++.+.  +. .+++..+..+.+||++||+|||++   |||||||||+|||++. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999875  22 689999999999999999999999   9999999999999999 79999999999987653


Q ss_pred             -CCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          898 -PYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       898 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                       ...........||+.|||||++..+ ....++||||+||++.||+||+.||...     .+...+...+......+.+.
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip  245 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP  245 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC
Confidence             1112234457899999999998853 3446999999999999999999999753     22233333333333222222


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +         .......+++.+|+..||++||||+++++
T Consensus       246 ~---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  246 D---------SLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             c---------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1         12235789999999999999999999987

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=359.30  Aligned_cols=410  Identities=22%  Similarity=0.240  Sum_probs=213.6

Q ss_pred             cCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCC--CCCcEEecCCCCCCCCCCccccCCCCCCeeecc
Q 035998           64 HWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNL--VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLS  141 (1020)
Q Consensus        64 ~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  141 (1020)
                      .-.-|.|.+......|.+.+ -+...++.+++.+...--..+..+  ..-+.||+++|.++..-+..|.++++|+++++.
T Consensus        32 ~g~vvd~ga~~~~~cpa~c~-c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~  110 (873)
T KOG4194|consen   32 VGNVVDAGAGDLSECPATCP-CNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLN  110 (873)
T ss_pred             cCcccccCCCccccCCCcCC-CCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeec
Confidence            33445555443333344332 234455655555443211111111  233456666666666666666666666666666


Q ss_pred             CCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccc
Q 035998          142 SNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG  220 (1020)
Q Consensus       142 ~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  220 (1020)
                      +|.++ .+|... ...+|++|+|.+|.|+ ++..+-.+.++.|+.||||.|.|+...-+.|..-.               
T Consensus       111 ~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~---------------  173 (873)
T KOG4194|consen  111 KNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKV---------------  173 (873)
T ss_pred             cchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCC---------------
Confidence            66665 333333 3344555555555555 33333333444444555555544443334444444               


Q ss_pred             cchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCC
Q 035998          221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNS  300 (1020)
Q Consensus       221 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  300 (1020)
                               ++++|+|++|+|+......|.++.+|..|.|++|+++..++..|.+|++|+.|+|..|+|.-.---.|.++
T Consensus       174 ---------ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL  244 (873)
T KOG4194|consen  174 ---------NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGL  244 (873)
T ss_pred             ---------CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCc
Confidence                     45555555555554444455555555555555555555455555555555555555555543333345555


Q ss_pred             cccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeC
Q 035998          301 PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL  380 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  380 (1020)
                      ++|+.|.|..|.+.......|..+.++++|+|+.|+++..-..++-++++|+.|+||+|.|..+.++.|...++|+.|+|
T Consensus       245 ~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdL  324 (873)
T KOG4194|consen  245 PSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDL  324 (873)
T ss_pred             hhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEec
Confidence            55555555555555555555555555666666666655544555555666666666666665555555555566666666


Q ss_pred             CCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccc
Q 035998          381 SNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL  460 (1020)
Q Consensus       381 ~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l  460 (1020)
                      ++|+|+.+++.  .|..+..|++|.|+.|                         .+...-...|.++++|+.|||++|.|
T Consensus       325 s~N~i~~l~~~--sf~~L~~Le~LnLs~N-------------------------si~~l~e~af~~lssL~~LdLr~N~l  377 (873)
T KOG4194|consen  325 SSNRITRLDEG--SFRVLSQLEELNLSHN-------------------------SIDHLAEGAFVGLSSLHKLDLRSNEL  377 (873)
T ss_pred             cccccccCChh--HHHHHHHhhhhccccc-------------------------chHHHHhhHHHHhhhhhhhcCcCCeE
Confidence            66665554432  1222222222222221                         11112223455556666666666666


Q ss_pred             cccccc---cccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCee
Q 035998          461 SGTIPV---WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI  537 (1020)
Q Consensus       461 ~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l  537 (1020)
                      ++.+.+   .|.+|++|+.|+|.+|++.                                                    
T Consensus       378 s~~IEDaa~~f~gl~~LrkL~l~gNqlk----------------------------------------------------  405 (873)
T KOG4194|consen  378 SWCIEDAAVAFNGLPSLRKLRLTGNQLK----------------------------------------------------  405 (873)
T ss_pred             EEEEecchhhhccchhhhheeecCceee----------------------------------------------------
Confidence            655543   3555555666665555554                                                    


Q ss_pred             ecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEcc
Q 035998          538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLS  588 (1020)
Q Consensus       538 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  588 (1020)
                              ...-.+|.+|..|+.|||.+|.|....|+.|..+ .|++|-++
T Consensus       406 --------~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  406 --------SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             --------ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence                    2222356677777777777777777777777777 67777654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-38  Score=357.43  Aligned_cols=263  Identities=28%  Similarity=0.441  Sum_probs=205.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      +.++|++.++||+|+||.||+|.+      .+++.||||++..... ...+.+.+|+++++++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456799999999999999999974      2356899999875432 2345688999999999 8999999999887654


Q ss_pred             -ceEEEEEeccCCChhhhhhhcCCC-------------------------------------------------------
Q 035998          812 -DRLLIYSFMENGSLDYWLHEKLDG-------------------------------------------------------  835 (1020)
Q Consensus       812 -~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  835 (1020)
                       ..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999998753210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccC
Q 035998          836 ---PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG  912 (1020)
Q Consensus       836 ---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  912 (1020)
                         ...+++.++..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               23578889999999999999999999   999999999999999999999999999986543222222233456778


Q ss_pred             ccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHH
Q 035998          913 YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRV  991 (1020)
Q Consensus       913 y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  991 (1020)
                      |+|||++.+..++.++|||||||++|||++ |..||......+  ...   ........ ..     .    +......+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~---~~~~~~~~-~~-----~----~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC---QRLKDGTR-MR-----A----PENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH---HHHhcCCC-CC-----C----CCCCCHHH
Confidence            999999999999999999999999999997 999997543211  111   11111110 00     0    11122468


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          992 LDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       992 ~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .+++.+||+.||++||++.|+++.|++++
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            89999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=343.53  Aligned_cols=264  Identities=26%  Similarity=0.393  Sum_probs=219.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ....+.++||+|-||+|..++...+..||||+++.+... ..++|.+|+++|.+++|||||+++|+|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            456678999999999999999987899999999987644 3478999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+|+.+...  +.........|+.|||.||+||.+.   ++||||+.++|+|+|.++++||+|||+++.+.+.+.
T Consensus       618 EnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  618 ENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             hcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999987622  2234456678999999999999999   999999999999999999999999999998877666


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT--GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ....+..+-+.+|||||.+.-++++.++|||+||+++||+++  ...||....+.   +.++-...+.....      +.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~------~~  763 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQG------RQ  763 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCC------cc
Confidence            667777778899999999999999999999999999999877  78899755432   22222222221111      11


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .....++.+...++++|.+||+.|-++||+++++...|++.
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            22234555667899999999999999999999999988763

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=348.37  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=205.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCC----ch-hhHHHHHHHHHHHHHcC-CCccceEeeEEeccCc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGD----CG-QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKND  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  812 (1020)
                      ...+|.+.+.||+|+||+|+.|.. .++..||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999975 47899999977653    12 23456778999999998 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGL  891 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~  891 (1020)
                      .++||||+.||+|.+++...    ..+.+.++..+++|++.|++|+|++   +|+||||||+||+++.+ +.+||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999874    5688899999999999999999999   99999999999999999 9999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-hh
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASV-AT-YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-QE  968 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~  968 (1020)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.....      .....+. ..
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~  239 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGE  239 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCC
Confidence            98763  2234456679999999999998876 65 8999999999999999999999862211      1111111 11


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...+..++           ..++..++.+|+..||.+|+++.++++
T Consensus       240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            11222110           246789999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=344.46  Aligned_cols=248  Identities=27%  Similarity=0.454  Sum_probs=205.4

Q ss_pred             ccccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          730 KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      -+++++++       ..++-+|.|+.|.||.|+.+ ++.||||+++.       .-+.+++-+++++||||+.+.|+|..
T Consensus       119 WeiPFe~I-------sELeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEI-------SELEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHh-------hhhhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecC
Confidence            34566665       44678999999999999985 68999998753       23457889999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      ...++||||||..|-|...++..    ..++....+.|..+||.||.|||.+   .|||||||.-||||..+..|||+||
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             CceeEEeeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccc
Confidence            99999999999999999998865    5788889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      |-++...+.   .......||..|||||+++.++.+.|+||||||||+|||+||..||.......    +-|..    ..
T Consensus       257 GTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGV----Gs  325 (904)
T KOG4721|consen  257 GTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGV----GS  325 (904)
T ss_pred             cchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEec----cC
Confidence            999887432   33445899999999999999999999999999999999999999996432211    11111    00


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .       .+.-..+..++..+.-|++.||+-.|..||+|++++..|+
T Consensus       326 N-------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  326 N-------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             C-------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            0       0111233445567888999999999999999999998775

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=341.27  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=207.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+...  ...+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999865 678899999876543  234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+.| +|..++..-    ..++++.+..++.|++.||.|||+.   +|+|||+||.||+++..|.+|+||||+|+.+.. 
T Consensus        82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9987 888888754    6789999999999999999999999   999999999999999999999999999998743 


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                       ...+.+...|||.|||||...+++|+..+|.||+|||+|||++|++||...      ...+.+..+..+        |.
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v  217 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PV  217 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CC
Confidence             445667789999999999999999999999999999999999999999631      222222222221        11


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .   .+......+..++...+..||..|.+-.+++.
T Consensus       218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1   12244456889999999999999999888765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=356.68  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=208.0

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeCC--C---CEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEe
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLPD--G---RNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCM  808 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  808 (1020)
                      ++-..++....++||+|+||+||+|+++.  +   ..||||..+.+.   .....+|.+|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33345566677999999999999998642  2   238999988633   445678999999999999999999999999


Q ss_pred             ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       809 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      .+...++|||+|.||+|.+|++..   +..++..++..++.++|.||+|||++   ++|||||.++|+|++.++.+||+|
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            999999999999999999999976   23689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCccccc-ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          889 FGLARLILSPYDTHVTT-DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      ||+++...   ...... ...-+..|+|||.+..+.+++++|||||||++||+++ |..||.+....+.      ...+.
T Consensus       306 FGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------~~kI~  376 (474)
T KOG0194|consen  306 FGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------KAKIV  376 (474)
T ss_pred             cccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------HHHHH
Confidence            99987642   111111 2234679999999999999999999999999999999 8999986544321      11111


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+....         .+...+..+..++.+||..+|++||+|.++.++++.+
T Consensus       377 ~~~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  377 KNGYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             hcCccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            1111000         1112334677888899999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=309.86  Aligned_cols=266  Identities=25%  Similarity=0.334  Sum_probs=214.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----ce
Q 035998          740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----DR  813 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  813 (1020)
                      ..++|++.+.+|+|+|+.||.++ ..+++.||+|++.-...+..+...+|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999998 5578899999998776666778899999999999999999998876543     48


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      |++++|...|+|.+.+.+...++..+++.+.++|+.+|++||++||+. .++++||||||.||++.+++.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999999998877788999999999999999999999998 5569999999999999999999999999987


Q ss_pred             cccCCCCc-------ccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHH
Q 035998          894 LILSPYDT-------HVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-DLISWV  962 (1020)
Q Consensus       894 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~  962 (1020)
                      ...-....       ........|..|+|||.+.-   ...+.++|||||||++|.|+.|..||+.....++. .+.   
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA---  254 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA---  254 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe---
Confidence            64211010       11233567899999997754   46789999999999999999999999753322211 111   


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                                 +..+.+..+......+.+.+++.+|++.||.+||++.+++..++.++
T Consensus       255 -----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 -----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                       11111111222224567899999999999999999999999988753

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-38  Score=325.37  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=208.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ..+|++.+.+|+|.||+|-+|+. ..|+.||||.++++.-.   +.-.+++|+++|+.++||||+.+|++|...+..++|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45788899999999999999974 68999999999876533   334578999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||..+|.|.+|+.++    +.+++.+++++++||..|+.|+|++   +++|||||.+|||+|+++.+||+|||++..+.
T Consensus       132 MEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999886    6799999999999999999999999   99999999999999999999999999998773


Q ss_pred             CCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                         +.......+|++-|.+||+..+.+| ++.+|-||+||++|-++.|..||++..      .-..+.++.....    .
T Consensus       205 ---~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaY----r  271 (668)
T KOG0611|consen  205 ---DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAY----R  271 (668)
T ss_pred             ---cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhcccc----c
Confidence               3345567899999999999999877 588999999999999999999998542      2222222222111    1


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                              .++.+....-+|++|+..+|++|.|+.||..
T Consensus       272 --------EP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  272 --------EPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             --------CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                    1112234667999999999999999999865

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-37  Score=341.64  Aligned_cols=265  Identities=25%  Similarity=0.372  Sum_probs=205.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-----------------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-----------------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHL  803 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  803 (1020)
                      ++|++.+.||+|+||.||+|++++                 +..||+|.+.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3369999987653 3334578999999999999999999


Q ss_pred             eeEEeccCceEEEEEeccCCChhhhhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEe
Q 035998          804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLD---------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH  868 (1020)
Q Consensus       804 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  868 (1020)
                      ++++.+.+..++||||+++|+|.+++.....               ....+++..+..++.||+.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999998865321               123578889999999999999999999   9999


Q ss_pred             cCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 035998          869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT--GKRP  946 (1020)
Q Consensus       869 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~p  946 (1020)
                      |||||+||+++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999987643322222333456789999999988899999999999999999987  5667


Q ss_pred             CCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          947 MDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       947 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      |......   ..................      ...++.....+.+++.+||+.||++|||+++|.+.|++
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            7644322   222222111111100000      00111223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.2e-37  Score=350.90  Aligned_cols=263  Identities=27%  Similarity=0.426  Sum_probs=206.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ..++|++.+.||+|+||.||+|+..      ++..||||++..... .....+.+|+++++.+ +|+||++++++|....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457899999999999999998742      345799999976542 2345688999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC---------------------------------------------------------
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD---------------------------------------------------------  834 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  834 (1020)
                      ..++||||+++|+|.++++....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999864311                                                         


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          835 ---------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       835 ---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                               ....+++.+++.++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                     113478889999999999999999999   99999999999999999999999999998764332222222


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccC
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH  984 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  984 (1020)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||.......  ....   .. ......  ..+.      
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~---~~-~~~~~~--~~~~------  338 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK---MV-KRGYQM--SRPD------  338 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH---HH-HcccCc--cCCC------
Confidence            3345678999999988899999999999999999997 999997543211  1111   11 111000  0110      


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          985 DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       985 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                       ....++.+++.+||+.||++||++.++++.|++++
T Consensus       339 -~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 -FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence             01246889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=346.23  Aligned_cols=241  Identities=26%  Similarity=0.359  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|...++||+|.||+|++|..+ +++.+|||+++++.   ....+..+.|.+++... +||.++.++..|+..++.|.|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            56899999999999999999875 67899999999875   33445677888888877 599999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+.|||+..+.+     ...+++..+..++..|+.||+|||++   +|||||||.+|||+|.+|++||+|||+++.-.
T Consensus       448 mey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence            99999999544433     25789999999999999999999999   99999999999999999999999999998753


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .  ....+++.+||+.|||||++.++.|+.++|+|||||+||||+.|+.||.+.+..+..+.+      ..+    +.  
T Consensus       520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d----~~--  585 (694)
T KOG0694|consen  520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VND----EV--  585 (694)
T ss_pred             C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcC----CC--
Confidence            2  334667899999999999999999999999999999999999999999754433222211      111    11  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                           .++.....+...++++++..+|++|..+
T Consensus       586 -----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 -----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 1222334568899999999999999976

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=333.70  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=208.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhh-HHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..|+..+.||+|+||.||+|.. ..++.||+|++.-+.... ..++++|+.++..++++||.++|+.+......+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577789999999999999985 468899999998765433 46789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |.||++.+.++..    ..+++.....+++++..|+.|+|.+   +.+|||||+.||++..+|.+|++|||++..+....
T Consensus        93 ~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             hcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            9999998888753    3457788889999999999999999   99999999999999999999999999998875432


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        ......+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+....            ..++.-..|.+
T Consensus       166 --~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------flIpk~~PP~L  231 (467)
T KOG0201|consen  166 --KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------FLIPKSAPPRL  231 (467)
T ss_pred             --hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------EeccCCCCCcc
Confidence              3336789999999999999999999999999999999999999999876552211            11122222222


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+    .....+.+++..|+.+||+.||+|.++++
T Consensus       232 ~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            22    22345889999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.6e-37  Score=336.49  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=203.5

Q ss_pred             ccccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeE
Q 035998          730 KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGY  806 (1020)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~  806 (1020)
                      +.++.+++     +......||+|++|.||+|.+ +|+.||||++......   ..+.+.+|++++++++||||++++++
T Consensus        13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988         13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             eecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            45566665     223346799999999999998 6899999999765322   24567899999999999999999999


Q ss_pred             Eec----cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          807 CMH----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       807 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      +.+    ....++||||+++|+|.+++...    ..+++..+..++.|++.|++|||+..  +++||||||+||+++.++
T Consensus        87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~  160 (283)
T PHA02988         87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY  160 (283)
T ss_pred             EEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence            876    34678999999999999998764    46789999999999999999999732  788999999999999999


Q ss_pred             CeEEeeccccccccCCCCcccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHH
Q 035998          883 GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS  960 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  960 (1020)
                      .+|++|||+++....+.     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......   +.. 
T Consensus       161 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~-  231 (283)
T PHA02988        161 KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY-  231 (283)
T ss_pred             cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH-
Confidence            99999999998653321     23467889999999876  68999999999999999999999999754321   111 


Q ss_pred             HHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          961 WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       961 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ...........         .+......+.+++.+||+.||++|||++|+++.|+.+
T Consensus       232 --~~i~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        232 --DLIINKNNSLK---------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --HHHHhcCCCCC---------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              11111111000         0112234688999999999999999999999998864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=327.81  Aligned_cols=252  Identities=25%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--------------hhHHHHHHHHHHHHHcCCCccceEee
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--------------QMEREFRAEVEALSRAQHPNLVHLQG  805 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~  805 (1020)
                      -++|++.+.||+|.||.|-+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            468999999999999999999854 789999999865321              01246889999999999999999999


Q ss_pred             EEec--cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          806 YCMH--KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       806 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      +..+  .+..|||+|||..|.+...    ......+++++++++++++..||+|||.+   +||||||||+|+|++.+|+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            9876  4678999999998875332    22223389999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCC---CCcccccccccccCccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 035998          884 AHLADFGLARLILSP---YDTHVTTDLVGTLGYIPPEYGQAS----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR  956 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  956 (1020)
                      +||+|||.+......   .........+|||.|+|||...++    ..+.+.||||+||++|.|+.|+.||.+....+. 
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l-  327 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL-  327 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-
Confidence            999999999865221   111222347899999999976653    346799999999999999999999964322111 


Q ss_pred             cHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          957 DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ...+..        +| +..+..+++...+.++|.+|+++||+.|.+..+|..
T Consensus       328 -----~~KIvn--------~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  328 -----FDKIVN--------DP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             -----HHHHhc--------Cc-ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence                 111111        11 111112234457899999999999999999998854

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-37  Score=316.01  Aligned_cols=264  Identities=27%  Similarity=0.296  Sum_probs=204.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  816 (1020)
                      ++|+.+..|++|+||.||+|+.+ +++.||+|+++-+..  .-.-...+|+.++.+.+|||||.+.++...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45788899999999999999864 688999999976532  112346789999999999999999998875  3678999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      ||||+. ||...+...   ++++...++.-++.|+++|++|||.+   .|+||||||+|+|+...|.+||+|||+||.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999987 788888765   35788999999999999999999999   99999999999999999999999999999998


Q ss_pred             CCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ++.  ...+..+-|..|+|||.+.+ ..|+.++|+||+|||+.||+++++-|.+...-+..+.+-.....+.+..++...
T Consensus       229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            763  33455678999999997655 579999999999999999999999997654332222222222222222222211


Q ss_pred             Ccccc-----CccC--------HH--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIY-----DKQH--------DK--EMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~-----~~~~--------~~--~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....     ..++        ..  -...-++++..++.+||.+|.|++|.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            11100     0000        01  1245678999999999999999999886

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=339.13  Aligned_cols=263  Identities=27%  Similarity=0.389  Sum_probs=219.0

Q ss_pred             HHHHHhccCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          735 DDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      +++.-...+..+..+||.|-||.||.|.|+. .-.||||.++.+... .++|..|+.+|+.++|||+|+++|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4444455677888999999999999999874 456999999987654 56899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      |||+|||..|+|.+|+++.  ....++....+.++.||+.||+||..+   .+|||||.++|+|+.++..+|++|||+++
T Consensus       339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999986  345677788899999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .+..+.. .......-...|.|||-+....++.|+|||+|||++||+.| |-.||.+.......++.+...++.+++   
T Consensus       414 lMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe---  489 (1157)
T KOG4278|consen  414 LMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE---  489 (1157)
T ss_pred             hhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC---
Confidence            8754321 11122223568999999999999999999999999999999 888997655444444444433333332   


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                                   .++..+++||+.||++.|.+||+++|+-+.||.|+
T Consensus       490 -------------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  490 -------------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -------------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                         33457999999999999999999999999998763

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-37  Score=349.74  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=206.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45789999999999999999963      245689999987543 23345688999999999 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCC----------------------------------------------------------
Q 035998          813 RLLIYSFMENGSLDYWLHEKLD----------------------------------------------------------  834 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  834 (1020)
                      .++||||+++|+|.+++++...                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999865321                                                          


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          835 -------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       835 -------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                                   ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         112578899999999999999999999   9999999999999999999999999999876433222


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||+..+..++.++|||||||++|||++ |..||.......  .....   ...... ..  .+   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~---~~~~~~-~~--~~---  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM---IKEGYR-ML--SP---  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH---HHhCcc-CC--CC---
Confidence            22223345678999999999999999999999999999998 889986543211  11111   111100 00  01   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                          .....++.+++.+||+.||++||+++|+++.|++.+
T Consensus       340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                011236889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-37  Score=339.47  Aligned_cols=245  Identities=27%  Similarity=0.367  Sum_probs=206.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      -|+.++-||.|+-|.|..|++ .+|+.+|||++.+..   ......+.+|+.+|+-+.|||++++|+++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            367788999999999999985 579999999998763   2223468899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|-|.+|+.++    +++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|....  
T Consensus        93 yv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--  163 (786)
T ss_pred             ecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence            99999999999876    6789999999999999999999999   99999999999999999999999999997542  


Q ss_pred             CCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                       ....-...+|++.|.|||++.+.+| +.++||||.|||+|.|+||+.||++   +....+...+.+...  .++.    
T Consensus       164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f--~MPs----  233 (786)
T KOG0588|consen  164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVF--EMPS----  233 (786)
T ss_pred             -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcc--cCCC----
Confidence             2344456799999999999999877 5799999999999999999999983   223333333322211  1111    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                              ....+.++|+.+|+..||++|.|++||++
T Consensus       234 --------~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  234 --------NISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --------cCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                    12236789999999999999999999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=323.69  Aligned_cols=264  Identities=26%  Similarity=0.340  Sum_probs=202.5

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCC--chhhHHHHHHHHHHHHHcCCCccceEeeEEec-----c
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQHPNLVHLQGYCMH-----K  810 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  810 (1020)
                      +....|...+.||+|+||.|+.|..+ +|+.||||++...  .....+...+|++.++.++|+||+.+++++.-     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456777899999999999999854 7899999998733  23345677899999999999999999998865     3


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ...|+|+|+|+ .||...++..    ..++.+++..++.|+++||.|+|+.   +|+|||+||+|++++.+..+||+|||
T Consensus        99 ~DvYiV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   99 NDVYLVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             ceeEEehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            57899999994 4777777654    4589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHH---------
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS---------  960 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~---------  960 (1020)
                      +|+...........+.++.|..|+|||++ ....|+.++||||+|||++||++|++-|.+...-.....+.         
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            99987543234455678889999999965 56789999999999999999999999997533211111110         


Q ss_pred             ---HHH------HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          961 ---WVI------RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       961 ---~~~------~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ...      .+......    .+..+....+......++++.+|+..||.+|+|++|+++
T Consensus       251 ~l~~i~s~~ar~yi~slp~~----p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQI----PKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCC----CCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               000      00000000    011111111222335789999999999999999999986

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-38  Score=303.88  Aligned_cols=247  Identities=28%  Similarity=0.396  Sum_probs=206.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .+.++++.+|+++-+.++||||.++|++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            46899999999999999999865 57789999987653   345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||..+|.+...+.+..  ...+++.....+..|+|.|+.|+|..   +||||||||+|+|++.++..|++|||-+.... 
T Consensus       102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999988542  24578888999999999999999999   99999999999999999999999999987532 


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                         .......+||..|.|||...+..++..+|+|++|++.||++.|.+||......+...      ++..    .+..+|
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------rI~k----~~~~~p  242 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------RIRK----VDLKFP  242 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------HHHH----ccccCC
Confidence               334456789999999999999999999999999999999999999997543221111      1111    111122


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             ........++|.+|+..+|.+|.+..|+++
T Consensus       243 -------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 -------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence                   122346789999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-36  Score=333.53  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             CCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      |+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|++++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999986 478999999986543   12234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|..++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-  155 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-
Confidence            9999998887653  223588999999999999999999999   9999999999999999999999999999865321 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......|+..|+|||++.+..++.++||||+||++|||++|+.||...........+.  .... ... ..      
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~~~-~~~-~~------  223 (285)
T cd05631         156 --ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVK-EDQ-EE------  223 (285)
T ss_pred             --CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HHhh-ccc-cc------
Confidence              12234578999999999999999999999999999999999999997543322111111  1111 000 00      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                         ........+.+++.+||+.||.+||+     ++++++
T Consensus       224 ---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 ---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               11112235789999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.7e-37  Score=331.43  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=204.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++.... ...+.+.+|++.+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888999999999999999753    356899999886542 3345788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...   ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999998754   24688999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ... ........++..|+|||...+..++.++||||+||++||+++ |+.||......   +..   .........   .
T Consensus       159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~---~~~~~~~~~---~  228 (266)
T cd05064         159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVI---KAVEDGFRL---P  228 (266)
T ss_pred             ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH---HHHHCCCCC---C
Confidence            211 111112344678999999999999999999999999999875 99999754321   111   111111100   0


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                             .+......+.+++.+||+.+|.+||+++++.+.|++++
T Consensus       229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence                   11123346889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=337.95  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=211.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-eEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-RLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  817 (1020)
                      ++|..++++|+|+||.++.++++ +++.||+|++....  ....+..++|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999865 67789999987554  2334578899999999999999999999999988 89999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      +|++||++.+.+.+..  +..++++.+..|+.|++.|+.|||++   +|+|||||+.||+++.++.||++|||+|+....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998763  56789999999999999999999988   999999999999999999999999999998865


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      +.  ......+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+..   .++.......        .  
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~~~--------~--  223 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINRGL--------Y--  223 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhhcc--------C--
Confidence            43  3456689999999999999999999999999999999999999999754322   2222111111        1  


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                         .+.+.....++..++..|++.+|+.||++.+++..
T Consensus       224 ---~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 ---SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               11222334578899999999999999999999873

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-36  Score=334.94  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=198.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999865 68899999987543 22334677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ +|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 888887653   23578899999999999999999999   99999999999999999999999999997653221


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc---
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL---  975 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  975 (1020)
                        .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+................   
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              12233567899999998765 568999999999999999999999997543222111111100000000001100   


Q ss_pred             ------CccccC----ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 ------DPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 ------d~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .+....    ...+....+..+++.+|+++||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                  000000    000111235789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-36  Score=333.63  Aligned_cols=259  Identities=29%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888999999999999999742      345689999877655556779999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          816 IYSFMENGSLDYWLHEKL---------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      ||||+++++|.+++....         .....+++..+..++.|++.||+|||++   +++||||||+||++++++.+|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999987542         1223589999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   ..   ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~---~~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---ECI  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHH
Confidence            99999986543222222233445778999999999999999999999999999998 999986443211   11   111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ... .....  +   .    .....+.+++.+||+.||.+|||++++.+.|+++
T Consensus       236 ~~~-~~~~~--~---~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         236 TQG-RVLQR--P---R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             HcC-CcCCC--C---C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            111 10000  0   0    1123589999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-36  Score=332.88  Aligned_cols=259  Identities=31%  Similarity=0.500  Sum_probs=207.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357889999999999999998542      2579999987543 334467899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          815 LIYSFMENGSLDYWLHEKLDG------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      ++|||+++++|.+++......            ...+++.++..++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999764211            14578899999999999999999999   999999999999999999


Q ss_pred             CeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 035998          883 GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  961 (1020)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   +... 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999986544332233344566788999999988899999999999999999998 99999754322   1111 


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .+.. .....         .+.....++.+++.+||+.||.+||+++|+++.|+.+
T Consensus       238 --~i~~-~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         238 --MIRS-RQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --HHHc-CCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence              1111 11111         1112335688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-36  Score=333.44  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC------CCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|.+.+.||+|+||.||+|+..+      ++.||||.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457888999999999999998643      478999999765443 4578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          815 LIYSFMENGSLDYWLHEKL----------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      +||||+++++|.+++....          .....+++..+..++.|++.|++|||++   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997642          2234578999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      |++|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||......   ....   
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~---  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIE---  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---
Confidence            9999999976533222222233456788999999999999999999999999999999 99998644321   1111   


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ... .......         +......+.+++.+||+.||++||++.|+++.|++
T Consensus       236 ~~~-~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 CIT-QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHH-cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            111 1111110         01122468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-36  Score=337.28  Aligned_cols=199  Identities=27%  Similarity=0.465  Sum_probs=175.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999875 68889999987653 3344678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...    ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999998764    35789999999999999999999852  6999999999999999999999999998765322


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDM  949 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~  949 (1020)
                          ......|++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                22345789999999999999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=333.20  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC---CC--EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD---GR--NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      .+..+..++||+|-||.||+|.+.+   |.  .||||.-+.++ ....+.|.+|+.+|+.++|||||+++|+|.+. ..|
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3445667889999999999998643   33  58999988765 44567899999999999999999999999755 689


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +|||.++-|-|.+|++..   +..++......++.||..||+|||+.   ++|||||..+|||+.....+|++|||+++.
T Consensus       467 ivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             EEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            999999999999999875   45788899999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      +.+..... .+...-+..|||||.+.-++++.++|||.|||.|||++. |..||.+....+....++...          
T Consensus       541 ~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe----------  609 (974)
T KOG4257|consen  541 LEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE----------  609 (974)
T ss_pred             ccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC----------
Confidence            86543332 223344678999999999999999999999999999998 999998765544332221111          


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                            .-+.++.++..++.++.+||.+||.+||.+.++...|+++
T Consensus       610 ------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  610 ------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                  1123445566899999999999999999999999998876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=318.93  Aligned_cols=263  Identities=27%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHH--cCCCccceEeeEEeccC----ceEEEE
Q 035998          744 FDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR--AQHPNLVHLQGYCMHKN----DRLLIY  817 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~  817 (1020)
                      .+..++||+|.||.||+|.+. ++.||||+|...   ..+.|.+|.++++.  ++|+||++++++-...+    .+++|+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            345678999999999999985 599999999743   35678888888875  48999999999866554    789999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC------EPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ||.+.|+|.+|++..     .++|....+|+..+++||+|||+..      +++|+|||||.+|||+..|++..|+|||+
T Consensus       288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999976     6899999999999999999999754      46899999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCC-----------
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASV------ATYKGDVYSFGVVLLELLTGKRPMDMCKPKG-----------  954 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~-----------  954 (1020)
                      |..+............+||.+|||||++.+..      .-.+.||||+|.|+|||++...-++.....+           
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99886443334444589999999999887642      1247999999999999999755442111100           


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....-+...-..+.+.-+.+.+.+...    ..+.-+.+.+..||..||+.|.|+.=+-+++.++
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            001111111112222223333333222    3445688999999999999999998888877664

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-37  Score=322.99  Aligned_cols=259  Identities=26%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-----eEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-----RLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv  816 (1020)
                      .|+..+++|.|+||.||+|... +++.||||+.-.+..    .-.+|+++|++++|||||++.-+|.....     ..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            3566789999999999999864 578999999876533    33579999999999999999988864322     2489


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLI  895 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~  895 (1020)
                      ||||+. +|..+++.....+..++...+.-+..||++||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 89999887666667888889999999999999999998   99999999999999976 89999999999987


Q ss_pred             cCCCCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh--ccc-
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE--NRE-  971 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~-  971 (1020)
                      ...   ....++..|..|+|||.+. ...|+.+.||||.|||+.||+-|++-|.+....+  .+.........+  ..+ 
T Consensus       177 ~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  177 VKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             ccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence            543   2234567788999999765 4689999999999999999999999997633221  222222211110  000 


Q ss_pred             ------ccccCccccC----c-cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 ------SEVLDPFIYD----K-QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ------~~~~d~~~~~----~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .+...|.+..    . .......+..+++.++++++|.+|.++.|+++
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  0111111111    1 22333456889999999999999999999986

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-36  Score=355.73  Aligned_cols=253  Identities=24%  Similarity=0.279  Sum_probs=205.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-C-CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-D-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999754 3 6788888876555454566788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++.........+++.++..++.||+.||+|+|+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998876544556789999999999999999999999   999999999999999999999999999987643322


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ............     .+   
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~-----~~---  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKY-----DP---  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----CC---
Confidence            2233456799999999999999999999999999999999999999964321      111111111110     00   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .+......+.+++.+||+.||++||+++++++
T Consensus       291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              00112235889999999999999999999875

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=332.31  Aligned_cols=244  Identities=23%  Similarity=0.299  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999865 68999999986432   123456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999998764    4688999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     .....|++.|+|||++.+..++.++||||+||++|||++|+.||......   ...   ..+.....  ..   
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~---~~i~~~~~--~~---  217 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIY---EKILAGKL--EF---  217 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCc--CC---
Confidence            1     12346899999999999999999999999999999999999999753221   111   11111100  00   


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                            +......+.+++.+|++.||.+||+     ++|+++
T Consensus       218 ------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         218 ------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                  0011235789999999999999995     888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-37  Score=332.30  Aligned_cols=250  Identities=35%  Similarity=0.548  Sum_probs=195.0

Q ss_pred             cCCeeeccCCeEEEEEEeC-----CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          746 QANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999876     356799999965433 3467899999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.+++...  ....+++..+..|+.||++||+|||+.   +++||||+++||+++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999875  335689999999999999999999999   99999999999999999999999999998763322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .............|+|||.+....++.++||||||+++|||++ |+.||.....      ............. ..    
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~~~~~~~-~~----  226 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKLKQGQRL-PI----  226 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHHHTTEET-TS----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccc-ee----
Confidence            2233334556789999999988889999999999999999999 7888864321      1122222222111 10    


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1016 (1020)
                           +......+.+++.+||+.||++||+++++++.|
T Consensus       227 -----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 -----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 111224588999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-36  Score=317.08  Aligned_cols=265  Identities=26%  Similarity=0.349  Sum_probs=204.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCc-cceEeeEEeccC------
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPN-LVHLQGYCMHKN------  811 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  811 (1020)
                      ..|+..++||+|+||+||+|+. .+|+.||+|++..+..  .......+|+.++++++|+| ||.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3466678899999999999985 4789999999876543  24456789999999999999 999999998877      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++|+||++. +|..|+.........++...+..++.|++.|++|||++   +|+||||||.||+++.+|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78899999965 89999887643224567788999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH---Hh
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM---RQ  967 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~---~~  967 (1020)
                      |+...-+..  ..+..++|..|+|||++.+. .|+...||||+|||++||++++.-|.+..+   .++.....+.   +.
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence            997653332  24567889999999988776 899999999999999999999999976544   2222222222   11


Q ss_pred             hccccccc-Ccccc----Ccc-----C---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          968 ENRESEVL-DPFIY----DKQ-----H---DKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       968 ~~~~~~~~-d~~~~----~~~-----~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                      +..++... -|...    ...     .   +.......+++.+|++++|.+|.|++.+++.
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            12222211 01110    000     0   1111367899999999999999999999874

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.5e-36  Score=326.38  Aligned_cols=252  Identities=28%  Similarity=0.479  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999999888899999886543 234678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.++....... 
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            999999887532   3578999999999999999999999   999999999999999999999999999986533221 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||......   ..   .........   ...+.. 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~---~~~i~~~~~---~~~~~~-  225 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EV---VEMISRGFR---LYRPKL-  225 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHHHHCCCC---CCCCCC-
Confidence            11222345668999999988899999999999999999999 89999643221   11   111111111   011111 


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                            ....+.+++.+||+.+|.+||+++++++.|.
T Consensus       226 ------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 ------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  1235889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-36  Score=326.29  Aligned_cols=257  Identities=30%  Similarity=0.459  Sum_probs=207.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|.++    +...||||.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56889999999999999999874    24579999987554 33446788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998764   23689999999999999999999998   99999999999999999999999999998775


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ............++..|+|||...+..++.++||||||+++|||++ |..||......   ...   .........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~~----  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVI---KAVEDGYRL----  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHH---HHHHcCCCC----
Confidence            2222222223345678999999998899999999999999999998 99998643221   111   111111000    


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                       +.     .......+.+++.+||+.+|++||+++++++.|++++
T Consensus       228 -~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         228 -PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             -CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence             00     1112346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-36  Score=328.96  Aligned_cols=257  Identities=30%  Similarity=0.437  Sum_probs=210.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +..+|++.+.||+|+||.||+|...+++.+|+|.+.........++.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568899999999999999999888999999999876654566789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.+.......
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999997642  34689999999999999999999998   99999999999999999999999999998764322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                        .......++..|+|||......++.++||||||+++|+|++ |+.||......+   ....   .......       
T Consensus       159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~---~~~~~~~-------  223 (261)
T cd05148         159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQ---ITAGYRM-------  223 (261)
T ss_pred             --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH---HHhCCcC-------
Confidence              11223345678999999988899999999999999999998 899996543211   1111   1111100       


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         ..+......+.+++.+||+.||.+|||++++++.|+.+
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               00112234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-36  Score=332.08  Aligned_cols=259  Identities=28%  Similarity=0.447  Sum_probs=209.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999742      355699999887665556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          816 IYSFMENGSLDYWLHEKL------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      ||||+++++|.+++....            .....+++..++.++.|++.|++|||++   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999997532            1223589999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  962 (1020)
                      ++++|||+++...............++..|+|||+..+..++.++||||||+++|||+| |+.||......   ..+.  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence            99999999986644332222334556788999999999999999999999999999999 99998654321   1111  


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       ... .......         .......+.+++.+||+.+|.+||++++++++|+++
T Consensus       237 -~~~-~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 -CIT-QGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             -HHh-CCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             111 1111110         111234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=347.16  Aligned_cols=257  Identities=23%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCC-CEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEee-EEec------cC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDG-RNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQG-YCMH------KN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~  811 (1020)
                      ..++++.+.|.+|+|+.||.|+...+ ..||+|++........+.+++|+++|++|+ |||||.+++ ....      ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45677889999999999999997655 999999987776777788999999999996 999999999 3322      13


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      +.++.||||+||.|-+++..+...+  +++.++++|+.|+++|+++||.. .++|||||||-+|||++.+++.||||||.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            4679999999999999998876543  99999999999999999999987 77899999999999999999999999999


Q ss_pred             cccccCCCCccc-------ccccccccCccCccc---cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 035998          892 ARLILSPYDTHV-------TTDLVGTLGYIPPEY---GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       892 ~~~~~~~~~~~~-------~~~~~gt~~y~aPE~---~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  961 (1020)
                      +...........       .-....|+-|+|||.   ..+..+++|+|||+|||++|-|+....||+......       
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------  265 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------  265 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence            976543321111       012467899999995   467899999999999999999999999997542211       


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                                  +++-.+.-+..+.+...+.+||+.||+.||.+||++.+|+..+.+|
T Consensus       266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                        1111122222345667899999999999999999999999988765

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.3e-36  Score=326.47  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=207.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            356899999999999999999988888999999875432 3467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++.......
T Consensus        84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            999999998764  234678899999999999999999998   999999999999999999999999999987643211


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       .......++..|+|||+..+..++.++||||||+++|+|++ |+.||......   .....   .......     +. 
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~---~~~~~~~-----~~-  225 (261)
T cd05072         159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA---LQRGYRM-----PR-  225 (261)
T ss_pred             -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH---HHcCCCC-----CC-
Confidence             11223345678999999988889999999999999999998 99999643221   11111   1111110     00 


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          .......+.+++.+|++.+|++||+++++.+.|+++
T Consensus       226 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         226 ----MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                011223588999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.9e-36  Score=342.84  Aligned_cols=263  Identities=25%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcC-CCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  811 (1020)
                      ..++|.+.++||+|+||.||+|...      .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3568899999999999999999752      234699999975433 33457889999999996 999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC---------------------------------------------------------
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD---------------------------------------------------------  834 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  834 (1020)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998865311                                                         


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          835 -----------------------------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       835 -----------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                                                         ....+++..+..++.|+++|++|||+.   +|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                               113478889999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  958 (1020)
                      .++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......  ..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence            999999999999987643322222233456788999999988899999999999999999997 999986532211  11


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .   .........          .........+.+++.+||+.||++||++.++.++|++++
T Consensus       350 ~---~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 Y---NKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H---HHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1   111111100          011122346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=307.18  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=201.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +++|++.+.||+|.|+.||++.. ++|+.+|+|++....  ....+++.+|+.+.+.++|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35688889999999999999864 578999998875432  235678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~  894 (1020)
                      |+|+|++|..-+-.+    ...++..+-+.++||++||.|+|.+   +|||||+||+|+++.   ...-+|++|||+|..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999986555433    3567888999999999999999999   999999999999994   344589999999998


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      +.   ........+|||+|||||+....+|+..+|||+.|||+|-++.|.+||.+...      .....++.....   -
T Consensus       163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~~g~y---d  230 (355)
T KOG0033|consen  163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIKAGAY---D  230 (355)
T ss_pred             eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHhcccc---C
Confidence            85   34556678999999999999999999999999999999999999999974221      111122211111   0


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +++.    +-+...+...+++++|+..||.+|.|+.|++.
T Consensus       231 ~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1111    11223346789999999999999999999885

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.9e-36  Score=330.82  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999875 57889999987543  2234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++++.+..+...    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999877655432    24688999999999999999999999   9999999999999999999999999999876332


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH---------HHHHhhc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV---------IRMRQEN  969 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~---------~~~~~~~  969 (1020)
                      . ........|++.|+|||++.+..++.++||||+||++|||++|+.||......+....+...         .......
T Consensus       154 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 S-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             c-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            1 11223456899999999998888999999999999999999999999754321111111000         0000000


Q ss_pred             ccccccCccccCcc------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQ------HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .......+......      .......+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000001000000      1112346899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=340.74  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=203.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999875 588999999975421   23456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999998754    4678999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                           ......|++.|+|||++.+..++.++||||+||++|||++|..||......+   ..................++
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHHHhccccccCCCCCcc
Confidence                 2334578999999999999999999999999999999999999997543221   11111111100000111111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .      ......+.+++.+|++.+|.+||+++++++
T Consensus       226 ~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         226 R------FNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             c------cccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            0      112346789999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-36  Score=324.27  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=206.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            457889999999999999999987788999999875432 3567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999987642  34689999999999999999999999   999999999999999999999999999987643211


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       ........+..|+|||+..+..++.++||||||+++|||++ |+.||......   ...   .........     +  
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~-----~--  224 (261)
T cd05068         159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVL---QQVDQGYRM-----P--  224 (261)
T ss_pred             -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCCC-----C--
Confidence             11111223457999999999999999999999999999999 99999643221   111   111111100     0  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         ........+.+++.+|++.+|.+||+++++++.|+++
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               0111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-36  Score=313.53  Aligned_cols=252  Identities=23%  Similarity=0.283  Sum_probs=205.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .|+.++.||+|.-|+||+++.++ +..+|+|++.+..-.   .......|.++++.++||.++.+|+.|+.++..++|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            46778899999999999999764 589999999876532   23456779999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC-
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS-  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-  897 (1020)
                      ||+||+|....+++  ....++++.++.++..|+.||+|||-.   |||+|||||+|||+.++|++.++||.++..... 
T Consensus       158 yCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999888765  456799999999999999999999999   999999999999999999999999999754310 


Q ss_pred             --------------------------------CCC---------------------cccccccccccCccCccccCCCCC
Q 035998          898 --------------------------------PYD---------------------THVTTDLVGTLGYIPPEYGQASVA  924 (1020)
Q Consensus       898 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  924 (1020)
                                                      ...                     .......+||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     011224688999999999999999


Q ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCC
Q 035998          925 TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPK 1004 (1020)
Q Consensus       925 ~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1004 (1020)
                      +.++|+|+|||++|||+.|..||-+.+..++...+     ..++...          ...+.....+.+||++.+.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-----v~~~l~F----------p~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-----VGQPLKF----------PEEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-----hcCCCcC----------CCCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999876655443222     1111111          11113345689999999999999


Q ss_pred             CCCC----HHHHHH
Q 035998         1005 VRPT----TQQLVS 1014 (1020)
Q Consensus      1005 ~RPs----~~evl~ 1014 (1020)
                      +|..    ++||.+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9998    888765

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-36  Score=329.00  Aligned_cols=260  Identities=23%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      .+++|++.+.||+|+||.||+|...      ++..||||++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999753      35679999986543 2234568899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDG------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      .++||||+++++|.+++......      ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998754221      23467888999999999999999998   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||......   ....   ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~---~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR---FV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HH
Confidence            99999876543222222223345778999999998899999999999999999999 78888643221   1111   11


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                       ........         +......+.+++.+||+.+|++||++.|+++.|++
T Consensus       235 -~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 -MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -HcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             11111110         11122468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-36  Score=336.27  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=199.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46889999999999999999875 68899999987542   122356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999988764    4678899999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     .....|++.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+... .. .  -|
T Consensus       171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~-~~-~--~p  235 (329)
T PTZ00263        171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAG-RL-K--FP  235 (329)
T ss_pred             C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcC-Cc-C--CC
Confidence            1     1235689999999999999999999999999999999999999964321      1111111111 10 0  01


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                      .   .    ....+.+++.+||+.||.+||+     ++++++
T Consensus       236 ~---~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 N---W----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             C---C----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0   0    1135789999999999999997     677764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.6e-36  Score=334.12  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=201.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|++.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 333    48999987543 34456788999999999999999999998764 5679


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      |+||+++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998764   24578899999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||...+..++.++||||||+++|||++ |+.||......   ...   .........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~---  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS---SILEKGERL---  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHHhCCCCC---
Confidence            43322222222334678999999999999999999999999999998 99999643211   111   111111110   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+       +.+...+.+++.+||+.+|++||++.+++..|.++
T Consensus       231 ~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         231 PQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            011       11223578999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-36  Score=335.86  Aligned_cols=263  Identities=28%  Similarity=0.439  Sum_probs=205.0

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEecc-
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHK-  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  810 (1020)
                      +.++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+++++++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457999999999999999999632      357899999875432 2235678899999999 899999999988754 


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCC-------------------------------------------------------
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDG-------------------------------------------------------  835 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  835 (1020)
                      ...+++|||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5678999999999999998643210                                                       


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCc
Q 035998          836 --PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY  913 (1020)
Q Consensus       836 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  913 (1020)
                        ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              13689999999999999999999999   9999999999999999999999999999876433222223334567789


Q ss_pred             cCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHH
Q 035998          914 IPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL  992 (1020)
Q Consensus       914 ~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  992 (1020)
                      +|||++.+..++.++||||+||++|||++ |..||......+  ....   ... ......  .+       ......+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~---~~~-~~~~~~--~~-------~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR---RLK-EGTRMR--AP-------EYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH---HHh-ccCCCC--CC-------ccCCHHHH
Confidence            99999999999999999999999999998 999996533221  1111   111 110000  01       11224688


Q ss_pred             HHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          993 DIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       993 ~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      +++.+||+.+|++||++.|+++.|++++
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-35  Score=328.27  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999875 688999999875432 223457789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++ +++.+++...   ...++...+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 5777776643   24578899999999999999999999   9999999999999999999999999998754322


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc---cc--
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR---ES--  972 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~--  972 (1020)
                      .  .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||....+  ..+.............   ..  
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccch
Confidence            1  22234567899999998765 5688999999999999999999999975432  1112221111110000   00  


Q ss_pred             ---cccCccccCccCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 ---EVLDPFIYDKQHD----------KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ---~~~d~~~~~~~~~----------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ...++.......+          .....+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               0000000000000          01135779999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8e-36  Score=333.49  Aligned_cols=241  Identities=21%  Similarity=0.302  Sum_probs=194.9

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+|+.+ +|+.||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999987542   122345778999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      +|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~  151 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT  151 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence            999888754    4689999999999999999999999   9999999999999999999999999998754221  122


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.... . .     +    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~-~-~-----~----  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE-I-R-----F----  214 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC-C-C-----C----
Confidence            3345789999999999999999999999999999999999999964321      11111111110 0 0     0    


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      +......+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            111223578999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.2e-36  Score=331.67  Aligned_cols=262  Identities=27%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ..++|++.+.||+|+||.||+|...      ....||+|.+.... ......+.+|+++++++ +|+||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3457889999999999999999864      23679999987543 23345688999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKL------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      ..+++|||+++|+|..++....            .....+++..++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            9999999999999999987532            2345689999999999999999999998   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  958 (1020)
                      +++.+|++|||.++...............++..|+|||+..+..++.++|||||||++|||++ |..||......+   .
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---H
Confidence            999999999999987644322222223345678999999988999999999999999999998 999986432211   1


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .   ........ ..         .+......+.+++.+||+.+|.+|||++|+++.|++++
T Consensus       244 ~---~~~~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 F---KLLKEGYR-ME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H---HHHHcCCc-CC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1   11111110 00         01112346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2e-35  Score=331.50  Aligned_cols=200  Identities=25%  Similarity=0.457  Sum_probs=174.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367999999999999999999875 68889999887543 2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...    ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999998753    35788999999999999999999741  7999999999999999999999999998765322


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                          ......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                123356889999999999989999999999999999999999999743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-36  Score=351.42  Aligned_cols=256  Identities=26%  Similarity=0.340  Sum_probs=205.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  811 (1020)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++....  ......+.+|+..+..++|+|+++..+.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346899999999999999999985 478999999986542  233456788999999999999999988775432     


Q ss_pred             ---ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          812 ---DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       812 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               25799999999999999987655556789999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ..........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLAG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC
Confidence            9999876443222333456799999999999999999999999999999999999999964321      1111111111


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..    ++     .+......+.+++.+||+.||.+||++.++++
T Consensus       261 -~~----~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        261 -RY----DP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             -CC----CC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence             10    01     11112346889999999999999999999986

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-35  Score=322.58  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|..+ .++.||+|.+..+.. ...++.+|++++++++||||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999865 588999999876532 3457889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++....  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|++|||.++.......
T Consensus        85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999987542  34678999999999999999999998   999999999999999999999999999987643211


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       .......++..|+|||...+..++.++||||||+++|||++ |..||.....   .+.   ......... ..      
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~---~~~~~~~~~-~~------  225 (263)
T cd05052         160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV---YELLEKGYR-ME------  225 (263)
T ss_pred             -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH---HHHHHCCCC-CC------
Confidence             11112234568999999999999999999999999999998 9999864321   111   111111100 00      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                         .+......+.+++.+||+.+|++||++.++++.|++++
T Consensus       226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence               01112246889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-35  Score=318.73  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=208.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999864 78999999875422   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++.........++++.+..++.|++.||+|||++   +++||||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998876544445688999999999999999999999   999999999999999999999999999887533


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..  .......+++.|+|||...+..++.++|+||+|+++|||++|+.||.....    ..............      +
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~------~  226 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDY------P  226 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCC------C
Confidence            21  122235678899999999888899999999999999999999999854221    11111122111111      0


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..   ........+.+++.+||+.+|++||++.++++.|+++
T Consensus       227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            00   0112234688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-35  Score=322.99  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=199.4

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCC-C--EEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------Cc
Q 035998          744 FDQANIIGCGGFGLVYRATLPDG-R--NVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------ND  812 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~-~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  812 (1020)
                      |.+.+.||+|+||.||+|...+. +  .||+|.++...  ....+.+.+|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34678899999999999987543 2  58999887542  33346788899999999999999999987532      24


Q ss_pred             eEEEEEeccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          813 RLLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      .+++|||+++|+|..++....  .....+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998875322  2234589999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      +++...............+++.|+|||...+..++.++||||||+++|||++ |+.||......   ..   ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~---~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EI---YDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHHHHcCC
Confidence            9987643222111223345678999999999999999999999999999999 88998643221   11   11111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .. .  .       .+.....+.+++.+||+.||++|||+.++++.|++++
T Consensus       232 ~~-~--~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         232 RL-K--Q-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             CC-C--C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            10 0  0       1112235789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.8e-36  Score=322.36  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=203.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||.||+|++.++..||+|.+.... ....++.+|++++++++||||+++++++.+.+..++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999998777789999987543 234678999999999999999999999998888999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...   ...+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+|++|||.++....+.. 
T Consensus        83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            99999998754   23689999999999999999999999   999999999999999999999999999886543221 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||||+++|||++ |..||.......   ...   ........ .  .+.  
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~~~~~-~--~~~--  224 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KVSQGLRL-Y--RPH--  224 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HHhcCCCC-C--CCC--
Confidence            11122345678999999988889999999999999999999 999986443211   111   11111110 0  000  


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                           .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 11246889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.5e-36  Score=334.54  Aligned_cols=244  Identities=25%  Similarity=0.285  Sum_probs=197.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC--CCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD--GRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|..+.  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468899999999999999998543  3689999986432   22335678899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999998764    4688999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..     .....||+.|+|||++.+..++.++||||+||++|||++|+.||....+.      .....+.... . .  -
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~-~-~--~  247 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGI-I-Y--F  247 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCC-C-C--C
Confidence            21     23457899999999999988999999999999999999999999743221      1111111110 0 0  0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      |       ......+.+++.+|++.||++|+     +++++++
T Consensus       248 p-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        248 P-------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             C-------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            1       01113477999999999999995     8888876

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.5e-39  Score=345.31  Aligned_cols=371  Identities=27%  Similarity=0.409  Sum_probs=299.5

Q ss_pred             ceEEEecCCCccc-ccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeec
Q 035998           86 RVTGLFLYKRRLK-GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDIS  164 (1020)
Q Consensus        86 ~v~~l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls  164 (1020)
                      -|.++|+++|.++ +..|.+...++.++.|.|...++. .+|+.++.|.+|++|.+++|++..                 
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-----------------   69 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-----------------   69 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-----------------
Confidence            4556666666666 345666666666666666666665 566666666666666666555542                 


Q ss_pred             cCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccc-cccchhhhhhcccccccccccccCC
Q 035998          165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT-GGIADDIFQLQKLRLLGLQDNQLSG  243 (1020)
Q Consensus       165 ~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~  243 (1020)
                                                      +-..++.++.|+.+.+..|++. ..+|..++++..|++||||+|+++ 
T Consensus        70 --------------------------------vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-  116 (1255)
T KOG0444|consen   70 --------------------------------VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-  116 (1255)
T ss_pred             --------------------------------hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-
Confidence                                            2223445666666677766663 457888999999999999999998 


Q ss_pred             CCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCC
Q 035998          244 KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA  323 (1020)
Q Consensus       244 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  323 (1020)
                      ..|..+...+++-+|+||+|+|..++-..|.+++.|-+|+|++|++. .+|+.+..+..|+.|+|++|.+.......+..
T Consensus       117 EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPs  195 (1255)
T KOG0444|consen  117 EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPS  195 (1255)
T ss_pred             hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCcc
Confidence            78999999999999999999999777778889999999999999998 56777889999999999999998777777888


Q ss_pred             CCCcCEEEcCCCccC-CCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccc
Q 035998          324 LTNLTSLDLGTNKFN-GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT  402 (1020)
Q Consensus       324 l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~  402 (1020)
                      +++|++|.+++.+=+ ..+|.++..+.+|..+|||.|++. .+|+.+-++.+|+.|+||+|+|+.+...           
T Consensus       196 mtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~-----------  263 (1255)
T KOG0444|consen  196 MTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMT-----------  263 (1255)
T ss_pred             chhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeecc-----------
Confidence            999999999987643 478999999999999999999998 7899999999999999999998765432           


Q ss_pred             hhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCC
Q 035998          403 TLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN  482 (1020)
Q Consensus       403 ~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  482 (1020)
                                                               .+.+.+|++|+||.|+|+ .+|++++.++.|+.|.+.+|
T Consensus       264 -----------------------------------------~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~N  301 (1255)
T KOG0444|consen  264 -----------------------------------------EGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNN  301 (1255)
T ss_pred             -----------------------------------------HHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccC
Confidence                                                     234567889999999998 89999999999999999999


Q ss_pred             cccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEE
Q 035998          483 TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFD  562 (1020)
Q Consensus       483 ~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~  562 (1020)
                      +++      |.                                                     -+|..+|.|.+|+++.
T Consensus       302 kL~------Fe-----------------------------------------------------GiPSGIGKL~~Levf~  322 (1255)
T KOG0444|consen  302 KLT------FE-----------------------------------------------------GIPSGIGKLIQLEVFH  322 (1255)
T ss_pred             ccc------cc-----------------------------------------------------CCccchhhhhhhHHHH
Confidence            886      11                                                     2466788899999999


Q ss_pred             ecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC
Q 035998          563 LKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG  623 (1020)
Q Consensus       563 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~  623 (1020)
                      .++|.|. .+|+.++.+..|+.|.|+.|+|- ++|+.+.-|+.|+.|||.+|.=--.+|..
T Consensus       323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             hhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence            9999997 89999999999999999999998 89999999999999999999865555553

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-35  Score=326.89  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999753      235789998875543 334578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          816 IYSFMENGSLDYWLHEKLD--------------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.|++|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999865321                    123578999999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 035998          876 ILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKG  954 (1020)
Q Consensus       876 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  954 (1020)
                      |++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||....+. 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222223345678999999888899999999999999999999 99999643321 


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        .....   ...... ..         .+......+.+++.+||+.+|++||+++|+++.|++++
T Consensus       237 --~~~~~---~~~~~~-~~---------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 --RLFNL---LKTGYR-ME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             --HHHHH---HhCCCC-CC---------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence              11111   111100 00         01112246889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-35  Score=325.59  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=204.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||.||+|..     .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3578889999999999999974     246789999987543 3334678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          816 IYSFMENGSLDYWLHEKLD-------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      ||||+++++|.+++.....             ....+++.++..++.|++.||+|||++   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999864321             123578899999999999999999999   999999999999999999


Q ss_pred             CeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 035998          883 GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  961 (1020)
                      .+|++|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||....+.   .... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999987644332223334455678999999988889999999999999999999 99998643221   1111 


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                        .... .....     .    +......+.+++.+||+.||++||++.++.+.|..
T Consensus       238 --~~~~-~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --MVRK-RQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHc-CCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              1111 11000     0    01122367899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=313.91  Aligned_cols=266  Identities=29%  Similarity=0.386  Sum_probs=208.1

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc--CCCccceEeeEEecc----C
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYCMHK----N  811 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~  811 (1020)
                      +...++....+.||+|.||+||+|+|+ |+.||||+|...   .++.+.+|.++++..  +|+||..+++.-..+    .
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            444567888999999999999999996 899999999753   467788899988764  999999999876543    3


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-----cCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-----SCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      +.++|++|.+.|+|.+|+.+.     .++....++++..+|.||+|||.     +.+|.|.|||||..|||+..++...|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            678999999999999999975     68899999999999999999995     34688999999999999999999999


Q ss_pred             eeccccccccCCCCc--ccccccccccCccCccccCCCCC------CchhhHHHHHHHHHHHHcC----------CCCCC
Q 035998          887 ADFGLARLILSPYDT--HVTTDLVGTLGYIPPEYGQASVA------TYKGDVYSFGVVLLELLTG----------KRPMD  948 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~------~~~~DvwSlGvil~elltg----------~~pf~  948 (1020)
                      +|+|+|....+..+.  ......+||.+|||||++....-      -..+||||||.|+||++..          +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999887554221  23345789999999999876432      2369999999999998863          47776


Q ss_pred             CCCCCCc-ccHHHHHHHHHhhcccccccCc-cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          949 MCKPKGS-RDLISWVIRMRQENRESEVLDP-FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       949 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      +.-+.+. .+.+..+.       +.+.+.| ........+.+..+.++|+.||..+|..|.|+-.+.+.|.++
T Consensus       438 d~Vp~DPs~eeMrkVV-------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVV-------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             cCCCCCCCHHHHhcce-------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            5443322 11111111       1111112 122344567788899999999999999999999998888765

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=323.05  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=203.2

Q ss_pred             CCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-----
Q 035998          744 FDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-----  812 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  812 (1020)
                      |++.+.||+|+||.||+|....    +..||+|+++.+.  ......+.+|++.+++++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999987543  2334578899999999999999999998876554     


Q ss_pred             -eEEEEEeccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          813 -RLLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       813 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                       .+++|||+++|+|..++....  .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             689999999999999886542  2234689999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+++...............++..|+|||...+..++.++||||+|+++|||++ |..||......   ...   ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~---~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY---DYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcC
Confidence            99987644332222222345678999999988899999999999999999999 88998653321   111   111111


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .. ..         .+......+.+++.+||+.||.+||++.|+++.|++++
T Consensus       232 ~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         232 NR-LK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             CC-CC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11 00         01122346889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-35  Score=319.74  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999864 78899999876543 33456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++............
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998653   24578999999999999999999999   99999999999999999999999999987643211111111


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccC
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH  984 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  984 (1020)
                      ....+..|+|||.+.++.++.++||||+|+++|||++ |..||........   .   ........ ..         .+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~---~~~~~~~~-~~---------~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---R---EAIEQGVR-LP---------CP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---H---HHHHcCCC-CC---------Cc
Confidence            1223457999999999899999999999999999998 8888864322111   0   11111000 00         01


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          985 DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       985 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ......+.+++.+|++.+|++||+++++.+.|++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            1123468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.5e-36  Score=337.41  Aligned_cols=264  Identities=27%  Similarity=0.397  Sum_probs=194.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----CceE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----NDRL  814 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  814 (1020)
                      +|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999864 68999999987432  22335688999999999999999999988643     2479


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||++ ++|.+++...    ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 6888887653    4589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCC-cccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH---------H
Q 035998          895 ILSPYD-THVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW---------V  962 (1020)
Q Consensus       895 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~---------~  962 (1020)
                      ...... ........|++.|+|||++.+  ..++.++||||+||++|||++|+.||...........+..         .
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            532221 112234578999999998765  6789999999999999999999999965332111000000         0


Q ss_pred             HHHHhh---cccccc--cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 IRMRQE---NRESEV--LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 ~~~~~~---~~~~~~--~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......   ......  ..+.......+.....+.+++.+||+.||++||+++|+++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000000   000000  0000000000111235789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-35  Score=327.15  Aligned_cols=261  Identities=26%  Similarity=0.352  Sum_probs=194.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC--CCCEEEEEEecCCch--hhHHHHHHHHHHHHHc---CCCccceEeeEEec-----
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP--DGRNVAIKRLSGDCG--QMEREFRAEVEALSRA---QHPNLVHLQGYCMH-----  809 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  809 (1020)
                      .+|++.+.||+|+||.||+|+..  +++.||+|++.....  .....+.+|+++++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999863  467899998865431  2234566777777766   69999999999852     


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      ....++||||++ ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            345789999996 58888887542  23578999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh--
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ--  967 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  967 (1020)
                      |+++.....   .......|++.|+|||.+.+..++.++||||+||++|||++|+.||......   +..........  
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~  228 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP  228 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCC
Confidence            999765322   2233456899999999998889999999999999999999999999754332   11211111100  


Q ss_pred             -hcccc-------cccCccc---cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 -ENRES-------EVLDPFI---YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 -~~~~~-------~~~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .....       ....+..   .....+.....+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence             00000       0000000   00001112345779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-35  Score=323.35  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=199.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||.||+|.+. +++    .|++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999864 344    478888764432 233567888889999999999999998754 45788


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ++||+++|+|.+++...   ...+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+|++|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999998754   24689999999999999999999998   9999999999999999999999999999875


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||...++.++.++||||||+++|||++ |+.||.........       .........  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~--  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGERL--  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCcC--
Confidence            43222222233456778999999988899999999999999999998 99999754322111       111111111  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+..       ....+.+++.+||..||++||++.|+++.|..+
T Consensus       231 ~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11111       123578899999999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-35  Score=328.84  Aligned_cols=241  Identities=22%  Similarity=0.308  Sum_probs=193.8

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999987542   122345678999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      +|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            998888654    4688999999999999999999999   99999999999999999999999999987542221  12


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      .....|++.|+|||++.+..++.++||||+||++|||++|+.||......   ..   .........  .     +    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~---~~~~~~~~~--~-----~----  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RL---FELILMEEI--R-----F----  214 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHhcCCC--C-----C----
Confidence            23456899999999999999999999999999999999999999643221   11   111111100  0     0    


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      +......+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            011123578999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-35  Score=325.18  Aligned_cols=261  Identities=23%  Similarity=0.376  Sum_probs=207.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCC-----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEec-cCc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMH-KND  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  812 (1020)
                      ..++|++.+.||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35678999999999999999998765     6889999987553 2334668899999999999999999998776 467


Q ss_pred             eEEEEEeccCCChhhhhhhcCCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDG----PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      .++++||+++++|.+++......    +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998765332    25689999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHh
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ  967 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  967 (1020)
                      ||+++.+.............++..|+|||+..+..++.++||||+|+++||+++ |+.||....+.   +   .......
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~---~~~~~~~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---E---MAAYLKD  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---H---HHHHHHc
Confidence            999986543221111222345678999999988899999999999999999999 99999753221   1   1111111


Q ss_pred             hcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          968 ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       968 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .....   .       .......+.+++.+||+.||++||++.++++.|+++
T Consensus       235 ~~~~~---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GYRLA---Q-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CCCCC---C-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11110   0       111224688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-35  Score=334.73  Aligned_cols=246  Identities=29%  Similarity=0.498  Sum_probs=192.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4567889999999999999865 68999999986543 234467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|...        ...++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus       155 ~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        155 DGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             CCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            99987543        2345677889999999999999999   99999999999999999999999999998753221 


Q ss_pred             cccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                       .......|+..|+|||++..     ...+.++|||||||++|||++|+.||......+   +............ ..  
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-~~--  295 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQP-PE--  295 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccCC-CC--
Confidence             12234578999999998643     345579999999999999999999997332221   1111111111100 00  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             ........+.+++.+||+.||++||+++|+++
T Consensus       296 -------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        296 -------APATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -------CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   01112246889999999999999999999987

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-35  Score=324.05  Aligned_cols=267  Identities=28%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             CCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEE
Q 035998          744 FDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLL  815 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  815 (1020)
                      |+..+.||+|+||.||++.+     .+++.||+|.+..... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     3578899999876532 3456788999999999999999999988754  35789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...     .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999998753     589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcc-cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....... ......++..|+|||...+..++.++||||||+++|||++|..||...... ..+.................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhh
Confidence            4322111 112234566799999998888999999999999999999999998643221 00111000000000000000


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .+.......+......+.+++.+||+.+|++||++++++++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            000000111122335688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=319.87  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999999988778899999865432 24568889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...   ...++++.+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++...+... 
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence            99999998754   23689999999999999999999999   999999999999999999999999999986543211 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||......+   ..   .........   ..+   
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~~---~~~---  223 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ESVSAGYRL---YRP---  223 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HHHHcCCcC---CCC---
Confidence            11112223457999999998999999999999999999999 899997543221   11   111111000   001   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                          .....++.+++.+||+.+|++||++.|+++.|.
T Consensus       224 ----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         224 ----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                112346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-35  Score=328.01  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=206.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|++.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+++++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888999999999999999741        34579999987543 23346788999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      ...++||||+++|+|.+++.....            ....+++.++..++.||+.||+|||++   +++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999976421            123578899999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      ++++.+|++|||.++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....     
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence            9999999999999987643322222233445678999999988899999999999999999998 7888864321     


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                       ............. .         .+......+.+++.+||+.+|.+||++.|+++.|++++
T Consensus       246 -~~~~~~~~~~~~~-~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 -EELFKLLKEGHRM-D---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             -HHHHHHHHcCCcC-C---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence             1111111111110 0         01122346889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-35  Score=323.63  Aligned_cols=258  Identities=29%  Similarity=0.441  Sum_probs=205.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .+|...+.||+|+||.||+|...      ++..+|+|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788899999999999999642      356899999887666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          816 IYSFMENGSLDYWLHEKLD-----------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      +|||+++++|.+++.....           ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999875421           123578999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||......   +...   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE---  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH---
Confidence            9999999976543222122223345678999999998999999999999999999998 99998643321   1111   


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ....... ..  .+       ......+.+++.+||+.||.+||+++|+.+.|++
T Consensus       236 ~~~~~~~-~~--~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQGRE-LE--RP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcCcc-CC--CC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1111100 00  01       1122357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=323.42  Aligned_cols=266  Identities=25%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC---------------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD---------------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQ  804 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  804 (1020)
                      .++|++.+.||+|+||.||+++...               ...||+|.+.... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999987532               2248999987653 23345789999999999999999999


Q ss_pred             eEEeccCceEEEEEeccCCChhhhhhhcC--------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCE
Q 035998          805 GYCMHKNDRLLIYSFMENGSLDYWLHEKL--------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNI  876 (1020)
Q Consensus       805 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  876 (1020)
                      +++......++||||+++++|.+++....        .....+++..+..++.|++.|++|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            99999999999999999999999986531        1112468899999999999999999999   999999999999


Q ss_pred             EEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCCC
Q 035998          877 LLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT--GKRPMDMCKPKG  954 (1020)
Q Consensus       877 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~~  954 (1020)
                      +++.++.+|++|||+++...............++..|+|||+..++.++.++||||||+++|||++  |..||...... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            999999999999999976543222222233455778999999988899999999999999999998  66777643321 


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                        ..+...............      ....+.....+.+++.+||+.||++||++++|++.|++
T Consensus       240 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 --QVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              122211111111100000      00011122468999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-35  Score=333.79  Aligned_cols=259  Identities=22%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|++.+.||+|+||.||+|... +++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999864 688999997532      3467899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +. ++|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 6787777653    4578999999999999999999999   99999999999999999999999999997543221


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc----ccHHHHHHHHHhhcccc---
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS----RDLISWVIRMRQENRES---  972 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~---  972 (1020)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||........    ...+.............   
T Consensus       237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             1222345799999999999999999999999999999999999988753221110    01111111100000000   


Q ss_pred             ----------------cccCcccc--CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 ----------------EVLDPFIY--DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ----------------~~~d~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                      ....+...  ..........+.+++.+|++.||++|||++|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                            00000000  0001123346889999999999999999999986

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=328.71  Aligned_cols=239  Identities=26%  Similarity=0.300  Sum_probs=191.7

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 57899999986532   22335678899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~  151 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN  151 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence            9988753    4588999999999999999999999   9999999999999999999999999999754321  12233


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ........... . .     .    +.
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~-~-~-----~----~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP-L-R-----F----PD  214 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC-C-C-----C----CC
Confidence            45789999999999999999999999999999999999999974321      11111111110 0 0     0    01


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPT---TQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1014 (1020)
                      .....+.+++.+||+.||++||+   +.|++.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            12235789999999999999985   556553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=323.22  Aligned_cols=251  Identities=27%  Similarity=0.375  Sum_probs=200.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      +|++.++||+|+||.||++... +++.||+|++.....   .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999864 688999999865421   223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888653  234689999999999999999999999   9999999999999999999999999999765321


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                         .......|++.|+|||++.+..++.++||||+||++|||++|+.||.........   ........... .      
T Consensus       156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-~------  222 (285)
T cd05605         156 ---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ-E------  222 (285)
T ss_pred             ---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc-c------
Confidence               1223357899999999999889999999999999999999999999753322111   11111111100 0      


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                         ..+......+.+++.+||+.||++||     +++++++
T Consensus       223 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 ---EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence               01111234578999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=338.27  Aligned_cols=252  Identities=27%  Similarity=0.423  Sum_probs=213.1

Q ss_pred             CcCCeeeccCCeEEEEEEe-CCC----CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          745 DQANIIGCGGFGLVYRATL-PDG----RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ...++||.|+||+||+|.| ++|    -+||+|++.... .....++.+|+-+|.+++|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4468899999999999985 343    468999987654 344578999999999999999999999998776 789999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ||+.|.|.+|++..   +..+-.+..+.|..|||+||.|||++   ++|||||.++|||+..-.++||+|||+++....+
T Consensus       778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999985   35677789999999999999999999   9999999999999999999999999999987655


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..........-.+.|||=|.+....++.++|||||||++||++| |..||+.....+..+..+...+.            
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL------------  919 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL------------  919 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC------------
Confidence            44443344444678999999999999999999999999999999 99999987766655555432222            


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          .+++-+..+++.++.+||..|+..||+|+++..++.++
T Consensus       920 ----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  920 ----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                33455666899999999999999999999999998875

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.9e-35  Score=322.26  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=204.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-----------------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-----------------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH  802 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  802 (1020)
                      .++|++.+.||+|+||.||+++..                 ++..||+|++.... .....++.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999998542                 23468999987653 334567899999999999999999


Q ss_pred             EeeEEeccCceEEEEEeccCCChhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       803 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                      +++++...+..++||||+++++|.+++......       ...+++.++..++.|++.|++|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       13477889999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 035998          876 ILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT--GKRPMDMCKPK  953 (1020)
Q Consensus       876 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~  953 (1020)
                      |+++.++.++++|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986543222222223345678999998888889999999999999999998  77888643322


Q ss_pred             CcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          954 GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      +   .+.............. ..+     .+..+...+.+++.+||+.||.+||+++++++.|++
T Consensus       241 ~---~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 Q---VIENTGEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   1111111111110000 000     011122468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=324.09  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=206.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457889999999999999999864      24689999987553 23345788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKLDG------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                      ++||||+++++|.+++......      ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999999764322      23478899999999999999999998   99999999999999999999999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++...............++..|+|||...++.++.++|||||||++||+++ |..||......   ....   ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~---~~~  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLK---FVI  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHH---HHh
Confidence            9999987644332222334456789999999988889999999999999999998 99998643221   1111   111


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                       ........+         .....+.+++.+||+.+|++|||+.++++.|++
T Consensus       236 -~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -DGGHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -cCCCCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             111111111         113468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-35  Score=322.38  Aligned_cols=259  Identities=29%  Similarity=0.442  Sum_probs=203.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      +++|++.+.||+|++|.||+|.+.+      +..||+|.+.... ...+..+.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678899999999999999998753      5678999887543 33345788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC---CeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  887 (1020)
                      ++||||+++++|.+++.....   ....+++..+..++.||+.|++|||+.   +++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999876532   223589999999999999999999999   999999999999998654   59999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......   ....   ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~---~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME---FVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHH
Confidence            9999987632221111122334568999999998899999999999999999997 99999753322   1111   111


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ..... .         .+......+.+++.+|++.+|++||++.++++.|+.
T Consensus       236 ~~~~~-~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         236 GGGRL-D---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             cCCcC-C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11110 0         011122468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.1e-35  Score=328.18  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ++|.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+.+|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            56899999999999999999752        23569999997653 23345688899999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      ..++||||+++|+|.+++.....            ....+++.++..++.|++.||+|||+.   +++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            99999999999999999976422            123588999999999999999999998   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  958 (1020)
                      .++.+|++|||.++...............+++.|+|||+..+..++.++||||+||++|||++ |..||......   + 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~-  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E-  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H-
Confidence            999999999999876533211111222334568999999988899999999999999999998 88888643211   1 


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        .......... ..         .+......+.+++.+||+.+|.+||++.++++.|++++
T Consensus       251 --~~~~~~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 --LFKLLKEGHR-MD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             --HHHHHHcCCC-CC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              1111111110 00         11122346889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.5e-35  Score=322.69  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-----------------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-----------------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH  802 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  802 (1020)
                      ..+|++.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999987542                 2458999987654 234567889999999999999999


Q ss_pred             EeeEEeccCceEEEEEeccCCChhhhhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       803 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                      +++++...+..++||||+++++|.+++.+...       ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999976531       123689999999999999999999999   99999999999


Q ss_pred             EEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 035998          876 ILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT--GKRPMDMCKPK  953 (1020)
Q Consensus       876 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--g~~pf~~~~~~  953 (1020)
                      |+++.++.++++|||+++...............++..|+|||+..+..++.++||||||+++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999987544332233344556788999999888889999999999999999998  6778754322 


Q ss_pred             CcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          954 GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                        ...................      .........++.+++.+||+.||.+||+++|++++|++
T Consensus       240 --~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              1122221111110000000      00111122468999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-35  Score=325.51  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      +|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677889999999999999753      357899999976543 234568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          816 IYSFMENGSLDYWLHEKL------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      ++||+++++|..++....            .....+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123578889999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +|++|||+++...............+++.|+|||...++.++.++||||+|+++|||++ |..||......   +   ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~---~~  236 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D---VI  236 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H---HH
Confidence            99999999887643322222334456789999999988889999999999999999998 88888643221   1   11


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ........ ..         .+......+.+++.+||+.+|++||+++++++.|+.
T Consensus       237 ~~i~~~~~-~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQV-LP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCc-CC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111111 00         011223458899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-35  Score=334.80  Aligned_cols=263  Identities=25%  Similarity=0.392  Sum_probs=206.1

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcC-CCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  811 (1020)
                      ..++|.+.+.||+|+||.||+|++.      .++.||||++..... ...+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456788899999999999999853      346799999976532 22346889999999997 999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC---------------------------------------------------------
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD---------------------------------------------------------  834 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  834 (1020)
                      ..++||||+++|+|.+++++...                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999875321                                                         


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEE
Q 035998          835 -------------------------------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNIL  877 (1020)
Q Consensus       835 -------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  877 (1020)
                                                           ....+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                                 113467888899999999999999998   9999999999999


Q ss_pred             EcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcc
Q 035998          878 LDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSR  956 (1020)
Q Consensus       878 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~  956 (1020)
                      ++.++.+|++|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            99999999999999986533222122223456788999999988889999999999999999998 8999864432111 


Q ss_pred             cHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          957 DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        .  ..........   ..|       ......+.+++.+||+.+|.+||+++|+++.|++++
T Consensus       351 --~--~~~~~~~~~~---~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 --F--YNAIKRGYRM---AKP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --H--HHHHHcCCCC---CCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              1  1111111000   011       112246889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-35  Score=342.62  Aligned_cols=261  Identities=21%  Similarity=0.298  Sum_probs=193.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc--------
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--------  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  810 (1020)
                      ...+|++.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999864 68899999886542    2345799999999999999999887432        


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeec
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADF  889 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  889 (1020)
                      ...++||||+++ ++.+++.........+++..+..++.||+.||+|||+.   +|+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999975 67777765444456789999999999999999999999   999999999999999665 6999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+++.....   .......||+.|+|||++.+ ..++.++||||+||++|||++|.+||......+   ...........
T Consensus       216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence            999876332   12234578999999998765 468999999999999999999999997543221   11111111000


Q ss_pred             cc----------cccccCcc-----ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NR----------ESEVLDPF-----IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~----------~~~~~d~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..          .....-+.     .....+.....++.+++.+||++||.+|||+.|+++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00          00000000     000011112346889999999999999999999986

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-35  Score=331.98  Aligned_cols=241  Identities=21%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+++.. +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999997542   223356788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      +|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  ...
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  151 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT  151 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence            998887653    4688999999999999999999999   9999999999999999999999999998754221  122


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||......      ..........    .   .+    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~----~---~~----  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED----I---KF----  214 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC----c---cC----
Confidence            23457899999999999999999999999999999999999999643211      1111111100    0   00    


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      +......+.+++.+|++.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            011123578999999999999997     8898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3e-35  Score=330.65  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEe----CCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          743 NFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+.+|+++++++ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999975    357899999986532    12234577899999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999998754    4688999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ...... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+  .......    
T Consensus       154 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~----  226 (332)
T cd05614         154 EFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC----  226 (332)
T ss_pred             cccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcC----
Confidence            653322 1222345789999999998765 4788999999999999999999999754333222111  1111110    


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                         ++.+.    ......+.+++.+||+.||++||     +++++++
T Consensus       227 ---~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 ---DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               11111    11123578999999999999999     7778765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-35  Score=324.18  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=204.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4568999999999999999999753      245799998865432 233467889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          813 RLLIYSFMENGSLDYWLHEKLD------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      .++||||+++|+|.+++.....      .....++..+..++.|++.|++|||++   +|+||||||+||+++.++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321      124457788899999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||......   +..   ...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~---~~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVL---KFV  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHH
Confidence            99999986543222222222345678999999988899999999999999999999 78888643221   111   111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..... ...         +......+.+++.+|++.||++||++.++++.|++.
T Consensus       235 ~~~~~-~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDGGY-LDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcCCC-CCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111 000         011124689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-35  Score=324.09  Aligned_cols=259  Identities=30%  Similarity=0.485  Sum_probs=205.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457899999999999999999853      46789999987653 33456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcC------------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          814 LLIYSFMENGSLDYWLHEKL------------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                      ++||||+++++|.+++....                  .....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999997532                  1123578899999999999999999998   99999999999


Q ss_pred             EEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 035998          876 ILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKG  954 (1020)
Q Consensus       876 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  954 (1020)
                      |+++.++.++++|||+++................+..|+|||...+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543222222223345678999999988899999999999999999998 88888643221 


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                        +   ......... ...         .+.....++.+++.+||+.||++||++.|+++.|++
T Consensus       240 --~---~~~~~~~~~-~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --E---VIYYVRDGN-VLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --H---HHHHHhcCC-CCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              1   111111111 100         011122468899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9e-35  Score=316.39  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=209.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999876 78999999886422   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|..++.........++++.+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999876544556789999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..  .......++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ........... ...    .+
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~~~----~~  227 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-CDY----PP  227 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc-CCC----CC
Confidence            21  112334678899999999888899999999999999999999999854321    11111111111 100    00


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..    .......+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 ~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            00    112234688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-35  Score=318.00  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=203.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ..+|++.++||+|+||.||+|+..+...||+|++..... ..+.+.+|++++++++||||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356899999999999999999987777899999876432 3457889999999999999999999874 45679999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++...  ....++++.+..++.|+++||+|+|+.   +++||||||+||++++++.++|+|||.++.......
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999999754  234578999999999999999999999   999999999999999999999999999976543221


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       .......++..|+|||+..+..++.++||||+|+++|||+| |..||......+   ..   .........        
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~~~~~~~~~--------  222 (262)
T cd05071         158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQVERGYRM--------  222 (262)
T ss_pred             -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---HHHhcCCCC--------
Confidence             11223345678999999988899999999999999999999 888886433211   11   111111000        


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .........+.+++.+|++.+|++||+++++++.|++.
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              01122335688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7e-35  Score=317.25  Aligned_cols=260  Identities=24%  Similarity=0.365  Sum_probs=208.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+....   .....++.+|+++++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 478999999876432   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++.........+++..++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999876444445789999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..  .......++..|+|||...+..++.++|+||+|+++|+|++|..||.....    +............      .+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~------~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCD------YP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCC------CC
Confidence            21  112234688899999999888999999999999999999999999964321    1111111111100      01


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...   .......+.+++.+||+.||.+|||+.+|++.++++
T Consensus       227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            000   112334688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.3e-35  Score=317.55  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=203.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||.||+|..+++..||+|.+..... ..+.+.+|++++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46888999999999999999988888999999876433 3457899999999999999999999875 456889999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...  ....++++++..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+........ 
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            99999998753  234579999999999999999999999   999999999999999999999999999976543211 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||||+++|||++ |..||......   +..   .........         
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~~---------  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVL---EQVERGYRM---------  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCCC---------
Confidence            11122345668999999888899999999999999999999 89999643221   111   111111000         


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                       ..+......+.+++.+|++.+|.+|||++++.+.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0011223468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.6e-35  Score=326.12  Aligned_cols=241  Identities=26%  Similarity=0.349  Sum_probs=193.5

Q ss_pred             CeeeccCCeEEEEEEe----CCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATL----PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +.||+|+||.||+++.    .+++.||||++....    ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357899999987532    12234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  153 (323)
T cd05584          82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-  153 (323)
T ss_pred             CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence            9999999988754    4578889999999999999999999   9999999999999999999999999998754322 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       ........|++.|+|||++.+..++.++||||+||++|||++|+.||......      .....+.....  . .    
T Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~--~-~----  219 (323)
T cd05584         154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL--N-L----  219 (323)
T ss_pred             -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC--C-C----
Confidence             12223457899999999999888999999999999999999999999743221      11111111110  0 0    


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                          +......+.+++.+|++.||++||     +++++++
T Consensus       220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                011123578999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.6e-35  Score=322.97  Aligned_cols=260  Identities=27%  Similarity=0.426  Sum_probs=206.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      .++|.+.+.||+|+||.||+|...      ++..||||.++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356899999999999999999741      34579999987543 23345688999999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+.+|+|.++++...  ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999987542  23489999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      +...............++..|+|||.+.+..++.++||||+||++|||++ |..||......+.  ..    ........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~  262 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----KLIKEGYR  262 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----HHHHcCCc
Confidence            86643322222223345678999999998899999999999999999998 9999875432111  11    11111100


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ..         ........+.+++.+|++.+|++||++.|+++.|++++
T Consensus       263 ~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         263 MA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             CC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            00         00111236889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.1e-35  Score=320.30  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=195.7

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||+||++... +++.||+|.+.....   ...+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 688999999865432   1234567899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      ..++.........+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            988865544456789999999999999999999999   99999999999999999999999999997654322  1223


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...|++.|+|||++.+..++.++||||+|+++|||++|+.||..........  ........ .       +.   ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~-~-------~~---~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILN-D-------SV---TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcc-c-------CC---CCcc
Confidence            4578999999999999999999999999999999999999997533211110  00111100 0       00   0111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      .....+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            2234678999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.1e-35  Score=317.69  Aligned_cols=255  Identities=29%  Similarity=0.445  Sum_probs=204.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|++++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            457899999999999999999988899999999876543 2457889999999999999999999864 55789999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...  ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.++++|||.+....... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05067          83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-  156 (260)
T ss_pred             CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence            999999988654  234688999999999999999999998   99999999999999999999999999997654211 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........++..|+|||+.....++.++||||||+++|||++ |+.||......   +...   ........ ..     
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~~~~~~~-~~-----  224 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ---NLERGYRM-PR-----  224 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH---HHHcCCCC-CC-----
Confidence            111223345678999999988889999999999999999999 99999754321   1111   11111100 00     


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          ......++.+++.+|++.+|++||+++++++.|+..
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                011223688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5e-35  Score=323.49  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-CC--EEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-GR--NVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.++... ....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998653 33  47888887432 33456788999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          817 YSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      +||+++++|.+++.....            ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999875321            123588999999999999999999998   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||++......   ........+..|+|||+..+..++.++|||||||++|||++ |..||......   ...   .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~---~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY---E  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---H
Confidence            99999998643211   11111233557999999988899999999999999999998 99999643321   111   1


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....... ..         .+......+.+++.+||+.+|.+||+++++++.|+++
T Consensus       230 ~~~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         230 KLPQGYR-ME---------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHhcCCC-CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111100 00         0111223578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-35  Score=321.97  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=201.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-----CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  814 (1020)
                      .+|++.+.||+|+||.||+|..+     ++..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888999999999999999742     578999999987665556788999999999999999999998754  34678


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999998753   23588999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCccc-ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--------c-ccHHHHHHH
Q 035998          895 ILSPYDTHV-TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG--------S-RDLISWVIR  964 (1020)
Q Consensus       895 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--------~-~~~~~~~~~  964 (1020)
                      ......... .....++..|+|||+..+..++.++||||+|+++|||++|..|+......-        . .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            643222111 111223456999999988899999999999999999999877754221100        0 000000000


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......         ...........+.+++.+||+.+|++|||++|+++.|+.+
T Consensus       238 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000         0001112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=325.61  Aligned_cols=250  Identities=26%  Similarity=0.329  Sum_probs=209.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchh---hHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  815 (1020)
                      ...|++.+.||+|.||.||+++.+. |+.+|+|.+.+....   ....+.+|+++|+++. |||||.++++|.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4578889999999999999998764 999999999876532   3458899999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC----CCCeEEeeccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG----NFGAHLADFGL  891 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~  891 (1020)
                      |||+++||.|.+.+...     .+++..+..++.|++.|++|||+.   ||+|||+||+|+|+..    ++.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999998876     289999999999999999999998   9999999999999953    35799999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      +.....   .......+||+.|+|||++....|+.++||||+||++|.|++|..||......+...      .+..... 
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence            998743   345566899999999999999999999999999999999999999997654332211      1111111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .+..+..+.....+.++++.|+..||.+|+|+.++++
T Consensus       256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                  1111222333456889999999999999999999987

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-35  Score=333.69  Aligned_cols=202  Identities=28%  Similarity=0.360  Sum_probs=174.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ......+.+|++++.+++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999864 68899999997542   122346788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999998754    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc---------------------------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 035998          898 PYDT---------------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK  944 (1020)
Q Consensus       898 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~  944 (1020)
                      ....                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012357999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 035998          945 RPMDMC  950 (1020)
Q Consensus       945 ~pf~~~  950 (1020)
                      .||...
T Consensus       234 ~Pf~~~  239 (363)
T cd05628         234 PPFCSE  239 (363)
T ss_pred             CCCCCC
Confidence            999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.9e-35  Score=319.95  Aligned_cols=255  Identities=24%  Similarity=0.411  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.++||+|+||.||+|++. +++    .||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888999999999999999853 444    48999987543 3345678899999999999999999999875 45779


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ++||+++|+|.++++..   ...+++..++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999998754   24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||...+..++.++|||||||++|||++ |..||......   ....+   ......... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~~-  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL---LEKGERLPQ-  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---HHCCCcCCC-
Confidence            43222111222344678999999988899999999999999999998 99998643221   11111   111111000 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                               .......+.+++.+||+.||++||++.++++.|+++
T Consensus       233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     011224578999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-35  Score=336.81  Aligned_cols=252  Identities=23%  Similarity=0.273  Sum_probs=195.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .|+.++.||+|+||+||+|+.. +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999864 68899999996532   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999998764    4578899999999999999999999   9999999999999999999999999997643110


Q ss_pred             CCc---------------------------------------------ccccccccccCccCccccCCCCCCchhhHHHH
Q 035998          899 YDT---------------------------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSF  933 (1020)
Q Consensus       899 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl  933 (1020)
                      ...                                             ......+||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            000                                             00123479999999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhh--ccCCCCCCCCCHHH
Q 035998          934 GVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACL--CLSESPKVRPTTQQ 1011 (1020)
Q Consensus       934 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e 1011 (1020)
                      ||++|||++|+.||......+.   .   ..+...........+   ..    ...++.+++.+  |+..+|..||+++|
T Consensus       235 G~il~elltG~~Pf~~~~~~~~---~---~~i~~~~~~~~~~~~---~~----~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTET---Q---LKVINWENTLHIPPQ---VK----LSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHH---H---HHHHccccccCCCCC---CC----CCHHHHHHHHHHccCcccccCCCCHHH
Confidence            9999999999999975432111   0   111100000000000   01    11346678877  55566667999999


Q ss_pred             HHH
Q 035998         1012 LVS 1014 (1020)
Q Consensus      1012 vl~ 1014 (1020)
                      +++
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.4e-35  Score=317.67  Aligned_cols=245  Identities=27%  Similarity=0.390  Sum_probs=192.3

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||.||+++.+ +|+.||+|.+....   ....+.+..|++++++++||||+++++++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++......   ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence            9888653  234578999999999999999999999   9999999999999999999999999998765332   1223


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...|+..|+|||++.+..++.++||||+||++|||++|+.||.........  ........... .. ..        ..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~-~~-~~--------~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE-VK-FE--------HQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc-cc-cc--------cc
Confidence            456889999999998888999999999999999999999999753322111  11111111100 00 00        00


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....++.+++.+||+.||++||+++|+++
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            12235789999999999999999976654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.7e-35  Score=317.60  Aligned_cols=257  Identities=26%  Similarity=0.456  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CC---CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DG---RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|+..+.||+|+||.||+|..+ ++   ..+|+|.+.... ....+.+.+|++++++++|||++++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999864 23   379999987553 33346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...   ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998753   24689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCcccc-cccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ........ .....+..|+|||+..++.++.++||||||+++|||++ |+.||......   +   ....+......   
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~---~~~~i~~~~~~---  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---E---VMKAINDGFRL---  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---H---HHHHHhcCCCC---
Confidence            32211111 11223457999999988889999999999999999998 99999643221   1   11112111111   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        +.     .......+.+++.+||+.+|++||++.++++.|++++
T Consensus       230 --~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         230 --PA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             --CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence              00     1112346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.2e-35  Score=315.13  Aligned_cols=247  Identities=23%  Similarity=0.398  Sum_probs=195.9

Q ss_pred             eeeccCCeEEEEEEeC---CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          749 IIGCGGFGLVYRATLP---DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      .||+|+||.||+|.++   ++..||+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999653   57889999986543  234567899999999999999999999875 45678999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc-
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-  902 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-  902 (1020)
                      +|.+++...    ..++++.+..++.|++.|++|+|++   +|+||||||+||+++.++.+|++|||.++......... 
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999998653    3588999999999999999999999   99999999999999999999999999998764432211 


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                      ......++..|+|||......++.++||||||+++|||++ |+.||......   ..   ......... ...       
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~---~~~i~~~~~-~~~-------  219 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV---TQMIESGER-MEC-------  219 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHCCCC-CCC-------
Confidence            1122334578999999888889999999999999999998 99999754322   11   111111111 111       


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        +......+.+++.+||+.||++||++++|++.|++.
T Consensus       220 --~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 --PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              111224688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-34  Score=325.35  Aligned_cols=248  Identities=22%  Similarity=0.385  Sum_probs=194.7

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 68899999997542   22234577899999888 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~  151 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D  151 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence            9998887653    4689999999999999999999999   99999999999999999999999999987532221  2


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC--cccHHHHHHHHHhhcccccccCcccc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG--SRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+  ......+.......... ..  |   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--p---  225 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RI--P---  225 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-CC--C---
Confidence            2334578999999999999999999999999999999999999997433222  11111111111111110 00  0   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPT------TQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 1014 (1020)
                          ......+.+++.+|++.||.+||+      ++++++
T Consensus       226 ----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         226 ----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                111235789999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-35  Score=324.69  Aligned_cols=256  Identities=32%  Similarity=0.465  Sum_probs=200.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC--EEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR--NVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|+++ ++.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788999999999999999864 444  46788776433 23446788999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          817 YSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      |||+++++|.+++.....            ....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999975421            123678999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++....   ........++..|+|||+..+..++.++|||||||++|||+| |..||......   +   ...
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~---~~~  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E---LYE  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H---HHH
Confidence            9999999864311   111112234568999999988889999999999999999998 99999643221   1   111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ........ .         ........+.+++.+||+.+|++||+++++++.|+++
T Consensus       235 ~~~~~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 KLPQGYRL-E---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHhcCCcC-C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111000 0         0001123578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=334.40  Aligned_cols=252  Identities=26%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999865 68999999987542   123456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998764    4688999999999999999999998   999999999999999999999999999987643


Q ss_pred             CC---------------------------CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          898 PY---------------------------DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       898 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      ..                           .........||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                           001223457899999999999999999999999999999999999999754


Q ss_pred             CCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 035998          951 KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-TQQLVS 1014 (1020)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1014 (1020)
                      ...      .....+....  .....|..     ......+.+++.+|++ ||.+||+ ++++++
T Consensus       234 ~~~------~~~~~i~~~~--~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 TLQ------ETYNKIINWK--ESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CHH------HHHHHHhccC--CcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            321      1111111100  00000100     0022457899999998 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.8e-35  Score=325.64  Aligned_cols=243  Identities=22%  Similarity=0.382  Sum_probs=191.0

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 67899999997542   22334577888888777 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~  151 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D  151 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence            9998887653    4689999999999999999999999   99999999999999999999999999987542221  1


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc--ccHHHHHHHHHhhcccccccCcccc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS--RDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||........  .....+.......... .       
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-------  223 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-------  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-------
Confidence            22345789999999999999999999999999999999999999964322211  1111122111111111 0       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                        .+......+.+++.+||+.||++||++
T Consensus       224 --~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 --IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence              011122357899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.8e-35  Score=316.36  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .+|++.+.||+|+||.||+|+..    .+..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888999999999999999863    23479999987543 23346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...   ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999754   24578999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccc-ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPYDTHV-TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....... .....++..|+|||...++.++.++|+||||+++||+++ |..||......   +....   .......   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~---~~~~~~~---  228 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA---IEEGYRL---  228 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH---HhCCCcC---
Confidence            3221111 111233568999999998899999999999999999887 99999654321   11111   1111100   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        +.     .......+.+++.+|++.+|.+||++.++++.|++++
T Consensus       229 --~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         229 --PA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             --CC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence              00     1112245789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-35  Score=317.94  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999986 46889999998765444456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.++++|||+++......
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999988653    4678999999999999999999999   99999999999999999999999999998764321


Q ss_pred             CcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                        .......++..|+|||.+.   ...++.++||||+||++|||++|+.||....+......      .....    ...
T Consensus       161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------~~~~~----~~~  228 (267)
T cd06646         161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MSKSN----FQP  228 (267)
T ss_pred             --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------eecCC----CCC
Confidence              1123346788999999874   44578899999999999999999999864332211000      00000    000


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                      +....  .......+.+++.+||+.+|++||+++++++.
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            10000  11122468899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-35  Score=332.36  Aligned_cols=252  Identities=24%  Similarity=0.305  Sum_probs=198.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999865 68999999997532   223355788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999998754    4689999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCc------------------------------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHH
Q 035998          898 PYDT------------------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL  941 (1020)
Q Consensus       898 ~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  941 (1020)
                      ....                                    ......+||+.|+|||++....++.++||||+||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                    0011246899999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 035998          942 TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT---TQQLVS 1014 (1020)
Q Consensus       942 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1014 (1020)
                      +|..||......+      .................       ......+.+++.+|+. +|.+|++   ++|+++
T Consensus       234 ~G~~Pf~~~~~~~------~~~~i~~~~~~~~~~~~-------~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQE------TYRKIINWKETLQFPDE-------VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHH------HHHHHHcCCCccCCCCC-------CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999997543211      11111110000000000       0112357789999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=328.78  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             CcCCeeeccCCeEEEEEEeC--CCC--EEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          745 DQANIIGCGGFGLVYRATLP--DGR--NVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ...++||+|+||.|++|.|+  +|+  .||||.+..+... ...+|.+|+.+|.+|+|||++++||+..+ ....||||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            45678999999999999985  343  5899999877643 56789999999999999999999999887 677899999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++.|+|.+.++.  .....+-......++.|||.||+||..+   ++||||+.++|+++-....|||+|||+++-++...
T Consensus       192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999987  3456788888999999999999999999   99999999999999999999999999999887544


Q ss_pred             Cccc-ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          900 DTHV-TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       900 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      +... .....-...|+|||.+....++.++|||+|||++|||+| |..||.+.........+.      ..         
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------~~---------  331 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------AG---------  331 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------cc---------
Confidence            4332 223344568999999999999999999999999999999 899998765432222221      11         


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       -.-..+..+.+++++++..||..+|++||+|..+.+
T Consensus       332 -erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  332 -ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence             111223446678999999999999999999999975

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.6e-35  Score=325.14  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|.+.+.||+|+||.||+|+..        ....||+|.+.... ......+.+|+++++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356888999999999999999742        24579999987543 23345688999999999 699999999999998


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      ...++||||+++|+|.+++.....            ....+++.++..++.|++.||+|||++   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            899999999999999999976421            124588999999999999999999998   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+|++|||.++...............++..|+|||.+.++.++.++||||||+++|||++ |..||......   +
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence            9999999999999986643221111222334567999999988899999999999999999999 88998643321   1


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...   .... .....         ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus       245 ~~~---~~~~-~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 LFK---LLRE-GHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHH---HHHc-CCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111   1111 11000         0111223678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-35  Score=329.25  Aligned_cols=244  Identities=23%  Similarity=0.326  Sum_probs=192.5

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHH---HHcCCCccceEeeEEeccCceEEE
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEAL---SRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+.+|++++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999865 68999999997542   12234566666655   456799999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887754     3689999999999999999999999   99999999999999999999999999987542


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..  ........|++.|+|||++.+..++.++||||+||++|||++|+.||......   ..   ...+.....    ..
T Consensus       153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~---~~~i~~~~~----~~  220 (324)
T cd05589         153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EV---FDSIVNDEV----RY  220 (324)
T ss_pred             CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC----CC
Confidence            21  12233467899999999999999999999999999999999999999743221   11   111111110    00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                             +......+.+++.+||+.||.+||     ++.++++
T Consensus       221 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 -------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                   011123578999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-35  Score=315.92  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=207.0

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..++|++.+.||+|+||.||+|..++++.||||.+..... ..+++.+|++++++++|+|++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3467899999999999999999988888999999876533 346788999999999999999999999988899999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++......
T Consensus        83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999998764  234689999999999999999999999   99999999999999999999999999988764311


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                       .........+..|+|||...+..++.++||||+|+++|||++ |+.||......   .....   .......   ..+ 
T Consensus       158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~---~~~~~~~---~~~-  226 (261)
T cd05034         158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ---VERGYRM---PRP-  226 (261)
T ss_pred             -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHcCCCC---CCC-
Confidence             111122334568999999998899999999999999999999 99999643221   11111   1111000   000 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                            ......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       227 ------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 ------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  1112468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=313.33  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=205.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999875 78999999987644 4567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++....  ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++...... 
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            9999999987642  23689999999999999999999999   99999999999999999999999999998763211 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                          .....+..|+|||+...+.++.++||||+|+++|||++ |..||......   +...   .... ......     
T Consensus       157 ----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~-~~~~~~-----  220 (256)
T cd05039         157 ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---HVEK-GYRMEA-----  220 (256)
T ss_pred             ----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHhc-CCCCCC-----
Confidence                12334568999999988899999999999999999998 99998643221   1111   1111 100000     


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          +......+.+++.+||..+|++||+++|++++|+++
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                111234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-34  Score=325.04  Aligned_cols=262  Identities=28%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEecc-C
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHK-N  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  811 (1020)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++..... .....+.+|++++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35789999999999999999973      3577899999976432 2345688899999999 689999999988654 4


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC---------------------------------------------------------
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD---------------------------------------------------------  834 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  834 (1020)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999865311                                                         


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccc
Q 035998          835 ------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV  908 (1020)
Q Consensus       835 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  908 (1020)
                            ....+++..+..++.|+++|++|||++   +|+||||||+||+++.++.+|++|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  012468888999999999999999999   99999999999999999999999999998754332222222344


Q ss_pred             cccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHH
Q 035998          909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKE  987 (1020)
Q Consensus       909 gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  987 (1020)
                      ++..|+|||...+..++.++||||||+++|||++ |..||.......  ...   ........ ..  .|.   .    .
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~---~~~~~~~~-~~--~~~---~----~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC---RRLKEGTR-MR--APD---Y----T  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH---HHHhccCC-CC--CCC---C----C
Confidence            5678999999988899999999999999999997 999986532211  111   11111110 00  010   0    1


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          988 MLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       988 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ...+.+++.+||+.||++||++.|+++.|+.++
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            135789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-35  Score=291.07  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--------hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--------GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ..|...+.+|+|..+.|.++.++ +|+.+|+|++....        ....++-.+|+.+++++ .||+|+++.+++..+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45777889999999999988754 68889999875321        12234567899999998 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++|+|.|+.|-|.+|+.+.    ..+++.....|++|+.+|++|||..   .|||||+||+|||+|++.++||+|||+
T Consensus        97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            999999999999999999875    5789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      ++.+..   .......+|||+|.|||.+..      ..|+..+|+|+.|||||-++.|.+||-..      .++-... +
T Consensus       170 a~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR------kQmlMLR-~  239 (411)
T KOG0599|consen  170 ACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR------KQMLMLR-M  239 (411)
T ss_pred             eeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH------HHHHHHH-H
Confidence            998743   344566899999999997654      46788999999999999999999999521      1121111 1


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..++... +     ..+...+......++|.+|++.||.+|.|++|+++
T Consensus       240 ImeGkyq-F-----~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKYQ-F-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhcccc-c-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1221111 1     11122334456889999999999999999999987

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-35  Score=332.80  Aligned_cols=252  Identities=25%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999864 688999999975432   23456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999998764   24689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQ------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ... .......||+.|+|||++.      ...++.++||||+||++|||++|+.||......      .....+......
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~  227 (330)
T cd05601         155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRF  227 (330)
T ss_pred             CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCc
Confidence            221 1223357899999999876      456789999999999999999999999643221      111111111111


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....+       .+.....+.+++.+|++ +|.+||+++++++
T Consensus       228 ~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11110       11122457889999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-34  Score=314.24  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=198.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.++||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 478899999986543 33446788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++++++..+.        .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        357888999999999999999999   9999999999999999999999999999765322 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCccc-HHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD-LISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                         ......++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ............ .     +.
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~-----~~  219 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-P-----PV  219 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-C-----CC
Confidence               2233578899999999999999999999999999999999999997543222111 111111111110 0     00


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..   ......++.+++.+|++.+|++||+++|+++
T Consensus       220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00   0111235789999999999999999999976

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.4e-35  Score=316.96  Aligned_cols=256  Identities=30%  Similarity=0.484  Sum_probs=202.8

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CC---CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DG---RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +|++.+.||+|+||.||+|+.. ++   ..||||.+.... ....+++..|++++++++||||+++++++.+....++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4778899999999999999864 23   369999987643 334567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...   ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998754   24578999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCcccccc-c--ccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          898 PYDTHVTTD-L--VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       898 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ......... .  ..+..|+|||...+..++.++||||+|+++|||++ |..||......   +...+.   ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---~~~~~~~~  232 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---EQDYRLPP  232 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH---HcCCcCCC
Confidence            221111111 1  12457999999999999999999999999999987 99999653321   111111   11111000


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                                ..+....+.+++.+||+.+|.+||++.++++.|++++
T Consensus       233 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         233 ----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             ----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence                      1112345789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-34  Score=346.53  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.++||+|+||.||+|+.. +++.||+|++..+.   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999865 58999999987543   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          818 SFMENGSLDYWLHEKLDG-------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ||++||+|.+++......       ....++..++.++.||++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998753211       23456778899999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCC----------------cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 035998          891 LARLILSPYD----------------THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG  954 (1020)
Q Consensus       891 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  954 (1020)
                      +++.......                .......+||+.|+|||+..+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                011123568999999999999999999999999999999999999996522211


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHHhc
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-TQQLVSWLDSI 1019 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i 1019 (1020)
                         .. .......+..    ..+      .......+.+++.+|++.||++||+ ++++++.|+..
T Consensus       239 ---i~-~~~~i~~P~~----~~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ---IS-YRDVILSPIE----VAP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             ---hh-hhhhccChhh----ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               10 0000000000    000      0112235788999999999999974 66677777654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-35  Score=330.89  Aligned_cols=241  Identities=22%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999997542   122345678999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      +|..++...    ..+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~  151 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA  151 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence            998887653    468999999999999999999997 6   9999999999999999999999999998754321  11


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ...   ....... . .     +   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~---~~i~~~~-~-~-----~---  215 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF---ELILMEE-I-R-----F---  215 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHH---HHHhcCC-C-C-----C---
Confidence            223456899999999999999999999999999999999999999643221   111   1111100 0 0     0   


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                       +......+.+++.+|++.||++|+     +++++++
T Consensus       216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence             011123578999999999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-34  Score=323.11  Aligned_cols=241  Identities=25%  Similarity=0.342  Sum_probs=192.1

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCC-ccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHP-NLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  817 (1020)
                      +|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999865 57889999987542   22335677899999999764 6888999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999888754    4578999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .  ........||+.|+|||++.+..++.++||||+||++|||+||+.||......   ...   ..+....  ..    
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~~~~--~~----  219 (324)
T cd05587         154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF---QSIMEHN--VS----  219 (324)
T ss_pred             C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCC--CC----
Confidence            1  11223457899999999999999999999999999999999999999743221   111   1111110  00    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                       +    +......+.+++.+|++.||.+|++.
T Consensus       220 -~----~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 -Y----PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -C----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             0    01112357899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-34  Score=312.69  Aligned_cols=247  Identities=21%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             eeccCCeEEEEEEeC---CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP---DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   355799999876532 33467899999999999999999999875 4578999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc-c
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV-T  904 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~  904 (1020)
                      .+++...   ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|++|||+++.......... .
T Consensus        82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998753   24689999999999999999999999   999999999999999999999999999986543222111 1


Q ss_pred             cccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       905 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      ....++..|+|||....+.++.++||||||+++||+++ |..||......+   ..   ........ ..         .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~---~~~~~~~~-~~---------~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM---SFIEQGKR-LD---------C  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH---HHHHCCCC-CC---------C
Confidence            12233578999999988889999999999999999997 999997543221   11   11111111 00         1


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      +.....++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-35  Score=327.58  Aligned_cols=236  Identities=27%  Similarity=0.387  Sum_probs=189.3

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.+ +++.||||++....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999987542   12234567788888776 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~  151 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK  151 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence            9999888754    4688999999999999999999999   9999999999999999999999999998754221  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   .   ....+.....    ..+     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~---~~~~i~~~~~----~~~-----  216 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---D---LFEAILNDEV----VYP-----  216 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---H---HHHHHhcCCC----CCC-----
Confidence            233457899999999999999999999999999999999999999753321   1   1111111110    011     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                        ......+.+++.+|++.||++||++
T Consensus       217 --~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 --TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCHHHHHHHHHHcccCHHHCCCC
Confidence              0112357899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2e-34  Score=313.96  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=193.0

Q ss_pred             CeeeccCCeEEEEEEeCC---CCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLPD---GRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+|.+.+   +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45799998876543 33457888999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          824 SLDYWLHEKLD-GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       824 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      +|.+++..... .....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 223467778889999999999999999   99999999999999999999999999987543322112


Q ss_pred             cccccccccCccCccccCCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          903 VTTDLVGTLGYIPPEYGQAS-------VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+   .....  .  .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~--~--~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT--V--REQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH--h--hcccCCC
Confidence            22234567889999987542       35789999999999999996 999996543221   11111  1  1111111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .++.....    ....+.+++..|| .+|++|||++||++.|+
T Consensus       231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22222111    1234778999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-34  Score=320.50  Aligned_cols=240  Identities=26%  Similarity=0.363  Sum_probs=189.0

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +++.||+|+++....   ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 578899999875421   2233455666666654 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            9999888754    4688999999999999999999999   99999999999999999999999999997643221  2


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ..   ...+....       +.+   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~---~~~i~~~~-------~~~---  215 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---EL---FDSILNDR-------PHF---  215 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHcCC-------CCC---
Confidence            233457899999999999999999999999999999999999999753321   11   11111110       000   


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQ-QLV 1013 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1013 (1020)
                       +......+.+++.+||+.||.+||++. +++
T Consensus       216 -~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 -PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             111123578999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=315.21  Aligned_cols=251  Identities=32%  Similarity=0.472  Sum_probs=196.3

Q ss_pred             CeeeccCCeEEEEEEeCC-CC--EEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLPD-GR--NVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.++ +.  .+|+|.++... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998753 43  46888887543 33446788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          823 GSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       823 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      |+|.+++.....            ....++++++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999875421            123578999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      +++....   .........+..|+|||+.....++.++||||||+++|||++ |..||......   +.   ........
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~---~~~~~~~~  228 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL---YEKLPQGY  228 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HH---HHHHhCCC
Confidence            9863211   111112234567999999988899999999999999999997 99999643211   11   11111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .. +         ........+.+++.+||+.+|.+||++.++++.|++++
T Consensus       229 ~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RL-E---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CC-C---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            10 0         01112235789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-34  Score=313.14  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|++|.||+|..+.+..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4588889999999999999998777789999886543 23466888999999999999999999875 456789999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++...... .
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05069          84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence            99999999764  234578999999999999999999998   99999999999999999999999999997653321 1


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||+|+++|||++ |..||....+.   ....   ........   .     
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~---~~~~~~~~---~-----  223 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE---QVERGYRM---P-----  223 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcCCCC---C-----
Confidence            11122345678999999988899999999999999999999 89999753321   1111   11111000   0     


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                        .+......+.+++.+||+.||++||++++++++|++
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 --CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              011223468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-34  Score=310.44  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=198.1

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChh
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD  826 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  826 (1020)
                      ++||+|+||.||+|..++++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999988899999999876543 33456889999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccc
Q 035998          827 YWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD  906 (1020)
Q Consensus       827 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  906 (1020)
                      +++...   ...+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++....... ......
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~  153 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGL  153 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCC
Confidence            988653   23578999999999999999999998   99999999999999999999999999987543211 111112


Q ss_pred             cccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       907 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ..++..|+|||+..+..++.++||||||+++|++++ |..||.......   .   .......... .         ...
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~---~~~~~~~~~~-~---------~~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---A---REQVEKGYRM-S---------CPQ  217 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---H---HHHHHcCCCC-C---------CCC
Confidence            234567999999988899999999999999999999 999996442211   1   1111111110 0         011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .....+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            12346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=313.47  Aligned_cols=251  Identities=28%  Similarity=0.473  Sum_probs=204.2

Q ss_pred             CeeeccCCeEEEEEEeCC----CCEEEEEEecCCchhh-HHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLPD----GRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|....    +..||+|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998753    7889999998765433 56789999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          823 GSLDYWLHEKLDG-----PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       823 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ++|.+++......     ...+++..++.++.|++.|++|||++   +++||||||+||+++.++.+|++|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998875222     36789999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...........++..|+|||......++.++||||+|+++|||++ |..||......   ...   ........   ...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~---~~~  228 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVL---EYLRKGYR---LPK  228 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCC---CCC
Confidence            332233344567889999999988899999999999999999999 69999754221   111   11111110   001


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                             +......+.+++.+||+.+|++||++.|+++.|+
T Consensus       229 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 -------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   1112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.2e-35  Score=324.38  Aligned_cols=241  Identities=28%  Similarity=0.399  Sum_probs=190.7

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 57899999987542   12234456677777764 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  151 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DA  151 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CC
Confidence            9999988753    4578899999999999999999999   9999999999999999999999999998753221  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ....   .......    ..|     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~---~i~~~~~----~~~-----  216 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQ---SIRMDNP----CYP-----  216 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC----CCC-----
Confidence            233457899999999999999999999999999999999999999753221   1111   1111110    001     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQ-QLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1014 (1020)
                        ......+.+++.+||+.||++||++. ++.+
T Consensus       217 --~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 --RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              01123578999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=335.74  Aligned_cols=252  Identities=23%  Similarity=0.277  Sum_probs=195.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999864 78899999986532   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999988754    4678899999999999999999999   999999999999999999999999999864321


Q ss_pred             CCCc---------------------------------------------ccccccccccCccCccccCCCCCCchhhHHH
Q 035998          898 PYDT---------------------------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYS  932 (1020)
Q Consensus       898 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  932 (1020)
                      ....                                             .......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                             0001246899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCC---CCH
Q 035998          933 FGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR---PTT 1009 (1020)
Q Consensus       933 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~ 1009 (1020)
                      +||++|||++|..||......   ...   ..+..........+       .......+.+++.+|++ +|.+|   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~---~~~---~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH---ETY---RKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH---HHH---HHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            999999999999999643321   111   11111000000000       00112357889999998 66665   599


Q ss_pred             HHHHH
Q 035998         1010 QQLVS 1014 (1020)
Q Consensus      1010 ~evl~ 1014 (1020)
                      .|+++
T Consensus       300 ~~~l~  304 (377)
T cd05629         300 HEIKS  304 (377)
T ss_pred             HHHhc
Confidence            99876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-34  Score=329.46  Aligned_cols=263  Identities=25%  Similarity=0.321  Sum_probs=196.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----ceE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----DRL  814 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  814 (1020)
                      +|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999986 478999999986532  223457889999999999999999999998766     789


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+. ++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999997 4677666542    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH-----------
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV-----------  962 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-----------  962 (1020)
                      .... .........+++.|+|||++.+. .++.++||||+||++|||++|+.||....+......+...           
T Consensus       153 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPD-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccC-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            5322 12222345678899999988764 5789999999999999999999999754322111111000           


Q ss_pred             -HHHHhhcccccccCc-cc--cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 -IRMRQENRESEVLDP-FI--YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 -~~~~~~~~~~~~~d~-~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..............+ ..  ...........+.+++.+|++.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             000000000000000 00  00001112346789999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.2e-35  Score=323.29  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56899999999999999999865 678899999875432 2234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ ++.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 787777653   24578899999999999999999999   99999999999999999999999999997653322


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc---
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL---  975 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  975 (1020)
                        .......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+....+................   
T Consensus       159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12233467889999998754 568999999999999999999999997543322111111100000000000000   


Q ss_pred             ------Ccccc----CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 ------DPFIY----DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 ------d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .+...    ....+.....+.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                  00000    0000112335789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-34  Score=329.79  Aligned_cols=253  Identities=23%  Similarity=0.260  Sum_probs=199.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467899999999999999999865 68899999986432   1223457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...     .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999988653     478888999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCcccccccccccCccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQAS----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      .... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......      .....+......
T Consensus       193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~  265 (370)
T cd05596         193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS  265 (370)
T ss_pred             cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc
Confidence            3321 1122345789999999987653    4788999999999999999999999753321      111111111100


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      ....+       .......+.+++.+|++.+|.+  ||+++|+++
T Consensus       266 ~~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            01010       0112246789999999999988  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-35  Score=336.01  Aligned_cols=251  Identities=24%  Similarity=0.278  Sum_probs=193.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      +|+.++.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999864 68899999987542   2234568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++.+.    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999988754    4578889999999999999999999   9999999999999999999999999997532110


Q ss_pred             CC---------------------------------------------cccccccccccCccCccccCCCCCCchhhHHHH
Q 035998          899 YD---------------------------------------------THVTTDLVGTLGYIPPEYGQASVATYKGDVYSF  933 (1020)
Q Consensus       899 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl  933 (1020)
                      ..                                             ........||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            00                                             000123468999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC---HH
Q 035998          934 GVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT---TQ 1010 (1020)
Q Consensus       934 Gvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ 1010 (1020)
                      ||++|||++|+.||....+.+.      .........  ....|. ....    ...+.+++.+|+ .+|++|++   ++
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~~--~~~~p~-~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET------QMKVINWQT--SLHIPP-QAKL----SPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH------HHHHHccCC--CcCCCC-cccC----CHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999975432111      111111000  000000 0011    124567777765 49999997   88


Q ss_pred             HHHH
Q 035998         1011 QLVS 1014 (1020)
Q Consensus      1011 evl~ 1014 (1020)
                      ++++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            8765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-34  Score=322.77  Aligned_cols=241  Identities=26%  Similarity=0.356  Sum_probs=192.6

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 57899999987542   12234567788888876 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  151 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V  151 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence            9999888654    4688999999999999999999999   99999999999999999999999999987643221  2


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||......   ...   ..+.....    ..|     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~---~~i~~~~~----~~p-----  216 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLF---ESILHDDV----LYP-----  216 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHH---HHHHcCCC----CCC-----
Confidence            233456899999999999999999999999999999999999999754321   111   11111110    011     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRP-------TTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 1014 (1020)
                        ......+.+++.+|++.||++||       +++++++
T Consensus       217 --~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 --VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence              01123578999999999999999       7777765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-34  Score=322.87  Aligned_cols=243  Identities=22%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 578999999976432   2234577899998888 699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  151 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D  151 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence            9998887653    4689999999999999999999999   99999999999999999999999999987532221  2


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.............+...........   .|     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~p-----  223 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---IP-----  223 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---CC-----
Confidence            2334678999999999999999999999999999999999999997543332222222222221111110   01     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                        ......+.+++.+|++.||++||++
T Consensus       224 --~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 --RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCCHHHHHHHHHHhccCHHHcCCC
Confidence              0112357899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=303.82  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=208.6

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |++.+++|+|+||.||+|.++ +|+.||||++..+  .+.+++..|+.+|++.+.|++|++||.+......|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            677889999999999999865 6999999998755  3467889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+..+.++-+   ..+++++++..++++-+.||+|||..   .-||||||+.|||++.+|.+|++|||.+..+.+..  .
T Consensus       113 GSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  113 GSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             CcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            9999998765   35799999999999999999999998   88999999999999999999999999998775432  3


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|||||++..-.|..++||||+|+...||..|++||.+..+-..       ..+....+.+.+..      
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIPT~PPPTF~K------  251 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIPTKPPPTFKK------  251 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEeccCCCCCCCCC------
Confidence            34568999999999999999999999999999999999999999986544221       11111122222222      


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       +.....++.++++.|+-..|++|-|+.++++
T Consensus       252 -PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 -PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             3334457899999999999999999999876

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-34  Score=330.68  Aligned_cols=261  Identities=24%  Similarity=0.281  Sum_probs=200.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC---CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP---DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ..+|++.+.||+|+||.||++...   .+..||+|.+...     +...+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999753   3578999988653     23568999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |++. ++|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            9996 578777743    25689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc----
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE----  973 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----  973 (1020)
                      ...........||+.|+|||++.+..++.++||||+||++|||++|+.||...........+..............    
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            3333333446789999999999999999999999999999999999999976544332222222111111000000    


Q ss_pred             -------------ccCcccc-Ccc--CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 -------------VLDPFIY-DKQ--HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 -------------~~d~~~~-~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   ...+... ...  .......+.+++.+|++.||++||++.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                         0000000 000  0011235778999999999999999999987

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-34  Score=312.22  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=200.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEe-ccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM-HKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|..+ ++.||+|.+..+.  ..+.+.+|+.++++++|+|++++++++. +....++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999874 7889999987543  2457889999999999999999999765 456789999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...  ....+++..+..++.|++.|++|||++   +++||||||+||++++++.+|++|||+++...... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999998764  234578999999999999999999999   99999999999999999999999999987643221 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                          ....++..|+|||+..+..++.++||||+|+++|||++ |+.||.....      ........... ...      
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~-~~~------  219 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKGY-KMD------  219 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCC-CCC------
Confidence                22344568999999998899999999999999999998 9999864321      11111111110 001      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         ........+.+++.+||+.+|++|||++++++.|+++
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 ---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence               0112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=309.08  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-----hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-----QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|++|.||+|... +++.||+|.+.....     ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999854 689999999864321     123468889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      |+||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++..
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999988754    4578899999999999999999999   9999999999999999999999999999765


Q ss_pred             cCCCCcc-cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....... ......++..|+|||...+..++.++||||+|+++|||++|+.||......      .............. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~-  227 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNPQ-  227 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCCC-
Confidence            3221111 112345778999999999989999999999999999999999999643211      11111111111000 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                              .+......+.+++.+||+.+|.+||++.++++.
T Consensus       228 --------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 --------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    111223467899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-35  Score=336.33  Aligned_cols=252  Identities=23%  Similarity=0.275  Sum_probs=195.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .+|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999864 68899999986432   122356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999998764    4578889999999999999999999   999999999999999999999999999753210


Q ss_pred             CCC-----------------------------------------cccccccccccCccCccccCCCCCCchhhHHHHHHH
Q 035998          898 PYD-----------------------------------------THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVV  936 (1020)
Q Consensus       898 ~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvi  936 (1020)
                      ...                                         ........||+.|+|||++.+..++.++||||+||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            000                                         000113478999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCC---CHHHHH
Q 035998          937 LLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP---TTQQLV 1013 (1020)
Q Consensus       937 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 1013 (1020)
                      +|||++|+.||....+.+.   .   ..+.....  ....+.     .......+.+++.+|+ .+|.+|+   ++.+++
T Consensus       234 lyell~G~~Pf~~~~~~~~---~---~~i~~~~~--~~~~~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAET---Q---LKVINWET--TLHIPS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHHH---H---HHHhccCc--cccCCC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            9999999999975432211   1   11110000  000000     0011234667777776 4999999   889887


Q ss_pred             H
Q 035998         1014 S 1014 (1020)
Q Consensus      1014 ~ 1014 (1020)
                      +
T Consensus       300 ~  300 (376)
T cd05598         300 A  300 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-34  Score=312.57  Aligned_cols=263  Identities=26%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--Cce
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  813 (1020)
                      ..|++.+.||+|+||.||+|++     .++..||+|.+.... ......+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478899999999999999974     357889999987553 33346789999999999999999999998775  567


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++.+.   ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999998653   23579999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------CCcc-cHHHHHH
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP--------KGSR-DLISWVI  963 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~--------~~~~-~~~~~~~  963 (1020)
                      ........ .......++..|+|||+..+..++.++||||+|+++|||++++.|+.....        .... .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76432221 112234567789999998888899999999999999999998776532110        0000 1111111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ........          +........+.+++.+||+.+|.+||+++++++.|++++
T Consensus       238 ~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         238 VLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            11111100          001122346899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=310.80  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=196.6

Q ss_pred             CeeeccCCeEEEEEEeC--C--CCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP--D--GRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|.+.  +  +..||+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999753  2  36899999886653 34567899999999999999999999876 4567999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|.+++...    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999764    3678999999999999999999999   99999999999999999999999999998764322211


Q ss_pred             -cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          903 -VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       903 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       ......++..|+|||...+..++.++||||||+++|||++ |+.||......   +...+.   ...... .       
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~---~~~~~~-~-------  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML---ESGERL-P-------  218 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---HcCCcC-C-------
Confidence             1111223467999999998999999999999999999998 99999754321   122111   111110 0       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .+......+.+++.+||+.+|.+||++.++++.|+++
T Consensus       219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              1111224688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-34  Score=325.89  Aligned_cols=259  Identities=27%  Similarity=0.390  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.+.... ....+++.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46899999999999999999742        12368999887543 23346788999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      ..+++|||+++|+|.+++.....            ....+++.++..++.|++.||+|||+.   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            99999999999999999876421            123578899999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  958 (1020)
                      .++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||......     
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-----  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence            999999999999986543221112222334567999999999999999999999999999998 88888643211     


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       ........... ..         .+......+.+++.+||+.+|.+||++.|+++.|+++
T Consensus       244 -~~~~~~~~~~~-~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         244 -ELFKLLKEGHR-MD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             -HHHHHHHcCCC-CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             11111111110 01         0111234688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.9e-35  Score=326.10  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=192.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999865 578999999875432   2234466778888777 5899999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999888654    4588999999999999999999999   999999999999999999999999999875422


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......   ....   .+.....  .    
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~---~i~~~~~--~----  219 (323)
T cd05616         154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIMEHNV--A----  219 (323)
T ss_pred             C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCCC--C----
Confidence            1  12233457899999999999999999999999999999999999999753321   1111   1111100  0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                           .+......+.+++.+|++.||.+|+++
T Consensus       220 -----~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 -----YPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 011122457899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-34  Score=328.03  Aligned_cols=255  Identities=21%  Similarity=0.254  Sum_probs=198.4

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999999875 57899999986422   12234578899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++|+|.+++...     .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999988653     478889999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQAS----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      ...... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......      .....+....
T Consensus       191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~  263 (370)
T cd05621         191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHK  263 (370)
T ss_pred             ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence            764321 1122346799999999987654    3788999999999999999999999743221      1111111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      ......+       .......+.+++.+|++.+|.+  ||+++|+++
T Consensus       264 ~~~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         264 NSLNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             cccCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            1001000       0112235678889999866544  899999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-34  Score=309.66  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=199.2

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChh
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD  826 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  826 (1020)
                      ++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998765433 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccc
Q 035998          827 YWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD  906 (1020)
Q Consensus       827 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  906 (1020)
                      +++...   ...+++..+..++.|++.|++|||++   +++||||||+||+++.++.+|++|||.++.............
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998754   23578899999999999999999999   999999999999999999999999999976532111111112


Q ss_pred             cccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       907 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...+..|+|||...++.++.++|+||+|+++|||+| |..||........      ..........   .       .+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~------~~~~~~~~~~---~-------~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT------RERIESGYRM---P-------APQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH------HHHHhcCCCC---C-------CCc
Confidence            234567999999988899999999999999999999 8888865432111      1111111000   0       011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      .....+.+++.+|++.+|.+||++.|+++.|+.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            123468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.3e-35  Score=324.05  Aligned_cols=240  Identities=28%  Similarity=0.399  Sum_probs=190.2

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.+ +|+.||+|.++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 68899999987542   12234566677777754 899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  151 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN  151 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence            9999888753    4678999999999999999999999   9999999999999999999999999998753211  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ...   ..+....       +.+.. 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~---~~~~~~~-------~~~~~-  217 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF---ESIRVDT-------PHYPR-  217 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCC-------CCCCC-
Confidence            233467899999999999999999999999999999999999999643221   111   1111111       00000 


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQ-QLV 1013 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1013 (1020)
                         ....++.+++.+|++.||++||++. ++.
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ---WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               1123578999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-34  Score=317.74  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|... ++..||+|.+.... .....++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999865 57889999887543 23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..+++..+..++.|+++||+|||+..  +++||||||+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998754    45789999999999999999999732  8999999999999999999999999998765322 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc-------
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES-------  972 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  972 (1020)
                         ......++..|+|||...+..++.++||||||+++|||++|+.||............   ..........       
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF---GRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh---cCccccccccCCccccc
Confidence               223457889999999988888999999999999999999999998643221111000   0000000000       


Q ss_pred             --------------------cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 --------------------EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 --------------------~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                          ....|...   .......+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  286 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTK  286 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                                00000000   0012235889999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-34  Score=308.67  Aligned_cols=240  Identities=23%  Similarity=0.400  Sum_probs=189.4

Q ss_pred             CeeeccCCeEEEEEEeCC-------------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          748 NIIGCGGFGLVYRATLPD-------------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      +.||+|+||.||+|.+.+             ...||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358999887655555567888999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC-------eEEe
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-------AHLA  887 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~  887 (1020)
                      +||||+++++|+.++...   ...+++..++.++.||++|++|||+.   +|+||||||+||+++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999887653   24589999999999999999999999   9999999999999987664       8999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCCcccHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELL-TGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      |||.+......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.       ...
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~  221 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERF  221 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHH
Confidence            99998754321      2345778899999876 567899999999999999998 58888764321110       011


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      ....  .....+         ....+.+++.+||+.||.+||++.++++.|+
T Consensus       222 ~~~~--~~~~~~---------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 YEGQ--CMLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HhcC--ccCCCC---------ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1100  000111         1235789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.3e-34  Score=319.74  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=192.9

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.+ +++.||||++....   ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 57899999997542   12234567788888888 799999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~  151 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV  151 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence            9998888654    4689999999999999999999999   9999999999999999999999999998753221  11


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||.....   ..   ....+.....    ..+     
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~---~~~~i~~~~~----~~~-----  216 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DE---LFQSILEDEV----RYP-----  216 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HH---HHHHHHcCCC----CCC-----
Confidence            22335689999999999999999999999999999999999999964321   11   1111111110    001     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTT-----QQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1014 (1020)
                        ......+.+++.+||+.||.+||++     .++++
T Consensus       217 --~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 --RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              1122357899999999999999999     87765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.7e-34  Score=316.12  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+++++.++|||++++++++......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35789999999999999999985 46889999998765544456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...     .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999988642     478899999999999999999999   99999999999999999999999999987653221


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......+++.|+|||...+..++.++|||||||++|+|++|+.||....+..  .   +...... . ......   
T Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~---~~~~~~~-~-~~~~~~---  238 (296)
T cd06654         171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A---LYLIATN-G-TPELQN---  238 (296)
T ss_pred             --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--h---HHHHhcC-C-CCCCCC---
Confidence              11233468889999999988889999999999999999999999996433211  1   1111110 0 001001   


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +......+.+++.+||..+|++||++.++++
T Consensus       239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 ----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                1122345789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4e-34  Score=314.02  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=198.7

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .|+..+.||+|+||.||+|... +++.||||.+....   ....+.+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999865 68899999986542   1223456789999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++......
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999988653  224588999999999999999999998   9999999999999999999999999998764321


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                         .......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.....................         .
T Consensus       156 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~  223 (285)
T cd05630         156 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE---------E  223 (285)
T ss_pred             ---ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---------h
Confidence               1122347899999999999999999999999999999999999999754322111111111000000         0


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                      .    .......+.+++.+||+.||++||+     ++|+++
T Consensus       224 ~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 Y----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             c----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0    0111235789999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-35  Score=325.35  Aligned_cols=238  Identities=24%  Similarity=0.302  Sum_probs=191.3

Q ss_pred             CeeeccCCeEEEEEEe----CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          748 NIIGCGGFGLVYRATL----PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+.+|++++++++||||+++++++.+....|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    3678999999975432  123456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999888653    4689999999999999999999999   99999999999999999999999999988653321  


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....  .        
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~--~--------  216 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKL--G--------  216 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCC--C--------
Confidence            223345789999999999988899999999999999999999999974321      111111111110  0        


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1011 (1020)
                       .+......+.+++.+||+.||++||++.+
T Consensus       217 -~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 -MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             00111235789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-34  Score=312.13  Aligned_cols=252  Identities=32%  Similarity=0.491  Sum_probs=200.4

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHH--HHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMER--EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      |++.+.||+|+||+||+++.. +++.||+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999976 4568999999877543222  3456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...    ..+++..+..++.|+++||++||+.   +++||||||+||+++.++.++|+|||.+....  ..
T Consensus        81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN  151 (260)
T ss_dssp             TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred             cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            999999999833    4679999999999999999999999   99999999999999999999999999997641  12


Q ss_pred             cccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........++..|+|||+.. +..++.++||||+|+++|+|++|..||.....   .+...................   
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~---  225 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRPLPSSSQQ---  225 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTHHHHHTTS---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhcccccccccccc---
Confidence            23344567889999999988 88999999999999999999999999975411   111111111111000000000   


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .......+.+++.+||+.||++||++.++++
T Consensus       226 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 ----SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0001157899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-34  Score=312.79  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|++++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3467888999999999999998643    3468999987665 3445678999999999999999999998875 45789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++..
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999764   23589999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .... ........++..|+|||......++.++||||||+++|||++ |..||......+   ...   .........  
T Consensus       158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~~~~~~~--  228 (270)
T cd05056         158 EDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG---RIENGERLP--  228 (270)
T ss_pred             cccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHcCCcCC--
Confidence            4321 111222334568999999888889999999999999999996 999997543221   111   111111110  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       .       +......+.+++.+|+..+|.+|||+.++++.|+++
T Consensus       229 -~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         229 -M-------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0       111224688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.4e-34  Score=311.57  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=204.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46789999999999999999998778889999887543 234578899999999999999999999887 7789999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++...... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  156 (260)
T cd05073          83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  156 (260)
T ss_pred             CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence            999999998764  234578899999999999999999998   99999999999999999999999999997653321 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........++..|+|||++....++.++|+||||+++|++++ |..||......   +...+   ....... .      
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~---~~~~~~~-~------  223 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA---LERGYRM-P------  223 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---HhCCCCC-C------
Confidence            112222345678999999988899999999999999999999 89999643221   11111   1111000 0      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         ........+.+++.+|++.+|++||++.++.+.|+.+
T Consensus       224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence               0112234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=309.99  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      -|+..+-||+|.|+.|-+|++ -+|..||||++.+..-  .....+.+|++.|+.++|||||++|++.......|+|.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            477778899999999999974 4799999999976542  2345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE-cCCCCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL-DGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      =++|+|.+|+...   ...+.++-+.+++.||+.|+.|+|+.   .+|||||||+||++ ..-|-+|++|||++..+.. 
T Consensus        99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            9999999999765   34688999999999999999999999   99999999999876 6778999999999987632 


Q ss_pred             CCcccccccccccCccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVAT-YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                        .......+|+..|-|||++.+..|+ +++||||+|||+|-+++|+.||+..++.+....+...+.             
T Consensus       172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------------  236 (864)
T KOG4717|consen  172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------------  236 (864)
T ss_pred             --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-------------
Confidence              3345567899999999999887775 689999999999999999999998777665443321111             


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                          ..+..-..+..++|..|+..||.+|.+.++|+.  ||+
T Consensus       237 ----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  237 ----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             ----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence                112333456889999999999999999999986  554

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.5e-34  Score=306.59  Aligned_cols=249  Identities=29%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+....  ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999865 68899999986432  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999987642  34688999999999999999999998   99999999999999999999999999988764322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......|++.|+|||+..+..++.++|+||||+++|||++|+.||.....   ....   ..... .....     .
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~~-~~~~~-----~  221 (256)
T cd08529         156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI---LKIIR-GVFPP-----V  221 (256)
T ss_pred             --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHc-CCCCC-----C
Confidence              122334678899999999999999999999999999999999999964331   1111   11111 11111     0


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .......+.+++.+||+.+|++||++.++++
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                1122346889999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-34  Score=310.87  Aligned_cols=252  Identities=28%  Similarity=0.487  Sum_probs=202.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ...++.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999887788999998875432 24578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...   ...++++.+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++....... 
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            99999988753   23578999999999999999999999   999999999999999999999999999876543211 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...++.++.++||||+|+++|||++ |..||......   .   .........   ....+.. 
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~---~~~~~~~~~---~~~~~~~-  225 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---E---VVETINAGF---RLYKPRL-  225 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H---HHHHHhCCC---CCCCCCC-
Confidence            11122334578999999988899999999999999999998 99999643211   1   111111110   1111111 


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                            ....+.+++.+||+.+|++||++.+++++|.
T Consensus       226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                  1246889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-34  Score=311.41  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++|||++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999865 68899999986432 334467888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      +++++.+++...  ....++.+.+..++.|++.|++|||+.   +++|+||||+||++++++.++++|||.++...... 
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            999999988653  234578999999999999999999999   99999999999999999999999999997654322 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       .......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||.....      .......... .....      
T Consensus       155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~------  220 (255)
T cd08219         155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQG-SYKPL------  220 (255)
T ss_pred             -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcC-CCCCC------
Confidence             122345688899999999988999999999999999999999999974321      1111111111 11100      


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                         +......+.+++.+||+.||++||++.++++.
T Consensus       221 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               11122357899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-34  Score=313.96  Aligned_cols=255  Identities=24%  Similarity=0.434  Sum_probs=202.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .+|++.+.||+|+||.||+|..+ +|+    .||+|....... ....++.+|++.+++++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788999999999999999864 233    589998876543 344678899999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998764   23589999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||......++.++|+||+|+++||+++ |+.||......   +..   ........   .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~---~~~~~~~~---~  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP---DLLEKGER---L  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH---HHHhCCCC---C
Confidence            43222111112233568999999888899999999999999999999 99999754321   111   11111111   0


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+       ..+...+.+++.+||..+|.+||++.++++.|+++
T Consensus       231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111       11223578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-34  Score=326.12  Aligned_cols=259  Identities=22%  Similarity=0.263  Sum_probs=200.2

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      +.++....++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3444555688999999999999999999875 67899999986422   1223457789999999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      .+..++||||+++|+|.+++...     .++...+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999988653     478888999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      |+++...... ........||+.|+|||++...    .++.++||||+||++|||++|+.||.....      ......+
T Consensus       187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI  259 (371)
T ss_pred             CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            9998764321 1222346799999999987654    378899999999999999999999974322      1111122


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      ..........++       ......+.+++.+|+..++.+  ||+++|+++
T Consensus       260 ~~~~~~~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         260 MNHKNSLTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             HcCCCcccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            111111111111       112235778999999844433  789999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-34  Score=313.41  Aligned_cols=250  Identities=27%  Similarity=0.369  Sum_probs=197.7

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      |+..+.||+|+||+||+|... +++.||+|.+....   ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999864 68899999986542   12234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|..++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++...... 
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-  155 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-  155 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence            9999999888653  234689999999999999999999999   9999999999999999999999999998764321 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......|+..|+|||++.+..++.++|+||+|+++|||++|+.||...........+  ........   .    ..
T Consensus       156 --~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~~~~~---~----~~  224 (285)
T cd05632         156 --ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRVLETE---E----VY  224 (285)
T ss_pred             --CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhhhccc---c----cc
Confidence              1123357899999999998889999999999999999999999999753321111111  11111100   0    00


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                          .......+.+++.+|++.||++||+     +.++++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 ----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                1111235789999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-34  Score=314.62  Aligned_cols=252  Identities=30%  Similarity=0.495  Sum_probs=198.5

Q ss_pred             CeeeccCCeEEEEEEeCC-------CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATLPD-------GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886543 23356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-----CeEEeeccc
Q 035998          820 MENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-----GAHLADFGL  891 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~  891 (1020)
                      +++++|.+++.....   ....+++.++..++.|++.|++|||+.   +++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999976432   224578899999999999999999998   999999999999999877     899999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ++...............++..|+|||++.++.++.++||||||+++|||++ |+.||......   ..   .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~---~~~~~~~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EV---LQHVTAGGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HH---HHHHhcCCc
Confidence            986643322222233345678999999999999999999999999999998 99999643221   11   111111110


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      .          .........+.+++.+||+.+|.+||+++++++.|++
T Consensus       232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0          0011223467899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-34  Score=314.91  Aligned_cols=264  Identities=26%  Similarity=0.397  Sum_probs=205.4

Q ss_pred             ccHHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEe-
Q 035998          732 ISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCM-  808 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  808 (1020)
                      +.++.+..+.++|++.+.||+|+||.||+|... +++.||+|++.... ....++.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445666778899999999999999999999864 57899999886532 2245678899999999 6999999999884 


Q ss_pred             ----ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          809 ----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       809 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                          .....++||||+++++|.+++.........+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                33467999999999999998875444445788999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  959 (1020)
                      |++|||+++......  .......|++.|+|||++.     ...++.++||||+||++|||++|+.||........   .
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---~  238 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---L  238 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---H
Confidence            999999988653221  1223356889999999875     34578899999999999999999999975432110   0


Q ss_pred             HHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          960 SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       960 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                         ..... .......++..       ....+.+++.+||+.||++||++.|+++.
T Consensus       239 ---~~~~~-~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         239 ---FKIPR-NPPPTLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---hhccc-cCCCcccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               00000 01111111111       12358899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-34  Score=316.81  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=193.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHc---CCCccceEeeEEecc-----C
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRA---QHPNLVHLQGYCMHK-----N  811 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  811 (1020)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+.....  .....+.+|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999865 688999999875421  2223456677777665   799999999988642     3


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++ +|.+++....  ...++++.+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            47899999975 8888876542  24589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh-h--
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ-E--  968 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~--  968 (1020)
                      ++.....   .......++..|+|||++.+..++.++||||+||++|||++|++||.......   .......... .  
T Consensus       155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~  228 (288)
T cd07863         155 ARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPE  228 (288)
T ss_pred             cccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCCh
Confidence            9865322   12233567889999999988899999999999999999999999996433211   1111111100 0  


Q ss_pred             ccccc-------ccCccc---cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESE-------VLDPFI---YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~-------~~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....       ...+..   .....+.....+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000       000000   00011122345789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-34  Score=342.70  Aligned_cols=256  Identities=22%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRL  814 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  814 (1020)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+....  ......+..|+.++++++|||||+++++|.+.  ...|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999865 57789999886542  23345788999999999999999999988653  4578


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCC----CCeEecCCCCCCEEEcC----------
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE----PHILHRDIKSSNILLDG----------  880 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~----------  880 (1020)
                      +||||+++|+|.+++.........+++..++.|+.||+.||+|||+...    .+||||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999998755445678999999999999999999998521    25999999999999964          


Q ss_pred             -------CCCeEEeeccccccccCCCCcccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 035998          881 -------NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCK  951 (1020)
Q Consensus       881 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~  951 (1020)
                             .+.+||+|||+++.....   .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   334899999999865322   22234578999999998754  468899999999999999999999996432


Q ss_pred             CCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          952 PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .     ............   ....    ..    ....+.++|..||+.+|.+||++.|++.
T Consensus       248 ~-----~~qli~~lk~~p---~lpi----~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N-----FSQLISELKRGP---DLPI----KG----KSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c-----HHHHHHHHhcCC---CCCc----CC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1     111111111111   0000    01    1235889999999999999999999984

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-34  Score=326.79  Aligned_cols=261  Identities=23%  Similarity=0.274  Sum_probs=195.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ...|.+.+.||+|+||.||+|... .++.||||....      ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999875 578899996432      3456899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +. ++|..++...   ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6888877653   23689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CcccHHHHHHHH-Hhhcc-ccccc-
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK-GSRDLISWVIRM-RQENR-ESEVL-  975 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~~~~~~~-~~~~~-~~~~~-  975 (1020)
                      .........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...........+ ..... ..+.. 
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            222223457899999999999999999999999999999999988765322211 111111111111 11000 00000 


Q ss_pred             ------------------CccccC---ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 ------------------DPFIYD---KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 ------------------d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                        .+....   .........+.+++.+||+.||.+|||+.|+++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                              000000   000011125788999999999999999999987

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.1e-34  Score=306.60  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=200.2

Q ss_pred             CeeeccCCeEEEEEEeCC--C--CEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLPD--G--RNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  3699999987665 556789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc-
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT-  901 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  901 (1020)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++........ 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999886522  4689999999999999999999999   9999999999999999999999999999876442221 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......++..|+|||...+..++.++||||+|+++|||++ |+.||......   +...   .......  ....    
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~---~~~~~~~--~~~~----  222 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILK---KIDKEGE--RLER----  222 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHhcCC--cCCC----
Confidence            11223456788999999999999999999999999999999 99999643221   1111   1111110  0001    


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                         +......+.+++.+|++.+|++||++.++++.|.+
T Consensus       223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence               11123468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.3e-35  Score=325.46  Aligned_cols=237  Identities=26%  Similarity=0.347  Sum_probs=187.1

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHH-HHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVE-ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||+||+|+.. +|+.||+|++.....   ...+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 689999999875321   12233444544 55778999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~  151 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK  151 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence            9999888753    4688999999999999999999999   9999999999999999999999999998754221  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......      .....+... .. . ..+     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~~-~-~~~-----  217 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNK-PL-R-LKP-----  217 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcC-CC-C-CCC-----
Confidence            233457899999999999999999999999999999999999999743211      111111111 00 0 011     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQ 1010 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1010 (1020)
                         .....+.+++.+|++.||.+||++.
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 ---NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence               1123578999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=302.47  Aligned_cols=268  Identities=23%  Similarity=0.316  Sum_probs=223.6

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhh-HHHHHHHHHHHHHcCCCccceEee
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQG  805 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~  805 (1020)
                      ...++.....+++...++.+|.||.||.|.|.      +.+.|.||.++....+. ...+..|...+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34566666788999999999999999999764      34557788877665443 345778888888899999999999


Q ss_pred             EEec-cCceEEEEEeccCCChhhhhhhc----CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC
Q 035998          806 YCMH-KNDRLLIYSFMENGSLDYWLHEK----LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG  880 (1020)
Q Consensus       806 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  880 (1020)
                      ++.+ .+..+++|.++..|+|..|+...    ....+.++..+.+.++.|++.|++|||++   +|||.||.++|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            9875 45678999999999999999832    23455778889999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHH
Q 035998          881 NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       881 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  959 (1020)
                      .-++|++|=.++|.....+..........+..||+||.+....|+.++|||||||++|||+| |+.||....+.+...++
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            99999999999998876544444444556789999999999999999999999999999999 99999988887777776


Q ss_pred             HHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          960 SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       960 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....+..++..+                +.+++.+|..||+.+|++||++++++..|.++
T Consensus       512 kdGyRlaQP~NC----------------PDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 KDGYRLAQPFNC----------------PDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             hccceecCCCCC----------------cHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            655555554443                33689999999999999999999999998764

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.2e-34  Score=322.89  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999864 68899999986542  233456788999999999999999999986543      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++ ++...+..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            46899999976 45554432      368888999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc------------cHH
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR------------DLI  959 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~------------~~~  959 (1020)
                      ++....   ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.........            ...
T Consensus       170 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             cccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            976422   12233457899999999999999999999999999999999999999754321100            000


Q ss_pred             HHH----HHHHhhcc-c-----ccccCccccC---ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          960 SWV----IRMRQENR-E-----SEVLDPFIYD---KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       960 ~~~----~~~~~~~~-~-----~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    ........ .     .+....+...   .........+.+++.+|++.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            000    00000000 0     0000000000   000112245789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-34  Score=321.93  Aligned_cols=192  Identities=24%  Similarity=0.357  Sum_probs=164.2

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++......++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3467999999999999999999875 5678999975432      23468999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+. ++|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.++.... 
T Consensus       138 ~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  209 (357)
T PHA03209        138 HYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-  209 (357)
T ss_pred             ccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence            995 5788877653   34689999999999999999999999   999999999999999999999999999975322 


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM  947 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf  947 (1020)
                        ........||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus       210 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 --APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              11223456899999999999999999999999999999999965544

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.6e-34  Score=309.86  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=192.1

Q ss_pred             CeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEe-ccCceEEEEEecc
Q 035998          748 NIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCM-HKNDRLLIYSFME  821 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  821 (1020)
                      +.||+|+||.||+|.+.    ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    24579999885432 334567888999999999999999999876 4556789999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...   ....++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998754   23457788899999999999999998   9999999999999999999999999999765332111


Q ss_pred             --ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          902 --HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG-KRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       902 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                        .......++..|+|||...+..++.++||||||+++|||++| .+||.....   .+..   .........   ..+ 
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~---~~~~~~~~~---~~~-  224 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDIT---VYLLQGRRL---LQP-  224 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH---HHHhcCCCC---CCC-
Confidence              111233456789999999888999999999999999999995 556643221   1111   111111100   000 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                            ......+.+++.+||+.+|++||++.|+++.|++++
T Consensus       225 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         225 ------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                  011235889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-34  Score=311.79  Aligned_cols=239  Identities=24%  Similarity=0.394  Sum_probs=187.8

Q ss_pred             eeeccCCeEEEEEEeCC-------------------------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceE
Q 035998          749 IIGCGGFGLVYRATLPD-------------------------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL  803 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  803 (1020)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999996421                         13589999876554455678889999999999999999


Q ss_pred             eeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-
Q 035998          804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-  882 (1020)
Q Consensus       804 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-  882 (1020)
                      ++++.+....++||||+++|+|..++...   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            99999999999999999999999988653   24678999999999999999999998   999999999999997643 


Q ss_pred             ------CeEEeeccccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCCC
Q 035998          883 ------GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELL-TGKRPMDMCKPKG  954 (1020)
Q Consensus       883 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tg~~pf~~~~~~~  954 (1020)
                            .+|++|||.+......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+.+
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  3799999988654221      12356788999998765 56899999999999999995 6999997543321


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .   ...   .........        ..    ...+.+++.+||+.+|++||+++++++.|+
T Consensus       230 ~---~~~---~~~~~~~~~--------~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 K---ERF---YEKKHRLPE--------PS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---HHH---HHhccCCCC--------CC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1   111   111111110        01    125789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.1e-34  Score=315.24  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-----CCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEec--cCce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  813 (1020)
                      ++|+..+.||+|+||.||+|++.     ++..||||.+...... ..+.+.+|++.+++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999853     3678999999866443 46689999999999999999999999887  5578


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999764   23589999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc--------cHHHHH-H
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR--------DLISWV-I  963 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--------~~~~~~-~  963 (1020)
                      ........ .......++..|+|||...+..++.++||||||+++|||++|+.|+.........        ...... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            76432221 1111234456799999998889999999999999999999999998643221110        001111 1


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ........          ..+.....++.+++.+||+.+|++||++.|++++|+++
T Consensus       238 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111100          00112224688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-34  Score=324.19  Aligned_cols=241  Identities=25%  Similarity=0.317  Sum_probs=188.1

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHH-HHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEV-EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +++.||+|++.....   .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 578899999875321   1223344444 356778999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|.+++...    ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~  151 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG  151 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence            9999988753    4577888899999999999999999   9999999999999999999999999999754322  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......   ....   ..... ..  ...+     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~-~~--~~~~-----  217 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILNK-PL--QLKP-----  217 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHHhC-Cc--CCCC-----
Confidence            233457899999999999999999999999999999999999999743221   1111   11111 00  0011     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .....+.+++.+|++.||.+||++.+.+.
T Consensus       218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ---CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence               11235789999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-34  Score=310.10  Aligned_cols=253  Identities=25%  Similarity=0.323  Sum_probs=199.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ...|+++++||+|+.++||++...+.+.||+|++....  .+....|.+|+..+.++ .|.+||++++|-..++..||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            45789999999999999999998888899998765432  34556799999999999 5999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||= ..||..++..+.   ..++.-.++.+..|++.|+.++|.+   ||||.||||.|+|+- .|.+||+|||.|..+..
T Consensus       440 E~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            964 459999998763   2233227889999999999999999   999999999999985 46899999999998866


Q ss_pred             CCCcccccccccccCccCccccCCC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQAS-----------VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      +...-.....+||+.||+||.+...           +.+.++||||+|||+|+|+.|+.||...     ...+.....+.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~  586 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAIT  586 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhc
Confidence            5555556678999999999976433           2567999999999999999999999632     12222222222


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+.  .++.-|.+...      .+++++|+.|+++||.+||++.++++
T Consensus       587 ~P~--~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  587 DPN--HEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCC--ccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            221  22111211111      13899999999999999999999987

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-34  Score=321.29  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=192.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|.++++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999865 68899999987542   122345677888888885 577888999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999988754    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......   ....   .+.... . .    
T Consensus       154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~---~i~~~~-~-~----  219 (323)
T cd05615         154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ---SIMEHN-V-S----  219 (323)
T ss_pred             C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCC-C-C----
Confidence            2  12223456899999999999999999999999999999999999999753221   1111   111110 0 0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                           .+......+.+++.+|++.+|.+|++.
T Consensus       220 -----~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 -----YPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 011122357899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=318.28  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=203.5

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChh
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD  826 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  826 (1020)
                      -++|+|.||+||-|+.. +...+|||.+........+-++.|+..-++++|+|||+++|.+.+.+..-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            36999999999999965 45679999998766666677899999999999999999999999999888999999999999


Q ss_pred             hhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-CCCCeEEeeccccccccCCCCccccc
Q 035998          827 YWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       827 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      +.++.+. ++-.-.+.+.-.+-+||++||.|||+.   .|||||||-+|||++ -.|.+||+|||-+++...  -...+.
T Consensus       661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            9999764 222237788889999999999999999   999999999999996 588999999999998743  345566


Q ss_pred             ccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          906 DLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      ...||..|||||++..+  .|+.++|||||||++.||.||++||.......  ..+-.+...+.        .|    +.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmyKv--------HP----~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMYKV--------HP----PI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhhcceec--------CC----CC
Confidence            78899999999998765  58899999999999999999999997654321  11211111111        11    22


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.+...+...+|.+|+.+||.+||+++++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            4455667889999999999999999999986

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.7e-34  Score=308.95  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=189.9

Q ss_pred             CeeeccCCeEEEEEEeCC---CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          748 NIIGCGGFGLVYRATLPD---GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......+.+|++.++.++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   4568888876443 233456888999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          824 SLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       824 ~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      +|.+++...... ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999765322 23456788899999999999999999   99999999999999999999999999987543221111


Q ss_pred             cccccccccCccCccccC-------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          903 VTTDLVGTLGYIPPEYGQ-------ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ......++..|+|||+..       ...++.++||||+||++|||++ |..||....+.   +...   ..... .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~~-~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLK---QVVRE-QDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHH---HHhhc-cCccC
Confidence            122334567899999764       3456889999999999999999 78888643221   1111   11111 11111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .++....    .....+.+++..|| .||++||++++|++.|.
T Consensus       231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2221111    12235667888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.2e-34  Score=316.80  Aligned_cols=261  Identities=21%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56899999999999999999865 67899999986443 22334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++....+.
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888887653   24578999999999999999999999   99999999999999999999999999997653221


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh---hccccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ---ENRESEVL  975 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  975 (1020)
                        .......+++.|+|||...+ ..++.++||||+||++|||++|+.||......   +..........   ........
T Consensus       159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhh
Confidence              12223456889999998755 45788999999999999999999999754321   11111111100   00000000


Q ss_pred             C---------ccccCc----cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 D---------PFIYDK----QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d---------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +         +.....    ..+.....+.+++.+|++.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0         000000    00112235789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=322.19  Aligned_cols=198  Identities=25%  Similarity=0.328  Sum_probs=171.1

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-C-----CccceEeeEEeccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-H-----PNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  815 (1020)
                      +|++.+.||+|+||.|.+|.. ++++.||||+++.... -.++...|+.++..++ |     -|+|+++++|..+.+.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            799999999999999999975 5699999999987643 2456677999999996 4     489999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC--CCeEEeeccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN--FGAHLADFGLAR  893 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~~~  893 (1020)
                      |+|.++ -+|.++++..  ....++...++.|+.||+.||.+||+.   +|||+||||+|||+.+-  ..+||+|||.|.
T Consensus       266 VfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999885 5899999875  345689999999999999999999999   99999999999999643  369999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP  952 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  952 (1020)
                      ....     ....++-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+...
T Consensus       340 ~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  340 FESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            7532     12256778899999999999999999999999999999999888865443

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.1e-34  Score=317.01  Aligned_cols=255  Identities=26%  Similarity=0.453  Sum_probs=199.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46788899999999999999864 343    578998876543 2334688999999999999999999998754 4678


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999988754   23578999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||...+..++.++||||||+++|||++ |+.||......   .....   .......   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~---  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL---LEKGERL---  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHCCCCC---
Confidence            43222212223345678999999999999999999999999999998 99999643211   11111   1111110   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+       ..+...+.+++.+||..+|++||+++++++.|+++
T Consensus       231 ~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         231 PQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000       11224678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-34  Score=310.68  Aligned_cols=252  Identities=27%  Similarity=0.392  Sum_probs=199.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46788899999999999999864 68899999987665444556788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...    ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......  
T Consensus        89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            999999988654    4688999999999999999999999   9999999999999999999999999998765322  


Q ss_pred             cccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          901 THVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ........|+..|+|||++.   ...++.++||||+||++|+|++|+.||....+...  .    ...........    
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~~~~~~~~----  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMTKSNFQPP----  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----HhhhccCCCCC----
Confidence            12223457889999999864   45688999999999999999999999864332111  1    01111110000    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....  .......+.+++.+|++.+|++||+++++++
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000  0011235789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-33  Score=312.42  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36799999999999999999985 47899999999765544456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++.+.     .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.......
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999988653     578899999999999999999999   99999999999999999999999999987653221


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......+++.|+|||...+..++.++|+||+||++|+|++|+.||....+......      ..... ......   
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~~~~---  237 (297)
T cd06656         170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPELQN---  237 (297)
T ss_pred             --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCCCCC---
Confidence              122334678899999999888899999999999999999999999965332111000      00000 000000   


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +......+.+++.+||+.+|++||+++++++
T Consensus       238 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 ----PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1122245789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-33  Score=305.59  Aligned_cols=254  Identities=21%  Similarity=0.366  Sum_probs=190.4

Q ss_pred             eeeccCCeEEEEEEeCCC---CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCC
Q 035998          749 IIGCGGFGLVYRATLPDG---RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGS  824 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  824 (1020)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   356677766543 2345678999999999999999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccc
Q 035998          825 LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT  904 (1020)
Q Consensus       825 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  904 (1020)
                      |.+++.+........++..+..++.||++||+|||+.   +++||||||+||+++.++.+|++|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986533334567778889999999999999998   9999999999999999999999999998643221111222


Q ss_pred             cccccccCccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          905 TDLVGTLGYIPPEYGQA-------SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       905 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ....++..|+|||+...       ..++.++||||||+++|||++ |..||......   ....   ..... ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~~-~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---HVIKD-QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHhh-cccccCC
Confidence            34567889999998643       245789999999999999997 57787643221   1111   11111 1112222


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      +.+...+.    ..+.+++..|| .+|++||+++++++.|.
T Consensus       232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            32222222    35778899999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-33  Score=305.41  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=200.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc------hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC------GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478899999999999999998889999999886432      11234688899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++.+.    ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++++|||.++...
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999998764    3578899999999999999999998   99999999999999999999999999987653


Q ss_pred             CCCC----cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh-ccc
Q 035998          897 SPYD----THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE-NRE  971 (1020)
Q Consensus       897 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  971 (1020)
                      ....    ........++..|+|||+..+..++.++||||+|+++|+|++|+.||.......  .    ....... ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~~  227 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--A----MFYIGAHRGLM  227 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--H----HHHhhhccCCC
Confidence            2111    111223568889999999999899999999999999999999999996432111  1    1111111 111


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..     ...    .....+.+++.+||+.+|.+||++.++++
T Consensus       228 ~~-----~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 PR-----LPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC-----CCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11     111    12245789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-33  Score=306.03  Aligned_cols=250  Identities=27%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|+..+.||+|+||.||+|...+ ++.||+|.+.....  .+++.+|++++++++||||+++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3578999999999999999999764 78999999876533  56899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||++.......
T Consensus        80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            9999999998653   24689999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......++..|+|||++.+..++.++||||||+++|+|++|+.||....+...   .   .... ......      
T Consensus       154 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~---~~~~-~~~~~~------  218 (256)
T cd06612         154 --AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---I---FMIP-NKPPPT------  218 (256)
T ss_pred             --cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---h---hhhc-cCCCCC------
Confidence              122334578899999999888999999999999999999999999974322111   0   0000 000000      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ...+......+.+++.+||+.+|.+||+++|+++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             0011122246889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-34  Score=308.28  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=205.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357899999999999999999864 5788999999876555567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999988753   24688999999999999999999999   99999999999999999999999999987653321


Q ss_pred             CcccccccccccCccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQAS---VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                        .......++..|+|||.....   .++.++||||+|+++|||++|+.||....+...      ..........    .
T Consensus       156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~~----~  223 (262)
T cd06613         156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNFP----P  223 (262)
T ss_pred             --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCC----C
Confidence              122345678899999998776   889999999999999999999999975432111      1111111000    0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +..  .........+.+++.+||+.+|.+||++++++.
T Consensus       224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000  112233456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-34  Score=324.12  Aligned_cols=238  Identities=28%  Similarity=0.370  Sum_probs=187.3

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHH-HHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVE-ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999864 68999999987542   122234555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~  151 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD  151 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence            9998887653    4688999999999999999999999   9999999999999999999999999998754221  12


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||......      ..........   ....+     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~---~~~~~-----  217 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP---LVLRP-----  217 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC---ccCCC-----
Confidence            223457899999999999999999999999999999999999999643211      1111111110   00111     


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1011 (1020)
                         .....+.+++.+|++.+|.+||++++
T Consensus       218 ---~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 ---GASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ---CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence               12235778999999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.9e-34  Score=334.38  Aligned_cols=263  Identities=21%  Similarity=0.268  Sum_probs=192.1

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC------CccceEeeEEecc
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH------PNLVHLQGYCMHK  810 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  810 (1020)
                      ...+++|++.++||+|+||.||+|... .++.||||+++... ...+++..|++++++++|      .+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345688999999999999999999864 57889999986532 223456678888877754      4588898888765


Q ss_pred             -CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCC------
Q 035998          811 -NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNF------  882 (1020)
Q Consensus       811 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~------  882 (1020)
                       ...++|||++ +++|.+++.+.    ..+++..+..++.||+.||+|||+ .   +||||||||+|||++.++      
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccc
Confidence             4678999988 67888877654    468999999999999999999997 5   899999999999998765      


Q ss_pred             ----------CeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 035998          883 ----------GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP  952 (1020)
Q Consensus       883 ----------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  952 (1020)
                                .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999876431     223346789999999999999999999999999999999999999975433


Q ss_pred             CCcccHHHHHHH-----------------HH-hhcccccccCcccc-----Ccc--CHHHHHHHHHHHhhccCCCCCCCC
Q 035998          953 KGSRDLISWVIR-----------------MR-QENRESEVLDPFIY-----DKQ--HDKEMLRVLDIACLCLSESPKVRP 1007 (1020)
Q Consensus       953 ~~~~~~~~~~~~-----------------~~-~~~~~~~~~d~~~~-----~~~--~~~~~~~l~~li~~cl~~dP~~RP 1007 (1020)
                      .+....+.....                 .. .........++...     ...  .......+.+|+.+||++||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            211111111000                 00 00000000000000     000  001123577999999999999999


Q ss_pred             CHHHHHH
Q 035998         1008 TTQQLVS 1014 (1020)
Q Consensus      1008 s~~evl~ 1014 (1020)
                      |++|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999987

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=319.74  Aligned_cols=254  Identities=24%  Similarity=0.261  Sum_probs=194.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999865 68899999986421   122345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++.+.   ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999998753   24588999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCcccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .. ........||+.|+|||++..     ..++.++||||+||++|||++|+.||.....      ......+.......
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~  227 (331)
T cd05597         155 DG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF  227 (331)
T ss_pred             CC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence            21 112223468999999998763     4578899999999999999999999964321      11111111111100


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCC--CCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPK--VRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~ 1014 (1020)
                      ....  .    .......+.+++.+|+..++.  .||+++++++
T Consensus       228 ~~~~--~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         228 QFPP--D----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cCCC--c----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            1000  0    011223567888887765443  3889999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.9e-34  Score=312.60  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=203.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|++.++.++|||++++++++...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35689999999999999999985 47899999998765544556788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|..++...     .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999988643     578999999999999999999999   99999999999999999999999999987653321


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......++..|+|||...+..++.++|||||||++|+|++|+.||.......      ........ .......+  
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~-~~~~~~~~--  238 (296)
T cd06655         170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATN-GTPELQNP--  238 (296)
T ss_pred             --ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-CCcccCCc--
Confidence              11233467889999999988889999999999999999999999996533211      11111111 11111111  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ......+.+++.+||..||.+||++.+++.
T Consensus       239 -----~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 -----EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -----ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 112235788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.6e-33  Score=305.08  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ..+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566666788999999999999854 6788999998876655667899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLI  895 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~  895 (1020)
                      +||+++++|.+++..... ....++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.++|+|||.+...
T Consensus        84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          84 MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999875421 11227888899999999999999998   9999999999999986 678999999998765


Q ss_pred             cCCCCcccccccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ....  .......+++.|+|||+....  .++.++||||+|+++|+|++|+.||........   ..+......  .   
T Consensus       160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~--~---  229 (268)
T cd06624         160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK--I---  229 (268)
T ss_pred             ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc--c---
Confidence            3211  112234578899999987654  378899999999999999999999964322111   111110000  0   


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .+.    .+.....++.+++.+||+.+|.+||++.|+++
T Consensus       230 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 --HPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --CCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              010    11122245789999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-33  Score=308.05  Aligned_cols=249  Identities=25%  Similarity=0.437  Sum_probs=199.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh---------hHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---------MEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      +|.+.+.||+|++|.||+|... +++.||+|.+......         ..+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 6789999988654321         22468889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999764    4578889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCc----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          893 RLILSPYDT----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       893 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      +........    .......|+..|+|||...+..++.++||||+|+++|+|++|+.||......      ........ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-  226 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE-  226 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc-
Confidence            876432111    1112345788999999998888999999999999999999999999753211      11111111 


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .     ..+.    .+......+.+++.+||+.||.+||++.|+++
T Consensus       227 ~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 N-----ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             c-----CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0     0111    11122346889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-33  Score=310.65  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=201.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++|||++++++++..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            356899999999999999999875 5889999999876655567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++++++..++.+.   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+...... 
T Consensus        91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-  163 (292)
T cd06644          91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-  163 (292)
T ss_pred             CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence            9999998887653   23588999999999999999999998   9999999999999999999999999998754322 


Q ss_pred             CcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                       ........+++.|+|||++.     ...++.++|||||||++|||++|..||.....      ........... ....
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~  235 (292)
T cd06644         164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTL  235 (292)
T ss_pred             -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-CccC
Confidence             11223456788999999874     34578899999999999999999999864322      11111111111 1111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..       +......+.+++.+||+.+|++||++.++++
T Consensus       236 ~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11       1122235789999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-34  Score=328.10  Aligned_cols=252  Identities=25%  Similarity=0.317  Sum_probs=195.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|++++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999865 68899999987432   223356788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999998754    4688999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCCc---------------------------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCC
Q 035998          898 PYDT---------------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK  944 (1020)
Q Consensus       898 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~  944 (1020)
                      ....                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 0112357899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 035998          945 RPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT---TQQLVS 1014 (1020)
Q Consensus       945 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1014 (1020)
                      .||....+...      ...+........ ..+..      .....+.+++.+|+. ||.+|++   ++|+++
T Consensus       234 ~Pf~~~~~~~~------~~~i~~~~~~~~-~p~~~------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQET------YRKVMNWKETLV-FPPEV------PISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHHHH------HHHHHcCCCcee-cCCCC------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            99975432211      111111000000 00000      012356778878764 9999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.9e-33  Score=307.35  Aligned_cols=258  Identities=24%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      3467999988765433 4467899999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          815 LIYSFMENGSLDYWLHEKLDG-----PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      +||||+++++|.+++......     ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999765322     12689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+++...... ........++..|+|||...+..++.++||||+|+++|+|++ |..||......   ....   .... 
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~---~~~~-  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN---RLQA-  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH---HHHc-
Confidence            9987543221 112223456778999999888889999999999999999999 88898643221   1111   1111 


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ..... ..       .......+.+++.+||+.+|++||++.|+++.|++
T Consensus       234 ~~~~~-~~-------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLEL-PV-------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcCC-CC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            11000 00       11122468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.1e-34  Score=324.51  Aligned_cols=260  Identities=22%  Similarity=0.270  Sum_probs=195.1

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  810 (1020)
                      ..++|++.+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3568999999999999999999854 68899999987542  22345677899999999999999999988643      


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ...++||||+++ ++..++..      .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346899999976 55555542      378889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH-----
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM-----  965 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-----  965 (1020)
                      +++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.  ........     
T Consensus       165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence            99865322   222345789999999999999999999999999999999999999975321110  00000000     


Q ss_pred             -------------Hhh-cccccccCccc-----c---CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 -------------RQE-NRESEVLDPFI-----Y---DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 -------------~~~-~~~~~~~d~~~-----~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   ... ........+..     .   ..........+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                         000 00000000000     0   0001112346789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-33  Score=316.25  Aligned_cols=198  Identities=28%  Similarity=0.414  Sum_probs=161.3

Q ss_pred             CCeeeccCCeEEEEEEeC---CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEEEEecc
Q 035998          747 ANIIGCGGFGLVYRATLP---DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLIYSFME  821 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  821 (1020)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999987542  23457789999999999999999999864  345789999986


Q ss_pred             CCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE----cCCCCeEEeecccc
Q 035998          822 NGSLDYWLHEKL-----DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGAHLADFGLA  892 (1020)
Q Consensus       822 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~  892 (1020)
                      + +|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 7777765321     1233588999999999999999999999   99999999999999    45678999999999


Q ss_pred             ccccCCCCc-ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          893 RLILSPYDT-HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       893 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      +........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433211 12234678999999998876 46899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-33  Score=309.97  Aligned_cols=253  Identities=23%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999875 78999999887542 23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|..++.... ....+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+|++|||.+...... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999998887532 2346899999999999999999999632  8999999999999999999999999998765322 


Q ss_pred             CcccccccccccCccCccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQAS------VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                         ......++..|+|||.+.+.      .++.++|+||+||++|+|++|+.||........   ......... .....
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~-~~~~~  229 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVD-GDPPT  229 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhh-cCCCC
Confidence               22334678899999987544      358899999999999999999999964322111   111111111 11000


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                               .+......+.+++.+||+.+|++||+++++++
T Consensus       230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 ---------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                     11123346789999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.5e-34  Score=309.42  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=199.3

Q ss_pred             CCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          744 FDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      |++.+.||+|+||.||+|.+.    +++.||||++....  ....+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    36789999987643  233557889999999999999999999886542      


Q ss_pred             ceEEEEEeccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          812 DRLLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      ..++++||+++|+|..++....  .....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2368899999999998875332  1223578899999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |.++...............+++.|++||......++.++||||+|+++|||++ |+.||......   +...   .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~---~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN---YLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH---HHHcC
Confidence            99987643222222223345678999999988889999999999999999999 88988643221   1111   11111


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....   .       .+.....+.+++.+||+.+|++||++.++++.|+++
T Consensus       232 ~~~~---~-------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLK---Q-------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCC---C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100   0       011234688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-33  Score=310.43  Aligned_cols=262  Identities=25%  Similarity=0.313  Sum_probs=196.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999865 68899999986542  22345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++ ++|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....+.
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 58888876542 235689999999999999999999999   99999999999999999999999999997653321


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh--c-------
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE--N-------  969 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~-------  969 (1020)
                        .......+++.|+|||++.+ ..++.++||||+|+++|||+||+.||.......  ............  .       
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchh
Confidence              12233466889999998765 457899999999999999999999997432211  111100000000  0       


Q ss_pred             ------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 ------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .......... .........++.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  0000000000 0000112245779999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.3e-33  Score=306.66  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=198.3

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++......++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999875 4778899998765555556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|..++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++......  .
T Consensus        87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            9998887643   24689999999999999999999999   99999999999999999999999999987653221  1


Q ss_pred             cccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ......++..|+|||++.     +..++.++||||+||++|||++|+.||......      ........... .....+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~~~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP-PTLAQP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCC-CCCCCc
Confidence            223356889999999873     456788999999999999999999999643221      11111111110 011111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             ......+.+++.+||+.+|.+||++.++++
T Consensus       232 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 -------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   112246889999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-34  Score=306.98  Aligned_cols=240  Identities=20%  Similarity=0.402  Sum_probs=189.3

Q ss_pred             CeeeccCCeEEEEEEeCC--------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATLPD--------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        234888888665545556788899999999999999999999998999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC--------eEEeeccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--------AHLADFGL  891 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg~  891 (1020)
                      +++|+|..+++..   ...+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998764   23678999999999999999999999   9999999999999987765        69999998


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGK-RPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      +.....      .....++..|+|||++.+ ..++.++||||+|+++|||++|. .||......      ..........
T Consensus       155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~~  222 (258)
T cd05078         155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQFYEDRH  222 (258)
T ss_pred             ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHHHHHccc
Confidence            865432      123457889999998876 45899999999999999999985 555432211      1111111100


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                         ..         +......+.+++.+||+.||++|||++++++.|+
T Consensus       223 ---~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 ---QL---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---cC---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00         1111235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-33  Score=310.85  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=206.0

Q ss_pred             ccHHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEec
Q 035998          732 ISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMH  809 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  809 (1020)
                      ++++++..+.++|++.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455666777899999999999999999999864 68899999986542 2245678899999999 89999999999875


Q ss_pred             c-----CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          810 K-----NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       810 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      .     ...++||||+++++|.++++........+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357899999999999998876544455789999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  959 (1020)
                      |++|||.++......  .......++..|+|||.+...     .++.++||||+||++|||++|+.||.......     
T Consensus       168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----  240 (291)
T cd06639         168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----  240 (291)
T ss_pred             EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence            999999988654321  112334678899999987543     36889999999999999999999996432211     


Q ss_pred             HHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          960 SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       960 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ........ ......++       ......+.+++.+||+.+|++||++.|+++
T Consensus       241 -~~~~~~~~-~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 -TLFKIPRN-PPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHHHHhcC-CCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             11111111 11111111       112235889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6.4e-37  Score=330.81  Aligned_cols=367  Identities=24%  Similarity=0.307  Sum_probs=245.6

Q ss_pred             ccEEEccCCCCC-CCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEcc
Q 035998          183 IRVINLSVNYFS-GTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVS  261 (1020)
Q Consensus       183 L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  261 (1020)
                      .+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+++|++|.+++|++. .+-..++.|+.|+.+++.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            445566666666 356666666777777777777766 56777777777777777777776 445566666667777776


Q ss_pred             CCcCcc-cCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCC
Q 035998          262 SNNFSG-NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP  340 (1020)
Q Consensus       262 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  340 (1020)
                      +|++.. -+|..+-.+..|+.|+|++|+++ ..|..+..                        .+++-.|+||+|+|..+
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~------------------------AKn~iVLNLS~N~IetI  141 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY------------------------AKNSIVLNLSYNNIETI  141 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhhhh-hcchhhhh------------------------hcCcEEEEcccCccccC
Confidence            666642 12333334444444444444444 33444444                        44455555555555422


Q ss_pred             CCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCcc
Q 035998          341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPR  420 (1020)
Q Consensus       341 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~  420 (1020)
                      +-.-|.++..|-.||||+|++. ..|..+..+..|++|+|++|++..+.  +..+..+++|+.|++              
T Consensus       142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ--LrQLPsmtsL~vLhm--------------  204 (1255)
T KOG0444|consen  142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ--LRQLPSMTSLSVLHM--------------  204 (1255)
T ss_pred             CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH--HhcCccchhhhhhhc--------------
Confidence            2223344555555555555554 34444555555555555555543211  111222222222222              


Q ss_pred             ccccCceEEEeccccc-ccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccc
Q 035998          421 LHFANLKVLVIASCGL-RGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLI  499 (1020)
Q Consensus       421 ~~~~~L~~L~l~~n~l-~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  499 (1020)
                                 ++.+- ...+|..+.++.+|..+|||.|.|. .+|+.+..+.+|+.|+||+|+|+ ++.-..+.-    
T Consensus       205 -----------s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W----  267 (1255)
T KOG0444|consen  205 -----------SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEW----  267 (1255)
T ss_pred             -----------ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHH----
Confidence                       22211 2367888999999999999999998 89999999999999999999998 333333222    


Q ss_pred             cccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCccee-ccCccccC
Q 035998          500 TRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSG-PIPSELTG  578 (1020)
Q Consensus       500 ~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~  578 (1020)
                                                      .-..+|+||.|+++ .+|.++..|++|+.|++.+|+|+- -||+.++.
T Consensus       268 --------------------------------~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGK  314 (1255)
T KOG0444|consen  268 --------------------------------ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGK  314 (1255)
T ss_pred             --------------------------------hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhh
Confidence                                            22346777888887 588999999999999999999863 59999999


Q ss_pred             CCcccEEEccCCcccccCCccccccccccccccccccccccCCCCCCCCCcCCccccCCC-CCCCCC
Q 035998          579 MTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHR  644 (1020)
Q Consensus       579 l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~-l~~~~~  644 (1020)
                      |.+|+.+..++|+|. .+|++++.+..|+.|.|++|+|-..+-....+..+..+.+..|+ |-.||.
T Consensus       315 L~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  315 LIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence            999999999999998 99999999999999999999998766556667788889999997 666544

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-33  Score=315.76  Aligned_cols=237  Identities=25%  Similarity=0.326  Sum_probs=186.3

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHH-HHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVE-ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ++||+|+||.||+|+.. +++.||+|++.....   .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 688999999875421   12234445544 57888999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|..++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~  151 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E  151 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence            9998887653    4578889999999999999999999   99999999999999999999999999987542221  2


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......|++.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+... .. .         
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~-~~-~---------  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHK-PL-Q---------  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcC-CC-C---------
Confidence            23345789999999999998999999999999999999999999964321      1111111111 00 0         


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQ 1010 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1010 (1020)
                      .+......+.+++.+|++.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            0111223578999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-33  Score=304.53  Aligned_cols=250  Identities=27%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|+..+.||+|+||.||.++. .+++.|++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999975 468899999876542  33345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+|++|||.++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987642  34678999999999999999999998   99999999999999999999999999998664322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......+++.|+|||...+..++.++||||+|+++|||++|..||......      ........... ...     
T Consensus       156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~-~~~-----  221 (256)
T cd08221         156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQGNY-TPV-----  221 (256)
T ss_pred             --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC-CCC-----
Confidence              1223456889999999998888999999999999999999999999643211      11111111111 100     


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                          .......+.+++.+||+.+|.+||+++++++.
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                11223468899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.7e-34  Score=309.97  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=198.4

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEecc------
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK------  810 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  810 (1020)
                      ++++.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++++ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677889999999999999999864 68899999987543 3345788899999998 799999999998753      


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ...++||||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            3578999999999999998763  234688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +++.....  ........|+..|+|||++.     ...++.++||||+||++|||++|+.||......     .... ..
T Consensus       157 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~-~~  228 (272)
T cd06637         157 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF-LI  228 (272)
T ss_pred             Cceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH-HH
Confidence            98765321  12233456889999999875     346788999999999999999999999643221     1111 11


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .. ..     .+....   ......+.+++.+||+.+|.+||+++++++
T Consensus       229 ~~-~~-----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PR-NP-----APRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hc-CC-----CCCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11 10     011111   112235789999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-33  Score=316.46  Aligned_cols=262  Identities=21%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             cCCeeecc--CCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          746 QANIIGCG--GFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       746 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +.++||+|  +|++||+++. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7889999976 478999999987543  233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999986542  23588999999999999999999999   999999999999999999999999987654322111


Q ss_pred             c-----ccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh------
Q 035998          901 T-----HVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ------  967 (1020)
Q Consensus       901 ~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~------  967 (1020)
                      .     .......++..|+|||++.+  ..++.++||||+||++|||++|+.||........  ..........      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCcccccccc
Confidence            1     01122356778999999865  4688999999999999999999999975332110  0000000000      


Q ss_pred             ----h----cccccccCccc-----------------cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ----E----NRESEVLDPFI-----------------YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ----~----~~~~~~~d~~~-----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .    .......+...                 ...........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                0    00000000000                 00011122346889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-33  Score=305.83  Aligned_cols=238  Identities=24%  Similarity=0.442  Sum_probs=190.1

Q ss_pred             CeeeccCCeEEEEEEeCCCC-----------EEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          748 NIIGCGGFGLVYRATLPDGR-----------NVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      +.||+|+||.||+|...+..           .|++|.+...... ...+.+|++++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999875432           5788887655433 5778899999999999999999999988 778999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-------CeEEeec
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-------GAHLADF  889 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df  889 (1020)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+|++||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999988642   2688999999999999999999998   999999999999999887       7999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |+++....      .....++..|+|||++.+.  .++.++||||+|+++|||++ |..||......+   ...+   ..
T Consensus       153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~---~~  220 (259)
T cd05037         153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF---YQ  220 (259)
T ss_pred             Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH---Hh
Confidence            99986532      1223566789999998776  78999999999999999999 577776543211   1111   11


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      ...   ....+         ....+.+++.+||..+|.+||++.++++.|+
T Consensus       221 ~~~---~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH---RLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC---CCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            100   00010         0146889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-33  Score=302.00  Aligned_cols=247  Identities=28%  Similarity=0.443  Sum_probs=199.8

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      +|+..+.||+|++|.||+|... +++.||+|.+....     ....+.+.+|++++++++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999876 78999999886533     22446788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999998754    3578999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCcccccccccccCccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASV-ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...   ......++..|+|||...... ++.++|+||+|+++|+|++|+.||.....      ...............  
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~--  222 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP--  222 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC--
Confidence            322   223456788999999887766 89999999999999999999999975431      111111111011111  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         +    +......+.+++.+||+.+|.+||++.++++
T Consensus       223 ---~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 ---I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               0    1112245788999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-33  Score=306.46  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCC--CCEEEEEEecCCc----------hhhHHHHHHHHHHHHH-cCCCccceEeeEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLPD--GRNVAIKRLSGDC----------GQMEREFRAEVEALSR-AQHPNLVHLQGYCMH  809 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  809 (1020)
                      +|++.+.||+|+||.||+|..+.  ++.+|+|.+....          .....++.+|++++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  6889999875321          2233456778888875 699999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      .+..++||||+++++|.+++.........+++..++.++.|++.|+.|||+ .   +++||||+|+||+++.++.+|++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886644445678999999999999999999996 5   899999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      ||.+.......   ......++..|+|||...+..++.++||||||+++|||++|+.||.....      ..........
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEA  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhc
Confidence            99998654322   23345688899999999888899999999999999999999999863321      1111111111


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      .. .    +....    .....+.+++.+||+.||++||++.|+.+++++
T Consensus       229 ~~-~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VY-E----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cC-C----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11 0    10000    112468899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.6e-33  Score=320.59  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=194.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------C
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------N  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  811 (1020)
                      .++|++.+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999864 68899999987542  23345678899999999999999999987643      3


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++ ++..++..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            46899999976 56666542      367889999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHH-----------
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS-----------  960 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-----------  960 (1020)
                      ++.....   .......++..|+|||++.+..++.++||||+||++|||++|+.||......+....+.           
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9865321   22234578999999999999999999999999999999999999997543211100000           


Q ss_pred             -HHH----HHHhhccc-c-----cccCcccc---CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          961 -WVI----RMRQENRE-S-----EVLDPFIY---DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       961 -~~~----~~~~~~~~-~-----~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ...    ........ .     ........   ..........+.+++.+|++.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000    00000000 0     00000000   0001112235789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-33  Score=308.99  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46788899999999999999865 68899999876543 34456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|..++...    ..+++..+..++.+++.|+.|||+..  +++||||||+||+++.++.++++|||++...... 
T Consensus        85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            9999999888653    46899999999999999999999631  8999999999999999999999999998754221 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-----cHHHHHHHHHhhcccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-----DLISWVIRMRQENRESEV  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  974 (1020)
                         ......|+..|+|||++.+..++.++||||+||++|+|++|+.||......+..     ..............    
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  230 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP----  230 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence               122356889999999988889999999999999999999999999854432111     11111111111110    


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                        +.+.   .......+.+++.+|++.||++||+++|+++.
T Consensus       231 --~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 --PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             --CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              0000   01123468899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=307.56  Aligned_cols=252  Identities=26%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456899999999999999999864 6889999999766555567788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+.......
T Consensus        84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999988753   24689999999999999999999999   99999999999999999999999999987653221


Q ss_pred             CcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                        .......+++.|+|||.+.     ...++.++||||+|+++|||++|+.||......      .......... ....
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~  228 (280)
T cd06611         158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSE-PPTL  228 (280)
T ss_pred             --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCC-CCCc
Confidence              1223356888999999864     345778999999999999999999999753221      1111111110 0010


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..       +......+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 DQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            00       1112235789999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-33  Score=304.47  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=201.2

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc------hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC------GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      +|+..+.||+|++|.||+|.. .+++.||+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 578999999986533      1234678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeecccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARL  894 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~  894 (1020)
                      ||||+++++|.+++.+.    ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++ .+|++|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999998754    4678999999999999999999999   999999999999998776 599999999987


Q ss_pred             ccCCCCc--ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          895 ILSPYDT--HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       895 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .......  .......++..|+|||...+..++.++||||+|+++|+|++|..||..........   ........... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~-  229 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASATTA-  229 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhccCCC-
Confidence            6443111  11223467889999999988889999999999999999999999996433221111   11111111100 


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                              ...+......+.+++.+|++.+|.+||++.+++.
T Consensus       230 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 --------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    1112223346889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=308.00  Aligned_cols=248  Identities=29%  Similarity=0.422  Sum_probs=202.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+|++++++++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999865 68899999987553 33345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...     .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999988753     688999999999999999999998   99999999999999999999999999998764332


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......+++.|+|||+..+..++.++||||||+++|+|+||+.||....+..      ....... .......    
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~-~~~~~~~----  219 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK-NNPPSLE----  219 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh-cCCCCCc----
Confidence              22234567889999999988889999999999999999999999997543211      1111111 1111111    


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..   .....+.+++.+||+.+|++||+++++++
T Consensus       220 -~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 -GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             11   02235789999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-34  Score=317.85  Aligned_cols=241  Identities=25%  Similarity=0.438  Sum_probs=194.2

Q ss_pred             cCCeeeccCCeEEEEEEeC-CCCEEEE---EEecC-CchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc--eEEEEE
Q 035998          746 QANIIGCGGFGLVYRATLP-DGRNVAI---KRLSG-DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND--RLLIYS  818 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~-~~~~vav---K~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  818 (1020)
                      ...+||+|+|-+||+|... +|..||=   |.-.. ..+...+.|..|+++++.|+||||+++|.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4567999999999999864 4666652   22111 113334679999999999999999999999987665  678999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~  897 (1020)
                      .|..|+|..|.++.    +.++......|++||++||.|||++ .|+|||||||-+||+|++ .|.|||+|+|+|.....
T Consensus       124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999987    4678889999999999999999998 789999999999999975 68999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH---hhcccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR---QENRESEV  974 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~  974 (1020)
                          ......+|||.|||||... ..|...+||||||++|.||+|+.+||..+...     .+..+...   .+.....+
T Consensus       199 ----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~SGiKP~sl~kV  268 (632)
T KOG0584|consen  199 ----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVTSGIKPAALSKV  268 (632)
T ss_pred             ----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHHcCCCHHHhhcc
Confidence                2234479999999999887 78999999999999999999999999866532     22222221   12222222


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      -||            ++.++|.+|+.. ..+|||+.|++.
T Consensus       269 ~dP------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 KDP------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            333            578999999999 999999999986

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-33  Score=304.97  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  817 (1020)
                      ++|+..+.||.|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999874 578999999875432 3456789999999999999999999998654  3678999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++.........++...+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998876544456688999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..    .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... .....+........ ......+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNM-PNPELKDE  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcC-CchhhccC
Confidence            21    12345678999999999999999999999999999999999999754321 11111111111110 10111000


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .  .........+.+++.+||+.+|.+|||+.|+++
T Consensus       232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             0  000112346889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-33  Score=305.25  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=197.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+..+.  ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 57889999987543  235788999999999999999999998654 5789999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...  ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.....   
T Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999998764  234578999999999999999999998   9999999999999999999999999998764221   


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                        ......+..|+|||...+..++.++|+||+|+++|||++ |+.||......+      .......... .   ++   
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~-~---~~---  218 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKGYR-M---EP---  218 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhCCCC-C---CC---
Confidence              112234568999999988899999999999999999998 999986433211      1111111110 0   00   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                         .......+.+++.+||+.+|++||+++++++.|++
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               11123467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=304.48  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=200.6

Q ss_pred             CCcCCeeeccCCeEEEEEEeCC-----CCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          744 FDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      |++.+.||+|+||.||+|...+     +..||+|++...... ..+.+.+|++.++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998753     478999999766433 4568899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++.....  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||+++....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999876421  1289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..... .....+++.|+|||...+..++.++||||+|+++|+|++ |..||.....   ......   ...... ..  .
T Consensus       156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~---~~~~~~-~~--~  225 (258)
T smart00219      156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY---LKKGYR-LP--K  225 (258)
T ss_pred             ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HhcCCC-CC--C
Confidence            32111 112336789999999988899999999999999999999 7888864221   111111   111111 00  0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1016 (1020)
                             ......++.+++.+|++.||++|||+.|+++.|
T Consensus       226 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 -------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   111234688999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-33  Score=308.60  Aligned_cols=264  Identities=24%  Similarity=0.318  Sum_probs=199.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999876 58899999886442  2234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++++++..+....    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999888776532    3589999999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH-H-------HHhh-
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI-R-------MRQE-  968 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-~-------~~~~-  968 (1020)
                      ..  ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+.... .       .... 
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            21  2223457789999998765 567899999999999999999999997543321111110000 0       0000 


Q ss_pred             cccccccCccccCcc-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEVLDPFIYDKQ-----HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........+......     .+.....+.+++.+||+.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000000000000     0112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.8e-33  Score=302.79  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-ceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-DRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  818 (1020)
                      +|++.+.||+|++|.||++..+ +++.||+|++....  ....+.+.+|++++++++|+|++++++.+...+ ..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999865 57889999986543  233456888999999999999999998876444 5789999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++....  ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999987642  34589999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .  .......+++.|+|||+..+..++.++||||+|+++|+|++|+.||.....      .......... ....     
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~-~~~~-----  221 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG-KLPP-----  221 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc-CCCC-----
Confidence            2  223345678899999999999999999999999999999999999864221      1111111111 1101     


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ........+.+++.+|++.+|++||++.++++
T Consensus       222 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 ----MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                11122346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=342.65  Aligned_cols=463  Identities=28%  Similarity=0.316  Sum_probs=334.8

Q ss_pred             eEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccC
Q 035998           87 VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN  166 (1020)
Q Consensus        87 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N  166 (1020)
                      +.+|++++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+..++.+|++|+|.+|.+...+.....+.+|++|++|.|
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~N  124 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSFN  124 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCchhHHhhhcccccccchh
Confidence            456666666554 45666667777777777777766 5666667777777777777666633322236677777777777


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCC
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS  246 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  246 (1020)
                      ++. .+|..+. .++.+..++.++|.....    ++... .+.++|..|.+.+.++.++..++.  .|+|.+|.+. .  
T Consensus       125 ~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--  192 (1081)
T KOG0618|consen  125 HFG-PIPLVIE-VLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--  192 (1081)
T ss_pred             ccC-CCchhHH-hhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--
Confidence            765 6665553 455666666666622211    22222 677777777777777777777766  7888888776 2  


Q ss_pred             cccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCC
Q 035998          247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTN  326 (1020)
Q Consensus       247 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  326 (1020)
                      ..+.++.+|+.|....|+++...    -..++|+.|+.++|.++...+.  ..-.+|+++++++|++++.+ .++..+.+
T Consensus       193 ~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~n  265 (1081)
T KOG0618|consen  193 LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACAN  265 (1081)
T ss_pred             hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhccc
Confidence            34566777888888888776321    2346788899999988843332  23458999999999999655 88999999


Q ss_pred             cCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcc-cchhh
Q 035998          327 LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN-LTTLV  405 (1020)
Q Consensus       327 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~-L~~L~  405 (1020)
                      |+.|+..+|+|+ .+|..+....+|+.|.+.+|.++ -+|....++++|++|+|..|.|..+|..  .+.-+.. |..|.
T Consensus       266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~--~l~v~~~~l~~ln  341 (1081)
T KOG0618|consen  266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDN--FLAVLNASLNTLN  341 (1081)
T ss_pred             ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchH--HHhhhhHHHHHHh
Confidence            999999999997 88989999999999999999998 5777888899999999999999999983  3333333 66666


Q ss_pred             hhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCccc
Q 035998          406 LTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       406 l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      .+.|+.. ..+......++.|+.|++++|.++...-+.+.+..+|+.|+|++|+|.......+.++..|+.|+||+|+++
T Consensus       342 ~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~  420 (1081)
T KOG0618|consen  342 VSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT  420 (1081)
T ss_pred             hhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh
Confidence            6666543 334444556778999999999999988888999999999999999998444456789999999999999999


Q ss_pred             ccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecC
Q 035998          486 GEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH  565 (1020)
Q Consensus       486 ~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~  565 (1020)
                       .+|.++.++..|.++                                    ...+|++. +.| ++..+++|+.+|+|.
T Consensus       421 -~Lp~tva~~~~L~tL------------------------------------~ahsN~l~-~fP-e~~~l~qL~~lDlS~  461 (1081)
T KOG0618|consen  421 -TLPDTVANLGRLHTL------------------------------------RAHSNQLL-SFP-ELAQLPQLKVLDLSC  461 (1081)
T ss_pred             -hhhHHHHhhhhhHHH------------------------------------hhcCCcee-ech-hhhhcCcceEEeccc
Confidence             888988888887543                                    33444443 233 788899999999999


Q ss_pred             CcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccc
Q 035998          566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN  614 (1020)
Q Consensus       566 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N  614 (1020)
                      |+|+...-+.-..-++|++|||++|.=.-..-..|..+.++...+++-|
T Consensus       462 N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  462 NNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             chhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9997533222222388999999999833244455666666666666655

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-34  Score=320.11  Aligned_cols=258  Identities=23%  Similarity=0.287  Sum_probs=193.9

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc-----
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----  810 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  810 (1020)
                      +..++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            4457899999999999999999985 4688999999875432  2234577899999999999999999987543     


Q ss_pred             -CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          811 -NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       811 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                       ...++++|++ +++|..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3468999988 7788877653     3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+++.....     .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||......   +...........
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~  234 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVGT  234 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCC
Confidence            999865321     233568999999998866 57899999999999999999999999643211   111111100000


Q ss_pred             c------------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 N------------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~------------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .                  .......+... .........+.+++.+|++.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0                  00000000000 000001124679999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.9e-33  Score=303.71  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35778899999999999999865 58899999987543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++..     ..+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999998864     2578889999999999999999998   99999999999999999999999999997654321


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......++..|+|||+..+..++.++|+||||+++|||++|+.||....+....      ..... ..         
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~~~-~~---------  217 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLIPK-NN---------  217 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hhhhc-CC---------
Confidence              1223346788999999998889999999999999999999999999754322111      00100 00         


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...........+.+++.+||+.+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            01122334557889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=306.32  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=202.5

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC-----
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN-----  811 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  811 (1020)
                      .++++|++.+.||+|++|.||+|..+ +++.|++|++..... ..+.+.+|+++++++ +|+||+++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999875 578899999876543 346789999999999 7999999999997654     


Q ss_pred             -ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          812 -DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       812 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                       ..++||||+++++|.+++.........+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+|++|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             37899999999999999876544456789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      .+......  ........++..|+|||++..     ..++.++||||+|+++|+|++|+.||.......      ....+
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~  230 (275)
T cd06608         159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKI  230 (275)
T ss_pred             cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHh
Confidence            98765322  122334568889999998653     346789999999999999999999996432211      11111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ... ......       ........+.+++.+||..||++|||+.++++
T Consensus       231 ~~~-~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRN-PPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hcc-CCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            110 000111       11123346889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=317.34  Aligned_cols=269  Identities=27%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             CCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------CceEE
Q 035998          744 FDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------NDRLL  815 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  815 (1020)
                      +...+.||+|+||.||+|+. .+|+.||||.+.... ....+...+|++++++++|+|||+++++-.+.      +...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            44567899999999999995 479999999998654 23345678999999999999999999875543      35689


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc--CCCC--eEEeeccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD--GNFG--AHLADFGL  891 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~Dfg~  891 (1020)
                      |||||.||||...+.+. .+...+++.+.+.++.+++.||.|||++   +||||||||.||++-  .+|+  .||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999875 3445789999999999999999999999   999999999999983  3344  69999999


Q ss_pred             cccccCCCCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      |+...+   .....+.+||..|.+||... .+.|+..+|.|||||++|+++||..||..........-+.|....+.+..
T Consensus       171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            998743   34667889999999999988 48999999999999999999999999975543332222444444443332


Q ss_pred             cccccCccccC------------ccCHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYD------------KQHDKEMLRVLDIACLCLSESPKVRP--TTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i 1019 (1020)
                      .....++...+            ...+.....+...+..++..+|++|-  .+.+....+..|
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            22222222111            11234445677788888999999998  666666555544

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-33  Score=317.32  Aligned_cols=254  Identities=24%  Similarity=0.265  Sum_probs=195.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999875 57789999986432   122345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999753   23578999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .. ........||+.|+|||++.     ...++.++|||||||++|||++|+.||.....      ......+.......
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~  227 (332)
T cd05623         155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF  227 (332)
T ss_pred             CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc
Confidence            21 12223357899999999875     34688999999999999999999999964321      11222221111000


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      .  -|.    ........+.+++.+|+..++.+  |++++|+++
T Consensus       228 ~--~p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         228 Q--FPA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             c--CCC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            0  010    01112245778888988655444  789999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=309.56  Aligned_cols=243  Identities=31%  Similarity=0.425  Sum_probs=197.5

Q ss_pred             CCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      |..++.||.|+||.||.|+. .+.+.||||++.....+   .-.++..|+..+++++|||++.+.|+|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999985 46788999998755432   235788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |-| +-.+.+.-.   +.++-+.++..|..+.+.||+|||++   +.||||||+.|||+++.|.||++|||.|.....  
T Consensus       108 ClG-SAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  108 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             Hhc-cHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            965 555555433   34688889999999999999999999   999999999999999999999999999976522  


Q ss_pred             CcccccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          900 DTHVTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                          ....+|||.|||||++   ..+.|+-|+||||+|+++.|+.-.++|+-.++      .+.....+.+....  .+ 
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNesP--tL-  245 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP--TL-  245 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcCCC--CC-
Confidence                3457899999999976   45789999999999999999999999975432      23333444333221  11 


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            +..+....+..++..|++.-|.+|||.+++++
T Consensus       246 ------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 ------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  12334456889999999999999999999876

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-33  Score=317.38  Aligned_cols=254  Identities=24%  Similarity=0.249  Sum_probs=195.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....   ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 67889999986532   122345788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++.+.   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999763   24678899999999999999999999   999999999999999999999999999976643


Q ss_pred             CCCcccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .. ........|++.|+|||++.+     +.++.++||||+||++|||++|+.||......      .....+.......
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~  227 (331)
T cd05624         155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF  227 (331)
T ss_pred             CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc
Confidence            22 112233568999999998765     56788999999999999999999999643221      1111111111000


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      . . |..    .......+.+++.+|++.++.+  |++++++++
T Consensus       228 ~-~-p~~----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 Q-F-PSH----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             c-C-CCc----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0 0 000    0112245788999999866544  567888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.2e-33  Score=311.49  Aligned_cols=198  Identities=27%  Similarity=0.406  Sum_probs=160.4

Q ss_pred             CCeeeccCCeEEEEEEeC---CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEEEEecc
Q 035998          747 ANIIGCGGFGLVYRATLP---DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLIYSFME  821 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  821 (1020)
                      ..+||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   45789999987543  23457889999999999999999999854  456789999987


Q ss_pred             CCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE----cCCCCeEEeecccc
Q 035998          822 NGSLDYWLHEKL-----DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGAHLADFGLA  892 (1020)
Q Consensus       822 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~  892 (1020)
                      + ++.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 6766664321     1233588999999999999999999999   99999999999999    46678999999999


Q ss_pred             ccccCCCCc-ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          893 RLILSPYDT-HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       893 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      +........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221 12234568899999998866 46899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-33  Score=309.50  Aligned_cols=261  Identities=28%  Similarity=0.398  Sum_probs=198.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999975 588999998865432  234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++++++..+....    ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999988776542    3589999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh---------
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE---------  968 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------  968 (1020)
                      .  .......++..|+|||+..+ ..++.++||||||+++|||++|+.||......   +...........         
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI---DQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHHHhCCCchhhHHHh
Confidence            2  22233567889999998765 45788999999999999999999998643211   111110000000         


Q ss_pred             --cc-cccccCccccC-----ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 --NR-ESEVLDPFIYD-----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 --~~-~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .. ......+....     ...+.....+.+++.+||+.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              00 00000000000     001122456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-33  Score=303.22  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=198.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch----------hhHHHHHHHHHHHHHcCCCccceEeeEEeccC
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG----------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  811 (1020)
                      +|...+.||+|+||.||+|... +++.||+|.+.....          ...+.+.+|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677899999999999999754 688999998853211          11245788999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++++|.+++++.    ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998764    4688999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASV--ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      ++...............++..|+|||......  ++.++|+||+|+++||+++|..||.....      ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~  228 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc
Confidence            97654322222233456788999999877654  78999999999999999999999963221      11111111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      . .....+    .........+.+++.+||+.+|.+||+++++++
T Consensus       229 ~-~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 S-APPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             c-CCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0 011111    111123356889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.6e-33  Score=299.91  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  817 (1020)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+....  ....+.+.+|++++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999985 468899999986432  2334568889999999999999999998764  34578999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-----QSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      ||+++++|.+++.........+++..++.++.|++.|++|||     +.   +++||||+|+||+++.++.+|++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999876555567899999999999999999999     66   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      .......  .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....   ..   ....... ....
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~---~~~~~~~-~~~~  228 (265)
T cd08217         158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQ---LASKIKE-GKFR  228 (265)
T ss_pred             ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HH---HHHHHhc-CCCC
Confidence            8764322  112335688999999999888899999999999999999999999975331   11   1111111 1110


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                               ..+......+.+++.+|++.+|++||++.+|++
T Consensus       229 ---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 ---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                     111223346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-33  Score=308.30  Aligned_cols=246  Identities=27%  Similarity=0.432  Sum_probs=198.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999864 57889999987543 333457889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++..     ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....... 
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999988753     3578999999999999999999998   99999999999999999999999999987653321 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       .......++..|+|||+..+..++.++||||||+++|||++|+.||....+...      ...... ..     .+.. 
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~-~~-----~~~~-  221 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIPK-NS-----PPTL-  221 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhhhhc-CC-----CCCC-
Confidence             122234678899999999998999999999999999999999999864332211      001100 00     1111 


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .......+.+++.+||+.+|.+||++.++++
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               1122346889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.4e-33  Score=307.27  Aligned_cols=261  Identities=24%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5788999999999999999864 68999999987653  33356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      + +++|.+++....   ..+++.+++.++.||++||+|||+.   +++|+||||+||+++.++.++++|||.+.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999887542   4689999999999999999999999   99999999999999999999999999998764432


Q ss_pred             CcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc---ccc---
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN---RES---  972 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~---  972 (1020)
                      . .......++..|+|||.+.+. .++.++||||+|+++|||++|.+||....+.   ....+........   ...   
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhcc
Confidence            1 122345688899999987654 5689999999999999999998888643221   1111111110000   000   


Q ss_pred             ------cccCc----cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 ------EVLDP----FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ------~~~d~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            ....+    .......+.....+.+++.+|++.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  00000    0000001122357889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1e-32  Score=299.67  Aligned_cols=251  Identities=27%  Similarity=0.484  Sum_probs=206.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|++|.||+|+.. +++.||||++..... ...+.+.+|++.+++++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999876 589999999876643 3456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      +++++|.+++...    ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999998764    468999999999999999999999 8   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ..  ......++..|+|||...+..++.++|+||||+++|+|++|+.||.........+...   ....... ..     
T Consensus       154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~-~~-----  222 (264)
T cd06623         154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AICDGPP-PS-----  222 (264)
T ss_pred             CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHhcCCC-CC-----
Confidence            21  1223467889999999999899999999999999999999999997654322222221   1111110 00     


Q ss_pred             ccCccCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDK-EMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .    +.. ....+.+++.+|++.+|++||++.++++
T Consensus       223 ~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         223 L----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             C----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0    111 2346889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.9e-33  Score=300.07  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=194.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--Cce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  813 (1020)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     ......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999864 68899999886432     12234688899999999999999999988753  567


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++++||+++++|.+++...    ..+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            8999999999999998753    3578899999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCC-cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYD-THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ....... ........++..|+|||.+.+..++.++||||+||++|||++|+.||.....      ............  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~--  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT--  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC--
Confidence            6532111 1111234578899999999988899999999999999999999999974321      111111111110  


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .+..    +......+.+++ +||..+|++||+++|+++
T Consensus       227 ---~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               1111    111223456666 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.9e-33  Score=303.16  Aligned_cols=253  Identities=27%  Similarity=0.455  Sum_probs=203.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+.... ....+++.+|++++++++||||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35788899999999999999875 68899999987653 34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      +++++|.+++....   ..++...+..++.|++.|++|+|+ .   +++||||||+||++++++.++++|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999987642   568889999999999999999999 7   9999999999999999999999999998765322


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .    .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ................      +.
T Consensus       155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~------~~  223 (265)
T cd06605         155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPP------PR  223 (265)
T ss_pred             H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCC------CC
Confidence            1    11256788999999999899999999999999999999999999754321 1122222222211111      00


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....   .....+.+++.+||..+|++||++.++++
T Consensus       224 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0000   02345889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-33  Score=307.17  Aligned_cols=261  Identities=25%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999875 68899999986542  12234677899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ +|.+++...   ...+++..++.++.||++||+|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            974 777776543   24589999999999999999999999   99999999999999999999999999998653322


Q ss_pred             CcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc------cc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR------ES  972 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~  972 (1020)
                        .......++..|+|||.+.+. .++.++||||+||++|||+||..||......  ...............      ..
T Consensus       154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhh
Confidence              112334678899999987664 5789999999999999999999986432221  111111111000000      00


Q ss_pred             cccCcccc---------CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIY---------DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...+....         ....+.....+.+++.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000         0011122346789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.7e-33  Score=303.96  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=195.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHH-HHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEA-LSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+.. ++..+||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999865 68999999987653 2233455556665 566689999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++ |+|.+++.........+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||.++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 6888888765444567899999999999999999999753  8999999999999999999999999999865322


Q ss_pred             CCcccccccccccCccCccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                         .......++..|+|||.+.+    ..++.++|+||+|+++|||++|+.||.....  .....   ....... ....
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~---~~~~~~~-~~~~  228 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQL---KQVVEEP-SPQL  228 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHH---HHHHhcC-CCCC
Confidence               11223467889999998765    4568899999999999999999999964221  11111   1111110 0110


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..        ......+.+++.+||+.+|++||++.++++
T Consensus       229 ~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 PA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             Cc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00        012245889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.5e-33  Score=306.48  Aligned_cols=260  Identities=25%  Similarity=0.423  Sum_probs=202.3

Q ss_pred             ccHHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEec
Q 035998          732 ISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMH  809 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  809 (1020)
                      .+..++..+.+.|++.+.||+|+||.||+|+.. +++.||+|.+..... ...++..|+.+++++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355566667788999999999999999999864 688999999865532 235678899999998 79999999999863


Q ss_pred             ------cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          810 ------KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       810 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                            ....+++|||+++|+|.+++....  ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  356789999999999999887643  23578888999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                      ++|+|||+++......  .......|+..|+|||.+.     ...++.++||||+||++|||++|+.||....+....  
T Consensus       160 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--  235 (282)
T cd06636         160 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--  235 (282)
T ss_pred             EEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence            9999999987653221  1223356888999999875     356788999999999999999999999643321110  


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .......      .+...   .......+.+++.+||+.||.+||++.|+++
T Consensus       236 ----~~~~~~~------~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 ----FLIPRNP------PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ----hhHhhCC------CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                0010000      00000   0112246889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.7e-33  Score=300.73  Aligned_cols=258  Identities=29%  Similarity=0.463  Sum_probs=205.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+...+..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999864 67899999987543 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++..... ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999876422 24688999999999999999999999   99999999999999999999999999998775543


Q ss_pred             Ccc--cccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          900 DTH--VTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       900 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  ......++..|+|||++... .++.++|+||+|+++|||++|+.||.......  .....    ..... .. ..
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~~~-~~-~~  228 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQNDP-PS-LE  228 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcCCC-CC-cC
Confidence            321  22345688899999988766 78999999999999999999999997543321  11111    11100 00 00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..   .........+.+++.+||+.||++||+++++++
T Consensus       229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             Cc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00   001122346789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.3e-33  Score=300.38  Aligned_cols=248  Identities=25%  Similarity=0.429  Sum_probs=199.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....  ....+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788999999999999999864 68899999986542  23346788999999999999999999999989999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~  898 (1020)
                      +++++|.+++....  ...+++..+..++.|++.|++|||++   +++||||+|+||+++++ +.+|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997642  34578999999999999999999999   99999999999999865 45899999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .   ......++..|+|||...+..++.++||||+|+++|+|++|+.||......   ...   ....... .....+  
T Consensus       156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~---~~~~~~~-~~~~~~--  223 (256)
T cd08220         156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALV---LKIMSGT-FAPISD--  223 (256)
T ss_pred             c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHH---HHHHhcC-CCCCCC--
Confidence            1   222356788999999998888999999999999999999999999643321   111   1111111 111111  


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             .....+.+++.+||+.+|.+|||+.|+++
T Consensus       224 -------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 -------RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   12235889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.5e-33  Score=307.54  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=198.1

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+..+++++|||++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999864 6889999998765555556788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|.+++..     ..++++++..++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||++.......  .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~  173 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P  173 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence            999998754     2478999999999999999999999   99999999999999999999999999987653221  1


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......++..|+|||...+..++.++||||+|+++|||++|+.||......   ...   ....... .....+      
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~~~-~~~~~~------  240 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM---RRIRDNL-PPRVKD------  240 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhcC-CCcccc------
Confidence            223356888999999998888999999999999999999999999643211   111   1111110 000001      


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .......+.+++.+||+.||.+|||++|+++
T Consensus       241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             -ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             0012235788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-33  Score=301.50  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=200.7

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||+++.. +++.||+|.+....  ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999854 68899999986432  23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999887532  23578899999999999999999998   99999999999999999999999999997654321


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......|++.|+|||+..++.++.++|+||||+++|+|++|+.||.....      ........... ...      
T Consensus       156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~-~~~------  220 (256)
T cd08218         156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGS-YPP------  220 (256)
T ss_pred             --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCC-CCC------
Confidence              112234678899999999888999999999999999999999999864221      11111111111 000      


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .+......+.+++.+||+.+|.+||++.++++
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 ---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               01112346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-34  Score=319.84  Aligned_cols=240  Identities=25%  Similarity=0.284  Sum_probs=184.4

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCchh---hHHHHHHHHHHHHHc---CCCccceEeeEEeccCceEEEEEeccC
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRA---QHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ||+|+||.||+|+.. +++.||||++......   ....+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 6899999998643211   122344566666655   699999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|..++...    ..+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            9999888653    4688999999999999999999999   99999999999999999999999999987543221  2


Q ss_pred             cccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          903 VTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                      ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......      .....+.....  ....     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~--~~~~-----  218 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV--RFPK-----  218 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC--CCCC-----
Confidence            23345789999999988654 5889999999999999999999999643211      11111111100  0000     


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRP----TTQQLVS 1014 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 1014 (1020)
                      .   .....+.+++.+||+.||.+||    ++.++++
T Consensus       219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0   0123567899999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.5e-33  Score=305.72  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=197.7

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334557999999999999864 6899999998654444456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|..++..     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.......  .
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~  172 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  172 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence            999887754     3578999999999999999999999   99999999999999999999999999987653221  1


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......++..|+|||++.+..++.++||||+|+++|||++|+.||.....      ............ ....       
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~-~~~~-------  238 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRLRDSPP-PKLK-------  238 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhccCC-CCcc-------
Confidence            22345688999999999888999999999999999999999999964321      111111111110 0000       


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........+.+++.+||+.+|.+||+++++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00111235789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=305.69  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57899999999999999999865 688999999865432 2234567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ +|.+++.+.   ...+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|++|||+++....+.
T Consensus        85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            985 898888754   23678999999999999999999999   99999999999999999999999999987543221


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh---cccccc-
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE---NRESEV-  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  974 (1020)
                      .  ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||......  .+...........   ...... 
T Consensus       158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhh
Confidence            1  1122346788999998765 56889999999999999999999999644311  1111111110000   000000 


Q ss_pred             ------------cCccccCcc--CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 ------------LDPFIYDKQ--HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ------------~d~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                  ..+......  .......+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                        000000000  0001146789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-32  Score=302.52  Aligned_cols=244  Identities=24%  Similarity=0.311  Sum_probs=199.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999865 68999999986542   123456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999998764    4688999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     .....+++.|+|||...+...+.++||||+|+++|+|++|+.||.....      ......... ... .    
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~-~----  216 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILE-GKV-R----  216 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCc-c----
Confidence            2     2334688999999998888899999999999999999999999964331      111111111 100 0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                       +    +......+.+++.+||+.||.+||     +++|+++
T Consensus       217 -~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 -F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             0    001123678999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=306.95  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....  ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999875 57899999886542  2234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |++++.+..+...    ...+++..+..++.||+.|++|||+.   +++||||+|+||++++++.+|++|||.+......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777665543    24578999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh---------
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE---------  968 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------  968 (1020)
                      .. .......++..|+|||+..+. .++.++||||+|+++|+|++|+.||......   +...........         
T Consensus       154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhc
Confidence            22 122345678899999998887 8899999999999999999999999743221   111111110000         


Q ss_pred             ---c-----ccccccCccc-cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 ---N-----RESEVLDPFI-YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ---~-----~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .     ......++.. ...++......+.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence               0     0000000000 00111122457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.8e-33  Score=307.19  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=198.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||++... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999865 578999999875532   22346788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999998754    4588999999999999999999999   999999999999999999999999999874211


Q ss_pred             CCCc-------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          898 PYDT-------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       898 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      ....             .......++..|+|||.+....++.++|+||||+++|||++|+.||......      +....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence            1000             0111235678899999998889999999999999999999999999643211      11111


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      .....    ...+....    .....+.+++.+||+.||++||++.++.+.++
T Consensus       228 ~~~~~----~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDD----IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhcc----cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            11111    00111000    12235789999999999999999665555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-32  Score=303.77  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5789999999999999999975 468899999987554444567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++.+.     .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++....... 
T Consensus        99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-  169 (293)
T cd06647          99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (293)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence            999999998753     478899999999999999999999   99999999999999999999999999987654322 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       .......+++.|+|||......++.++||||||+++|++++|+.||...........      ..... ...       
T Consensus       170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~-~~~-------  234 (293)
T cd06647         170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPE-------  234 (293)
T ss_pred             -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC-CCC-------
Confidence             122334688899999998888899999999999999999999999975432211110      00000 000       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..........+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011122345889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=298.11  Aligned_cols=247  Identities=29%  Similarity=0.399  Sum_probs=198.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .+.|+.-++||+|+||+||-++.+ +|+-+|.|.+.+..   ...+.....|-+++++++.+.||.+--.|...+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456888899999999999999865 68889998875443   23345678899999999999999998889999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +..|.||||..++...  +.+.++++.++.++.+|+.||++||+.   +||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus       264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999988876  346799999999999999999999999   99999999999999999999999999999874


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .   .......+||.+|||||++.++.|+...|+||+||++|||+.|+.||.......-..-+  ..+...        |
T Consensus       339 ~---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv--drr~~~--------~  405 (591)
T KOG0986|consen  339 E---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV--DRRTLE--------D  405 (591)
T ss_pred             C---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--HHHHhc--------c
Confidence            3   23334458999999999999999999999999999999999999999754322111011  011110        1


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                      +.   .++..-.++..++.+..++.||++|..
T Consensus       406 ~~---ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 PE---EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hh---hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            11   112222335677888889999999974

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.8e-33  Score=306.36  Aligned_cols=260  Identities=27%  Similarity=0.321  Sum_probs=198.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh-----hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ-----MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      +|+..+.||+|+||.||+|... +++.||||++......     ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999865 6899999999755322     345577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+ +++|.+++....   ..+++..++.++.||++||+|||++   +++||||||+||+++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999987541   3689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc------
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN------  969 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------  969 (1020)
                      ....  ......++..|+|||.+.+ ..++.++||||+||++|||++|.+||....+.   +............      
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhh
Confidence            4321  2223456778999998754 56789999999999999999998887643321   1111111100000      


Q ss_pred             ---ccccccCccccCc-----cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 ---RESEVLDPFIYDK-----QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ---~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .............     ........+.+++.+||+.||++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               0000000000000     01122356889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-32  Score=296.66  Aligned_cols=252  Identities=31%  Similarity=0.439  Sum_probs=200.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999864 688999999876544  2557789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999988753    3578899999999999999999999   99999999999999999999999999998764432


Q ss_pred             Cccc--ccccccccCccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          900 DTHV--TTDLVGTLGYIPPEYGQASV---ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       900 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....  .....++..|+|||++.+..   ++.++||||||+++|||++|+.||......     ......... ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~~  227 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GHKPPI  227 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CCCCCC
Confidence            2111  12346788999999987766   889999999999999999999999643211     111111111 110110


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+       .......+.+++.+||+.+|.+||++.|++.
T Consensus       228 ~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Cc-------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00       0011235779999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-32  Score=298.94  Aligned_cols=250  Identities=24%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--Cce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  813 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999864 58899999875322     12235688899999999999999999988764  457


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            7999999999999998754    3478888999999999999999999   99999999999999999999999999988


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ........ .......++..|+|||...+..++.++||||||+++|||++|+.||.....      ............  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~--  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT--  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC--
Confidence            65322111 112234678899999999888899999999999999999999999964311      111111111110  


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .+    ..+......+.+++.+|+. +|++||+++|+++
T Consensus       227 ---~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ---NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               11    1122333457789999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=285.98  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHH---HHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMER---EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|+.++++|+|.||+|-+++-+ +++.+|+|+++++.-....   .-..|-++++..+||.+..+.-.|+..+..+.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56899999999999999999854 7899999999887532222   3356889999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||..||.|..++.+.    ..++++..+.+-..|..||.|||++   +||+||+|.+|.++|.||++||+|||+++.-..
T Consensus       248 eyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  248 EYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            999999998887764    5788889999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                        ....+...+|||.|.|||++....|+.++|+|.+||+||||++|+.||....-.....++. ...++.    +.    
T Consensus       321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-~ed~kF----Pr----  389 (516)
T KOG0690|consen  321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-MEDLKF----PR----  389 (516)
T ss_pred             --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-hhhccC----Cc----
Confidence              2344567899999999999999999999999999999999999999997432211111111 011111    11    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                              ....+...++...+..||.+|.     .++||.+
T Consensus       390 --------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  390 --------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             --------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                    1112467788899999999997     3555544

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=337.50  Aligned_cols=463  Identities=26%  Similarity=0.297  Sum_probs=254.3

Q ss_pred             ccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccC
Q 035998          101 LSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNS  180 (1020)
Q Consensus       101 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~  180 (1020)
                      +|..+..-..++.|+++.|.+-...-+.+.+.-+|+.||+++|+++..+-..-.+.+|+.|.++.|.+. .+|.+. ..+
T Consensus        13 ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~-~~~   90 (1081)
T KOG0618|consen   13 IPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSC-SNM   90 (1081)
T ss_pred             cchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhh-hhh
Confidence            444444444455555555554411112223333455555555555432222224555555555555555 455332 345


Q ss_pred             CcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEc
Q 035998          181 SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV  260 (1020)
Q Consensus       181 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  260 (1020)
                      .+|++++|.+|.+. ..|..+..+.+|+.|+++.|++. .+|..+..++.+..+..++|.....++.    . .++.++|
T Consensus        91 ~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~-~ik~~~l  163 (1081)
T KOG0618|consen   91 RNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----T-SIKKLDL  163 (1081)
T ss_pred             hcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----c-cchhhhh
Confidence            55566666655555 55666666666666666666665 5566666666666666666622211111    1 1555566


Q ss_pred             cCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCC
Q 035998          261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP  340 (1020)
Q Consensus       261 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  340 (1020)
                      ..|.+.+.++..+..++.  .|+|.+|.+.   -..+.++.+|+.|....|++....-    ..++|+.|+.++|.++..
T Consensus       164 ~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~----~g~~l~~L~a~~n~l~~~  234 (1081)
T KOG0618|consen  164 RLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI----SGPSLTALYADHNPLTTL  234 (1081)
T ss_pred             hhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe----cCcchheeeeccCcceee
Confidence            666665555555554444  4666666655   1234455556666666665553221    235566666666666522


Q ss_pred             CCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCcc
Q 035998          341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPR  420 (1020)
Q Consensus       341 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~  420 (1020)
                      .+...  -.+|+++++++|++++ +|++++.+.+|+.++..+|+++.+|..   +...++|+.|.+..|......+.  .
T Consensus       235 ~~~p~--p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~~lp~r---i~~~~~L~~l~~~~nel~yip~~--l  306 (1081)
T KOG0618|consen  235 DVHPV--PLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLVALPLR---ISRITSLVSLSAAYNELEYIPPF--L  306 (1081)
T ss_pred             ccccc--cccceeeecchhhhhc-chHHHHhcccceEecccchhHHhhHHH---HhhhhhHHHHHhhhhhhhhCCCc--c
Confidence            22221  2456666666666653 446666666666666666666555443   33444455555554433222211  1


Q ss_pred             ccccCceEEEecccccccccchhhhcCCC-CcEEecccccccccccc-cccCcCcCcEEeCCCCcccccCCCCCCCCccc
Q 035998          421 LHFANLKVLVIASCGLRGSIPQWLRGCSK-LQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL  498 (1020)
Q Consensus       421 ~~~~~L~~L~l~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  498 (1020)
                      ..++.|+.|+|..|++....+..+.-+.. |+.|+.+.|+++ ..|. .=..++.|+.|+|.+|.|+...-+.+.+.++|
T Consensus       307 e~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL  385 (1081)
T KOG0618|consen  307 EGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL  385 (1081)
T ss_pred             cccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccce
Confidence            12455666666666665444433333333 555555555555 2331 11123445556666666655555555555554


Q ss_pred             ccccCcCCCCCCCcccceeecccccccccccccCCC----------CeeecccCccccCCCccccCCCcceEEEecCCcc
Q 035998          499 ITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFP----------PTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNL  568 (1020)
Q Consensus       499 ~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~----------~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l  568 (1020)
                      +.++                      |+||++.+||          ++|+||+|+++. +|+++..+..|++|...+|+|
T Consensus       386 KVLh----------------------LsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l  442 (1081)
T KOG0618|consen  386 KVLH----------------------LSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQL  442 (1081)
T ss_pred             eeee----------------------ecccccccCCHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCce
Confidence            3332                      3344444443          357788888874 668888999999999999999


Q ss_pred             eeccCccccCCCcccEEEccCCccccc-CCccccccccccccccccccc
Q 035998          569 SGPIPSELTGMTSLETLDLSYNNLSGA-IPISLEKLSFLSKFSVANNHL  616 (1020)
Q Consensus       569 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~-ip~~l~~l~~L~~l~ls~N~l  616 (1020)
                      . ..| ++.++++|+.+|+|.|+|+.. +|..... ++|++||+++|.-
T Consensus       443 ~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  443 L-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             e-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            7 677 889999999999999998843 4443333 7899999999984

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-33  Score=283.01  Aligned_cols=269  Identities=26%  Similarity=0.359  Sum_probs=199.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC---C--CCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec-cCce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP---D--GRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH-KNDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  813 (1020)
                      ..|+..+.||+|.||.||+|..+   +  ...+|+|+++.+.  ........+|+..+++++|||++.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45889999999999999999532   2  2379999998663  2334567899999999999999999999987 7788


Q ss_pred             EEEEEeccCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC----CCeEEee
Q 035998          814 LLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN----FGAHLAD  888 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  888 (1020)
                      ++++||.+. ||.+.++-... ....++...+..|+.||+.|+.|||++   -|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 67776654322 235788899999999999999999999   99999999999999888    9999999


Q ss_pred             ccccccccCCCCcc-cccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc------ccHHH
Q 035998          889 FGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS------RDLIS  960 (1020)
Q Consensus       889 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~------~~~~~  960 (1020)
                      ||+++.+.++-... .....+-|..|+|||.+.+ ..|+.+.|||+.|||+.||+|-++-|.+....-.      .+++.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999987765433 2334677999999997765 5799999999999999999999888864322111      12222


Q ss_pred             HHHHHHhhcccccccC----ccc-----------cCccC-HH-------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          961 WVIRMRQENRESEVLD----PFI-----------YDKQH-DK-------EMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       961 ~~~~~~~~~~~~~~~d----~~~-----------~~~~~-~~-------~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..-..........+.+    |..           +.... ..       .....++++.+++.+||.+|.|++++++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            2211111111111111    100           00000 00       0012678999999999999999999986

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=307.91  Aligned_cols=268  Identities=24%  Similarity=0.320  Sum_probs=197.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC---CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP---DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRL  814 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  814 (1020)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999864   47899999998643   33345678899999999999999999999988  7889


Q ss_pred             EEEEeccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC----CCCeEEeec
Q 035998          815 LIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG----NFGAHLADF  889 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  889 (1020)
                      +||||+++ ++.+++...... ...+++..++.++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 566666543332 23789999999999999999999999   9999999999999999    999999999


Q ss_pred             cccccccCCCCc-ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-------cHHH
Q 035998          890 GLARLILSPYDT-HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-------DLIS  960 (1020)
Q Consensus       890 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-------~~~~  960 (1020)
                      |+++........ .......++..|+|||+..+ ..++.++||||+|+++|+|++|+.||.........       ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876433221 12233467889999998765 46789999999999999999999999754433200       0000


Q ss_pred             HHHHHHhhc--------cccc-------ccCcccc-Cc----cCH--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          961 WVIRMRQEN--------RESE-------VLDPFIY-DK----QHD--KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       961 ~~~~~~~~~--------~~~~-------~~d~~~~-~~----~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....+....        ...+       ....... ..    ...  ....++.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000        0000       0000000 00    000  22246889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-32  Score=303.18  Aligned_cols=264  Identities=25%  Similarity=0.320  Sum_probs=196.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999864 688999999865432 22346778999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++ +++.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 6776666543   23567888999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh---------
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ---------  967 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------  967 (1020)
                      ...  ......+++.|+|||...+ ..++.++||||+|+++|||++|+.||....+.  ............         
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhh
Confidence            221  1233456889999998765 45788999999999999999999999754321  111111110000         


Q ss_pred             ----hcccccccCccccCc-----cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ----ENRESEVLDPFIYDK-----QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ----~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +..............     ........+.+++.+|++.||++|||++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                000000000000000     00011246789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=306.56  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=203.8

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCCC-EEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATLPDGR-NVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |+++..||.|+||.||+|..++.. ..|.|++........+++.-|++++....||+||++++.|..+...+|+.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            566778999999999999876533 4567888776666667889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |-.+..+-+.   +..+++.++..++.|++.||.|||++   .|||||||+.|||++-+|.++++|||.+.....  ...
T Consensus       114 GAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q  185 (1187)
T KOG0579|consen  114 GAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ  185 (1187)
T ss_pred             chHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence            9999888765   45789999999999999999999999   999999999999999999999999999865422  223


Q ss_pred             cccccccccCccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          903 VTTDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .....+|||.|||||+.     ...+|+.++||||||+++.||..+.+|-...++      +.....+.... .+..+. 
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSe-PPTLlq-  257 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPTLLQ-  257 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcC-CCcccC-
Confidence            44568999999999974     457899999999999999999999999764433      22222222111 112222 


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            +......+.+++.+|+..+|..||+++++++
T Consensus       258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  2344457889999999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-32  Score=299.73  Aligned_cols=245  Identities=27%  Similarity=0.434  Sum_probs=198.6

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      |+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++.+++++||||+++++++.+.+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            677889999999999999864 68899999886443 2334578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++..     ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.......  
T Consensus        86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            9999988864     3578999999999999999999998   99999999999999999999999999987653221  


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                      .......++..|+|||...+..++.++|+||+||++|+|++|..||......      ........ ...     +..  
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~~--  221 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK-NNP-----PTL--  221 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc-CCC-----CCC--
Confidence            1223346788999999998888999999999999999999999999643221      11111111 100     001  


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .......+.+++.+||+.+|.+||++.++++
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             --CcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              1122345789999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=306.29  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=201.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......   ..+.+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999865 5899999999765322   3456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+.+++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999988753  234689999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCc---------------------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          898 PYDT---------------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       898 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      ....                           .......|+..|+|||+..+..++.++||||+|+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                           0111246788999999998888999999999999999999999999744


Q ss_pred             CCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 035998          951 KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT----TQQLVS 1014 (1020)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 1014 (1020)
                      ....      ..........  ..  +     ........+.+++.+||+.||++||+    ++|+++
T Consensus       236 ~~~~------~~~~~~~~~~--~~--~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDE------TFSNILKKEV--TF--P-----GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHH------HHHHHhcCCc--cC--C-----CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            3211      1111111000  00  0     00113346899999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-32  Score=300.48  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=199.4

Q ss_pred             CCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          744 FDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      |...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            45567999999999999985 46889999998755444456688999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|.+++..     ..++++.+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+.......  .
T Consensus       101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~  170 (285)
T cd06648         101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--P  170 (285)
T ss_pred             CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--c
Confidence            999998875     2578899999999999999999999   99999999999999999999999999887653221  1


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                      ......|++.|+|||...+..++.++||||+|+++|||++|+.||.....      .......... .......      
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-~~~~~~~------  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-LPPKLKN------  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-CCCCCcc------
Confidence            22335688999999999888899999999999999999999999864321      1111112111 1111100      


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .......+.+++.+||+.+|++||++.++++
T Consensus       238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             0112246889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.4e-33  Score=299.21  Aligned_cols=247  Identities=27%  Similarity=0.335  Sum_probs=200.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      +|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999875 58999999987543   2335678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...    ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999988754    4688999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .   ......|+..|+|||...+..++.++|+||+|+++|+|++|+.||............   ......   .. .   
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~---~~-~---  220 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQETA---DV-L---  220 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH---HHhccc---cc-c---
Confidence            1   223456788999999998888999999999999999999999999754432111111   111100   00 0   


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTT--QQLV 1013 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 1013 (1020)
                          .+......+.+++.+||+.||.+||++  +|++
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 ----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                011122468899999999999999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=299.29  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=198.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcC---CCccceEeeEEeccCceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQ---HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... .....++.+|++++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999986 478999999987543 233456888999999996   999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...     .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999987642     688999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..  .......|+..|+|||...+ ..++.++|+||||+++|+|++|+.||........      ..... ..     ..
T Consensus       154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~~-~~-----~~  219 (277)
T cd06917         154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLIP-KS-----KP  219 (277)
T ss_pred             Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhccc-cC-----CC
Confidence            32  22233568889999998765 4578999999999999999999999975322111      10000 00     00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.....   .....+.+++.+||+.||++||++.|+++
T Consensus       220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111111   12346889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-32  Score=300.57  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|+..+.||.|++|.||+|+.. +++.||||++..+..  .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999865 688999998875432  2335688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +. ++|..++...  ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||+++......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5888887653  234689999999999999999999999   99999999999999999999999999987653321


Q ss_pred             CcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc---------
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN---------  969 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------  969 (1020)
                        .......++..|+|||+..+. .++.++||||||+++|||+||+.||......  ..............         
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhH
Confidence              112234567899999987654 4688999999999999999999999643211  11111111100000         


Q ss_pred             ------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 ------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .......... ....+.....+.+++.+|++.||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                  0000000000 0000111235778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-32  Score=303.52  Aligned_cols=265  Identities=20%  Similarity=0.256  Sum_probs=195.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcC-CCccceEeeEEeccCc-----
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKND-----  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  812 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999865 689999998765432  22356788999999995 6999999999887665     


Q ss_pred             eEEEEEeccCCChhhhhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeecc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFG  890 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  890 (1020)
                      .++||||+++ ++.+++...... ...+++..++.++.||+.||+|||+.   +|+||||||+||+++. ++.+|++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 788887654322 34689999999999999999999999   9999999999999998 8899999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      .++....+.  .......+++.|+|||++.+ ..++.++||||+|+++|+|++|..||.......  ...........+.
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            988653321  11223356788999998754 567899999999999999999999997532211  1111111000000


Q ss_pred             --ccccc---cC--------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 --RESEV---LD--------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 --~~~~~---~d--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .....   .+        +.......+.....+.+++.+||+.||.+||+++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              00000   00        00000000122346889999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-32  Score=303.45  Aligned_cols=261  Identities=25%  Similarity=0.304  Sum_probs=197.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.++....  .....+.+|++++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999875 588999999875432  2234567899999999999999999998877  889999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++ +|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++...
T Consensus        85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999975 8888876542   3689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh--------
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ--------  967 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------  967 (1020)
                      .+.  .......+++.|+|||...+. .++.++|+||+|+++|||++|..||........   .........        
T Consensus       158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHH
Confidence            432  122334578899999987654 468899999999999999999999975432111   111100000        


Q ss_pred             -----h----cccccccCccccCccCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 -----E----NRESEVLDPFIYDKQHDK-EMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 -----~----~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           .    ..........+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                 0    000000000001111111 2345789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=281.90  Aligned_cols=263  Identities=23%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ++|+.+.+     .+.||+|+|+.|..+. ..+|..||||++.+........+.+|++++.+. .|+||++++++|.+++
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            45555544     3679999999999886 678999999999988777778899999999988 5999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEee
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLAD  888 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  888 (1020)
                      ..|+|||-|.||.|-.++.++    ..+++.++..+.++|+.||.|||.+   ||.|||+||+|||.....+   +||||
T Consensus       150 ~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             eEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence            999999999999999988876    5689999999999999999999999   9999999999999975443   89999


Q ss_pred             ccccccccC-----CCCcccccccccccCccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC----
Q 035998          889 FGLARLILS-----PYDTHVTTDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG----  954 (1020)
Q Consensus       889 fg~~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~----  954 (1020)
                      |.+...+.-     +.......+.+|+..|||||+.     ....|+.++|.||+|||+|-|++|.+||.+.-..+    
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            988755321     2222233457889999999953     34578999999999999999999999997643322    


Q ss_pred             ---cccHHHHH-HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          955 ---SRDLISWV-IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       955 ---~~~~~~~~-~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .-...+.. -...+++. -+++|     ........+..+++...+..|+.+|.++.+++.
T Consensus       303 rGe~Cr~CQ~~LFesIQEGk-YeFPd-----kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGK-YEFPD-----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccC-CcCCh-----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               10111100 00111111 11111     111233445778999999999999999998876

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8e-32  Score=291.53  Aligned_cols=251  Identities=28%  Similarity=0.404  Sum_probs=204.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  817 (1020)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++++.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999876 688999999876542  3456789999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998764    2789999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ...........++..|+|||...+...+.++||||+|+++|+|++|..||....     +................    
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~----  224 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE----  224 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC----
Confidence            322112334568889999999988889999999999999999999999997543     11111111111011111    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           .+......+.+++.+|++.+|.+||++.|+++
T Consensus       225 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 -----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                 11122356889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-32  Score=293.47  Aligned_cols=249  Identities=31%  Similarity=0.519  Sum_probs=203.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +|+..+.||+|++|.||+|... +++.|++|++........+.+.+|++.+++++|++++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999875 688999999987655456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++....   ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999887642   4689999999999999999999998   999999999999999999999999999987643221 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                        .....++..|+|||...+..++.++||||+|+++|+|++|+.||......      ........ ........+    
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~~----  220 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGLRNP----  220 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCcCcc----
Confidence              23456788999999998888999999999999999999999999743211      11111111 111111111    


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ......+.+++.+||+.||++|||+.|+++
T Consensus       221 ---~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 ---EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               001246889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.7e-33  Score=323.42  Aligned_cols=253  Identities=29%  Similarity=0.434  Sum_probs=189.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--------  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  810 (1020)
                      ..+|+.+++||+|+||.||+++.+ ||+.||||++.... ......+.+|+..+.+++|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356888899999999999999977 89999999997654 23345688999999999999999988522110        


Q ss_pred             --------------------------------------------------------------------------------
Q 035998          811 --------------------------------------------------------------------------------  810 (1020)
Q Consensus       811 --------------------------------------------------------------------------------  810 (1020)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 035998          811 -------------------------------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH  859 (1020)
Q Consensus       811 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH  859 (1020)
                                                     ...||-||||+..++.+++++..-..   .....++++++|++||+|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence                                           01367889998888777777642111   35778999999999999999


Q ss_pred             hcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc------C----------CCCcccccccccccCccCccccCCCC
Q 035998          860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL------S----------PYDTHVTTDLVGTLGYIPPEYGQASV  923 (1020)
Q Consensus       860 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~~~  923 (1020)
                      +.   |||||||||.||++|.++.|||+|||+|....      +          .......+..+||.-|+|||++.+..
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998722      0          01112345578999999999887654


Q ss_pred             ---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccC
Q 035998          924 ---ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLS 1000 (1020)
Q Consensus       924 ---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~ 1000 (1020)
                         |+.|+|+||+|||++||+.   ||+.     ..+.+......+ ....+..  +.+    ...++..=..+|++|++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T-----sMERa~iL~~LR-~g~iP~~--~~f----~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGT-----SMERASILTNLR-KGSIPEP--ADF----FDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCc-----hHHHHHHHHhcc-cCCCCCC--ccc----ccccchHHHHHHHHHhc
Confidence               9999999999999999996   4642     122222222232 2222221  111    22222334679999999


Q ss_pred             CCCCCCCCHHHHHH
Q 035998         1001 ESPKVRPTTQQLVS 1014 (1020)
Q Consensus      1001 ~dP~~RPs~~evl~ 1014 (1020)
                      .||.+||||.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999986

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-32  Score=305.14  Aligned_cols=262  Identities=29%  Similarity=0.372  Sum_probs=195.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  .....+.+|++++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999864 689999999864432  2223466899999999999999999998765  45799


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++ +|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++..
T Consensus        86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            9999975 788777653   24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh---ccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE---NRE  971 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~  971 (1020)
                      ....  .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....+.+   ...........   ...
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIW  233 (309)
T ss_pred             CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhc
Confidence            4322  11222345778999998765 567899999999999999999999997543221   11111111000   000


Q ss_pred             ccc----------cCccccCc---cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEV----------LDPFIYDK---QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~----------~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...          ........   ........+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000          00000000   00112345789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-32  Score=295.10  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=204.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|+||+++.+++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999754 68899999987543  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++.+.......++++.++.++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999877544456789999999999999999999999   9999999999999999999999999999876432 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                         ......++..|+|||...+..++.++|+||+|+++|||++|+.||......   ...   .... .....       
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~-~~~~~-------  219 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR---YKVQ-RGKYP-------  219 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHh-cCCCC-------
Confidence               222356788999999999999999999999999999999999999643321   111   1111 11111       


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        ........++.+++.+|++.+|++||++.|+++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              111233356899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.2e-32  Score=298.27  Aligned_cols=262  Identities=23%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +|++.+.||+|++|.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788999999999999999975 688999999876532 22356778999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++|||+++...... 
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-  154 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-  154 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence            85 88888765422 34689999999999999999999998   99999999999999999999999999997653321 


Q ss_pred             cccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-hh--c------c
Q 035998          901 THVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-QE--N------R  970 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~--~------~  970 (1020)
                       .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+.   ........ .+  .      .
T Consensus       155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhc
Confidence             12233456889999998755 4578899999999999999999999975432211   11111000 00  0      0


Q ss_pred             cccccC--ccc----cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLD--PFI----YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d--~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......  +..    .....+.....+.+++.+|++.||.+||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000  000    00011122346789999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.8e-32  Score=300.34  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=193.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999864 68999999987543 234557889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEK-LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      +.. ++.++.... ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+|++|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 554433221 112356899999999999999999999632  8999999999999999999999999999765432


Q ss_pred             CCcccccccccccCccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQAS---VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .   ......|+..|+|||++.+.   .++.++||||+||++|||++|+.||....     .............      
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------  227 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------  227 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------
Confidence            2   12234578899999988765   68899999999999999999999996432     1111111111100      


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+.+...........+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            011111111223346889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.9e-32  Score=296.84  Aligned_cols=252  Identities=25%  Similarity=0.403  Sum_probs=204.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++.|+..+.||+|++|.||+|..+ +++.||+|++..... ..+.+.+|++.+++++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999876 688999999976544 45678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999999999998752   3789999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ..  ......++..|+|||+..+..++.++||||||+++|+|++|+.||....+.      ........ .......+  
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~--  238 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIPPLKN--  238 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCCCCcc--
Confidence            21  122345788999999998888999999999999999999999998643221      11111111 11111111  


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           .......+.+++.+||+.+|.+||++.++++
T Consensus       239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 -----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 1112346889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.1e-32  Score=294.57  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=205.7

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||++... +++.||+|++.....  ...+.+.+|++++++++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999865 688999999876532  4456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++.........+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987654456789999999999999999999999   99999999999999999999999999998764432


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||.....      .......... .....     
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~-----  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKG-QYPPI-----  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcC-CCCCC-----
Confidence              223345688899999998888899999999999999999999999964321      1111111111 11110     


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +......+.+++.+||..+|++||++.++++
T Consensus       224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1112246889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.3e-32  Score=300.78  Aligned_cols=245  Identities=30%  Similarity=0.410  Sum_probs=194.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +.|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++|||++++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888999999999999999864 68999999886432   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++ |++.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 4666665533   23589999999999999999999998   999999999999999999999999999875422


Q ss_pred             CCCcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                            .....++..|+|||++.   .+.++.++||||||+++|||++|+.||......      ......... .... 
T Consensus       168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~-~~~~-  233 (307)
T cd06607         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-DSPT-  233 (307)
T ss_pred             ------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcC-CCCC-
Confidence                  12346788999999863   456889999999999999999999998643211      111111111 0000 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .   ........+.+++.+||+.+|++||++.++++
T Consensus       234 ----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         234 ----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             ----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0   01123346889999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.7e-32  Score=292.07  Aligned_cols=249  Identities=23%  Similarity=0.281  Sum_probs=191.7

Q ss_pred             HHHHHhccCCCcCCee--eccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          735 DDILESTNNFDQANII--GCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .+.....++|++.+.+  |+|+||.||+++.+ ++..+|+|.+......   .  .|+.....+ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            3344445677777776  99999999999864 6888999998653211   1  122222223 799999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeec
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADF  889 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df  889 (1020)
                      +..++||||+++++|.+++...    ..++++.+..++.|+++|++|||+.   +++||||||+||+++.++ .++++||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999998764    3789999999999999999999999   999999999999999988 9999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      |.++.....      ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... .+...+........
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~  227 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQQKKL  227 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhhcccC
Confidence            998765322      22457889999999998899999999999999999999999997443221 11111111111000


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-TQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1014 (1020)
                         ..         .......+.+++.+||+.+|.+||+ ++++++
T Consensus       228 ---~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 ---PF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---Cc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               00         0122346889999999999999996 699875

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=297.92  Aligned_cols=260  Identities=25%  Similarity=0.319  Sum_probs=195.7

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      |++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999864 79999999987543  222356788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++++|||.++...... 
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-  153 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-  153 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence            5 689888875421  3689999999999999999999998   99999999999999999999999999997653221 


Q ss_pred             cccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc---------
Q 035998          901 THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR---------  970 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  970 (1020)
                       .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......  ...............         
T Consensus       154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhc
Confidence             112233568899999987654 5788999999999999999999999643221  111111110000000         


Q ss_pred             ------cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ------ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            ......+. .....+.....+.+++.+|++.||++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  00000000 00001112246789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=309.78  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=194.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----ce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----DR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  813 (1020)
                      +++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999985 468999999986432 233456788999999999999999999876543     47


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++|+||+++ ++..++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            899999975 77666653     3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc--
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN--  969 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  969 (1020)
                      ........ .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||......   .............  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCH
Confidence            65432211 11223567889999997644 56899999999999999999999999643211   1111111100000  


Q ss_pred             -ccccccC-------------cccc-CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 -RESEVLD-------------PFIY-DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 -~~~~~~d-------------~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ....+.+             +... ....+.....+.+++.+||+.||++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~  291 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA  291 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0000000             0000 0000112345889999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=328.15  Aligned_cols=260  Identities=29%  Similarity=0.471  Sum_probs=206.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----C----CCEEEEEEecCCchh-hHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----D----GRNVAIKRLSGDCGQ-MEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ++..+.+.+|+|+||.|++|...    .    ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|..+.
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            34456679999999999999742    1    457999999866543 456789999999999 5999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcC-----CCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKL-----DGP-------SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~-----~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      ..++|+||+..|+|.+|++...     ...       ..++..+.+.++.|||.||+||++.   ++||||+.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEec
Confidence            9999999999999999998765     011       2488999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccc-cccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      ++..+||+|||+|+............. ..-+..|||||.+....++.|+|||||||++||++| |..||.+...  ..+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence            999999999999997654333321211 113456999999999999999999999999999999 9999975321  112


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..++   .+...+.          ..+..+..+++++|+.||+.+|++||++.++++.|+..
T Consensus       531 l~~~---l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 LLEF---LKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHH---HhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            2221   2111111          12223345799999999999999999999999998864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-32  Score=321.65  Aligned_cols=266  Identities=20%  Similarity=0.249  Sum_probs=187.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC--CCEEEEE------------------EecCCchhhHHHHHHHHHHHHHcCCCcc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD--GRNVAIK------------------RLSGDCGQMEREFRAEVEALSRAQHPNL  800 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ni  800 (1020)
                      .++|++.+.||+|+||+||++..+.  +..+++|                  .... .......+.+|++++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999987532  2222222                  1111 12234568899999999999999


Q ss_pred             ceEeeEEeccCceEEEEEeccCCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          801 VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK-LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       801 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      +++++++...+..|+|+|++.+ ++..++... ...........+..++.|++.||+|||++   +||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999864 666665432 12222344667788999999999999999   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCCCcccH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP-MDMCKPKGSRDL  958 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p-f~~~~~~~~~~~  958 (1020)
                      .++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..+ +...........
T Consensus       302 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            99999999999998764322 1222345789999999999999999999999999999999998754 433222211122


Q ss_pred             HHHHHHHHhhcccccccCcc-----------cc--CccCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPF-----------IY--DKQHD------KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~-----------~~--~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .........  ...++.++.           +.  ....+      .....+.+++.+|+++||.+|||+.|+++
T Consensus       381 ~~~~~~~~~--~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSV--CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhccc--ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111100  000000000           00  00000      01124677899999999999999999987

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.8e-32  Score=307.99  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=195.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  810 (1020)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|++++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999864 78999999986432  22345677899999999999999999988643      


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ...++||||+++ +|.+++..      .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            346899999965 77776653      278889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc------------cH
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR------------DL  958 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~------------~~  958 (1020)
                      +++.....   .......++..|+|||.+.+..++.++||||+||++|+|++|+.||.........            .+
T Consensus       164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99875332   1223346788999999999999999999999999999999999999643211000            00


Q ss_pred             HHHHHH---HHhhcc-------cccccCcccc----CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          959 ISWVIR---MRQENR-------ESEVLDPFIY----DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       959 ~~~~~~---~~~~~~-------~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......   ......       ..........    ..........+.+++.+|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000000   000000       0000000000    0001123446789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-31  Score=296.21  Aligned_cols=257  Identities=21%  Similarity=0.273  Sum_probs=183.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCchhh--H---------HHHHHHHHHHHHcCCCccceEee
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDCGQM--E---------REFRAEVEALSRAQHPNLVHLQG  805 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~  805 (1020)
                      .++|++.+.||+|+||.||+|...+    +..+|+|+........  +         .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998654    3456666543222111  1         11122334455668999999999


Q ss_pred             EEeccC----ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC
Q 035998          806 YCMHKN----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN  881 (1020)
Q Consensus       806 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  881 (1020)
                      ++....    ..++++|++.. ++.+.+...    ...++..+..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            766543    23577776643 555554432    2356788899999999999999999   99999999999999999


Q ss_pred             CCeEEeeccccccccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 035998          882 FGAHLADFGLARLILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR  956 (1020)
Q Consensus       882 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  956 (1020)
                      +.++|+|||+++........     .......||+.|+|||+..+..++.++||||+||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432111     1122346899999999999999999999999999999999999999765322211


Q ss_pred             cHH---HHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          957 DLI---SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       957 ~~~---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      ...   ..........         ....   .....+.+++..|++.+|++||+++++++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGK---------IKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhh---------hccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111   1111111110         0001   11246889999999999999999999998763

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.5e-32  Score=297.01  Aligned_cols=257  Identities=25%  Similarity=0.263  Sum_probs=192.2

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcC-CCccceEeeEEecc--CceEEEEE
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHK--NDRLLIYS  818 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  818 (1020)
                      |++.+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999854 68899999987542 222234457888888885 99999999999987  88999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++ ++.+++...   ...+++.++..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.++.....
T Consensus        81 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9975 777776643   24689999999999999999999999   9999999999999999 99999999999876432


Q ss_pred             CCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh----------
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ----------  967 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------  967 (1020)
                      ..   .....++..|+|||... ++.++.++||||+||++|||++|+.||......+   .+.+......          
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence            21   12345788999999754 4567899999999999999999999997543221   1111111100          


Q ss_pred             -hcccccccCcccc----CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 -ENRESEVLDPFIY----DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 -~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .........+...    ....+.....+.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence             0000000000000    0001123457899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=277.92  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=194.1

Q ss_pred             cCCCcC-CeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEec----cCceE
Q 035998          742 NNFDQA-NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       742 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  814 (1020)
                      ++|.+. ++||-|-.|.|..+..+ +|+.+|+|++...     ...++|++.--.. .|||||.++++|..    .....
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            445543 67999999999999764 7899999998643     3456777764443 79999999999864    35667


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~  891 (1020)
                      +|||.|+||.|...+.++  +...+++.++..|++||+.|+.|||+.   .|.||||||+|+|..   .+..+|++|||+
T Consensus       136 iVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            999999999999998876  446799999999999999999999999   999999999999996   456699999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      |+....+   ......+-|+.|.|||++..++|+..+|+||+||+||-|++|.+||..........-+....+..    .
T Consensus       211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g----q  283 (400)
T KOG0604|consen  211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG----Q  283 (400)
T ss_pred             ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc----C
Confidence            9976432   22344567999999999999999999999999999999999999997544322211111111110    1


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      -++.+|     ......+...++|+.+++.+|.+|.|+.+++.
T Consensus       284 y~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 YEFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            111111     11233456789999999999999999999986

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-32  Score=302.62  Aligned_cols=247  Identities=26%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh--hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ--MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ...|.+.+.||+|.|++|..|++. ++..||||.+.+..-.  ..+.+.+|+++|..++|||||+++++.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456888999999999999999864 6899999999876522  2345889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+.+|.+.+|+...    ..+.+..+..++.|+.+|++|||++   .|||||||++||+++.+..+||+|||++..+. 
T Consensus       135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence            999999999999875    4455688899999999999999999   99999999999999999999999999998873 


Q ss_pred             CCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                        ........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+....+-.     ...++     
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----gk~rI-----  274 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----GKYRI-----  274 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----eeecc-----
Confidence              3345566899999999999988765 6899999999999999999999986544332221110     00000     


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      |.+       ...+..+++++++-.+|.+|++.+++.+
T Consensus       275 p~~-------ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  275 PFY-------MSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             cce-------eechhHHHHHHhhccCccccCCHHHhhh
Confidence            000       1124568999999999999999999976

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-32  Score=294.99  Aligned_cols=249  Identities=27%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|+||.||+|..+ +|..||+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999865 58899999986542  12345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC-eEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~  898 (1020)
                      +++++|.+++.+.  ....+++..+..++.|+++|++|||+.   +++|+||||+||++++++. +|++|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998754  223578999999999999999999999   9999999999999998864 699999999776432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .  .......|++.|+|||+..+..++.++|+||+|+++|||++|+.||.....      .......... ....     
T Consensus       156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~-----  221 (257)
T cd08225         156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG-YFAP-----  221 (257)
T ss_pred             c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc-cCCC-----
Confidence            2  122234688899999998888899999999999999999999999964321      1111111111 1111     


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ..+.....+.+++.+||+.+|++||++.|+++
T Consensus       222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                01112246889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-33  Score=322.36  Aligned_cols=258  Identities=24%  Similarity=0.269  Sum_probs=205.5

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      +.+++-..++|+++++||+|+||.|..++.+ +++.||+|++.+..   .....-|..|..+|..-+.+.|+.++-.|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455556788999999999999999999875 68889999998743   2233568899999998899999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      +...|+|||||+||||-..+...    ..++++.++.++..|+.||.-+|+.   |+|||||||+|||+|..|++|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999988765    3789999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccC----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHH-HHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQ----A-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS-WVI  963 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~  963 (1020)
                      |.|-.+..++ .......+|||.|++||++.    + +.|+..+|+||+||++|||+.|..||...      .++. +..
T Consensus       220 GsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~K  292 (1317)
T KOG0612|consen  220 GSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGK  292 (1317)
T ss_pred             hhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHH
Confidence            9998875433 33455689999999999763    3 67899999999999999999999999742      2222 222


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT---TQQLVS 1014 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1014 (1020)
                      .+..... -.+++       ..+......+||++.+. +|+.|..   ++|+..
T Consensus       293 Im~hk~~-l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  293 IMNHKES-LSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             Hhchhhh-cCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            2211111 11111       11133457788888776 6788877   777754

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.8e-32  Score=295.33  Aligned_cols=241  Identities=28%  Similarity=0.323  Sum_probs=186.1

Q ss_pred             eeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHH---cCCCccceEeeEEeccCceEEEEEecc
Q 035998          749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSR---AQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++.   .+||+++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 688999998865421   112234445444443   379999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++...    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++......   
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---  150 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence            99999888754    4689999999999999999999999   9999999999999999999999999998755322   


Q ss_pred             ccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       ......|+..|+|||... +..++.++||||+||++|||++|..||......... ..   .......      ...  
T Consensus       151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~---~~~~~~~------~~~--  217 (279)
T cd05633         151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI---DRMTLTV------NVE--  217 (279)
T ss_pred             -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HH---HHHhhcC------CcC--
Confidence             122346899999999876 456889999999999999999999999754332211 11   1111000      000  


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                        .+.....++.+++.+|++.||++||     +++++++
T Consensus       218 --~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         218 --LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             --CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence              1111234688999999999999999     5999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-31  Score=291.19  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|++|.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+....++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999875 48899999987543   23346789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++...    ..+++..+..++.|++.||+|+|+.   +++|+||+|+||+++.++.++++|||.++......   ...
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            9998764    3578999999999999999999998   99999999999999999999999999998764321   223


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...++..|+|||...+..++.++|+||+|+++|+|++|..||......    ................         .+.
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~---------~~~  217 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGKLE---------FPN  217 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCCCC---------CCc
Confidence            346788999999988888999999999999999999999999754321    1111111111000000         111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                      .....+.+++.+||+.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            11346899999999999999999     888876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.6e-32  Score=294.94  Aligned_cols=244  Identities=26%  Similarity=0.367  Sum_probs=192.2

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||+||+|... +|+.||+|.+....   ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 68899999986532   12234567899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++....  ...+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+.....   .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence            99987642  24689999999999999999999999   999999999999999999999999999876532   11223


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...++..|+|||...+..++.++||||+|+++|+|++|+.||...........+..  .. ...       +.   ..+.
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~-~~~-------~~---~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RT-LEM-------AV---EYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--cc-ccc-------cc---cCCc
Confidence            34678899999998888899999999999999999999999975433211111110  00 000       00   0111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1223578999999999999999     6766764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-32  Score=297.73  Aligned_cols=260  Identities=27%  Similarity=0.344  Sum_probs=197.0

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEEEE
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLIYS  818 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  818 (1020)
                      |++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++|||++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999876 58899999998663  33345688899999999999999999999888  78999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++ +|.+++...   ...+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.+|++|||.+......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888777643   24689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc---ccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN---RESEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~  974 (1020)
                      .. .......++..|+|||...+ ..++.++||||||+++|||++|+.||......   .............   .....
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhcccc
Confidence            21 11223456788999997654 46789999999999999999999999754321   1111111110000   00000


Q ss_pred             cC--------------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LD--------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+              ..........+...+.+++.+||+.+|.+||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00              00000000111456889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=8.6e-32  Score=296.36  Aligned_cols=244  Identities=24%  Similarity=0.338  Sum_probs=195.9

Q ss_pred             CCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ..+||+|+||.||+|... +++.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999864 7889999998655444556788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||++.......  ....
T Consensus       105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~  174 (292)
T cd06657         105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK  174 (292)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence            987754     2478899999999999999999999   99999999999999999999999999987653321  1223


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...+++.|+|||...+..++.++|+||+|+++|+|++|+.||.....      ............ ..     ...  ..
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~~~~~~~~-~~-----~~~--~~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLP-PK-----LKN--LH  240 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhhCC-cc-----cCC--cc
Confidence            35678899999998888899999999999999999999999864221      111111111100 00     000  01


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....+.+++.+||+.+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            12235788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=4.7e-32  Score=301.98  Aligned_cols=267  Identities=25%  Similarity=0.297  Sum_probs=193.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-----
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-----  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  812 (1020)
                      -++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999865 68899999886432  2223456689999999999999999999876543     


Q ss_pred             ---eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          813 ---RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       813 ---~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                         .++||||+.+ ++.+++...   ...+++++++.++.|++.||+|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               4899999975 777776543   23689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCc--ccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          890 GLARLILSPYDT--HVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       890 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |.+.........  .......++..|+|||...+. .++.++||||+|+++|||++|+.||...........+.......
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999876432211  111234567889999987654 47889999999999999999999997543221111111111000


Q ss_pred             hhcccccc-----cCc-cccCcc---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEV-----LDP-FIYDKQ---------HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~-----~d~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....+..     .+. ......         .......+.+++.+||+.||++||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00000000     000 000000         0001234678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.2e-31  Score=300.63  Aligned_cols=259  Identities=24%  Similarity=0.294  Sum_probs=191.1

Q ss_pred             eeecc--CCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          749 IIGCG--GFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       749 ~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      .||+|  +||+||+|+.. +|+.||+|++....  ....+.+.+|+.+++.++||||++++++|...+..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            45666  99999999864 78999999987543  223467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc-
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-  902 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-  902 (1020)
                      ++.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.......... 
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999988653  23588999999999999999999998   99999999999999999999999998654432211110 


Q ss_pred             ----cccccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH------------
Q 035998          903 ----VTTDLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR------------  964 (1020)
Q Consensus       903 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~------------  964 (1020)
                          ......++..|+|||++.+.  .++.++||||+||++|||++|+.||.......  ........            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence                01112345679999998764  47899999999999999999999997543211  00000000            


Q ss_pred             ----HH----------------hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          965 ----MR----------------QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       965 ----~~----------------~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ..                .........+..............+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                00                000000000111111112334557899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=270.54  Aligned_cols=248  Identities=23%  Similarity=0.416  Sum_probs=192.6

Q ss_pred             CcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEecc
Q 035998          745 DQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +.+..||.|..|.||+++++ +|...|||.+..... +..+.+...+.++.+- .+|+||+-+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            45677999999999999976 588999999876543 2234566777777665 48999999999999999999999985


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      . -.+.++++.   ..++++..+-++...+..||.||.++.  +|+|||+||+|||+|+.|.+|+||||.+-++.+   .
T Consensus       175 ~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---S  245 (391)
T KOG0983|consen  175 T-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---S  245 (391)
T ss_pred             H-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec---c
Confidence            3 445555543   245888888899999999999998764  999999999999999999999999999988754   3


Q ss_pred             ccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          902 HVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ...+...|.+.|||||-+..   ..|+.++||||||+.++|+.||+.||..+..  +.+....+..     ..+..+++.
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln-----~ePP~L~~~  318 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLN-----EEPPLLPGH  318 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHh-----cCCCCCCcc
Confidence            44556789999999997754   4788999999999999999999999976532  1222222221     111222221


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..      ....+.+++..|++.|+.+||...++++
T Consensus       319 ~g------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 MG------FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cC------cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11      1235789999999999999999998875

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.5e-31  Score=286.89  Aligned_cols=247  Identities=30%  Similarity=0.470  Sum_probs=201.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  .....+.+|++++++++|||++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 678999999976643  3446789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..++++.+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999988754    4689999999999999999999999   99999999999999999999999999998764332


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      .  ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....  .    ......... .... .    
T Consensus       154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~----~~~~~~~~~-~~~~-~----  219 (254)
T cd06627         154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--M----AALFRIVQD-DHPP-L----  219 (254)
T ss_pred             c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--H----HHHHHHhcc-CCCC-C----
Confidence            2  12335678899999998888889999999999999999999999964321  1    111111111 0000 0    


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +......+.+++.+|++.+|++||++.+++.
T Consensus       220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                1111246789999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=6.5e-32  Score=299.64  Aligned_cols=264  Identities=29%  Similarity=0.345  Sum_probs=195.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  811 (1020)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++....  ......+.+|++++++++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567899999999999999999975 58899999987543  223356778999999999999999999987654     


Q ss_pred             -----ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          812 -----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       812 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                           ..++|+||+++ ++..++...   ...++++.+..++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence                 68899999986 666665543   34689999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....   ..........
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~---~~~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE---LAQLELISRL  233 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Confidence            99999986543221 11122345778999997754 4578999999999999999999999974322   1111111111


Q ss_pred             Hhhcc---cccccCcccc-------------CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENR---ESEVLDPFIY-------------DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~---~~~~~d~~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....   ..........             ..........+.+++.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11000   0000000000             0000012346889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=2.6e-32  Score=307.18  Aligned_cols=260  Identities=24%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----ND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  812 (1020)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+....  ......+.+|+++++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999854 68999999986532  22345677899999999999999999988644     34


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+. ++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 6787777643    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc--
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN--  969 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  969 (1020)
                      +......  .......++..|+|||.+.. ..++.++||||+||++|+|++|+.||.......   ............  
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  230 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSE  230 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence            8764321  22234567889999997654 568899999999999999999999996432111   111000000000  


Q ss_pred             ----------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 ----------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ----------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                      ......++... ...+.....+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence                            00000000000 001123346789999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.4e-31  Score=298.68  Aligned_cols=245  Identities=30%  Similarity=0.409  Sum_probs=193.4

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .|+..+.||+|+||.||+|... ++..||+|++....   ......+.+|++++++++|||++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677889999999999999864 68899999986432   2334568889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+.+ ++.+++...   ...+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||++..... 
T Consensus       106 ~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         106 YCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             CCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            9975 676666543   24589999999999999999999999   999999999999999999999999999875422 


Q ss_pred             CCcccccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                           .....++..|+|||++   ..+.++.++||||+||++|||++|+.||......      ............ .  
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~--  243 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-T--  243 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCC-C--
Confidence                 1234678899999986   3467889999999999999999999998643211      111111111100 0  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                            .........+.+++.+||+.+|.+||++.++++.
T Consensus       244 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         244 ------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             ------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence                  0011223458899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=7.6e-32  Score=296.08  Aligned_cols=259  Identities=27%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      |++.+.||+|++|.||+|... +++.+|+|++.....  .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567889999999999999865 688999999875532  23467888999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++ ++.+++...   ...+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++++|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 787777653   24689999999999999999999999   99999999999999999999999999998764432 


Q ss_pred             cccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh---cccccccC
Q 035998          901 THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE---NRESEVLD  976 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d  976 (1020)
                       .......++..|+|||...+. .++.++|+||+|+++|+|++|+.||......   +...........   .......+
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchh
Confidence             122334677889999988776 7899999999999999999999999643321   111111110000   00000000


Q ss_pred             -------------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 -------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   ........+....++.+++.+||+.||.+||++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                         00000111223457889999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=2.6e-32  Score=306.94  Aligned_cols=263  Identities=23%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEec----cCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999864 689999999876432  234567789999999999999999998763    3457


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+. ++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            89999996 5888877543    4589999999999999999999999   99999999999999999999999999997


Q ss_pred             cccCCCCc--ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          894 LILSPYDT--HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       894 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      ........  .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......   .+.......... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCCh
Confidence            65432211  11223568889999998755 568899999999999999999999996543211   111111100000 


Q ss_pred             --c--------c----ccc--cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 --R--------E----SEV--LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 --~--------~----~~~--~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .        .    ...  ..+.......+.....+.+++.+|++.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0        0    000  0000000011122456899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=8.6e-32  Score=297.33  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+.....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999865 688999998865422  233567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~  897 (1020)
                      |++ +++.+++...  .....++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+|++|||+++....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 4777776543  223457888899999999999999999   9999999999999985 56799999999976533


Q ss_pred             CCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh--ccccc-
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE--NRESE-  973 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~-  973 (1020)
                      ..  .......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||......+  ...........+  ..... 
T Consensus       156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhcccc
Confidence            21  11233457889999998765 457899999999999999999999996432211  111100000000  00000 


Q ss_pred             --ccC-----ccccC----ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 --VLD-----PFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 --~~d-----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        ..+     +....    ...+.....+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000     00000    001112235789999999999999999999987

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=291.17  Aligned_cols=241  Identities=25%  Similarity=0.315  Sum_probs=185.5

Q ss_pred             CeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHH-HHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEAL-SRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999864 688999999875431   1122344555444 345899999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+|++|||+++....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999998754    4578999999999999999999999   999999999999999999999999999875422     


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                       .....++..|+|||...+..++.++||||+|+++|||++|..||......   ...   ..... ....  ..+    .
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~-~~~~--~~~----~  215 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF---DNILS-RRIN--WPE----E  215 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHh-cccC--CCC----c
Confidence             22346788999999988888999999999999999999999999643321   111   11111 0000  000    0


Q ss_pred             cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          983 QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       983 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........+.+++.+||+.+|++||++.++.+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            01112346889999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=9.7e-32  Score=302.85  Aligned_cols=262  Identities=27%  Similarity=0.352  Sum_probs=194.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc--CceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK--NDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  814 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+++++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467889999999999999999865 58899999885432  22234577899999999 999999999998654  3578


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||++ ++|..++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.++.
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 4888877642     678889999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCc---ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh--
Q 035998          895 ILSPYDT---HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE--  968 (1020)
Q Consensus       895 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  968 (1020)
                      .......   .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........   ..........  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            6433221   22234568889999997654 5678899999999999999999999964332111   1110000000  


Q ss_pred             ---------cccccccC------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 ---------NRESEVLD------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ---------~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                               .......+      ........+.....+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence                     00000000      00000001112346889999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.4e-31  Score=286.75  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=195.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--Cce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  813 (1020)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+....     ....+.+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999864 68899999875321     22345788999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++++||+++++|.+++...    ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999988753    3478889999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCC-cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYD-THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ....... ........++..|+|||...+..++.++|+|||||++|+|++|+.||......   ..+   ........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~~~~--  226 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAI---FKIATQPT--  226 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHH---HHHHcCCC--
Confidence            6532111 11112346888999999998888999999999999999999999999643211   111   11111100  


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .+.    .+......+.+++.+|++ +|.+||++.++++
T Consensus       227 ---~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 ---KPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               011    112223468899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=2.3e-31  Score=292.83  Aligned_cols=260  Identities=24%  Similarity=0.344  Sum_probs=194.7

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHc---CCCccceEeeEEeccCc-----
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRA---QHPNLVHLQGYCMHKND-----  812 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  812 (1020)
                      |++.+.||+|+||.||+|+.+ +++.||+|++.....  .....+.+|+++++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 489999999974432  2234566788877766   59999999999988776     


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .+++|||+.+ +|.+++....  ...+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+|++|||.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 7888886542  23589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc--
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR--  970 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  970 (1020)
                      .......   ......++..|+|||+..+..++.++|+||+|+++|||++|..||......+  ..............  
T Consensus       155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence            7763321   1223457889999999998899999999999999999999999987533221  11111111100000  


Q ss_pred             -cccc------cCccc---cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 -ESEV------LDPFI---YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 -~~~~------~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ....      .....   .....+.....+.+++.+||+.||.+||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence             0000      00000   00111223356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.7e-33  Score=328.07  Aligned_cols=251  Identities=31%  Similarity=0.435  Sum_probs=201.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +-+++....||.|.||.||.|.. .+|.-.|||.+.....  .....+.+|..++..++|||+|++||+-..++..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            44677788999999999999974 5688899998765432  23356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |||++|+|.+.+...    ...++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|+.+..
T Consensus      1314 EyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999988754    3445556667889999999999999   999999999999999999999999999998865


Q ss_pred             CCCc--ccccccccccCccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-hhccc
Q 035998          898 PYDT--HVTTDLVGTLGYIPPEYGQAS---VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-QENRE  971 (1020)
Q Consensus       898 ~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~  971 (1020)
                      ....  .......||+-|||||++.+.   ...-+.||||+|||+.||+||+.||.....       .|..+.. ..+..
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC
Confidence            4322  223357899999999998664   356799999999999999999999975432       2333322 22232


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.++.         ....+-.+++..|+..||++|.++.|+++
T Consensus      1460 Pq~P~---------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 PQIPE---------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCCch---------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            22222         23446789999999999999999998876

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=4.2e-31  Score=294.85  Aligned_cols=261  Identities=21%  Similarity=0.255  Sum_probs=191.5

Q ss_pred             cCCeeeccCCeEEEEEEeCCCCEEEEEEecCC--chhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          746 QANIIGCGGFGLVYRATLPDGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.+.+|.|+++.||++.. +++.||||++...  .....+.+.+|++++++++||||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555544 6899999998755  2334567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc--
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--  901 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--  901 (1020)
                      ++.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.+.........  
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999988653  23578899999999999999999999   9999999999999999999999999998765432211  


Q ss_pred             ---ccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh--------
Q 035998          902 ---HVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE--------  968 (1020)
Q Consensus       902 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------  968 (1020)
                         .......++..|+|||++..  ..++.++||||+||++|||++|+.||.......  ...+........        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence               11223456778999998765  358889999999999999999999997533211  111111000000        


Q ss_pred             ---ccccc----ccCccc----cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 ---NRESE----VLDPFI----YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ---~~~~~----~~d~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .....    ..++..    ..........++.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence               00000    000000    00112223346889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.2e-31  Score=293.13  Aligned_cols=254  Identities=26%  Similarity=0.322  Sum_probs=196.8

Q ss_pred             CCCcCCeeeccCCeEEEEEEe----CCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          743 NFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      +|++.+.||+|++|.||+|+.    .+++.||||.+....    ....+.+.+|+++++++ +||||+++.+++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999974    357889999987532    12235678899999999 599999999999988899


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...    ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++++|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999888653    3578899999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCCcccccccccccCccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASV--ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ...... ........|+..|+|||...+..  .+.++||||+|+++|||++|..||........  ............  
T Consensus       154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~--  228 (288)
T cd05583         154 EFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK--  228 (288)
T ss_pred             cccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC--
Confidence            654322 11222346788999999876654  78899999999999999999999963222111  111111111110  


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                           +..    +......+.+++.+||+.||++|||++++.+.|+
T Consensus       229 -----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 -----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             -----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                 000    1111235789999999999999999888876654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.4e-31  Score=290.84  Aligned_cols=244  Identities=28%  Similarity=0.363  Sum_probs=193.3

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||.||+|... +++.||+|.+.....   ...+.+.+|++++++++||||+++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999876533   3445788899999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC-----
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-----  900 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----  900 (1020)
                      .+++...    ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998764    3689999999999999999999999   999999999999999999999999999876533211     


Q ss_pred             -cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 -THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       ........++..|+|||.......+.++||||+|+++|++++|+.||......      ........ ... ..  +  
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-~~--~--  221 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKI-EW--P--  221 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCc-CC--C--
Confidence             11223456788999999988888999999999999999999999999744321      11111111 000 00  0  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                         ........+.+++.+||+.+|.+||++.++.+.
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         222 ---EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             ---ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence               000013467899999999999999999444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.3e-31  Score=291.76  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=201.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999865 78999999987532   233456888999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999998764    3689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc------------------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          897 SPYDT------------------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       897 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                      .....                  .......++..|+|||......++.++||||+|++++++++|+.||.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------  227 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------  227 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence            32211                  122234578899999998888899999999999999999999999974431      


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT----QQLVS 1014 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 1014 (1020)
                      ............  .         .+......+.+++.+||+.+|.+||++    +++++
T Consensus       228 ~~~~~~~~~~~~--~---------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 YLTFQKILKLEY--S---------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHHHhcCC--C---------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111111111000  0         011113458899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-31  Score=292.08  Aligned_cols=262  Identities=26%  Similarity=0.342  Sum_probs=195.3

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEec
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      |++.+.||+|++|.||+|... +++.||||++..... .......+|+..+++++ |||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999975 578899999875432 22234567899999998 999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                       +|++.+++....  +..+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.++...... 
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             788888877542  34689999999999999999999999   99999999999999999999999999998653321 


Q ss_pred             cccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH----------HHHHHHHhhc
Q 035998          901 THVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI----------SWVIRMRQEN  969 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~----------~~~~~~~~~~  969 (1020)
                        ......++..|+|||+.. ...++.++|+||||+++|||++|+.||......+.....          .|........
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              123356788999999764 456789999999999999999999999644321110000          0000000000


Q ss_pred             ccccccCccc---cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFI---YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..........   .....+.....+.+++.+||+.+|++||+++|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   00001111356889999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=250.99  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|+..++||+|.||+||+|+.+ +++.||+|...-+.  ........+|+-++++++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566788999999999999854 57889999887543  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |+. +|..|....   .+.++.+.+..++.|+++|+.++|++   .+.|||+||.|.+++.+|+.|++|||+++-++-+.
T Consensus        83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            965 677766543   35688899999999999999999999   99999999999999999999999999999875442


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc---
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV---  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---  974 (1020)
                        ......+-|..|++|.++.+ +-|+...|+||.|||+.|+.. |++-|.+....+....+-|......+..++.+   
T Consensus       156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence              23445677899999998766 468899999999999999998 66666543322211222222222222222221   


Q ss_pred             cCccccCccC---------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQH---------DKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .|-..+.-++         +.....-.+++++.+.-+|..|.+++++++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2211111111         122224578889999999999999999876

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.2e-32  Score=302.78  Aligned_cols=265  Identities=27%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----ceE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----DRL  814 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  814 (1020)
                      +|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+++++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999865 58999999987643  334467889999999999999999999988775     789


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++ +|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+..
T Consensus        81 lv~e~~~~-~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999984 787777643    3789999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCc-ccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc-
Q 035998          895 ILSPYDT-HVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE-  971 (1020)
Q Consensus       895 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  971 (1020)
                      ....... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+   .............. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~  229 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE  229 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence            6443210 122345678899999998877 88999999999999999999999997543211   11111000000000 


Q ss_pred             ----------cccc------CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          972 ----------SEVL------DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       972 ----------~~~~------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                                ....      .+.......+.....+.+++.+||+.+|.+||+++++++  +|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                      0000      000000001112346889999999999999999999988  4543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4.3e-31  Score=291.12  Aligned_cols=251  Identities=26%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             CCCcCCeeeccCCeEEEEEEe----CCCCEEEEEEecCCch----hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          743 NFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLSGDCG----QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|++.....    ...+.+.+|+++++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    3688999999875321    2235678899999999 599999999999988889


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999998754    4578899999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ...... ........|+..|+|||....  ..++.++||||+|+++|+|++|+.||........  ............. 
T Consensus       154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~-  229 (290)
T cd05613         154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP-  229 (290)
T ss_pred             eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCC-
Confidence            653221 112223567889999998765  3467899999999999999999999964322211  1111111111100 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                       .         .+......+.+++.+||+.||++||     ++++++.
T Consensus       230 -~---------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 -P---------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -C---------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             0         0111223578999999999999997     6677664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.2e-31  Score=300.24  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec-cCc
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH-KND  812 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  812 (1020)
                      +...+++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999854 78999999886432  2234567889999999999999999999875 457


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++|+||+ +++|..++..     ..+++..+..++.|+++||+|||+.   +|+||||+|+||+++.++.++++|||.+
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 5688877754     2467888899999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH---------H
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW---------V  962 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~---------~  962 (1020)
                      +....     ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...........+..         .
T Consensus       156 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            75422     1123456889999998765 5789999999999999999999999965332111000000         0


Q ss_pred             HHHHhhcc---ccccc--CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 IRMRQENR---ESEVL--DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 ~~~~~~~~---~~~~~--d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........   .....  .+.......+.....+.+++.+|++.+|++||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000   00000  000000000112346889999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3.8e-31  Score=292.42  Aligned_cols=250  Identities=25%  Similarity=0.455  Sum_probs=191.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|..++ ++.||||.+.... ......+.+|+.++.+. .||||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567889999999999999999764 8899999997543 22344566677777666 49999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+.+ ++..+....   ...+++..+..++.|++.|++|||+ .   +|+||||+|+||+++.++.+||+|||++.....
T Consensus        95 ~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9854 676665543   2368899999999999999999997 5   899999999999999999999999999876533


Q ss_pred             CCCcccccccccccCccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASV----ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ..   ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......     ........... ...
T Consensus       168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~  238 (296)
T cd06618         168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS  238 (296)
T ss_pred             CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC
Confidence            21   122335778999999887554    788999999999999999999999642111     11111111111 000


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...       ......++.+++.+||+.||.+||++.++++
T Consensus       239 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         239 LPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             CCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000       0012246889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=2.4e-31  Score=299.44  Aligned_cols=262  Identities=23%  Similarity=0.241  Sum_probs=194.1

Q ss_pred             cCCC-cCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhh--------------HHHHHHHHHHHHHcCCCccceEee
Q 035998          742 NNFD-QANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQM--------------EREFRAEVEALSRAQHPNLVHLQG  805 (1020)
Q Consensus       742 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  805 (1020)
                      ++|. +.+.||+|+||.||+|... +++.||||++.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4577999999999999864 68999999986543211              124678999999999999999999


Q ss_pred             EEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeE
Q 035998          806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH  885 (1020)
Q Consensus       806 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  885 (1020)
                      ++...+..++||||++ ++|.+++...    ..++++....++.|++.||+|||+.   +++||||+|+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence            9999999999999997 5888887643    4588999999999999999999999   999999999999999999999


Q ss_pred             EeeccccccccCCC------------CcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 035998          886 LADFGLARLILSPY------------DTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKP  952 (1020)
Q Consensus       886 l~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~  952 (1020)
                      ++|||.++....+.            .........++..|+|||.+.+. .++.++||||+|+++|||++|+.||....+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997664111            01111223467889999987654 478999999999999999999999975432


Q ss_pred             CCcccHHHHHHHHHhhcc---ccccc-----C------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          953 KGSRDLISWVIRMRQENR---ESEVL-----D------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~---~~~~~-----d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .   +.............   .....     .      +.............+.+++.+|++.+|++||+++|++.
T Consensus       240 ~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 I---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             H---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            2   11111111110000   00000     0      00000001112345789999999999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.3e-31  Score=301.99  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=190.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|...+.||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999864 68999999987532  222356788999999999999999999987543      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++|+||+.. ++..+..      ..++++.+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            45899999964 6655432      2578899999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      ++.....     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......   ............. 
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~  235 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG  235 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence            8764221     123467889999998765 56889999999999999999999999753211   1111111000000 


Q ss_pred             -----------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 -----------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 -----------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                       .......... ....+.....+.+++.+||+.||++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchH-HHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                             0000000000 0000112235789999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=286.29  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=197.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCC--chh-----hHHHHHHHHHHHHHcCCCccceEeeEEe-cc
Q 035998          740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD--CGQ-----MEREFRAEVEALSRAQHPNLVHLQGYCM-HK  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~  810 (1020)
                      ..++|-.+.+||+|+|++||+|. ....+.||||+-...  ...     -.+...+|..+-+.+.||.||++|+||. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34678889999999999999996 456889999986432  211     1234678999999999999999999997 55


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEe
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLA  887 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~  887 (1020)
                      +..+-|.|||+|.+|+.|++..    ..+++.+++.|++||+.||.||.+. .++|||-||||.|||+-   .-|.+||+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            6778999999999999999876    5789999999999999999999987 77899999999999984   45889999


Q ss_pred             eccccccccCCCCcc-----cccccccccCccCccccC----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          888 DFGLARLILSPYDTH-----VTTDLVGTLGYIPPEYGQ----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                      |||+++.+.+.....     .+....||..|.+||.+.    ..+.+.|+||||+|||+|+++.|+.||.....  ..+.
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI  693 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI  693 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence            999999886543332     234468999999999653    34678899999999999999999999974322  1222


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1013 (1020)
                      .+....+ ....+.....        +.-..+...+|++|+++--++|..+.++.
T Consensus       694 LqeNTIl-kAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  694 LQENTIL-KATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             Hhhhchh-cceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            2221111 1111111111        11223577899999999999998887764

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=3.5e-31  Score=294.21  Aligned_cols=245  Identities=29%  Similarity=0.419  Sum_probs=192.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCC---chhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD---CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+...   .....+++.+|+++++.++|+|++++.+++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34677788999999999999864 6788999988642   2233456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+. |++.+++...   ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||++.....
T Consensus        95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9997 5777766533   24578999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                            .....++..|+|||.+.   .+.++.++||||+||++|+|++|+.||......      ......... .... 
T Consensus       168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~-  233 (308)
T cd06634         168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESPA-  233 (308)
T ss_pred             ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhc-CCCC-
Confidence                  12346788999999864   456788999999999999999999998643211      111111111 1000 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          .   ........+.+++.+||+.+|++||+++++++
T Consensus       234 ----~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~  266 (308)
T cd06634         234 ----L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (308)
T ss_pred             ----c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence                0   01122345789999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-31  Score=299.96  Aligned_cols=264  Identities=24%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      ...++...+++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456667789999999999999999999975 478899999987542  2224567789999999999999999998864


Q ss_pred             c------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          810 K------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       810 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      .      ...+++++++ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            3      3467888876 7788877654     2588999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +|++|||+++....     ......++..|+|||...+ ..++.++||||+||++|||++|+.||.......   .....
T Consensus       159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~  230 (345)
T cd07877         159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLI  230 (345)
T ss_pred             EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            99999999876422     1223467889999998765 568889999999999999999999996432211   11111


Q ss_pred             HHHHh---hccc---------------ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 IRMRQ---ENRE---------------SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 ~~~~~---~~~~---------------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....   ....               ........ ..........+.+++.+|++.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00000   0000               00000000 0000011235789999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=6.7e-31  Score=287.41  Aligned_cols=241  Identities=26%  Similarity=0.307  Sum_probs=185.6

Q ss_pred             eeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHH---HHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          749 IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVE---ALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|..   .++...||+|+++++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999998865421   11222334443   3444579999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|..++...    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++.....   
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---  150 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---  150 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence            99999888643    4689999999999999999999998   9999999999999999999999999998765322   


Q ss_pred             ccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                       ......|+..|+|||...++ .++.++||||+|+++|||++|+.||............   ......       .+.. 
T Consensus       151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-------~~~~-  218 (278)
T cd05606         151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM-------AVEL-  218 (278)
T ss_pred             -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhcc-------CCCC-
Confidence             12234688999999998644 6889999999999999999999999754332211111   111000       0000 


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                         +......+.+++.+|+..+|.+||     ++.++++
T Consensus       219 ---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               001124688999999999999999     9999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=6.2e-31  Score=284.93  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=196.0

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      +|.+.+.||+|+||.||++.... +..+++|..+...     .....++.+|++++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998643 4445566554321     12234577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|..++.+.......+++..++.++.|++.|++|||+.   +++|+||+|+||+++. +.++++|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876555556789999999999999999999998   9999999999999975 569999999987764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  .......++..|+|||...+..++.++|+||+|+++|+|++|..||....      .......... ..     .
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~-----~  222 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GP-----T  222 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CC-----C
Confidence            322  12233567889999999888888999999999999999999999985321      1111111111 11     1


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.    .+......+.+++.+||+.+|++||++.|+++
T Consensus       223 ~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11    11223346889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=291.45  Aligned_cols=244  Identities=26%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             CCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCC
Q 035998          747 ANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      .+++|.|-||+||-|.+ ++|+.||||++.+..  ...+.++++|+++++.+.||.||.+-.-|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            37899999999999986 479999999997654  334578999999999999999999999999999999999999664


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccccccccCCCC
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      -|...+..   ..+.+++.....++.||+.||.|||.+   +|||+||||+|||+..   -.++|+||||+|+.++.   
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---  719 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---  719 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence            44444432   346788888899999999999999999   9999999999999953   45799999999999853   


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......+||+.|.|||+++.+.|...-|+||+|||+|--++|..||...  .+..++++-+..+..+..+.+       
T Consensus       720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~e-------  790 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSE-------  790 (888)
T ss_pred             hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhh-------
Confidence            45566789999999999999999999999999999999999999999742  233455554444444433333       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            .....+++|...++..-++|.+++..+.
T Consensus       791 ------is~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  791 ------ISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ------cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence                  2235789999999999999999988765

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-33  Score=274.15  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=193.9

Q ss_pred             CcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEecc
Q 035998          745 DQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +....||.|+||+|++-.++ .|+..|||++..... ...+++..|.++..+- +.||||++||.+..++..|+.||.|+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            33567999999999999865 799999999986653 3446788888876655 79999999999999999999999996


Q ss_pred             CCChhhhhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          822 NGSLDYWLHEK-LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       822 ~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      - +++.+.+.. ......+++.-.-+|......||.||-+..  .|||||+||+|||++..|.+|+||||.+..+.+   
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---  220 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---  220 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH---
Confidence            4 666544322 123356888888889999999999998764  899999999999999999999999999987743   


Q ss_pred             cccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          901 THVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ....+..+|...|||||-+..  ..|+.++||||+|+++||+.||..||....     +..+...+...... +. +.+ 
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdp-p~-l~~-  292 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDP-PI-LLF-  292 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCC-Ce-ecC-
Confidence            344555678899999997754  358899999999999999999999997432     22222222222111 11 110 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .....+....+..++..|+..|-.+||.+.++..
T Consensus       293 --~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 --DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              1111233446889999999999999999999875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.9e-30  Score=288.86  Aligned_cols=243  Identities=29%  Similarity=0.413  Sum_probs=191.2

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      |...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566788999999999999864 68899999986432   22335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +. |++.+++...   ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||++.....  
T Consensus       103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 4676666543   24688999999999999999999999   999999999999999999999999999864321  


Q ss_pred             CcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                          .....|+..|+|||++.   ...++.++||||+|+++|||++|..||......   .   .......... .....
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~---~~~~~~~~~~-~~~~~  242 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---S---ALYHIAQNDS-PTLQS  242 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---H---HHHHHHhcCC-CCCCc
Confidence                22356788999999874   466888999999999999999999998643221   1   1111111111 11010


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                              ......+.+++.+||+.+|.+||++.++++
T Consensus       243 --------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         243 --------NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             --------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    111235789999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.9e-31  Score=297.25  Aligned_cols=267  Identities=27%  Similarity=0.331  Sum_probs=192.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999865 688999998864322  22345678999999999999999999876543      


Q ss_pred             --ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          812 --DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       812 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                        ..++|+||+++ ++...+...   ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              35899999975 565555432   34689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCc---------ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 035998          890 GLARLILSPYDT---------HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       890 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  959 (1020)
                      |+++........         .......+++.|+|||...+ ..++.++||||+|+++|||++|+.||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999865432211         11123456788999997654 45889999999999999999999999653322111111


Q ss_pred             HHHHHHHhhc------ccccccCccccCcc-------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          960 SWVIRMRQEN------RESEVLDPFIYDKQ-------HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       960 ~~~~~~~~~~------~~~~~~d~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........+.      ......+.......       .......+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0000000000      00000000000000       0111246789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=3.5e-31  Score=298.60  Aligned_cols=263  Identities=23%  Similarity=0.300  Sum_probs=192.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc---------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK---------  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  810 (1020)
                      ..+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468999999999999999999864 6889999998765555556788999999999999999999876543         


Q ss_pred             -----CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCe
Q 035998          811 -----NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGA  884 (1020)
Q Consensus       811 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~  884 (1020)
                           ...++||||++ ++|.+++..     ..+++..++.++.||+.|++|||+.   +|+||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 34689999997 588777753     2578999999999999999999999   9999999999999974 5678


Q ss_pred             EEeeccccccccCCCCc-ccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 035998          885 HLADFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  962 (1020)
                      |++|||.++........ .......++..|+|||.+. +..++.++||||+||++|||++|+.||....+.+........
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999765322111 1112345788999999754 456888999999999999999999999754321110000000


Q ss_pred             -------------HHHHhhc--ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          963 -------------IRMRQEN--RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       963 -------------~~~~~~~--~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   .......  .......+  .....+....++.+++.+|++.||++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRP--LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCC--HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                         0000000  00000000  00000112245789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=280.75  Aligned_cols=242  Identities=25%  Similarity=0.326  Sum_probs=192.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh---hHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ..+|..+.+||+|+||+|-+|..+ +.+.+|||+++++.-.   +.+--..|-+++... +-|.++++..+|+.-+..|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356889999999999999999765 4567999999887521   112223455565544 57899999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+.||+|...+++.    +.+.+..++.+|..||-||-+||++   |||+||||.+|||+|.+|++||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999998888876    5677788999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .-  ....+...+|||.|+|||++..++|+..+|+||+||++|||+.|++||++....+.   .+.   +...    .. 
T Consensus       501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~a---I~eh----nv-  567 (683)
T KOG0696|consen  501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQA---IMEH----NV-  567 (683)
T ss_pred             cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH---HHHc----cC-
Confidence            32  23445668999999999999999999999999999999999999999986433221   111   1110    01 


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                            .++.....+..++....+...|.+|..
T Consensus       568 ------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 ------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------cCcccccHHHHHHHHHHhhcCCccccC
Confidence                  122233345677888888999998863

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-30  Score=293.28  Aligned_cols=258  Identities=23%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-----
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-----  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  811 (1020)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....  ......+.+|++++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999999999975 478999999986432  223456789999999999999999999987553     


Q ss_pred             -ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          812 -DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       812 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                       ..++||||+ +++|..++..     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999999 6788887753     3588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH------
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI------  963 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~------  963 (1020)
                      +++.....     .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.......  .......      
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~  236 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPS  236 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence            99865321     123456889999998765 468899999999999999999999997432210  0000000      


Q ss_pred             -----HHHhh------cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          964 -----RMRQE------NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       964 -----~~~~~------~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           .....      ........+.+ ..........+.+++.+|++.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         237 KEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 00000      00000000000 0000112235789999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=252.93  Aligned_cols=222  Identities=24%  Similarity=0.430  Sum_probs=180.0

Q ss_pred             hhhccceEEEecCCCccccHHHHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch-hhHHHHHHHHHHH
Q 035998          715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG-QMEREFRAEVEAL  792 (1020)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l  792 (1020)
                      +.+.++.........-+++.+++       ..+..||+|++|.|-+.++ .+|+..|+|.+..... +..+...+|+.+.
T Consensus        26 ~~Ld~~a~i~I~~~~~eV~ad~L-------~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~   98 (282)
T KOG0984|consen   26 RNLDSRALIYIGDRNFEVPADDL-------VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDII   98 (282)
T ss_pred             cccCCCceEEEecCccccchhhh-------hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhh
Confidence            33333433333333344555554       4456799999999988875 4799999999876543 3345667777765


Q ss_pred             HH-cCCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 035998          793 SR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI  871 (1020)
Q Consensus       793 ~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  871 (1020)
                      .+ ..+|.+|.+||...+....++.||.|+. +|+.+-++....+..+++...-+|+..|.+||.|||++.  .+||||+
T Consensus        99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDv  175 (282)
T KOG0984|consen   99 MRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDV  175 (282)
T ss_pred             ccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccC
Confidence            44 4799999999999999999999999965 899988888888889999999999999999999999985  8999999


Q ss_pred             CCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCC----CCCCchhhHHHHHHHHHHHHcCCCCC
Q 035998          872 KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA----SVATYKGDVYSFGVVLLELLTGKRPM  947 (1020)
Q Consensus       872 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltg~~pf  947 (1020)
                      ||+|||++.+|++|+||||.+-.+.+.   -..+...|...|||||.+..    ..|+-|+||||+|+.+.||.+++.||
T Consensus       176 KPsNiLIn~~GqVKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY  252 (282)
T KOG0984|consen  176 KPSNILINYDGQVKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY  252 (282)
T ss_pred             CcceEEEccCCcEEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence            999999999999999999999887543   33344678889999997643    47899999999999999999999999


Q ss_pred             CC
Q 035998          948 DM  949 (1020)
Q Consensus       948 ~~  949 (1020)
                      +.
T Consensus       253 ~~  254 (282)
T KOG0984|consen  253 ES  254 (282)
T ss_pred             cc
Confidence            74

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.5e-31  Score=296.64  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=190.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-C--CCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc----Cc
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-D--GRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK----ND  812 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  812 (1020)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999865 3  7789999986532  22345678899999999 599999999875432    45


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++++||+. ++|.+++...    ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678899886 5888877543    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc--ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH----
Q 035998          893 RLILSPYDT--HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM----  965 (1020)
Q Consensus       893 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~----  965 (1020)
                      +........  .......|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||......   .........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  229 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTP  229 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCC
Confidence            865432211  11233568899999997655 56899999999999999999999999753311   111100000    


Q ss_pred             --------Hhhc------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 --------RQEN------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 --------~~~~------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                              ....      ........ ......+.....+.+++.+|++.||++|||+++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKK-PFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCc-chHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    0000      00000000 000000111346889999999999999999999976

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=9.1e-31  Score=287.33  Aligned_cols=259  Identities=27%  Similarity=0.366  Sum_probs=197.5

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      |+..+.||+|.+|.||+|... +++.||+|.+....  ....+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999875 58999999988653  233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      + ++|.+++....   ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.++.......
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            8 58999887642   4689999999999999999999999   999999999999999999999999999987643221


Q ss_pred             cccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc---------c
Q 035998          901 THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN---------R  970 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------~  970 (1020)
                        ......++..|+|||...+. .++.++||||+|+++|||++|+.||......   +............         .
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhcc
Confidence              12234457789999988766 8899999999999999999999999643321   1111111100000         0


Q ss_pred             c---ccccCcc---ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 E---SEVLDPF---IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~---~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .   .......   ......+.....+.+++.+||+.||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0   0000000   000001112346899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=294.81  Aligned_cols=239  Identities=23%  Similarity=0.311  Sum_probs=190.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      +..|+....+|.|+|+.|-.+.. .+++..+||++.+...    +-.+|+.++... +||||+++.+++.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45677888899999999998875 4688899999987632    334567666555 79999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE-cCCCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL-DGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ++.|+-+.+.+...    +... ..+.+|+.+|+.|+.|||++   ||||||+||+|||+ ++.++++|+|||.++...+
T Consensus       397 ~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99998776665543    2223 67889999999999999999   99999999999999 5899999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     ....+-|..|.|||++....|++++||||+|+++|+|++|+.||.....+     ++...++... ...     
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~-~~s-----  532 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMP-KFS-----  532 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCC-ccc-----
Confidence            2     22335578999999999999999999999999999999999999755443     2222222211 111     


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             ........+|+.+|++.||.+||++.++..
T Consensus       533 -------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 -------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                   112235789999999999999999999865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-31  Score=299.85  Aligned_cols=257  Identities=25%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc----
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND----  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  812 (1020)
                      ..++|++.+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999875 57899999986532  2233567789999999999999999988766554    


Q ss_pred             --eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          813 --RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       813 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                        .++|+||+ +++|.+++..     ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 5688888764     3589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      ++......     .....++..|+|||...+ ..++.++||||+|+++|||++|+.||......   .............
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~  235 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTP  235 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCC
Confidence            99865322     233467889999998755 46789999999999999999999999643221   1111111100000


Q ss_pred             c------------------cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 R------------------ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .                  ......+.. ..........+.+++.+|++.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCH-HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0                  000000000 0000112346889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=296.17  Aligned_cols=262  Identities=26%  Similarity=0.414  Sum_probs=215.3

Q ss_pred             cccHHHHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEe
Q 035998          731 EISIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCM  808 (1020)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  808 (1020)
                      .+.++.+...++.|++.+.||+|.+|.||+++. ++++.+|+|+...+... .++++.|.++++.. .|||++.+++++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            345666667788899999999999999999984 47888999998776443 45788899999888 6999999999987


Q ss_pred             c-----cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          809 H-----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       809 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      .     +++.|+|||||.+|+..++++...  +..+.|+.+..|++.++.|++|||..   .++|||||-.|||++.++.
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            4     578899999999999999998765  67899999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-----VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                      ||++|||++.....  ........+||+.|||||++...     .|+..+|+||+|++..||.-|.+|+.++.+...   
T Consensus       162 VKLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---  236 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---  236 (953)
T ss_pred             EEEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---
Confidence            99999999988743  23445667999999999987543     467799999999999999999999976544211   


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                               ...+  ...|...-..+....+++.++|..|+..|-++||++.++++
T Consensus       237 ---------LF~I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  237 ---------LFLI--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------hccC--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     0111  11222222334455678999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.5e-30  Score=313.72  Aligned_cols=145  Identities=28%  Similarity=0.428  Sum_probs=130.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.++||+|+||.||+|... +++.||||++....   ......+.+|+++++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999875 68999999987542   223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ||+.+++|.+++...    ..+++..++.++.||+.||+|||..   +||||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998754    3578899999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=277.37  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC--CC----ccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ--HP----NLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~~  813 (1020)
                      +++|.+...+|+|.||.|-.+... .+..||||+++... ...+...-|+++++++.  .|    -+|.+.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999998654 47889999987542 22345667999999993  23    378899999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc--------------
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD--------------  879 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--------------  879 (1020)
                      ++|+|.+ |-++.+++...  +-.+++..++..|+.|+++++++||+.   +++|-||||+||++.              
T Consensus       167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999988 56889999864  446789999999999999999999999   999999999999982              


Q ss_pred             ------CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 035998          880 ------GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK  953 (1020)
Q Consensus       880 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  953 (1020)
                            .+..+|++|||.|++..     ......+.|..|+|||++.+-.++.++||||+|||++|+.||..-|+.....
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                  13458999999998642     2235567899999999999999999999999999999999999999865544


Q ss_pred             CcccHHHHHHHHHhhccccc-------------ccC------------------c-cccCccCHHHHHHHHHHHhhccCC
Q 035998          954 GSRDLISWVIRMRQENRESE-------------VLD------------------P-FIYDKQHDKEMLRVLDIACLCLSE 1001 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~-------------~~d------------------~-~~~~~~~~~~~~~l~~li~~cl~~ 1001 (1020)
                      +....++.+.   .+.+..-             .+|                  | .........+..++.+|+++|+.+
T Consensus       316 EHLaMMerIl---Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  316 EHLAMMERIL---GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             HHHHHHHHhh---CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            3322222221   1100000             000                  0 001122345666799999999999


Q ss_pred             CCCCCCCHHHHHH
Q 035998         1002 SPKVRPTTQQLVS 1014 (1020)
Q Consensus      1002 dP~~RPs~~evl~ 1014 (1020)
                      ||.+|+|+.|+++
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.3e-31  Score=284.07  Aligned_cols=220  Identities=26%  Similarity=0.321  Sum_probs=182.3

Q ss_pred             ccccHHHHHHhc---cCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccce
Q 035998          730 KEISIDDILEST---NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVH  802 (1020)
Q Consensus       730 ~~~~~~~~~~~~---~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~  802 (1020)
                      |+..+--+..+.   .-|..++.||-|+||+|.+++ .++...||+|.+.+..-   .....+.+|..++.+...+.||+
T Consensus       614 KESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVr  693 (1034)
T KOG0608|consen  614 KESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVR  693 (1034)
T ss_pred             hhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEE
Confidence            333444444443   347778999999999999997 44567799999876542   22345678999999999999999


Q ss_pred             EeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       803 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      +|-.|++++..|+||+|++|||+..+|.+.    +.+.++-++.++..+..|+++.|+.   |+|||||||+|||||.+|
T Consensus       694 LyySFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdG  766 (1034)
T KOG0608|consen  694 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDG  766 (1034)
T ss_pred             EEEEeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCC
Confidence            999999999999999999999999999876    6788889999999999999999999   999999999999999999


Q ss_pred             CeEEeeccccccccCC--------CCc--------------------------------ccccccccccCccCccccCCC
Q 035998          883 GAHLADFGLARLILSP--------YDT--------------------------------HVTTDLVGTLGYIPPEYGQAS  922 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~--------~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~  922 (1020)
                      ++||+|||+|.-+.-.        .+.                                ......+||+.|+|||++...
T Consensus       767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~  846 (1034)
T KOG0608|consen  767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART  846 (1034)
T ss_pred             ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence            9999999998543210        000                                000124899999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 035998          923 VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR  956 (1020)
Q Consensus       923 ~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  956 (1020)
                      .|+..+|+||.|||+|||+.|+.||....+.+..
T Consensus       847 g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  847 GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             CccccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence            9999999999999999999999999887776654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.9e-30  Score=274.99  Aligned_cols=236  Identities=27%  Similarity=0.306  Sum_probs=190.7

Q ss_pred             eeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          750 IGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      ||+|+||.||++... +++.||+|.+.....   .....+..|++++++++|||++++++++......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 588999999875432   2345788999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT  905 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  905 (1020)
                      .+++...    ..+++..+..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            9998764    3588999999999999999999998   99999999999999999999999999997753321  1233


Q ss_pred             ccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       906 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ...++..|+|||...+...+.++|+||+|+++|++++|+.||.....      ...........    ..       .+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~----~~-------~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP----LR-------FPE  214 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC----CC-------CCC
Confidence            45678899999999888899999999999999999999999964322      11111111110    00       001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQ 1011 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~e 1011 (1020)
                      .....+.+++.+||..||++||++++
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            11245789999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.2e-32  Score=265.11  Aligned_cols=266  Identities=26%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCC--chhhHHHHHHHHHHHHHcCCCccceEeeEEecc--------
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--------  810 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  810 (1020)
                      ..|+...+||+|.||+||+|+.+ +|+.||+|+.--+  ...-.....+|+.++..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999865 5777898865321  112234567899999999999999999888632        


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ...|+||.+|+. +|.-.+...   ...++..++.+++.++..||.|+|+.   .|+|||+||.|+||+.+|.+|++|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            347899999986 565555433   35688899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCc--ccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh
Q 035998          891 LARLILSPYDT--HVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ  967 (1020)
Q Consensus       891 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  967 (1020)
                      +++.+..+...  ...+..+.|..|.+||.+. .+.|+++.|||..|||+.||+||.+-|++.........++.......
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99876543322  2233456689999999765 46799999999999999999999999986555444444443332222


Q ss_pred             hcccccccC----------ccccCcc--CHHHHH------HHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ENRESEVLD----------PFIYDKQ--HDKEML------RVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ~~~~~~~~d----------~~~~~~~--~~~~~~------~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+.++....          |......  -++...      +..+++..++..||.+|+++++++.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            222222111          0000000  011111      5678999999999999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=262.17  Aligned_cols=246  Identities=23%  Similarity=0.380  Sum_probs=196.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      -.+|+.+++||+|+|++|..++++ +.+.+|+|+++++.   .+...-.+.|-.++.+. +||.+|.+..+|+.+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999865 57789999987653   22223456677777666 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      |.||++||+|..++++.    ..++++.++.+...|.-||.|||++   |||+||+|.+||++|.+|++|++|+|+++.-
T Consensus       329 vieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999998777765    5689999999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----CCcccHHHHHHHHHhhccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP----KGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~----~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ..+.  ..+...+|||.|+|||++++..|.+.+|+|++||+|+||+.|+.||+....    ...+++.-.+.-   +.. 
T Consensus       402 l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil---ekq-  475 (593)
T KOG0695|consen  402 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL---EKQ-  475 (593)
T ss_pred             CCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh---hhc-
Confidence            4443  345678999999999999999999999999999999999999999974332    223333322221   111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                        +.-|+.       ...+...+++.-+..||.+|..
T Consensus       476 --iriprs-------lsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  476 --IRIPRS-------LSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --ccccce-------eehhhHHHHHHhhcCCcHHhcC
Confidence              111111       1123556778889999999863

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=283.25  Aligned_cols=240  Identities=23%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCCC-EEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATLPDGR-NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++.+.-||-|+||.|-++..+... .+|+|.+++..   ...++.+..|..+|...+.|.||++|-.|.+.+..|++||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            455667999999999999876433 38888776542   23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |-||.+...++.+    +.++..++..++..+.+|++|||++   +||+|||||+|.++|.+|-+|+.|||+|+.++.  
T Consensus       502 ClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--  572 (732)
T KOG0614|consen  502 CLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--  572 (732)
T ss_pred             hcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence            9999999999876    6788889999999999999999999   999999999999999999999999999999854  


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       ...+...+|||.|+|||++.++..+.++|.||+|+++||+++|.+||.+..+-.....+-....+.             
T Consensus       573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i-------------  638 (732)
T KOG0614|consen  573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI-------------  638 (732)
T ss_pred             -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------------
Confidence             455677899999999999999999999999999999999999999998665543333322221111             


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                        ..+........+++++..+.+|.+|..
T Consensus       639 --~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 --EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --hcccccchhHHHHHHHHHhcCcHhhhc
Confidence              111223345788999999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1e-29  Score=271.07  Aligned_cols=219  Identities=22%  Similarity=0.225  Sum_probs=175.0

Q ss_pred             cCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChhhhhhh
Q 035998          753 GGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE  831 (1020)
Q Consensus       753 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  831 (1020)
                      |.+|.||+++.. +++.||+|++....     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999864 68899999987642     233455555566799999999999999999999999999999999876


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccccccccc
Q 035998          832 KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL  911 (1020)
Q Consensus       832 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  911 (1020)
                      .    ..+++..+..++.|+++||+|+|+.   +|+||||||+||+++.++.++++|||.+......     .....++.
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence            4    3589999999999999999999998   9999999999999999999999999988665321     12234567


Q ss_pred             CccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHH
Q 035998          912 GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRV  991 (1020)
Q Consensus       912 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  991 (1020)
                      .|+|||...+..++.++||||+|+++|||++|+.|+........            ..  ...       ..+......+
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~--~~~-------~~~~~~~~~~  205 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH--TTL-------NIPEWVSEEA  205 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc--ccc-------CCcccCCHHH
Confidence            89999999888899999999999999999999988753211100            00  000       0011122357


Q ss_pred             HHHHhhccCCCCCCCCCH
Q 035998          992 LDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       992 ~~li~~cl~~dP~~RPs~ 1009 (1020)
                      .+++.+|++.||++||++
T Consensus       206 ~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         206 RSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHccCCHHHhcCC
Confidence            899999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.9e-28  Score=279.83  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=180.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-----------------CCCCEEEEEEecCCchhhHHH--------------HHHH
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-----------------PDGRNVAIKRLSGDCGQMERE--------------FRAE  788 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  788 (1020)
                      ..++|++.++||+|+||.||+|..                 .+++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 235689999987543322222              3346


Q ss_pred             HHHHHHcCCCcc-----ceEeeEEec--------cCceEEEEEeccCCChhhhhhhcCC--------------------C
Q 035998          789 VEALSRAQHPNL-----VHLQGYCMH--------KNDRLLIYSFMENGSLDYWLHEKLD--------------------G  835 (1020)
Q Consensus       789 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~  835 (1020)
                      +.++.+++|.++     ++++++|..        ....++||||+++++|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766654     677777653        3567999999999999998874311                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccC
Q 035998          836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP  915 (1020)
Q Consensus       836 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  915 (1020)
                      ...+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+++...... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence            12356788899999999999999999   99999999999999999999999999997653221 111122345789999


Q ss_pred             ccccCCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCCCCCCCCc------ccHHHHHHHHH
Q 035998          916 PEYGQASVA----------------------TYKGDVYSFGVVLLELLTGKR-PMDMCKPKGS------RDLISWVIRMR  966 (1020)
Q Consensus       916 PE~~~~~~~----------------------~~~~DvwSlGvil~elltg~~-pf~~~~~~~~------~~~~~~~~~~~  966 (1020)
                      ||.+.....                      ..+.||||+||++|||++|.. ||........      .+...|...  
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence            997653221                      134799999999999999875 7653221111      011111110  


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESP---KVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 1014 (1020)
                      ....    .+-..    .........+++.+|+..+|   .+|+|++|+++
T Consensus       457 ~~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0000    00000    11122457889999999766   68999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3.4e-28  Score=260.11  Aligned_cols=238  Identities=31%  Similarity=0.399  Sum_probs=192.1

Q ss_pred             CCeEEEEEEeC-CCCEEEEEEecCCchhh-HHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChhhhhhh
Q 035998          754 GFGLVYRATLP-DGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE  831 (1020)
Q Consensus       754 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  831 (1020)
                      +||.||+|... +++.||+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999997665433 57899999999999999999999999998999999999999999999876


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccccccccc
Q 035998          832 KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL  911 (1020)
Q Consensus       832 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  911 (1020)
                      .    ..+++..++.++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            4    2378999999999999999999999   99999999999999999999999999998764321   233456788


Q ss_pred             CccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHH
Q 035998          912 GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRV  991 (1020)
Q Consensus       912 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  991 (1020)
                      .|+|||...+..++.++||||+|+++|+|++|..||.....  .....   ...........  .      .......++
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~---~~~~~~~~~~~--~------~~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELF---KKIGKPKPPFP--P------PEWKISPEA  217 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHH---HHHhccCCCCc--c------ccccCCHHH
Confidence            99999999888899999999999999999999999964311  11111   11111110000  0      000022468


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHH
Q 035998          992 LDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       992 ~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=286.42  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=187.8

Q ss_pred             CCcCCeeeccCCeE-EEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEecc
Q 035998          744 FDQANIIGCGGFGL-VYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      |...+.+|.|+.|+ ||+|.+ +|+.||||++-...   ..-+.+|++.++.- +|||||++++.-.++...||+.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            34446789999996 699998 58999999986442   34567899999888 69999999998888889999999996


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---C--CCeEEeecccccccc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---N--FGAHLADFGLARLIL  896 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~~~~~~  896 (1020)
                      . +|++++...............+.++.|+++|++|||+.   +||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 89999886311111112145678999999999999998   9999999999999965   3  468999999999986


Q ss_pred             CCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ..... .......||-+|+|||++.....+.++||||+||++|+.++ |.+||...-..+        ..+......-..
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee
Confidence            44322 23455789999999999999988999999999999999999 599997432211        111111111111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.+      ..++  +..+||.+|+++||..||++.+|+.
T Consensus       735 L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111      1111  5789999999999999999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.4e-28  Score=290.73  Aligned_cols=260  Identities=17%  Similarity=0.218  Sum_probs=167.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-C----CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeE------Ee
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-D----GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY------CM  808 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  808 (1020)
                      ..++|++.+.||+|+||.||+|+.. +    +..||||++......  +....|  .++...+.+++.+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999875 4    689999987643211  111111  1111222222222211      23


Q ss_pred             ccCceEEEEEeccCCChhhhhhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC
Q 035998          809 HKNDRLLIYSFMENGSLDYWLHEKLD----------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK  872 (1020)
Q Consensus       809 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  872 (1020)
                      .....++||||+++++|.+++.....                .........+..++.|++.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            55678999999999999998865310                001112344668999999999999999   99999999


Q ss_pred             CCCEEEcC-CCCeEEeeccccccccCCCCcccccccccccCccCccccCCC----------------------CCCchhh
Q 035998          873 SSNILLDG-NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS----------------------VATYKGD  929 (1020)
Q Consensus       873 p~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  929 (1020)
                      |+|||++. ++.+||+|||+++...... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 5789999999998653321 2233456789999999954322                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc----cccccCccc----cC--ccCHHHHHHHHHHHhhcc
Q 035998          930 VYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR----ESEVLDPFI----YD--KQHDKEMLRVLDIACLCL  999 (1020)
Q Consensus       930 vwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~~----~~--~~~~~~~~~l~~li~~cl  999 (1020)
                      |||+||++|||+++..|++.       +.............    ......+..    ..  ...........+|+.+|+
T Consensus       362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            99999999999997766532       11111111110000    000000000    00  000001123568999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 035998         1000 SESPKVRPTTQQLVS 1014 (1020)
Q Consensus      1000 ~~dP~~RPs~~evl~ 1014 (1020)
                      +.||++|||++|+++
T Consensus       435 ~~dP~kR~ta~e~L~  449 (566)
T PLN03225        435 RFKGRQRISAKAALA  449 (566)
T ss_pred             cCCcccCCCHHHHhC
Confidence            999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-29  Score=249.80  Aligned_cols=261  Identities=27%  Similarity=0.366  Sum_probs=191.5

Q ss_pred             CcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc-----CceEEE
Q 035998          745 DQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----NDRLLI  816 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  816 (1020)
                      +..+.||-|+||.||.++. ++|+.||.|++.....  ...+.+.+|++++..++|.|+...++..+-.     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4457899999999999986 4899999999864322  2345678899999999999999888776532     345778


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +|.|.. +    +++.+-++..++.+.+.-++.||++||.|||+.   +|.||||||.|.+++.+..+||||||+++...
T Consensus       136 TELmQS-D----LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQS-D----LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHh-h----hhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            888754 4    444555678899999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH------H--h
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM------R--Q  967 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~------~--~  967 (1020)
                      . ++...++..+-|..|+|||++.+ +.|+.++||||+|||+.|++..+.-|....+-+..+.+......      +  -
T Consensus       208 ~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 Q-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             h-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            3 33444455677889999998876 47899999999999999999999888765543322222211100      0  0


Q ss_pred             hccccccc-----C---ccccC-ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ENRESEVL-----D---PFIYD-KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ~~~~~~~~-----d---~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ++-...++     .   +.++. ........+...+...++..||.+|.+..+.+.
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            00000000     0   11111 111222334667888999999999999998875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=3.3e-28  Score=234.01  Aligned_cols=257  Identities=19%  Similarity=0.299  Sum_probs=191.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEecc--CceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHK--NDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  816 (1020)
                      .++|++.+++|+|.+++||.|. ..+.+.++||++++.   ..+.+.+|+.+++.+. ||||++++++..+.  ....+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4678999999999999999997 457889999999753   3567899999999996 99999999998765  445799


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLI  895 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~  895 (1020)
                      +||+++.+......       .++...+...+.+++.||.|+|+.   ||+|||+||.|+++|.. ..++++|+|+|.++
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999988765433       467778899999999999999999   99999999999999864 56999999999887


Q ss_pred             cCCCCcccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh------
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE------  968 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------  968 (1020)
                      ....+   ....+.+..|--||.+ .-+.|+..-|+|||||+++.|+..+.||-...+.. ..++..+.-....      
T Consensus       184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHH
Confidence            43322   2234556678899976 45778999999999999999999999985332221 1122111110000      


Q ss_pred             cccccccCccccC---------------ccCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEVLDPFIYD---------------KQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~~d~~~~~---------------~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..-.-.+||.+.+               .... -...+.++++.+.+.+|..+|||++|+++
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0000112222211               0000 11236789999999999999999999876

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=259.77  Aligned_cols=304  Identities=18%  Similarity=0.168  Sum_probs=250.4

Q ss_pred             CCCCCCCcC---ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCC
Q 035998           57 ASSSDCCHW---VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLP  133 (1020)
Q Consensus        57 ~~~~~~C~w---~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  133 (1020)
                      ++..+-|+=   .-|.|+..+.+.||.+.+ ...++++|..|+|+...+.+|+.+++|++||||+|+|+.+-|++|.+|.
T Consensus        37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP-~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~  115 (498)
T KOG4237|consen   37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLP-PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA  115 (498)
T ss_pred             CCCCcccCCCCCceEEccCCCcccCcccCC-CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence            344445664   449999999999999987 5788999999999988889999999999999999999999999999999


Q ss_pred             CCCeeeccC-CCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccc
Q 035998          134 NLEVLDLSS-NDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC  211 (1020)
Q Consensus       134 ~L~~L~L~~-n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  211 (1020)
                      +|.+|-+-+ |+|+..+...| +|.+|+.|.+.-|++. -++...++.+++|..|.+-.|.+..+--..|..+.+++++.
T Consensus       116 ~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlh  194 (498)
T KOG4237|consen  116 SLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLH  194 (498)
T ss_pred             hhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHh
Confidence            988877766 99998888888 8999999999999998 88899999999999999999999855555899999999999


Q ss_pred             cccccc------------ccccchhhhhhcccccccccccccCCCCCcccccC-CCcc-EEEccCCcCcccCcccccCCc
Q 035998          212 LGMNDL------------TGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADL-SNLV-RLDVSSNNFSGNIPDVFAGLG  277 (1020)
Q Consensus       212 L~~N~l------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~-~L~Ls~N~l~~~~p~~~~~l~  277 (1020)
                      +..|.+            ....|..+++..-..-..+.++++..+-+..|..- .++. .+....+...-.+...|..|+
T Consensus       195 lA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~  274 (498)
T KOG4237|consen  195 LAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP  274 (498)
T ss_pred             hhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence            999983            23445566666666666777777765555444322 2222 222222233323335788999


Q ss_pred             ccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecC
Q 035998          278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA  357 (1020)
Q Consensus       278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  357 (1020)
                      +|+.|+|++|+|+++-+.+|.++..+++|.|..|+|..+....|.++..|++|+|.+|+|+..-|.+|..+.+|.+|+|-
T Consensus       275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~  354 (498)
T KOG4237|consen  275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL  354 (498)
T ss_pred             cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence            99999999999999999999999999999999999988877888899999999999999998889999999999999999


Q ss_pred             CCccc
Q 035998          358 RNNFS  362 (1020)
Q Consensus       358 ~N~l~  362 (1020)
                      .|.+.
T Consensus       355 ~Np~~  359 (498)
T KOG4237|consen  355 SNPFN  359 (498)
T ss_pred             cCccc
Confidence            88874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=262.25  Aligned_cols=198  Identities=24%  Similarity=0.314  Sum_probs=169.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCch---hhH-----HHHHHHHHHHHHcC---CCccceEeeEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCG---QME-----REFRAEVEALSRAQ---HPNLVHLQGYC  807 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~  807 (1020)
                      ...+|...+.+|+|+||.|+.|.++. ...|+||.+.++.-   .+.     -.+-.|+++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34578999999999999999998764 56789998876531   111     12456999999997   99999999999


Q ss_pred             eccCceEEEEEec-cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          808 MHKNDRLLIYSFM-ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       808 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      ++++.+|++||-- ++-+|.+++..+    +.+++.++..|++||+.|+++||++   +|||||||-+||.++.+|.+|+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence            9999999999976 355888888765    6789999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      +|||.+....+    ......+||..|.|||++.+.+| +..-|||++|+++|-++....||.
T Consensus       712 idfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999987633    23345789999999999998876 567999999999999999998884

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=245.96  Aligned_cols=132  Identities=23%  Similarity=0.364  Sum_probs=110.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-----C---CccceEeeEEec--
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-----H---PNLVHLQGYCMH--  809 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--  809 (1020)
                      ..+|.+.++||.|.|++||+|.. ...+.||+|+.+... .-.+....|++++++++     |   ..||+++++|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36899999999999999999964 467889999988653 23456778999999883     3   469999999964  


Q ss_pred             --cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          810 --KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       810 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                        ..+++||+|++ |.+|-.+++..  .-+.++...+.+|++||+.||.|||++|  +|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              46789999998 56787877754  2356889999999999999999999998  99999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=240.09  Aligned_cols=255  Identities=24%  Similarity=0.282  Sum_probs=190.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------C
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------N  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  811 (1020)
                      ..+|.-.+.+|.|+- .|..|... .+++||+|+.....  ....+...+|...+..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999998 56555432 58899999876543  22335677899999999999999999998633      4


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..|+|||||+. +|.+.+..      .++-.+...++.|++.|++|+|+.   +|+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            57999999954 77777763      356678899999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ++.-.   .....+.++.+..|.|||++.+..+.+.+||||+||++.||++|+.-|.+..     ..-+|.+....-+..
T Consensus       165 ar~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  165 ARTED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTP  236 (369)
T ss_pred             hcccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCC
Confidence            98642   2245667888999999999988889999999999999999999999886321     111222211111110


Q ss_pred             ---------------------------ccc-cCccccC--ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 ---------------------------SEV-LDPFIYD--KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ---------------------------~~~-~d~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                                 .+. .|.....  ..++-....+.+++.+|+-.+|++|.+++++++
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                       000 0100000  011122234789999999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=9.4e-26  Score=235.39  Aligned_cols=210  Identities=37%  Similarity=0.585  Sum_probs=183.1

Q ss_pred             eeccCCeEEEEEEeCC-CCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChhh
Q 035998          750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY  827 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  827 (1020)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999866432 34678999999999999999999999999899999999999999999


Q ss_pred             hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccccCCCCcccccc
Q 035998          828 WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILSPYDTHVTTD  906 (1020)
Q Consensus       828 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  906 (1020)
                      ++....   ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++++|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            987642   3578999999999999999999999   9999999999999999 89999999999987643221  2233


Q ss_pred             cccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCH
Q 035998          907 LVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD  985 (1020)
Q Consensus       907 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  985 (1020)
                      ..+...|++||..... .++.++|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            5577899999998777 888999999999999999                                             


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 035998          986 KEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015 (1020)
Q Consensus       986 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1015 (1020)
                         ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               247899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3e-27  Score=259.77  Aligned_cols=253  Identities=25%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ..++|+....+|.|.||.||+|+. .+++..|||+++-+......-+.+|+-+++..+|||||.+++.+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            456789999999999999999985 4789999999998877777788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+.+|+|.+.-+    ...++++.++..+++...+|++|||+.   +-+|||||-.||++++.|.+|++|||.+..+...
T Consensus        93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence            999999876543    346889999999999999999999999   8999999999999999999999999999877532


Q ss_pred             CCcccccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-hhcccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-QENRESEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  974 (1020)
                        -.......||+.|||||+.   +.+.|..++|||+.|+...|+---++|.....+      ++...-+. ........
T Consensus       166 --i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~~qpp~l  237 (829)
T KOG0576|consen  166 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSGFQPPTL  237 (829)
T ss_pred             --hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccCCCCCcc
Confidence              2345568999999999963   567899999999999999999887777532211      11111111 11111122


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      -|+.       .....+.++++.|+..+|.+||+++.+++
T Consensus       238 kDk~-------kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCc-------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            2221       22245789999999999999999987764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=1.8e-26  Score=246.24  Aligned_cols=265  Identities=24%  Similarity=0.235  Sum_probs=200.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC------CCccceEeeEEeccCc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ------HPNLVHLQGYCMHKND  812 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~  812 (1020)
                      ...+|.+....|+|-|++|..|... -|..||||++.... .+.+.=..|++++++|.      --|+++++-.|....+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3468999999999999999999854 47799999998652 33455678999999995      3489999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGL  891 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~  891 (1020)
                      .|+|+|-+ .-+|.+.++.+ .....+....+..++.|+.-||.+|-..   +|+|.||||+|||++.. ..+||||||.
T Consensus       509 LClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence            99999976 45788888765 3344678889999999999999999988   99999999999999865 4589999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH------H
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR------M  965 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~------~  965 (1020)
                      |.......    .+.+..+..|.|||++.+-+|+...|+||+||++||+.||+..|.+........+..-...      +
T Consensus       584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            98764322    2234456689999999999999999999999999999999999976554332222111110      0


Q ss_pred             HhhcccccccCcc--------------------------------c-----cCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          966 RQENRESEVLDPF--------------------------------I-----YDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       966 ~~~~~~~~~~d~~--------------------------------~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                      +...-..+-+|..                                +     ..+..+.....+.+|+..|+..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence            0000000111100                                0     11223455667899999999999999999


Q ss_pred             HHHHHH
Q 035998         1009 TQQLVS 1014 (1020)
Q Consensus      1009 ~~evl~ 1014 (1020)
                      ..+++.
T Consensus       740 ~nqAL~  745 (752)
T KOG0670|consen  740 VNQALK  745 (752)
T ss_pred             HHHHhc
Confidence            999886

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=9.4e-25  Score=230.67  Aligned_cols=199  Identities=33%  Similarity=0.466  Sum_probs=172.9

Q ss_pred             CCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      |++.+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999998764 889999999876544 56788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +++|.+++.....   .+++..+..++.+++.++++||+.   +++|+|++|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            9999999876421   178999999999999999999999   999999999999999999999999999987644321 


Q ss_pred             ccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 035998          902 HVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMDM  949 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~  949 (1020)
                      .......++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334677889999988 677788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=222.24  Aligned_cols=244  Identities=19%  Similarity=0.317  Sum_probs=180.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEE-eccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYC-MHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-~~~~~~~lv~e  818 (1020)
                      +.|++.+.+|+|.||.+-+++++ +.+.+|+|.+.... ...++|.+|...--.+ .|.||+.-|++. +..+.++.++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45889999999999999999976 57889999887653 2356788888765445 589999988765 45566679999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE-c-CCCCeEEeecccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL-D-GNFGAHLADFGLARLIL  896 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~Dfg~~~~~~  896 (1020)
                      |++.|+|.+-+..     ..+.+.....++.|+++|+.|||++   .+||||||.+|||+ + +..++|+||||..+..+
T Consensus       103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999877654     3567788899999999999999999   99999999999998 3 34579999999988754


Q ss_pred             CCCCcccccccccccCccCccccCC---C--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA---S--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ....     ..--+..|.|||....   +  ...+.+|+|.||+++|.++||+.||+.. ...+..++.|.....+... 
T Consensus       175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~-  247 (378)
T KOG1345|consen  175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP-  247 (378)
T ss_pred             ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc-
Confidence            3211     1223457889996432   2  3467899999999999999999999832 2234455655554433322 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1008 (1020)
                         .-|.......    ..+.++.++-+..+|++|=-
T Consensus       248 ---~~P~~F~~fs----~~a~r~Fkk~lt~~~~drck  277 (378)
T KOG1345|consen  248 ---ALPKKFNPFS----EKALRLFKKSLTPRFKDRCK  277 (378)
T ss_pred             ---cCchhhcccC----HHHHHHHHHhcCCcccccch
Confidence               1122222222    24667778889999999933

>PLN03210 Resistant to P

Probab=99.92  E-value=1.2e-23  Score=269.72  Aligned_cols=357  Identities=21%  Similarity=0.282  Sum_probs=241.5

Q ss_pred             CCCceEEEecCCCcccc--cccccccCCCCCcEEecCCCC------CCCCCCccccCCC-CCCeeeccCCCCCCCCCCcc
Q 035998           83 GSGRVTGLFLYKRRLKG--KLSESLGNLVQLRFLNLSHNL------LKGTVPVSLVNLP-NLEVLDLSSNDLSGPLPQTI  153 (1020)
Q Consensus        83 ~~~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~  153 (1020)
                      ++.+|.++.+.-..+..  .-+.+|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..+
T Consensus       530 g~~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f  608 (1153)
T PLN03210        530 GTKKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF  608 (1153)
T ss_pred             ccceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC
Confidence            34567777666555432  224568999999999997654      3345788887775 5999999999886 456667


Q ss_pred             CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccc
Q 035998          154 NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRL  233 (1020)
Q Consensus       154 ~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  233 (1020)
                      ...+|++|+|++|++. .+|..+ ..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..+..+++|+.
T Consensus       609 ~~~~L~~L~L~~s~l~-~L~~~~-~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~  685 (1153)
T PLN03210        609 RPENLVKLQMQGSKLE-KLWDGV-HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLED  685 (1153)
T ss_pred             CccCCcEEECcCcccc-cccccc-ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCE
Confidence            8899999999999997 677766 568999999999887655666 4888999999999998776788999999999999


Q ss_pred             ccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccc
Q 035998          234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL  313 (1020)
Q Consensus       234 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  313 (1020)
                      |++++|..-+.+|..+ ++++|+.|++++|...+.+|..   ..+|+.|++++|.++ .+|..+ .+++|+.|++.++..
T Consensus       686 L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~  759 (1153)
T PLN03210        686 LDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKS  759 (1153)
T ss_pred             EeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccch
Confidence            9999875444677665 7889999999998766566653   357888889988887 455554 567788888776432


Q ss_pred             c-------cccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc
Q 035998          314 D-------GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       314 ~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~  386 (1020)
                      .       ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|+..+.+|..+ ++++|+.|++++|.. 
T Consensus       760 ~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~-  837 (1153)
T PLN03210        760 EKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR-  837 (1153)
T ss_pred             hhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc-
Confidence            2       1111122234567777777776666677777777777777777665444556554 566667777666531 


Q ss_pred             chhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccc-cccccccc
Q 035998          387 NLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSW-NQLSGTIP  465 (1020)
Q Consensus       387 ~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p  465 (1020)
                                               ...++.    ...+|+.|++.+|.+. .+|.++..+++|+.|+|++ |+|+ .+|
T Consensus       838 -------------------------L~~~p~----~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~  886 (1153)
T PLN03210        838 -------------------------LRTFPD----ISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVS  886 (1153)
T ss_pred             -------------------------cccccc----cccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccC
Confidence                                     001110    1134455555555554 3455555555555555555 3333 345


Q ss_pred             ccccCcCcCcEEeCCCC
Q 035998          466 VWFGGFQDLFYLDLSNN  482 (1020)
Q Consensus       466 ~~~~~l~~L~~L~Ls~N  482 (1020)
                      ..+..+++|+.|++++|
T Consensus       887 ~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        887 LNISKLKHLETVDFSDC  903 (1153)
T ss_pred             cccccccCCCeeecCCC
Confidence            55555555555555555

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-27  Score=245.84  Aligned_cols=288  Identities=22%  Similarity=0.216  Sum_probs=173.1

Q ss_pred             ccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccC-CcCcccCcccccCCcccceeec
Q 035998          206 SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS-NNFSGNIPDVFAGLGEFQYLVA  284 (1020)
Q Consensus       206 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L  284 (1020)
                      .-.+++|..|+|+.+.+.+|..+++|+.|||++|+|+.+-|++|.++.+|.+|-+.+ |+|+....+.|++|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            344555666666655555555555555555555555555555555555554444433 5555544455555555555555


Q ss_pred             ccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc
Q 035998          285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ  364 (1020)
Q Consensus       285 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  364 (1020)
                      .-|++..+..+.|..+++|..|.+-+|.+..+.-..|..+..++.+.+..|.+-     ...+++.+..       +...
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-------~~a~  215 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-------DLAM  215 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-------HHhh
Confidence            555555544455555555555555555554333334444555555555544422     1111111111       1123


Q ss_pred             CcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhh
Q 035998          365 IPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL  444 (1020)
Q Consensus       365 ~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l  444 (1020)
                      .|..++...-..-..+.++++..+++.- ....+..+.+-..+..+.....|...+..+++|++|++++|.++++-+.+|
T Consensus       216 ~~ietsgarc~~p~rl~~~Ri~q~~a~k-f~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF  294 (498)
T KOG4237|consen  216 NPIETSGARCVSPYRLYYKRINQEDARK-FLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF  294 (498)
T ss_pred             chhhcccceecchHHHHHHHhcccchhh-hhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence            3444455555555555566655554321 111112222222223334445555567788899999999999999999999


Q ss_pred             hcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCC
Q 035998          445 RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLE  506 (1020)
Q Consensus       445 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~  506 (1020)
                      .++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+..-|..|..+.+|.++++-.+
T Consensus       295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N  356 (498)
T KOG4237|consen  295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN  356 (498)
T ss_pred             cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence            99999999999999998777788999999999999999999889999999999988887433

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=4.5e-25  Score=232.78  Aligned_cols=202  Identities=29%  Similarity=0.403  Sum_probs=166.2

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      +....+.|...++||+|.|++||++...    ..+.||+|.+.....  ...+.+|++++..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999743    467899999875432  34588999999999 5999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeecc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFG  890 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  890 (1020)
                      +..+|+||++.....++...       ++...+..+++.+..||+++|.+   |||||||||+|++.+. .+.-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            99999999999998888764       46788999999999999999999   9999999999999974 5678999999


Q ss_pred             ccccccC----------------C-----------------CC---------cccccccccccCccCcccc-CCCCCCch
Q 035998          891 LARLILS----------------P-----------------YD---------THVTTDLVGTLGYIPPEYG-QASVATYK  927 (1020)
Q Consensus       891 ~~~~~~~----------------~-----------------~~---------~~~~~~~~gt~~y~aPE~~-~~~~~~~~  927 (1020)
                      +|.....                +                 ..         ........||++|.|||++ ..+..+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9972110                0                 00         0011125799999999976 45678899


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCC
Q 035998          928 GDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       928 ~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      +||||.|||+..+++++.||-..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             cceeeccceeehhhccccccccC
Confidence            99999999999999999999644

>PLN03210 Resistant to P

Probab=99.91  E-value=7.3e-24  Score=271.84  Aligned_cols=57  Identities=19%  Similarity=0.394  Sum_probs=35.0

Q ss_pred             CcceEEEecCCcceeccCccccCCCcccEEEccC-CcccccCCccccccccccccccccc
Q 035998          556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSY-NNLSGAIPISLEKLSFLSKFSVANN  614 (1020)
Q Consensus       556 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~l~~l~~L~~l~ls~N  614 (1020)
                      .+|+.|+|++|.++ .+|.++..+++|++|+|++ |+|+ .+|..+..+++|+.++++++
T Consensus       846 ~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        846 TNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             cccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            35566666666665 4666666666666666666 3344 46666666666666666655

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=9e-24  Score=250.53  Aligned_cols=262  Identities=25%  Similarity=0.309  Sum_probs=160.1

Q ss_pred             ccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccc
Q 035998          230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLR  309 (1020)
Q Consensus       230 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  309 (1020)
                      .-..|+|++|+|+ .+|..+.  ++|+.|++++|+|+. +|..   .++|++|++++|+|+.. |..   .++|+.|+++
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls  270 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELSIF  270 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence            4567888888887 5676665  478888888888874 4432   35677777777777743 432   2456666666


Q ss_pred             ccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchh
Q 035998          310 NNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       310 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~  389 (1020)
                      +|.++... ..   +++|+.|+|++|+|+ .+|..   .++|+.|+|++|++++ +|..   ..+|+.|++++|.|+.+|
T Consensus       271 ~N~L~~Lp-~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~LP  338 (788)
T PRK15387        271 SNPLTHLP-AL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSLP  338 (788)
T ss_pred             CCchhhhh-hc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccccc
Confidence            66665322 11   245666666666666 33432   2456666666666653 2321   123445555555544332


Q ss_pred             hHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccccccccccccc
Q 035998          390 SALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFG  469 (1020)
Q Consensus       390 ~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~  469 (1020)
                      .                                                    .   ..+|+.|+|++|+|+ .+|..  
T Consensus       339 ~----------------------------------------------------l---p~~Lq~LdLS~N~Ls-~LP~l--  360 (788)
T PRK15387        339 T----------------------------------------------------L---PSGLQELSVSDNQLA-SLPTL--  360 (788)
T ss_pred             c----------------------------------------------------c---ccccceEecCCCccC-CCCCC--
Confidence            1                                                    0   135667777777776 34442  


Q ss_pred             CcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCC
Q 035998          470 GFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIW  549 (1020)
Q Consensus       470 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~  549 (1020)
                       ..+|+.|++++|+|+ .+|..+.+   |                                    ..|++++|+|++ +|
T Consensus       361 -p~~L~~L~Ls~N~L~-~LP~l~~~---L------------------------------------~~LdLs~N~Lt~-LP  398 (788)
T PRK15387        361 -PSELYKLWAYNNRLT-SLPALPSG---L------------------------------------KELIVSGNRLTS-LP  398 (788)
T ss_pred             -Ccccceehhhccccc-cCcccccc---c------------------------------------ceEEecCCcccC-CC
Confidence             235666677777766 34433221   1                                    245566666664 33


Q ss_pred             ccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCC
Q 035998          550 PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS  622 (1020)
Q Consensus       550 ~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~  622 (1020)
                      ..   .++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|.++.++++|+.|+|++|+|+|.+|.
T Consensus       399 ~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        399 VL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             Cc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            32   246788888888887 477543   46778888888887 7888888888888888888888887764

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=2.5e-23  Score=246.80  Aligned_cols=268  Identities=25%  Similarity=0.270  Sum_probs=195.6

Q ss_pred             cccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeec
Q 035998          205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA  284 (1020)
Q Consensus       205 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  284 (1020)
                      ..-..|+|++|.|+ .+|..+.  ++|+.|++++|+|+. +|..   .++|++|+|++|+|+. +|..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            34567999999999 6788775  489999999999994 5643   5899999999999995 4543   368899999


Q ss_pred             ccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc
Q 035998          285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ  364 (1020)
Q Consensus       285 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  364 (1020)
                      ++|.++. +|..+   ++|+.|++++|+++.. |.   .+++|+.|+|++|+|++ +|...   .+|+.|++++|++++ 
T Consensus       270 s~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-  336 (788)
T PRK15387        270 FSNPLTH-LPALP---SGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-  336 (788)
T ss_pred             cCCchhh-hhhch---hhcCEEECcCCccccc-cc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-
Confidence            9999985 44433   5688999999999954 33   34789999999999995 55432   468899999999985 


Q ss_pred             CcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhh
Q 035998          365 IPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL  444 (1020)
Q Consensus       365 ~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l  444 (1020)
                      +|..   ..+|++|+|++|+|+.+|..                                                     
T Consensus       337 LP~l---p~~Lq~LdLS~N~Ls~LP~l-----------------------------------------------------  360 (788)
T PRK15387        337 LPTL---PSGLQELSVSDNQLASLPTL-----------------------------------------------------  360 (788)
T ss_pred             cccc---ccccceEecCCCccCCCCCC-----------------------------------------------------
Confidence            5542   25799999999998766531                                                     


Q ss_pred             hcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccc
Q 035998          445 RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARG  524 (1020)
Q Consensus       445 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~  524 (1020)
                        ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|+ .+|..+.+   |                          
T Consensus       361 --p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l~s~---L--------------------------  404 (788)
T PRK15387        361 --PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLPSE---L--------------------------  404 (788)
T ss_pred             --Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCcccC---C--------------------------
Confidence              023445556666665 34432   234666666666665 23432211   1                          


Q ss_pred             cccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccc
Q 035998          525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKL  603 (1020)
Q Consensus       525 l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l  603 (1020)
                                ..|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|+|.+|..+..+
T Consensus       405 ----------~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        405 ----------KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             ----------CEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence                      235556666654 3432   236788999999998 799999999999999999999999988877544

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=6.5e-24  Score=264.70  Aligned_cols=195  Identities=18%  Similarity=0.229  Sum_probs=137.5

Q ss_pred             cCC-CccceEeeEE-------eccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 035998          795 AQH-PNLVHLQGYC-------MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI  866 (1020)
Q Consensus       795 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  866 (1020)
                      ++| +||++++++|       ...+..+.++||+ +++|.+++...   ...+++.+++.++.||++||+|||++   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            455 5788888877       2334567788987 55999999743   24589999999999999999999999   99


Q ss_pred             EecCCCCCCEEEcCC-------------------CCeEEeeccccccccCCCC--------------cccccccccccCc
Q 035998          867 LHRDIKSSNILLDGN-------------------FGAHLADFGLARLILSPYD--------------THVTTDLVGTLGY  913 (1020)
Q Consensus       867 vH~Dlkp~NIll~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y  913 (1020)
                      +||||||+|||++..                   +.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4456666666653211000              0001124578889


Q ss_pred             cCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHH
Q 035998          914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLD  993 (1020)
Q Consensus       914 ~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~  993 (1020)
                      ||||++.+..++.++|||||||++|||++|..|+....     ...   .......     ..+..     ........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---~~~~~~~-----~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---SSLRHRV-----LPPQI-----LLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---HHHHHhh-----cChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999988864211     111   1111000     01100     011223567


Q ss_pred             HHhhccCCCCCCCCCHHHHHH
Q 035998          994 IACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       994 li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ++.+||+.+|.+||++.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=1.3e-22  Score=205.60  Aligned_cols=166  Identities=22%  Similarity=0.227  Sum_probs=124.2

Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|.+++...   ...+++.+++.++.|++.||+|||++   +      ||+||+++.++.+|+  ||.++.....    
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence            6888888753   34689999999999999999999998   6      999999999999999  9998865332    


Q ss_pred             cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK  982 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  982 (1020)
                         ...|++.|+|||++.+..++.++||||+||++|||+||+.||.......  .............      ++.. ..
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~~-~~  130 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPRD-RS  130 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cccc-cc
Confidence               1257899999999999999999999999999999999999996432211  1111111110000      0000 00


Q ss_pred             cCHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          983 QHDKEM--LRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       983 ~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ......  ..+.+++.+||+.+|.+||++.|+++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            111111  258999999999999999999999997654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-23  Score=206.81  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=189.4

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCC--chhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGD--CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ....+|.+...|+.|+|+|+ |..+++|++.-.  .....++|..|.-.++.+.||||.++++.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            44567899999999999996 455666776533  244567899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcc
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH  902 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  902 (1020)
                      |+|...+++.  ....++..++++++.+||+|++|||+. ++-|.---+....+++|++.+++|+- +-+++..      
T Consensus       272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------  341 (448)
T ss_pred             hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------
Confidence            9999999875  334567789999999999999999998 44455557899999999998887641 1111111      


Q ss_pred             cccccccccCccCccccCCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          903 VTTDLVGTLGYIPPEYGQASVAT---YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       903 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ......-.+.||+||.++.++-+   .++|+|||++++||+.|...||....+-+.-      ..+..++.     .+  
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkialegl-----rv--  408 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALEGL-----RV--  408 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhccc-----cc--
Confidence            11122346789999988776543   5899999999999999999999866553321      11111111     11  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                        ..++.....+.+++.-|+..||.+||.++.|+-.||++.
T Consensus       409 --~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 --HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              112223346788999999999999999999999999873

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=8.1e-22  Score=200.58  Aligned_cols=259  Identities=18%  Similarity=0.262  Sum_probs=196.1

Q ss_pred             CCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .|.+.++||+|+||.++.|. .-++++||||.-.....  .-+++.|.+.++.+ ..++|..++-+..+..+-.+|+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            58999999999999999997 44789999997543322  24678899999988 5789999988878888888999988


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-----CCeEEeeccccccc
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-----FGAHLADFGLARLI  895 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~~~~~  895 (1020)
                       |.+|.++..-.   +..++..++..+|.|++.-++|+|++   .+|+|||||+|+||..-     ..+.++|||+|+.+
T Consensus       107 -GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  107 -GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             -CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence             66777765533   34689999999999999999999999   99999999999999643     34899999999999


Q ss_pred             cCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          896 LSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       896 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      .++...     .......||.+||+-....++..+.+.|.=|+|-++.+.+.|..||++.........-+.+...++...
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~  259 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP  259 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence            887543     233457899999999999999999999999999999999999999998766544443333333333222


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      +.+..+     . .++++.....   -.-+.+-.+-|..+-+...+.++
T Consensus       260 i~~Lc~-----g-~P~efa~Yl~---yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  260 IEVLCE-----G-FPEEFATYLR---YVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             HHHHHh-----c-CHHHHHHHHH---HHHhcCcccCCCHHHHHHHHHHH
Confidence            222111     1 2333333333   33455667778877666655443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=5.6e-22  Score=237.31  Aligned_cols=268  Identities=24%  Similarity=0.396  Sum_probs=134.5

Q ss_pred             CCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccc
Q 035998          134 NLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       134 ~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      +.+.|+++++.++.. |..+ .++|+.|+|++|+|+ .+|..++   ++|+.|++++|+++ .+|..+.  .+|+.|+|+
T Consensus       179 ~~~~L~L~~~~LtsL-P~~I-p~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        179 NKTELRLKILGLTTI-PACI-PEQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             CceEEEeCCCCcCcC-Cccc-ccCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            456677766666643 3222 135666677777666 5665543   35666666666665 3444332  356666666


Q ss_pred             ccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC
Q 035998          214 MNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI  293 (1020)
Q Consensus       214 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  293 (1020)
                      +|+++ .+|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|++++|+|++ +|..+.  .+|+.|++++|+++. +
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L  319 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L  319 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence            66666 4454443  35666666666666 3444443  356666666666653 232221  234444444444442 2


Q ss_pred             CCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCC
Q 035998          294 PHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFE  373 (1020)
Q Consensus       294 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  373 (1020)
                      |..+                          .++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+.  +
T Consensus       320 P~~l--------------------------~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~  367 (754)
T PRK15370        320 PETL--------------------------PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P  367 (754)
T ss_pred             Cccc--------------------------cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence            2211                          1345555555555542 343332  45555555555555 2343332  3


Q ss_pred             CCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEE
Q 035998          374 SLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLV  453 (1020)
Q Consensus       374 ~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L  453 (1020)
                      +|++|++++|+|+.+|..+.     ..|+.|++++|.+. .                     +...+|..+..++++..|
T Consensus       368 ~L~~LdLs~N~Lt~LP~~l~-----~sL~~LdLs~N~L~-~---------------------LP~sl~~~~~~~~~l~~L  420 (754)
T PRK15370        368 TITTLDVSRNALTNLPENLP-----AALQIMQASRNNLV-R---------------------LPESLPHFRGEGPQPTRI  420 (754)
T ss_pred             CcCEEECCCCcCCCCCHhHH-----HHHHHHhhccCCcc-c---------------------CchhHHHHhhcCCCccEE
Confidence            55556666665555554321     12333333333211 0                     001223344455677778


Q ss_pred             ecccccccccccccccCcCcCcEEeCCCCcccc
Q 035998          454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG  486 (1020)
Q Consensus       454 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  486 (1020)
                      ++.+|.++.      ..+.+|+.| ++.+.+.|
T Consensus       421 ~L~~Npls~------~tl~~L~~L-l~s~~~~g  446 (754)
T PRK15370        421 IVEYNPFSE------RTIQNMQRL-MSSVGYQG  446 (754)
T ss_pred             EeeCCCccH------HHHHHHHHh-hhcccccC
Confidence            888887761      344445555 34444443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=216.00  Aligned_cols=167  Identities=20%  Similarity=0.188  Sum_probs=129.7

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC--CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccce-EeeEEec
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP--DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVH-LQGYCMH  809 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~  809 (1020)
                      ....++|++.+.||+|+||+||+|+++  +++.||||+.....     ....+.+.+|++++++++|+|+++ +++    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            344578999999999999999999864  57778999875331     223456899999999999999985 433    


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC-CCCCEEEcCCCCeEEee
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI-KSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D  888 (1020)
                      ....++||||++|++|... ..       ..   ...++.|+++||+|||+.   ||+|||| ||+||+++.++.+||+|
T Consensus        90 ~~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             cCCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence            2457999999999998622 10       01   146788999999999999   9999999 99999999999999999


Q ss_pred             ccccccccCCCCccc------ccccccccCccCccccCCC
Q 035998          889 FGLARLILSPYDTHV------TTDLVGTLGYIPPEYGQAS  922 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  922 (1020)
                      ||+|+.+........      .....+++.|+|||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999997754322111      1345678889999987554

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-20  Score=209.54  Aligned_cols=259  Identities=22%  Similarity=0.266  Sum_probs=191.7

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCCC--CEEEEEEecCCchhhHHHHHHHHHHHHHcCC----CccceEeeEE-eccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLPDG--RNVAIKRLSGDCGQMEREFRAEVEALSRAQH----PNLVHLQGYC-MHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  815 (1020)
                      +|.+.+.||+|+||.||.|...+.  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986543  4788888765433222267788888888863    6889998888 46777899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-----CCeEEeecc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-----FGAHLADFG  890 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg  890 (1020)
                      ||+.+ |.+|.++.....  ...++..++..|+.|++.+|+++|+.   |++||||||.|+.+...     ..+.+.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99977 779988765543  56799999999999999999999999   99999999999999754     458999999


Q ss_pred             ccc--cccCCCCc----cc--ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 035998          891 LAR--LILSPYDT----HV--TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       891 ~~~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +++  ........    ..  .....||..|++++...+...+.+.|+||++.++.|+..|..||........   ....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~  249 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKF  249 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHH
Confidence            999  43222211    11  2235699999999999999999999999999999999999999965443322   1111


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...........      .....+.   .+.++...+-..+..++|....+...|++.
T Consensus       250 ~~~~~~~~~~~------~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  250 EKDPRKLLTDR------FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHHhhhhcccc------ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            11111111110      1111223   344555555558899999999998877653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.8e-21  Score=188.07  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=194.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEE-eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC-CccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH-PNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ...|.++++||.|+||.+|.|. ..+|..||||.-+.....  .++.-|..+.+.+++ ..|..+..|..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3579999999999999999997 568999999997765433  356778999999964 678888888888889999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC---CCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~  895 (1020)
                      .+ |.+|.+...-.   ...++..+++..+.|++.-++|+|.+   ++|||||||+|+|+.-+   ..+.++|||+|+.+
T Consensus        92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            88 77888776543   24678899999999999999999999   99999999999999633   45899999999988


Q ss_pred             cCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          896 LSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       896 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      .+....     .......||.+|.+-....+...+.+.|+=|+|.++.+.-.|..||++.....-....+.....+....
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            664332     223456899999998877777888999999999999999999999997665433222222222211111


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1017 (1020)
                      ...     +-..+    +.++.-.+.-|-..--++-|+...+-+.+.
T Consensus       245 ie~-----LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  245 IEV-----LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHH-----HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            111     11111    124555666777777788888776666554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.5e-21  Score=229.64  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=188.2

Q ss_pred             cCCeeeccCCeEEEEEEeC-CCCEEEEEEec----C-CchhhH-HHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          746 QANIIGCGGFGLVYRATLP-DGRNVAIKRLS----G-DCGQME-REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~-~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ..+++|.|++|.|+.+... ....++.|.+.    . ...... ..+..|+.+-..++|||++.....+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999988877532 34444444433    1 111111 125667777788899999888777776666666699


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++ ||..++...    ..++..++..++.|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||.+....-+
T Consensus       402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 998888764    3578889999999999999999999   9999999999999999999999999999876655


Q ss_pred             CCc--ccccccccccCccCccccCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDT--HVTTDLVGTLGYIPPEYGQASVATY-KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .+.  ......+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+..-     .............
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~  548 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFE  548 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccccccc
Confidence            544  5566788999999999998888764 6999999999999999999996443322210     0111111110000


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                      .   ..........+-..++.+|++.||.+|.|+++|++  |+++
T Consensus       549 ~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  549 G---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             C---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            0   01111233345678999999999999999999987  6554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=3.2e-21  Score=230.79  Aligned_cols=229  Identities=24%  Similarity=0.402  Sum_probs=140.7

Q ss_pred             CCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccccc
Q 035998          156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLG  235 (1020)
Q Consensus       156 ~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  235 (1020)
                      .+...|++++++++ .+|..+.   +.|+.|+|++|+++ .+|..+.  ++|++|+|++|+|+ .+|..+.  .+|+.|+
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~  247 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME  247 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence            34667777777777 5666542   35666677777666 3444332  35666666666665 3343332  2455555


Q ss_pred             ccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccc
Q 035998          236 LQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDG  315 (1020)
Q Consensus       236 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  315 (1020)
                      |++|+++ .+|..+.  ++|+.|++++|+|                        +. +|..+.  ++|+.|++++|+|+.
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L------------------------~~-LP~~l~--~sL~~L~Ls~N~Lt~  297 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKI------------------------SC-LPENLP--EELRYLSVYDNSIRT  297 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCcc------------------------Cc-cccccC--CCCcEEECCCCcccc
Confidence            5555554 3343332  2445555555544                        42 333332  356666666666664


Q ss_pred             ccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHH
Q 035998          316 SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVL  395 (1020)
Q Consensus       316 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l  395 (1020)
                      . |..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+.+|..    
T Consensus       298 L-P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~----  364 (754)
T PRK15370        298 L-PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPET----  364 (754)
T ss_pred             C-cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChh----
Confidence            2 22222  46888888888888 4565443  689999999999995 676654  7899999999987665432    


Q ss_pred             hhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCc
Q 035998          396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF  475 (1020)
Q Consensus       396 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  475 (1020)
                                                                      +  .++|+.|+|++|+|+ .+|..+.  ..|+
T Consensus       365 ------------------------------------------------l--p~~L~~LdLs~N~Lt-~LP~~l~--~sL~  391 (754)
T PRK15370        365 ------------------------------------------------L--PPTITTLDVSRNALT-NLPENLP--AALQ  391 (754)
T ss_pred             ------------------------------------------------h--cCCcCEEECCCCcCC-CCCHhHH--HHHH
Confidence                                                            1  135778888888887 4565553  3688


Q ss_pred             EEeCCCCcccccCCCC
Q 035998          476 YLDLSNNTFTGEIPKN  491 (1020)
Q Consensus       476 ~L~Ls~N~l~~~~p~~  491 (1020)
                      .|++++|+|+ .+|..
T Consensus       392 ~LdLs~N~L~-~LP~s  406 (754)
T PRK15370        392 IMQASRNNLV-RLPES  406 (754)
T ss_pred             HHhhccCCcc-cCchh
Confidence            8888888887 45543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=3.5e-19  Score=200.50  Aligned_cols=260  Identities=30%  Similarity=0.445  Sum_probs=196.5

Q ss_pred             CCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCC-ccceEeeEEeccCceEEEEEe
Q 035998          744 FDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHP-NLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+..++.+.|+ +++++.+++......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999876  88999998765432   356789999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  898 (1020)
                      +.++++.+++...... ..++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666654211 3678899999999999999999999   999999999999999988 7999999999865433


Q ss_pred             CCcc----cccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-CcccHHHHHHHHHhhcc
Q 035998          899 YDTH----VTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPK-GSRDLISWVIRMRQENR  970 (1020)
Q Consensus       899 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  970 (1020)
                      ....    ......|+..|+|||...+   ..++...|+||+|++++++++|..||...... ............... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence            2221    3456789999999999887   68899999999999999999999997644321 011111111111100 0


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......+    .........+.+++..|+..+|..|.+..+...
T Consensus       235 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         235 LASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            0000000    000222345788999999999999999887654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=2.8e-20  Score=190.00  Aligned_cols=171  Identities=13%  Similarity=0.145  Sum_probs=133.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHH---------HHHHHHHHHHcCCCccceEeeEEecc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE---------FRAEVEALSRAQHPNLVHLQGYCMHK  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~  810 (1020)
                      ..++|+..+++|.|+||.||.+.. +++.+|||.+.......++.         +.+|++.+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            368899999999999999999766 57789999997654332222         68899999999999999999886643


Q ss_pred             --------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          811 --------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       811 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                              ...++||||++|.+|.++..        ++.    ....+++.++..+|+.   |++|||+||+||+++++|
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999977631        222    2456899999999999   999999999999999988


Q ss_pred             CeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHH
Q 035998          883 GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL  941 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  941 (1020)
                       ++++|||..+......   ..           ..+.....+..++|+|++|+.+....
T Consensus       173 -i~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence             9999999887542111   00           11334445667999999999876544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=7.5e-21  Score=220.58  Aligned_cols=250  Identities=21%  Similarity=0.235  Sum_probs=181.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch-hhHHHHHHHHHH--HHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG-QMEREFRAEVEA--LSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +|...+.+|.+.|=+|.+|++++|. |+||+|-+..+ ...+.+.++++-  ...++|||.+++..+-...+..|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677889999999999999998776 99999876542 223444443333  4455899999998887777888899999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ..+ +|.+.+..    ++.+...+.+.|+.|++.|+..+|+.   ||+|||||.+|||++.-..+.++||..-+...-+.
T Consensus       103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            866 55555543    46788889999999999999999999   99999999999999999999999998776654333


Q ss_pred             Cccc-----ccccccccCccCccccCC----------CC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 035998          900 DTHV-----TTDLVGTLGYIPPEYGQA----------SV-ATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       900 ~~~~-----~~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +...     ......-..|.|||-+..          .. .+++.||||+||+++|+++ |++||.-.      .+.++.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh
Confidence            3211     112233458999995432          12 5789999999999999999 88988521      111110


Q ss_pred             HH--HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          963 IR--MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       963 ~~--~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..  ...+.....+.|+            .+++++..|++.||++|.++++.++.-+++
T Consensus       249 ~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             ccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            00  0000111111111            478999999999999999999999875543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.81  E-value=1.5e-19  Score=183.53  Aligned_cols=140  Identities=16%  Similarity=0.131  Sum_probs=109.7

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh--h------------------------HHHHHHHHHHHHHcCCCcc
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ--M------------------------EREFRAEVEALSRAQHPNL  800 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  800 (1020)
                      .+.||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998754211  0                        1123459999999988877


Q ss_pred             ceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEecCCCCCCEEEc
Q 035998          801 VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       801 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      .....+..  ...++||||++++++......    ...++...+..++.|++.+|+|+ |+.   +|+||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            54433322  234899999999876544322    13678899999999999999999 688   999999999999998


Q ss_pred             CCCCeEEeecccccccc
Q 035998          880 GNFGAHLADFGLARLIL  896 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~  896 (1020)
                       ++.++++|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.8e-18  Score=172.38  Aligned_cols=187  Identities=17%  Similarity=0.105  Sum_probs=140.9

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhh----HHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEe
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM----EREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .+...|++|+||+||.+.. .+.+++.+.+.......    .+.+.+|+++++++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998876 67888888887654321    125789999999995 5889999886    457999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC-CCCCEEEcCCCCeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI-KSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ++|.+|......           ....++.|++.+++++|+.   ||+|||| ||+||+++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999988643211           1135778999999999999   9999999 799999999999999999999864322


Q ss_pred             CCc----cc-------ccccccccCccCccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          899 YDT----HV-------TTDLVGTLGYIPPEYGQ--ASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       899 ~~~----~~-------~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      ...    ..       ......++.|++|+...  ...--...++++.|..+|.++|+..|+-..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            110    00       11123567888887432  223336789999999999999999887543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=4e-19  Score=187.07  Aligned_cols=233  Identities=22%  Similarity=0.325  Sum_probs=147.9

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCC----------CccceEeeEEe-
Q 035998          744 FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH----------PNLVHLQGYCM-  808 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-  808 (1020)
                      +...+.||.|+++.||.+++. +++++|||++....   ....+++++|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345688999999999999875 58999999986443   2234556666655444322          12222222221 


Q ss_pred             --------cc---C-----ceEEEEEeccCCChhhhhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEec
Q 035998          809 --------HK---N-----DRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR  869 (1020)
Q Consensus       809 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  869 (1020)
                              ..   .     ..+++|+-+ .+||.+++..   ............+..+..|+++.+++||+.   |+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     235678877 4578776543   211122234455667779999999999999   99999


Q ss_pred             CCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCC--------CCCCchhhHHHHHHHHHHHH
Q 035998          870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA--------SVATYKGDVYSFGVVLLELL  941 (1020)
Q Consensus       870 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ell  941 (1020)
                      ||+|+|++++++|.++++||+.....+..    ... ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999988765321    111 344578999996533        35789999999999999999


Q ss_pred             cCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCC
Q 035998          942 TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR 1006 (1020)
Q Consensus       942 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1006 (1020)
                      +|..||+...+....+.                    ...... +.++.+..+|..+++.+|++|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543322211                    111222 556678999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=2e-18  Score=176.29  Aligned_cols=139  Identities=18%  Similarity=0.185  Sum_probs=111.3

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh--------------------------hHHHHHHHHHHHHHcCCCcc
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ--------------------------MEREFRAEVEALSRAQHPNL  800 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  800 (1020)
                      .+.||+|++|.||+|...+|+.||||++......                          ....+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999878999999998764211                          01123578999999999987


Q ss_pred             ceEeeEEeccCceEEEEEeccCCChhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEE
Q 035998          801 VHLQGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       801 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll  878 (1020)
                      .....+...  ..++||||++|+++... +..     ..++..++..++.|++.++.++|+ .   ||+||||||+||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            555444333  34899999998855433 322     346778899999999999999999 8   99999999999999


Q ss_pred             cCCCCeEEeecccccccc
Q 035998          879 DGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~  896 (1020)
                      + ++.++++|||+++...
T Consensus       152 ~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         152 H-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             E-CCCEEEEEcccceecC
Confidence            9 8899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=2.4e-19  Score=199.36  Aligned_cols=225  Identities=25%  Similarity=0.272  Sum_probs=175.0

Q ss_pred             eeeccCCeEEEEEE----eCCCCEEEEEEecCCchh--hHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEecc
Q 035998          749 IIGCGGFGLVYRAT----LPDGRNVAIKRLSGDCGQ--MEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      .+|+|+||.|+.++    .+.+.-+|+|+.++....  .......|..++...+ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36999999999874    335777899988765421  1123456778888886 9999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +|++...+...    ..++..........++-|++++|+.   +++|||+|++||+++.+|++++.|||.++......  
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--  151 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--  151 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence            99987766654    4567777777888899999999999   99999999999999999999999999998764321  


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD  981 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  981 (1020)
                          ..+||..|||||+..  ....++|.||||++++||+||..||..       +.+.   ++....           .
T Consensus       152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~---~Il~~~-----------~  204 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMK---RILKAE-----------L  204 (612)
T ss_pred             ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHH---HHhhhc-----------c
Confidence                128899999999987  677799999999999999999999974       1111   111110           0


Q ss_pred             ccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          982 KQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       982 ~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                      ..+.+....+.+++..+...+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1123334456778888888888888754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=5.4e-18  Score=189.63  Aligned_cols=215  Identities=29%  Similarity=0.440  Sum_probs=162.6

Q ss_pred             HHcCCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe-EecCC
Q 035998          793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI-LHRDI  871 (1020)
Q Consensus       793 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl  871 (1020)
                      +.+.|.|+.+++|.+.+....++|.+|+..|+|.+.+...   ...+++.....+.++|+.||+|+|..   +| .|+.+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            4678999999999999999999999999999999998763   45688999999999999999999987   55 99999


Q ss_pred             CCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCC-------CCCchhhHHHHHHHHHHHHcCC
Q 035998          872 KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-------VATYKGDVYSFGVVLLELLTGK  944 (1020)
Q Consensus       872 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~elltg~  944 (1020)
                      +.+|.++|....+|++|||+.....+...........-..-|.|||.+.+.       ..+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998766431111111222334579999987664       1467899999999999999999


Q ss_pred             CCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          945 RPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       945 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .||+........  .+.+.+...  .....+.|.+....  +....+..++..||..+|++||+++++-..++.+
T Consensus       156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            999865444332  122222222  11222233332211  2233688999999999999999999998877653

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=6e-18  Score=176.20  Aligned_cols=197  Identities=22%  Similarity=0.256  Sum_probs=134.4

Q ss_pred             CCCccceEeeEEecc---------------------------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHH
Q 035998          796 QHPNLVHLQGYCMHK---------------------------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA  848 (1020)
Q Consensus       796 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~  848 (1020)
                      +|||||++.++|.+.                           ...|+||.-++. +|..|+-..     ..+...+.-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence            599999999887642                           245788887754 788877654     34556778899


Q ss_pred             HHHHHHHHHhHhcCCCCeEecCCCCCCEEE--cCCC--CeEEeeccccccccCC----CCcccccccccccCccCccccC
Q 035998          849 QGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNF--GAHLADFGLARLILSP----YDTHVTTDLVGTLGYIPPEYGQ  920 (1020)
Q Consensus       849 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~  920 (1020)
                      .|+++|+.|||++   ||.|||+|.+|||+  |+|+  .+.++|||++---..-    .........-|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  3444  3689999997432110    0011112345677899999875


Q ss_pred             CCCC------CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHH
Q 035998          921 ASVA------TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDI  994 (1020)
Q Consensus       921 ~~~~------~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l  994 (1020)
                      ..+-      -.|+|.|+.|.+.||+++...||...... ..+...     .++...+.     +    +......+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qLPa-----l----p~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQLPA-----L----PSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhCCC-----C----cccCChHHHHH
Confidence            5432      24899999999999999999999752211 111111     11111111     1    11222357788


Q ss_pred             HhhccCCCCCCCCCHHHHHHHH
Q 035998          995 ACLCLSESPKVRPTTQQLVSWL 1016 (1020)
Q Consensus       995 i~~cl~~dP~~RPs~~evl~~L 1016 (1020)
                      +...++.||.+|+++.-....|
T Consensus       490 V~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHH
Confidence            9999999999999976554433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=7.7e-18  Score=201.08  Aligned_cols=199  Identities=24%  Similarity=0.267  Sum_probs=162.6

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC---CCccceEeeEEeccCce
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ---HPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  813 (1020)
                      .....+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....   +|.=-.+++.+++   -+-|..+...+...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34456678899999999999999999888999999997765432   2222344445554   24456666666777888


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-------CCCCeEE
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-------GNFGAHL  886 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl  886 (1020)
                      ++|+||.+.|+|.+++.    ..+.++|.-++.+..|++..+++||..   +||||||||+|+++.       +...++|
T Consensus       770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence            99999999999999887    346789999999999999999999999   999999999999994       2345899


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR  945 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  945 (1020)
                      +|||.+..+.--.+.......++|-.+-.+|...++.++..+|.|.++-+++-|+.|++
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999977654334445566788999999999999999999999999999999999975

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=8.1e-20  Score=204.31  Aligned_cols=60  Identities=17%  Similarity=0.175  Sum_probs=35.7

Q ss_pred             CceEEEecccccc----cccchhhhcCCCCcEEeccccccccc----ccccccCc-CcCcEEeCCCCcc
Q 035998          425 NLKVLVIASCGLR----GSIPQWLRGCSKLQLVDLSWNQLSGT----IPVWFGGF-QDLFYLDLSNNTF  484 (1020)
Q Consensus       425 ~L~~L~l~~n~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l  484 (1020)
                      .|+.|++.+|.++    ..+...+..+++|+++++++|.++..    +...+... +.|++||+.+|.+
T Consensus       251 ~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         251 SLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            3445555555443    12334455567788888888888744    33344444 6778888877754

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=6.1e-20  Score=169.54  Aligned_cols=180  Identities=27%  Similarity=0.428  Sum_probs=116.5

Q ss_pred             hhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccc
Q 035998          227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLL  306 (1020)
Q Consensus       227 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  306 (1020)
                      .++..+.|.||+|+++ .+|+.++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3444555555555555 45555555555555555555555 45555555566666666666655 556666666667777


Q ss_pred             cccccccc-cccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCC
Q 035998          307 NLRNNSLD-GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       307 ~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i  385 (1020)
                      ||++|++. ...|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- ..|..++.+..|+.|++.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            77666665 345666666777777777777776 67777777777777777777776 5677777777777777777777


Q ss_pred             cchhhHHHHHhhhcccchhhhhcccc
Q 035998          386 YNLSSALQVLQQCRNLTTLVLTLNFR  411 (1020)
Q Consensus       386 ~~l~~~~~~l~~l~~L~~L~l~~n~~  411 (1020)
                      +-+|..+..+.-..+-+.+.+..|.+
T Consensus       186 ~vlppel~~l~l~~~k~v~r~E~NPw  211 (264)
T KOG0617|consen  186 TVLPPELANLDLVGNKQVMRMEENPW  211 (264)
T ss_pred             eecChhhhhhhhhhhHHHHhhhhCCC
Confidence            77777766665555555555555543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.73  E-value=4.5e-20  Score=206.34  Aligned_cols=57  Identities=33%  Similarity=0.350  Sum_probs=32.4

Q ss_pred             EecCCCccc-ccccccccCCCCCcEEecCCCCCCC----CCCccccCCCCCCeeeccCCCCC
Q 035998           90 LFLYKRRLK-GKLSESLGNLVQLRFLNLSHNLLKG----TVPVSLVNLPNLEVLDLSSNDLS  146 (1020)
Q Consensus        90 l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~  146 (1020)
                      |+|.++.++ +.....+..+.+|+.|++++|.+++    .++..+...++|++|+++++.+.
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~   64 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG   64 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence            455555555 2334445556666666666666643    24445555666666666666554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.72  E-value=3.4e-19  Score=164.62  Aligned_cols=164  Identities=34%  Similarity=0.548  Sum_probs=119.2

Q ss_pred             ccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCccc
Q 035998          105 LGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIR  184 (1020)
Q Consensus       105 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~  184 (1020)
                      +.++.+.+.|-||+|+++ .+|+.++.|.+|+.|++++|+|+..++....+++|+.|+++-|++.               
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~---------------   92 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN---------------   92 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh---------------
Confidence            556677777888888887 6777788888888888888888765555556777777777666665               


Q ss_pred             EEEccCCCCCCCCCCccccccccccccccccccc-cccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCC
Q 035998          185 VINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT-GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSN  263 (1020)
Q Consensus       185 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  263 (1020)
                                 .+|..|+.++.|+.|||.+|++. ...|..|+.++.|+.|+|++|.+. .+|+.++++++|+.|.+..|
T Consensus        93 -----------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen   93 -----------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             -----------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence                       56666777777777777777774 356777777888888888888777 77777888888888888887


Q ss_pred             cCcccCcccccCCcccceeecccccccccCCCCCc
Q 035998          264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS  298 (1020)
Q Consensus       264 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  298 (1020)
                      .+- ..|..++.++.|+.|.+.+|+++ .+|..++
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~  193 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA  193 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence            776 56777777777777777777777 3444443

>PRK10345 hypothetical protein; Provisional

Probab=99.72  E-value=7.4e-17  Score=165.00  Aligned_cols=136  Identities=17%  Similarity=0.193  Sum_probs=106.0

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-----CCCccceEeeEEeccC---ceE-E
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-----QHPNLVHLQGYCMHKN---DRL-L  815 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  815 (1020)
                      .-.++||+|+||.||.  +++....+||+.........+.+.+|+++++.+     .||||+++++++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996  443333479988765444567899999999999     5799999999998764   333 7


Q ss_pred             EEEe--ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHhHhcCCCCeEecCCCCCCEEEcC----CCCeEEee
Q 035998          816 IYSF--MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL-AYLHQSCEPHILHRDIKSSNILLDG----NFGAHLAD  888 (1020)
Q Consensus       816 v~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  888 (1020)
                      |+||  +.+++|.+++.+.     .+++.  ..++.|++.++ +|||++   +||||||||+||+++.    ++.++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  5579999999653     24444  35677888777 999999   9999999999999974    34799999


Q ss_pred             cccc
Q 035998          889 FGLA  892 (1020)
Q Consensus       889 fg~~  892 (1020)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5443

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.2e-16  Score=167.96  Aligned_cols=150  Identities=15%  Similarity=0.131  Sum_probs=115.5

Q ss_pred             HHHHHhccCCCcCCeeeccCCeEEEEEE--eCCCCEEEEEEecCCchh------------------------hHHHHHHH
Q 035998          735 DDILESTNNFDQANIIGCGGFGLVYRAT--LPDGRNVAIKRLSGDCGQ------------------------MEREFRAE  788 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E  788 (1020)
                      ..+..-..-|++.+.||+|++|.||+|.  ..+|+.||||++......                        ....+.+|
T Consensus        21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  100 (237)
T smart00090       21 YSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE  100 (237)
T ss_pred             HHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence            3344445568899999999999999998  568999999998743210                        11235789


Q ss_pred             HHHHHHcCCCc--cceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-
Q 035998          789 VEALSRAQHPN--LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH-  865 (1020)
Q Consensus       789 ~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-  865 (1020)
                      ++.+.++.+.+  +.+++++    ...++||||++++++..+....    ......++..++.|++.++++||+.   + 
T Consensus       101 ~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~  169 (237)
T smart00090      101 FRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GE  169 (237)
T ss_pred             HHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence            99999997533  3344432    2358999999998876654221    2345666789999999999999999   9 


Q ss_pred             eEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          866 ILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       866 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |+||||||+||+++ ++.++++|||.+....
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999999 8899999999987653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=5.9e-17  Score=188.80  Aligned_cols=214  Identities=24%  Similarity=0.288  Sum_probs=144.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|+.++.|-.|+||.||.++++ ..+++|+|+ .++.     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            467899999999999999999876 467788843 3321     11110  22222333333                  


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                         ||-...++.    .+.++.+        ++.+++|+|+.   +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus       136 ---gDc~tllk~----~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ---GDCATLLKN----IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ---chhhhhccc----CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence               332222332    2333332        27889999999   99999999999999999999999999987642111


Q ss_pred             C-------------cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          900 D-------------THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       900 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      .             .......+||+.|+|||++..+.|+..+|+|++|+|+||.+.|+.||.+..+.+-...+.....  
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i--  275 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI--  275 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--
Confidence            1             0112235899999999999999999999999999999999999999987655433222211111  


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1012 (1020)
                         .+.+-         +..-..++.+++.+.++.+|.+|--....
T Consensus       276 ---~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga  309 (1205)
T KOG0606|consen  276 ---EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGA  309 (1205)
T ss_pred             ---ccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence               11111         11112357789999999999999754433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=8.8e-16  Score=158.25  Aligned_cols=145  Identities=18%  Similarity=0.128  Sum_probs=113.5

Q ss_pred             HHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh----------------------hHHHHHHHHHHH
Q 035998          735 DDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ----------------------MEREFRAEVEAL  792 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  792 (1020)
                      .++......|.+.+.||+|+||.||+|..++|+.||||++......                      ......+|+..+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444555568889999999999999999888999999987643210                      112356788899


Q ss_pred             HHcCCCc--cceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecC
Q 035998          793 SRAQHPN--LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRD  870 (1020)
Q Consensus       793 ~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  870 (1020)
                      .++.|++  +++.++    ....++||||+++++|......          .....++.+++.++.++|+.   +|+|||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D  150 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD  150 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence            9998774  444433    2456899999999998664321          23467889999999999998   999999


Q ss_pred             CCCCCEEEcCCCCeEEeecccccccc
Q 035998          871 IKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       871 lkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+||++++++.++++|||.+....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.66  E-value=4e-16  Score=187.10  Aligned_cols=156  Identities=29%  Similarity=0.522  Sum_probs=130.1

Q ss_pred             CCCCHHHHHHHHHHHHHhccCC-CCCCCCCCCCCC----CcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccc
Q 035998           29 LTCNPNDLAALEDFMKNFESGI-DGWGTNASSSDC----CHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSE  103 (1020)
Q Consensus        29 ~~~~~~~~~aL~~~k~~~~~~~-~~~~~~~~~~~~----C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~  103 (1020)
                      ..+.+.|.+||++||+++..+. .+|.    +..|    |.|.||.|+....      .+...|+.|+|.++.+.|.+|.
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~----g~~C~p~~~~w~Gv~C~~~~~------~~~~~v~~L~L~~n~L~g~ip~  436 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLRFGWN----GDPCVPQQHPWSGADCQFDST------KGKWFIDGLGLDNQGLRGFIPN  436 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCcccCCCC----CCCCCCcccccccceeeccCC------CCceEEEEEECCCCCccccCCH
Confidence            4578899999999999987543 2453    3334    3799999964210      1123699999999999999999


Q ss_pred             cccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCc
Q 035998          104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSR  182 (1020)
Q Consensus       104 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~  182 (1020)
                      +++++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+ ++++|++|+|++|+++|.+|..+.....+
T Consensus       437 ~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~  516 (623)
T PLN03150        437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH  516 (623)
T ss_pred             HHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcccc
Confidence            99999999999999999999999999999999999999999999999988 89999999999999999999887654556


Q ss_pred             ccEEEccCCCCC
Q 035998          183 IRVINLSVNYFS  194 (1020)
Q Consensus       183 L~~L~L~~N~l~  194 (1020)
                      +..+++.+|...
T Consensus       517 ~~~l~~~~N~~l  528 (623)
T PLN03150        517 RASFNFTDNAGL  528 (623)
T ss_pred             CceEEecCCccc
Confidence            667777777644

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=8.7e-16  Score=160.41  Aligned_cols=134  Identities=22%  Similarity=0.339  Sum_probs=114.0

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchh--------hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ--------MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      +.||+|++|.||+|+. .|..|++|+.......        ....+.+|++++..+.|++++....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986643211        123577899999999999998888787778888999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ++|++|.+++...       .. .+..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.++.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988643       11 7889999999999999999   999999999999999 78899999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=9.1e-17  Score=175.63  Aligned_cols=174  Identities=25%  Similarity=0.380  Sum_probs=130.2

Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..|+.|++++-++|.+|+.+... ....++.....++.|++.|+.|   +   +.+|||+||.||+...+.++||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            46799999999999999976533 3456788899999999999999   5   899999999999999999999999999


Q ss_pred             cccccCCC----CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          892 ARLILSPY----DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       892 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      ........    .....+..+||..||+||.+.++.|+.|+||||+|++++|+++ =..+|.         .+.....+ 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~d~-  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLTDI-  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhhhh-
Confidence            88764432    1234456789999999999999999999999999999999998 222221         11111111 


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1011 (1020)
                      +.+    .++|....+++.     =+.++.+++...|.+||++.+
T Consensus       473 r~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 RDG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hcC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence            111    112222222222     357888999999999995444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.8e-15  Score=179.90  Aligned_cols=139  Identities=19%  Similarity=0.261  Sum_probs=112.8

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEe-cCCc-------hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL-SGDC-------GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  811 (1020)
                      ....|...+.||+|+||.||+|.+... .+++|+. .+..       ....+.+.+|++++++++|++++....++.+..
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            344567789999999999999987544 3444432 2211       112345789999999999999998888887777


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++++|.+++.            ....++.+++++++|||+.   +++|||+||+||++ .++.++++|||+
T Consensus       410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            8899999999999988875            3467899999999999999   99999999999999 678899999999


Q ss_pred             cccc
Q 035998          892 ARLI  895 (1020)
Q Consensus       892 ~~~~  895 (1020)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            9753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.62  E-value=2.5e-15  Score=155.28  Aligned_cols=130  Identities=23%  Similarity=0.355  Sum_probs=107.1

Q ss_pred             eeeccCCeEEEEEEeCCCCEEEEEEecCCch---h-----hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDCG---Q-----MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       749 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .||+|+||.||+|.+ ++..|++|.......   .     ....+.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999996 578899998654321   1     1245778999999999887766666666677789999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +|++|.+++...    .       ..++.+++.+++++|+.   +++|||++|+||+++ ++.++++|||.++.
T Consensus        80 ~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----N-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998876542    0       07899999999999999   999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.59  E-value=2.4e-15  Score=180.32  Aligned_cols=137  Identities=34%  Similarity=0.573  Sum_probs=112.8

Q ss_pred             CeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccc
Q 035998          535 PTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN  614 (1020)
Q Consensus       535 ~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N  614 (1020)
                      ..|+|++|.++|.+|+.++.|++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|++|
T Consensus       421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N  500 (623)
T PLN03150        421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN  500 (623)
T ss_pred             EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC--CCCCCcCCccccCCC-CCCCC-CCCCccCCcCCccccccccCCCceEEEEEEehhhhhHHHHH
Q 035998          615 HLTGRIPSG--GQFQTFPNSSFDGNN-LCGEH-RYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFGSAFLL  684 (1020)
Q Consensus       615 ~l~g~~p~~--~~~~~~~~~~~~~n~-l~~~~-~~~c~~~~~~~~~~~~~~~~~~~~~i~~~~i~~~~~~~~~~  684 (1020)
                      +++|.+|..  +.+..+....+.+|+ +||.+ ...|...             .....++++++++++++++++
T Consensus       501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~-------------~~~~~~i~~~~~~~~~~l~~~  561 (623)
T PLN03150        501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPH-------------LSVGAKIGIAFGVSVAFLFLV  561 (623)
T ss_pred             cccccCChHHhhccccCceEEecCCccccCCCCCCCCccc-------------CCCceEEEEEhHHHHHHHHHH
Confidence            999999974  222334567789998 99875 3566421             123445666666655444333

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=6.8e-14  Score=137.58  Aligned_cols=135  Identities=21%  Similarity=0.164  Sum_probs=114.2

Q ss_pred             cCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC--CccceEeeEEeccCceEEEEEeccCC
Q 035998          746 QANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH--PNLVHLQGYCMHKNDRLLIYSFMENG  823 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  823 (1020)
                      +.+.||+|.++.||++...+ +.+++|.......  ...+.+|++.++.++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35779999999999999854 7899999876543  4578899999999976  58999998888778899999999988


Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      .+..+           +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            65433           4566778899999999999986445799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=5e-14  Score=144.02  Aligned_cols=136  Identities=22%  Similarity=0.208  Sum_probs=99.0

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhh---HHH---------------------HHHHHHHHHHcCCCc--c
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM---ERE---------------------FRAEVEALSRAQHPN--L  800 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~---------------------~~~E~~~l~~l~h~n--i  800 (1020)
                      .+.||+|+||.||+|...+++.||||++.......   ...                     ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987543211   111                     135666666664433  3


Q ss_pred             ceEeeEEeccCceEEEEEeccCCChhhh-hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEE
Q 035998          801 VHLQGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       801 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll  878 (1020)
                      .+.+++    ...++||||++++.+... +....     .. ..+..++.+++.++.++|. .   +|+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            444432    246899999999643221 11110     01 5678899999999999999 7   99999999999999


Q ss_pred             cCCCCeEEeecccccccc
Q 035998          879 DGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~  896 (1020)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=2.8e-13  Score=142.80  Aligned_cols=136  Identities=23%  Similarity=0.273  Sum_probs=105.1

Q ss_pred             CCeee-ccCCeEEEEEEeCCCCEEEEEEecCCc-------------hhhHHHHHHHHHHHHHcCCCcc--ceEeeEEecc
Q 035998          747 ANIIG-CGGFGLVYRATLPDGRNVAIKRLSGDC-------------GQMEREFRAEVEALSRAQHPNL--VHLQGYCMHK  810 (1020)
Q Consensus       747 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  810 (1020)
                      ...|| .|+.|+||.+... +..+|||.+....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999874 7789999885311             0122457889999999998875  6677665433


Q ss_pred             Cc----eEEEEEeccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeE
Q 035998          811 ND----RLLIYSFMEN-GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH  885 (1020)
Q Consensus       811 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  885 (1020)
                      ..    .++||||++| .+|.+++...     .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            22    3599999997 6888887542     34443    357899999999999   999999999999999999999


Q ss_pred             Eeeccccccc
Q 035998          886 LADFGLARLI  895 (1020)
Q Consensus       886 l~Dfg~~~~~  895 (1020)
                      ++|||.++..
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=6.3e-15  Score=173.87  Aligned_cols=257  Identities=26%  Similarity=0.308  Sum_probs=188.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC--CCEEEEEEecCCc--hhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD--GRNVAIKRLSGDC--GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  815 (1020)
                      ...|.+.+.||+|+|+.|-......  ...+|+|.+....  ......+..|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4467888889999999998886532  3456666665442  222234455777777776 9999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCCeEecCCCCCCEEEcCCC-CeEEeeccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-QSCEPHILHRDIKSSNILLDGNF-GAHLADFGLAR  893 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~  893 (1020)
                      +.||.+++++...+..  ......+...+-..+.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998776631  11124555667788999999999999 77   999999999999999999 99999999998


Q ss_pred             cccC-CCCccccccccc-ccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          894 LILS-PYDTHVTTDLVG-TLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       894 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      .+.. ...........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...... ..+..|.....    
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~----  248 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG----  248 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc----
Confidence            8765 444445556778 999999998877 466788999999999999999999997544332 11121111110    


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ......+...    .....++..+++..+|..|.+.+++..
T Consensus       249 ---~~~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 ---RFTQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---ccccCccccC----ChhhhhcccccccCCchhccccccccc
Confidence               0001111111    124567888999999999999887643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1e-13  Score=141.85  Aligned_cols=204  Identities=21%  Similarity=0.298  Sum_probs=145.4

Q ss_pred             HHHHHcCCCccceEeeEEeccC-----ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 035998          790 EALSRAQHPNLVHLQGYCMHKN-----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP  864 (1020)
Q Consensus       790 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  864 (1020)
                      .-+-.+.|-|+|++..|+.+.+     ...++.|||..|++.+++++.......+......+|+.||..||.|||+. .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3344557999999999987543     45789999999999999998766667788888899999999999999986 88


Q ss_pred             CeEecCCCCCCEEEcCCCCeEEeec--cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 035998          865 HILHRDIKSSNILLDGNFGAHLADF--GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT  942 (1020)
Q Consensus       865 ~ivH~Dlkp~NIll~~~~~~kl~Df--g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  942 (1020)
                      .|+|+++..+-|++..+|-+|++--  ...................+.++|.|||.......+.++|||+||+...||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999999987531  11111111111122233566789999999888888899999999999999998


Q ss_pred             CCCCCCCCCC-CCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          943 GKRPMDMCKP-KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       943 g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +..--..... ......+......     ..   ++            .=.+++.+|++..|..||+|.+++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~-----le---n~------------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIG-----LE---NG------------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhhheee-----cc---Cc------------cccCcCcccccCCCCCCcchhhhhc
Confidence            7653211111 0011111100000     00   00            0135788999999999999998865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=2.2e-12  Score=147.91  Aligned_cols=141  Identities=22%  Similarity=0.259  Sum_probs=102.7

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhh----------------------------------------HHHHH
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM----------------------------------------EREFR  786 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  786 (1020)
                      .+.||.|++|.||+|+.++|+.||||+.+......                                        +-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986542110                                        01245


Q ss_pred             HHHHHHHHcC----CCccceEeeEEe-ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHhHh
Q 035998          787 AEVEALSRAQ----HPNLVHLQGYCM-HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR-GLAYLHQ  860 (1020)
Q Consensus       787 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~  860 (1020)
                      +|++.+.+++    |.+-+.+-.++. ..+..++||||++|+++.++......   ..   .+..++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence            5666666652    333344444443 34567999999999999887653211   11   23456666665 4788898


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       861 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      .   |++|+|++|.||+++.+++++++|||++..+.
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   99999999999999999999999999998763

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.38  E-value=5.4e-14  Score=153.70  Aligned_cols=159  Identities=31%  Similarity=0.408  Sum_probs=93.1

Q ss_pred             CCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccC
Q 035998          196 TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAG  275 (1020)
Q Consensus       196 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  275 (1020)
                      .+|..+..+..|+.+.|..|.+. .+|..+.++..|++|+|+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.
T Consensus        89 elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~  164 (722)
T KOG0532|consen   89 ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL  164 (722)
T ss_pred             cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc
Confidence            34444445566666666666666 56666777777777777777776 5666666554 666777777766 55555666


Q ss_pred             CcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEe
Q 035998          276 LGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNIN  355 (1020)
Q Consensus       276 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  355 (1020)
                      +..|..|+.+.|.+. .+|..++++.+|+.|.+..|++...++ .+..| .|..||+|.|+++ .+|-.|.+|+.|++|-
T Consensus       165 ~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~-El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~  240 (722)
T KOG0532|consen  165 LPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPE-ELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQ  240 (722)
T ss_pred             chhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCH-HHhCC-ceeeeecccCcee-ecchhhhhhhhheeee
Confidence            666666666666665 345555666666666666666553322 22222 3455555555555 4555555555555555


Q ss_pred             cCCCccc
Q 035998          356 LARNNFS  362 (1020)
Q Consensus       356 L~~N~l~  362 (1020)
                      |.+|.+.
T Consensus       241 LenNPLq  247 (722)
T KOG0532|consen  241 LENNPLQ  247 (722)
T ss_pred             eccCCCC
Confidence            5555554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.38  E-value=4.4e-14  Score=154.38  Aligned_cols=185  Identities=24%  Similarity=0.387  Sum_probs=165.8

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      .++.-...||+.|++. .+|..+..+..|+.+.|.+|.+. .+|.+++++..|++|||+.|+++ ..|..++.| -|+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeE
Confidence            3455677899999999 89999999999999999999999 89999999999999999999999 777778777 58999


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      .+++|+++ .+|..++.+.+|..||.+.|.+. .+|..+..+.+|+.|.+..|++. .+|..+. .-.|..||+|.|+++
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis  224 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS  224 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee
Confidence            99999999 78888999999999999999998 56667889999999999999999 7788888 567999999999999


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcchhhHHHHHh
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQ  396 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~  396 (1020)
                       .+|-.|.+|+.|++|-|.+|+++.-|..+-.-+
T Consensus       225 -~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kG  257 (722)
T KOG0532|consen  225 -YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKG  257 (722)
T ss_pred             -ecchhhhhhhhheeeeeccCCCCCChHHHHhcc
Confidence             799999999999999999999998887654333

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=8.3e-13  Score=152.02  Aligned_cols=198  Identities=31%  Similarity=0.463  Sum_probs=116.9

Q ss_pred             eeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccC-CcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          137 VLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNS-SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~-~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      .|+++.|.+...+.....++.++.|++.+|.++ .+|.... .. ++|+.|+++.|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~-~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIG-LLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccCchhhhcccceeEEecCCcccc-cCccccc-cchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            466666666544444445566666666666666 4444432 22 25666666666665 44455666677777777777


Q ss_pred             ccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCC
Q 035998          216 DLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPH  295 (1020)
Q Consensus       216 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  295 (1020)
                      +++ .+|...+.++.|+.|++++|+++ .+|........|++|++++|.+. ..+..+..+.++..+.+.+|++.. .+.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            776 45555556666677777777766 45555555555677777766533 345555666666666666666653 245


Q ss_pred             CCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCC
Q 035998          296 SLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT  343 (1020)
Q Consensus       296 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  343 (1020)
                      .++.++.++.|++++|.++....  +..+.+++.|++++|.+....|.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            55666666666666666664433  55566666666666666544443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.34  E-value=2e-12  Score=148.81  Aligned_cols=198  Identities=28%  Similarity=0.416  Sum_probs=124.8

Q ss_pred             ceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccc-ccccccccccccccccchhhhhhccccccccc
Q 035998          159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA-SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ  237 (1020)
Q Consensus       159 ~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  237 (1020)
                      ..|+++.|.+...+...  ..++.++.|++.+|.++ .+++..+.+. +|+.|++++|++. .+|..+..+++|+.|+++
T Consensus        96 ~~l~~~~~~~~~~~~~~--~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~  171 (394)
T COG4886          96 PSLDLNLNRLRSNISEL--LELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS  171 (394)
T ss_pred             ceeeccccccccCchhh--hcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccC
Confidence            46888888774233222  23467888888888887 5666666664 8888888888887 556677788888888888


Q ss_pred             ccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccccc
Q 035998          238 DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL  317 (1020)
Q Consensus       238 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  317 (1020)
                      +|+++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+.+++++..+.+.+|++... 
T Consensus       172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-  247 (394)
T COG4886         172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-  247 (394)
T ss_pred             Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-
Confidence            88887 55555556777888888888887 55555445555677777777433 3444555666666666666665532 


Q ss_pred             ccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc
Q 035998          318 LLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP  366 (1020)
Q Consensus       318 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  366 (1020)
                      +..+..++++++|++++|.++ .++. ++.+.+|+.|++++|.++...|
T Consensus       248 ~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         248 PESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             cchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccch
Confidence            334444555555555555555 2222 5555555555555555554433

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.27  E-value=1.1e-10  Score=131.97  Aligned_cols=166  Identities=17%  Similarity=0.229  Sum_probs=129.5

Q ss_pred             eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHH
Q 035998          763 LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD  842 (1020)
Q Consensus       763 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  842 (1020)
                      ..++.+|.|..++...........+-++.++.++||+|+++++.+..++..|+|+|-+.  -|..++.+.       ...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence            44788999998877655445567778889999999999999999999999999999874  466666654       356


Q ss_pred             HHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCC
Q 035998          843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS  922 (1020)
Q Consensus       843 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  922 (1020)
                      .....+.||+.||.|||..|  +++|+++..+.|+++..|+.||++|.++........  ......--..|..|+.....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            77788999999999999766  999999999999999999999999998865432111  11112222356777754433


Q ss_pred             CCCchhhHHHHHHHHHHHHcC
Q 035998          923 VATYKGDVYSFGVVLLELLTG  943 (1020)
Q Consensus       923 ~~~~~~DvwSlGvil~elltg  943 (1020)
                      .  -..|.|-||++++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            3  357999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=8.7e-12  Score=140.00  Aligned_cols=248  Identities=22%  Similarity=0.258  Sum_probs=178.8

Q ss_pred             CCCcCCeeec--cCCeEEEEEEe---CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceE
Q 035998          743 NFDQANIIGC--GGFGLVYRATL---PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       743 ~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  814 (1020)
                      .|.+.+.+|.  |.+|.||.+..   .++..+|+|+-+...  +.....-.+|+....++ .|++.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999976   367889999844332  23233345567666666 4999999889989999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeec
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR----GLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADF  889 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  889 (1020)
                      +-+|++. .++.++.+...   ..++....+....+..+    |+.++|..   .++|-|+||.||+...+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999885 68877776642   34666777888888888    99999999   99999999999999999 88999999


Q ss_pred             cccccccCCCCccc---ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          890 GLARLILSPYDTHV---TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       890 g~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |+...+.+......   .....|...|++||... +.++.+.|+|++|.++.+..+|...........      |... +
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~~-r  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQL-R  339 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------cccc-c
Confidence            99998876442211   12235777899999854 467789999999999999999887664321110      1000 0


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...         +..++......++...+..|++.+|..|++++.+..
T Consensus       340 ~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 QGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            000         001111111223455888999999999999887764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=4e-11  Score=138.71  Aligned_cols=144  Identities=17%  Similarity=0.213  Sum_probs=97.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchh----------------------------------hHH---
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQ----------------------------------MER---  783 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~---  783 (1020)
                      ..|+. +.||.|++|.||+|+.++ |+.||||+..+....                                  ..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999887 999999999754210                                  011   


Q ss_pred             ---HHHHHHHHHHHcC----CCccceEeeEEec-cCceEEEEEeccCCChhhhhhhcCCC--CCCCCHHHHHHHHHHHHH
Q 035998          784 ---EFRAEVEALSRAQ----HPNLVHLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQGAAR  853 (1020)
Q Consensus       784 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~  853 (1020)
                         ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-.-...+  ...+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence               2444555555552    4444555555543 56678999999999997743211111  011222223333333   


Q ss_pred             HHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeecccccccc
Q 035998          854 GLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADFGLARLIL  896 (1020)
Q Consensus       854 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~~~~~~  896 (1020)
                          ++..   |++|+|+||.||+++.++    ++++.|||++..+.
T Consensus       276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                3445   999999999999999888    99999999998763

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=3.7e-11  Score=120.70  Aligned_cols=131  Identities=21%  Similarity=0.185  Sum_probs=97.1

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccc-eEeeEEeccCceEEEEEeccCCCh
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV-HLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      .+.++.|.++.||+++.. ++.|++|....... ....+.+|+++++.+.+.+++ +++.+  .....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence            357899999999999875 78899999765432 123567899999988665544 44443  23346899999999876


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC--EPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ...  .          .....++.+++++++.||...  ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            532  0          111345678999999999882  12369999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.22  E-value=5.1e-12  Score=134.65  Aligned_cols=118  Identities=27%  Similarity=0.271  Sum_probs=80.4

Q ss_pred             cccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccc-cchhhhc
Q 035998          368 TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS-IPQWLRG  446 (1020)
Q Consensus       368 ~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~p~~l~~  446 (1020)
                      ....+++++.||||+|-+.++.......+++++|+.|+++.|....-.....-..++.|+.|.+.+|+++-. +-..+..
T Consensus       141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~  220 (505)
T KOG3207|consen  141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT  220 (505)
T ss_pred             hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence            344556666666666666666666666666777777777766655544444445678889999999998832 2333556


Q ss_pred             CCCCcEEecccccccccccccccCcCcCcEEeCCCCccc
Q 035998          447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       447 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      +++|..|+|..|.....-.....-++.|+.|||++|++-
T Consensus       221 fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li  259 (505)
T KOG3207|consen  221 FPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI  259 (505)
T ss_pred             CCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence            788999999988644344455566778888888888875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=2.5e-10  Score=114.58  Aligned_cols=138  Identities=16%  Similarity=0.163  Sum_probs=100.6

Q ss_pred             CCeeeccCCeEEEEEEeCC-------CCEEEEEEecCCch----------------------hhHHHH----HHHHHHHH
Q 035998          747 ANIIGCGGFGLVYRATLPD-------GRNVAIKRLSGDCG----------------------QMEREF----RAEVEALS  793 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~  793 (1020)
                      ...||.|.-+.||.|...+       +..+|||+++....                      ...+.+    ++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       47999998753210                      012223    38999999


Q ss_pred             HcCC--CccceEeeEEeccCceEEEEEeccCCChhh-hhhhcCCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEec
Q 035998          794 RAQH--PNLVHLQGYCMHKNDRLLIYSFMENGSLDY-WLHEKLDGPSSLDWDSRLHIAQGAARGLAYL-HQSCEPHILHR  869 (1020)
Q Consensus       794 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~  869 (1020)
                      ++..  -++.+++++    ...++||||+.++.+.. .+++     ..++.++...+..+++.+|..+ |+.   ++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            9854  455666654    56789999998754321 2222     1344556678889999999999 788   99999


Q ss_pred             CCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          870 DIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       870 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+++.||+++ ++.+.++|||.+.....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999997 46799999999876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.11  E-value=1.4e-11  Score=124.52  Aligned_cols=132  Identities=25%  Similarity=0.245  Sum_probs=79.3

Q ss_pred             cccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccc
Q 035998          201 LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ  280 (1020)
Q Consensus       201 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  280 (1020)
                      +.....|++|||++|.|+ .+.++..-+++++.|++|+|.|...  ..+..+++|+.||||+|.++ .+..+-..+.+.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334456777777777777 5666677777778888888877732  23677777888888888776 3334444566667


Q ss_pred             eeecccccccccCCCCCcCCcccccccccccccccccc-cCCCCCCCcCEEEcCCCccC
Q 035998          281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLL-LNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       281 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      .|.|+.|.|...  ..++.+-+|..||+++|+|..... ..++++|.|+.|.|.+|.+.
T Consensus       356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            777777766532  234445555555555555543221 23444444444444444444

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.09  E-value=2.6e-11  Score=122.52  Aligned_cols=43  Identities=33%  Similarity=0.308  Sum_probs=31.3

Q ss_pred             hhcCCCCcEEecccccccccc-cccccCcCcCcEEeCCCCcccc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTI-PVWFGGFQDLFYLDLSNNTFTG  486 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~  486 (1020)
                      ++.+.+|..||+++|+|...- -..+++++-|+.|.|-+|.+.+
T Consensus       370 L~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  370 LRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            556677888888888887321 2357788888888888888873

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.08  E-value=1.9e-11  Score=130.39  Aligned_cols=209  Identities=25%  Similarity=0.261  Sum_probs=105.0

Q ss_pred             cCCCCCcEEecCCCCCCCCCC--ccccCCCCCCeeeccCCCCCCCCCCcc---CCCCcceeeeccCccCCCCCccccccC
Q 035998          106 GNLVQLRFLNLSHNLLKGTVP--VSLVNLPNLEVLDLSSNDLSGPLPQTI---NLPSIQVLDISSNSLNGSVPTSICKNS  180 (1020)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~p~~~---~l~~L~~L~Ls~N~l~~~ip~~~~~~~  180 (1020)
                      .++..|+...|.+..+. ..+  .....|++++.||||+|-|....|-.-   .|++|+.|+|+.|++.-......-.  
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~--  194 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL--  194 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh--
Confidence            34555555666555554 222  234455666666666665554332211   4556666666666554222221112  


Q ss_pred             CcccEEEccCCCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCCcccccCCCccEEE
Q 035998          181 SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLD  259 (1020)
Q Consensus       181 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  259 (1020)
                                            .++.|+.|.|+.|.++- .+..-...+++|+.|+|..|...+.......-+..|++||
T Consensus       195 ----------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld  252 (505)
T KOG3207|consen  195 ----------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD  252 (505)
T ss_pred             ----------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence                                  33445555555555541 1111122345555555555532222223333345555555


Q ss_pred             ccCCcCcccC-cccccCCcccceeecccccccccC-CCC-----CcCCcccccccccccccccccc-cCCCCCCCcCEEE
Q 035998          260 VSSNNFSGNI-PDVFAGLGEFQYLVAHSNRFTGRI-PHS-----LSNSPTLNLLNLRNNSLDGSLL-LNCPALTNLTSLD  331 (1020)
Q Consensus       260 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~-p~~-----~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  331 (1020)
                      |++|++-... -...+.++.|+.|+++.+.++.+- |+.     ....++|++|+++.|++..... ..+..+++|+.|.
T Consensus       253 Ls~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~  332 (505)
T KOG3207|consen  253 LSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR  332 (505)
T ss_pred             ccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence            5555554211 123344555555555555554332 222     2456778888888888764332 3455677888888


Q ss_pred             cCCCccCC
Q 035998          332 LGTNKFNG  339 (1020)
Q Consensus       332 L~~N~l~~  339 (1020)
                      +..|.|+.
T Consensus       333 ~~~n~ln~  340 (505)
T KOG3207|consen  333 ITLNYLNK  340 (505)
T ss_pred             cccccccc
Confidence            88888873

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.06  E-value=6.8e-12  Score=130.34  Aligned_cols=246  Identities=23%  Similarity=0.285  Sum_probs=135.2

Q ss_pred             CCceEEEecCCCcccc----cccccccCCCCCcEEecCCC---CCCCCCCcc-------ccCCCCCCeeeccCCCCCCCC
Q 035998           84 SGRVTGLFLYKRRLKG----KLSESLGNLVQLRFLNLSHN---LLKGTVPVS-------LVNLPNLEVLDLSSNDLSGPL  149 (1020)
Q Consensus        84 ~~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~n---~l~~~~p~~-------l~~l~~L~~L~L~~n~l~~~~  149 (1020)
                      ...++.++|++|.+..    .+.+.+.+.++|+..++|+-   .+...+|+.       +..+++|++||||+|.|.-..
T Consensus        29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g  108 (382)
T KOG1909|consen   29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG  108 (382)
T ss_pred             cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence            3578889999988854    34556788888888888752   222245543       445678899999998886544


Q ss_pred             CCcc-----CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccccc---
Q 035998          150 PQTI-----NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGI---  221 (1020)
Q Consensus       150 p~~~-----~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~---  221 (1020)
                      +..+     ++.+|++|+|.+|.+.-.--..+.+   -|..|  ..|+.       .++-+.|+.+..++|++....   
T Consensus       109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~---al~~l--~~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~  176 (382)
T KOG1909|consen  109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR---ALFEL--AVNKK-------AASKPKLRVFICGRNRLENGGATA  176 (382)
T ss_pred             hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH---HHHHH--HHHhc-------cCCCcceEEEEeeccccccccHHH
Confidence            4433     5788888888888775111111111   11111  11111       233456777777777765322   


Q ss_pred             -chhhhhhcccccccccccccCCC----CCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCC
Q 035998          222 -ADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHS  296 (1020)
Q Consensus       222 -~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  296 (1020)
                       ...|...+.|+.+.++.|.|...    +..+|..+++|++|||..|-++......                    +...
T Consensus       177 ~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~--------------------Laka  236 (382)
T KOG1909|consen  177 LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA--------------------LAKA  236 (382)
T ss_pred             HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH--------------------HHHH
Confidence             23344455667777777766421    2234556667777777777665322111                    1122


Q ss_pred             CcCCcccccccccccccccccccCC-----CCCCCcCEEEcCCCccCC----CCCCCCCCCCCCCeEecCCCcc
Q 035998          297 LSNSPTLNLLNLRNNSLDGSLLLNC-----PALTNLTSLDLGTNKFNG----PLPTNLPRCRKLKNINLARNNF  361 (1020)
Q Consensus       297 ~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l  361 (1020)
                      ++.++.|+.|++++|.+.......|     ...++|++|.|.+|.|+.    .+.......+.|..|+|++|++
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            3333444444444444432221111     124566666666666652    1222334466777777777777

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=3e-09  Score=101.49  Aligned_cols=144  Identities=19%  Similarity=0.293  Sum_probs=108.6

Q ss_pred             cCCeeeccCCeEEEEEEeCCCCEEEEEEe-cCCc--h-----hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          746 QANIIGCGGFGLVYRATLPDGRNVAIKRL-SGDC--G-----QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ...++-+|+-+.|+++.+ .|+.++||.- .+.-  +     -..+...+|++.+.+++--.|....-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999998 4777777743 2221  1     12245678999999987667766666777777888999


Q ss_pred             EeccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEeeccccc
Q 035998          818 SFMEN-GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLADFGLAR  893 (1020)
Q Consensus       818 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~  893 (1020)
                      ||++| .++.+++.......  ...+....++..|-+.+.-||..   ++|||||..+||++.+++.   +.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 47788887654322  22233368899999999999999   9999999999999965543   5899999986


Q ss_pred             cc
Q 035998          894 LI  895 (1020)
Q Consensus       894 ~~  895 (1020)
                      .-
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            43

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.5e-09  Score=102.85  Aligned_cols=131  Identities=24%  Similarity=0.377  Sum_probs=102.3

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCc---hh-----hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDC---GQ-----MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+++|+-+.+|.+.+. |.++++|.-.+..   +.     ......+|+.++.+++--.|....=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45889999999999774 4456776543221   11     113456799999999877777666677788888999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ++|..|.+++.+.           ...++..+-.-+.-||..   +|||+|+.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999988888753           245667777788889999   999999999999998775 99999999874

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.02  E-value=3.7e-11  Score=138.39  Aligned_cols=243  Identities=24%  Similarity=0.269  Sum_probs=115.5

Q ss_pred             CCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccc
Q 035998          132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC  211 (1020)
Q Consensus       132 l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  211 (1020)
                      +..++.+++..|.|.......-.+.+|..|++.+|+|. .+... ...+++|++|++++|+|+...  .+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~-l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENL-LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhhhhcccccccceeeeeccccchh-hcccc-hhhhhcchheecccccccccc--chhhccchhhhe
Confidence            33444444444444431111223444444444444443 11110 123444555555555554322  234555677777


Q ss_pred             ccccccccccchhhhhhcccccccccccccCCCCC-cccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccc
Q 035998          212 LGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS-PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT  290 (1020)
Q Consensus       212 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  290 (1020)
                      +++|.|+.  ...+..+..|+.+++++|+++...+ . ...+.+++.+++.+|.+..  ...+..+..+..+++..|+++
T Consensus       147 l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence            77777763  2334446677777777777764433 2 4556667777777776652  223333444455566666665


Q ss_pred             ccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc---Ccc
Q 035998          291 GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ---IPE  367 (1020)
Q Consensus       291 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~---~p~  367 (1020)
                      ..-+-.......|+.+++++|.+.... ..+..+.++..|++.+|++...  ..+.....+..+.+..|.+...   ...
T Consensus       222 ~~~~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (414)
T KOG0531|consen  222 KLEGLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQE  298 (414)
T ss_pred             eccCcccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcc
Confidence            332211111112566666666665221 3344455556666666655421  1233334455555555554311   111


Q ss_pred             c-ccCCCCCCeeeCCCCCCc
Q 035998          368 T-YKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       368 ~-~~~l~~L~~L~l~~N~i~  386 (1020)
                      . ....+.++...+..|.+.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~  318 (414)
T KOG0531|consen  299 YITSAAPTLVTLTLELNPIR  318 (414)
T ss_pred             ccccccccccccccccCccc
Confidence            1 333444555555555443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=2.5e-09  Score=112.63  Aligned_cols=142  Identities=20%  Similarity=0.266  Sum_probs=108.5

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCC--ccceEeeEEeccC---ceEEEEEecc
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHP--NLVHLQGYCMHKN---DRLLIYSFME  821 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~  821 (1020)
                      +.++.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++.  .+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999987778999999765432 1345688999999999764  4566777765532   5689999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC---------------------------------------  862 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  862 (1020)
                      |.++......     ..++..+...++.++++++++||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9887665421     24566777788888888888888421                                       


Q ss_pred             --------------CCCeEecCCCCCCEEEcC--CCCeEEeecccccc
Q 035998          863 --------------EPHILHRDIKSSNILLDG--NFGAHLADFGLARL  894 (1020)
Q Consensus       863 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~  894 (1020)
                                    ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246899999999999998  66689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.02  E-value=2.3e-11  Score=126.48  Aligned_cols=249  Identities=19%  Similarity=0.248  Sum_probs=132.3

Q ss_pred             cccccccccccccccccc----cchhhhhhccccccccccc---ccCCCCC-------cccccCCCccEEEccCCcCccc
Q 035998          203 NCASLEHLCLGMNDLTGG----IADDIFQLQKLRLLGLQDN---QLSGKLS-------PSIADLSNLVRLDVSSNNFSGN  268 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N---~l~~~~~-------~~~~~l~~L~~L~Ls~N~l~~~  268 (1020)
                      .+.+++.++|++|.+...    +...+.+.++|+..++++-   ++...+|       .++...++|++||||.|.|...
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~  107 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK  107 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence            344555555555555422    2222333445555555442   1111223       2334456788888888877644


Q ss_pred             Ccccc----cCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCC--
Q 035998          269 IPDVF----AGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP--  342 (1020)
Q Consensus       269 ~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--  342 (1020)
                      .+..|    .....|++|+|.+|.+.-.--..++.  .|..|.  .|+       ..+.-++|+++..++|++.....  
T Consensus       108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~  176 (382)
T KOG1909|consen  108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATA  176 (382)
T ss_pred             chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHH
Confidence            44333    33455555555555543211111111  122222  111       12334667777777777763222  


Q ss_pred             --CCCCCCCCCCeEecCCCccccc----CcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCC
Q 035998          343 --TNLPRCRKLKNINLARNNFSGQ----IPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLP  416 (1020)
Q Consensus       343 --~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~  416 (1020)
                        ..|...+.|+.+.++.|.|...    ....|..+++|+.|||.+|.++.-....  +                     
T Consensus       177 ~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~--L---------------------  233 (382)
T KOG1909|consen  177 LAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVA--L---------------------  233 (382)
T ss_pred             HHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHH--H---------------------
Confidence              2344556677777777766421    1234566777777777777665432210  0                     


Q ss_pred             CCccccccCceEEEecccccccccchhh-----hcCCCCcEEecccccccc----cccccccCcCcCcEEeCCCCccc
Q 035998          417 TDPRLHFANLKVLVIASCGLRGSIPQWL-----RGCSKLQLVDLSWNQLSG----TIPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       417 ~~~~~~~~~L~~L~l~~n~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      ..+...++.|+.+++.+|.+...--.+|     ...++|+.|.|.+|.|+.    .+-..+...+.|..|+|++|++.
T Consensus       234 akaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  234 AKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            0112234456677777776664333222     246789999999999873    23445566888999999999983

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.99  E-value=1e-10  Score=134.73  Aligned_cols=249  Identities=26%  Similarity=0.255  Sum_probs=174.6

Q ss_pred             cCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          106 GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                      ..+..++.+++..|.+. .+-..+..+++|+.|++.+|+|..+....-.+++|++|+|++|.|+..-+-   ..++.|+.
T Consensus        69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~l---~~l~~L~~  144 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEGL---STLTLLKE  144 (414)
T ss_pred             HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccch---hhccchhh
Confidence            45677777778888887 444557778888888888888876544344688888888888888733322   34556888


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchh-hhhhcccccccccccccCCCCCcccccCCCccEEEccCCc
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADD-IFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      |++++|.|+..  ..+..+++|+.+++++|+++..-+ . ...+.+++.+.+.+|.+..  ...+..+..+..+++..|.
T Consensus       145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             heeccCcchhc--cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence            88888888632  345568888889999998884433 2 5778888889999998873  2345555666667888888


Q ss_pred             CcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCC---C
Q 035998          265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP---L  341 (1020)
Q Consensus       265 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~  341 (1020)
                      ++..-+-......+|+.+++++|++.. .+..+..+..+..|++.+|++...-  .+...+.+..+.+..|.+...   .
T Consensus       220 i~~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  296 (414)
T KOG0531|consen  220 ISKLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAIS  296 (414)
T ss_pred             ceeccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhh
Confidence            874432211111137888999998873 3366777888999999999887443  345567788888888887632   2


Q ss_pred             CCC-CCCCCCCCeEecCCCcccccCc
Q 035998          342 PTN-LPRCRKLKNINLARNNFSGQIP  366 (1020)
Q Consensus       342 p~~-l~~l~~L~~L~L~~N~l~~~~p  366 (1020)
                      ... .+..+.++.+.+..|.+....+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  297 QEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccccccccccccccccCccccccc
Confidence            222 5667889999999998876554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.98  E-value=3.6e-10  Score=111.13  Aligned_cols=107  Identities=21%  Similarity=0.343  Sum_probs=31.6

Q ss_pred             CCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhh-hhhcccccc
Q 035998          156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDI-FQLQKLRLL  234 (1020)
Q Consensus       156 ~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L  234 (1020)
                      .++++|+|++|+|+ .|. .+...+.+|+.|+|++|.|+..  ..+..++.|++|++++|+|+. +.+.+ ..+++|++|
T Consensus        19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred             cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence            34444444444443 221 1212334455555555555422  135566777777777777773 33334 356777777


Q ss_pred             cccccccCCCC-CcccccCCCccEEEccCCcCcc
Q 035998          235 GLQDNQLSGKL-SPSIADLSNLVRLDVSSNNFSG  267 (1020)
Q Consensus       235 ~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~  267 (1020)
                      +|++|+|...- -..+..+++|++|+|.+|.++.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            77777776422 1455667777777777777763

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.97  E-value=4.1e-10  Score=110.72  Aligned_cols=110  Identities=34%  Similarity=0.413  Sum_probs=31.5

Q ss_pred             ccCCCCCcEEecCCCCCCCCCCcccc-CCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcc
Q 035998          105 LGNLVQLRFLNLSHNLLKGTVPVSLV-NLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRI  183 (1020)
Q Consensus       105 l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L  183 (1020)
                      +.+...+++|+|++|.|+ .|. .++ .+.+|+.|||++|.|+.. +....+++|+.|++++|+|+ .++..+...+++|
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            344456777777777777 332 354 467777777777777743 33335677777777777776 4544333345666


Q ss_pred             cEEEccCCCCCCCCC-Cccccccccccccccccccc
Q 035998          184 RVINLSVNYFSGTLS-PGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       184 ~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      ++|+|++|+|...-. ..++.+++|+.|+|.+|.++
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            666666666653211 23445566666666666655

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=4.7e-10  Score=126.23  Aligned_cols=243  Identities=20%  Similarity=0.217  Sum_probs=171.0

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe--CCCCEEEEEEecCCchhhHHH--HHHHHHHHHHc-CCCccceEeeEEeccCceE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL--PDGRNVAIKRLSGDCGQMERE--FRAEVEALSRA-QHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  814 (1020)
                      ...+|..+..||.|.|+.|+....  .++..|++|...........+  -..|+.+...+ .|.+++..+..+...++.|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            356789999999999999999864  367889999876554332222  23455555555 5889999888888888888


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLAR  893 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~  893 (1020)
                      +--||+++++.......    ...++...++.+..|++.++.++|+.   .++|+|+||+||++..+ +.-++.|||...
T Consensus       343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence            99999999988766532    24567778899999999999999988   99999999999999886 778999999986


Q ss_pred             cccCCCCcccccccccccCcc--CccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYI--PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      .+.    .. .......-+++  +|+......+-.+.|+||||.-+.|..+|..--.. .       ..|...  +.+..
T Consensus       416 ~~~----~~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~-------~~~~~i--~~~~~  480 (524)
T KOG0601|consen  416 RLA----FS-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G-------VQSLTI--RSGDT  480 (524)
T ss_pred             ccc----ee-cccccccccccccchhhccccccccccccccccccccccccCcccCcc-c-------ccceee--ecccc
Confidence            421    11 11112233444  55566677888999999999999999987643210 0       001000  00100


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           +..     +.....+..+...+...++..||.+.+...
T Consensus       481 -----p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  481 -----PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             -----cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence                 000     111134667788899999999999988765

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.89  E-value=1.8e-09  Score=132.32  Aligned_cols=130  Identities=19%  Similarity=0.269  Sum_probs=95.2

Q ss_pred             CCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCc--cCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccc
Q 035998          132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNS--LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEH  209 (1020)
Q Consensus       132 l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~--l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~  209 (1020)
                      ....+...+-+|.+. .++.....++|++|-+..|.  +. .++..+|..++.|++|||++|.=-+.+|..++++-+|++
T Consensus       522 ~~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  522 WNSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hhheeEEEEeccchh-hccCCCCCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            356677777777765 34444556678888888886  43 777777788888888888887776778888888888888


Q ss_pred             ccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCc
Q 035998          210 LCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       210 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      |+|++..++ .+|..+..+++|.+|++..+.-...+|.....+++|++|.+..-.
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            888888877 677778888888888887776554556666667777777775554

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1.6e-08  Score=101.26  Aligned_cols=126  Identities=24%  Similarity=0.320  Sum_probs=83.3

Q ss_pred             EEEEEEeCCCCEEEEEEecCCch--------------------------hhHHHHHHHHHHHHHcCCC--ccceEeeEEe
Q 035998          757 LVYRATLPDGRNVAIKRLSGDCG--------------------------QMEREFRAEVEALSRAQHP--NLVHLQGYCM  808 (1020)
Q Consensus       757 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  808 (1020)
                      .||.|...+|..+|||+......                          .......+|++.|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988999999998853210                          0123467899999999765  45666544  


Q ss_pred             ccCceEEEEEecc--CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-hHhcCCCCeEecCCCCCCEEEcCCCCeE
Q 035998          809 HKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY-LHQSCEPHILHRDIKSSNILLDGNFGAH  885 (1020)
Q Consensus       809 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k  885 (1020)
                        ...++||||++  |..+.. +...     .++.+....++.+++..+.. +|+.   |+||||+.+.||+++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  544433 3222     11123456777888886666 4677   99999999999999988 899


Q ss_pred             Eeecccccccc
Q 035998          886 LADFGLARLIL  896 (1020)
Q Consensus       886 l~Dfg~~~~~~  896 (1020)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.86  E-value=5e-10  Score=131.94  Aligned_cols=251  Identities=21%  Similarity=0.254  Sum_probs=167.3

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ...+.+.+.+.+-.|.++.++.+.-. .|...+.|......   ....+...++-.+.-.-++|-++....-+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34566788889999999999987632 34334444332221   111122233333322234566666555555667789


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ++++|..+++|...++..    ...+.+.+......+..+.+|||..   .+.|||++|.|.+...+++.+++|||....
T Consensus       881 L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            999999999998887754    2345455566666788999999988   799999999999999999999999984332


Q ss_pred             ccCC-----------------------------CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 035998          895 ILSP-----------------------------YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR  945 (1020)
Q Consensus       895 ~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  945 (1020)
                      .+..                             ++........||+.|.+||...+......+|+|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            2100                             00011234678999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 035998          946 PMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010 (1020)
Q Consensus       946 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1010 (1020)
                      ||....+......+     ....       .++  ...+........+++...+..+|.+|-.+.
T Consensus      1034 p~na~tpq~~f~ni-----~~~~-------~~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENI-----LNRD-------IPW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhhhcc-----ccCC-------CCC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99865543322111     0000       011  111222223466788888888998888765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=3.3e-08  Score=100.95  Aligned_cols=149  Identities=21%  Similarity=0.191  Sum_probs=107.4

Q ss_pred             ccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc----------------------hhhHHHHHHHH
Q 035998          732 ISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----------------------GQMEREFRAEV  789 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~  789 (1020)
                      +.+..+.+...-+.+...||-|.-+.||.|..++|.++|||.-..-.                      .......++|.
T Consensus        81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf  160 (304)
T COG0478          81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF  160 (304)
T ss_pred             HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence            34444444444456789999999999999999999999999643110                      01223467899


Q ss_pred             HHHHHcCCC--ccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeE
Q 035998          790 EALSRAQHP--NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL  867 (1020)
Q Consensus       790 ~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  867 (1020)
                      ++|.++...  .+.+.+++    +...+||||++|--|...         .++......++..|++-+..+-..   |+|
T Consensus       161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiV  224 (304)
T COG0478         161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIV  224 (304)
T ss_pred             HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence            999999644  66666553    567899999998654321         112344455666666666666666   999


Q ss_pred             ecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          868 HRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       868 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |+|+.+-||++++||.+.++||--+....
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccccCC
Confidence            99999999999999999999998776543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=9.5e-08  Score=102.09  Aligned_cols=261  Identities=17%  Similarity=0.173  Sum_probs=156.5

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEE------eccCc-eEEE
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYC------MHKND-RLLI  816 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~~-~~lv  816 (1020)
                      ...+.+|+|+-+.+|-.-  +-...+.|++.........+..   +.|.+. .||-+-.=+.|=      -++.. .-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            456789999999999653  1123456887766543333222   223322 455433211111      11122 4467


Q ss_pred             EEeccCC-Chhhhhh--hcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          817 YSFMENG-SLDYWLH--EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       817 ~e~~~~g-~L~~~l~--~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      |+.+.+. -...+..  .++.+.....|+..+.+++.+|.+.+.||..   |.+-+|+.++|+|+.+++.+.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            7777654 1112211  2234556789999999999999999999999   99999999999999999999999865433


Q ss_pred             cccCCCCcccccccccccCccCcccc-----CCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCC-----cccHHHHH
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLTG-KRPMDMCKPKG-----SRDLISWV  962 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~-----~~~~~~~~  962 (1020)
                      ..   .........+|...|.+||.-     .+-..+...|.|.+|+++++++.| ++||.+..-..     .+..+...
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32   122233346788999999953     344567789999999999999985 99997643211     11111111


Q ss_pred             HHHHhh-cccccccCccccCccCHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHh
Q 035998          963 IRMRQE-NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSES--PKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       963 ~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~ 1018 (1020)
                      ...... ....-..-|  ......--...+..+..+|+...  +.-||+++..+..|.+
T Consensus       243 ~f~ya~~~~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         243 RFAYASDQRRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eeeechhccCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            111000 000000111  01111111224566777787543  5689999988876654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=1.1e-07  Score=101.41  Aligned_cols=141  Identities=16%  Similarity=0.107  Sum_probs=101.9

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchh-----------hHHHHHHHHHHHHHcCCCcc--ceEeeEEec-----
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-----------MEREFRAEVEALSRAQHPNL--VHLQGYCMH-----  809 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  809 (1020)
                      +.+-+.....|+++.+ +|+.|.||........           ....+.+|...+.++...+|  ++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4454444455777766 5788999987543211           11147789999988854443  344555543     


Q ss_pred             cCceEEEEEeccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-------C
Q 035998          810 KNDRLLIYSFMENG-SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-------N  881 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~  881 (1020)
                      ....++|+|++++. +|.+++.....  ...+...+..++.+++..+..||..   ||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999986 88888764321  2345667789999999999999999   9999999999999975       4


Q ss_pred             CCeEEeecccccc
Q 035998          882 FGAHLADFGLARL  894 (1020)
Q Consensus       882 ~~~kl~Dfg~~~~  894 (1020)
                      +.+.++||+.++.
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6799999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.77  E-value=4.7e-09  Score=84.82  Aligned_cols=61  Identities=36%  Similarity=0.539  Sum_probs=48.6

Q ss_pred             CcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccc
Q 035998          556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHL  616 (1020)
Q Consensus       556 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l  616 (1020)
                      ++|++|++++|+|+...+..|.++++|++|++++|++++..|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3678888888888855556788888888888888888877777888888888888888875

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.76  E-value=1.8e-07  Score=102.78  Aligned_cols=170  Identities=21%  Similarity=0.263  Sum_probs=128.1

Q ss_pred             CCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceEEEEEeccC-CChhh
Q 035998          754 GFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRLLIYSFMEN-GSLDY  827 (1020)
Q Consensus       754 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  827 (1020)
                      -..+.|++.. .||..|++|+++.+..........-+++++++.|+|+|++.++|..    +...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3457789874 4899999999976544333333456888999999999999998873    3467899999985 46655


Q ss_pred             hhhhc-----------CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          828 WLHEK-----------LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       828 ~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +-...           ...+...++...|.++.|++.||.++|+.   |+.-+-+.+++|+++++.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            43221           12334578899999999999999999999   99999999999999999999998888765543


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR  945 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  945 (1020)
                      .+.              .  |.+.+   -.+-|.=.+|.++..+.||..
T Consensus       445 ~d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            221              0  11111   236788899999999999854

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.74  E-value=8.1e-09  Score=126.76  Aligned_cols=58  Identities=26%  Similarity=0.305  Sum_probs=34.1

Q ss_pred             CCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc-CcccccCCCCCCeeeCC
Q 035998          324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ-IPETYKNFESLSYLSLS  381 (1020)
Q Consensus       324 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~  381 (1020)
                      .++|+.|++...+....+.+....+..++.+-+..+.+.+. .-...+.++++..+.++
T Consensus       769 ~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  769 APHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             cCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence            47788888877776656666666666666666666666654 23333444444444443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.69  E-value=1.2e-08  Score=82.44  Aligned_cols=59  Identities=36%  Similarity=0.623  Sum_probs=35.9

Q ss_pred             CcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCC
Q 035998          326 NLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS  384 (1020)
Q Consensus       326 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  384 (1020)
                      +|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45566666666665445556666666666666666665555566666666666666665

...

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=3.1e-07  Score=105.89  Aligned_cols=140  Identities=22%  Similarity=0.256  Sum_probs=96.5

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchh----------------------------------------hHHHHHH
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ----------------------------------------MEREFRA  787 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  787 (1020)
                      +.|+.++-|.||+|++++|+.||||+.++....                                        .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999998653211                                        1113556


Q ss_pred             HHHHHHHcC----CCccceEeeEEe-ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHH-HHHhHhc
Q 035998          788 EVEALSRAQ----HPNLVHLQGYCM-HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG-LAYLHQS  861 (1020)
Q Consensus       788 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~  861 (1020)
                      |+..+.+++    ..--+++-.++. .....+++|||++|-.+.+...-..   ...+...   ++..++++ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHHhc
Confidence            777666662    233344444444 4677899999999998877743321   2233222   22222222 2333334


Q ss_pred             CCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       862 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                         |+.|+|.+|.||+++.+|++.+.|||++....
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence               99999999999999999999999999987764

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.51  E-value=9.8e-08  Score=70.40  Aligned_cols=38  Identities=34%  Similarity=0.825  Sum_probs=26.2

Q ss_pred             HHHHHHHHHHHHHhccC----CCCCCCCCCCCCCCcCceEEcC
Q 035998           33 PNDLAALEDFMKNFESG----IDGWGTNASSSDCCHWVGITCN   71 (1020)
Q Consensus        33 ~~~~~aL~~~k~~~~~~----~~~~~~~~~~~~~C~w~gv~C~   71 (1020)
                      ++|++||++||+++..+    ..+|.... ..+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence            67999999999999853    35554321 3799999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=1.3e-06  Score=87.85  Aligned_cols=139  Identities=15%  Similarity=0.134  Sum_probs=103.2

Q ss_pred             eeccCCeEEEEEEeCCCCEEEEEEecCCc------hhhHHHHHHHHHHHHHcCCCc--cceEeeEEe-c----cCceEEE
Q 035998          750 IGCGGFGLVYRATLPDGRNVAIKRLSGDC------GQMEREFRAEVEALSRAQHPN--LVHLQGYCM-H----KNDRLLI  816 (1020)
Q Consensus       750 lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lv  816 (1020)
                      -|+|+.+.|+..... |+.+-+|+-....      +-.+..|.+|+..+.++...+  +.++. ++. .    ....++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477899999998874 4578888765211      224567999999999985333  44444 332 1    1235799


Q ss_pred             EEeccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC--eEEeeccccc
Q 035998          817 YSFMEN-GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--AHLADFGLAR  893 (1020)
Q Consensus       817 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~  893 (1020)
                      +|-+++ .+|.+++.+..  -...+...+..++.+++.+++-||+.   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 58888876542  22456777889999999999999999   9999999999999986667  9999998876


Q ss_pred             cc
Q 035998          894 LI  895 (1020)
Q Consensus       894 ~~  895 (1020)
                      ..
T Consensus       179 ~~  180 (216)
T PRK09902        179 RR  180 (216)
T ss_pred             hh
Confidence            53

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=5.7e-08  Score=110.94  Aligned_cols=151  Identities=24%  Similarity=0.267  Sum_probs=103.4

Q ss_pred             HHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc-------ccccccccCccCccccCC
Q 035998          849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV-------TTDLVGTLGYIPPEYGQA  921 (1020)
Q Consensus       849 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  921 (1020)
                      .+++.|+.|+|...  ++||++|.|++|.++..+..|++.|+++.....+.+...       ..-......|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34569999999874  899999999999999999999999999876544222111       111233467999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccC
Q 035998          922 SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLS 1000 (1020)
Q Consensus       922 ~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~ 1000 (1020)
                      ...+.++|+||+|+.+|.+.. |+.-+............     . ..       +..-...+......++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-----~-~~-------~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-----R-NL-------LNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-----h-cc-------cccccccccccCcHHHHHHHHHHhc
Confidence            889999999999999999995 55555432221111110     0 00       0000011112333467888889999


Q ss_pred             CCCCCCCCHHHHHH
Q 035998         1001 ESPKVRPTTQQLVS 1014 (1020)
Q Consensus      1001 ~dP~~RPs~~evl~ 1014 (1020)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.41  E-value=7.5e-09  Score=116.82  Aligned_cols=197  Identities=23%  Similarity=0.230  Sum_probs=88.5

Q ss_pred             CCcccEEEccCCCCCCCC-CCccccccccccccccccccccccchhhhhh-cccccccccccccC----------CCCCc
Q 035998          180 SSRIRVINLSVNYFSGTL-SPGLGNCASLEHLCLGMNDLTGGIADDIFQL-QKLRLLGLQDNQLS----------GKLSP  247 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~----------~~~~~  247 (1020)
                      ++++++|.+-.-.=.+.. |-.+..+.+|++|.|.++.|..  ...+..+ .+|+.|.. +|.++          |.+..
T Consensus        83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~n  159 (1096)
T KOG1859|consen   83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISN  159 (1096)
T ss_pred             HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhcccccc
Confidence            444555554433222222 5556677788888888877763  2222222 23444422 22221          11111


Q ss_pred             ccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCc
Q 035998          248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNL  327 (1020)
Q Consensus       248 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  327 (1020)
                      ++. ...|...+.++|.+. .....+.-++.|+.|+|++|+++...  .+..+++|+.|||++|.+....-....++. |
T Consensus       160 s~~-Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L  234 (1096)
T KOG1859|consen  160 SPV-WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-L  234 (1096)
T ss_pred             chh-hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-h
Confidence            111 124555555666555 33344444555555555555555332  445555555555555555533322222222 5


Q ss_pred             CEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc-ccccCCCCCCeeeCCCCCCc
Q 035998          328 TSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP-ETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       328 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~i~  386 (1020)
                      ..|.|++|.++.  -..+.++++|+.||+++|-|++.-- ..+..+..|+.|+|.+|++-
T Consensus       235 ~~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  235 QLLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             eeeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            555555555441  1123444555555555554443211 12233344444555555443

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.40  E-value=1.2e-07  Score=96.74  Aligned_cols=206  Identities=20%  Similarity=0.214  Sum_probs=124.5

Q ss_pred             cccccccccccccccccc-chhhh-hhcccccccccccccCC--CCCcccccCCCccEEEccCCcCcccCcccccCCccc
Q 035998          204 CASLEHLCLGMNDLTGGI-ADDIF-QLQKLRLLGLQDNQLSG--KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF  279 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~-~~~~~-~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  279 (1020)
                      +.-++-|.+.+..|...- ...|+ ..+.++.|||..|+|+.  .+-.-+.+++.|++|+|++|++...+-..-..+.+|
T Consensus        44 ~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl  123 (418)
T KOG2982|consen   44 LRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNL  123 (418)
T ss_pred             ccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccce
Confidence            334445555555554211 11122 34667777777777773  223345567788888888888775443322455677


Q ss_pred             ceeeccccccccc-CCCCCcCCccccccccccccccccccc--CCC-CCCCcCEEEcCCC---------ccCCCCCCCCC
Q 035998          280 QYLVAHSNRFTGR-IPHSLSNSPTLNLLNLRNNSLDGSLLL--NCP-ALTNLTSLDLGTN---------KFNGPLPTNLP  346 (1020)
Q Consensus       280 ~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~--~~~-~l~~L~~L~L~~N---------~l~~~~p~~l~  346 (1020)
                      +.|.|.+..+.-. ....+..+|.++.|++|.|++.....+  ... .-+.+.+|++..|         ++...      
T Consensus       124 ~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~------  197 (418)
T KOG2982|consen  124 RVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI------  197 (418)
T ss_pred             EEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh------
Confidence            7777777665422 233456778888888888854422111  111 1123444444443         33322      


Q ss_pred             CCCCCCeEecCCCcccccC-cccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCC
Q 035998          347 RCRKLKNINLARNNFSGQI-PETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT  417 (1020)
Q Consensus       347 ~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~  417 (1020)
                       ++++..+-+..|++.... ...+..++.+..|+|+.|+|.+..+ ++.+.+++.|..|.++.+.+.+.+..
T Consensus       198 -Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswas-vD~Ln~f~~l~dlRv~~~Pl~d~l~~  267 (418)
T KOG2982|consen  198 -FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWAS-VDALNGFPQLVDLRVSENPLSDPLRG  267 (418)
T ss_pred             -cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHH-HHHHcCCchhheeeccCCcccccccC
Confidence             356777888888876433 3466778888899999999988754 56788888888888887766554443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.38  E-value=1.6e-06  Score=89.53  Aligned_cols=106  Identities=25%  Similarity=0.280  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHHcCCCc--cceEeeEEeccC----ceEEEEEeccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHH
Q 035998          783 REFRAEVEALSRAQHPN--LVHLQGYCMHKN----DRLLIYSFMENG-SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL  855 (1020)
Q Consensus       783 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L  855 (1020)
                      ....+|...+..+...+  +++.+++.....    ..++|+|++++. +|.+++.....    .+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            35677888888875433  455666655432    347999999874 88888876421    45567789999999999


Q ss_pred             HHhHhcCCCCeEecCCCCCCEEEcCCC---CeEEeeccccccc
Q 035998          856 AYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLI  895 (1020)
Q Consensus       856 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~  895 (1020)
                      +-||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999   999999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.37  E-value=5.4e-06  Score=83.67  Aligned_cols=138  Identities=16%  Similarity=0.206  Sum_probs=94.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHH---------HHHHHHHHHHcC---CCccceEeeEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE---------FRAEVEALSRAQ---HPNLVHLQGYC  807 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~  807 (1020)
                      ...+|...+++.......|.+... +|+.+++|.........++.         ..+++..+.+++   ......++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            356788888888888888877776 57999999887654333332         233444444442   23333333333


Q ss_pred             e-----ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          808 M-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       808 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      .     .....+++|||++|..+.++..        ++.    .++..+++++.-+|+.   |+.|+|..|.|+++++++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence            2     2234568999999987655421        222    3456677889999999   999999999999999655


Q ss_pred             CeEEeecccccc
Q 035998          883 GAHLADFGLARL  894 (1020)
Q Consensus       883 ~~kl~Dfg~~~~  894 (1020)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1020
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-61
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-60
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-50
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-50
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-44
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-35
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-25
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-23
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-21
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-17
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		6e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-13
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-11
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		8e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-07
3soa_A	444	Full-Length Human Camkii Length = 444		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		9e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		1e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-04
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		1e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  233 bits (593), Expect = 5e-61,   Method: Composition-based stats.
 Identities = 120/291 (41%), Positives = 179/291 (61%), Gaps = 4/291 (1%)
Query: 730  KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAE 788
            K  S+ ++  +++NF   NI+G GGFG VY+  L DG  VA+KRL  +  Q  E +F+ E
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            VE +S A H NL+ L+G+CM   +RLL+Y +M NGS+   L E+ +    LDW  R  IA
Sbjct: 78   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
             G+ARGLAYLH  C+P I+HRD+K++NILLD  F A + DFGLA+L +   D HV   + 
Sbjct: 138  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVR 196
Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD--LISWVIRMR 966
            G +G+I PEY     ++ K DV+ +GV+LLEL+TG+R  D+ +     D  L+ WV  + 
Sbjct: 197  GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 967  QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
            +E +   ++D  +     D+E+ +++ +A LC   SP  RP   ++V  L+
Sbjct: 257  KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  229 bits (585), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 180/291 (61%), Gaps = 4/291 (1%)
Query: 730  KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAE 788
            K  S+ ++  +++NF   NI+G GGFG VY+  L DG  VA+KRL  +  Q  E +F+ E
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            VE +S A H NL+ L+G+CM   +RLL+Y +M NGS+   L E+ +    LDW  R  IA
Sbjct: 86   VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
             G+ARGLAYLH  C+P I+HRD+K++NILLD  F A + DFGLA+L +   D HV   + 
Sbjct: 146  LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVR 204
Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD--LISWVIRMR 966
            GT+G+I PEY     ++ K DV+ +GV+LLEL+TG+R  D+ +     D  L+ WV  + 
Sbjct: 205  GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 967  QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
            +E +   ++D  +     D+E+ +++ +A LC   SP  RP   ++V  L+
Sbjct: 265  KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  196 bits (497), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 113/277 (40%), Positives = 159/277 (57%), Gaps = 3/277 (1%)
Query: 732  ISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEA 791
            + + D+ E+TNNFD   +IG G FG VY+  L DG  VA+KR + +  Q   EF  E+E 
Sbjct: 29   VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            LS  +HP+LV L G+C  +N+ +LIY +MENG+L   L+       S+ W+ RL I  GA
Sbjct: 89   LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            ARGL YLH      I+HRD+KS NILLD NF   + DFG+++       TH+   + GTL
Sbjct: 149  ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTL 205
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
            GYI PEY      T K DVYSFGVVL E+L  +  +    P+   +L  W +      + 
Sbjct: 206  GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
             +++DP + DK   + + +  D A  CL+ S + RP+
Sbjct: 266  EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  196 bits (497), Expect = 8e-50,   Method: Compositional matrix adjust.
 Identities = 115/278 (41%), Positives = 162/278 (58%), Gaps = 5/278 (1%)
Query: 732  ISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEA 791
            + + D+ E+TNNFD   +IG G FG VY+  L DG  VA+KR + +  Q   EF  E+E 
Sbjct: 29   VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS-SLDWDSRLHIAQG 850
            LS  +HP+LV L G+C  +N+ +LIY +MENG+L   L+   D P+ S+ W+ RL I  G
Sbjct: 89   LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIG 147
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            AARGL YLH      I+HRD+KS NILLD NF   + DFG+++       TH+   + GT
Sbjct: 148  AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
            LGYI PEY      T K DVYSFGVVL E+L  +  +    P+   +L  W +      +
Sbjct: 205  LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
              +++DP + DK   + + +  D A  CL+ S + RP+
Sbjct: 265  LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  176 bits (445), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 193/677 (28%), Positives = 283/677 (41%), Gaps = 106/677 (15%)
Query: 84  SGRVTGLFLYKRRLKGKLSE--SLGNLVQLRFLNLSHNLLKGTVPVS-LVNLPNLEVLDL 140
           S  +T L L +  L G ++   SLG+   L+FLN+S N L     VS  + L +LEVLDL
Sbjct: 96  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 155
Query: 141 SSNDLSGP----LPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT 196
           S+N +SG        +     ++ L IS N ++G V  S C N   +  +++S N FS T
Sbjct: 156 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVN---LEFLDVSSNNFS-T 211
Query: 197 LSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP--------- 247
             P LG+C++L+HL +  N L+G  +  I    +L+LL +  NQ  G + P         
Sbjct: 212 GIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYL 271
Query: 248 SIAD--------------LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI 293
           S+A+                 L  LD+S N+F G +P  F      + L   SN F+G +
Sbjct: 272 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 331
Query: 294 PHXXXXXXXXXXXXXXXXXXXXXXXXXCPALTNLT----SLDLGTNKFNGPLPTNLPRCR 349
           P                            +LTNL+    +LDL +N F+GP+  NL +  
Sbjct: 332 PMDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSASLLTLDLSSNNFSGPILPNLCQNP 389
Query: 350 K--LKNINLARNNFSGQIPETYKNF-EXXXXXXXXXXXXXXXXXALQVLQQCRNLTTLVL 406
           K  L+ + L  N F+G+IP T  N  E                 +L  L + R+L    L
Sbjct: 390 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK---L 446
Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
            LN    ++P +  ++   L+ L++    L G IP  L  C+ L  + LS N+L+G IP 
Sbjct: 447 WLNMLEGEIPQE-LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 505
Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRN------- 519
           W G  ++L  L LSNN+F+G IP  L    SLI  +++    +   P  M +        
Sbjct: 506 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 565
Query: 520 -VSARGLQY-------------NQIWSFPPTIDLSLNRLD-------------GSIWPEF 552
            ++ +   Y               +  F       LNRL              G   P F
Sbjct: 566 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 625
Query: 553 GNLKKLHVFD------------------------LKHNNLSGPIPSELTGMTSLETLDLS 588
            N   +   D                        L HN++SG IP E+  +  L  LDLS
Sbjct: 626 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 685
Query: 589 YNNLSGAIPIXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYSC 647
            N L G IP             ++NN+L+G IP  GQF+TFP + F  N  LCG     C
Sbjct: 686 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 745
Query: 648 TIDRESGQVKSAKKSRR 664
                 G     +   R
Sbjct: 746 DPSNADGYAHHQRSHGR 762

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  174 bits (441), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 190/667 (28%), Positives = 281/667 (42%), Gaps = 106/667 (15%)
Query: 84  SGRVTGLFLYKRRLKGKLSE--SLGNLVQLRFLNLSHNLLKGTVPVS-LVNLPNLEVLDL 140
           S  +T L L +  L G ++   SLG+   L+FLN+S N L     VS  + L +LEVLDL
Sbjct: 99  SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 141 SSNDLSGP----LPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT 196
           S+N +SG        +     ++ L IS N ++G V  S C N   +  +++S N FS  
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVN---LEFLDVSSNNFSTG 215
Query: 197 LSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP--------- 247
           + P LG+C++L+HL +  N L+G  +  I    +L+LL +  NQ  G + P         
Sbjct: 216 I-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYL 274
Query: 248 SIAD--------------LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI 293
           S+A+                 L  LD+S N+F G +P  F      + L   SN F+G +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 294 PHXXXXXXXXXXXXXXXXXXXXXXXXXCPALTNLT----SLDLGTNKFNGPLPTNLPRCR 349
           P                            +LTNL+    +LDL +N F+GP+  NL +  
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
Query: 350 K--LKNINLARNNFSGQIPETYKNF-EXXXXXXXXXXXXXXXXXALQVLQQCRNLTTLVL 406
           K  L+ + L  N F+G+IP T  N  E                 +L  L + R+L    L
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK---L 449
Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
            LN    ++P +  ++   L+ L++    L G IP  L  C+ L  + LS N+L+G IP 
Sbjct: 450 WLNMLEGEIPQE-LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRN------- 519
           W G  ++L  L LSNN+F+G IP  L    SLI  +++    +   P  M +        
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAAN 568
Query: 520 -VSARGLQY-------------NQIWSFPPTIDLSLNRLD-------------GSIWPEF 552
            ++ +   Y               +  F       LNRL              G   P F
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 553 GNLKKLHVFDLK------------------------HNNLSGPIPSELTGMTSLETLDLS 588
            N   +   D+                         HN++SG IP E+  +  L  LDLS
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLS 688
Query: 589 YNNLSGAIPIXXXXXXXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYSC 647
            N L G IP             ++NN+L+G IP  GQF+TFP + F  N  LCG     C
Sbjct: 689 SNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 748
Query: 648 TIDRESG 654
                 G
Sbjct: 749 DPSNADG 755

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (396), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 106/292 (36%), Positives = 159/292 (54%), Gaps = 24/292 (8%)
Query: 741  TNNFDQ------ANIIGCGGFGLVYRATLPDGRNVAIKRLSG----DCGQMEREFRAEVE 790
            TNNFD+       N +G GGFG+VY+  + +   VA+K+L+        +++++F  E++
Sbjct: 24   TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +++ QH NLV L G+    +D  L+Y +M NGSL   L   LDG   L W  R  IAQG
Sbjct: 83   VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQG 141
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            AA G+ +LH   E H +HRDIKS+NILLD  F A ++DFGLAR       T + + +VGT
Sbjct: 142  AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGT 198
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              Y+ PE  +  + T K D+YSFGVVLLE++TG   +D       R+    +    +   
Sbjct: 199  TAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVD-----EHREPQLLLDIKEEIED 252
Query: 971  ESEVLDPFIYDKQHDKEMLRV---LDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            E + ++ +I  K +D +   V     +A  CL E    RP  +++   L  +
Sbjct: 253  EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  156 bits (394), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 106/292 (36%), Positives = 158/292 (54%), Gaps = 24/292 (8%)
Query: 741  TNNFDQ------ANIIGCGGFGLVYRATLPDGRNVAIKRLSG----DCGQMEREFRAEVE 790
            TNNFD+       N +G GGFG+VY+  + +   VA+K+L+        +++++F  E++
Sbjct: 24   TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +++ QH NLV L G+    +D  L+Y +M NGSL   L   LDG   L W  R  IAQG
Sbjct: 83   VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQG 141
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            AA G+ +LH   E H +HRDIKS+NILLD  F A ++DFGLAR       T +   +VGT
Sbjct: 142  AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGT 198
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              Y+ PE  +  + T K D+YSFGVVLLE++TG   +D       R+    +    +   
Sbjct: 199  TAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVD-----EHREPQLLLDIKEEIED 252
Query: 971  ESEVLDPFIYDKQHDKEMLRV---LDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            E + ++ +I  K +D +   V     +A  CL E    RP  +++   L  +
Sbjct: 253  EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  154 bits (388), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 107/306 (34%), Positives = 157/306 (51%), Gaps = 52/306 (16%)
Query: 741  TNNFDQ------ANIIGCGGFGLVYRATLPDGRNVAIKRLSG----DCGQMEREFRAEVE 790
            TNNFD+       N +G GGFG+VY+  + +   VA+K+L+        +++++F  E++
Sbjct: 18   TNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 76
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +++ QH NLV L G+    +D  L+Y +M NGSL   L   LDG   L W  R  IAQG
Sbjct: 77   VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQG 135
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            AA G+ +LH   E H +HRDIKS+NILLD  F A ++DFGLAR         +   +VGT
Sbjct: 136  AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGT 192
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              Y+ PE  +  + T K D+YSFGVVLLE++TG   +D                   E+R
Sbjct: 193  TAYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVD-------------------EHR 232
Query: 971  ESEVL--------------DPFIYDKQHDKEMLRV---LDIACLCLSESPKVRPTTQQLV 1013
            E ++L              + +I  K +D +   V     +A  CL E    RP  +++ 
Sbjct: 233  EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 292
Query: 1014 SWLDSI 1019
              L  +
Sbjct: 293  QLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 104/289 (35%), Positives = 152/289 (52%), Gaps = 24/289 (8%)
Query: 741  TNNFDQ------ANIIGCGGFGLVYRATLPDGRNVAIKRLSG----DCGQMEREFRAEVE 790
            TNNFD+       N  G GGFG+VY+  + +   VA+K+L+        +++++F  E++
Sbjct: 15   TNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 73
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
              ++ QH NLV L G+    +D  L+Y +  NGSL   L   LDG   L W  R  IAQG
Sbjct: 74   VXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPLSWHXRCKIAQG 132
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            AA G+ +LH   E H +HRDIKS+NILLD  F A ++DFGLAR           + +VGT
Sbjct: 133  AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGT 189
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              Y  PE  +  + T K D+YSFGVVLLE++TG   +D       R+    +    +   
Sbjct: 190  TAYXAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDE-----HREPQLLLDIKEEIED 243
Query: 971  ESEVLDPFIYDKQHDKEMLRV---LDIACLCLSESPKVRPTTQQLVSWL 1016
            E + ++ +I  K +D +   V     +A  CL E    RP  +++   L
Sbjct: 244  EEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/199 (37%), Positives = 105/199 (52%), Gaps = 7/199 (3%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER--EFRAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+RA    G +VA+K L       ER  EF  EV  + R +HPN+V   G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               +  ++  ++  GSL   LH K      LD   RL +A   A+G+ YLH    P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           HRD+KS N+L+D  +   + DFGL+RL  S +    +    GT  ++ PE  +   +  K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXF--LXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 928 GDVYSFGVVLLELLTGKRP 946
            DVYSFGV+L EL T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 74/199 (37%), Positives = 106/199 (53%), Gaps = 7/199 (3%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER--EFRAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+RA    G +VA+K L       ER  EF  EV  + R +HPN+V   G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               +  ++  ++  GSL   LH K      LD   RL +A   A+G+ YLH    P I+
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIV 161
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           HR++KS N+L+D  +   + DFGL+RL  S + +  +    GT  ++ PE  +   +  K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 928 GDVYSFGVVLLELLTGKRP 946
            DVYSFGV+L EL T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 141/295 (47%), Gaps = 39/295 (13%)
Query: 740  STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRL-----SGDCGQMER--EFRAEVEA 791
            + N  +    IG GGFGLV++  L  D   VAIK L      G+   +E+  EF+ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            +S   HPN+V L G  MH   R+++  F+  G L    H  LD    + W  +L +    
Sbjct: 77   MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILL-----DGNFGAHLADFGLARLILSPYDTHVTTD 906
            A G+ Y+ Q+  P I+HRD++S NI L     +    A +ADFGL++        H  + 
Sbjct: 132  ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSG 185
Query: 907  LVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
            L+G   ++ PE   A   +Y  K D YSF ++L  +LTG+ P D    + S   I ++  
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINM 241
Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            +R+E      L P I +        R+ ++  LC S  PK RP    +V  L  +
Sbjct: 242  IREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/214 (35%), Positives = 109/214 (50%), Gaps = 26/214 (12%)
Query: 748 NIIGCGGFGLVYRATLPDGRNVAIKRL----SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            IIG GGFG VYRA    G  VA+K        D  Q     R E +  +  +HPN++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           +G C+ + +  L+  F   G L+  L  K   P     D  ++ A   ARG+ YLH    
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-----DILVNWAVQIARGMNYLHDEAI 126
Query: 864 PHILHRDIKSSNILL-----DGNFG---AHLADFGLARLILSPYDTHVTTDL--VGTLGY 913
             I+HRD+KSSNIL+     +G+       + DFGLAR      + H TT +   G   +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAW 180
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + PE  +AS+ +   DV+S+GV+L ELLTG+ P 
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 140/295 (47%), Gaps = 39/295 (13%)
Query: 740  STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRL-----SGDCGQMER--EFRAEVEA 791
            + N  +    IG GGFGLV++  L  D   VAIK L      G+   +E+  EF+ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            +S   HPN+V L G  MH   R+++  F+  G L    H  LD    + W  +L +    
Sbjct: 77   MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILL-----DGNFGAHLADFGLARLILSPYDTHVTTD 906
            A G+ Y+ Q+  P I+HRD++S NI L     +    A +ADFG ++        H  + 
Sbjct: 132  ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSG 185
Query: 907  LVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
            L+G   ++ PE   A   +Y  K D YSF ++L  +LTG+ P D    + S   I ++  
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINM 241
Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            +R+E      L P I +        R+ ++  LC S  PK RP    +V  L  +
Sbjct: 242  IREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 140/295 (47%), Gaps = 39/295 (13%)
Query: 740  STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRL-----SGDCGQMER--EFRAEVEA 791
            + N  +    IG GGFGLV++  L  D   VAIK L      G+   +E+  EF+ EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            +S   HPN+V L G  MH   R+++  F+  G L    H  LD    + W  +L +    
Sbjct: 77   MSNLNHPNIVKLYG-LMHNPPRMVM-EFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDI 131
Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILL-----DGNFGAHLADFGLARLILSPYDTHVTTD 906
            A G+ Y+ Q+  P I+HRD++S NI L     +    A +ADF L++        H  + 
Sbjct: 132  ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSG 185
Query: 907  LVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
            L+G   ++ PE   A   +Y  K D YSF ++L  +LTG+ P D    + S   I ++  
Sbjct: 186  LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINM 241
Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            +R+E      L P I +        R+ ++  LC S  PK RP    +V  L  +
Sbjct: 242  IREEG-----LRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Composition-based stats.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 742  NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGD-CGQMEREFRAEVEALSRAQHPN 799
            ++++   +IG G   +V  A   P    VAIKR++ + C     E   E++A+S+  HPN
Sbjct: 10   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSS---LDWDSRLHIAQGAARGL 855
            +V      + K++  L+   +  GS LD   H    G      LD  +   I +    GL
Sbjct: 70   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD---THVTTDLVGTLG 912
             YLH++ +   +HRD+K+ NILL  +    +ADFG++  + +  D     V    VGT  
Sbjct: 130  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 913  YIPPE-YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
            ++ PE   Q     +K D++SFG+  +EL TG  P     P         V+ +  +N  
Sbjct: 187  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDP 239
Query: 972  SEVLDPFIYDKQHDKEMLR-----VLDIACLCLSESPKVRPTTQQLV 1013
                 P +     DKEML+        +  LCL + P+ RPT  +L+
Sbjct: 240  -----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Composition-based stats.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 742  NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGD-CGQMEREFRAEVEALSRAQHPN 799
            ++++   +IG G   +V  A   P    VAIKR++ + C     E   E++A+S+  HPN
Sbjct: 15   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSS---LDWDSRLHIAQGAARGL 855
            +V      + K++  L+   +  GS LD   H    G      LD  +   I +    GL
Sbjct: 75   IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD---THVTTDLVGTLG 912
             YLH++ +   +HRD+K+ NILL  +    +ADFG++  + +  D     V    VGT  
Sbjct: 135  EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 913  YIPPE-YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
            ++ PE   Q     +K D++SFG+  +EL TG  P     P         V+ +  +N  
Sbjct: 192  WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDP 244
Query: 972  SEVLDPFIYDKQHDKEMLR-----VLDIACLCLSESPKVRPTTQQLV 1013
                 P +     DKEML+        +  LCL + P+ RPT  +L+
Sbjct: 245  -----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEAL 792
           I E   +F   N++G G F  VYRA ++  G  VAIK +         M +  + EV+  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            + +HP+++ L  Y    N   L+     NG ++ +L  ++   S    +   H      
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE---NEARHFMHQII 122
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ YLH      ILHRD+  SN+LL  N    +ADFGLA  +  P++ H T  L GT  
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPN 177
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           YI PE    S    + DV+S G +   LL G+ P D
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  100 bits (250), Expect = 4e-21,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 749  IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            ++G G FG+V +A     ++VAIK++  +  +  + F  E+  LSR  HPN+V L G C+
Sbjct: 16   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ---GAARGLAYLHQSCEPH 865
              N   L+  + E GSL   LH    G   L + +  H        ++G+AYLH      
Sbjct: 73   --NPVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+LL  G     + DFG A  I     TH+T +  G+  ++ PE  + S  
Sbjct: 127  LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNN-KGSAAWMAPEVFEGSNY 181
Query: 925  TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
            + K DV+S+G++L E++T ++P D       R  I W +        +    P I +   
Sbjct: 182  SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV-------HNGTRPPLIKNLPK 232
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              E L        C S+ P  RP+ +++V
Sbjct: 233  PIESLMT-----RCWSKDPSQRPSMEEIV 256

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 4e-21,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 32/269 (11%)
Query: 749  IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            ++G G FG+V +A     ++VAIK++  +  +  + F  E+  LSR  HPN+V L G C+
Sbjct: 15   VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ---GAARGLAYLHQSCEPH 865
              N   L+  + E GSL   LH    G   L + +  H        ++G+AYLH      
Sbjct: 72   --NPVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+LL  G     + DFG A  I     TH+T +  G+  ++ PE  + S  
Sbjct: 126  LIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 925  TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
            + K DV+S+G++L E++T ++P D       R  I W +        +    P I +   
Sbjct: 181  SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV-------HNGTRPPLIKNLPK 231
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              E L        C S+ P  RP+ +++V
Sbjct: 232  PIESLMT-----RCWSKDPSQRPSMEEIV 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  100 bits (249), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 748 NIIGCGGFGLVYRA--TLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +IG G FG V      LP  R   VAIK L SG   +  R+F +E   + +  HPN++H
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L+G        ++I  FMENGSLD +L +  DG  ++     + + +G A G+ YL    
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTV--IQLVGMLRGIAAGMKYL---A 152
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE 917
           + + +HRD+ + NIL++ N    ++DFGL+R +         T  +G  G IP     PE
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPE 210
Query: 918 YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
             Q    T   DV+S+G+V+ E+++ G+RP
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Composition-based stats.
 Identities = 71/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 749 IIGCGGFGLVY--RATLPDGRNVA--IKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +IG G FG V   R  LP  R+VA  IK L  G   +  R+F  E   + +  HPN+VHL
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           +G        +++  FMENG+LD +L  K DG  ++     + + +G A G+ YL    +
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQFTV--IQLVGMLRGIAAGMRYL---AD 163
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQAS 922
              +HRD+ + NIL++ N    ++DFGL+R+I   P   + TT     + +  PE  Q  
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             T   DV+S+G+V+ E+++ G+RP
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 19/210 (9%)
Query: 748 NIIGCGGFGLVYRA--TLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +IG G FG V      LP  R   VAIK L SG   +  R+F +E   + +  HPN++H
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L+G        ++I  FMENGSLD +L +  DG  ++     + + +G A G+ YL    
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTV--IQLVGMLRGIAAGMKYL---A 126
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE 917
           + + +HR + + NIL++ N    ++DFGL+R +         T  +G  G IP     PE
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--GKIPIRWTAPE 184
Query: 918 YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
             Q    T   DV+S+G+V+ E+++ G+RP
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 78
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  ARG+ YLH      I+HR
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE      ++  ++
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 193 QSDVYAFGIVLYELMTGQLP 212

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 111/209 (53%), Gaps = 14/209 (6%)
Query: 746 QANIIGCGGFGLVYRATLP--DGRN---VAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           +  +IG G FG VY+  L    G+    VAIK L     + +R +F  E   + +  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           ++ L+G        ++I  +MENG+LD +L EK DG  S+     + + +G A G+ YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSV--LQLVGMLRGIAAGMKYL- 163
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEY 918
                + +HRD+ + NIL++ N    ++DFGL+R++   P  T+ T+     + +  PE 
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 919 GQASVATYKGDVYSFGVVLLELLT-GKRP 946
                 T   DV+SFG+V+ E++T G+RP
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 750 IGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A         D   VA+K L        ++F  E E L+  QH ++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 804 QGYCMHKNDRLLIYSFMENGSL---------DYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            G C+  +  ++++ +M++G L         D  L  + + P+ L     LHIAQ  A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + YL      H +HRD+ + N L+  N    + DFG++R + S     V    +  + ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           PPE       T + DV+S GVVL E+ T GK+P
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FGLV+     +   VAIK +  +    E +F  E E + +  HP LV L G C+ 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    L++ FME+G L  +L  +    ++   ++ L +      G+AYL ++C   ++HR
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
           D+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K D
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 930 VYSFGVVLLELLT-GKRPMD 948
           V+SFGV++ E+ + GK P +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYE 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  ARG+ YLH      I+HR
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA        +H    L G++ ++ PE      ++  ++
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FGLV+     +   VAIK +  +    E +F  E E + +  HP LV L G C+ 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    L++ FME+G L  +L  +    ++   ++ L +      G+AYL ++C   ++HR
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
           D+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K D
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 930 VYSFGVVLLELLT-GKRPMD 948
           V+SFGV++ E+ + GK P +
Sbjct: 190 VWSFGVLMWEVFSEGKIPYE 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 9/200 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FGLV+     +   VAIK +  +    E +F  E E + +  HP LV L G C+ 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    L++ FME+G L  +L  +    ++   ++ L +      G+AYL ++C   ++HR
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
           D+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K D
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 930 VYSFGVVLLELLT-GKRPMD 948
           V+SFGV++ E+ + GK P +
Sbjct: 187 VWSFGVLMWEVFSEGKIPYE 206

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 127/276 (46%), Gaps = 35/276 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCM 808
            IG G FGLV+     +   VAIK +    G M E +F  E E + +  HP LV L G C+
Sbjct: 35   IGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    L++ FME+G L  +L  +    ++   ++ L +      G+AYL ++C   ++H
Sbjct: 93   EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
            RD+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K 
Sbjct: 147  RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKS 205
Query: 929  DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE-SEVLDPFIYDKQHDK 986
            DV+SFGV++ E+ + GK P                     ENR  SEV++      +  K
Sbjct: 206  DVWSFGVLMWEVFSEGKIPY--------------------ENRSNSEVVEDISTGFRLYK 245
Query: 987  EML---RVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
              L    V  I   C  E P+ RP   +L+  L  I
Sbjct: 246  PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 748 NIIGCGGFGLVY--RATLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +IG G FG V   R  +P  R   VAIK L +G   +  R+F +E   + +  HPN++H
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------GAARGLA 856
           L+G        ++I  +MENGSLD +L +          D R  + Q      G   G+ 
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKN---------DGRFTVIQLVGMLRGIGSGMK 145
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YL    +   +HRD+ + NIL++ N    ++DFG++R++    +   TT      G IP 
Sbjct: 146 YLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT----RGGKIPI 198
Query: 917 EYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
            +       Y+      DV+S+G+V+ E+++ G+RP
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FGLV+     +   VAIK +  +    E +F  E E + +  HP LV L G C+ 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    L+  FME+G L  +L  +    ++   ++ L +      G+AYL ++C   ++HR
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
           D+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 930 VYSFGVVLLELLT-GKRPMD 948
           V+SFGV++ E+ + GK P +
Sbjct: 188 VWSFGVLMWEVFSEGKIPYE 207

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 76
Query: 810 KNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           K    ++  + E  SL + LH    K +    +D      IA+  A+G+ YLH      I
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID------IARQTAQGMDYLHAKS---I 127
Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASV 923
           +HRD+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       + 
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            +++ DVY+FG+VL EL+TG+ P
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 91/284 (32%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 749  IIGCGGFGLVY--RATLPDGRNV--AIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            IIG G  G V   R  +P  R+V  AIK L +G   +  R+F +E   + +  HPN++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            +G        +++  +MENGSLD +L    DG  ++     + + +G   G+ YL    +
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTI--MQLVGMLRGVGAGMRYL---SD 169
Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
               +HRD+ + N+L+D N    ++DFGL+R++    D   TT    T G IP     PE 
Sbjct: 170  LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEA 225
Query: 919  GQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLD 976
                  +   DV+SFGVV+ E+L  G+RP  +M     +RD+IS V        E     
Sbjct: 226  IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSV--------EEGYRL 273
Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            P      H    L +LD    C  +    RP   Q+VS LD++I
Sbjct: 274  PAPMGCPHALHQL-MLD----CWHKDRAQRPRFSQIVSVLDALI 312

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 748 NIIGCGGFGLVY--RATLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +IG G FG V   R  +P  R   VAIK L +G   +  R+F +E   + +  HPN++H
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------GAARGLA 856
           L+G        ++I  +MENGSLD +L +          D R  + Q      G   G+ 
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKN---------DGRFTVIQLVGMLRGIGSGMK 130
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YL    +   +HRD+ + NIL++ N    ++DFG++R++    +   TT      G IP 
Sbjct: 131 YLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT----RGGKIPI 183
Query: 917 EYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
            +       Y+      DV+S+G+V+ E+++ G+RP
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 91/284 (32%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 749  IIGCGGFGLVY--RATLPDGRNV--AIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            IIG G  G V   R  +P  R+V  AIK L +G   +  R+F +E   + +  HPN++ L
Sbjct: 56   IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            +G        +++  +MENGSLD +L    DG  ++     + + +G   G+ YL    +
Sbjct: 116  EGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTI--MQLVGMLRGVGAGMRYL---SD 169
Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
               +HRD+ + N+L+D N    ++DFGL+R++    D   TT    T G IP     PE 
Sbjct: 170  LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEA 225
Query: 919  GQASVATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLD 976
                  +   DV+SFGVV+ E+L  G+RP  +M     +RD+IS V        E     
Sbjct: 226  IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSV--------EEGYRL 273
Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            P      H    L +LD    C  +    RP   Q+VS LD++I
Sbjct: 274  PAPMGCPHALHQL-MLD----CWHKDRAQRPRFSQIVSVLDALI 312

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  A+G+ YLH      I+HR
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       +  ++
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 79
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  A+G+ YLH      I+HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       +  ++
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 79
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  A+G+ YLH      I+HR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       +  ++
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 748 NIIGCGGFGLVY--RATLPDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +IG G FG V   R  +P  R   VAIK L +G   +  R+F +E   + +  HPN++H
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------GAARGLA 856
           L+G        ++I  +MENGSLD +L +          D R  + Q      G   G+ 
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKN---------DGRFTVIQLVGMLRGIGSGMK 124
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YL    +   +HRD+ + NIL++ N    ++DFG++R++    +   TT      G IP 
Sbjct: 125 YLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT----RGGKIPI 177
Query: 917 EYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
            +       Y+      DV+S+G+V+ E+++ G+RP
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 101
Query: 810 KNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           K    ++  + E  SL + LH    K +    +D      IA+  A+G+ YLH      I
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID------IARQTAQGMDYLHAKS---I 152
Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASV 923
           +HRD+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       + 
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            +++ DVY+FG+VL EL+TG+ P
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
                ++  + E  SL + LH      +  +    + IA+  ARG+ YLH      I+HR
Sbjct: 92  PQ-LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA        +H    L G++ ++ PE      ++  ++
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 205 QSDVYAFGIVLYELMTGQLP 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 17/219 (7%)
Query: 731 EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
           EI   +++ ST        IG G FG VY+        V I ++     +  + FR EV 
Sbjct: 32  EIEASEVMLSTR-------IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVA 84
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            L + +H N++   GY M K++  ++  + E  SL   LH +    +       + IA+ 
Sbjct: 85  VLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQ 140
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A+G+ YLH     +I+HRD+KS+NI L       + DFGLA +      +       G+
Sbjct: 141 TAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 911 LGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRP 946
           + ++ PE  +    +  +++ DVYS+G+VL EL+TG+ P
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 102
Query: 810 KNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           K    ++  + E  SL + LH    K +    +D      IA+  A+G+ YLH      I
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID------IARQTAQGMDYLHAKS---I 153
Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASV 923
           +HRD+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       + 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            +++ DVY+FG+VL EL+TG+ P
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 749 IIGCGGFGLVY--RATLPDGRN--VAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +IG G FG V   R  LP  R   VAIK L  G   +  R+F  E   + +  HPN++HL
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           +G        +++  +MENGSLD +L +K DG  ++     + + +G + G+ YL    +
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTV--IQLVGMLRGISAGMKYL---SD 142
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQAS 922
              +HRD+ + NIL++ N    ++DFGL+R++   P   + T      + +  PE     
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             T   DV+S+G+V+ E+++ G+RP
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGLAR++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 15/208 (7%)
Query: 748 NIIGCGGFGLVYRATL--PDGRN--VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +IG G FG V R  L  P  +   VAIK L G   + +R EF +E   + + +HPN++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L+G   +    +++  FMENG+LD +L    DG  ++     + + +G A G+ YL    
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLN-DGQFTV--IQLVGMLRGIASGMRYL---A 133
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILS-PYDTHVTTDLVGT--LGYIPPEYG 919
           E   +HRD+ + NIL++ N    ++DFGL+R +     D   T+ L G   + +  PE  
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 920 QASVATYKGDVYSFGVVLLELLT-GKRP 946
                T   D +S+G+V+ E+++ G+RP
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            IG G FGLV+     +   VAIK +  +    E +F  E E + +  HP LV L G C+ 
Sbjct: 15   IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 810  KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
            +    L++ FME+G L  +L  +    ++   ++ L +      G+AYL    E  ++HR
Sbjct: 74   QAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLE---EASVIHR 127
Query: 870  DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD 929
            D+ + N L+  N    ++DFG+ R +L    T  +T     + +  PE    S  + K D
Sbjct: 128  DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 930  VYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE-SEVLDPFIYDKQHDKE 987
            V+SFGV++ E+ + GK P                     ENR  SEV++      +  K 
Sbjct: 187  VWSFGVLMWEVFSEGKIPY--------------------ENRSNSEVVEDISTGFRLYKP 226
Query: 988  ML---RVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             L    V  I   C  E P+ RP   +L+  L +I
Sbjct: 227  RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 748 NIIGCGGFGLVYRATL--PDGRN--VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +IG G FG V R  L  P  +   VAIK L G   + +R EF +E   + + +HPN++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L+G   +    +++  FMENG+LD +L    DG  ++     + + +G A G+ YL    
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLN-DGQFTV--IQLVGMLRGIASGMRYL---A 135
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE 917
           E   +HRD+ + NIL++ N    ++DFGL+R +         T  +G  G IP     PE
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG--GKIPIRWTAPE 193
Query: 918 YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
                  T   D +S+G+V+ E+++ G+RP
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 38/236 (16%)
Query: 733 SIDDILESTNNFDQANI-----IGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQME 782
           S   + E     D  NI     +G G FG V   R  LP  +  +VAIK L  G   +  
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
           R+F  E   + +  HPN++ L+G        +++  +MENGSLD +L +          D
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------D 112
Query: 843 SRLHIAQ------GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
           ++  + Q      G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++ 
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169
Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
              +   TT      G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 170 DDPEAAYTT----RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 38/236 (16%)
Query: 733 SIDDILESTNNFDQANI-----IGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQME 782
           S   + E     D  NI     +G G FG V   R  LP  +  +VAIK L  G   +  
Sbjct: 19  STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 78
Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
           R+F  E   + +  HPN++ L+G        +++  +MENGSLD +L +          D
Sbjct: 79  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------D 129
Query: 843 SRLHIAQ------GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
           ++  + Q      G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++ 
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 186
Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
              +   TT      G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 187 DDPEAAYTT----RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           K    ++  + E  SL + LH      +  +    + IA+  A+G+ YLH      I+HR
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA        +H    L G++ ++ PE       +  ++
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 94
Query: 810 KNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           K    ++  + E  SL + LH    K +    +D      IA+  A+G+ YLH      I
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID------IARQTAQGMDYLHAKS---I 145
Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASV 923
           +HRD+KS+NI L  +    + DFGLA        +H    L G++ ++ PE       + 
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            +++ DVY+FG+VL EL+TG+ P
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 102
Query: 810 KNDRLLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
           K    ++  + E  SL + LH    K +    +D      IA+  A+G+ YLH      I
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID------IARQTAQGMDYLHAKS---I 153
Query: 867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASV 923
           +HRD+KS+NI L  +    + DFGLA        +H    L G++ ++ PE       + 
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            +++ DVY+FG+VL EL+TG+ P
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 42  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 152
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 153 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 205
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 206 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 750 IGCGGFGLVYRAT------LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A         D   VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL---DWDSR-----------LHIAQ 849
            G C   +  ++++ +M++G L+ +L  +  GP ++   D   R           LHIA 
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFL--RAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A G+ YL      H +HRD+ + N L+  N    + DFG++R + S     V    + 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            + ++PPE       T + DV+SFGV+L E+ T GK+P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
                ++  + E  SL + LH      +  +    + IA+  A+G+ YLH      I+HR
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATY 926
           D+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE       +  ++
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 927 KGDVYSFGVVLLELLTGKRP 946
           + DVY+FG+VL EL+TG+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++  +MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 111/236 (47%), Gaps = 38/236 (16%)
Query: 733 SIDDILESTNNFDQANI-----IGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQME 782
           S   + E     D  NI     +G G FG V   R  LP  +  +VAIK L  G   +  
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
           R+F  E   + +  HPN++ L+G        +++   MENGSLD +L +          D
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH---------D 112
Query: 843 SRLHIAQ------GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
           ++  + Q      G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++ 
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 169
Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
              +   TT      G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 170 DDPEAAYTT----RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++   MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 54   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 112
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 113  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 167
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 168  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 227  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 283
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 284  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 313

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY--RATLPDGR--NVAIKRLS-GDCGQMEREFRAEVEALSRA 795
             N     ++G G FG V   R  LP  +  +VAIK L  G   +  R+F  E   + + 
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ------ 849
            HPN++ L+G        +++   MENGSLD +L +          D++  + Q      
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH---------DAQFTVIQLVGMLR 154
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
           G A G+ YL    +   +HRD+ + NIL++ N    ++DFGL+R++    +   TT    
Sbjct: 155 GIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT---- 207
Query: 910 TLGYIPPEYGQASVATYK-----GDVYSFGVVLLELLT-GKRP 946
             G IP  +       Y+      DV+S+G+VL E+++ G+RP
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 36   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 94
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 149
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 150  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 209  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 265
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 266  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 55   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 113
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 114  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 168
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 169  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 228  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 284
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 285  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 314

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 28   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 86
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 87   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 141
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 142  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 201  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 257
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 258  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 287

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 35   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 93
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 148
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 149  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 208  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 264
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 265  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 36   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 94
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 149
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 150  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 209  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 265
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 266  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 34   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 92
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 147
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 148  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 207  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 263
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 264  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 33   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 91
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 92   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 146
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 147  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 206  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 262
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 263  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 131/282 (46%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 31   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 89
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 90   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 144
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +     Y  H  T     + ++  E 
Sbjct: 145  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 204  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 260
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 261  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 290

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +   TDL GTL Y+P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTDLCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 69  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 124
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P  +   TDL GTL Y+PPE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTDLCGTLDYLPPE 177
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 753 GGFGLVYRATLPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN 811
           G FG V++A L +   VA+K     D    + E+  EV +L   +H N++   G      
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 812 ----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC----- 862
               D  LI +F E GSL  +L   +     + W+   HIA+  ARGLAYLH+       
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 863 --EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
             +P I HRDIKS N+LL  N  A +ADFGLA    +      T   VGT  Y+ PE  +
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206
Query: 921 ASV-----ATYKGDVYSFGVVLLELLT 942
            ++     A  + D+Y+ G+VL EL +
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 73  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 128
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P  +   TDL GTL Y+PPE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTDLCGTLDYLPPE 181
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +   TDL GTL Y+P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTDLCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 37/277 (13%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            +G G FG+V         +VA+K +  +    E EF  E + + +  HP LV   G C  
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 810  KNDRLLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH-I 866
            +    ++  ++ NG L  +L  H K   PS L     L +      G+A+L    E H  
Sbjct: 75   EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFL----ESHQF 125
Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASV 923
            +HRD+ + N L+D +    ++DFG+ R +L   D +V++  VGT   + +  PE      
Sbjct: 126  IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSS--VGTKFPVKWSAPEVFHYFK 181
Query: 924  ATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK 982
             + K DV++FG+++ E+ + GK P D+         +S   R+ + +  S+ +   +Y  
Sbjct: 182  YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS- 240
Query: 983  QHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                           C  E P+ RPT QQL+S ++ +
Sbjct: 241  ---------------CWHELPEKRPTFQQLLSSIEPL 262

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 194 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 195 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 195 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 17  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 76
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 137 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 194 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 209 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 9   KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 68
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 129 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 185
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 186 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 91
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 209 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 34  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 93
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 154 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 210
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 211 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 24  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 83
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 144 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 200
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 201 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHP 798
             + +   +G G +G+VY+A    GR VA+KR+   + D G      R E+  L    HP
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHP 79
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAY 857
           N+V L      +    L++ FME       L + LD   +   DS++ I      RG+A+
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            HQ     ILHRD+K  N+L++ +    LADFGLAR    P  ++  T  V TL Y  P+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189
Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGK 944
              G    +T   D++S G +  E++TGK
Sbjct: 190 VLMGSKKYST-SVDIWSIGCIFAEMITGK 217

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 44  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 103
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 164 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 220
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 221 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHP 798
             + +   +G G +G+VY+A    GR VA+KR+   + D G      R E+  L    HP
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHP 79
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAY 857
           N+V L      +    L++ FME       L + LD   +   DS++ I      RG+A+
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKD-----LKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            HQ     ILHRD+K  N+L++ +    LADFGLAR    P  ++  T  V TL Y  P+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189
Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGK 944
              G    +T   D++S G +  E++TGK
Sbjct: 190 VLMGSKKYST-SVDIWSIGCIFAEMITGK 217

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 37   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 95
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 150
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +L   +D+ H  T     + ++  E 
Sbjct: 151  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 210  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 266
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 267  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSR 794
           NN +    IG G FG V++A  P          VA+K L  +    M+ +F+ E   ++ 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL------------HEKLD-------- 834
             +PN+V L G C       L++ +M  G L+ +L            H  L         
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
           GP  L    +L IA+  A G+AYL    E   +HRD+ + N L+  N    +ADFGL+R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
           I S        +    + ++PPE    +  T + DV+++GVVL E+ +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 58  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 178 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 21   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 78   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 130  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 185
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 186  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 240
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 241  ------QLMR------LCWKERPEDRPTFDYLRSVLE 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 68  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 123
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P  +   T+L GTL Y+PPE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTELCGTLDYLPPE 176
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 29   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 85
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 86   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 137
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 138  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 193
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 194  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 248
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 249  ------QLMR------LCWKERPEDRPTFDYLRSVLE 273

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 27   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 84   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 135
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 136  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 191
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 192  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 246
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 247  ------QLMR------LCWKERPEDRPTFDYLRSVLE 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 22   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 78
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 79   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 130
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 131  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 186
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 187  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 241
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 242  ------QLMR------LCWKERPEDRPTFDYLRSVLE 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 23   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 79
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 80   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 131
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 132  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 187
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 188  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 242
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 243  ------QLMR------LCWKERPEDRPTFDYLRSVLE 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 21   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 78   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 130  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 185
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 186  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 240
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 241  ------QLMR------LCWKERPEDRPTFDYLRSVLE 265

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 30   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 86
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 87   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 138
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 139  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEXTAREGAKFPIKWTAPEAINYG 194
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 195  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 249
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 250  ------QLMR------LCWKERPEDRPTFDYLRSVLE 274

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 45/291 (15%)
Query: 715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKR 773
           EEL SK      +K+++ +++D       F+    +G G FG VY A     + + A+K 
Sbjct: 15  EELASKQKNE-ESKKRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 774 LSG---DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLH 830
           L     +   +E + R EVE  S  +HPN++ L GY    +D   +Y  +E   L   ++
Sbjct: 67  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF---HDATRVYLILEYAPLGT-VY 122
Query: 831 EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG 890
            +L   S  D           A  L+Y H      ++HRDIK  N+LL       +ADFG
Sbjct: 123 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179
Query: 891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC 950
            +  + +P     T  L GTL Y+PPE  +  +   K D++S GV+  E L GK P +  
Sbjct: 180 WS--VHAPSSRRTT--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235
Query: 951 K-------------------PKGSRDLISWVIRMRQENRE--SEVLD-PFI 979
                                +G+RDLIS +++     R    EVL+ P+I
Sbjct: 236 TYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 35  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 94
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 155 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 211
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 212 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 113/238 (47%), Gaps = 23/238 (9%)
Query: 715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKR 773
           EEL SK      +K+++ +++D       F+    +G G FG VY A     + + A+K 
Sbjct: 15  EELASKQKNE-ESKKRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 774 LSG---DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLH 830
           L     +   +E + R EVE  S  +HPN++ L GY    +D   +Y  +E   L   ++
Sbjct: 67  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF---HDATRVYLILEYAPLGT-VY 122
Query: 831 EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG 890
            +L   S  D           A  L+Y H      ++HRDIK  N+LL       +ADFG
Sbjct: 123 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 179
Query: 891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            +  + +P  +    DL GTL Y+PPE  +  +   K D++S GV+  E L GK P +
Sbjct: 180 WS--VHAP--SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY        LI  +   G +    +++L   S  D           A  L+Y
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALSY 128
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPE 181
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 117/252 (46%), Gaps = 23/252 (9%)
Query: 715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKR 773
           EEL SK      +K+++ +++D       F+    +G G FG VY A     + + A+K 
Sbjct: 6   EELASKQKNE-ESKKRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKV 57
Query: 774 LSG---DCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLH 830
           L     +   +E + R EVE  S  +HPN++ L GY    +D   +Y  +E   L   ++
Sbjct: 58  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF---HDATRVYLILEYAPLGT-VY 113
Query: 831 EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG 890
            +L   S  D           A  L+Y H      ++HRDIK  N+LL       +ADFG
Sbjct: 114 RELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 170
Query: 891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC 950
            +  + +P     T  L GTL Y+PPE  +  +   K D++S GV+  E L GK P +  
Sbjct: 171 WS--VHAPSSRRTT--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226
Query: 951 KPKGSRDLISWV 962
             + +   IS V
Sbjct: 227 TYQETYKRISRV 238

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 37/266 (13%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +FD    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 70  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSRFDEQRTATYITELANAL 125
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL  N    +ADFG +  + +P     T  L GTL Y+P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT--LCGTLDYLP 178
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSR 956
           PE  +  +   K D++S GV+  E L G  P +                       +G+R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 957 DLISWVIRMRQENRES--EVLD-PFI 979
           DLIS +++     R +  EVL+ P+I
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 750 IGCGGFGLVYRAT----LP--DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A     LP  D   VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEK------LDG-----PSSLDWDSRLHIAQGAA 852
            G C      L+++ +M +G L+ +L         L G     P  L     L +A   A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ YL      H +HRD+ + N L+       + DFG++R I S     V    +  + 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           ++PPE       T + DV+SFGVVL E+ T GK+P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 750 IGCGGFGLVYRAT----LP--DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A     LP  D   VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEK------LDG-----PSSLDWDSRLHIAQGAA 852
            G C      L+++ +M +G L+ +L         L G     P  L     L +A   A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ YL      H +HRD+ + N L+       + DFG++R I S     V    +  + 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           ++PPE       T + DV+SFGVVL E+ T GK+P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 750 IGCGGFGLVYRAT----LP--DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G FG V+ A     LP  D   VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEK------LDG-----PSSLDWDSRLHIAQGAA 852
            G C      L+++ +M +G L+ +L         L G     P  L     L +A   A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ YL      H +HRD+ + N L+       + DFG++R I S     V    +  + 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           ++PPE       T + DV+SFGVVL E+ T GK+P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 35   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 93
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ YL  
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL-- 148
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-----THVTTDLVGTLGYIP 915
                  +HRD+ + N +LD  F   +ADFGLAR +   YD      H  T     + ++ 
Sbjct: 149  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEXXSVHNKTGAKLPVKWMA 204
Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
             E  Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     
Sbjct: 205  LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCP 262
Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            DP             + ++   C     ++RP+  +LVS + +I 
Sbjct: 263  DP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            +G G FG V+ AT      VA+K +      +E  F AE   +   QH  LV L    + 
Sbjct: 196  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 810  KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
            K    +I  FM  GSL  +L  K D  S       +  +   A G+A++ Q    + +HR
Sbjct: 254  KEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 870  DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVATY 926
            D++++NIL+  +    +ADFGLAR+I    + +  T   G    + +  PE       T 
Sbjct: 309  DLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 927  KGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
            K DV+SFG++L+E++T G+ P   M  P+  R L       R EN   E           
Sbjct: 365  KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE----------- 413
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  + +I   C    P+ RPT + + S LD
Sbjct: 414  ------LYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 27   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 84   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 135
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 136  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 191
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 192  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 246
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 247  ------QLMR------LCWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 31   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 87
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 88   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 139
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 140  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 195
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 196  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 250
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 251  ------QLMR------LCWKERPEDRPTFDYLRSVLE 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 21   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 78   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 130  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 186  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 240
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 241  ------QLMR------LCWKERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 16   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 72
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 73   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 124
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 125  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 180
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 181  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 235
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 236  ------QLMR------LCWKERPEDRPTFDYLRSVLE 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 26   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 82
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 83   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 134
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HRD++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 135  YIHRDLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 190
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 191  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 245
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 246  ------QLMR------LCWKERPEDRPTFDYLRSVLE 270

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DG--RNVAIKRLSGDCGQME-REFRAEVEALSR-AQ 796
           N+    ++IG G FG V +A +  DG   + AIKR+     + + R+F  E+E L +   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKL-----------DGPSSLDWDSR 844
           HPN+++L G C H+    L   +  +G+L D+    ++              S+L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           LH A   ARG+ YL Q      +HRD+ + NIL+  N+ A +ADFGL+R      + +V 
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 197
Query: 905 TDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLT 942
                T+G +P  +        SV T   DV+S+GV+L E+++
Sbjct: 198 K----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DG--RNVAIKRLSGDCGQME-REFRAEVEALSR-AQ 796
           N+    ++IG G FG V +A +  DG   + AIKR+     + + R+F  E+E L +   
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKL-----------DGPSSLDWDSR 844
           HPN+++L G C H+    L   +  +G+L D+    ++              S+L     
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           LH A   ARG+ YL Q      +HRD+ + NIL+  N+ A +ADFGL+R      + +V 
Sbjct: 135 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK 187
Query: 905 TDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLT 942
                T+G +P  +        SV T   DV+S+GV+L E+++
Sbjct: 188 K----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 71  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 126
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPE 179
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 73  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 128
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPE 181
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 37/264 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 68  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 123
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPE 176
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSRDL 958
             +  +   K D++S GV+  E L GK P +                       +G+RDL
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 236
Query: 959 ISWVIRMRQENRE--SEVLD-PFI 979
           IS +++     R    EVL+ P+I
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 84/274 (30%), Positives = 125/274 (45%), Gaps = 35/274 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+ AT      VA+K +    G M  E F AE   +   QH  LV L    +
Sbjct: 23   LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 79
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             K    +I  FM  GSL  +L  K D  S       +  +   A G+A++ Q    + +H
Sbjct: 80   TKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
            RD++++NIL+  +    +ADFGLAR+I    + +  T   G    + +  PE       T
Sbjct: 135  RDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 926  YKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
             K DV+SFG++L+E++T G+ P   M  P+  R L       R EN   E+ +       
Sbjct: 191  IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI------ 244
Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                M+R       C    P+ RPT + + S LD
Sbjct: 245  ----MMR-------CWKNRPEERPTFEYIQSVLD 267

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 101/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L   C  Q 
Sbjct: 18  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD 77
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+A+ I
Sbjct: 138 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI 194
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 195 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 37   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 95
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 150
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 151  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 210  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 266
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 267  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 65  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 120
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+P
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLP 173
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 34   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 92
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 147
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 148  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 207  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 263
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 264  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 41   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 99
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 100  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 154
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 155  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 214  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 270
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 271  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 300

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 36   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 94
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 149
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 150  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 209  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 265
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 266  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 124
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLP 177
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 124
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +    DL GTL Y+P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRDDLCGTLDYLP 177
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 746 QANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
              ++G G FG   + T  + G  + +K L     + +R F  EV+ +   +HPN++   
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 805 GYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           G  ++K+ RL  I  +++ G+L   + + +D  S   W  R+  A+  A G+AYLH    
Sbjct: 74  G-VLYKDKRLNFITEYIKGGTLRGII-KSMD--SQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLI------------LSPYDTHVTTDLVGTL 911
            +I+HRD+ S N L+  N    +ADFGLARL+            L   D      +VG  
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELL 941
            ++ PE         K DV+SFG+VL E++
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 36   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 94
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 149
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 150  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 209  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 265
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 266  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 748  NIIGCGGFGLVYRATL--PDGRNV--AIKRLS--GDCGQMEREFRAEVEALSRAQHPNLV 801
             +IG G FG VY  TL   DG+ +  A+K L+   D G++  +F  E   +    HPN++
Sbjct: 95   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVL 153
Query: 802  HLQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             L G C+  +   L++  +M++G L  ++  +   P+  D    +      A+G+ +L  
Sbjct: 154  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL-- 208
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSPYDT-HVTTDLVGTLGYIPPEY 918
                  +HRD+ + N +LD  F   +ADFGLAR +    +D+ H  T     + ++  E 
Sbjct: 209  -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             Q    T K DV+SFGV+L EL+T   P        + D+  ++++ R+  +     DP 
Sbjct: 268  LQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDP- 324
Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                        + ++   C     ++RP+  +LVS + +I 
Sbjct: 325  ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIF 354

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 37/266 (13%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +FD    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 10  TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 70  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSRFDEQRTATYITELANAL 125
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL  N    +ADFG +  + +P     T  L GTL Y+P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT--LCGTLDYLP 178
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSR 956
           PE  +  +   K D++S GV+  E L G  P +                       +G+R
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGAR 238
Query: 957 DLISWVIRMRQENRES--EVLD-PFI 979
           DLIS +++     R +  EVL+ P+I
Sbjct: 239 DLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 70  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 125
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+P
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLP 178
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +   T L GTL Y+P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRTXLCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 21/241 (8%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRLSGDCG-QMEREFRAEVE 790
           IL+ T    +  ++G G FG VY+   +P+G  V    AIK L+   G +   EF  E  
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   HP+LV L G C+    +L +   M +G L  ++HE  D   S   L+W  ++  
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 149
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    E  ++HRD+ + N+L+       + DFGLARL+      +     
Sbjct: 150 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR 966
              + ++  E       T++ DV+S+GV + EL+T G +P D    +   DL+    R+ 
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 262
Query: 967 Q 967
           Q
Sbjct: 263 Q 263

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 21/241 (8%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRLSGDCG-QMEREFRAEVE 790
           IL+ T    +  ++G G FG VY+   +P+G  V    AIK L+   G +   EF  E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   HP+LV L G C+    +L +   M +G L  ++HE  D   S   L+W  ++  
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    E  ++HRD+ + N+L+       + DFGLARL+      +     
Sbjct: 127 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR 966
              + ++  E       T++ DV+S+GV + EL+T G +P D    +   DL+    R+ 
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 239
Query: 967 Q 967
           Q
Sbjct: 240 Q 240

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 117/264 (44%), Gaps = 37/264 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 73  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 128
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPE 181
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSRDL 958
             +      K D++S GV+  E L GK P +                       +G+RDL
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 959 ISWVIRMRQENRES--EVLD-PFI 979
           IS +++     R    EVL+ P+I
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 63  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 118
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+P
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLP 171
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 69  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 124
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P     T  L GTL Y+PPE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPPE 177
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 84/277 (30%), Positives = 130/277 (46%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 17   LGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 73
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 74   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 125
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQAS 922
             +HR+++++NIL+       +ADFGLARLI    + +  T   G    + +  PE     
Sbjct: 126  YIHRNLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYG 181
Query: 923  VATYKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
              T K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+      
Sbjct: 182  TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY----- 236
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  +++R      LC  E P+ RPT   L S L+
Sbjct: 237  ------QLMR------LCWKERPEDRPTFDYLRSVLE 261

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DG--RNVAIKRLSGDCGQME-REFRAEVEALSR-AQ 796
           N+    ++IG G FG V +A +  DG   + AIKR+     + + R+F  E+E L +   
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKL-----------DGPSSLDWDSR 844
           HPN+++L G C H+    L   +  +G+L D+    ++              S+L     
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           LH A   ARG+ YL Q      +HR++ + NIL+  N+ A +ADFGL+R      + +V 
Sbjct: 142 LHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK 194
Query: 905 TDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLT 942
                T+G +P  +        SV T   DV+S+GV+L E+++
Sbjct: 195 K----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 70  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 125
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +A+FG +  + +P     T  L GTL Y+PPE
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--LCGTLDYLPPE 178
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV 962
             +  +   K D++S GV+  E L GK P +    + +   IS V
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY        LI  +   G +    +++L   S  D           A  L+Y
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELANALSY 128
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P  +     L GTL Y+PPE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRXXLXGTLDYLPPE 181
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 37/266 (13%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A   + + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDSTRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P        L GTL Y+P
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA--LCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPM------DMCK-------------PKGSR 956
           PE  +  +   K D++S GV+  E L GK P       D  K              +G+R
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGAR 234
Query: 957 DLISWVIRMRQENRE--SEVLD-PFI 979
           DLIS +++     R    EVL+ P+I
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 70  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 125
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P  +     L GTL Y+PPE
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRXXLCGTLDYLPPE 178
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 117/264 (44%), Gaps = 37/264 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 69  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 124
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +    +P     T  L GTL Y+PPE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--LSGTLDYLPPE 177
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSRDL 958
             +  +   K D++S GV+  E L GK P +                       +G+RDL
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237
Query: 959 ISWVIRMRQENRE--SEVLD-PFI 979
           IS +++     R    EVL+ P+I
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 71  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 126
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +A+FG +  + +P     T  L GTL Y+PPE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--LCGTLDYLPPE 179
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             +  +   K D++S GV+  E L GK P +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 117/264 (44%), Gaps = 37/264 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRAQH 797
            +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  +H
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           PN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L+Y
Sbjct: 71  PNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANALSY 126
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H      ++HRDIK  N+LL       +ADFG +  + +P        L GTL Y+PPE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA--LCGTLDYLPPE 179
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKGSRDL 958
             +  +   K D++S GV+  E L GK P +                       +G+RDL
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 959 ISWVIRMRQENRE--SEVLD-PFI 979
           IS +++     R    EVL+ P+I
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P        L GTL Y+P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAA--LCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 118/273 (43%), Gaps = 43/273 (15%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            +G G FG V+ AT      VA+K +      +E  F AE   +   QH  LV L    + 
Sbjct: 190  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 810  KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
            K    +I  FM  GSL  +L  K D  S       +  +   A G+A++ Q    + +HR
Sbjct: 248  KEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 302
Query: 870  DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVATY 926
            D++++NIL+  +    +ADFGLAR              VG    + +  PE       T 
Sbjct: 303  DLRAANILVSASLVCKIADFGLAR--------------VGAKFPIKWTAPEAINFGSFTI 348
Query: 927  KGDVYSFGVVLLELLT-GKRPMD-MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
            K DV+SFG++L+E++T G+ P   M  P+  R L       R EN   E           
Sbjct: 349  KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE----------- 397
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                  + +I   C    P+ RPT + + S LD
Sbjct: 398  ------LYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 35/274 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G  G V+         VA+K L    G M  + F AE   + + QH  LV L    +
Sbjct: 21   LGAGQAGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 809  HKNDRLLIYSFMENGSL-DYWLHEKLDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             +    +I  +MENGSL D+     L  PS   L  +  L +A   A G+A++    E +
Sbjct: 78   TQEPIYIITEYMENGSLVDF-----LKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
             +HRD++++NIL+       +ADFGLARLI     T         + +  PE       T
Sbjct: 130  YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTFT 188
Query: 926  YKGDVYSFGVVLLELLT-GKRPM-DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
             K DV+SFG++L E++T G+ P   M  P+  ++L      +R +N   E+         
Sbjct: 189  IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-------- 240
Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
               +++R      LC  E P+ RPT   L S L+
Sbjct: 241  ---QLMR------LCWKERPEDRPTFDYLRSVLE 265

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L D R+VA+K L  D  +       FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMEN----GSLDYWLHEKLDGPSSLDW---------DS 843
           HP +V              +Y   E     G L Y + E +DG +  D            
Sbjct: 71  HPAIV-------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTH 902
            + +   A + L + HQ+    I+HRD+K +NIL+       + DFG+AR I  S     
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 69  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 124
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +     L GTL Y+P
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRXXLCGTLDYLP 177
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSG---DCGQMEREFRAEVEALSRA 795
           +  +F+    +G G FG VY A     + + A+K L     +   +E + R EVE  S  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN++ L GY    +D   +Y  +E   L   ++ +L   S  D           A  L
Sbjct: 66  RHPNILRLYGYF---HDATRVYLILEYAPLGT-VYRELQKLSKFDEQRTATYITELANAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           +Y H      ++HRDIK  N+LL       +ADFG +  + +P  +     L GTL Y+P
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAP--SSRRXXLCGTLDYLP 174
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  +  +   K D++S GV+  E L GK P +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 116/258 (44%), Gaps = 13/258 (5%)
Query: 766  GRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMEN 822
            G  VA+K L  DCG   R  ++ E++ L    H +++  +G C  + ++   L+  ++  
Sbjct: 43   GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 823  GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
            GSL  +L     G + L     L  AQ    G+AYLH     H +HR++ + N+LLD + 
Sbjct: 103  GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDR 154
Query: 883  GAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
               + DFGLA+ +   ++ + V  D    + +  PE  +     Y  DV+SFGV L ELL
Sbjct: 155  LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 942  TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE 1001
            T         P    +LI          R +E+L+      + DK    V  +   C   
Sbjct: 215  T-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWET 273
Query: 1002 SPKVRPTTQQLVSWLDSI 1019
                RPT + L+  L ++
Sbjct: 274  EASFRPTFENLIPILKTV 291

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 100/227 (44%), Gaps = 17/227 (7%)
Query: 730 KEISIDDILE-STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QM 781
           K  SI D+ E    N      +G G FG VY   +      P    VA+K L      Q 
Sbjct: 32  KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQD 91
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSS 838
           E +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   PSS
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI 895
           L     LH+A+  A G  YL ++   H +HRDI + N LL        A + DFG+AR I
Sbjct: 152 LAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
                       +  + ++PPE     + T K D +SFGV+L E+ +
Sbjct: 209 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 116/258 (44%), Gaps = 13/258 (5%)
Query: 766  GRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMEN 822
            G  VA+K L  DCG   R  ++ E++ L    H +++  +G C  + ++   L+  ++  
Sbjct: 43   GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 823  GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
            GSL  +L     G + L     L  AQ    G+AYLH     H +HR++ + N+LLD + 
Sbjct: 103  GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDR 154
Query: 883  GAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
               + DFGLA+ +   ++ + V  D    + +  PE  +     Y  DV+SFGV L ELL
Sbjct: 155  LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 942  TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE 1001
            T         P    +LI          R +E+L+      + DK    V  +   C   
Sbjct: 215  T-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWET 273
Query: 1002 SPKVRPTTQQLVSWLDSI 1019
                RPT + L+  L ++
Sbjct: 274  EASFRPTFENLIPILKTV 291

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 15/226 (6%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER 783
           ++ +  EI  D +L   +++D    +G G FG+V+R T    G N A K +       + 
Sbjct: 143 YYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 784 EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
             R E++ +S  +HP LV+L       N+ ++IY FM  G L     +  D  + +  D 
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDE 256
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLARLILSPYDT 901
            +   +   +GL ++H++   + +H D+K  NI+        L   DFGL   +      
Sbjct: 257 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            VTT   GT  +  PE  +     Y  D++S GV+   LL+G  P 
Sbjct: 314 KVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 15/220 (6%)
Query: 731 EISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEV 789
           EI  D +L   +++D    +G G FG+V+R T    G N A K +       +   R E+
Sbjct: 43  EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 99
Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
           + +S  +HP LV+L       N+ ++IY FM  G L     +  D  + +  D  +   +
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMR 156
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLARLILSPYDTHVTTDL 907
              +GL ++H++   + +H D+K  NI+        L   DFGL   +       VTT  
Sbjct: 157 QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 211
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GT  +  PE  +     Y  D++S GV+   LL+G  P 
Sbjct: 212 -GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 37/292 (12%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 38   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGP------SSLDWDSRLHI 847
              QH N+V+L G C H    L+I  +   G L  +L  K +          L+    LH 
Sbjct: 98   LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 848  AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR I++  +  V  + 
Sbjct: 158  SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT---GKRPMDMCKPKGSRDLISWVIR 964
               + ++ PE     V T + DV+S+G++L E+ +      P  +   K  + L+    +
Sbjct: 215  RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-LVKDGYQ 273
Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            M Q         P    K        +  I   C +  P  RPT QQ+ S+L
Sbjct: 274  MAQ---------PAFAPKN-------IYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L D R+VA+K L  D  +       FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMEN----GSLDYWLHEKLDGPSSLDW---------DS 843
           HP +V              +Y   E     G L Y + E +DG +  D            
Sbjct: 71  HPAIV-------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTH 902
            + +   A + L + HQ+    I+HRD+K +NI++       + DFG+AR I  S     
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L D R+VA+K L  D  +       FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMEN----GSLDYWLHEKLDGPSSLDW---------DS 843
           HP +V              +Y   E     G L Y + E +DG +  D            
Sbjct: 71  HPAIV-------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTH 902
            + +   A + L + HQ+    I+HRD+K +NI++       + DFG+AR I  S     
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 11/239 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 870 DIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+ + N L++      ++DFGL+R +L   Y + V +     + + PPE    S  + K 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKS 202
Query: 929 DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
           D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 15/241 (6%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 91  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 144
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVATY 926
           D+ + N L++      ++DFGL+R +L   +T      VG+   + + PPE    S  + 
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS----VGSKFPVRWSPPEVLMYSKFSS 200
Query: 927 KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
           K D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 260
Query: 986 K 986
           K
Sbjct: 261 K 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
           NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 795 -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGP------SSLDWDSRLHI 847
             QH N+V+L G C H    L+I  +   G L  +L  K +          L+    LH 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
           +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR I++  +  V  + 
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
              + ++ PE     V T + DV+S+G++L E+ +
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 50/291 (17%)
Query: 743  NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            +F +  +IG GGFG V++A    DG+   IKR+  +  + ERE    V+AL++  H N+V
Sbjct: 12   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 802  HLQG---------------YCMHKNDRLLI-YSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
            H  G                   K   L I   F + G+L+ W+ EK  G   LD    L
Sbjct: 68   HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRG-EKLDKVLAL 125
Query: 846  HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
             + +   +G+ Y+H      +++RD+K SNI L       + DFGL   + S  +     
Sbjct: 126  ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL---VTSLKNDGKRX 179
Query: 906  DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
               GTL Y+ PE   +     + D+Y+ G++L ELL       +C      D      + 
Sbjct: 180  RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC------DTAFETSKF 227
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
              + R+  + D  I+DK+ +K +L+ L      LS+ P+ RP T +++  L
Sbjct: 228  FTDLRDGIISD--IFDKK-EKTLLQKL------LSKKPEDRPNTSEILRTL 269

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 85/304 (27%), Positives = 137/304 (45%), Gaps = 63/304 (20%)
Query: 743  NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            +F +  +IG GGFG V++A    DG+   I+R+  +  + ERE    V+AL++  H N+V
Sbjct: 13   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 802  HLQG------YCMHKNDRLLIYS-----------------------FMENGSLDYWLHEK 832
            H  G      Y    +D  L  S                       F + G+L+ W+ EK
Sbjct: 69   HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 833  LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA 892
              G   LD    L + +   +G+ Y+H      ++HRD+K SNI L       + DFG  
Sbjct: 128  RRG-EKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG-- 181
Query: 893  RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
             L+ S  +    T   GTL Y+ PE   +     + D+Y+ G++L ELL       +C  
Sbjct: 182  -LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL------HVC-- 232
Query: 953  KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                D      +   + R+  + D  I+DK+ +K +L+ L      LS+ P+ RP T ++
Sbjct: 233  ----DTAFETSKFFTDLRDGIISD--IFDKK-EKTLLQKL------LSKKPEDRPNTSEI 279
Query: 1013 VSWL 1016
            +  L
Sbjct: 280  LRTL 283

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +H
Sbjct: 249  SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 411
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 412  -------DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +H
Sbjct: 249  SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 411
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 412  -------DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 50/305 (16%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 31   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD---GPS------------- 837
              QH N+V+L G C H    L+I  +   G L  +L  K +   GPS             
Sbjct: 91   LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 838  ---SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                L+    LH +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR 
Sbjct: 151  DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT---GKRPMDMCK 951
            I++  +  V  +    + ++ PE     V T + DV+S+G++L E+ +      P  +  
Sbjct: 208  IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 267
Query: 952  PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
             K  + L+    +M Q         P    K        +  I   C +  P  RPT QQ
Sbjct: 268  SKFYK-LVKDGYQMAQ---------PAFAPKN-------IYSIMQACWALEPTHRPTFQQ 310
Query: 1012 LVSWL 1016
            + S+L
Sbjct: 311  ICSFL 315

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 11/239 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 82  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 135
Query: 870 DIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+ + N L++      ++DFGL+R +L   Y + V +     + + PPE    S  + K 
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKS 193
Query: 929 DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
           D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 252

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 11/239 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 75  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 128
Query: 870 DIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+ + N L++      ++DFGL+R +L   Y + V +     + + PPE    S  + K 
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKS 186
Query: 929 DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
           D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 245

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 11/239 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 870 DIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+ + N L++      ++DFGL+R +L   Y + V +     + + PPE    S  + K 
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKS 187
Query: 929 DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
           D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 246

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 11/239 (4%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 71  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 124
Query: 870 DIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+ + N L++      ++DFGL+R +L   Y + V +     + + PPE    S  + K 
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKS 182
Query: 929 DVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
           D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +H
Sbjct: 332  SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 387  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 444  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 494
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 495  -------DLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 738 LESTNNFDQANIIGCGGFG-LVYRATLPDGRNVAIKRL--SGDCGQMEREFRAEVEALSR 794
            +S   + +   IG G FG  +   +  DGR   IK +  S    +   E R EV  L+ 
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK----LDGPSSLDWDSRLHIAQG 850
            +HPN+V  +          ++  + E G L   ++ +          LDW  ++ +A  
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA-- 137
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
               L ++H   +  ILHRDIKS NI L  +    L DFG+AR++ S     +    +GT
Sbjct: 138 ----LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
             Y+ PE  +      K D+++ G VL EL T K   +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 128/296 (43%), Gaps = 41/296 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK----------LDGPSSLDWDS 843
              QH N+V+L G C H    L+I  +   G L  +L  K              S+L    
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
             LH +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR I++  +  V
Sbjct: 166  LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 904  TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT---GKRPMDMCKPKGSRDLIS 960
              +    + ++ PE     V T + DV+S+G++L E+ +      P  +   K  + L+ 
Sbjct: 223  KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-LVK 281
Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
               +M Q         P    K        +  I   C +  P  RPT QQ+ S+L
Sbjct: 282  DGYQMAQ---------PAFAPKN-------IYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 34/227 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
            +F+    +G GGFG+V+ A    D  N AIKR+     ++ RE    EV+AL++ +HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 800 LVHLQGYCMHKND---------RLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSR--- 844
           +V      + KN          ++ +Y  M+     +L  W+    +G  +++   R   
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM----NGRCTIEERERSVC 120
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA---------RLI 895
           LHI    A  + +LH      ++HRD+K SNI    +    + DFGL          + +
Sbjct: 121 LHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 896 LSPYDTHVT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
           L+P   +   T  VGT  Y+ PE    +  ++K D++S G++L ELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 12/181 (6%)
Query: 766 GRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMEN 822
           G  VA+K L   CG Q+   ++ E+E L    H ++V  +G C  + ++   L+  ++  
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
           GSL  +L     G + L     L  AQ    G+AYLH     H +HR + + N+LLD + 
Sbjct: 97  GSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDR 148
Query: 883 GAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
              + DFGLA+ +   ++ + V  D    + +  PE  +     Y  DV+SFGV L ELL
Sbjct: 149 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 942 T 942
           T
Sbjct: 209 T 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 12/181 (6%)
Query: 766 GRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMEN 822
           G  VA+K L   CG Q+   ++ E+E L    H ++V  +G C  + ++   L+  ++  
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
           GSL  +L     G + L     L  AQ    G+AYLH     H +HR + + N+LLD + 
Sbjct: 98  GSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDR 149
Query: 883 GAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
              + DFGLA+ +   ++ + V  D    + +  PE  +     Y  DV+SFGV L ELL
Sbjct: 150 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 942 T 942
           T
Sbjct: 210 T 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +H
Sbjct: 249  SEEPIYIVGEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 304  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 411
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 412  -------DLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 79/278 (28%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+     +   VA+K L    G M  + F  E   +   QH  LV L     
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDG----PSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             +    +I  FM  GSL  +L     G    P  +D+ +++      A G+AY+ +    
Sbjct: 78   KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERK--- 128
Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQA 921
            + +HRD++++N+L+  +    +ADFGLAR+I    + +  T   G    + +  PE    
Sbjct: 129  NYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINF 184
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM-RQENRESEVLDPFI 979
               T K +V+SFG++L E++T GK P            +S   RM R EN   E      
Sbjct: 185  GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDE------ 238
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                       + DI  +C  E  + RPT   L S LD
Sbjct: 239  -----------LYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 38/225 (16%)
Query: 748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR--AQHPNLVHLQG 805
            I   G FG V++A L +   VA+K       Q ++ +++E E  S    +H NL  LQ 
Sbjct: 21  EIKARGRFGCVWKAQLMND-FVAVKIFPL---QDKQSWQSEREIFSTPGMKHENL--LQF 74
Query: 806 YCMHKN------DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
               K       +  LI +F + GSL  +L   +     + W+   H+A+  +RGL+YLH
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLH 129
Query: 860 QSC--------EPHILHRDIKSSNILLDGNFGAHLADFGLARLI---LSPYDTHVTTDLV 908
           +          +P I HRD KS N+LL  +  A LADFGLA        P DTH     V
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH---GQV 186
Query: 909 GTLGYIPPEYGQASV-----ATYKGDVYSFGVVLLELLTGKRPMD 948
           GT  Y+ PE  + ++     A  + D+Y+ G+VL EL++  +  D
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 79/278 (28%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+     +   VA+K L    G M  + F  E   +   QH  LV L     
Sbjct: 21   LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDG----PSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             +    +I  +M  GSL  +L     G    P  +D+ +++      A G+AY+ +    
Sbjct: 79   REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERK--- 129
Query: 865  HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQA 921
            + +HRD++++N+L+  +    +ADFGLAR+I    + +  T   G    + +  PE    
Sbjct: 130  NYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINF 185
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM-RQENRESEVLDPFI 979
               T K DV+SFG++L E++T GK P            +S   RM R EN   E      
Sbjct: 186  GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDE------ 239
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                       + DI  +C  E  + RPT   L S LD
Sbjct: 240  -----------LYDIMKMCWKEKAEERPTFDYLQSVLD 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 37/299 (12%)
Query: 738  LESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKR-LSGDCGQMEREFRA-EVEALSR 794
             +S   ++   ++G G +G+V +    D GR VAIK+ L  D  +M ++    E++ L +
Sbjct: 21   FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAAR 853
             +H NLV+L   C  K    L++ F+++  LD      L+  P+ LD+            
Sbjct: 81   LRHENLVNLLEVCKKKKRWYLVFEFVDHTILD-----DLELFPNGLDYQVVQKYLFQIIN 135
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+ + H     +I+HRDIK  NIL+  +    L DFG AR + +P +  V  D V T  Y
Sbjct: 136  GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWY 190
Query: 914  IPPEYGQASVATYKG-DVYSFGVVLLELLTGKR--PMD----------MCKPKGSRDLIS 960
              PE     V   K  DV++ G ++ E+  G+   P D          MC      +LI 
Sbjct: 191  RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG----NLIP 246
Query: 961  WVIRMRQEN------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                +  +N      R  E+ +    ++++ K    V+D+A  CL   P  RP   +L+
Sbjct: 247  RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 744  FDQANIIGCGGFGLVYRATLPDGRNV-AIKRLS-GDCGQMEREFRAEVEALSRAQHPNLV 801
            F + + IG G FG VY+      + V AIK +   +      + + E+  LS+   P + 
Sbjct: 21   FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 802  HLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
               G  +      +I  ++  GS LD      L  P  L+      I +   +GL YLH 
Sbjct: 81   RYFGSYLKSTKLWIIMEYLGGGSALD------LLKPGPLEETYIATILREILKGLDYLHS 134
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYG 919
              +   +HRDIK++N+LL       LADFG+A  +    DT +  +  VGT  ++ PE  
Sbjct: 135  ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNXFVGTPFWMAPEVI 188
Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
            + S   +K D++S G+  +EL  G+ P     P         V+ +  +N       P  
Sbjct: 189  KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKN------SPPT 235
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             + QH K     ++    CL++ P+ RPT ++L+ 
Sbjct: 236  LEGQHSKPFKEFVEA---CLNKDPRFRPTAKELLK 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 11/221 (4%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+     T H        + +  PE    +  + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 928 GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            DV++FGV+L E+ T G  P     P    +L+    RM +
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 743 NFDQANI---IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER-EFR---AEVEALSRA 795
           NFD   I   IG G FG V      D + +   +       +ER E R    E++ +   
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HP LV+L      + D  ++   +  G L Y L + +          +L I +     L
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICE-LVMAL 128
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YL       I+HRD+K  NILLD +   H+ DF +A ++  P +T +TT + GT  Y+ 
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML--PRETQITT-MAGTKPYMA 182
Query: 916 PEY---GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI 959
           PE     + +  ++  D +S GV   ELL G+RP  +     S++++
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 81/274 (29%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 16   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +
Sbjct: 72   VSEEPIXIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 126
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVA 924
            HRD++++NIL+  N    +ADFGLARLI    + +  T   G    + +  PE       
Sbjct: 127  HRDLRAANILVGENLVCKVADFGLARLI----EDNEXTARQGAKFPIKWTAPEAALYGRF 182
Query: 925  TYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
            T K DV+SFG++L EL T G+ P      +   D +    RM       E L        
Sbjct: 183  TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------- 235
Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                     D+ C C  + P+ RPT + L ++L+
Sbjct: 236  ---------DLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +H
Sbjct: 83   SEEPIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
            RD++++NIL+  N    +ADFGLARLI    + +  T   G    + +  PE       T
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLI----EDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 194  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 245
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 246  --------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 249
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +H
Sbjct: 250  SEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVH 304
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGL RLI    D   T        + +  PE       T 
Sbjct: 305  RDLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 362  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 412
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 413  -------DLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 82   VSEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 194  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 245
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 246  --------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 81/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 19   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  K +    L     + +A   A G+AY+ +    + +
Sbjct: 75   VSEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 129
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 130  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 187  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 238
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 239  --------DLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 131/300 (43%), Gaps = 47/300 (15%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD----------- 842
              QH N+V+L G C H    L+I  +   G L  +L  K   P  L++            
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKR--PPGLEYSYNPSHNPEEQL 163
Query: 843  -SR--LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
             SR  LH +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR I++  
Sbjct: 164  SSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT---GKRPMDMCKPKGSR 956
            +  V  +    + ++ PE     V T + DV+S+G++L E+ +      P  +   K  +
Sbjct: 221  NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 280
Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
             L+    +M Q         P    K        +  I   C +  P  RPT QQ+ S+L
Sbjct: 281  -LVKDGYQMAQ---------PAFAPKN-------IYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 15   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 71   VSEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 125
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 126  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 183  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 234
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 235  --------DLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 17   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 73   VSEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 127
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 128  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 185  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 236
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 237  --------DLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 80/273 (29%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 82   VSEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 194  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 245
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 246  --------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 78/272 (28%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +H
Sbjct: 83   SEEPIYIVIEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 195  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 245
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 246  -------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  F+  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 134
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 135 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 189
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L   R+VA+K L  D  +       FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW---------DSRLHI 847
           HP +V +  Y   + +          G L Y + E +DG +  D             + +
Sbjct: 71  HPAIVAV--YATGEAE-------TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTD 906
              A + L + HQ+    I+HRD+K +NI++       + DFG+AR I  S      T  
Sbjct: 122 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 74/262 (28%), Positives = 114/262 (43%), Gaps = 27/262 (10%)
Query: 750  IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 40   LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 99   LEPPFYIVTEYMPYGNLLDYLREC--NREEVTAVVLLYMATQISSAMEYLEKK---NFIH 153
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
            RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 154  RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNTFSIK 211
Query: 928  GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
             DV++FGV+L E+ T G  P          DL+    RM Q     E   P +Y      
Sbjct: 212  SDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQ----PEGCPPKVY------ 261
Query: 987  EMLRVLDIACLCLSESPKVRPT 1008
            E++R       C   SP  RP+
Sbjct: 262  ELMRA------CWKWSPADRPS 277

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 72/258 (27%), Positives = 112/258 (43%), Gaps = 13/258 (5%)
Query: 766  GRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCMHKN--DRLLIYSFMEN 822
            G  VA+K L  D G   R  ++ E++ L    H +++  +G C         L+  ++  
Sbjct: 60   GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 823  GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF 882
            GSL  +L     G + L     L  AQ    G+AYLH     H +HRD+ + N+LLD + 
Sbjct: 120  GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDR 171
Query: 883  GAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
               + DFGLA+ +   ++ + V  D    + +  PE  +     Y  DV+SFGV L ELL
Sbjct: 172  LVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 942  TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE 1001
            T         P    +LI          R +E+L+      + DK    V  +   C   
Sbjct: 232  T-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWET 290
Query: 1002 SPKVRPTTQQLVSWLDSI 1019
                RPT + L+  L ++
Sbjct: 291  EASFRPTFENLIPILKTV 308

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 11/221 (4%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    +  H        + +  PE    +  + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 928 GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            DV++FGV+L E+ T G  P     P    +L+    RM +
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 78/272 (28%), Positives = 120/272 (44%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +H
Sbjct: 83   SEEPIYIVCEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 195  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 245
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 246  -------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 82/277 (29%), Positives = 124/277 (44%), Gaps = 41/277 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 809  HKNDRLLIYS-FMENGSL-DYWLHEK---LDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
               + + I + +M  GSL D+   E    L  P  +D  +++      A G+AY+ +   
Sbjct: 79   VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI------ASGMAYVERM-- 130
Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQA 921
             + +HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE    
Sbjct: 131  -NYVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALY 186
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               T K DV+SFG++L EL T G+ P      +   D +    RM       E L     
Sbjct: 187  GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH---- 242
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                        D+ C C  + P+ RPT + L ++L+
Sbjct: 243  ------------DLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 11/221 (4%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 132
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+     T H        + +  PE    +  + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 190
Query: 928 GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            DV++FGV+L E+ T G  P     P    +L+    RM +
Sbjct: 191 SDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER 231

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L   R+VA+K L  D  +       FR E +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMEN----GSLDYWLHEKLDGPSSLDW---------DS 843
           HP +V              +Y   E     G L Y + E +DG +  D            
Sbjct: 88  HPAIV-------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 134
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTH 902
            + +   A + L + HQ+    I+HRD+K +NI++       + DFG+AR I  S     
Sbjct: 135 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 93  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 147
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 205
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 84  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 138
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 196
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 194
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 127/296 (42%), Gaps = 41/296 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGR-----NVAIKRLSGDCGQMERE-FRAEVEALSR 794
            NN      +G G FG V  AT    G+      VA+K L       E+E   +E++ +S 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK----------LDGPSSLDWDS 843
              QH N+V+L G C H    L+I  +   G L  +L  K              S+     
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
             LH +   A+G+A+L      + +HRD+ + N+LL     A + DFGLAR I++  +  V
Sbjct: 166  LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 904  TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT---GKRPMDMCKPKGSRDLIS 960
              +    + ++ PE     V T + DV+S+G++L E+ +      P  +   K  + L+ 
Sbjct: 223  KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-LVK 281
Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
               +M Q         P    K        +  I   C +  P  RPT QQ+ S+L
Sbjct: 282  DGYQMAQ---------PAFAPKN-------IYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 110/256 (42%), Gaps = 38/256 (14%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRLSGDCGQMERE-----FRAEVEALS 793
           + ++F+    +G G FG VY A        VA+K L     Q+E+E      R E+E  +
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFK--SQIEKEGVEHQLRREIEIQA 78
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
              HPN++ L  Y   +    LI  +   G L    +++L    + D      I +  A 
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIMEELAD 134
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L Y H      ++HRDIK  N+LL       +ADFG +  + +P     T  + GTL Y
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDY 187
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK-------------------PKG 954
           +PPE  +  +   K D++  GV+  ELL G  P +                      P G
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG 247
Query: 955 SRDLISWVIRMRQENR 970
           ++DLIS ++R     R
Sbjct: 248 AQDLISKLLRHNPSER 263

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 73/271 (26%), Positives = 110/271 (40%), Gaps = 53/271 (19%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMERE--- 784
           +++ +IDD       FD    +G G FG VY A     + + A+K L     Q+E+E   
Sbjct: 8   KRKFTIDD-------FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVE 58
Query: 785 --FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
              R E+E  S  +HPN++ +  Y   +    L+  F   G L    +++L      D  
Sbjct: 59  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQ 114
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
                 +  A  L Y H   E  ++HRDIK  N+L+       +ADFG        +  H
Sbjct: 115 RSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG--------WSVH 163
Query: 903 VTT----DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK------- 951
             +     + GTL Y+PPE  +      K D++  GV+  E L G  P D          
Sbjct: 164 APSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223
Query: 952 ------------PKGSRDLISWVIRMRQENR 970
                         GS+DLIS ++R     R
Sbjct: 224 IVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
           ++ ++   I+G GG   V+ A  L   R+VA+K L  D  +       FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMEN----GSLDYWLHEKLDGPSSLDW---------DS 843
           HP +V              +Y   E     G L Y + E +DG +  D            
Sbjct: 71  HPAIV-------------AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTH 902
            + +   A + L + HQ+    I+HRD+K +NI++       + DFG+AR I  S     
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++GT  Y+ PE  +      + DVYS G VL E+LTG+ P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 15/214 (7%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSR 794
           + S++ F Q   +G G +  VY+      G  VA+K  +L  + G      R E+  +  
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKE 59
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQGAA 852
            +H N+V L      +N   L++ FM+N  L  ++  +  G  P  L+ +   +      
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           +GLA+ H   E  ILHRD+K  N+L++      L DFGLAR    P +T  +   V TL 
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VVTLW 173
Query: 913 YIPPEYGQASVATYKG--DVYSFGVVLLELLTGK 944
           Y  P+    S  TY    D++S G +L E++TGK
Sbjct: 174 YRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGK 206

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 73/271 (26%), Positives = 110/271 (40%), Gaps = 53/271 (19%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMERE--- 784
           +++ +IDD       FD    +G G FG VY A     + + A+K L     Q+E+E   
Sbjct: 9   KRKFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVE 59
Query: 785 --FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
              R E+E  S  +HPN++ +  Y   +    L+  F   G L    +++L      D  
Sbjct: 60  HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQ 115
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
                 +  A  L Y H   E  ++HRDIK  N+L+       +ADFG        +  H
Sbjct: 116 RSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG--------WSVH 164
Query: 903 VTT----DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK------- 951
             +     + GTL Y+PPE  +      K D++  GV+  E L G  P D          
Sbjct: 165 APSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 224
Query: 952 ------------PKGSRDLISWVIRMRQENR 970
                         GS+DLIS ++R     R
Sbjct: 225 IVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 255

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 13/240 (5%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
           +G G FG+V         +VAIK +  +    E EF  E + +    H  LV L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
           +    +I  +M NG L  +L E             L + +     + YL        LHR
Sbjct: 76  QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHR 129
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATYK 927
           D+ + N L++      ++DFGL+R +L   D   T+       + + PPE    S  + K
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 928 GDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
            D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE +   +Y   H+K
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 246

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 43/278 (15%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 809  HKNDRLLIYS-FMENGSL-DYWLHEK---LDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
               + + I + +M  GSL D+   E    L  P  +D  +++      A G+AY+ +   
Sbjct: 79   VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI------ASGMAYVERM-- 130
Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQ 920
             + +HRD++++NIL+  N    +ADFGLARLI    + +  T   G    + +  PE   
Sbjct: 131  -NYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEWTARQGAKFPIKWTAPEAAL 185
Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                T K DV+SFG++L EL T G+ P      +   D +    RM       E L    
Sbjct: 186  YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--- 242
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                         D+ C C  + P+ RPT + L ++L+
Sbjct: 243  -------------DLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKP--GTMSPESFLEEAQIMKKLKHDKLVQLYA-VV 73
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPS-SLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
            +    ++  +M  GSL  +L    DG   +L   + + +A   A G+AY+ +    + +
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLK---DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 127
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVA 924
           HRD++S+NIL+       +ADFGLARLI    + +  T   G    + +  PE       
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLI----EDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 925 TYKGDVYSFGVVLLELLTGKR 945
           T K DV+SFG++L EL+T  R
Sbjct: 184 TIKSDVWSFGILLTELVTKGR 204

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/316 (23%), Positives = 136/316 (43%), Gaps = 34/316 (10%)
Query: 705  EEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-L 763
            E+  T+     +L SK  +   N+  E+  DD+       +    +G G +G+V +   +
Sbjct: 21   EQPQTSSTPPRDLDSKACISIGNQNFEVKADDL-------EPIMELGRGAYGVVEKMRHV 73
Query: 764  PDGRNVAIKRLSGDC-GQMEREFRAEVE-ALSRAQHPNLVHLQGYCMHKNDRLLIYSFME 821
            P G+ +A+KR+      Q ++    +++ ++     P  V   G    + D  +    M+
Sbjct: 74   PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 133
Query: 822  NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN 881
              SLD +  + +D   ++  D    IA    + L +LH      ++HRD+K SN+L++  
Sbjct: 134  T-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL 190
Query: 882  FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV----ATYKGDVYSFGVVL 937
                + DFG++  ++   D+   T   G   Y+ PE     +     + K D++S G+ +
Sbjct: 191  GQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 247
Query: 938  LELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACL 997
            +EL   + P D           SW    +Q  +  E   P +     DK     +D    
Sbjct: 248  IELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL---PADKFSAEFVDFTSQ 293
Query: 998  CLSESPKVRPTTQQLV 1013
            CL ++ K RPT  +L+
Sbjct: 294  CLKKNSKERPTYPELM 309

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 80/273 (29%), Positives = 121/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  GSL  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 82   VSEEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD+ ++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 137  HRDLAAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 194  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 245
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 246  --------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 134
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 192
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       +     L++A   +  + YL +    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMEREFRAEVEALSRAQHPN 799
            F +   IG G FG V++    D R    VAIK +   +      + + E+  LS+   P 
Sbjct: 29   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +    G  +      +I  ++  GS LD      L  P  LD      I +   +GL YL
Sbjct: 87   VTKYYGSYLKDTKLWIIMEYLGGGSALD------LLEPGPLDETQIATILREILKGLDYL 140
Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE 917
            H   +   +HRDIK++N+LL  +    LADFG+A  +    DT +  +  VGT  ++ PE
Sbjct: 141  HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPE 194
Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              + S    K D++S G+  +EL  G+ P     P     LI        E   S+ L  
Sbjct: 195  VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 254
Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            F+                  CL++ P  RPT ++L+ 
Sbjct: 255  FVE----------------ACLNKEPSFRPTAKELLK 275

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 750 IGCGGFGLVYRA--TLPDGRNVAIKRLSGDCGQME---REFRAEVEALSRAQHPNLVHLQ 804
           +G GG   VY A  T+ + + VAIK +     + E   + F  EV   S+  H N+V + 
Sbjct: 19  LGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
                 +   L+  ++E  +L  ++     GP S+D  + ++       G+ + H   + 
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVD--TAINFTNQILDGIKHAH---DM 130
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            I+HRDIK  NIL+D N    + DFG+A+  LS      T  ++GT+ Y  PE  +    
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
               D+YS G+VL E+L G+ P +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMEREFRAEVEALSRAQHPN 799
            F +   IG G FG V++    D R    VAIK +   +      + + E+  LS+   P 
Sbjct: 24   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +    G  +      +I  ++  GS LD      L  P  LD      I +   +GL YL
Sbjct: 82   VTKYYGSYLKDTKLWIIMEYLGGGSALD------LLEPGPLDETQIATILREILKGLDYL 135
Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPE 917
            H   +   +HRDIK++N+LL  +    LADFG+A  +    DT +  +  VGT  ++ PE
Sbjct: 136  HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNXFVGTPFWMAPE 189
Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
              + S    K D++S G+  +EL  G+ P     P     LI        E   S+ L  
Sbjct: 190  VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 249
Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            F+                  CL++ P  RPT ++L+ 
Sbjct: 250  FVE----------------ACLNKEPSFRPTAKELLK 270

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 131
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 186
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 16/229 (6%)
Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLP--DGRN--VAIKRLSGD-CGQM 781
           ++E +  ++D++   N      I+G G FG V    L   DG +  VA+K +  D   Q 
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 782 E-REFRAEVEALSRAQHPNLVHLQGYCMHKNDR-----LLIYSFMENGSLD-YWLHEKLD 834
           E  EF +E   +    HPN++ L G C+  + +     ++I  FM+ G L  Y L+ +L+
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 835 -GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR 893
            GP  +   + L      A G+ YL      + LHRD+ + N +L  +    +ADFGL++
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
            I S             + +I  E     V T K DV++FGV + E+ T
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 135
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 136 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 190
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 77/272 (28%), Positives = 119/272 (43%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L    +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
             +    ++  +M  G L  +L  ++     L     + +A   A G+AY+ +    + +H
Sbjct: 83   SEEPIYIVMEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVH 137
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVATY 926
            RD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T 
Sbjct: 138  RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 927  KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHD 985
            K DV+SFG++L EL T G+ P      +   D +    RM       E L          
Sbjct: 195  KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH--------- 245
Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                   D+ C C  + P+ RPT + L ++L+
Sbjct: 246  -------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 130
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 131 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 185
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 136
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 137 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 191
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 33/273 (12%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG V+  T      VAIK L    G M  E F  E + + + +H  LV L  Y +
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 809  HKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               + + I + +M  G L  +L  ++     L     + +A   A G+AY+ +    + +
Sbjct: 82   VSEEPIYIVTEYMSKGCLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 136
Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASVAT 925
            HRD++++NIL+  N    +ADFGLARLI    D   T        + +  PE       T
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
             K DV+SFG++L EL T G+ P      +   D +    RM       E L         
Sbjct: 194  IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-------- 245
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                    D+ C C  + P+ RPT + L ++L+
Sbjct: 246  --------DLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 129
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 130 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 184
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 134
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 135 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 189
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 131
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEFFKVKEPGESPIFWYAP 186
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 326 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 380
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           R++ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + K
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 438
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 162
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 163 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 217
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 131
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 186
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 149
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 150 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 204
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 809 HKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
            +    +I  FM  G+ LDY         S++     L++A   +  + YL +    + +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKK---NFI 340
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASVATY 926
           HR++ + N L+  N    +ADFGL+RL+    Y  H        + +  PE    +  + 
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 398
Query: 927 KGDVYSFGVVLLELLT 942
           K DV++FGV+L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 138
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 139 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 193
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI------CKGMEYLG 134
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 135 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 189
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 137
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 138 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 192
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+     T H        + +  PE    +  + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 193
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 149
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HRD+ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 150 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEXXKVKEPGESPIFWYAP 204
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 139
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYK 927
           RD+ + N L+  N    +ADFGL+RL+     T H        + +  PE    +  + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLAYNKFSIK 197
Query: 928 GDVYSFGVVLLELLT 942
            DV++FGV+L E+ T
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+     D+     L G P  L       + QG    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 171 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 115/272 (42%), Gaps = 25/272 (9%)
Query: 744  FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            FD    +G G +G VY+A   + G+ VAIK++  +     +E   E+  + +   P++V 
Sbjct: 31   FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
              G      D  ++  +   GS+   +  +     +L  D    I Q   +GL YLH   
Sbjct: 89   YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
            +   +HRDIK+ NILL+    A LADFG+A  +           ++GT  ++ PE  Q  
Sbjct: 146  K---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQEI 200
Query: 923  VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDK 982
                  D++S G+  +E+  GK P     P  +       I M   N       P ++  
Sbjct: 201  GYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFMIPTNPPPTFRKPELWSD 253
Query: 983  QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                      D    CL +SP+ R T  QL+ 
Sbjct: 254  N-------FTDFVKQCLVKSPEQRATATQLLQ 278

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 81  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 135
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
           RD+ + N L+  N    +ADFGL+RL+    DT+  T   G    + +  PE    +  +
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTG--DTY--TAPAGAKFPIKWTAPESLAYNKFS 191
Query: 926 YKGDVYSFGVVLLELLT 942
            K DV++FGV+L E+ T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +    +I  FM  G+L  +L E       ++    L++A   +  + YL +    + +H
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 136
Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT---LGYIPPEYGQASVAT 925
           RD+ + N L+  N    +ADFGL+RL+    DT+  T   G    + +  PE    +  +
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTG--DTY--TAPAGAKFPIKWTAPESLAYNKFS 192
Query: 926 YKGDVYSFGVVLLELLT 942
            K DV++FGV+L E+ T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 59
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+     D+     L G P  L       + QG  
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQG-- 117
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL 
Sbjct: 118 --LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLW 170
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 171 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+     D+     L G P  L       + QG  
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQG-- 118
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL 
Sbjct: 119 --LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLW 171
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 172 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSR 794
           S  +F     +G G FG V+   +  +GR  A+K L  +      Q+E     E   LS 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSI 62
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             HP ++ + G         +I  ++E G L   L +    P+ +   ++ + A+     
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAE-VCLA 118
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH      I++RD+K  NILLD N    + DFG A+     Y   VT  L GT  YI
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYXLCGTPDYI 170
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            PE           D +SFG+++ E+L G  P 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 15/234 (6%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V +    P G  +A K +  +     R +   E++ L     P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L E    P  +    ++ IA    RGLAYL 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL--GKVSIA--VLRGLAYLR 131
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 132 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMAPERL 185
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
           Q +  + + D++S G+ L+EL  G+ P+    P  +++L +   R   +  E E
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI---PPPDAKELEAIFGRPVVDGEEGE 236

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSR 794
           E   NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L  
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 65
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAAR 853
             HPN+V L      +N   L++ F+      +     L G P  L       + QG   
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG--- 122
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y
Sbjct: 123 -LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 914 IPPEY--GQASVATYKGDVYSFGVVLLELLTGK 944
             PE   G    +T   D++S G +  E++T +
Sbjct: 177 RAPEILLGXKYYST-AVDIWSLGCIFAEMVTRR 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRL---SGDCGQMEREFRAEVEALSRA 795
           +T+ ++    IG G +G VY+A  P  G  VA+K +   +G+ G      R EV  L R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 796 Q---HPNLVHLQGYC-MHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQ 849
           +   HPN+V L   C   + DR +  + +    +D  L   LD   P  L  ++   + +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LV 908
              RGL +LH +C   I+HRD+K  NIL+       LADFGLAR+    Y   +  D +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALDPVV 172
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            TL Y  PE    S      D++S G +  E+   ++P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 116
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y 
Sbjct: 117 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 171
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 172 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 72/243 (29%), Positives = 115/243 (47%), Gaps = 23/243 (9%)
Query: 730 KEISIDDILES------TNNFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLSGDCG 779
           KEISI   +++       ++F+   ++G G FG   LV + T PD G   A+K L     
Sbjct: 10  KEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATL 69
Query: 780 QMEREFRAEVE--ALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGP 836
           ++    R ++E   L+   HP +V L  Y      +L LI  F+  G L   L +++   
Sbjct: 70  KVRDRVRTKMERDILADVNHPFVVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV--- 125
Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
              + D + ++A+  A GL +LH      I++RD+K  NILLD      L DFGL++  +
Sbjct: 126 MFTEEDVKFYLAE-LALGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI 181
Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
                       GT+ Y+ PE       ++  D +S+GV++ E+LTG  P      K + 
Sbjct: 182 D--HEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETM 239
Query: 957 DLI 959
            LI
Sbjct: 240 TLI 242

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER------EFRAEVEAL 792
           + N+F    IIG GGFG VY     D G+  A+K L     +M++        R  +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           S    P +V +  Y  H  D+L  I   M  G L Y L +   G  S + D R + A+  
Sbjct: 247 STGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFS-EADMRFYAAE-I 301
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             GL ++H      +++RD+K +NILLD +    ++D GLA    S    H +   VGT 
Sbjct: 302 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTH 354
Query: 912 GYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           GY+ PE  Q  VA     D +S G +L +LL G  P    K K   ++    + M  E
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER------EFRAEVEAL 792
           + N+F    IIG GGFG VY     D G+  A+K L     +M++        R  +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           S    P +V +  Y  H  D+L  I   M  G L Y L +   G  S + D R + A+  
Sbjct: 247 STGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFS-EADMRFYAAE-I 301
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             GL ++H      +++RD+K +NILLD +    ++D GLA    S    H +   VGT 
Sbjct: 302 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTH 354
Query: 912 GYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           GY+ PE  Q  VA     D +S G +L +LL G  P    K K   ++    + M  E
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER------EFRAEVEAL 792
           + N+F    IIG GGFG VY     D G+  A+K L     +M++        R  +  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           S    P +V +  Y  H  D+L  I   M  G L Y L +   G  S + D R + A+  
Sbjct: 247 STGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFS-EADMRFYAAE-I 301
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             GL ++H      +++RD+K +NILLD +    ++D GLA    S    H +   VGT 
Sbjct: 302 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTH 354
Query: 912 GYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           GY+ PE  Q  VA     D +S G +L +LL G  P    K K   ++    + M  E
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 738  LESTNNFDQANIIGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMEREFRAEVEALS 793
            L+    F +   IG G FG V++    D R    VAIK +   +      + + E+  LS
Sbjct: 3    LDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +   P +    G  +      +I  ++  GS LD      L  P  LD      I +   
Sbjct: 61   QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD------LLEPGPLDETQIATILREIL 114
Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTL 911
            +GL YLH   +   +HRDIK++N+LL  +    LADFG+A  +    DT +  +  VGT 
Sbjct: 115  KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNXFVGTP 168
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
             ++ PE  + S    K D++S G+  +EL  G+ P     P     LI        E   
Sbjct: 169  FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY 228
Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            S+ L  F+                  CL++ P  RPT ++L+
Sbjct: 229  SKPLKEFVE----------------ACLNKEPSFRPTAKELL 254

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 36/282 (12%)
Query: 738  LESTNNFDQANIIGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMEREFRAEVEALS 793
            L+    F +   IG G FG V++    D R    VAIK +   +      + + E+  LS
Sbjct: 3    LDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGS-LDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +   P +    G  +      +I  ++  GS LD      L  P  LD      I +   
Sbjct: 61   QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD------LLEPGPLDETQIATILREIL 114
Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTL 911
            +GL YLH   +   +HRDIK++N+LL  +    LADFG+A  +    DT +  +  VGT 
Sbjct: 115  KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTP 168
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
             ++ PE  + S    K D++S G+  +EL  G+ P     P     LI        E   
Sbjct: 169  FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY 228
Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
            S+ L  F+                  CL++ P  RPT ++L+
Sbjct: 229  SKPLKEFVE----------------ACLNKEPSFRPTAKELL 254

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER------EFRAEVEAL 792
           + N+F    IIG GGFG VY     D G+  A+K L     +M++        R  +  +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
           S    P +V +  Y  H  D+L  I   M  G L Y L +   G  S + D R + A+  
Sbjct: 246 STGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFS-EADMRFYAAE-I 300
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             GL ++H      +++RD+K +NILLD +    ++D GLA    S    H +   VGT 
Sbjct: 301 ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTH 353
Query: 912 GYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
           GY+ PE  Q  VA     D +S G +L +LL G  P    K K   ++    + M  E
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 411

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 91/213 (42%), Gaps = 14/213 (6%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFR---AEVEALSRA 795
              +F+   ++G G FG V+ A      +  AIK L  D   M+ +      E   LS A
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 796 -QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HP L H+      K +   +  ++  G L Y     +      D       A     G
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY----HIQSCHKFDLSRATFYAAEIILG 131
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L +LH      I++RD+K  NILLD +    +ADFG+ +  +       T +  GT  YI
Sbjct: 132 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNEFCGTPDYI 186
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            PE        +  D +SFGV+L E+L G+ P 
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 744  FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFR---AEVEALSRAQH 797
            F     IG G FG VY A   D RN   VAIK++S    Q   +++    EV  L + +H
Sbjct: 56   FSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            PN +  +G  + ++   L+  +    + D   +H+K      L       +  GA +GLA
Sbjct: 114  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLA 168
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YLH     +++HRD+K+ NILL       L DFG A  I++P         VGT  ++ P
Sbjct: 169  YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAP-----ANXFVGTPYWMAP 219
Query: 917  EYGQA-SVATYKG--DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            E   A     Y G  DV+S G+  +EL   K P+       + + +S +  + Q   ES 
Sbjct: 220  EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQN--ESP 271
Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             L        H  E  R  +    CL + P+ RPT++ L+ 
Sbjct: 272  AL-----QSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLLK 305

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSR 794
           E   NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L  
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 65
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAAR 853
             HPN+V L      +N   L++ F+      +     L G P  L       + QG   
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG--- 122
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y
Sbjct: 123 -LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 914 IPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
             PE      Y   +V     D++S G +  E++T +
Sbjct: 177 RAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFR---AEVEALSRAQH 797
           F     IG G FG VY A   D RN   VAIK++S    Q   +++    EV  L + +H
Sbjct: 17  FSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           PN +  +G  + ++   L+  +    + D   +H+K      L       +  GA +GLA
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLA 129
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH     +++HRD+K+ NILL       L DFG A  I++P         VGT  ++ P
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAP-----ANXFVGTPYWMAP 180
Query: 917 EYGQA-SVATYKG--DVYSFGVVLLELLTGKRPM 947
           E   A     Y G  DV+S G+  +EL   K P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
            ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 9    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 69   IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 124
Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
            +  +  I+HRD+K SNIL++      L DFG++  ++      +  + VGT  Y+ PE  
Sbjct: 125  EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMSPERL 178
Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
            Q +  + + D++S G+ L+E+  G+ P     P    +L+ +++        S V     
Sbjct: 179  QGTHYSVQSDIWSMGLSLVEMAVGRYPR---PPMAIFELLDYIVNEPPPKLPSAVFS--- 232
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                     L   D    CL ++P  R   +QL+
Sbjct: 233  ---------LEFQDFVNKCLIKNPAERADLKQLM 257

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 172
Query: 917 EY--GQASVATYKGDVYSFGVVLLELLTGK 944
           E   G    +T   D++S G +  E++T +
Sbjct: 173 EILLGXKYYST-AVDIWSLGCIFAEMVTRR 201

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 128 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 750 IGCGGFGLVYRAT---LPD--GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V       L D  G  VA+K+L     +  R+F  E+E L   QH N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 805 GYCMHKNDR--LLIYSFMENGSLDYWLH---EKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           G C     R   LI  ++  GSL  +L    E++D    L + S++       +G+ YL 
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGMEYLG 132
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH---VTTDLVGTLGYIPP 916
                  +HR++ + NIL++      + DFGL +++  P D     V       + +  P
Sbjct: 133 TK---RYIHRNLATRNILVENENRVKIGDFGLTKVL--PQDKEYYKVKEPGESPIFWYAP 187
Query: 917 EYGQASVATYKGDVYSFGVVLLELLT 942
           E    S  +   DV+SFGVVL EL T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 131 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 127
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 128 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 181 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+      +     L G P  L       + QG  
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG-- 118
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL 
Sbjct: 119 --LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLW 171
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 172 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 172
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 61
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+      +     L G P  L       + QG  
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG-- 119
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL 
Sbjct: 120 --LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLW 172
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 173 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L    NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 61
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+      +     L G P  L       + QG  
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG-- 119
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL 
Sbjct: 120 --LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLW 172
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 173 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 205

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 172
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLV 801
           ++    +G GGFG V R    D G  VAIK+   +     RE +  E++ + +  HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 802 HLQGY-----CMHKND-RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             +        +  ND  LL   + E G L  +L++  +    L       +    +  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSAL 134
Query: 856 AYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   E  I+HRD+K  NI+L          + D G A+ +       + T+ VGTL 
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQ 188
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE  +    T   D +SFG +  E +TG RP
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 744 FDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLV 801
           ++    +G GGFG V R    D G  VAIK+   +     RE +  E++ + +  HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 802 HLQGY-----CMHKND-RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             +        +  ND  LL   + E G L  +L++  +    L       +    +  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSAL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   E  I+HRD+K  NI+L          + D G A+ +       + T+ VGTL 
Sbjct: 136 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQ 189
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE  +    T   D +SFG +  E +TG RP
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 129
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 130 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 183 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 171 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 132
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 133 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 186 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 116
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 117 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 171
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 172 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 171 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 151
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 152 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 205 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 117
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 172
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 173 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY+A   +   +A  ++     + E E +  E++ L+   HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAYLHQSCEPHIL 867
           ++N+  ++  F   G++D  + E L+ P +   +S++ +  +     L YLH +    I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-LERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT-- 925
           HRD+K+ NIL   +    LADFG++    +          +GT  ++ PE      +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 926 ---YKGDVYSFGVVLLELLTGKRPMDMCKP 952
              YK DV+S G+ L+E+   + P     P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 117
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 118 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 172
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 173 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 117
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 172
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 173 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 203

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 29/289 (10%)
Query: 31  CNPNDLAALEDFMKNF--ESGIDGWGTNASSSDCCH--WVGITCNSSSSL---------G 77
           CNP D  AL    K+    + +  W     ++DCC+  W+G+ C++ +           G
Sbjct: 3   CNPQDKQALLQIKKDLGNPTTLSSW---LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59
Query: 78  LNDSIGSGRVTGL-------FLYK---RRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV 127
           LN        + L       FLY      L G +  ++  L QL +L ++H  + G +P 
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI 186
            L  +  L  LD S N LSG LP +I +LP++  +    N ++G++P S    S     +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS 246
            +S N  +G + P   N  +L  + L  N L G  +      +  + + L  N L+  L 
Sbjct: 180 TISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPH 295
             +    NL  LD+ +N   G +P     L     L    N   G IP 
Sbjct: 239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 14/226 (6%)
Query: 436 LRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGL 495
           L G IP  +   ++L  + ++   +SG IP +    + L  LD S N  +G +P +++ L
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 496 PSLITRNISLEEPS---PDFPFFMRRNVSARGLQYNQIW-SFPPT--------IDLSLNR 543
           P+L+         S   PD      +  ++  +  N++    PPT        +DLS N 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 544 LDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXXXXX 603
           L+G     FG+ K      L  N+L+  +  ++    +L  LDL  N + G +P      
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 604 XXXXXXXVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCT 648
                  V+ N+L G IP GG  Q F  S++  N  LCG    +CT
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 2/104 (1%)
Query: 541 LNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIXX 600
           +N L G I P    L +LH   + H N+SG IP  L+ + +L TLD SYN LSG +P   
Sbjct: 86  INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 601 XXXXXXXXXXVANNHLTGRIP-SGGQF-QTFPNSSFDGNNLCGE 642
                        N ++G IP S G F + F + +   N L G+
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 116
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 117 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 171
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 172 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 88/330 (26%), Positives = 142/330 (43%), Gaps = 65/330 (19%)
Query: 732  ISID--DILESTN-NFDQANII-----GCGGFGLVYRATL--PDGR----NVAIKRLSGD 777
            +S+D   ILE     F + N++     G G FG V +AT     GR     VA+K L  +
Sbjct: 5    LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN 64
Query: 778  CGQME-REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK---- 832
                E R+  +E   L +  HP+++ L G C      LLI  + + GSL  +L E     
Sbjct: 65   ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 833  --------------LDGPS--SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNI 876
                          LD P   +L     +  A   ++G+ YL    E  ++HRD+ + NI
Sbjct: 125  PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNI 181
Query: 877  LLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-----VATYKGDVY 931
            L+       ++DFGL+R +    D++V      + G IP ++         + T + DV+
Sbjct: 182  LVAEGRKMKISDFGLSRDVYEE-DSYVKR----SQGRIPVKWMAIESLFDHIYTTQSDVW 236
Query: 932  SFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLR 990
            SFGV+L E++T G  P     P+   +L+    RM + +  SE             EM R
Sbjct: 237  SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSE-------------EMYR 283
Query: 991  VLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            ++     C  + P  RP    +   L+ ++
Sbjct: 284  LM---LQCWKQEPDKRPVFADISKDLEKMM 310

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 173
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 174 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 171 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY+A   +   +A  ++     + E E +  E++ L+   HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAYLHQSCEPHIL 867
           ++N+  ++  F   G++D  + E L+ P +   +S++ +  +     L YLH +    I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-LERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT-- 925
           HRD+K+ NIL   +    LADFG++    +          +GT  ++ PE      +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 926 ---YKGDVYSFGVVLLELLTGKRPMDMCKP 952
              YK DV+S G+ L+E+   + P     P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 170
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 171 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 30/238 (12%)
Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDC-G 779
           N+ K+  + +I  S   F +   +G   FG VY+  L         + VAIK L     G
Sbjct: 13  NQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 70
Query: 780 QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL-----HEKLD 834
            +  EFR E    +R QHPN+V L G         +I+S+  +G L  +L     H  + 
Sbjct: 71  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 130
Query: 835 G-------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA 887
                    S+L+    +H+    A G+ YL      H++H+D+ + N+L+       ++
Sbjct: 131 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKIS 187
Query: 888 DFGLARLILSPYDTHVTTDLVGTLGYIPPE---YGQASVATYKGDVYSFGVVLLELLT 942
           D GL R + +     +  + +  + ++ PE   YG+ S+ +   D++S+GVVL E+ +
Sbjct: 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 242

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG VY+A   +   +A  ++     + E E +  E++ L+   HPN+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA-QGAARGLAYLHQSCEPHIL 867
           ++N+  ++  F   G++D  + E L+ P +   +S++ +  +     L YLH +    I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLE-LERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT-- 925
           HRD+K+ NIL   +    LADFG++    +          +GT  ++ PE      +   
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 926 ---YKGDVYSFGVVLLELLTGKRPMDMCKP 952
              YK DV+S G+ L+E+   + P     P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 173
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 174 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALS 793
           L S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA 852
              HPN+V L      +N   L++ F+      +     L G P  L       + QG  
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQG-- 118
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL 
Sbjct: 119 --LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLW 171
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE      Y   +V     D++S G +  E++T +
Sbjct: 172 YRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 82/281 (29%), Positives = 116/281 (41%), Gaps = 31/281 (11%)
Query: 749  IIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
            +IG G FG+VY     D        AIK LS      + E F  E   +    HPN++ L
Sbjct: 28   VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 804  QGYCMHKND-RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
             G  +       ++  +M +G L  ++      P+  D  S        ARG+ YL    
Sbjct: 88   IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS---FGLQVARGMEYL---A 141
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--YDTHVTTDLVGTLGYIPPEYGQ 920
            E   +HRD+ + N +LD +F   +ADFGLAR IL    Y           + +   E  Q
Sbjct: 142  EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                T K DV+SFGV+L ELLT G  P     P    DL  ++ + R+  +     D   
Sbjct: 202  TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGRRLPQPEYCPDSLY 258
Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               Q              C    P VRPT + LV  ++ I+
Sbjct: 259  QVMQQ-------------CWEADPAVRPTFRVLVGEVEQIV 286

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 11/219 (5%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +  +T +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRST-M 176
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 9/207 (4%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLS-GDCGQMERE-FRAEVEALSRAQH 797
             +++    IG G +G   +     DG+ +  K L  G   + E++   +EV  L   +H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 798 PNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           PN+V      + + +  L  +  + E G L   + +       LD +  L +       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 856 AYLHQSCE--PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
              H+  +    +LHRD+K +N+ LDG     L DFGLAR++   +DT      VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYY 182
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLEL 940
           + PE         K D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
            ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 66   IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 121
Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
            +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 122  EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPM-------DMCKPKGSRDLISWVIRMRQENRES 972
            Q +  + + D++S G+ L+E+  G+ P+       D   P    +L+ +++        S
Sbjct: 176  QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPS 235
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
             V              L   D    CL ++P  R   +QL+
Sbjct: 236  GVFS------------LEFQDFVNKCLIKNPAERADLKQLM 264

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 19/229 (8%)
Query: 731 EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
           EI +  + +    F+   ++G G +G VY+        +A  ++    G  E E + E+ 
Sbjct: 13  EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN 72
Query: 791 ALSR-AQHPNLVHLQGYCMHKN-----DRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
            L + + H N+    G  + KN     D+L L+  F   GS+   +          +W +
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
             +I +   RGL++LHQ     ++HRDIK  N+LL  N    L DFG++  +        
Sbjct: 133 --YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 904 TTDLVGTLGYIPPEY---GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
           T   +GT  ++ PE     +   ATY  K D++S G+  +E+  G  P+
Sbjct: 188 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++ F+      +     L G P  L       + QG    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 116
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 117 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 171
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 172 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 17/235 (7%)
Query: 715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKR 773
           E+   +L      K+K   + D     ++F++ + +G G  G+V++ +  P G  +A K 
Sbjct: 46  EQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 100
Query: 774 LSGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK 832
           +  +     R +   E++ L     P +V   G      +  +    M+ GSLD  L + 
Sbjct: 101 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 160
Query: 833 LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA 892
              P  +    ++ IA    +GL YL +  +  I+HRD+K SNIL++      L DFG++
Sbjct: 161 GRIPEQIL--GKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 214
Query: 893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             ++      +    VGT  Y+ PE  Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 215 GQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRL---SGDCGQMEREFRAEVEALSRA 795
           +T+ ++    IG G +G VY+A  P  G  VA+K +   +G+ G      R EV  L R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 796 Q---HPNLVHLQGYC-MHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQ 849
           +   HPN+V L   C   + DR +  + +    +D  L   LD   P  L  ++   + +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLV 908
              RGL +LH +C   I+HRD+K  NIL+       LADFGLAR+    Y   +    +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALAPVV 172
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            TL Y  PE    S      D++S G +  E+   ++P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 9/207 (4%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLS-GDCGQMERE-FRAEVEALSRAQH 797
             +++    IG G +G   +     DG+ +  K L  G   + E++   +EV  L   +H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 798 PNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           PN+V      + + +  L  +  + E G L   + +       LD +  L +       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 856 AYLHQSCE--PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
              H+  +    +LHRD+K +N+ LDG     L DFGLAR++   +DT      VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYY 182
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLEL 940
           + PE         K D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    L+
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LS 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 172
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 114/244 (46%), Gaps = 23/244 (9%)
Query: 712 KDLEELG------SKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LP 764
           K LEEL        +L      K+K   + D     ++F++ + +G G  G+V++ +  P
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKP 56
Query: 765 DGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENG 823
            G  +A K +  +     R +   E++ L     P +V   G      +  +    M+ G
Sbjct: 57  SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116
Query: 824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG 883
           SLD  L +    P  +    ++ IA    +GL YL +  +  I+HRD+K SNIL++    
Sbjct: 117 SLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLREKHK--IMHRDVKPSNILVNSRGE 170
Query: 884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             L DFG++  ++      +    VGT  Y+ PE  Q +  + + D++S G+ L+E+  G
Sbjct: 171 IKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
Query: 944 KRPM 947
           + P+
Sbjct: 227 RYPI 230

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 11/219 (5%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +   +++
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSK-RSEM 176
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 136
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    +  ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 137 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 190 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    +  ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 127 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 120
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    +  ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 121 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA----EVEALSRAQH 797
           NF     IG G F  VYRA  L DG  VA+K++      M+ + RA    E++ L +  H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNH 91
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSL----DYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           PN++      +  N+  ++    + G L     ++  +K   P    W   + +      
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L ++H      ++HRDIK +N+ +       L D GL R   S   T     LVGT  Y
Sbjct: 149 -LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYY 202
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + PE    +   +K D++S G +L E+   + P 
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRL---SGDCGQMEREFRAEVEALSRA 795
           +T+ ++    IG G +G VY+A  P  G  VA+K +   +G+ G      R EV  L R 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVR-EVALLRRL 60
Query: 796 Q---HPNLVHLQGYC-MHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHIAQ 849
           +   HPN+V L   C   + DR +  + +    +D  L   LD   P  L  ++   + +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT-DLV 908
              RGL +LH +C   I+HRD+K  NIL+       LADFGLAR+    Y   +    +V
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALFPVV 172
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            TL Y  PE    S      D++S G +  E+   ++P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 739 ESTNNFDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR 794
           E    +D  ++IG G   +V    +RAT   G   A+K +     ++  E   EV   +R
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRAT---GHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 795 ---------AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
                    A HP+++ L       +   L++  M  G L  +L EK+    +L      
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETR 203
Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
            I +     +++LH +   +I+HRD+K  NILLD N    L+DFG +   L P +     
Sbjct: 204 SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEK--LR 257
Query: 906 DLVGTLGYIPPEYGQASV-ATYKG-----DVYSFGVVLLELLTGKRPM 947
           +L GT GY+ PE  + S+  T+ G     D+++ GV+L  LL G  P 
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 57/312 (18%)
Query: 742  NNFDQANIIGCGGFGLVYRATL--PDGR----NVAIKRLSGDCGQME-REFRAEVEALSR 794
             N      +G G FG V +AT     GR     VA+K L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------------LDGP 836
              HP+++ L G C      LLI  + + GSL  +L E                   LD P
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 837  S--SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
               +L     +  A   ++G+ YL    E  ++HRD+ + NIL+       ++DFGL+R 
Sbjct: 143  DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQAS-----VATYKGDVYSFGVVLLELLT-GKRPMD 948
            +    D+ V      + G IP ++         + T + DV+SFGV+L E++T G  P  
Sbjct: 200  VYEE-DSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 949  MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
               P+   +L+    RM + +  SE             EM R++     C  + P  RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE-------------EMYRLM---LQCWKQEPDKRPV 298
Query: 1009 TQQLVSWLDSII 1020
               +   L+ ++
Sbjct: 299  FADISKDLEKMM 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 736 DILESTNNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRL-----SGDCGQMEREFRAEV 789
           D+      +++ + +G G F  VY+A   +    VAIK++     S     + R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK--LDGPSSLDWDSRLHI 847
           + L    HPN++ L     HK++  L++ FME   L+  + +   +  PS +     + +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
                +GL YLHQ     ILHRD+K +N+LLD N    LADFGLA+   SP   +     
Sbjct: 123 -----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ-- 172
Query: 908 VGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELL 941
           V T  Y  PE  +G A +     D+++ G +L ELL
Sbjct: 173 VVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELL 207

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 14/213 (6%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFR---AEVEALSRA 795
              +F    ++G G FG V+ A      +  AIK L  D   M+ +      E   LS A
Sbjct: 15  KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 796 -QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HP L H+      K +   +  ++  G L Y     +      D       A     G
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY----HIQSCHKFDLSRATFYAAEIILG 130
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L +LH      I++RD+K  NILLD +    +ADFG+ +  +       T    GT  YI
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM--LGDAKTNXFCGTPDYI 185
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            PE        +  D +SFGV+L E+L G+ P 
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 9/207 (4%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLS-GDCGQMERE-FRAEVEALSRAQH 797
             +++    IG G +G   +     DG+ +  K L  G   + E++   +EV  L   +H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 798 PNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           PN+V      + + +  L  +  + E G L   + +       LD +  L +       L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 856 AYLHQSCE--PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
              H+  +    +LHRD+K +N+ LDG     L DFGLAR++   +D     + VGT  Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFVGTPYY 182
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLEL 940
           + PE         K D++S G +L EL
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 140
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 141 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 194
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 57/312 (18%)
Query: 742  NNFDQANIIGCGGFGLVYRATL--PDGR----NVAIKRLSGDCGQME-REFRAEVEALSR 794
             N      +G G FG V +AT     GR     VA+K L  +    E R+  +E   L +
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------------LDGP 836
              HP+++ L G C      LLI  + + GSL  +L E                   LD P
Sbjct: 83   VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 837  S--SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
               +L     +  A   ++G+ YL    E  ++HRD+ + NIL+       ++DFGL+R 
Sbjct: 143  DERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQAS-----VATYKGDVYSFGVVLLELLT-GKRPMD 948
            +    D+ V      + G IP ++         + T + DV+SFGV+L E++T G  P  
Sbjct: 200  VYEE-DSXVKR----SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 949  MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
               P+   +L+    RM + +  SE             EM R++     C  + P  RP 
Sbjct: 255  GIPPERLFNLLKTGHRMERPDNCSE-------------EMYRLM---LQCWKQEPDKRPV 298
Query: 1009 TQQLVSWLDSII 1020
               +   L+ ++
Sbjct: 299  FADISKDLEKMM 310

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 121
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 35/226 (15%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAE--VEALSRAQHPN 799
           +N     +IG G +G VY+ +L D R VA+K  S    Q    F  E  +  +   +H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDN 68
Query: 800 LVHL-----QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           +        +     + + LL+  +  NGSL  +L        + DW S   +A    RG
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRG 123
Query: 855 LAYLHQSC------EPHILHRDIKSSNILLDGNFGAHLADFGLA------RLILSPYDTH 902
           LAYLH         +P I HRD+ S N+L+  +    ++DFGL+      RL+    + +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 903 VTTDLVGTLGYIPPEYGQASV-------ATYKGDVYSFGVVLLELL 941
                VGT+ Y+ PE  + +V       A  + D+Y+ G++  E+ 
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 121
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 118
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y  P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYRAP 173
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 121
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 102/208 (49%), Gaps = 12/208 (5%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPN 799
           ++F++ + +G G  G+V++ +  P G  +A K +  +     R +   E++ L     P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           +V   G      +  +    M+ GSLD  L +    P  +    ++ IA    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL--GKVSIA--VIKGLTYLR 121
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
           +  +  I+HRD+K SNIL++      L DFG++  ++      +    VGT  Y+ PE  
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 79/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            ++HL G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++  G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++  G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+ ++  D    G      R E+  L    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 172
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+ ++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++ F+      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
            +FD   +IG G +  V    L          V  K L  D   ++   + E     +A 
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 78
Query: 797 -HPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP LV L   C     RL  +  ++  G L + +  +   P      +R + A+  +  
Sbjct: 79  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAE-ISLA 133
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  YI
Sbjct: 134 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 188
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
            PE  +     +  D ++ GV++ E++ G+ P D+    GS D
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSSD 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AI  L      +  +E   E  
Sbjct: 45  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 160
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 161 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 214 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 123
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A G+ YL    +  ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 124 ----AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 177 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 126
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 127 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 129 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 182 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 121
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +   + +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSK-RSXM 176
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 729 EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
           EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 8   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 67
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E     + +D      +
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAV 122
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            +   + L +LH +    ++HRDIKS NILL  +    L DFG    I +P  +   + +
Sbjct: 123 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSK-RSXM 177
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++  G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 133
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL       ++HRD+ + N+L+       + DFGLA+L+ +    +     
Sbjct: 134 ----AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 187 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 112/233 (48%), Gaps = 21/233 (9%)
Query: 715 EELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKR 773
           EE+  KL ++       +S+ D  +    F++   IG G  G VY A  +  G+ VAI++
Sbjct: 4   EEILEKLRII-------VSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQ 53
Query: 774 LSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKL 833
           ++      +     E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E  
Sbjct: 54  MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-- 111
Query: 834 DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR 893
              + +D      + +   + L +LH +    ++HR+IKS NILL  +    L DFG   
Sbjct: 112 ---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCA 165
Query: 894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            I +P  +  +T +VGT  ++ PE         K D++S G++ +E++ G+ P
Sbjct: 166 QI-TPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
            +FD   +IG G +  V    L          V  K L  D   ++   + E     +A 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQAS 110
Query: 797 -HPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP LV L   C     RL  +  ++  G L + +  +   P      +R + A+  +  
Sbjct: 111 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAE-ISLA 165
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  YI
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYI 220
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
            PE  +     +  D ++ GV++ E++ G+ P D+    GS D
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSSD 260

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
            +FD   +IG G +  V    L          V  K L  D   ++   + E     +A 
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 63
Query: 797 -HPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP LV L   C     RL  +  ++  G L + +  +   P      +R + A+  +  
Sbjct: 64  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAE-ISLA 118
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  YI
Sbjct: 119 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 173
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
            PE  +     +  D ++ GV++ E++ G+ P D+    GS D
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSSD 213

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 21/223 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
            +FD   +IG G +  V    L          V  K L  D   ++   + E     +A 
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQAS 67
Query: 797 -HPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP LV L   C     RL  +  ++  G L + +  +   P      +R + A+  +  
Sbjct: 68  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAE-ISLA 122
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L YLH   E  I++RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  YI
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 177
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
            PE  +     +  D ++ GV++ E++ G+ P D+    GS D
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSSD 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 750 IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHL 803
           +G G FG V      P+G N    VA+K L  + G     + + E+E L    H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 804 QGYCMHK--NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
           +G C     N   LI  F+ +GSL  +L +     + ++   +L  A    +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQ 920
                +HRD+ + N+L++      + DFGL + I +  +   V  D    + +  PE   
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 921 ASVATYKGDVYSFGVVLLELLT 942
            S      DV+SFGV L ELLT
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 36/239 (15%)
Query: 736 DILESTNNFDQAN---IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEA 791
           D+LE    +D+     ++G G +G+VY    L +   +AIK +     +  +    E+  
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN---GSLDYWLHEKLDGPSSLDWDSRLHIA 848
               +H N+V    Y    ++   I  FME    GSL   L  K  GP   +  +     
Sbjct: 73  HKHLKHKNIVQ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYT 128
Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLI--LSPYDTHVTT 905
           +    GL YLH +    I+HRDIK  N+L++   G   ++DFG ++ +  ++P     T 
Sbjct: 129 KQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CTE 181
Query: 906 DLVGTLGYIPPE--------YGQASVATYKGDVYSFGVVLLELLTGKRPM-DMCKPKGS 955
              GTL Y+ PE        YG+A+      D++S G  ++E+ TGK P  ++ +P+ +
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPPFYELGEPQAA 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
           S  NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARG 854
            HPN+V L      +N   L++  ++     +     L G P  L       + QG    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           LA+ H      +LHRD+K  N+L++      LADFGLAR    P  T+     V TL Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVTLWYR 173
Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE      Y   +V     D++S G +  E++T +
Sbjct: 174 APEILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 750 IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHL 803
           +G G FG V      P+G N    VA+K L  + G     + + E+E L    H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 804 QGYCMHK--NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
           +G C     N   LI  F+ +GSL  +L +     + ++   +L  A    +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH-VTTDLVGTLGYIPPEYGQ 920
                +HRD+ + N+L++      + DFGL + I +  +   V  D    + +  PE   
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 921 ASVATYKGDVYSFGVVLLELLT 942
            S      DV+SFGV L ELLT
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 799 NLVHLQGYCMHKNDRLLI-YSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGLA 856
             V L  +C   +++L    S+ +NG L  ++ +      S D   +R + A+     L 
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSALE 151
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIP 915
           YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+ 
Sbjct: 152 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYVS 207
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           PE      A    D+++ G ++ +L+ G  P
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQH 797
            +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 798 PNLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARG 854
           P  V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     
Sbjct: 92  PFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKI----GSFDETCTRFYTAE-IVSA 144
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGY 913
           L YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQY 200
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + PE      A+   D+++ G ++ +L+ G  P 
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQH 797
            NF +   IG G +G+VY+A     G  VA+K++  D    G      R E+  L    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
           PN+V L      +N   L++  +      +     L G P  L       + QG    LA
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQG----LA 116
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H      +LHRD+K  N+L++      LADFGLAR    P  T+  T  V TL Y  P
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAP 171
Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGK 944
           E      Y   +V     D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYC 807
           +G G FG V+       G    IK ++ D  Q+  E   AE+E L    HPN++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
              ++  ++    E G L   +        +L       + +     LAY H     H++
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 868 HRDIKSSNILLDGNFGAH----LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
           H+D+K  NIL   +   H    + DFGLA L  S  D H +T+  GT  Y+ PE  +  V
Sbjct: 147 HKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKS--DEH-STNAAGTALYMAPEVFKRDV 202
Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
            T+K D++S GVV+  LLTG  P
Sbjct: 203 -TFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRL-SGDCGQMEREFRAEVE 790
           IL+ T  F +  ++G G FG VY+   +P+G  V    AIK L      +  +E   E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS---LDWDSRLHI 847
            ++   +P++  L G C+    +L I   M  G L  ++ E  D   S   L+W  ++  
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 130
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
               A+G+ YL    +  ++HRD+ + N+L+       + DFG A+L+ +    +     
Sbjct: 131 ----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMD 948
              + ++  E     + T++ DV+S+GV + EL+T G +P D
Sbjct: 184 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 750 IGCGGFGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVH 802
           +G   FG VY+  L         + VAIK L     G +  EFR E    +R QHPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWL-----HEKLDG-------PSSLDWDSRLHIAQG 850
           L G         +I+S+  +G L  +L     H  +          S+L+    +H+   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A G+ YL      H++H+D+ + N+L+       ++D GL R + +     +  + +  
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 911 LGYIPPE---YGQASVATYKGDVYSFGVVLLELLT 942
           + ++ PE   YG+ S+ +   D++S+GVVL E+ +
Sbjct: 194 IRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFS 225

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           +G G +G+V+++     G  VA+K++     +    +R FR  +     + H N+V+L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 806 YCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                NDR   L++ +ME       LH  +   + L+   + ++     + + YLH    
Sbjct: 77  VLRADNDRDVYLVFDYMETD-----LHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY-------------------DTHVT 904
             +LHRD+K SNILL+      +ADFGL+R  ++                     D  + 
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 905 TDLVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGK 944
           TD V T  Y  PE    S    KG D++S G +L E+L GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YL+       +HRD+ + N ++  +F   + DFG+ R I            +  + ++ P
Sbjct: 145  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E  +  V T   D++SFGVVL E+ +  ++P                     +   +E +
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGLSNEQV 241
Query: 976  DPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
              F+ D     Q D    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 242  LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 18   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 77   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 134
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I            +  + +
Sbjct: 135  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 191
Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            + PE  +  V T   DV+SFGVVL E+ T  ++P                  +  E    
Sbjct: 192  MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSNEQVLR 236
Query: 973  EVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             V++  + DK  +  +ML  L++  +C   +PK+RP+  +++S
Sbjct: 237  FVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIIS 277

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 32/229 (13%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N +   ++G G FG V  AT            VA+K L       ERE   +E++ +++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 795 -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS--------------- 838
              H N+V+L G C       LI+ +   G L  +L  K +  S                
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 839 ----LDWDSRLHIAQGAARGLAYLH-QSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR 893
               L ++  L  A   A+G+ +L  +SC    +HRD+ + N+L+       + DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
            I+S  +  V  +    + ++ PE     + T K DV+S+G++L E+ +
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP- 915
            YL+       +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G +P 
Sbjct: 145  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLPV 196
Query: 916  ----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR 970
                PE  +  V T   D++SFGVVL E+ +  ++P                     +  
Sbjct: 197  RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGL 236
Query: 971  ESEVLDPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
             +E +  F+ D     Q D    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 237  SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/310 (26%), Positives = 136/310 (43%), Gaps = 41/310 (13%)
Query: 728  KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLP--DGR--NVAIKRLSGDCGQME- 782
            KEK   ++D+L     F    ++G G FG V  A L   DG    VA+K L  D      
Sbjct: 12   KEK---LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 783  -REFRAEVEALSRAQHPNLVHLQGYCMHKNDR------LLIYSFMENGSLDYWLHEKLDG 835
              EF  E   +    HP++  L G  +    +      ++I  FM++G L  +L     G
Sbjct: 69   IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 836  --PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR 893
              P +L   + +      A G+ YL      + +HRD+ + N +L  +    +ADFGL+R
Sbjct: 129  ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 894  LILSP--YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMC 950
             I S   Y     + L   + ++  E    ++ T   DV++FGV + E++T G+ P    
Sbjct: 186  KIYSGDYYRQGCASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
Query: 951  KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010
            +   + ++ +++I     NR           KQ  + M  V D+   C S  PK RP+  
Sbjct: 244  E---NAEIYNYLI---GGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFT 287
Query: 1011 QLVSWLDSII 1020
             L   L++I+
Sbjct: 288  CLRMELENIL 297

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 22   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 82   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YL+       +HRD+ + N ++  +F   + DFG+ R I            +  + ++ P
Sbjct: 142  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E  +  V T   D++SFGVVL E+ +  ++P                     +   +E +
Sbjct: 199  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGLSNEQV 238
Query: 976  DPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
              F+ D     Q D    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 239  LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 117/289 (40%), Gaps = 49/289 (16%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 24   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 84   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP- 915
            YL+       +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G +P 
Sbjct: 144  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLPV 195
Query: 916  ----PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
                PE  +  V T   D++SFGVVL E                   I+ +     +   
Sbjct: 196  RWMAPESLKDGVFTTSSDMWSFGVVLWE-------------------ITSLAEQPYQGLS 236
Query: 972  SEVLDPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            +E +  F+ D     Q D    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 237  NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 69/221 (31%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRL-----SGDCGQMEREFRAEVEALS 793
           +T+ ++    IG G +G VY+A  P  G  VA+K +      G  G +      EV  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 794 RAQ---HPNLVHLQGYC-MHKNDRLLIYSFMENGSLDYWLHEKLDG--PSSLDWDSRLHI 847
           R +   HPN+V L   C   + DR +  + +    +D  L   LD   P  L  ++   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TD 906
            +   RGL +LH +C   I+HRD+K  NIL+       LADFGLAR+    Y   +  T 
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI----YSYQMALTP 178
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           +V TL Y  PE    S      D++S G +  E+   ++P+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 79   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 136
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N  +  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 137  GMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 188
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 189  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 233
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML  L++  +C   +PK+RP+  +++S
Sbjct: 234  EQVLRFVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIIS 279

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 51/290 (17%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP- 915
            YL+       +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G +P 
Sbjct: 145  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI---YETAYYRK--GGKGLLPV 196
Query: 916  ----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR 970
                PE  +  V T   D++SFGVVL E+ +  ++P                     +  
Sbjct: 197  RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGL 236
Query: 971  ESEVLDPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
             +E +  F+ D     Q D    RV D+  +C   +PK+RPT  ++V+ L
Sbjct: 237  SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQH 797
            +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 798 PNLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARG 854
           P  V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     
Sbjct: 95  PFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSA 147
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGY 913
           L YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQY 203
Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + PE      A    D+++ G ++ +L+ G  P 
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I ++   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 33   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 92   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGEIAD 149
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 150  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 201
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 202  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 246
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 247  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 24   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 83   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 140
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 141  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 192
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 193  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 237
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 238  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 20   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 79   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 136
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 137  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 188
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 189  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 233
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 234  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 23   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 82   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGEIAD 139
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 140  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 191
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 192  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 236
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 237  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 55   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 114  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 171
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 172  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 223
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 224  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 268
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 269  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 314

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 26   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 85   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 142
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 143  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 194
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 195  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 239
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 240  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 26   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 85   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 142
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 143  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 194
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 195  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 239
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 240  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 33   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 92   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 149
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 150  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 201
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 202  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 246
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 247  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 292

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 27   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 86   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 143
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I   Y+T       G  G 
Sbjct: 144  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYRK--GGKGL 195
Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ 967
            +P     PE  +  V T   DV+SFGVVL E+ T  ++P                  +  
Sbjct: 196  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSN 240
Query: 968  ENRESEVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E     V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 241  EQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 750 IGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G FG V    YR     G  VA+K +  D     + F AE   +++ +H NLV L G
Sbjct: 20  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 806 YCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             + +   L I + +M  GSL  +L  +  G S L  D  L  +      + YL  +   
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 127
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
           + +HRD+ + N+L+  +  A ++DFGL +   S  DT       G L   +  PE  + +
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREA 180
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             + K DV+SFG++L E+ + G+ P
Sbjct: 181 AFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 111/235 (47%), Gaps = 23/235 (9%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV----AIKRLSGDCG-QMEREFRAEVE 790
           IL+ T    +  ++G G FG VY+   +PDG NV    AIK L  +   +  +E   E  
Sbjct: 13  ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHI 847
            ++    P +  L G C+    +L +   M  G L   + E   +L     L+W  ++  
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI-- 128
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHVTTD 906
               A+G++YL    +  ++HRD+ + N+L+       + DFGLARL+ +   + H    
Sbjct: 129 ----AKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 181
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLIS 960
            V  + ++  E       T++ DV+S+GV + EL+T G +P D    +   DL+ 
Sbjct: 182 KV-PIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N       +G G FG V  AT            VA+K L       ERE   +E++ LS 
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRL- 845
               H N+V+L G C      L+I  +   G L  +L  K D        P+ ++ D    
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 846  ------HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                    +   A+G+A+L      + +HRD+ + NILL       + DFGLAR I +  
Sbjct: 143  DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL 958
            +  V  +    + ++ PE     V T++ DV+S+G+ L EL + G  P     P    D 
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD- 254
Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
             S   +M +E     +L P    +    EM    DI   C    P  RPT +Q+V  ++ 
Sbjct: 255  -SKFYKMIKEG--FRMLSP----EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 1019 II 1020
             I
Sbjct: 305  QI 306

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW--------------DSRL 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 154  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 210  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 270  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 77   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 137  IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 195  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 251  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 311  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 351

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N       +G G FG V  AT            VA+K L       ERE   +E++ LS 
Sbjct: 39   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRL- 845
               H N+V+L G C      L+I  +   G L  +L  K D        P+ ++ D    
Sbjct: 99   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 846  ------HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                    +   A+G+A+L      + +HRD+ + NILL       + DFGLAR I +  
Sbjct: 159  DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL 958
            +  V  +    + ++ PE     V T++ DV+S+G+ L EL + G  P     P    D 
Sbjct: 216  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD- 270
Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
             S   +M +E     +L P    +    EM    DI   C    P  RPT +Q+V  ++ 
Sbjct: 271  -SKFYKMIKEG--FRMLSP----EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 320
Query: 1019 II 1020
             I
Sbjct: 321  QI 322

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 89   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 149  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 209  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 265  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 324
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 325  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 363

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSG-DCGQMEREFRAEVEALS 793
           ++N+D    +G G F +V R            + +  K+LS  D  ++ERE R       
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CR 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + QHPN+V L      ++   L++  +  G L     E +            H  Q    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
            +AY H +    I+HR++K  N+LL          LADFGLA   +   D+       GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGT 170
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +    +   D+++ GV+L  LL G  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 145
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 201
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N       +G G FG V  AT            VA+K L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRLH 846
               H N+V+L G C      L+I  +   G L  +L  K D        P+ ++ D    
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 847  -------IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                    +   A+G+A+L      + +HRD+ + NILL       + DFGLAR I +  
Sbjct: 166  DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL 958
            +  V  +    + ++ PE     V T++ DV+S+G+ L EL + G  P     P    D 
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD- 277
Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
             S   +M +E     +L P    +    EM    DI   C    P  RPT +Q+V  ++ 
Sbjct: 278  -SKFYKMIKEG--FRMLSP----EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 1019 II 1020
             I
Sbjct: 328  QI 329

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            +++L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 750 IGCGGFGLVYRATLPDGRN-VAIK----------RLSGDCGQMER---EFRAEVEALSRA 795
           +G G +G V      +G +  AIK          R S D   +E+   E   E+  L   
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            HPN++ L      K    L+  F E G     L E++      D     +I +    G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSGI 159
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH+    +I+HRDIK  NILL+         + DFGL+      Y      D +GT  
Sbjct: 160 CYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAY 213
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           YI PE  +      K DV+S GV++  LL G  P 
Sbjct: 214 YIAPEVLKKKYNE-KCDVWSCGVIMYILLCGYPPF 247

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSG-DCGQMEREFRAEVEALS 793
           ++N+D    +G G F +V R            + +  K+LS  D  ++ERE R       
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CR 83
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + QHPN+V L      ++   L++  +  G L     E +            H  Q    
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 139
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
            +AY H +    I+HR++K  N+LL          LADFGLA   +   D+       GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGT 193
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +    +   D+++ GV+L  LL G  P 
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 68  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 120
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 121 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 176
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 143
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANAFVGTAQYV 199
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 143
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 199
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 70  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 122
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 123 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 178
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 71  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 123
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 124 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 179
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 145
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 201
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 145
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 201
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 75  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 127
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 128 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 183
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 69  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 121
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 122 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 177
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 142
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 198
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 90  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 142
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 143 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYV 198
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 143
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 199
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 146
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 202
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 145
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 201
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 93  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 145
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 146 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 201
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F  V  A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 94  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 146
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 147 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQYV 202
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N       +G G FG V  AT            VA+K L       ERE   +E++ LS 
Sbjct: 41   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRLH 846
               H N+V+L G C      L+I  +   G L  +L  K D        P+ ++ D    
Sbjct: 101  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 847  -------IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                    +   A+G+A+L      + +HRD+ + NILL       + DFGLAR I +  
Sbjct: 161  DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL 958
            +  V  +    + ++ PE     V T++ DV+S+G+ L EL + G  P     P    D 
Sbjct: 218  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD- 272
Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
             S   +M +E     +L P    +    EM    DI   C    P  RPT +Q+V  ++ 
Sbjct: 273  -SKFYKMIKEG--FRMLSP----EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 322
Query: 1019 II 1020
             I
Sbjct: 323  QI 324

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSG-DCGQMEREFRAEVEALS 793
           ++N+D    +G G F +V R            + +  K+LS  D  ++ERE R       
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CR 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + QHPN+V L      ++   L++  +  G L     E +            H  Q    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
            +AY H +    I+HR++K  N+LL          LADFGLA   +   D+       GT
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGT 170
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +    +   D+++ GV+L  LL G  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 742 NNFDQANIIGCGGFG---LVYRATLPDGRNV-AIKRLSGDCGQMEREFRAEVE--ALSRA 795
           + F+   ++G G FG   LV + +  D R + A+K L     ++    R ++E   L   
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 796 QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP +V L  Y      +L LI  F+  G L   L +++      + D + ++A+  A  
Sbjct: 85  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALA 139
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L +LH      I++RD+K  NILLD      L DFGL++  +            GT+ Y+
Sbjct: 140 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYM 194
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE       T   D +SFGV++ E+LTG  P
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 742 NNFDQANIIGCGGFG---LVYRATLPDGRNV-AIKRLSGDCGQMEREFRAEVE--ALSRA 795
           + F+   ++G G FG   LV + +  D R + A+K L     ++    R ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 796 QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP +V L  Y      +L LI  F+  G L   L +++      + D + ++A+  A  
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALA 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L +LH      I++RD+K  NILLD      L DFGL++  +            GT+ Y+
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYM 193
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE       T   D +SFGV++ E+LTG  P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 742 NNFDQANIIGCGGFG---LVYRATLPDGRNV-AIKRLSGDCGQMEREFRAEVE--ALSRA 795
           + F+   ++G G FG   LV + +  D R + A+K L     ++    R ++E   L   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 796 QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            HP +V L  Y      +L LI  F+  G L   L +++      + D + ++A+  A  
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAE-LALA 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L +LH      I++RD+K  NILLD      L DFGL++  +            GT+ Y+
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYM 193
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE       T   D +SFGV++ E+LTG  P
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 750 IGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G FG V    YR     G  VA+K +  D     + F AE   +++ +H NLV L G
Sbjct: 14  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 806 YCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             + +   L I + +M  GSL  +L  +  G S L  D  L  +      + YL  +   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
           + +HRD+ + N+L+  +  A ++DFGL +   S  DT       G L   +  PE  +  
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREK 174
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             + K DV+SFG++L E+ + G+ P
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  GR VA+K +     +   +++ FR EV  +    HP
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 128
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR--LILSPYDTHVTTDLVGTLGYI 914
           Y HQ    +I+HRD+K+ N+LLDG+    +ADFG +    + +  DT       G+  Y 
Sbjct: 129 YCHQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-----FCGSPPYA 180
Query: 915 PPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 181 APELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 126/302 (41%), Gaps = 41/302 (13%)
Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            N       +G G FG V  AT            VA+K L       ERE   +E++ LS 
Sbjct: 46   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 795  -AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-------PSSLDWDSRLH 846
               H N+V+L G C      L+I  +   G L  +L  K D        P+ ++ D    
Sbjct: 106  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 847  -------IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                    +   A+G+A+L      + +HRD+ + NILL       + DFGLAR I +  
Sbjct: 166  DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDL 958
            +  V  +    + ++ PE     V T++ DV+S+G+ L EL + G  P     P    D 
Sbjct: 223  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGMPVD- 277
Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018
             S   +M +E     +L P    +    EM    DI   C    P  RPT +Q+V  ++ 
Sbjct: 278  -SKFYKMIKEG--FRMLSP----EHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 1019 II 1020
             I
Sbjct: 328  QI 329

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 750  IGCGGFGLVYRATL-------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
            +G G FG+VY           P+ R VAIK ++      ER EF  E   +      ++V
Sbjct: 27   LGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL--------HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G        L+I   M  G L  +L        +  +  P SL     + +A   A 
Sbjct: 86   RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIAD 143
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I            +  + +
Sbjct: 144  GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            + PE  +  V T   DV+SFGVVL E+ T  ++P                  +  E    
Sbjct: 201  MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ---------------GLSNEQVLR 245
Query: 973  EVLDPFIYDKQHD-KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             V++  + DK  +  +ML   ++  +C   +PK+RP+  +++S
Sbjct: 246  FVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 286

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 28   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 88   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 146  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 202  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 261
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 262  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 302

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 25   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 85   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 143  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 199  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 258
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 259  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 154  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 210  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 270  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--EPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 154  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 210  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 270  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQG 805
           +G G FG V  AT     + VA+K +S        M      E+  L   +HP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                 D +++  +      DY + +K      +  D      Q     + Y H+     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV-A 924
           I+HRD+K  N+LLD N    +ADFGL+ ++    D +      G+  Y  PE     + A
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
             + DV+S G+VL  +L G+ P D
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 29   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR--------------L 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 89   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 147  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 203  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 262
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 263  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 303

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 21   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW--------------DSRL 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 81   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 139  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 195  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 255  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 295

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 769  VAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
            VA+K L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L 
Sbjct: 57   VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 827  YWLHEKLDGPSSLDWD-SRLHIAQGA-----------ARGLAYL-HQSCEPHILHRDIKS 873
             +L  +        +D +R+   Q             ARG+ YL  Q C    +HRD+ +
Sbjct: 117  EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLTA 172
Query: 874  SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSF 933
             N+L+  N    +ADFGLAR I +      TT+    + ++ PE     V T++ DV+SF
Sbjct: 173  RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 232
Query: 934  GVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL 992
            GV++ E+ T G  P      +    L+    RM +    +  L   + D           
Sbjct: 233  GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD----------- 281
Query: 993  DIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 C    P  RPT +QLV  LD I+
Sbjct: 282  -----CWHAVPSQRPTFKQLVEDLDRIL 304

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 769  VAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
            VA+K L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L 
Sbjct: 62   VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 827  YWLHEKLDGPSSLDWD-SRLHIAQGA-----------ARGLAYL-HQSCEPHILHRDIKS 873
             +L  +        +D +R+   Q             ARG+ YL  Q C    +HRD+ +
Sbjct: 122  EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAA 177
Query: 874  SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSF 933
             N+L+  N    +ADFGLAR I +      TT+    + ++ PE     V T++ DV+SF
Sbjct: 178  RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 237
Query: 934  GVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL 992
            GV++ E+ T G  P      +    L+    RM +    +  L   + D           
Sbjct: 238  GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD----------- 286
Query: 993  DIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 C    P  RPT +QLV  LD I+
Sbjct: 287  -----CWHAVPSQRPTFKQLVEDLDRIL 309

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 750 IGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G FG V    YR     G  VA+K +  D     + F AE   +++ +H NLV L G
Sbjct: 201 IGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 806 YCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             + +   L I + +M  GSL  +L  +  G S L  D  L  +      + YL  +   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
           + +HRD+ + N+L+  +  A ++DFGL +   S  DT       G L   +  PE  +  
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREK 361
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             + K DV+SFG++L E+ + G+ P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 769  VAIKRLSGDCGQME-REFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
            VA+K L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L 
Sbjct: 59   VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 827  YWLHEKLDGPSSLDWD-SRLHIAQGA-----------ARGLAYL-HQSCEPHILHRDIKS 873
             +L  +        +D +R+   Q             ARG+ YL  Q C    +HRD+ +
Sbjct: 119  EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAA 174
Query: 874  SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSF 933
             N+L+  N    +ADFGLAR I +      TT+    + ++ PE     V T++ DV+SF
Sbjct: 175  RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 234
Query: 934  GVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL 992
            GV++ E+ T G  P      +    L+    RM +    +  L   + D           
Sbjct: 235  GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD----------- 283
Query: 993  DIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 C    P  RPT +QLV  LD I+
Sbjct: 284  -----CWHAVPSQRPTFKQLVEDLDRIL 306

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 750 IGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G FG V    YR     G  VA+K +  D     + F AE   +++ +H NLV L G
Sbjct: 29  IGKGEFGDVMLGDYR-----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 806 YCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
             + +   L I + +M  GSL  +L  +  G S L  D  L  +      + YL  +   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
           + +HRD+ + N+L+  +  A ++DFGL +   S  DT       G L   +  PE  +  
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------GKLPVKWTAPEALREK 189
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             + K DV+SFG++L E+ + G+ P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 750  IGCGGFGLVYRATL--------PDGRNVAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A           +   VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGA------- 851
            ++ L G C       +I  +   G+L  +L  +        +D +R+   Q         
Sbjct: 103  IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 852  ----ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
                ARG+ YL  Q C    +HRD+ + N+L+  N    +ADFGLAR I +      TT+
Sbjct: 163  TYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 907  LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM 965
                + ++ PE     V T++ DV+SFGV++ E+ T G  P      +    L+    RM
Sbjct: 219  GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM 278
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 279  DKPANCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIL 317

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDC-GQMEREFRAEVE-ALSRAQHPNLVHLQGY 806
            +G G +G+V +   +P G+ +A+KR+      Q ++    +++ ++     P  V   G 
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 807  CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
               + D  +    M+  SLD +  + +D   ++  D    IA    + L +LH      +
Sbjct: 75   LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-VGTLGYIPPEYGQASVA- 924
            +HRD+K SN+L++      + DFG++  ++      V  D+  G   Y+ PE     +  
Sbjct: 132  IHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPELNQ 187
Query: 925  ---TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
               + K D++S G+ ++EL   + P D           SW    +Q  +  E   P +  
Sbjct: 188  KGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL-- 234
Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
               DK     +D    CL ++ K RPT  +L+
Sbjct: 235  -PADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 34/284 (11%)
Query: 735  DDILESTNNFDQANIIGCGGFGLVYRATLPDGRN---VAIKRLS-GDCGQMEREFRAEVE 790
            ++I +    F +   IG G FG V++    D R    VAIK +   +      + + E+ 
Sbjct: 16   NNIADPEELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEIT 73
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             LS+     +    G  +  +   +I  ++  GS    L     GP   D      + + 
Sbjct: 74   VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA---GP--FDEFQIATMLKE 128
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVG 909
              +GL YLH   +   +HRDIK++N+LL       LADFG+A  +    DT +  +  VG
Sbjct: 129  ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVG 182
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN 969
            T  ++ PE  Q S    K D++S G+  +EL  G+ P     P         V+ +  +N
Sbjct: 183  TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLIPKN 235
Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
                ++  F       K     +D    CL++ P  RPT ++L+
Sbjct: 236  NPPTLVGDFT------KSFKEFIDA---CLNKDPSFRPTAKELL 270

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 750  IGCGGFGLVYRATL----PDGRN----VAIKRLSGDCGQME-REFRAEVEALSR-AQHPN 799
            +G G FG V  A       D  N    VA+K L  D  + +  +  +E+E +    +H N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW--------------DSRL 845
            +++L G C       +I  +   G+L  +L  +   P  L++                 +
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQAR--RPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 846  HIAQGAARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
              A   ARG+ YL  + C    +HRD+ + N+L+  +    +ADFGLAR I        T
Sbjct: 154  SCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI 963
            T+    + ++ PE     + T++ DV+SFGV+L E+ T G  P      +    L+    
Sbjct: 210  TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 269
Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            RM + +  +  L   + D                C    P  RPT +QLV  LD I+
Sbjct: 270  RMDKPSNCTNELYMMMRD----------------CWHAVPSQRPTFKQLVEDLDRIV 310

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRL--SGDCGQMEREFRAEVEALSRAQHP 798
             +++   IG G +G+V++    D G+ VAIK+   S D   +++    E+  L + +HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR---LHIAQGAARGL 855
           NLV+L      K    L++ + ++  L    HE       LD   R    H+ +      
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVL----HE-------LDRYQRGVPEHLVKSITWQT 111
Query: 856 AYLHQSCEPH-ILHRDIKSSNILLDGNFGAHLADFGLARLILSP---YDTHVTTD----- 906
                 C  H  +HRD+K  NIL+  +    L DFG ARL+  P   YD  V T      
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 907 --LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             LVG   Y PP            DV++ G V  ELL+G
Sbjct: 172 ELLVGDTQYGPP-----------VDVWAIGCVFAELLSG 199

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 24/235 (10%)
Query: 740 STNNFDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA 795
           + N F Q  ++G GGFG V     RAT   G+  A K+L     +  ++ + E  AL+  
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEK---KRIKKRKGEAMALNEK 235
Query: 796 Q-----HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
           Q     +   V    Y     D L L+ + M  G L + ++    G +       +  A 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAA 293
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               GL  LH+     I++RD+K  NILLD +    ++D GLA  +  P +       VG
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVP-EGQTIKGRVG 347
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
           T+GY+ PE  +    T+  D ++ G +L E++ G+ P    K K  R+ +  +++
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 24/235 (10%)
Query: 740 STNNFDQANIIGCGGFGLV----YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA 795
           + N F Q  ++G GGFG V     RAT   G+  A K+L     +  ++ + E  AL+  
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEK---KRIKKRKGEAMALNEK 235
Query: 796 Q-----HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
           Q     +   V    Y     D L L+ + M  G L + ++    G +       +  A 
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAA 293
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               GL  LH+     I++RD+K  NILLD +    ++D GLA  +  P +       VG
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVP-EGQTIKGRVG 347
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
           T+GY+ PE  +    T+  D ++ G +L E++ G+ P    K K  R+ +  +++
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 32/285 (11%)
Query: 732  ISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVE 790
            +S  D  E   NF +   IG G  G+V  AT    G+ VA+K++     Q       EV 
Sbjct: 38   VSPGDPREYLANFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV 94
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQ 849
             +    H N+V +    +  ++  ++  F+E G+L D   H +++       +    +  
Sbjct: 95   IMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQIATVCL 148
Query: 850  GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               R L+YLH      ++HRDIKS +ILL  +    L+DFG    +    +      LVG
Sbjct: 149  SVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKXLVG 203
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN 969
            T  ++ PE         + D++S G++++E++ G+ P     P            ++   
Sbjct: 204  TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------------LQAMR 251
Query: 970  RESEVLDPFIYDKQHDKEMLR-VLDIACLCLSESPKVRPTTQQLV 1013
            R  + L P + D      +LR  LD   L L   P  R T Q+L+
Sbjct: 252  RIRDSLPPRVKDLHKVSSVLRGFLD---LMLVREPSQRATAQELL 293

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 115/285 (40%), Gaps = 41/285 (14%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YL+       +HRD+ + N ++  +F   + DFG+ R I            +  + ++ P
Sbjct: 145  YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E  +  V T   D++SFGVVL E+ +  ++P                     +   +E +
Sbjct: 202  ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGLSNEQV 241
Query: 976  DPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
              F+ D     Q D    RV D+  +C   +P +RPT  ++V+ L
Sbjct: 242  LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 33/269 (12%)
Query: 750  IGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            IG G  G+V  A     GR VA+K +     Q       EV  +   QH N+V +    +
Sbjct: 53   IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
               +  ++  F++ G+L       +     L+ +    + +   + LAYLH      ++H
Sbjct: 113  VGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
            RDIKS +ILL  +    L+DFG    I    D      LVGT  ++ PE    S+   + 
Sbjct: 165  RDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 929  DVYSFGVVLLELLTGKRPMDMCKP----KGSRDLISWVIRMRQENRESEVLDPFIYDKQH 984
            D++S G++++E++ G+ P     P    K  RD  S   +++  ++ S VL  F+     
Sbjct: 223  DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFL----- 275
Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              E + V D         P+ R T Q+L+
Sbjct: 276  --ERMLVRD---------PQERATAQELL 293

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 36/237 (15%)
Query: 738 LESTNNFDQAN---IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           LE    +D+     ++G G +G+VY    L +   +AIK +     +  +    E+    
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMEN---GSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             +H N+V    Y    ++   I  FME    GSL   L  K  GP   +  +     + 
Sbjct: 61  HLKHKNIVQ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQ 116
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLI--LSPYDTHVTTDL 907
              GL YLH +    I+HRDIK  N+L++   G   ++DFG ++ +  ++P     T   
Sbjct: 117 ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CTETF 169
Query: 908 VGTLGYIPPE--------YGQASVATYKGDVYSFGVVLLELLTGKRPM-DMCKPKGS 955
            GTL Y+ PE        YG+A+      D++S G  ++E+ TGK P  ++ +P+ +
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPPFYELGEPQAA 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA+K +     +   +++ FR EV  +    HP
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAA 852
           N+V L      +    L+  +   G + DY     W+ EK         ++R    Q  +
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK---------EARAKFRQIVS 117
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             + Y HQ     I+HRD+K+ N+LLD +    +ADFG +      +   + T   G+  
Sbjct: 118 -AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDT-FCGSPP 170
Query: 913 YIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           Y  PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 171 YAAPELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 750  IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G G FG V      P G N    VA+K+L       +R+F+ E++ L       +V  +
Sbjct: 31   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 805  G--YCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARGLAYL- 858
            G  Y   +    L+  ++ +G L  +L     +LD    L + S++       +G+ YL 
Sbjct: 91   GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYLG 144
Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPE 917
             + C    +HRD+ + NIL++      +ADFGLA+L+    D +V  +   + + +  PE
Sbjct: 145  SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
                ++ + + DV+SFGVVL EL T       C P          +RM    R+   L  
Sbjct: 201  SLSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAE------FLRMMGCERDVPALSR 252
Query: 978  FIYDKQHDKEM-------LRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             +   +  + +         V ++  LC + SP+ RP+   L   LD +
Sbjct: 253  LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 743 NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHP 798
           +F    I+G G F     A  L   R  AIK L       E +      E + +SR  HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 799 NLVHLQGYCMHKNDRLLIY--SFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAARGL 855
             V L  Y   ++D  L +  S+ +NG L  ++ +      S D   +R + A+     L
Sbjct: 91  FFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAE-IVSAL 143
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYI 914
            YLH      I+HRD+K  NILL+ +    + DFG A+ +LSP       +  VGT  Y+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANXFVGTAQYV 199
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            PE      A    D+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 38/215 (17%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYC 807
           +G G +G V+R +   G NVA+K  S    + E+ +  E E  +    +H N++      
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 808 M---HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH---- 859
           M   H + +L LI  + E GSL  +L       ++LD  S L I    A GLA+LH    
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 860 -QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-------VGTL 911
               +P I HRD+KS NIL+  N    +AD GLA +      +  T  L       VGT 
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM-----HSQSTNQLDVGNNPRVGTK 210
Query: 912 GYIPPEYGQASVA-----TYKG-DVYSFGVVLLEL 940
            Y+ PE    ++      +YK  D+++FG+VL E+
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSG-DCGQMEREFRAEVEALS 793
           ++N+D    +G G F +V R            + +  K+LS  D  ++ERE R       
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI----CR 59
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           + QHPN+V L      ++   L++  +  G L     E +            H  Q    
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 115
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
            +AY H +    I+HR++K  N+LL          LADFGLA   +   D+       GT
Sbjct: 116 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGT 169
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            GY+ PE  +    +   D+++ GV+L  LL G  P
Sbjct: 170 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 750  IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G G FG V      P G N    VA+K+L       +R+F+ E++ L       +V  +
Sbjct: 18   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 805  G--YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            G  Y   +    L+  ++ +G L  +L       + LD    L  +    +G+ YL    
Sbjct: 78   GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR- 133
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-VGTLGYIPPEYGQA 921
                +HRD+ + NIL++      +ADFGLA+L+    D +V  +     + +  PE    
Sbjct: 134  --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 922  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
            ++ + + DV+SFGVVL EL T       C P          +RM    R+   L   +  
Sbjct: 192  NIFSRQSDVWSFGVVLYELFTYCD--KSCSPSAE------FLRMMGSERDVPALSRLLEL 243
Query: 982  KQHDKEM-------LRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             +  + +         V ++  LC + SP+ RP+   L   LD +
Sbjct: 244  LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 288

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 735 DDILESTNNFDQAN--------IIGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMEREF 785
           +D  + +NN D+          ++G G FG V  A       + AIK L  D    + + 
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDV 63
Query: 786 R---AEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSL 839
                E   L+    P  +     C    DRL  +  ++  G L Y + +  K   P ++
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
            + + + I      GL +LH+     I++RD+K  N++LD      +ADFG+ +  +   
Sbjct: 124 FYAAEISI------GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM-- 172
Query: 900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           D   T +  GT  YI PE           D +++GV+L E+L G+ P D
Sbjct: 173 DGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFG---LVYRATLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ 796
           N+     +G G FG   L Y  T   G+ VA+K ++        M+     E+  L   +
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           HP+++ L      K++ +++  +  N   DY +         +         Q     + 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-----DKMSEQEARRFFQQIISAVE 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     I+HRD+K  N+LLD +    +ADFGL+ ++    D +      G+  Y  P
Sbjct: 128 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 181
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   DV+S GV+L  +L  + P D
Sbjct: 182 EV--ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 38/215 (17%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYC 807
           +G G +G V+R +   G NVA+K  S    + E+ +  E E  +    +H N++      
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 808 M---HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC- 862
           M   H + +L LI  + E GSL  +L       ++LD  S L I    A GLA+LH    
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 863 ----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-------VGTL 911
               +P I HRD+KS NIL+  N    +AD GLA +      +  T  L       VGT 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM-----HSQSTNQLDVGNNPRVGTK 181
Query: 912 GYIPPEYGQASVA-----TYKG-DVYSFGVVLLEL 940
            Y+ PE    ++      +YK  D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFG---LVYRATLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ 796
           N+     +G G FG   L Y  T   G+ VA+K ++        M+     E+  L   +
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           HP+++ L      K++ +++  +  N   DY +         +         Q     + 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-----DKMSEQEARRFFQQIISAVE 117
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     I+HRD+K  N+LLD +    +ADFGL+ ++    D +      G+  Y  P
Sbjct: 118 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 171
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   DV+S GV+L  +L  + P D
Sbjct: 172 EV--ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFG---LVYRATLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ 796
           N+     +G G FG   L Y  T   G+ VA+K ++        M+     E+  L   +
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           HP+++ L      K++ +++  +  N   DY +         +         Q     + 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-----DKMSEQEARRFFQQIISAVE 126
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     I+HRD+K  N+LLD +    +ADFGL+ ++    D +      G+  Y  P
Sbjct: 127 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 180
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   DV+S GV+L  +L  + P D
Sbjct: 181 EV--ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 750  IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG VY+A   + G   A K +     +   ++  E+E L+   HP +V L G   
Sbjct: 19   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            H     ++  F   G++D  + E   G +         + +     L +LH      I+H
Sbjct: 79   HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK---RIIH 132
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT--- 925
            RD+K+ N+L+       LADFG++   L           +GT  ++ PE           
Sbjct: 133  RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMKDTP 190
Query: 926  --YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
              YK D++S G+ L+E+   + P     P      +  ++++ + +  + +L P      
Sbjct: 191  YDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPT-LLTP------ 237
Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              K  +   D   + L ++P+ RP+  QL+
Sbjct: 238  -SKWSVEFRDFLKIALDKNPETRPSAAQLL 266

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 28/270 (10%)
Query: 750  IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG VY+A   + G   A K +     +   ++  E+E L+   HP +V L G   
Sbjct: 27   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            H     ++  F   G++D  + E   G +         + +     L +LH      I+H
Sbjct: 87   HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---VCRQMLEALNFLHSK---RIIH 140
Query: 869  RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT--- 925
            RD+K+ N+L+       LADFG++   L           +GT  ++ PE           
Sbjct: 141  RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMKDTP 198
Query: 926  --YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ 983
              YK D++S G+ L+E+   + P     P      +  ++++ + +  + +L P      
Sbjct: 199  YDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDPPT-LLTP------ 245
Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              K  +   D   + L ++P+ RP+  QL+
Sbjct: 246  -SKWSVEFRDFLKIALDKNPETRPSAAQLL 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFG---LVYRATLPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQ 796
           N+     +G G FG   L Y  T   G+ VA+K ++        M+     E+  L   +
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           HP+++ L      K++ +++  +  N   DY +         +         Q     + 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-----DKMSEQEARRFFQQIISAVE 121
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     I+HRD+K  N+LLD +    +ADFGL+ ++    D +      G+  Y  P
Sbjct: 122 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAP 175
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   DV+S GV+L  +L  + P D
Sbjct: 176 EV--ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +    +IG G FG+V++A L +   VAIK++  D    +R    E++ +   +HPN+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDL 97
Query: 804 QGYCMHKNDRL------LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           + +     D+       L+  ++         H      +      +L++ Q   R LAY
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAY 156
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           +H      I HRDIK  N+LLD   G   L DFG A+++++          + +  Y  P
Sbjct: 157 IHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---GEPNVSXICSRYYRAP 210
Query: 917 E--YGQASVATYKGDVYSFGVVLLELLTGK 944
           E  +G A+  T   D++S G V+ EL+ G+
Sbjct: 211 ELIFG-ATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 38/215 (17%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYC 807
           +G G +G V+R +   G NVA+K  S    + E+ +  E E  +    +H N++      
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 808 M---HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC- 862
           M   H + +L LI  + E GSL  +L       ++LD  S L I    A GLA+LH    
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 863 ----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-------VGTL 911
               +P I HRD+KS NIL+  N    +AD GLA +      +  T  L       VGT 
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM-----HSQSTNQLDVGNNPRVGTK 181
Query: 912 GYIPPEYGQASVA-----TYKG-DVYSFGVVLLEL 940
            Y+ PE    ++      +YK  D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/341 (23%), Positives = 134/341 (39%), Gaps = 89/341 (26%)
Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
             +F+    +G GGFG+V+ A    D  N AIKR+     ++ RE    EV+AL++ +HP 
Sbjct: 6    TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 800  LVHLQGYCMH----KNDRLLIYSFMENGSLDYWLHEK--LDGPSSL-------------- 839
            +V      +     K    +   ++++ S D+ L     +D PS                
Sbjct: 66   IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 840  ------------------------DWDSR------------LHIAQGAARGLAYLHQSCE 863
                                    DW +R            LHI    A  + +LH    
Sbjct: 126  QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLA---------RLILSPYDTHVT-TDLVGTLGY 913
              ++HRD+K SNI    +    + DFGL          + +L+P   + T    VGT  Y
Sbjct: 185  --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLY 242
Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + PE    +  ++K D++S G++L ELL                  + + R+R       
Sbjct: 243  MSPEQIHGNNYSHKVDIFSLGLILFELLYS--------------FSTQMERVRIITDVRN 288
Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            +  P ++ +++ +E + V D+    LS SP  RP    ++ 
Sbjct: 289  LKFPLLFTQKYPQEHMMVQDM----LSPSPTERPEATDIIE 325

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 14/206 (6%)
Query: 746 QANIIGCGGFGLVYR-ATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +  I+G G FG V++      G  +A K +     + + E + E+  +++  H NL+ L 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLHIAQGAARGLAYLHQSCE 863
                KND +L+  +++ G L       +D   +L + D+ L + Q    G+ ++HQ   
Sbjct: 153 DAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTELDTILFMKQ-ICEGIRHMHQM-- 206
Query: 864 PHILHRDIKSSNILLDGNFGAHLA--DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
            +ILH D+K  NIL        +   DFGLAR         V     GT  ++ PE    
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNY 262
Query: 922 SVATYKGDVYSFGVVLLELLTGKRPM 947
              ++  D++S GV+   LL+G  P 
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 743 NFDQANIIGCGGFGLVYRATLPDGRN-VAIKRLSGDCGQM--EREFRAEVEALSRAQHPN 799
            + Q   IG G +G+V  A     +  VAIK++S    Q   +R  R E++ L R +H N
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHEN 102
Query: 800 LVHLQGYCMHKN-----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           ++ ++            D  ++   ME    D +   KL     L  D   +      RG
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMET---DLY---KLLKSQQLSNDHICYFLYQILRG 156
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGY 913
           L Y+H +   ++LHRD+K SN+L++      + DFGLAR+    +D T   T+ V T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 914 IPPEYGQASVATYKG-DVYSFGVVLLELLTGK 944
             PE    S    K  D++S G +L E+L+ +
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 734 IDDIL---ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFR 786
           I D+L    +   + +   +G GGF   Y  T  D + V   ++           + +  
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            E+       +P++V   G+    +   ++       SL   LH++    +  + ++R  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVT--EPEARYF 147
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           + Q   +G+ YLH +    ++HRD+K  N+ L+ +    + DFGLA  I   +D     D
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKD 201
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           L GT  YI PE       +++ D++S G +L  LL GK P +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 16/222 (7%)
Query: 734 IDDIL---ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFR 786
           I D+L    +   + +   +G GGF   Y  T  D + V   ++           + +  
Sbjct: 15  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 74
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            E+       +P++V   G+    +   ++       SL   LH++    +  + ++R  
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVT--EPEARYF 131
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           + Q   +G+ YLH +    ++HRD+K  N+ L+ +    + DFGLA  I   +D     D
Sbjct: 132 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKD 185
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           L GT  YI PE       +++ D++S G +L  LL GK P +
Sbjct: 186 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 142 SA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-----EPHILHR 869
           LI  + ENGSL  +L       ++LD  S L +A  +  GL +LH        +P I HR
Sbjct: 112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-----VGTLGYIPPEYGQASV- 923
           D+KS NIL+  N    +AD GLA   +S  DT+   D+     VGT  Y+PPE    S+ 
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFIS--DTN-EVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 924 -----ATYKGDVYSFGVVLLEL 940
                +    D+YSFG++L E+
Sbjct: 224 RNHFQSYIMADMYSFGLILWEV 245

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRL---SGDCGQMEREFRAEVEALSRAQH 797
             +++   IG G +G V++A   +    VA+KR+     D G      R E+  L   +H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 798 PNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            N+V L    +H + +L L++ F +     Y+  +  +G   LD +          +GL 
Sbjct: 61  KNIVRLHD-VLHSDKKLTLVFEFCDQDLKKYF--DSCNG--DLDPEIVKSFLFQLLKGLG 115
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H     ++LHRD+K  N+L++ N    LADFGLAR    P   +     V TL Y PP
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPP 170
Query: 917 E--YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           +  +G A + +   D++S G +  EL    RP+
Sbjct: 171 DVLFG-AKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 51/290 (17%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP- 915
            YL+       +HR++ + N ++  +F   + DFG+ R I   Y+T       G  G +P 
Sbjct: 145  YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLPV 196
Query: 916  ----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR 970
                PE  +  V T   D++SFGVVL E+ +  ++P                     +  
Sbjct: 197  RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGL 236
Query: 971  ESEVLDPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
             +E +  F+ D     Q D    RV D+  +C   +P +RPT  ++V+ L
Sbjct: 237  SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ-----MEREFRAEVEALSRAQHPNLVHL 803
           IG G FG V+   L  D   VA+K     C +     ++ +F  E   L +  HPN+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            G C  K    ++   ++ G  D+    + +G + L   + L +   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGG--DFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
              +HRD+ + N L+       ++DFG++R      +        G L  +P ++     
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVXAASGGLRQVPVKWTAPEA 286
Query: 924 ATY-----KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLIS 960
             Y     + DV+SFG++L E  + G  P      + +R+ + 
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 142 SA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIK-----RL-SGDCGQMEREFRAEVEALSR 794
           ++++    +G G F +V +      G+  A K     RL S   G    E   EV  L  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN++ L     +K D +LI   +  G L  +L EK     SL  D      +    G
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDG 141
Query: 855 LAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
           + YLH      I H D+K  NI LLD N       L DFG+A  I +  +     ++ GT
Sbjct: 142 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 195
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             ++ PE         + D++S GV+   LL+G  P 
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 142 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQ--MEREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 142 SA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 51/290 (17%)
Query: 750  IGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
            +G G FG+VY     D         VA+K ++      ER EF  E   +      ++V 
Sbjct: 26   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIAQGAARGLA 856
            L G        L++   M +G L  +L       E   G         + +A   A G+A
Sbjct: 86   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP- 915
            YL+       +HR++ + N ++  +F   + DFG+ R I   Y+T       G  G +P 
Sbjct: 146  YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDI---YETDYYRK--GGKGLLPV 197
Query: 916  ----PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENR 970
                PE  +  V T   D++SFGVVL E+ +  ++P                     +  
Sbjct: 198  RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--------------------QGL 237
Query: 971  ESEVLDPFIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
             +E +  F+ D     Q D    RV D+  +C   +P +RPT  ++V+ L
Sbjct: 238  SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  GR VAIK +     +   +++ FR EV  +    HP
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    LI  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-----EKEARSKFRQIVS-AVQ 125
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR--LILSPYDTHVTTDLVGTLGYI 914
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +    +    DT       G+  Y 
Sbjct: 126 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-----FCGSPPYA 177
Query: 915 PPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 178 APELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVH 802
            + +G G FG V        G  VA+K L+    +   +  + R E++ L   +HP+++ 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 803 LQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
           L       +D  ++  ++  G L DY           LD      + Q    G+ Y H+ 
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRH 135
Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
               ++HRD+K  N+LLD +  A +ADFGL+ ++    D        G+  Y  PE    
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRXSCGSPNYAAPEV--I 187
Query: 922 SVATYKG---DVYSFGVVLLELLTGKRPMD 948
           S   Y G   D++S GV+L  LL G  P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 36  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 92
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 147 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 37  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 93
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 148 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 28  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 84
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 139 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 29  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 85
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 140 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 89
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 144 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 29  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 85
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 140 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ-----MEREFRAEVEALSRAQHPNLVHL 803
           IG G FG V+   L  D   VA+K     C +     ++ +F  E   L +  HPN+V L
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
            G C  K    ++   ++ G  D+    + +G + L   + L +   AA G+ YL   C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGG--DFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
              +HRD+ + N L+       ++DFG++R      +        G L  +P ++     
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 924 ATY-----KGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLIS 960
             Y     + DV+SFG++L E  + G  P      + +R+ + 
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 39  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 95
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 150 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 31  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 142 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRAT--LPDGRNVAIKRL---SGDCGQMEREFR--A 787
           D +  +   ++    IG G +G V++A      GR VA+KR+   +G+ G      R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 788 EVEALSRAQHPNLVHLQGYC-MHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            +  L   +HPN+V L   C + + DR     L++  ++     Y   +K+  P      
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTET 121
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
            +  + Q   RGL +LH      ++HRD+K  NIL+  +    LADFGLAR+    Y   
Sbjct: 122 IKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQ 173
Query: 903 VT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           +  T +V TL Y  PE    S      D++S G +  E+   K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMEREFRAEV 789
           D  +    +    + +G G FG V      P G N    VA+K+L       +R+F+ E+
Sbjct: 4   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 63
Query: 790 EALSRAQHPNLVHLQG--YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           + L       +V  +G  Y   +    L+  ++ +G L  +L       + LD    L  
Sbjct: 64  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLY 120
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
           +    +G+ YL        +HRD+ + NIL++      +ADFGLA+L+    D +V  + 
Sbjct: 121 SSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 177
Query: 908 -VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT 942
               + +  PE    ++ + + DV+SFGVVL EL T
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 51  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 107
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 162 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 21/231 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNV----AIKRLSGDC----GQMEREFRAEVEALS 793
            NF+   ++G G +G V+      G +     A+K L         +     R E + L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 794 RA-QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              Q P LV L  Y      +L LI  ++  G L   L ++       + + ++++ +  
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGE-I 168
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L +LH+     I++RDIK  NILLD N    L DFGL++  ++  +T    D  GT+
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTI 224
Query: 912 GYIPPEY--GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
            Y+ P+   G  S      D +S GV++ ELLTG  P  +   K S+  IS
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 16/213 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFR---AEVEALSRAQ- 796
           +NF+   ++G G FG V  A + + G   A+K L  D    + +      E   LS A+ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 797 HPNLVHLQGYCMHKNDRLL-IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           HP L  L   C    DRL  +  F+  G L + + +        D       A      L
Sbjct: 83  HPFLTQL-FCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISAL 137
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            +LH      I++RD+K  N+LLD      LADFG+ +  +   +   T    GT  YI 
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIA 192
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE  Q  +     D ++ GV+L E+L G  P +
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--- 865
             ++  ++  F+E G+L           + +   +R++  Q AA  LA L      H   
Sbjct: 88  VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE        
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYG 194
Query: 926 YKGDVYSFGVVLLELLTGKRP 946
            + D++S G++++E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRAT--LPDGRNVAIKRL---SGDCGQMEREFR--A 787
           D +  +   ++    IG G +G V++A      GR VA+KR+   +G+ G      R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 788 EVEALSRAQHPNLVHLQGYC-MHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            +  L   +HPN+V L   C + + DR     L++  ++     Y   +K+  P      
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTET 121
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
            +  + Q   RGL +LH      ++HRD+K  NIL+  +    LADFGLAR+    Y   
Sbjct: 122 IKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQ 173
Query: 903 VT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           +  T +V TL Y  PE    S      D++S G +  E+   K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 750 IGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V      P G N    VA+K+L       +R+F+ E++ L       +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 805 G--YCMHKNDRLLIYSFMENGSLDYWLHE---KLDGPSSLDWDSRLHIAQGAARGLAYL- 858
           G  Y   + +  L+  ++ +G L  +L     +LD    L + S++       +G+ YL 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEYLG 128
Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPE 917
            + C    +HRD+ + NIL++      +ADFGLA+L+    D  V  +   + + +  PE
Sbjct: 129 SRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 918 YGQASVATYKGDVYSFGVVLLELLT 942
               ++ + + DV+SFGVVL EL T
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--- 865
             ++  ++  F+E G+L           + +   +R++  Q AA  LA L      H   
Sbjct: 99  VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE        
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYG 205
Query: 926 YKGDVYSFGVVLLELLTGKRP 946
            + D++S G++++E++ G+ P
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--- 865
             ++  ++  F+E G+L           + +   +R++  Q AA  LA L      H   
Sbjct: 97  VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE        
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYG 203
Query: 926 YKGDVYSFGVVLLELLTGKRP 946
            + D++S G++++E++ G+ P
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPP 224

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIK-----RLSGDCGQMERE-FRAEVEALSR 794
           ++++    +G G F +V +      G+  A K     RLS     + RE    EV  L  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN++ L     +K D +LI   +  G L  +L EK     SL  D      +    G
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDG 120
Query: 855 LAYLHQSCEPHILHRDIKSSNI-LLDGNFG---AHLADFGLARLILSPYDTHVTTDLVGT 910
           + YLH      I H D+K  NI LLD N       L DFG+A  I +  +     ++ GT
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 174
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ PE         + D++S GV+   LL+G  P
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 21/216 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIK-----RLSGDCGQMERE-FRAEVEALSR 794
           ++++    +G G F +V +      G+  A K     RLS     + RE    EV  L  
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN++ L     +K D +LI   +  G L  +L EK     SL  D      +    G
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDG 127
Query: 855 LAYLHQSCEPHILHRDIKSSNI-LLDGNFG---AHLADFGLARLILSPYDTHVTTDLVGT 910
           + YLH      I H D+K  NI LLD N       L DFG+A  I +  +     ++ GT
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 181
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ PE         + D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRAT--LPDGRNVAIKRL---SGDCGQMEREFR--A 787
           D +  +   ++    IG G +G V++A      GR VA+KR+   +G+ G      R  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 788 EVEALSRAQHPNLVHLQGYC-MHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            +  L   +HPN+V L   C + + DR     L++  ++     Y   +K+  P      
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTET 121
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
            +  + Q   RGL +LH      ++HRD+K  NIL+  +    LADFGLAR+    Y   
Sbjct: 122 IKDMMFQ-LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI----YSFQ 173
Query: 903 VT-TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           +  T +V TL Y  PE    S      D++S G +  E+   K
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--- 865
             ++  ++  F+E G+L           + +   +R++  Q AA  LA L      H   
Sbjct: 92  VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE        
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYG 198
Query: 926 YKGDVYSFGVVLLELLTGKRP 946
            + D++S G++++E++ G+ P
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPP 219

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  GR VAIK +     +   +++ FR EV  +    HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    LI  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-----EKEARSKFRQIVS-AVQ 128
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIP 915
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +    + +      D   G   Y  
Sbjct: 129 YCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS----NEFTVGGKLDAFCGAPPYAA 181
Query: 916 PEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 182 PELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 42   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L+ I  F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 99   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 159  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 269
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 270  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 309

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAI+++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA+K   +   +   +++ FR EV  +    HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +      +   + T   G+  Y  P
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDT-FCGSPPYAAP 181
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 182 ELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA+K   +   +   +++ FR EV  +    HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +      +   + T   G+  Y  P
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDT-FCGSPPYAAP 181
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 182 ELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 42   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L+ I  F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 99   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 159  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 269
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 270  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 309

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 809 HKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH-- 865
             ++  ++  F+E G+L D   H            +R++  Q AA  LA L      H  
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 866 -ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE       
Sbjct: 267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPY 324
Query: 925 TYKGDVYSFGVVLLELLTGKRP 946
             + D++S G++++E++ G+ P
Sbjct: 325 GPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQME-REFRAEVEALSRAQH-PNLVHLQGY 806
           IG G +G V +    P G+ +A+KR+     + E ++   +++ + R+   P +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 807 CMHKNDRLLIYSFMENGSLDYW--LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
              + D  +    M      ++  ++  LD     +   ++ +A    + L +L ++ + 
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA--TVKALNHLKENLK- 146
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            I+HRDIK SNILLD +    L DFG++  ++   D+   T   G   Y+ PE    S +
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 925 T----YKGDVYSFGVVLLELLTGKRP 946
                 + DV+S G+ L EL TG+ P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 743 NFDQANIIGCGGFG-LVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNL 800
           +F   +++G G  G +VYR    D R+VA+KR+  +C         EV+ L  + +HPN+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 801 VHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
           +  + +C  K DR   Y  +E    +L  ++ +K      L+    + + Q    GLA+L
Sbjct: 81  I--RYFCTEK-DRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 859 HQSCEPHILHRDIKSSNILLD-----GNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLG 912
           H     +I+HRD+K  NIL+      G   A ++DFGL  +L +  +     + + GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 913 YIPPEYGQASVA---TYKGDVYSFGVVLLELLT-GKRPM 947
           +I PE          TY  D++S G V   +++ G  P 
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 33   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L+ I  F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 90   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 149
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 150  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 206  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 260
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 261  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 300

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 44   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 100
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKL-------DGPSSL--DWDSRLHI---AQGAA 852
             C      L+ I  F + G+L  +L  K        + P  L  D+ +  H+   +   A
Sbjct: 101  ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVA 160
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 161  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 217  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 271
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 272  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 311

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 120/290 (41%), Gaps = 39/290 (13%)
Query: 747  ANIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQ 804
              +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L 
Sbjct: 43   GQVIEADAFGIDKTATX---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 805  GYCMHKNDRLL-IYSFMENGSLDYWLHEKLD-----GPSSL--DWDSRLHIAQ---GAAR 853
            G C      L+ I  F + G+L  +L  K +      P  L  D+ +  H+       A+
Sbjct: 100  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAK 159
Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+ +L        +HRD+ + NILL       + DFGLAR I    D     D    L +
Sbjct: 160  GMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--ENR 970
            + PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++    R
Sbjct: 217  MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRMR 271
Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 272  APDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 122/291 (41%), Gaps = 42/291 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 43   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 99
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEK------LDGPSSL--DWDSRLHI---AQGAAR 853
             C      L+ I  F + G+L  +L  K         P  L  D+ +  H+   +   A+
Sbjct: 100  ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAK 159
Query: 854  GLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L 
Sbjct: 160  GMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 913  YIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--EN 969
            ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++    
Sbjct: 216  WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRM 270
Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 271  RAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 309

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 33   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 806  YCMHKNDRLLIYS-FMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L++ + F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 90   ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 149
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 150  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 206  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 260
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 261  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 300

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 43/293 (14%)
Query: 747  ANIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQ 804
              +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L 
Sbjct: 78   GQVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134
Query: 805  GYCMHKNDRLL-IYSFMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGA 851
            G C      L+ I  F + G+L  +L  K +        P  L  D+ +  H+   +   
Sbjct: 135  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 194
Query: 852  ARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A+G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    
Sbjct: 195  AKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ-- 967
            L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++  
Sbjct: 251  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGT 305
Query: 968  ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 306  RMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 346

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 123/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 42   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L+ I  F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 99   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 159  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 269
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 270  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 309

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRNVA------------IKRLSGDCGQMEREFRAEVEA 791
           F+   ++G GG+G V++     G N              I R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 792 LSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           L   +HP +V L  Y      +L LI  ++  G L      +L+       D+       
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE 129
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            +  L +LHQ     I++RD+K  NI+L+      L DFGL +   S +D  VT    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGT 184
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + Y+ PE    S      D +S G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 750 IGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G  G+V  AT+   G+ VA+K++     Q       EV  +   QH N+V +    +
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--- 865
             ++  ++  F+E G+L           + +   +R++  Q AA  LA L      H   
Sbjct: 142 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
           ++HRDIKS +ILL  +    L+DFG    +    +      LVGT  ++ PE        
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYWMAPELISRLPYG 248
Query: 926 YKGDVYSFGVVLLELLTGKRP 946
            + D++S G++++E++ G+ P
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPP 269

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 117
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 118 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRNVA------------IKRLSGDCGQMEREFRAEVEA 791
           F+   ++G GG+G V++     G N              I R + D        +AE   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT----KAERNI 74
Query: 792 LSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           L   +HP +V L  Y      +L LI  ++  G L      +L+       D+       
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE 129
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            +  L +LHQ     I++RD+K  NI+L+      L DFGL +   S +D  VT    GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHXFCGT 184
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           + Y+ PE    S      D +S G ++ ++LTG  P 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 103/226 (45%), Gaps = 57/226 (25%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLV--- 801
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++   
Sbjct: 51  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 107
Query: 802 ------------------HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
                             HL G  ++K   LL    + N  + Y+L++ L          
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQIL---------- 154
Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-TH 902
                    RGL Y+H +   ++LHRD+K SN+LL+      + DFGLAR+    +D T 
Sbjct: 155 ---------RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTG 202
Query: 903 VTTDLVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPM 947
             T+ V T  Y  PE    S    K  D++S G +L E+L+  RP+
Sbjct: 203 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 117
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 60
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 116
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 117 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 33   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 806  YCMHKNDRLLIYS-FMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L++ + F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 90   ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 149
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 150  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 206  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 260
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 261  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 118
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRL---SGDCGQMEREFRAEVEALSRAQH 797
             +++   IG G +G V++A   +    VA+KR+     D G      R E+  L   +H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 798 PNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            N+V L    +H + +L L++ F +     Y+  +  +G   LD +          +GL 
Sbjct: 61  KNIVRLHD-VLHSDKKLTLVFEFCDQDLKKYF--DSCNG--DLDPEIVKSFLFQLLKGLG 115
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           + H     ++LHRD+K  N+L++ N    LA+FGLAR    P   +     V TL Y PP
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPP 170
Query: 917 E--YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           +  +G A + +   D++S G +  EL    RP+
Sbjct: 171 DVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 117
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 118 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 92/223 (41%), Gaps = 24/223 (10%)
Query: 750 IGCGGFGLV-YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G GGF  V     L DG   A+KR+     Q   E + E +      HPN++ L  YC+
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 809 H----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
                K++  L+  F + G+L   +    D  + L  D  L +  G  RGL  +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGL----------ARLILSPYDTHVTTDLVGTLGYI 914
              HRD+K +NILL       L D G           +R  L+  D         T+ Y 
Sbjct: 155 -YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR---CTISYR 210
Query: 915 PPEYGQAS---VATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
            PE        V   + DV+S G VL  ++ G+ P DM   KG
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 136
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 124/292 (42%), Gaps = 43/292 (14%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 33   QVIEADAFGIDKTATC---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 806  YCMHKNDRLLIYS-FMENGSLDYWLHEKLD-------GPSSL--DWDSRLHI---AQGAA 852
             C      L++ + F + G+L  +L  K +        P  L  D+ +  H+   +   A
Sbjct: 90   ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 149
Query: 853  RGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D    L
Sbjct: 150  KGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--E 968
             ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++   
Sbjct: 206  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR 260
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 261  MRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 300

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 140
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA++   +   +   +++ FR EV  +    HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +      +   + T   G+  Y  P
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDT-FCGSPPYAAP 181
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 182 ELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYC 807
           +G G +G V+R  L  G +VA+K  S    + E+ +  E E  +    +H N++      
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSS---RDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 808 MHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC- 862
           M   +      LI  + E+GSL  +L  +     +L+    L +A  AA GLA+LH    
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQ-----TLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 863 ----EPHILHRDIKSSNILLDGNFGAHLADFGLARLIL--SPYDTHVTTDLVGTLGYIPP 916
               +P I HRD KS N+L+  N    +AD GLA +    S Y        VGT  Y+ P
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 917 EYGQASVAT-----YKG-DVYSFGVVLLEL 940
           E     + T     YK  D+++FG+VL E+
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 35  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T    + V T  Y  PE 
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 16/222 (7%)
Query: 734 IDDIL---ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFR 786
           I D+L    +   + +   +G GGF   Y  T  D + V   ++           + +  
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            E+       +P++V   G+    +   ++       SL   LH++    +  + ++R  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVT--EPEARYF 147
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           + Q   +G+ YLH +    ++HRD+K  N+ L+ +    + DFGLA  I   +D      
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKT 201
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           L GT  YI PE       +++ D++S G +L  LL GK P +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L R +H N++ + 
Sbjct: 36  IGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 92
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T    + V T  Y  PE 
Sbjct: 147 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 118
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 118
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 136
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G +G V  A        VA+K    + + DC +     + E+      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 62
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 118
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 16/222 (7%)
Query: 734 IDDIL---ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFR 786
           I D+L    +   + +   +G GGF   Y  T  D + V   ++           + +  
Sbjct: 31  IPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS 90
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            E+       +P++V   G+    +   ++       SL   LH++    +  + ++R  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKAVT--EPEARYF 147
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           + Q   +G+ YLH +    ++HRD+K  N+ L+ +    + DFGLA  I   +D      
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKX 201
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           L GT  YI PE       +++ D++S G +L  LL GK P +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 243

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA++   +   +   +++ FR EV  +    HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +         +   +  G+  Y  P
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTF---GNKLDEFCGSPPYAAP 181
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 182 ELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREF--RAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER +   AE+      +H N++   G+ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 157
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 158
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 42   QVIEADAFGIDKTATX---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLDG--------PSSLDWDSRLHIAQGAARGLA 856
             C      L+ I  F + G+L  +L  K +            L  +  +  +   A+G+ 
Sbjct: 99   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGME 158
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +L        +HRD+ + NILL       + DFGLAR I    D     D    L ++ P
Sbjct: 159  FL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAP 215
Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--ENRESE 973
            E     V T + DV+SFGV+L E+ + G  P       G +    +  R+++    R  +
Sbjct: 216  ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFXRRLKEGTRMRAPD 270
Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 271  YTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 305

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 750 IGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL----- 803
           +GCGG GLV+ A   D  + VAIK++     Q  +    E++ + R  H N+V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 804 ---------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
                     G     N   ++  +ME       L   L+    L+  +RL + Q   RG
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQ-LLRG 132
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILSPYDT---HVTTDLVGT 910
           L Y+H +   ++LHRD+K +N+ ++  +    + DFGLAR I+ P+ +   H++  LV  
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPHYSHKGHLSEGLVTK 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
               P      +  T   D+++ G +  E+LTGK
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRL-SGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             +I    FG+   AT    R VA+K L  G      R   +E++ L     H N+V+L G
Sbjct: 42   QVIEADAFGIDKTATX---RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 806  YCMHKNDRLL-IYSFMENGSLDYWLHEKLDG--------PSSLDWDSRLHIAQGAARGLA 856
             C      L+ I  F + G+L  +L  K +            L  +  +  +   A+G+ 
Sbjct: 99   ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGME 158
Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +L        +HRD+ + NILL       + DFGLAR I    D     D    L ++ P
Sbjct: 159  FLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 215
Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ--ENRESE 973
            E     V T + DV+SFGV+L E+ + G  P       G +    +  R+++    R  +
Sbjct: 216  ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRMRAPD 270
Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 271  YTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 305

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 83/172 (48%), Gaps = 12/172 (6%)
Query: 784 EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL----DYWLHEKLDGPSSL 839
           +F+ E++ ++  ++   +  +G   + ++  +IY +MEN S+    +Y+     +    +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                  I +      +Y+H   E +I HRD+K SNIL+D N    L+DFG +  ++   
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--- 203
Query: 900 DTHVTTDLVGTLGYIPPEY--GQASVATYKGDVYSFGVVLLELLTGKRPMDM 949
           D  +     GT  ++PPE+   ++S    K D++S G+ L  +     P  +
Sbjct: 204 DKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+ +    +G G  G V++      G  +A+K  R SG+  + +R        L     P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            +V   G  +   D  +    M  G+    L +++ GP       ++ +A    + L YL
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVA--IVKALYYL 140
Query: 859 HQSCEPH-ILHRDIKSSNILLDGNFGAHLADFGLA-RLILSPYDTHVTTDLVGTLGYIPP 916
               E H ++HRD+K SNILLD      L DFG++ RL+    D        G   Y+ P
Sbjct: 141 K---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAYMAP 193
Query: 917 EYGQASVAT-----YKGDVYSFGVVLLELLTGKRPMDMCK 951
           E       T      + DV+S G+ L+EL TG+ P   CK
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 67
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 123
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 124 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 67/272 (24%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGY 806
            +G G +G+V +   +P G+  A+KR+      Q ++    +++   R    P  V   G 
Sbjct: 42   LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 807  CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
               + D + I   + + SLD +  + +D   ++  D    IA    + L +LH      +
Sbjct: 102  LFREGD-VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 158
Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL-VGTLGY-----IPPEYGQ 920
            +HRD+K SN+L++        DFG++  ++      V  D+  G   Y     I PE  Q
Sbjct: 159  IHRDVKPSNVLINALGQVKXCDFGISGYLVD----DVAKDIDAGCKPYXAPERINPELNQ 214
Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               +  K D++S G+  +EL   + P D           SW    +Q  +  E   P + 
Sbjct: 215  KGYSV-KSDIWSLGITXIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQL- 261
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                DK     +D    CL ++ K RPT  +L
Sbjct: 262  --PADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL-HEKLDGPSSLDWDSRLHIAQG 850
              +HP L  L+ Y    +DRL  +  +   G L + L  E++         +R + A+ 
Sbjct: 65  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER----ARFYGAEI 119
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            +  L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT
Sbjct: 120 VS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXFCGT 173
Query: 911 LGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
             Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 174 PEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 210

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 160
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L   +H N++ + 
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGIN 89
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 144 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREF--RAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER +   AE+      +H N++   G+ 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 144
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 67
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 123
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 124 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREF--RAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER +   AE+      +H N++   G+ 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 119
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA+K +     +   +++ FR EV  +    HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H ++      + ++R    Q  +  + 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFRQIVS-AVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIP 915
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +    + +      D   G   Y  
Sbjct: 128 YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPYAA 180
Query: 916 PEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 181 PELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 74/263 (28%), Positives = 113/263 (42%), Gaps = 45/263 (17%)
Query: 704 KEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL 763
           +EE N    D+EEL +K  V   N  + +  D  +E          IG G F  VY+  L
Sbjct: 1   QEERNQQQDDIEELETK-AVGXSNDGRFLKFD--IE----------IGRGSFKTVYKG-L 46
Query: 764 PDGRNVAI-------KRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL----QGYCMHKN 811
                V +       ++L+    + ER+ F+ E E L   QHPN+V      +     K 
Sbjct: 47  DTETTVEVAWCELQDRKLT----KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 812 DRLLIYSFMENGSLDYWLHE-KLDGPSSL-DWDSRLHIAQGAARGLAYLHQSCEPHILHR 869
             +L+     +G+L  +L   K+     L  W  ++       +GL +LH    P I+HR
Sbjct: 103 CIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLHTRTPP-IIHR 155
Query: 870 DIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG 928
           D+K  NI + G  G+  + D GLA L  + +   V    +GT  +  PE  +        
Sbjct: 156 DLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFXAPEXYEEKYDE-SV 210
Query: 929 DVYSFGVVLLELLTGKRPMDMCK 951
           DVY+FG   LE  T + P   C+
Sbjct: 211 DVYAFGXCXLEXATSEYPYSECQ 233

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREF--RAEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER +   AE+      +H N++   G+ 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 121
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD-------CGQMEREFRAEVEALSRAQHP 798
            + +G G FG V        G  VA+K L+          G+++RE    ++ L   +HP
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHP 71
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           +++ L        D  ++  ++  G L DY   H +++     + ++R  + Q     + 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVD 125
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     ++HRD+K  N+LLD +  A +ADFGL+ ++    D     D  G+  Y  P
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRDSCGSPNYAAP 179
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   D++S GV+L  LL G  P D
Sbjct: 180 EV--ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N F+   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             ++HP L  L+ Y    +DRL       NG  + + H   +   S D  +R + A+  +
Sbjct: 206 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAEIVS 262
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L YLH   E ++++RD+K  N++LD +    + DFGL +  +   D        GT  
Sbjct: 263 -ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPE 317
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 318 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 352

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQH 797
            +F+   +IG G FG V    L +   V   ++      ++R     FR E + L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
             +  L       N+  L+  +   G L   L +  D  P  +   +R ++A+     + 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVI-AID 189
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +HQ    H +HRDIK  NIL+D N    LADFG + L L    T  ++  VGT  YI P
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 917 EYGQASVATYKG------DVYSFGVVLLELLTGKRPM 947
           E  QA +   KG      D +S GV + E+L G+ P 
Sbjct: 246 EILQA-MEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQM--EREFRAEVEALSRAQHPNLVHLQ 804
           IG G +G+V  A   D  N   VAIK++S    Q   +R  R E++ L   +H N++ + 
Sbjct: 33  IGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGIN 89
Query: 805 GYCM-----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                       D  ++   ME          KL     L  D   +      RGL Y+H
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLY------KLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-THVTTDLVGTLGYIPPEY 918
            +   ++LHRD+K SN+LL+      + DFGLAR+    +D T   T+ V T  Y  PE 
Sbjct: 144 SA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 919 GQASVATYKG-DVYSFGVVLLELLTGKRPM 947
              S    K  D++S G +L E+L+  RP+
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N F+   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             ++HP L  L+ Y    +DRL       NG  + + H   +   S D  +R + A+  +
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAEIVS 259
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L YLH   E ++++RD+K  N++LD +    + DFGL +  +   D        GT  
Sbjct: 260 -ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPE 314
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 315 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 349

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQ 804
            +G GGF   +  +  D + V   ++             +   E+       H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G+    +   ++       SL   LH++    +  + ++R ++ Q    G  YLH++   
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL-LELHKRRKALT--EPEARYYLRQ-IVLGCQYLHRN--- 134
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            ++HRD+K  N+ L+ +    + DFGLA  +   YD      L GT  YI PE       
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 925 TYKGDVYSFGVVLLELLTGKRPMD 948
           +++ DV+S G ++  LL GK P +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FR-AEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER  FR AE+      +H N++   G+ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 118
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FR-AEVEALSRAQHPNLVHLQGYC 807
           IG G FG V+R     G  VA+K  S    + ER  FR AE+      +H N++   G+ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 808 MHKNDR-------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
              N          L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 124
Query: 861 SC-----EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGY 913
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 914 IPPEYGQASV------ATYKGDVYSFGVVLLEL 940
           + PE    S+      +  + D+Y+ G+V  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 34/79 (43%), Positives = 44/79 (55%), Gaps = 1/79 (1%)
Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           HRD+K  NIL+  +  A+L DFG+A        T +  + VGTL Y  PE    S ATY+
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG-NTVGTLYYXAPERFSESHATYR 215
Query: 928 GDVYSFGVVLLELLTGKRP 946
            D+Y+   VL E LTG  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R  G C +   E   EV  L
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR-RGVCRE---EIEREVSIL 69
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +  HPN++ L     ++ D +LI   +  G L  +L +K     SL  +      +   
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQIL 125
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       L DFGLA  I    D     ++ 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 16/214 (7%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRA 795
             ++D    +G G  G V  A        VA+K    + + DC +     + E+      
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKML 61
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            H N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GV 117
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ 
Sbjct: 118 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 916 PE-YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           PE   +        DV+S G+VL  +L G+ P D
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 22/177 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDG-RNVAIKRLSG------DCGQMEREFRAEVEALSR 794
           +N++  ++IG G +G VY A   +  +NVAIK+++       DC ++ RE    +  L+R
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE----ITILNR 83
Query: 795 AQHPNLVHLQGYCMHKN----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            +   ++ L    + ++    D L  Y  +E    D  L +    P  L       I   
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDEL--YIVLEIADSD--LKKLFKTPIFLTEQHVKTILYN 139
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
              G  ++H+S    I+HRD+K +N LL+ +    + DFGLAR I S  D H+  DL
Sbjct: 140 LLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 99/239 (41%), Gaps = 24/239 (10%)
Query: 737 ILESTNNFDQANIIGCGGFGL--VYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR 794
           I+  ++ +D    IG G FG+  + R  L     VA+K +      ++   + E+     
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAA-IDENVQREIINHRS 72
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN+V  +   +      +I  +   G L    +E++        D      Q    G
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSG 128
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLAR---LILSPYDTHVTTDLVG 909
           ++Y H      I HRD+K  N LLDG+    L   DFG ++   L   P  T      VG
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VG 179
Query: 910 TLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMR 966
           T  YI PE         K  DV+S GV L  +L G  P  D  +P+  R  I  ++ ++
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 104
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 163
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 164 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 217
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 218 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N F+   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             ++HP L  L+ Y    +DRL       NG  + + H   +   S D  +R + A+  +
Sbjct: 63  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAEIVS 119
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L YLH   E ++++RD+K  N++LD +    + DFGL +  +   D        GT  
Sbjct: 120 -ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 174
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 175 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 209

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 21/218 (9%)
Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRA 795
              ++D   +IG G FG V        + V   +L      ++R     F  E + ++ A
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 796 QHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             P +V L  +C  ++D+ L  +  +M  G L   L    D P    W ++ + A+    
Sbjct: 133 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEK--W-AKFYTAE-VVL 185
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L  +H      ++HRD+K  N+LLD +    LADFG    +      H  T  VGT  Y
Sbjct: 186 ALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVGTPDY 241
Query: 914 IPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
           I PE    Q     Y  + D +S GV L E+L G  P 
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 77
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 136
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 137 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 190
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 191 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 189
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 190 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 95
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 154
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 155 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 208
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 209 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 189
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 190 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 43/294 (14%)
Query: 744  FDQANI---IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
            F+Q  I   IG G FG VY         + +  +  D     + F+ EV A  + +H N+
Sbjct: 32   FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            V   G CM      +I S  +  +L   +    D    LD +    IAQ   +G+ YLH 
Sbjct: 92   VLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARL--------------ILSPYDTHVTTD 906
                 ILH+D+KS N+  D N    + DFGL  +              I + +  H+  +
Sbjct: 149  KG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 907  LVGTLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
            ++  L    P+  +  +   K  DV++ G +  EL   + P    +P    + I W +  
Sbjct: 205  IIRQLS---PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPA---EAIIWQM-- 255
Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                     + P +      KE   + DI   C +   + RPT  +L+  L+ +
Sbjct: 256  ------GTGMKPNLSQIGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 89
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 148
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 149 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 202
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 203 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 110
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 223
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 224 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N F+   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             ++HP L  L+ Y    +DRL       NG  + + H   +   S D  +R + A+  +
Sbjct: 64  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAEIVS 120
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L YLH   E ++++RD+K  N++LD +    + DFGL +  +   D        GT  
Sbjct: 121 -ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 175
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 176 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 210

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 112
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 171
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 172 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 225
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 226 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N F+   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             ++HP L  L+ Y    +DRL       NG  + + H   +   S D  +R + A+  +
Sbjct: 65  QNSRHPFLTALK-YSFQTHDRLCFVMEYANGG-ELFFHLSRERVFSED-RARFYGAEIVS 121
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             L YLH   E ++++RD+K  N++LD +    + DFGL +  +   D        GT  
Sbjct: 122 -ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 176
Query: 913 YIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           Y+ PE      YG+A       D +  GVV+ E++ G+ P 
Sbjct: 177 YLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 211

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 84
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 143
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 144 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 197
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 198 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 189
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 190 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 88
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 201
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 202 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 110
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 223
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 224 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG-----QMEREFR----AEVEA 791
            N++   I+G G   +V R    P  +  A+K +    G     +  +E R     EV+ 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 792 LSRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           L +   HPN++ L+          L++  M+ G L  +L EK+    +L       I + 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 119
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
               +  LH+    +I+HRD+K  NILLD +    L DFG +   L P +     ++ GT
Sbjct: 120 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEK--LREVCGT 173
Query: 911 LGYIPPEYGQASV------ATYKGDVYSFGVVLLELLTGKRPM 947
             Y+ PE  + S+         + D++S GV++  LL G  P 
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 114
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 173
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 174 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 227
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 228 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEIXINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 81
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 140
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 141 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 194
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 195 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 80
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 140 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 193
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 194 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 63  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 117
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 118 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 172
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 173 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 114
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 169
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 114
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTP 169
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEIXINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEIXINKMLNH 64
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 120
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 88
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 147
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 148 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYR 201
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 202 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 114
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXFCGTP 169
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 40/221 (18%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA--------- 852
            L         R   YS  E   + Y L+  LD      +    H ++            
Sbjct: 77  RL---------RYFFYSSGEKKDVVY-LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 853 ------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTT 905
                 R LAY+H      I HRDIK  N+LLD +     L DFG A+ ++         
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNV 180
Query: 906 DLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
             + +  Y  PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 181 SXICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 114
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXFCGTP 169
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 155
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 214
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 215 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 268
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 269 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)
Query: 740 STNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFR---AEVEAL 792
           + N+FD   ++G G FG V     +AT   GR  A+K L  +    + E      E   L
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              +HP L  L+ Y    +DRL  +  +   G L + L  +       +  +R + A+  
Sbjct: 60  QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAE-I 114
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              L YLH      +++RDIK  N++LD +    + DFGL +  +S  D        GT 
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKXFCGTP 169
Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE      YG+A       D +  GVV+ E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 779 GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGP 836
           G +E+ ++ E+  L +  HPN+V L       N+    +++  +  G +       ++ P
Sbjct: 78  GPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------MEVP 129
Query: 837 S--SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
           +   L  D      Q   +G+ YLH      I+HRDIK SN+L+  +    +ADFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRP-MD-- 948
                   + ++ VGT  ++ PE    +   + G   DV++ GV L   + G+ P MD  
Sbjct: 187 FKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 949 -MC--------------KPKGSRDLISWVIRMRQENRESEVLDPFI 979
            MC              +P  + DL   + RM  +N ES ++ P I
Sbjct: 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG-----QMEREFR----AEVEA 791
            N++   I+G G   +V R    P  +  A+K +    G     +  +E R     EV+ 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 792 LSRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           L +   HPN++ L+          L++  M+ G L  +L EK+    +L       I + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 132
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
               +  LH+    +I+HRD+K  NILLD +    L DFG +   L P +     ++ GT
Sbjct: 133 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEK--LREVCGT 186
Query: 911 LGYIPPEYGQASV------ATYKGDVYSFGVVLLELLTGKRPM 947
             Y+ PE  + S+         + D++S GV++  LL G  P 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQH 797
            +F+   +IG G FG V    + +   +   ++      ++R     FR E + L     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
             +  L      +N   L+  +   G L   L +  D  P  +   +R +I +     + 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---ARFYIGE-MVLAID 189
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +HQ    H +HRDIK  N+LLD N    LADFG + L ++   T  ++  VGT  YI P
Sbjct: 190 SIHQL---HYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 917 EYGQA---SVATY--KGDVYSFGVVLLELLTGKRPM 947
           E  QA    +  Y  + D +S GV + E+L G+ P 
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+   +   H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINAMLNH 64
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 120
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAEVEALSRAQH 797
            +F+   +IG G FG V    + +   +   ++      ++R     FR E + L     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAARGLA 856
             +  L      +N   L+  +   G L   L +  D  P  +   +R +I +     + 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---ARFYIGE-MVLAID 205
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +HQ    H +HRDIK  N+LLD N    LADFG + L ++   T  ++  VGT  YI P
Sbjct: 206 SIHQL---HYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 917 EYGQA---SVATY--KGDVYSFGVVLLELLTGKRPM 947
           E  QA    +  Y  + D +S GV + E+L G+ P 
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+  N    L DFGL+R +    D+       G L   ++ PE     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESINFR 187
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G +G+VY+A    G   A+K++     D G      R E+  L   +H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLD----GPSSLDWDSRLHIAQGAARGLAYLHQSC 862
              K   +L++       LD  L + LD    G  S+   S L        G+AY H   
Sbjct: 69  IHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR- 119
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQ 920
              +LHRD+K  N+L++      +ADFGLAR    P   +  T  V TL Y  P+   G 
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGS 175
Query: 921 ASVATYKGDVYSFGVVLLELLTG 943
              +T   D++S G +  E++ G
Sbjct: 176 KKYST-TIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G +G+VY+A    G   A+K++     D G      R E+  L   +H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLD----GPSSLDWDSRLHIAQGAARGLAYLHQSC 862
              K   +L++       LD  L + LD    G  S+   S L        G+AY H   
Sbjct: 69  IHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR- 119
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQ 920
              +LHRD+K  N+L++      +ADFGLAR    P   +  T  V TL Y  P+   G 
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGS 175
Query: 921 ASVATYKGDVYSFGVVLLELLTG 943
              +T   D++S G +  E++ G
Sbjct: 176 KKYST-TIDIWSVGCIFAEMVNG 197

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 63/218 (28%), Positives = 87/218 (39%), Gaps = 29/218 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           GT  ++ PE         + D++S GV+   LL+G  P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 63/218 (28%), Positives = 87/218 (39%), Gaps = 29/218 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           GT  ++ PE         + D++S GV+   LL+G  P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 63/218 (28%), Positives = 87/218 (39%), Gaps = 29/218 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R       +ERE    V  L
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE----VSIL 68
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
              QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +   
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQIL 124
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNFGA---HLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       + DFGLA  I    +     ++ 
Sbjct: 125 NGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           GT  ++ PE         + D++S GV+   LL+G  P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+  N    L DFGL+R +    D+       G L   ++ PE     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 750 IGCGGFGLVYRATLPDGRN-VAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           +G G +  VY+       N VA+K  RL  + G      R EV  L   +H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 68
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL--DWDSRLHIAQGAARGLAYLHQSCEP 864
              +    L++ +     LD  L + LD   ++    + +L + Q   RGLAY H+    
Sbjct: 69  IHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQ-LLRGLAYCHRQ--- 119
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY--GQAS 922
            +LHRD+K  N+L++      LADFGLAR    P  T+   + V TL Y PP+   G   
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDILLGSTD 177
Query: 923 VATYKGDVYSFGVVLLELLTGKRPM 947
            +T + D++  G +  E+ TG RP+
Sbjct: 178 YST-QIDMWGVGCIFYEMATG-RPL 200

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+  N    L DFGL+R +    D+       G L   ++ PE     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 64
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 120
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 64
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 120
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 121 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 750 IGCGGFGLVYRATLPDGRNVAIKRL---SGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G +G+VY+A    G   A+K++     D G      R E+  L   +H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLD----GPSSLDWDSRLHIAQGAARGLAYLHQSC 862
              K   +L++       LD  L + LD    G  S+   S L        G+AY H   
Sbjct: 69  IHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHDR- 119
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQ 920
              +LHRD+K  N+L++      +ADFGLAR    P   +  T  + TL Y  P+   G 
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGS 175
Query: 921 ASVATYKGDVYSFGVVLLELLTG 943
              +T   D++S G +  E++ G
Sbjct: 176 KKYST-TIDIWSVGCIFAEMVNG 197

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 106 G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASV 923
             +HRDI + N+L+  N    L DFGL+R +  S Y       L   + ++ PE      
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRR 216
Query: 924 ATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
            T   DV+ FGV + E+L  G +P    K
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQGVK 245

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 75  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+  N    L DFGL+R +    D+       G L   ++ PE     
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 184
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG-DCGQMEREFRAEVEALSRAQHP 798
           +++F   +++G G +G+V  AT  P G  VAIK++   D          E++ L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 799 NLVHLQGYCMHKNDRLL----IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           N++ +  + + + D       +Y   E    D  LH ++     L  D   +      R 
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTD--LH-RVISTQMLSDDHIQYFIYQTLRA 124
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHVTT-------D 906
           +  LH S   +++HRD+K SN+L++ N    + DFGLAR+I  S  D    T       +
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 907 LVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPM 947
            V T  Y  PE    S    +  DV+S G +L EL   +RP+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK----RLSGDCGQMEREFRAEVEALSRAQH 797
           ++D    +G G +G V  A        VA+K    + + DC +     + E+       H
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE---NIKKEICINKMLNH 63
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            N+V   G+    N + L   +   G L   +   +  P     D++    Q  A G+ Y
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP---DAQRFFHQLMA-GVVY 119
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE
Sbjct: 120 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              +        DV+S G+VL  +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 36/236 (15%)
Query: 730 KEISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD---CGQMEREF 785
           K  S D   +  + ++    IG G +G+V  A     G+ VAIK++          +R  
Sbjct: 43  KARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL 102
Query: 786 RAEVEALSRAQHPNLVHLQG-------YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS 838
           R E++ L   +H N++ ++        Y   K+   ++   ME+      LH+ +     
Sbjct: 103 R-ELKILKHFKHDNIIAIKDILRPTVPYGEFKS-VYVVLDLMESD-----LHQIIHSSQP 155
Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILS 897
           L  +   +      RGL Y+H +    ++HRD+K SN+L++ N    + DFG+AR L  S
Sbjct: 156 LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 212
Query: 898 PYD-THVTTDLVGTLGYIPP-------EYGQASVATYKGDVYSFGVVLLELLTGKR 945
           P +  +  T+ V T  Y  P       EY QA       D++S G +  E+L  ++
Sbjct: 213 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAI------DLWSVGCIFGEMLARRQ 262

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 27/223 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--------RLSGDCGQMEREFR-AEVEA 791
            N++   I+G G   +V R    P  +  A+K          S +  Q  RE    EV+ 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 792 LSRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           L +   HPN++ L+          L++  M+ G L  +L EK+    +L       I + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 132
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
               +  LH+    +I+HRD+K  NILLD +    L DFG +   L P +      + GT
Sbjct: 133 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEK--LRSVCGT 186
Query: 911 LGYIPPEYGQASV------ATYKGDVYSFGVVLLELLTGKRPM 947
             Y+ PE  + S+         + D++S GV++  LL G  P 
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGD-------CGQMEREFRAEVEALSRAQHP 798
            + +G G FG V        G  VA+K L+          G+++RE    ++ L   +HP
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRHP 71
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           +++ L        D  ++  ++  G L DY   H +++     + ++R  + Q     + 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVD 125
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           Y H+     ++HRD+K  N+LLD +  A +ADFGL+ ++    D        G+  Y  P
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRTSCGSPNYAAP 179
Query: 917 EYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           E    S   Y G   D++S GV+L  LL G  P D
Sbjct: 180 EV--ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 83  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASV 923
             +HRDI + N+L+  N    L DFGL+R +  S Y       L   + ++ PE      
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRR 193
Query: 924 ATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
            T   DV+ FGV + E+L  G +P    K
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 80  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASV 923
             +HRDI + N+L+  N    L DFGL+R +  S Y       L   + ++ PE      
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRR 190
Query: 924 ATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
            T   DV+ FGV + E+L  G +P    K
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQGVK 219

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 89/209 (42%), Gaps = 16/209 (7%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 81  G-VITENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPPEYGQASV 923
             +HRDI + N+L+  N    L DFGL+R +  S Y       L   + ++ PE      
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRR 191
Query: 924 ATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
            T   DV+ FGV + E+L  G +P    K
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQGVK 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 767 RNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSL 825
           ++V I+    +C  +E+     V AL   + P L  L   C    DRL  +  ++  G L
Sbjct: 376 KDVVIQDDDVECTMVEKR----VLALP-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDL 429
Query: 826 DYWLHE--KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG 883
            Y + +  +   P ++ + + + I      GL +L       I++RD+K  N++LD    
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAI------GLFFLQSK---GIIYRDLKLDNVMLDSEGH 480
Query: 884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             +ADFG+ +  +  +D   T    GT  YI PE           D ++FGV+L E+L G
Sbjct: 481 IKIADFGMCKENI--WDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538
Query: 944 KRPMD 948
           + P +
Sbjct: 539 QAPFE 543

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 106/235 (45%), Gaps = 34/235 (14%)
Query: 730 KEISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRL--SGDCGQMEREFR 786
           K  S D   +  + ++    IG G +G+V  A     G+ VAIK++  + D     +   
Sbjct: 42  KARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL 101
Query: 787 AEVEALSRAQHPNLVHLQG-------YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
            E++ L   +H N++ ++        Y   K+   ++   ME+      LH+ +     L
Sbjct: 102 RELKILKHFKHDNIIAIKDILRPTVPYGEFKS-VYVVLDLMESD-----LHQIIHSSQPL 155
Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-LILSP 898
             +   +      RGL Y+H +    ++HRD+K SN+L++ N    + DFG+AR L  SP
Sbjct: 156 TLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212
Query: 899 YD-THVTTDLVGTLGYIPP-------EYGQASVATYKGDVYSFGVVLLELLTGKR 945
            +  +  T+ V T  Y  P       EY QA       D++S G +  E+L  ++
Sbjct: 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAI------DLWSVGCIFGEMLARRQ 261

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 749 IIGCGGFGLVYRATLPDGR----NVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
           I+G G FG VY     + +    NVA+K    DC    +E F +E   +    HP++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SC 862
            G  + +    +I      G L ++L       +SL   + +  +    + +AYL   +C
Sbjct: 91  IG-IIEEEPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
               +HRDI   NIL+       L DFGL+R I    D +  +     + ++ PE     
Sbjct: 147 ----VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFR 201
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             T   DV+ F V + E+L+ GK+P
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 749 IIGCGGFGLVYRATLPDGR----NVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
           I+G G FG VY     + +    NVA+K    DC    +E F +E   +    HP++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SC 862
            G  + +    +I      G L ++L       +SL   + +  +    + +AYL   +C
Sbjct: 75  IG-IIEEEPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
               +HRDI   NIL+       L DFGL+R I    D +  +     + ++ PE     
Sbjct: 131 ----VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFR 185
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             T   DV+ F V + E+L+ GK+P
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 749 IIGCGGFGLVYRATLPDGR----NVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHL 803
           I+G G FG VY     + +    NVA+K    DC    +E F +E   +    HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SC 862
            G  + +    +I      G L ++L       +SL   + +  +    + +AYL   +C
Sbjct: 79  IG-IIEEEPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
               +HRDI   NIL+       L DFGL+R I    D +  +     + ++ PE     
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFR 189
Query: 923 VATYKGDVYSFGVVLLELLT-GKRP 946
             T   DV+ F V + E+L+ GK+P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 767 RNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSL 825
           ++V I+    +C  +E+     V AL   + P L  L   C    DRL  +  ++  G L
Sbjct: 55  KDVVIQDDDVECTMVEKR----VLALP-GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDL 108
Query: 826 DYWLHE--KLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG 883
            Y + +  +   P ++ + + + I      GL +L       I++RD+K  N++LD    
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAI------GLFFLQSKG---IIYRDLKLDNVMLDSEGH 159
Query: 884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             +ADFG+ +  +  +D   T    GT  YI PE           D ++FGV+L E+L G
Sbjct: 160 IKIADFGMCKENI--WDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217
Query: 944 KRPMD 948
           + P +
Sbjct: 218 QAPFE 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG-DCGQMEREFRAEVEALSRAQHP 798
           +++F   +++G G +G+V  AT  P G  VAIK++   D          E++ L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 799 NLVHLQGYCMHKNDRLL----IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           N++ +  + + + D       +Y   E    D  LH ++     L  D   +      R 
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTD--LH-RVISTQMLSDDHIQYFIYQTLRA 124
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHV-------TTD 906
           +  LH S   +++HRD+K SN+L++ N    + DFGLAR+I  S  D           T+
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 907 LVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPM 947
            V T  Y  PE    S    +  DV+S G +L EL   +RP+
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+  N    L DFGL+R +    D+       G L   ++ PE     
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 567
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG-DCGQMEREFRAEVEALSRAQHP 798
           +++F   +++G G +G+V  AT  P G  VAIK++   D          E++ L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 799 NLVHLQGYCMHKNDRLL----IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           N++ +  + + + D       +Y   E    D  LH ++     L  D   +      R 
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTD--LH-RVISTQMLSDDHIQYFIYQTLRA 124
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI-LSPYDTHV-------TTD 906
           +  LH S   +++HRD+K SN+L++ N    + DFGLAR+I  S  D           T+
Sbjct: 125 VKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 907 LVGTLGYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPM 947
            V T  Y  PE    S    +  DV+S G +L EL   +RP+
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 22/177 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPDG-RNVAIKRLSG------DCGQMEREFRAEVEALSR 794
           +N+   ++IG G +G VY A   +  +NVAIK+++       DC ++ RE    +  L+R
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNR 81
Query: 795 AQHPNLVHLQGYCMHKNDRLL----IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            +   ++ L  Y +   D LL    +Y  +E    D  L +    P  L  +    I   
Sbjct: 82  LKSDYIIRL--YDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTILYN 137
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
              G  ++H+S    I+HRD+K +N LL+ +    + DFGLAR I S  DT++  DL
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 16/212 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC---GQMEREFRAEVEALSR-AQ 796
           ++F    +IG G FG V  A    +    A+K L        + E+   +E   L +  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           HP LV L  +     D+L  +  ++  G L Y L  +      L+  +R + A+  A  L
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAE-IASAL 152
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH     +I++RD+K  NILLD      L DFGL +  +    T  T+   GT  Y+ 
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLA 207
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE           D +  G VL E+L G  P 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 750 IGCGGFGLVYRATLPDGR---NVAIKRLSGDCGQME-REFRAEVEALSRAQHPNLVHLQG 805
           +GCG FG V +      +   +VAIK L     + +  E   E + + +  +P +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
            C      +L+      G L  +L  K +     +    LH     + G+ YL    E +
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---QVSMGMKYLE---EKN 130
Query: 866 ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT--LGYIPPEYGQASV 923
            +HRD+ + N+LL     A ++DFGL++  L   D++ T    G   L +  PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 924 ATYKGDVYSFGVVLLELLT-GKRP 946
            + + DV+S+GV + E L+ G++P
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHP 798
           N+     IG G F  V  A  +  G+ VA+K   +   +   +++ FR EV       HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           N+V L      +    L+  +   G + DY + H +       + ++R    Q     + 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK-----EKEARAKFRQ-IVSAVQ 127
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIP 915
           Y HQ     I+HRD+K+ N+LLD +    +ADFG +    + +      D   G   Y  
Sbjct: 128 YCHQK---FIVHRDLKAENLLLDADXNIKIADFGFS----NEFTFGNKLDAFCGAPPYAA 180
Query: 916 PEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           PE  Q     Y G   DV+S GV+L  L++G  P D
Sbjct: 181 PELFQGK--KYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 17/254 (6%)
Query: 731 EISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE 784
           +++ DD+L   + ++   +IG G F +V R      G+  A+K     + +   G    +
Sbjct: 14  DMADDDVL-FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 785 FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR 844
            + E       +HP++V L           +++ FM+   L + + ++ D          
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDT 901
            H  +     L Y H +   +I+HRD+K  N+LL   + +    L DFG+A  I      
Sbjct: 133 SHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESG 187
Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW 961
            V    VGT  ++ PE  +        DV+  GV+L  LL+G  P    K +    +I  
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 962 VIRM--RQENRESE 973
             +M  RQ +  SE
Sbjct: 248 KYKMNPRQWSHISE 261

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 748 NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVHL 803
            ++G GGFG V+   +   G+  A K+L+    +  + ++    E + L++     +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE-KLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                 K D  L+ + M  G + Y ++    D P   +  +  + AQ    GL +LHQ  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  N+LLD +    ++D GLA + L    T  T    GT G++ PE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 923 VATYKGDVYSFGVVLLELLTGKRPM 947
              +  D ++ GV L E++  + P 
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 748 NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVHL 803
            ++G GGFG V+   +   G+  A K+L+    +  + ++    E + L++     +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE-KLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                 K D  L+ + M  G + Y ++    D P   +  +  + AQ    GL +LHQ  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  N+LLD +    ++D GLA + L    T  T    GT G++ PE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 923 VATYKGDVYSFGVVLLELLTGKRPM 947
              +  D ++ GV L E++  + P 
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 748 NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVHL 803
            ++G GGFG V+   +   G+  A K+L+    +  + ++    E + L++     +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE-KLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                 K D  L+ + M  G + Y ++    D P   +  +  + AQ    GL +LHQ  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  N+LLD +    ++D GLA + L    T  T    GT G++ PE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 923 VATYKGDVYSFGVVLLELLTGKRPM 947
              +  D ++ GV L E++  + P 
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++        RE    ++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 189
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 190 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 748 NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQHPNLVHL 803
            ++G GGFG V+   +   G+  A K+L+    +  + ++    E + L++     +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE-KLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                 K D  L+ + M  G + Y ++    D P   +  +  + AQ    GL +LHQ  
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQR- 308
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS 922
             +I++RD+K  N+LLD +    ++D GLA + L    T  T    GT G++ PE     
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 923 VATYKGDVYSFGVVLLELLTGKRPM 947
              +  D ++ GV L E++  + P 
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 748 NIIGCGGFGLVYRAT-LPDGRN----VAIKRLSGDCGQMEREFRAEVE---ALSRAQHPN 799
            ++G G FG V++   +P+G +    V IK +    G+  + F+A  +   A+    H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAH 94
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSL--DYWLHEKLDGPSSL-DWDSRLHIAQGAARGLA 856
           +V L G C   + +L +  ++  GSL      H    GP  L +W  ++      A+G+ 
Sbjct: 95  IVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMY 147
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIP 915
           YL    E  ++HR++ + N+LL       +ADFG+A L L P D  +      T + ++ 
Sbjct: 148 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKTPIKWMA 203
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            E       T++ DV+S+GV + EL+T G  P
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++        RE    ++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 802 HLQGYCM---HKNDRL---LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            L+ +      K D +   L+  ++         H      +      +L++ Q   R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 135
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           AY+H      I HRDIK  N+LLD +     L DFG A+ ++           + +  Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYR 189
Query: 915 PPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
            PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 190 APELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 26/218 (11%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRN----VAIKRLSGDCGQMEREFRAEVE---ALS 793
               +  ++G G FG V++   +P+G +    V IK +    G+  + F+A  +   A+ 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIG 70
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL--DYWLHEKLDGPSSL-DWDSRLHIAQG 850
              H ++V L G C   + +L +  ++  GSL      H    GP  L +W  ++     
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----- 124
Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            A+G+ YL    E  ++HR++ + N+LL       +ADFG+A L L P D  +      T
Sbjct: 125 -AKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL-LPPDDKQLLYSEAKT 179
Query: 911 -LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            + ++  E       T++ DV+S+GV + EL+T G  P
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAE 788
            I D+     +++   +IG G FG V        R V   +L      ++R     F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            + ++ A  P +V L  +   ++DR L  +  +M  G L   L    D P    W +R +
Sbjct: 120 RDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEK--W-ARFY 173
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+     L  +H       +HRD+K  N+LLD +    LADFG    +         T 
Sbjct: 174 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 228
Query: 907 LVGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
            VGT  YI PE    Q     Y  + D +S GV L E+L G  P 
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVVAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARGL 855
             HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             Y  PE           D++S GV++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 42/213 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARGL 855
             HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             Y  PE           D++S GV++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 743 NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
           ++    +IG G FG+VY+A L D G  VAIK++        R    E++ + +  H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA--------- 852
            L         R   YS  E    + +L+  LD   +  +    H ++            
Sbjct: 77  RL---------RYFFYSSGEKKD-EVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL 126
Query: 853 ------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTT 905
                 R LAY+H      I HRDIK  N+LLD +     L DFG A+ ++         
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNV 180
Query: 906 DLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
             + +  Y  PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 181 SXICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAE 788
            I D+     +++   +IG G FG V        R V   +L      ++R     F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            + ++ A  P +V L  +   ++DR L  +  +M  G L   L    D P    W +R +
Sbjct: 125 RDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEK--W-ARFY 178
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+     L  +H       +HRD+K  N+LLD +    LADFG    +         T 
Sbjct: 179 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 233
Query: 907 LVGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
            VGT  YI PE    Q     Y  + D +S GV L E+L G  P 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 24/239 (10%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRN--VAIKRLSGDCGQMEREFRAEVEALSR 794
           I+  ++ ++    IG G FG V R       N  VA+K +     +++   + E+     
Sbjct: 13  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRS 70
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN+V  +   +      ++  +   G L     E++        D      Q    G
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISG 126
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLAR---LILSPYDTHVTTDLVG 909
           ++Y H      + HRD+K  N LLDG+    L   DFG ++   L   P  T      VG
Sbjct: 127 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VG 177
Query: 910 TLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMR 966
           T  YI PE         K  DV+S GV L  +L G  P  D  +PK  R  I  ++ ++
Sbjct: 178 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 236

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 17   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 77   YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 129  IVHSDLKPANFLIVDGMLK--LIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P          + IS +  +   N E 
Sbjct: 186  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQISKLHAIIDPNHEI 240
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            E  D    D Q         D+   CL   PK R +  +L++
Sbjct: 241  EFPDIPEKDLQ---------DVLKCCLKRDPKQRISIPELLA 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 93/225 (41%), Gaps = 21/225 (9%)
Query: 733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE----FRAE 788
            I D+     +++   +IG G FG V        R V   +L      ++R     F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            + ++ A  P +V L  +   ++DR L  +  +M  G L   L    D P    W +R +
Sbjct: 125 RDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEK--W-ARFY 178
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+     L  +H       +HRD+K  N+LLD +    LADFG    +         T 
Sbjct: 179 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT- 233
Query: 907 LVGTLGYIPPEY--GQASVATY--KGDVYSFGVVLLELLTGKRPM 947
            VGT  YI PE    Q     Y  + D +S GV L E+L G  P 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 124  YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 176  IVHSDLKPANFLIVDGMLK--LIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P         + +I+ + ++       
Sbjct: 233  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQISKLH------ 278
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 279  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 98/239 (41%), Gaps = 24/239 (10%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRN--VAIKRLSGDCGQMEREFRAEVEALSR 794
           I+  ++ ++    IG G FG V R       N  VA+K +     +++   + E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRS 71
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN+V  +   +      ++  +   G L     E++        D      Q    G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISG 127
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLAR---LILSPYDTHVTTDLVG 909
           ++Y H      + HRD+K  N LLDG+    L    FG ++   L   P DT      VG
Sbjct: 128 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT------VG 178
Query: 910 TLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMR 966
           T  YI PE         K  DV+S GV L  +L G  P  D  +PK  R  I  ++ ++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+       L DFGL+R +    D+       G L   ++ PE     
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 187
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 188 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 23/217 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVA-----IKRLSG-DCGQMEREFRAEVEALS 793
           T+ +     +G G F +V R   +P G+  A      K+LS  D  ++ERE R       
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARI----CR 58
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +HPN+V L      +    L++  +  G L     E +            H  Q    
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLILSPYDTHVTTDLVGT 910
            + + H +    I+HRD+K  N+LL          LADFGLA  I    D        GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGT 169
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +        D+++ GV+L  LL G  P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRN--------VAIKRLSGDCGQMEREFRAEVEALSRA 795
           +D  +++G G F  V  A   D R         +A K L G  G ME E    +  L + 
Sbjct: 20  YDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKEGSMENE----IAVLHKI 73
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN+V L           LI   +  G L   + EK  G  +    SRL I Q     +
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRL-IFQ-VLDAV 129
Query: 856 AYLHQSCEPHILHRDIKSSNIL---LDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   +  I+HRD+K  N+L   LD +    ++DFGL+++        V +   GT G
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 183
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE       +   D +S GV+   LL G  P
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 124  YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 176  IVHSDLKPANFLIVDGML--KLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P         + +I+ + ++       
Sbjct: 233  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQISKLH------ 278
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 279  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 750 IGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQ 804
           IG G FG V++       N    VAIK          RE F  E   + +  HP++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           G  + +N   +I      G L  +L  +     SLD  S +  A   +  LAYL      
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL--GYIPPEYGQAS 922
             +HRDI + N+L+       L DFGL+R +    D+       G L   ++ PE     
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 567
Query: 923 VATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
             T   DV+ FGV + E+L  G +P    K
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 748 NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHL-Q 804
            ++  GGF  VY A  +  GR  A+KRL  +  +  R    EV  + + + HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 805 GYCMHKND------RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
              + K +        L+ + +  G L  +L +K++    L  D+ L I     R + ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 859 HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
           H+  +P I+HRD+K  N+LL       L DFG A  I
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 30/242 (12%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRN--VAIKRLS-GDCGQMEREFRAEVEALS 793
           I+  ++ ++    IG G FG V R       N  VA+K +  G+  +++   + E+    
Sbjct: 14  IMHDSDRYELVKDIGAGNFG-VARLMRDKQANELVAVKYIERGE--KIDENVKREIINHR 70
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +HPN+V  +   +      ++  +   G L     E++        D      Q    
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLIS 126
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLAR---LILSPYDTHVTTDLV 908
           G++Y H      + HRD+K  N LLDG+    L  ADFG ++   L   P         V
Sbjct: 127 GVSYAHAM---QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA------V 177
Query: 909 GTLGYIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIR 964
           GT  YI PE        Y G   DV+S GV L  +L G  P  D  +PK  R  I  ++ 
Sbjct: 178 GTPAYIAPEVLLKK--EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 965 MR 966
           ++
Sbjct: 236 VQ 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 23/217 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRA-TLPDGRNVA-----IKRLSG-DCGQMEREFRAEVEALS 793
           T+ +     +G G F +V R   +P G+  A      K+LS  D  ++ERE R       
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARI----CR 58
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +HPN+V L      +    L++  +  G L     E +            H  Q    
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLILSPYDTHVTTDLVGT 910
            + + H +    I+HRD+K  N+LL          LADFGLA  I    D        GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGT 169
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +        D+++ GV+L  LL G  P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R      ++ERE    V  L
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSIL 69
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +  H N++ L     ++ D +LI   +  G L  +L +K     SL  +      +   
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQIL 125
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       L DFGLA  I    D     ++ 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R      ++ERE    V  L
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSIL 69
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +  H N++ L     ++ D +LI   +  G L  +L +K     SL  +      +   
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQIL 125
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       L DFGLA  I    D     ++ 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R      ++ERE    V  L
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSIL 69
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +  H N++ L     ++ D +LI   +  G L  +L +K     SL  +      +   
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQIL 125
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       L DFGLA  I    D     ++ 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 16   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 76   YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---G 127
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 128  IVHSDLKPANFLIVDGML--KLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P                  + Q ++  
Sbjct: 185  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQISKLH 230
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 231  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 272

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 17/203 (8%)
Query: 750 IGCGGFGLVYRATLPDGRNV-AIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYC 807
           +G G F +  +          A+K +S    +ME   + E+ AL   + HPN+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             +    L+   +  G L     E++            +I +     ++++H   +  ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 868 HRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           HRD+K  N+L    + N    + DFG ARL   P D         TL Y  PE    +  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 925 TYKGDVYSFGVVLLELLTGKRPM 947
               D++S GV+L  +L+G+ P 
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPF 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRN--VAIKRLSGDCGQMEREFRAEVEALSR 794
           I+  ++ ++    IG G FG V R       N  VA+K +     ++    + E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERG-EKIAANVKREIINHRS 71
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN+V  +   +      ++  +   G L     E++        D      Q    G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISG 127
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLAR---LILSPYDTHVTTDLVG 909
           ++Y H      + HRD+K  N LLDG+    L   DFG ++   L   P  T      VG
Sbjct: 128 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VG 178
Query: 910 TLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMR 966
           T  YI PE         K  DV+S GV L  +L G  P  D  +PK  R  I  ++ ++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 87/219 (39%), Gaps = 29/219 (13%)
Query: 744 FDQANIIGCGGF-----------GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEAL 792
           +D    +G G F           GL Y A     R     R      ++ERE    V  L
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE----VSIL 69
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            +  H N++ L     ++ D +LI   +  G L  +L +K     SL  +      +   
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQIL 125
Query: 853 RGLAYLHQSCEPHILHRDIKSSNI-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLV 908
            G+ YLH      I H D+K  NI LLD N       L DFGLA  I    D     ++ 
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIF 179
Query: 909 GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           GT  ++ PE         + D++S GV+   LL+G  P 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 16/230 (6%)
Query: 730 KEISIDDILESTNNFDQANI-IGCGGFGLVYRATLPDGR---NVAIKRLSGDCGQME-RE 784
           +E+    +    +N   A+I +GCG FG V +      +   +VAIK L     + +  E
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 785 FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR 844
              E + + +  +P +V L G C      +L+      G L  +L  K +     +    
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
           LH     + G+ YL    E + +HR++ + N+LL     A ++DFGL++  L   D++ T
Sbjct: 442 LH---QVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYT 494
Query: 905 TDLVGT--LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCK 951
               G   L +  PE       + + DV+S+GV + E L+ G++P    K
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQ 796
           ++ +    ++G G FG V        G+  A+K +S    + + +  +   EV+ L +  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD-WDSRLHIAQ-GAAR- 853
           HPN++ L             Y F E+    Y + E   G    D   SR   ++  AAR 
Sbjct: 85  HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 854 ------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVT 904
                 G+ Y+H++    I+HRD+K  N+LL+    +    + DFGL+    +   +   
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKM 185
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            D +GT  YI PE    +    K DV+S GV+L  LL+G  P +
Sbjct: 186 KDKIGTAYYIAPEVLHGTYDE-KCDVWSTGVILYILLSGCPPFN 228

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 39/292 (13%)
Query: 738  LESTN---NFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
            +++TN    F    ++G G F  V+    R T   G+  A+K +       +     E+ 
Sbjct: 2    MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLT---GKLFALKCIKKSPAFRDSSLENEIA 58
Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
             L + +H N+V L+          L+   +  G L       L+     + D+ L + Q 
Sbjct: 59   VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL---FDRILERGVYTEKDASL-VIQQ 114
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDL 907
                + YLH   E  I+HRD+K  N+L    + N    + DFGL+++        + +  
Sbjct: 115  VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTA 167
Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
             GT GY+ PE       +   D +S GV+   LL G  P      +    L     ++++
Sbjct: 168  CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF---YEETESKLFE---KIKE 221
Query: 968  ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017
               E E   PF  D     +     D  C  L + P  R T ++ +S  W+D
Sbjct: 222  GYYEFE--SPFWDDISESAK-----DFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 148  IVHSDLKPANFLIVDGML--KLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P                  + Q ++  
Sbjct: 205  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQISKLH 250
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 251  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRN---VAIK-----RLSGDCGQMEREFRAEVEALSRA 795
           +D  +++G G F  V  A   D R    VAIK      L G  G ME E    +  L + 
Sbjct: 20  YDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKI 73
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN+V L           LI   +  G L   + EK  G  +    SRL I Q     +
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRL-IFQ-VLDAV 129
Query: 856 AYLHQSCEPHILHRDIKSSNIL---LDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   +  I+HRD+K  N+L   LD +    ++DFGL+++        V +   GT G
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 183
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE       +   D +S GV+   LL G  P
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRN---VAIK-----RLSGDCGQMEREFRAEVEALSRA 795
           +D  +++G G F  V  A   D R    VAIK      L G  G ME E    +  L + 
Sbjct: 20  YDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKI 73
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN+V L           LI   +  G L   + EK  G  +    SRL I Q     +
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRL-IFQ-VLDAV 129
Query: 856 AYLHQSCEPHILHRDIKSSNIL---LDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   +  I+HRD+K  N+L   LD +    ++DFGL+++        V +   GT G
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 183
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE       +   D +S GV+   LL G  P
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 67/214 (31%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 744 FDQANIIGCGGFGLVYRATLPDGRN---VAIK-----RLSGDCGQMEREFRAEVEALSRA 795
           +D  +++G G F  V  A   D R    VAIK      L G  G ME E    +  L + 
Sbjct: 20  YDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENE----IAVLHKI 73
Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HPN+V L           LI   +  G L   + EK  G  +    SRL I Q     +
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRL-IFQ-VLDAV 129
Query: 856 AYLHQSCEPHILHRDIKSSNIL---LDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            YLH   +  I+HRD+K  N+L   LD +    ++DFGL+++        V +   GT G
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPG 183
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           Y+ PE       +   D +S GV+   LL G  P
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 750 IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           +G G +G VY+A   DG++    A+K++ G    M      E+  L   +HPN++ LQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86
Query: 807 CMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR--------GLA 856
            +   DR   L++ + E+   D W   K    S  +    + + +G  +        G+ 
Sbjct: 87  FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIH 142
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFG----AHLADFGLARLILSPYDTHVTTD-LVGTL 911
           YLH +    +LHRD+K +NIL+ G         +AD G ARL  SP       D +V T 
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 912 GYIPPEYGQASVATYKG-DVYSFGVVLLELLTGKRPMDMCK 951
            Y  PE    +    K  D+++ G +  ELLT + P+  C+
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 73/282 (25%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 20   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 80   YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---G 131
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VGT+ Y+PPE  +   
Sbjct: 132  IVHSDLKPANFLIVDGML--KLIDFGIANQ-MQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P                  + Q ++  
Sbjct: 189  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQISKLH 234
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 235  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 102/246 (41%), Gaps = 40/246 (16%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
           L   ++F++  ++G G FG V +A    D R  AIK++     ++     +EV  L+   
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 797 HPNLVHLQGY------------CMHKNDRLLI-YSFMENGSLDYWLH-EKLDGPSSLDWD 842
           H  +V                  + K   L I   + ENG+L   +H E L+      W 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW- 119
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-- 900
               + +     L+Y+H      I+HRD+K  NI +D +    + DFGLA+ +    D  
Sbjct: 120 ---RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 901 ----------THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELL----TGKR 945
                     +   T  +GT  Y+  E    +     K D+YS G++  E++    TG  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 946 PMDMCK 951
            +++ K
Sbjct: 234 RVNILK 239

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQ 796
           ++ +    ++G G FG V        G+  A+K +S    + + +  +   EV+ L +  
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQ-GAAR- 853
           HPN++ L             Y F E+    Y + E   G    D   SR   ++  AAR 
Sbjct: 108 HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 854 ------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVT 904
                 G+ Y+H++    I+HRD+K  N+LL+    +    + DFGL+    +   +   
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKM 208
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            D +GT  YI PE    +    K DV+S GV+L  LL+G  P +
Sbjct: 209 KDKIGTAYYIAPEVLHGTYDE-KCDVWSTGVILYILLSGCPPFN 251

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 749 IIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           ++G G FG V     R T  +     I + S          R EVE L +  HPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKL- 86
Query: 805 GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD--WDSRLHIAQGAAR-------GL 855
                       +  +E+ S  Y + E   G    D     +      AAR       G+
Sbjct: 87  ------------FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 856 AYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            Y+H+    +I+HRD+K  NILL+    +    + DFGL+       +T +  D +GT  
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKM-KDRIGTAY 188
Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           YI PE  + +    K DV+S GV+L  LL+G  P 
Sbjct: 189 YIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPPF 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 744 FDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN 799
           + +   +G G +G V     + T  + R + I R +        +   EV  L    HPN
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVE-RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           ++ L  +   K +  L+    + G L     E +      + D+ + I Q    G+ YLH
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHRMKFNEVDAAVIIKQ-VLSGVTYLH 153
Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHL---ADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           +    +I+HRD+K  N+LL+      L    DFGL+ +     +     + +GT  YI P
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           E  +      K DV+S GV+L  LL G  P 
Sbjct: 208 EVLRKKYDE-KCDVWSIGVILFILLAGYPPF 237

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 764 PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME 821
           P G  V ++R++ +    +M    + E+       HPN+V  +   +  N+  ++ SFM 
Sbjct: 34  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 93
Query: 822 NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
            GS  D      +DG + L   +  +I QG  + L Y+H       +HR +K+S+IL+  
Sbjct: 94  YGSAKDLICTHFMDGMNEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISV 147
Query: 881 NFGAHLADFGLA---RLILSPYDTHVTTDL----VGTLGYIPPEYGQASVATY--KGDVY 931
           +   +L+  GL     +I       V  D     V  L ++ PE  Q ++  Y  K D+Y
Sbjct: 148 DGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 205
Query: 932 SFGVVLLELLTGKRPM 947
           S G+   EL  G  P 
Sbjct: 206 SVGITACELANGHVPF 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 42/213 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARGL 855
             HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             Y  PE           D++S G ++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 20/196 (10%)
Query: 764 PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME 821
           P G  V ++R++ +    +M    + E+       HPN+V  +   +  N+  ++ SFM 
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 822 NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
            GS  D      +DG + L   +  +I QG  + L Y+H       +HR +K+S+IL+  
Sbjct: 110 YGSAKDLICTHFMDGMNEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISV 163
Query: 881 NFGAHLADFGLA---RLILSPYDTHVTTDL----VGTLGYIPPEYGQASVATY--KGDVY 931
           +   +L+  GL     +I       V  D     V  L ++ PE  Q ++  Y  K D+Y
Sbjct: 164 DGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 932 SFGVVLLELLTGKRPM 947
           S G+   EL  G  P 
Sbjct: 222 SVGITACELANGHVPF 237

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQ 796
           ++ +    ++G G FG V        G+  A+K +S    + + +  +   EV+ L +  
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQ-GAAR- 853
           HPN++ L             Y F E+    Y + E   G    D   SR   ++  AAR 
Sbjct: 109 HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 854 ------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVT 904
                 G+ Y+H++    I+HRD+K  N+LL+    +    + DFGL+    +   +   
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKM 209
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            D +GT  YI PE    +    K DV+S GV+L  LL+G  P +
Sbjct: 210 KDKIGTAYYIAPEVLHGTYDE-KCDVWSTGVILYILLSGCPPFN 252

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 741 TNNFDQANIIGCGGFG-LVYRATLPDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQ 796
           ++ +    ++G G FG ++       G+  A+K +S    + + +  +   EV+ L +  
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD-WDSRLHIAQ-GAAR- 853
           HPN++ L             Y F E+    Y + E   G    D   SR   ++  AAR 
Sbjct: 91  HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 137
Query: 854 ------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVT 904
                 G+ Y+H++    I+HRD+K  N+LL+    +    + DFGL+    +   +   
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKM 191
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            D +GT  YI PE    +    K DV+S GV+L  LL+G  P +
Sbjct: 192 KDKIGTAYYIAPEVLHGTYDE-KCDVWSTGVILYILLSGCPPFN 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
             ARG+ +L        +HRD+ + NILL  N    + DFGLAR I    D     D    
Sbjct: 208  VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ-- 967
            L ++ PE     + + K DV+S+GV+L E+ + G  P       G +    +  R+R+  
Sbjct: 265  LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY-----PGVQMDEDFCSRLREGM 319
Query: 968  ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              R  E   P IY    D            C    PK RP   +LV  L  ++
Sbjct: 320  RMRAPEYSTPEIYQIMLD------------CWHRDPKERPRFAELVEKLGDLL 360

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 112/268 (41%), Gaps = 31/268 (11%)
Query: 750  IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
            +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G  +    ++ +      GSL   L  K  G   L   SR  +    A G+ YL    
Sbjct: 80   LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQ--VAEGMGYLESK- 134
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
                +HRD+ + N+LL       + DFGL R +    D +V  +       +  PE  + 
Sbjct: 135  --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               ++  D + FGV L E+ T G+ P       GS+ L        + ++E E L P   
Sbjct: 193  RTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQIL-------HKIDKEGERL-PRPE 242
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPT 1008
            D   D     + ++   C +  P+ RPT
Sbjct: 243  DCPQD-----IYNVMVQCWAHKPEDRPT 265

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 42/282 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 124  YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTD-LVGTLGYIPPEYGQASV 923
            I+H D+K +N L+ DG     L DFG+A   + P  T V  D  VG + Y+PPE  +   
Sbjct: 176  IVHSDLKPANFLIVDGML--KLIDFGIANQ-MQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 924  ATYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            ++ +            DV+S G +L  +  GK P         + +I+ + ++       
Sbjct: 233  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--------QQIINQISKLH------ 278
Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 279  AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 40/281 (14%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   ++ Y 
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 808  MHKNDRLLIYSFMENGSLDY--WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
                D+  IY  ME G++D   WL +K     S+D   R    +     +  +HQ     
Sbjct: 96   YEITDQY-IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 866  ILHRDIKSSNILL-DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
            I+H D+K +N L+ DG     L DFG+A  +       V    VGT+ Y+PPE  +   +
Sbjct: 148  IVHSDLKPANFLIVDGML--KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 925  TYKG-----------DVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + +            DV+S G +L  +  GK P                  + Q ++   
Sbjct: 206  SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------------INQISKLHA 251
Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            ++DP    +  D     + D+   CL   PK R +  +L++
Sbjct: 252  IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 79/195 (40%), Gaps = 18/195 (9%)
Query: 756 GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL 815
           GL Y A     R     R     G    E   EV  L +  H N++ L     ++ D +L
Sbjct: 37  GLEYAAKFIKKRQSRASRR----GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92
Query: 816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN 875
           I   +  G L  +L +K     SL  +      +    G+ YLH      I H D+K  N
Sbjct: 93  ILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPEN 145
Query: 876 I-LLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVY 931
           I LLD N       L DFGLA  I    D     ++ GT  ++ PE         + D++
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 932 SFGVVLLELLTGKRP 946
           S GV+   LL+G  P
Sbjct: 203 SIGVITYILLSGASP 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKX 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARGL 855
             HKN   L+  F    +L+     Y + E +D          LD +   ++      G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE           D++S G ++ E++  K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 42/213 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKV 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARGL 855
             HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
             Y  PE           D++S G ++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 23/217 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSG-DCGQMEREFRAEVEALS 793
           T+++     +G G F +V R            + +  K+LS  D  ++ERE R       
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI----CR 85
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +HPN+V L      +    L++  +  G L     E +            H       
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIHQILE 141
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLILSPYDTHVTTDLVGT 910
            + ++HQ     I+HRD+K  N+LL          LADFGLA  I    +        GT
Sbjct: 142 SVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGT 196
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +        D+++ GV+L  LL G  P 
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRN--VAIKRLSGDCGQMEREFRAEVEALSR 794
           I+  ++ ++    IG G FG V R       N  VA+K +     +++   + E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRS 71
Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            +HPN+V  +   +      ++  +   G L     E++        D      Q    G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISG 127
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA--DFGLAR---LILSPYDTHVTTDLVG 909
           ++Y H      + HRD+K  N LLDG+    L    FG ++   L   P  T      VG
Sbjct: 128 VSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST------VG 178
Query: 910 TLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPM-DMCKPKGSRDLISWVIRMR 966
           T  YI PE         K  DV+S GV L  +L G  P  D  +PK  R  I  ++ ++
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           T  Y  PE           D++S G ++ E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 750 IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
           +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L G  +    ++ +      GSL   L  K  G   L   SR   A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSR--YAVQVAEGMGYLESK- 130
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
               +HRD+ + N+LL       + DFGL R +    D +V  +       +  PE  + 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 922 SVATYKGDVYSFGVVLLELLT-GKRP 946
              ++  D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 750  IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
            +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G  +    ++ +      GSL   L  K  G   L   SR  +    A G+ YL    
Sbjct: 86   LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQ--VAEGMGYLESK- 140
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
                +HRD+ + N+LL       + DFGL R +    D +V  +       +  PE  + 
Sbjct: 141  --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               ++  D + FGV L E+ T G+ P       GS+ L        + ++E E L P   
Sbjct: 199  RTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQIL-------HKIDKEGERL-PRPE 248
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            D   D     + ++   C +  P+ RPT   L  +L
Sbjct: 249  DCPQD-----IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 71
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXG 131
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--------VV 180
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 44/214 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDGPSS------LDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D   S      LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           T  Y  PE           D++S G ++ E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 31/276 (11%)
Query: 750  IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
            +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G  +    ++ +      GSL   L  K  G   L   SR   A   A G+ YL    
Sbjct: 80   LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSR--YAVQVAEGMGYLESK- 134
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
                +HRD+ + N+LL       + DFGL R +    D +V  +       +  PE  + 
Sbjct: 135  --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               ++  D + FGV L E+ T G+ P       GS+ L        + ++E E L P   
Sbjct: 193  RTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQIL-------HKIDKEGERL-PRPE 242
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            D   D     + ++   C +  P+ RPT   L  +L
Sbjct: 243  DCPQD-----IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQ 796
           ++ +    ++G G FG V        G+  A+K +S    + + +  +   EV+ L +  
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQ-GAAR- 853
           HPN+  L             Y F E+    Y + E   G    D   SR   ++  AAR 
Sbjct: 85  HPNIXKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 854 ------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVT 904
                 G+ Y H++    I+HRD+K  N+LL+    +    + DFGL+    +   +   
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKX 185
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            D +GT  YI PE    +    K DV+S GV+L  LL+G  P +
Sbjct: 186 KDKIGTAYYIAPEVLHGTYDE-KCDVWSTGVILYILLSGCPPFN 228

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 750 IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
           +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L G  +    ++ +      GSL   L  K  G   L   SR   A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSR--YAVQVAEGMGYLESK- 130
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
               +HRD+ + N+LL       + DFGL R +    D +V  +       +  PE  + 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 922 SVATYKGDVYSFGVVLLELLT-GKRP 946
              ++  D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/171 (29%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD--WDSRL 845
           EVE L +  HPN++ L             +  +E+ S  Y + E   G    D     + 
Sbjct: 71  EVELLKKLDHPNIMKL-------------FEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 846 HIAQGAAR-------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLI 895
                AAR       G+ Y+H+    +I+HRD+K  NILL+    +    + DFGL+   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
                     D +GT  YI PE  + +    K DV+S GV+L  LL+G  P
Sbjct: 175 ---QQNTKMKDRIGTAYYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 51/171 (29%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD--WDSRL 845
           EVE L +  HPN++ L             +  +E+ S  Y + E   G    D     + 
Sbjct: 71  EVELLKKLDHPNIMKL-------------FEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 846 HIAQGAAR-------GLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLI 895
                AAR       G+ Y+H+    +I+HRD+K  NILL+    +    + DFGL+   
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
                     D +GT  YI PE  + +    K DV+S GV+L  LL+G  P
Sbjct: 175 ---QQNTKMKDRIGTAYYIAPEVLRGTYDE-KCDVWSAGVILYILLSGTPP 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 44/214 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           T  Y  PE           D++S G ++ E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 44/214 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           T  Y  PE           D++S G ++ E++ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 84/208 (40%), Gaps = 23/208 (11%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVA-----IKRLSG-DCGQMEREFRAEVEALSRAQHPNLVH 802
           +G G F +V R   +  G+  A      K+LS  D  ++ERE R         +HPN+V 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARI----CRLLKHPNIVR 85
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L      +    LI+  +  G     L E +            H  Q     + + HQ  
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 863 EPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
              ++HRD+K  N+LL          LADFGLA  I    +        GT GY+ PE  
Sbjct: 142 ---VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           +        D+++ GV+L  LL G  P 
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 44/214 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 79
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 188
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           T  Y  PE           D++S G ++ E++ G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 741 TNNFDQANIIGCGGFGLVYRATLPDGRN-VAIKRLSGDCGQMEREFRAEVEALSRAQHPN 799
           ++ F+  + +G G   +VYR      +   A+K L     +  +  R E+  L R  HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           ++ L+       +  L+   +  G L   + EK         D+   I +     +AYLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA----VAYLH 165
Query: 860 QSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLILSPYDTHVTTDLV-GTLGYIP 915
              E  I+HRD+K  N+L      +    +ADFGL++++    +  V    V GT GY  
Sbjct: 166 ---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV----EHQVLMKTVCGTPGYCA 218
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE  +      + D++S G++   LL G  P 
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAE-VEALSRAQHPNLVHLQGYC 807
           +G G FG V+R      G   A+K++  +       FRAE + A +    P +V L G  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPRIVPLYGAV 154
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
                  +    +E GSL   + E+      L  D  L+    A  GL YLH      IL
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQALEGLEYLHSR---RIL 207
Query: 868 HRDIKSSNILL--DGNFGAHLADFGLARLILSP---YDTHVTTDLV-GTLGYIPPEYGQA 921
           H D+K+ N+LL  DG+  A L DFG A + L P     + +T D + GT  ++ PE    
Sbjct: 208 HGDVKADNVLLSSDGSHAA-LCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 922 SVATYKGDVYSFGVVLLELLTGKRP 946
                K DV+S   ++L +L G  P
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKX 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARGL 855
             HKN   L+  F    +L+     Y + E +D          LD +   ++      G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE           D++S G ++ E++  K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + +LH +    I+HRD+K SNI++  +    + DFGLAR   + +   + T  V T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPEVVTRYYR 192
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTG 943
            PE           D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           A  +G G FG+V+R      +   + +     G  +   + E+  L+ A+H N++HL   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP-- 864
                + ++I+ F+    LD  + E+++  S+ + + R          ++Y+HQ CE   
Sbjct: 70  FESMEELVMIFEFIS--GLD--IFERIN-TSAFELNER--------EIVSYVHQVCEALQ 116
Query: 865 -----HILHRDIKSSNILLDGNFGA--HLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
                +I H DI+  NI+      +   + +FG AR  L P D      L     Y  PE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRL--LFTAPEYYAPE 173
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             Q  V +   D++S G ++  LL+G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV L   
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELV-LMKX 79
Query: 807 CMHKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARGL 855
             HKN   L+  F    +L+     Y + E +D          LD +   ++      G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGI 139
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVGT 910
            +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V T
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPY--------VVT 188
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE           D++S G ++ E++  K
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 750 IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
           +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           L G  +    ++ +      GSL   L  K  G   L   SR   A   A G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSR--YAVQVAEGMGYLESK- 130
Query: 863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
               +HRD+ + N+LL       + DFGL R +    D  V  +       +  PE  + 
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 922 SVATYKGDVYSFGVVLLELLT-GKRP 946
              ++  D + FGV L E+ T G+ P
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 116
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 177 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 225
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 114/276 (41%), Gaps = 31/276 (11%)
Query: 750  IGCGGFGLVYRATL--PDGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVH 802
            +G G FG+V R     P G+  +VA+K L  D     +   +F  EV A+    H NL+ 
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
            L G  +    ++ +      GSL   L  K  G   L   SR  +    A G+ YL    
Sbjct: 86   LYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQ--VAEGMGYLESK- 140
Query: 863  EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT-LGYIPPEYGQA 921
                +HRD+ + N+LL       + DFGL R +    D  V  +       +  PE  + 
Sbjct: 141  --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
               ++  D + FGV L E+ T G+ P       GS+ L        + ++E E L P   
Sbjct: 199  RTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQIL-------HKIDKEGERL-PRPE 248
Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            D   D     + ++   C +  P+ RPT   L  +L
Sbjct: 249  DCPQD-----IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 110/271 (40%), Gaps = 57/271 (21%)
Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCGQM 781
            K+ E   + + + +N F   + IG G F  VY AT      P+ + +A+K L      +
Sbjct: 6   KKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEK-IALKHLIPTSHPI 64
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK-LDGPSSLD 840
                AE++ L+ A   + V    YC  KND ++I       ++ Y  HE  LD  +SL 
Sbjct: 65  R--IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI-------AMPYLEHESFLDILNSLS 115
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH-LADFGLARLILSPY 899
           +           + L  +HQ     I+HRD+K SN L +     + L DFGLA+     +
Sbjct: 116 FQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ---GTH 169
Query: 900 DTHV-----------------------------TTDLVGTLGYIPPEY-GQASVATYKGD 929
           DT +                                  GT G+  PE   +    T   D
Sbjct: 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229
Query: 930 VYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
           ++S GV+ L LL+G+ P      K S DL +
Sbjct: 230 MWSAGVIFLSLLSGRYPFY----KASDDLTA 256

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 109
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 110 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 167 XYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 77
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 137
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 138 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 186
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 187 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           D        + Q   IG G  G+V  A     G NVA+K+LS       R F+ +  A  
Sbjct: 17  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHA-- 67
Query: 794 RAQHPNLVHLQGYCM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDW 841
           +  +  LV L+  C+ HKN   L+  F    +L+     Y + E +D          LD 
Sbjct: 68  KRAYRELVLLK--CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 125
Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT 901
           +   ++      G+ +LH +    I+HRD+K SNI++  +    + DFGLAR   + +  
Sbjct: 126 ERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-- 180
Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
            + T  V T  Y  PE           D++S G ++ EL+ G
Sbjct: 181 -MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 79
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 188
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 187
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 80
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 140
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + +LH +    I+HRD+K SNI++  +    + DFGLAR   + +   +    V T  Y 
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMVPFVVTRYYR 194
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTG 943
            PE           D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 79
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 188
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 116
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 176
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 225
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 71
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 180
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 23/217 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVA-----IKRLSG-DCGQMEREFRAEVEALS 793
           T  +     +G G F +V R   +  G+  A      K+LS  D  ++ERE R       
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI----CR 65
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +HPN+V L      +    LI+  +  G     L E +            H  Q    
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILE 121
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVTTDLVGT 910
            + + HQ     ++HR++K  N+LL          LADFGLA  I    +        GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGT 176
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            GY+ PE  +        D+++ GV+L  LL G  P 
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 60/216 (27%), Positives = 85/216 (39%), Gaps = 23/216 (10%)
Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVA-----IKRLSG-DCGQMEREFRAEVEALS 793
           T+ +     IG G F +V R   L  G   A      K+LS  D  ++ERE R       
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARI----CR 58
Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
             +H N+V L      +    L++  +  G L     E +            H  Q    
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 114
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARLILSPYDTHVTTDLVGT 910
            + + HQ     ++HRD+K  N+LL          LADFGLA  I    D        GT
Sbjct: 115 AVLHCHQM---GVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGT 169
Query: 911 LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            GY+ PE  +        D+++ GV+L  LL G  P
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRL------SGDCGQMEREFRAEVEAL 792
           S + + +   +G G +G VY+A        VAIKR+       G  G   RE    V  L
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLL 87
Query: 793 SRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
              QH N++ L+   +H N RL LI+ + EN      L + +D    +            
Sbjct: 88  KELQHRNIIELKS-VIHHNHRLHLIFEYAEND-----LKKYMDKNPDVSMRVIKSFLYQL 141
Query: 852 ARGLAYLH-QSCEPHILHRDIKSSNILLDGNFGAH-----LADFGLARLILSPYDTHVTT 905
             G+ + H + C    LHRD+K  N+LL  +  +      + DFGLAR    P     T 
Sbjct: 142 INGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-RQFTH 196
Query: 906 DLVGTLGYIPPEY--GQASVATYKGDVYSFGVVLLELL 941
           +++ TL Y PPE   G    +T   D++S   +  E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHYST-SVDIWSIACIWAEML 232

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 72
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 181
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 72
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    +L+     Y + E +D          LD +   ++      G
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 181
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 103
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 104 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 161 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 115
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 116 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 125
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 126 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 125
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 126 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 183 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 105
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 106 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 109
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 110 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 167 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 40/168 (23%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
           ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       + 
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVK 123
Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  +
Sbjct: 124 DKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180
Query: 901 TH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            +   T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 181 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 40/246 (16%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
           L   ++F++  ++G G FG V +A    D R  AIK++     ++     +EV  L+   
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 797 HPNLVHLQGY------------CMHKNDRLLI-YSFMENGSLDYWLH-EKLDGPSSLDWD 842
           H  +V                  + K   L I   + EN +L   +H E L+      W 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW- 119
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-- 900
               + +     L+Y+H      I+HRD+K  NI +D +    + DFGLA+ +    D  
Sbjct: 120 ---RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 901 ----------THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELL----TGKR 945
                     +   T  +GT  Y+  E    +     K D+YS G++  E++    TG  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 946 PMDMCK 951
            +++ K
Sbjct: 234 RVNILK 239

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAE-VEALSRAQHPNLVHLQGYC 807
           +G G FG V+R      G   A+K++  +       FRAE + A +    P +V L G  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPRIVPLYGAV 135
Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
                  +    +E GSL   + E+      L  D  L+    A  GL YLH      IL
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQALEGLEYLHSR---RIL 188
Query: 868 HRDIKSSNILL--DGNFGAHLADFGLARLILSP----YDTHVTTDLVGTLGYIPPEYGQA 921
           H D+K+ N+LL  DG+  A L DFG A + L P     D      + GT  ++ PE    
Sbjct: 189 HGDVKADNVLLSSDGSHAA-LCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 922 SVATYKGDVYSFGVVLLELLTGKRP 946
                K DV+S   ++L +L G  P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA-------EVE 790
           +  + +++   IG G FG V++A     G+ VA+K++      ME E          E++
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIK 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRL--------LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            L   +H N+V+L   C  K            L++ F E+  L   L   L         
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLS 125
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
               + Q    GL Y+H++    ILHRD+K++N+L+  +    LADFGLAR      ++ 
Sbjct: 126 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 903 VT--TDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLT 942
                + V TL Y PPE   G+        D++  G ++ E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGP-PIDLWGAGCIMAEMWT 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G FG V+R      G   A+K++  +  ++E     E+ A +    P +V L G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
                 +    +E GSL   + +       L  D  L+    A  GL YLH      ILH
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILH 173
Query: 869 RDIKSSNILL--DGNFGAHLADFGLARLILSP---YDTHVTTDLV-GTLGYIPPEYGQAS 922
            D+K+ N+LL  DG+  A L DFG A L L P     + +T D + GT  ++ PE     
Sbjct: 174 GDVKADNVLLSSDGSRAA-LCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
               K D++S   ++L +L G  P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 22/231 (9%)
Query: 723 VLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM 781
           VL   K K +  +   E  +       +G G FG V+R      G   A+K++  +  ++
Sbjct: 56  VLLTEKLKPVDYE-YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 114
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW 841
           E     E+ A +    P +V L G         +    +E GSL   + +       L  
Sbjct: 115 E-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM----GCLPE 165
Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNFGAHLADFGLARLILSP- 898
           D  L+    A  GL YLH      ILH D+K+ N+LL  DG+  A L DFG A L L P 
Sbjct: 166 DRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA-LCDFGHA-LCLQPD 220
Query: 899 --YDTHVTTDLV-GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
               + +T D + GT  ++ PE         K D++S   ++L +L G  P
Sbjct: 221 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + IG G +G V  A     G  VA+K+LS     +  
Sbjct: 13  FYRQELNKTIWEVPERYQNL---SPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 69
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 70  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 129 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR- 178
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 179 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 39/236 (16%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 4   FYRQELAKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 60
Query: 782 -EREFRAEVEALSRAQHPNLVHL-----QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            +R +R E+  L   +H N++ L         + + + + + + +    L+      +  
Sbjct: 61  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-----NIVK 114
Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            + L  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR  
Sbjct: 115 CAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-- 169
Query: 896 LSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
              +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 170 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCGQME 782
           + KE+ +D  L +  + +    +G G FG V +             V I +   +   ++
Sbjct: 359 RPKEVYLDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 414
Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            E  AE   + +  +P +V + G C      +L+    E G L+ +L +       +   
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDK 469
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
           + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  + +
Sbjct: 470 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 903 -VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
              T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA-------EVE 790
           +  + +++   IG G FG V++A     G+ VA+K++      ME E          E++
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIK 69
Query: 791 ALSRAQHPNLVHLQGYCMHK--------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            L   +H N+V+L   C  K            L++ F E+  L   L   L         
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLS 125
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
               + Q    GL Y+H++    ILHRD+K++N+L+  +    LADFGLAR      ++ 
Sbjct: 126 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 903 VT--TDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLT 942
                + V TL Y PPE   G+        D++  G ++ E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGP-PIDLWGAGCIMAEMWT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA-------EVE 790
           +  + +++   IG G FG V++A     G+ VA+K++      ME E          E++
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIK 69
Query: 791 ALSRAQHPNLVHLQGYCMHKNDRL--------LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            L   +H N+V+L   C  K            L++ F E+  L   L   L         
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVL---VKFTLS 125
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
               + Q    GL Y+H++    ILHRD+K++N+L+  +    LADFGLAR      ++ 
Sbjct: 126 EIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 903 VT--TDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLT 942
                + V TL Y PPE   G+        D++  G ++ E+ T
Sbjct: 183 PNRYXNRVVTLWYRPPELLLGERDYGP-PIDLWGAGCIMAEMWT 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 15  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 71
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 72  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 131 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 180
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 15  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 71
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 72  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 131 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 180
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 103/244 (42%), Gaps = 41/244 (16%)
Query: 718 GSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSG 776
           GS+    F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS 
Sbjct: 1   GSQERPTFYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 777 DCGQM---EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDY 827
               +   +R +R E+  L   +H N++ L             ND  L+   M     + 
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 828 WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA 887
              +KL        D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + 
Sbjct: 117 VKCQKLTD------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 167
Query: 888 DFGLARLILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLEL 940
           DFGLAR     +     T  V T  Y  PE       Y Q        D++S G ++ EL
Sbjct: 168 DFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAEL 216
Query: 941 LTGK 944
           LTG+
Sbjct: 217 LTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 4   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 60
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 61  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 120 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 169
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 170 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 22/231 (9%)
Query: 723 VLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM 781
           VL   K K +  +   E  +       +G G FG V+R      G   A+K++  +  ++
Sbjct: 54  VLLTEKLKPVDYE-YREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV 112
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW 841
           E     E+ A +    P +V L G         +    +E GSL   + +       L  
Sbjct: 113 E-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM----GCLPE 163
Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNFGAHLADFGLARLILSP- 898
           D  L+    A  GL YLH      ILH D+K+ N+LL  DG+  A L DFG A L L P 
Sbjct: 164 DRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA-LCDFGHA-LCLQPD 218
Query: 899 --YDTHVTTDLV-GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
               + +T D + GT  ++ PE         K D++S   ++L +L G  P
Sbjct: 219 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 15  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 71
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 72  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 131 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 180
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCGQME 782
           + KE+ +D  L +  + +    +G G FG V +             V I +   +   ++
Sbjct: 360 RPKEVYLDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 415
Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            E  AE   + +  +P +V + G C      +L+    E G L+ +L +       +   
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN----RHVKDK 470
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
           + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  + +
Sbjct: 471 NIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 903 -VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
              T     + +  PE       + K DV+SFGV++ E  + G++P
Sbjct: 528 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA--EVEALSRA 795
           +  + +++   IG G FG V++A     G+ VA+K++  +  +      A  E++ L   
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 796 QHPNLVHLQGYCMHK--------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
           +H N+V+L   C  K            L++ F E+  L   L   L             +
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRV 129
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT--T 905
            Q    GL Y+H++    ILHRD+K++N+L+  +    LADFGLAR      ++      
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 906 DLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLT 942
           + V TL Y PPE   G+        D++  G ++ E+ T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGP-PIDLWGAGCIMAEMWT 224

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 133/311 (42%), Gaps = 64/311 (20%)
Query: 743  NFDQA--------NIIGCGGFGLVYRATLPDGRNVAIKRLSGD-CGQMEREFRAEVEALS 793
            NF+Q+         I+G G  G V       GR VA+KR+  D C     E +   E+  
Sbjct: 8    NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-- 65
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH------- 846
               HPN++  + YC    DR L Y  +E  +L+  L + ++  +  D + +L        
Sbjct: 66   -DDHPNVI--RYYCSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPIS 119
Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILL--------DGNFGAH-----LADFGLAR 893
            + +  A G+A+LH      I+HRD+K  NIL+        D   GA      ++DFGL +
Sbjct: 120  LLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 894  LILSPYDTHVT--TDLVGTLGYIPPEYGQAS-------VATYKGDVYSFGVVLLELLT-G 943
             + S   +  T   +  GT G+  PE  + S         T   D++S G V   +L+ G
Sbjct: 177  KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 944  KRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEML-RVLDIACLCLSES 1002
            K P      K SR+  S +IR      E + L        HD+ ++    D+    +   
Sbjct: 237  KHPFG---DKYSRE--SNIIRGIFSLDEMKCL--------HDRSLIAEATDLISQMIDHD 283
Query: 1003 PKVRPTTQQLV 1013
            P  RPT  +++
Sbjct: 284  PLKRPTAMKVL 294

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           D        + Q   IG G  G+V  A     G NVA+K+LS       R F+ +  A  
Sbjct: 15  DSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQTHA-- 65
Query: 794 RAQHPNLVHLQGYCM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDW 841
           +  +  LV L+  C+ HKN   L+  F    +L+     Y + E +D          LD 
Sbjct: 66  KRAYRELVLLK--CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 123
Query: 842 DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LIL 896
           +   ++      G+ +LH +    I+HRD+K SNI++  +    + DFGLAR      ++
Sbjct: 124 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM 180
Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 943
           +PY        V T  Y  PE           D++S G ++ EL+ G
Sbjct: 181 TPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 28  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 84
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 85  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 144 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 193
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 194 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 27  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 83
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 84  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 143 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 192
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 193 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 13  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 69
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 70  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 129 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR- 178
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 179 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 20  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIH 76
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 77  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 136 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 185
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 186 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 851  AARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A+G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D   
Sbjct: 207  VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ- 967
             L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++ 
Sbjct: 263  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 317
Query: 968  -ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 318  TRMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 359

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 851  AARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A+G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D   
Sbjct: 202  VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ- 967
             L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++ 
Sbjct: 258  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 312
Query: 968  -ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 313  TRMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 354

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 19  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 75
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 76  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 135 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLAR- 184
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 185 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 851  AARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A+G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D   
Sbjct: 209  VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ- 967
             L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++ 
Sbjct: 265  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 319
Query: 968  -ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 320  TRMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 361

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 851  AARGLAYL-HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
             A+G+ +L  + C    +HRD+ + NILL       + DFGLAR I    D     D   
Sbjct: 200  VAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQ- 967
             L ++ PE     V T + DV+SFGV+L E+ + G  P       G +    +  R+++ 
Sbjct: 256  PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 310
Query: 968  -ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R  +   P +Y    D            C    P  RPT  +LV  L +++
Sbjct: 311  TRMRAPDYTTPEMYQTMLD------------CWHGEPSQRPTFSELVEHLGNLL 352

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 29/231 (12%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE    A       D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 4   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 61  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 120 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 169
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 170 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 37  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 83
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 143
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 144 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 192
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 193 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 18  FYRQELNKTIWEVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 74
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 75  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 134 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 183
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 184 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 6   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 62
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 63  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 122 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 171
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 172 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 89/224 (39%), Gaps = 38/224 (16%)
Query: 747 ANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           + ++G G +  V  A +L +G+  A+K +    G        EVE L +           
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ----------- 66
Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL---------HIAQGAARGLA 856
            C    + L +  F E+ +  Y + EKL G S L    +           + +  A  L 
Sbjct: 67  -CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALD 125
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGA---HLADFGLARLI-----LSPYDTHVTTDLV 908
           +LH      I HRD+K  NIL +         + DF L   +      +P  T   T   
Sbjct: 126 FLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 909 GTLGYIPPEY-----GQASVATYKGDVYSFGVVLLELLTGKRPM 947
           G+  Y+ PE       QA+    + D++S GVVL  +L+G  P 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGXVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 5   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 61
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 62  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 121 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 170
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 171 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 5   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 61
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 62  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 121 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 170
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 171 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 13  FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 69
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 70  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 129 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 178
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 179 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 44/215 (20%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 26  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 72
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 132
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR-----LILSPYDTHVTTDLVG 909
           + +LH +    I+HRD+K SNI++  +    + DFGLAR      +++PY        V 
Sbjct: 133 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--------VV 181
Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE           D++S G ++ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 10  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 66
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 67  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 126 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 175
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 176 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 15  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 71
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 72  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 131 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 180
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 181 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 10  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 66
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 67  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 126 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 175
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 176 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 10  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 66
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 67  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 126 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR- 175
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 176 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 31  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 87
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 88  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 147 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 196
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 197 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 13  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 69
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 70  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 129 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 178
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 179 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 7   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 63
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 64  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 123 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 172
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 173 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 219

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   IG G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  +M  G  D + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      +ADFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 20  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 76
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 77  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 136 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 185
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 186 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 19  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 75
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 76  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 135 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 184
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 185 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 20  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 76
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 77  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 136 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 185
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 186 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 232

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   IG G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  +M  G  D + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      +ADFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 130/307 (42%), Gaps = 60/307 (19%)
Query: 743  NFDQA--------NIIGCGGFGLVYRATLPDGRNVAIKRLSGD-CGQMEREFRAEVEALS 793
            NF+Q+         I+G G  G V       GR VA+KR+  D C     E +   E+  
Sbjct: 26   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-- 83
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH------- 846
               HPN++    YC    DR L Y  +E  +L+  L + ++  +  D + +L        
Sbjct: 84   -DDHPNVIRY--YCSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPIS 137
Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILL--------DGNFGAH-----LADFGLAR 893
            + +  A G+A+LH      I+HRD+K  NIL+        D   GA      ++DFGL +
Sbjct: 138  LLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 894  LILSPYDTHVT--TDLVGTLGYIPPEYGQASVA---TYKGDVYSFGVVLLELLT-GKRPM 947
             + S          +  GT G+  PE  + S     T   D++S G V   +L+ GK P 
Sbjct: 195  KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 948  DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEML-RVLDIACLCLSESPKVR 1006
                 K SR+  S +IR      E + L        HD+ ++    D+    +   P  R
Sbjct: 255  G---DKYSRE--SNIIRGIFSLDEMKCL--------HDRSLIAEATDLISQMIDHDPLKR 301
Query: 1007 PTTQQLV 1013
            PT  +++
Sbjct: 302  PTAMKVL 308

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 28  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 84
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 85  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 144 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 193
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 194 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 10  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 66
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 67  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 126 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 175
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 176 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 19/168 (11%)
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRL 845
            E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL 243
Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTH 902
           +  Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T 
Sbjct: 244 YFYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 296
Query: 903 VTTDLVGTLGYIPPEY-GQASVATYKG--DVYSFGVVLLELLTGKRPM 947
           +   L GT  Y+ PE       A Y    D +S GV+L   L+G  P 
Sbjct: 297 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 27  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 83
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 84  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 143 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 192
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 193 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 239

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 78/168 (46%), Gaps = 19/168 (11%)
Query: 787 AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRL 845
            E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL 257
Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTH 902
           +  Q     + YLH   E  I+HRD+K  N+LL   + +    + DFG ++++    +T 
Sbjct: 258 YFYQ-MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETS 310
Query: 903 VTTDLVGTLGYIPPEY-GQASVATYKG--DVYSFGVVLLELLTGKRPM 947
           +   L GT  Y+ PE       A Y    D +S GV+L   L+G  P 
Sbjct: 311 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 14  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 70
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 71  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 130 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 179
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 180 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 34/244 (13%)
Query: 783  REFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLIYSFMENGSLDYWLHEKLDGPSSLD 840
            R+F  E   L    HPN++ + G C         LI  +M  GSL   LHE  +    +D
Sbjct: 52   RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVD 109
Query: 841  WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
                +  A   ARG+A+LH + EP I    + S ++++D +  A ++   +     SP  
Sbjct: 110  QSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 901  THVTTDLVGTLGYIPPEYGQAS---VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD 957
             +          ++ PE  Q           D++SF V+L EL+T + P          D
Sbjct: 169  MYAP-------AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--------AD 213
Query: 958  LISWVIRMRQENRESEVLDPFIYD--KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSW 1015
            L +  I M+      E L P I      H  +++++      C++E P  RP    +V  
Sbjct: 214  LSNMEIGMKV---ALEGLRPTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPI 264
Query: 1016 LDSI 1019
            L+ +
Sbjct: 265  LEKM 268

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 41/244 (16%)
Query: 718 GSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSG 776
           GS+    F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS 
Sbjct: 1   GSQERPTFYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 57
Query: 777 DCGQM---EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDY 827
               +   +R +R E+  L   +H N++ L             ND  L+   M     + 
Sbjct: 58  PFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 116
Query: 828 WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA 887
              +KL        D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + 
Sbjct: 117 VKSQKLTD------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKIL 167
Query: 888 DFGLARLILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLEL 940
           DFGL R     +     T  V T  Y  PE       Y Q        D++S G ++ EL
Sbjct: 168 DFGLCR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAEL 216
Query: 941 LTGK 944
           LTG+
Sbjct: 217 LTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 14  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 70
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 71  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 130 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLAR- 179
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 180 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +        V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 35/225 (15%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS----GDCGQMEREFRAEVEAL---- 792
           + +    ++G GGFG VY    + D   VAIK +      D G++    R  +E +    
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             +    ++ L  +    +  +LI   ME       + +  D  +      R  + +  A
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEP------VQDLFDFITE-----RGALQEELA 116
Query: 853 RGLAYLHQSCEPH-----ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTD 906
           R   +       H     +LHRDIK  NIL+D N G   L DFG   L+    DT V TD
Sbjct: 117 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTD 172
Query: 907 LVGTLGYIPPEYGQASVATYKGD---VYSFGVVLLELLTGKRPMD 948
             GT  Y PPE+       Y G    V+S G++L +++ G  P +
Sbjct: 173 FDGTRVYSPPEW--IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 746 QANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHL 803
           Q +++G G    V     L   +  A+K +    G +      EVE L + Q H N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             +   ++   L++  M  GS+   +H++       +      + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-- 130
Query: 864 PHILHRDIKSSNILLDGN---FGAHLADFGLARLI-----LSPYDTHVTTDLVGTLGYIP 915
             I HRD+K  NIL +         + DFGL   I      SP  T       G+  Y+ 
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 916 PEY-----GQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE       +AS+   + D++S GV+L  LL+G  P 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 130/307 (42%), Gaps = 60/307 (19%)
Query: 743  NFDQA--------NIIGCGGFGLVYRATLPDGRNVAIKRLSGD-CGQMEREFRAEVEALS 793
            NF+Q+         I+G G  G V       GR VA+KR+  D C     E +   E+  
Sbjct: 26   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-- 83
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH------- 846
               HPN++    YC    DR L Y  +E  +L+  L + ++  +  D + +L        
Sbjct: 84   -DDHPNVIRY--YCSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPIS 137
Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILL--------DGNFGAH-----LADFGLAR 893
            + +  A G+A+LH      I+HRD+K  NIL+        D   GA      ++DFGL +
Sbjct: 138  LLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 894  LILSPYDTHVT--TDLVGTLGYIPPEYGQASVA---TYKGDVYSFGVVLLELLT-GKRPM 947
             + S          +  GT G+  PE  + S     T   D++S G V   +L+ GK P 
Sbjct: 195  KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 948  DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEML-RVLDIACLCLSESPKVR 1006
                 K SR+  S +IR      E + L        HD+ ++    D+    +   P  R
Sbjct: 255  G---DKYSRE--SNIIRGIFSLDEMKCL--------HDRSLIAEATDLISQMIDHDPLKR 301
Query: 1007 PTTQQLV 1013
            PT  +++
Sbjct: 302  PTAMKVL 308

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 17/254 (6%)
Query: 731 EISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE 784
           +++ DD+L   + ++   +IG G F +V R      G+  A+K     + +   G    +
Sbjct: 14  DMADDDVL-FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 785 FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR 844
            + E       +HP++V L           +++ FM+   L + + ++ D          
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDT 901
            H  +     L Y H +   +I+HRD+K   +LL   + +    L  FG+A  I      
Sbjct: 133 SHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESG 187
Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW 961
            V    VGT  ++ PE  +        DV+  GV+L  LL+G  P    K +    +I  
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKG 247
Query: 962 VIRM--RQENRESE 973
             +M  RQ +  SE
Sbjct: 248 KYKMNPRQWSHISE 261

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +        V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLH 846
           E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L+
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 119
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV 903
             Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +
Sbjct: 120 FYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 172
Query: 904 TTDLVGTLGYIPPEYGQASVATY----KGDVYSFGVVLLELLTGKRPM 947
              L GT  Y+ PE    SV T       D +S GV+L   L+G  P 
Sbjct: 173 MRTLCGTPTYLAPEV-LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N      +G G +G V  A     G  VA+K+LS     +  
Sbjct: 4   FYRQELNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 60
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 61  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 120 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 169
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +        V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 170 ----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLS---GDCGQ 780
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS        
Sbjct: 14  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 70
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 71  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 130 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 179
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 180 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLH 846
           E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L+
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 119
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV 903
             Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +
Sbjct: 120 FYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 172
Query: 904 TTDLVGTLGYIPPEYGQASVATY----KGDVYSFGVVLLELLTGKRPM 947
              L GT  Y+ PE    SV T       D +S GV+L   L+G  P 
Sbjct: 173 MRTLCGTPTYLAPEV-LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLH 846
           E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L+
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 119
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV 903
             Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +
Sbjct: 120 FYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 172
Query: 904 TTDLVGTLGYIPPEYGQASVATY----KGDVYSFGVVLLELLTGKRPM 947
              L GT  Y+ PE    SV T       D +S GV+L   L+G  P 
Sbjct: 173 MRTLCGTPTYLAPEV-LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLH 846
           E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L+
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 118
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV 903
             Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +
Sbjct: 119 FYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 171
Query: 904 TTDLVGTLGYIPPEYGQASVATY----KGDVYSFGVVLLELLTGKRPM 947
              L GT  Y+ PE    SV T       D +S GV+L   L+G  P 
Sbjct: 172 MRTLCGTPTYLAPEV-LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 218

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 17/250 (6%)
Query: 735 DDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAE 788
           DD+L   + ++   +IG G F +V R      G+  A+K     + +   G    + + E
Sbjct: 20  DDVL-FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 78
Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
                  +HP++V L           +++ FM+   L + + ++ D           H  
Sbjct: 79  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 138
Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTT 905
           +     L Y H +   +I+HRD+K   +LL   + +    L  FG+A  I       V  
Sbjct: 139 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAG 193
Query: 906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
             VGT  ++ PE  +        DV+  GV+L  LL+G  P    K +    +I    +M
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM 253
Query: 966 --RQENRESE 973
             RQ +  SE
Sbjct: 254 NPRQWSHISE 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 108/255 (42%), Gaps = 57/255 (22%)
Query: 721 LVVLF---HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS- 775
           L VLF   H KEKE      LES   +    ++G GGFG VY    + D   VAIK +  
Sbjct: 14  LEVLFQGPHMKEKEP-----LES--QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK 66
Query: 776 ---GDCGQMEREFRAEVEAL----SRAQHPNLVHLQGYCMHKNDRLLI----------YS 818
               D G++    R  +E +      +    ++ L  +    +  +LI          + 
Sbjct: 67  DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 126
Query: 819 FM-ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNIL 877
           F+ E G+L     E+L    S  W             + + H      +LHRDIK  NIL
Sbjct: 127 FITERGAL----QEEL--ARSFFWQ--------VLEAVRHCHNCG---VLHRDIKDENIL 169
Query: 878 LDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGD---VYSF 933
           +D N G   L DFG   L+    DT V TD  GT  Y PPE+       Y G    V+S 
Sbjct: 170 IDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYHRYHGRSAAVWSL 223
Query: 934 GVVLLELLTGKRPMD 948
           G++L +++ G  P +
Sbjct: 224 GILLYDMVCGDIPFE 238

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 57/221 (25%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEA---------LSRAQHPN 799
           +G G +G V  A     G  VAIK+LS       R F++E+ A         L   QH N
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 800 LVHLQGYCMHKN------DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ L       +      D  L+  FM+         +K+ G      +   ++     +
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDL------QKIMG-MEFSEEKIQYLVYQMLK 155
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG---T 910
           GL Y+H +    ++HRD+K  N+ ++ +    + DFGLAR        H   ++ G   T
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 204
Query: 911 LGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE       Y Q        D++S G ++ E+LTGK
Sbjct: 205 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 239

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 66/298 (22%)
Query: 739  ESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIK-----RLSGDCGQMEREF---RAEV 789
            E +  +   + +G G FG V+ A   +  + V +K     ++  DC   + +      E+
Sbjct: 21   EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 790  EALSRAQHPNLVHL------QGY---CMHKNDR-LLIYSFMENGSLDYWLHEKLDGPSSL 839
              LSR +H N++ +      QG+    M K+   L +++F++        H +LD P + 
Sbjct: 81   AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLAS 133
Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                  +I +     + YL       I+HRDIK  NI++  +F   L DFG A  +    
Sbjct: 134  ------YIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-- 182
Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMDMCKPKGSR 956
               +     GT+ Y  PE    +   Y+G   +++S GV L  L+  + P   C+     
Sbjct: 183  -GKLFYTFCGTIEYCAPEVLMGN--PYRGPELEMWSLGVTLYTLVFEENP--FCE----- 232
Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                      +E  E+ +  P++  K+       ++ +    L   P+ R T ++LV+
Sbjct: 233  ---------LEETVEAAIHPPYLVSKE-------LMSLVSGLLQPVPERRTTLEKLVT 274

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL-DWDSRLH 846
           E+E L +  HP ++ ++ +     D  ++   ME G L     +K+ G   L +   +L+
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLY 125
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV 903
             Q     + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +
Sbjct: 126 FYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSL 178
Query: 904 TTDLVGTLGYIPPEYGQASVATY----KGDVYSFGVVLLELLTGKRPM 947
              L GT  Y+ PE    SV T       D +S GV+L   L+G  P 
Sbjct: 179 MRTLCGTPTYLAPEV-LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 738 LESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
           L   ++F++  ++G G FG V +A    D R  AIK++     ++     +EV  L+   
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLN 60
Query: 797 HPNLVHLQGY------------CMHKNDRLLI-YSFMENGSLDYWLH-EKLDGPSSLDWD 842
           H  +V                  + K   L I   + EN +L   +H E L+      W 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW- 119
Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD-- 900
               + +     L+Y+H      I+HR++K  NI +D +    + DFGLA+ +    D  
Sbjct: 120 ---RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 901 ----------THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELL----TGKR 945
                     +   T  +GT  Y+  E    +     K D YS G++  E +    TG  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXE 233
Query: 946 PMDMCK 951
            +++ K
Sbjct: 234 RVNILK 239

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 47/240 (19%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 28  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 84
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 85  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 144 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 193
Query: 895 ILSPYDTHVTTDLVGTLG---YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
                  H   ++ G +    Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 194 -------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 57/221 (25%)
Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEA---------LSRAQHPN 799
           +G G +G V  A     G  VAIK+LS       R F++E+ A         L   QH N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 800 LVHLQGYCMHKN------DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ L       +      D  L+  FM+         +K+ G      +   ++     +
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDL------QKIMG-LKFSEEKIQYLVYQMLK 137
Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG---T 910
           GL Y+H +    ++HRD+K  N+ ++ +    + DFGLAR        H   ++ G   T
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 186
Query: 911 LGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE       Y Q        D++S G ++ E+LTGK
Sbjct: 187 RWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + D+GLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLS---GDCGQ 780
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS        
Sbjct: 14  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 70
Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 71  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 130 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 179
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 180 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 739 ESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQH 797
           +  + F    + G G FG V        G +VAIK++  D     RE +  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHH 78
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG-PSSLDWDSRLHIAQGAA---- 852
           PN+V LQ Y          Y+  E    D +L+  ++  P +L    R +  +  A    
Sbjct: 79  PNIVQLQSY---------FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 853 ----------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDT 901
                     R +  LH     ++ HRDIK  N+L++   G   L DFG A+  LSP + 
Sbjct: 130 LIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK-LSPSEP 187
Query: 902 HVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
           +V    + +  Y  PE  +G     T   D++S G +  E++ G+
Sbjct: 188 NVA--YICSRYYRAPELIFGNQHYTT-AVDIWSVGCIFAEMMLGE 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 81/286 (28%), Positives = 124/286 (43%), Gaps = 53/286 (18%)
Query: 743  NFDQANIIGCGGFGLVYRA-TLPDGRNVAIKR-LSGDCGQMEREFR-AEVEALSR-AQHP 798
            +F + + +G G +G V++  +  DGR  A+KR +S   G  +R  + AEV +  +  QHP
Sbjct: 58   SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLD----WDSRLHIAQ--GAA 852
              V L+             ++ E G L  +L  +L GPS       W + L  AQ  G  
Sbjct: 118  CCVRLE------------QAWEEGGIL--YLQTELCGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 853  R----GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
            R     LA+LH      ++H D+K +NI L       L DFGL   + +     V     
Sbjct: 164  RDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--- 217
Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            G   Y+ PE  Q S  T   DV+S G+ +LE+       +M  P G      W     Q+
Sbjct: 218  GDPRYMAPELLQGSYGT-AADVFSLGLTILEV-----ACNMELPHGGE---GW-----QQ 263
Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             R+  +  P  +      E+  VL    + L   PK+R T + L++
Sbjct: 264  LRQGYL--PPEFTAGLSSELRSVL---VMMLEPDPKLRATAEALLA 304

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 40/168 (23%)
Query: 860  QSCEPH-ILHRDIKSSNILLDGNFG-AHLADFGLARLIL-SPYDTHVTTDLVGTLGYIPP 916
            Q C    ++HRDIK  NIL+D   G A L DFG   L+   PY     TD  GT  Y PP
Sbjct: 153  QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-----TDFDGTRVYSPP 207
Query: 917  EY-GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E+  +         V+S G++L +++ G  P +                     R+ E+L
Sbjct: 208  EWISRHQYHALPATVWSLGILLYDMVCGDIPFE---------------------RDQEIL 246
Query: 976  DPFIYDKQHDKEMLRVLDIACL---CLSESPKVRPTTQQLV--SWLDS 1018
            +  ++   H        D   L   CL+  P  RP+ ++++   W+ +
Sbjct: 247  EAELHFPAHVSP-----DCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 24/178 (13%)
Query: 782 EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW 841
           E   + E++ L R +H N++ L    ++  ++  +Y  ME       + E LD       
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVD-VLYNEEKQKMYMVMEYCVCG--MQEMLDSVP---- 102
Query: 842 DSRLHIAQGAAR------GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
           + R  + Q          GL YLH      I+H+DIK  N+LL       ++  G+A   
Sbjct: 103 EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE-A 158
Query: 896 LSPY---DTHVTTDLVGTLGYIPPEY--GQASVATYKGDVYSFGVVLLELLTGKRPMD 948
           L P+   DT  T+   G+  + PPE   G  + + +K D++S GV L  + TG  P +
Sbjct: 159 LHPFAADDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 47/240 (19%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 31  FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 87
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 88  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR 
Sbjct: 147 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR- 196
Query: 895 ILSPYDTHVTTDL---VGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
                  H   ++   V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 197 -------HTDDEMXGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 243

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 231
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 216
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 188
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 114/296 (38%), Gaps = 58/296 (19%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDC------GQMEREFRAEV 789
           +LE    +     IG G +G+V  A     R + AIK ++ +         +ER  + EV
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER-IKTEV 79
Query: 790 EALSRAQHPNLVHL-------QGYCM--------HKNDRLLIYSFMENGSLDYWL----- 829
             + +  HPN+  L       Q  C+        H  D+L ++     G     +     
Sbjct: 80  RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 830 -------HEKLDGP-----SSLDWDSRLHIAQGAAR----GLAYLHQSCEPHILHRDIKS 873
                   E ++G       SLD+  R  +     R     L YLH      I HRDIK 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKP 196
Query: 874 SNILLDGN--FGAHLADFGLARLI--LSPYDTHVTTDLVGTLGYIPPEYGQASVATY--K 927
            N L   N  F   L DFGL++    L+  + +  T   GT  ++ PE    +  +Y  K
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
Query: 928 GDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ--ENRESEVLDPFIYD 981
            D +S GV+L  LL G  P          D IS V+  +   EN    VL P   D
Sbjct: 257 CDAWSAGVLLHLLLMGAVPFPGV---NDADTISQVLNKKLCFENPNYNVLSPLARD 309

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 203
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 189
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 189
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 204
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 231
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 189
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 203
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 217
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 204
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 223
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 216
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 217
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 187
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 217
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 204
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + +LH +    I+HRD+K SNI++  +    + DFGLAR   + +   +    V T  Y 
Sbjct: 139 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMEPEVVTRYYR 192
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGK 944
            PE           D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 231
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 217
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 216
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 216
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 236
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 184
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 184
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 866 ILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA 924
           +LHRDIK  NIL+D N G   L DFG   L+    DT V TD  GT  Y PPE+      
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDT-VYTDFDGTRVYSPPEW--IRYH 184
Query: 925 TYKGD---VYSFGVVLLELLTGKRPMD 948
            Y G    V+S G++L +++ G  P +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 737 ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM---EREFRAEVEAL 792
           I E    +   + +G G +G V  +  +  G  +A+K+LS     +   +R +R E+  L
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLL 104
Query: 793 SRAQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
              +H N++ L             ND  L+   M     +    +KL        D    
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD------DHVQF 158
Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
           +     RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR     +     T 
Sbjct: 159 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 907 LVGTLGYIPPE----YGQASVATYKGDVYSFGVVLLELLTGK 944
            V T  Y  PE    +   ++     D++S G ++ ELLTG+
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTV---DIWSVGCIMAELLTGR 249

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 28/207 (13%)
Query: 750 IGCGGFGLVYRATLPDGR---NVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHL 803
           +G G +G V  A   DGR    VAIK+L          +R +R E+  L   +H N++ L
Sbjct: 33  VGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 804 QGYCMHKN------DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
                         D  L+  FM         HEKL G   + +     +     +GL Y
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL-GEDRIQF-----LVYQMLKGLRY 143
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           +H +    I+HRD+K  N+ ++ +    + DFGLAR      D+ +   +V      P  
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMXGXVVTRWYRAPEV 196
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGK 944
                  T   D++S G ++ E++TGK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 741 TNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ 796
           ++ + +   +G G +G V     + T  +     IK+ S            EV  L +  
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSL--DYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
           HPN++ L  +   K +  L+      G L  +  L +K       + D+ + I +    G
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS-----EVDAAV-IMKQVLSG 133
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHL---ADFGLARLILSPYDTHVTT-----D 906
             YLH+    +I+HRD+K  N+LL+      L    DFGL+         H        +
Sbjct: 134 TTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS--------AHFEVGGKMKE 182
Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            +GT  YI PE  +      K DV+S GV+L  LL G  P 
Sbjct: 183 RLGTAYYIAPEVLRKKYDE-KCDVWSCGVILYILLCGYPPF 222

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + DF LAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 738 LESTNNFD--QANIIGCGGFGLVYRA-TLPDGRNVAIK-----RLSGDCGQMEREFRAEV 789
           +E+ NNF    +  +G G F +V +  +   G+  A K     R   DC     E   E+
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEILHEI 79
Query: 790 EALSRAQH-PNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHI 847
             L  A+  P +++L     + ++ +LI  +   G +    L E  +  S  D    + +
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIRL 136
Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDTHVT 904
            +    G+ YLHQ+   +I+H D+K  NILL   +      + DFG++R I    +    
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-- 191
Query: 905 TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            +++GT  Y+ PE       T   D+++ G++   LLT   P 
Sbjct: 192 -EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 32/186 (17%)
Query: 113 FLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLP---QTINLPSIQVLDISSNSLN 169
           FLN + N+   +V      L  L+ L L  N L         T N+ S++ LD+S NSLN
Sbjct: 357 FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416
Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
                  C  +  I V+NLS N  +G++             CL                 
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSV-----------FRCLP---------------P 450
Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD-VFAGLGEFQYLVAHSNR 288
           K+++L L +N++   +   +  L  L  L+V+SN     +PD VF  L   QY+  H N 
Sbjct: 451 KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNP 508
Query: 289 FTGRIP 294
           +    P
Sbjct: 509 WDCTCP 514

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   IG G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      +ADFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 20/166 (12%)
Query: 788 EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL--DYWLHEKLDGPSSLDWDSRL 845
           EV  L +  HPN++ L  +   K +  L+      G L  +  L +K    S +D     
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKF---SEVD---AA 107
Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL---ADFGLARLILSPYDT- 901
            I +    G  YLH+    +I+HRD+K  N+LL+      L    DFGL+    + ++  
Sbjct: 108 VIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS----AHFEVG 160
Query: 902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
               + +GT  YI PE  +      K DV+S GV+L  LL G  P 
Sbjct: 161 GKMKERLGTAYYIAPEVLRKKYDE-KCDVWSCGVILYILLCGYPPF 205

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 750 IGCGGFGLV---YRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G  G+V   Y A L   RNVAIK+LS       R F+ +  A  +  +  LV ++  
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLS-------RPFQNQTHA--KRAYRELVLMK-- 78
Query: 807 CM-HKNDRLLIYSFMENGSLD-----YWLHEKLDG------PSSLDWDSRLHIAQGAARG 854
           C+ HKN   L+  F    SL+     Y + E +D          LD +   ++      G
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           + +LH +    I+HRD+K SNI++  +    + DFGLAR   + +   +    V T  Y 
Sbjct: 139 IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMEPEVVTRYYR 192
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGK 944
            PE           D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 131/311 (42%), Gaps = 64/311 (20%)
Query: 743  NFDQA--------NIIGCGGFGLVYRATLPDGRNVAIKRLSGD-CGQMEREFRAEVEALS 793
            NF+Q+         I+G G  G V       GR VA+KR+  D C     E +   E+  
Sbjct: 8    NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-- 65
Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH------- 846
               HPN++  + YC    DR L Y  +E  +L+  L + ++  +  D + +L        
Sbjct: 66   -DDHPNVI--RYYCSETTDRFL-YIALELCNLN--LQDLVESKNVSDENLKLQKEYNPIS 119
Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILL--------DGNFGAH-----LADFGLAR 893
            + +  A G+A+LH      I+HRD+K  NIL+        D   GA      ++DFGL +
Sbjct: 120  LLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 894  LILSPYDTHVT--TDLVGTLGYIPPEYGQAS-------VATYKGDVYSFGVVLLELLT-G 943
             + S          +  GT G+  PE  + S         T   D++S G V   +L+ G
Sbjct: 177  KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 944  KRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEML-RVLDIACLCLSES 1002
            K P      K SR+  S +IR      E + L        HD+ ++    D+    +   
Sbjct: 237  KHPFG---DKYSRE--SNIIRGIFSLDEMKCL--------HDRSLIAEATDLISQMIDHD 283
Query: 1003 PKVRPTTQQLV 1013
            P  RPT  +++
Sbjct: 284  PLKRPTAMKVL 294

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 120
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 176
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 177 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAP 228
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    +  FGLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 22/217 (10%)
Query: 746 QANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHL 803
           Q +++G G    V     L   +  A+K +    G +      EVE L + Q H N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             +   ++   L++  M  GS+   +H++       +      + Q  A  L +LH    
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-- 130
Query: 864 PHILHRDIKSSNILLDGN---FGAHLADFGLARLI-----LSPYDTHVTTDLVGTLGYIP 915
             I HRD+K  NIL +         + DF L   I      SP  T       G+  Y+ 
Sbjct: 131 -GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 916 PEY-----GQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE       +AS+   + D++S GV+L  LL+G  P 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + D GLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 26/208 (12%)
Query: 756 GLVYRATLPDGRNVAIKRLSGDCGQME----------REFRAEVEALSR-AQHPNLVHLQ 804
           G V + T+  G     KR       ME          R+   E+E L R  QHPN++ L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 805 GYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                     L+   M  G L D  L +K        +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQG- 141
Query: 864 PHILHRDIKSSNILLDGNFG----AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
             ++HRD+K SNIL     G      + DFG A+ + +     +T     T  ++ PE  
Sbjct: 142 --VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVL 197
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           +        D++S G++L  +L G  P 
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 738 LESTNNFDQANIIGCGGFGL----VYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALS 793
           ++ T+ ++    IG G + +    +++AT       A+K +     + +R+   E+E L 
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIID----KSKRDPTEEIEILL 70
Query: 794 R-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGA 851
           R  QHPN++ L+          ++   M+ G L D  L +K              +    
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-----AVLFTI 125
Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFG----AHLADFGLAR-------LILSPYD 900
            + + YLH      ++HRD+K SNIL     G      + DFG A+       L+++P  
Sbjct: 126 TKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-- 180
Query: 901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
                    T  ++ PE  +        D++S GV+L  +LTG  P 
Sbjct: 181 -------CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 100
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 156
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + D GLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 26/208 (12%)
Query: 756 GLVYRATLPDGRNVAIKRLSGDCGQME----------REFRAEVEALSR-AQHPNLVHLQ 804
           G V + T+  G     KR       ME          R+   E+E L R  QHPN++ L+
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 805 GYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                     L+   M  G L D  L +K        +     +     + + YLH    
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQG- 141
Query: 864 PHILHRDIKSSNILLDGNFG----AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
             ++HRD+K SNIL     G      + DFG A+ + +     +T     T  ++ PE  
Sbjct: 142 --VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVL 197
Query: 920 QASVATYKGDVYSFGVVLLELLTGKRPM 947
           +        D++S G++L  +L G  P 
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 36/225 (16%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL-HIAQGAARGL 855
            P LV L+            +SF +N +L Y + E + G        R+   A+  AR  
Sbjct: 100 FPFLVKLE------------FSFKDNSNL-YMVMEYVAGGEMFSHLRRIGRFAEPHARFY 146
Query: 856 A--------YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
           A        YLH      +++RD+K  N+L+D      + DFG A+ +        T  L
Sbjct: 147 AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXL 198
Query: 908 VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            GT  Y+ PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 41/237 (17%)
Query: 725 FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQM-- 781
           F+ +E   +I ++ E   N    + +G G +G V  A     G  VA+K+LS     +  
Sbjct: 8   FYRQELNKTIWEVPERYQNL---SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 64
Query: 782 -EREFRAEVEALSRAQHPNLVHLQGYCM------HKNDRLLIYSFMENGSLDYWLHEKLD 834
            +R +R E+  L   +H N++ L             ND  L+   M     +    +KL 
Sbjct: 65  AKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 835 GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
                  D    +     RGL Y+H +    I+HRD+K SN+ ++ +    + D GLAR 
Sbjct: 124 D------DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLAR- 173
Query: 895 ILSPYDTHVTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
               +     T  V T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 174 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 21/99 (21%)
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR           T  V T  
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA-----DEEMTGYVATRW 185
Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE       Y Q        D++S G ++ ELL GK
Sbjct: 186 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 21/99 (21%)
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR           T  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRW 193
Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE       Y Q        D++S G ++ ELL GK
Sbjct: 194 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 21/99 (21%)
Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR           T  V T  
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEMTGYVATRW 193
Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  PE       Y Q        D++S G ++ ELL GK
Sbjct: 194 YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLQGK 226

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 36/197 (18%)
Query: 762 TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL-------VHLQGYCMHKNDRL 814
           T+ DGR V I   S  C ++ RE R     L+   HPN+       VH +   MHK   L
Sbjct: 57  TVSDGRTVNILSDSFLCKRVLREIRL----LNHFHHPNILGLRDIFVHFEEPAMHK---L 109
Query: 815 LIYSFMENGSLDYWLHEK--LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK 872
            + + +    L   +H++  +  P  + +    HI  G       LH   E  ++HRD+ 
Sbjct: 110 YLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILLG-------LHVLHEAGVVHRDLH 161
Query: 873 SSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG---- 928
             NILL  N    + DF LAR   +  +    T  V    Y  PE     V  +KG    
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPEL----VMQFKGFTKL 214
Query: 929 -DVYSFGVVLLELLTGK 944
            D++S G V+ E+   K
Sbjct: 215 VDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 36/197 (18%)
Query: 762 TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL-------VHLQGYCMHKNDRL 814
           T+ DGR V I   S  C ++ RE R     L+   HPN+       VH +   MHK   L
Sbjct: 57  TVSDGRTVNILSDSFLCKRVLREIRL----LNHFHHPNILGLRDIFVHFEEPAMHK---L 109
Query: 815 LIYSFMENGSLDYWLHEK--LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK 872
            + + +    L   +H++  +  P  + +    HI  G       LH   E  ++HRD+ 
Sbjct: 110 YLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILLG-------LHVLHEAGVVHRDLH 161
Query: 873 SSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKG---- 928
             NILL  N    + DF LAR   +  +    T  V    Y  PE     V  +KG    
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPEL----VMQFKGFTKL 214
Query: 929 -DVYSFGVVLLELLTGK 944
            D++S G V+ E+   K
Sbjct: 215 VDMWSAGCVMAEMFNRK 231

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+++D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 100
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 156
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEYLAP 208
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ ++  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 94
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            P LV L+      ++  ++  ++  G +   L    +   P +     R + AQ     
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-----RFYAAQ-IVLT 148
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
             YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+
Sbjct: 149 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 200
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 201 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            P LV L+      ++  ++  ++  G +   L    +   P +     R + AQ     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-----RFYAAQ-IVLT 153
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
             YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            P LV L+      ++  ++  ++  G +   L    +   P +     R + AQ     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-----RFYAAQ-IVLT 153
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
             YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 15/208 (7%)
Query: 744 FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLV 801
           F+    +G G F  V  A     G+  A+K +     +  E     E+  L + +H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L+      N   L+   +  G L   + EK       + D+   I Q     + YLH+ 
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK---GFYTEKDASTLIRQ-VLDAVYYLHRM 139
Query: 862 CEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
               I+HRD+K  N+L    D      ++DFGL+++        V +   GT GY+ PE 
Sbjct: 140 ---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEV 193
Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
                 +   D +S GV+   LL G  P
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            P LV L+ Y    N  L ++  ++  G +  + H +  G  S +  +R + AQ      
Sbjct: 100 FPFLVKLE-YSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTF 154
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ 
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLA 206
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 100
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 156
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            P LV L+      ++  ++  ++  G +   L    +   P +     R + AQ     
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-----RFYAAQ-IVLT 153
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
             YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 205
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            P LV L+ Y    N  L ++  ++  G +  + H +  G  S +  +R + AQ      
Sbjct: 100 FPFLVKLE-YSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTF 154
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ 
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLA 206
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 129/303 (42%), Gaps = 76/303 (25%)
Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER-----------------EFRAEVEAL 792
            +G G F  +++          ++R  GD GQ+                    F      +
Sbjct: 16   LGQGTFTKIFKG---------VRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66
Query: 793  SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            S+  H +LV   G C+  ++ +L+  F++ GSLD +L +  +  + L W  +L +A+  A
Sbjct: 67   SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLA 123
Query: 853  RGLAYLHQSCEPHILHRDIKSSNILL----DGNFG----AHLADFGLARLILSPYDTHVT 904
              + +L ++    ++H ++ + NILL    D   G      L+D G++  +L P D    
Sbjct: 124  AAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL-PKDI--- 176
Query: 905  TDLVGTLGYIPPEYGQ----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
              L   + ++PPE  +     ++AT   D +SFG  L E+ +G       KP  + D   
Sbjct: 177  --LQERIPWVPPECIENPKNLNLAT---DKWSFGTTLWEICSGGD-----KPLSALD--- 223
Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACL---CLSESPKVRPTTQQLVSWLD 1017
                     R+ +      Y+ +H     +  ++A L   C+   P  RP+ + ++  L+
Sbjct: 224  -------SQRKLQ-----FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 1018 SII 1020
            S+ 
Sbjct: 272  SLF 274

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V     +  G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            P LV L+ Y    N  L ++  ++  G +  + H +  G  S +  +R + AQ      
Sbjct: 100 FPFLVKLE-YSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTF 154
Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ 
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLA 206
Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 22/218 (10%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 120
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWDSRLHIAQGAARG 854
            P LV L+      ++  ++  ++  G +   L    +   P +     R + AQ     
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-----RFYAAQ-IVLT 174
Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
             YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+
Sbjct: 175 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYL 226
Query: 915 PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
            PE   +       D ++ GV++ E+  G  P    +P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 92
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 148
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 149 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 200
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 17/189 (8%)
Query: 766 GRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLIYSFME 821
           G ++ +K  ++     +  R+F  E   L    HPN++ + G C         LI  +  
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN 881
            GSL   LHE  +    +D    +  A   ARG A+LH + EP I    + S ++ +D +
Sbjct: 93  YGSLYNVLHEGTN--FVVDQSQAVKFALDXARGXAFLH-TLEPLIPRHALNSRSVXIDED 149
Query: 882 FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS---VATYKGDVYSFGVVLL 938
             A ++   +     SP   +          ++ PE  Q           D +SF V+L 
Sbjct: 150 XTARISXADVKFSFQSPGRXYAP-------AWVAPEALQKKPEDTNRRSADXWSFAVLLW 202
Query: 939 ELLTGKRPM 947
           EL+T + P 
Sbjct: 203 ELVTREVPF 211

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 15/204 (7%)
Query: 748 NIIGCGGFGLVYRATLPDGR-NVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           N IG G +G V  A     R   A K++     +    F+ E+E +    HPN++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
                D  L+      G     L E++             I +     +AY H+    ++
Sbjct: 75  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NV 127
Query: 867 LHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
            HRD+K  N L      +    L DFGLA     P     T   VGT  Y+ P+  +   
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTK--VGTPYYVSPQVLEGLY 184
Query: 924 ATYKGDVYSFGVVLLELLTGKRPM 947
              + D +S GV++  LL G  P 
Sbjct: 185 GP-ECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 15/204 (7%)
Query: 748 NIIGCGGFGLVYRATLPDGR-NVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           N IG G +G V  A     R   A K++     +    F+ E+E +    HPN++ L   
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 91
Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
                D  L+      G     L E++             I +     +AY H+    ++
Sbjct: 92  FEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NV 144
Query: 867 LHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV 923
            HRD+K  N L      +    L DFGLA     P     T   VGT  Y+ P+  +   
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-FKPGKMMRTK--VGTPYYVSPQVLEGLY 201
Query: 924 ATYKGDVYSFGVVLLELLTGKRPM 947
              + D +S GV++  LL G  P 
Sbjct: 202 GP-ECDEWSAGVMMYVLLCGYPPF 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQH 797
           + F++   +G G FG V     +  G + A+K L        +E      E   L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           P LV L+      ++  ++  +   G +  + H +  G  S +  +R + AQ       Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFEY 156
Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      +++RD+K  N+++D      + DFGLA+ +        T  L GT  Y+ PE
Sbjct: 157 LHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR-----TWXLCGTPEYLAPE 208
Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
              +       D ++ GV++ E+  G  P    +P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSG------DCGQMEREFRAEVEALSR 794
           + ++  ++IG G +G V  A    + R VAIK++        DC ++ RE    +  L+R
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNR 108
Query: 795 AQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ--- 849
             H ++V +    + K+      +Y  +E    D+   +    P  L   + LHI     
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDF--KKLFRTPVYL---TELHIKTLLY 163
Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
               G+ Y+H +    ILHRD+K +N L++ +    + DFGLAR +  P
Sbjct: 164 NLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 100
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 156
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 28/221 (12%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + FD+   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 99
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 155
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT     P
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGT-----P 202
Query: 917 EYGQASVATYKG-----DVYSFGVVLLELLTGKRPMDMCKP 952
           EY   ++   KG     D ++ GV++ E+  G  P    +P
Sbjct: 203 EYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 5/176 (2%)
Query: 109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTIN-LPSIQVLDISSNS 167
           V  R+LNL  N ++     +  +L +LE+L LS N +        N LPS+  L++  N 
Sbjct: 35  VNTRYLNLQENSIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNR 94
Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           L  +VPT   +  S++R + L  N      S       SL  L LG       I++  F+
Sbjct: 95  LT-TVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFE 153
Query: 228 -LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
            L  LR L L    L  K  P++  L  L  L++S N      P  F GL   + L
Sbjct: 154 GLVNLRYLNLGMCNL--KDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKL 207

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD----CGQMEREFRAEVEALSRAQ 796
           + F++   +G G FG V      + G + A+K L         Q+E     E   L    
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVN 100
Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            P LV L+      ++  ++  ++  G +  + H +  G  S +  +R + AQ       
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFS-EPHARFYAAQ-IVLTFE 156
Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RD+K  N+L+D      + DFG A+ +        T  L GT  Y+ P
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 208
Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
           E   +       D ++ GV++ E+  G  P    +P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1020
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-151
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-132
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-42
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-125
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-116
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-82
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-66
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-42
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-29
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-39
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-79
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-63
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-55
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-70
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-50
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-66
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-40
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-24
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-10
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-66
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-57
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-56
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-51
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-50
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-49
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-37
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-47
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-46
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-45
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-33
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-30
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-04
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-40
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-39
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-37
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-37
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-32
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-07
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-24
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-16
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-29
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-12
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-09
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-25
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-05
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-07
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-18
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-16
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-17
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-09
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-19
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-19
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-19
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-09
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-12
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-06
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-10
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  450 bits (1160), Expect = e-151
 Identities = 125/313 (39%), Positives = 188/313 (60%), Gaps = 11/313 (3%)

Query: 709  TNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN 768
               ++  E+    +  F       S+ ++  +++NF   NI+G GGFG VY+  L DG  
Sbjct: 4    VPAEEDPEVHLGQLKRF-------SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL 56

Query: 769  VAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY 827
            VA+KRL  +  Q  E +F+ EVE +S A H NL+ L+G+CM   +RLL+Y +M NGS+  
Sbjct: 57   VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116

Query: 828  WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA 887
             L E+ +    LDW  R  IA G+ARGLAYLH  C+P I+HRD+K++NILLD  F A + 
Sbjct: 117  CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176

Query: 888  DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            DFGLA+L +   DTHVTT + GT+G+I PEY     ++ K DV+ +GV+LLEL+TG+R  
Sbjct: 177  DFGLAKL-MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

Query: 948  DMCKPKGSRD--LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV 1005
            D+ +     D  L+ WV  + +E +   ++D  +     D+E+ +++ +A LC   SP  
Sbjct: 236  DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 295

Query: 1006 RPTTQQLVSWLDS 1018
            RP   ++V  L+ 
Sbjct: 296  RPKMSEVVRMLEG 308

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  416 bits (1072), Expect = e-132
 Identities = 153/597 (25%), Positives = 242/597 (40%), Gaps = 99/597 (16%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV-NLPNLEVLDLSSNDLSGP 148
           L +   +  G +      L  L++L+L+ N   G +P  L      L  LDLS N   G 
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309

Query: 149 LPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNC-AS 206
           +P    +   ++ L +SSN+ +G +P         ++V++LS N FSG L   L N  AS
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369

Query: 207 LEHLCLGMNDLTGGIADDIFQLQK--LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN 264
           L  L L  N+ +G I  ++ Q  K  L+ L LQ+N  +GK+ P++++ S LV L +S N 
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL---LLNC 321
            SG IP     L + + L    N   G IP  L    TL  L L  N L G +   L NC
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489

Query: 322 PALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLS 381
              TNL  + L  N+  G +P  + R   L  + L+ N+FSG IP    +  SL +L L+
Sbjct: 490 ---TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546

Query: 382 N--------SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS 433
                    ++++  S  +                                         
Sbjct: 547 TNLFNGTIPAAMFKQSGKIAANF------------------------------------- 569

Query: 434 CGLRGSIPQWLRGCSKLQLVDLSWN--QLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN 491
             + G    +++     +    + N  +  G               ++++  + G     
Sbjct: 570 --IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627

Query: 492 LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPE 551
                S++                                     +D+S N L G I  E
Sbjct: 628 FDNNGSMMF------------------------------------LDMSYNMLSGYIPKE 651

Query: 552 FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSV 611
            G++  L + +L HN++SG IP E+  +  L  LDLS N L G IP ++  L+ L++  +
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711

Query: 612 ANNHLTGRIPSGGQFQTFPNSSFDGN-NLCGEHRYSCTIDRESGQVKSAKKSRRNKY 667
           +NN+L+G IP  GQF+TFP + F  N  LCG     C      G     +    + +
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHHHHH 768

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  372 bits (958), Expect = e-115
 Identities = 166/607 (27%), Positives = 242/607 (39%), Gaps = 122/607 (20%)

Query: 31  CNPNDLAALEDFMKNFESG--IDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVT 88
               ++  L  F         +  W    S+ + C + G+TC               +VT
Sbjct: 9   SLYREIHQLISFKDVLPDKNLLPDWS---SNKNPCTFDGVTCRD------------DKVT 53

Query: 89  GLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGP 148
            + L  + L                           V  SL++L  LE L LS++ ++G 
Sbjct: 54  SIDLSSKPLNVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGS 92

Query: 149 LPQTINLPSIQVLDISSNSLNGSVPTSIC-KNSSRIRVINLSVNYFSGTLS-PGLGNCAS 206
           +       S+  LD+S NSL+G V T     + S ++ +N+S N         G     S
Sbjct: 93  VSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNS 152

Query: 207 LEHLCLGMNDLTGGIADDIFQ---LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSN 263
           LE L L  N ++G             +L+ L +  N++SG +   ++   NL  LDVSSN
Sbjct: 153 LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSN 210

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA 323
           NFS  IP         Q+L    N+ +G    ++S    L LLN+ +N   G +    P 
Sbjct: 211 NFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI----PP 265

Query: 324 --LTNLTSLDLGTNKFNGPLPTNLP-RCRKLKNINLARNNFSGQIPETYKNFESLSYLSL 380
             L +L  L L  NKF G +P  L   C  L  ++L+ N+F G +P  + +   L  L+L
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325

Query: 381 SNSSIYNLSSAL--QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG 438
           S++   N S  L    L + R L  L L+ N                            G
Sbjct: 326 SSN---NFSGELPMDTLLKMRGLKVLDLSFN-------------------------EFSG 357

Query: 439 SIPQWLRGCS-KLQLVDLSWNQLSGTIPVWFGGFQ--DLFYLDLSNNTFTGEIPKNLTGL 495
            +P+ L   S  L  +DLS N  SG I           L  L L NN FTG+IP  L+  
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417

Query: 496 PSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNL 555
             L+                                    ++ LS N L G+I    G+L
Sbjct: 418 SELV------------------------------------SLHLSFNYLSGTIPSSLGSL 441

Query: 556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNH 615
            KL    L  N L G IP EL  + +LETL L +N+L+G IP  L   + L+  S++NN 
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501

Query: 616 LTGRIPS 622
           LTG IP 
Sbjct: 502 LTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  165 bits (421), Expect = 2e-42
 Identities = 72/347 (20%), Positives = 120/347 (34%), Gaps = 97/347 (27%)

Query: 302 TLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF 361
           +++L +   N    ++  +  +LT L SL L  +  NG +         L +++L+RN+ 
Sbjct: 54  SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112

Query: 362 SGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL 421
           SG +               + +S+ + S                                
Sbjct: 113 SGPVT--------------TLTSLGSCS-------------------------------- 126

Query: 422 HFANLKVLVIASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGTIPVWF---GGFQDLFYL 477
               LK L ++S  L            + L+++DLS N +SG   V +    G  +L +L
Sbjct: 127 ---GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183

Query: 478 DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
            +S N  +G++   ++   +L                                      +
Sbjct: 184 AISGNKISGDVD--VSRCVNLEF------------------------------------L 205

Query: 538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP 597
           D+S N     I P  G+   L   D+  N LSG     ++  T L+ L++S N   G IP
Sbjct: 206 DVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264

Query: 598 ISLEKLSFLSKFSVANNHLTGRIPS--GGQFQTFPNSSFDGNNLCGE 642
                L  L   S+A N  TG IP    G   T       GN+  G 
Sbjct: 265 PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  381 bits (982), Expect = e-125
 Identities = 116/297 (39%), Positives = 168/297 (56%), Gaps = 3/297 (1%)

Query: 724  LFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER 783
            L   +   + + D+ E+TNNFD   +IG G FG VY+  L DG  VA+KR + +  Q   
Sbjct: 21   LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
            EF  E+E LS  +HP+LV L G+C  +N+ +LIY +MENG+L   L+       S+ W+ 
Sbjct: 81   EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140

Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
            RL I  GAARGL YLH      I+HRD+KS NILLD NF   + DFG+++       TH+
Sbjct: 141  RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197

Query: 904  TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI 963
            +T + GTLGYI PEY      T K DVYSFGVVL E+L  +  +    P+   +L  W +
Sbjct: 198  STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257

Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                  +  +++DP + DK   + + +  D A  CL+ S + RP+   ++  L+  +
Sbjct: 258  ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  358 bits (921), Expect = e-116
 Identities = 108/324 (33%), Positives = 166/324 (51%), Gaps = 36/324 (11%)

Query: 711  DKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQ------ANIIGCGGFGLVYRATLP 764
            +K LE   ++            S  ++   TNNFD+       N +G GGFG+VY+  + 
Sbjct: 2    NKSLEVSDTRF--------HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV- 52

Query: 765  DGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM 820
            +   VA+K+L+        +++++F  E++ +++ QH NLV L G+    +D  L+Y +M
Sbjct: 53   NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 821  ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
             NGSL   L    DG   L W  R  IAQGAA G+ +LH   E H +HRDIKS+NILLD 
Sbjct: 113  PNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE 168

Query: 881  NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY--GQASVATYKGDVYSFGVVLL 938
             F A ++DFGLAR       T +T+ +VGT  Y+ PE   G+ +    K D+YSFGVVLL
Sbjct: 169  AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP---KSDIYSFGVVLL 225

Query: 939  ELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE-SEVLDPFI--YDKQHDKEMLRVLDIA 995
            E++TG   +D  +      L+     +  E +   + +D  +   D      +  +  +A
Sbjct: 226  EIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADS---TSVEAMYSVA 280

Query: 996  CLCLSESPKVRPTTQQLVSWLDSI 1019
              CL E    RP  +++   L  +
Sbjct: 281  SQCLHEKKNKRPDIKKVQQLLQEM 304

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  279 bits (715), Expect = 2e-82
 Identities = 90/604 (14%), Positives = 177/604 (29%), Gaps = 90/604 (14%)

Query: 53  WGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLR 112
           W  N          G++ NS+           GRVTGL L      G++ +++G L +L 
Sbjct: 60  WNFNKELDMWGAQPGVSLNSN-----------GRVTGLSLEGFGASGRVPDAIGQLTELE 108

Query: 113 FLNLSHNLLKG----TVPVSLVNLPNLEVLDLSSNDLSGPLPQTI---NLPSIQVLDISS 165
            L L  +  K       P  +    + E                    +   +    I+S
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168

Query: 166 NSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDI 225
           +    S+  S    + +   I    N  +  +S  +     L    +G +          
Sbjct: 169 DPQQKSIKKSSR-ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI--- 223

Query: 226 FQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
              +       +  Q          +L +L  ++V +      +P     L E Q +   
Sbjct: 224 --CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 286 SNRFT--------GRIPHSLSNSPTLNLLNLRNNSL-DGSLLLNCPALTNLTSLDLGTNK 336
            NR           +          + ++ +  N+L    +  +   +  L  L+   N+
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341

Query: 337 FNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQ 396
             G LP       KL ++NLA N  +          E +  LS +++ +  + +     +
Sbjct: 342 LEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFD-AK 399

Query: 397 QCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLS 456
               ++ +  + N    ++ +    +F                +         +  ++LS
Sbjct: 400 SVSVMSAIDFSYN----EIGSVDGKNF--------------DPLDPTPFKGINVSSINLS 441

Query: 457 WNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFM 516
            NQ+S      F     L  ++L  N  T     +L            L           
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSID------- 494

Query: 517 RRNVSARGLQYNQIWSFPPTI-----------DLSLNRLDGSIWPEFGNLKKL------H 559
                   L++N++                  DLS N        +  N   L      +
Sbjct: 495 --------LRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545

Query: 560 VFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGR 619
             D + N      P  +T   SL  L +  N++   +   +     +S   + +N     
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISI 602

Query: 620 IPSG 623
             S 
Sbjct: 603 DLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  233 bits (596), Expect = 6e-66
 Identities = 65/564 (11%), Positives = 153/564 (27%), Gaps = 103/564 (18%)

Query: 72  SSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVN 131
             + +  +       +    +     +  + +S    ++   +    N +   V  +++ 
Sbjct: 146 QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMR 204

Query: 132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN 191
           L  L    + ++               +  +        +       N   +  + +   
Sbjct: 205 LTKLRQFYMGNSPFVAENICEA----WENENSEYAQQYKTEDLKWD-NLKDLTDVEVYNC 259

Query: 192 YFSGTLSPGLGNCASLEHLCLGMNDLTGG--------IADDIFQLQKLRLLGLQDNQL-S 242
                L   L     ++ + +  N    G           D    +K++++ +  N L +
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319

Query: 243 GKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT 302
             +  S+  +  L  L+   N   G +P  F    +   L    N+ T    +    +  
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQ 378

Query: 303 LNLLNLRNNSLDG-SLLLNCPALTNLTSLDLGTNKFNG-------PLPTNLPRCRKLKNI 354
           +  L+  +N L     + +  +++ ++++D   N+          PL     +   + +I
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438

Query: 355 NLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEK 414
           NL+ N  S    E +     LS ++L      N             LT +          
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMG----N------------MLTEI---------- 472

Query: 415 LPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP-VWFGGFQD 473
                                      +  +    L  +DL +N+L+             
Sbjct: 473 ------------------PKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514

Query: 474 LFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSF 533
           L  +DLS N+F+   P       +L    I                              
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN---------------------------- 545

Query: 534 PPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLS 593
               D   NR              L    +  N++   +  ++    ++  LD+  N   
Sbjct: 546 --QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNI 600

Query: 594 GAIPISLEKLSFLSKFSVANNHLT 617
                 +        + +  +   
Sbjct: 601 SIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  163 bits (414), Expect = 4e-42
 Identities = 51/314 (16%), Positives = 98/314 (31%), Gaps = 27/314 (8%)

Query: 99  GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPS 157
             +  SL  + +L  L   +N L+G +P +  +   L  L+L+ N ++            
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378

Query: 158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG-------TLSPGLGNCASLEHL 210
           ++ L  + N L         K+ S +  I+ S N            L P      ++  +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438

Query: 211 CLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG-------KLSPSIADLSNLVRLDVSSN 263
            L  N ++    +       L  + L  N L+          + +  +   L  +D+  N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498

Query: 264 NFSGNIPDVFAG-LGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN------NSLDGS 316
             +    D  A  L     +    N F+   P    NS TL    +RN      N     
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557

Query: 317 LLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
                    +LT L +G+N     +   +     +  +++  N            +    
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAG 614

Query: 377 YLSLSNSSIYNLSS 390
              L      ++  
Sbjct: 615 MYMLFYDKTQDIRG 628

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  123 bits (311), Expect = 3e-29
 Identities = 35/316 (11%), Positives = 86/316 (27%), Gaps = 55/316 (17%)

Query: 319 LNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYL 378
                  N    +   + +      +L    ++  ++L     SG++P+       L  L
Sbjct: 52  FGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVL 110

Query: 379 SLS--NSSIYNLSSALQVLQQCRNLTTLVLTLN-FRNEKLPTDPRLHFANLKVLVIASCG 435
           +L      +       + +    +          ++   +  DPR  F++L    I S  
Sbjct: 111 ALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDP 170

Query: 436 LRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGL 495
            + SI +  R   K   +    N ++  +         L    + N+ F  E        
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229

Query: 496 PSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNL 555
            +                                             +   +   ++ NL
Sbjct: 230 ENS-----------------------------------------EYAQQYKTEDLKWDNL 248

Query: 556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNL--------SGAIPISLEKLSFLS 607
           K L   ++ +      +P+ L  +  ++ ++++ N                       + 
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308

Query: 608 KFSVANNHL-TGRIPS 622
              +  N+L T  + +
Sbjct: 309 IIYIGYNNLKTFPVET 324

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  268 bits (687), Expect = 4e-82
 Identities = 77/311 (24%), Positives = 124/311 (39%), Gaps = 29/311 (9%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
            ++  +++   +       +   G FG V++A       VA+K       Q   +   EV 
Sbjct: 13   DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 791  ALSRAQHPNLVHLQGYCMHKND----RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
            +L   +H N++   G             LI +F E GSL  +L         + W+   H
Sbjct: 71   SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 847  IAQGAARGLAYLHQ-------SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
            IA+  ARGLAYLH+         +P I HRDIKS N+LL  N  A +ADFGLA    +  
Sbjct: 126  IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 900  DTHVTTDLVGTLGYIPPEYGQASV-----ATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
                T   VGT  Y+ PE  + ++     A  + D+Y+ G+VL EL +     D    + 
Sbjct: 186  SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 955  SRDLISWV-----IRMRQENRESEVLDPFIYDKQHDKEMLRVL-DIACLCLSESPKVRPT 1008
                   +     +   QE    +   P + D       + +L +    C     + R +
Sbjct: 246  MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 1009 TQQLVSWLDSI 1019
               +   +  +
Sbjct: 306  AGCVGERITQM 316

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  279 bits (715), Expect = 8e-82
 Identities = 120/579 (20%), Positives = 192/579 (33%), Gaps = 60/579 (10%)

Query: 96  RLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-N 154
            L     ++      L  L+L  N ++       V   NL  LDLS N LS     T   
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 155 LPSIQVLDISSNSLNGSVPTSICK-NSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG 213
           L ++Q L +S+N +       +    +S ++ + LS N               L  L L 
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203

Query: 214 MNDLTGGIADDIF---QLQKLRLLGLQDNQLSGKLSPSIADL--SNLVRLDVSSNNFSGN 268
              L   + + +        +R L L ++QLS   + +   L  +NL  LD+S NN +  
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 269 IPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLN-------- 320
             D FA L + +Y     N       HSL     +  LNL+ +    S+ L         
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323

Query: 321 -CPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ--IPETYKNFE--SL 375
               L  L  L++  N   G           LK ++L+ +  S +    ET+ +     L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 376 SYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCG 435
             L+L+ + I  + S         +L  L L LN   ++L         N+  + ++   
Sbjct: 384 HILNLTKNKISKIES--DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 436 LRGSIPQWLRGCSKLQLVDLSWNQLSG--TIPVWFGGFQDLFYLDLSNNTFTGEIPKNLT 493
                         LQ + L    L    + P  F   ++L  LDLSNN         L 
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 494 GLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFG 553
           GL  L   +                      LQ+N +           +   G       
Sbjct: 502 GLEKLEILD----------------------LQHNNLARLWK------HANPGGPIYFLK 533

Query: 554 NLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVAN 613
            L  LH+ +L+ N            +  L+ +DL  NNL+            L   ++  
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593

Query: 614 NHLTGRIPS--GGQFQTFPNSSFDGNNLCGEHRYSCTID 650
           N +T       G  F+         N         CT +
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPF------DCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  271 bits (694), Expect = 7e-79
 Identities = 120/571 (21%), Positives = 196/571 (34%), Gaps = 61/571 (10%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
           L L    ++   +        L  L+LSHN L  T   + V L NL+ L LS+N +    
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161

Query: 150 PQTI---NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLG---N 203
            + +      S++ L++SSN +    P        R+  + L+      +L+  L     
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCF-HAIGRLFGLFLNNVQLGPSLTEKLCLELA 220

Query: 204 CASLEHLCLGMNDLTGGIADDIFQLQ--KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVS 261
             S+ +L L  + L+         L+   L +L L  N L+   + S A L  L    + 
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280

Query: 262 SNNFSGNIPDVFAGLGEFQYLVAHSN---------RFTGRIPHSLSNSPTLNLLNLRNNS 312
            NN          GL   +YL    +                 S      L  LN+ +N 
Sbjct: 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP----RCRKLKNINLARNNFSGQIPET 368
           + G        L NL  L L  +  +    TN          L  +NL +N  S    + 
Sbjct: 341 IPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA 400

Query: 369 YKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA---N 425
           +     L  L L  + I    +  Q  +   N+  + L+ N    K     R  FA   +
Sbjct: 401 FSWLGHLEVLDLGLNEIGQELTG-QEWRGLENIFEIYLSYN----KYLQLTRNSFALVPS 455

Query: 426 LKVLVIASCGLRG--SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNT 483
           L+ L++    L+   S P   +    L ++DLS N ++        G + L  LDL +N 
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515

Query: 484 FTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNR 543
                     G P    + +S                    L           ++L  N 
Sbjct: 516 LARLWKHANPGGPIYFLKGLS-------------------HLHI---------LNLESNG 547

Query: 544 LDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEK- 602
            D      F +L +L + DL  NNL+    S      SL++L+L  N ++          
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607

Query: 603 LSFLSKFSVANNHLTGRIPSGGQFQTFPNSS 633
              L++  +  N       S   F  + N +
Sbjct: 608 FRNLTELDMRFNPFDCTCESIAWFVNWINET 638

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (652), Expect = 3e-73
 Identities = 106/557 (19%), Positives = 180/557 (32%), Gaps = 70/557 (12%)

Query: 109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNS 167
           V     + SH  L   VP  L    N+ VL+L+ N L             +  LD+  N+
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           ++   P         ++V+NL  N  S         C +L  L L  N +     +   +
Sbjct: 61  ISKLEPELCQ-KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG--EFQYLVAH 285
            + L  L L  N LS     +   L NL  L +S+N       +          + L   
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL---LLNCPALTNLTSLDLGTNKFNGPLP 342
           SN+     P        L  L L N  L  SL   L    A T++ +L L  ++ +    
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 343 TNLPRCR--KLKNINLARNNFSGQIPETYKNFESLSYLSLSN--------SSIYNLSSAL 392
           T     +   L  ++L+ NN +    +++     L Y  L           S++ L + +
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN-V 298

Query: 393 QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQL 452
           + L   R+ T   ++L     K+          L+ L +    + G       G   L+ 
Sbjct: 299 RYLNLKRSFTKQSISLA-SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357

Query: 453 VDLSWNQLSGT--IPVWFGGFQ--DLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEP 508
           + LS +  S        F       L  L+L+ N  +       + L  L          
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE--------- 408

Query: 509 SPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP-EFGNLKKLHVFDLKHNN 567
                                       +DL LN +   +   E+  L+ +    L +N 
Sbjct: 409 ---------------------------VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 568 LSGPIPSELTGMTSLETLDLSYNNLSG--AIPISLEKLSFLSKFSVANNHLTGRIPSGGQ 625
                 +    + SL+ L L    L    + P   + L  L+   ++NN++         
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND--DM 499

Query: 626 FQTFPN---SSFDGNNL 639
            +            NNL
Sbjct: 500 LEGLEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  154 bits (391), Expect = 6e-39
 Identities = 67/295 (22%), Positives = 109/295 (36%), Gaps = 21/295 (7%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNS 167
            L  LNL+ N +      +   L +LEVLDL  N++   L       L +I  + +S N 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPG-LGNCASLEHLCLGMNDLTGGIADDI 225
                  S     S ++ + L          SP       +L  L L  N++     D +
Sbjct: 442 YLQLTRNSFALVPS-LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500

Query: 226 FQLQKLRLLGLQDNQLS--------GKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
             L+KL +L LQ N L+        G     +  LS+L  L++ SN F     +VF  L 
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560

Query: 278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDG-SLLLNCPALTNLTSLDLGTNK 336
           E + +    N          +N  +L  LNL+ N +      +  PA  NLT LD+  N 
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620

Query: 337 FNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSA 391
           F+    +       +   +         IPE   ++   +        +    ++
Sbjct: 621 FDCTCESIAWFVNWINETHT-------NIPELSSHYLCNTPPHYHGFPVRLFDTS 668

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 45.8 bits (109), Expect = 7e-05
 Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 7/88 (7%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL-VNLPNLEVLDLSSND 144
            +  + L    L    +    N V L+ LNL  NL+             NL  LD+  N 
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620

Query: 145 LSG------PLPQTINLPSIQVLDISSN 166
                         IN     + ++SS+
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSH 648

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  270 bits (692), Expect = 2e-79
 Identities = 111/587 (18%), Positives = 198/587 (33%), Gaps = 79/587 (13%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
              L L    L+   S S  +  +L+ L+LS   ++     +  +L +L  L L+ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 147 GPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYF-SGTLSPGLGNC 204
                    L S+Q L     +L       I  +   ++ +N++ N   S  L     N 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPI-GHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRL----LGLQDNQLSGKLSPSIADLSNLVRLDV 260
            +LEHL L  N +      D+  L ++ L    L L  N ++  + P       L +L +
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207

Query: 261 SSNNFSGNIP-DVFAGLGEFQYLVAHSNRFTGR------IPHSLSNSPTLNLLNLRNNSL 313
            +N  S N+      GL   +        F            +L     L +   R   L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 314 DGSLLLNCPA---LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYK 370
           D  L         LTN++S  L +                 +++ L    F        K
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLK 325

Query: 371 NFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL-HFANLKVL 429
           + + L++ S    + ++            +L  L L+ N  + K           +LK L
Sbjct: 326 SLKRLTFTSNKGGNAFSEVD-------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 430 VIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFTGEI 488
            ++  G+   +     G  +L+ +D   + L        F   ++L YLD+S+       
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 489 PKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSI 548
                GL SL                                      + ++ N    + 
Sbjct: 438 NGIFNGLSSLEV------------------------------------LKMAGNSFQENF 461

Query: 549 WPE-FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLS 607
            P+ F  L+ L   DL    L    P+    ++SL+ L++S+NN         + L+ L 
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521

Query: 608 KFSVANNHLTGRIPSGGQFQTFPNS----SFDGNNLCGEHRYSCTID 650
               + NH+        + Q FP+S    +   N+       +CT +
Sbjct: 522 VLDYSLNHIMTSKKQ--ELQHFPSSLAFLNLTQNDF------ACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  224 bits (574), Expect = 3e-63
 Identities = 106/555 (19%), Positives = 189/555 (34%), Gaps = 94/555 (16%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGT-VPVSLVNLPNLEVLDLSSNDLSGP 148
           L   +  L    +  +G+L  L+ LN++HNL++   +P    NL NLE LDLSSN +   
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164

Query: 149 LPQTI-NLPSIQV----LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LG 202
               +  L  + +    LD+S N +N   P +      R+  + L  N+ S  +    + 
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 203 NCASLEHLCLGMNDLTGGI---ADDIFQLQKLRLLGLQDNQLS------GKLSPSIADLS 253
             A LE   L + +          D   L+ L  L +++ +L+        +      L+
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282

Query: 254 NLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL 313
           N+    + S          F+    +Q+L   + +F       L +   L   + +  + 
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 340

Query: 314 DGSLLLNCPALTNLTSLDLGTNKFN--GPLPTNLPRCRKLKNINLARNNFSGQIPETYKN 371
              +      L +L  LDL  N  +  G    +      LK ++L+ N     +   +  
Sbjct: 341 FSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVI 431
            E L +L   +S++  +S    V    RNL  L +                         
Sbjct: 395 LEQLEHLDFQHSNLKQMSE-FSVFLSLRNLIYLDI------------------------- 428

Query: 432 ASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTI-PVWFGGFQDLFYLDLSNNTFTGEIPK 490
           +    R +      G S L+++ ++ N       P  F   ++L +LDLS        P 
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 491 NLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP 550
               L SL                                      +++S N        
Sbjct: 489 AFNSLSSLQ------------------------------------VLNMSHNNFFSLDTF 512

Query: 551 EFGNLKKLHVFDLKHNNLSGPIPSELTGM-TSLETLDLSYNNLSGAIPIS--LEKLSFLS 607
            +  L  L V D   N++      EL    +SL  L+L+ N+ +        L+ +    
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 608 KFSVANNHLTGRIPS 622
           +  V    +    PS
Sbjct: 573 QLLVEVERMECATPS 587

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  200 bits (511), Expect = 9e-55
 Identities = 82/476 (17%), Positives = 136/476 (28%), Gaps = 60/476 (12%)

Query: 160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG 219
                  +    +P ++       + ++LS N      S    +   L+ L L   ++  
Sbjct: 11  TYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 220 GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF 279
                   L  L  L L  N +      + + LS+L +L     N +         L   
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 280 QYLVAHSNRFTG-RIPHSLSNSPTLNLLNLRNNSLDG---SLLLNCPALTNL-TSLDLGT 334
           + L    N     ++P   SN   L  L+L +N +     + L     +  L  SLDL  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 335 NKFNGPLPTNLPRCRKLKNINLARNNFSGQIPET-YKNFESLSYLSLSNSSIYNLSS--- 390
           N  N  +     +  +L  + L  N  S  + +T  +    L    L      N  +   
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 391 -ALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSK 449
                L+   NLT     L + +                           I       + 
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLD----------------------YYLDDIIDLFNCLTN 283

Query: 450 LQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPS 509
           +    L    +       F       +L+L N  F       L  L  L   +       
Sbjct: 284 VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF 341

Query: 510 PDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLD--GSIWPEFGNLKKLHVFDLKHNN 567
            +             L++         +DLS N L   G           L   DL  N 
Sbjct: 342 SEVDL--------PSLEF---------LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 568 LSGPIPSELTGMTSLETLDLSYNNLSGAIPIS-LEKLSFLSKFSVANNHLTGRIPS 622
           +   + S   G+  LE LD  ++NL      S    L  L    +++ H       
Sbjct: 385 VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (412), Expect = 5e-42
 Identities = 63/282 (22%), Positives = 101/282 (35%), Gaps = 14/282 (4%)

Query: 74  SSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLL--KGTVPVSLVN 131
            +            +   L     KG  + S  +L  L FL+LS N L  KG    S   
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN 191
             +L+ LDLS N +       + L  ++ LD   ++L      S+  +   +  +++S  
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 192 YFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIA 250
           +     +      +SLE L +  N        DIF  L+ L  L L   QL      +  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 251 DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLR 309
            LS+L  L++S NNF       +  L   Q L    N         L + P+ L  LNL 
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 310 NNSLDGSLLLNCPA------LTNLTSLDLGTNKFNGPLPTNL 345
            N    +    C        + +   L +   +     P++ 
Sbjct: 552 QNDFACT----CEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  251 bits (643), Expect = 1e-70
 Identities = 91/623 (14%), Positives = 191/623 (30%), Gaps = 97/623 (15%)

Query: 53  WGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLR 112
           W  N          G+  +++           GRVTGL L     KG++ +++G L +L+
Sbjct: 302 WNFNKELDMWGDQPGVDLDNN-----------GRVTGLSLAGFGAKGRVPDAIGQLTELK 350

Query: 113 FLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNG 170
            L+   +    +  +        ++ +   + +     +        + + D+  +++N 
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410

Query: 171 SVPTSICKNSSRIRVINLSVNYFS---GTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           +      K  SRI + +  +   +     +S  +     L+ +    +  T         
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI----- 465

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
                       +       S ++L +L  +++ +      +PD    L E Q L    N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

Query: 288 RFTG---------RIPHSLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLGT 334
           R            R+       P + +  +  N+L      + L     +  L  LD   
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK---MVKLGLLDCVH 582

Query: 335 NKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQV 394
           NK    L        KL ++ L  N       +     + +  L  S++ +  + +    
Sbjct: 583 NKVRH-LEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN- 639

Query: 395 LQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVD 454
            +    + ++  + N    K+ ++ R    ++                          V 
Sbjct: 640 AKSVYVMGSVDFSYN----KIGSEGRNISCSMDDY----------------KGINASTVT 679

Query: 455 LSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPF 514
           LS+N++       F     +  + LSNN  T     +L            L         
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID----- 734

Query: 515 FMRRNVSARGLQYNQIWSFPPTI-----------DLSLNRLDGSIWPEFGNLKKLHVFDL 563
                     L++N++ S                D+S N    S   +  N  +L  F +
Sbjct: 735 ----------LRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783

Query: 564 KH------NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           +H      N +    P+ +T   SL  L +  N++   +   L     L    +A+N   
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI 840

Query: 618 -GRIPSGGQFQTFPNSSFDGNNL 639
              + S   +          +  
Sbjct: 841 SIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  192 bits (489), Expect = 1e-50
 Identities = 75/520 (14%), Positives = 148/520 (28%), Gaps = 98/520 (18%)

Query: 104 SLGNLVQLRFLNLSHNLLKG------TVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPS 157
            +  + +   ++L    +         +  ++  L  L+++  +++  +           
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE-- 470

Query: 158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDL 217
               +        +   S   N   +  + L        L   L +   L+ L +  N  
Sbjct: 471 --DANSDYAKQYENEELSW-SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 218 TG---------GIADDIFQLQKLRLLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNNFSG 267
                       +ADD     K+++  +  N L     S S+  +  L  LD   N    
Sbjct: 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR- 586

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSL-SNSPTLNLLNLRNNSLDGSL-LLNCPALT 325
              + F    +   L    N+    IP    + +  +  L   +N L     + N  ++ 
Sbjct: 587 -HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644

Query: 326 NLTSLDLGTNKF-----NGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL 380
            + S+D   NK      N     +  +      + L+ N       E +     +S + L
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 381 SNSSIYNLSSAL-----QVLQQCRNLTTLVLTLNFRNEKLPTDPRL-HFANLKVLVIASC 434
           SN+ + ++            +    LTT+ L  N +   L  D R      L  + ++  
Sbjct: 705 SNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN-KLTSLSDDFRATTLPYLSNMDVSYN 763

Query: 435 GLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTG 494
               S P      S+L+   +                      D   N    + P  +T 
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITT 804

Query: 495 LPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN 554
            PSLI   I                        N I      +                 
Sbjct: 805 CPSLIQLQIG----------------------SNDIRKVDEKL----------------- 825

Query: 555 LKKLHVFDLKHNNL-SGPIPSELTGMTSLETLDLSYNNLS 593
             +L++ D+  N   S  + S    + +     L Y+   
Sbjct: 826 TPQLYILDIADNPNISIDVTSVCPYIEAG-MYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  123 bits (309), Expect = 1e-28
 Identities = 41/333 (12%), Positives = 95/333 (28%), Gaps = 56/333 (16%)

Query: 306 LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
           L+ +N       + N     N  + +   + +      +L    ++  ++LA     G++
Sbjct: 281 LDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 366 PETYKNFESLSYLSLSN---SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLH 422
           P+       L  LS      +    L    ++           + ++++   L  D RL+
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 423 FANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
            ++L    I        I +  R   K   +    N+++  I         L  +  +N+
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANS 458

Query: 483 TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLN 542
                     T     +                                      +    
Sbjct: 459 --------PFTYDNIAVDWE---------------------------------DANSDYA 477

Query: 543 RLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG-------- 594
           +   +    + NLK L   +L +      +P  L  +  L++L+++ N            
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537

Query: 595 -AIPISLEKLSFLSKFSVANNHLTGRIPSGGQF 626
             +    +    +  F +  N+L    P+    
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASL 569

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 25/164 (15%), Positives = 46/164 (28%), Gaps = 15/164 (9%)

Query: 99  GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV--NLPNLEVLDLSSNDLSGPLPQTI-NL 155
                +  N   L  ++L  N L  ++        LP L  +D+S N  S   P    N 
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775

Query: 156 PSIQVLDI------SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEH 209
             ++   I        N +    PT I      +  + +  N     +   L     L  
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGIT-TCPSLIQLQIGSNDIR-KVDEKL--TPQLYI 831

Query: 210 LCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLS 253
           L +  N         +    +  +  L  ++           + 
Sbjct: 832 LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.2 bits (125), Expect = 9e-07
 Identities = 15/93 (16%), Positives = 33/93 (35%)

Query: 561 FDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRI 620
           F+ + +        +L     +  L L+     G +P ++ +L+ L   S   +  T   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 621 PSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRES 653
              G  +  P+ S +  +    H     +D + 
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQ 396

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  234 bits (598), Expect = 2e-66
 Identities = 92/564 (16%), Positives = 186/564 (32%), Gaps = 69/564 (12%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
              L      L    + +   L+ L FL+L+   +      +  +   L+ L L++N L 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 147 GPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA 205
                 +    +++ L      ++      +  N   +  + L  N+ S    P      
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPL-HNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 206 SLEHLCLGMNDLTGGIADDIFQLQKLRL--LGLQDNQLSGKLSPSIADLSNLVRLDVSSN 263
            L+ L    N +     +D+  LQ+     L L  N ++G + P   D +    L+    
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGT 212

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA 323
                I                          ++ +       ++ +  +  ++      
Sbjct: 213 QNLLVIFKGLKNS-------------------TIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS 383
           + ++ S++L  + F             L+ ++L   + S ++P       +L  L LS +
Sbjct: 254 M-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311

Query: 384 SIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS--IP 441
              NL           +LT L +  N +  +L T    +  NL+ L ++   +  S    
Sbjct: 312 KFENLCQ--ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLIT 500
             LR  S LQ ++LS+N+        F     L  LDL+      +  ++    L  L  
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 501 RNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSI-- 548
            N+S                      ++ +                ++L  N        
Sbjct: 430 LNLS----------------------HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467

Query: 549 -WPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLS 607
                  L +L +  L   +LS       T +  +  +DLS+N L+ +   +L  L  + 
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526

Query: 608 KFSVANNHLTGRIPSGGQFQTFPN 631
             ++A+NH++  +PS         
Sbjct: 527 YLNLASNHISIILPS--LLPILSQ 548

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  190 bits (486), Expect = 1e-51
 Identities = 84/481 (17%), Positives = 158/481 (32%), Gaps = 53/481 (11%)

Query: 159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT 218
           +  +  +  LN  +P ++    +    +  S N      +       +L  L L    + 
Sbjct: 15  KTYNCENLGLN-EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 219 GGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
             I +D FQ   +L  L L  N L      +++    L  L       S           
Sbjct: 71  W-IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQK 129

Query: 278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGT 334
             + L   SN  +         +  L +L+ +NN    L    + +    TNL+ L+L  
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-LNLNG 188

Query: 335 NKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKN--FESLSYLSLSNSSIYNLSSAL 392
           N   G +          +++N         I +  KN   +SL   +  +    ++S A+
Sbjct: 189 NDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 393 QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQL 452
                  ++ ++ L  ++    + ++    F+ L+ L + +  L   +P  L G S L+ 
Sbjct: 248 FEGLCEMSVESINLQKHYF-FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK 305

Query: 453 VDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPD 511
           + LS N+      +    F  L +L +  NT   E+    L  L +L   +         
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD--------- 356

Query: 512 FPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP 571
                        L ++ I +                  +  NL  L   +L +N     
Sbjct: 357 -------------LSHDDIETSDCCNL------------QLRNLSHLQSLNLSYNEPLSL 391

Query: 572 IPSELTGMTSLETLDLSYNNLSGAIPIS-LEKLSFLSKFSVANNHLTGRIPSGGQFQTFP 630
                     LE LDL++  L      S  + L  L   +++++ L         F   P
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE--QLFDGLP 449

Query: 631 N 631
            
Sbjct: 450 A 450

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (399), Expect = 3e-40
 Identities = 54/307 (17%), Positives = 106/307 (34%), Gaps = 11/307 (3%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLN 169
            +  +NL  +        +      L+ LDL++  LS      + L +++ L +S+N   
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLT--GGIADDIF 226
             +      N   +  +++  N     L  G L N  +L  L L  +D+         + 
Sbjct: 315 N-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD-VFAGLGEFQYLVAH 285
            L  L+ L L  N+     + +  +   L  LD++            F  L   + L   
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA---LTNLTSLDLGTNKFNGPLP 342
            +             P L  LNL+ N      +    +   L  L  L L     +    
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493

Query: 343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT 402
                 + + +++L+ N  +    E   + + + YL+L+++ I  +     +L       
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP--SLLPILSQQR 550

Query: 403 TLVLTLN 409
           T+ L  N
Sbjct: 551 TINLRQN 557

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.1 bits (154), Expect = 3e-10
 Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 1/95 (1%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVL 161
           + SL  L +L  L LS   L      +  +L  +  +DLS N L+    + ++      L
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL 528

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT 196
           +++SN ++  +  S+    S+ R INL  N    T
Sbjct: 529 NLASNHIS-IILPSLLPILSQQRTINLRQNPLDCT 562

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  233 bits (597), Expect = 3e-66
 Identities = 106/532 (19%), Positives = 180/532 (33%), Gaps = 62/532 (11%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQV 160
            ++   L  L  L L+ N ++   P S   L +LE L      L+      I  L +++ 
Sbjct: 73  DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG----TLSPGLGNCASLEHLCLGMND 216
           L+++ N ++     +   N + +  ++LS NY        L     N      L + +N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 217 LTGGIADDIFQLQKLRLLGLQDNQLSGKLSP-SIADLSNLVRLDVSSNNFSGNI------ 269
           +   I D  FQ  KL  L L+ N  S  +    + +L+ L    +    F          
Sbjct: 193 IDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 270 PDVFAGLGEFQYLVAH--SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNL 327
           P +  GL +                          ++ ++L   S+    L + P     
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309

Query: 328 TSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN 387
            SL +   +       +LP    LK++ L  N  S  I        SLSYL LS +++  
Sbjct: 310 QSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364

Query: 388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW-LRG 446
                       +L  L L+ N     + +   +    L+ L      L+          
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFN--GAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISL 505
             KL  +D+S+          F G   L  L ++ N+F      N      +L       
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF----- 477

Query: 506 EEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH 565
                                          +DLS  +L+   W  F  L +L + ++ H
Sbjct: 478 -------------------------------LDLSKCQLEQISWGVFDTLHRLQLLNMSH 506

Query: 566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           NNL     S    + SL TLD S+N +  +  I       L+ F++ NN + 
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  213 bits (545), Expect = 2e-59
 Identities = 107/539 (19%), Positives = 169/539 (31%), Gaps = 69/539 (12%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSV 172
                  L   VP  +    + + +DLS N L      +  N   +Q LD+S   +  ++
Sbjct: 16  YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TI 71

Query: 173 PTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLR 232
                     +  + L+ N              SLE+L      L    +  I QL  L+
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131

Query: 233 LLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE----FQYLVAHSN 287
            L +  N +   KL    ++L+NLV +D+S N       +    L E       L    N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 288 RFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCP-ALTNLTSLDLGTNKFNG------- 339
                I         L+ L LR N    +++  C   L  L    L   +F         
Sbjct: 192 PIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 340 --PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQ 397
              +   L          L   N        +    ++S +SL+  SI  L      + +
Sbjct: 251 EPSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED----VPK 305

Query: 398 CRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSW 457
                +L +       +L   P L    LK L +     +GSI         L  +DLS 
Sbjct: 306 HFKWQSLSIIRC----QLKQFPTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSR 359

Query: 458 NQLSGTIP--VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFF 515
           N LS +        G   L +LDLS N     +  N  GL  L   +             
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLD------------- 405

Query: 516 MRRNVSARGLQYNQIWSFPP-----------TIDLSLNRLDGSIWPEFGNLKKLHVFDLK 564
                     Q++ +                 +D+S           F  L  L+   + 
Sbjct: 406 ---------FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456

Query: 565 HNNLSGPIPSE-LTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS 622
            N+      S      T+L  LDLS   L        + L  L   ++++N+L     S
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  155 bits (395), Expect = 8e-40
 Identities = 79/468 (16%), Positives = 138/468 (29%), Gaps = 42/468 (8%)

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
           GS+   I    +            S  +   + +  S +++ L  N L    +       
Sbjct: 2   GSLNPCIEVVPNI--TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFS 56

Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
           +L+ L L   ++      +   L +L  L ++ N      P  F+GL   + LVA   + 
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 290 TGRIPHSLSNSPTLNLLNLRNNSLDG-SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRC 348
                  +    TL  LN+ +N +    L      LTNL  +DL  N        +L   
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 349 RKLKN----INLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTL 404
           R+       ++++ N       + ++    L  L+L  +   + +     LQ    L   
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFN-SSNIMKTCLQNLAGLHVH 234

Query: 405 VLTLN--FRNEKLPTDPRLHFANLKVLVIASCGL-----RGSIPQWLRGCSKLQLVDLSW 457
            L L        L          L  + I    L                + +  + L+ 
Sbjct: 235 RLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294

Query: 458 NQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMR 517
             +     V          L +           +L  L SL                   
Sbjct: 295 VSIKYLEDVPK--HFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFK------- 345

Query: 518 RNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLK--KLHVFDLKHNNLSGPIPSE 575
             V+   L Y         +DLS N L  S    + +L    L   DL  N     + + 
Sbjct: 346 -KVALPSLSY---------LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN 394

Query: 576 LTGMTSLETLDLSYNNLSGAIPIS-LEKLSFLSKFSVANNHLTGRIPS 622
             G+  L+ LD  ++ L      S    L  L    ++  +       
Sbjct: 395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  140 bits (354), Expect = 1e-34
 Identities = 58/315 (18%), Positives = 110/315 (34%), Gaps = 12/315 (3%)

Query: 72  SSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVN 131
                 + + +    +    L               L  +  ++L+   +       +  
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPK 305

Query: 132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN 191
               + L +    L    P T++LP ++ L ++ N  + S       +   +  ++LS N
Sbjct: 306 HFKWQSLSIIRCQLKQ-FP-TLDLPFLKSLTLTMNKGSISFKKVALPS---LSYLDLSRN 360

Query: 192 --YFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPS- 248
              FSG  S       SL HL L  N     ++ +   L++L+ L  Q + L      S 
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

Query: 249 IADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHS-LSNSPTLNLLN 307
              L  L+ LD+S  N   +   +F GL     L    N F      +  +N+  L  L+
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479

Query: 308 LRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE 367
           L    L+         L  L  L++  N       ++  +   L  ++ + N        
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 368 TYKNFESLSYLSLSN 382
                +SL++ +L+N
Sbjct: 540 LQHFPKSLAFFNLTN 554

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  106 bits (266), Expect = 9e-24
 Identities = 32/168 (19%), Positives = 67/168 (39%), Gaps = 2/168 (1%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKGTVPVS-LVNLPNLEVLDLSSNDLSGPLPQTI-NLPSI 158
           +S +   L +L+ L+  H+ LK     S  ++L  L  LD+S  +           L S+
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

Query: 159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT 218
             L ++ NS   +  +++  N++ +  ++LS                 L+ L +  N+L 
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510

Query: 219 GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS 266
              +    QL  L  L    N++            +L   ++++N+ +
Sbjct: 511 FLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.7 bits (153), Expect = 4e-10
 Identities = 22/116 (18%), Positives = 43/116 (37%), Gaps = 9/116 (7%)

Query: 96  RLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-N 154
           +L+         L +L+ LN+SHN L          L +L  LD S N +          
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

Query: 155 LPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHL 210
             S+   ++++NS+       IC++   ++ +     +           CA+   +
Sbjct: 544 PKSLAFFNLTNNSV-----ACICEHQKFLQWVKEQKQFLVNVEQM---TCATPVEM 591

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  224 bits (573), Expect = 4e-66
 Identities = 84/369 (22%), Positives = 135/369 (36%), Gaps = 98/369 (26%)

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA----LTNLTSLDL-GTNKFNGPL 341
             + G +  + + +  +N L+L   +L     +  P+    L  L  L + G N   GP+
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI--PSSLANLPYLNFLYIGGINNLVGPI 93

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNL 401
           P  + +  +L  + +   N SG IP+     ++L  L  S ++                 
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA----------------- 136

Query: 402 TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
                                             L G++P  +     L  +    N++S
Sbjct: 137 ----------------------------------LSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 462 GTIPVWFGGFQDLF-YLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV 520
           G IP  +G F  LF  + +S N  TG+IP            N++L               
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF--------ANLNLA-------------- 200

Query: 521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMT 580
                           +DLS N L+G     FG+ K      L  N+L+  +   +    
Sbjct: 201 ---------------FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK 244

Query: 581 SLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-L 639
           +L  LDL  N + G +P  L +L FL   +V+ N+L G IP GG  Q F  S++  N  L
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

Query: 640 CGEHRYSCT 648
           CG    +CT
Sbjct: 305 CGSPLPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  209 bits (534), Expect = 8e-61
 Identities = 79/317 (24%), Positives = 127/317 (40%), Gaps = 33/317 (10%)

Query: 31  CNPNDLAALEDFMKNFE--SGIDGWGTNASSSDCCH--WVGITCNSSS--------SLGL 78
           CNP D  AL    K+    + +  W     ++DCC+  W+G+ C++ +         L  
Sbjct: 3   CNPQDKQALLQIKKDLGNPTTLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 79  NDSIGSGRV----------TGLFLYKR-RLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV 127
            +      +            L++     L G +  ++  L QL +L ++H  + G +P 
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI 186
            L  +  L  LD S N LSG LP +I +LP++  +    N ++G++P S    S     +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS 246
            +S N  +G + P   N  +L  + L  N L G  +      +  + + L  N L+  L 
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL- 237

Query: 247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHS--LSNSPTLN 304
             +    NL  LD+ +N   G +P     L     L    N   G IP    L       
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297

Query: 305 LLNLRNNSLDGSLLLNC 321
             N  N  L GS L  C
Sbjct: 298 YAN--NKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  110 bits (278), Expect = 1e-26
 Identities = 52/193 (26%), Positives = 69/193 (35%), Gaps = 39/193 (20%)

Query: 454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGE--IPKNLTGLPSLITRNISLEEPSPD 511
           D       G +         +  LDLS         IP +L  LP L    I        
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG------- 84

Query: 512 FPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP 571
                                        +N L G I P    L +LH   + H N+SG 
Sbjct: 85  ----------------------------GINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 572 IPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-GQFQTFP 630
           IP  L+ + +L TLD SYN LSG +P S+  L  L   +   N ++G IP   G F    
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 631 NS-SFDGNNLCGE 642
            S +   N L G+
Sbjct: 177 TSMTISRNRLTGK 189

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (540), Expect = 1e-61
 Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 29/292 (9%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAE 788
            +I   D+            IG G FG V+RA    G +VA+K L       +   EF  E
Sbjct: 33   DIPWCDLNIK-------EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLRE 84

Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            V  + R +HPN+V   G      +  ++  ++  GSL   LH+       LD   RL +A
Sbjct: 85   VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMA 143

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
               A+G+ YLH +  P I+HR++KS N+L+D  +   + DFGL+RL  S + +  +    
Sbjct: 144  YDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAA 200

Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            GT  ++ PE  +   +  K DVYSFGV+L EL T ++P     P     +++ V      
Sbjct: 201  GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKC-- 255

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                      I  +  + ++  ++     C +  P  RP+   ++  L  +I
Sbjct: 256  ------KRLEI-PRNLNPQVAAII---EGCWTNEPWKRPSFATIMDLLRPLI 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (535), Expect = 2e-61
 Identities = 84/309 (27%), Positives = 135/309 (43%), Gaps = 46/309 (14%)

Query: 726  HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ---- 780
             ++   ++ ++I            IG GGFGLV++   + D   VAIK L     +    
Sbjct: 10   KSRLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62

Query: 781  ---MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS 837
                 +EF+ EV  +S   HPN+V L G     N   ++  F+  G L + L +K     
Sbjct: 63   MIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK---AH 117

Query: 838  SLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-----GNFGAHLADFGLA 892
             + W  +L +    A G+ Y+  +  P I+HRD++S NI L          A +ADFGL+
Sbjct: 118  PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

Query: 893  RLILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGKRPMDMC 950
            +        H  + L+G   ++ PE    +    T K D YSF ++L  +LTG+ P D  
Sbjct: 177  QQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

Query: 951  KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010
                    I ++  +R+E      L P I +    +    + ++  LC S  PK RP   
Sbjct: 232  SYGK----IKFINMIREEG-----LRPTIPEDCPPR----LRNVIELCWSGDPKKRPHFS 278

Query: 1011 QLVSWLDSI 1019
             +V  L  +
Sbjct: 279  YIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  210 bits (536), Expect = 3e-61
 Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 35/294 (11%)

Query: 729  EKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAE 788
               I   +I           ++G G FG+V +A     ++VAIK++  +     + F  E
Sbjct: 2    LHMIDYKEIEVE-------EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVE 51

Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            +  LSR  HPN+V L G C++     L+  + E GSL   LH   +          +   
Sbjct: 52   LRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWC 108

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDL 907
               ++G+AYLH      ++HRD+K  N+LL        + DFG A  I         T+ 
Sbjct: 109  LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNN 163

Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP-MDMCKPKGSRDLISWVIRMR 966
             G+  ++ PE  + S  + K DV+S+G++L E++T ++P  ++  P      I W +   
Sbjct: 164  KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAV--H 218

Query: 967  QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R      P +           +  +   C S+ P  RP+ +++V  +  ++
Sbjct: 219  NGTR------PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  211 bits (538), Expect = 4e-61
 Identities = 71/333 (21%), Positives = 123/333 (36%), Gaps = 60/333 (18%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
            E +  +     +N     +IG G +G VY+ +L D R VA+K  S       + F  E  
Sbjct: 2    EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKN 57

Query: 791  --ALSRAQHPNLVHLQGYCMHKNDR-----LLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
               +   +H N+                  LL+  +  NGSL  +L        + DW S
Sbjct: 58   IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVS 112

Query: 844  RLHIAQGAARGLAYLHQS------CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS 897
               +A    RGLAYLH         +P I HRD+ S N+L+  +    ++DFGL+  +  
Sbjct: 113  SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 898  PY------DTHVTTDLVGTLGYIPPEYGQASV-------ATYKGDVYSFGVVLLELLTGK 944
                    + +     VGT+ Y+ PE  + +V       A  + D+Y+ G++  E+    
Sbjct: 173  NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 945  RPM--------------DMCKPKGS-RDLISWVIRMRQENRESEVLDPFIYDK-QHDKEM 988
              +                     +  D+   V R +          P   +  + +   
Sbjct: 233  TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK--------QRPKFPEAWKENSLA 284

Query: 989  LRVL-DIACLCLSESPKVRPTTQQLVSWLDSII 1020
            +R L +    C  +  + R T Q     +  ++
Sbjct: 285  VRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  203 bits (518), Expect = 3e-59
 Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 40/300 (13%)

Query: 727  NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMERE 784
            NK   I    +            +     G +++     G ++ +K L       +  R+
Sbjct: 2    NKHSGIDFKQLNFL-------TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRD 53

Query: 785  FRAEVEALSRAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWD 842
            F  E   L    HPN++ + G C          I  +M  GSL   LHE       +D  
Sbjct: 54   FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQS 111

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              +  A   ARG+A+LH + EP I    + S ++++D +  A ++   +         + 
Sbjct: 112  QAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SF 163

Query: 903  VTTDLVGTLGYIPPE---YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI 959
             +   +    ++ PE              D++SF V+L EL+T + P            +
Sbjct: 164  QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------M 217

Query: 960  SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
               +++  E      L P I        + +++ I   C++E P  RP    +V  L+ +
Sbjct: 218  EIGMKVALEG-----LRPTI-PPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (508), Expect = 9e-58
 Identities = 82/305 (26%), Positives = 126/305 (41%), Gaps = 52/305 (17%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL----SGDCGQMEREFR 786
            EI   ++           IIG GGFG VYRA    G  VA+K        D  Q     R
Sbjct: 3    EIDFAEL-------TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVR 54

Query: 787  AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
             E +  +  +HPN++ L+G C+ + +  L+  F   G L+  L  K      +  D  ++
Sbjct: 55   QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVN 109

Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--------LADFGLARLILSP 898
             A   ARG+ YLH      I+HRD+KSSNIL+               + DFGLAR     
Sbjct: 110  WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--- 166

Query: 899  YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP-MDMCKPKGSRD 957
            + T   +   G   ++ PE  +AS+ +   DV+S+GV+L ELLTG+ P   +       D
Sbjct: 167  HRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-------D 218

Query: 958  LISWVIRMRQENRESEV---LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
             ++    +        +                      +   C +  P  RP+   ++ 
Sbjct: 219  GLAVAYGVAMNKLALPIPSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILD 266

Query: 1015 WLDSI 1019
             L +I
Sbjct: 267  QLTTI 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (504), Expect = 4e-57
 Identities = 74/300 (24%), Positives = 130/300 (43%), Gaps = 42/300 (14%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAE 788
            EI    I            IG G FG VY+       +VA+K L+      Q  + F+ E
Sbjct: 20   EIPDGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNE 70

Query: 789  VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            V  L + +H N++   GY        ++  + E  SL + LH      +  +    + IA
Sbjct: 71   VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIA 126

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
            +  ARG+ YLH      I+HRD+KS+NI L  +    + DFGLA        +H    L 
Sbjct: 127  RQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 909  GTLGYIPPE---YGQASVATYKGDVYSFGVVLLELLTGKRP-MDMCKPKGSRDLISWVI- 963
            G++ ++ PE      ++  +++ DVY+FG+VL EL+TG+ P  ++     +RD I  ++ 
Sbjct: 184  GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN----NRDQIIEMVG 239

Query: 964  ---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                    ++        +              +   CL +    RP+  ++++ ++ + 
Sbjct: 240  RGSLSPDLSKVRSNCPKRMK------------RLMAECLKKKRDERPSFPRILAEIEELA 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  198 bits (505), Expect = 6e-57
 Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 56/314 (17%)

Query: 728  KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFR 786
              +     D+           ++G G FG   + T    G  + +K L     + +R F 
Sbjct: 3    PHRIFRPSDL-------IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55

Query: 787  AEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
             EV+ +   +HPN++   G          I  +++ G+L   +       S   W  R+ 
Sbjct: 56   KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVS 112

Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT----- 901
             A+  A G+AYLH     +I+HRD+ S N L+  N    +ADFGLARL++          
Sbjct: 113  FAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 902  -------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM-DMCKPK 953
                        +VG   ++ PE         K DV+SFG+VL E++       D     
Sbjct: 170  SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY---- 225

Query: 954  GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLR-------VLDIACLCLSESPKVR 1006
                        R  +        F  + +   +             I   C    P+ R
Sbjct: 226  ----------LPRTMD--------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

Query: 1007 PTTQQLVSWLDSII 1020
            P+  +L  WL+++ 
Sbjct: 268  PSFVKLEHWLETLR 281

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  196 bits (500), Expect = 3e-56
 Identities = 75/335 (22%), Positives = 124/335 (37%), Gaps = 53/335 (15%)

Query: 702  PEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA 761
            PE   +  + +      S+  +    +E +I  + +           +IG G FG VY  
Sbjct: 2    PEMNLSLLSARSFPRKASQTSIFL--QEWDIPFEQLEIG-------ELIGKGRFGQVYHG 52

Query: 762  TLPDGRNVAIKRL--SGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF 819
                G  VAI+ +    D     + F+ EV A  + +H N+V   G CM      +I S 
Sbjct: 53   RW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110

Query: 820  MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD 879
             +  +L   + +       LD +    IAQ   +G+ YLH      ILH+D+KS N+  D
Sbjct: 111  CKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD 164

Query: 880  GNFGAHLADFGLARLILSPYDTHVTTDL---VGTLGYIPPE---------YGQASVATYK 927
             N    + DFGL  +            L    G L ++ PE                +  
Sbjct: 165  -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH 223

Query: 928  GDVYSFGVVLLELLTGKRP-MDMCKPKGSRDLISWVIR--MRQENRESEVLDPFIYDKQH 984
             DV++ G +  EL   + P           + I W +   M+            +     
Sbjct: 224  SDVFALGTIWYELHAREWPFKTQ-----PAEAIIWQMGTGMKPN----------LSQIGM 268

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             KE+  +L     C +   + RPT  +L+  L+ +
Sbjct: 269  GKEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  196 bits (499), Expect = 3e-56
 Identities = 77/304 (25%), Positives = 117/304 (38%), Gaps = 49/304 (16%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE--ALSRAQHPNLVHLQG 805
              +G G +G V+R +   G NVA+K  S    + E+ +  E E       +H N++    
Sbjct: 14   ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 806  YCMHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-- 859
              M          LI  + E GSL  +L        +LD  S L I    A GLA+LH  
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIE 124

Query: 860  ---QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT--TDLVGTLGYI 914
                  +P I HRD+KS NIL+  N    +AD GLA +     +         VGT  Y+
Sbjct: 125  IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 915  PPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK------------GSR 956
             PE            +  + D+++FG+VL E+        + +                 
Sbjct: 185  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL-DIACLCLSESPKVRPTTQQLVSW 1015
            D+   V   +Q  R      P I ++      L  L  +   C  ++P  R T  ++   
Sbjct: 245  DMRKVVCVDQQ--R------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296

Query: 1016 LDSI 1019
            L  I
Sbjct: 297  LTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (493), Expect = 6e-55
 Identities = 74/305 (24%), Positives = 113/305 (37%), Gaps = 49/305 (16%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE--ALSRAQHPNLVHLQG 805
              IG G +G V+      G  VA+K         E  +  E E       +H N++    
Sbjct: 43   KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 806  YCMHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-- 859
              +          LI  + ENGSL  +L        +LD  S L +A  +  GL +LH  
Sbjct: 99   ADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 860  ---QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH--VTTDLVGTLGYI 914
                  +P I HRD+KS NIL+  N    +AD GLA   +S  +         VGT  Y+
Sbjct: 154  IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 915  PPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK------------GSR 956
            PPE            +    D+YSFG++L E+        + +                 
Sbjct: 214  PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL-DIACLCLSESPKVRPTTQQLVSW 1015
            D+   V   +   R      P   ++    E LR +  +   C + +P  R T  ++   
Sbjct: 274  DMREIVCIKKL--R------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 1016 LDSII 1020
            L  + 
Sbjct: 326  LAKMS 330

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (491), Expect = 1e-54
 Identities = 75/304 (24%), Positives = 117/304 (38%), Gaps = 49/304 (16%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE--ALSRAQHPNLVHLQG 805
              IG G FG V+R     G  VA+K  S    + ER +  E E       +H N++    
Sbjct: 48   ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 806  YCMHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ- 860
                 N       L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH  
Sbjct: 104  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 158

Query: 861  ----SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH--VTTDLVGTLGYI 914
                  +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y+
Sbjct: 159  IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 915  PPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP------------KGSR 956
             PE        +   +  + D+Y+ G+V  E+        + +                 
Sbjct: 219  APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL-DIACLCLSESPKVRPTTQQLVSW 1015
            ++   V   +   R      P I ++    E LRV+  I   C   +   R T  ++   
Sbjct: 279  EMRKVVCEQKL--R------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 1016 LDSI 1019
            L  +
Sbjct: 331  LSQL 334

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  189 bits (483), Expect = 2e-51
 Identities = 106/550 (19%), Positives = 190/550 (34%), Gaps = 69/550 (12%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
              L L    L+   S S  +  +L+ L+LS   ++     +  +L +L  L L+ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 147 GPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYF-SGTLSPGLGN 203
             L       L S+Q L     +L  S+      +   ++ +N++ N   S  L     N
Sbjct: 90  S-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 204 CASLEHLCLGMNDLTGGIADDIFQLQKLRL----LGLQDNQLSGKLSPSIADLSNLVRLD 259
             +LEHL L  N +      D+  L ++ L    L L  N ++  + P       L +L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206

Query: 260 VSSNNFSGNIPD-VFAGLGEFQYL------VAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
           + +N  S N+      GL   +          +          +L     L +   R   
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 313 LDGSLLLNC---PALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETY 369
           LD  L         LTN++S  L +         +       +++ L    F  Q P   
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFG-QFPTL- 322

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN-FRNEKLPTDPRLHFANLKV 428
              +SL  L+ +++   N  S         +L  L L+ N    +   +       +LK 
Sbjct: 323 -KLKSLKRLTFTSNKGGNAFS----EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 429 LVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFTGE 487
           L ++  G+  ++     G  +L+ +D   + L        F   ++L YLD+S+      
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 488 IPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGS 547
                 GL SL                                      + ++ N    +
Sbjct: 437 FNGIFNGLSSLE------------------------------------VLKMAGNSFQEN 460

Query: 548 IWPE-FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
             P+ F  L+ L   DL    L    P+    ++SL+ L+++ N L        ++L+ L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520

Query: 607 SKFSVANNHL 616
            K  +  N  
Sbjct: 521 QKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  185 bits (471), Expect = 9e-50
 Identities = 101/545 (18%), Positives = 177/545 (32%), Gaps = 79/545 (14%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLN 169
            + L+LS N L+     S  + P L+VLDLS  ++         +L  +  L ++ N + 
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-L 228
            S+        S ++ +       +   +  +G+  +L+ L +  N +      + F  L
Sbjct: 90  -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 229 QKLRLLGLQDNQLSGKLSPSIADLSNL----VRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
             L  L L  N++       +  L  +    + LD+S N  +   P  F  +     L  
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTL 207

Query: 285 HSNRFTGRIP----HSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP 340
            +N  +  +       L+      L+     +       +  AL  L +L +   +    
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
                             + +   I + +    ++S  SL + +I  +            
Sbjct: 268 ------------------DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD----FSYNFG 305

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
              L L      +     P L   +LK L   S     +          L+ +DLS N L
Sbjct: 306 WQHLELVNCKFGQ----FPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGL 359

Query: 461 S--GTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRR 518
           S  G       G   L YLDLS N     +  N  GL  L   +                
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD---------------- 402

Query: 519 NVSARGLQYNQIWSFPP-----------TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNN 567
                  Q++ +                 +D+S      +    F  L  L V  +  N+
Sbjct: 403 ------FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 568 LSGPIPSE-LTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQF 626
                  +  T + +L  LDLS   L    P +   LS L   ++A+N L   +P  G F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD-GIF 514

Query: 627 QTFPN 631
               +
Sbjct: 515 DRLTS 519

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  137 bits (346), Expect = 9e-34
 Identities = 92/456 (20%), Positives = 142/456 (31%), Gaps = 64/456 (14%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN 264
            S ++L L  N L    +   F   +L++L L   ++      +   LS+L  L ++ N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL-DGSLLLNCPA 323
                   F+GL   Q LVA            + +  TL  LN+ +N +    L      
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKN----INLARNNFSGQIPETYKNFESLSYLS 379
           LTNL  LDL +NK      T+L    ++      ++L+ N  +   P  +K    L  L+
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206

Query: 380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLNF--RNEKLPTDPRLHFANLKVLVIASCGLR 437
           L N+   +L+     +Q    L    L L        L    +     L  L I    L 
Sbjct: 207 LRNNFD-SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 438 G------SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN 491
                   I       + +    L    +       F       +L+L N  F       
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLK 323

Query: 492 LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP--------TIDLSLNR 543
           L  L  L                             N+  +            +DLS N 
Sbjct: 324 LKSLKRLT-------------------------FTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 544 LD--GSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS-L 600
           L   G           L   DL  N +   + S   G+  LE LD  ++NL      S  
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 601 EKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDG 636
             L  L    +++ H               N  F+G
Sbjct: 418 LSLRNLIYLDISHTHTR----------VAFNGIFNG 443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  120 bits (302), Expect = 2e-28
 Identities = 81/408 (19%), Positives = 138/408 (33%), Gaps = 54/408 (13%)

Query: 100 KLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEV----LDLSSNDLSGPLPQTINL 155
           KL E   NL  L  L+LS N ++      L  L  + +    LDLS N ++   P     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT---------LSPGLGNCAS 206
             +  L + +N  + +V  +  +  + + V  L +  F               GL N  +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL-T 258

Query: 207 LEHLCLGMNDLTGGIADDIFQ--------------------------LQKLRLLGLQDNQ 240
           +E   L   D       D+F                            Q L L+  +  Q
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318

Query: 241 LSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT--GRIPHSLS 298
                      L +L RL  +SN            L   ++L    N  +  G    S  
Sbjct: 319 FPTL------KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 299 NSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG-PLPTNLPRCRKLKNINLA 357
            + +L  L+L  N +  ++  N   L  L  LD   +        +     R L  ++++
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 358 RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPT 417
             +        +    SL  L ++ +S         +  + RNLT L L+   + E+L  
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTELRNLTFLDLSQC-QLEQLSP 487

Query: 418 DPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
                 ++L+VL +AS  L+          + LQ + L  N    + P
Sbjct: 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.1 bits (190), Expect = 1e-14
 Identities = 41/235 (17%), Positives = 69/235 (29%), Gaps = 43/235 (18%)

Query: 406 LTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
           +T           P     + K L ++   LR           +LQ++DLS  ++     
Sbjct: 10  ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 466 VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGL 525
             +     L  L L+ N          +GL SL                           
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV----------------------A 107

Query: 526 QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNL-SGPIPSELTGMTSLET 584
               + S                    G+LK L   ++ HN + S  +P   + +T+LE 
Sbjct: 108 VETNLASLENFP--------------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153

Query: 585 LDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNL 639
           LDLS N +       L  L  +   +++ +       S          +F    L
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL------SLNPMNFIQPGAFKEIRL 202

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  194 bits (494), Expect = 2e-51
 Identities = 100/573 (17%), Positives = 193/573 (33%), Gaps = 61/573 (10%)

Query: 100 KLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPS 157
            L++    L     L LS N ++     S   L  L++L+L S      + +    NLP+
Sbjct: 15  NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG--LGNCASLEHLCLGMN 215
           +++LD+ S+ +   +     +    +  + L     S  +       N  +L  L L  N
Sbjct: 75  LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133

Query: 216 DLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLS--NLVRLDVSSNNFSGNIPDV 272
            +        F  L  L+ +    NQ+       +  L    L    +++N+    +   
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193

Query: 273 FAGLGE-FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLD 331
           +      F+ +V      +G       N  T+++    +N++  S   +     ++    
Sbjct: 194 WGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAG 246

Query: 332 LGTNKFNGPLPTNLPRCRK--LKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLS 389
            G +    P         +  +++++L+           ++  + L  L+L+ + I  ++
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306

Query: 390 SALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA---NLKVLVIASCGLRGSIPQWLRG 446
              +      NL  L L+ N     L      +F     +  + +    +     Q  + 
Sbjct: 307 D--EAFYGLDNLQVLNLSYN----LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLE 506
             KLQ +DL  N L+            +  + LS N     +PK       +      LE
Sbjct: 361 LEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLE 414

Query: 507 EPSPDFPFFMRRNVSARGLQYNQIWSFPP-----------TIDLSLNRLDGSI-----WP 550
                +      ++    L  N+  S               + L  N L  +      W 
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474

Query: 551 EFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLS----GAIPISLEKLSFL 606
            F  L  L V  L HN L+   P   + +T+L  L L+ N L+      +P +LE L   
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEIL--- 531

Query: 607 SKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNL 639
               ++ N L    P+   F +        N  
Sbjct: 532 ---DISRNQLL--APNPDVFVSLSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  188 bits (480), Expect = 1e-49
 Identities = 110/535 (20%), Positives = 189/535 (35%), Gaps = 46/535 (8%)

Query: 106 GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDIS 164
           G +   RF NL+       VP     L   E L LS N +      +   L  +Q+L++ 
Sbjct: 6   GRIAFYRFCNLTQ------VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELG 56

Query: 165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLT-GGIA 222
           S     ++     +N   +R+++L  +     L P        L  L L    L+   + 
Sbjct: 57  SQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 223 DDIFQ-LQKLRLLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG--E 278
           D  F+ L+ L  L L  NQ+    L PS   L++L  +D SSN            L    
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 279 FQYLVAHSNRFTGRIPHSLSNSP-TLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKF 337
             +    +N    R+             + L    + G+          +      +N  
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW-------TVDITGNFSNAI 228

Query: 338 NGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFE--SLSYLSLSNSSIYNLSSALQVL 395
           +     +L     +       +N       T+      S+ +L LS+  +++L+S  +V 
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS--RVF 286

Query: 396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDL 455
           +  ++L  L L  N +  K+  +      NL+VL ++   L         G  K+  +DL
Sbjct: 287 ETLKDLKVLNLAYN-KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345

Query: 456 SWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFF 515
             N ++      F   + L  LDL +N  T      +  +P +      L          
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI--HFIPSIPDIFLSGNKLVTLPKINLTA 403

Query: 516 MRRNVSARGLQYNQIWSFPP------TIDLSLNRLDGSIWPE--FGNLKKLHVFDLKHNN 567
              ++S   L+   I  F         + L+ NR   S   +        L    L  N 
Sbjct: 404 NLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENM 462

Query: 568 LSGPIPSEL-----TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           L     +EL      G++ L+ L L++N L+   P     L+ L   S+ +N LT
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  148 bits (376), Expect = 9e-37
 Identities = 97/526 (18%), Positives = 176/526 (33%), Gaps = 45/526 (8%)

Query: 102 SESLGNLVQLRFLNLSHNLLKG-TVPVSLVNLPNLEVLDLSSNDLSGPLPQT---INLPS 157
                NL  L  L+LS N ++   +  S   L +L+ +D SSN +          +   +
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG-----------------TLSPG 200
           +    +++NSL   V     K  +  R + L +   SG                 + +  
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235

Query: 201 LGNCASLEHLCLGMNDLTGGIADDIFQLQK---LRLLGLQDNQLSGKLSPSIADLSNLVR 257
           L     +     G +++      + F       +R L L    +    S     L +L  
Sbjct: 236 LILAHHIMGAGFGFHNIKD-PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL 317
           L+++ N  +    + F GL   Q L    N        +    P +  ++L+ N +    
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 318 LLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSY 377
                 L  L +LDL  N       T +     + +I L+ N          K   + + 
Sbjct: 355 DQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV----TLPKINLTANL 405

Query: 378 LSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLR 437
           + LS + + NL   L  L +  +L  L+L  N  +            +L+ L +    L+
Sbjct: 406 IHLSENRLENLDI-LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ 464

Query: 438 GSI-----PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN- 491
            +           G S LQ++ L+ N L+   P  F     L  L L++N  T  +  N 
Sbjct: 465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND 523

Query: 492 -LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP 550
               L  L      L  P+PD  F     +     ++         I+  LN  + +I  
Sbjct: 524 LPANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECELSTFINW-LNHTNVTIAG 581

Query: 551 EFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAI 596
              ++  ++       +L             L++L  S   +    
Sbjct: 582 PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVT 627

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  112 bits (281), Expect = 2e-25
 Identities = 81/347 (23%), Positives = 132/347 (38%), Gaps = 37/347 (10%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
            +  L L   ++     E+   L  L+ LNLS+NLL      +   LP +  +DL  N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

Query: 146 SGPLPQTI-NLPSIQVLDISSN--------------SLNGSVPTSICKNSSRIRVINLSV 190
           +    QT   L  +Q LD+  N               L+G+   ++ K +    +I+LS 
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE 410

Query: 191 NYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPS 248
           N      +   L     L+ L L  N  +    D        L  L L +N L       
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

Query: 249 I-----ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTL 303
           +       LS+L  L ++ N  +   P VF+ L   + L  +SNR T    + L  +  L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPAN--L 528

Query: 304 NLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG 363
            +L++  N L   L  N     +L+ LD+  NKF          C     IN   +  + 
Sbjct: 529 EILDISRNQL---LAPNPDVFVSLSVLDITHNKFICE-------CELSTFINWLNHT-NV 577

Query: 364 QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNF 410
            I     +   +   S S  S+++LS   +   +   L +L  +L  
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLS--TEGCDEEEVLKSLKFSLFI 622

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  176 bits (448), Expect = 5e-47
 Identities = 85/507 (16%), Positives = 171/507 (33%), Gaps = 56/507 (11%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQ 159
              L     L+ L L  + +      +  +L +LE LDLS N LS  L  +    L S++
Sbjct: 43  HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLK 101

Query: 160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLT 218
            L++  N       TS+  N + ++ + +        +         SL  L +    L 
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

Query: 219 GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE 278
              +  +  ++ +  L L  ++ +  L      LS++  L++   N +            
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 279 FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN 338
              +   + R +     S +    L    L  + ++     +C  L  L   +   +   
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE---FDDCT-LNGLGDFNPSESDVV 277

Query: 339 GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQC 398
             L         ++ +++ +      +   Y   E +  +++ NS ++ +       Q  
Sbjct: 278 SELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC--SFSQHL 333

Query: 399 RNLTTLVLTLNFRNEKLPTDPRL--HFANLKVLVIASCGLR--GSIPQWLRGCSKLQLVD 454
           ++L  L L+ N   E+   +      + +L+ LV++   LR      + L     L  +D
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393

Query: 455 LSWNQLSGTIPVWFGGFQDLFYLDLSNN---TFTGEIPKNLTGLPSLITRNISLEEPSPD 511
           +S N     +P      + + +L+LS+         IP+ L  L                
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL---------------- 436

Query: 512 FPFFMRRNVSARGLQYNQIWSFPP------TIDLSLNRLDGSIWPEFGNLKKLHVFDLKH 565
                        +  N + SF         + +S N+L     P+      L V  +  
Sbjct: 437 ------------DVSNNNLDSFSLFLPRLQELYISRNKL--KTLPDASLFPVLLVMKISR 482

Query: 566 NNLSGPIPSELTGMTSLETLDLSYNNL 592
           N L          +TSL+ + L  N  
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  172 bits (437), Expect = 1e-45
 Identities = 92/517 (17%), Positives = 175/517 (33%), Gaps = 64/517 (12%)

Query: 130 VNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS 189
           ++     V D  S   +  +P  +   +++ LD+S N +   +     +  + ++V+ L 
Sbjct: 2   LSCDASGVCDGRSRSFTS-IPSGL-TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILK 58

Query: 190 VNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSG-KLS 246
            +  + T+      +  SLEHL L  N L+  ++   F  L  L+ L L  N      ++
Sbjct: 59  SSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 247 PSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNL 305
               +L+NL  L + +      I    FAGL     L   +         SL +   ++ 
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 306 LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
           L L  +     L +    L+++  L+L          + LP       +       S   
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 366 PETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN 425
            E++     L    L  S +      L  L                ++ +    ++    
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE---------SDVVSELGKVETVT 287

Query: 426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFT 485
           ++ L I    L   +        K++ + +  +++      +    + L +LDLS N   
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 486 GEIPKN---LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP------- 535
            E  KN       PSL T                        L  N + S          
Sbjct: 348 EEYLKNSACKGAWPSLQTLV----------------------LSQNHLRSMQKTGEILLT 385

Query: 536 -----TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
                ++D+S N     +       +K+   +L    +   + + +    +LE LD+S N
Sbjct: 386 LKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNN 441

Query: 591 NLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQ 627
           NL  +  + L +L  L    ++ N L   +P    F 
Sbjct: 442 NLD-SFSLFLPRLQEL---YISRNKLK-TLPDASLFP 473

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (296), Expect = 1e-27
 Identities = 70/399 (17%), Positives = 136/399 (34%), Gaps = 30/399 (7%)

Query: 70  CNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL 129
             + S +   D  G   +  L +    L+   S+SL ++  +  L L  +     + +  
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192

Query: 130 VNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS 189
             L ++  L+L   +L+      + +  +             +         ++    L 
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252

Query: 190 VNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI 249
           ++           +C          ++          +   +R L +    L   LS   
Sbjct: 253 LSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306

Query: 250 ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHS---LSNSPTLNLL 306
           + L  + R+ V ++            L   ++L    N        +       P+L  L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 307 NLRNNSL-----DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF 361
            L  N L      G +LL    L NLTSLD+  N F+ P+P +     K++ +NL+    
Sbjct: 367 VLSQNHLRSMQKTGEILLT---LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422

Query: 362 SGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL 421
              +       ++L  L +SN+++ + S  L        L  L ++ N + + LP     
Sbjct: 423 R-VVKT--CIPQTLEVLDVSNNNLDSFSLFLP------RLQELYISRN-KLKTLP--DAS 470

Query: 422 HFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
            F  L V+ I+   L+          + LQ + L  N  
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 93.6 bits (233), Expect = 7e-20
 Identities = 44/249 (17%), Positives = 81/249 (32%), Gaps = 15/249 (6%)

Query: 71  NSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV 130
           + S  +     + +  +  L + +  L   LS     L +++ + + ++ +         
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ 331

Query: 131 NLPNLEVLDLSSNDLSGPLPQT----INLPSIQVLDISSNSLNG-SVPTSICKNSSRIRV 185
           +L +LE LDLS N +     +        PS+Q L +S N L        I      +  
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391

Query: 186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKL 245
           +++S N F   +         +  L L    +   +   I   Q L +L + +N L    
Sbjct: 392 LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SF 446

Query: 246 SPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNL 305
           S     L  L  L +S N                  +    N+             +L  
Sbjct: 447 S---LFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501

Query: 306 LNLRNNSLD 314
           + L  N  D
Sbjct: 502 IWLHTNPWD 510

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  170 bits (434), Expect = 8e-46
 Identities = 93/499 (18%), Positives = 165/499 (33%), Gaps = 92/499 (18%)

Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN 187
           +   L       L   +++  + QT +L  +  L      +      SI           
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGI-----KSI----------- 61

Query: 188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP 247
                       G+    +L  +    N LT      +  L KL  + + +NQ++     
Sbjct: 62  -----------DGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIAD--IT 106

Query: 248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN 307
            +A+L+NL  L + +N  +   P     L     L   SN  +     +LS   +L  L+
Sbjct: 107 PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162

Query: 308 LRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE 367
             N   D   L N   LT L  LD+ +NK +    + L +   L+++    N  S   P 
Sbjct: 163 FGNQVTDLKPLAN---LTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP- 216

Query: 368 TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLK 427
                 +L  LSL+ + + ++ +    L    NLT L L  N +   L   P      L 
Sbjct: 217 -LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANN-QISNLA--PLSGLTKLT 268

Query: 428 VLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGE 487
            L + +  +    P  L G + L  ++L+ NQL    P      ++L YL L  N  +  
Sbjct: 269 ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI 324

Query: 488 IP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP--------TID 538
            P  +LT L  L                             N++              + 
Sbjct: 325 SPVSSLTKLQRLF-------------------------FYNNKVSDVSSLANLTNINWLS 359

Query: 539 LSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPI 598
              N++  S      NL ++    L     +    +    ++   T+      L    P 
Sbjct: 360 AGHNQI--SDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APA 415

Query: 599 SLEKLSFLSKFSVANNHLT 617
           ++      ++  +  N  +
Sbjct: 416 TISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  168 bits (428), Expect = 6e-45
 Identities = 100/516 (19%), Positives = 166/516 (32%), Gaps = 122/516 (23%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
            +   L +     L    +  TV  +  +L  +  L      +   +     L ++  ++
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQIN 74

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA 222
            S+N L     T I                        L N   L  + +  N +     
Sbjct: 75  FSNNQL-----TDI----------------------TPLKNLTKLVDILMNNNQIAD--I 105

Query: 223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
             +  L  L  L L +NQ++      + +L+NL RL++SSN  S                
Sbjct: 106 TPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--------------- 148

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP 342
                        +LS   +L  L+  N   D   L N   LT L  LD+ +NK +    
Sbjct: 149 -----------ISALSGLTSLQQLSFGNQVTDLKPLAN---LTTLERLDISSNKVSD--I 192

Query: 343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT 402
           + L +   L+++    N  S   P       +L  LSL+ + + ++ +    L    NLT
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLT 246

Query: 403 TLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG 462
            L L  N +   L   P      L  L + +  +    P  L G + L  ++L+ NQL  
Sbjct: 247 DLDLANN-QISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301

Query: 463 TIPVWFGGFQDLFYLDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVS 521
             P      ++L YL L  N  +   P  +LT L  L                       
Sbjct: 302 ISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLF---------------------- 337

Query: 522 ARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTS 581
                 N++                S      NL  ++     HN +S   P  L  +T 
Sbjct: 338 ---FYNNKV----------------SDVSSLANLTNINWLSAGHNQISDLTP--LANLTR 376

Query: 582 LETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           +  L L+    + A       +S  +        L 
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  153 bits (390), Expect = 5e-40
 Identities = 94/456 (20%), Positives = 161/456 (35%), Gaps = 67/456 (14%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
           + +  L  L  +N S+N L    P+   NL  L  + +++N ++   P   NL ++  L 
Sbjct: 62  DGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLA-NLTNLTGLT 118

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA 222
           + +N +                                L N  +L  L L  N ++    
Sbjct: 119 LFNNQITD---------------------------IDPLKNLTNLNRLELSSNTISD--I 149

Query: 223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
             +  L  L+ L   +          +A+L+ L RLD+SSN  S     V A L   + L
Sbjct: 150 SALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 204

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDG-SLLLNCPALTNLTSLDLGTNKFNGPL 341
           +A +N+ +   P  L     L+ L+L  N L     L +   LTNLT LDL  N+ +   
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLAS---LTNLTDLDLANNQISN-- 257

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNL 401
              L    KL  + L  N  S   P       +L+ L L+ + + ++S     +   +NL
Sbjct: 258 LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP----ISNLKNL 311

Query: 402 TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
           T L L  N  ++  P         L+ L   +  +  S    L   + +  +    NQ+S
Sbjct: 312 TYLTLYFNNISDISPVS---SLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQIS 366

Query: 462 GTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVS 521
              P        +  L L++  +T         +    T                  + +
Sbjct: 367 DLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYT 424

Query: 522 ARGLQYNQI---------WSFPPTIDLSLNRLDGSI 548
              + +N           +S P TI        G++
Sbjct: 425 EPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  146 bits (370), Expect = 2e-37
 Identities = 96/408 (23%), Positives = 157/408 (38%), Gaps = 35/408 (8%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG 147
             + +   ++       L NL  L  L L +N +    P  L NL NL  L+LSSN +S 
Sbjct: 93  VDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148

Query: 148 PLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASL 207
               +  L S+Q L    N +    P +       +  +++S N  S      L    +L
Sbjct: 149 ISALS-GLTSLQQLSFG-NQVTDLKPLANLTT---LERLDISSNKVSDI--SVLAKLTNL 201

Query: 208 EHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG 267
           E L    N ++      +  L  L  L L  NQL      ++A L+NL  LD+++N  S 
Sbjct: 202 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNL 327
             P   +GL +   L   +N+ +   P  L+    L  L L  N L+   +     L NL
Sbjct: 258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNL 311

Query: 328 TSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN 387
           T L L  N  +   P  +    KL+ +    N  S     +  N  ++++LS  ++ I +
Sbjct: 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD 367

Query: 388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVL-VIASCGLRGSIPQWLRG 446
           L+     L     +T L L            P  + AN+ +   + +       P  +  
Sbjct: 368 LTP----LANLTRITQLGLNDQ----AWTNAPVNYKANVSIPNTVKNVTGALIAPATISD 419

Query: 447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTG 494
                  D++WN  S T  V +  F     +     TF+G + + L  
Sbjct: 420 GGSYTEPDITWNLPSYTNEVSYT-FSQPVTIGKGTTTFSGTVTQPLKA 466

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  152 bits (385), Expect = 4e-41
 Identities = 62/272 (22%), Positives = 105/272 (38%), Gaps = 32/272 (11%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
             IG G F  VY+         VA    +         + F+ E E L   QHPN+V    
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 806  YCMH---KNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
                       +++ +  M +G+L       L     +         +   +GL +LH +
Sbjct: 93   SWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147

Query: 862  CEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
              P I+HRD+K  NI + G  G   + D GLA L            ++GT  ++ PE  +
Sbjct: 148  RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYE 203

Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
                    DVY+FG+ +LE+ T + P   C+   +  +   V    +     +V  P + 
Sbjct: 204  EK-YDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKPASFDKVAIPEV- 259

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                 KE++        C+ ++   R + + L
Sbjct: 260  -----KEIIE------GCIRQNKDERYSIKDL 280

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  152 bits (386), Expect = 2e-40
 Identities = 60/381 (15%), Positives = 138/381 (36%), Gaps = 54/381 (14%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
               +L +     L    +   V      L ++  L ++   ++  +     L +++ L+
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVAS-IQGIEYLTNLEYLN 72

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA 222
           ++ N +                                L N   L +L +G N +T    
Sbjct: 73  LNGNQITD---------------------------ISPLSNLVKLTNLYIGTNKIT--DI 103

Query: 223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
             +  L  LR L L ++ +S      +A+L+ +  L++ +N+   ++    + +    YL
Sbjct: 104 SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYL 160

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP 342
               ++     P  ++N   L  L+L  N ++   +    +LT+L       N+      
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--I 214

Query: 343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT 402
           T +    +L ++ +  N  +   P    N   L++L +  + I ++++    ++    L 
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA----VKDLTKLK 268

Query: 403 TLVLTLNFRNEKLPTDPRL-HFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
            L +  N    ++     L + + L  L + +  L     + + G + L  + LS N ++
Sbjct: 269 MLNVGSN----QISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324

Query: 462 GTIPVWFGGFQDLFYLDLSNN 482
              P        +   D +N 
Sbjct: 325 DIRP--LASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  141 bits (357), Expect = 9e-37
 Identities = 73/392 (18%), Positives = 140/392 (35%), Gaps = 66/392 (16%)

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
            L +     LQ   ++     +  +L ++ +L V+    + +I      L   +YL  + 
Sbjct: 20  DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNG 75

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
           N+ T   P  LSN   L  L +  N +  + +     LTNL  L L  +  +    + L 
Sbjct: 76  NQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDI--SPLA 129

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
              K+ ++NL  N+          N   L+YL+++ S + +++     +    +L +L L
Sbjct: 130 NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP----IANLTDLYSLSL 184

Query: 407 TLNFRNEKLPTDPRL-HFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
             N    ++     L    +L         +    P  +   ++L  + +  N+++   P
Sbjct: 185 NYN----QIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238

Query: 466 VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGL 525
                   L +L++  N  +      +  L  L   N+                      
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVG--------------------- 273

Query: 526 QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETL 585
             NQI                       NL +L+   L +N L       + G+T+L TL
Sbjct: 274 -SNQISDISV----------------LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 586 DLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
            LS N+++   P++   LS +     AN  + 
Sbjct: 317 FLSQNHITDIRPLA--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  129 bits (327), Expect = 8e-33
 Identities = 56/295 (18%), Positives = 116/295 (39%), Gaps = 21/295 (7%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG 147
             L L   ++       L NLV+L  L +  N +  T   +L NL NL  L L+ +++S 
Sbjct: 69  EYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD 124

Query: 148 PLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASL 207
            +    NL  +  L++ +N    S  + +   +  +  + ++ +         + N   L
Sbjct: 125 -ISPLANLTKMYSLNLGANHN-LSDLSPLSNMTG-LNYLTVTESKVKD--VTPIANLTDL 179

Query: 208 EHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG 267
             L L  N +       +  L  L       NQ++      +A+++ L  L + +N  + 
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD 235

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNL 327
             P   A L +  +L   +N+ +    +++ +   L +LN+ +N +    +     L+ L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289

Query: 328 TSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
            SL L  N+        +     L  + L++N+ +   P    +   +     +N
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (305), Expect = 7e-30
 Identities = 60/260 (23%), Positives = 107/260 (41%), Gaps = 17/260 (6%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
            +L NL  LR L L+ + +    P  L NL  +  L+L +N     L    N+  +  L 
Sbjct: 104 SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLT 161

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA 222
           ++ + +    P +   +   +  ++L+ N         L +  SL +    +N +T    
Sbjct: 162 VTESKVKDVTPIANLTD---LYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216

Query: 223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
             +  + +L  L + +N+++      +A+LS L  L++ +N  S    +    L + + L
Sbjct: 217 --VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP 342
              SN+ +      L+N   LN L L NN L    +     LTNLT+L L  N      P
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

Query: 343 TNLPRCRKLKNINLARNNFS 362
             L    K+ + + A     
Sbjct: 329 --LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.8 bits (247), Expect = 2e-22
 Identities = 45/295 (15%), Positives = 96/295 (32%), Gaps = 58/295 (19%)

Query: 327 LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY 386
             +L       N   P       +     L + + +     T +  ES++ L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 387 NLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRG 446
           ++      ++   NL  L L  N +   +   P  +   L  L I +  +  +    L+ 
Sbjct: 58  SIQG----IEYLTNLEYLNLNGN-QITDIS--PLSNLVKLTNLYIGTNKI--TDISALQN 108

Query: 447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLE 506
            + L+ + L+ + +S   P        ++ L+L  N         L+ +  L    ++  
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVT-- 163

Query: 507 EPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHN 566
                                +++    P                  NL  L+   L +N
Sbjct: 164 --------------------ESKVKDVTP----------------IANLTDLYSLSLNYN 187

Query: 567 NLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP 621
            +    P  L  +TSL       N ++   P++   ++ L+   + NN +T   P
Sbjct: 188 QIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.3 bits (103), Expect = 3e-04
 Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 2/59 (3%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
             LFL   +L  +  E +G L  L  L LS N +    P  L +L  ++  D ++  + 
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  153 bits (390), Expect = 3e-40
 Identities = 100/532 (18%), Positives = 175/532 (32%), Gaps = 98/532 (18%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
              +   L  ++     N+        + +  +   P        + V  L         
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC------ 68

Query: 150 PQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEH 209
                      L++++  L+ S+P         +  +  S N  +  L     +  SL  
Sbjct: 69  ----LDRQAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLKSLLV 118

Query: 210 LCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNI 269
               +  L+            L  LG+ +NQL     P + + S L  +DV +N+    +
Sbjct: 119 DNNNLKALSD-------LPPLLEYLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KL 168

Query: 270 PDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTS 329
           PD+   L   +++ A +N+        L N P L  +   NNSL   L        +L S
Sbjct: 169 PDLPPSL---EFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KL---PDLPLSLES 219

Query: 330 LDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLS 389
           +  G N         L     L  I    N     +P+      SL  L++ ++ + +L 
Sbjct: 220 IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLP 273

Query: 390 SALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSK 449
              Q      +LT L ++ N  +  L   P     NL  L  +S  +R S+         
Sbjct: 274 ELPQ------SLTFLDVSENIFS-GLSELP----PNLYYLNASSNEIR-SLCDLP---PS 318

Query: 450 LQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPS 509
           L+ +++S N+L   +P        L  L  S N        +L  +P L      L    
Sbjct: 319 LEELNVSNNKLI-ELPALPPR---LERLIASFN--------HLAEVPELPQNLKQLH--- 363

Query: 510 PDFPFFMRRNVSARGLQYNQIWSFPPTI----DLSLNRLDGSIWPEFGNLKKLHVFDLKH 565
                          ++YN +  FP       DL +N     +     NLK+L    ++ 
Sbjct: 364 ---------------VEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQL---HVET 405

Query: 566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           N L    P       S+E L ++   +      + E    L      ++H  
Sbjct: 406 NPLRE-FPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  102 bits (257), Expect = 4e-23
 Identities = 74/398 (18%), Positives = 112/398 (28%), Gaps = 106/398 (26%)

Query: 225 IFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
                 L+      + L+ ++     ++ +      + + +  N P       E      
Sbjct: 7   NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS-- 63

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN 344
                  R+   L      + L L N  L  SL        +L SL    N     LP  
Sbjct: 64  -------RLRDCLDRQ--AHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPEL 109

Query: 345 LPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTL 404
               + L   N      S   P        L YL +SN+ +  L      LQ    L  +
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEKLPE----LQNSSFLKII 158

Query: 405 VLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTI 464
            +  N               +LK            +P        L+ +    NQL   +
Sbjct: 159 DVDNN---------------SLK-----------KLPDLP---PSLEFIAAGNNQLE-EL 188

Query: 465 PVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARG 524
           P        L  +   NN        +L  LP L     SLE                  
Sbjct: 189 PE-LQNLPFLTAIYADNN--------SLKKLPDLPL---SLES----------------- 219

Query: 525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLET 584
                       I    N L     PE  NL  L      +N L   +P       SLE 
Sbjct: 220 ------------IVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEA 261

Query: 585 LDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS 622
           L++  N L+  +P   + L+FL       + L+   P+
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (379), Expect = 2e-39
 Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 54/319 (16%)

Query: 716  ELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRL 774
            + G  L       +  ++ +D+            IG G FG V+   L  D   VA+K  
Sbjct: 95   KSGVVLHRAVPKDKWVLNHEDL-------VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC 147

Query: 775  SGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKL 833
                    + +F  E   L +  HPN+V L G C  K    ++   ++ G    +L  + 
Sbjct: 148  RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE- 206

Query: 834  DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR 893
               + L   + L +   AA G+ YL        +HRD+ + N L+       ++DFG++R
Sbjct: 207  --GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR 261

Query: 894  LILSPYDTHVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP- 946
                  D        G L  +P     PE       + + DV+SFG++L E  + G  P 
Sbjct: 262  EE---ADGVYAAS--GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

Query: 947  --MDMCKPKGSRDLISWVI---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE 1001
              +       ++    +V    R+       E+    ++       M +       C + 
Sbjct: 317  PNLS------NQQTREFVEKGGRLPC----PELCPDAVFRL-----MEQ-------CWAY 354

Query: 1002 SPKVRPTTQQLVSWLDSII 1020
             P  RP+   +   L SI 
Sbjct: 355  EPGQRPSFSTIYQELQSIR 373

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  143 bits (363), Expect = 6e-38
 Identities = 70/209 (33%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 750 IGCGGFGLVYRATLPD---GRNVAIK----RLSGDCGQMEREFRAEVEALSRAQHPNLV- 801
           +G GG G VY A   D    R VA+K     LS D     R  + E     R Q P++V 
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVP 98

Query: 802 -HLQGYCMHKNDRLLIYSFME--NG-SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            H  G     + +L  Y  M   NG  L   L     GP  L     + I +     L  
Sbjct: 99  IHDFG---EIDGQL--YVDMRLINGVDLAAMLRR--QGP--LAPPRAVAIVRQIGSALDA 149

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            H +      HRD+K  NIL+  +  A+L DFG+A        T    + VGTL Y+ PE
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPE 205

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRP 946
               S ATY+ D+Y+   VL E LTG  P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (361), Expect = 8e-38
 Identities = 81/292 (27%), Positives = 117/292 (40%), Gaps = 51/292 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
             +IG G FG+VY     D        AIK LS      +   F  E   +    HPN++ 
Sbjct: 27   RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 803  LQGYCMHKNDRLLI-YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L G  +       +   +M +G L  ++      P+  D    +      ARG+ YL + 
Sbjct: 87   LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLAEQ 143

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
                 +HRD+ + N +LD +F   +ADFGLAR I    D    +        +P      
Sbjct: 144  ---KFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTAL 197

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-E 968
            E  Q    T K DV+SFGV+L ELLT G  P   +D        DL  ++    R+ Q E
Sbjct: 198  ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID------PFDLTHFLAQGRRLPQPE 251

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                      +Y       M +       C    P VRPT + LV  ++ I+
Sbjct: 252  YCPDS-----LYQV-----MQQ-------CWEADPAVRPTFRVLVGEVEQIV 286

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (360), Expect = 1e-37
 Identities = 65/297 (21%), Positives = 113/297 (38%), Gaps = 50/297 (16%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA---EVEALSRAQH 797
             +F+    +G GGFG+V+ A    D  N AIKR+       E        EV+AL++ +H
Sbjct: 5    TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62

Query: 798  PNLVHLQGYCMHKN---------DRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRL 845
            P +V      + KN          ++ +Y  M+     +L  W++ +       +    L
Sbjct: 63   PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCL 121

Query: 846  HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT- 904
            HI    A  + +LH      ++HRD+K SNI    +    + DFGL   +    +     
Sbjct: 122  HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 905  ---------TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
                     T  VGT  Y+ PE    +  ++K D++S G++L E         +  P  +
Sbjct: 179  TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE---------LLYPFST 229

Query: 956  RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            +      +   +  +   +       +           +    LS SP  RP    +
Sbjct: 230  QMERVRTLTDVRNLKFPPLFTQKYPCEY---------VMVQDMLSPSPMERPEAINI 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  150 bits (380), Expect = 1e-37
 Identities = 52/207 (25%), Positives = 73/207 (35%), Gaps = 29/207 (14%)

Query: 750 IGCGGFGLVYRA--TLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPNLV--HL 803
           I  GG G +Y A     +GR V +K    SGD         AE + L+   HP++V    
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFN 146

Query: 804 QGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
                 ++   + Y  ME   G     L         L     +         L+YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQS---LKRSKGQK--LPVAEAIAYLLEILPALSYLHSI 201

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YG 919
               +++ D+K  NI+L       L D G    I           L GT G+  PE    
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NS-FGYLYGTPGFQAPEIVRT 251

Query: 920 QASVATYKGDVYSFGVVLLELLTGKRP 946
             +VAT   D+Y+ G  L  L      
Sbjct: 252 GPTVAT---DIYTVGRTLAALTLDLPT 275

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  141 bits (358), Expect = 2e-37
 Identities = 80/292 (27%), Positives = 128/292 (43%), Gaps = 51/292 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVH 802
             +IG G FG VY  TL D        A+K L+      E  +F  E   +    HPN++ 
Sbjct: 31   EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 803  LQGYCMHKND-RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L G C+      L++  +M++G L  ++  +   P+  D    +      A+G+ YL   
Sbjct: 91   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLA-- 145

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
                 +HRD+ + N +LD  F   +ADFGLAR +   YD    +    T   +P      
Sbjct: 146  -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMAL 201

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-E 968
            E  Q    T K DV+SFGV+L EL+T G  P   ++      + D+  +++   R+ Q E
Sbjct: 202  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLLQPE 255

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                      +Y+      ML+       C     ++RP+  +LVS + +I 
Sbjct: 256  YCPDP-----LYEV-----MLK-------CWHPKAEMRPSFSELVSRISAIF 290

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  143 bits (363), Expect = 2e-37
 Identities = 93/381 (24%), Positives = 153/381 (40%), Gaps = 59/381 (15%)

Query: 660  KKSRRNKYTIVGMAIGI-TFGSAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELG 718
               RR      G+ +   + G   +  +  +        G  +   + ANT   DL  L 
Sbjct: 13   HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 719  SKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN----VAIKRL 774
             +LV    +     S   +           +IG G FG VY  TL D        A+K L
Sbjct: 73   PELVQAVQHVVIGPSSLIV-------HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125

Query: 775  SGDCGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKND-RLLIYSFMENGSLDYWLHEK 832
            +      E  +F  E   +    HPN++ L G C+      L++  +M++G L  ++  +
Sbjct: 126  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185

Query: 833  LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA 892
               P+  D    +      A+G+ +L        +HRD+ + N +LD  F   +ADFGLA
Sbjct: 186  THNPTVKD---LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 239

Query: 893  RLILSPYDTHVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            R +   YD    +    T   +P      E  Q    T K DV+SFGV+L EL+T G  P
Sbjct: 240  RDM---YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

Query: 947  ---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCL 999
               ++      + D+  +++   R+ Q E          +Y+      ML+       C 
Sbjct: 297  YPDVN------TFDITVYLLQGRRLLQPEYCPDP-----LYEV-----MLK-------CW 333

Query: 1000 SESPKVRPTTQQLVSWLDSII 1020
                ++RP+  +LVS + +I 
Sbjct: 334  HPKAEMRPSFSELVSRISAIF 354

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (355), Expect = 4e-37
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 49/282 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPN 799
            +F +  +IG GGFG V++A    DG+   IKR+     +   E    EV+AL++  H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVN 65

Query: 800 LVHLQGY-------------CMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDS 843
           +VH  G                 ++    ++  ME    G+L+ W+ ++      LD   
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVL 123

Query: 844 RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
            L + +   +G+ Y+H      +++RD+K SNI L       + DFGL    L       
Sbjct: 124 ALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVT-SLKNDGKRT 179

Query: 904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCK-----PKGS-- 955
            +   GTL Y+ PE   +     + D+Y+ G++L ELL       +  K       G   
Sbjct: 180 RS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIIS 237

Query: 956 -------RDLISWVIRMRQENRES--EVLD-PFIYDKQHDKE 987
                  + L+  ++  + E+R +  E+L    ++ K  +K 
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  140 bits (355), Expect = 4e-37
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 36/213 (16%)

Query: 750 IGCGGFGLVYRATLPD---GRNVAIK----RLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
           +G GG   VY A   D      VAIK            ++R F  EV   S+  H N+V 
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVS 75

Query: 803 LQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS---------SLDWDSRLHIAQGAAR 853
                        +    E     Y + E ++GP+          L  D+ ++       
Sbjct: 76  -------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           G+ + H      I+HRDIK  NIL+D N    + DFG+A+ +     T  T  ++GT+ Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQY 178

Query: 914 IPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
             PE  +        D+YS G+VL E+L G+ P
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (355), Expect = 7e-37
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 24/276 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREF-RAEVEALSRAQH 797
             NF     IG G F  VYRA  L DG  VA+K  ++        R     E++ L +  H
Sbjct: 32   ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 798  PNLVHLQGYCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            PN++      +  ++ L I     + G L   +         +   +           L 
Sbjct: 92   PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            ++H      ++HRDIK +N+ +       L D GL R   S         LVGT  Y+ P
Sbjct: 151  HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSP 205

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
            E    +   +K D++S G +L E+   + P          +L S   ++ Q +     L 
Sbjct: 206  ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCDYPP--LP 259

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               Y ++     LR   +  +C++  P+ RP    +
Sbjct: 260  SDHYSEE-----LR--QLVNMCINPDPEKRPDVTYV 288

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (355), Expect = 9e-37
 Identities = 69/295 (23%), Positives = 116/295 (39%), Gaps = 38/295 (12%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQME--REFRAEVEALSRAQHPN 799
            ++     +G GGF  V     L DG   A+KR+   C + +   E + E +      HPN
Sbjct: 30   HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPN 87

Query: 800  LVHLQGYCMHKNDR----LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            ++ L  YC+ +        L+  F + G+L   +    D  + L  D  L +  G  RGL
Sbjct: 88   ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV------- 908
              +H        HRD+K +NILL       L D G         +       +       
Sbjct: 148  EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 909  GTLGYIPPE----YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
             T+ Y  PE         +   + DV+S G VL  ++ G+ P DM   KG  D ++  ++
Sbjct: 205  CTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQ 261

Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
             +                +H   + ++L+     ++  P  RP    L+S L+++
Sbjct: 262  NQL---------SIPQSPRHSSALWQLLNS---MMTVDPHQRPHIPLLLSQLEAL 304

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (354), Expect = 9e-37
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 750 IGCGGFGLVYRATLPD---GRNVAIK----RLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
           +G GG   V+ A   D    R+VA+K     L+ D     R FR E +  +   HP +V 
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76

Query: 803 L--QGYCMHKNDRLLIYSFME--NG-SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           +   G         L Y  ME  +G +L   +H +  GP  +     + +   A + L +
Sbjct: 77  VYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE--GP--MTPKRAIEVIADACQALNF 131

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV-GTLGYIPP 916
            HQ+    I+HRD+K +NI++       + DFG+AR I    ++   T  V GT  Y+ P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           E  +      + DVYS G VL E+LTG+ P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (345), Expect = 7e-36
 Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 31/281 (11%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM---EREF-RAEVEALSRAQ 796
             +++    IG G +G   +     DG+ +  K L  D G M   E++   +EV  L   +
Sbjct: 6    EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 63

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            HPN+V      + + +  L Y  ME    G L   + +       LD +  L +      
Sbjct: 64   HPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 854  GLAYLHQSCEP--HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             L   H+  +    +LHRD+K +N+ LDG     L DFGLAR++    DT      VGT 
Sbjct: 123  ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180

Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
             Y+ PE         K D++S G +L EL     P        +        ++R+    
Sbjct: 181  YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFR 234

Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                 P+ Y  +     L   +I    L+     RP+ +++
Sbjct: 235  R---IPYRYSDE-----LN--EIITRMLNLKDYHRPSVEEI 265

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  139 bits (351), Expect = 7e-36
 Identities = 28/304 (9%), Positives = 64/304 (21%), Gaps = 52/304 (17%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRLSGD---CGQMEREFRAEVEALSRAQHPNLVHLQ 804
             +  G   +V+    +    + A+K  +                  A +R    +    +
Sbjct: 69   PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 805  GYC--------------------------MHKNDRLLIYSFM--ENGSLDYWLHEKLDGP 836
                                             + LL+      +   L   L       
Sbjct: 129  DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 837  SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
                  +   +     R  A L       ++H      N+ +  +    L D        
Sbjct: 189  GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 897  SPYDTHVTTDLVGTLGYIPPEY--GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
                          + Y P E+     +  T+  + +  G+ +  +     P  +  P  
Sbjct: 243  --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV- 1013
                     +             F            V  +    L+   + R    + + 
Sbjct: 301  KGS-----WKRPSLRVPGTDSLAFGSCTPLPDF---VKTLIGRFLNFDRRRRLLPLEAME 352

Query: 1014 -SWL 1016
                
Sbjct: 353  TPEF 356

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (351), Expect = 1e-35
 Identities = 86/314 (27%), Positives = 138/314 (43%), Gaps = 60/314 (19%)

Query: 726  HNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATL--PDGRN--VAIKRLSGDCGQ 780
            H   KE+   +I ++         ++G G FG V    L  P  +   VAIK L     +
Sbjct: 36   HEFAKELDATNISID--------KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87

Query: 781  MER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
             +R +F  E   + +  HPN++ L+G        +++  +MENGSLD +L +     +  
Sbjct: 88   KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQF 144

Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                 + + +G A G+ YL        +HRD+ + NIL++ N    ++DFGL R++    
Sbjct: 145  TVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

Query: 900  DTHVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP-MDMCKP 952
            +   TT      G IP     PE       T   DV+S+G+VL E+++ G+RP  +M   
Sbjct: 202  EAAYTT----RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--- 254

Query: 953  KGSRDLISWVIRMRQENRESEVLDP------FIYDKQHDKEMLRVLDIACLCLSESPKVR 1006
              ++D+I  V        E   L P       +Y       ML        C  +    R
Sbjct: 255  -SNQDVIKAV-------DEGYRLPPPMDCPAALYQL-----MLD-------CWQKDRNNR 294

Query: 1007 PTTQQLVSWLDSII 1020
            P  +Q+VS LD +I
Sbjct: 295  PKFEQIVSILDKLI 308

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (343), Expect = 1e-35
 Identities = 74/312 (23%), Positives = 126/312 (40%), Gaps = 64/312 (20%)

Query: 724  LFHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME 782
             F+     +++ ++ L           IG G FG V       G  VA+K +  D     
Sbjct: 10   EFYRSGWALNMKELKLL--------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TA 58

Query: 783  REFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDW 841
            + F AE   +++ +H NLV L G  + +   L I + +M  GSL  +L  +  G S L  
Sbjct: 59   QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGG 116

Query: 842  DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT 901
            D  L  +      + YL  +   + +HRD+ + N+L+  +  A ++DFGL +       T
Sbjct: 117  DCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SST 170

Query: 902  HVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKP 952
                      G +P     PE  +    + K DV+SFG++L E+ + G+ P   +     
Sbjct: 171  Q-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---- 219

Query: 953  KGSRDLISWVI---RM-RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
               +D++  V    +M   +        P +Y+      M         C      +RP+
Sbjct: 220  --LKDVVPRVEKGYKMDAPDG-----CPPAVYEV-----MKN-------CWHLDAAMRPS 260

Query: 1009 TQQLVSWLDSII 1020
              QL   L+ I 
Sbjct: 261  FLQLREQLEHIK 272

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (347), Expect = 1e-35
 Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 50/290 (17%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
             ++G G FG VY+    P+G      VAIK L          E   E   ++   +P++ 
Sbjct: 21   KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L G C+  +   LI   M  G L  ++ E  D   S      L+     A+G+ YL   
Sbjct: 81   RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLE-- 134

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
             +  ++HRD+ + N+L+       + DFGLA+L+ +    +         G +P      
Sbjct: 135  -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E     + T++ DV+S+GV + EL+T G +P D         ++    R+ Q        
Sbjct: 189  ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-------- 240

Query: 976  DPF-----IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             P      +Y       M +       C       RP  ++L+     + 
Sbjct: 241  -PPICTIDVYMI-----MRK-------CWMIDADSRPKFRELIIEFSKMA 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  137 bits (346), Expect = 2e-35
 Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 55/301 (18%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            + +G G FG V      P G N    VA+K+L       +R+F+ E++ L       +V 
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 803  LQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             +G       +   L+  ++ +G L  +L       + LD    L  +    +G+ YL  
Sbjct: 89   YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG- 144

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP----- 915
                  +HRD+ + NIL++      +ADFGLA+L+    D +V        G  P     
Sbjct: 145  --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYA 198

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
            PE    ++ + + DV+SFGVVL EL T   +    C P      +    R         +
Sbjct: 199  PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEFLRMMGCERDVPALS--RL 253

Query: 975  LD---------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            L+                 +++      M         C + SP+ RP+   L   LD +
Sbjct: 254  LELLEEGQRLPAPPACPAEVHEL-----MKL-------CWAPSPQDRPSFSALGPQLDML 301

Query: 1020 I 1020
             
Sbjct: 302  W 302

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  137 bits (347), Expect = 2e-35
 Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 30/276 (10%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQM---EREF-RAEVEALSRAQ 796
              + +   IG G FG         DGR   IK +  +  +M   ERE  R EV  L+  +
Sbjct: 24   EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMK 81

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            HPN+V  +          ++  + E G L   ++ +         D  L         L 
Sbjct: 82   HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALK 139

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            ++H   +  ILHRDIKS NI L  +    L DFG+AR++ S     +    +GT  Y+ P
Sbjct: 140  HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSP 194

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
            E  +      K D+++ G VL EL T K   +      +  + + V+++   +       
Sbjct: 195  EICENKPYNNKSDIWALGCVLYELCTLKHAFE------AGSMKNLVLKIISGSFPP---V 245

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               Y        LR   +       +P+ RP+   +
Sbjct: 246  SLHYSYD-----LR--SLVSQLFKRNPRDRPSVNSI 274

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 3e-35
 Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 54/301 (17%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
              +G G FG V      P+G N    VA+K L  + G     + + E+E L    H N+V
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 802  HLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
              +G C         LI  F+ +GSL  +L +     + ++   +L  A    +G+ YL 
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLG 143

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP---- 915
                   +HRD+ + N+L++      + DFGL + I +  + +            P    
Sbjct: 144  ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWY 196

Query: 916  -PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
             PE    S      DV+SFGV L ELLT             + +     +M        +
Sbjct: 197  APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RL 252

Query: 975  LD---------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            ++                 +Y       M +       C    P  R + Q L+   +++
Sbjct: 253  VNTLKEGKRLPCPPNCPDEVYQL-----MRK-------CWEFQPSNRTSFQNLIEGFEAL 300

Query: 1020 I 1020
            +
Sbjct: 301  L 301

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (342), Expect = 6e-35
 Identities = 92/314 (29%), Positives = 139/314 (44%), Gaps = 60/314 (19%)

Query: 726  HNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATL--PDGRN--VAIKRLSGDCGQ 780
             +  +EI    I +E         IIG G  G V    L  P  R+  VAIK L     +
Sbjct: 40   RSFTREIEASRIHIE--------KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91

Query: 781  MER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
             +R +F +E   + +  HPN++ L+G        +++  +MENGSLD +L          
Sbjct: 92   RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQF 148

Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                 + + +G   G+ YL        +HRD+ + N+L+D N    ++DFGL+R++    
Sbjct: 149  TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

Query: 900  DTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP-MDM 949
            D   TT    T G IP     PE   +   S A+   DV+SFGVV+ E+L  G+RP  +M
Sbjct: 206  DAAYTT----TGGKIPIRWTAPEAIAFRTFSSAS---DVWSFGVVMWEVLAYGERPYWNM 258

Query: 950  CKPKGSRDLISWVI---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR 1006
                 +RD+IS V    R+         L    +       ML        C  +    R
Sbjct: 259  ----TNRDVISSVEEGYRLPAPMGCPHAL----HQL-----MLD-------CWHKDRAQR 298

Query: 1007 PTTQQLVSWLDSII 1020
            P   Q+VS LD++I
Sbjct: 299  PRFSQIVSVLDALI 312

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (341), Expect = 7e-35
 Identities = 80/312 (25%), Positives = 134/312 (42%), Gaps = 55/312 (17%)

Query: 726  HNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATL--PDGRN---VAIKRLSGDCG 779
                 EI    +  +         +IG G FG VY+  L    G+    VAIK L     
Sbjct: 35   LKFTTEIHPSCVTRQ--------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86

Query: 780  QMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS 838
            + +R +F  E   + +  H N++ L+G        ++I  +MENG+LD +L E       
Sbjct: 87   EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGE 143

Query: 839  LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
                  + + +G A G+ YL      + +HRD+ + NIL++ N    ++DFGL+R++   
Sbjct: 144  FSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

Query: 899  YDTHVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP-MDMCK 951
             +   TT   G  G IP     PE       T   DV+SFG+V+ E++T G+RP  ++  
Sbjct: 201  PEATYTTS--G--GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-- 254

Query: 952  PKGSRDLISWVI---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
               + +++  +    R+         +    Y       M++       C  +    RP 
Sbjct: 255  --SNHEVMKAINDGFRLPTPMDCPSAI----YQL-----MMQ-------CWQQERARRPK 296

Query: 1009 TQQLVSWLDSII 1020
               +VS LD +I
Sbjct: 297  FADIVSILDKLI 308

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  134 bits (339), Expect = 7e-35
 Identities = 62/305 (20%), Positives = 108/305 (35%), Gaps = 61/305 (20%)

Query: 741  TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN 799
             ++F++  ++G G FG V +A    D R  AIK++     ++      EV  L+   H  
Sbjct: 5    ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63

Query: 800  LVHLQGYCMHKNDRLL----------IYSFME---NGSLDYWLHEKLDGPSSLDWDSRLH 846
            +V      + + + +           ++  ME   NG+L   +H +     +   D    
Sbjct: 64   VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWR 120

Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-- 904
            + +     L+Y+H      I+HRD+K  NI +D +    + DFGLA+ +    D      
Sbjct: 121  LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 905  ----------TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
                      T  +GT  Y+  E       Y +        D+YS G++  E++      
Sbjct: 178  QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI------DMYSLGIIFFEMIYP---- 227

Query: 948  DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007
                    R  I   +R           D      +          I  L +   P  RP
Sbjct: 228  --FSTGMERVNILKKLR-SVSIEFPPDFDDNKMKVEK--------KIIRLLIDHDPNKRP 276

Query: 1008 TTQQL 1012
              + L
Sbjct: 277  GARTL 281

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  138 bits (350), Expect = 7e-35
 Identities = 62/414 (14%), Positives = 128/414 (30%), Gaps = 39/414 (9%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
           R     +    LK  L+    +   ++ L+LS N L       L     LE+L+LSSN L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 146 SGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA 205
                   +L +++ LD+++N +       +      I  ++ + N  S  +S   G   
Sbjct: 71  YE-TLDLESLSTLRTLDLNNNYV-----QEL-LVGPSIETLHAANNNIS-RVSCSRGQ-- 120

Query: 206 SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNN 264
             +++ L  N +T     D     +++ L L+ N++     +   A    L  L++  N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPAL 324
              ++        + + L   SN+    +     ++  +  ++LRNN L   +       
Sbjct: 181 IY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS 384
            NL   DL  N F+     +    +  +   +A+        +  +     +        
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295

Query: 385 IYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL 444
             +L +      +   L      L                               +    
Sbjct: 296 CEDLPAPF--ADRLIALKRKEHALLSGQGSETE---------------------RLECER 332

Query: 445 RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL 498
              ++ + +D    Q    I       Q    L+        ++         L
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  131 bits (331), Expect = 2e-32
 Identities = 66/400 (16%), Positives = 116/400 (29%), Gaps = 31/400 (7%)

Query: 220 GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF 279
            I +      + ++  + D+ L   L+       N+  LD+S N  S       A   + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 280 QYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG 339
           + L   SN         L +  TL  L+L NN +   L        ++ +L    N  + 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-QEL----LVGPSIETLHAANNNISR 113

Query: 340 PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCR 399
            +  +    +  KNI LA N  +            + YL L  + I  ++ A ++     
Sbjct: 114 -VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAASSD 169

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ 459
            L  L L  N     +          LK L ++S  L   +    +  + +  + L  N+
Sbjct: 170 TLEHLNLQYN-FIYDVKGQVVFA--KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 460 LSGTIPVWFGGFQDLFYLDLSNNTF-TGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRR 518
           L   I       Q+L + DL  N F  G +    +    + T      +           
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 519 NVSARGLQYNQIWSFPPTIDLSLNRLD--------------GSIWPEFGNLKKLHVFDLK 564
             +            P      L  L                 +  E  N  +    D  
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 565 HNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLS 604
                  I        +  TL+     L   +       +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.5 bits (144), Expect = 3e-09
 Identities = 20/82 (24%), Positives = 35/82 (42%), Gaps = 2/82 (2%)

Query: 536 TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGA 595
              ++ + L  ++     +   +   DL  N LS    ++L   T LE L+LS N L   
Sbjct: 14  IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET 73

Query: 596 IPISLEKLSFLSKFSVANNHLT 617
           + +    LS L    + NN++ 
Sbjct: 74  LDLE--SLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.2 bits (125), Expect = 6e-07
 Identities = 15/72 (20%), Positives = 30/72 (41%)

Query: 547 SIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
           +I     N  +  +  +  ++L   + S      +++ LDLS N LS      L   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 607 SKFSVANNHLTG 618
              ++++N L  
Sbjct: 61  ELLNLSSNVLYE 72

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  133 bits (337), Expect = 8e-35
 Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 47/260 (18%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC---GQME 782
           +K+++ +++D       F+    +G G FG VY A        +A+K L         +E
Sbjct: 1   SKKRQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 53

Query: 783 REFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSL 839
            + R EVE  S  +HPN++ L GY  H   R+ LI  +   G++   L    K D     
Sbjct: 54  HQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFD----- 107

Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
           +  +  +I +  A  L+Y H      ++HRDIK  N+LL       +ADFG +  + +P 
Sbjct: 108 EQRTATYITE-LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPS 161

Query: 900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP------MDMCK-- 951
                  L GTL Y+PPE  +  +   K D++S GV+  E L GK P       +  K  
Sbjct: 162 SRRTD--LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

Query: 952 -----------PKGSRDLIS 960
                       +G+RDLIS
Sbjct: 220 SRVEFTFPDFVTEGARDLIS 239

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  134 bits (340), Expect = 9e-35
 Identities = 80/322 (24%), Positives = 123/322 (38%), Gaps = 68/322 (21%)

Query: 727  NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQ 780
            +  KE+   +I            +G G FG VY   +    N      VA+K L   C +
Sbjct: 22   SDLKEVPRKNIT-------LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 74

Query: 781  MER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDGP 836
             +  +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   P
Sbjct: 75   QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134

Query: 837  SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL---ADFGLAR 893
            SSL     LH+A+  A G  YL    E H +HRDI + N LL       +    DFG+AR
Sbjct: 135  SSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

Query: 894  LILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GK 944
             I   Y         G    +P     PE    G   + T K D +SFGV+L E+ + G 
Sbjct: 192  DI---YRASYYR--KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGY 243

Query: 945  RP---MDMCKPKGSRDLISWVI---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLC 998
             P           +++++ +V    RM       +     +Y       M +       C
Sbjct: 244  MPYPSKS------NQEVLEFVTSGGRMDP----PKNCPGPVYRI-----MTQ-------C 281

Query: 999  LSESPKVRPTTQQLVSWLDSII 1020
                P+ RP    ++  ++   
Sbjct: 282  WQHQPEDRPNFAIILERIEYCT 303

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (341), Expect = 9e-35
 Identities = 74/308 (24%), Positives = 120/308 (38%), Gaps = 71/308 (23%)

Query: 748  NIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
              +G G FG V+ A   +         VA+K L        ++F+ E E L+  QH ++V
Sbjct: 47   WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWL-----------HEKLDGPSSLDWDSRLHIAQG 850
               G C      L+++ +M +G L+ +L             +   P  L     L +A  
Sbjct: 107  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
             A G+ YL      H +HRD+ + N L+       + DFG++R I   Y T      VG 
Sbjct: 167  VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYR--VGG 218

Query: 911  LGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDL 958
               +P     PE   Y      T + DV+SFGVVL E+ T GK+P   +       + + 
Sbjct: 219  RTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTEA 269

Query: 959  ISWVIRMRQENRESEVLD------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            I  +        +   L+      P +Y       M         C    P+ R + + +
Sbjct: 270  IDCI-------TQGRELERPRACPPEVYAI-----MRG-------CWQREPQQRHSIKDV 310

Query: 1013 VSWLDSII 1020
             + L ++ 
Sbjct: 311  HARLQALA 318

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  133 bits (337), Expect = 9e-35
 Identities = 67/287 (23%), Positives = 109/287 (37%), Gaps = 51/287 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGY 806
              +G G FG+V         +VAIK +      M  + F  E + +    H  LV L G 
Sbjct: 30   KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 807  CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
            C  +    +I  +M NG L  +L E             L + +     + YL        
Sbjct: 88   CTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QF 141

Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQA 921
            LHRD+ + N L++      ++DFGL+R +    D   T+  VG+    P     PE    
Sbjct: 142  LHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSS-VGSK--FPVRWSPPEVLMY 195

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RM-RQENRESE 973
            S  + K D+++FGV++ E+ + GK P           + +    +    R+ R       
Sbjct: 196  SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGLRLYRPHL---- 245

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 +Y       M         C  E    RPT + L+S +  ++
Sbjct: 246  -ASEKVYTI-----MYS-------CWHEKADERPTFKILLSNILDVM 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  132 bits (334), Expect = 1e-34
 Identities = 75/287 (26%), Positives = 120/287 (41%), Gaps = 51/287 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGY 806
              IG G FGLV+     +   VAIK +      M  E F  E E + +  HP LV L G 
Sbjct: 14   QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 807  CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
            C+ +    L+  FME+G L  +L            ++ L +      G+AYL ++    +
Sbjct: 72   CLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CV 125

Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQA 921
            +HRD+ + N L+  N    ++DFG+ R +L   D + ++   GT    P     PE    
Sbjct: 126  IHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSST--GTK--FPVKWASPEVFSF 179

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RM-RQENRESE 973
            S  + K DV+SFGV++ E+ + GK P           + +++  +    R+ +       
Sbjct: 180  SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRLYKPRL---- 229

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 +Y       M         C  E P+ RP   +L+  L  I 
Sbjct: 230  -ASTHVYQI-----MNH-------CWRERPEDRPAFSRLLRQLAEIA 263

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (338), Expect = 2e-34
 Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 57/299 (19%)

Query: 748  NIIGCGGFGLVYRATLPDGRN----VAIKRL-SGDCGQMER-EFRAEVEALSRAQHPNLV 801
             I+G G FG V    L         VA+K +   +  Q E  EF +E   +    HPN++
Sbjct: 40   KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 802  HLQGYCMHKNDR-----LLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARG 854
             L G C+  + +     ++I  FM+ G L  +L       GP  +   + L      A G
Sbjct: 100  RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
            + YL      + LHRD+ + N +L  +    +ADFGL++ I   Y         G +  +
Sbjct: 160  MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKI---YSGDYYR--QGRIAKM 211

Query: 915  P-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI-- 963
            P      E     V T K DV++FGV + E+ T G  P   +       + ++  +++  
Sbjct: 212  PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ------NHEMYDYLLHG 265

Query: 964  -RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             R++Q E+   E     +Y+      M         C    P  RPT   L   L+ ++
Sbjct: 266  HRLKQPEDCLDE-----LYEI-----MYS-------CWRTDPLDRPTFSVLRLQLEKLL 307

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (345), Expect = 2e-34
 Identities = 72/308 (23%), Positives = 136/308 (44%), Gaps = 39/308 (12%)

Query: 717  LGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSG 776
            +GS   +   + ++E S+  +     +F   +++G G  G +    + D R+VA+KR+  
Sbjct: 1    MGSSPSLEQDDGDEETSVVIV--GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP 58

Query: 777  DCGQMEREFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKL 833
            +C       R EV+ L    +HPN++    +C  K DR   Y  +E    +L  ++ +K 
Sbjct: 59   EC--FSFADR-EVQLLRESDEHPNVIRY--FCTEK-DRQFQYIAIELCAATLQEYVEQKD 112

Query: 834  DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL-----DGNFGAHLAD 888
                 L+    + + Q    GLA+LH     +I+HRD+K  NIL+      G   A ++D
Sbjct: 113  FAHLGLE---PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISD 166

Query: 889  FGLAR-LILSPYDTHVTTDLVGTLGYIPPEYGQASV---ATYKGDVYSFGVVLLELLTGK 944
            FGL + L +  +     + + GT G+I PE          TY  D++S G V   +++  
Sbjct: 167  FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226

Query: 945  RPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPK 1004
                   P G        I +   +         ++ ++H+  + R  ++    ++  P+
Sbjct: 227  SH-----PFGKSLQRQANILLGACS------LDCLHPEKHEDVIAR--ELIEKMIAMDPQ 273

Query: 1005 VRPTTQQL 1012
             RP+ + +
Sbjct: 274  KRPSAKHV 281

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (337), Expect = 2e-34
 Identities = 71/288 (24%), Positives = 110/288 (38%), Gaps = 42/288 (14%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKR--LSGDCGQMEREFRAEVEALSRAQHPN 799
              +     IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +
Sbjct: 28   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 800  L--VHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
               + L  Y +       IY  ME  N  L+ WL +K     S+D   R    +     +
Sbjct: 88   DKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAV 140

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
              +HQ     I+H D+K +N L+       L DFG+A  +     + V    VGT+ Y+P
Sbjct: 141  HTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 916  PE-----------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
            PE               S  + K DV+S G +L  +  GK P          + IS +  
Sbjct: 197  PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHA 251

Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            +   N          +    +K++  VL     CL   PK R +  +L
Sbjct: 252  IIDPN------HEIEFPDIPEKDLQDVL---KCCLKRDPKQRISIPEL 290

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  131 bits (333), Expect = 2e-34
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 51/285 (17%)

Query: 749  IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGYC 807
             +G G FG+V         +VA+K +      M  + F  E + + +  HP LV   G C
Sbjct: 15   ELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 808  MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
              +    ++  ++ NG L  +L         L+    L +      G+A+L        +
Sbjct: 73   SKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 868  HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQAS 922
            HRD+ + N L+D +    ++DFG+ R +L   D +V++   GT    P     PE     
Sbjct: 127  HRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSV--GTK--FPVKWSAPEVFHYF 180

Query: 923  VATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RM-RQENRESEV 974
              + K DV++FG+++ E+ + GK P           + +++  V    R+ R        
Sbjct: 181  KYSSKSDVWAFGILMWEVFSLGKMPYDLYT------NSEVVLKVSQGHRLYRPHLASDT- 233

Query: 975  LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                IY       M         C  E P+ RPT QQL+S ++ +
Sbjct: 234  ----IYQI-----MYS-------CWHELPEKRPTFQQLLSSIEPL 262

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (347), Expect = 3e-34
 Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 29/277 (10%)

Query: 748  NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQG 805
            + +G G +G VY          VA+K L  D   ME E F  E   +   +HPNLV L G
Sbjct: 226  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             C  +    +I  FM  G+L  +L E       +     L++A   +  + YL +    +
Sbjct: 284  VCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVAT 925
             +HR++ + N L+  N    +ADFGL+RL+     T         + +  PE    +  +
Sbjct: 339  FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFS 397

Query: 926  YKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM-RQENRESEVLDPFIYDKQ 983
             K DV++FGV+L E+ T G  P          +L+    RM R E          +Y+  
Sbjct: 398  IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG-----CPEKVYEL- 451

Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                M         C   +P  RP+  ++    +++ 
Sbjct: 452  ----MRA-------CWQWNPSDRPSFAEIHQAFETMF 477

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  131 bits (333), Expect = 3e-34
 Identities = 84/287 (29%), Positives = 122/287 (42%), Gaps = 51/287 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQGY 806
              +G G FG V+         VA+K L    G M  + F AE   + + QH  LV L   
Sbjct: 19   ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 807  CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
               +    +I  +MENGSL  +L  K      L  +  L +A   A G+A++ +    + 
Sbjct: 77   VT-QEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 867  LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQA 921
            +HRD++++NIL+       +ADFGLARLI    D   T          P     PE    
Sbjct: 131  IHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAK---FPIKWTAPEAINY 184

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RM-RQENRESE 973
               T K DV+SFG++L E++T G+ P   M       + ++I  +    RM R +N   E
Sbjct: 185  GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGYRMVRPDNCPEE 238

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 +Y       M         C  E P+ RPT   L S L+   
Sbjct: 239  -----LYQL-----MRL-------CWKERPEDRPTFDYLRSVLEDFF 268

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  132 bits (334), Expect = 3e-34
 Identities = 71/287 (24%), Positives = 114/287 (39%), Gaps = 49/287 (17%)

Query: 748  NIIGCGGFGLVYRATLPDGR-NVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLVHLQG 805
            + +G G +G VY          VA+K L      ME E F  E   +   +HPNLV L G
Sbjct: 19   HKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             C  +    +I  FM  G+L  +L E       +     L++A   +  + YL +    +
Sbjct: 77   VCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQ 920
             +HRD+ + N L+  N    +ADFGL+RL+     T             P     PE   
Sbjct: 132  FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLA 185

Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQENRESE 973
             +  + K DV++FGV+L E+ T G  P   +D         +   +    RM +     E
Sbjct: 186  YNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKDYRMERPEGCPE 239

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +    Y+      M         C   +P  RP+  ++    +++ 
Sbjct: 240  KV----YEL-----MRA-------CWQWNPSDRPSFAEIHQAFETMF 270

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 3e-34
 Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 72/307 (23%)

Query: 750  IGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            +G G FG V+ A   +         VA+K L        ++F+ E E L+  QH ++V  
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWL------------HEKLDGPSSLDWDSRLHIAQGA 851
             G C   +  ++++ +M++G L+ +L             +       L     LHIA   
Sbjct: 83   YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            A G+ YL      H +HRD+ + N L+  N    + DFG++R +   Y T      VG  
Sbjct: 143  ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYR--VGGH 194

Query: 912  GYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLI 959
              +P     PE   Y      T + DV+SFGV+L E+ T GK+P   +       + ++I
Sbjct: 195  TMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPWFQLS------NTEVI 245

Query: 960  SWVIRMRQENRESEVLD------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
              +        +  VL+        +YD      ML        C    P+ R   +++ 
Sbjct: 246  ECI-------TQGRVLERPRVCPKEVYDV-----MLG-------CWQREPQQRLNIKEIY 286

Query: 1014 SWLDSII 1020
              L ++ 
Sbjct: 287  KILHALG 293

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  131 bits (331), Expect = 5e-34
 Identities = 75/290 (25%), Positives = 112/290 (38%), Gaps = 54/290 (18%)

Query: 749  IIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHL 803
             IG G FG V++       N    VAIK          R +F  E   + +  HP++V L
Sbjct: 22   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             G    +N   +I      G L  +L  +     SLD  S +  A   +  LAYL     
Sbjct: 82   IGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
               +HRDI + N+L+  N    L DFGL+R +    D+        + G +P     PE 
Sbjct: 136  -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYK---ASKGKLPIKWMAPES 188

Query: 919  GQASVATYKGDVYSFGVVLLELLT-GKRP-MDMCKPKGSRDLISWVIRMRQENRESEVLD 976
                  T   DV+ FGV + E+L  G +P   +     + D+I  +          E L 
Sbjct: 189  INFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRI-------ENGERLP 237

Query: 977  ------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                  P +Y       M +       C +  P  RP   +L + L +I+
Sbjct: 238  MPPNCPPTLYSL-----MTK-------CWAYDPSRRPRFTELKAQLSTIL 275

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  131 bits (331), Expect = 6e-34
 Identities = 74/301 (24%), Positives = 111/301 (36%), Gaps = 54/301 (17%)

Query: 748  NIIGCGGFGLVYRAT---LPDGRN--VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
              +G G FG V       L D     VA+K+L     +  R+F  E+E L   QH N+V 
Sbjct: 16   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 803  LQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             +G C     R   LI  ++  GSL  +L +       +D    L       +G+ YL  
Sbjct: 76   YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 132

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP----- 915
                  +HRD+ + NIL++      + DFGL +++  P D       V   G  P     
Sbjct: 133  K---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEFFK--VKEPGESPIFWYA 185

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE-SEV 974
            PE    S  +   DV+SFGVVL EL T          +  R +       +Q       +
Sbjct: 186  PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHL 241

Query: 975  LD---------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            ++                 IY       M         C + +   RP+ + L   +D I
Sbjct: 242  IELLKNNGRLPRPDGCPDEIYMI-----MTE-------CWNNNVNQRPSFRDLALRVDQI 289

Query: 1020 I 1020
             
Sbjct: 290  R 290

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (331), Expect = 7e-34
 Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 73/308 (23%)

Query: 748  NIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNL 800
              +G   FG VY+  L           VAIK L        R EFR E    +R QHPN+
Sbjct: 15   EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------LDGPSSLDWDSRLHIA 848
            V L G         +I+S+  +G L  +L  +                S+L+    +H+ 
Sbjct: 75   VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
               A G+ YL      H++H+D+ + N+L+       ++D GL R +   Y        +
Sbjct: 135  AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYK--L 186

Query: 909  GTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSR 956
                 +P     PE   YG+ S+ +   D++S+GVVL E+ + G +P           ++
Sbjct: 187  LGNSLLPIRWMAPEAIMYGKFSIDS---DIWSYGVVLWEVFSYGLQPYCGYS------NQ 237

Query: 957  DLISWVIRMRQENRESEVLDP------FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010
            D++  +       R  +VL        ++Y       M+        C +E P  RP  +
Sbjct: 238  DVVEMI-------RNRQVLPCPDDCPAWVYAL-----MIE-------CWNEFPSRRPRFK 278

Query: 1011 QLVSWLDS 1018
             + S L +
Sbjct: 279  DIHSRLRA 286

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (341), Expect = 7e-34
 Identities = 80/299 (26%), Positives = 124/299 (41%), Gaps = 36/299 (12%)

Query: 725  FHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER 783
                  EI  + + LE          +G G FG V+  T      VAIK L    G M  
Sbjct: 174  LAKDAWEIPRESLRLE--------VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSP 223

Query: 784  E-FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            E F  E + + + +H  LV L      +    ++  +M  GSL  +L  +      L   
Sbjct: 224  EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLP 280

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              + +A   A G+AY+ +    + +HRD++++NIL+  N    +ADFGLARLI     T 
Sbjct: 281  QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

Query: 903  VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW 961
                    + +  PE       T K DV+SFG++L EL T G+ P      +   D +  
Sbjct: 338  RQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

Query: 962  VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              RM       E     ++D      M +       C  + P+ RPT + L ++L+   
Sbjct: 397  GYRMPCPPECPES----LHDL-----MCQ-------CWRKEPEERPTFEYLQAFLEDYF 439

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 7e-34
 Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 45/285 (15%)

Query: 750  IGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHLQG 805
            +GCG FG V +      +    VAIK L     + +  E   E + + +  +P +V L G
Sbjct: 18   LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 806  YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
             C      +L+      G L  +L  K      +   +   +    + G+ YL    E +
Sbjct: 78   VCQ-AEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 866  ILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEYGQ 920
             +HRD+ + N+LL     A ++DFGL++ + +    +       + G  P     PE   
Sbjct: 131  FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWPLKWYAPECIN 186

Query: 921  ASVATYKGDVYSFGVVLLELLT-GKRP-MDMCKPKGSRDLISWV---IRMRQENRESEVL 975
                + + DV+S+GV + E L+ G++P   M       ++++++    RM          
Sbjct: 187  FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIEQGKRMEC----PPEC 238

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             P +Y       M         C     + RP    +   + +  
Sbjct: 239  PPELYAL-----MSD-------CWIYKWEDRPDFLTVEQRMRACY 271

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (335), Expect = 9e-34
 Identities = 80/323 (24%), Positives = 123/323 (38%), Gaps = 68/323 (21%)

Query: 726  HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCG 779
             +  KE+   +I            +G G FG VY   +    N      VA+K L   C 
Sbjct: 62   ISDLKEVPRKNIT-------LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS 114

Query: 780  QMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE---KLDG 835
            + +  +F  E   +S+  H N+V   G  +    R ++   M  G L  +L E   +   
Sbjct: 115  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL---ADFGLA 892
            PSSL     LH+A+  A G  YL    E H +HRDI + N LL       +    DFG+A
Sbjct: 175  PSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

Query: 893  RLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-G 943
            R I   Y         G    +P     PE    G   + T K D +SFGV+L E+ + G
Sbjct: 232  RDI---YRAGYYR--KGGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLG 283

Query: 944  KRP---MDMCKPKGSRDLISWVI---RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACL 997
              P           +++++ +V    RM       +     +Y       M +       
Sbjct: 284  YMPYPSKS------NQEVLEFVTSGGRMDP----PKNCPGPVYRI-----MTQ------- 321

Query: 998  CLSESPKVRPTTQQLVSWLDSII 1020
            C    P+ RP    ++  ++   
Sbjct: 322  CWQHQPEDRPNFAIILERIEYCT 344

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  131 bits (332), Expect = 1e-33
 Identities = 60/288 (20%), Positives = 113/288 (39%), Gaps = 46/288 (15%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
             ++G G FG V++    P+G +    V IK +    G+         + A+    H ++V
Sbjct: 19   KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L G C   +   L+  ++  GSL   + +             L+     A+G+ YL   
Sbjct: 79   RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLE-- 132

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
             E  ++HR++ + N+LL       +ADFG+A L+       + ++        P      
Sbjct: 133  -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMAL 186

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV---IRMRQENRES 972
            E       T++ DV+S+GV + EL+T G  P    +     ++   +    R+ Q    +
Sbjct: 187  ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEKGERLAQPQICT 243

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              +    Y       M++       C      +RPT ++L +    + 
Sbjct: 244  IDV----YMV-----MVK-------CWMIDENIRPTFKELANEFTRMA 275

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (333), Expect = 1e-33
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 42/282 (14%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKR--LSGDCGQMEREFRAEVEALSRAQHPNL--VHL 803
              IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   + L
Sbjct: 15   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 804  QGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
              Y +       IY  ME  N  L+ WL +K     S+D   R    +     +  +HQ 
Sbjct: 75   YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---- 917
                I+H D+K +N L+  +    L DFG+A  +     + V    VGT+ Y+PPE    
Sbjct: 128  ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 918  -------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
                       S  + K DV+S G +L  +  GK P          + IS +  +   N 
Sbjct: 184  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPN- 237

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                     +    +K++  VL     CL   PK R +  +L
Sbjct: 238  -----HEIEFPDIPEKDLQDVL---KCCLKRDPKQRISIPEL 271

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (338), Expect = 2e-33
 Identities = 76/311 (24%), Positives = 125/311 (40%), Gaps = 64/311 (20%)

Query: 725  FHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER 783
            F+     +++ ++ L           IG G FG V       G  VA+K +  D     +
Sbjct: 183  FYRSGWALNMKELKLL--------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQ 231

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS-FMENGSLDYWLHEKLDGPSSLDWD 842
             F AE   +++ +H NLV L G  + +   L I + +M  GSL  +L  +  G S L  D
Sbjct: 232  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGD 289

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              L  +      + YL  +   + +HRD+ + N+L+  +  A ++DFGL +       T 
Sbjct: 290  CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQ 343

Query: 903  VTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPK 953
                     G +P     PE  +    + K DV+SFG++L E+ + G+ P   +      
Sbjct: 344  -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----- 391

Query: 954  GSRDLISWVI---RM-RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009
              +D++  V    +M   +        P +YD      M         C       RPT 
Sbjct: 392  -LKDVVPRVEKGYKMDAPDG-----CPPAVYDV-----MKN-------CWHLDAATRPTF 433

Query: 1010 QQLVSWLDSII 1020
             QL   L+ I 
Sbjct: 434  LQLREQLEHIR 444

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (327), Expect = 2e-33
 Identities = 80/276 (28%), Positives = 124/276 (44%), Gaps = 52/276 (18%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD---CGQMEREFRAEVEALSR 794
           E   +F   N++G G F  VYRA  +  G  VAIK +         M +  + EV+   +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            +HP+++ L  Y    ++   +Y  +E   NG ++ +L  +   P S + ++R  + Q  
Sbjct: 68  LKHPSILELYNY-FEDSNY--VYLVLEMCHNGEMNRYLKNR-VKPFS-ENEARHFMHQ-I 121

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             G+ YLH      ILHRD+  SN+LL  N    +ADFGLA  +  P++ H T  L GT 
Sbjct: 122 ITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTP 176

Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP------MDMCK-------- 951
            YI PE      +G       + DV+S G +   LL G+ P       +           
Sbjct: 177 NYISPEIATRSAHG------LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE 230

Query: 952 -----PKGSRDLISWVIRMRQENRES--EVL-DPFI 979
                   ++DLI  ++R    +R S   VL  PF+
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (330), Expect = 2e-33
 Identities = 75/328 (22%), Positives = 125/328 (38%), Gaps = 76/328 (23%)

Query: 729  EKEISIDDILESTNNFDQANI-----IGCGGFGLVYRATLPDGRN------VAIKRLSGD 777
              ++ + D  E      +  I     +G G FG+VY               VAIK ++  
Sbjct: 11   AADVYVPDEWE----VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 66

Query: 778  CGQMER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL------H 830
                ER EF  E   +      ++V L G        L+I   M  G L  +L       
Sbjct: 67   ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 126

Query: 831  EKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG 890
                  +       + +A   A G+AYL+ +     +HRD+ + N ++  +F   + DFG
Sbjct: 127  ANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183

Query: 891  LARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT 942
            + R I   Y+T       G  G +P     PE    G   V T   DV+SFGVVL E+ T
Sbjct: 184  MTRDI---YETDYYR--KGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIAT 235

Query: 943  -GKRP---MDMCKPKGSRDLISWVIRMRQENRESEVLD------PFIYDKQHDKEMLRVL 992
              ++P   +       +  ++ +V        E  +LD        +++      M    
Sbjct: 236  LAEQPYQGLS------NEQVLRFV-------MEGGLLDKPDNCPDMLFEL-----MRM-- 275

Query: 993  DIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 C   +PK+RP+  +++S +   +
Sbjct: 276  -----CWQYNPKMRPSFLEIISSIKEEM 298

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (329), Expect = 2e-33
 Identities = 74/297 (24%), Positives = 112/297 (37%), Gaps = 48/297 (16%)

Query: 748  NIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
              +G G FG V            G  VA+K L  D G   R  ++ E++ L    H +++
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 802  HLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
              +G C         L+  ++  GSL  +L        S+     L  AQ    G+AYLH
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLH 151

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP---- 915
                 H +HRD+ + N+LLD +    + DFGLA+ +   ++ +         G  P    
Sbjct: 152  AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDSPVFWY 204

Query: 916  -PEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW----VIRMRQEN 969
             PE  +     Y  DV+SFGV L ELLT                 I+     V+R+ +  
Sbjct: 205  APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 970  RESEVLD------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               E L         +Y       M         C       RPT + L+  L ++ 
Sbjct: 265  ERGERLPRPDKCPAEVYHL-----MKN-------CWETEASFRPTFENLIPILKTVH 309

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 2e-33
 Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 40/285 (14%)

Query: 748  NIIGCGGFGLVYRATL-PDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLV 801
             ++G G FG VY+    P+G      VAIK L          E   E   ++   +P++ 
Sbjct: 21   KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L G C+  +   LI   M  G L  ++ E  D   S      L+     A+G+ YL   
Sbjct: 81   RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLE-- 134

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
             +  ++HRD+ + N+L+       + DFGLA+L+ +    +         G +P      
Sbjct: 135  -DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMAL 188

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E     + T++ DV+S+GV + EL+T G +P D         ++    R+ Q      + 
Sbjct: 189  ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----PPIC 244

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               +Y       M++       C       RP  ++L+     + 
Sbjct: 245  TIDVYMI-----MVK-------CWMIDADSRPKFRELIIEFSKMA 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (333), Expect = 3e-33
 Identities = 70/282 (24%), Positives = 109/282 (38%), Gaps = 42/282 (14%)

Query: 748  NIIGCGGFGLVYRATLPDGRNVAIKR--LSGDCGQMEREFRAEVEALSRAQHPNL--VHL 803
              IG GG   V++      +  AIK   L     Q    +R E+  L++ Q  +   + L
Sbjct: 62   KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 804  QGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
              Y +       IY  ME  N  L+ WL +K     S+D   R    +     +  +HQ 
Sbjct: 122  YDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---- 917
                I+H D+K +N L+  +    L DFG+A  +     + V    VG + Y+PPE    
Sbjct: 175  ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 918  -------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
                       S  + K DV+S G +L  +  GK P          + IS +  +   N 
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPN- 284

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                     +    +K++  VL     CL   PK R +  +L
Sbjct: 285  -----HEIEFPDIPEKDLQDVL---KCCLKRDPKQRISIPEL 318

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (337), Expect = 3e-33
 Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 14/305 (4%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNSLN 169
            R L+L  N +K        + P+LE L+L+ N +S   P    NL +++ L + SN L 
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-GNCASLEHLCLGMNDLTGGIADDIFQ- 227
             +P  +    S +  +++S N     L   +  +  +L+ L +G NDL   I+   F  
Sbjct: 94  -LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSG 150

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
           L  L  L L+   L+   + +++ L  L+ L +   N +      F  L   + L     
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210

Query: 288 RFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN 344
            +   +  +      L  L++ +    ++    + +   L  L  L+L  N  +    + 
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH---LVYLRFLNLSYNPISTIEGSM 267

Query: 345 LPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTL 404
           L    +L+ I L     +   P  ++    L  L++S + +  L     V     NL TL
Sbjct: 268 LHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEE--SVFHSVGNLETL 325

Query: 405 VLTLN 409
           +L  N
Sbjct: 326 ILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  117 bits (295), Expect = 9e-28
 Identities = 68/381 (17%), Positives = 131/381 (34%), Gaps = 66/381 (17%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNS 167
           Q R +          VP  +       +LDL  N +   L Q    + P ++ L+++ N 
Sbjct: 12  QDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENI 67

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIF 226
           +  +V      N   +R + L  N     +  G     ++L  L +  N +   + D +F
Sbjct: 68  V-SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMF 124

Query: 227 Q-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
           Q L  L+ L + DN L   +S    + L++L +L +   N +    +  + L     L  
Sbjct: 125 QDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN 344
                                  +R+ S           L  L  L++    +   +  N
Sbjct: 184 RHLNIN----------------AIRDYSFKR--------LYRLKVLEISHWPYLDTMTPN 219

Query: 345 LPRCRKLKNINLARNNFSGQIPE-TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
                 L ++++   N +  +P    ++   L +L+LS + I  +     +L +   L  
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEG--SMLHELLRLQE 276

Query: 404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGT 463
           + L       +L       F  L                     + L+++++S NQL+  
Sbjct: 277 IQLVGG----QLAVVEPYAFRGL---------------------NYLRVLNVSGNQLTTL 311

Query: 464 IPVWFGGFQDLFYLDLSNNTF 484
               F    +L  L L +N  
Sbjct: 312 EESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  115 bits (290), Expect = 3e-27
 Identities = 51/254 (20%), Positives = 94/254 (37%), Gaps = 10/254 (3%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
           L L   RLK         L  L  L++S N +   +     +L NL+ L++  NDL    
Sbjct: 85  LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYIS 144

Query: 150 PQT-INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLE 208
            +    L S++ L +   +L  S+PT    +   + V+ L     +            L+
Sbjct: 145 HRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203

Query: 209 HLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP-SIADLSNLVRLDVSSNNFSG 267
            L +        +  +      L  L +    L+  +   ++  L  L  L++S N  S 
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPAL 324
               +   L   Q +     +     P++      L +LN+  N   +L+ S+  +   +
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHS---V 319

Query: 325 TNLTSLDLGTNKFN 338
            NL +L L +N   
Sbjct: 320 GNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  111 bits (279), Expect = 8e-26
 Identities = 50/267 (18%), Positives = 93/267 (34%), Gaps = 12/267 (4%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQV 160
             +  NL  LR L L  N LK         L NL  LD+S N +   L     +L +++ 
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTG 219
           L++  N L   +        + +  + L     + ++    L +   L  L L   ++  
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN- 189

Query: 220 GIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE 278
            I D  F+ L +L++L +        ++P+     NL  L ++  N +         L  
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249

Query: 279 FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTN 335
            ++L    N  +      L     L  + L       ++         L  L  L++  N
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG---LNYLRVLNVSGN 306

Query: 336 KFNGPLPTNLPRCRKLKNINLARNNFS 362
           +      +       L+ + L  N  +
Sbjct: 307 QLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  107 bits (270), Expect = 1e-24
 Identities = 67/368 (18%), Positives = 117/368 (31%), Gaps = 69/368 (18%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSN 263
                L LG N +     D+      L  L L +N +S  + P    +L NL  L + SN
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA 323
                   VF GL     L    N+    + +   +   L  L + +N            
Sbjct: 91  RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN------------ 138

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS 383
             +L  +      F+G     L     L+ + L + N +    E   +   L  L L + 
Sbjct: 139 --DLVYISHRA--FSG-----LNS---LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186

Query: 384 SIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW 443
           +I  +       ++   L  L ++     + +  +  L+  NL  L I  C L  ++P  
Sbjct: 187 NINAIRD--YSFKRLYRLKVLEISHWPYLDTMTPN-CLYGLNLTSLSITHCNLT-AVPYL 242

Query: 444 -LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITR 501
            +R    L+ ++LS+N +S            L  + L        +      GL  L   
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVL 301

Query: 502 NISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVF 561
           N                      +  NQ+ +   ++              F ++  L   
Sbjct: 302 N----------------------VSGNQLTTLEESV--------------FHSVGNLETL 325

Query: 562 DLKHNNLS 569
            L  N L+
Sbjct: 326 ILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (256), Expect = 6e-23
 Identities = 67/348 (19%), Positives = 115/348 (33%), Gaps = 33/348 (9%)

Query: 300 SPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARN 359
           S     +         ++    P  T    LDLG N+              L+ + L  N
Sbjct: 10  SAQDRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66

Query: 360 NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDP 419
             S   P  + N  +L  L L ++ +  +     V     NLT L ++ N +   L    
Sbjct: 67  IVSAVEPGAFNNLFNLRTLGLRSNRLKLIPL--GVFTGLSNLTKLDISEN-KIVILLDYM 123

Query: 420 RLHFANLKVLVIASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLD 478
                NLK L +    L   I  +   G + L+ + L    L+            L  L 
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182

Query: 479 LSNNTFTGEIPKNLTGLPSLITRNIS----LEEPSPDFPFFMRRNVSARGLQYNQIWSFP 534
           L +         +   L  L    IS    L+  +P+       N+++  + +  + + P
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC--LYGLNLTSLSITHCNLTAVP 240

Query: 535 PTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG 594
                              +L  L   +L +N +S    S L  +  L+ + L    L+ 
Sbjct: 241 YLA--------------VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286

Query: 595 AIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNS---SFDGNNL 639
             P +   L++L   +V+ N LT  +     F +  N      D N L
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSNPL 332

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (336), Expect = 4e-33
 Identities = 88/309 (28%), Positives = 130/309 (42%), Gaps = 56/309 (18%)

Query: 725  FHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER 783
            +     EI  + + LE          +G G FG V+ AT      VA+K +    G M  
Sbjct: 178  WEKDAWEIPRESLKLE--------KKLGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSV 227

Query: 784  -EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
              F AE   +   QH  LV L      K    +I  FM  GSL  +L    D  S     
Sbjct: 228  EAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKS--DEGSKQPLP 284

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              +  +   A G+A++ Q    + +HRD++++NIL+  +    +ADFGLAR+I     T 
Sbjct: 285  KLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341

Query: 903  VTTDLVGTLGYI---PPEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGS 955
                  G    I    PE       T K DV+SFG++L+E++T G+ P   M       +
Sbjct: 342  RE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------N 391

Query: 956  RDLISWVI---RM-RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
             ++I  +    RM R EN   E     +Y+      M+R       C    P+ RPT + 
Sbjct: 392  PEVIRALERGYRMPRPENCPEE-----LYNI-----MMR-------CWKNRPEERPTFEY 434

Query: 1012 LVSWLDSII 1020
            + S LD   
Sbjct: 435  IQSVLDDFY 443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  132 bits (332), Expect = 4e-33
 Identities = 35/303 (11%), Positives = 73/303 (24%), Gaps = 63/303 (20%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG---QMEREFRAEVEA---LSRAQHPNLV 801
            ++G         AT    G +  +              ++ + EV     L   ++    
Sbjct: 85   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 802  HLQGYCMHKNDRLLI--------------------------YSFMENGSLDYWLHEKLDG 835
             +    +   D +                                   +    L      
Sbjct: 145  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
              SL   +RL +     R LA LH      ++H  ++  +I+LD   G  L  F      
Sbjct: 205  HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 896  LSPYDTHVTTDLVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELLTGKRPMDMC 950
             +   + +                       ++ T+  D ++ G+ +  +     P    
Sbjct: 262  GASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 951  KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010
               G  + I      R      + +   +                   L    + R    
Sbjct: 321  AALGGSEWI-----FRSCKNIPQPVRALLEG----------------FLRYPKEDRLLPL 359

Query: 1011 QLV 1013
            Q +
Sbjct: 360  QAM 362

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  129 bits (326), Expect = 5e-33
 Identities = 70/276 (25%), Positives = 104/276 (37%), Gaps = 37/276 (13%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRL-SGDCGQMERE-FRAEVEALSR-AQHP 798
            +F + + +G G +G V++     DGR  A+KR  S   G  +R    AEV +  +  QHP
Sbjct: 58   SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 799  NLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
              V L+     +   L +    E    SL           +SL         +     LA
Sbjct: 118  CCVRLEQ-AWEEGGILYLQ--TELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALA 171

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +LH      ++H D+K +NI L       L DFGL   + +     V     G   Y+ P
Sbjct: 172  HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
            E  Q S      DV+S G+ +LE+           P G         ++RQ     E   
Sbjct: 226  ELLQGS-YGTAADVFSLGLTILEVACNMEL-----PHGGEGW----QQLRQGYLPPEFTA 275

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                      E+  VL    + L   PK+R T + L
Sbjct: 276  GL------SSELRSVLV---MMLEPDPKLRATAEAL 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (327), Expect = 5e-33
 Identities = 74/301 (24%), Positives = 111/301 (36%), Gaps = 54/301 (17%)

Query: 748  NIIGCGGFGLVYRAT---LPDGRN--VAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
              +G G FG V       L D     VA+K+L     +  R+F  E+E L   QH N+V 
Sbjct: 47   QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 803  LQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             +G C     R   LI  ++  GSL  +L +       +D    L       +G+ YL  
Sbjct: 107  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 163

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP----- 915
                  +HRD+ + NIL++      + DFGL +++  P D       V   G  P     
Sbjct: 164  K---RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEYYK--VKEPGESPIFWYA 216

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE-SEV 974
            PE    S  +   DV+SFGVVL EL T          +  R +       +Q       +
Sbjct: 217  PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHL 272

Query: 975  LD---------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
            ++                 IY       M         C + +   RP+ + L   +D I
Sbjct: 273  IELLKNNGRLPRPDGCPDEIYMI-----MTE-------CWNNNVNQRPSFRDLALRVDQI 320

Query: 1020 I 1020
             
Sbjct: 321  R 321

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  129 bits (326), Expect = 6e-33
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 58/300 (19%)

Query: 748  NIIGCGGFGLVYRATLPDGRN----VAIKRL-SGDCGQMERE-FRAEVEALSRAQHPNLV 801
             ++G G FG V  A L         VA+K L +      + E F  E   +    HP++ 
Sbjct: 29   RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 802  HLQGYCMHKNDR------LLIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAAR 853
             L G  +    +      ++I  FM++G L  +L      + P +L   + +      A 
Sbjct: 89   KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            G+ YL      + +HRD+ + N +L  +    +ADFGL+R I   Y         G    
Sbjct: 149  GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI---YSGDYYR--QGCASK 200

Query: 914  IP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI- 963
            +P      E    ++ T   DV++FGV + E++T G+ P   ++      + ++ +++I 
Sbjct: 201  LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE------NAEIYNYLIG 254

Query: 964  --RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              R++Q      E     +YD      M +       C S  PK RP+   L   L++I+
Sbjct: 255  GNRLKQPPECMEE-----VYDL-----MYQ-------CWSADPKQRPSFTCLRMELENIL 297

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (322), Expect = 8e-33
 Identities = 68/290 (23%), Positives = 107/290 (36%), Gaps = 54/290 (18%)

Query: 749  IIGCGGFGLVYRATL--PDGRN--VAIKRL-SGDCGQMEREFRAEVEALSRAQHPNLVHL 803
            I+G G FG VY        G    VA+K          + +F +E   +    HP++V L
Sbjct: 19   ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             G    +    +I      G L ++L    +    L     +  +    + +AYL     
Sbjct: 79   IGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLESI-- 132

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
             + +HRDI   NIL+       L DFGL+R I    D         ++  +P     PE 
Sbjct: 133  -NCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYK---ASVTRLPIKWMSPES 185

Query: 919  GQASVATYKGDVYSFGVVLLELLT-GKRP-MDMCKPKGSRDLISWVIRMRQENRESEVLD 976
                  T   DV+ F V + E+L+ GK+P   +     ++D+I  +        + + L 
Sbjct: 186  INFRRFTTASDVWMFAVCMWEILSFGKQPFFWL----ENKDVIGVL-------EKGDRLP 234

Query: 977  ------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                  P +Y       M R       C    P  RP   +LV  L  + 
Sbjct: 235  KPDLCPPVLYTL-----MTR-------CWDYDPSDRPRFTELVCSLSDVY 272

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (336), Expect = 9e-33
 Identities = 80/299 (26%), Positives = 124/299 (41%), Gaps = 36/299 (12%)

Query: 725  FHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMER 783
                  EI  + + LE          +G G FG V+  T      VAIK L    G M  
Sbjct: 257  LAKDAWEIPRESLRLE--------VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSP 306

Query: 784  E-FRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            E F  E + + + +H  LV L      +    ++  +M  GSL  +L    +    L   
Sbjct: 307  EAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLP 363

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              + +A   A G+AY+ +    + +HRD++++NIL+  N    +ADFGLARLI     T 
Sbjct: 364  QLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

Query: 903  VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW 961
                    + +  PE       T K DV+SFG++L EL T G+ P      +   D +  
Sbjct: 421  RQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

Query: 962  VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              RM       E     ++D      M +       C  + P+ RPT + L ++L+   
Sbjct: 480  GYRMPCPPECPES----LHDL-----MCQ-------CWRKEPEERPTFEYLQAFLEDYF 522

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 1e-32
 Identities = 71/332 (21%), Positives = 128/332 (38%), Gaps = 42/332 (12%)

Query: 712  KDLEELGSKLVVLFHNKEKEISIDDILE-STNNFDQANIIGCGGFGLVYRATL-PDGRNV 769
            K LEEL          +        + E   ++F++ + +G G  G+V++ +  P G  +
Sbjct: 2    KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 770  AIKRLSGDCGQMEREF-RAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYW 828
            A K +  +     R     E++ L     P +V   G      +  +    M+ GSLD  
Sbjct: 62   ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121

Query: 829  LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD 888
            L  K  G           ++    +GL YL +  +  I+HRD+K SNIL++      L D
Sbjct: 122  L--KKAGRIPEQILG--KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 889  FGLA-RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            FG++ +LI S  ++ V     GT  Y+ PE  Q +  + + D++S G+ L+E+  G+ P+
Sbjct: 176  FGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

Query: 948  DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKE---MLRVLDIACL------- 997
                 K    +    +             P     +   +    + + ++          
Sbjct: 231  PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290

Query: 998  -----------------CLSESPKVRPTTQQL 1012
                             CL ++P  R   +QL
Sbjct: 291  KLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (323), Expect = 2e-32
 Identities = 83/303 (27%), Positives = 133/303 (43%), Gaps = 64/303 (21%)

Query: 748  NIIGCGGFGLVYRATLPDG---RNVAIKRLSGDCGQMER-EFRAEVEALSR-AQHPNLVH 802
            ++IG G FG V +A +       + AIKR+     + +  +F  E+E L +   HPN+++
Sbjct: 31   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 803  LQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------LDGPSSLDWDSRLHIAQG 850
            L G C H+    L   +  +G+L  +L +                 S+L     LH A  
Sbjct: 91   LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
             ARG+ YL    +   +HRD+ + NIL+  N+ A +ADFGL+R         V      T
Sbjct: 151  VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYV--KKT 199

Query: 911  LGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISW 961
            +G +P      E    SV T   DV+S+GV+L E+++ G  P   M         +L   
Sbjct: 200  MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK 253

Query: 962  VI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
            +    R+ +  N + EV     YD      M +       C  E P  RP+  Q++  L+
Sbjct: 254  LPQGYRLEKPLNCDDEV-----YDL-----MRQ-------CWREKPYERPSFAQILVSLN 296

Query: 1018 SII 1020
             ++
Sbjct: 297  RML 299

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  129 bits (325), Expect = 2e-32
 Identities = 50/306 (16%), Positives = 93/306 (30%), Gaps = 73/306 (23%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLS-------GDCGQMERE---------------- 784
           ++G         AT    G +  +               QM+ E                
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 785 -----FRAEVEALSRAQHPNLVHLQGYCMHKN--DRLLIYSFMENGSLDY--WLHEKLDG 835
                F    + +   Q   ++ ++          R  +Y  M++    +   L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
             SL   +RL +     R LA LH      ++H  ++  +I+LD   G  L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 255

Query: 896 LSPYDTHVTTDLVGTLGYIPPEY-----------GQASVATYKGDVYSFGVVLLELLTGK 944
                         + G+ PPE             + ++ T+  D ++ G+V+  +    
Sbjct: 256 -----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 945 RP-------------MDMCK--PKGSRDLISWVIRMRQENRES--EVL-DPFIYDKQHDK 986
            P                CK  P+  R L+   +R  +E+R    + +  P    +Q   
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY--EQLRT 368

Query: 987 EMLRVL 992
           E+   L
Sbjct: 369 ELSAAL 374

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  126 bits (319), Expect = 2e-32
 Identities = 79/295 (26%), Positives = 126/295 (42%), Gaps = 52/295 (17%)

Query: 724 LFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGD---CG 779
           L    +++ +IDD       FD    +G G FG VY A    +   +A+K L        
Sbjct: 3   LAEMPKRKFTIDD-------FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE 55

Query: 780 QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGP 836
            +E + R E+E  S  +HPN++ +  Y  H   R+ L+  F   G L   L  H + D  
Sbjct: 56  GVEHQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFD-- 112

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
              +  S   + +  A  L Y H+     ++HRDIK  N+L+       +ADFG +  + 
Sbjct: 113 ---EQRSATFMEE-LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS--VH 163

Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP------MDMC 950
           +P     T  + GTL Y+PPE  +      K D++  GV+  E L G  P       +  
Sbjct: 164 APSLRRRT--MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

Query: 951 K-------------PKGSRDLISWVIRMRQENRES--EVL-DPFIYDKQHDKEML 989
           +               GS+DLIS ++R     R     V+  P++  K + + +L
Sbjct: 222 RRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV--KANSRRVL 274

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  127 bits (320), Expect = 4e-32
 Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 47/294 (15%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHLQGYC 807
            +  GGF  VY A  +  GR  A+KRL  +  +  R    EV  + + + HPN+V      
Sbjct: 36   LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 808  MHKNDRL-----LIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                +             E      +++    +  GP  L  D+ L I     R + ++H
Sbjct: 96   SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP--LSCDTVLKIFYQTCRAVQHMH 153

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL----------VG 909
               +P I+HRD+K  N+LL       L DFG A  I    D   +               
Sbjct: 154  -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 910  TLGYIPPE----YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
            T  Y  PE    Y    +   K D+++ G +L  L   + P +         +++    +
Sbjct: 213  TPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFED---GAKLRIVNGKYSI 268

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
               + +  V    I      + ML+V          +P+ R +  ++V  L  I
Sbjct: 269  PPHDTQYTVFHSLI------RAMLQV----------NPEERLSIAEVVHQLQEI 306

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  125 bits (316), Expect = 6e-32
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 37/237 (15%)

Query: 725 FHNKEKEISIDDI-LESTNNFDQANIIGCGGFGLVYRATLPDGR---NVAIKRLSGDC-- 778
              KE  +    + LE          +G G FG V +      +    VA+K L  +   
Sbjct: 6   IRPKEVYLDRKLLTLEDK-------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58

Query: 779 GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS 838
             ++ E  AE   + +  +P +V + G C      +L+    E G L+ +L +       
Sbjct: 59  PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN----RH 113

Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
           +   + + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + + 
Sbjct: 114 VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170

Query: 899 YDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
            + +       T G  P     PE   Y + S    K DV+SFGV++ E  + G++P
Sbjct: 171 ENYYKAQ----THGKWPVKWYAPECINYYKFSS---KSDVWSFGVLMWEAFSYGQKP 220

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  126 bits (319), Expect = 7e-32
 Identities = 81/337 (24%), Positives = 126/337 (37%), Gaps = 73/337 (21%)

Query: 723  VLFHNKEKEISIDDILE-STNNFDQANIIGCGGFGLVYRATLPDGRN--------VAIKR 773
            +L    E E+  D   E   +       +G G FG V  A               VA+K 
Sbjct: 15   MLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74

Query: 774  LSGDCGQMER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------ 825
            L  D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L      
Sbjct: 75   LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 134

Query: 826  ------DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD 879
                  +Y           + +   +      ARG+ YL        +HRD+ + N+L+ 
Sbjct: 135  RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT 191

Query: 880  GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVY 931
             N    +ADFGLAR I    +         T G +P     PE        V T++ DV+
Sbjct: 192  ENNVMKIADFGLARDI---NNIDYYK--KTTNGRLPVKWMAPEALFDR---VYTHQSDVW 243

Query: 932  SFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQ 983
            SFGV++ E+ T G  P   +         +L   +    RM +  N  +E     +Y   
Sbjct: 244  SFGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDKPANCTNE-----LYMM- 291

Query: 984  HDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                M         C    P  RPT +QLV  LD I+
Sbjct: 292  ----MRD-------CWHAVPSQRPTFKQLVEDLDRIL 317

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (316), Expect = 8e-32
 Identities = 58/214 (27%), Positives = 84/214 (39%), Gaps = 30/214 (14%)

Query: 749 IIGCGGFGLVYRATL--PDGRN--VAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLV 801
            +G G FG+V R     P G+   VA+K L  D     +   +F  EV A+    H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 802 HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L G  +      ++      GSL   L +           +    A   A G+ YL   
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 862 CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----P 916
                +HRD+ + N+LL       + DFGL R +    D +V          +P     P
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ----EHRKVPFAWCAP 193

Query: 917 E---YGQASVATYKGDVYSFGVVLLELLT-GKRP 946
           E       S A+   D + FGV L E+ T G+ P
Sbjct: 194 ESLKTRTFSHAS---DTWMFGVTLWEMFTYGQEP 224

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (330), Expect = 1e-31
 Identities = 66/337 (19%), Positives = 123/337 (36%), Gaps = 30/337 (8%)

Query: 620 IPSGGQFQTFPNSSFDGNNLCGEHRYSCTIDRESGQVKSAKKSRRNKYTIVGMAIGITFG 679
           IP G +F T          L  +        +E+    SA  +       +         
Sbjct: 223 IPEGTKFDTLWQLV---EYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTH 279

Query: 680 SAFLLILIFMILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILE 739
               +  +              P+K      D  + E          +K+  +  D++L 
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339

Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRN---VAIKRLSGDCGQMER-EFRAEVEALSRA 795
           +         +GCG FG V +      +    VAIK L     + +  E   E + + + 
Sbjct: 340 ADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            +P +V L G C  +   +L+      G L  +L  K      +   +   +    + G+
Sbjct: 394 DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 449

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
            YL    E + +HR++ + N+LL     A ++DFGL++ + +    +       + G  P
Sbjct: 450 KYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR----SAGKWP 502

Query: 916 -----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP 946
                PE       + + DV+S+GV + E L+ G++P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (318), Expect = 1e-31
 Identities = 57/278 (20%), Positives = 102/278 (36%), Gaps = 57/278 (20%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSR 794
            S   + +   +G GGF   +  +        A K   +          +   E+     
Sbjct: 38  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFME---NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQ 849
             H ++V   G+    ND   ++  +E     SL +     + L      + ++R ++ Q
Sbjct: 98  LAHQHVVGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALT-----EPEARYYLRQ 149

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               G  YLH++    ++HRD+K  N+ L+ +    + DFGLA  +    +      L G
Sbjct: 150 -IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCG 203

Query: 910 TLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP------MDMCK------ 951
           T  YI PE      +       ++ DV+S G ++  LL GK P       +         
Sbjct: 204 TPNYIAPEVLSKKGHS------FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257

Query: 952 -------PKGSRDLISWVIRMRQENRES--EVL-DPFI 979
                     +  LI  +++     R +  E+L D F 
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (316), Expect = 1e-31
 Identities = 84/335 (25%), Positives = 126/335 (37%), Gaps = 80/335 (23%)

Query: 729  EKEISIDDILESTNNFDQANI-----IGCGGFGLVYRATLPDGRN------VAIKRLSGD 777
              ++  D   E    F +  +     +G G FG V  AT            VA+K L   
Sbjct: 9    PTQLPYDHKWE----FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64

Query: 778  CGQMER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK--- 832
                ER    +E++ LS    H N+V+L G C      L+I  +   G L  +L  K   
Sbjct: 65   AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 833  -----------LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN 881
                        D   +LD +  L  +   A+G+A+L      + +HRD+ + NILL   
Sbjct: 125  FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

Query: 882  FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSF 933
                + DFGLAR I    +       V     +P     PE        V T++ DV+S+
Sbjct: 182  RITKICDFGLARDI---KNDSNYV--VKGNARLPVKWMAPESIFNC---VYTFESDVWSY 233

Query: 934  GVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHD 985
            G+ L EL + G  P   M +            +    RM   E+  +E     +Y     
Sbjct: 234  GIFLWELFSLGSSPYPGMPV-----DSKFYKMIKEGFRMLSPEHAPAE-----MY----- 278

Query: 986  KEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                   DI   C    P  RPT +Q+V  ++  I
Sbjct: 279  -------DIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (315), Expect = 1e-31
 Identities = 58/272 (21%), Positives = 102/272 (37%), Gaps = 45/272 (16%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSR 794
            S   + +   +G GGF   +  +        A K   +          +   E+     
Sbjct: 12  RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71

Query: 795 AQHPNLVHLQGYCMHKNDRLLIYSFME---NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQ 849
             H ++V   G+    ND   ++  +E     SL +     + L  P     ++R ++ Q
Sbjct: 72  LAHQHVVGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEP-----EARYYLRQ 123

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
               G  YLH++    ++HRD+K  N+ L+ +    + DFGLA  +    +      L G
Sbjct: 124 -IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCG 177

Query: 910 TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP------MDMCK------------ 951
           T  YI PE       +++ DV+S G ++  LL GK P       +               
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237

Query: 952 -PKGSRDLISWVIRMRQENRES--EVL-DPFI 979
               +  LI  +++     R +  E+L D F 
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  128 bits (324), Expect = 1e-31
 Identities = 82/489 (16%), Positives = 154/489 (31%), Gaps = 81/489 (16%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNG 170
                 +   ++ T  +S   L  L  LD  ++ ++  +     L  +  L  +SN++  
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT- 77

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQK 230
           ++  S   N   +  +    N  +  L   +     L +L    N LT     D+ Q   
Sbjct: 78  TLDLSQNTN---LTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT 290
           L  L    N L+      ++  + L  LD   N     +        +   L    N+ T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 291 GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP--RC 348
                 +S +  LN LN   N++     L+      LT LD  +NK      T +     
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKL-----TEIDVTPL 232

Query: 349 RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTL 408
            +L   + + N  + ++  +      L+ L    + +  +      L     L       
Sbjct: 233 TQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEID-----LTHNTQLIYFQAE- 283

Query: 409 NFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWF 468
                K+      H   L +L   + G+   +   L    KL  + L+  +L+  + V  
Sbjct: 284 --GCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDV-- 335

Query: 469 GGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYN 528
                L  L   N     +   ++  +P+L                              
Sbjct: 336 SHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNF----------------------EAEG 371

Query: 529 QIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLS 588
           Q  + P    L+ N L  ++           + D   N ++  I     G+    T  ++
Sbjct: 372 QTITMPKET-LTNNSLTIAV--------SPDLLDQFGNPMN--IEPGDGGVYDQATNTIT 420

Query: 589 YNNLSGAIP 597
           + NLS   P
Sbjct: 421 WENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  114 bits (288), Expect = 5e-27
 Identities = 77/421 (18%), Positives = 130/421 (30%), Gaps = 65/421 (15%)

Query: 224 DIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV 283
           D F             ++    + S   L+ L  LD  +++ + ++      L     L+
Sbjct: 13  DWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLI 70

Query: 284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT 343
             SN  T  +   LS +  L  L   +N L     L+   LT LT L+  TNK      +
Sbjct: 71  CTSNNITT-LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVS 124

Query: 344 NLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
             P    L  +N ARN  + +I     +   L+ L        N       +     LTT
Sbjct: 125 QNP---LLTYLNCARNTLT-EID--VSHNTQLTELDCHL----NKKITKLDVTPQTQLTT 174

Query: 404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGT 463
           L  + N    K+          L  L   +  +   +   L    +L  +D S N+L+  
Sbjct: 175 LDCSFN----KITELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-E 226

Query: 464 IPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSAR 523
           I         L Y D S N  T      L+ L +L                         
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH------------------------ 260

Query: 524 GLQYNQIWSFPPT-----IDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTG 578
                 +     T     I             +  +  +L++ D +   ++     +L+ 
Sbjct: 261 -CIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQ 316

Query: 579 MTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN 638
              L  L L+   L+    + +   + L   S  N H+     S G+     N+      
Sbjct: 317 NPKLVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQ 372

Query: 639 L 639
            
Sbjct: 373 T 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  109 bits (275), Expect = 2e-25
 Identities = 65/390 (16%), Positives = 117/390 (30%), Gaps = 42/390 (10%)

Query: 104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDI 163
            L     L +L    N L     + +  L  L  L+  +N L+  L  +   P +  L+ 
Sbjct: 80  DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLDVS-QNPLLTYLNC 134

Query: 164 SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIAD 223
           + N+L   +  S         +  L  +         +     L  L    N +T     
Sbjct: 135 ARNTLT-EIDVSHNTQ-----LTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT---EL 185

Query: 224 DIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV 283
           D+ Q + L  L    N ++      +     L  LD SSN  +  I      L +  Y  
Sbjct: 186 DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239

Query: 284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT 343
              N  T     +LS   TL+ +      +D +        T L        +    L  
Sbjct: 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLT------HNTQLIYFQAEGCRKIKEL-- 291

Query: 344 NLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
           ++    +L  ++      + ++  +      L YL L+N+ +  L      +     L +
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELDLS--QNPKLVYLYLNNTELTELD-----VSHNTKLKS 343

Query: 404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG- 462
           L        +   +  ++    L     A         + L   S    V        G 
Sbjct: 344 LSCVNA-HIQDFSSVGKIP--ALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGN 400

Query: 463 --TIPVWFGGFQDLFYLDLSNNTFTGEIPK 490
              I    GG  D     ++    + + P 
Sbjct: 401 PMNIEPGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.4 bits (204), Expect = 2e-16
 Identities = 69/356 (19%), Positives = 111/356 (31%), Gaps = 79/356 (22%)

Query: 261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLN 320
            + +F+   PD       F   VA +         S     TL  L+  N+S+  + +  
Sbjct: 7   QTQSFNDWFPDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTG 59

Query: 321 CPALTNLTSLDLGTNKFNGPLPTNLP--RCRKLKNINLARNNFSGQIPETYKNFESLSYL 378
              LT LT L   +N       T L   +   L  +    N  +  +         L+YL
Sbjct: 60  IEKLTGLTKLICTSNNI-----TTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111

Query: 379 SLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG 438
           +   + +  L      + Q   LT L    N     L      H   L  L         
Sbjct: 112 NCDTNKLTKLD-----VSQNPLLTYLNCARN----TLTEIDVSHNTQLTELDCHLNKKIT 162

Query: 439 SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL 498
            +   +   ++L  +D S+N+++  +       + L  L+   N        N+T L   
Sbjct: 163 KLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTN--------NITKLD-- 207

Query: 499 ITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKL 558
           + +NI L                               +D S N+L   I  +   L +L
Sbjct: 208 LNQNIQLTF-----------------------------LDCSSNKLT-EI--DVTPLTQL 235

Query: 559 HVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
             FD   N L+    S L   + L TL     +L     I L   + L  F     
Sbjct: 236 TYFDCSVNPLTELDVSTL---SKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGC 285

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 80.5 bits (199), Expect = 8e-16
 Identities = 43/299 (14%), Positives = 93/299 (31%), Gaps = 25/299 (8%)

Query: 92  LYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQ 151
           L     K      +    QL  L+ S N +     + +     L  L+  +N+++  L  
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK-LDL 208

Query: 152 TINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC 211
                 +  LD SSN L   +  +       +   + SVN  +      +   + L  L 
Sbjct: 209 N-QNIQLTFLDCSSNKLT-EIDVTPLTQ---LTYFDCSVNPLT---ELDVSTLSKLTTLH 260

Query: 212 LGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD 271
               DL      D+    +L     +  +   +L   +   + L  LD  +   +  +  
Sbjct: 261 CIQTDLL---EIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD- 313

Query: 272 VFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLD 331
             +   +  YL  ++   T  +   +S++  L  L+  N  +      +   +  L +  
Sbjct: 314 -LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI--QDFSSVGKIPALNNNF 367

Query: 332 LGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSS 390
               +        L        ++    +  G           +   + +  +  NLS+
Sbjct: 368 EAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  131 bits (330), Expect = 2e-31
 Identities = 75/287 (26%), Positives = 111/287 (38%), Gaps = 48/287 (16%)

Query: 749  IIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNLVHL 803
             IG G FG V++       N    VAIK          R +F  E   + +  HP++V L
Sbjct: 397  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 804  QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             G    +N   +I      G L  +L  +     SLD  S +  A   +  LAYL     
Sbjct: 457  IGVIT-ENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLE---S 509

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PEY 918
               +HRDI + N+L+  N    L DFGL+R +    D+        + G +P     PE 
Sbjct: 510  KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYK---ASKGKLPIKWMAPES 563

Query: 919  GQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI---RM-RQENRESE 973
                  T   DV+ FGV + E+L  G +P    K     D+I  +    R+    N    
Sbjct: 564  INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLPMPPNCPPT 620

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                 +Y       M +       C +  P  RP   +L + L +I+
Sbjct: 621  -----LYSL-----MTK-------CWAYDPSRRPRFTELKAQLSTIL 650

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  124 bits (314), Expect = 3e-31
 Identities = 66/339 (19%), Positives = 119/339 (35%), Gaps = 89/339 (26%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPN 799
             +F+    +G GGFG+V+ A    D  N AIKR+   +      +   EV+AL++ +HP 
Sbjct: 6    TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 800  LVHLQGYCMH------------------------KNDRLLIYSFMENGSLDYW------- 828
            +V      +                          +   +    ++   +D +       
Sbjct: 66   IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 829  ----------------------LHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                                  L + ++        +    LHI    A  + +LH    
Sbjct: 126  QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183

Query: 864  PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT----------TDLVGTLGY 913
              ++HRD+K SNI    +    + DFGL   +    +              T  VGT  Y
Sbjct: 184  -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
            + PE    +  ++K D++S G++L ELL       M + +   D+           R  +
Sbjct: 243  MSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-QMERVRIITDV-----------RNLK 290

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               P ++ +++ +E      +    LS SP  RP    +
Sbjct: 291  F--PLLFTQKYPQEH----MMVQDMLSPSPTERPEATDI 323

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (314), Expect = 3e-31
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 21/215 (9%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH 797
           E  +       +G G FG V+R      G   A+K++  +  ++E     E+ A +    
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSS 109

Query: 798 PNLVHLQGYCMHKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           P +V L G  + +   + I+   +E GSL     + +     L  D  L+    A  GL 
Sbjct: 110 PRIVPLYG-AVREGPWVNIFMELLEGGSL----GQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILSPYDTHVTT---DLVGTL 911
           YLH      ILH D+K+ N+LL  + G+   L DFG A  +              + GT 
Sbjct: 165 YLHTR---RILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 912 GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
            ++ PE         K D++S   ++L +L G  P
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (311), Expect = 3e-31
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 12/203 (5%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
           ++G G +G+VY    L +   +AIK +     +  +    E+      +H N+V   G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 808 MHKNDRLLIY-SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI 866
              N  + I+   +  GSL   L  K  GP   +  +     +    GL YLH +    I
Sbjct: 89  SE-NGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 867 LHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQASV 923
           +HRDIK  N+L++   G   ++DFG ++ +        T    GTL Y+ PE        
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG 201

Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
                D++S G  ++E+ TGK P
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPP 224

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (317), Expect = 4e-31
 Identities = 73/363 (20%), Positives = 130/363 (35%), Gaps = 32/363 (8%)

Query: 53  WGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLR 112
             +N       + V I   +       + I       +      ++   +  L +  Q+ 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 113 FLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNG 170
            LNL+   ++     +      ++ L +  N +   LP  +  N+P + VL +  N L+ 
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS- 130

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
           S+P  I  N+ ++  +++S N     +         SL++L L  N LT     D+  + 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 186

Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
            L    +  N LS     ++A    +  LD S N+ +     V   L     L    N  
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNL 238

Query: 290 TGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
           T      L N P L  ++L  N    +     +    +  L  L +  N+    L     
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK---MQRLERLYISNNRLVA-LNLYGQ 292

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
               LK ++L+ N+    +      F+ L  L L ++SI  L      L     L  L L
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTL 346

Query: 407 TLN 409
           + N
Sbjct: 347 SHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  119 bits (300), Expect = 5e-29
 Identities = 59/423 (13%), Positives = 129/423 (30%), Gaps = 66/423 (15%)

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
           I  ++        + +               L+N   +   ++        +     + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKF 337
            L  +  +      ++ + + T+  L +  N    L   +  N   +  LT L L  N  
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN---VPLLTVLVLERNDL 129

Query: 338 NGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQ 397
           +           KL  ++++ NN      +T++   SL  L LS++ + ++      L  
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----LSL 184

Query: 398 CRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSW 457
             +L    ++ N     L          ++ L  +   +   +   +    +L ++ L  
Sbjct: 185 IPSLFHANVSYN-LLSTLAIPI-----AVEELDASHNSIN-VVRGPV--NVELTILKLQH 235

Query: 458 NQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFM 516
           N L+     W   +  L  +DLS N    +I  +    +  L                  
Sbjct: 236 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY-------------- 278

Query: 517 RRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL 576
                   +  N++ +                      +  L V DL HN+L   +    
Sbjct: 279 --------ISNNRLVALNLY---------------GQPIPTLKVLDLSHNHLLH-VERNQ 314

Query: 577 TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDG 636
                LE L L +N++     + L     L   ++++N           F+     + D 
Sbjct: 315 PQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDD 370

Query: 637 NNL 639
            + 
Sbjct: 371 ADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  115 bits (290), Expect = 1e-27
 Identities = 65/350 (18%), Positives = 112/350 (32%), Gaps = 44/350 (12%)

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP 340
           Y V         I  +L        +++   + D         L N   +    +     
Sbjct: 1   YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
               L   R+++ +NL            +    ++  L +  ++I  L     V Q    
Sbjct: 61  PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPP--HVFQNVPL 118

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
           LT LVL  N     LP     +   L  L +++  L        +  + LQ + LS N+L
Sbjct: 119 LTVLVLERN-DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177

Query: 461 SGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV 520
           +  +         LF+ ++S N         L+ L   I    ++EE             
Sbjct: 178 T-HVD--LSLIPSLFHANVSYN--------LLSTLAIPI----AVEELD----------- 211

Query: 521 SARGLQYNQIWSFPP-------TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIP 573
                 +N I             + L  N L  +      N   L   DL +N L   + 
Sbjct: 212 ----ASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 265

Query: 574 SELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG 623
                M  LE L +S N L  A+ +  + +  L    +++NHL   +   
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 313

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 21/88 (23%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQV 160
           L+     +  L+ L+LSHN L   V  +      LE L L  N +   L  +    +++ 
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS-THHTLKN 343

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINL 188
           L +S N  + +   ++ +N +R  V + 
Sbjct: 344 LTLSHNDWDCNSLRALFRNVARPAVDDA 371

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (312), Expect = 4e-31
 Identities = 72/336 (21%), Positives = 122/336 (36%), Gaps = 78/336 (23%)

Query: 729  EKEISIDDILE-STNNFDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQM 781
              +I  D   E    N      +G G FG V +AT    +       VA+K L  +    
Sbjct: 9    AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68

Query: 782  ER-EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL-DY------------ 827
            E  +  +E   L +  HP+++ L G C      LLI  + + GSL  +            
Sbjct: 69   ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128

Query: 828  -------WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
                             +L     +  A   ++G+ YL +     ++HRD+ + NIL+  
Sbjct: 129  GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

Query: 881  NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYS 932
                 ++DFGL+R +   Y+         + G IP      E        + T + DV+S
Sbjct: 186  GRKMKISDFGLSRDV---YEEDSYV--KRSQGRIPVKWMAIESLFDH---IYTTQSDVWS 237

Query: 933  FGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQH 984
            FGV+L E++T G  P   +          L + +    RM + +N         +Y    
Sbjct: 238  FGVLLWEIVTLGGNPYPGIP------PERLFNLLKTGHRMERPDN-----CSEEMY---- 282

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                     +   C  + P  RP    +   L+ ++
Sbjct: 283  --------RLMLQCWKQEPDKRPVFADISKDLEKMM 310

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (312), Expect = 6e-31
 Identities = 80/318 (25%), Positives = 123/318 (38%), Gaps = 81/318 (25%)

Query: 748  NIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQMER-EFRAEVEALSRAQHPNL 800
              IG G FG V++A  P          VA+K L  +     + +F+ E   ++   +PN+
Sbjct: 53   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWL--------------------HEKLDGPSSLD 840
            V L G C       L++ +M  G L+ +L                         GP  L 
Sbjct: 113  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 841  WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
               +L IA+  A G+AYL +      +HRD+ + N L+  N    +ADFGL+R I S   
Sbjct: 173  CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS--- 226

Query: 901  THVTTD--LVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP--- 946
                 D         IP     PE   Y      T + DV+++GVVL E+ + G +P   
Sbjct: 227  ----ADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPYYG 279

Query: 947  MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSES 1002
            M         ++I +V     +   EN   E     +Y+      M         C S+ 
Sbjct: 280  MA------HEEVIYYVRDGNILACPENCPLE-----LYNL-----MRL-------CWSKL 316

Query: 1003 PKVRPTTQQLVSWLDSII 1020
            P  RP+   +   L  + 
Sbjct: 317  PADRPSFCSIHRILQRMC 334

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (309), Expect = 6e-31
 Identities = 51/304 (16%), Positives = 112/304 (36%), Gaps = 76/304 (25%)

Query: 749  IIGCGGFGLVYRATLPDGRN--------VAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
             +G G F  +++    +  +        V +K L          F      +S+  H +L
Sbjct: 15   SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            V   G C+  ++ +L+  F++ GSLD +L +     + ++   +L +A+  A  + +L +
Sbjct: 75   VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 861  SCEPHILHRDIKSSNILLDGNFGAH--------LADFGLARLILSPYDTHVTTDLVGTLG 912
            +    ++H ++ + NILL               L+D G++  +       +         
Sbjct: 132  N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LPKDILQ------- 178

Query: 913  YIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLIS 960
                    PE     +        D +SFG  L E+ + G +P   +D      S+  + 
Sbjct: 179  -ERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKPLSALD------SQRKLQ 229

Query: 961  WVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
            +     ++   +  E       + +      +         C+   P  RP+ + ++  L
Sbjct: 230  FYEDRHQLPAPKAAE-------LANL-----INN-------CMDYEPDHRPSFRAIIRDL 270

Query: 1017 DSII 1020
            +S+ 
Sbjct: 271  NSLF 274

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (313), Expect = 1e-30
 Identities = 81/336 (24%), Positives = 127/336 (37%), Gaps = 81/336 (24%)

Query: 728  KEKEISIDDILESTNNFDQANI-----IGCGGFGLVYRATLPDGRN--------VAIKRL 774
             E E+  D   E      +  +     +G G FG V  A               VA+K L
Sbjct: 54   SEYELPEDPRWE----LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 109

Query: 775  SGDCGQMER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------- 825
              D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L       
Sbjct: 110  KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 169

Query: 826  -----DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
                 +Y  +   +    L     +  A   ARG+ YL        +HRD+ + N+L+  
Sbjct: 170  RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE 226

Query: 881  NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYS 932
            +    +ADFGLAR I   +          T G +P     PE        + T++ DV+S
Sbjct: 227  DNVMKIADFGLARDI---HHIDYYK--KTTNGRLPVKWMAPEALFDR---IYTHQSDVWS 278

Query: 933  FGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQH 984
            FGV+L E+ T G  P   +         +L   +    RM +  N  +E     +Y    
Sbjct: 279  FGVLLWEIFTLGGSPYPGVP------VEELFKLLKEGHRMDKPSNCTNE-----LYMM-- 325

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               M         C    P  RPT +QLV  LD I+
Sbjct: 326  ---MRD-------CWHAVPSQRPTFKQLVEDLDRIV 351

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  122 bits (309), Expect = 1e-30
 Identities = 82/326 (25%), Positives = 123/326 (37%), Gaps = 66/326 (20%)

Query: 729  EKEISIDDILE-STNNFDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCGQM 781
              ++  ++  E   NN      +G G FG V  AT            VA+K L       
Sbjct: 32   PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91

Query: 782  ER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------- 832
            E+    +E++ +S   QH N+V+L G C H    L+I  +   G L  +L  K       
Sbjct: 92   EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151

Query: 833  ---LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF 889
                   S+      LH +   A+G+A+L      + +HRD+ + N+LL     A + DF
Sbjct: 152  PAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 890  GLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELL 941
            GLAR I    +       V     +P     PE        V T + DV+S+G++L E+ 
Sbjct: 209  GLARDI---MNDSNYI--VKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIF 260

Query: 942  T-GKRPMDMCKP--KGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDI 994
            + G  P     P    +      V    +M Q            IY       M      
Sbjct: 261  SLGLNPY----PGILVNSKFYKLVKDGYQMAQPAFAPKN-----IYSI-----MQA---- 302

Query: 995  ACLCLSESPKVRPTTQQLVSWLDSII 1020
               C +  P  RPT QQ+ S+L    
Sbjct: 303  ---CWALEPTHRPTFQQICSFLQEQA 325

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (307), Expect = 1e-30
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 34/290 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQH 797
            + ++++   +IG G   +V  A   P    VAIKR++ +  Q   +    E++A+S+  H
Sbjct: 13   NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72

Query: 798  PNLVHLQGYCMHKNDRL-LIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIA---QGAA 852
            PN+V          D L L+   +  GS+ D   H    G           IA   +   
Sbjct: 73   PNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT---TDLVG 909
             GL YLH++     +HRD+K+ NILL  +    +ADFG++  + +  D          VG
Sbjct: 132  EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 910  TLGYIPPE-YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            T  ++ PE   Q     +K D++SFG+  +EL TG  P     P         V+ +  +
Sbjct: 189  TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQ 241

Query: 969  NR----ESEVLDPFIYDK--QHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            N     E+ V D  +  K  +  ++M+       LCL + P+ RPT  +L
Sbjct: 242  NDPPSLETGVQDKEMLKKYGKSFRKMIS------LCLQKDPEKRPTAAEL 285

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  122 bits (307), Expect = 2e-30
 Identities = 56/299 (18%), Positives = 113/299 (37%), Gaps = 22/299 (7%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
           R     +    LK  L+    +   ++ L+LS N L       L     LE+L+LSSN L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 146 SGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA 205
                   +L +++ LD+++N +       +      I  ++ + N  S  +S   G   
Sbjct: 71  YE-TLDLESLSTLRTLDLNNNYV-----QEL-LVGPSIETLHAANNNIS-RVSCSRGQ-- 120

Query: 206 SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNN 264
             +++ L  N +T     D     +++ L L+ N++     +   A    L  L++  N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNC 321
              ++        + + L   SN+    +     ++  +  ++LRNN    ++ +L    
Sbjct: 181 IY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALR--- 234

Query: 322 PALTNLTSLDLGTNKFN-GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLS 379
               NL   DL  N F+ G L     + ++++ +            E      +L +  
Sbjct: 235 -FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 50/295 (16%), Positives = 87/295 (29%), Gaps = 54/295 (18%)

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS 383
                   +  +     L +       +K ++L+ N  S         F  L  L+LS++
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 384 SIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW 443
            +Y        L+    L TL L  N     +         +++ L  A+  +       
Sbjct: 69  VLYETLD----LESLSTLRTLDLNNN----YVQELLVGP--SIETLHAANNNISRVSCSR 118

Query: 444 LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-EIPKNLTGLPSLITRN 502
            +G    + + L+ N+++    +  G    + YLDL  N        +      +L   N
Sbjct: 119 GQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 503 ISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFD 562
                                 LQYN I+     +                   KL   D
Sbjct: 176 ----------------------LQYNFIYDVKGQV----------------VFAKLKTLD 197

Query: 563 LKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           L  N L+  +  E      +  + L  N L   I  +L     L  F +  N   
Sbjct: 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 24/201 (11%), Positives = 59/201 (29%), Gaps = 39/201 (19%)

Query: 439 SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL 498
           +I +  +  ++ ++  ++ + L   +        ++  LDLS N  +     +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 499 ITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP--------TIDLSLNRLDGSIWP 550
              N                      L  N ++            T+DL+ N +      
Sbjct: 61  ELLN----------------------LSSNVLYETLDLESLSTLRTLDLNNNYVQ----- 93

Query: 551 EFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFS 610
           E      +      +NN+S  +          + + L+ N ++    +     S +    
Sbjct: 94  ELLVGPSIETLHAANNNISR-VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 611 VANNHLTGRIPSGGQFQTFPN 631
           +  N +   +       +   
Sbjct: 151 LKLNEID-TVNFAELAASSDT 170

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  123 bits (310), Expect = 2e-30
 Identities = 79/336 (23%), Positives = 123/336 (36%), Gaps = 73/336 (21%)

Query: 724  LFHNKEKEISIDDILE-STNNFDQANIIGCGGFGLVYRATLPDGRN--------VAIKRL 774
            L    E E+  D   E   +       +G G FG V  A               VA+K L
Sbjct: 62   LAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML 121

Query: 775  SGDCGQMER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------- 825
              D  + +  +  +E+E +    +H N+++L G C       +I  +   G+L       
Sbjct: 122  KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR 181

Query: 826  -----DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG 880
                 +Y           + +   +      ARG+ YL        +HRD+ + N+L+  
Sbjct: 182  RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE 238

Query: 881  NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASVATYKGDVYS 932
            N    +ADFGLAR I    +         T G +P     PE        V T++ DV+S
Sbjct: 239  NNVMKIADFGLARDI---NNIDYYK--KTTNGRLPVKWMAPEALFDR---VYTHQSDVWS 290

Query: 933  FGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQH 984
            FGV++ E+ T G  P   +         +L   +    RM +  N         +Y    
Sbjct: 291  FGVLMWEIFTLGGSPYPGIP------VEELFKLLKEGHRMDKPAN-----CTNELY---- 335

Query: 985  DKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                     +   C    P  RPT +QLV  LD I+
Sbjct: 336  --------MMMRDCWHAVPSQRPTFKQLVEDLDRIL 363

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (304), Expect = 3e-30
 Identities = 65/283 (22%), Positives = 120/283 (42%), Gaps = 33/283 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRA-Q 796
              ++ +    +G G +G+V +   +P G+ +A+KR+       E++    +++   R   
Sbjct: 5    KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             P  V   G    + D   ++  ME  + SLD +  + +D   ++  D    IA    + 
Sbjct: 65   CPFTVTFYGALFREGD---VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL-ARLILSPYDTHVTTDLVGTLGY 913
            L +LH   +  ++HRD+K SN+L++      + DFG+   L+    D        G   Y
Sbjct: 122  LEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDAGCKPY 175

Query: 914  IPPE--YGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN 969
            + PE    + +   Y  K D++S G+ ++EL   + P D           SW    +Q  
Sbjct: 176  MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLK 224

Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            +  E   P +   +   E +        CL ++ K RPT  +L
Sbjct: 225  QVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPEL 264

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (306), Expect = 3e-30
 Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 46/301 (15%)

Query: 731  EISIDDILE-STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRA 787
            +IS +   + +  +      IG G +G V +    P G+ +A+KR+     + E++    
Sbjct: 10   KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM 69

Query: 788  EVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHE-KLDGPSSLDWDS 843
            +++ + R+   P +V   G    + D    +  ME  + S D +           +  + 
Sbjct: 70   DLDVVMRSSDCPYIVQFYGALFREGD---CWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126

Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL-ARLILSPYDTH 902
               I     + L +L +     I+HRDIK SNILLD +    L DFG+  +L+    D+ 
Sbjct: 127  LGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV----DSI 180

Query: 903  VTTDLVGTLGYIPPE--YGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL 958
              T   G   Y+ PE     AS   Y  + DV+S G+ L EL TG+ P          D 
Sbjct: 181  AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS--VFDQ 238

Query: 959  ISWVIRM-------RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
            ++ V++         +E   S     F+                 LCL++    RP  ++
Sbjct: 239  LTQVVKGDPPQLSNSEEREFSPSFINFV----------------NLCLTKDESKRPKYKE 282

Query: 1012 L 1012
            L
Sbjct: 283  L 283

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  121 bits (305), Expect = 4e-30
 Identities = 73/310 (23%), Positives = 111/310 (35%), Gaps = 70/310 (22%)

Query: 748  NIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSR-AQHPN 799
              +G G FG V  A           R VA+K L       E     +E++ L     H N
Sbjct: 33   KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 800  LVHLQGYCMHKND-RLLIYSFMENGSL------------DYWLHEKLDGPSSLDWDSRLH 846
            +V+L G C       ++I  F + G+L             Y +  +      L  +  + 
Sbjct: 93   VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 847  IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
             +   A+G+ +L        +HRD+ + NILL       + DFGLAR I   Y       
Sbjct: 153  YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPDYV- 205

Query: 907  LVGTLGYIP-----PE---YGQASVATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKG 954
                   +P     PE        V T + DV+SFGV+L E+ + G  P   +     K 
Sbjct: 206  -RKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGASPYPGV-----KI 256

Query: 955  SRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ 1010
              +    +    RMR  +    E     +Y                 C    P  RPT  
Sbjct: 257  DEEFCRRLKEGTRMRAPDYTTPE-----MY------------QTMLDCWHGEPSQRPTFS 299

Query: 1011 QLVSWLDSII 1020
            +LV  L +++
Sbjct: 300  ELVEHLGNLL 309

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  120 bits (304), Expect = 6e-30
 Identities = 45/260 (17%), Positives = 89/260 (34%), Gaps = 18/260 (6%)

Query: 68  ITCNSSSSL-GLNDSIGSGRVTGLF---LYKRRLKGKLSESLGNLVQLRFLNLSHNLLKG 123
           I   +  +L    D +      G     L    L  +  +    L  L+ + +    L  
Sbjct: 60  IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM- 117

Query: 124 TVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSR 182
            +P ++     LE L L+ N L   LP +I +L  ++ L I +      +P  +    + 
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 183 I--------RVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLL 234
                    + + L       +L   + N  +L+ L +  + L+  +   I  L KL  L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234

Query: 235 GLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIP 294
            L+         P     + L RL +   +    +P     L + + L         R+P
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 295 HSLSNSPTLNLLNLRNNSLD 314
             ++  P   ++ +  +   
Sbjct: 295 SLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  115 bits (290), Expect = 4e-28
 Identities = 58/405 (14%), Positives = 100/405 (24%), Gaps = 84/405 (20%)

Query: 99  GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSI 158
           G       +      L    +         L         D +    +       N  + 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA---NSNNP 58

Query: 159 QVLDISSNSLNGSVPTSICK-NSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDL 217
           Q+   +  +L  +    +          + L                + L+H+ +    L
Sbjct: 59  QIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

Query: 218 TGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
              + D + Q   L  L L  N L   L  SIA L+ L  L + +      +P+  A   
Sbjct: 117 ME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST- 173

Query: 278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA----LTNLTSLDLG 333
                                    L  L L    +  SL    PA    L NL SL + 
Sbjct: 174 --------------DASGEHQGLVNLQSLRLEWTGIR-SL----PASIANLQNLKSLKIR 214

Query: 334 TNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQ 393
            +  +  L   +    KL+ ++L         P  +     L  L L +           
Sbjct: 215 NSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD----------- 262

Query: 394 VLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLV 453
               C NL TL                                    P  +   ++L+ +
Sbjct: 263 ----CSNLLTL------------------------------------PLDIHRLTQLEKL 282

Query: 454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL 498
           DL        +P           + +  +             P+ 
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  110 bits (278), Expect = 1e-26
 Identities = 51/311 (16%), Positives = 106/311 (34%), Gaps = 38/311 (12%)

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS 383
            +   +L    +    P    L + ++  N +  R + + +           +   +   
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-------SNNPQIETR 63

Query: 384 SIYNLSSALQVLQQCRNLTTLVLTLNFRN-EKLPTDPRLHFANLKVLVIASCGLRGSIPQ 442
           +   L +   +L+       + L L      + P D     ++L+ + I + GL   +P 
Sbjct: 64  TGRALKATADLLEDATQPGRVALELRSVPLPQFP-DQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 443 WLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGL--PSLIT 500
            ++  + L+ + L+ N L   +P        L  L +       E+P+ L          
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 501 RNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI---------DLSLNRLDGSIWPE 551
             ++L+                  L++  I S P +I          +  + L  ++ P 
Sbjct: 181 GLVNLQSLR---------------LEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPA 224

Query: 552 FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSV 611
             +L KL   DL+        P    G   L+ L L   +    +P+ + +L+ L K  +
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284

Query: 612 ANNHLTGRIPS 622
                  R+PS
Sbjct: 285 RGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  110 bits (277), Expect = 2e-26
 Identities = 56/372 (15%), Positives = 110/372 (29%), Gaps = 66/372 (17%)

Query: 252 LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN 311
            S    L    +     +      L ++Q                 +NS    +      
Sbjct: 11  SSGRENLYFQGST---ALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQIETRTGR 66

Query: 312 SL--DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETY 369
           +L     LL +        +L+L +       P    R   L+++ +       ++P+T 
Sbjct: 67  ALKATADLLEDA-TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVL 429
           + F  L  L+L+ + +  L +++        L  L +       +LP             
Sbjct: 124 QQFAGLETLTLARNPLRALPASIA---SLNRLRELSIRACPELTELPEP----------- 169

Query: 430 VIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIP 489
            +AS           +G   LQ + L W  +  ++P      Q+L  L + N+  +  + 
Sbjct: 170 -LAST----DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222

Query: 490 KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIW 549
             +  LP L   ++                          + ++PP              
Sbjct: 223 PAIHHLPKLEELDLR---------------------GCTALRNYPPIF------------ 249

Query: 550 PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKF 609
              G    L    LK  +    +P ++  +T LE LDL        +P  + +L      
Sbjct: 250 ---GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306

Query: 610 SVANNHLTGRIP 621
            V  +       
Sbjct: 307 LVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 23/241 (9%), Positives = 46/241 (19%), Gaps = 56/241 (23%)

Query: 388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGC 447
           + S+            L    +              +  +    A      S  +     
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHD----VLSQWQRHYNADRNRWHSAWR-QANS 55

Query: 448 SKLQLVDLSWNQLSGTIPVWFGGFQD--LFYLDLSNNTFTGEIPKNLTGLPSLITRNISL 505
           +  Q+   +   L                  L+L +          L   P    R   L
Sbjct: 56  NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSV--------PLPQFPDQAFRLSHL 106

Query: 506 EEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH 565
           +                              + +    L   +         L    L  
Sbjct: 107 QH-----------------------------MTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSF---------LSKFSVANNHL 616
           N L   +P+ +  +  L  L +        +P  L              L    +    +
Sbjct: 137 NPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 617 T 617
            
Sbjct: 196 R 196

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  125 bits (315), Expect = 7e-30
 Identities = 73/363 (20%), Positives = 130/363 (35%), Gaps = 32/363 (8%)

Query: 53  WGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLR 112
             +N       + V I   +       + I       +      ++   +  L +  Q+ 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 113 FLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNG 170
            LNL+   ++     +      ++ L +  N +   LP  +  N+P + VL +  N L+ 
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS- 136

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
           S+P  I  N+ ++  +++S N     +         SL++L L  N LT     D+  + 
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIP 192

Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
            L    +  N LS     ++A    +  LD S N+ +     V   L     L    N  
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNL 244

Query: 290 TGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
           T      L N P L  ++L  N    +     +    +  L  L +  N+    L     
Sbjct: 245 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK---MQRLERLYISNNRLVA-LNLYGQ 298

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
               LK ++L+ N+    +      F+ L  L L ++SI  L      L     L  L L
Sbjct: 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-----LSTHHTLKNLTL 352

Query: 407 TLN 409
           + N
Sbjct: 353 SHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  114 bits (286), Expect = 2e-26
 Identities = 57/401 (14%), Positives = 123/401 (30%), Gaps = 65/401 (16%)

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
           I  ++        + +               L+N   +   ++        +     + +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKF 337
            L  +  +      ++ + + T+  L +  N    L   +  N   +  LT L L  N  
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN---VPLLTVLVLERNDL 135

Query: 338 NGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQ 397
           +           KL  ++++ NN      +T++   SL  L LS++ + ++      L  
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD-----LSL 190

Query: 398 CRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSW 457
             +L    ++ N     L          ++ L  +   +   +        +L ++ L  
Sbjct: 191 IPSLFHANVSYN-LLSTLAIPI-----AVEELDASHNSIN-VVRG--PVNVELTILKLQH 241

Query: 458 NQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFM 516
           N L+     W   +  L  +DLS N    +I  +    +  L                  
Sbjct: 242 NNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY-------------- 284

Query: 517 RRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL 576
                   +  N++ +                      +  L V DL HN+L   +    
Sbjct: 285 --------ISNNRLVALNLY---------------GQPIPTLKVLDLSHNHLLH-VERNQ 320

Query: 577 TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
                LE L L +N++     + L     L   ++++N   
Sbjct: 321 PQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 10/99 (10%), Positives = 33/99 (33%), Gaps = 15/99 (15%)

Query: 525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLET 584
            + + +   P  +                + +++ + +L    +            +++ 
Sbjct: 58  FKNSTMRKLPAAL--------------LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQK 103

Query: 585 LDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG 623
           L + +N +    P   + +  L+   +  N L+  +P G
Sbjct: 104 LYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (300), Expect = 1e-29
 Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 52/283 (18%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHPNLV 801
            F +   IG G FG V++       + VAIK +  +  + E E  + E+  LS+   P + 
Sbjct: 24   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 802  HLQGYCMHKNDRL-LIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIA---QGAARGLA 856
               G    K+ +L +I  ++  GS  D      LD            IA   +   +GL 
Sbjct: 84   KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---------QIATILREILKGLD 133

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YLH       +HRDIK++N+LL  +    LADFG+A  +        T   VGT  ++ P
Sbjct: 134  YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 188

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM-------RQEN 969
            E  + S    K D++S G+  +EL  G+ P     P         V+ +         E 
Sbjct: 189  EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNPPTLEG 241

Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
              S+ L  F+                  CL++ P  RPT ++L
Sbjct: 242  NYSKPLKEFVE----------------ACLNKEPSFRPTAKEL 268

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  118 bits (299), Expect = 1e-29
 Identities = 61/304 (20%), Positives = 97/304 (31%), Gaps = 68/304 (22%)

Query: 741  TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMERE-FRAEVEALSR-AQ 796
            T  F +   IG G FG V++     DG   AIKR      G ++ +    EV A +   Q
Sbjct: 10   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            H ++V         +D +LI    E    GSL   + E     S         +     R
Sbjct: 70   HSHVVRYFSAWAE-DDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGN-------------------FGAHLADFGLARL 894
            GL Y+H      ++H DIK SNI +                          + D G    
Sbjct: 127  GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRP---MDMC 950
            I SP          G   ++  E  Q +     K D+++  + ++     +      D  
Sbjct: 184  ISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

Query: 951  K--PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
                +G    I  V+        S+     +                 + +   P+ RP+
Sbjct: 238  HEIRQGRLPRIPQVL--------SQEFTELLK----------------VMIHPDPERRPS 273

Query: 1009 TQQL 1012
               L
Sbjct: 274  AMAL 277

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 1e-29
 Identities = 64/332 (19%), Positives = 110/332 (33%), Gaps = 52/332 (15%)

Query: 725  FHNKEKEISIDDILESTNNFDQANIIGCG--GFGLVYRAT-LPDGRNVAIKRLSGDCGQM 781
                     +   L     ++   +IG G      V  A   P G  V ++R++ +    
Sbjct: 8    HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 782  ER--EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSL 839
            E     + E+       HPN+V  +   +  N+  ++ SFM  GS    +        + 
Sbjct: 68   EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127

Query: 840  DWDSRLHIA---QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
                   IA   QG  + L Y+H       +HR +K+S+IL+  +   +L+       ++
Sbjct: 128  LA-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179

Query: 897  SPYDTHVT-----TDLVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELLTGKRP--- 946
            S               V  L ++ PE  Q ++  Y  K D+YS G+   EL  G  P   
Sbjct: 180  SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239

Query: 947  -----MDMCKPKGS----RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIAC- 996
                 M + K  G+     D  +        +    V +  + D             +  
Sbjct: 240  MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPS 299

Query: 997  ----------------LCLSESPKVRPTTQQL 1012
                             CL  +P  RP+   L
Sbjct: 300  HPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (301), Expect = 2e-29
 Identities = 77/345 (22%), Positives = 126/345 (36%), Gaps = 85/345 (24%)

Query: 724  LFHNKEKEISIDDILESTNNFDQANI-----IGCGGFGLVYRATLPDGRN------VAIK 772
             F+   +E   D   E    F + N+     +G G FG V  AT            VA+K
Sbjct: 26   YFYVDFREYEYDLKWE----FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 81

Query: 773  RLSGDCGQMER-EFRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL- 829
             L       ER    +E++ +++   H N+V+L G C       LI+ +   G L  +L 
Sbjct: 82   MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141

Query: 830  ------------------HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI 871
                               E+ +  + L ++  L  A   A+G+ +L        +HRD+
Sbjct: 142  SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198

Query: 872  KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP-----PE---YGQASV 923
             + N+L+       + DFGLAR I            V     +P     PE    G   +
Sbjct: 199  AARNVLVTHGKVVKICDFGLARDI---MSDSNYV--VRGNARLPVKWMAPESLFEG---I 250

Query: 924  ATYKGDVYSFGVVLLELLT-GKRP---MDMCKPKGSRDLISWVI---RMRQ-ENRESEVL 975
             T K DV+S+G++L E+ + G  P   + +       +    +    +M Q      E  
Sbjct: 251  YTIKSDVWSYGILLWEIFSLGVNPYPGIPV-----DANFYKLIQNGFKMDQPFYATEE-- 303

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               IY             I   C +   + RP+   L S+L   +
Sbjct: 304  ---IY------------IIMQSCWAFDSRKRPSFPNLTSFLGCQL 333

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  122 bits (308), Expect = 3e-29
 Identities = 77/497 (15%), Positives = 163/497 (32%), Gaps = 54/497 (10%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
              LN+S N +       +++L  L +L +S N +   L  ++      ++ LD+S N L
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKL 81

Query: 169 NGSVPTSICKNSSRIRVINLSVNYF-SGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
              +    C  +  ++ ++LS N F +  +    GN + L+ L L    L       I  
Sbjct: 82  V-KIS---CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
           L   ++L +       K  P    L +     +     +         +          +
Sbjct: 138 LNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 288 RFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR 347
                +  +  +     L  L+ N    +L LN    T  + + +    ++  +      
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV-----W 250

Query: 348 CRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLT 407
              + N+ L           +  + ++LS   + +       S   + +   N+     T
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY--IYEIFSNMNIKNFT 308

Query: 408 LNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW 467
           ++     +        +    L  ++  L  ++ +     ++L+ + L  NQL   +   
Sbjct: 309 VS-GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKI 366

Query: 468 FGGFQD---LFYLDLSNNTFTGEIPKNL-TGLPSLITRNISLEEPSPDFPFFMRRNVSAR 523
                    L  LD+S N+ + +  K   +   SL++ N                     
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN--------------------- 405

Query: 524 GLQYNQIWSFPPT--------IDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSE 575
            +  N +              +DL  N++  SI  +   L+ L   ++  N L       
Sbjct: 406 -MSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGI 463

Query: 576 LTGMTSLETLDLSYNNL 592
              +TSL+ + L  N  
Sbjct: 464 FDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.2 bits (229), Expect = 2e-19
 Identities = 76/403 (18%), Positives = 134/403 (33%), Gaps = 46/403 (11%)

Query: 100 KLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLP-------QT 152
            + +  GN+ QL+FL LS   L+ +  + + +L   +VL +                  T
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNT 165

Query: 153 INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLS--PGLGNCASLEHL 210
            +L  +   +   + +      ++           L  N  S  LS    L     L +L
Sbjct: 166 ESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225

Query: 211 CLGMNDLTGGIADDIFQLQK---LRLLGLQDNQLSGKLSPSIADLSN-----LVRLDVSS 262
            L   + T      I QL     +    + + +L G+L     D S      L    V S
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCP 322
           + F      ++             +          S       L+  NN L  ++  NC 
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345

Query: 323 ALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
            LT L +L L  N              +LK ++                 +SL  L +S 
Sbjct: 346 HLTELETLILQMN--------------QLKELSKIAEMT--------TQMKSLQQLDISQ 383

Query: 383 SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF-ANLKVLVIASCGLRGSIP 441
           +S+ +           ++L +L ++ N     L           +KVL + S  ++ SIP
Sbjct: 384 NSV-SYDEKKGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSNKIK-SIP 437

Query: 442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTF 484
           + +     LQ ++++ NQL       F     L  + L  N +
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 53/389 (13%), Positives = 109/389 (28%), Gaps = 44/389 (11%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
                L++S N  S         L + + L+   NR           +  L  L+L +N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNG-PLPTNLPRCRKLKNINLARNNFSGQIPETYKN 371
           L     ++C    NL  LDL  N F+  P+        +LK + L+  +          +
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 372 FES--LSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFR---NEKLPTDPRLHFANL 426
                +  +             LQ                F    +  + T   L  +N+
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 427 KVLVIA-SCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQD---LFYLDLSNN 482
           K ++    C    SI   L+   KL  + L+  + +    +          ++Y  +SN 
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257

Query: 483 TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLN 542
              G++            + +S+                                 +  +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIH-------------------------------QVVSD 286

Query: 543 RLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEK 602
                    +     +++ +   +          + ++    LD S N L+  +  +   
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346

Query: 603 LSFLSKFSVANNHLTGRIPSGGQFQTFPN 631
           L+ L    +  N L              +
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKS 375

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.1 bits (200), Expect = 6e-16
 Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 21/245 (8%)

Query: 107 NLVQLRFLNLSHNLLKG-----TVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQV 160
               + + ++S+  L+G         S  +L  L +  + S+    P         ++ +
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNI 304

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT-- 218
            + + +     V        S    ++ S N  + T+    G+   LE L L MN L   
Sbjct: 305 KNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL 363

Query: 219 GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGLG 277
             IA+   Q++ L+ L +  N +S            +L+ L++SSN  +  I        
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PP 421

Query: 278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLG 333
             + L  HSN+    IP  +     L  LN+ +N L    DG        LT+L  + L 
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIF----DRLTSLQKIWLH 476

Query: 334 TNKFN 338
           TN ++
Sbjct: 477 TNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.4 bits (167), Expect = 6e-12
 Identities = 37/202 (18%), Positives = 75/202 (37%), Gaps = 32/202 (15%)

Query: 68  ITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV 127
            T + +  + +           L      L   + E+ G+L +L  L L  N LK    +
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366

Query: 128 SLV--NLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRI 183
           + +   + +L+ LD+S N +S    +       S+  L++SSN L  ++   +       
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR---- 422

Query: 184 RVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG 243
                                  ++ L L  N +   I   + +L+ L+ L +  NQL  
Sbjct: 423 -----------------------IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458

Query: 244 KLSPSIADLSNLVRLDVSSNNF 265
                   L++L ++ + +N +
Sbjct: 459 VPDGIFDRLTSLQKIWLHTNPW 480

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  116 bits (292), Expect = 2e-28
 Identities = 73/296 (24%), Positives = 127/296 (42%), Gaps = 36/296 (12%)

Query: 730  KEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAE 788
             EI +  + +    F+   ++G G +G VY+   +  G+  AIK +    G  E E + E
Sbjct: 12   DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQE 70

Query: 789  VEALSRA-QHPNLVH-----LQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDW 841
            +  L +   H N+       ++      +D+L L+  F   GS+   +          +W
Sbjct: 71   INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130

Query: 842  DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT 901
             +  +I +   RGL++LHQ     ++HRDIK  N+LL  N    L DFG++  +      
Sbjct: 131  IA--YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185

Query: 902  HVTTDLVGTLGYIPPE---YGQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSR 956
              T   +GT  ++ PE     +   ATY  K D++S G+  +E+  G  P+    P    
Sbjct: 186  RNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---- 239

Query: 957  DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                  + +   N       P +  K+  K+    ++    CL ++   RP T+QL
Sbjct: 240  ---MRALFLIPRNPA-----PRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQL 284

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  114 bits (288), Expect = 4e-28
 Identities = 62/276 (22%), Positives = 118/276 (42%), Gaps = 37/276 (13%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            + +   IG G  G VY A  +  G+ VAI++++      +     E+  +   ++PN+V+
Sbjct: 22   YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 803  LQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIA---QGAARGLAYL 858
                 +  ++  ++  ++  GSL D      +D            IA   +   + L +L
Sbjct: 82   YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---------QIAAVCRECLQALEFL 132

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
            H +    ++HRDIKS NILL  +    L DFG     ++P  +  +T +VGT  ++ PE 
Sbjct: 133  HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRST-MVGTPYWMAPEV 187

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI--SWVIRMRQENRESEVLD 976
                    K D++S G++ +E++ G+ P     P  +  LI  +    ++   + S +  
Sbjct: 188  VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             F+                  CL    + R + ++L
Sbjct: 248  DFLN----------------RCLEMDVEKRGSAKEL 267

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (295), Expect = 5e-28
 Identities = 68/299 (22%), Positives = 108/299 (36%), Gaps = 50/299 (16%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNL 800
            N      I+G G  G V       GR VA+KR+  D          E++ L+    HPN+
Sbjct: 15   NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 801  VHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRL---HIAQGAARGL 855
            +    YC        +Y  +E  N +L   +  K     +L          + +  A G+
Sbjct: 72   IRY--YCSET-TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 856  AYLHQSCEPHILHRDIKSSNILLD-------------GNFGAHLADFGLARLILSPYDTH 902
            A+LH      I+HRD+K  NIL+               N    ++DFGL +  L    + 
Sbjct: 129  AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-KLDSGQSS 184

Query: 903  VTTDL---VGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP 952
              T+L    GT G+  PE              T   D++S G V   +L+  +      P
Sbjct: 185  FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----P 239

Query: 953  KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
             G +      I     + +       ++D+    E     D+    +   P  RPT  +
Sbjct: 240  FGDKYSRESNIIRGIFSLDEM---KCLHDRSLIAE---ATDLISQMIDHDPLKRPTAMK 292

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (285), Expect = 1e-27
 Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 46/289 (15%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRA-Q 796
              N+ +    +G G  G V++      G  +A+K++     + E +    +++ + ++  
Sbjct: 23   EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             P +V   G  +   D   ++  ME      +  L +++ GP          +     + 
Sbjct: 83   CPYIVQCFGTFITNTD---VFIAMELMGTCAEK-LKKRMQGPIPERILG--KMTVAIVKA 136

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL-ARLILSPYDTHVTTDLVGTLGY 913
            L YL +  +  ++HRD+K SNILLD      L DFG+  RL+    D        G   Y
Sbjct: 137  LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKDRSAGCAAY 190

Query: 914  IPPEYGQASVA-----TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI----- 963
            + PE              + DV+S G+ L+EL TG+ P      K   ++++ V+     
Sbjct: 191  MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP--YKNCKTDFEVLTKVLQEEPP 248

Query: 964  RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             +      S     F+                  CL++  + RP   +L
Sbjct: 249  LLPGHMGFSGDFQSFV----------------KDCLTKDHRKRPKYNKL 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (287), Expect = 1e-27
 Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 43/249 (17%)

Query: 726 HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLS---------- 775
           + KEK+  I+D       +     +  G F  +      D +  A+K+            
Sbjct: 22  YVKEKDKYIND-------YRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDF 73

Query: 776 -------GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSL-D 826
                          +F+ E++ ++  ++   +  +G  +   D + +IY +MEN S+  
Sbjct: 74  TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILK 132

Query: 827 Y-----WLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN 881
           +      L +            +  I        +Y+H   E +I HRD+K SNIL+D N
Sbjct: 133 FDEYFFVLDKNYTCFIP-IQVIKCIIKS-VLNSFSYIHN--EKNICHRDVKPSNILMDKN 188

Query: 882 FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLE 939
               L+DFG +  +    D  +     GT  ++PPE    ++S    K D++S G+ L  
Sbjct: 189 GRVKLSDFGESEYM---VDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

Query: 940 LLTGKRPMD 948
           +     P  
Sbjct: 245 MFYNVVPFS 253

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  113 bits (285), Expect = 1e-27
 Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 37/276 (13%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
             D    IG G  G+V  A     GR VA+K +     Q       EV  +   QH N+V 
Sbjct: 47   LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 803  LQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIA---QGAARGLAYL 858
            +    +   +  ++  F++ G+L D     +L+            IA   +   + LAYL
Sbjct: 107  MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---------QIATVCEAVLQALAYL 157

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
            H      ++HRDIKS +ILL  +    L+DFG    I        +  LVGT  ++ PE 
Sbjct: 158  HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEV 212

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI--SWVIRMRQENRESEVLD 976
               S+   + D++S G++++E++ G+ P     P  +   +  S   +++  ++ S VL 
Sbjct: 213  ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR 272

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             F+                   L   P+ R T Q+L
Sbjct: 273  DFLE----------------RMLVRDPQERATAQEL 292

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (282), Expect = 3e-27
 Identities = 65/300 (21%), Positives = 104/300 (34%), Gaps = 37/300 (12%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPN 799
            + +  ++I+G G    V+R      G   AIK  +     +       E E L +  H N
Sbjct: 9    HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 800  LVHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            +V L      +         ME    GSL   L E       L     L + +    G+ 
Sbjct: 69   IVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMN 126

Query: 857  YLHQSCEPHILHRDIKSSNILL----DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            +L ++    I+HR+IK  NI+     DG     L DFG AR +    D      L GT  
Sbjct: 127  HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEE 180

Query: 913  YIPPEYGQASVATYKG--------DVYSFGVVLLELLTGKRP-MDMCKPKGSRDLISWVI 963
            Y+ P+  + +V             D++S GV      TG  P      P+ +++++  +I
Sbjct: 181  YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 964  RMRQENRESEVLDP------FIYDKQHDKEMLRVL-----DIACLCLSESPKVRPTTQQL 1012
              +     S V         +  D      + R L      +    L    +      Q 
Sbjct: 241  TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 3e-27
 Identities = 64/282 (22%), Positives = 114/282 (40%), Gaps = 42/282 (14%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            ++    +G G FG VY+A     G   A K +     +   ++  E+E L+   HP +V 
Sbjct: 21   WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 803  LQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
            L G   + + +L ++  F   G++D  +  +LD   +        + +     L +LH  
Sbjct: 81   LLG-AYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQ--VVCRQMLEALNFLHSK 136

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE---Y 918
                I+HRD+K+ N+L+       LADFG++   L       +   +GT  ++ PE    
Sbjct: 137  ---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMC 191

Query: 919  GQASVATY--KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI------RMRQENR 970
                   Y  K D++S G+ L+E+   + P     P   R L    I       +   ++
Sbjct: 192  ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL--LKIAKSDPPTLLTPSK 247

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             S     F+                 + L ++P+ RP+  QL
Sbjct: 248  WSVEFRDFLK----------------IALDKNPETRPSAAQL 273

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (294), Expect = 3e-27
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 20/222 (9%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRA 795
           ++   ++    +G GGFG V R      G  VAIK  R        ER    E++ + + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKL 69

Query: 796 QHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
            HPN+V               +  LL   + E G L  +L++  +    L       +  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLS 128

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH---LADFGLARLILSPYDTHVTTD 906
             +  L YLH++    I+HRD+K  NI+L          + D G A+ +       + T+
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTE 182

Query: 907 LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
            VGTL Y+ PE  +    T   D +SFG +  E +TG RP  
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  116 bits (291), Expect = 7e-27
 Identities = 76/350 (21%), Positives = 121/350 (34%), Gaps = 46/350 (13%)

Query: 78  LNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEV 137
           L D + +  +T L +    L   L      L   R L +S N L  ++PV    L  L +
Sbjct: 55  LPDCLPA-HITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT-SLPVLPPGLLELSI 108

Query: 138 LDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTL 197
                  L            +  L I  N L  S+P         ++ +++S N  + +L
Sbjct: 109 FSNPLTHLPA------LPSGLCKLWIFGNQLT-SLPVLP----PGLQELSVSDNQLA-SL 156

Query: 198 SPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVR 257
                    L  L    N LT  +      LQ+L +    DNQL+  L       S L +
Sbjct: 157 PALPSE---LCKLWAYNNQLTS-LPMLPSGLQELSV---SDNQLA-SLPTLP---SELYK 205

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL 317
           L   +N  + ++P + +GL   + L+   NR T  +P   S    L  L +  N L  SL
Sbjct: 206 LWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SL 256

Query: 318 LLNCPA-LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
               P   + L SL +  N+    LP +L        +NL  N  S +  +  +   S  
Sbjct: 257 ----PMLPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311

Query: 377 YLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANL 426
               S   I    +     ++ R L            +    P   +   
Sbjct: 312 G--YSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (284), Expect = 5e-26
 Identities = 79/436 (18%), Positives = 124/436 (28%), Gaps = 100/436 (22%)

Query: 134 NLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYF 193
              VL++  + L+  LP  +    I  L I  N+L  S+P         +R + +S N  
Sbjct: 41  GNAVLNVGESGLTT-LPDCL-PAHITTLVIPDNNLT-SLPALP----PELRTLEVSGNQL 93

Query: 194 SGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLS 253
           + +L         L      +  L             L  L +  NQL+  L        
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT-SLPVLP---P 141

Query: 254 NLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL 313
            L  L VS N  +                          +P   S    L   N +  SL
Sbjct: 142 GLQELSVSDNQLA-------------------------SLPALPSELCKLWAYNNQLTSL 176

Query: 314 DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFE 373
                      + L  L +  N+       +LP                           
Sbjct: 177 PML-------PSGLQELSVSDNQL-----ASLP-----------------------TLPS 201

Query: 374 SLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS 433
            L  L   N+ + +L +          L  L+++ N R   LP  P      LK L+++ 
Sbjct: 202 ELYKLWAYNNRLTSLPA------LPSGLKELIVSGN-RLTSLPVLPS----ELKELMVSG 250

Query: 434 CGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLT 493
             L  S+P    G   L    +  NQL+  +P           ++L  N  +    + L 
Sbjct: 251 NRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305

Query: 494 GLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFG 553
            + S    +  +           R     R L         P  +      D   W  FG
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPR---ETRALHLAAADWLVPAREGEPAPAD--RWHMFG 360

Query: 554 NLKKLHVFDLKHNNLS 569
                  F L  + LS
Sbjct: 361 QEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  112 bits (281), Expect = 1e-25
 Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 46/300 (15%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLN 169
               LN+  + L  T+P  L    ++  L +  N+L+  LP     P ++ L++S N L 
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT 94

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
            S+P         + + +  + +     S        L  L +  N LT  +      LQ
Sbjct: 95  -SLPVLPP-GLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPGLQ 144

Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
           +L +    DNQL+  L       S L +L   +N  + ++P + +GL   Q L    N+ 
Sbjct: 145 ELSVS---DNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPSGL---QELSVSDNQL 193

Query: 290 TGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCR 349
              +P   S    L   N R  SL           + L  L +  N+    LP       
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTSLPAL-------PSGLKELIVSGNRLTS-LPVLPS--- 241

Query: 350 KLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
           +LK + ++ N  +  +P        L  LS+  + +  L  +   L    + TT+ L  N
Sbjct: 242 ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPES---LIHLSSETTVNLEGN 294

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  110 bits (277), Expect = 3e-25
 Identities = 69/370 (18%), Positives = 125/370 (33%), Gaps = 83/370 (22%)

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
                +L + ++ L+  L   +   +++  L +  NN + ++P +   L   + L    N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91

Query: 288 RFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR 347
           + T  +P        L++ +     L           + L  L +  N+    LP   P 
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLTS-LPVLPP- 141

Query: 348 CRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLT 407
              L+ ++++ N  +  +P        L  L   N+ + +L            L  L ++
Sbjct: 142 --GLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTSLPMLPS------GLQELSVS 189

Query: 408 LNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW 467
            N +   LPT P    + L  L   +  L  S+P      S L+ + +S N+L+ ++PV 
Sbjct: 190 DN-QLASLPTLP----SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVL 239

Query: 468 FGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQY 527
                +L  L +S N         LT LP L +  +SL                   +  
Sbjct: 240 PS---ELKELMVSGN--------RLTSLPMLPSGLLSLS------------------VYR 270

Query: 528 NQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDL 587
           NQ+   P                   +L      +L+ N LS      L  +TS      
Sbjct: 271 NQLTRLPE---------------SLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSG 315

Query: 588 SYNNLSGAIP 597
                  A  
Sbjct: 316 PIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.0 bits (114), Expect = 2e-05
 Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 17/105 (16%)

Query: 536 TIDLSLNRLDGSIWPEFG-NLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG 594
            +++  + L  ++      ++  L    +  NNL+  +P+       L TL++S N L+ 
Sbjct: 44  VLNVGESGL-TTLPDCLPAHITTL---VIPDNNLTS-LPALPP---ELRTLEVSGNQLT- 94

Query: 595 AIPISLEKLSFLSKFSVANNHLTGRIP-------SGGQFQTFPNS 632
           ++P+    L  LS FS    HL             G Q  + P  
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVL 139

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (280), Expect = 1e-26
 Identities = 40/241 (16%), Positives = 72/241 (29%), Gaps = 22/241 (9%)

Query: 725 FHNKEKEISIDDILESTNN-FDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGD 777
           +  K   I      +  +      +++G G F  VY AT  D  +        +K     
Sbjct: 47  WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106

Query: 778 CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGP 836
                      +E L  +     +      + +N  +L+      G+L +     K    
Sbjct: 107 NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL-----------DGNFGAH 885
             +     +  A      +  +H      I+H DIK  N +L           D + G  
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223

Query: 886 LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR 945
           L D G +  +       + T    T G+   E        Y+ D +     +  +L G  
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

Query: 946 P 946
            
Sbjct: 284 M 284

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  113 bits (284), Expect = 1e-26
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 15/233 (6%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNSL 168
             R+LNL  N ++     +  +L +LEVL L  N +          L S+  L++  N L
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLG-MNDLTGGIADDIF 226
              +P+   +  S++R + L  N    ++         SL  L LG +  L   I++  F
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY-ISEGAF 192

Query: 227 Q-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
           + L  L+ L L    +     P++  L  L  L++S N+F    P  F GL   + L   
Sbjct: 193 EGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTN 335
           +++ +    ++     +L  LNL +N   SL   L      L  L  L L  N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF---TPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 92.5 bits (230), Expect = 8e-20
 Identities = 62/278 (22%), Positives = 99/278 (35%), Gaps = 38/278 (13%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNSL 168
           Q   +  +   L   VP  +    N   L+L  N++      T  +L  ++VL +  N  
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN-- 109

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ- 227
                         IR I        G  + GL +   L  L L  N LT  I    F+ 
Sbjct: 110 -------------SIRQIE------VGAFN-GLAS---LNTLELFDNWLT-VIPSGAFEY 145

Query: 228 LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAH 285
           L KLR L L++N +   +       + +L+RLD+        I    F GL   +YL   
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA-LTNLTSLDLGTNKFNGPLPTN 344
                  +P+ L+    L  L +  N     +       L++L  L +  ++ +      
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261

Query: 345 LPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
                 L  +NLA NN S    + +     L  L L +
Sbjct: 262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 92.1 bits (229), Expect = 1e-19
 Identities = 56/257 (21%), Positives = 89/257 (34%), Gaps = 13/257 (5%)

Query: 156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGM 214
                +  +   L+  VP  I    S  R +NL  N     +      +   LE L LG 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGR 108

Query: 215 NDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVF 273
           N +   I    F  L  L  L L DN L+   S +   LS L  L + +N         F
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167

Query: 274 AGLGEFQYL-VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDL 332
             +     L +    +       +      L  LNL   ++    + N   L  L  L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEM 225

Query: 333 GTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSAL 392
             N F    P +      LK + +  +  S      +    SL  L+L+++++ +L    
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH-- 283

Query: 393 QVLQQCRNLTTLVLTLN 409
            +    R L  L L  N
Sbjct: 284 DLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.4 bits (209), Expect = 4e-17
 Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 20/238 (8%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN- 311
           SN   L++  NN      D F  L   + L    N        + +   +LN L L +N 
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

Query: 312 --SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE-T 368
              +          L+ L  L L  N           R   L  ++L        I E  
Sbjct: 135 LTVIPSGAFEY---LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191

Query: 369 YKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA---N 425
           ++   +L YL+L   +I      +  L     L  L ++ N      P      F    +
Sbjct: 192 FEGLFNLKYLNLGMCNI----KDMPNLTPLVGLEELEMSGN----HFPEIRPGSFHGLSS 243

Query: 426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNN 482
           LK L + +  +         G + L  ++L+ N LS ++P   F   + L  L L +N
Sbjct: 244 LKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 56/327 (17%), Positives = 97/327 (29%), Gaps = 78/327 (23%)

Query: 321 CPAL----TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
           CP++       + +       +  +P  +P     + +NL  NN      +T+++   L 
Sbjct: 46  CPSVCSCSNQFSKVVCTRRGLSE-VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLE 102

Query: 377 YLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGL 436
            L L  +SI  +           +L TL L  N                L V+       
Sbjct: 103 VLQLGRNSIRQIEV--GAFNGLASLNTLELFDN---------------WLTVIP------ 139

Query: 437 RGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGL 495
                      SKL+ + L  N +       F     L  LDL        I +    GL
Sbjct: 140 ----SGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL 195

Query: 496 PSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNL 555
            +L   N                      L    I   P                    L
Sbjct: 196 FNLKYLN----------------------LGMCNIKDMP----------------NLTPL 217

Query: 556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNH 615
             L   ++  N+     P    G++SL+ L +  + +S     + + L+ L + ++A+N+
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 616 LTGRIPSGGQFQTFPNS---SFDGNNL 639
           L+  +P    F             N  
Sbjct: 278 LS-SLP-HDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 57.1 bits (138), Expect = 2e-08
 Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 2/89 (2%)

Query: 104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLD 162
           +L  LV L  L +S N      P S   L +L+ L + ++ +S         L S+  L+
Sbjct: 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVN 191
           ++ N+L+ S+P  +      +  ++L  N
Sbjct: 273 LAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 3/82 (3%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
           L +           S   L  L+ L + ++ +      +   L +L  L+L+ N+LS  L
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-L 281

Query: 150 PQTI--NLPSIQVLDISSNSLN 169
           P  +   L  +  L +  N  N
Sbjct: 282 PHDLFTPLRYLVELHLHHNPWN 303

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (279), Expect = 1e-26
 Identities = 77/304 (25%), Positives = 121/304 (39%), Gaps = 54/304 (17%)

Query: 727  NKEKEISIDDILESTN---NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQME 782
               K+  + ++    +    F     IG G FG VY A  + +   VAIK++S    Q  
Sbjct: 36   GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95

Query: 783  REF---RAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSS 838
             ++     EV  L + +HPN +  +G C  +     L+  +    + D  L E    P  
Sbjct: 96   EKWQDIIKEVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGSASD--LLEVHKKPLQ 152

Query: 839  LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
                +   +  GA +GLAYLH     +++HRD+K+ NILL       L DFG A  I++P
Sbjct: 153  EVEIA--AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAP 206

Query: 899  YDTHVTTDLVGTLGYIPPE---YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS 955
             ++      VGT  ++ PE            K DV+S G+  +EL   K P+        
Sbjct: 207  ANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 258

Query: 956  RDLISWVIRMRQENRESEVL-------DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT 1008
                     M         L        P +      +     +D    CL + P+ RPT
Sbjct: 259  ---------MS-------ALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 299

Query: 1009 TQQL 1012
            ++ L
Sbjct: 300  SEVL 303

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (276), Expect = 2e-26
 Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 42/296 (14%)

Query: 728  KEKEISIDDILESTN---NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER 783
            + +   +D+   +      FD    +G G +G VY+A     G+ VAIK++        +
Sbjct: 12   RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQ 69

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            E   E+  + +   P++V   G    KN  L ++  +   GS+   +  +     +L  D
Sbjct: 70   EIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTED 125

Query: 843  SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
                I Q   +GL YLH       +HRDIK+ NILL+    A LADFG+A  +       
Sbjct: 126  EIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

Query: 903  VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV 962
             T  ++GT  ++ PE  Q        D++S G+  +E+  GK P     P   R +  ++
Sbjct: 183  NT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAI--FM 236

Query: 963  I------RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            I        R+    S+    F+                  CL +SP+ R T  QL
Sbjct: 237  IPTNPPPTFRKPELWSDNFTDFVK----------------QCLVKSPEQRATATQL 276

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (275), Expect = 3e-26
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 43/228 (18%)

Query: 738 LESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-------FRAEV 789
           + S++ F Q   +G G +  VY+      G  VA+K +     +++ E        R E+
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIR-EI 54

Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
             +   +H N+V L      +N   L++ FM+    D  L + +D  +  +    L +  
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMD---ND--LKKYMDSRTVGNTPRGLELNL 109

Query: 850 GAA------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
                    +GLA+ H++    ILHRD+K  N+L++      L DFGLAR    P +T  
Sbjct: 110 VKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF- 165

Query: 904 TTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            +  V TL Y  P+       Y   S+     D++S G +L E++TGK
Sbjct: 166 -SSEVVTLWYRAPDVLMGSRTYS-TSI-----DIWSCGCILAEMITGK 206

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 4e-26
 Identities = 67/301 (22%), Positives = 104/301 (34%), Gaps = 39/301 (12%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRL--SGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
            I+G G    V+R      G   AIK          ++ + R E E L +  H N+V L  
Sbjct: 16   ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74

Query: 806  YCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
                +         ME    GSL   L E       L     L + +    G+ +L ++ 
Sbjct: 75   -IEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLREN- 131

Query: 863  EPHILHRDIKSSNILL----DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
               I+HR+IK  NI+     DG     L DFG AR +    D      L GT  Y+ P+ 
Sbjct: 132  --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDM 186

Query: 919  GQASVATYKG--------DVYSFGVVLLELLTGKRP-MDMCKPKGSRDLISWVIRMRQEN 969
             + +V             D++S GV      TG  P      P+ +++++  +I  +   
Sbjct: 187  YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 970  RESEVLDP------FIYDKQHDKEMLRVL-----DIACLCLSESPKVRPTTQQLVSWLDS 1018
              S V         +  D      + R L      +    L    +      Q  +    
Sbjct: 247  AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 1019 I 1019
            I
Sbjct: 307  I 307

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (271), Expect = 8e-26
 Identities = 64/235 (27%), Positives = 94/235 (40%), Gaps = 10/235 (4%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLL--KGTVPVSLVNLPNLEVLDLSSND 144
            T L L   +L+         L QL  L+LS N L  KG    S     +L+ LDLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 145 LSGPLPQT-INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LG 202
           +   +    + L  ++ LD   ++L      S+  +   +  +++S  +       G   
Sbjct: 90  VIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147

Query: 203 NCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDV 260
             +SLE L +  N        DIF  L+ L  L L   QL  +LSP+    LS+L  L++
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206

Query: 261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLD 314
           S NNF       +  L   Q L    N         L + P+ L  LNL  N   
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (270), Expect = 1e-25
 Identities = 51/237 (21%), Positives = 83/237 (35%), Gaps = 14/237 (5%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG---PLPQTINLPSIQVLDISSNS 167
              L L  N L+         L  L  L LSSN LS             S++ LD+S N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-GNCASLEHLCLGMNDLTGGIADDIF 226
           +  ++ ++      ++  ++   +         +  +  +L +L +          + IF
Sbjct: 90  VI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146

Query: 227 Q-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
             L  L +L +  N       P I  +L NL  LD+S        P  F  L   Q L  
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 206

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFN 338
             N F            +L +L+   N   +     L + P  ++L  L+L  N F 
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  104 bits (261), Expect = 2e-24
 Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 21/262 (8%)

Query: 112 RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLN 169
             +  +   L  +VP  +    +   L+L SN L   LP  +   L  +  L +SSN L+
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLS 65

Query: 170 -GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ- 227
                +     ++ ++ ++LS N    T+S        LEHL    ++L       +F  
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124

Query: 228 LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNI-PDVFAGLGEFQYLVAH 285
           L+ L  L +            I   LS+L  L ++ N+F  N  PD+F  L    +L   
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPLP 342
             +     P + ++  +L +LN+ +N   SLD         L +L  LD   N       
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC---LNSLQVLDYSLNHIMT-SK 239

Query: 343 TNL--PRCRKLKNINLARNNFS 362
                     L  +NL +N+F+
Sbjct: 240 KQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 52/252 (20%), Positives = 88/252 (34%), Gaps = 30/252 (11%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
           S+  RL++ SN        VF  L +   L   SN               L+     + S
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG--------------LSFKGCCSQS 73

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE--TYK 370
             G         T+L  LDL  N     + +N     +L++++   +N   Q+ E   + 
Sbjct: 74  DFG--------TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 123

Query: 371 NFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLV 430
           +  +L YL +S++      +   +     +L  L +  N   E    D      NL  L 
Sbjct: 124 SLRNLIYLDISHTHTRVAFN--GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 431 IASCGLRGSIPQ-WLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIP 489
           ++ C L   +        S LQ++++S N         +     L  LD S N       
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 490 KNLTGLPSLITR 501
           + L   PS +  
Sbjct: 241 QELQHFPSSLAF 252

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 51/265 (19%), Positives = 93/265 (35%), Gaps = 46/265 (17%)

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN-FRNEKLPTDPRLHFANLKVLV 430
             S + L L ++ + +L     V  +   LT L L+ N    +   +       +LK L 
Sbjct: 27  PSSATRLELESNKLQSLPHG--VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 431 IASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIP 489
           ++  G+  ++     G  +L+ +D   + L        F   ++L YLD+S+        
Sbjct: 85  LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAF 142

Query: 490 KN-LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSI 548
                GL SL                                      + ++ N    + 
Sbjct: 143 NGIFNGLSSLEV------------------------------------LKMAGNSFQENF 166

Query: 549 WPE-FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLS 607
            P+ F  L+ L   DL    L    P+    ++SL+ L++S+NN         + L+ L 
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226

Query: 608 KFSVANNHLTGRIPSGGQFQTFPNS 632
               + NH+        + Q FP+S
Sbjct: 227 VLDYSLNHIM-TSKK-QELQHFPSS 249

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  111 bits (280), Expect = 1e-25
 Identities = 81/525 (15%), Positives = 155/525 (29%), Gaps = 84/525 (16%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
            + L+LS N +       +  L  L VL LS N +   L   +      ++ LD+S N L
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRL 112

Query: 169 NGSVPTSICKNSSRIRVINLSVNYF-SGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
             ++    C   + +R ++LS N F    +    GN   L  L L            +  
Sbjct: 113 -QNIS---CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 228 LQ-KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
           L     LL L    + G  + S+    N   L +  +  S     V   +    +L   +
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
            +        L    +         ++          L ++ +    + K          
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVT---------LQHIETTWKCSVKLFQFFWPRPV 278

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
               + N+ +       +   +    +SL    + N        A  +      +   +L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA--LYSVFAEMNIKML 336

Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
           +++               +   +    C             S    ++ + N  + ++  
Sbjct: 337 SIS---------------DTPFIH-MVC---------PPSPSSFTFLNFTQNVFTDSVFQ 371

Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQ 526
                + L  L L  N         L                       M +N+S+    
Sbjct: 372 GCSTLKRLQTLILQRN--------GLKNFFK---------------VALMTKNMSSLETL 408

Query: 527 YNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLD 586
              + S                       + + V +L  N L+G +   L     ++ LD
Sbjct: 409 DVSLNSLNSHAYDRT----------CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLD 456

Query: 587 LSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPN 631
           L  N +  +IP  +  L  L + +VA+N L   +P  G F    +
Sbjct: 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 94.2 bits (234), Expect = 5e-20
 Identities = 73/423 (17%), Positives = 146/423 (34%), Gaps = 56/423 (13%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL-SGPLPQTI-NLPSIQVLDIS 164
               L +L++SHN L+    +S   + +L  LDLS ND    P+ +   NL  +  L +S
Sbjct: 98  FNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154

Query: 165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGN-CASLEHLCLGMNDLTGGIAD 223
           +          +        +++L   +  G  +  L     ++ HL    N L     +
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214

Query: 224 DIFQ-LQKLRLLGLQDNQLSGKLSPS-------------------------------IAD 251
                L  L+L  ++ N  + +   +                                  
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274

Query: 252 LSNLVRLDVSSNNFSGNIPDVFAGLGE-----FQYLVAHSNRFTGRIPHSLSNSPTLNLL 306
              +  L++ +   +  I        E            +  F        S    +N+ 
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334

Query: 307 NLRNNSLDGSLLLNCPA-LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
            L  +     + + CP   ++ T L+   N F   +       ++L+ + L RN      
Sbjct: 335 MLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392

Query: 366 PETYKNFESLSYLSLSNSSIYNLSSAL--QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF 423
            +     +++S L   + S+ +L+S    +      ++  L L+ N     L        
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN----MLTGSVFRCL 448

Query: 424 -ANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSN 481
              +KVL + +  +  SIP+ +     LQ ++++ NQL  ++P   F     L Y+ L +
Sbjct: 449 PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD 506

Query: 482 NTF 484
           N +
Sbjct: 507 NPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 81.5 bits (201), Expect = 5e-16
 Identities = 54/304 (17%), Positives = 111/304 (36%), Gaps = 18/304 (5%)

Query: 72  SSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVP----- 126
           S       +++G  +++ + L     +  ++           LN++   ++ T       
Sbjct: 210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL 269

Query: 127 VSLVNLPNLEVLDLSSNDLSGPLP------QTINLPSIQVLDISSNSLNGSVPTSICKNS 180
                   +E L++ +  ++  +           L S+ +  + +         ++    
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVF 328

Query: 181 SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQ 240
           + + +  LS++           + +S   L    N  T  +      L++L+ L LQ N 
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388

Query: 241 LS--GKLSPSIADLSNLVRLDVSSNNF-SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
           L    K++    ++S+L  LDVS N+  S       A       L   SN  TG +   L
Sbjct: 389 LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448

Query: 298 SNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA 357
              P + +L+L NN +  S+  +   L  L  L++ +N+          R   L+ I L 
Sbjct: 449 P--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505

Query: 358 RNNF 361
            N +
Sbjct: 506 DNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 78.0 bits (192), Expect = 6e-15
 Identities = 43/235 (18%), Positives = 82/235 (34%), Gaps = 12/235 (5%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
            +  L + +R  + + + S   L  L   ++ + +   +          + +  LS +D 
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 146 -SGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG---L 201
               +    +  S   L+ + N          C    R++ + L  N             
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMT 399

Query: 202 GNCASLEHLCLGMNDLTGGIADDIFQL-QKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV 260
            N +SLE L + +N L     D      + + +L L  N L+G +   +     +  LD+
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457

Query: 261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSLD 314
            +N    +IP     L   Q L   SN+    +P        +L  + L +N  D
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 61/367 (16%), Positives = 123/367 (33%), Gaps = 53/367 (14%)

Query: 106 GNLVQLRFLNLSHNLLKGTVPVSLVNLP-NLEVLDLSSNDLSGPLPQTINLPSIQVLDIS 164
           GNL +L FL LS    +    + + +L  +  +LDL S  + G   +++ +P+  VL + 
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202

Query: 165 SNSLN----------------------------GSVPTSICKNSSRIRVINLSVNYFSGT 196
            +  +                              + T + + +    ++N+++ +   T
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

Query: 197 LSP-----GLGNCASLEHLCLGMNDLTGGIADDIFQ-----LQKLRLLGLQDNQLSGKLS 246
                          +E+L +    +T  I  + F      L+ L +  +++        
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322

Query: 247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLL 306
              +  + +    +S ++              F +L    N FT  +    S    L  L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382

Query: 307 NLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN----GPLPTNLPRCRKLKNINLARNNFS 362
            L+ N L  +         N++SL+      N                +  +NL+ N  +
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 363 GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLH 422
           G +         +  L L N+ I ++   +  LQ    L  L +  N    +L + P   
Sbjct: 442 GSVFR--CLPPKVKVLDLHNNRIMSIPKDVTHLQA---LQELNVASN----QLKSVPDGV 492

Query: 423 FANLKVL 429
           F  L  L
Sbjct: 493 FDRLTSL 499

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.1 bits (117), Expect = 7e-06
 Identities = 47/314 (14%), Positives = 92/314 (29%), Gaps = 52/314 (16%)

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNL 401
           P +LP   + K ++L++N+ S            L  L LS++ I +L     V    ++L
Sbjct: 47  PKDLPP--RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH--VFLFNQDL 102

Query: 402 TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
             L ++ N    +L        A+L+ L                        DLS+N   
Sbjct: 103 EYLDVSHN----RLQNISCCPMASLRHL------------------------DLSFNDFD 134

Query: 462 GTIPVW--FGGFQDLFYLDLSNNTFTGEIPKNLTGL--PSLITRNISLEEPSPDFPFFMR 517
             +PV   FG    L +L LS   F       +  L    ++   +S      +      
Sbjct: 135 -VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193

Query: 518 RNVSARGLQYNQIWSFPPTIDLSLNRL---------------DGSIWPEFGNLKKLHVFD 562
            N +   L ++    F   +++S+N L                  +       +   + +
Sbjct: 194 PNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN 253

Query: 563 LKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS 622
           +   ++       +          + Y N+              +    A   L      
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313

Query: 623 GGQFQTFPNSSFDG 636
              F     + +  
Sbjct: 314 NQVFLFSKEALYSV 327

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  107 bits (270), Expect = 2e-25
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 41/224 (18%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE--------FRAEV 789
           +S   ++   ++G G +G+V +      GR VAIK+          +         R E+
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMR-EI 75

Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDS-RLHI 847
           + L + +H NLV+L   C  K    L++ F+++      + + L+  P+ LD+   + ++
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH---T--ILDDLELFPNGLDYQVVQKYL 130

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
            Q    G+ + H     +I+HRDIK  NIL+  +    L DFG AR + +P + +   D 
Sbjct: 131 FQ-IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDE 184

Query: 908 VGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           V T  Y  PE       YG  +V     DV++ G ++ E+  G+
Sbjct: 185 VATRWYRAPELLVGDVKYG-KAV-----DVWAIGCLVTEMFMGE 222

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (270), Expect = 2e-25
 Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 24/285 (8%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLN 169
              L+L +N +          L +L  L L +N +S    +    L  +Q L IS N L 
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLT-GGIADDIFQ 227
             +P ++  +   +  + +  N     +  G      ++  + +G N L   G     F 
Sbjct: 116 -EIPPNLPSS---LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD-VFAGLGEFQYLVAHS 286
             KL  L + + +L+  +   +     L  L +  N     I         +   L    
Sbjct: 171 GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN-------G 339
           N+       SLS  PTL  L+L NN L   +    P L  L  + L TN           
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285

Query: 340 PLPTNLPRCRKLKNINLARNNFSGQI--PETYKNFESLSYLSLSN 382
           P+   + R      I+L  N        P T++       +   N
Sbjct: 286 PVGFGVKRAY-YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 48/251 (19%), Positives = 93/251 (37%), Gaps = 30/251 (11%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQ 159
            ++   L +L+ L +S N L   +P +L    +L  L +  N +   +P+ +   L ++ 
Sbjct: 95  EKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLRNMN 150

Query: 160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG 219
            +++  N L  S       +  ++  + +S    +  +   L    +L  L L  N +  
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ- 206

Query: 220 GIADDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
            I  +      KL  LGL  NQ+   +     + L  L  L + +N  S  +P     L 
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264

Query: 278 EFQYLVAHSNRFTGRIP-------HSLSNSPTLNLLNLRNNSLDGSLLLNCPA-----LT 325
             Q +  H+N  T ++                 N ++L NN +               +T
Sbjct: 265 LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP---YWEVQPATFRCVT 320

Query: 326 NLTSLDLGTNK 336
           +  ++  G  K
Sbjct: 321 DRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.8 bits (226), Expect = 8e-20
 Identities = 64/317 (20%), Positives = 118/317 (37%), Gaps = 34/317 (10%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT--INLPSIQVLDISSNS 167
            LR +  S   LK  VP  +   P+  +LDL +ND+S  L +     L  +  L + +N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNK 89

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           ++  +         +++ + +S N+    + P L   +SL  L +  N +   +   +F 
Sbjct: 90  IS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFS 144

Query: 228 -LQKLRLLGLQDNQL-SGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
            L+ +  + +  N L +    P   D   L  L +S    +G   D+   L     L   
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL---NELHLD 201

Query: 286 SNRFTGRIP-HSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPL 341
            N+    I    L     L  L L +N    ++   L     L  L  L L  NK +  +
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF---LPTLRELHLDNNKLSR-V 256

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPET-------YKNFESLSYLSLSNSSIYNLSSALQV 394
           P  LP  + L+ + L  NN + ++                 + +SL N+ +         
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315

Query: 395 LQQCRNLTTLVLTLNFR 411
            +   +   +    N++
Sbjct: 316 FRCVTDRLAIQFG-NYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 61/307 (19%), Positives = 98/307 (31%), Gaps = 47/307 (15%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN 264
                L L  ND++    DD   LQ L  L L +N++S     + + L  L +L +S N+
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL-DGSLLLNCPA 323
                P++ + L     L  H NR         S    +N + +  N L +         
Sbjct: 114 LVEIPPNLPSSL---VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETY-KNFESLSYLSLSN 382
              L  L +   K  G +P +LP    L  ++L  N     I       +  L  L L +
Sbjct: 171 GLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGH 226

Query: 383 SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQ 442
           + I  + +    L     L  L L  N                L             +P 
Sbjct: 227 NQIRMIEN--GSLSFLPTLRELHLDNN---------------KLS-----------RVPA 258

Query: 443 WLRGCSKLQLVDLSWNQLSGTIPV-------WFGGFQDLFYLDLSNNTFT-GEIPKNL-T 493
            L     LQ+V L  N ++  + V       +         + L NN     E+      
Sbjct: 259 GLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317

Query: 494 GLPSLIT 500
            +   + 
Sbjct: 318 CVTDRLA 324

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 66/344 (19%), Positives = 117/344 (34%), Gaps = 44/344 (12%)

Query: 301 PTLNLLNLRNNSLDGSLLLNCPA--LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLAR 358
            T  + +L   SL  +    CP     +L  +          +P  +        ++L  
Sbjct: 9   TTSGIPDLD--SLPPTYSAMCPFGCHCHLRVVQCSDLGLKA-VPKEISP--DTTLLDLQN 63

Query: 359 NNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTD 418
           N+ S    + +K  + L  L L N+ I  +    +     R L  L ++ N     L   
Sbjct: 64  NDISELRKDDFKGLQHLYALVLVNNKISKIHE--KAFSPLRKLQKLYISKN----HLVEI 117

Query: 419 PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQD--LFY 476
           P    ++L  L I    +R        G   +  +++  N L        G F    L Y
Sbjct: 118 PPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNY 176

Query: 477 LDLSNNTFTGEIPKNL-TGLPSLITRNISLEE-PSPDFPFFMRRNVSARGLQYNQIWSFP 534
           L +S    T  IPK+L   L  L   +  ++     D   +    +   GL +NQI    
Sbjct: 177 LRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRY--SKLYRLGLGHNQIRMIE 233

Query: 535 PTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG 594
                               L  L    L +N LS  +P+ L  +  L+ + L  NN++ 
Sbjct: 234 NGS--------------LSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT- 277

Query: 595 AIPIS-------LEKLSFLSKFSVANNHLTGRIPSGGQFQTFPN 631
            + ++         K ++ +  S+ NN +         F+   +
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 54/341 (15%), Positives = 95/341 (27%), Gaps = 67/341 (19%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
            +   LD+ +N+ S    D F GL     LV  +N+ +     + S    L  L +  N 
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNF 372
           L     +     ++L  L +  N+                   + +  FSG         
Sbjct: 114 LV---EIPPNLPSSLVELRIHDNRIR----------------KVPKGVFSG--------L 146

Query: 373 ESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIA 432
            +++ + +  + + N             L  L ++      KL   P+     L  L + 
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA----KLTGIPKDLPETLNELHLD 201

Query: 433 SCGLRGSIPQW-LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN 491
              ++ +I    L   SKL  + L  NQ+             L  L L NN  +  +P  
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

Query: 492 LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPE 551
           L  L  L                          L  N I          +          
Sbjct: 260 LPDLKLLQVVY----------------------LHTNNITKVGVNDFCPVG--------F 289

Query: 552 FGNLKKLHVFDLKHNNLSGPI--PSELTGMTSLETLDLSYN 590
                  +   L +N +      P+    +T    +     
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (270), Expect = 2e-25
 Identities = 54/245 (22%), Positives = 82/245 (33%), Gaps = 51/245 (20%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           IG G +G+V  A         AIK     ++     +     + EV  + +  HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG------------- 850
                 +    L+      G L   L+  +D  +       +                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 851 ----------------AAR-------GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL- 886
                            +         L YLH      I HRDIK  N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 887 -ADFGLARLI--LSPYDTHVTTDLVGTLGYIPPEYGQASVATY--KGDVYSFGVVLLELL 941
             DFGL++    L+  + +  T   GT  ++ PE    +  +Y  K D +S GV+L  LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 942 TGKRP 946
            G  P
Sbjct: 271 MGAVP 275

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  107 bits (269), Expect = 2e-25
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 43/226 (19%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE--------FRAEVE 790
           S + + +   +G G +G VY+A        VAIKR+     ++E E         R EV 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-----RLEHEEEGVPGTAIR-EVS 85

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            L   QH N++ L+    H +   LI+ + E    D  L + +D    +           
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAE---ND--LKKYMDKNPDVSMRVIKSFLYQ 140

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH-----LADFGLARLILSPYDTHVTT 905
              G+ + H       LHRD+K  N+LL  +  +      + DFGLAR    P      T
Sbjct: 141 LINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--T 195

Query: 906 DLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             + TL Y PPE       Y   SV     D++S   +  E+L   
Sbjct: 196 HEIITLWYRPPEILLGSRHYS-TSV-----DIWSIACIWAEMLMKT 235

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  109 bits (275), Expect = 2e-25
 Identities = 66/406 (16%), Positives = 128/406 (31%), Gaps = 62/406 (15%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
           + +++LS N +      S   L +L+ L +        +       L S+ +L +  N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 169 NGSVPTSICKNSSRIRVINLSVNYF-SGTLSPGL-GNCASLEHLCLGMNDLTGGIADDIF 226
              + T      + + V+ L+        LS        SLE L L  N++        F
Sbjct: 92  -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 227 Q-LQKLRLLGLQDNQLS----------GKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAG 275
             +++  +L L  N++                ++  LS++   D++              
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 276 LGEFQYLVAHSNRFTGRIPHSLSNSPTLN---LLNLRNN-----SLDGSLLLNCPALT-- 325
                 L    N F   +     ++        L L N+     S   +   +    T  
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 326 -----NLTSLDLGTNKFNGPLPTNLPR-CRKLKNINLARNNFSGQIPETYKNFESLSYLS 379
                 + + DL  +K    L  ++      L+ + LA+N  +      +     L  L+
Sbjct: 271 GLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329

Query: 380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS 439
           LS + + ++ S   + +    L  L L+ N     +       F  L             
Sbjct: 330 LSQNFLGSIDSR--MFENLDKLEVLDLSYN----HIRALGDQSFLGL------------- 370

Query: 440 IPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTF 484
                     L+ + L  NQL  ++P   F     L  + L  N +
Sbjct: 371 --------PNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  109 bits (273), Expect = 4e-25
 Identities = 75/445 (16%), Positives = 142/445 (31%), Gaps = 75/445 (16%)

Query: 156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-GNCASLEHLCLGM 214
             +  +D+S NS+   +  +       ++ + +        +        +SL  L L  
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 215 NDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIA--DLSNLVRLDVSSNNFSGNIPD 271
           N     +    F  L  L +L L    L G +        L++L  L +  NN     P 
Sbjct: 89  NQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147

Query: 272 -VFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSL 330
             F  +  F  L    N+        L N    +   LR              L+++T  
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQ 193

Query: 331 DLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSS 390
           D+           N  +   +  ++L+ N F   + + +       + +++ + I +L  
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF-------FDAIAGTKIQSL-- 244

Query: 391 ALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL-RGCSK 449
              +L    N+ +     NF++    T   L  + +K   ++   +  ++ + +    + 
Sbjct: 245 ---ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTD 300

Query: 450 LQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFTGEIPKNL-TGLPSLITRNISLEE 507
           L+ + L+ N+++  I    F G   L  L+LS N     I   +   L  L    + L  
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKL--EVLDL-- 354

Query: 508 PSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNN 567
                              YN I +                   F  L  L    L  N 
Sbjct: 355 ------------------SYNHIRALGDQS--------------FLGLPNLKELALDTNQ 382

Query: 568 LSGPIPSELTGMTSLETLDLSYNNL 592
           L          +TSL+ + L  N  
Sbjct: 383 LKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  108 bits (272), Expect = 5e-25
 Identities = 77/408 (18%), Positives = 125/408 (30%), Gaps = 71/408 (17%)

Query: 234 LGLQDNQLSGKLSP-SIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSNRFTG 291
           + L  N ++ +L+  S + L +L  L V        I  + F GL     L    N+F  
Sbjct: 35  VDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ 93

Query: 292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNC--PALTNLTSLDLGTNKF----NGPLPTNL 345
               + +    L +L L   +LDG++L       LT+L  L L  N            N+
Sbjct: 94  LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM 153

Query: 346 PRCRKLKNINLARNNFSGQIPETYKNFES--LSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
               +   ++L  N       E   NF+    + L LS+ ++ +++      ++C N   
Sbjct: 154 R---RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 404 LVL--TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
                TL+             F +              I   +   S             
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGT--------KIQSLILSNSYNMGSSFGHTNFK 262

Query: 462 GTIPVWFGGFQ--DLFYLDLSNNTFT---GEIPKNLTGLPSLITRNISLEEPSPDFPFFM 516
                 F G +   +   DLS +        +  + T L  L                  
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQL------------------ 304

Query: 517 RRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL 576
                   L  N+I                     F  L  L   +L  N L        
Sbjct: 305 -------TLAQNEINKIDDNA--------------FWGLTHLLKLNLSQNFLGSIDSRMF 343

Query: 577 TGMTSLETLDLSYNNLSGAIPI-SLEKLSFLSKFSVANNHLTGRIPSG 623
             +  LE LDLSYN++  A+   S   L  L + ++  N L   +P G
Sbjct: 344 ENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.9 bits (192), Expect = 5e-15
 Identities = 42/240 (17%), Positives = 86/240 (35%), Gaps = 25/240 (10%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISS 165
            L  +   +++   L      +     ++  LDLS N     + +   +  +   +    
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 166 NSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDI 225
            S + ++ +S    +      +     F G         + ++   L  + +   +   +
Sbjct: 246 LSNSYNMGSSFGHTN----FKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSV 294

Query: 226 FQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV 283
           F     L  L L  N+++ K+  +    L++L++L++S N        +F  L + + L 
Sbjct: 295 FSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353

Query: 284 AHSNRFTGRIPH-SLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLGTNKFN 338
              N     +   S    P L  L L  N L    DG        LT+L  + L TN ++
Sbjct: 354 LSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIF----DRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 62/349 (17%), Positives = 112/349 (32%), Gaps = 39/349 (11%)

Query: 322 PAL-TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE-TYKNFESLSYLS 379
           P L  ++  +DL  N       T+  R + L+ + + +      I   T++   SL  L 
Sbjct: 26  PELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85

Query: 380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLN-FRNEKLPTDPRLHFANLKVLVIASCGLRG 438
           L  +    L +         NL  L LT        L  +      +L++LV+    ++ 
Sbjct: 86  LDYNQFLQLET--GAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK 143

Query: 439 SIPQWL-RGCSKLQLVDLSWNQLSGTIPVWFGGFQ--DLFYLDLSNNTFTG--------- 486
             P        +  ++DL++N++          FQ      L LS+ T            
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203

Query: 487 --EIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRL 544
               P   T + +L       +E      F        + L  +   S+           
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS--NSYNMGSSFGHTNF 261

Query: 545 DGSIWPEFGNLK--KLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEK 602
                  F  L+   +   DL  + +   + S  +  T LE L L+ N ++     +   
Sbjct: 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG 321

Query: 603 LSFLSKFSVANNHLTGRIPSGG---------------QFQTFPNSSFDG 636
           L+ L K +++ N L   I S                   +   + SF G
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG 369

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.8 bits (171), Expect = 2e-12
 Identities = 45/228 (19%), Positives = 77/228 (33%), Gaps = 15/228 (6%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
             + +  L  +   +      +  L+LS N  K ++     +        + S  LS   
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG--TKIQSLILSNSY 250

Query: 150 PQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-GNCASLE 208
               +       D  + +  G   +        ++  +LS +     L   +  +   LE
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASG-------VKTCDLSKSKIF-ALLKSVFSHFTDLE 302

Query: 209 HLCLGMNDLTGGIADDIF-QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG 267
            L L  N++   I D+ F  L  L  L L  N L    S    +L  L  LD+S N+   
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHS-LSNSPTLNLLNLRNNSLD 314
                F GL   + L   +N+    +P        +L  + L  N  D
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 41/198 (20%), Positives = 63/198 (31%), Gaps = 36/198 (18%)

Query: 454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNL-TGLPSLITRNISLEEPSPDF 512
           DLS N ++      F   QDL +L +   T    I  N   GL SLI     L+      
Sbjct: 36  DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII----LK------ 85

Query: 513 PFFMRRNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSIWPE--FGNLKKLHV 560
                       L YNQ                 + L+   LDG++     F  L  L +
Sbjct: 86  ------------LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133

Query: 561 FDLKHNNLSGPIPSEL-TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGR 619
             L+ NN+    P+     M     LDL++N +       L          +  + +T +
Sbjct: 134 LVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ 193

Query: 620 IPSGGQFQTFPNSSFDGN 637
             +          +   N
Sbjct: 194 DMNEYWLGWEKCGNPFKN 211

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 51.7 bits (124), Expect = 9e-07
 Identities = 29/132 (21%), Positives = 52/132 (39%), Gaps = 6/132 (4%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
           V    L K ++   L     +   L  L L+ N +      +   L +L  L+LS N L 
Sbjct: 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336

Query: 147 GPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGN 203
             +   +  NL  ++VLD+S N +  ++          ++ + L  N    ++  G    
Sbjct: 337 S-IDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393

Query: 204 CASLEHLCLGMN 215
             SL+ + L  N
Sbjct: 394 LTSLQKIWLHTN 405

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (268), Expect = 3e-25
 Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 19/284 (6%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
              L L   ++         NL  L  L L +N +    P +   L  LE L LS N L 
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 147 GPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN-YFSGTLSPG-LGNC 204
             LP+ +   ++Q L +  N +   V  S+    +++ V+ L  N   S  +  G     
Sbjct: 114 E-LPEKM-PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP-SIADLSNLVRLDVSSN 263
             L ++ +   ++T  I   +     L  L L  N+++ K+   S+  L+NL +L +S N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN 226

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL------DGSL 317
           + S       A     + L  ++N+   ++P  L++   + ++ L NN++      D   
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285

Query: 318 LLNCPALTNLTSLDLGTNKFN-GPLPTNLPRC-RKLKNINLARN 359
                   + + + L +N      +  +  RC      + L   
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  105 bits (263), Expect = 1e-24
 Identities = 50/247 (20%), Positives = 103/247 (41%), Gaps = 21/247 (8%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQ 159
             +   LV+L  L LS N LK  +P  +     L+ L +  N+++  + +++   L  + 
Sbjct: 93  PGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMI 148

Query: 160 VLDISSNSL-NGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT 218
           V+++ +N L +  +     +   ++  I ++    + T+  GL    SL  L L  N +T
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205

Query: 219 GGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
             +     + L  L  LGL  N +S   + S+A+  +L  L +++N     +P   A   
Sbjct: 206 K-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263

Query: 278 EFQYLVAHSNRFTG------RIPHSLSNSPTLNLLNLRNNSLDGSLLLNC--PALTNLTS 329
             Q +  H+N  +         P   +   + + ++L +N +    +       +    +
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323

Query: 330 LDLGTNK 336
           + LG  K
Sbjct: 324 VQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 30/311 (9%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT--INLPSIQVLDISSNS 167
            LR +  S   L+  VP  L   P+  +LDL +N ++  +      NL ++  L + +N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNK 87

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           ++  +         ++  + LS N     L   +    +L+ L +  N++T  +   +F 
Sbjct: 88  IS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFN 142

Query: 228 -LQKLRLLGLQDNQL-SGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
            L ++ ++ L  N L S  +       +  L  + ++  N +     +   L     L  
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL---TELHL 199

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPL 341
             N+ T     SL     L  L L  N   ++D   L N     +L  L L  NK    +
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN---TPHLRELHLNNNKLVK-V 255

Query: 342 PTNLPRCRKLKNINLARNNFSG------QIPETYKNFESLSYLSLSNSSIYNLSSALQVL 395
           P  L   + ++ + L  NN S         P       S S +SL ++ +          
Sbjct: 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315

Query: 396 QQCRNLTTLVL 406
           +       + L
Sbjct: 316 RCVYVRAAVQL 326

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 52/342 (15%), Positives = 91/342 (26%), Gaps = 68/342 (19%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
            +   LD+ +N  +      F  L     L+  +N+ +   P + +    L  L L  N 
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF-SGQIPE-TYK 370
           L     L       L  L +  N+      +      ++  + L  N   S  I    ++
Sbjct: 112 LK---ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 371 NFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLV 430
             + LSY+ +++++I  +   L       +LT L L  N    K+          L    
Sbjct: 169 GMKKLSYIRIADTNITTIPQGL-----PPSLTELHLDGN----KITKVDAASLKGLN--- 216

Query: 431 IASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPK 490
                              L  + LS+N +S            L  L L+NN    ++P 
Sbjct: 217 ------------------NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257

Query: 491 NLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP 550
            L     +                          L  N I +                  
Sbjct: 258 GLADHKYIQVVY----------------------LHNNNISAIGSNDFCPPG-------- 287

Query: 551 EFGNLKKLHVFDLKHNNLS-GPIPSEL-TGMTSLETLDLSYN 590
                       L  N +    I       +     + L   
Sbjct: 288 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 67/303 (22%), Positives = 105/303 (34%), Gaps = 42/303 (13%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSN 263
                L L  N +T     D   L+ L  L L +N++S K+SP   A L  L RL +S N
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKN 110

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA 323
                   +   L   Q L  H N  T       +    + ++ L  N            
Sbjct: 111 QLKELPEKMPKTL---QELRVHENEITKVRKSVFNGLNQMIVVELGTN------------ 155

Query: 324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS 383
              L S  +    F G         +KL  I +A  N +  IP+      SL+ L L  +
Sbjct: 156 --PLKSSGIENGAFQG--------MKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202

Query: 384 SIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW 443
            I  + +A   L+   NL  L L+ N     +      +  +L+ L + +  L   +P  
Sbjct: 203 KITKVDAA--SLKGLNNLAKLGLSFN-SISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258

Query: 444 LRGCSKLQLVDLSWNQLSG------TIPVWFGGFQDLFYLDLSNNTFT-GEIPKNL-TGL 495
           L     +Q+V L  N +S         P +         + L +N     EI  +    +
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318

Query: 496 PSL 498
              
Sbjct: 319 YVR 321

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 63/309 (20%), Positives = 104/309 (33%), Gaps = 56/309 (18%)

Query: 320 NCPAL--TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSY 377
            CP     +L  +          +P +LP       ++L  N  +      +KN ++L  
Sbjct: 24  VCPFRCQCHLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHT 80

Query: 378 LSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLR 437
           L L N+ I  +S           L  L L+ N    +L   P      L+ L +    + 
Sbjct: 81  LILINNKISKISP--GAFAPLVKLERLYLSKN----QLKELPEKMPKTLQELRVHENEIT 134

Query: 438 GSIPQ-WLRGCSKLQLVDLSWNQL-SGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTG 494
             + +    G +++ +V+L  N L S  I    F G + L Y+ +++   T  IP+ L  
Sbjct: 135 -KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-- 190

Query: 495 LPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN 554
            PSL      L                   L  N+I                        
Sbjct: 191 PPSLTE----LH------------------LDGNKITKVDAAS--------------LKG 214

Query: 555 LKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
           L  L    L  N++S      L     L  L L+ N L   +P  L    ++    + NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273

Query: 615 HLTGRIPSG 623
           +++  I S 
Sbjct: 274 NIS-AIGSN 281

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 15/70 (21%), Positives = 28/70 (40%), Gaps = 5/70 (7%)

Query: 562 DLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP 621
           DL++N ++     +   + +L TL L  N +S   P +   L  L +  ++ N L   +P
Sbjct: 58  DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP 116

Query: 622 SGGQFQTFPN 631
                     
Sbjct: 117 EK----MPKT 122

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (273), Expect = 4e-25
 Identities = 59/258 (22%), Positives = 96/258 (37%), Gaps = 41/258 (15%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
               L L++ +++     S  +L  L  L LS N ++     +   L NL  L+L  N L
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 146 SGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-G 202
           +  +P      L  ++ L + +N +                           ++      
Sbjct: 125 TT-IPNGAFVYLSKLKELWLRNNPIE--------------------------SIPSYAFN 157

Query: 203 NCASLEHLCLG-MNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV 260
              SL  L LG +  L+  I++  F+ L  LR L L    L     P++  L  L  LD+
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDL 214

Query: 261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSL 317
           S N+ S   P  F GL   Q L    ++      ++  N  +L  +NL +N    L   L
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274

Query: 318 LLNCPALTNLTSLDLGTN 335
                 L +L  + L  N
Sbjct: 275 F---TPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.0 bits (226), Expect = 3e-19
 Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 7/220 (3%)

Query: 71  NSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV 130
           N    + +N       +  L L +  ++     +   L  L  L L  N L      + V
Sbjct: 74  NQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFV 133

Query: 131 NLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS 189
            L  L+ L L +N +          +PS++ LD+        +     +  S +R +NL+
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 190 VNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSP- 247
           +        P L     L+ L L  N L+  I    FQ L  L+ L +  +Q+   +   
Sbjct: 194 MCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249

Query: 248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
           +  +L +LV ++++ NN +    D+F  L   + +  H N
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 90.6 bits (225), Expect = 4e-19
 Identities = 61/282 (21%), Positives = 100/282 (35%), Gaps = 46/282 (16%)

Query: 110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNSL 168
           Q   +      L+  VP  +    N  +L+L  N +      +  +L  +++L +S N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIFQ 227
                                      T+  G     A+L  L L  N LT  I +  F 
Sbjct: 101 R--------------------------TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133

Query: 228 -LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVA 284
            L KL+ L L++N +   +       + +L RLD+        I    F GL   +YL  
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLGTNKFNGP 340
                   IP+ L+    L+ L+L  N L     GS       L +L  L +  ++    
Sbjct: 193 AMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSF----QGLMHLQKLWMIQSQIQVI 246

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
                   + L  INLA NN +    + +     L  + L +
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 84.4 bits (209), Expect = 3e-17
 Identities = 41/234 (17%), Positives = 77/234 (32%), Gaps = 12/234 (5%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN- 311
           +N   L++  N       + F  L   + L    N        + +    LN L L +N 
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 312 --SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE-T 368
             ++     +    L+ L  L L  N           R   L+ ++L        I E  
Sbjct: 124 LTTIPNGAFVY---LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 369 YKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKV 428
           ++   +L YL+L+  ++      +  L     L  L L+ N     +         +L+ 
Sbjct: 181 FEGLSNLRYLNLAMCNL----REIPNLTPLIKLDELDLSGN-HLSAIRPGSFQGLMHLQK 235

Query: 429 LVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
           L +    ++            L  ++L+ N L+      F     L  + L +N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 49/255 (19%), Positives = 87/255 (34%), Gaps = 41/255 (16%)

Query: 399 RNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN 458
            N   L L  N     +  +   H  +L++L ++   +R        G + L  ++L  N
Sbjct: 64  TNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122

Query: 459 QLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNL-TGLPSLITRNISLEEPSPDFPFFMR 517
           +L+      F     L  L L NN     IP      +PSL   ++              
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG------------- 168

Query: 518 RNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNN 567
                   +  ++                ++L++  L   I P    L KL   DL  N+
Sbjct: 169 --------ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI-PNLTPLIKLDELDLSGNH 218

Query: 568 LSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQ 627
           LS   P    G+  L+ L +  + +      + + L  L + ++A+N+LT  +P    F 
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLP-HDLFT 276

Query: 628 TFPNS---SFDGNNL 639
              +        N  
Sbjct: 277 PLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 18/82 (21%), Positives = 36/82 (43%), Gaps = 3/82 (3%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
           L L    L      S   L+ L+ L +  + ++     +  NL +L  ++L+ N+L+  L
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-L 270

Query: 150 PQTI--NLPSIQVLDISSNSLN 169
           P  +   L  ++ + +  N  N
Sbjct: 271 PHDLFTPLHHLERIHLHHNPWN 292

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  106 bits (267), Expect = 6e-25
 Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 736 DILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE------FRAE 788
           D+      +++ + +G G F  VY+A      + VAIK++        ++       R E
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62

Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
           ++ L    HPN++ L     HK++  L++ FME    D  L   +   S       L  +
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFME---TD--LEVIIKDNSL-----VLTPS 112

Query: 849 QGAA------RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
              A      +GL YLHQ     ILHRD+K +N+LLD N    LADFGLA+   SP   +
Sbjct: 113 HIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 903 VTTDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             T  V T  Y  PE       YG   V     D+++ G +L ELL   
Sbjct: 170 --THQVVTRWYRAPELLFGARMYG-VGV-----DMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (267), Expect = 7e-25
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 51/234 (21%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE--------FRAEVE 790
             + +++   IG G FG V++A     G+ VA+K++      ME E         R E++
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALR-EIK 68

Query: 791 ALSRAQHPNLVHLQGYCMHKNDRL--------LIYSFMEN---GSLDYWLHEKLDGPSSL 839
            L   +H N+V+L   C  K            L++ F E+   G L        +     
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKF 121

Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                  + Q    GL Y+H++    ILHRD+K++N+L+  +    LADFGLAR      
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 900 DTHVT--TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           ++     T+ V TL Y PPE       YG   +     D++  G ++ E+ T  
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYG-PPI-----DLWGAGCIMAEMWTRS 226

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (264), Expect = 7e-25
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 39/220 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-----FRA--EVEALS 793
             +++   IG G +G+V++      G+ VAIK+          +       A  E+  L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDS-RLHIAQGA 851
           + +HPNLV+L      K    L++ + ++      +  +LD     +     +    Q  
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH---T--VLHELDRYQRGVPEHLVKSITWQ-T 111

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            + + + H+    + +HRD+K  NIL+  +    L DFG ARL+  P D +   D V T 
Sbjct: 112 LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATR 166

Query: 912 GYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            Y  PE       YG   V     DV++ G V  ELL+G 
Sbjct: 167 WYRSPELLVGDTQYG-PPV-----DVWAIGCVFAELLSGV 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  104 bits (262), Expect = 7e-25
 Identities = 29/210 (13%), Positives = 53/210 (25%), Gaps = 60/210 (28%)

Query: 750 IGCGGFGLVYRATLPD---GRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHL 803
            G       ++A   D    R VA+  +         + +E  +    LSR   P +   
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR- 95

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS-------SLDWDSRLHIAQGAARGLA 856
                       +   +   +    + E + G S       S      +   Q  A    
Sbjct: 96  ------------VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAAD 143

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
             H++    +       S + +  +    LA                          +P 
Sbjct: 144 AAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD 178

Query: 917 EYGQASVATYKGDVYSFGVVLLELLTGKRP 946
                  A  + D+   G  L  LL  + P
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWP 201

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (267), Expect = 1e-24
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP 798
           +    +    +IG G FG+V++A L +   VAIK++  D      + R E++ +   +HP
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD---KRFKNR-ELQIMRIVKHP 92

Query: 799 NLVHLQGYCMHKNDRL-------LIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIA 848
           N+V L+    + N          L+  ++      +  ++   K   P  L    +L++ 
Sbjct: 93  NVVDLK-AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL---IKLYMY 148

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDL 907
           Q   R LAY+H      I HRDIK  N+LLD   G   L DFG A+ IL   + +     
Sbjct: 149 Q-LLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-ILIAGEPN--VSY 201

Query: 908 VGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
           + +  Y  PE  +G A+  T   D++S G V+ EL+ G+
Sbjct: 202 ICSRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQ 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  104 bits (262), Expect = 1e-24
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE--------FRAEVEAL 792
             +++   IG G +G V++A        VA+KR+     +++ +         R E+  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSSALR-EICLL 55

Query: 793 SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGA 851
              +H N+V L           L++ F +    D  L +  D     LD +         
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCD---QD--LKKYFDSCNGDLDPEIVKSFLFQL 110

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
            +GL + H     ++LHRD+K  N+L++ N    LA+FGLAR    P   +  +  V TL
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTL 165

Query: 912 GYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            Y PP+       Y   S+     D++S G +  EL    RP+
Sbjct: 166 WYRPPDVLFGAKLYS-TSI-----DMWSAGCIFAELANAGRPL 202

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (262), Expect = 2e-24
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 38/219 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE--------FRAEVEALS 793
             + +   +G G +G+VY+A    GR VA+KR+     +++ E         R E+  L 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIPSTAIR-EISLLK 74

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAA 852
              HPN+V L      +    L++ FME    D  L + LD   + L             
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME---KD--LKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RG+A+ HQ     ILHRD+K  N+L++ +    LADFGLAR    P  ++  T  V TL 
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLW 184

Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  P+       Y   SV     D++S G +  E++TGK
Sbjct: 185 YRAPDVLMGSKKYS-TSV-----DIWSIGCIFAEMITGK 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  105 bits (263), Expect = 3e-24
 Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 29/268 (10%)

Query: 689 MILLRAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQAN 748
           M     H         +       D ++    +   +  +  E+    +    + +D   
Sbjct: 1   MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILE 57

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            +G G FG+V+R      GR    K ++      +   + E+  +++  HP L++L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 808 MHKNDRLLIYSFMENGSL-------DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
             K + +LI  F+  G L       DY + E          +   ++ Q A  GL ++H+
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA---------EVINYMRQ-ACEGLKHMHE 167

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHL--ADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
                I+H DIK  NI+ +    + +   DFGLA  +       +      T  +  PE 
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEI 221

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
                  +  D+++ GV+   LL+G  P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (267), Expect = 5e-24
 Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 25/241 (10%)

Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRA 795
             + F    ++G GGFG V+   +   G+  A K+L+    +  + +     E + L++ 
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 796 QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIAQGAAR 853
               +V L  Y       L L+ + M  G + Y ++   +         +  + AQ    
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVS 300

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGY 913
           GL +LHQ    +I++RD+K  N+LLD +    ++D GLA  + +      T    GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355

Query: 914 IPPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
           + PE      Y  +       D ++ GV L E++  + P      K     +   +  + 
Sbjct: 356 MAPELLLGEEYDFSV------DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409

Query: 968 E 968
            
Sbjct: 410 V 410

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  103 bits (260), Expect = 5e-24
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH 797
           +  + F    + G G FG V        G +VAIK++  D     RE +  ++ L+   H
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78

Query: 798 PNLVHLQGYCMHKNDR--------LLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLH 846
           PN+V LQ    +             ++  ++    +     +   ++  P  L    ++ 
Sbjct: 79  PNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL---IKVF 134

Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTT 905
           + Q   R +  LH     ++ HRDIK  N+L++   G   L DFG A+  LSP + +   
Sbjct: 135 LFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK-KLSPSEPN--V 189

Query: 906 DLVGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
             + +  Y  PE  +G     T   D++S G +  E++ G+
Sbjct: 190 AYICSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  102 bits (256), Expect = 6e-24
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 38/219 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMERE--------FRAEVEALS 793
             +     IG G +G+VY+A    G   A+K++     ++E+E         R E+  L 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTTIR-EISILK 55

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAA 852
             +H N+V L      K   +L++  ++    D  L + LD     L+  +         
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLD---QD--LKKLLDVCEGGLESVTAKSFLLQLL 110

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
            G+AY H      +LHRD+K  N+L++      +ADFGLAR    P   +  T  + TL 
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLW 165

Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y  P+       Y   ++     D++S G +  E++ G 
Sbjct: 166 YRAPDVLMGSKKYS-TTI-----DIWSVGCIFAEMVNGT 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (256), Expect = 7e-24
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 36/232 (15%)

Query: 728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREF- 785
           + ++   +D       F    I+G G F  V  A      R  AIK L       E +  
Sbjct: 23  QPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75

Query: 786 --RAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHE--KLDGPSSLD 840
               E + +SR  HP  V L  +    +++L    S+ +NG L  ++ +    D      
Sbjct: 76  YVTRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET---- 130

Query: 841 WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             +R + A+     L YLH      I+HRD+K  NILL+ +    + DFG A+++     
Sbjct: 131 -CTRFYTAE-IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185

Query: 901 THVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
                  VGT  Y+ PE        ++S      D+++ G ++ +L+ G  P
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSACKSS------DLWALGCIIYQLVAGLPP 231

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  102 bits (256), Expect = 8e-24
 Identities = 63/254 (24%), Positives = 93/254 (36%), Gaps = 52/254 (20%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS-------GDCGQMEREFRAEVEALSRAQH--PN 799
           +G GGFG VY    + D   VAIK +        G+     R    EV  L +       
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSG 109

Query: 800 LVHLQGYCMHKNDRLLIYSFME----NGSL-DY-WLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ L  +    +        +E       L D+      L         +R         
Sbjct: 110 VIRLLDWFERPDS---FVLILERPEPVQDLFDFITERGALQEE-----LAR-SFFWQVLE 160

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLG 912
            + + H      +LHRDIK  NIL+D N G   L DFG   L     DT  T    GT  
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTD-FDGTRV 213

Query: 913 YIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMDMCK-------------PKGSR 956
           Y PPE+ +     Y G    V+S G++L +++ G  P +  +                 +
Sbjct: 214 YSPPEWIRYH--RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271

Query: 957 DLISWVIRMRQENR 970
            LI W + +R  +R
Sbjct: 272 HLIRWCLALRPSDR 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  102 bits (255), Expect = 1e-23
 Identities = 57/245 (23%), Positives = 82/245 (33%), Gaps = 50/245 (20%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS-------GDCGQMEREFRAEVEALSR----AQH 797
           +G GGFG V+    L D   VAIK +                    EV  L +      H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGH 97

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGS--LDY-WLHEKLDGPSSLDWDSRLHIAQGAARG 854
           P ++ L  +   +   +L+           DY      L         SR          
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-----PSR-CFFGQVVAA 151

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLIL-SPYDTHVTTDLVGTLG 912
           + + H      ++HRDIK  NIL+D   G   L DFG   L+   PY         GT  
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-----FDGTRV 203

Query: 913 YIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMDMCK-------------PKGSR 956
           Y PPE+       Y      V+S G++L +++ G  P +  +                  
Sbjct: 204 YSPPEWISRH--QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCC 261

Query: 957 DLISW 961
            LI  
Sbjct: 262 ALIRR 266

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (254), Expect = 1e-23
 Identities = 56/227 (24%), Positives = 92/227 (40%), Gaps = 51/227 (22%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLS---------GDCGQMEREFRAEVEALSR-AQH 797
           I+G G   +V R    P  +  A+K +           +  ++      EV+ L + + H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGA 851
           PN++ L+          L++  M+ G L DY      L EK         ++R  +    
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETRKIMRA-L 133

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
              +  LH+    +I+HRD+K  NILLD +    L DFG +  +          ++ GT 
Sbjct: 134 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 187

Query: 912 GYIPPE------------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE            YG+        D++S GV++  LL G  P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEV------DMWSTGVIMYTLLAGSPP 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  103 bits (259), Expect = 2e-23
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 28/219 (12%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH 797
               ++    +IG G FG+VY+A L   G  VAIK++  D      + R E++ + +  H
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNR-ELQIMRKLDH 106

Query: 798 PNLVHLQGYCMH----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWD-SRLHIA---- 848
            N+V L+ Y  +    K D + +   ++   +   ++      S        +++     
Sbjct: 107 CNIVRLR-YFFYSSGEKKDEVYLNLVLD--YVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDL 907
           Q   R LAY+H      I HRDIK  N+LLD +     L DFG A+ ++           
Sbjct: 164 Q-LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSY 216

Query: 908 VGTLGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGK 944
           + +  Y  PE  +G A+  T   DV+S G VL ELL G+
Sbjct: 217 ICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (255), Expect = 2e-23
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 38/219 (17%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMERE-------FRAEVEALS 793
             + + + +G G +  VY+         VA+K +     ++E E        R EV  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----RLEHEEGAPCTAIR-EVSLLK 55

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAA 852
             +H N+V L      +    L++ +++    D  L + LD   + ++  +         
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLD---KD--LKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
           RGLAY H+     +LHRD+K  N+L++      LADFGLAR    P  T+   + V TL 
Sbjct: 111 RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLW 165

Query: 913 YIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           Y PP+       Y    +     D++  G +  E+ TG+
Sbjct: 166 YRPPDILLGSTDYS-TQI-----DMWGVGCIFYEMATGR 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 4e-23
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 40/220 (18%)

Query: 750 IGCGGFGLVYRA---TLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGY 806
           +G G +G VY+A      D ++ A+K++ G  G      R E+  L   +HPN++ LQ  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQKV 86

Query: 807 CMHKNDRL--LIYSFMENGSLDYW-LHEKLDGPSSLDWDSRLHIAQGAA------RGLAY 857
            +   DR   L++ + E    D W + +      +     +L      +       G+ Y
Sbjct: 87  FLSHADRKVWLLFDYAE---HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAH----LADFGLARLILSPYD--THVTTDLVGTL 911
           LH +    +LHRD+K +NIL+ G         +AD G ARL  SP      +   +V T 
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199

Query: 912 GYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            Y  PE       Y +A +     D+++ G +  ELLT +
Sbjct: 200 WYRAPELLLGARHYTKA-I-----DIWAIGCIFAELLTSE 233

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  100 bits (250), Expect = 4e-23
 Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 25/213 (11%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS----GDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G +G V            A+K L           E   + E++ L R +H N++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 805 GY-CMHKNDRLLIYSFME---NGS---LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
               ++  ++  +Y  ME    G    LD    ++          +  +  Q    GL Y
Sbjct: 72  -VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP-----VCQAHGYFCQLID-GLEY 124

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      I+H+DIK  N+LL       ++  G+A  +             G+  + PPE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 918 --YGQASVATYKGDVYSFGVVLLELLTGKRPMD 948
              G  + + +K D++S GV L  + TG  P +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  101 bits (253), Expect = 7e-23
 Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 42/236 (17%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF 785
           ++ ++++ D        F+    IG G FG V      D  +  A+K ++        E 
Sbjct: 7   DENEDVNFDH-------FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV 59

Query: 786 R---AEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSL 839
           R    E++ +   +HP LV+L  Y     + + ++   +  G L Y L  +         
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE--- 115

Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
               +L I +     L YL       I+HRD+K  NILLD +   H+ DF +A ++    
Sbjct: 116 --TVKLFICE-LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--- 166

Query: 900 DTHVTTDLVGTLGYIPPE---------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
                T + GT  Y+ PE         Y  A V     D +S GV   ELL G+RP
Sbjct: 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFA-V-----DWWSLGVTAYELLRGRRP 216

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.6 bits (249), Expect = 8e-23
 Identities = 45/223 (20%), Positives = 85/223 (38%), Gaps = 41/223 (18%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSRAQHP 798
              +  A  +G G FG+V+R       +    K +       ++   + E+  L+ A+H 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 799 NLVHLQGYCMHKNDRLLIYSFMENGSL-------DYWLHEKLDGPSSLDWDSRLHIAQGA 851
           N++HL        + ++I+ F+    +        + L+E+         +   ++ Q  
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER---------EIVSYVHQ-V 111

Query: 852 ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLARLILSPYDTHVTTDLVG 909
              L +LH     +I H DI+  NI+      + +   +FG AR +           L  
Sbjct: 112 CEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFT 165

Query: 910 TLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
              Y  PE         A+      D++S G ++  LL+G  P
Sbjct: 166 APEYYAPEVHQHDVVSTAT------DMWSLGTLVYVLLSGINP 202

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 9e-23
 Identities = 52/267 (19%), Positives = 96/267 (35%), Gaps = 21/267 (7%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS 146
           V  L L   R+    +  L   V L+ L L+ N +      S  +L +LE LDLS N LS
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 147 GPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGN 203
             L  +    L S+  L++  N       TS+  + ++++++ +        +       
Sbjct: 114 N-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG 172

Query: 204 CASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS 262
              LE L +  +DL         + +Q +  L L   Q    L   +   S++  L++  
Sbjct: 173 LTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231

Query: 263 NNFSGN--------IPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN--- 311
            +              +       F+ +         ++   L+    L  L    N   
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290

Query: 312 SLDGSLLLNCPALTNLTSLDLGTNKFN 338
           S+   +      LT+L  + L TN ++
Sbjct: 291 SVPDGIFDR---LTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 55/267 (20%), Positives = 96/267 (35%), Gaps = 23/267 (8%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
           ++ L+LS+N +       L    NL+ L L+SN ++  + +    +L S++ LD+S N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYL 112

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPG--LGNCASLEHLCLGMNDLTGGIADDIF 226
             ++ +S  K  S +  +NL  N +  TL       +   L+ L +G  D    I    F
Sbjct: 113 -SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 227 Q-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
             L  L  L +  + L      S+  + N+  L +        +          + L   
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 286 SNRFTGRIPHSLSNSPT---LNLLNLRNNSLDGSLLLNCPA----LTNLTSLDLGTNKFN 338
                      LS   T   +     RN  +    L         ++ L  L+   N+  
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK 290

Query: 339 GPLP----TNLPRCRKLKNINLARNNF 361
             +P      L     L+ I L  N +
Sbjct: 291 S-VPDGIFDRLT---SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 85.2 bits (211), Expect = 9e-18
 Identities = 52/283 (18%), Positives = 98/283 (34%), Gaps = 28/283 (9%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSN 263
            +++ L L  N +T     D+ +   L+ L L  N ++  +     + L +L  LD+S N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHS--LSNSPTLNLLNLRNNSLDGSLLLNC 321
             S      F  L    +L    N +   +  +   S+   L +L + N      +    
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 322 PA-LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL 380
            A LT L  L++  +      P +L   + + ++ L        +        S+  L L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229

Query: 381 SNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI 440
            ++ +               L+T             T+  +     + + I    L   +
Sbjct: 230 RDTDLDTF--------HFSELSTGE-----------TNSLIKKFTFRNVKITDESLF-QV 269

Query: 441 PQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNN 482
            + L   S L  ++ S NQL  ++P   F     L  + L  N
Sbjct: 270 MKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.9 bits (205), Expect = 5e-17
 Identities = 50/312 (16%), Positives = 99/312 (31%), Gaps = 41/312 (13%)

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPL 341
            S      IP  L+    +  L+L NN    +  S L       NL +L L +N  N  +
Sbjct: 39  SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQR---CVNLQALVLTSNGINT-I 91

Query: 342 PTNLPRC-RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
             +       L++++L+ N  S      +K   SL++L+L  +    L     +      
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET-SLFSHLTK 150

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
           L  L +       K+          L+ L I +  L+   P+ L+    +  + L   Q 
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210

Query: 461 SGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV 520
              + ++      +  L+L +         + + L +  T ++                 
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDT---FHFSELSTGETNSL----------------- 250

Query: 521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMT 580
                   +       + ++   L   +      +  L   +   N L          +T
Sbjct: 251 --IKKFTFR------NVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301

Query: 581 SLETLDLSYNNL 592
           SL+ + L  N  
Sbjct: 302 SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 82.5 bits (204), Expect = 8e-17
 Identities = 50/268 (18%), Positives = 89/268 (33%), Gaps = 26/268 (9%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN- 311
             +  LD+S+N  +             Q LV  SN        S S+  +L  L+L  N 
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111

Query: 312 --SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR-CRKLKNINLARNNFSGQIPE- 367
             +L  S       L++LT L+L  N +     T+L     KL+ + +   +   +I   
Sbjct: 112 LSNLSSSWFKP---LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 368 TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN---------FRNEKLPTD 418
            +     L  L +  S + +     + L+  +N++ L+L +                 + 
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEP--KSLKSIQNVSHLILHMKQHILLLEIFVDV--TSSV 224

Query: 419 PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLD 478
             L   +  +       L       L      + V ++   L   +         L  L+
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283

Query: 479 LSNNTFTGEIPKN-LTGLPSLITRNISL 505
            S N     +P      L SL  + I L
Sbjct: 284 FSRNQLKS-VPDGIFDRLTSL--QKIWL 308

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 54/276 (19%), Positives = 95/276 (34%), Gaps = 40/276 (14%)

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVI 431
            E++  L LSN+ I  +S++   LQ+C NL  LVLT N     +  D      +L+ L +
Sbjct: 51  TEAVKSLDLSNNRITYISNS--DLQRCVNLQALVLTSN-GINTIEEDSFSSLGSLEHLDL 107

Query: 432 ASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGTIP--VWFGGFQDLFYLDLSNNTFTGEI 488
           +   L  ++   W +  S L  ++L  N    T+     F     L  L + N     +I
Sbjct: 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 489 PKN-LTGLPSLITRNISLEEPS----PDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNR 543
            +    GL  L    + ++               +NVS   L   Q              
Sbjct: 166 QRKDFAGLTFL--EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF------ 217

Query: 544 LDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL--------TGMTSLETLDLSYNNLSGA 595
                         +   +L+  +L     SEL            +   + ++  +L   
Sbjct: 218 --------VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-Q 268

Query: 596 IPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPN 631
           +   L ++S L +   + N L   +P  G F    +
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKS-VPD-GIFDRLTS 302

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 54.7 bits (132), Expect = 7e-08
 Identities = 45/207 (21%), Positives = 64/207 (30%), Gaps = 42/207 (20%)

Query: 419 PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLD 478
           P   +    + VI S     S  Q    C +  +   S   L+ +IP   G  + +  LD
Sbjct: 2   PHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIP--SGLTEAVKSLD 58

Query: 479 LSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTID 538
           LSNN  T     +L    +L                          L  N I +      
Sbjct: 59  LSNNRITYISNSDLQRCVNLQALV----------------------LTSNGINTIEEDS- 95

Query: 539 LSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL-TGMTSLETLDLSYNNLSGAIP 597
                        F +L  L   DL +N LS  + S     ++SL  L+L  N       
Sbjct: 96  -------------FSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGE 141

Query: 598 ISL-EKLSFLSKFSVANNHLTGRIPSG 623
            SL   L+ L    V N     +I   
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRK 168

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 34/213 (15%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIK---RLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG G F  V  A  +  GR VAIK   +   +   +++ FR EV  +    HPN+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 806 YCMHKNDRLLIYSFME---NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
               +     +Y  ME    G + DY + H ++        ++R    +     + Y HQ
Sbjct: 82  VIETEKT---LYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSAVQYCHQ 132

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--Y 918
                I+HRD+K+ N+LLD +    +ADFG +          +     G   Y  PE   
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDA-FCGAPPYAAPELFQ 186

Query: 919 GQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           G+     Y G   DV+S GV+L  L++G  P D
Sbjct: 187 GKK----YDGPEVDVWSLGVILYTLVSGSLPFD 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (254), Expect = 1e-22
 Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 31/225 (13%)

Query: 737 ILESTNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRL--SGDCGQMEREFRAEV 789
           I     +  +       +G G +G V            AIK +  +        +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 790 EALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
             L    HPN++ L  +   K +  L+    + G L   +  +       +      I +
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIK 143

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTD 906
               G+ YLH+    +I+HRD+K  N+LL   + +    + DFGL+ +     +     +
Sbjct: 144 QVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKE 197

Query: 907 LVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            +GT  YI PE     Y +        DV+S GV+L  LL G  P
Sbjct: 198 RLGTAYYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 64/282 (22%), Positives = 108/282 (38%), Gaps = 58/282 (20%)

Query: 693 RAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGC 752
              +  +   + +   T +   + +G +  +      KE            +D  ++IG 
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGR 104

Query: 753 GGFGLVYRAT-LPDGRNVAIKRLS--------GDCGQMEREFRAEVEALSR-AQHPNLVH 802
           G   +V R      G   A+K +             ++    R E   L + A HP+++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 803 LQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           L       +   L++  M  G L DY      L EK         ++R  +       ++
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---------ETRSIMRS-LLEAVS 214

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           +LH +   +I+HRD+K  NILLD N    L+DFG +  +          +L GT GY+ P
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAP 268

Query: 917 E------------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           E            YG+        D+++ GV+L  LL G  P
Sbjct: 269 EILKCSMDETHPGYGKEV------DLWACGVILFTLLAGSPP 304

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 2e-22
 Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 26/240 (10%)

Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRA 795
           + N F Q  ++G GGFG V    +   G+  A K+L     +  +       E + L + 
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241

Query: 796 QHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
               +V L  Y     D L L+ + M  G L + ++            +  + A+    G
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAAE-ICCG 298

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYI 914
           L  LH+     I++RD+K  NILLD +    ++D GLA  +    +       VGT+GY+
Sbjct: 299 LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRVGTVGYM 352

Query: 915 PPE------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            PE      Y  +       D ++ G +L E++ G+ P    K K  R+ +  +++   E
Sbjct: 353 APEVVKNERYTFSP------DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  100 bits (251), Expect = 2e-22
 Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 29/231 (12%)

Query: 728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMERE-- 784
           K+  +  +D       F+   +IG G FG V    L +  +  A+K L+        E  
Sbjct: 67  KQMRLHRED-------FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119

Query: 785 -FRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
            FR E + L       +  L  Y    ++ L L+  +   G L   L  K +     +  
Sbjct: 120 CFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM- 176

Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILSPYD 900
           +R ++A+     +  +HQ    H +HRDIK  NIL+D N   H  LADFG    ++    
Sbjct: 177 ARFYLAE-MVIAIDSVHQL---HYVHRDIKPDNILMDMN--GHIRLADFGSCLKLM-EDG 229

Query: 901 THVTTDLVGTLGYIPPEYGQASVATYKG-----DVYSFGVVLLELLTGKRP 946
           T  ++  VGT  YI PE  QA            D +S GV + E+L G+ P
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (253), Expect = 2e-22
 Identities = 60/276 (21%), Positives = 94/276 (34%), Gaps = 64/276 (23%)

Query: 702 PEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRA 761
                +   +   + +     +    KE +I          ++ +   +G G +G V   
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKI--------GESYFKVRKLGSGAYGEVLLC 55

Query: 762 T-LPDGRNVAIKRLS-------------GDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
                    AIK +               +  +   E   E+  L    HPN++ L    
Sbjct: 56  KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115

Query: 808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDW-DSRLHIAQGAAR--------GLAYL 858
             K    L+  F E G L              +   +R    +  A         G+ YL
Sbjct: 116 EDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDAANIMKQILSGICYL 162

Query: 859 HQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           H+    +I+HRDIK  NILL   +      + DFGL+         +   D +GT  YI 
Sbjct: 163 HKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYIA 216

Query: 916 PE-----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           PE     Y +        DV+S GV++  LL G  P
Sbjct: 217 PEVLKKKYNEKC------DVWSCGVIMYILLCGYPP 246

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  101 bits (254), Expect = 2e-22
 Identities = 61/270 (22%), Positives = 106/270 (39%), Gaps = 41/270 (15%)

Query: 693 RAHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGC 752
           R +   E         T   + +     +   ++ +  EI  D +    +++D    +G 
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV---LDHYDIHEELGT 167

Query: 753 GGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN 811
           G FG+V+R T    G N A K +       +   R E++ +S  +HP LV+L       N
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 812 DRLLIYSFMENGSL-------DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
           + ++IY FM  G L          + E          ++  ++ Q   +GL ++H++   
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSED---------EAVEYMRQ-VCKGLCHMHEN--- 274

Query: 865 HILHRDIKSSNILLDGNFGAHL--ADFGLARLILSPYDTHVTTDLVGTLGYIPPE----- 917
           + +H D+K  NI+        L   DFGL   +             GT  +  PE     
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGK 331

Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             G  +      D++S GV+   LL+G  P
Sbjct: 332 PVGYYT------DMWSVGVLSYILLSGLSP 355

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 61/236 (25%), Positives = 90/236 (38%), Gaps = 33/236 (13%)

Query: 726 HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNV-AIKRLSGDC----GQ 780
             KE  +  DD       F+   +IG G F  V    +     V A+K ++       G+
Sbjct: 52  RLKEVRLQRDD-------FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104

Query: 781 MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSL 839
           +   FR E + L       +  L  +     + L L+  +   G L   L  K       
Sbjct: 105 VSC-FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPA 161

Query: 840 DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILS 897
           +  +R ++A+     +  +H+      +HRDIK  NILLD     H  LADFG   L L 
Sbjct: 162 EM-ARFYLAE-IVMAIDSVHRL---GYVHRDIKPDNILLDRC--GHIRLADFGSC-LKLR 213

Query: 898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVY-------SFGVVLLELLTGKRP 946
              T  +   VGT  Y+ PE  QA         Y       + GV   E+  G+ P
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 28/214 (13%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
           +IG G F +V R      G+  A+K     + +   G    + + E       +HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 803 LQGYCMHKNDRLLIYSFMENGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
           L           +++ FM+   L    +     G    +  +  ++ Q     L Y H +
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ-ILEALRYCHDN 149

Query: 862 CEPHILHRDIKSSNILLDGNFGAH---LADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
              +I+HRD+K   +LL     +    L  FG+A  +       V    VGT  ++ PE 
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEV 204

Query: 918 -----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
                YG+        DV+  GV+L  LL+G  P
Sbjct: 205 VKREPYGKPV------DVWGCGVILFILLSGCLP 232

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (251), Expect = 3e-22
 Identities = 62/245 (25%), Positives = 93/245 (37%), Gaps = 49/245 (20%)

Query: 726 HNKEKEISIDDILESTNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD--C 778
           H+     S  + L     F +      ++G G FG V +       +  A+K ++     
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 779 GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN---GSL-DY-----WL 829
            +       EVE L +  HPN++ L        D    Y   E    G L D        
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILE---DSSSFYIVGELYTGGELFDEIIKRKRF 118

Query: 830 HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHL 886
            E          D+   I +    G+ Y+H+    +I+HRD+K  NILL   + +    +
Sbjct: 119 SEH---------DAA-RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165

Query: 887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELL 941
            DFGL+             D +GT  YI PE     Y +        DV+S GV+L  LL
Sbjct: 166 IDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILL 216

Query: 942 TGKRP 946
           +G  P
Sbjct: 217 SGTPP 221

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 50/235 (21%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS---------------------------GDCGQM 781
           IG G +G+V  A    D    A+K LS                              G +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 782 EREFRAEVEALSRAQHPNLVHLQGYC-MHKNDRLLIYSFME---NGSL-DYWLHEKLDGP 836
           E+ ++ E+  L +  HPN+V L     +   +   +Y   E    G + +    + L   
Sbjct: 81  EQVYQ-EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS-- 135

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL 896
              +  +R    Q   +G+ YLH      I+HRDIK SN+L+  +    +ADFG++    
Sbjct: 136 ---EDQAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
              D  ++   VGT  ++ PE    +   + G   DV++ GV L   + G+ P  
Sbjct: 189 GS-DALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 58/233 (24%), Positives = 80/233 (34%), Gaps = 35/233 (15%)

Query: 109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT-INLPSIQVLDISSNS 167
              + + L  N +      S     NL +L L SN L+         L  ++ LD+S N+
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
                         ++R ++        T          L  L L    L   +   +F+
Sbjct: 92  --------------QLRSVD------PATFH----GLGRLHTLHLDRCGLQE-LGPGLFR 126

Query: 228 -LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
            L  L+ L LQDN L   L      DL NL  L +  N  S      F GL     L+ H
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTN 335
            NR     PH+  +   L  L L  N   +L    L     L  L  L L  N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP---LRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 7/204 (3%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG 147
             +FL+  R+    + S      L  L L  N+L      +   L  LE LDLS N    
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94

Query: 148 PLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNC 204
            +       L  +  L +    L   +   + +  + ++ + L  N     L      + 
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152

Query: 205 ASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSN 263
            +L HL L  N ++  + +  F+ L  L  L L  N+++     +  DL  L+ L + +N
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSN 287
           N S    +  A L   QYL  + N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 52/254 (20%), Positives = 86/254 (33%), Gaps = 44/254 (17%)

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
           +P  +P     + I L  N  S     +++   +L+ L L ++ +  + +          
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA--AAFTGLAL 81

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQ-WLRGCSKLQLVDLSWNQ 459
           L  L L+ N +   +          L  L +  CGL+  +     RG + LQ + L  N 
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140

Query: 460 LSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRR 518
           L   +P   F    +L +L L  N  +    +   GL SL      L             
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR----LL------------ 183

Query: 519 NVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTG 578
                 L  N++    P                F +L +L    L  NNLS      L  
Sbjct: 184 ------LHQNRVAHVHPHA--------------FRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 579 MTSLETLDLSYNNL 592
           + +L+ L L+ N  
Sbjct: 224 LRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 55/227 (24%), Positives = 76/227 (33%), Gaps = 19/227 (8%)

Query: 164 SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIA 222
               L  +VP  I    +  + I L  N  S  +       C +L  L L  N L   I 
Sbjct: 19  PQQGLQ-AVPVGI---PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RID 72

Query: 223 DDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIP-DVFAGLGEF 279
              F  L  L  L L DN     + P+    L  L  L +        +   +F GL   
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131

Query: 280 QYLVAHSNRFTGRIP-HSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTN 335
           QYL    N     +P  +  +   L  L L  N   S+          L +L  L L  N
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG---LHSLDRLLLHQN 187

Query: 336 KFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
           +     P       +L  + L  NN S    E      +L YL L++
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 15/212 (7%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSN 263
           A+ + + L  N ++   A      + L +L L  N L+ ++  +    L+ L +LD+S N
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90

Query: 264 NFSGNIP-DVFAGLGEFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSL----DGSL 317
               ++    F GLG    L          +          L  L L++N+L    D + 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTF 149

Query: 318 LLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSY 377
                 L NLT L L  N+ +            L  + L +N  +   P  +++   L  
Sbjct: 150 ----RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 378 LSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
           L L  +++  L +  + L   R L  L L  N
Sbjct: 206 LYLFANNLSALPT--EALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 50/229 (21%), Positives = 72/229 (31%), Gaps = 38/229 (16%)

Query: 399 RNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN 458
                + L  N R   +P        NL +L + S  L         G + L+ +DLS N
Sbjct: 32  AASQRIFLHGN-RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 459 QLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFM 516
               ++    F G   L  L L       E+      GL +L                  
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY-------------- 135

Query: 517 RRNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSIWPE-FGNLKKLHVFDLKH 565
                   LQ N + + P            + L  NR+  S+    F  L  L    L  
Sbjct: 136 --------LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186

Query: 566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
           N ++   P     +  L TL L  NNLS     +L  L  L    + +N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 31/183 (16%), Positives = 50/183 (27%), Gaps = 39/183 (21%)

Query: 453 VDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDF 512
                  L   +PV  G       + L  N  +     +     +L              
Sbjct: 16  TSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILW---------- 62

Query: 513 PFFMRRNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSIWPE-FGNLKKLHVF 561
                       L  N +                +DLS N    S+ P  F  L +LH  
Sbjct: 63  ------------LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110

Query: 562 DLKHNNLSGPIPSE-LTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRI 620
            L    L   +      G+ +L+ L L  N L      +   L  L+   +  N ++  +
Sbjct: 111 HLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SV 168

Query: 621 PSG 623
           P  
Sbjct: 169 PER 171

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 19/65 (29%), Positives = 28/65 (43%), Gaps = 3/65 (4%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDIS 164
            L  L  L L  N +    P +  +L  L  L L +N+LS  LP      L ++Q L ++
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLN 233

Query: 165 SNSLN 169
            N   
Sbjct: 234 DNPWV 238

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.2 bits (245), Expect = 6e-22
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 26/214 (12%)

Query: 743 NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
              +  I+G G FG V++      G  +A K +     + + E + E+  +++  H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 802 HLQGYCMHKNDRLLIYSFMENGSL-------DYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
            L      KND +L+  +++ G L        Y L E          D+ L + Q    G
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL---------DTILFMKQ-ICEG 199

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLARLILSPYDTHVTTDLVGTLG 912
           + ++HQ    +ILH D+K  NIL        +   DFGLAR               GT  
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPE 253

Query: 913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           ++ PE       ++  D++S GV+   LL+G  P
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.1 bits (242), Expect = 6e-22
 Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 42/240 (17%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDC----GQMEREFRAEVEALSRAQHPN 799
           +G G FG V+ A      + V +K     ++  DC     ++ +    E+  LSR +H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
           ++ +    + +N        ME       L   +D    LD     +I +     + YL 
Sbjct: 91  IIKV--LDIFENQGF-FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-- 917
                 I+HRDIK  NI++  +F   L DFG A  +      +      GT+ Y  PE  
Sbjct: 148 LK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPEVL 201

Query: 918 YGQASVATYKG---DVYSFGVVLLELLTGKRPMDMCK-------------PKGSRDLISW 961
            G      Y+G   +++S GV L  L+  + P    +              K    L+S 
Sbjct: 202 MGNP----YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSG 257

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 99.0 bits (247), Expect = 1e-21
 Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 32/226 (14%)

Query: 737 ILESTNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRLS---GDCGQMEREFRAE 788
           +  ST  F        ++G G FG V        G+  A+K +S         +     E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 789 VEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
           V+ L +  HPN++ L  +   K    L+      G L     +++             I 
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARII 132

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTT 905
           +    G+ Y+H++    I+HRD+K  N+LL     +    + DFGL+        +    
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMK 186

Query: 906 DLVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           D +GT  YI PE     Y +        DV+S GV+L  LL+G  P
Sbjct: 187 DKIGTAYYIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP 226

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 59/238 (24%), Positives = 87/238 (36%), Gaps = 32/238 (13%)

Query: 726 HNKEKEISIDDILESTNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCG 779
           H+     S  + L      D        +G G FG V+       G    IK ++     
Sbjct: 2   HHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ 61

Query: 780 QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME---NGSLDYWLHEKLDGP 836
               +  AE+E L    HPN++ +        D   +Y  ME    G L   +       
Sbjct: 62  VPMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARG 118

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLAR 893
            +L       + +     LAY H     H++H+D+K  NIL      +    + DFGLA 
Sbjct: 119 KALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 894 LILSPYDTHVTTDLVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           L         +T+  GT  Y+ PE                D++S GVV+  LLTG  P
Sbjct: 176 LF---KSDEHSTNAAGTALYMAPEVFKRDVTFKC------DIWSAGVVMYFLLTGCLP 224

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 57/229 (24%), Positives = 86/229 (37%), Gaps = 45/229 (19%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE-FRAEVEALS 793
            + +D    +G G F +V +      G   A K     +       + RE    EV  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------DYWLHEKLDGPSSLDWDSRLHI 847
           +  H N++ L     ++ D +LI   +  G L         L E+         ++   I
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---------EATSFI 121

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH----LADFGLARLILSPYDTHV 903
            Q    G+ YLH      I H D+K  NI+L           L DFGLA  I    D   
Sbjct: 122 KQ-ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVE 174

Query: 904 TTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ GT  ++ PE       G  +      D++S GV+   LL+G  P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 217

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 63/245 (25%), Positives = 93/245 (37%), Gaps = 49/245 (20%)

Query: 726 HNKEKEISIDDILESTNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGD--C 778
           H+     S  + L     F +      ++G G FG V +       +  A+K ++     
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 779 GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME---NGSL-DY-----WL 829
            +       EVE L +  HPN++ L        D    Y   E    G L D        
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRF 118

Query: 830 HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHL 886
            E          D+   I Q    G+ Y+H+    +I+HRD+K  NILL   + +    +
Sbjct: 119 SEH---------DAARIIKQ-VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165

Query: 887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPE-----YGQASVATYKGDVYSFGVVLLELL 941
            DFGL+             D +GT  YI PE     Y +        DV+S GV+L  LL
Sbjct: 166 IDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILL 216

Query: 942 TGKRP 946
           +G  P
Sbjct: 217 SGTPP 221

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.9 bits (237), Expect = 1e-21
 Identities = 60/229 (26%), Positives = 92/229 (40%), Gaps = 45/229 (19%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE-FRAEVEALS 793
            ++++    +G G F +V +      G+  A K     RLS     + RE    EV  L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------DYWLHEKLDGPSSLDWDSRLHI 847
             +HPN++ L     +K D +LI   +  G L         L E          ++   +
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED---------EATQFL 114

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILL-DGNFGAH---LADFGLARLILSPYDTHV 903
            Q    G+ YLH      I H D+K  NI+L D N       L DFG+A  I      + 
Sbjct: 115 KQ-ILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNE 167

Query: 904 TTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ GT  ++ PE       G  +      D++S GV+   LL+G  P
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 60/229 (26%), Positives = 90/229 (39%), Gaps = 43/229 (18%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEV--------- 789
           +T+ ++    IG G +G VY+A     G  VA+K +              +         
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP---NGGGGGGGLPISTVREVA 63

Query: 790 --EALSRAQHPNLVHLQGYCMHKNDRL-----LIYSFMENGSLDYWLHEKLDGPSSLDWD 842
               L   +HPN+V L   C            L++  ++    D  L   LD        
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD---QD--LRTYLDKAPPPGLP 118

Query: 843 SRL--HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
           +     + +   RGL +LH +    I+HRD+K  NIL+       LADFGLAR     Y 
Sbjct: 119 AETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR----IYS 171

Query: 901 THVT-TDLVGTLGYIPPE--YGQASVATYKG--DVYSFGVVLLELLTGK 944
             +  T +V TL Y  PE        +TY    D++S G +  E+   K
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQ----STYATPVDMWSVGCIFAEMFRRK 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 54/216 (25%), Positives = 78/216 (36%), Gaps = 43/216 (19%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            IG G +G V  A         A K++     +    F+ E+E +    HPN++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 808 MHKNDRLLIYSFME---NGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
               D   IY  ME    G L +         E          D+   +       +AY 
Sbjct: 76  ---EDNTDIYLVMELCTGGELFERVVHKRVFRES---------DAARIMKD-VLSAVAYC 122

Query: 859 HQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           H+    ++ HRD+K  N L      +    L DFGLA          +    VGT  Y+ 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVS 176

Query: 916 PE-----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           P+     YG         D +S GV++  LL G  P
Sbjct: 177 PQVLEGLYGPEC------DEWSAGVMMYVLLCGYPP 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.0 bits (237), Expect = 4e-21
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 47/230 (20%)

Query: 740 STNNFDQANIIGCGGFGLVYRA--TLPDGRNVAIKRLSGDCGQMERE--------FRAEV 789
           +   ++    IG G +G V++A      GR VA+KR+     +++           R EV
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIR-EV 62

Query: 790 EAL---SRAQHPNLVHLQGYCMHKNDRL-----LIYSFMENGSLDYWLHEKLDGPSSLDW 841
             L      +HPN+V L   C            L++  ++    D  L   LD       
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QD--LTTYLDKVPEPGV 117

Query: 842 DSRL--HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
            +     +     RGL +LH      ++HRD+K  NIL+  +    LADFGLAR     Y
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR----IY 170

Query: 900 DTHVT-TDLVGTLGYIPPE--YGQASVATYKG--DVYSFGVVLLELLTGK 944
              +  T +V TL Y  PE        ++Y    D++S G +  E+   K
Sbjct: 171 SFQMALTSVVVTLWYRAPEVLLQ----SSYATPVDLWSVGCIFAEMFRRK 216

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 50/222 (22%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G +G V  A        VA+K     R       +++E    +       H N+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 804 QGYCMHKNDRLLIYSFME---NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAAR------ 853
            G+    N     Y F+E    G L D            ++ D  +      A+      
Sbjct: 71  YGHRREGNI---QYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQL 114

Query: 854 --GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             G+ YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 912 GYIPPE--YGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            Y+ PE    +     +     DV+S G+VL  +L G+ P D
Sbjct: 172 PYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 97.3 bits (242), Expect = 5e-21
 Identities = 47/285 (16%), Positives = 98/285 (34%), Gaps = 30/285 (10%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL--SGPLPQTINLPSIQVLDISSNSLNGS 171
            N  +N + GT           E   L   +   +  L +   +     L ++  +L+ S
Sbjct: 15  QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-S 73

Query: 172 VPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKL 231
           +P ++      I V+ ++ N    +L     +   LE+L    N L+  + +    L+ L
Sbjct: 74  LPDNLPPQ---ITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL 125

Query: 232 RLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG 291
               + +NQL+  L       + L  ++  +N  +  +P++   L   + L   +N+ T 
Sbjct: 126 D---VDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT- 173

Query: 292 RIPHSLSNSPTLNLLNLRNNSLDG--SLLLNCPALTNL-TSLDLGTNKFNGPLPTNLPRC 348
            +P    +   L  L++  N L+   ++ +                N+    +P N+   
Sbjct: 174 FLPELPES---LEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSL 229

Query: 349 RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQ 393
                I L  N  S +I E+     +                   
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 92.3 bits (229), Expect = 2e-19
 Identities = 61/315 (19%), Positives = 116/315 (36%), Gaps = 34/315 (10%)

Query: 108 LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNS 167
           + Q   L L+   L  ++P +L   P + VL+++ N L   LP+     S++ LD   N 
Sbjct: 58  INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELP--ASLEYLDACDNR 111

Query: 168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ 227
           L+ ++P       + ++ +++  N  +  L         LE++    N LT  + +    
Sbjct: 112 LS-TLPELP----ASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLTM-LPE---L 158

Query: 228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ----YLV 283
              L +L +++NQL+  L        +L  LDVS+N    ++P V       +    +  
Sbjct: 159 PTSLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213

Query: 284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT 343
              NR T  IP ++ +      + L +N L   +  +    T           F+     
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

Query: 344 NLPRCRKLKNINLA--RNNFSGQIPETYKNFESLSY---LSLSNSSIYNLSSALQVLQQC 398
                R L +   A    N    + + +  FE   +    S     + +  SA       
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFR 332

Query: 399 RNLTTLVLTLNFRNE 413
             +   +  L+   E
Sbjct: 333 EQVAAWLEKLSASAE 347

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 90.0 bits (223), Expect = 1e-18
 Identities = 65/423 (15%), Positives = 126/423 (29%), Gaps = 83/423 (19%)

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
           + +K  L G   N+    L   +  ++    L ++  N S                    
Sbjct: 35  KWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-------------------- 72

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
                 +P +L     + +L +  N+L  SL        +L  LD   N+ +  LP    
Sbjct: 73  -----SLPDNLPPQ--ITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPELPA 120

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
             + L   ++  N  +  +PE       L Y++  N+ +  L           +L  L +
Sbjct: 121 SLKHL---DVDNNQLT-MLPEL---PALLEYINADNNQLTMLPELPT------SLEVLSV 167

Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLV----DLSWNQLSG 462
             N +   LP  P     +L+ L +++  L  S+P         +          N+++ 
Sbjct: 168 RNN-QLTFLPELPE----SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT- 220

Query: 463 TIPVWFGGFQDLFYLDLSNN---TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRN 519
            IP           + L +N   +   E     T  P      I             R  
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP- 279

Query: 520 VSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP-------- 571
                L       FP      ++++    W  F + +  + F    + LS          
Sbjct: 280 -----LADAVTAWFPENKQSDVSQI----WHAFEHEEHANTFSAFLDRLSDTVSARNTSG 330

Query: 572 ----IPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQ 627
               + + L  +++   L      ++     S E    L+  ++    L  +   G    
Sbjct: 331 FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDN 390

Query: 628 TFP 630
              
Sbjct: 391 DTG 393

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 86.2 bits (213), Expect = 2e-17
 Identities = 60/307 (19%), Positives = 102/307 (33%), Gaps = 61/307 (19%)

Query: 348 CRKLKNINLARNNFSGQIPETYKNF----ESLSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
                N +L++N+F   I  TY ++    +     +L   +     S L+        + 
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI-NQFSE 63

Query: 404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGT 463
           L L        L + P      + VL I    L  S+P+     + L+ +D   N+LS T
Sbjct: 64  LQLNRL----NLSSLPDNLPPQITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-T 114

Query: 464 IPVWFGGFQDLFYLDLSNNTFTGEIPK-------------NLTGLPSLITRNISLEEPSP 510
           +P      +   +LD+ NN  T  +P+              LT LP L T    L     
Sbjct: 115 LPELPASLK---HLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVLS---- 166

Query: 511 DFPFFMRRNVSARGLQYNQIWSFPPTI------DLSLNRLDGSIWPEFGNLKKL----HV 560
                         ++ NQ+   P         D+S N L+ S+                
Sbjct: 167 --------------VRNNQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211

Query: 561 FDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRI 620
           F  + N ++  IP  +  +    T+ L  N LS  I  SL + +    +     + +   
Sbjct: 212 FRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270

Query: 621 PSGGQFQ 627
                  
Sbjct: 271 GQQNTLH 277

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 39/265 (14%), Positives = 75/265 (28%), Gaps = 25/265 (9%)

Query: 78  LNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEV 137
           L +      +  +     +L   L E   +L     L++ +N L   +P       +LE 
Sbjct: 135 LPELPAL--LEYINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLPEL---PESLEA 184

Query: 138 LDLSSNDLSGPLPQTI----NLPSIQV-LDISSNSLNGSVPTSICKNSSRIRVINLSVNY 192
           LD+S+N L   LP       +    ++      N +   +P +I         I L  N 
Sbjct: 185 LDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDP-TCTIILEDNP 241

Query: 193 FSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADL 252
            S  +   L    +           +              L               ++ +
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQI 299

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
            +    +  +N FS         L +       S  F  ++   L        L  ++ +
Sbjct: 300 WHAFEHEEHANTFSAF----LDRLSDTVSARNTSG-FREQVAAWLEKLSASAELRQQSFA 354

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKF 337
           +      +C     LT  +L     
Sbjct: 355 VAADATESCEDRVALTWNNLRKTLL 379

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.8 bits (234), Expect = 5e-21
 Identities = 52/221 (23%), Positives = 83/221 (37%), Gaps = 53/221 (23%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
           ++G G F  V+       G+  A+K +       +     E+  L + +H N+V L+   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 808 MHKNDRLLIYSFME-------------NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
                    Y  M+              G       EK         D+ L I Q     
Sbjct: 76  ---ESTTHYYLVMQLVSGGELFDRILERGVYT----EK---------DASLVIQQ-VLSA 118

Query: 855 LAYLHQSCEPHILHRDIKSSNILLDGNF-GAHL--ADFGLARLILSPYDTHVTTDLVGTL 911
           + YLH++    I+HRD+K  N+L       + +   DFGL+++        + +   GT 
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTP 171

Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           GY+ PE      Y +A       D +S GV+   LL G  P
Sbjct: 172 GYVAPEVLAQKPYSKAV------DCWSIGVITYILLCGYPP 206

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 5e-21
 Identities = 58/229 (25%), Positives = 87/229 (37%), Gaps = 45/229 (19%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE-FRAEVEALS 793
            + +D    +G G F +V +      G   A K     +       + RE    EV  L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------DYWLHEKLDGPSSLDWDSRLHI 847
           +  HPN++ L     ++ D +LI   +  G L         L E+         ++   I
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---------EATSFI 121

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH----LADFGLARLILSPYDTHV 903
            Q    G+ YLH      I H D+K  NI+L           L DFGLA  I    D   
Sbjct: 122 KQ-ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVE 174

Query: 904 TTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ GT  ++ PE       G  +      D++S GV+   LL+G  P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 217

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.2 bits (235), Expect = 6e-21
 Identities = 60/229 (26%), Positives = 89/229 (38%), Gaps = 45/229 (19%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMERE-FRAEVEALS 793
            + +D    +G G F +V +      G   A K     R       + RE    EV  L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL------DYWLHEKLDGPSSLDWDSRLHI 847
             QHPN++ L     +K D +LI   +  G L         L E+         ++   +
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE---------EATEFL 120

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILL-DGNFGAH---LADFGLARLILSPYDTHV 903
            Q    G+ YLH      I H D+K  NI+L D N       + DFGLA  I      + 
Sbjct: 121 KQ-ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNE 173

Query: 904 TTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             ++ GT  ++ PE       G  +      D++S GV+   LL+G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 95.1 bits (237), Expect = 6e-21
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 30/219 (13%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG------DCGQMEREFRAEVEA 791
                +     IG G  G+V  A      RNVAIK+LS            +R +R E+  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYR-ELVL 77

Query: 792 LSRAQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
           +    H N++ L      Q       D  ++   M+  +L   +  +LD           
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELD-----HERMSY 131

Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
            + Q    G+ +LH +    I+HRD+K SNI++  +    + DFGLAR   +   + + T
Sbjct: 132 LLYQ-MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMT 184

Query: 906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
             V T  Y  PE           D++S G ++ E++ G 
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 43/251 (17%), Positives = 83/251 (33%), Gaps = 22/251 (8%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLV---NLPNLEVLDLSSNDLSGPLPQTI---NLPSIQV 160
             + L+ L +    +   +    +    +  L+ L L + +++G  P  +     P + +
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 161 LDISSNSLNG---SVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDL 217
           L++ + S       +          ++V++++  +        +    +L  L L  N  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 218 TGGIA-------DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP 270
            G               LQ L L        SG  S   A    L  LD+S N+      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 271 DV-FAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTS 329
                   +   L         ++P  L     L++L+L  N LD +   +   L  + +
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVGN 300

Query: 330 LDLGTNKFNGP 340
           L L  N F   
Sbjct: 301 LSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 63/327 (19%), Positives = 88/327 (26%), Gaps = 77/327 (23%)

Query: 305 LLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR---CRKLKNINLARNNF 361
           LL   +   D     +     +L  L +   +    +     R      L+ + L     
Sbjct: 48  LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107

Query: 362 SGQIPETYKNF--ESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDP 419
           +G  P          L+ L+L N S     + L  LQQ                      
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP------------------ 149

Query: 420 RLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW----FGGFQDLF 475
                 LKVL IA         + +R    L  +DLS N   G   +        F  L 
Sbjct: 150 -----GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 476 YLDLSNN---TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWS 532
            L L N    T +G           L                                  
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQ--------------------------------- 231

Query: 533 FPPTIDLSLNRLDGSIWPE-FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNN 591
               +DLS N L  +          +L+  +L    L   +P  L     L  LDLSYN 
Sbjct: 232 ---GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNR 285

Query: 592 LSGAIPISLEKLSFLSKFSVANNHLTG 618
           L    P   E L  +   S+  N    
Sbjct: 286 LDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 50/281 (17%), Positives = 96/281 (34%), Gaps = 53/281 (18%)

Query: 360 NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDP 419
           NFS   P+    F  L             ++ +++    R+L  L+  ++   +      
Sbjct: 16  NFSDPKPDWSSAFNCLG------------AADVELYGGGRSLEYLLKRVDTEADLGQFTD 63

Query: 420 RLHFANLKVLVIASCGLRGSIPQW---LRGCSKLQLVDLSWNQLSGTIPVWFGGFQ--DL 474
            +   +LK L + +  +   I      + G S LQ + L   +++GT P         DL
Sbjct: 64  IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123

Query: 475 FYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFP 534
             L+L N ++                     +    +   +++  +    +      +F 
Sbjct: 124 NILNLRNVSWAT------------------RDAWLAELQQWLKPGLKVLSIAQAHSLNFS 165

Query: 535 P----------TIDLSLNRLDGSIW-------PEFGNLKKLHVFDLKHNNLSGPIPSELT 577
                      T+DLS N   G           +F  L+ L + +      SG   +   
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225

Query: 578 GMTSLETLDLSYNNLSGAIP-ISLEKLSFLSKFSVANNHLT 617
               L+ LDLS+N+L  A    S +  S L+  +++   L 
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 24/123 (19%), Positives = 41/123 (33%), Gaps = 11/123 (8%)

Query: 102 SESLGNLVQLRFLNLSHNLLK---GTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLP 156
           +        L+ L L +  ++   G           L+ LDLS N L             
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253

Query: 157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMND 216
            +  L++S   L   VP  +    +++ V++LS N       P       + +L L  N 
Sbjct: 254 QLNSLNLSFTGLK-QVPKGL---PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNP 307

Query: 217 LTG 219
              
Sbjct: 308 FLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 6/102 (5%)

Query: 95  RRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL-VNLPNLEVLDLSSNDLSGPLPQTI 153
               G  S      VQL+ L+LSHN L+             L  L+LS   L   +P+ +
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL 272

Query: 154 NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG 195
               + VLD+S N L+   P+       ++  ++L  N F  
Sbjct: 273 -PAKLSVLDLSYNRLD-RNPSPD--ELPQVGNLSLKGNPFLD 310

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 7e-21
 Identities = 57/228 (25%), Positives = 89/228 (39%), Gaps = 44/228 (19%)

Query: 741 TNNFDQA----NIIGCGGFGLVYRAT-LPDGRNVAIKRL--SGDCGQMEREFRAEVEALS 793
           +  F         +G G F +V R      G   A K +       +  ++   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 794 RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHI 847
           + QHPN+V L      ++   L++  +  G L +      +  E          D+  H 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DAS-HC 110

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHL--ADFGLARLILSPYDTHVT 904
            Q     +AY H +    I+HR++K  N+LL     GA +  ADFGLA  +    D+   
Sbjct: 111 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAW 164

Query: 905 TDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
               GT GY+ PE      Y +        D+++ GV+L  LL G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPV------DIWACGVILYILLVGYPP 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.1 bits (237), Expect = 9e-21
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 50/224 (22%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS--------GDCGQMEREFRAEVEALSRAQHPNL 800
           +G G  G V  A      + VAI+ +S                    E+E L +  HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 801 VHLQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAARG 854
           + ++ +     D  ++   ME G L D       L E            +L+  Q     
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA---------TCKLYFYQ-MLLA 251

Query: 855 LAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
           + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +   L GT 
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTP 305

Query: 912 GYIPPE---------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            Y+ PE         Y +A       D +S GV+L   L+G  P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAV------DCWSLGVILFICLSGYPP 343

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.2 bits (237), Expect = 9e-21
 Identities = 58/232 (25%), Positives = 92/232 (39%), Gaps = 34/232 (14%)

Query: 728 KEKEISIDDILESTNNFDQANIIGCGGFGLVY----RATLPDGRNVAIKRLSGDC----G 779
           ++  +  +D       ++   +IG G FG V     ++T    +  A+K LS        
Sbjct: 62  RDLRMKAED-------YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRS 111

Query: 780 QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSS 838
                F  E + ++ A  P +V L  Y    +  L ++  +M  G L   +         
Sbjct: 112 DSAF-FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVP 166

Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
             W +R + A+     L  +H       +HRD+K  N+LLD +    LADFG   + ++ 
Sbjct: 167 EKW-ARFYTAEVVL-ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNK 220

Query: 899 YDTHVTTDLVGTLGYIPPE--YGQASVATYKGDV--YSFGVVLLELLTGKRP 946
                    VGT  YI PE    Q     Y  +   +S GV L E+L G  P
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 43/249 (17%)

Query: 724 LFHNKEKEISIDDILESTNNFDQANI----------IGCGGFGLVYRAT-LPDGRNVAIK 772
           + H+      +D   E+       N           +G G F +V +      G+  A K
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60

Query: 773 -----RLSGDCGQMEREFRAEVEALSRAQH-PNLVHLQGYCMHKNDRLLIYSFMENGSLD 826
                R   DC     E   E+  L  A+  P +++L     + ++ +LI  +   G + 
Sbjct: 61  FLKKRRRGQDC---RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117

Query: 827 YWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH- 885
                +L    S + D    I Q    G+ YLHQ+   +I+H D+K  NILL   +    
Sbjct: 118 SLCLPELAEMVS-ENDVIRLIKQ-ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGD 172

Query: 886 --LADFGLARLILSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVL 937
             + DFG++R I          +++GT  Y+ PE         A+      D+++ G++ 
Sbjct: 173 IKIVDFGMSRKIG---HACELREIMGTPEYLAPEILNYDPITTAT------DMWNIGIIA 223

Query: 938 LELLTGKRP 946
             LLT   P
Sbjct: 224 YMLLTHTSP 232

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.8 bits (231), Expect = 2e-20
 Identities = 58/222 (26%), Positives = 86/222 (38%), Gaps = 50/222 (22%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           +G G +G V  A        VA+K     R       +++E    +       H N+V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70

Query: 804 QGYCMHKNDRLLIYSFME---NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAAR------ 853
            G+    N     Y F+E    G L D            ++ D  +      A+      
Sbjct: 71  YGHRREGNI---QYLFLEYCSGGELFDR-----------IEPDIGMPEPD--AQRFFHQL 114

Query: 854 --GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             G+ YLH      I HRDIK  N+LLD      ++DFGLA +        +   + GTL
Sbjct: 115 MAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 912 GYIPPE--YGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            Y+ PE    +     +     DV+S G+VL  +L G+ P D
Sbjct: 172 PYVAPELLKRRE----FHAEPVDVWSCGIVLTAMLAGELPWD 209

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 50/222 (22%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLS--------GDCGQMEREFRAEVEALSRAQHPN 799
            +G G  G V  A      + VAIK +S                    E+E L +  HP 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 800 LVHLQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAAR 853
           ++ ++ +     D  ++   ME G L D       L E            +L+  Q    
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA---------TCKLYFYQ-MLL 125

Query: 854 GLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            + YLH++    I+HRD+K  N+LL   + +    + DFG ++++    +T +   L GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGT 179

Query: 911 LGYIPPE---------YGQASVATYKGDVYSFGVVLLELLTG 943
             Y+ PE         Y +A       D +S GV+L   L+G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAV------DCWSLGVILFICLSG 215

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.7 bits (238), Expect = 3e-20
 Identities = 66/227 (29%), Positives = 93/227 (40%), Gaps = 43/227 (18%)

Query: 740 STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD---------CGQMEREFRAEV 789
           + N+F    IIG GGFG VY     D G+  A+K L                ER     +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM---L 243

Query: 790 EALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLH 846
             +S    P +V +  Y  H  D+L  I   M  G L Y L  H           D R +
Sbjct: 244 SLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFY 297

Query: 847 IAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTD 906
            A+    GL ++H      +++RD+K +NILLD +    ++D GLA              
Sbjct: 298 AAE-IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHA 349

Query: 907 LVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            VGT GY+ PE       Y  ++      D +S G +L +LL G  P
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA------DWFSLGCMLFKLLRGHSP 390

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.8 bits (233), Expect = 4e-20
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 30/219 (13%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG------DCGQMEREFRAEVEA 791
                +     IG G  G+V  A      RNVAIK+LS            +R +R E+  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYR-ELVL 114

Query: 792 LSRAQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
           +    H N++ L      Q       D  L+   M+    +  L + +     LD +   
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---N--LCQVI--QMELDHERMS 167

Query: 846 HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
           ++      G+ +LH +    I+HRD+K SNI++  +    + DFGLAR   +   + + T
Sbjct: 168 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMT 221

Query: 906 DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK 944
             V T  Y  PE           D++S G ++ E++  K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 91.6 bits (228), Expect = 7e-20
 Identities = 59/219 (26%), Positives = 87/219 (39%), Gaps = 46/219 (21%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIK-----RLSGDCGQMEREFRAEVEALSRAQHPNLVH 802
            +G G F +V R      G   A K     +LS    Q       E     + QHPN+V 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK---LEREARICRKLQHPNIVR 92

Query: 803 LQGYCMHKNDRLLIYSFMENGSL-DY-----WLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           L      ++   L++  +  G L +      +  E          D+  H  Q     +A
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---------DAS-HCIQQILESIA 142

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNF-GAHL--ADFGLARLILSPYDTHVTTDLVGTLGY 913
           Y H +    I+HR++K  N+LL     GA +  ADFGLA  +    D+       GT GY
Sbjct: 143 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV---NDSEAWHGFAGTPGY 196

Query: 914 IPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           + PE      Y +        D+++ GV+L  LL G  P
Sbjct: 197 LSPEVLKKDPYSKPV------DIWACGVILYILLVGYPP 229

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 51/301 (16%), Positives = 99/301 (32%), Gaps = 22/301 (7%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVS-LVNLPNLEVLDLS-SND 144
              L     +L+     +      L  + +S N +   +      NLP L  + +  +N+
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 145 LSGPLPQT-INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-- 201
           L    P+   NLP++Q L IS+  +   +P     +S +  ++++  N    T+      
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 202 GNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLD 259
           G       L L  N +   I +  F   Q   L    +N L  +L   +    S  V LD
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208

Query: 260 VSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLL 319
           +S              L + +    ++ +   ++P +L     L   +L   S       
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS------- 257

Query: 320 NCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLS 379
           +C A  N        +               +      R++ +     +Y     ++Y  
Sbjct: 258 HCCAFANWRRQISELHPICN-KSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTE 316

Query: 380 L 380
            
Sbjct: 317 F 317

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 47/280 (16%), Positives = 85/280 (30%), Gaps = 45/280 (16%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGS 171
                + +   +P  L    N   L      L   + +        ++ ++IS N +   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 172 VPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQK 230
           +   +                FS      L     +       N+L   I  + FQ L  
Sbjct: 70  IEADV----------------FS-----NLPKLHEIRI--EKANNLL-YINPEAFQNLPN 105

Query: 231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD-VFAGL-GEFQYLVAHSNR 288
           L+ L + +  +              V LD+  N     I    F GL  E   L  + N 
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165

Query: 289 FTGRIPHSLSNSPTLNLLNLRNN---SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL 345
                  + + +    L    NN    L   +       +    LD+   + +  LP+  
Sbjct: 166 IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG---ASGPVILDISRTRIH-SLPSYG 221

Query: 346 PRC-RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS 384
               +KL+  +    N   ++P T +   +L   SL+  S
Sbjct: 222 LENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 37/250 (14%), Positives = 72/250 (28%), Gaps = 29/250 (11%)

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVI 431
             +   L    + +  +           +L  + ++ N   E +  D   +   L  + I
Sbjct: 29  PRNAIELRFVLTKLRVIQK--GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86

Query: 432 ASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGTIP-VWFGGFQDLFYLDLSNNTFTGEIP 489
                   I  +  +    LQ + +S   +   +P V          LD+ +N     I 
Sbjct: 87  EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 490 KN-LTGLPSLITRNISLEEPS----PDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRL 544
           +N   GL    +  + L +       +  F   +         N +   P  +       
Sbjct: 146 RNSFVGLSFE-SVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDV------- 197

Query: 545 DGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLS 604
                  F       + D+    +       L  +  L        NL   +P +LEKL 
Sbjct: 198 -------FHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLV 246

Query: 605 FLSKFSVANN 614
            L + S+   
Sbjct: 247 ALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 51.4 bits (123), Expect = 9e-07
 Identities = 30/181 (16%), Positives = 56/181 (30%), Gaps = 23/181 (12%)

Query: 450 LQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSL----ITRNIS 504
              +     +L       F GF DL  +++S N     I  +  + LP L    I +  +
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 505 LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLK 564
           L   +P+  F    N+    +    I   P                   +  +  + D++
Sbjct: 92  LLYINPEA-FQNLPNLQYLLISNTGIKHLPDVH--------------KIHSLQKVLLDIQ 136

Query: 565 HNNLSGPIPSE-LTGMTS-LETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS 622
            N     I      G++     L L+ N +      +             NN+L   +P+
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPN 195

Query: 623 G 623
            
Sbjct: 196 D 196

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 92.3 bits (230), Expect = 1e-19
 Identities = 94/473 (19%), Positives = 159/473 (33%), Gaps = 94/473 (19%)

Query: 111 LRFLNLSHNLLKGT-VPVSLVNLPNLEVLDLSSNDLSGPLPQTI-----NLPSIQVLDIS 164
           ++ L++    L        L  L   +V+ L    L+    + I       P++  L++ 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 165 SNSLNGSVPTSICK----NSSRIRVINLSVNYFSGT----LSPGLGNCASLEHLCLGMND 216
           SN L       + +     S +I+ ++L     +G     LS  L    +L+ L L  N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 217 LTGGIADDIFQLQ-----KLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFSG 267
           L       + +       +L  L L+   LS      L+  +    +   L VS+N+ + 
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 268 N-IPDVFAGLGEF----QYLVAHSNRFTGR----IPHSLSNSPTLNLLNLRNNSL--DGS 316
             +  +  GL +     + L   S   T      +   +++  +L  L L +N L   G 
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244

Query: 317 LLLNCPAL----TNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLARNNFSG----Q 364
             L CP L    + L +L +            L   L     LK ++LA N         
Sbjct: 245 AEL-CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 365 IPETYKNFE-SLSYLSLSNSSI-----YNLSSALQVLQQCRNLTTLVLTLN-FRNEKLPT 417
           + ET       L  L + + S       + SS L    Q R L  L ++ N   +  +  
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA---QNRFLLELQISNNRLEDAGV-- 358

Query: 418 DPRLHFA--------NLKVLVIASCGLR----GSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
                           L+VL +A C +      S+   L     L+ +DLS N L     
Sbjct: 359 ---RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA-- 413

Query: 466 VWFGGFQDLF-----------YLDLSNNTFTGEIPKNLTGLPSLITRNISLEE 507
               G   L             L L +  ++ E+   L    +L     SL  
Sbjct: 414 ----GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ---ALEKDKPSLRV 459

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 81.5 bits (202), Expect = 4e-16
 Identities = 91/484 (18%), Positives = 150/484 (30%), Gaps = 123/484 (25%)

Query: 157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT----LSPGLGNCASLEHLCL 212
            IQ LDI    L+ +    +     + +V+ L     +      +S  L    +L  L L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 213 GMNDLTGGIADDIFQL-----QKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSN 263
             N+L       + Q       K++ L LQ+  L+G     LS ++  L  L  L +S N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD-------GS 316
                       L E                  L     L  L L   SL         S
Sbjct: 124 LLG---DAGLQLLCEGL----------------LDPQCRLEKLQLEYCSLSAASCEPLAS 164

Query: 317 LLLNCPALTNLTSLDLGTNKFNGP----LPTNLPRCR-KLKNINLARNNFSGQIPETYKN 371
           +L       +   L +  N  N      L   L     +L+ + L               
Sbjct: 165 VLRAK---PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG----------- 210

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEK----LPTDPRLHFANLK 427
                   +++ +  +L   +       +L  L L  N   +     L        + L+
Sbjct: 211 --------VTSDNCRDLCGIVA---SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259

Query: 428 VLVIASCGLR----GSIPQWLRGCSKLQLVDLSWNQL--SGTIPVWFGGFQD---LFYLD 478
            L I  CG+     G + + LR    L+ + L+ N+L   G   +     +    L  L 
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 319

Query: 479 LSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTID 538
           + + +FT     + +   S++ +N  L E                             + 
Sbjct: 320 VKSCSFTAACCSHFS---SVLAQNRFLLE-----------------------------LQ 347

Query: 539 LSLNRLDGSIWPEFG-----NLKKLHVFDLKHNNLS----GPIPSELTGMTSLETLDLSY 589
           +S NRL+ +   E           L V  L   ++S      + + L    SL  LDLS 
Sbjct: 348 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407

Query: 590 NNLS 593
           N L 
Sbjct: 408 NCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 74.6 bits (184), Expect = 6e-14
 Identities = 68/376 (18%), Positives = 121/376 (32%), Gaps = 82/376 (21%)

Query: 110 QLRFLNLSHNLL--KGTVPVS--LVNLPNLEVLDLSSNDLS--------------GPLPQ 151
           +++ L+L +  L   G   +S  L  LP L+ L LS N L                   +
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 152 TINL--------------------PSIQVLDISSNSLNGSVPTSICK----NSSRIRVIN 187
            + L                    P  + L +S+N +N +    +C+    +  ++  + 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 188 LSVNYFS----GTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-----LQKLRLLGLQD 238
           L     +      L   + + ASL  L LG N L      ++         +LR L + +
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 239 NQLSGK----LSPSIADLSNLVRLDVSSNNFSGN-IPDVFAGLGEF----QYLVAHSNRF 289
             ++ K    L   +    +L  L ++ N         +   L E     + L   S  F
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

Query: 290 TGR----IPHSLSNSPTLNLLNLRNNSL--DGSLLLNCPAL----TNLTSLDLGTNKFN- 338
           T          L+ +  L  L + NN L   G   L C  L    + L  L L     + 
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL-CQGLGQPGSVLRVLWLADCDVSD 384

Query: 339 ---GPLPTNLPRCRKLKNINLARNNFSGQ----IPETYK-NFESLSYLSLSNSSIYN--L 388
                L   L     L+ ++L+ N         + E+ +     L  L L +        
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 444

Query: 389 SSALQVLQQCRNLTTL 404
                + +   +L  +
Sbjct: 445 DRLQALEKDKPSLRVI 460

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 74.2 bits (183), Expect = 6e-14
 Identities = 56/280 (20%), Positives = 102/280 (36%), Gaps = 43/280 (15%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKGTVPVSL-----VNLPNLEVLDLSSNDLSGPLPQTI-- 153
           L+  L      + L +S+N +       L      +   LE L L S  ++    + +  
Sbjct: 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221

Query: 154 ---NLPSIQVLDISSNSLNGSVPTSIC----KNSSRIRVINLSVNYFS----GTLSPGLG 202
              +  S++ L + SN L       +C      SSR+R + +     +    G L   L 
Sbjct: 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 203 NCASLEHLCLGMNDLTGGIADDIFQL-----QKLRLLGLQDNQLSGK----LSPSIADLS 253
              SL+ L L  N+L    A  + +       +L  L ++    +       S  +A   
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 254 NLVRLDVSSNNFSGN-IPDVFAGLGEF----QYLVAHSNRFT----GRIPHSLSNSPTLN 304
            L+ L +S+N      + ++  GLG+     + L       +      +  +L  + +L 
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 305 LLNLRNNSLD--GSLLLNCPAL----TNLTSLDLGTNKFN 338
            L+L NN L   G L L   ++      L  L L    ++
Sbjct: 402 ELDLSNNCLGDAGILQL-VESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 57.7 bits (140), Expect = 1e-08
 Identities = 63/352 (17%), Positives = 107/352 (30%), Gaps = 61/352 (17%)

Query: 300 SPTLNLLNLRNNSL-DGSLLLNCPALTNLTSLDLGTNKFN----GPLPTNLPRCRKLKNI 354
           S  +  L+++   L D       P L     + L            + + L     L  +
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 355 NLARNNFSGQ----IPETYKNFE-SLSYLSLSNSSIYNLS-SAL-QVLQQCRNLTTLVLT 407
           NL  N         + +  +     +  LSL N  +       L   L+    L  L L+
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 408 LNFRNEK----LPTDPRLHFANLKVLVIASCGLR----GSIPQWLRGCSKLQLVDLSWNQ 459
            N   +     L          L+ L +  C L       +   LR     + + +S N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 460 LSGT-IPVWFGGFQD----LFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPF 514
           ++   + V   G +D    L  L L +   T     N   L  ++    SL E +     
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCGIVASKASLRELA----- 233

Query: 515 FMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP--- 571
                     L  N++       D+ +  L   +      L+ L    +    ++     
Sbjct: 234 ----------LGSNKLG------DVGMAELCPGLLHPSSRLRTL---WIWECGITAKGCG 274

Query: 572 -IPSELTGMTSLETLDLSYNNL--SGAIPIS---LEKLSFLSKFSVANNHLT 617
            +   L    SL+ L L+ N L   GA  +    LE    L    V +   T
Sbjct: 275 DLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 49/247 (19%), Positives = 86/247 (34%), Gaps = 54/247 (21%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP 798
           S+  +     +G G FG+V     +  G+  A+K++  D      + R E++ +    H 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNR-ELDIMKVLDHV 60

Query: 799 NLVHLQGYCMH-------KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG- 850
           N++ L     +       K  +         G  +   +       +   +  L++    
Sbjct: 61  NIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 851 ------------------------------AARGLAYLHQSCEPHILHRDIKSSNILLDG 880
                                           R + ++H      I HRDIK  N+L++ 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176

Query: 881 NFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--YGQASVATYKGDVYSFGVVL 937
                 L DFG A+  L P +       + +  Y  PE   G A+  T   D++S G V 
Sbjct: 177 KDNTLKLCDFGSAK-KLIPSEPS--VAYICSRFYRAPELMLG-ATEYTPSIDLWSIGCVF 232

Query: 938 LELLTGK 944
            EL+ GK
Sbjct: 233 GELILGK 239

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 2e-19
 Identities = 47/287 (16%), Positives = 104/287 (36%), Gaps = 20/287 (6%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS--GPLPQTINLPSIQV 160
                  +    NL    +   V  +   L +++ +  +++D+     +     LP++  
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ---YLPNVTK 69

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG 220
           L ++ N L    P +  KN   +  + L  N     LS  L +   L+ L L  N ++  
Sbjct: 70  LFLNGNKLTDIKPLTNLKN---LGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-- 122

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
             + +  L +L  L L +N+++  ++  ++ L+ L  L +  N  S +I    AGL + Q
Sbjct: 123 DINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQ 178

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP 340
            L    N  +     +L+    L++L L +       + +   L    ++         P
Sbjct: 179 NLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 236

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN 387
              +     +  N+      F+ ++   +    ++            
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVT 283

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.1 bits (228), Expect = 3e-19
 Identities = 61/292 (20%), Positives = 118/292 (40%), Gaps = 25/292 (8%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
            +   L  +  +  +++ +K    +    LPN+  L L+ N L+  +    NL ++  L 
Sbjct: 37  VTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLF 93

Query: 163 ISSNSLNGSVPTSIC--KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG 220
           +  N +       +   K+  +++ ++L  N  S  ++  L +   LE L LG N +T  
Sbjct: 94  LDENKI-----KDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-- 144

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDV--FAGLGE 278
               + +L KL  L L+DNQ+S  + P +A L+ L  L +S N    +I D+   AGL  
Sbjct: 145 DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN----HISDLRALAGLKN 198

Query: 279 FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN 338
              L   S     +  +  SN    N +   + SL    +++        ++     +F 
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258

Query: 339 GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSS 390
             +        +   I  A+  F G++ +  K   ++SY          + +
Sbjct: 259 NEVSFI---FYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEA 307

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.2 bits (223), Expect = 1e-18
 Identities = 48/284 (16%), Positives = 96/284 (33%), Gaps = 44/284 (15%)

Query: 129 LVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINL 188
                     +L    ++  + Q   L SI  +  +++ +      S+            
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVTQN-ELNSIDQIIANNSDI-----KSV------------ 58

Query: 189 SVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPS 248
                      G+    ++  L L  N LT      +  L+ L  L L +N++   LS  
Sbjct: 59  ----------QGIQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIK-DLSS- 104

Query: 249 IADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNL 308
           + DL  L  L +  N  S +I +    L + + L   +N+ T      LS    L+ L+L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSL 160

Query: 309 RNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPET 368
            +N +  S ++    LT L +L L  N  +      L   + L  + L       +    
Sbjct: 161 EDNQI--SDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINH 216

Query: 369 YKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRN 412
             N    + +  ++ S+       +++    +     +  +   
Sbjct: 217 QSNLVVPNTVKNTDGSLVT----PEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.8 bits (196), Expect = 2e-15
 Identities = 58/316 (18%), Positives = 93/316 (29%), Gaps = 56/316 (17%)

Query: 343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT 402
                  +    NL + + +     T     S+  +  +NS I ++      +Q   N+T
Sbjct: 15  FPDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVT 68

Query: 403 TLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG 462
            L L  N +   +     L   NL  L +    ++  +   L+   KL+ + L  N +S 
Sbjct: 69  KLFLNGN-KLTDIKPLTNLK--NLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS- 122

Query: 463 TIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSA 522
            I         L  L L NN  T      L+ L  L T +                    
Sbjct: 123 DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLS-------------------- 159

Query: 523 RGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSL 582
             L+ NQI    P                   L KL    L  N++S      L G+ +L
Sbjct: 160 --LEDNQISDIVP----------------LAGLTKLQNLYLSKNHIS--DLRALAGLKNL 199

Query: 583 ETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP-SGGQFQTFPNSSFDGNNLCG 641
           + L+L               L   +     +  L      S       PN  +       
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTN 259

Query: 642 EHRYSCTIDRESGQVK 657
           E  +        G+ K
Sbjct: 260 EVSFIFYQPVTIGKAK 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.8 bits (226), Expect = 3e-19
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 27/210 (12%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMERE-FRAEVEALSRAQHPNLVHLQG 805
            +G G F +V R   +  G+  A   ++       + +    E       +HPN+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH 865
               +    LI+  +  G L   +  +     S + D+  H  Q     + + HQ     
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYS-EADAS-HCIQQILEAVLHCHQM---G 130

Query: 866 ILHRDIKSSNILLDGNF-GAHL--ADFGLARLILSPYDTHVTTDLVGTLGYIPPE----- 917
           ++HR++K  N+LL     GA +  ADFGLA  +             GT GY+ PE     
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKD 188

Query: 918 -YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            YG+        D+++ GV+L  LL G  P
Sbjct: 189 PYGKPV------DLWACGVILYILLVGYPP 212

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 35/214 (16%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS----GDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V        G  VA+K L+         + +  R E++ L   +HP+++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY 77

Query: 805 GYCMHKNDRLLIYSFME---NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                  D    +  ME    G L DY   H +++       ++R    Q  +  + Y H
Sbjct: 78  QVISTPTD---FFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILS-AVDYCH 128

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-- 917
           +     ++HRD+K  N+LLD +  A +ADFGL+ ++       + T   G+  Y  PE  
Sbjct: 129 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRT-SCGSPNYAAPEVI 182

Query: 918 YGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            G+     Y G   D++S GV+L  LL G  P D
Sbjct: 183 SGRL----YAGPEVDIWSCGVILYALLCGTLPFD 212

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 53/226 (23%), Positives = 82/226 (36%), Gaps = 48/226 (21%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGY 806
           ++G G    V     L   +  A+K +    G +      EVE L + Q H N++ L  +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG------AAR------- 853
              ++   L++  M  GS+             L     +   +       A+        
Sbjct: 80  FEEEDRFYLVFEKMRGGSI-------------LS---HI-HKRRHFNELEASVVVQDVAS 122

Query: 854 GLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLI-----LSPYDTHVTT 905
            L +LH      I HRD+K  NIL    +      + DF L   I      SP  T    
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 906 DLVGTLGYIPPEYGQASVATYKG-----DVYSFGVVLLELLTGKRP 946
              G+  Y+ PE  +A            D++S GV+L  LL+G  P
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.8 bits (221), Expect = 4e-19
 Identities = 67/238 (28%), Positives = 108/238 (45%), Gaps = 39/238 (16%)

Query: 730 KEISIDDILESTN------NFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLSGDC- 778
           KEI+I   ++  +       F+   ++G G FG   LV + +  D  +  A+K L     
Sbjct: 6   KEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL 65

Query: 779 -GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGP 836
             +     + E + L    HP +V L  Y      +L LI  F+  G L   L +  +  
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK--EVM 122

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARL 894
            + + D + ++A+  A  L +LH      I++RD+K  NILLD   G H  L DFGL++ 
Sbjct: 123 FTEE-DVKFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEE-G-HIKLTDFGLSKE 175

Query: 895 ILSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            +            GT+ Y+ PE      + Q++      D +SFGV++ E+LTG  P
Sbjct: 176 SIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 30/219 (13%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQ 796
            + +++     +G G +  V+ A  + +   V +K L     + ++  R E++ L     
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKR-EIKILENLRG 89

Query: 797 HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            PN++ L         R     F    + D    +     +  D+D R ++ +   + L 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTD--FKQLYQTLT--DYDIRFYMYE-ILKALD 144

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGA-HLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           Y H      I+HRD+K  N+++D       L D+GLA     P   +     V +  +  
Sbjct: 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEY--NVRVASRYFKG 198

Query: 916 PE-------YGQASVATYKGDVYSFGVVLLELLTGKRPM 947
           PE       Y       Y  D++S G +L  ++  K P 
Sbjct: 199 PELLVDYQMY------DYSLDMWSLGCMLASMIFRKEPF 231

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 61/269 (22%), Positives = 111/269 (41%), Gaps = 29/269 (10%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS--GPLPQTINLPSIQV 160
            +   L  +  +  +++ +K      +  LPN+  L L+ N L+   PL    NL ++  
Sbjct: 40  VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLA---NLKNLGW 94

Query: 161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG 220
           L +  N +         K    ++ ++L  N  S  ++  L +   LE L LG N +T  
Sbjct: 95  LFLDENKVKDLSSLKDLKK---LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-- 147

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDV--FAGLGE 278
               + +L KL  L L+DNQ+S  + P +A L+ L  L +S N    +I D+   AGL  
Sbjct: 148 DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN----HISDLRALAGLKN 201

Query: 279 FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN 338
              L   S     +  +  SN    N +   + S     L+    +++    +    K++
Sbjct: 202 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS-----LVTPEIISDDGDYEKPNVKWH 256

Query: 339 GPLPTNLPRCRKLKNINLARN--NFSGQI 365
            P  TN       + + + +    F G++
Sbjct: 257 LPEFTNEVSFIFYQPVTIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 51/275 (18%), Positives = 84/275 (30%), Gaps = 55/275 (20%)

Query: 343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT 402
            +     +    NL + + +     T     S+  +  +NS I ++      +Q   N+T
Sbjct: 18  FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG----IQYLPNVT 71

Query: 403 TLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG 462
            L L  N +   +     L   NL  L +    ++  +   L+   KL+ + L  N +S 
Sbjct: 72  KLFLNGN-KLTDIKPLANLK--NLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD 126

Query: 463 TIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSA 522
                      L  L L NN  T      L+ L  L T +                    
Sbjct: 127 ING--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLS-------------------- 162

Query: 523 RGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSL 582
             L+ NQI    P                   L KL    L  N++S      L G+ +L
Sbjct: 163 --LEDNQISDIVP----------------LAGLTKLQNLYLSKNHISDL--RALAGLKNL 202

Query: 583 ETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           + L+L               L   +     +  L 
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 89.8 bits (223), Expect = 7e-19
 Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 33/264 (12%)

Query: 694 AHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCG 753
           A    +    + +  +          ++ V     +  +++++       F+   ++G G
Sbjct: 107 ADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKG 159

Query: 754 GFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRAQHPNLVHLQGYCMH 809
            FG V        GR  A+K L  +    + E      E   L  ++HP L  L+ Y   
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218

Query: 810 KNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
            +DRL  +  +   G L + L    +   S D  +R + A+  +  L YLH   E ++++
Sbjct: 219 THDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGAEIVS-ALDYLHS--EKNVVY 272

Query: 869 RDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE------YGQAS 922
           RD+K  N++LD +    + DFGL +  +    T       GT  Y+ PE      YG+A 
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAV 330

Query: 923 VATYKGDVYSFGVVLLELLTGKRP 946
                 D +  GVV+ E++ G+ P
Sbjct: 331 ------DWWGLGVVMYEMMCGRLP 348

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.0 bits (219), Expect = 8e-19
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 44/238 (18%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFG---LVYRATLPD-GRNVAIKRLS-----GD 777
              ++I  +        F+   ++G GG+G    V + T  + G+  A+K L       +
Sbjct: 9   RGPEKIRPEC-------FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61

Query: 778 CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGP 836
                   +AE   L   +HP +V L  Y      +L LI  ++  G L   L    +G 
Sbjct: 62  AKDTAHT-KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER--EGI 117

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARL 894
              D  +  ++A+  +  L +LHQ     I++RD+K  NI+L+   G H  L DFGL + 
Sbjct: 118 FMED-TACFYLAE-ISMALGHLHQK---GIIYRDLKPENIMLNHQ-G-HVKLTDFGLCKE 170

Query: 895 ILSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            +       T    GT+ Y+ PE      + +A       D +S G ++ ++LTG  P
Sbjct: 171 SIHDGTV--THTFCGTIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.5 bits (220), Expect = 8e-19
 Identities = 71/263 (26%), Positives = 104/263 (39%), Gaps = 39/263 (14%)

Query: 698 GEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGL 757
           G   P++ E    +       S+ + L  +        D       F    +IG G FG 
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSD-------FHFLKVIGKGSFGK 53

Query: 758 VYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRA-QHPNLVHLQGYCMHKND 812
           V  A         A+K L       ++E     +E   L +  +HP LV L  +     D
Sbjct: 54  VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTAD 112

Query: 813 RL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI 871
           +L  +  ++  G L Y L    +        +R + A+  A  L YLH     +I++RD+
Sbjct: 113 KLYFVLDYINGGELFYHLQR--ERCFLEP-RARFYAAE-IASALGYLHSL---NIVYRDL 165

Query: 872 KSSNILLDGNFGAH--LADFGLARLILSPYDTHVTTDLVGTLGYIPPE------YGQASV 923
           K  NILLD   G H  L DFGL +  +    T  T+   GT  Y+ PE      Y +  V
Sbjct: 166 KPENILLDSQ-G-HIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRT-V 220

Query: 924 ATYKGDVYSFGVVLLELLTGKRP 946
                D +  G VL E+L G  P
Sbjct: 221 -----DWWCLGAVLYEMLYGLPP 238

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 34/213 (15%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS----GDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V  AT     + VA+K +S           R  R E+  L   +HP+++ L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKLY 75

Query: 805 GYCMHKNDRLLIYSFME--NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
                  D   I   +E   G L DY +  +++      + + R    Q     + Y H+
Sbjct: 76  DVITTPTD---IVMVIEYAGGELFDYIVEKKRMT-----EDEGRRFFQQIIC-AIEYCHR 126

Query: 861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE--Y 918
                I+HRD+K  N+LLD N    +ADFGL+ ++       + T   G+  Y  PE   
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-SCGSPNYAAPEVIN 180

Query: 919 GQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
           G+     Y G   DV+S G+VL  +L G+ P D
Sbjct: 181 GKL----YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 56/291 (19%), Positives = 113/291 (38%), Gaps = 26/291 (8%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
                L     +    + +  TV     +L  +  L      ++  +     L ++  L+
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLE 69

Query: 163 ISSNSLNGSVPTSI--CKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG 220
           +  N +     T +   KN ++I  + LS N     +S  +    S++ L L    +T  
Sbjct: 70  LKDNQI-----TDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD- 121

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
               +  L  L++L L  NQ++  +SP +A L+NL  L + +   S ++    A L +  
Sbjct: 122 -VTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLT 176

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP 340
            L A  N+ +  I   L++ P L  ++L+NN +  S +      +NL  + L        
Sbjct: 177 TLKADDNKISD-IS-PLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQ 232

Query: 341 LPTNLPRCRKLKNINLARNNFSGQI-PETYKNFESLSYLSLSNSSIYNLSS 390
                     L   N+ +      I P T  +  + +  +L+ +    +++
Sbjct: 233 PVFYNN---NLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINN 280

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 60/328 (18%), Positives = 109/328 (33%), Gaps = 62/328 (18%)

Query: 322 PALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLS 381
           PAL N   +  G +     +         +  ++      +  I E  +   +L  L L 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELK 71

Query: 382 NSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIP 441
           ++ I +L+     L+    +T L L+ N   + +     L   ++K L + S  +    P
Sbjct: 72  DNQITDLAP----LKNLTKITELELSGN-PLKNVSAIAGLQ--SIKTLDLTSTQITDVTP 124

Query: 442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIP-KNLTGLPSLIT 500
             L G S LQ++ L  NQ++   P    G  +L YL + N   +   P  NL+ L +L  
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK- 179

Query: 501 RNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHV 560
                                      N+I    P                  +L  L  
Sbjct: 180 ------------------------ADDNKISDISP----------------LASLPNLIE 199

Query: 561 FDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT--G 618
             LK+N +S    S L   ++L  + L+   ++         L   +     +       
Sbjct: 200 VHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257

Query: 619 RIPSGGQFQTFPNSSFDGNNLCGEHRYS 646
            I   G +   PN +++  +      Y+
Sbjct: 258 TISDNGTY-ASPNLTWNLTSFINNVSYT 284

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.1 bits (219), Expect = 1e-18
 Identities = 53/221 (23%), Positives = 80/221 (36%), Gaps = 43/221 (19%)

Query: 749 IIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQME------------REFRAEVEALSRAQ 796
            I  G +G V      +G  VAIKR+                    R  R E+  L+   
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFH 87

Query: 797 HPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA----QG 850
           HPN++ L+   +H  +  +  +Y   E   +   L + +         S  HI       
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTE--LMRTDLAQVIH--DQRIVISPQHIQYFMYH- 142

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
              GL  LH++    ++HRD+   NILL  N    + DF LAR           T  V  
Sbjct: 143 ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196

Query: 911 LGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             Y  PE       + +        D++S G V+ E+   K
Sbjct: 197 RWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNRK 231

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 55/222 (24%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGY 806
            +G G F +  +       +  A+K +S    +ME   + E+ AL   + HPN+V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG------AAR------- 853
              +    L+   +  G L              +   R+   +       A+        
Sbjct: 75  FHDQLHTFLVMELLNGGEL-------------FE---RI-KKKKHFSETEASYIMRKLVS 117

Query: 854 GLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
            ++++H      ++HRD+K  N+L    + N    + DFG ARL   P D         T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK--PPDNQPLKTPCFT 172

Query: 911 LGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           L Y  PE      Y ++       D++S GV+L  +L+G+ P
Sbjct: 173 LHYAAPELLNQNGYDESC------DLWSLGVILYTMLSGQVP 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 57/224 (25%)

Query: 748 NIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHLQG 805
             IG G + +  R          A+K +     + +R+   E+E L R  QHPN++ L+ 
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG------AAR------ 853
                    ++   M+ G L             LD   ++ + Q       A+       
Sbjct: 84  VYDDGKYVYVVTELMKGGEL-------------LD---KI-LRQKFFSEREASAVLFTIT 126

Query: 854 -GLAYLHQSCEPHILHRDIKSSNILLDGNFGAH----LADFGLARLILSPYDTHVTTDLV 908
             + YLH      ++HRD+K SNIL     G      + DFG A+ + +  +  +     
Sbjct: 127 KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPC 181

Query: 909 GTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            T  ++ PE      Y  A       D++S GV+L  +LTG  P
Sbjct: 182 YTANFVAPEVLERQGYDAAC------DIWSLGVLLYTMLTGYTP 219

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 47/227 (20%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS---GDCGQMEREFRAEVEALSR 794
           E    +     +G G +G V  A     G  VAIK+LS         +R +R E+  L  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKH 79

Query: 795 AQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            QH N++ L           +  D  L+  FM+    D  L + +    S +      I 
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---D--LQKIMGLKFSEE-----KIQ 129

Query: 849 ----QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
               Q   +GL Y+H +    ++HRD+K  N+ ++ +    + DFGLAR      D  + 
Sbjct: 130 YLVYQ-MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEM- 180

Query: 905 TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           T  V T  Y  PE       Y Q        D++S G ++ E+LTGK
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 221

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 54/221 (24%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC 807
            +G G   +VYR       +  A+K L       ++  R E+  L R  HPN++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 808 MHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDW----------DSRLHIAQGAARG 854
                   I   +E    G L              D           D+   + Q     
Sbjct: 118 ---ETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQ-ILEA 160

Query: 855 LAYLHQSCEPHILHRDIKSSNILL-DGNFGAHL--ADFGLARLILSPYDTHVTTDLVGTL 911
           +AYLH++    I+HRD+K  N+L       A L  ADFGL++++       +   + GT 
Sbjct: 161 VAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTP 214

Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           GY  PE      YG         D++S G++   LL G  P
Sbjct: 215 GYCAPEILRGCAYGPEV------DMWSVGIITYILLCGFEP 249

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 41/229 (17%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHP 798
            + +     +GCGG GLV+ A      + VAIK++   D   ++   R E++ + R  H 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68

Query: 799 NLVHL--------------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR 844
           N+V +               G     N   ++  +ME    D  L   L+    L+  +R
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---D--LANVLEQGPLLEEHAR 123

Query: 845 LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGAHLADFGLARLILSPYDTHV 903
           L + Q   RGL Y+H +   ++LHRD+K +N+ ++  +    + DFGLAR++   Y    
Sbjct: 124 LFMYQ-LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 904 T-TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
             ++ + T  Y  P        Y +A       D+++ G +  E+LTGK
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAI------DMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 87.0 bits (216), Expect = 3e-18
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS--GDCGQMEREFRAEVEALSRA 795
           +    +   + IG G +G+V  A    +   VAIK++S        +R  R E++ L R 
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82

Query: 796 QHPNLVHLQ-----GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
           +H N++ +             D  ++   ME    D  L++ L      +      + Q 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMET---D--LYKLLKTQHLSNDHICYFLYQ- 136

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVG 909
             RGL Y+H +   ++LHRD+K SN+LL+      + DFGLAR+    +D     T+ V 
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 910 TLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
           T  Y  PE       Y ++       D++S G +L E+L+ +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSNR 229

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 59/219 (26%), Positives = 82/219 (37%), Gaps = 47/219 (21%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           IG G FG+            VA+K +       E   R E+      +HPN+V  +   +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86

Query: 809 HKNDRLLIYSFME---NGSL-DYWLHEKLDGPSSLDWDSRLHIAQGAAR--------GLA 856
                  +   ME    G L +   +             R    +  AR        G++
Sbjct: 87  TPTH---LAIIMEYASGGELYERICNAG-----------RFSEDE--ARFFFQQLLSGVS 130

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHL--ADFGLARLILSPYDTHVTTDLVGTLGYI 914
           Y H      I HRD+K  N LLDG+    L   DFG ++  +       +T  VGT  YI
Sbjct: 131 YCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-ST--VGTPAYI 184

Query: 915 PPE--YGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            PE    Q     Y G   DV+S GV L  +L G  P +
Sbjct: 185 APEVLLRQE----YDGKIADVWSCGVTLYVMLVGAYPFE 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.5 bits (217), Expect = 4e-18
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLS----GDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
           +G G FG V        G  VA+K L+         + +  R E++ L   +HP+++ L 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKLY 82

Query: 805 GYCMHKNDRLLIYSFME---NGSL-DYWL-HEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
                 +D   I+  ME    G L DY   + +LD       +SR    Q  + G+ Y H
Sbjct: 83  QVISTPSD---IFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS-GVDYCH 133

Query: 860 QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-- 917
           +     ++HRD+K  N+LLD +  A +ADFGL+ +     D        G+  Y  PE  
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVI 187

Query: 918 YGQASVATYKG---DVYSFGVVLLELLTGKRPMD 948
            G+     Y G   D++S GV+L  LL G  P D
Sbjct: 188 SGRL----YAGPEVDIWSSGVILYALLCGTLPFD 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 35/213 (16%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHLQG- 805
           ++G G  G V        G+  A+K L  D  +  +E    V+   + +  P++V +   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQE----VDHHWQASGGPHIVCILDV 90

Query: 806 YCMHKNDRLLIYSFME---NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           Y    + +  +   ME    G L   + E+ D   + + ++   +       + +LH   
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT-EREAAEIMRD-IGTAIQFLHSH- 147

Query: 863 EPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-- 917
             +I HRD+K  N+L    + +    L DFG A+        +       T  Y+ PE  
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVL 201

Query: 918 ----YGQASVATYKGDVYSFGVVLLELLTGKRP 946
               Y ++       D++S GV++  LL G  P
Sbjct: 202 GPEKYDKSC------DMWSLGVIMYILLCGFPP 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 7e-18
 Identities = 61/264 (23%), Positives = 97/264 (36%), Gaps = 43/264 (16%)

Query: 694 AHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCG 753
           A    E +  KE      +D  +            +    +D        FD+   +G G
Sbjct: 6   AKKGSEQESVKEFLAKAKEDFLKKWET------PSQNTAQLDQ-------FDRIKTLGTG 52

Query: 754 GFGLVYRATL-PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            FG V        G + A+K L         Q+E     E   L     P LV L+ +  
Sbjct: 53  SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAVNFPFLVKLE-FSF 110

Query: 809 HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
             N  L ++  ++  G +  + H +  G  S    +R + AQ       YLH      ++
Sbjct: 111 KDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPH-ARFYAAQ-IVLTFEYLHSL---DLI 163

Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYK 927
           +RD+K  N+L+D      + DFG A+          T  L GT   + PE     +   K
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPE-----IILSK 213

Query: 928 G-----DVYSFGVVLLELLTGKRP 946
           G     D ++ GV++ E+  G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 85.5 bits (212), Expect = 8e-18
 Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 38/223 (17%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS---GDCGQMEREFRAEVEALSR 794
           E    +     +G G +G V  A     G  VAIK+L          +R +R E+  L  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH 80

Query: 795 AQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            +H N++ L              D  L+  FM     D  L  KL     L  D    + 
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---D--LG-KLMKHEKLGEDRIQFLV 134

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
               +GL Y+H +    I+HRD+K  N+ ++ +    + DFGLAR      D+ + T  V
Sbjct: 135 YQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEM-TGYV 186

Query: 909 GTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            T  Y  PE       Y Q        D++S G ++ E++TGK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.4 bits (212), Expect = 8e-18
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 694 AHSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCG 753
             S G      +  +  ++ L               +++ I++       F+   ++G G
Sbjct: 13  GSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIEN-------FELLKVLGTG 65

Query: 754 GFG---LVYRATLPD-GRNVAIKRLS----------GDCGQMEREFRAEVEALSRAQHPN 799
            +G   LV + +  D G+  A+K L            +  + ER+    +      Q P 
Sbjct: 66  AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPF 120

Query: 800 LVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAARGLA 856
           LV L  Y      +L LI  ++  G L   L   E+         + ++++ +     L 
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGE-IVLALE 173

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILSPYDTHVTTDLVGTLGYI 914
           +LH+     I++RDIK  NILLD N G H  L DFGL++  ++           GT+ Y+
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSN-G-HVVLTDFGLSKEFVADETERAYD-FCGTIEYM 227

Query: 915 PPE--------YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI 963
            P+        + +A V     D +S GV++ ELLTG  P  +   K S+  IS  I
Sbjct: 228 APDIVRGGDSGHDKA-V-----DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 85.6 bits (212), Expect = 2e-17
 Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 70/264 (26%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS------GDCGQMEREFRAEVEA 791
           +  + ++  ++IG G +G V  A    + R VAIK++        DC   +R  R E+  
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILR-EIAI 105

Query: 792 LSRAQHPNLVHLQ-----GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLH 846
           L+R  H ++V +            ++  ++    +    D    +    P  L   + LH
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYL---TELH 157

Query: 847 IA----QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTH 902
           I          G+ Y+H +    ILHRD+K +N L++ +    + DFGLAR +  P + +
Sbjct: 158 IKTLLYN-LLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 903 VT-------------------------TDLVGTLGYIPPE-------YGQASVATYKGDV 930
                                      T  V T  Y  PE       Y +A       DV
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI------DV 267

Query: 931 YSFGVVLLELLTGKRPMDMCKPKG 954
           +S G +  ELL   +         
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADR 291

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 27/216 (12%)

Query: 742 NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREF---RAEVEALSRAQH 797
           N+FD   ++G G FG V        GR  A+K L  +    + E      E   L   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 798 PNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           P L  L+ Y    +DRL  +  +   G L + L    +   + +  +R + A+     L 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEE-RARFYGAE-IVSALE 119

Query: 857 YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
           YLH      +++RDIK  N++LD +    + DFGL +  +S   T       GT  Y+ P
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAP 174

Query: 917 E------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           E      YG+A V     D +  GVV+ E++ G+ P
Sbjct: 175 EVLEDNDYGRA-V-----DWWGLGVVMYEMMCGRLP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.2 bits (213), Expect = 2e-17
 Identities = 64/269 (23%), Positives = 105/269 (39%), Gaps = 45/269 (16%)

Query: 695 HSRGEVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGG 754
             R + +  K    T   + +   +      +     + + D       F+   ++G G 
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLGKGS 353

Query: 755 FGLVYRATLPD-GRNVAIKRLSGD---------CGQMEREFRAEVEALSRAQHPNLVHLQ 804
           FG V  +         A+K L  D         C  +E+   A        + P L  L 
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-----GKPPFLTQLH 408

Query: 805 GYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
             C    DRL  +  ++  G L Y + +   G       +  + A+  A GL +L     
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEP-HAVFYAAE-IAIGLFFLQSK-- 461

Query: 864 PHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE------ 917
             I++RD+K  N++LD      +ADFG+ +  +    T  T    GT  YI PE      
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQP 518

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           YG++ V     D ++FGV+L E+L G+ P
Sbjct: 519 YGKS-V-----DWWAFGVLLYEMLAGQAP 541

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 47/240 (19%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG------DCGQMEREFRAEVEALS 793
            +N+   ++IG G +G VY A      +NVAIK+++       DC   +R  R E+  L+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILR-EITILN 80

Query: 794 RAQHPNLVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA--- 848
           R +   ++ L    +  +      +Y  +E    D  L +    P  L   +  HI    
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLE--IADSDLKKLFKTPIFL---TEEHIKTIL 135

Query: 849 -QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
                 G  ++H+S    I+HRD+K +N LL+ +    + DFGLAR I S  DT++  DL
Sbjct: 136 YN-LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 908 VGTLGYIPPEYGQAS-----VAT--------------YKG--DVYSFGVVLLELLTGKRP 946
                  P            V T              Y    D++S G +  ELL   + 
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 44/237 (18%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
            + L+LS N L+     S  + P L+VLDLS  ++   +      +L  +  L ++ N +
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPI 88

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ- 227
             S+                    FSG         +SL+ L     +L   + +     
Sbjct: 89  Q-SLALGA----------------FSG--------LSSLQKLVAVETNLA-SLENFPIGH 122

Query: 228 LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA-- 284
           L+ L+ L +  N +     P   ++L+NL  LD+SSN            L +   L    
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 285 --HSNRFTGRIPHSLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLGTN 335
               N     I         L  L L  N L    DG        LT+L  + L TN
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIF----DRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 48/238 (20%), Positives = 79/238 (33%), Gaps = 39/238 (16%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL-SNSPTLNLLNLRNN 311
            +   LD+S N         F    E Q L          I      +   L+ L L  N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 312 SLDGSLLLNCPA-LTNLTSLDLGTNKFNGPLPTNLP-----RCRKLKNINLARNNF-SGQ 364
            +  SL L   + L++L  L             +L        + LK +N+A N   S +
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAVETNL-----ASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 365 IPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA 424
           +PE + N  +L +L LS++ I ++      L+    +  L L+L+     +       F 
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198

Query: 425 NLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
            +                      +L+ + L  NQL       F     L  + L  N
Sbjct: 199 EI----------------------RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 39/200 (19%), Positives = 62/200 (31%), Gaps = 51/200 (25%)

Query: 445 RGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFT---GEIPKNLTGLPSLIT 500
               +LQ++DLS  ++  TI    +     L  L L+ N            L+ L  L  
Sbjct: 49  FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL-- 105

Query: 501 RNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHV 560
                                        + S                    G+LK L  
Sbjct: 106 -----------------------VAVETNLASLENFP--------------IGHLKTLKE 128

Query: 561 FDLKHNNL-SGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGR 619
            ++ HN + S  +P   + +T+LE LDLS N +  +I  +   L  L +  + N  L   
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD--LRVLHQMPLLNLSLD-- 183

Query: 620 IPSGGQFQTFPNSSFDGNNL 639
             S          +F    L
Sbjct: 184 -LSLNPMNFIQPGAFKEIRL 202

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 38/176 (21%), Positives = 73/176 (41%), Gaps = 24/176 (13%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL-SGP 148
           L L    ++     +   L  L+ L      L       + +L  L+ L+++ N + S  
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 149 LPQT-INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASL 207
           LP+   NL +++ LD+SSN +  S+  +  +   ++ ++NLS                  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS------------------ 181

Query: 208 EHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSN 263
             L L +N +   I    F+  +L+ L L  NQL          L++L ++ + +N
Sbjct: 182 --LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 45/234 (19%), Positives = 81/234 (34%), Gaps = 45/234 (19%)

Query: 374 SLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS 433
           S   L LS + + +L S          L  L L+     + +        ++L  L++  
Sbjct: 29  STKNLDLSFNPLRHLGSY--SFFSFPELQVLDLSRC-EIQTIEDGAYQSLSHLSTLILTG 85

Query: 434 CGLRGSIPQ-WLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-EIPKN 491
             ++ S+      G S LQ +      L+       G  + L  L++++N     ++P+ 
Sbjct: 86  NPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 492 LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP--------------TI 537
            + L +L   +                      L  N+I S                 ++
Sbjct: 145 FSNLTNLEHLD----------------------LSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 538 DLSLNRLDGSIWPE-FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
           DLSLN ++  I P  F  + +L    L  N L          +TSL+ + L  N
Sbjct: 183 DLSLNPMN-FIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 30/157 (19%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV--NLPNLEVLDLSSNDL 145
             L   +  L    +  +G+L  L+ LN++HNL++ +  +     NL NLE LDLSSN +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKI 161

Query: 146 SGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGN 203
              +  T    L  + +L++S                     ++LS+N  +  + PG   
Sbjct: 162 QS-IYCTDLRVLHQMPLLNLS---------------------LDLSLNPMN-FIQPGAFK 198

Query: 204 CASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDN 239
              L+ L L  N L   + D IF  L  L+ + L  N
Sbjct: 199 EIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 83.4 bits (207), Expect = 3e-17
 Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 45/237 (18%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD-------- 777
                + + D       F+   ++G G FG V  +         A+K L  D        
Sbjct: 12  GNRDRMKLTD-------FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV 64

Query: 778 -CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDG 835
            C  +E+   A        + P L  L   C    DRL  +  ++  G L Y + +   G
Sbjct: 65  ECTMVEKRVLALP-----GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VG 116

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
                  +  + A+  A GL +L       I++RD+K  N++LD      +ADFG+ +  
Sbjct: 117 RFKEPH-AVFYAAE-IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171

Query: 896 LSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           +    T  T    GT  YI PE      YG++ V     D ++FGV+L E+L G+ P
Sbjct: 172 IWDGVT--TKTFCGTPDYIAPEIIAYQPYGKS-V-----DWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 66/237 (27%), Positives = 96/237 (40%), Gaps = 45/237 (18%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD-------- 777
           N    + ID+       F+   ++G G FG V  A + + G   A+K L  D        
Sbjct: 15  NSSNRLGIDN-------FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV 67

Query: 778 -CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDG 835
            C   E+   +         HP L  L   C    DRL  +  F+  G L + + +    
Sbjct: 68  ECTMTEKRILSLA-----RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--R 119

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
                  +R + A+     L +LH      I++RD+K  N+LLD      LADFG+ +  
Sbjct: 120 RFDEAR-ARFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174

Query: 896 LSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
           +    T  T    GT  YI PE      YG A V     D ++ GV+L E+L G  P
Sbjct: 175 ICNGVT--TATFCGTPDYIAPEILQEMLYGPA-V-----DWWAMGVLLYEMLCGHAP 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.2 bits (206), Expect = 6e-17
 Identities = 62/265 (23%), Positives = 102/265 (38%), Gaps = 45/265 (16%)

Query: 699 EVDPEKEEANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLV 758
             +    +        EE  +            + + D       FD   +IG G +  V
Sbjct: 16  TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-------FDLLRVIGRGSYAKV 68

Query: 759 YRATLPD-GRNVAIKRLS---------GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
               L    R  A++ +           D  Q E+    +      + HP LV L   C 
Sbjct: 69  LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPFLVGLH-SCF 122

Query: 809 HKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHIL 867
               RL  +  ++  G L + +          +  +R + A+  +  L YLH+     I+
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQR--QRKLPEE-HARFYSAE-ISLALNYLHER---GII 175

Query: 868 HRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE------YGQA 921
           +RD+K  N+LLD      L D+G+ +  L P DT  T+   GT  YI PE      YG +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFS 233

Query: 922 SVATYKGDVYSFGVVLLELLTGKRP 946
            V     D ++ GV++ E++ G+ P
Sbjct: 234 -V-----DWWALGVLMFEMMAGRSP 252

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.9 bits (205), Expect = 8e-17
 Identities = 57/225 (25%), Positives = 82/225 (36%), Gaps = 58/225 (25%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQG- 805
           ++G G  G V +          A+K L  DC +  RE    VE   RA   P++V +   
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 123

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG--------AAR---- 853
           Y      R  +   ME           LDG        R+   +G        A+     
Sbjct: 124 YENLYAGRKCLLIVME----------CLDGGELFS---RI-QDRGDQAFTEREASEIMKS 169

Query: 854 ---GLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHVTTDL 907
               + YLH     +I HRD+K  N+L      N    L DFG A+        +  T  
Sbjct: 170 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---TSHNSLTTP 223

Query: 908 VGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             T  Y+ PE      Y ++       D++S GV++  LL G  P
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSC------DMWSLGVIMYILLCGYPP 262

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.3 bits (204), Expect = 9e-17
 Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 53/234 (22%)

Query: 741 TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-----GDCGQMEREFRAEVEALSR 794
           +++F   +++G G +G+V  AT  P G  VAIK++             R  R E++ L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA---LRTLR-EIKILKH 65

Query: 795 AQHPNLVHLQ-----GYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA- 848
            +H N++ +          + N+  +I   M+    D  LH ++     L   S  HI  
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT---D--LH-RVISTQML---SDDHIQY 116

Query: 849 ---QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT- 904
              Q   R +  LH S   +++HRD+K SN+L++ N    + DFGLAR+I      +   
Sbjct: 117 FIYQ-TLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 905 -------TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
                   + V T  Y  PE       Y +A       DV+S G +L EL   +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAELFLRR 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 45/234 (19%)

Query: 730 KEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLS---------GDCG 779
             + + D       FD   +IG G +  V    L    R  A+K +           D  
Sbjct: 4   DPLGLQD-------FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV 56

Query: 780 QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSS 838
           Q E+    +      + HP LV L   C     RL  +  ++  G L + +         
Sbjct: 57  QTEKHVFEQA-----SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLP 108

Query: 839 LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
            +  +R + A+  +  L YLH+     I++RD+K  N+LLD      L D+G+ +  L P
Sbjct: 109 EEH-ARFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163

Query: 899 YDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            DT  T+   GT  YI PE      YG + V     D ++ GV++ E++ G+ P
Sbjct: 164 GDT--TSTFCGTPNYIAPEILRGEDYGFS-V-----DWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 49/239 (20%)

Query: 727 NKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGD-------- 777
           + + ++ I+D       F    ++G G FG V+ A      +  AIK L  D        
Sbjct: 9   SLQIKLKIED-------FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61

Query: 778 -CGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDG 835
            C  +E+   +        +HP L H+        + L  +  ++  G L Y +      
Sbjct: 62  ECTMVEKRVLSLA-----WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--H 113

Query: 836 PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLAR 893
              L   +  + A+    GL +LH      I++RD+K  NILLD + G H  +ADFG+ +
Sbjct: 114 KFDLS-RATFYAAE-IILGLQFLHSK---GIVYRDLKLDNILLDKD-G-HIKIADFGMCK 166

Query: 894 LILSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
             +       T    GT  YI PE      Y  +       D +SFGV+L E+L G+ P
Sbjct: 167 ENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSP 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 40/221 (18%)

Query: 742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQ 796
            +F     +G G FG V+      +GR  A+K L  +      Q+E     E   LS   
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVT 64

Query: 797 HPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWL--HEKLDGPSSLDWDSRLHIAQGAAR 853
           HP ++ +         ++ +I  ++E G L   L   ++   P      ++ + A+    
Sbjct: 65  HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-----VAKFYAAE-VCL 117

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILSPYDTHVTTDLVGTL 911
            L YLH      I++RD+K  NILLD N G H  + DFG A+     Y   VT  L GT 
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKN-G-HIKITDFGFAK-----YVPDVTYTLCGTP 167

Query: 912 GYIPPE------YGQASVATYKGDVYSFGVVLLELLTGKRP 946
            YI PE      Y ++ +     D +SFG+++ E+L G  P
Sbjct: 168 DYIAPEVVSTKPYNKS-I-----DWWSFGILIYEMLAGYTP 202

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 62/223 (27%), Positives = 92/223 (41%), Gaps = 38/223 (17%)

Query: 739 ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSG---DCGQMEREFRAEVEALSR 794
           E    +   + +G G +G V  A     G  VA+K+LS         +R +R E+  L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84

Query: 795 AQHPNLVHL------QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            +H N++ L             ND  L+   M     D  L+  +      D   +  I 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---D--LNNIVKCQKLTDDHVQFLIY 139

Query: 849 QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
           Q   RGL Y+H +    I+HRD+K SN+ ++ +    + DFGLAR           T  V
Sbjct: 140 Q-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT-----ADEMTGYV 190

Query: 909 GTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
            T  Y  PE       Y Q        D++S G ++ ELLTG+
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 23/166 (13%), Positives = 63/166 (37%), Gaps = 11/166 (6%)

Query: 104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS--GPLPQTINLPSIQVL 161
           +   +  L ++ L++  +     +      N++ L +++   +   P+     L +++ L
Sbjct: 39  TEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNPIS---GLSNLERL 93

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGI 221
            I    +      ++   +S + ++++S +    ++   +     +  + L  N     I
Sbjct: 94  RIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 222 ADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG 267
              +  L +L+ L +Q + +       I D   L +L   S    G
Sbjct: 153 -MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 32/233 (13%), Positives = 67/233 (28%), Gaps = 58/233 (24%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN 166
                    L  +    T  ++   + +L  + L++ +++  L       +I+ L I++ 
Sbjct: 21  TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNI 76

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF 226
                               N             +   ++LE L +   D+T     ++ 
Sbjct: 77  ---------------HATNYN------------PISGLSNLERLRIMGKDVTSDKIPNLS 109

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
            L  L LL +  +     +   I  L  +  +D+S N    +I                 
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM---------------- 153

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG 339
                     L   P L  LN++ + +     +       L  L   +    G
Sbjct: 154 ---------PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 28/183 (15%), Positives = 67/183 (36%), Gaps = 12/183 (6%)

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
             +      L  +  +   + + A +++L  + +++ N + ++          + L  ++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
              T   P  +S    L  L +    +    + N   LT+LT LD+  +  +  + T + 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
              K+ +I+L+ N     I    K    L  L++    +++       ++    L  L  
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG----IEDFPKLNQLYA 188

Query: 407 TLN 409
              
Sbjct: 189 FSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 31/219 (14%), Positives = 70/219 (31%), Gaps = 44/219 (20%)

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ 459
                +  L  ++            +L  + +A+  +       +     ++ + ++   
Sbjct: 21  TFKAYLNGLLGQSSTANITE-AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77

Query: 460 LSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRN 519
            +   P    G  +L  L +     T +   NL+GL SL                     
Sbjct: 78  ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL------------------- 116

Query: 520 VSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGM 579
                            +D+S +  D SI  +   L K++  DL +N     I   L  +
Sbjct: 117 -----------------LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158

Query: 580 TSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTG 618
             L++L++ ++ +       +E    L++    +  + G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 35/226 (15%), Positives = 67/226 (29%), Gaps = 51/226 (22%)

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL-HFANLKV 428
             F++     L  SS  N++ A         + +L   +   N  +     + +  N+K 
Sbjct: 20  STFKAYLNGLLGQSSTANITEA--------QMNSLT-YITLANINVTDLTGIEYAHNIKD 70

Query: 429 LVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEI 488
           L I +       P  + G S L+ + +    ++        G   L  LD+S++     I
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 489 PKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSI 548
              +  LP +                                     +IDLS N     I
Sbjct: 129 LTKINTLPKVN------------------------------------SIDLSYNGAITDI 152

Query: 549 WPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG 594
                 L +L   +++ + +       +     L  L      + G
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 5/118 (4%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVL 161
             +  L  L  L +    +      +L  L +L +LD+S +     +   I  LP +  +
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG 219
           D+S N     +     K    ++ +N+  +         + +   L  L      + G
Sbjct: 142 DLSYNGAITDI--MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 28/229 (12%), Positives = 72/229 (31%), Gaps = 39/229 (17%)

Query: 259 DVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLL 318
            + ++  + NIPD       F+  +      +     + +   +L  + L N ++  + L
Sbjct: 7   GLKASQDNVNIPDS-----TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV--TDL 59

Query: 319 LNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYL 378
                  N+  L +            +     L+ + +   + +           SL+ L
Sbjct: 60  TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117

Query: 379 SLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG 438
            +S+S+  +  S L  +     + ++ L+ N     +                       
Sbjct: 118 DISHSAHDD--SILTKINTLPKVNSIDLSYNGAITDIMP--------------------- 154

Query: 439 SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGE 487
                L+   +L+ +++ ++ +          F  L  L   + T  G+
Sbjct: 155 -----LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 17/82 (20%), Positives = 36/82 (43%)

Query: 88  TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG 147
             L +  + +      +L  L  L  L++SH+    ++   +  LP +  +DLS N    
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 148 PLPQTINLPSIQVLDISSNSLN 169
            +     LP ++ L+I  + ++
Sbjct: 151 DIMPLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 8/72 (11%), Positives = 31/72 (43%), Gaps = 2/72 (2%)

Query: 552 FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSV 611
                 +    + + + +    + ++G+++LE L +   +++     +L  L+ L+   +
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 612 ANNHLTGRIPSG 623
           +++     I + 
Sbjct: 120 SHSAHDDSILTK 131

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 35/208 (16%), Positives = 73/208 (35%), Gaps = 11/208 (5%)

Query: 87  VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV-SLVNLPNLEVLDLSSNDL 145
              L L +  L+   S +  NL  +  + +S ++    +   S  NL  +  +++ +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 146 SGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-- 201
              +       LP ++ L I +  L      +   ++    ++ ++ N +  ++      
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152

Query: 202 GNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSI-ADL-SNLVRLD 259
           G C     L L  N  T  +    F   KL  + L  N+    +       + S    LD
Sbjct: 153 GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211

Query: 260 VSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
           VS  + +         L   + L+A + 
Sbjct: 212 VSQTSVTALPSKGLEHL---KELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 32/208 (15%), Positives = 64/208 (30%), Gaps = 10/208 (4%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSL 168
            + L L    L+     +  NLPN+  + +S +     L      NL  +  ++I +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPG--LGNCASLEHLCLGMNDLTGGIADDIF 226
              +     K    ++ + +              + +      L +  N     I  + F
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 227 Q--LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEF-QYL 282
           Q    +   L L +N  +  +     + + L  + ++ N +   I  D F G+      L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
                  T      L +   L   N   
Sbjct: 211 DVSQTSVTALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 42/276 (15%), Positives = 89/276 (32%), Gaps = 58/276 (21%)

Query: 347 RCRKLKNINLARNNFSG--QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTL 404
            C + ++  +   +      +P       S   L L  + +  + S         N++ +
Sbjct: 9   ECHQEEDFRVTCKDIQRIPSLPP------STQTLKLIETHLRTIPS--HAFSNLPNISRI 60

Query: 405 VLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGT 463
            ++++   ++L +    + + +  + I +      I    L+    L+ + +    L   
Sbjct: 61  YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-M 119

Query: 464 IP--VWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFMRRNV 520
            P           F L++++N +   IP N   GL +  T  + L               
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE-TLTLKL--------------- 163

Query: 521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSE-LTGM 579
                  N   S                   F N  KL    L  N     I  +   G+
Sbjct: 164 -----YNNGFTSVQGYA--------------F-NGTKLDAVYLNKNKYLTVIDKDAFGGV 203

Query: 580 TS-LETLDLSYNNLSGAIPI----SLEKLSFLSKFS 610
            S    LD+S  +++ A+P      L++L   + ++
Sbjct: 204 YSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 40/247 (16%), Positives = 71/247 (28%), Gaps = 48/247 (19%)

Query: 247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIP-HSLSNSPTLNL 305
           PS+    +   L +   +        F+ L     +    +    ++  HS  N   +  
Sbjct: 27  PSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84

Query: 306 LNLRNN----SLDGSLLLNCPALTNLTSLDLGTNKFNG-PLPTNLPRCRKLKNINLARNN 360
           + +RN      +D   L     L  L  L +        P  T +        + +  N 
Sbjct: 85  IEIRNTRNLTYIDPDALKE---LPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNP 141

Query: 361 FSGQIPETYKNFESLS----YLSLSNSSIYNLSS-ALQVLQQCRNLTTLVLTLNFRNEKL 415
           +   IP     F+ L      L L N+   ++   A         L  + L  N     +
Sbjct: 142 YMTSIPVN--AFQGLCNETLTLKLYNNGFTSVQGYAFNGT----KLDAVYLNKNKYLTVI 195

Query: 416 PTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF 475
             D    F  +                     S   L+D+S   ++  +P    G + L 
Sbjct: 196 DKDA---FGGVY--------------------SGPSLLDVSQTSVT-ALP--SKGLEHLK 229

Query: 476 YLDLSNN 482
            L   N 
Sbjct: 230 ELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 45/227 (19%), Positives = 80/227 (35%), Gaps = 19/227 (8%)

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP-- 342
                  RIP    ++ TL L+     ++      N P   N++ + +  +     L   
Sbjct: 19  TCKDIQ-RIPSLPPSTQTLKLIETHLRTIPSHAFSNLP---NISRIYVSIDVTLQQLESH 74

Query: 343 --TNLPRCRKLKNINLARNNFSGQIP-ETYKNFESLSYLSLSNSSIYNLSSALQVLQQCR 399
              NL +   + +I +        I  +  K    L +L + N+ +      L  +    
Sbjct: 75  SFYNLSK---VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF-PDLTKVYSTD 130

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFAN-LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN 458
               L +T N     +P +      N    L + + G   S+  +    +KL  V L+ N
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189

Query: 459 QLSGTIP--VWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRN 502
           +    I    + G +     LD+S  + T  +P   L  L  LI RN
Sbjct: 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 17/113 (15%), Positives = 35/113 (30%), Gaps = 15/113 (13%)

Query: 525 LQYNQIWSFPP----------TIDLSLNRLDGSIWPE-FGNLKKLHVFDLKHNNLSGPIP 573
           L    + + P            I +S++     +    F NL K+   ++++      I 
Sbjct: 38  LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97

Query: 574 SE-LTGMTSLETLDLSYNNLSGAIP--ISLEKLSFLSKFSVANNHLTGRIPSG 623
            + L  +  L+ L +    L    P    +          + +N     IP  
Sbjct: 98  PDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 53/258 (20%), Positives = 90/258 (34%), Gaps = 48/258 (18%)

Query: 776  GDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
            G   +  +++   +    + +  ++   Q             S +E       L++    
Sbjct: 132  GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
               L     +  +   A+G+ +L        +HRD+ + NILL       + DFGLAR I
Sbjct: 192  LEHL-----ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 896  LSPYDTHVTTDLVGTLGYIP-----PEYGQASVATYKGDVYSFGVVLLELLT-GKRP--- 946
                D     D       +P     PE     V T + DV+SFGV+L E+ + G  P   
Sbjct: 244  YKDPDYVRKGD-----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

Query: 947  MDMCKPKGSRDLISWVI---RMRQ-ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSES 1002
            + +       +    +    RMR  +    E     +Y                 C    
Sbjct: 299  VKI-----DEEFCRRLKEGTRMRAPDYTTPE-----MY------------QTMLDCWHGE 336

Query: 1003 PKVRPTTQQLVSWLDSII 1020
            P  RPT  +LV  L +++
Sbjct: 337  PSQRPTFSELVEHLGNLL 354

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 49/203 (24%), Positives = 72/203 (35%), Gaps = 32/203 (15%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNG 170
              L+LS NLL      +L+    L  L+L   +L+  L     LP +  LD+S N L  
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ- 90

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF-QLQ 229
           S+P                           L     L  L +  N LT  +       L 
Sbjct: 91  SLPLLG----------------------QTLPA---LTVLDVSFNRLT-SLPLGALRGLG 124

Query: 230 KLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNR 288
           +L+ L L+ N+L   L P +      L +L +++NN +     +  GL     L+   N 
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 289 FTGRIPHSLSNSPTLNLLNLRNN 311
               IP     S  L    L  N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 47/212 (22%), Positives = 72/212 (33%), Gaps = 46/212 (21%)

Query: 423 FANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
             +  +L ++   L       L   ++L  ++L   +L+  + V  G    L  LDLS+N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHN 87

Query: 483 TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLN 542
                +P     LP+L   +                      + +N++ S P        
Sbjct: 88  QLQ-SLPLLGQTLPALTVLD----------------------VSFNRLTSLPLGA----- 119

Query: 543 RLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISL-E 601
                       L +L    LK N L    P  LT    LE L L+ NNL+  +P  L  
Sbjct: 120 ---------LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN 169

Query: 602 KLSFLSKFSVANNHLTGRIPSGGQFQTFPNSS 633
            L  L    +  N L   IP G     F +  
Sbjct: 170 GLENLDTLLLQENSLY-TIPKG----FFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 10/172 (5%)

Query: 71  NSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV 130
           N   +  L   +   R+T L L +  L     +  G L  L  L+LSHN L+ ++P+   
Sbjct: 41  NLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQ 97

Query: 131 NLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINL 188
            LP L VLD+S N L+  LP      L  +Q L +  N L  ++P  +   + ++  ++L
Sbjct: 98  TLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155

Query: 189 SVNYFSGTLSPGL-GNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDN 239
           + N  +  L  GL     +L+ L L  N L   I    F    L    L  N
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 50/277 (18%), Positives = 85/277 (30%), Gaps = 82/277 (29%)

Query: 321 CPA--LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYL 378
           C    + +   ++         LP +LP+      ++L+ N        T   +  L+ L
Sbjct: 4   CEVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 379 SLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG 438
           +L  + +    + LQV      L TL L+ N          +L                 
Sbjct: 61  NLDRAEL----TKLQVDGTLPVLGTLDLSHN----------QLQ---------------- 90

Query: 439 SIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIP----KNLT 493
           S+P   +    L ++D+S+N+L+ ++P+    G  +L  L L  N     +P        
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148

Query: 494 GLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFG 553
            L  L                          L  N +   P  +                
Sbjct: 149 KLEKL-------------------------SLANNNLTELPAGL--------------LN 169

Query: 554 NLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
            L+ L    L+ N+L   IP    G   L    L  N
Sbjct: 170 GLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 44/180 (24%), Positives = 65/180 (36%), Gaps = 19/180 (10%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
            +   L +S N                  L       T ++       P L  L+L +N 
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQ 88

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP-----RCRKLKNINLARNNFSGQIPE 367
           L  SL L    L  LT LD+  N+      T+LP        +L+ + L  N      P 
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRL-----TSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 368 TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLK 427
                  L  LSL+N+++  L +   +L    NL TL+L  N     L T P+  F +  
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAG--LLNGLENLDTLLLQEN----SLYTIPKGFFGSHL 196

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 68/358 (18%), Positives = 115/358 (32%), Gaps = 68/358 (18%)

Query: 101 LSESLGNLVQLRFLNLSHNLL--KGTVPVS---LVNLPNLEVLDLSSNDLSGPLPQTI-- 153
           + E       +  L+LS N L    TV +         ++  L+LS N L       +  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 154 ----NLPSIQVLDISSNSLNGSVPTSICK----NSSRIRVINLSVNYFSGT----LSPGL 201
                  ++  L++S N L+      + K        I V++L  N FS           
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 202 GNC-ASLEHLCLGMNDLTGGIADDIFQL-----QKLRLLGLQDNQLSGKLSPSIADL--- 252
            N  AS+  L L  NDL    +D++ Q+       +  L L+ N L+ K    +A     
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193

Query: 253 --SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
             +++  LD+S+N         +A L                     S    +  LNL  
Sbjct: 194 IPASVTSLDLSANLLG---LKSYAELAYI----------------FSSIPNHVVSLNLCL 234

Query: 311 NSLDGS----LLLNCPALTNLTSLDLGTNKFNGP-------LPTNLPRCRKLKNINLARN 359
           N L G     L L   +L +L ++ L  +            L    P  +K+  ++    
Sbjct: 235 NCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294

Query: 360 NFSG----QIPETYKNFE-SLSYLSLSNSSIY---NLSSALQVLQQCRNLTTLVLTLN 409
                    I    +         SL N  +       + ++ L     L   + T  
Sbjct: 295 EIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 48/338 (14%), Positives = 95/338 (28%), Gaps = 90/338 (26%)

Query: 197 LSPGLGNCASLEHLCLGMNDLTGGIADDIFQL-----QKLRLLGLQDNQLSGKLSPSIAD 251
           +         +  L L +N+L      ++ Q        +  L L  N L  K S  +  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 252 L-----SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLL 306
           +     +N+  L++S N  S           E    +A                 T+ +L
Sbjct: 74  ILAAIPANVTSLNLSGNFLSY------KSSDELVKTLAAIPF-------------TITVL 114

Query: 307 NLRNNSLD-------GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARN 359
           +L  N               N P   ++TSL+L  N         L   + L  I     
Sbjct: 115 DLGWNDFSSKSSSEFKQAFSNLP--ASITSLNLRGNDLGIKSSDEL--IQILAAIPA--- 167

Query: 360 NFSGQIPETYKNFESLSYLSLSNSSIYN-----LSSALQVLQQCRNLTTLVLTLNFRNEK 414
                         +++ L+L  +++ +     L+  L       ++T+L L+ N     
Sbjct: 168 --------------NVNSLNLRGNNLASKNCAELAKFLA--SIPASVTSLDLSAN----- 206

Query: 415 LPTDPRLHFANLKVLVIASCGLRGSIPQWLRGC-SKLQLVDLSWNQLSGT----IPVWFG 469
                           +A                + +  ++L  N L G     + +   
Sbjct: 207 -------LLGLKSYAELAYI---------FSSIPNHVVSLNLCLNCLHGPSLENLKLLKD 250

Query: 470 GFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEE 507
             + L  + L  +       +    L +       +  
Sbjct: 251 SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 63/237 (26%)

Query: 748 NIIGCGGFGLVYRAT-LPDGRNVAIKRLSG------DCGQMEREFRAEVEALSR-AQHPN 799
             +G G +G+V+++     G  VA+K++        D    +R FR E+  L+  + H N
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFR-EIMILTELSGHEN 70

Query: 800 LVHLQGYCMHKNDR--LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA----QGAAR 853
           +V+L       NDR   L++ +ME    D  LH  +     L     +H      Q   +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET---D--LHAVIRANI-L---EPVHKQYVVYQ-LIK 120

Query: 854 GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT--------- 904
            + YLH      +LHRD+K SNILL+      +ADFGL+R  ++                
Sbjct: 121 VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 905 ----------TDLVGTLGYIPPE-------YGQASVATYKGDVYSFGVVLLELLTGK 944
                     TD V T  Y  PE       Y +        D++S G +L E+L GK
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI------DMWSLGCILGEILCGK 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 46/273 (16%), Positives = 101/273 (36%), Gaps = 26/273 (9%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
                L      NL    +   V      L  ++  +  ++++   L       +++ L 
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAGMQFFTNLKELH 69

Query: 163 ISSNSLNGSVPTSIC--KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG 220
           +S N +     + +   K+ +++  ++++ N        G+ +   L  L L  N+L   
Sbjct: 70  LSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNL--NGIPSA-CLSRLFLDNNELRD- 120

Query: 221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
             D +  L+ L +L +++N+L   +   +  LS L  LD+  N  + N       L +  
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVN 175

Query: 281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP 340
           ++     +        +   P L + N   +  DG  +     ++N  S   G   +  P
Sbjct: 176 WIDLTGQKCV---NEPVKYQPELYITNTVKD-PDGRWISP-YYISNGGSYVDGCVLWELP 230

Query: 341 LPTNLPRCR--KLKNINLARNNFSGQIPETYKN 371
           + T+    +  +  N+      F G + +  KN
Sbjct: 231 VYTDEVSYKFSEYINVGETEAIFDGTVTQPIKN 263

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 39/237 (16%), Positives = 72/237 (30%), Gaps = 54/237 (22%)

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVL 429
               +    +L   S+ +L S     ++   +       +   + L       F NLK L
Sbjct: 16  PGLANAVKQNLGKQSVTDLVS----QKELSGVQNFNGDNS-NIQSL--AGMQFFTNLKEL 68

Query: 430 VIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIP 489
            ++   +   +   L+  +KL+ + ++ N+L     +       L  L L NN       
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGI---PSACLSRLFLDNNELRD--T 121

Query: 490 KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIW 549
            +L  L +L   +I                        N++ S                 
Sbjct: 122 DSLIHLKNLEILSIR----------------------NNKLKSIVM-------------- 145

Query: 550 PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
              G L KL V DL  N ++      LT +  +  +DL+             +L   
Sbjct: 146 --LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 25/183 (13%), Positives = 59/183 (32%), Gaps = 21/183 (11%)

Query: 444 LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNI 503
             G +     +L    ++  +         +   +  N+     +   +    +L   ++
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70

Query: 504 S---LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGS------IWPEFGN 554
           S   + + S   P      +    +  N++ +        L+RL               +
Sbjct: 71  SHNQISDLS---PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDT-DSLIH 126

Query: 555 LKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
           LK L +  +++N L       L  ++ LE LDL  N ++      L +L  ++   +   
Sbjct: 127 LKNLEILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182

Query: 615 HLT 617
              
Sbjct: 183 KCV 185

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 74.1 bits (181), Expect = 2e-13
 Identities = 95/656 (14%), Positives = 182/656 (27%), Gaps = 206/656 (31%)

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPETYKNF--ESLSYLSLSNSSIYN-LSSALQVLQQC 398
              +    +L    L++        E  + F  E L      N   Y  L S ++   + 
Sbjct: 58  KDAVSGTLRLFWTLLSKQE------EMVQKFVEEVLRI----N---YKFLMSPIKT--EQ 102

Query: 399 RNLTTLVLTLNFRNEKLPTDPRLHFANLKV----LVIASCGLRGSIPQWLR--------- 445
           R  + +      + ++L  D ++ FA   V      +    LR ++ + LR         
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSRLQPYLK---LRQALLE-LRPAKNVLIDG 157

Query: 446 --GCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNI 503
             G  K  +             + F     +F+L+L N      + + L  L   I  N 
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFK----IFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 504 SLEEPSPDFPFFMRRN-VSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFD 562
           +           +R + + A   +  +   +       L  L   +     N K  + F+
Sbjct: 214 T-SRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----CLLVLLN-VQ----NAKAWNAFN 263

Query: 563 LK------------HNNLSGPIPSELT------GMTSLETLDLSYNNLSGAIPISLEKLS 604
           L              + LS    + ++       +T  E   L    L   +    + L 
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL----LLKYLDCRPQDL- 318

Query: 605 FLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGN----NLCGE--HRYSCTIDRESGQVKS 658
                                    P      N    ++  E       T D     V  
Sbjct: 319 -------------------------PREVLTTNPRRLSIIAESIRDGLATWDN-WKHVNC 352

Query: 659 AKKSRRNKYTIVGMAIGI----TFGSAFLLILIFMILLRAHSRGEVD-PEK--------E 705
            K +     TI+  ++ +     +   F  + +F              P           
Sbjct: 353 DKLT-----TIIESSLNVLEPAEYRKMFDRLSVF--------PPSAHIPTILLSLIWFDV 399

Query: 706 EANTNDKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD 765
             +     + +L    +V    KE  ISI  I                   L  +  L +
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY------------------LELKVKLEN 441

Query: 766 GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV----------HLQGYCMHKNDRLL 815
                          + R               +L+          H+ G+ +   +   
Sbjct: 442 EY------------ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI-GHHLKNIEHPE 488

Query: 816 IYSFMENGSLDY-WLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK 872
             +      LD+ +L +K+  D  +   W++   I     +   Y     +P+I   D K
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTA---WNASGSILNTLQQLKFY-----KPYICDNDPK 540

Query: 873 SSNILLDGNFGAHLADFGLAR----LILSPYDTHVTTDLVGTLGYIPPE---YGQA 921
              ++        + DF L +    LI S Y     TDL+  +  +  +   + +A
Sbjct: 541 YERLVNA------ILDF-LPKIEENLICSKY-----TDLL-RIALMAEDEAIFEEA 583

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 3e-09
 Identities = 97/610 (15%), Positives = 188/610 (30%), Gaps = 167/610 (27%)

Query: 27  QDLTCNPNDLAA--LEDFMKNFESGIDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGS 84
                   D+ +   + F+ NF              DC     +  +  S   ++  I S
Sbjct: 14  HQYQYK--DILSVFEDAFVDNF--------------DCKDVQDMPKSILSKEEIDHIIMS 57

Query: 85  G-RVTGLFLYKRRLKGKLSESLGNLVQLRF----LNLSHNLLKGTVPV-----SLVNLPN 134
              V+G      RL   L      +VQ +F    L +++  L   +       S++    
Sbjct: 58  KDAVSGT----LRLFWTLLSKQEEMVQ-KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY 112

Query: 135 LEVLDLSSNDLSGPLPQTINLPSIQ--------VLDISSNS---LNG------SVPT-SI 176
           +E  D   ND      +  N+  +Q        +L++       ++G      +     +
Sbjct: 113 IEQRDRLYNDNQ-VFAK-YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 177 CKNSSRIRVINLSVNYFSGTLSPGLGNCAS-------LEHLCLGMNDLTGGIADDIFQLQ 229
           C +      ++  + + +      L NC S       L+ L   + D       D     
Sbjct: 171 CLSYKVQCKMDFKIFWLN------LKNCNSPETVLEMLQKLLYQI-DPNWTSRSDHSSNI 223

Query: 230 KLRLLGLQD---NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF--QYLVA 284
           KLR+  +Q      L  K   +   L  LV L+V +        + F        + L+ 
Sbjct: 224 KLRIHSIQAELRRLLKSKPYEN--CL--LVLLNVQNA----KAWNAF----NLSCKILL- 270

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN 344
                T R       +  L+     + SLD         LT      L     +   P +
Sbjct: 271 -----TTR---FKQVTDFLSAATTTHISLDHHS----MTLTPDEVKSLLLKYLDCR-PQD 317

Query: 345 LPRCRKLKNIN-LARNNFSGQI---PETYKNFESLSYLSLSN---SSIYNLSSALQVLQQ 397
           LP  R++   N    +  +  I     T+ N++ ++   L+    SS+  L  A    ++
Sbjct: 318 LP--REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE--YRK 373

Query: 398 CRNLTTLVLTLNFR-NEKLPTDPRLHFANLKVLVIASCGLRGSIPQ-WLRGCSKLQLVDL 455
                 L +   F  +  +PT          +L +    +  S     +    K  LV+ 
Sbjct: 374 M--FDRLSV---FPPSAHIPT---------ILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419

Query: 456 SWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL---------ITRNISLE 506
              + + +IP        + YL+L            L    +L         I +    +
Sbjct: 420 QPKESTISIP-------SI-YLELK---------VKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 507 EPSPD------FPFFMRRNVSARGLQYNQIWSFPPTIDLSLN------RLDGSIWPEFGN 554
           +  P       +          + +++ +  +    + L         R D + W   G+
Sbjct: 463 DLIPPYLDQYFYSHIGHH---LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519

Query: 555 LKKLHVFDLK 564
           +    +  LK
Sbjct: 520 ILNT-LQQLK 528

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 2e-06
 Identities = 39/293 (13%), Positives = 90/293 (30%), Gaps = 78/293 (26%)

Query: 759  YRATLPDGRNVAIKRLSGDCGQMEREFR-----AEVEALSRAQHP-NLVHLQGYCMHKND 812
            Y+  L    +  +     DC  ++   +      E++ +  ++   +      + +    
Sbjct: 18   YKDILSVFEDAFVDNF--DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75

Query: 813  RLLIYSFMENG-SLDY-WLHEKL----DGPS--SLDWDSRLHIAQGAARGLAYLHQSCEP 864
              ++  F+E    ++Y +L   +      PS  +  +  +        +  A  + S   
Sbjct: 76   EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135

Query: 865  HI------LHRDIKSSNILLDGNFGAHLADFG---LARLILSPYDTHVTTDLVGTLGYIP 915
                    L     + N+L+DG  G      G   +A  +   Y      D         
Sbjct: 136  PYLKLRQALLELRPAKNVLIDGVLG-----SGKTWVALDVCLSYKVQCKMD--------- 181

Query: 916  PEYGQASVATYKGDVY--SFGVV-----LLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
                          ++  +         +LE+L  K    +     SR   S  I++R  
Sbjct: 182  ------------FKIFWLNLKNCNSPETVLEMLQ-KLLYQIDPNWTSRSDHSSNIKLRIH 228

Query: 969  NRESEVLDPFIYDKQH-----------DKEMLRVLDIACLCLSESPKVRPTTQ 1010
            + ++E L   +  K +           + +     +++C       K+  TT+
Sbjct: 229  SIQAE-LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-------KILLTTR 273

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 4e-06
 Identities = 63/395 (15%), Positives = 127/395 (32%), Gaps = 116/395 (29%)

Query: 8   LFIILAGFCFQAQLLHAQRQDLTCNP----NDL-AALEDFM--KNFESGI----DGWGTN 56
           +  +L    +Q       R D + N     + + A L   +  K +E+ +    +     
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257

Query: 57  ASSSDCCHW--VGITCN---SSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQL 111
                   W    ++C    ++    + D + +   T + L    +     E    L  L
Sbjct: 258 -------AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL--L 308

Query: 112 RFLNLSHNLL----KGTVP--VSL-----------------VNLPNL-EVLDLSSNDLSG 147
           ++L+     L      T P  +S+                 VN   L  +++ S N L  
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE- 367

Query: 148 P------------LPQTINLPSIQVLDI---------SSNSLNGSVPTSICK---NSSRI 183
           P             P + ++P+  +L +             +N     S+ +     S I
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPT-ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426

Query: 184 RVINLSVNYFSGTLSPGLGNCASLEH----------LCLGMNDLTGGIADD-IFQLQKLR 232
            + ++   Y    L   L N  +L H               +DL     D   +      
Sbjct: 427 SIPSI---YLE--LKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYS----- 475

Query: 233 LLG--LQDNQLSGKLS--PSI-ADLSNL---VRLDVSSNNFSGNIPDVFAGLGEF-QYLV 283
            +G  L++ +   +++    +  D   L   +R D ++ N SG+I +    L  +  Y+ 
Sbjct: 476 HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC 535

Query: 284 AHSNR----------FTGRIPHSLSNSPTLNLLNL 308
            +  +          F  +I  +L  S   +LL +
Sbjct: 536 DNDPKYERLVNAILDFLPKIEENLICSKYTDLLRI 570

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 51/314 (16%), Positives = 93/314 (29%), Gaps = 65/314 (20%)

Query: 111 LRFLNLSHNLL--KGTVPVS--LVNLPNLEVLDLSSNDLSGPLPQTI-----NLPSIQVL 161
           +   +L  + +  +    V   L+   +++ + LS N +     + +     +   +++ 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 162 DISSNSLNGSVP------TSIC---KNSSRIRVINLSVNYFSGT----LSPGLGNCASLE 208
           + S                 +        ++  + LS N F  T    L   L     LE
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 209 HLCLGMNDLT--GGIA-----------DDIFQLQKLRLLGLQDNQLSGK----LSPSIAD 251
           HL L  N L    G                     LR +    N+L        + +   
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185

Query: 252 LSNLVRLDVSSNNF-----SGNIPDVFAGLGEFQYLVAHSNRFTGR----IPHSLSNSPT 302
              L  + +  N          + +  A   E + L    N FT      +  +L + P 
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245

Query: 303 LNLLNLRNNSL--DGSLL----LNCPALTNLTSLDLGTNKFNGP--------LPTNLPRC 348
           L  L L +  L   G+       +      L +L L  N+            +   +P  
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP-- 303

Query: 349 RKLKNINLARNNFS 362
             L  + L  N FS
Sbjct: 304 -DLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 48/284 (16%), Positives = 84/284 (29%), Gaps = 67/284 (23%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKGTVPV----------SLVNLPNLEVLDLSSNDLSGPLP 150
           LSE++ +   L     S                    +L+  P L  + LS N       
Sbjct: 52  LSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 151 QTI-----NLPSIQVLDISSNS------------LNGSVPTSICKNSSRIRVINLSVNYF 193
           + +         ++ L + +N             L         KN+  +R I    N  
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 194 SG----TLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQL----QKLRLLGLQDNQLSGK 244
                   +    +   L  + +  N +   GI   + +     Q+L++L LQDN  +  
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231

Query: 245 ----LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF-QYLVAHSNRFTGRIPHSLSN 299
               L+ ++    NL  L ++    S        G            N            
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSA------RGAAAVVDAFSKLEN------------ 273

Query: 300 SPTLNLLNLRNNSL--DGSLLLNCPAL----TNLTSLDLGTNKF 337
              L  L L+ N +  D    L    +     +L  L+L  N+F
Sbjct: 274 -IGLQTLRLQYNEIELDAVRTL-KTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.6 bits (124), Expect = 8e-07
 Identities = 51/363 (14%), Positives = 104/363 (28%), Gaps = 89/363 (24%)

Query: 297 LSNSPTLNLLNLRNNSLD-------GSLLLNCPALTNLTSLDLGTNKFNGP----LPTNL 345
           ++   ++   +L+ +++         ++LL      ++  + L  N         L  N+
Sbjct: 1   MARF-SIEGKSLKLDAITTEDEKSVFAVLLED---DSVKEIVLSGNTIGTEAARWLSENI 56

Query: 346 PRCRKLKNINLARNNFSGQIPETYKNFE----------SLSYLSLSNSSIYNLS-SAL-Q 393
              + L+    +         E  +              L  + LS+++    +   L  
Sbjct: 57  ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116

Query: 394 VLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLV 453
            L +   L  L L  N                     IA      ++ +  +    L+ +
Sbjct: 117 FLSKHTPLEHLYLHNN------------GLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164

Query: 454 DLSWNQL-SGTIPVW---FGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPS 509
               N+L +G++  W   F   + L  + +  N    E  ++L  L   +     L+   
Sbjct: 165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL--LLEGLAYCQELK--- 219

Query: 510 PDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRL--DGSIW--PEFGNLKKLHVFDLKH 565
                                      +DL  N     GS        +   L    L  
Sbjct: 220 --------------------------VLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253

Query: 566 NNLSGP----IPSELTGM--TSLETLDLSYNNLS--GAIPIS---LEKLSFLSKFSVANN 614
             LS      +    + +    L+TL L YN +       +     EK+  L    +  N
Sbjct: 254 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313

Query: 615 HLT 617
             +
Sbjct: 314 RFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 17/113 (15%)

Query: 98  KGKLSESLGNLVQLRFLNLSHNLL--KGTVPVS--LVNLPNLEVLDLSSNDLSGP----- 148
           +  L E L    +L+ L+L  N     G+  ++  L + PNL  L L+   LS       
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264

Query: 149 ---LPQTINLPSIQVLDISSNSLNGSVPTSICK----NSSRIRVINLSVNYFS 194
                +  N   +Q L +  N +      ++          +  + L+ N FS
Sbjct: 265 VDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 50/235 (21%), Positives = 83/235 (35%), Gaps = 55/235 (23%)

Query: 750 IGCGGFGLVYRATLPDGRNV------AIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHL 803
           IG GGFG +Y A +    +V       +K    D G +  E +       RA  P  +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF----YQRAAKPEQIQ- 97

Query: 804 QGYCMHKNDRLLIYSFMENGSLDYWLHE------KLDGPS---SLDWDSR-------LHI 847
           +     K   L +  +  +G  D              G       + +++       L +
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQL 157

Query: 848 AQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLILSPYDTHV- 903
           +      L Y+H   E   +H DIK+SN+LL   + +   +L D+GLA         H  
Sbjct: 158 SLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPE-GVHKA 212

Query: 904 -----TTDLVGTLGYIPPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
                     GT+ +        S+  + G       D+   G  +++ LTG  P
Sbjct: 213 YAADPKRCHDGTIEF-------TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 45/221 (20%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGY 806
           IG G FG+++  T L + + VAIK         Q+  E+R           PN+ +   +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY---F 74

Query: 807 CMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEP 864
                  +L+   ++    SL+  L +      S+   +    A+     +  +H+    
Sbjct: 75  GQEGLHNVLV---IDLLGPSLED-LLDLCGRKFSVK--TVAMAAKQMLARVQSIHEK--- 125

Query: 865 HILHRDIKSSNILLDGNFGA-----HLADFGLARLILS-------PYDTHVTTDLVGTLG 912
            +++RDIK  N L+           ++ DFG+ +           PY      +L GT  
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK--KNLSGTAR 183

Query: 913 YIPPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
           Y        S+ T+ G       D+ + G V +  L G  P
Sbjct: 184 Y-------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 43/219 (19%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQH-PNLVHLQG 805
           IG G FG +Y  T +  G  VAIK         Q+  E +         Q    +  ++ 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI----YKMMQGGVGIPTIRW 72

Query: 806 YCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
                +  +++   ME    SL+  L        SL   + L +A      + Y+H    
Sbjct: 73  CGAEGDYNVMV---MELLGPSLED-LFNFCSRKFSLK--TVLLLADQMISRIEYIHSK-- 124

Query: 864 PHILHRDIKSSNILL----DGNFGAHLADFGLARLILSPYD-THV----TTDLVGTLGYI 914
            + +HRD+K  N L+     GN   ++ DFGLA+         H+      +L GT  Y 
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY- 181

Query: 915 PPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
                 AS+ T+ G       D+ S G VL+    G  P
Sbjct: 182 ------ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 70.0 bits (171), Expect = 2e-12
 Identities = 69/508 (13%), Positives = 156/508 (30%), Gaps = 80/508 (15%)

Query: 83  GSGRVTGLFLYKRRLKGKLSESLGNLVQ----LRFLNLSHNLL--KGTVPVSLVNLPNLE 136
           G  R     L      G ++  +  +      L+ ++    ++       ++     +LE
Sbjct: 82  GKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLE 141

Query: 137 VLDLSSNDL---SGPLPQTINLPSIQVLDISSNSLN---GSVPTSICKNSSRIRVINLSV 190
            L L         G L    +   I+ L +  +S +   G     + ++++ + V+N  +
Sbjct: 142 TLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYM 201

Query: 191 NYFSGTLSPGL----GNCASLEHLCLGMNDLT--GGIADDIFQLQKLRLLGLQDNQLSGK 244
             F+      L     NC SL  + +G  ++    G       L++     L ++    +
Sbjct: 202 TEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPE 261

Query: 245 LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL-VAHSNRFTGRIPHSLSNSPTL 303
              ++     L RL +S    +  +P +F    + + L + ++   T      +   P L
Sbjct: 262 KYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320

Query: 304 NLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR------------CRKL 351
            +L  RN   D  L +       L  L +        +                  C++L
Sbjct: 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQEL 380

Query: 352 KNINLARNNFSGQ----IPETYKNFESLSYLSLSNSS----IYNLSSALQVLQQCRNLTT 403
           + + +  ++ + +    I    KN      + L        +   +    +L  C+ L  
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR 440

Query: 404 LVLTLNFRNEKLPTDPRL-----HFANLKVLVIASCG--------------------LRG 438
               L        TD  L     +  N++ +++   G                    +RG
Sbjct: 441 FAFYLRQGGL---TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497

Query: 439 ------SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFG---GFQDLFYLDLSNNTFTGE-- 487
                 +I   +     L+ + +   + S T          + ++  +         +  
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQG 557

Query: 488 IPKNLTGLPSLITRNISLEEPSPDFPFF 515
             + +     ++    SL     D P  
Sbjct: 558 EIREMEHPAHILAYY-SLAGQRTDCPTT 584

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 65/470 (13%), Positives = 128/470 (27%), Gaps = 71/470 (15%)

Query: 178 KNSSRIRVINLSVNYFSGTLSPGL----GNCASLEHLCLGMNDLTGGIADDIFQ-----L 228
           K   R  + NL    + G ++P +     N   L+ +      ++    D + +     L
Sbjct: 81  KGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140

Query: 229 QKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN 287
           + L+L     +  +     SI      +  L +  ++FS         L +         
Sbjct: 141 ETLKLDKC--SGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ--------- 189

Query: 288 RFTGRIPHSLSNSPTLNLLNLRNNSL----DGSLLLNCPALTNLTSLDLGTNKFNGPLPT 343
                      ++ +L +LN             L        +L S+ +G  +    L  
Sbjct: 190 -----------HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE-ILELVG 237

Query: 344 NLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTT 403
                  L+       N    +PE Y N      L     S    +    +      +  
Sbjct: 238 FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297

Query: 404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGT 463
           L L       +          NL+VL   +      +    + C +L+ + +        
Sbjct: 298 LDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQG 357

Query: 464 IPVWFGGFQD------------LFYLDLSNNTFTGE----IPKNLTGLPSLITRNISLEE 507
           +    G                L Y+ +  +  T E    I   L  L     R + L+ 
Sbjct: 358 MEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF--RLVLLDR 415

Query: 508 PSPDFPFFMRRNVSA-----RGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFD 562
                   +   V +     + L+    +     +       D  +         +    
Sbjct: 416 EERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLT------DLGLSYIGQYSPNVRWML 469

Query: 563 LKHNNLSGP-IPSELTGMTSLETLDLSYNNLS----GAIPISLEKLSFLS 607
           L +   S   +     G  +L+ L++     S     A    L  L +L 
Sbjct: 470 LGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLW 519

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 45/229 (19%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHP 798
            NF     IGCG FG +     L     VAIK   +     Q+  E+R            
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR---FYKQLGSGD 65

Query: 799 NLVHLQGYCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            +  +  +        ++   +E    SL+  L +  D   SL   + L IA      + 
Sbjct: 66  GIPQVYYFGPCGKYNAMV---LELLGPSLED-LFDLCDRTFSLK--TVLMIAIQLISRME 119

Query: 857 YLHQSCEPHILHRDIKSSNILL--DGNFGA---HLADFGLARLILS-------PYDTHVT 904
           Y+H     ++++RD+K  N L+   GN      H+ DF LA+  +        PY  H  
Sbjct: 120 YVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH-- 174

Query: 905 TDLVGTLGYIPPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
             L GT  Y        S+ T+ G       D+ + G + +  L G  P
Sbjct: 175 KSLTGTARY-------MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 48/210 (22%), Positives = 77/210 (36%), Gaps = 32/210 (15%)

Query: 109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSN 166
              + L+L  N L      +   L  L +L L+ N L   LP  I   L +++ L ++ N
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF 226
            L  ++P  +                F            +L  L L  N L   +   +F
Sbjct: 96  KLQ-ALPIGV----------------FDQL--------VNLAELRLDRNQLKS-LPPRVF 129

Query: 227 -QLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA 284
             L KL  L L  N+L   L   + D L++L  L + +N         F  L E + L  
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLD 314
            +N+       +  +   L +L L+ N  D
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 46/191 (24%), Positives = 65/191 (34%), Gaps = 26/191 (13%)

Query: 231 LRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
            + L LQ N+LS  L       L+ L  L ++ N        +F  L   + L    N+ 
Sbjct: 39  TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97

Query: 290 TGRIPHSLSNSPT-LNLLNLRNNSLDGSLLLNCPA-----LTNLTSLDLGTNKFNGPLPT 343
              +P  + +    L  L L  N L  SL    P      LT LT L LG N+       
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLK-SL----PPRVFDSLTKLTYLSLGYNEL-----Q 146

Query: 344 NLP-----RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQC 398
           +LP     +   LK + L  N         +     L  L L N+ +  +          
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE--GAFDSL 204

Query: 399 RNLTTLVLTLN 409
             L  L L  N
Sbjct: 205 EKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 32/185 (17%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSL-VNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDI 163
            L +LR L L+ N L+ T+P  +   L NLE L ++ N L   LP  +   L ++  L +
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116

Query: 164 SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIAD 223
             N L  S+P  +                F       L     L +L LG N+L   +  
Sbjct: 117 DRNQLK-SLPPRV----------------FD-----SLTK---LTYLSLGYNELQ-SLPK 150

Query: 224 DIF-QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
            +F +L  L+ L L +NQL      +   L+ L  L + +N         F  L + + L
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210

Query: 283 VAHSN 287
               N
Sbjct: 211 QLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 46/220 (20%), Positives = 69/220 (31%), Gaps = 45/220 (20%)

Query: 374 SLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS 433
               L L ++ + +L S      +   L  L L  N + + LP        NL+ L +  
Sbjct: 38  DTKKLDLQSNKLSSLPSK--AFHRLTKLRLLYLNDN-KLQTLPAGIFKELKNLETLWVTD 94

Query: 434 CGLRGSIPQWL-RGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKN 491
             L+ ++P  +      L  + L  NQL  ++P   F     L YL L  N     +PK 
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKG 151

Query: 492 L-TGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP 550
           +   L SL                          L  NQ+   P                
Sbjct: 152 VFDKLTSLKELR----------------------LYNNQLKRVPEGA------------- 176

Query: 551 EFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
            F  L +L    L +N L          +  L+ L L  N
Sbjct: 177 -FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 42/186 (22%), Positives = 64/186 (34%), Gaps = 44/186 (23%)

Query: 445 RGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFT---GEIPKNLTGLPSLIT 500
              +KL+L+ L+ N+L  T+P   F   ++L  L +++N        +   L  L  L  
Sbjct: 58  HRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAEL-- 114

Query: 501 RNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI----------DLSLNRLDGSIWP 550
                                   L  NQ+ S PP +           L  N L  S+ P
Sbjct: 115 -----------------------RLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SL-P 149

Query: 551 E--FGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSK 608
           +  F  L  L    L +N L          +T L+TL L  N L      + + L  L  
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209

Query: 609 FSVANN 614
             +  N
Sbjct: 210 LQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 40/177 (22%), Positives = 64/177 (36%), Gaps = 43/177 (24%)

Query: 450 LQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNL-TGLPSLITRNISLEEP 508
            + +DL  N+LS      F     L  L L++N     +P  +   L +L T        
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLW------ 91

Query: 509 SPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNL 568
                           +  N++ + P  +              F  L  L    L  N L
Sbjct: 92  ----------------VTDNKLQALPIGV--------------FDQLVNLAELRLDRNQL 121

Query: 569 SGPIPSEL-TGMTSLETLDLSYNNLSGAIPISL-EKLSFLSKFSVANNHLTGRIPSG 623
              +P  +   +T L  L L YN L  ++P  + +KL+ L +  + NN L  R+P G
Sbjct: 122 KS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG 175

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 50/208 (24%), Positives = 77/208 (37%), Gaps = 45/208 (21%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHLQG- 805
           ++G G  G V +          A+K L  DC +  RE    VE   R +Q P++V +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 79

Query: 806 YCMHKNDRLLIYSFMEN---GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
           Y      R  +   ME    G L   + ++ D   + + ++   +       + YLH   
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT-EREASEIMKS-IGEAIQYLHSI- 136

Query: 863 EPHILHRDIKSSNILL---DGNFGAHLADFGLARLILS-PYDTHVTTDLVGTLGYIPPEY 918
             +I HRD+K  N+L      N    L DFG A+      YD                  
Sbjct: 137 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC--------------- 179

Query: 919 GQASVATYKGDVYSFGVVLLELLTGKRP 946
                     D++S GV++  LL G  P
Sbjct: 180 ----------DMWSLGVIMYILLCGYPP 197

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 50/231 (21%), Positives = 80/231 (34%), Gaps = 50/231 (21%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVA---IKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQG 805
           IG GGFGL+Y A         A   +K    + G +  E +       R    + +  + 
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKF----YQRVAKKDCIK-KW 99

Query: 806 YCMHKNDRLLIYSFMENGSLDYWLHE------KLDGPS---SLDWDSR------LHIAQG 850
               + D L I  F  +G  ++          +  G         +        L +   
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 851 AARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--AHLADFGLARLILSPYDTHV----- 903
               L Y+H++     +H DIK++N+LL        +LAD+GL+         H      
Sbjct: 160 MLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN-GNHKQYQEN 215

Query: 904 -TTDLVGTLGYIPPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
                 GT+ +        S+  +KG       DV   G  +L  L GK P
Sbjct: 216 PRKGHNGTIEF-------TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 3e-11
 Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 43/219 (19%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQ-HPNLVHLQG 805
           IG G FG +Y  T +     VAIK  +      Q+  E +         Q    + +++ 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVRW 70

Query: 806 YCMHKNDRLLIYSFME--NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCE 863
           + +  +  +L+   M+    SL+  L        SL   + L +A      + ++H    
Sbjct: 71  FGVEGDYNVLV---MDLLGPSLED-LFNFCSRKLSL--KTVLMLADQMINRVEFVHSK-- 122

Query: 864 PHILHRDIKSSNILL----DGNFGAHLADFGLARLILSPYD-THV----TTDLVGTLGYI 914
              LHRDIK  N L+      N   ++ DFGLA+         H+      +L GT  Y 
Sbjct: 123 -SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY- 179

Query: 915 PPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
                 ASV T+ G       D+ S G VL+  L G  P
Sbjct: 180 ------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 43/231 (18%), Positives = 73/231 (31%), Gaps = 47/231 (20%)

Query: 750 IGCGGFGLVYRAT---------LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
                 G++Y A           P  +  ++K  + D G++  E      A    Q    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKW 108

Query: 801 VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPS---SLDWDSR--------LHIAQ 849
             L            +   +      + +   L G S   +LD   +        L +A 
Sbjct: 109 KKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 850 GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA--HLADFGLARLILS-----PYDTH 902
                L +LH   E   +H ++ + NI +D    +   LA +G A           Y   
Sbjct: 167 RLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223

Query: 903 VTTDLVGTLGYIPPEYGQASVATYKG-------DVYSFGVVLLELLTGKRP 946
             +   G L +        S+  +KG       D+ S G  +L+ L G  P
Sbjct: 224 SRSPHEGDLEF-------ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 13/185 (7%)

Query: 138 LDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTL 197
           L  S   L   +PQ++      +LD+S N+L+           + +  + LS N+ +  +
Sbjct: 23  LSCSKQQLPN-VPQSLP-SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FI 79

Query: 198 SPG-LGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSN 254
           S        +L +L L  N L   + + +F  LQ L +L L +N +   +  +   D++ 
Sbjct: 80  SSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQ 137

Query: 255 LVRLDVSSNNFSGNIPDVFAG---LGEFQYLVAHSNRFTGRIPHSLSNSPTLNL--LNLR 309
           L +L +S N  S    ++      L +   L   SN+        L   P      L L 
Sbjct: 138 LQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

Query: 310 NNSLD 314
           NN L+
Sbjct: 198 NNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 12/159 (7%)

Query: 114 LNLSHNLLKGTVP-VSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNG 170
           L+LSHN L       +   L NL  L LS N L+  +       +P+++ LD+SSN L+ 
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH- 101

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIADDIFQ-- 227
           ++   +  +   + V+ L  N+    +      + A L+ L L  N ++     ++ +  
Sbjct: 102 TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159

Query: 228 --LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN 264
             L KL LL L  N+L       +  L   V+  +  +N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 45/199 (22%), Positives = 66/199 (33%), Gaps = 46/199 (23%)

Query: 432 ASCGLRG--SIPQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNNTFTGEI 488
            SC  +   ++PQ L   S   L+DLS N LS     W      +L  L LS+N     I
Sbjct: 23  LSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FI 79

Query: 489 PKN-LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP----------TI 537
                  +P+L      L+                  L  N + +              +
Sbjct: 80  SSEAFVPVPNLRY----LD------------------LSSNHLHTLDEFLFSDLQALEVL 117

Query: 538 DLSLNRLDGSIWPE-FGNLKKLHVFDLKHNNLSGPIPSE----LTGMTSLETLDLSYNNL 592
            L  N +   +    F ++ +L    L  N +S   P E       +  L  LDLS N L
Sbjct: 118 LLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKL 175

Query: 593 SGAIPISLEKLSFLSKFSV 611
                  L+KL    K  +
Sbjct: 176 KKLPLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 30/139 (21%), Positives = 48/139 (34%), Gaps = 27/139 (19%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDIS 164
            +  LR+L+LS N L         +L  LEVL L +N +   + +    ++  +Q L +S
Sbjct: 86  PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLS 144

Query: 165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADD 224
            N ++   P  +                              L  L L  N L      D
Sbjct: 145 QNQIS-RFPVEL----------------IK-----DGNKLPKLMLLDLSSNKLKKLPLTD 182

Query: 225 IFQLQKLRL--LGLQDNQL 241
           + +L       L L +N L
Sbjct: 183 LQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 28/91 (30%), Positives = 38/91 (41%), Gaps = 6/91 (6%)

Query: 536 TIDLSLNRLDGSIWPE--FGNLKKLHVFDLKHNNLSGPIPSE-LTGMTSLETLDLSYNNL 592
            +DLS N L   +  E     L  LH   L HN+L+  I SE    + +L  LDLS N+L
Sbjct: 43  LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHL 100

Query: 593 SGAIPISLEKLSFLSKFSVANNHLTGRIPSG 623
                     L  L    + NNH+   +   
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIV-VVDRN 130

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 24/106 (22%), Positives = 41/106 (38%), Gaps = 5/106 (4%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS--- 146
           L L    L         +L  L  L L +N +      +  ++  L+ L LS N +S   
Sbjct: 93  LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152

Query: 147 -GPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN 191
              +     LP + +LD+SSN L   +P +  +         L ++
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLH 197

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 45/224 (20%)

Query: 749 IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-----------AQ 796
            +G G F  V+ A  + +  +VA+K + GD          E++ L R             
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 797 HPNLVHLQGYCMHKNDRL----LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             +++ L  +  HK        +++  +   +L   + +       L    +  I++   
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI-YVK-QISKQLL 141

Query: 853 RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH------LADFGLARLILSPYDTHVTTD 906
            GL Y+H+ C   I+H DIK  N+L++            +AD G A       D H T  
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----DEHYTNS 195

Query: 907 LVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
           +  T  Y  PE      +G  +      D++S   ++ EL+TG 
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGA------DIWSTACLIFELITGD 232

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 1e-10
 Identities = 38/213 (17%), Positives = 67/213 (31%), Gaps = 19/213 (8%)

Query: 449 KLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEI---PKNLTGLPSLITRNISL 505
           +L   +LS  + +  +       ++L  L+  N      I    + L  L          
Sbjct: 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408

Query: 506 E-----EPSPDFPFFMRRNVSARGLQYNQIWSFPPT-IDLSLNRLDGSIWPEFGNLKKLH 559
                 +P         R+         ++       + L+   L  ++      L  + 
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVT 466

Query: 560 VFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGR 619
             DL HN L   +P  L  +  LE L  S N L   +   +  L  L +  + NN L   
Sbjct: 467 HLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ- 522

Query: 620 IPSGGQFQTFPN---SSFDGNNLCGEHRYSCTI 649
             +     + P     +  GN+LC E      +
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 555

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.7 bits (149), Expect = 7e-10
 Identities = 37/144 (25%), Positives = 51/144 (35%), Gaps = 30/144 (20%)

Query: 100 KLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQ 159
           + S        +R L+L+H  L  TV   L  L  +  LDLS N L    P    L  ++
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLE 489

Query: 160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG 219
           VL  S N+L      ++                       G+ N   L+ L L  N L  
Sbjct: 490 VLQASDNAL-----ENV----------------------DGVANLPRLQELLLCNNRLQQ 522

Query: 220 -GIADDIFQLQKLRLLGLQDNQLS 242
                 +    +L LL LQ N L 
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 55.1 bits (132), Expect = 9e-08
 Identities = 42/306 (13%), Positives = 85/306 (27%), Gaps = 29/306 (9%)

Query: 224 DIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV 283
           +   +     +  ++  LS   S  +   S +  L +  +    ++             V
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD--------GSLLLNCPALTNLTSLDLGTN 335
              +     +   L       +    ++  +             +      L   +L   
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 336 KFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNL------- 388
           K    L + L  C++L+ +          I    +  + L Y   +      L       
Sbjct: 360 KST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 389 --------SSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRL-HFANLKVLVIASCGLRGS 439
                   S  L      +     V  L+  ++ L     L     +  L ++   LR +
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-A 477

Query: 440 IPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-EIPKNLTGLPSL 498
           +P  L     L+++  S N L   +         L  L L NN        + L   P L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535

Query: 499 ITRNIS 504
           +  N+ 
Sbjct: 536 VLLNLQ 541

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.9 bits (108), Expect = 6e-05
 Identities = 47/326 (14%), Positives = 95/326 (29%), Gaps = 38/326 (11%)

Query: 154 NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG 213
               +  + +S      SV  S            L +   +                 + 
Sbjct: 241 PHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVW 300

Query: 214 MNDLTGGIADDIFQLQKLRLLGLQDNQLS---------GKLSPSIADLSNLVRLDVSSNN 264
           + DL     +D       R++    +                   A    L R ++S   
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360

Query: 265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPAL 324
                          Q  +          P +     T+ +L +R               
Sbjct: 361 -----------STVLQSELESCKELQELEPENKWCLLTI-ILLMRALDPLLYEKETLQYF 408

Query: 325 TNLTSLD--------LGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
           + L ++D           +KF             ++ ++LA  + +  +    +    ++
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVT 466

Query: 377 YLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGL 436
           +L LS++ +  L  AL  L+    L  L  + N   E +     L    L+ L++ +  L
Sbjct: 467 HLDLSHNRLRALPPALAALR---CLEVLQASDN-ALENVDGVANLP--RLQELLLCNNRL 520

Query: 437 RG-SIPQWLRGCSKLQLVDLSWNQLS 461
           +  +  Q L  C +L L++L  N L 
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 1e-10
 Identities = 39/252 (15%), Positives = 64/252 (25%), Gaps = 66/252 (26%)

Query: 740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRL--------SGDCGQMEREFRAEVEA 791
            T    +   IG G FG V++    D   VAIK +        +G   +   E   E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 792 L---------SRAQHPNLVHLQGYCM-----------------------------HKNDR 813
                        +    + L                                   K+D+
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKS 873
           L I    E G +D     +          +   I       LA           HRD+  
Sbjct: 137 LFIVLEFEFGGIDL----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 874 SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP--EYGQASVATYKGDVY 931
            N+LL       L      +              + + G      +Y  + +      V+
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSS-----------TIPSCGLQVSIIDYTLSRLERDGIVVF 239

Query: 932 SFGVVLLELLTG 943
               +  +L TG
Sbjct: 240 CDVSMDEDLFTG 251

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 5/108 (4%)

Query: 302 TLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF 361
            L L N ++N  DG +        NL  L L          +NLP+  KLK + L+ N  
Sbjct: 28  ELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRI 83

Query: 362 SGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
            G +    +   +L++L+LS + + ++S+ L+ L++   L +L L   
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDIST-LEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 28/85 (32%), Positives = 41/85 (48%), Gaps = 4/85 (4%)

Query: 87  VTGLFLYKRRLK-GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
           V  L L   +   GK+       V L FL+L +  L  +V  +L  LP L+ L+LS N +
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSENRI 83

Query: 146 SGPLPQTI-NLPSIQVLDISSNSLN 169
            G L      LP++  L++S N L 
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGP--LPQTINLPSIQV 160
            +L  L +L+ L LS N + G + +    LPNL  L+LS N L     L     L  ++ 
Sbjct: 65  SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS 124

Query: 161 LDISSN 166
           LD+ + 
Sbjct: 125 LDLFNC 130

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 53/344 (15%), Positives = 106/344 (30%), Gaps = 57/344 (16%)

Query: 93  YKRRLKGKLSESLGNLVQLRFLNLSHNL--LKGTVPVSLVNLPNLEVLDLSSNDLSGPLP 150
            K++L     +    L     L+        +     + V   +L  L+L+   ++    
Sbjct: 34  IKKKLGKLGRQ---VLPPSELLDHLFFHYEFQNQRFSAEVL-SSLRQLNLAGVRMTPVKC 89

Query: 151 QTI------NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT----LSPG 200
             +         ++  ++++S  L+ +   ++     R R + L +N         L   
Sbjct: 90  TVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL 149

Query: 201 L-GNCASLEHLCLGMNDLTGGIADDIFQL----QKLRLLGLQDNQLSGK----LSPSIAD 251
           L  +   +  L L  N LT      + +       +  L L    L  +    L+  +  
Sbjct: 150 LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR 209

Query: 252 LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN 311
              L  L+V+ N       D  A                  +  +    P+L LL+L  N
Sbjct: 210 NRQLQELNVAYN----GAGDTAALA----------------LARAAREHPSLELLHLYFN 249

Query: 312 SL--DGSLLL--NCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPE 367
            L  +G  +L     A      + +   +       +      L  +   RN  S     
Sbjct: 250 ELSSEGRQVLRDLGGAAEGGARVVVSLTEGT---AVSEYWSVILSEVQ--RNLNSWDRAR 304

Query: 368 TYKNFESLSYLSLSNSSIYNLSSAL--QVLQQCRNLTTLVLTLN 409
             ++   L    L +S    L+     Q+L+    +  L+  L 
Sbjct: 305 VQRH-LELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG 347

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 47/317 (14%), Positives = 98/317 (30%), Gaps = 60/317 (18%)

Query: 111 LRFLNLSHNLL--KGTVPVS---LVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDI 163
           LR LNL+   +       V+         L+ ++L+S  L     +T+       + L +
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 164 SSNSLNGSVPTSICK----NSSRIRVINLSVNYFSGT----LSPGLGNCASLEHLCLGMN 215
             NSL       +      +  +I  + LS N  +      L  GL    S+ HL L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 216 DLT--GG--IADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFSG 267
            L   G   +A  + + ++L+ L +  N         L+ +  +  +L  L +  N  S 
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS- 252

Query: 268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL-DGSLLLNCPALTN 326
              +    L +              +  +      + +      ++ +   ++      N
Sbjct: 253 --SEGRQVLRD--------------LGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRN 296

Query: 327 LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS----GQIPETYKNFESLSYLSLSN 382
           L S D             + R  +L   +L  +  +     +  +  +    +  L    
Sbjct: 297 LNSWDRA----------RVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQL 346

Query: 383 SSIYN-----LSSALQV 394
            S  +          + 
Sbjct: 347 GSSGSPSGSWSHPQFEK 363

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.8 bits (140), Expect = 6e-10
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 9/110 (8%)

Query: 302 TLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT--NLPRCRKLKNINLARN 359
            L L N R+N  +G L         L  L          L +  NLP+  KLK + L+ N
Sbjct: 21  ELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLELSDN 74

Query: 360 NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
             SG +    +   +L++L+LS + I +LS+ ++ L++  NL +L L   
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLST-IEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 19/66 (28%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGP--LPQTINLPSIQV 160
            +L  L +L+ L LS N + G + V     PNL  L+LS N +     +     L +++ 
Sbjct: 58  ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117

Query: 161 LDISSN 166
           LD+ + 
Sbjct: 118 LDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 30/148 (20%)

Query: 94  KRRLKGKL-SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQT 152
            RR+  +L + +  ++ +L   N   N  K  +         LE L   +  L+      
Sbjct: 4   GRRIHLELRNRTPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLT------ 55

Query: 153 INLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCL 212
               SI  L                   ++++ + LS N  SG L      C +L HL L
Sbjct: 56  ----SIANLP----------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95

Query: 213 GMNDLTG-GIADDIFQLQKLRLLGLQDN 239
             N +      + + +L+ L+ L L + 
Sbjct: 96  SGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 5/113 (4%)

Query: 396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDL 455
           +   ++  LVL  +  NE         F  L+ L   + GL  SI   L   +KL+ ++L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLEL 71

Query: 456 SWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-EIPKNLTGLPSLITRNISLEE 507
           S N++SG + V      +L +L+LS N        + L  L +L  +++ L  
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL--KSLDLFN 122

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 40/236 (16%)

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGI 221
            +S+       P       +     NL       T +       S++ +    +D+    
Sbjct: 4   TVSTPIKQ-IFPDDA---FAETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQ 57

Query: 222 ADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQY 281
                 L  +R L L  N+L   +  ++ +L+NL  L ++ N        VF  L   + 
Sbjct: 58  GIQ--YLPNVRYLALGGNKLH-DI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113

Query: 282 LVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDGSLLLNCPA-----LTNLTSLDLGTN 335
           LV   N+    +P  + +  T L  LNL +N L  SL    P      LTNLT LDL  N
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SL----PKGVFDKLTNLTELDLSYN 167

Query: 336 KFNGPLPTNLP-----RCRKLKNINLARNNFSGQ---IPE-TYKNFESLSYLSLSN 382
           +       +LP     +  +LK++ L +N    Q   +P+  +    SL Y+ L +
Sbjct: 168 QL-----QSLPEGVFDKLTQLKDLRLYQN----QLKSVPDGVFDRLTSLQYIWLHD 214

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 45/181 (24%), Positives = 70/181 (38%), Gaps = 22/181 (12%)

Query: 70  CNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL 129
               S            +  +      +K    + +  L  +R+L L  N L   +   L
Sbjct: 26  LKKKSVTDAVTQNELNSIDQIIANNSDIK--SVQGIQYLPNVRYLALGGNKLH-DISA-L 81

Query: 130 VNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN 187
             L NL  L L+ N L   LP  +   L +++ L +  N L  S+P  +    + +  +N
Sbjct: 82  KELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLN 139

Query: 188 LSVNYFSGTLSPG----LGNCASLEHLCLGMNDLT---GGIADDIFQLQKLRLLGLQDNQ 240
           L+ N    +L  G    L N   L  L L  N L     G+ D   +L +L+ L L  NQ
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTN---LTELDLSYNQLQSLPEGVFD---KLTQLKDLRLYQNQ 192

Query: 241 L 241
           L
Sbjct: 193 L 193

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 13/141 (9%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSI-ADLSNLVRLDVSS 262
                L L  N+ T   A  IF+ L +LR +   +N+++  +        S +  + ++S
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSL----DGSL 317
           N        +F GL   + L+  SNR T  + + S     ++ LL+L +N +     G+ 
Sbjct: 91  NRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149

Query: 318 LLNCPALTNLTSLDLGTNKFN 338
                 L +L++L+L  N FN
Sbjct: 150 ----DTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 32/162 (19%), Positives = 55/162 (33%), Gaps = 30/162 (18%)

Query: 156 PSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN 215
                L +++N       T I K   ++R IN S N  +  +  G               
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEG--------------- 75

Query: 216 DLTGGIADDIF-QLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVF 273
                     F     +  + L  N+L   +   +   L +L  L + SN  +    D F
Sbjct: 76  ---------AFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSF 125

Query: 274 AGLGEFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSLD 314
            GL   + L  + N+ T  +   +     +L+ LNL  N  +
Sbjct: 126 IGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 6/112 (5%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDIS 164
            L QLR +N S+N +      +      +  + L+SN L   +   +   L S++ L + 
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLR 113

Query: 165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMN 215
           SN +   V        S +R+++L  N  + T++PG      SL  L L  N
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 19/128 (14%), Positives = 38/128 (29%), Gaps = 31/128 (24%)

Query: 525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLET 584
           L  N+      T               F  L +L   +  +N ++        G + +  
Sbjct: 39  LNNNEFTVLEAT-------------GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE 85

Query: 585 LDLSYNNLSGAIPISL-EKLSFLSKFSVANNHLTGRIPSGG---------------QFQT 628
           + L+ N L   +   + + L  L    + +N +T  + +                 Q  T
Sbjct: 86  ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITT 143

Query: 629 FPNSSFDG 636
               +FD 
Sbjct: 144 VAPGAFDT 151

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 33/157 (21%)

Query: 114 LNLSHNLLKGTVPVSL-VNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNG 170
           L L++N         +   LP L  ++ S+N ++  + +        +  + ++SN L  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE- 94

Query: 171 SVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQ 229
           +V   +                F G          SL+ L L  N +T  + +D F  L 
Sbjct: 95  NVQHKM----------------FKG--------LESLKTLMLRSNRIT-CVGNDSFIGLS 129

Query: 230 KLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNF 265
            +RLL L DNQ++  ++P   D L +L  L++ +N F
Sbjct: 130 SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 28/144 (19%), Positives = 51/144 (35%), Gaps = 20/144 (13%)

Query: 490 KNLTGLPSLI---TRNISLE-----EPSPDFPFFMRRNVSARGLQYNQIWSFPP------ 535
           + L  +P  I   T  + L             F     +       N+I           
Sbjct: 21  QKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGA 80

Query: 536 ----TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL-TGMTSLETLDLSYN 590
                I L+ NRL+      F  L+ L    L+ N ++  + ++   G++S+  L L  N
Sbjct: 81  SGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDN 139

Query: 591 NLSGAIPISLEKLSFLSKFSVANN 614
            ++   P + + L  LS  ++  N
Sbjct: 140 QITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 3/86 (3%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
            V  + L   RL+    +    L  L+ L L  N +      S + L ++ +L L  N +
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141

Query: 146 SGPLPQTI--NLPSIQVLDISSNSLN 169
           +  +       L S+  L++ +N  N
Sbjct: 142 T-TVAPGAFDTLHSLSTLNLLANPFN 166

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 4/114 (3%)

Query: 296 SLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNIN 355
             +N+     L+LR   +     L    L    ++D   N+    L    P  R+LK + 
Sbjct: 14  QYTNAVRDRELDLRGYKIPVIENLGA-TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 356 LARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
           +  N          +    L+ L L+N+S+  L   L  L   ++LT L +  N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGD-LDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 25/119 (21%), Positives = 50/119 (42%), Gaps = 6/119 (5%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVL 161
           +    N V+ R L+L    +   +      L   + +D S N++   L     L  ++ L
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTL 69

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFS--GTLSPGLGNCASLEHLCLGMNDLT 218
            +++N +   +   + +    +  + L+ N     G L P L +  SL +LC+  N +T
Sbjct: 70  LVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 26/145 (17%), Positives = 39/145 (26%), Gaps = 34/145 (23%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVP 173
           + L+  L++        N      LDL    +         L     +D S N       
Sbjct: 2   VKLTAELIEQAA--QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNE------ 53

Query: 174 TSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRL 233
                    IR ++            G      L+ L +  N +          L  L  
Sbjct: 54  ---------IRKLD------------GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 92

Query: 234 LGLQDNQLSGKLSPSIADLSNLVRL 258
           L L +N L       + DL  L  L
Sbjct: 93  LILTNNSLV-----ELGDLDPLASL 112

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 3/111 (2%)

Query: 62  CCHW-VGITCNSSSSLGLNDSI-GSGRVTGLFLYKRRLKGKL-SESLGNLVQLRFLNLSH 118
           C H   G+ C    +L     + G+  +T L++  ++    L    L  L +LR L +  
Sbjct: 6   CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 119 NLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLN 169
           + L+   P +    P L  L+LS N L     +T+   S+Q L +S N L+
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 2/93 (2%)

Query: 247 PSIADLSNLVRLDVSSNNFSGNIPD-VFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNL 305
             +    NL  L + +     ++      GLGE + L    +      P +   +P L+ 
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 306 LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN 338
           LNL  N+L+ SL        +L  L L  N  +
Sbjct: 85  LNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 11/100 (11%)

Query: 541 LNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSE-LTGMTSLETLDLSYNNLSGAIPIS 599
                          + L    +++      +    L G+  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 600 LEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNL 639
                 LS+ +++ N L           +    +  G +L
Sbjct: 76  FHFTPRLSRLNLSFNALE----------SLSWKTVQGLSL 105

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 15/83 (18%), Positives = 31/83 (37%), Gaps = 2/83 (2%)

Query: 536 TIDLSLNRLDGSI-WPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG 594
            + +   +    +   +   L +L    +  + L    P        L  L+LS+N L  
Sbjct: 35  ELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94

Query: 595 AIPISLEKLSFLSKFSVANNHLT 617
               +++ LS L +  ++ N L 
Sbjct: 95  LSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 21/93 (22%), Positives = 30/93 (32%), Gaps = 5/93 (5%)

Query: 199 PGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVR 257
           PG  N   L  L +        +     + L +LR L +  + L      +      L R
Sbjct: 28  PGAEN---LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT 290
           L++S N           GL   Q LV   N   
Sbjct: 85  LNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 35/180 (19%), Positives = 71/180 (39%), Gaps = 26/180 (14%)

Query: 95  RRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI- 153
           R  + + S       ++  L+     ++  +  +L  L   + L LS+N++       I 
Sbjct: 12  RIFEERKSVVATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-----KIS 64

Query: 154 ---NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHL 210
               + ++++L +  N +      ++   +  +  + +S N  + +LS G+    +L  L
Sbjct: 65  SLSGMENLRILSLGRNLI--KKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120

Query: 211 CLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSPS----------IADLSNLVRLD 259
            +  N +T  G  D +  L KL  L L  N L      +          +  L NL +LD
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 29/129 (22%), Positives = 51/129 (39%), Gaps = 11/129 (8%)

Query: 234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDV--FAGLGEFQYLVAHSNRFTG 291
           L      +  K+  +++ L     L +S+N    NI  +   +G+   + L    N    
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIK- 83

Query: 292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP-TNLPRCRK 350
           +I +  + + TL  L +  N +  + L     L NL  L +  NK         L    K
Sbjct: 84  KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141

Query: 351 LKNINLARN 359
           L+++ LA N
Sbjct: 142 LEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 8/105 (7%)

Query: 306 LNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI 365
           L+     ++  +      L     L L TN       ++L     L+ ++L RN    +I
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIK-KI 85

Query: 366 PETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNF 410
                  ++L  L +S + I +LS     +++  NL  L ++ N 
Sbjct: 86  ENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNK 126

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 24/118 (20%), Positives = 45/118 (38%), Gaps = 6/118 (5%)

Query: 292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKL 351
           ++  +LS       L L  N++    + +   + NL  L LG N     +         L
Sbjct: 39  KMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGRNLIKK-IENLDAVADTL 95

Query: 352 KNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLN 409
           + + ++ N  +  +    +   +L  L +SN+ I N    +  L     L  L+L  N
Sbjct: 96  EELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGE-IDKLAALDKLEDLLLAGN 150

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 58.4 bits (141), Expect = 1e-08
 Identities = 69/538 (12%), Positives = 155/538 (28%), Gaps = 87/538 (16%)

Query: 86  RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL 145
            +      K  +    + S   +++ RF  +    LKG    +  NL            +
Sbjct: 39  EIERWCRRKVFIGNCYAVSPATVIR-RFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWI 97

Query: 146 SGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS-VNYFSGT-LSPGLGN 203
                   +   ++ + +    +       I K+    +V+ LS    FS   L+     
Sbjct: 98  EAMSS---SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAAT 154

Query: 204 CASLEHLCLGMNDLTGGIADDIFQLQKL--RLLGLQDNQLSGKLSPS-----IADLSNLV 256
           C +L+ L L  +D+       +         L+ L  + L+ ++S S     +    NL 
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLK 214

Query: 257 RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGS 316
            L ++       +  +     + + L                              +   
Sbjct: 215 SLKLNRAVPLEKLATLLQRAPQLEELGTGG------------------YTAEVRPDVYSG 256

Query: 317 LLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
           L +       L  L    +     LP     C +L  +N                   LS
Sbjct: 257 LSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLN-------------------LS 297

Query: 377 YLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGL 436
           Y ++ +  +      +++L QC  L  L +     +  L         +L+ L +     
Sbjct: 298 YATVQSYDL------VKLLCQCPKLQRLWVLDYIEDAGLEVLAS-TCKDLRELRVFPSEP 350

Query: 437 RGSIPQW----------LRGCSKLQLVDLSWNQLS--GTIPVWFGGFQDLFYLDLSNNTF 484
               P              GC KL+ V     Q++    I +      ++    L     
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIAR-NRPNMTRFRLCIIEP 409

Query: 485 TGEIPKNL----TGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP---TI 537
                  L     G  +++     L          +   ++ +  +Y  I ++      +
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRR------LSLSGLLTDKVFEY--IGTYAKKMEML 461

Query: 538 DLSLNRL-DGSIWPEFGNLKKLHVFDLKHNNLSGP-IPSELTGMTSLETLDLSYNNLS 593
            ++     D  +         L   +++        + +  + + ++ +L +S  ++S
Sbjct: 462 SVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 12/155 (7%)

Query: 164 SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTGGIA 222
               L   +PT++      I  I L  N     + PG       L  + L  N ++  +A
Sbjct: 19  RGKGLT-EIPTNL---PETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LA 72

Query: 223 DDIF-QLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
            D F  L+ L  L L  N+++ +L  S+ + L +L  L +++N  +    D F  L    
Sbjct: 73  PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131

Query: 281 YLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSLD 314
            L  + N+    I   + S    +  ++L  N   
Sbjct: 132 LLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 37/137 (27%), Positives = 55/137 (40%), Gaps = 18/137 (13%)

Query: 234 LGLQDNQLSGKLSPSI-ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT-- 290
           + L+ N +   + P   +    L R+D+S+N  S   PD F GL     LV + N+ T  
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITEL 95

Query: 291 -GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA-----LTNLTSLDLGTNKFNGPLPTN 344
              +   L +   L LL L  N +   L           L NL  L L  NK        
Sbjct: 96  PKSLFEGLFS---LQLLLLNANKI-NCL----RVDAFQDLHNLNLLSLYDNKLQTIAKGT 147

Query: 345 LPRCRKLKNINLARNNF 361
               R ++ ++LA+N F
Sbjct: 148 FSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 32/158 (20%), Positives = 73/158 (46%), Gaps = 16/158 (10%)

Query: 69  TCNSS----SSLGLNDSIGSG---RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLL 121
           TC+++       GL   I +     +T + L +  +K     +     +LR ++LS+N +
Sbjct: 10  TCSNNIVDCRGKGL-TEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI 68

Query: 122 KGTVPV-SLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSICK 178
              +   +   L +L  L L  N ++  LP+++   L S+Q+L +++N +N  +     +
Sbjct: 69  S-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQ 125

Query: 179 NSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMN 215
           +   + +++L  N    T++ G      +++ + L  N
Sbjct: 126 DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 39/155 (25%), Positives = 60/155 (38%), Gaps = 30/155 (19%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGS 171
           + L  N +K   P +      L  +DLS+N +S  L       L S+  L +  N +   
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 172 VPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQK 230
           +P S+                F G L        SL+ L L  N +   +  D FQ L  
Sbjct: 95  LPKSL----------------FEG-LF-------SLQLLLLNANKIN-CLRVDAFQDLHN 129

Query: 231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF 265
           L LL L DN+L      + + L  +  + ++ N F
Sbjct: 130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 32/166 (19%), Positives = 52/166 (31%), Gaps = 46/166 (27%)

Query: 454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKN----LTGLPSLITRNISLEEPS 509
            L  N +    P  F  ++ L  +DLSNN  + E+  +    L  L SL           
Sbjct: 38  RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL----------- 85

Query: 510 PDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLS 569
                          L  N+I   P ++              F  L  L +  L  N ++
Sbjct: 86  --------------VLYGNKITELPKSL--------------FEGLFSLQLLLLNANKIN 117

Query: 570 GPIPSEL-TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
             +  +    + +L  L L  N L      +   L  +    +A N
Sbjct: 118 C-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 29/152 (19%), Positives = 46/152 (30%), Gaps = 45/152 (29%)

Query: 444 LRGCSKLQLVDLSWNQLSGTIPVW-FGGFQDLFYLDLSNN---TFTGEIPKNLTGLPSLI 499
                KL+ +DLS NQ+S  +    F G + L  L L  N        + + L  L  L 
Sbjct: 52  FSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLL- 109

Query: 500 TRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLH 559
                                    L  N+I                     F +L  L+
Sbjct: 110 ------------------------LLNANKINCLRVDA--------------FQDLHNLN 131

Query: 560 VFDLKHNNLSGPIPSELTGMTSLETLDLSYNN 591
           +  L  N L        + + +++T+ L   N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 31/160 (19%)

Query: 342 PTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNL 401
           PTNLP    +  I L +N      P  +  ++ L  + LSN+ I  L+      Q  R+L
Sbjct: 27  PTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPD--AFQGLRSL 82

Query: 402 TTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS 461
            +LVL  N    K+   P+  F  L                       LQL+ L+ N+++
Sbjct: 83  NSLVLYGN----KITELPKSLFEGL---------------------FSLQLLLLNANKIN 117

Query: 462 GTIPVW-FGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLIT 500
             + V  F    +L  L L +N          + L ++ T
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT 156

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 50/164 (30%), Positives = 65/164 (39%), Gaps = 14/164 (8%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSN 263
           A  E L L    L          L KL  L L  NQL   LS  + D L+ L  L +++N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDGSLLLNCP 322
             +     VF  L +   L    N+    +P  + +  T L  L L  N L  S+    P
Sbjct: 94  QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSI----P 147

Query: 323 A-----LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF 361
           A     LTNL +L L TN+          R  KL+ I L  N F
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 22/160 (13%)

Query: 234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI 293
           L LQ   L+     +   L+ L  L++  N        VF  L E   L   +N+    +
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 294 PHSLSNSPT-LNLLNLRNNSLDGSLLLNCPA-----LTNLTSLDLGTNKFNGPLPTNLP- 346
           P  + +  T L+ L L  N L  SL    P+     LT L  L L TN+       ++P 
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLK-SL----PSGVFDRLTKLKELRLNTNQL-----QSIPA 148

Query: 347 ----RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
               +   L+ ++L+ N         +     L  ++L  
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 11/161 (6%)

Query: 159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNC-ASLEHLCLGMNDL 217
           + LD+ S  L  ++  +  +  +++  +NL  N    TLS G+ +    L  L L  N L
Sbjct: 38  EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL 95

Query: 218 TGGIADDIF-QLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPD-VFA 274
              +   +F  L +L  L L  NQL   L   + D L+ L  L +++N    +IP   F 
Sbjct: 96  AS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 275 GLGEFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNSLD 314
            L   Q L   +N+    +PH +      L  + L  N  D
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 48/184 (26%), Positives = 65/184 (35%), Gaps = 52/184 (28%)

Query: 257 RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDG 315
           +LD+ S   +      F GL +  +L    N+    +   + +  T L  L L NN L  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA- 96

Query: 316 SLLLNCPA-----LTNLTSLDLGTNKFNGPLPTNLP-----RCRKLKNINLARNNFSGQI 365
           SL    P      LT L  L LG N+       +LP     R  KLK + L  N     I
Sbjct: 97  SL----PLGVFDHLTQLDKLYLGGNQL-----KSLPSGVFDRLTKLKELRLNTNQLQ-SI 146

Query: 366 PETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN 425
           P     F+ L+                       NL TL L+ N    +L + P   F  
Sbjct: 147 PA--GAFDKLT-----------------------NLQTLSLSTN----QLQSVPHGAFDR 177

Query: 426 LKVL 429
           L  L
Sbjct: 178 LGKL 181

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 40/171 (23%), Positives = 59/171 (34%), Gaps = 39/171 (22%)

Query: 454 DLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFP 513
           DL    L+      F G   L +L+L  N         L  L + +              
Sbjct: 41  DLQSTGLATLSDATFRGLTKLTWLNLDYN--------QLQTLSAGV-------------- 78

Query: 514 FFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIP 573
           F     +   GL  NQ+ S P  +              F +L +L    L  N L     
Sbjct: 79  FDDLTELGTLGLANNQLASLPLGV--------------FDHLTQLDKLYLGGNQLKSLPS 124

Query: 574 SELTGMTSLETLDLSYNNLSGAIPISL-EKLSFLSKFSVANNHLTGRIPSG 623
                +T L+ L L+ N L  +IP    +KL+ L   S++ N L   +P G
Sbjct: 125 GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 54/212 (25%), Positives = 79/212 (37%), Gaps = 42/212 (19%)

Query: 67  GITCNSS------SSLGLNDSIGSG---RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
           G TCN            L DS+ SG       L L    L      +   L +L +LNL 
Sbjct: 9   GCTCNEGKKEVDCQGKSL-DSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLD 67

Query: 118 HNLLKGTVPVSLVN-LPNLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPT 174
           +N L+ T+   + + L  L  L L++N L+  LP  +  +L  +  L +  N L  S+P+
Sbjct: 68  YNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPS 124

Query: 175 SICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF-QLQKLRL 233
            +                F       L     L+ L L  N L   I    F +L  L+ 
Sbjct: 125 GV----------------FD-----RLTK---LKELRLNTNQLQ-SIPAGAFDKLTNLQT 159

Query: 234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF 265
           L L  NQL      +   L  L  + +  N F
Sbjct: 160 LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.1 bits (134), Expect = 3e-08
 Identities = 32/181 (17%), Positives = 59/181 (32%), Gaps = 31/181 (17%)

Query: 195 GTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIA--DL 252
             LSP L     L +L +     T  ++        L+ L +    L   +   I   DL
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 253 SNLVRLDVS--SNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
            NL +L +     ++  +       +  F+ L +                P L  L + +
Sbjct: 219 PNLEKLVLYVGVEDYGFD-----GDMNVFRPLFSKDR------------FPNLKWLGIVD 261

Query: 311 NSLDG---SLLLNCPALTNLTSLDLGTNKFNG----PLPTNLPRCRKLKNINLARNNFSG 363
                    + L    L  L ++D+            L  ++ + + LK IN+  N  S 
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321

Query: 364 Q 364
           +
Sbjct: 322 E 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 29/205 (14%), Positives = 73/205 (35%), Gaps = 23/205 (11%)

Query: 99  GKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI---NL 155
             LS  L  +  L  L +        + +     PNL+ L++ S  L   + + I   +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 156 PSIQVLDISSNSLNGSVPTSI--------CKNSSRIRVINLSVNYFSGTLSPGLGNC--- 204
           P+++ L +     +      +              ++ + +        +          
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 205 ASLEHLCLGMNDLTGG----IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV 260
             LE + +    LT      + D + +++ L+ + ++ N LS ++   +      +++DV
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP-MKIDV 337

Query: 261 SSNNFSGNIPDVFAGLGEFQYLVAH 285
           S +    +    +  + E ++   H
Sbjct: 338 SDSQEYDD-DYSYPMITELEHHHHH 361

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 46/224 (20%), Positives = 76/224 (33%), Gaps = 17/224 (7%)

Query: 294 PHSLSNSPTLNLLNLR-NNSLDGSLLLNCPALTNLTSLDL-GTNKFNGPLPTNLPRCRKL 351
           P       +  ++  R   S     L    +   +  +DL  +      L   L +C KL
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 352 KNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFR 411
           +N++L     S  I  T     +L  L+LS  S ++  +   +L  C  L  L L+    
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS---W 177

Query: 412 NEKLPTDPRLHFA------NLKVLVIASCGLR---GSIPQWLRGCSKLQLVDLSW-NQLS 461
                T+  +  A       +  L ++          +   +R C  L  +DLS    L 
Sbjct: 178 CFDF-TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236

Query: 462 GTIPVWFGGFQDLFYLDLSNNT-FTGEIPKNLTGLPSLITRNIS 504
                 F     L +L LS       E    L  +P+L T  + 
Sbjct: 237 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 280

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 51/301 (16%), Positives = 96/301 (31%), Gaps = 49/301 (16%)

Query: 59  SSDCCHWVGITCNSSS-SLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLS 117
           +SD   W  +     +    +   + S  V      +  +   L+E      +++ ++LS
Sbjct: 43  ASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLS 101

Query: 118 H-NLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISS-NSLNGSVPT 174
           +  +   T+   L     L+ L L    LS P+  T+    ++  L++S  +  +     
Sbjct: 102 NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ 161

Query: 175 SICKNSSRIRVINLSVNYF---SGTLSPGLGNCASLEHLCLGMNDLTGGIADD-----IF 226
           ++  + SR+  +NLS  +                ++  L L  +     +        + 
Sbjct: 162 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL--SGYRKNLQKSDLSTLVR 219

Query: 227 QLQKLRLLGLQD-NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH 285
           +   L  L L D   L          L+ L  L +S      +I      L         
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY---DIIP--ETL--------- 265

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGS----------LLLNCPALTNLTSLDLGTN 335
                      L   PTL  L +     DG+          L +NC   T +    +G  
Sbjct: 266 ---------LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNK 316

Query: 336 K 336
           K
Sbjct: 317 K 317

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 51/252 (20%), Positives = 87/252 (34%), Gaps = 16/252 (6%)

Query: 70  CNSSSSLGLNDSIGSGRVTGLFLYKRRL-KGKLSESLGNLVQLRFLNLSHNLLKGTVPVS 128
             S     L +     RV  + L    +    L   L    +L+ L+L    L   +  +
Sbjct: 78  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 137

Query: 129 LVNLPNLEVLDLSS-NDLSGPLPQTI--NLPSIQVLDISSNSL--NGSVPTSICKNSSRI 183
           L    NL  L+LS  +  S    QT+  +   +  L++S         V  ++   S  I
Sbjct: 138 LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 197

Query: 184 RVINLSVNYFSGTLSPGLG----NCASLEHLCL-GMNDLTGGIADDIFQLQKLRLLGLQD 238
             +NLS  Y        L      C +L HL L     L      + FQL  L+ L L  
Sbjct: 198 TQLNLS-GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256

Query: 239 -NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSL 297
              +  +    + ++  L  L V      G +  +   L    +L  + + FT     ++
Sbjct: 257 CYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL---PHLQINCSHFTTIARPTI 313

Query: 298 SNSPTLNLLNLR 309
            N     +  ++
Sbjct: 314 GNKKNQEIWGIK 325

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 50/284 (17%), Positives = 93/284 (32%), Gaps = 47/284 (16%)

Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN 187
             +    +       + +  PL +  +   +Q +D+S++ +  S    I    S+++ ++
Sbjct: 65  GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124

Query: 188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP 247
           L     S  +   L   ++L  L L                      G  +  L   LS 
Sbjct: 125 LEGLRLSDPIVNTLAKNSNLVRLNLSG------------------CSGFSEFALQTLLSS 166

Query: 248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN 307
                S L  L++S      +  +        Q  VAH          +++    LNL  
Sbjct: 167 ----CSRLDELNLSWCF---DFTEK-----HVQVAVAHV-------SETIT---QLNLSG 204

Query: 308 LRNNSLDGSLLLNCPALTNLTSLDL-GTNKFNGPLPTNLPRCRKLKNINLAR-NNFSGQI 365
            R N     L        NL  LDL  +            +   L++++L+R  +   + 
Sbjct: 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET 264

Query: 366 PETYKNFESLSYLSLSN----SSIYNLSSALQVLQQ-CRNLTTL 404
                   +L  L +       ++  L  AL  LQ  C + TT+
Sbjct: 265 LLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTI 308

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 69/386 (17%), Positives = 105/386 (27%), Gaps = 116/386 (30%)

Query: 732  ISIDDILESTNNFDQANIIGCGGFGLVYRA-TLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
            + I D+      +     +G G F  V+ +  +   + VA+K +       E     E+ 
Sbjct: 29   VKIGDLF--NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD-EIR 85

Query: 791  ALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDY---WLHEKLDGPSSLDWDSRL-- 845
             L   ++ +        M      L+  F  +G        + E L G   L W  +   
Sbjct: 86   LLKSVRNSDPND-PNREMV---VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY 140

Query: 846  ---------HIAQGAARGLAYLHQSCEPHILHRDIKSSNILL------------------ 878
                      I Q   +GL YLH  C   I+H DIK  NILL                  
Sbjct: 141  QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 879  -------------------------------DGNFGAHLADFGLARLILSPYDTHVTTDL 907
                                                  +AD G A         H T D 
Sbjct: 199  RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC----WVHKHFTED- 253

Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG---SRDLI----- 959
            + T  Y   E    S      D++S   +  EL TG    +    +      D I     
Sbjct: 254  IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313

Query: 960  -------SWVIRMR------------------QENRESEVLDPFIYDKQHDKEMLRVLDI 994
                     ++  +                  +     EVL       Q +       D 
Sbjct: 314  LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGF--TDF 371

Query: 995  ACLCLSESPKVRPTTQQLVS--WLDS 1018
                L   P+ R T  + +   WL+S
Sbjct: 372  LLPMLELIPEKRATAAECLRHPWLNS 397

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 37/230 (16%)

Query: 732 ISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVE 790
           +   +     + ++  ++IG G FG V +A    +   VAIK +  +      + + EV 
Sbjct: 46  VKNGEKW--MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVR 102

Query: 791 ALSRAQHP------NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHE--KLDGPSSLDWD 842
            L             +VHL+ + M +N   L+    E   L Y L++  +      +  +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV---FEM--LSYNLYDLLRNTNFRGVSLN 157

Query: 843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNFGAHLADFGLARLILSPYD 900
                AQ     L +L    E  I+H D+K  NILL         + DFG +        
Sbjct: 158 LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLG 212

Query: 901 THVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
             +   +  +  Y  PE      Y  A       D++S G +L+E+ TG+
Sbjct: 213 QRIYQYIQ-SRFYRSPEVLLGMPYDLAI------DMWSLGCILVEMHTGE 255

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 28/116 (24%), Positives = 51/116 (43%), Gaps = 11/116 (9%)

Query: 205 ASLEHLCLGMNDLTGGIADDIF-QLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSS 262
                L L  N+L    +D +F +L  L  L L+ NQL+  + P+  +  S++  L +  
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87

Query: 263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPH----SLSNSPTLNLLNLRNNSLD 314
           N        +F GL + + L  + N+ +  +       L++   L  LNL +N  +
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNS---LTSLNLASNPFN 139

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 51/236 (21%)

Query: 732 ISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVE 790
               D +     ++   +IG G FG V +A      ++VA+K +  +  +  R+   E+ 
Sbjct: 89  QVPHDHV--AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIR 145

Query: 791 ALS--RAQHP----NLVHLQGYCMHKN------DRLLI--YSFMENGSLDYWLHEKLDGP 836
            L   R Q      N++H+      +N      + L +  Y  ++               
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ---------G 196

Query: 837 SSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNFGAHLADFGLARL 894
            SL    R   A    + L  LH++    I+H D+K  NILL   G  G  + DFG +  
Sbjct: 197 FSLP-LVR-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS-- 249

Query: 895 ILSPYDTHVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFGVVLLELLTGK 944
                   V T +  +  Y  PE      YG         D++S G +L ELLTG 
Sbjct: 250 --CYEHQRVYTYIQ-SRFYRAPEVILGARYGMPI------DMWSLGCILAELLTGY 296

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 32/134 (23%), Positives = 50/134 (37%), Gaps = 17/134 (12%)

Query: 257 RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT---GRIPHSLSNSPTLNLLNLRNNSL 313
            L +  N  +   P VF  L   + L   SN+       +  SL+    L +L+L  N L
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLGTNQL 100

Query: 314 DGSLLLNCPA-----LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPET 368
              L    P+     L +L  L +  NK    LP  + R   L ++ L +N         
Sbjct: 101 T-VL----PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 369 YKNFESLSYLSLSN 382
           +    SL++  L  
Sbjct: 155 FDRLSSLTHAYLFG 168

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 23/159 (14%)

Query: 162 DISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGL-GNCASLEHLCLGMNDLT-- 218
           D  S     SVP  I  N+  +    L  N  +  L PG+  +  +L+ L LG N L   
Sbjct: 25  DCRSKRHA-SVPAGIPTNAQILY---LHDNQIT-KLEPGVFDSLINLKELYLGSNQLGAL 79

Query: 219 -GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSNNFSGNIPDVFAGL 276
             G+ D    L +L +L L  NQL+  L  ++ D L +L  L +  N  +  +P     L
Sbjct: 80  PVGVFD---SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERL 134

Query: 277 GEFQYLVAHSNRFTGRIPH----SLSNSPTLNLLNLRNN 311
               +L    N+    IPH     LS+   L    L  N
Sbjct: 135 THLTHLALDQNQLK-SIPHGAFDRLSS---LTHAYLFGN 169

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 36/137 (26%), Positives = 56/137 (40%), Gaps = 12/137 (8%)

Query: 205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIAD-LSNLVRLDVSSN 263
           A   +L L  N L         +L  L  L L  N+L   L   + + L++L  L++S+N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 264 NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSL----DGSLL 318
                   VF  L + + L  ++N+    +P  + +  T L  L L  N L    DG   
Sbjct: 87  QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVF- 144

Query: 319 LNCPALTNLTSLDLGTN 335
                LT+L  + L  N
Sbjct: 145 ---DRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 38/138 (27%), Positives = 56/138 (40%), Gaps = 24/138 (17%)

Query: 257 RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDG 315
            LD+ +N+       VF  L     L    N+    +P+ + N  T L  LNL  N L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 316 SLLLNCPA-----LTNLTSLDLGTNKFNGPLPTNLP-----RCRKLKNINLARNNFSGQI 365
           SL    P      LT L  L L TN+       +LP     +  +LK++ L   N    +
Sbjct: 90  SL----PNGVFDKLTQLKELALNTNQL-----QSLPDGVFDKLTQLKDLRL-YQNQLKSV 139

Query: 366 PE-TYKNFESLSYLSLSN 382
           P+  +    SL Y+ L +
Sbjct: 140 PDGVFDRLTSLQYIWLHD 157

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 64/345 (18%), Positives = 102/345 (29%), Gaps = 90/345 (26%)

Query: 732  ISIDDILESTNNFDQANIIGCGGFGLVYRA--TLPDGRNVAIKRLSGDCGQMEREFRAEV 789
              I D L     ++    +G G FG V            VA+K +    G+     R E+
Sbjct: 11   CRIGDWL--QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEI 67

Query: 790  EALS--RAQHP----NLVHLQGYCMHKN------DRLLI--YSFMENGSLDYWLHEKLDG 835
              L   + +        V +  +           + L    + F++  +           
Sbjct: 68   NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ--------- 118

Query: 836  PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI 895
            P  L    R H+A      L +LH++    + H D+K  NIL   +    L +   +   
Sbjct: 119  PYPLP-HVR-HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173

Query: 896  LSPYDT---------------HVTTDLVGTLGYIPPE------YGQASVATYKGDVYSFG 934
             S  +T               H TT +  T  Y PPE      + Q        DV+S G
Sbjct: 174  KSVKNTSIRVADFGSATFDHEHHTTIVA-TRHYRPPEVILELGWAQPC------DVWSIG 226

Query: 935  VVLLELLTGKR---------------------PMDMCKPKGSR------DLISWVIRMRQ 967
             +L E   G                       P  M   +  +        + W      
Sbjct: 227  CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH-RTRKQKYFYKGGLVWDENSSD 285

Query: 968  ENRESEVLDPF-IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
                 E   P   Y  Q   E +++ D+    L   P  R T  +
Sbjct: 286  GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 30/112 (26%), Positives = 38/112 (33%), Gaps = 27/112 (24%)

Query: 525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLET 584
           L  NQ    P                E  N K L + DL +N +S       + MT L T
Sbjct: 38  LDGNQFTLVPK---------------ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLT 82

Query: 585 LDLSYNNLSGAIPISL-EKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFD 635
           L LSYN L   IP    + L  L   S+  N               P  +F+
Sbjct: 83  LILSYNRLR-CIPPRTFDGLKSLRLLSLHGN----------DISVVPEGAFN 123

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 36/216 (16%), Positives = 63/216 (29%), Gaps = 62/216 (28%)

Query: 846  HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV-- 903
             +A    + + +LH +    + H D+K  NIL   +      +  + R   +  +  +  
Sbjct: 122  KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 904  --------TTDLVGTLGYI------PPE------YGQASVATYKGDVYSFGVVLLELLTG 943
                      +   T   +       PE      + Q        DV+S G +L+E   G
Sbjct: 179  VDFGSATYDDEHHST--LVSTRHYRAPEVILALGWSQPC------DVWSIGCILIEYYLG 230

Query: 944  ---------------------KRPMDMCKPKGSR------DLISWVIRMRQENRESEVLD 976
                                   P  M + K  +      D + W          S    
Sbjct: 231  FTVFPTHDSKEHLAMMERILGPLPKHMIQ-KTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289

Query: 977  PFI-YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
            P   +    D E  R+ D+    L   P  R T ++
Sbjct: 290  PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1020
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.9
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.78
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.76
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.72
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.72
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.68
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.67
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.51
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.5
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.49
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.41
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.4
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.39
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.26
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.26
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.26
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.2
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.16
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.95
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.9
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.86
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.78
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.77
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.25
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.24
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.13
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.67
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.39
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.3
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.27
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.17
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.14
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.05
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.91
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.88
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.79
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.65
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.51
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.5
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.44
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.31
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.3
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.19
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.82
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.54

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=6.9e-80  Score=768.66  Aligned_cols=599  Identities=32%  Similarity=0.522  Sum_probs=447.2

Q ss_pred             CCCHHHHHHHHHHHHHhccC--CCCCCCCCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCccccc---cc--
Q 035998           30 TCNPNDLAALEDFMKNFESG--IDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGK---LS--  102 (1020)
Q Consensus        30 ~~~~~~~~aL~~~k~~~~~~--~~~~~~~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~---~~--  102 (1020)
                      .+.++|++||++||+++.++  .++|.   .++|||+|.||+|+.            ++|++|+|+++.+.|.   +|  
T Consensus         8 ~~~~~~~~all~~k~~~~~~~~l~~W~---~~~~~C~w~gv~C~~------------~~v~~L~L~~~~l~g~~~~l~~~   72 (768)
T 3rgz_A            8 QSLYREIHQLISFKDVLPDKNLLPDWS---SNKNPCTFDGVTCRD------------DKVTSIDLSSKPLNVGFSAVSSS   72 (768)
T ss_dssp             CCHHHHHHHHHHHHTTCSCTTSSTTCC---TTSCGGGSTTEEEET------------TEEEEEECTTSCCCEEHHHHHHH
T ss_pred             cCCHHHHHHHHHHHhhCCCcccccCCC---CCCCCcCCcceEECC------------CcEEEEECCCCCcCCccCccChh
Confidence            35689999999999999865  34443   578999999999972            6888888888888876   43  


Q ss_pred             ---------------------ccccCCCCCcEEecCCCCCCCCCCc--cccCCCCCCeeeccCCCCCCCCCCcc--CCCC
Q 035998          103 ---------------------ESLGNLVQLRFLNLSHNLLKGTVPV--SLVNLPNLEVLDLSSNDLSGPLPQTI--NLPS  157 (1020)
Q Consensus       103 ---------------------~~l~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~p~~~--~l~~  157 (1020)
                                           +.++++++|++|+|++|.++|.+|.  .++++++|++|+|++|.+++.+|..+  ++++
T Consensus        73 l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~  152 (768)
T 3rgz_A           73 LLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNS  152 (768)
T ss_dssp             TTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTT
T ss_pred             HhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCC
Confidence                                 4677788888888888888888887  78888888888888888877776654  5667


Q ss_pred             cceeeeccCccCCCCCccc--c----------------------ccCCcccEEEccCCCCCCCCCCcccccccccccccc
Q 035998          158 IQVLDISSNSLNGSVPTSI--C----------------------KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       158 L~~L~Ls~N~l~~~ip~~~--~----------------------~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      |++|+|++|++++..|..+  +                      ..+++|++|+|++|++++.+|. ++++++|++|+|+
T Consensus       153 L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls  231 (768)
T 3rgz_A          153 LEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS  231 (768)
T ss_dssp             CSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECC
T ss_pred             CCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECc
Confidence            7777777766665444321  1                      3566777777777777776666 7888888888888


Q ss_pred             ccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCC-cccceeeccccccccc
Q 035998          214 MNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGL-GEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       214 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~  292 (1020)
                      +|++++.+|..+..+++|++|+|++|++++.+|..  .+++|++|++++|++++.+|..+..+ ++|++|++++|++++.
T Consensus       232 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            88888888888888888888888777777655543  55566666666666665666555543 6666666666666666


Q ss_pred             CCCCCcCCcccccccccccccccccccC-CCCCCCcCEEEcCCCccCCCCCCCCCC------------------------
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSLLLN-CPALTNLTSLDLGTNKFNGPLPTNLPR------------------------  347 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~------------------------  347 (1020)
                      +|..|+++++|++|++++|.+++.+|.. +..+++|++|+|++|++++.+|..+..                        
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~  389 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC  389 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTT
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhh
Confidence            6666666666666666666666555433 555555555555555555555544433                        


Q ss_pred             ---CCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc-hhhHHHHHhhhcccchhhhhccccCCCCCCCccccc
Q 035998          348 ---CRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN-LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF  423 (1020)
Q Consensus       348 ---l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~-l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~  423 (1020)
                         +++|++|++++|++++.+|..+.++++|++|++++|+++. +|.   .+..+++|+.|+++.|.+...++. .+..+
T Consensus       390 ~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~l~~l~~L~~L~L~~n~l~~~~p~-~~~~l  465 (768)
T 3rgz_A          390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS---SLGSLSKLRDLKLWLNMLEGEIPQ-ELMYV  465 (768)
T ss_dssp             CSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG---GGGGCTTCCEEECCSSCCCSCCCG-GGGGC
T ss_pred             hcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH---HHhcCCCCCEEECCCCcccCcCCH-HHcCC
Confidence               4556666666666666677777777777777777777663 332   356677777777777766554443 34467


Q ss_pred             cCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccC
Q 035998          424 ANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNI  503 (1020)
Q Consensus       424 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~  503 (1020)
                      ++|+.|++++|.+.+.+|..+.++++|++|+|++|++++.+|.+|+.+++|++|+|++|+++|.+|..++++++|+.+++
T Consensus       466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  545 (768)
T 3rgz_A          466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL  545 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred             CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence            78888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             cCCCCCCCcccceeec--c----------------------------------------------cccccccccc-----
Q 035998          504 SLEEPSPDFPFFMRRN--V----------------------------------------------SARGLQYNQI-----  530 (1020)
Q Consensus       504 s~~~~~~~~~~~~~~~--~----------------------------------------------~~~~l~~n~~-----  530 (1020)
                      +.+.....+|......  .                                              ....+..|.+     
T Consensus       546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~  625 (768)
T 3rgz_A          546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS  625 (768)
T ss_dssp             CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred             CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence            7776554444211100  0                                              0001111111     


Q ss_pred             -----cCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccc
Q 035998          531 -----WSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSF  605 (1020)
Q Consensus       531 -----~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~  605 (1020)
                           ..-.+.|||++|+++|.+|.+|+.+++|+.|+|++|+++|.+|.+|+++++|+.|||++|+++|.+|.++.++++
T Consensus       626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~  705 (768)
T 3rgz_A          626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM  705 (768)
T ss_dssp             CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCC
T ss_pred             hhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence                 122357999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccccccCCCCCCCCCcCCccccCCC-CCCCCCCCCccC
Q 035998          606 LSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCTID  650 (1020)
Q Consensus       606 L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~-l~~~~~~~c~~~  650 (1020)
                      |++|+|++|+|+|.||.+++|++|+..+|.||+ |||.+..+|...
T Consensus       706 L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             CSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred             CCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence            999999999999999999999999999999998 999987788533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.1e-62  Score=609.60  Aligned_cols=527  Identities=30%  Similarity=0.409  Sum_probs=407.8

Q ss_pred             CCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCC--cc-CCCCcceeeeccCccCCCCCccccccCCccc
Q 035998          108 LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQ--TI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIR  184 (1020)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~--~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~  184 (1020)
                      |++|+.++++.|.+. .+|..|+++++|++|||++|.++|.+|.  .+ ++++|++|+|++|.+++.+|..++..+++|+
T Consensus        76 L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~  154 (768)
T 3rgz_A           76 LTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE  154 (768)
T ss_dssp             CTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCS
T ss_pred             cCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCC
Confidence            455666666655554 3558899999999999999999998887  66 8999999999999999999998878899999


Q ss_pred             EEEccCCCCCCCCCCc---cccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEcc
Q 035998          185 VINLSVNYFSGTLSPG---LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVS  261 (1020)
Q Consensus       185 ~L~L~~N~l~~~~~~~---l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  261 (1020)
                      +|+|++|++++..|..   ++++++|++|+|++|.+++.++.  ..+++|++|+|++|++++.+|. ++++++|++|+|+
T Consensus       155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls  231 (768)
T 3rgz_A          155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS  231 (768)
T ss_dssp             EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECC
T ss_pred             EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECc
Confidence            9999999999888877   78899999999999999876664  7889999999999999987777 8999999999999


Q ss_pred             CCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCC-CCcCEEEcCCCccCCC
Q 035998          262 SNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPAL-TNLTSLDLGTNKFNGP  340 (1020)
Q Consensus       262 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~  340 (1020)
                      +|++++.+|..|..+++|++|++++|++++.+|..  .+++|++|++++|.+++.+|..+... ++|++|+|++|++++.
T Consensus       232 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            99999889999999999999999999998887775  78889999999999988888877665 8999999999999888


Q ss_pred             CCCCCCCCCCCCeEecCCCcccccCccc-ccCCCCCCeeeCCCCCCc-chhhHHHHHhhhc-ccchhhhhccccCCCCCC
Q 035998          341 LPTNLPRCRKLKNINLARNNFSGQIPET-YKNFESLSYLSLSNSSIY-NLSSALQVLQQCR-NLTTLVLTLNFRNEKLPT  417 (1020)
Q Consensus       341 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~l~~N~i~-~l~~~~~~l~~l~-~L~~L~l~~n~~~~~~~~  417 (1020)
                      +|..|..+++|++|+|++|++++.+|.. +..+++|++|++++|+++ .+|..+   ..++ +|+.|+++.|.+...++.
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l---~~l~~~L~~L~Ls~N~l~~~~~~  386 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL---TNLSASLLTLDLSSNNFSGPILP  386 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTH---HHHTTTCSEEECCSSEEEEECCT
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHH---HhhhcCCcEEEccCCCcCCCcCh
Confidence            8888999999999999999998888865 888899999999999887 566543   3343 555555555544322221


Q ss_pred             C-------------------------ccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcC
Q 035998          418 D-------------------------PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQ  472 (1020)
Q Consensus       418 ~-------------------------~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  472 (1020)
                      .                         .+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..|+.++
T Consensus       387 ~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~  466 (768)
T 3rgz_A          387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK  466 (768)
T ss_dssp             TTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred             hhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCC
Confidence            1                         123445566666666666666666666666666666666666666666666666


Q ss_pred             cCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcc--cceeeccccccccccccc-CCC---------Ceeecc
Q 035998          473 DLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFP--FFMRRNVSARGLQYNQIW-SFP---------PTIDLS  540 (1020)
Q Consensus       473 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~--~~~~~~~~~~~l~~n~~~-~~~---------~~l~Ls  540 (1020)
                      +|++|+|++|++++.+|..++++++|+.++++.+......|  +.....++.+++++|++. .+|         +.||++
T Consensus       467 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  546 (768)
T 3rgz_A          467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN  546 (768)
T ss_dssp             TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECC
T ss_pred             CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECC
Confidence            66666666666666666666666666666666665554444  223345566666666554 222         345666


Q ss_pred             cCccccCCCc----------------------------------------------------------------------
Q 035998          541 LNRLDGSIWP----------------------------------------------------------------------  550 (1020)
Q Consensus       541 ~N~l~~~~~~----------------------------------------------------------------------  550 (1020)
                      +|+++|.+|.                                                                      
T Consensus       547 ~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~  626 (768)
T 3rgz_A          547 TNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP  626 (768)
T ss_dssp             SSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCC
T ss_pred             CCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCch
Confidence            6666655554                                                                      


Q ss_pred             cccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC-CCCCCc
Q 035998          551 EFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-GQFQTF  629 (1020)
Q Consensus       551 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~  629 (1020)
                      .|+.+++|+.|||++|+++|.+|.+|+++++|+.|||++|+++|.+|.+++++++|+.|+|++|+++|.||.. +.+..+
T Consensus       627 ~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L  706 (768)
T 3rgz_A          627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML  706 (768)
T ss_dssp             SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCC
T ss_pred             hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCC
Confidence            3445677888999999999899999999999999999999999999999999999999999999999998864 556677


Q ss_pred             CCccccCCCCCCCC
Q 035998          630 PNSSFDGNNLCGEH  643 (1020)
Q Consensus       630 ~~~~~~~n~l~~~~  643 (1020)
                      ..+.+.+|++.|..
T Consensus       707 ~~L~ls~N~l~g~i  720 (768)
T 3rgz_A          707 TEIDLSNNNLSGPI  720 (768)
T ss_dssp             SEEECCSSEEEEEC
T ss_pred             CEEECcCCcccccC
Confidence            78888899888863

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.4e-57  Score=562.79  Aligned_cols=573  Identities=19%  Similarity=0.237  Sum_probs=413.3

Q ss_pred             CCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeecc
Q 035998           62 CCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLS  141 (1020)
Q Consensus        62 ~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  141 (1020)
                      .|.+..|.|+....+.+|.+.+ .+++.|+|++|.+++..+.+|+++++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus         3 ~~~~~~~~cs~~~L~~ip~~~~-~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~   81 (680)
T 1ziw_A            3 TVSHEVADCSHLKLTQVPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ   81 (680)
T ss_dssp             -CBSSEEECCSSCCSSCCSCSC-TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred             eeECCeeECCCCCccccccccC-CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence            4778889999999999998876 699999999999999888899999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccc
Q 035998          142 SNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG  220 (1020)
Q Consensus       142 ~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  220 (1020)
                      +|.+++.++..+ ++++|++|+|++|+++ .+|...+..+++|++|+|++|.+++..|..++++++|++|+|++|.+++.
T Consensus        82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  160 (680)
T 1ziw_A           82 HNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL  160 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred             CCccCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence            999998888777 8999999999999998 56666667899999999999999999999999999999999999999988


Q ss_pred             cchhhh--hhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCccccc---CCcccceeecccccccccCCC
Q 035998          221 IADDIF--QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFA---GLGEFQYLVAHSNRFTGRIPH  295 (1020)
Q Consensus       221 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~  295 (1020)
                      .+..+.  .+++|++|++++|++++..|..+..+.+|+.|++++|.+.+.....+.   ..++|+.|++++|++++..|.
T Consensus       161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~  240 (680)
T 1ziw_A          161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT  240 (680)
T ss_dssp             CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred             CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence            887765  458999999999999999998888877776666666655432221111   224566666666666666666


Q ss_pred             CCcCCcc--cccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc-----cCcc-
Q 035998          296 SLSNSPT--LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG-----QIPE-  367 (1020)
Q Consensus       296 ~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----~~p~-  367 (1020)
                      .|.+++.  |+.|++++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|++++|...+     .+|. 
T Consensus       241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i  320 (680)
T 1ziw_A          241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI  320 (680)
T ss_dssp             TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred             HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence            6655543  6666666666665555556666666666666666665556666666666666666554332     1222 


Q ss_pred             ---cccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccC-CCCCCCcccc--ccCceEEEecccccccccc
Q 035998          368 ---TYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRN-EKLPTDPRLH--FANLKVLVIASCGLRGSIP  441 (1020)
Q Consensus       368 ---~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~~--~~~L~~L~l~~n~l~~~~p  441 (1020)
                         .|..+++|++|++++|.++.++..  .+..+++|+.|+++.|... ..++...+..  .++|+.|++++|.+.+..|
T Consensus       321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~  398 (680)
T 1ziw_A          321 DDFSFQWLKCLEHLNMEDNDIPGIKSN--MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES  398 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCCCCTT--TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT
T ss_pred             ChhhcccCCCCCEEECCCCccCCCChh--HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh
Confidence               455566666666666666554432  3455566666666555421 1122222211  2356666666666666666


Q ss_pred             hhhhcCCCCcEEeccccccccccc-ccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCC--CC--cccce
Q 035998          442 QWLRGCSKLQLVDLSWNQLSGTIP-VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPS--PD--FPFFM  516 (1020)
Q Consensus       442 ~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~--~~--~~~~~  516 (1020)
                      ..+..+++|+.|+|++|++++.+| ..|.++++|++|+|++|++++..+..+..+++|+.++++.+...  ..  ..+..
T Consensus       399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~  478 (680)
T 1ziw_A          399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP  478 (680)
T ss_dssp             TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTT
T ss_pred             hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccccc
Confidence            666666666666666666655444 45666666666666666666555666666666666665544332  11  12333


Q ss_pred             eecccccccccccccCCC----------CeeecccCccccCC--------CccccCCCcceEEEecCCcceeccC-cccc
Q 035998          517 RRNVSARGLQYNQIWSFP----------PTIDLSLNRLDGSI--------WPEFGNLKKLHVFDLKHNNLSGPIP-SELT  577 (1020)
Q Consensus       517 ~~~~~~~~l~~n~~~~~~----------~~l~Ls~N~l~~~~--------~~~~~~L~~L~~L~Ls~N~l~~~~p-~~~~  577 (1020)
                      ...++.+++++|++..++          +.|+|++|++++..        +..|+++++|+.|+|++|+++ .+| ..|.
T Consensus       479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~  557 (680)
T 1ziw_A          479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFK  557 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTT
T ss_pred             CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcc
Confidence            445555666666555443          46899999998642        234899999999999999998 455 4699


Q ss_pred             CCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC-C-CCCCcCCccccCCCC
Q 035998          578 GMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-G-QFQTFPNSSFDGNNL  639 (1020)
Q Consensus       578 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~-~-~~~~~~~~~~~~n~l  639 (1020)
                      ++++|++|||++|+|++..|..+.++++|+.|++++|++++.+|.. + .+.++....+.+|++
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~  621 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF  621 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCC
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCc
Confidence            9999999999999999766677899999999999999999977753 2 466778888999974

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.6e-57  Score=551.45  Aligned_cols=535  Identities=19%  Similarity=0.198  Sum_probs=347.4

Q ss_pred             CCCCCCc--CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCC
Q 035998           58 SSSDCCH--WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNL  135 (1020)
Q Consensus        58 ~~~~~C~--w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  135 (1020)
                      +..+.|.  +..|.|+..+.+.+|.+.+ ..++.|+|++|.+++..|.+|+++++|++|+|++|++++..|.+|+++++|
T Consensus         5 ~~~C~~~~~~~~~~c~~~~l~~iP~~l~-~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L   83 (606)
T 3t6q_A            5 DQKCIEKEVNKTYNCENLGLNEIPGTLP-NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL   83 (606)
T ss_dssp             -CCCEEEETTTEEECTTSCCSSCCTTSC-TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTC
T ss_pred             cCceecccCCceEECCCCCcccCcCCCC-CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcccc
Confidence            3344454  6779999999999998876 489999999999999989999999999999999999998889999999999


Q ss_pred             CeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGM  214 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  214 (1020)
                      ++|+|++|++++..|..+ ++++|++|+|++|++++ ++...+..+++|++|+|++|++++...+.+..+++|++|+|++
T Consensus        84 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  162 (606)
T 3t6q_A           84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN  162 (606)
T ss_dssp             CEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC-GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCS
T ss_pred             CeeeCCCCcccccChhhhcccccccEeeccccCccc-CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEccc
Confidence            999999999999989888 89999999999999994 4444457899999999999999986655666699999999999


Q ss_pred             cccccccchhhhhhcccc--cccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccc--
Q 035998          215 NDLTGGIADDIFQLQKLR--LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT--  290 (1020)
Q Consensus       215 N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--  290 (1020)
                      |.+++..+..+..+++|+  .|++++|++++..|..+.. .+|++|++++|..   .+..+.++.++....+.-+.+.  
T Consensus       163 n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~  238 (606)
T 3t6q_A          163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDM  238 (606)
T ss_dssp             SCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTS
T ss_pred             CcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccc
Confidence            999998899999999999  8999999999877777654 6899999998862   2223333322222111111111  


Q ss_pred             ---ccCCCCCcCCc--ccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccC
Q 035998          291 ---GRIPHSLSNSP--TLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI  365 (1020)
Q Consensus       291 ---~~~p~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  365 (1020)
                         ...+..+..+.  +|+.|++++|.+++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..
T Consensus       239 ~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~  317 (606)
T 3t6q_A          239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC  317 (606)
T ss_dssp             CCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG
T ss_pred             cccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc
Confidence               11111122211  3444444444444444444444444444444444444 34444444444444444444444444


Q ss_pred             cccccCCCCCCeeeCCCCCCc-chhhHHHHHhhhcccchhhhhccccCCCCC-CCccccccCceEEEecccccccccchh
Q 035998          366 PETYKNFESLSYLSLSNSSIY-NLSSALQVLQQCRNLTTLVLTLNFRNEKLP-TDPRLHFANLKVLVIASCGLRGSIPQW  443 (1020)
Q Consensus       366 p~~~~~l~~L~~L~l~~N~i~-~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~-~~~~~~~~~L~~L~l~~n~l~~~~p~~  443 (1020)
                      |..+..+++|++|++++|.+. .++..  .+..+++|+.|+++.|.+..... ...+..+++|+.|++++|.+.+..|..
T Consensus       318 ~~~~~~l~~L~~L~l~~n~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  395 (606)
T 3t6q_A          318 QISASNFPSLTHLSIKGNTKRLELGTG--CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA  395 (606)
T ss_dssp             GGCGGGCTTCSEEECCSCSSCCBCCSS--TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT
T ss_pred             hhhhhccCcCCEEECCCCCcccccchh--hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH
Confidence            444444444444444444443 22221  23344444444444443322210 122345667777777777777777777


Q ss_pred             hhcCCCCcEEecccccccccccc-cccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSA  522 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~  522 (1020)
                      +..+++|+.|++++|++++..|. .|..+++|++|+|++|.+++.+|..++++++|+.                      
T Consensus       396 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~----------------------  453 (606)
T 3t6q_A          396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH----------------------  453 (606)
T ss_dssp             TTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCE----------------------
T ss_pred             hcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCE----------------------
Confidence            88888888888888888766554 4777888888888888888777777777777743                      


Q ss_pred             cccccccccCCCCeeecccCccccC---CCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcc
Q 035998          523 RGLQYNQIWSFPPTIDLSLNRLDGS---IWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS  599 (1020)
Q Consensus       523 ~~l~~n~~~~~~~~l~Ls~N~l~~~---~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~  599 (1020)
                                    |++++|++++.   .+..|+.+++|+.|+|++|++++..|..|+++++|++|||++|++++.+|..
T Consensus       454 --------------L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  519 (606)
T 3t6q_A          454 --------------LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA  519 (606)
T ss_dssp             --------------EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGG
T ss_pred             --------------EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhH
Confidence                          44444444431   1233455555555555555555444555555555555555555555555555


Q ss_pred             ccccccccccccccccccccCCCC-CCCCCcCCccccCCC
Q 035998          600 LEKLSFLSKFSVANNHLTGRIPSG-GQFQTFPNSSFDGNN  638 (1020)
Q Consensus       600 l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  638 (1020)
                      +.+++.| .|++++|++++.+|.. +.+.++....+.+|+
T Consensus       520 l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  558 (606)
T 3t6q_A          520 LSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNP  558 (606)
T ss_dssp             GTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCC
T ss_pred             hCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCC
Confidence            5555555 5555555555444431 223334444445554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-58  Score=561.59  Aligned_cols=474  Identities=20%  Similarity=0.255  Sum_probs=280.3

Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCC--------CCCCCCCCCcC---ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccc
Q 035998           31 CNPNDLAALEDFMKNFESGIDGWG--------TNASSSDCCHW---VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKG   99 (1020)
Q Consensus        31 ~~~~~~~aL~~~k~~~~~~~~~~~--------~~~~~~~~C~w---~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~   99 (1020)
                      ....|++||.+||+++.++.+.+.        .|..++|||.|   .||+|+..           ++|++|+|+++++.|
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-----------~~V~~L~L~~~~l~g   95 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-----------GRVTGLSLEGFGASG   95 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-----------CCEEEEECTTSCCEE
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-----------CCEEEEEecCcccCC
Confidence            446799999999999976532211        22346899999   99999752           799999999999999


Q ss_pred             cccccccCCCCCcEEecCCCCC------CC------CCCccccCCCCCCeeeccCCCCCCCCCCccC--CCCcceeeec-
Q 035998          100 KLSESLGNLVQLRFLNLSHNLL------KG------TVPVSLVNLPNLEVLDLSSNDLSGPLPQTIN--LPSIQVLDIS-  164 (1020)
Q Consensus       100 ~~~~~l~~l~~L~~L~L~~n~l------~~------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~--l~~L~~L~Ls-  164 (1020)
                      .+|+++++|++|++|+|++|.+      .|      .+|...  +.+|+ +++++|.+.+.+|..+.  +..+..+++. 
T Consensus        96 ~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~  172 (636)
T 4eco_A           96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQ  172 (636)
T ss_dssp             EECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTS
T ss_pred             cCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccc
Confidence            9999999999999999999977      33      344443  45566 77777777776665542  2223333332 


Q ss_pred             -------------------cCccCCCCCccccccCCcccEEEccCCCCCCC-----------------CCCccc--cccc
Q 035998          165 -------------------SNSLNGSVPTSICKNSSRIRVINLSVNYFSGT-----------------LSPGLG--NCAS  206 (1020)
Q Consensus       165 -------------------~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~-----------------~~~~l~--~l~~  206 (1020)
                                         .|+++| +|..+ ..+++|++|+|++|.+++.                 +|..++  ++++
T Consensus       173 ~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l-~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~  250 (636)
T 4eco_A          173 KSIKKSSRITLKDTQIGQLSNNITF-VSKAV-MRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD  250 (636)
T ss_dssp             CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred             cccccccccchhhhhhccccCCCcc-CCHHH-hcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCC
Confidence                               455554 55543 3455566666666665553                 555555  5566


Q ss_pred             cccccccccccccccchhhhhhcccccccccccc-cCC-CCCcccccC------CCccEEEccCCcCcccCcc--cccCC
Q 035998          207 LEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQ-LSG-KLSPSIADL------SNLVRLDVSSNNFSGNIPD--VFAGL  276 (1020)
Q Consensus       207 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l  276 (1020)
                      |++|+|++|++.+.+|..++++++|++|+|++|+ ++| .+|..++.+      ++|++|++++|+++ .+|.  .|+++
T Consensus       251 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l  329 (636)
T 4eco_A          251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM  329 (636)
T ss_dssp             CCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC
T ss_pred             CCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccC
Confidence            6666666666555555555556666666666665 555 455555554      55666666666655 4555  55555


Q ss_pred             cccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCC-cCEEEcCCCccCCCCCCCCCCCC--CCCe
Q 035998          277 GEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTN-LTSLDLGTNKFNGPLPTNLPRCR--KLKN  353 (1020)
Q Consensus       277 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~  353 (1020)
                      ++|++|++++|+++|.+| .++.+++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++
T Consensus       330 ~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~  406 (636)
T 4eco_A          330 KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSA  406 (636)
T ss_dssp             TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEE
T ss_pred             CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCE
Confidence            566666666666655555 5555556666666666555 44444555555 666666666655 4555554433  5566


Q ss_pred             EecCCCcccccCccccc-------CCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCc
Q 035998          354 INLARNNFSGQIPETYK-------NFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANL  426 (1020)
Q Consensus       354 L~L~~N~l~~~~p~~~~-------~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L  426 (1020)
                      |++++|++++.+|..|.       .+++|++|++++|+++.+|.                                    
T Consensus       407 L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~------------------------------------  450 (636)
T 4eco_A          407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK------------------------------------  450 (636)
T ss_dssp             EECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCT------------------------------------
T ss_pred             EECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCH------------------------------------
Confidence            66666666555555555       44455555555555443332                                    


Q ss_pred             eEEEecccccccccchhhhcCCCCcEEeccccccccccccc-ccCc-------CcCcEEeCCCCcccccCCCCCC--CCc
Q 035998          427 KVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGF-------QDLFYLDLSNNTFTGEIPKNLT--GLP  496 (1020)
Q Consensus       427 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~  496 (1020)
                                     ..+..+++|+.|+|++|+++ .+|.. +...       ++|++|+|++|+++ .+|..+.  .++
T Consensus       451 ---------------~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~  513 (636)
T 4eco_A          451 ---------------ELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLP  513 (636)
T ss_dssp             ---------------HHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCT
T ss_pred             ---------------HHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCC
Confidence                           22333444555555555554 33322 2211       14555555555554 3444433  444


Q ss_pred             ccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEe------cCCccee
Q 035998          497 SLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDL------KHNNLSG  570 (1020)
Q Consensus       497 ~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~L------s~N~l~~  570 (1020)
                      +|                                    +.|+|++|+|++ +|..++.+++|+.|+|      ++|++.+
T Consensus       514 ~L------------------------------------~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~  556 (636)
T 4eco_A          514 YL------------------------------------VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR  556 (636)
T ss_dssp             TC------------------------------------CEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCC
T ss_pred             Cc------------------------------------CEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccc
Confidence            33                                    234444555554 4555555555555555      4455666


Q ss_pred             ccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          571 PIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       571 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      .+|..++++++|++|||++|+| +.+|..+.  ++|+.|++++|++.
T Consensus       557 ~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          557 EWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             cChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence            6666666666666666666666 46666554  56666666666554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.6e-57  Score=558.31  Aligned_cols=491  Identities=18%  Similarity=0.218  Sum_probs=331.0

Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC--CCCCCC--CcC------------ceEEcCCCCCCCCCCCCCCCceEEEec
Q 035998           29 LTCNPNDLAALEDFMKNFESGIDGWGTN--ASSSDC--CHW------------VGITCNSSSSLGLNDSIGSGRVTGLFL   92 (1020)
Q Consensus        29 ~~~~~~~~~aL~~~k~~~~~~~~~~~~~--~~~~~~--C~w------------~gv~C~~~~~~~~~~~~~~~~v~~l~l   92 (1020)
                      .++..+|++||++||+++.++  +|...  |+..+|  |.|            .||+|+.           .++|++|+|
T Consensus       264 ~~~~~~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-----------~~~V~~L~L  330 (876)
T 4ecn_A          264 TAEYIKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-----------NGRVTGLSL  330 (876)
T ss_dssp             CCHHHHHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-----------TSCEEEEEC
T ss_pred             cccchHHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecC-----------CCCEEEEEC
Confidence            345678999999999999765  78543  222344  999            9999985           279999999


Q ss_pred             CCCcccccccccccCCCCCcEEec-CCCCCCCCCCccc------------------------------------------
Q 035998           93 YKRRLKGKLSESLGNLVQLRFLNL-SHNLLKGTVPVSL------------------------------------------  129 (1020)
Q Consensus        93 ~~~~l~~~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~l------------------------------------------  129 (1020)
                      +++++.|.+|++|++|++|++|+| ++|.++|..|...                                          
T Consensus       331 s~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~  410 (876)
T 4ecn_A          331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR  410 (876)
T ss_dssp             TTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHT
T ss_pred             ccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhh
Confidence            999999999999999999999999 8998887644321                                          


Q ss_pred             ---------cCCCCCCeeeccC--CCCCCCCCCcc-CCCCcceeeeccCccCC-----------------CCCccc-ccc
Q 035998          130 ---------VNLPNLEVLDLSS--NDLSGPLPQTI-NLPSIQVLDISSNSLNG-----------------SVPTSI-CKN  179 (1020)
Q Consensus       130 ---------~~l~~L~~L~L~~--n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~-----------------~ip~~~-~~~  179 (1020)
                               .....++.+.+..  |++++ +|..+ ++++|++|+|++|+++|                 .+|..+ |..
T Consensus       411 ~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~  489 (876)
T 4ecn_A          411 NPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN  489 (876)
T ss_dssp             CTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG
T ss_pred             CccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhcc
Confidence                     1122333444433  66666 55555 67777777777777776                 266655 345


Q ss_pred             CCcccEEEccCCCCCCCCCCccccccccccccccccc-ccc-ccchhhhhhc-------ccccccccccccCCCCCc--c
Q 035998          180 SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMND-LTG-GIADDIFQLQ-------KLRLLGLQDNQLSGKLSP--S  248 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~--~  248 (1020)
                      +++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|++|+|++|+++ .+|.  .
T Consensus       490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~  568 (876)
T 4ecn_A          490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS  568 (876)
T ss_dssp             CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHH
T ss_pred             CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhh
Confidence            6666666666666666666666666666666666666 665 5666666655       6666666666666 5555  6


Q ss_pred             cccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcc-cccccccccccccccccCCCCCCC-
Q 035998          249 IADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDGSLLLNCPALTN-  326 (1020)
Q Consensus       249 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~-  326 (1020)
                      +.++++|++|+|++|+++ .+| .|+.+++|+.|++++|+++ .+|..+.++++ |+.|+|++|.++ .+|..+..++. 
T Consensus       569 l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~  644 (876)
T 4ecn_A          569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY  644 (876)
T ss_dssp             HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred             hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence            666666666666666666 555 5666666666666666666 55666666666 666666666666 44455544433 


Q ss_pred             -cCEEEcCCCccCCCCCCCC---C--CCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcc
Q 035998          327 -LTSLDLGTNKFNGPLPTNL---P--RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN  400 (1020)
Q Consensus       327 -L~~L~L~~N~l~~~~p~~l---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~  400 (1020)
                       |+.|+|++|++++.+|...   .  .+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+.+|...        
T Consensus       645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~--------  716 (876)
T 4ecn_A          645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS--------  716 (876)
T ss_dssp             CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS--------
T ss_pred             CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH--------
Confidence             6666666666665444221   1  2235666666666666322223335566666666666655444320        


Q ss_pred             cchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccccccccccccc--CcCcCcEEe
Q 035998          401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFG--GFQDLFYLD  478 (1020)
Q Consensus       401 L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~  478 (1020)
                                         +                . ..+..+.++++|+.|+|++|+|+ .+|..+.  .+++|+.|+
T Consensus       717 -------------------~----------------~-~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~  759 (876)
T 4ecn_A          717 -------------------L----------------K-PKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD  759 (876)
T ss_dssp             -------------------S----------------S-CTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEE
T ss_pred             -------------------h----------------c-cccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEE
Confidence                               0                0 00011233447777777777777 6666665  777777777


Q ss_pred             CCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcc
Q 035998          479 LSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKL  558 (1020)
Q Consensus       479 Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L  558 (1020)
                      |++|++++ +|..+.++++|+.++++                      +|.        ++++|++.+.+|..|+.+++|
T Consensus       760 Ls~N~L~~-lp~~l~~L~~L~~L~Ls----------------------~N~--------~ls~N~l~~~ip~~l~~L~~L  808 (876)
T 4ecn_A          760 VSYNCFSS-FPTQPLNSSQLKAFGIR----------------------HQR--------DAEGNRILRQWPTGITTCPSL  808 (876)
T ss_dssp             CCSSCCSS-CCCGGGGCTTCCEEECC----------------------CCB--------CTTCCBCCCCCCTTGGGCSSC
T ss_pred             eCCCCCCc-cchhhhcCCCCCEEECC----------------------CCC--------CcccccccccChHHHhcCCCC
Confidence            77777775 67667777666554443                      221        467788999999999999999


Q ss_pred             eEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          559 HVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       559 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      +.|+|++|+| +.+|..+.  ++|+.|||++|++....+..+.....+..+.|++|++.
T Consensus       809 ~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          809 IQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             CEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             CEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence            9999999999 68998876  69999999999999877788888888888888888765

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-56  Score=543.41  Aligned_cols=506  Identities=21%  Similarity=0.232  Sum_probs=403.3

Q ss_pred             ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCC
Q 035998           66 VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL  145 (1020)
Q Consensus        66 ~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  145 (1020)
                      ..|.|+....+.+|.+.+ .+++.|+|++|.+++..+.+|+++++|++|+|++|.+++..|.+|+++++|++|+|++|++
T Consensus        14 ~~~~c~~~~l~~ip~~~~-~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           14 ITYQCMDQKLSKVPDDIP-SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             TEEECTTSCCSSCCTTSC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEccCCCcccCCCCCC-CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            479999999999998876 7999999999999999888999999999999999999988899999999999999999999


Q ss_pred             CCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccch
Q 035998          146 SGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIAD  223 (1020)
Q Consensus       146 ~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~  223 (1020)
                      ++.+|..+ ++++|++|+|++|+++ .+|...+..+++|++|+|++|.+.+ .+|..|+++++|++|+|++|++++..+.
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~  171 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN  171 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred             cccChhhcCCcccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence            99989888 8999999999999998 4554446789999999999999986 5799999999999999999999998899


Q ss_pred             hhhhhcccc----cccccccccCCCCCcccccCCCccEEEccCCcCc-ccCcccccCCcccceeec--------------
Q 035998          224 DIFQLQKLR----LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS-GNIPDVFAGLGEFQYLVA--------------  284 (1020)
Q Consensus       224 ~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L--------------  284 (1020)
                      .+..+++|+    +|++++|++++..+..+... +|++|++++|.++ +..|..+.++++|+.+.+              
T Consensus       172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~  250 (606)
T 3vq2_A          172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF  250 (606)
T ss_dssp             TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             hhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence            999998876    79999999997666666555 9999999999987 456777777777776665              


Q ss_pred             -------------------ccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC
Q 035998          285 -------------------HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL  345 (1020)
Q Consensus       285 -------------------~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  345 (1020)
                                         ..|.+++.+|. +..+++|+.|++++|.+... + .+..+++|++|++++|++ +.+| .+
T Consensus       251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l-~~lp-~~  325 (606)
T 3vq2_A          251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQL-KQFP-TL  325 (606)
T ss_dssp             CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCC-SSCC-CC
T ss_pred             ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccC-cccc-cC
Confidence                               56677777776 88888888888888888754 3 777888888888888888 4777 45


Q ss_pred             CCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       346 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                       .+++|++|++++|+..+..  .+..+++|++|++++|+++.++.....+..+++|+.|+++.|.+.. ++ ..+..+++
T Consensus       326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~-~~~~~l~~  400 (606)
T 3vq2_A          326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS-ANFMGLEE  400 (606)
T ss_dssp             -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-EC-CCCTTCTT
T ss_pred             -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-ch-hhccCCCC
Confidence             8888888888888665444  5678888888888888887764223346677777777777775443 22 33445667


Q ss_pred             ceEEEecccccccccc-hhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccc-cCCCCCCCCcccccccC
Q 035998          426 LKVLVIASCGLRGSIP-QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-EIPKNLTGLPSLITRNI  503 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~l~~  503 (1020)
                      |+.|++++|.+.+..| ..+..+++|+.|++++|++++..|..|..+++|++|+|++|++++ .+|..++++++|     
T Consensus       401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-----  475 (606)
T 3vq2_A          401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL-----  475 (606)
T ss_dssp             CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC-----
T ss_pred             CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC-----
Confidence            7777777777776666 567777777777777777776677777777777777777777776 356666666665     


Q ss_pred             cCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCccc
Q 035998          504 SLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLE  583 (1020)
Q Consensus       504 s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  583 (1020)
                                                     +.|+|++|++++..|..|+.+++|++|+|++|++++.+|..|+++++|+
T Consensus       476 -------------------------------~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  524 (606)
T 3vq2_A          476 -------------------------------TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS  524 (606)
T ss_dssp             -------------------------------CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCC
T ss_pred             -------------------------------CEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCC
Confidence                                           3566777777777777777777777777777777776677777777777


Q ss_pred             EEEccCCcccccCCccccccc-cccccccccccccccCC
Q 035998          584 TLDLSYNNLSGAIPISLEKLS-FLSKFSVANNHLTGRIP  621 (1020)
Q Consensus       584 ~L~Ls~N~l~g~ip~~l~~l~-~L~~l~ls~N~l~g~~p  621 (1020)
                      +|||++|+|+ .+|..+..++ +|+.|++++|++.+..+
T Consensus       525 ~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          525 TLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             EEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             EEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            7777777777 5666677775 47777777777776554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-56  Score=557.40  Aligned_cols=504  Identities=22%  Similarity=0.212  Sum_probs=364.6

Q ss_pred             CcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCC-CccccCCCCCCeeecc
Q 035998           63 CHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTV-PVSLVNLPNLEVLDLS  141 (1020)
Q Consensus        63 C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~  141 (1020)
                      |.-.-+.|+..+.+.||. . ..+++.|+|++|.+++..+.+|+++++|++|+|++|.+.+.+ |.+|+++++|++|+|+
T Consensus         4 ~~~~~~dcs~~~L~~vP~-l-p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls   81 (844)
T 3j0a_A            4 FDGRIAFYRFCNLTQVPQ-V-LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG   81 (844)
T ss_dssp             TTTEEEEESCCCSSCCCS-S-CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECT
T ss_pred             EeceEEEccCCCCCCCCC-C-CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECC
Confidence            344568899989999998 4 469999999999999999999999999999999999777677 7889999999999999


Q ss_pred             CCCCCCCCCCcc-CCCCcceeeeccCccCCCCCcc-ccccCCcccEEEccCCCCCCCCC-Cccccccccccccccccccc
Q 035998          142 SNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTS-ICKNSSRIRVINLSVNYFSGTLS-PGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       142 ~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~-~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      +|.|++..|..+ ++++|++|+|++|.+++.+|.. .+..+++|++|+|++|.+++..+ ..|+++++|++|+|++|.++
T Consensus        82 ~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             TCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             CCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            999999999988 8999999999999999866654 56889999999999999998765 57999999999999999999


Q ss_pred             cccchhhhhh--cccccccccccccCCCCCcccccCCC------ccEEEccCCcCcccCcccccCC--------------
Q 035998          219 GGIADDIFQL--QKLRLLGLQDNQLSGKLSPSIADLSN------LVRLDVSSNNFSGNIPDVFAGL--------------  276 (1020)
Q Consensus       219 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l--------------  276 (1020)
                      +..+..+..+  ++|+.|++++|.+++..|..+..+.+      |++|++++|.+++..|..+...              
T Consensus       162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~  241 (844)
T 3j0a_A          162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH  241 (844)
T ss_dssp             CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred             eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence            9999999988  89999999999999988888777766      9999999999887777665432              


Q ss_pred             ------------------------cccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEc
Q 035998          277 ------------------------GEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDL  332 (1020)
Q Consensus       277 ------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  332 (1020)
                                              ++|+.|++++|.+++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|
T Consensus       242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  321 (844)
T 3j0a_A          242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL  321 (844)
T ss_dssp             CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEE
T ss_pred             cccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEEC
Confidence                                    35666666666666666666666666666666666666655556666666666666


Q ss_pred             CCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccC
Q 035998          333 GTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRN  412 (1020)
Q Consensus       333 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~  412 (1020)
                      ++|++++..|..|..+++|+.|++++|++++..+..|..+++|++|+|++|.++.++.       +++|+.|+++.|.+.
T Consensus       322 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-------~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-------IPSIPDIFLSGNKLV  394 (844)
T ss_dssp             ESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS-------CCSCSEEEEESCCCC
T ss_pred             CCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC-------CCCcchhccCCCCcc
Confidence            6666665556666666666666666666665555556666666666666666554432       445555555555443


Q ss_pred             CCCCCCccccccCceEEEeccccccccc-chhhhcCCCCcEEecccccccccccc-cccCcCcCcEEeCCCCccc-----
Q 035998          413 EKLPTDPRLHFANLKVLVIASCGLRGSI-PQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFT-----  485 (1020)
Q Consensus       413 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----  485 (1020)
                       .++.    ...+++.|++++|.+.+.. +..+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++     
T Consensus       395 -~l~~----~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~  469 (844)
T 3j0a_A          395 -TLPK----INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET  469 (844)
T ss_dssp             -CCCC----CCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCS
T ss_pred             -cccc----cccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccccc
Confidence             1111    1234555555555555422 22234555555555555555543322 2344555555555555554     


Q ss_pred             ccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecC
Q 035998          486 GEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH  565 (1020)
Q Consensus       486 ~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~  565 (1020)
                      +..|..+.++++|                                    +.|+|++|+|++..|..|+.+++|+.|+|++
T Consensus       470 ~~~~~~~~~l~~L------------------------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  513 (844)
T 3j0a_A          470 ELCWDVFEGLSHL------------------------------------QVLYLNHNYLNSLPPGVFSHLTALRGLSLNS  513 (844)
T ss_dssp             CCCSSCSSCBCCE------------------------------------ECCCCCHHHHTTCCTTSSSSCCSCSEEEEES
T ss_pred             ccchhhhcCcccc------------------------------------cEEECCCCcccccChhHccchhhhheeECCC
Confidence            2222334444433                                    3567778888877777788888888888888


Q ss_pred             CcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCC
Q 035998          566 NNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP  621 (1020)
Q Consensus       566 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p  621 (1020)
                      |+|++..|..+.  ++|+.|||++|+|++.+|..+   .+|+.|++++|++....+
T Consensus       514 N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          514 NRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred             CCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence            888765555554  778888888888888777665   367778888888876554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.3e-55  Score=545.02  Aligned_cols=549  Identities=21%  Similarity=0.220  Sum_probs=467.0

Q ss_pred             EEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCc
Q 035998           89 GLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNS  167 (1020)
Q Consensus        89 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~  167 (1020)
                      .++.++++++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|.+++.+|..+ ++++|++|+|++|+
T Consensus         8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~   84 (680)
T 1ziw_A            8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE   84 (680)
T ss_dssp             EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred             eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence            4788888887 4776665  799999999999998888889999999999999999999999988 89999999999999


Q ss_pred             cCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCc
Q 035998          168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP  247 (1020)
Q Consensus       168 l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  247 (1020)
                      ++ .+|...+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..+.++++|++|++++|++++..+.
T Consensus        85 l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           85 LS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             cC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            98 78887778899999999999999988888999999999999999999999999999999999999999999987777


Q ss_pred             ccc--cCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCc---CCcccccccccccccccccccCCC
Q 035998          248 SIA--DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS---NSPTLNLLNLRNNSLDGSLLLNCP  322 (1020)
Q Consensus       248 ~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~~~  322 (1020)
                      .+.  .+++|++|++++|++++..|..|..+.+|+.|++.+|.+.+.....+.   ..++|+.|++++|.+++..+..+.
T Consensus       164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~  243 (680)
T 1ziw_A          164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL  243 (680)
T ss_dssp             HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred             HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence            665  458999999999999999999999999999999999988643322221   347899999999999999999998


Q ss_pred             CCCC--cCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc------chhh-HHH
Q 035998          323 ALTN--LTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY------NLSS-ALQ  393 (1020)
Q Consensus       323 ~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~------~l~~-~~~  393 (1020)
                      .++.  |++|+|++|++++..|..|..+++|++|++++|++++..|..|..+++|++|++++|...      .+|. .-.
T Consensus       244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~  323 (680)
T 1ziw_A          244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF  323 (680)
T ss_dssp             GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred             ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence            8765  999999999999999999999999999999999999999999999999999999987543      2221 001


Q ss_pred             HHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccc--cchhhhcC--CCCcEEeccccccccccccccc
Q 035998          394 VLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS--IPQWLRGC--SKLQLVDLSWNQLSGTIPVWFG  469 (1020)
Q Consensus       394 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~--~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~  469 (1020)
                      .+..+++|+.|+++.|.+.. ++...+..+++|+.|++++|.+...  .+..+..+  ++|+.|++++|++++..|.+|.
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~  402 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS  402 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCC-CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred             hcccCCCCCEEECCCCccCC-CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence            46788999999999997765 4445567889999999999986432  23344443  5899999999999999999999


Q ss_pred             CcCcCcEEeCCCCcccccCC-CCCCCCcccccccCcCCCCCCC--cccceeecccccccccccccC------------CC
Q 035998          470 GFQDLFYLDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPD--FPFFMRRNVSARGLQYNQIWS------------FP  534 (1020)
Q Consensus       470 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~s~~~~~~~--~~~~~~~~~~~~~l~~n~~~~------------~~  534 (1020)
                      .+++|++|+|++|++++.+| ..+.++++|+.++++.+.....  ..+.....++.+.++.|.+..            -.
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            99999999999999998776 6899999999999987764322  223445667788888876542            12


Q ss_pred             CeeecccCccccCCCccccCCCcceEEEecCCcceecc----C----ccccCCCcccEEEccCCcccccCCccccccccc
Q 035998          535 PTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPI----P----SELTGMTSLETLDLSYNNLSGAIPISLEKLSFL  606 (1020)
Q Consensus       535 ~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~----p----~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L  606 (1020)
                      +.|+|++|+|++..+..|+++++|++|+|++|++++..    |    ..|+++++|++|+|++|++++..+..|.++++|
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L  562 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL  562 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence            57999999999988889999999999999999998642    2    248999999999999999994444569999999


Q ss_pred             cccccccccccccCCCC-CCCCCcCCccccCCCCCCC
Q 035998          607 SKFSVANNHLTGRIPSG-GQFQTFPNSSFDGNNLCGE  642 (1020)
Q Consensus       607 ~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~l~~~  642 (1020)
                      +.|++++|++++.+|.. ..+..+..+.+.+|.+.+.
T Consensus       563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~  599 (680)
T 1ziw_A          563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSV  599 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBC
T ss_pred             ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCcc
Confidence            99999999999766653 4567788888899987654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.3e-54  Score=528.76  Aligned_cols=507  Identities=21%  Similarity=0.220  Sum_probs=428.8

Q ss_pred             EEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCc
Q 035998           89 GLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNS  167 (1020)
Q Consensus        89 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~  167 (1020)
                      .++..+.+++ .+|..+..  ++++|+|++|.+++..|.+|+++++|++|+|++|++++..|..+ ++++|++|+|++|+
T Consensus        16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            4677777776 56766654  79999999999998889999999999999999999999989888 89999999999999


Q ss_pred             cCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCc
Q 035998          168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP  247 (1020)
Q Consensus       168 l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  247 (1020)
                      +++..|.. +..+++|++|+|++|++++..+..++++++|++|+|++|++++.....+..+++|++|++++|++++..|.
T Consensus        93 l~~~~~~~-~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  171 (606)
T 3t6q_A           93 LIFMAETA-LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE  171 (606)
T ss_dssp             CSEECTTT-TSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred             ccccChhh-hcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence            98555554 56899999999999999987788899999999999999999975555566699999999999999988888


Q ss_pred             ccccCCCcc--EEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccc-----cccccC
Q 035998          248 SIADLSNLV--RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD-----GSLLLN  320 (1020)
Q Consensus       248 ~~~~l~~L~--~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~  320 (1020)
                      .++.+++|+  +|++++|.+++..|..|.. .+|+.|++++|..   .+..+..+..+....+..+.+.     ...+..
T Consensus       172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~  247 (606)
T 3t6q_A          172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV  247 (606)
T ss_dssp             HHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred             hhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChhH
Confidence            899999999  8999999999888887765 5899999998862   2233333333332222222111     111222


Q ss_pred             CCCCC--CcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhh
Q 035998          321 CPALT--NLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQC  398 (1020)
Q Consensus       321 ~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l  398 (1020)
                      +..+.  +|+.|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++..++.  ..+..+
T Consensus       248 ~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~l  324 (606)
T 3t6q_A          248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ--ISASNF  324 (606)
T ss_dssp             GGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG--GCGGGC
T ss_pred             hchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCch--hhhhcc
Confidence            22222  7999999999999888888999999999999999999 788899999999999999999998765  357889


Q ss_pred             cccchhhhhccccCCCCCCCccccccCceEEEeccccccccc--chhhhcCCCCcEEecccccccccccccccCcCcCcE
Q 035998          399 RNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI--PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFY  476 (1020)
Q Consensus       399 ~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  476 (1020)
                      ++|+.|+++.|.....++...+..+++|+.|++++|.+.+..  |..+.++++|++|++++|++++..|..|..+++|++
T Consensus       325 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  404 (606)
T 3t6q_A          325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL  404 (606)
T ss_dssp             TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred             CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence            999999999998877777777888999999999999999877  888999999999999999999899999999999999


Q ss_pred             EeCCCCcccccCCCC-CCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCC
Q 035998          477 LDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNL  555 (1020)
Q Consensus       477 L~Ls~N~l~~~~p~~-~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L  555 (1020)
                      |+|++|++++..|.. +.++++|                                    +.|++++|++++..|..|+.+
T Consensus       405 L~l~~n~l~~~~~~~~~~~l~~L------------------------------------~~L~l~~n~l~~~~~~~~~~l  448 (606)
T 3t6q_A          405 LDLAFTRLKVKDAQSPFQNLHLL------------------------------------KVLNLSHSLLDISSEQLFDGL  448 (606)
T ss_dssp             EECTTCCEECCTTCCTTTTCTTC------------------------------------CEEECTTCCCBTTCTTTTTTC
T ss_pred             EECCCCcCCCcccchhhhCcccC------------------------------------CEEECCCCccCCcCHHHHhCC
Confidence            999999999877654 8888777                                    468889999999999999999


Q ss_pred             CcceEEEecCCcceec---cCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC-CCCCCcCC
Q 035998          556 KKLHVFDLKHNNLSGP---IPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-GQFQTFPN  631 (1020)
Q Consensus       556 ~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~  631 (1020)
                      ++|++|+|++|++++.   .+..+..+++|++|+|++|++++.+|..+.++++|+.|++++|++++.+|.. ..+..+ .
T Consensus       449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~  527 (606)
T 3t6q_A          449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y  527 (606)
T ss_dssp             TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred             CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence            9999999999999872   3467999999999999999999999999999999999999999999988853 445566 7


Q ss_pred             ccccCCCCCCCC
Q 035998          632 SSFDGNNLCGEH  643 (1020)
Q Consensus       632 ~~~~~n~l~~~~  643 (1020)
                      ..+.+|.+.+.+
T Consensus       528 L~L~~N~l~~~~  539 (606)
T 3t6q_A          528 LNLASNHISIIL  539 (606)
T ss_dssp             EECCSSCCCCCC
T ss_pred             EECcCCcccccC
Confidence            778888877643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.9e-53  Score=516.98  Aligned_cols=523  Identities=19%  Similarity=0.192  Sum_probs=408.7

Q ss_pred             EEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCc
Q 035998           89 GLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNS  167 (1020)
Q Consensus        89 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~  167 (1020)
                      .++.++++++ .+|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..+ ++++|++|+|++|+
T Consensus        15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            4788888887 4676665  899999999999998888899999999999999999999989888 89999999999999


Q ss_pred             cCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCC
Q 035998          168 LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLS  246 (1020)
Q Consensus       168 l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~  246 (1020)
                      +++..|.. +..+++|++|+|++|.+++..+..|+++++|++|+|++|.+++ .+|..+.++++|++|++++|++++..|
T Consensus        92 l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A           92 IQSFSPGS-FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             CCCCCTTS-STTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             ccccChhh-cCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            99555655 4789999999999999998888899999999999999999986 579999999999999999999998888


Q ss_pred             cccccCCCcc----EEEccCCcCcccCcccccCCcccceeeccccccc-ccCCCCCcCCccccccccccccccccc----
Q 035998          247 PSIADLSNLV----RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT-GRIPHSLSNSPTLNLLNLRNNSLDGSL----  317 (1020)
Q Consensus       247 ~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~----  317 (1020)
                      ..++.+++|+    +|++++|.+++..+..+... +|+.|++++|.++ +..|..+.+++.|+.+++..+.+.+..    
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~  249 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI  249 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence            8888877665    89999999998888777766 8999999999987 456777888888888887655443211    


Q ss_pred             --ccCCCCCC--CcCEEEc-CCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHH
Q 035998          318 --LLNCPALT--NLTSLDL-GTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSAL  392 (1020)
Q Consensus       318 --~~~~~~l~--~L~~L~L-~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~  392 (1020)
                        +..+..+.  .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+..+|.  
T Consensus       250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l~~lp~--  324 (606)
T 3vq2_A          250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLKQFPT--  324 (606)
T ss_dssp             CCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCCSSCCC--
T ss_pred             cChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccCccccc--
Confidence              11111111  3555555 56666666665 667777777777777775 344 66667777777777777766662  


Q ss_pred             HHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccc--cchhhhcCCCCcEEecccccccccccccccC
Q 035998          393 QVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS--IPQWLRGCSKLQLVDLSWNQLSGTIPVWFGG  470 (1020)
Q Consensus       393 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  470 (1020)
                        + .+++|+.|+++.|......   ....+++|+.|++++|.+.+.  +|..+..+++|++|++++|+++ .+|..|..
T Consensus       325 --~-~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~  397 (606)
T 3vq2_A          325 --L-DLPFLKSLTLTMNKGSISF---KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG  397 (606)
T ss_dssp             --C-CCSSCCEEEEESCSSCEEC---CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTT
T ss_pred             --C-CCCccceeeccCCcCccch---hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccC
Confidence              2 6667777777766333222   344667777888887777765  3777777788888888888777 46677777


Q ss_pred             cCcCcEEeCCCCcccccCC-CCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCcccc-CC
Q 035998          471 FQDLFYLDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDG-SI  548 (1020)
Q Consensus       471 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~-~~  548 (1020)
                      +++|++|++++|++++.+| ..+.++++|+.++++.+......+....           . ..-.+.|++++|++++ .+
T Consensus       398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----------~-l~~L~~L~l~~n~l~~~~~  465 (606)
T 3vq2_A          398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL-----------G-LTSLNTLKMAGNSFKDNTL  465 (606)
T ss_dssp             CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT-----------T-CTTCCEEECTTCEEGGGEE
T ss_pred             CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc-----------C-CCCCCEEECCCCcCCCcch
Confidence            7888888888888777766 5777777777777766554332221100           0 0112578999999998 47


Q ss_pred             CccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCCCCCC-
Q 035998          549 WPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQ-  627 (1020)
Q Consensus       549 ~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~-  627 (1020)
                      |..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++.+|..+.++++|+.|++++|+++..++....+. 
T Consensus       466 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~  545 (606)
T 3vq2_A          466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK  545 (606)
T ss_dssp             CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCT
T ss_pred             HHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcc
Confidence            8899999999999999999999999999999999999999999999999999999999999999999995444333443 


Q ss_pred             CcCCccccCCCCC
Q 035998          628 TFPNSSFDGNNLC  640 (1020)
Q Consensus       628 ~~~~~~~~~n~l~  640 (1020)
                      ++....+.+|++.
T Consensus       546 ~L~~l~l~~N~~~  558 (606)
T 3vq2_A          546 SLAFFNLTNNSVA  558 (606)
T ss_dssp             TCCEEECCSCCCC
T ss_pred             cCcEEEccCCCcc
Confidence            4677888999753

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-52  Score=521.82  Aligned_cols=494  Identities=21%  Similarity=0.237  Sum_probs=381.6

Q ss_pred             EEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCC-CCcc-CCCCcceeeeccC
Q 035998           89 GLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL-PQTI-NLPSIQVLDISSN  166 (1020)
Q Consensus        89 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~-~l~~L~~L~Ls~N  166 (1020)
                      .++.++++++. +|.   -.++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..+ ++++|++|+|++|
T Consensus         8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            46677888875 554   4589999999999999888999999999999999999776655 6677 8999999999999


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCCCCCCc--cccccccccccccccccccccc-hhhhhhcccccccccccccCC
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPG--LGNCASLEHLCLGMNDLTGGIA-DDIFQLQKLRLLGLQDNQLSG  243 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~--l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  243 (1020)
                      .+++..|.. +..+++|++|+|++|.+++.+|..  |+++++|++|+|++|.+++..+ ..|.++++|++|+|++|++++
T Consensus        84 ~l~~~~p~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           84 KIYFLHPDA-FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCEECTTS-SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             cCcccCHhH-ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            999555555 468999999999999999877665  9999999999999999997755 679999999999999999999


Q ss_pred             CCCcccccC--CCccEEEccCCcCcccCcccccCCcc------cceeecccccccccCCCCCcCC---------------
Q 035998          244 KLSPSIADL--SNLVRLDVSSNNFSGNIPDVFAGLGE------FQYLVAHSNRFTGRIPHSLSNS---------------  300 (1020)
Q Consensus       244 ~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l---------------  300 (1020)
                      ..+..+..+  ++|+.|+++.|.+++..|..++.+.+      |+.|++++|++++..+..+...               
T Consensus       163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            999999988  89999999999999998888777665      9999999999887776655432               


Q ss_pred             -----------------------cccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecC
Q 035998          301 -----------------------PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA  357 (1020)
Q Consensus       301 -----------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  357 (1020)
                                             ++|+.|++++|.+.+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|+
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls  322 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS  322 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEE
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECC
Confidence                                   456677777777766666666667777777777777776666667777777777777


Q ss_pred             CCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccc
Q 035998          358 RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLR  437 (1020)
Q Consensus       358 ~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~  437 (1020)
                      +|++++..|..|..+++|++|++++|.+..++..  .+..+++|+.|+++.|.+...      ..+++|+.|.+++|.+.
T Consensus       323 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~Ls~N~l~~i------~~~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ--TFKFLEKLQTLDLRDNALTTI------HFIPSIPDIFLSGNKLV  394 (844)
T ss_dssp             SCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSS--CSCSCCCCCEEEEETCCSCCC------SSCCSCSEEEEESCCCC
T ss_pred             CCCCCccCHHHhcCCCCCCEEECCCCCCCccChh--hhcCCCCCCEEECCCCCCCcc------cCCCCcchhccCCCCcc
Confidence            7777666666677777777777777776666542  355566666666666654321      11556666666666666


Q ss_pred             cccchhhhcCCCCcEEecccccccccc-cccccCcCcCcEEeCCCCcccccCCC-CCCCCcccccccCcCCCCCCCcccc
Q 035998          438 GSIPQWLRGCSKLQLVDLSWNQLSGTI-PVWFGGFQDLFYLDLSNNTFTGEIPK-NLTGLPSLITRNISLEEPSPDFPFF  515 (1020)
Q Consensus       438 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~l~~s~~~~~~~~~~~  515 (1020)
                       .+|..   ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|                 
T Consensus       395 -~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L-----------------  453 (844)
T 3j0a_A          395 -TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL-----------------  453 (844)
T ss_dssp             -CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC-----------------
T ss_pred             -ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc-----------------
Confidence             33332   345666666666666422 22345666677777777766643332 22333333                 


Q ss_pred             eeecccccccccccccCCCCeeecccCccc-----cCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCC
Q 035998          516 MRRNVSARGLQYNQIWSFPPTIDLSLNRLD-----GSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN  590 (1020)
Q Consensus       516 ~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~-----~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  590 (1020)
                                         +.|+|++|.++     +..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus       454 -------------------~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  514 (844)
T 3j0a_A          454 -------------------EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN  514 (844)
T ss_dssp             -------------------CBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESC
T ss_pred             -------------------ccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCC
Confidence                               35677777776     455677999999999999999999888889999999999999999


Q ss_pred             cccccCCccccccccccccccccccccccCCCCCCCCCcCCccccCCCC
Q 035998          591 NLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNL  639 (1020)
Q Consensus       591 ~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~l  639 (1020)
                      +|++..|..+.  ++|+.|+|++|+|+|.+|..  +..+....+.+|++
T Consensus       515 ~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~  559 (844)
T 3j0a_A          515 RLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKF  559 (844)
T ss_dssp             CCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECC
T ss_pred             CCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCc
Confidence            99987777666  89999999999999999854  66788888999983

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=488.19  Aligned_cols=486  Identities=20%  Similarity=0.233  Sum_probs=377.1

Q ss_pred             ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCC
Q 035998           66 VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL  145 (1020)
Q Consensus        66 ~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  145 (1020)
                      .-|.|+..+.+.+|...+ .+++.|+|++|.+++..+.+|+++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus        10 ~~~~c~~~~l~~ip~~l~-~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           10 ITYQCMELNFYKIPDNLP-FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             TEEECCSSCCSSCCSSSC-SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             cEEEeCCCCccccCCCcc-ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            458999988999998765 5899999999999998889999999999999999999987788899999999999999999


Q ss_pred             CCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccch
Q 035998          146 SGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIAD  223 (1020)
Q Consensus       146 ~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~  223 (1020)
                      ++.+|..+ ++++|++|+|++|+++ .+|...+..+++|++|++++|.+++ .+|..|+++++|++|++++|++++..+.
T Consensus        89 ~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             CccCHhhhcCccccccccccccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            99888888 8999999999999998 5665456789999999999999997 4799999999999999999999988899


Q ss_pred             hhhhhccc----ccccccccccCCCCCcccccCCCccEEEccCCcCcc-cCcccccCCccc-------------------
Q 035998          224 DIFQLQKL----RLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG-NIPDVFAGLGEF-------------------  279 (1020)
Q Consensus       224 ~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L-------------------  279 (1020)
                      .+..+++|    +.|++++|.+++..|..+..+ +|++|++++|.... ..+..+.+++++                   
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  246 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  246 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence            99999999    899999999998888888766 89999999985431 223333333333                   


Q ss_pred             -------------ceeecccc-cccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC
Q 035998          280 -------------QYLVAHSN-RFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL  345 (1020)
Q Consensus       280 -------------~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  345 (1020)
                                   +.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|++. .+|.  
T Consensus       247 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--  321 (570)
T 2z63_A          247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--  321 (570)
T ss_dssp             CTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--
T ss_pred             chhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--
Confidence                         33444444 555556666666666666666666666 344445555 6666666666666 4443  


Q ss_pred             CCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       346 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                      ..+++|+.|++++|.+.+..+.  ..+++|++|++++|.++.+......+                         ..+++
T Consensus       322 ~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~-------------------------~~~~~  374 (570)
T 2z63_A          322 LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSD-------------------------FGTTS  374 (570)
T ss_dssp             CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHH-------------------------HTCSC
T ss_pred             ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccc-------------------------cccCc
Confidence            3556666666666666654443  55666666666666665442111111                         23455


Q ss_pred             ceEEEecccccccccchhhhcCCCCcEEeccccccccccc-ccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCc
Q 035998          426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP-VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS  504 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s  504 (1020)
                      |+.|++++|.+.+..+. +..+++|+.|++++|++++..| ..|..+++|++|+|++|++++.+|..+.++++|      
T Consensus       375 L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L------  447 (570)
T 2z63_A          375 LKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL------  447 (570)
T ss_dssp             CCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC------
T ss_pred             cCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcC------
Confidence            66666666666655444 7777888888888888876655 467778888888888888887777777777766      


Q ss_pred             CCCCCCCcccceeecccccccccccccCCCCeeecccCccc-cCCCccccCCCcceEEEecCCcceeccCccccCCCccc
Q 035998          505 LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLD-GSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLE  583 (1020)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~-~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  583 (1020)
                                                    +.|++++|+++ +.+|..|+.+++|+.|+|++|++++..|..|+.+++|+
T Consensus       448 ------------------------------~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  497 (570)
T 2z63_A          448 ------------------------------EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  497 (570)
T ss_dssp             ------------------------------CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ------------------------------cEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence                                          35778888887 57888888899999999999999888888899999999


Q ss_pred             EEEccCCcccccCCccccccccccccccccccccccCCCC
Q 035998          584 TLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG  623 (1020)
Q Consensus       584 ~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~  623 (1020)
                      +|+|++|++++..|..+.++++|+.|++++|++++.+|..
T Consensus       498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9999999999887778888999999999999999888764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.7e-52  Score=451.59  Aligned_cols=259  Identities=28%  Similarity=0.465  Sum_probs=213.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999864      467899999987766667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          816 IYSFMENGSLDYWLHEKL---------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      |||||++|+|.++++...         .....++|.++..|+.|||+||+|||++   +||||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642         2345799999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      +|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......   +..   ..+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---~~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI---ECI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---HHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HHH
Confidence            99999987644333333344578999999999999999999999999999999999 99999754321   222   122


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..... ..         .+.....++.+++.+||+.||++||||+||+++|+++
T Consensus       244 ~~~~~-~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          244 TQGRV-LQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCC-CC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            22111 11         1112234688999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=451.85  Aligned_cols=259  Identities=28%  Similarity=0.426  Sum_probs=206.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|.+.++||+|+||+||+|+++      +++.||||+++.......++|.+|++++++++|||||+++++|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999864      477899999987766667889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          816 IYSFMENGSLDYWLHEKLD-----------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      |||||++|+|.++++....           ...+++|.+++.|+.|||+||+|||++   +||||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            9999999999999976432           234699999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||......   +.+   .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI---D  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH---H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH---H
Confidence            9999999987654433344455789999999999999999999999999999999999 99999754321   122   1


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .+...... .         .+.....++.+++.+||+.||++||||+||+++|+.+
T Consensus       272 ~i~~g~~~-~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          272 CITQGREL-E---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHHHTCCC-C---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHcCCCC-C---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            22221111 1         0112234688999999999999999999999999876

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.7e-50  Score=482.65  Aligned_cols=485  Identities=18%  Similarity=0.203  Sum_probs=369.0

Q ss_pred             CCcCceEEcCC--CCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeee
Q 035998           62 CCHWVGITCNS--SSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLD  139 (1020)
Q Consensus        62 ~C~w~gv~C~~--~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  139 (1020)
                      .|.|.|| |+.  ...+.+|.... .+++.|+|++|.+++..|.+|+++++|++|+|++|++++..|.+|+++++|++|+
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~-~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLT-AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCC-TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCCce-EECCCCccccccccCC-CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            5999998 864  35677777665 6888999999999888888899999999999999999887778899999999999


Q ss_pred             ccCCCCCCCCCCcc-CCCCcceeeeccCccCCC-CCccccccCCcccEEEccCCCCCCCCC-Cccccccccccccccccc
Q 035998          140 LSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGS-VPTSICKNSSRIRVINLSVNYFSGTLS-PGLGNCASLEHLCLGMND  216 (1020)
Q Consensus       140 L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~-ip~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~  216 (1020)
                      |++|++++.+|..+ ++++|++|+|++|++++. +|. .+..+++|++|++++|.+.+.+| ..|+++++|++|++++|+
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~-~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS-LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSC-SCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhh-hhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            99999988888766 789999999999988853 333 45678889999999888544554 578888889999999998


Q ss_pred             cccccchhhhhhcccccccccccccCCCCCcc-cccCCCccEEEccCCcCcccC---cccccCCcccceeeccccccccc
Q 035998          217 LTGGIADDIFQLQKLRLLGLQDNQLSGKLSPS-IADLSNLVRLDVSSNNFSGNI---PDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       217 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      +++..|..+..+++|++|+++.|.+. .+|.. +..+++|++|++++|++++..   ......+++|+.|++++|++++.
T Consensus       160 l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  238 (549)
T 2z81_A          160 LRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE  238 (549)
T ss_dssp             CCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHH
T ss_pred             ccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchh
Confidence            88888888888888888888888887 34443 456888888888888888642   22334567888888888888765


Q ss_pred             CC----CCCcCCcccccccccccccccccc------cCCCCCCCcCEEEcCCCccCCCC-----CCCCCCCCCCCeEecC
Q 035998          293 IP----HSLSNSPTLNLLNLRNNSLDGSLL------LNCPALTNLTSLDLGTNKFNGPL-----PTNLPRCRKLKNINLA  357 (1020)
Q Consensus       293 ~p----~~~~~l~~L~~L~L~~N~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~~-----p~~l~~l~~L~~L~L~  357 (1020)
                      .+    ..+..+++|+.|++++|.+.+...      ..+..+++|+.|++.++.+....     +..+....+|+.|+++
T Consensus       239 ~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~  318 (549)
T 2z81_A          239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE  318 (549)
T ss_dssp             HHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEE
T ss_pred             HHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEec
Confidence            43    334566788888888888775421      23456677778888777665311     1112234567777777


Q ss_pred             CCcccccCcccc-cCCCCCCeeeCCCCCCcchh-hHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccc
Q 035998          358 RNNFSGQIPETY-KNFESLSYLSLSNSSIYNLS-SALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCG  435 (1020)
Q Consensus       358 ~N~l~~~~p~~~-~~l~~L~~L~l~~N~i~~l~-~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~  435 (1020)
                      +|+++ .+|..+ ..+++|++|++++|+++... ...                         .....+++|+.|++++|.
T Consensus       319 ~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------------------~~~~~l~~L~~L~Ls~N~  372 (549)
T 2z81_A          319 NSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS-------------------------ACKGAWPSLQTLVLSQNH  372 (549)
T ss_dssp             SSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHH-------------------------TCTTSSTTCCEEECTTSC
T ss_pred             cCccc-cCCHHHHhcCccccEEEccCCccccccccch-------------------------hhhhccccCcEEEccCCc
Confidence            77776 455544 46777777777777766421 110                         012245677777888887


Q ss_pred             cccccc--hhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcc
Q 035998          436 LRGSIP--QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFP  513 (1020)
Q Consensus       436 l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~  513 (1020)
                      +++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+++ .+|..+.  ++|               
T Consensus       373 l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L---------------  433 (549)
T 2z81_A          373 LRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTL---------------  433 (549)
T ss_dssp             CCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTC---------------
T ss_pred             ccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCc---------------
Confidence            776543  55788888888999998888 67888888888888999888887 3333221  122               


Q ss_pred             cceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCccc
Q 035998          514 FFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLS  593 (1020)
Q Consensus       514 ~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  593 (1020)
                                           +.|||++|+|++..    +.+++|++|+|++|+|+ .+|. .+.+++|++|||++|+|+
T Consensus       434 ---------------------~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~  486 (549)
T 2z81_A          434 ---------------------EVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLK  486 (549)
T ss_dssp             ---------------------SEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCC
T ss_pred             ---------------------eEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccC
Confidence                                 46889999998753    68899999999999998 7887 678999999999999999


Q ss_pred             ccCCccccccccccccccccccccccCCC
Q 035998          594 GAIPISLEKLSFLSKFSVANNHLTGRIPS  622 (1020)
Q Consensus       594 g~ip~~l~~l~~L~~l~ls~N~l~g~~p~  622 (1020)
                      +.+|..+..+++|+.|++++|++++..|.
T Consensus       487 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          487 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            99998999999999999999999998874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.3e-51  Score=445.34  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=211.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++++.+.||+|+||+||+|++.      +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4567889999999999999863      46789999997553 3345789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          816 IYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      |||||++|+|.+++.....            ....+++.++..|+.|||+||+|||++   +||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            9999999999999975421            124689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +||+|||+++...........+...||+.|||||++.++.++.++|||||||++|||+| |+.||.....   .+...  
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~--  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVE--  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHH--
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHH--
Confidence            99999999987654433344456789999999999999999999999999999999999 8999975432   12222  


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       .+..... ..         .+..+...+.+++.+||+.||++||||+||++.|+.+
T Consensus       259 -~i~~~~~-~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 -MIRNRQV-LP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHTTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHcCCC-CC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             2221111 11         1122334688999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=432.35  Aligned_cols=259  Identities=27%  Similarity=0.447  Sum_probs=202.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||+||+|+++  ..||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            456788999999999999999975  469999987443  3445689999999999999999999998864 56899999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ||++|+|.++++..   ...+++.++..|+.|||+||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus       112 y~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999754   34689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .........+||+.|||||++.+   ..|+.++|||||||++|||+||+.||......   ..+.  .........    
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~--~~~~~~~~~----  256 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQII--FMVGRGYAS----  256 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHH--HHHHTTCCC----
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHH--HHHhcCCCC----
Confidence            33334456789999999998753   46899999999999999999999999754321   1111  111111111    


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       |.. ...+......+.+++.+||+.||++||||+||++.|+.+
T Consensus       257 -p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          257 -PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             -CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             -CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             100 011122334688999999999999999999999988754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=472.47  Aligned_cols=501  Identities=19%  Similarity=0.221  Sum_probs=414.5

Q ss_pred             EecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCcc
Q 035998           90 LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSL  168 (1020)
Q Consensus        90 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l  168 (1020)
                      ++-.+.+++ .+|..+.  +++++|+|++|++++..+.+|.++++|++|+|++|++++..|..+ ++++|++|+|++|++
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            555666665 4665554  579999999999998888899999999999999999999888888 799999999999999


Q ss_pred             CCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCCc
Q 035998          169 NGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSP  247 (1020)
Q Consensus       169 ~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~  247 (1020)
                      + .+|...+..+++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..|.++++|++|++++|++++..+.
T Consensus        89 ~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             C-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             C-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            8 5665666789999999999999997777689999999999999999987 4699999999999999999999988888


Q ss_pred             ccccCCCc----cEEEccCCcCcccCcccccCCcccceeecccccccc-cCCCCCcCCcccccccccccccc------cc
Q 035998          248 SIADLSNL----VRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG-RIPHSLSNSPTLNLLNLRNNSLD------GS  316 (1020)
Q Consensus       248 ~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~------~~  316 (1020)
                      .+..+++|    ++|++++|.+++..|..|... +|+.|++++|.... .++..+..++.++.+.+..+.+.      ..
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  246 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  246 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEEC
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhc
Confidence            89998888    899999999999888888876 89999999885432 23344555566655554433222      11


Q ss_pred             cccCCCCCC--CcCEEEcCCC-ccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHH
Q 035998          317 LLLNCPALT--NLTSLDLGTN-KFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQ  393 (1020)
Q Consensus       317 ~~~~~~~l~--~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~  393 (1020)
                      ....+..++  .++.+++++| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+..+|.   
T Consensus       247 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~---  321 (570)
T 2z63_A          247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT---  321 (570)
T ss_dssp             CTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB---
T ss_pred             chhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc---
Confidence            122222222  3566777777 777778888888888888888888887 577777777 88888888888887765   


Q ss_pred             HHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccccc--chhhhcCCCCcEEecccccccccccccccCc
Q 035998          394 VLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI--PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGF  471 (1020)
Q Consensus       394 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l  471 (1020)
                        ..+++|+.|+++.|......+.   ..+++|+.|++++|.+.+..  |..+.++++|++|++++|++++..+. |..+
T Consensus       322 --~~l~~L~~L~l~~n~~~~~~~~---~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l  395 (570)
T 2z63_A          322 --LKLKSLKRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGL  395 (570)
T ss_dssp             --CBCSSCCEEEEESCBSCCBCCC---CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETC
T ss_pred             --ccccccCEEeCcCCcccccccc---ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-cccc
Confidence              3677888888888766554443   57889999999999998765  78899999999999999999955444 9999


Q ss_pred             CcCcEEeCCCCcccccCC-CCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCc
Q 035998          472 QDLFYLDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWP  550 (1020)
Q Consensus       472 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~  550 (1020)
                      ++|++|++++|.+++..| ..+.++++|                                    +.|++++|++++..|.
T Consensus       396 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L------------------------------------~~L~l~~n~l~~~~~~  439 (570)
T 2z63_A          396 EQLEHLDFQHSNLKQMSEFSVFLSLRNL------------------------------------IYLDISHTHTRVAFNG  439 (570)
T ss_dssp             TTCCEEECTTSEEESCTTSCTTTTCTTC------------------------------------CEEECTTSCCEECCTT
T ss_pred             CCCCEEEccCCccccccchhhhhcCCCC------------------------------------CEEeCcCCcccccchh
Confidence            999999999999998766 467777776                                    4688899999999999


Q ss_pred             cccCCCcceEEEecCCcce-eccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC-CCCCC
Q 035998          551 EFGNLKKLHVFDLKHNNLS-GPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG-GQFQT  628 (1020)
Q Consensus       551 ~~~~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~-~~~~~  628 (1020)
                      .|+++++|++|+|++|+++ +.+|..++.+++|++|+|++|++++..|..+.++++|+.|++++|++++.+|.. ..+..
T Consensus       440 ~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  519 (570)
T 2z63_A          440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS  519 (570)
T ss_dssp             TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             hhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccC
Confidence            9999999999999999998 679999999999999999999999999999999999999999999999988763 56677


Q ss_pred             cCCccccCCCCCCC
Q 035998          629 FPNSSFDGNNLCGE  642 (1020)
Q Consensus       629 ~~~~~~~~n~l~~~  642 (1020)
                      +....+.+|++.+.
T Consensus       520 L~~L~l~~N~~~~~  533 (570)
T 2z63_A          520 LQKIWLHTNPWDCS  533 (570)
T ss_dssp             CCEEECCSSCBCCC
T ss_pred             CcEEEecCCcccCC
Confidence            88889999987653

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=4.2e-50  Score=488.69  Aligned_cols=453  Identities=19%  Similarity=0.258  Sum_probs=374.5

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCC------CC------CCCCccCCCCcceeeeccCccCCCCCccc
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL------SG------PLPQTINLPSIQVLDISSNSLNGSVPTSI  176 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l------~~------~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~  176 (1020)
                      .+++.|+|++|+++|.+|++|++|++|++|+|++|.+      .+      .+|... +..|+ +++++|.+.+.+|..+
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~-~~~l~-l~l~~~~l~~~~~~~~  158 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ-KQKMR-MHYQKTFVDYDPREDF  158 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH-HHHHH-THHHHHHTCCCGGGGS
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH-HHHHH-hhHHHhhhccCchhhH
Confidence            5789999999999999999999999999999999976      22      222222 56677 8899999988888777


Q ss_pred             cccCCcccEEEccCCCCCCCCCCcccccccccccccc--ccccccccchhhhhhcccccccccccccCCC----------
Q 035998          177 CKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG--MNDLTGGIADDIFQLQKLRLLGLQDNQLSGK----------  244 (1020)
Q Consensus       177 ~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~--~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------  244 (1020)
                      ...+..+..+++....+..      .....++.+++.  +|++++ +|..++++++|++|+|++|++++.          
T Consensus       159 ~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~  231 (636)
T 4eco_A          159 SDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN  231 (636)
T ss_dssp             CHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred             HHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccc
Confidence            6555555566665544432      222344445444  588887 888899999999999999999875          


Q ss_pred             -------CCcccc--cCCCccEEEccCCcCcccCcccccCCcccceeeccccc-ccc-cCCCCCcCC------ccccccc
Q 035998          245 -------LSPSIA--DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNR-FTG-RIPHSLSNS------PTLNLLN  307 (1020)
Q Consensus       245 -------~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L~  307 (1020)
                             +|..++  ++++|++|+|++|++.+.+|..|+++++|++|++++|+ ++| .+|..++.+      ++|++|+
T Consensus       232 ~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~  311 (636)
T 4eco_A          232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY  311 (636)
T ss_dssp             SHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEE
T ss_pred             cchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEE
Confidence                   888888  99999999999999999999999999999999999998 888 788888776      8999999


Q ss_pred             cccccccccccc--CCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCC-CCeeeCCCCC
Q 035998          308 LRNNSLDGSLLL--NCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFES-LSYLSLSNSS  384 (1020)
Q Consensus       308 L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~  384 (1020)
                      +++|+++ .+|.  .+..+++|++|+|++|+++|.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|.
T Consensus       312 L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~  388 (636)
T 4eco_A          312 IGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNK  388 (636)
T ss_dssp             CCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred             CCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCc
Confidence            9999998 6777  78899999999999999998888 8999999999999999998 78888999998 9999999999


Q ss_pred             CcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhh-------cCCCCcEEeccc
Q 035998          385 IYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLR-------GCSKLQLVDLSW  457 (1020)
Q Consensus       385 i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~-------~l~~L~~L~Ls~  457 (1020)
                      ++.+|..+                          ....+++|+.|++++|.+.+.+|..+.       .+.+|+.|+|++
T Consensus       389 l~~lp~~~--------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~  442 (636)
T 4eco_A          389 LKYIPNIF--------------------------DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN  442 (636)
T ss_dssp             CSSCCSCC--------------------------CTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCS
T ss_pred             Ccccchhh--------------------------hhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcC
Confidence            87665421                          112345788999999999999998888       888999999999


Q ss_pred             ccccccccccccCcCcCcEEeCCCCcccccCCCCCCC-Cc-------ccccccCcCCCCCCCcccceeeccccccccccc
Q 035998          458 NQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTG-LP-------SLITRNISLEEPSPDFPFFMRRNVSARGLQYNQ  529 (1020)
Q Consensus       458 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~-------~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~  529 (1020)
                      |++++..+..+..+++|++|+|++|+++ .+|..... +.       +|                               
T Consensus       443 N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L-------------------------------  490 (636)
T 4eco_A          443 NQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL-------------------------------  490 (636)
T ss_dssp             SCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC-------------------------------
T ss_pred             CccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc-------------------------------
Confidence            9999544445677999999999999999 66654322 21       22                               


Q ss_pred             ccCCCCeeecccCccccCCCcccc--CCCcceEEEecCCcceeccCccccCCCcccEEEc------cCCcccccCCcccc
Q 035998          530 IWSFPPTIDLSLNRLDGSIWPEFG--NLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDL------SYNNLSGAIPISLE  601 (1020)
Q Consensus       530 ~~~~~~~l~Ls~N~l~~~~~~~~~--~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~g~ip~~l~  601 (1020)
                           +.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..++.+++|++|+|      ++|++.+.+|.++.
T Consensus       491 -----~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~  563 (636)
T 4eco_A          491 -----TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT  563 (636)
T ss_dssp             -----CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGG
T ss_pred             -----cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHh
Confidence                 47899999999 6888887  99999999999999997 9999999999999999      56889999999999


Q ss_pred             ccccccccccccccccccCCCCCCCCCcCCccccCCCCC
Q 035998          602 KLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLC  640 (1020)
Q Consensus       602 ~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~l~  640 (1020)
                      ++++|+.|+|++|++ +.+|.. .+.++..+.+.+|++.
T Consensus       564 ~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          564 LCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNI  600 (636)
T ss_dssp             GCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTC
T ss_pred             cCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCc
Confidence            999999999999999 778875 3367888889999744

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-49  Score=471.14  Aligned_cols=452  Identities=18%  Similarity=0.236  Sum_probs=368.4

Q ss_pred             EEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccC
Q 035998           88 TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSN  166 (1020)
Q Consensus        88 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N  166 (1020)
                      +.+++++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+ ++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            35788999998 5777776  899999999999998778889999999999999999998888887 7999999999999


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccchhhhhhccc--cccccccccc--
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKL--RLLGLQDNQL--  241 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--  241 (1020)
                      +++ .+|..   .+++|++|+|++|++++ .+|..|+++++|++|+|++|.+++   ..+..+++|  ++|++++|++  
T Consensus        80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            998 77776   68899999999999987 478889999999999999999885   457777777  9999999998  


Q ss_pred             CCCCCcccccCC-CccEEEccCCcCcccCc-ccccCCcccceeeccccc-------ccccCCCCCcCCcccccccccccc
Q 035998          242 SGKLSPSIADLS-NLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSNR-------FTGRIPHSLSNSPTLNLLNLRNNS  312 (1020)
Q Consensus       242 ~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~L~~N~  312 (1020)
                      ++..|..+..+. +...+++++|++.+.++ ..+..+++|+.|++++|+       +.+.+| .++.+++|+.|++++|.
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence            778888887766 45567888888876554 467778888888888887       776666 67888888888888887


Q ss_pred             cccccccCCC---CCCCcCEEEcCCCccCCCCCCCC-----CCCCCCCeEecCCCcccccCc-ccccCC---CCCCeeeC
Q 035998          313 LDGSLLLNCP---ALTNLTSLDLGTNKFNGPLPTNL-----PRCRKLKNINLARNNFSGQIP-ETYKNF---ESLSYLSL  380 (1020)
Q Consensus       313 l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~l  380 (1020)
                      +++..+..+.   ..++|++|++++|+++|.+|..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l  309 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTV  309 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEE
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEc
Confidence            7753322111   13578888888888887778777     7777777777777777  344 444433   56777777


Q ss_pred             CCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccc
Q 035998          381 SNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL  460 (1020)
Q Consensus       381 ~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l  460 (1020)
                      ++|.+..++                             ....+++|+.|++++|.+.+.+|..++.+++|++|+|++|++
T Consensus       310 ~~n~l~~~~-----------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  360 (520)
T 2z7x_B          310 SGTRMVHML-----------------------------CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL  360 (520)
T ss_dssp             ESSCCCCCC-----------------------------CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCC
T ss_pred             CCCcccccc-----------------------------chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCcc
Confidence            777654322                             013567899999999999999999999999999999999999


Q ss_pred             cc--cccccccCcCcCcEEeCCCCcccccCCCC-CCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCee
Q 035998          461 SG--TIPVWFGGFQDLFYLDLSNNTFTGEIPKN-LTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI  537 (1020)
Q Consensus       461 ~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l  537 (1020)
                      ++  .+|.+|+.+++|++|+|++|++++.+|.. +..+++|                                    +.|
T Consensus       361 ~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L------------------------------------~~L  404 (520)
T 2z7x_B          361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL------------------------------------LSL  404 (520)
T ss_dssp             CBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC------------------------------------CEE
T ss_pred             CccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC------------------------------------CEE
Confidence            96  56788999999999999999999856654 6666666                                    467


Q ss_pred             ecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcc-ccccccccccccccccc
Q 035998          538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS-LEKLSFLSKFSVANNHL  616 (1020)
Q Consensus       538 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~l~ls~N~l  616 (1020)
                      ++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+++|+.|++++|++
T Consensus       405 ~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~  480 (520)
T 2z7x_B          405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW  480 (520)
T ss_dssp             ECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred             ECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCC
Confidence            8889999888877765  79999999999998 89998999999999999999999 67776 99999999999999999


Q ss_pred             cccCC
Q 035998          617 TGRIP  621 (1020)
Q Consensus       617 ~g~~p  621 (1020)
                      ++..+
T Consensus       481 ~c~c~  485 (520)
T 2z7x_B          481 DCSCP  485 (520)
T ss_dssp             CCCHH
T ss_pred             cccCC
Confidence            98655

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-49  Score=435.49  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            58999999999999999999864 69999999997553  3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ||+||+|.+++...  ....+++.+++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999754  234678999999999999999999999   9999999999999999999999999999876321


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                        .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....      ......+..... ..     
T Consensus       179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~-~~-----  244 (350)
T 4b9d_A          179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSF-PP-----  244 (350)
T ss_dssp             --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-CC-----
T ss_pred             --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCC-CC-----
Confidence              1223456899999999999999999999999999999999999999974321      112222222111 11     


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....    ...++.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 VSLH----YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111    1235889999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-48  Score=428.59  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=207.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ..|++.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|++++++++|||||+++++|.+.+..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999875 69999999997654444556889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      +||+|.+++...     .+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.....  
T Consensus       154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  223 (346)
T 4fih_A          154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--  223 (346)
T ss_dssp             TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred             CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence            999999998753     589999999999999999999999   9999999999999999999999999999876432  


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....      ......+.... ......    
T Consensus       224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-~~~~~~----  292 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL-PPRLKN----  292 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSS-CCCCSC----
T ss_pred             CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC-CCCCCc----
Confidence            2234557899999999999999999999999999999999999999974321      11112221111 111111    


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ......++.+++.+||+.||++|||++|+++
T Consensus       293 ---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 ---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               1112236789999999999999999999987

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-48  Score=428.71  Aligned_cols=253  Identities=23%  Similarity=0.218  Sum_probs=205.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .+.|+..++||+|+||.||+|+++ +|+.||||+++.+..     ..+|++++++++|||||++++++.+.+..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788899999999999999875 689999999976532     24699999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeeccccccccCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARLILSP  898 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  898 (1020)
                      |+||+|.+++++.    ..+++.++..++.||+.||+|||++   +||||||||+|||++.+| ++||+|||+|+.....
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999865    4689999999999999999999999   999999999999999987 6999999999876533


Q ss_pred             CCc---ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDT---HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...   ......+||+.|||||++.+..|+.++||||+||++|||+||+.||......+....+   ..  ......   
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~--~~~~~~---  276 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---AS--EPPPIR---  276 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HH--SCCGGG---
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---Hc--CCCCch---
Confidence            211   1123457999999999999999999999999999999999999999865544332211   11  111000   


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                            ..++.....+.+++.+||+.||++|||++|+++.|...
T Consensus       277 ------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          277 ------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                  11112234688999999999999999999999987654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-48  Score=422.69  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=207.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999864 78999999997542   223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++||+|.+++.+.    ..+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+..
T Consensus       112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999865    4689999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..........+||+.|||||++.++.|+.++||||+||++|||+||+.||.....   ....   ..+.....  ...  
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~---~~i~~~~~--~~p--  254 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIF---AKIIKLEY--DFP--  254 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCC--CCC--
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHcCCC--CCC--
Confidence            4334445567899999999999999999999999999999999999999974321   1111   12211110  110  


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1013 (1020)
                         ...    ..++.+++.+|++.||++|||++|++
T Consensus       255 ---~~~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 ---EKF----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---TTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---ccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence               111    23578999999999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-48  Score=431.02  Aligned_cols=269  Identities=27%  Similarity=0.397  Sum_probs=217.3

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCC-CccceEee
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQH-PNLVHLQG  805 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~  805 (1020)
                      .+++....++|++.+.||+|+||+||+|++.      .++.||||++..... ...+++.+|++++++++| ||||++++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            3445556788999999999999999999854      235799999976543 335679999999999965 89999999


Q ss_pred             EEecc-CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC
Q 035998          806 YCMHK-NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK  872 (1020)
Q Consensus       806 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  872 (1020)
                      +|.+. ...++|||||++|+|.++++....            ....+++.++..++.|||+||+|||++   +|||||||
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK  212 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  212 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence            99765 568999999999999999976422            134689999999999999999999999   99999999


Q ss_pred             CCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 035998          873 SSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCK  951 (1020)
Q Consensus       873 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  951 (1020)
                      |+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999997755444444556789999999999999999999999999999999998 999997644


Q ss_pred             CCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          952 PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ..+  ....   ....... ...         +.....++.+++.+||+.||++||||+|+++.|++++
T Consensus       293 ~~~--~~~~---~i~~g~~-~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          293 IDE--EFCR---RLKEGTR-MRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CSH--HHHH---HHHHTCC-CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH--HHHH---HHHcCCC-CCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            321  1111   1111111 111         1112246889999999999999999999999998764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.7e-47  Score=457.43  Aligned_cols=474  Identities=19%  Similarity=0.211  Sum_probs=386.7

Q ss_pred             EecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCcc
Q 035998           90 LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSL  168 (1020)
Q Consensus        90 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l  168 (1020)
                      .+.++++++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++.+|..+ ++++|++|+|++|++
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            677888887 5676665  799999999999998889999999999999999999999998888 899999999999999


Q ss_pred             CCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccc-hhhhhhcccccccccccccCCCCC
Q 035998          169 NGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIA-DDIFQLQKLRLLGLQDNQLSGKLS  246 (1020)
Q Consensus       169 ~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~  246 (1020)
                      + .+|...+..+++|++|+|++|.+++ ..|..++++++|++|++++|.+.+.+| ..+.++++|++|++++|++++..|
T Consensus        87 ~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  165 (549)
T 2z81_A           87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS  165 (549)
T ss_dssp             C-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             C-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence            9 5555555789999999999999997 467789999999999999999544554 689999999999999999999999


Q ss_pred             cccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC--C-CCCcCCcccccccccccccccccc----c
Q 035998          247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI--P-HSLSNSPTLNLLNLRNNSLDGSLL----L  319 (1020)
Q Consensus       247 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~L~L~~N~l~~~~~----~  319 (1020)
                      ..+..+++|++|+++.|.+....+..+..+++|++|++++|++++..  | .....+++|+.|++++|.+++..+    .
T Consensus       166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~  245 (549)
T 2z81_A          166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK  245 (549)
T ss_dssp             TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHG
T ss_pred             hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHH
Confidence            99999999999999999997544444567999999999999999753  2 234567899999999999886544    3


Q ss_pred             CCCCCCCcCEEEcCCCccCCCC------CCCCCCCCCCCeEecCCCccccc-----CcccccCCCCCCeeeCCCCCCcch
Q 035998          320 NCPALTNLTSLDLGTNKFNGPL------PTNLPRCRKLKNINLARNNFSGQ-----IPETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       320 ~~~~l~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                      .+..+++|+.|++++|.+.+..      ...+..+.+|+.|++.++.+...     .+..+....+|+.|++++|.+..+
T Consensus       246 ~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~i  325 (549)
T 2z81_A          246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV  325 (549)
T ss_dssp             GGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCC
T ss_pred             HhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccC
Confidence            3456789999999999987532      23456778888999888876532     122233456788888888888777


Q ss_pred             hhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccch---hhhcCCCCcEEeccccccccccc
Q 035998          389 SSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQ---WLRGCSKLQLVDLSWNQLSGTIP  465 (1020)
Q Consensus       389 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p  465 (1020)
                      |..+  +                         ..+++|+.|++++|.+.+.+|.   .++.+++|++|+|++|++++..+
T Consensus       326 p~~~--~-------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  378 (549)
T 2z81_A          326 PCSF--S-------------------------QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK  378 (549)
T ss_dssp             CHHH--H-------------------------HHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHH
T ss_pred             CHHH--H-------------------------hcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccccc
Confidence            6542  1                         2355677788888888887754   47889999999999999986543


Q ss_pred             --ccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCc
Q 035998          466 --VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNR  543 (1020)
Q Consensus       466 --~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~  543 (1020)
                        ..+..+++|++|+|++|+++ .+|..+..+++|+                                    .|++++|+
T Consensus       379 ~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~------------------------------------~L~Ls~N~  421 (549)
T 2z81_A          379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR------------------------------------FLNLSSTG  421 (549)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCC------------------------------------EEECTTSC
T ss_pred             chhhhhcCCCCCEEECCCCCCc-cCChhhccccccc------------------------------------EEECCCCC
Confidence              56899999999999999999 7888888877773                                    56777777


Q ss_pred             cccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCC-
Q 035998          544 LDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS-  622 (1020)
Q Consensus       544 l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~-  622 (1020)
                      |++ +|..+  .++|+.|+|++|+|++. +   ..+++|++|||++|+|+ .+|. ...+++|++|+|++|++++.+|. 
T Consensus       422 l~~-l~~~~--~~~L~~L~Ls~N~l~~~-~---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~  492 (549)
T 2z81_A          422 IRV-VKTCI--PQTLEVLDVSNNNLDSF-S---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGI  492 (549)
T ss_dssp             CSC-CCTTS--CTTCSEEECCSSCCSCC-C---CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTG
T ss_pred             ccc-ccchh--cCCceEEECCCCChhhh-c---ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHH
Confidence            764 23322  25899999999999964 2   57899999999999999 7887 57899999999999999998886 


Q ss_pred             CCCCCCcCCccccCCCCC
Q 035998          623 GGQFQTFPNSSFDGNNLC  640 (1020)
Q Consensus       623 ~~~~~~~~~~~~~~n~l~  640 (1020)
                      .+.+..+....+.+|++.
T Consensus       493 ~~~l~~L~~L~l~~N~~~  510 (549)
T 2z81_A          493 FDRLTSLQKIWLHTNPWD  510 (549)
T ss_dssp             GGGCTTCCEEECCSSCBC
T ss_pred             HhcCcccCEEEecCCCcc
Confidence            356778888899999863

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.9e-46  Score=459.77  Aligned_cols=485  Identities=19%  Similarity=0.196  Sum_probs=316.2

Q ss_pred             ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCC
Q 035998           66 VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL  145 (1020)
Q Consensus        66 ~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  145 (1020)
                      ..|.|+..+.+.||.+++ ..++.|+|++|.|++..+.+|.++++|++|+|++|+|++..|.+|++|++|++|+|++|+|
T Consensus        34 ~~~~c~~~~l~~vP~~lp-~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l  112 (635)
T 4g8a_A           34 ITYQCMELNFYKIPDNLP-FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI  112 (635)
T ss_dssp             TEEECTTSCCSSCCSSSC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CEEECCCCCcCccCCCCC-cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence            468999999999999886 5899999999999988888999999999999999999977788899999999999999999


Q ss_pred             CCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccch
Q 035998          146 SGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIAD  223 (1020)
Q Consensus       146 ~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~  223 (1020)
                      ++.++..+ ++++|++|+|++|+++ .+|...+..+++|++|+|++|++++ ..|..++.+++|++|+|++|++++..+.
T Consensus       113 ~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  191 (635)
T 4g8a_A          113 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  191 (635)
T ss_dssp             CEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             CCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence            99888888 8999999999999998 6777777899999999999999986 4678889999999999999999999999


Q ss_pred             hhhhhcccc----cccccccccCCCCCcccccCCCccEEEccCCcCcc-cCcccccCCcccceeeccccc------ccc-
Q 035998          224 DIFQLQKLR----LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG-NIPDVFAGLGEFQYLVAHSNR------FTG-  291 (1020)
Q Consensus       224 ~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~------l~~-  291 (1020)
                      .+..+.+++    .++++.|.++...+..+ ....+..+++++|..+. ..+..+.++..++...+..+.      +.. 
T Consensus       192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  270 (635)
T 4g8a_A          192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  270 (635)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             cccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence            999887765    57789999985554444 44567888888886553 223445555555544433221      111 


Q ss_pred             --------------------------cCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC
Q 035998          292 --------------------------RIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL  345 (1020)
Q Consensus       292 --------------------------~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  345 (1020)
                                                ..+..+....+++.+++.+|.+.....  +....+|+.|++.+|++.+..+.  
T Consensus       271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~~~~~~~~~~--  346 (635)
T 4g8a_A          271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTL--  346 (635)
T ss_dssp             CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG--GGSCCCCSEEEEESCEESSCCCC--
T ss_pred             cccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc--cccchhhhhhhcccccccCcCcc--
Confidence                                      122334444555666666665554332  33345667777777766643332  


Q ss_pred             CCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       346 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                       .+..|+.+++++|.+...  ..+..+++|+.|++++|.+............+.+|+.+                     
T Consensus       347 -~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L---------------------  402 (635)
T 4g8a_A          347 -KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYL---------------------  402 (635)
T ss_dssp             -BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEE---------------------
T ss_pred             -cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhh---------------------
Confidence             345666677776666532  23345667777777777765443322333344444444                     


Q ss_pred             ceEEEecccccccccchhhhcCCCCcEEeccccccccccc-ccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCc
Q 035998          426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP-VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS  504 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s  504 (1020)
                          ++..|.... .+..+..+++|+.+++++|+.....+ ..|..+.+++.+++++|.+++..|..+..+++|+     
T Consensus       403 ----~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~-----  472 (635)
T 4g8a_A          403 ----DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE-----  472 (635)
T ss_dssp             ----ECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC-----
T ss_pred             ----hcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh-----
Confidence                444444432 23334445555555555554443332 2344555555555555555555554444444432     


Q ss_pred             CCCCCCCcccceeecccccccccccccCCCCeeecccCcc-ccCCCccccCCCcceEEEecCCcceeccCccccCCCccc
Q 035998          505 LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRL-DGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLE  583 (1020)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l-~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  583 (1020)
                                                     .|+|++|++ .+..|..|..+++|++|+|++|+|++..|..|+++++|+
T Consensus       473 -------------------------------~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~  521 (635)
T 4g8a_A          473 -------------------------------VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  521 (635)
T ss_dssp             -------------------------------EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             -------------------------------hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence                                           334444432 223344455555555555555555554455555555555


Q ss_pred             EEEccCCcccccCCccccccccccccccccccccccCCC
Q 035998          584 TLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS  622 (1020)
Q Consensus       584 ~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~  622 (1020)
                      +|+|++|+|++..|..|..+++|+.|+|++|+|++.+|.
T Consensus       522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~  560 (635)
T 4g8a_A          522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ  560 (635)
T ss_dssp             EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSS
T ss_pred             EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHH
Confidence            555555555544444555555555555555555554443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-47  Score=413.14  Aligned_cols=246  Identities=25%  Similarity=0.386  Sum_probs=196.1

Q ss_pred             CcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceEEEE
Q 035998          745 DQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRLLIY  817 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  817 (1020)
                      ++.+.||+|+||+||+|++. +++.||||++....  ....+.|.+|++++++++|||||+++++|.+    +...|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999865 68899999986542  3344678999999999999999999999875    34578999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeecccccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLIL  896 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~  896 (1020)
                      |||++|+|.+++.+.    ..+++..+..++.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999875    4689999999999999999999998 112999999999999984 7999999999998642


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .    ......+||+.|||||++.+ .|+.++||||+||++|||+||+.||.....     .......+..... +.   
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~~-~~---  249 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK-PA---  249 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC-CG---
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCCC-CC---
Confidence            2    23445789999999998865 699999999999999999999999964321     1111111211111 11   


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .......    .++.+++.+||+.||++|||++|+++
T Consensus       250 -~~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 -SFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence             1111111    25789999999999999999999987

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=8.7e-48  Score=474.77  Aligned_cols=441  Identities=19%  Similarity=0.228  Sum_probs=346.9

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeec-cCCCCCCCCCCcc-CC----CC-----cceeee-------ccCccCC
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDL-SSNDLSGPLPQTI-NL----PS-----IQVLDI-------SSNSLNG  170 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-~~n~l~~~~p~~~-~l----~~-----L~~L~L-------s~N~l~~  170 (1020)
                      .+++.|+|++|+++|.+|++|++|++|++|+| ++|.++|..|... ..    ..     ++..++       ....+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 9998887744321 11    00     000000       0000000


Q ss_pred             -----------CCCccccccCCcccEEEcc--CCCCCCCCCCcccccccccccccccccccc-----------------c
Q 035998          171 -----------SVPTSICKNSSRIRVINLS--VNYFSGTLSPGLGNCASLEHLCLGMNDLTG-----------------G  220 (1020)
Q Consensus       171 -----------~ip~~~~~~~~~L~~L~L~--~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-----------------~  220 (1020)
                                 ..+.. ......++.+.+.  .|++++ +|..|+++++|++|+|++|++++                 .
T Consensus       403 l~~~~l~~~~~~~~i~-~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~  480 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIK-KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY  480 (876)
T ss_dssp             HHHHHHHTCTTSCCCC-CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHhhhCccccccc-cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence                       00000 0112223333333  377777 78788888888888888888887                 3


Q ss_pred             cchhhh--hhcccccccccccccCCCCCcccccCCCccEEEccCCc-Ccc-cCcccccCCc-------ccceeecccccc
Q 035998          221 IADDIF--QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN-FSG-NIPDVFAGLG-------EFQYLVAHSNRF  289 (1020)
Q Consensus       221 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l  289 (1020)
                      +|..++  ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..++.++       +|++|++++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            888877  99999999999999999999999999999999999998 888 7888777666       999999999999


Q ss_pred             cccCCC--CCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCC-CCeEecCCCcccccCc
Q 035998          290 TGRIPH--SLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRK-LKNINLARNNFSGQIP  366 (1020)
Q Consensus       290 ~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p  366 (1020)
                      + .+|.  .++++++|+.|+|++|+++ .+| .+..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+|
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp  635 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP  635 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence            9 7787  8999999999999999998 666 8889999999999999999 88888999998 999999999998 788


Q ss_pred             ccccCCCC--CCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchh-
Q 035998          367 ETYKNFES--LSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW-  443 (1020)
Q Consensus       367 ~~~~~l~~--L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~-  443 (1020)
                      ..+..+..  |+.|++++|++......+                      .........++|+.|++++|.+.. +|.. 
T Consensus       636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l----------------------~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~  692 (876)
T 4ecn_A          636 NIFNAKSVYVMGSVDFSYNKIGSEGRNI----------------------SCSMDDYKGINASTVTLSYNEIQK-FPTEL  692 (876)
T ss_dssp             SCCCTTCSSCEEEEECCSSCTTTTSSSC----------------------SSCTTTCCCCCEEEEECCSSCCCS-CCHHH
T ss_pred             hhhhccccCCCCEEECcCCcCCCccccc----------------------hhhhccccCCCcCEEEccCCcCCc-cCHHH
Confidence            88877754  999999999876532110                      001111234578999999999994 5554 


Q ss_pred             hhcCCCCcEEecccccccccccccccC--------cCcCcEEeCCCCcccccCCCCCC--CCcccccccCcCCCCCCCcc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTIPVWFGG--------FQDLFYLDLSNNTFTGEIPKNLT--GLPSLITRNISLEEPSPDFP  513 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~l~~s~~~~~~~~~  513 (1020)
                      +..+++|+.|+|++|+|+ .+|..+..        +++|++|+|++|+++ .+|..+.  .+++|               
T Consensus       693 ~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L---------------  755 (876)
T 4ecn_A          693 FATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYL---------------  755 (876)
T ss_dssp             HHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTC---------------
T ss_pred             HccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCc---------------
Confidence            458999999999999999 66665443        239999999999999 7888776  77776               


Q ss_pred             cceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecC------CcceeccCccccCCCcccEEEc
Q 035998          514 FFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH------NNLSGPIPSELTGMTSLETLDL  587 (1020)
Q Consensus       514 ~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~~L~L  587 (1020)
                                           +.|+|++|+|++ +|..++.+++|+.|+|++      |++.+.+|..|+++++|+.|+|
T Consensus       756 ---------------------~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~L  813 (876)
T 4ecn_A          756 ---------------------SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI  813 (876)
T ss_dssp             ---------------------CEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEEC
T ss_pred             ---------------------CEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEEC
Confidence                                 468889999998 788999999999999976      8889999999999999999999


Q ss_pred             cCCcccccCCccccccccccccccccccccccCC
Q 035998          588 SYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP  621 (1020)
Q Consensus       588 s~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p  621 (1020)
                      ++|+| +.+|..+.  ++|+.|+|++|++....+
T Consensus       814 s~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~  844 (876)
T 4ecn_A          814 GSNDI-RKVDEKLT--PQLYILDIADNPNISIDV  844 (876)
T ss_dssp             CSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred             CCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence            99999 69999876  699999999999876544

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-47  Score=407.36  Aligned_cols=248  Identities=22%  Similarity=0.375  Sum_probs=191.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999864 69999999997543   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+ +|+|.+++.+.    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...+
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 67999888764    4699999999999999999999999   999999999999999999999999999987533


Q ss_pred             CCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                         .......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.....      ......+.....  ..  
T Consensus       165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~~--~~--  231 (275)
T 3hyh_A          165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGVY--TL--  231 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC--CC--
T ss_pred             ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCC--CC--
Confidence               223345789999999999988776 5899999999999999999999974321      111122211110  00  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                      |   ..    ....+.+++.+||+.||++|||++|+++  |++
T Consensus       232 p---~~----~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          232 P---KF----LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             C---TT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             C---CC----CCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence            0   11    1235789999999999999999999997  554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=429.94  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=208.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .+.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|++++++++|||||+++++|.+.+..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999875 6999999999765544456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      |+||+|.+++...     .+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-  300 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-  300 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-
Confidence            9999999998753     589999999999999999999999   9999999999999999999999999999876432 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                       .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....      ......+.... ......   
T Consensus       301 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-~~~~~~---  369 (423)
T 4fie_A          301 -VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL-PPRLKN---  369 (423)
T ss_dssp             -CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCSC---
T ss_pred             -CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC-CCCCcc---
Confidence             2234567899999999999999999999999999999999999999974321      11112222111 111101   


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    ....+.+|+.+||+.||++|||++|+++
T Consensus       370 ~~~----~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHK----VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTS----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011    1235789999999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-47  Score=421.06  Aligned_cols=267  Identities=27%  Similarity=0.308  Sum_probs=202.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC----ceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN----DRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  817 (1020)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++...... ...+++|+..+.+++|||||+++++|.+.+    ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577789999999999999998 5899999999754321 223345666667889999999999998764    468999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-----EPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      |||++|+|.++++..     .++++.+.+++.|+++||+|||+++     .++||||||||+|||++.++.+||+|||+|
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999864     5899999999999999999999752     458999999999999999999999999999


Q ss_pred             ccccCCCCc--ccccccccccCccCccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc--------c
Q 035998          893 RLILSPYDT--HVTTDLVGTLGYIPPEYGQAS------VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS--------R  956 (1020)
Q Consensus       893 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--------~  956 (1020)
                      +........  ......+||+.|||||++.+.      .++.++|||||||++|||+||+.||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            877543322  122346799999999998764      467899999999999999999887754322111        0


Q ss_pred             cHHHHHHHHHhhcccccccCcccc-CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          957 DLISWVIRMRQENRESEVLDPFIY-DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .............    ..+|.+. .....+....+.+++.+||+.||++||||+||++.|+++
T Consensus       236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            1111111111111    1122221 122345667789999999999999999999999999876

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=453.65  Aligned_cols=452  Identities=20%  Similarity=0.219  Sum_probs=380.6

Q ss_pred             cEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccC
Q 035998          112 RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSV  190 (1020)
Q Consensus       112 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~  190 (1020)
                      ++|++++|+++ .+|..+.  ++|++|+|++|.+++.+|..+ ++++|++|+|++|++++..|. .+..+++|++|+|++
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~   78 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-VFKFNQELEYLDLSH   78 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-GGTTCTTCCEEECCS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH-HhhcccCCCEEecCC
Confidence            58999999999 7888776  899999999999999988777 899999999999999954454 457899999999999


Q ss_pred             CCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCCcccccCCCc--cEEEccCCcC--
Q 035998          191 NYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNL--VRLDVSSNNF--  265 (1020)
Q Consensus       191 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--  265 (1020)
                      |+++ .+|..  .+++|++|+|++|++++ .+|..|+.+++|++|++++|++++   ..+..+++|  ++|++++|.+  
T Consensus        79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             SCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             Ccee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            9999 56665  89999999999999997 578999999999999999999986   567888888  9999999999  


Q ss_pred             cccCcccccCCc-ccceeecccccccccCCC-CCcCCcccccccccccc-------cccccccCCCCCCCcCEEEcCCCc
Q 035998          266 SGNIPDVFAGLG-EFQYLVAHSNRFTGRIPH-SLSNSPTLNLLNLRNNS-------LDGSLLLNCPALTNLTSLDLGTNK  336 (1020)
Q Consensus       266 ~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~  336 (1020)
                      ++..|..+..+. +...+++++|++.+.++. .+.++++|+.|++++|.       +.+.++ .+..+++|+.|++++|+
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence            888898888876 455678899998876654 67889999999999998       777666 78889999999999999


Q ss_pred             cCCCCCCCCC---CCCCCCeEecCCCcccccCcccc-----cCCCCCCeeeCCCCCCcchh-hHHHHHhhhcccchhhhh
Q 035998          337 FNGPLPTNLP---RCRKLKNINLARNNFSGQIPETY-----KNFESLSYLSLSNSSIYNLS-SALQVLQQCRNLTTLVLT  407 (1020)
Q Consensus       337 l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~l~~N~i~~l~-~~~~~l~~l~~L~~L~l~  407 (1020)
                      +++..+..+.   ..++|++|++++|+++|.+|..+     ..+++|+.+++++|.+ .+| ..+..+..          
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~----------  300 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFS----------  300 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHH----------
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccc----------
Confidence            8754322211   24589999999999999999998     8999999999999998 666 22221111          


Q ss_pred             ccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccc-
Q 035998          408 LNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG-  486 (1020)
Q Consensus       408 ~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-  486 (1020)
                                     -.+|+.|++++|.+....  .+..+++|++|++++|++++.+|.+++.+++|++|+|++|++++ 
T Consensus       301 ---------------~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  363 (520)
T 2z7x_B          301 ---------------NMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKEL  363 (520)
T ss_dssp             ---------------TCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH
T ss_pred             ---------------cCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCcc
Confidence                           134677778887776432  12688999999999999999899999999999999999999996 


Q ss_pred             -cCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCcc-ccCCCcceEEEec
Q 035998          487 -EIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPE-FGNLKKLHVFDLK  564 (1020)
Q Consensus       487 -~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~-~~~L~~L~~L~Ls  564 (1020)
                       .+|..++++++|                                    +.|++++|++++.+|.. |..+++|++|+|+
T Consensus       364 ~~~~~~~~~l~~L------------------------------------~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls  407 (520)
T 2z7x_B          364 SKIAEMTTQMKSL------------------------------------QQLDISQNSVSYDEKKGDCSWTKSLLSLNMS  407 (520)
T ss_dssp             HHHHHHHTTCTTC------------------------------------CEEECCSSCCBCCGGGCSCCCCTTCCEEECC
T ss_pred             ccchHHHhhCCCC------------------------------------CEEECCCCcCCcccccchhccCccCCEEECc
Confidence             566777888777                                    46888999999866654 8999999999999


Q ss_pred             CCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCC-CCCCCCcCCccccCCCCCC
Q 035998          565 HNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS-GGQFQTFPNSSFDGNNLCG  641 (1020)
Q Consensus       565 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~l~~  641 (1020)
                      +|++++.+|..+.  ++|++|||++|+|+ .+|..+..+++|+.|++++|++++.++. ...+..+....+.+|++.+
T Consensus       408 ~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          408 SNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             SSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcc
Confidence            9999998888775  89999999999999 8999999999999999999999964443 3456677788889997543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-47  Score=411.58  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=196.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.....  .....+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    478999999975431  123457889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||++||+|.+++.+.    ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999875    4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .+..  ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....   .+.   ...+.....  .. 
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~---~~~i~~~~~--~~-  245 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KET---MTMILKAKL--GM-  245 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHCCC--CC-
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHH---HHHHHcCCC--CC-
Confidence            4322  233457899999999999999999999999999999999999999975322   111   112211110  00 


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT-----QQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1014 (1020)
                       |   ..    ...++.+++.+||+.||++|||+     +|+++
T Consensus       246 -p---~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          246 -P---QF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -C---TT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -C---Cc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             1   11    12357899999999999999984     67765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-45  Score=400.59  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=189.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-------
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-------  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  812 (1020)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35899999999999999999865 78999999987543 3344678999999999999999999999976543       


Q ss_pred             -----eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          813 -----RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       813 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                           .|+||||+++|+|.+++..... ....++..++.++.||++||+|||++   +||||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                 6899999999999999986422 23456777899999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCc----------ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCccc
Q 035998          888 DFGLARLILSPYDT----------HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD  957 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  957 (1020)
                      |||+|+........          ......+||+.|||||++.+..|+.++||||+||++|||++   ||..     ..+
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QME  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccH
Confidence            99999876532211          11234579999999999999999999999999999999996   7742     111


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........... ..     |.    ..........+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~-~~-----p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRTLTDVRNL-KF-----PP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHTT-CC-----CH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcC-CC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111111111 11     10    11122234678999999999999999999987

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.1e-45  Score=442.50  Aligned_cols=453  Identities=20%  Similarity=0.228  Sum_probs=342.9

Q ss_pred             EEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccC
Q 035998           88 TGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSN  166 (1020)
Q Consensus        88 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N  166 (1020)
                      +.++++++++++ +|..+.  ++|++|+|++|.+++..|.+|+++++|++|+|++|+|++..|..+ ++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            556777777775 666554  788888888888887777788888888888888888888777777 7888888888888


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCC-CCCCccccccccccccccccccccccchhhhhhccc--cccccccccc--
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSG-TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKL--RLLGLQDNQL--  241 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--  241 (1020)
                      +++ .+|..   .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++   ..+..+++|  ++|++++|++  
T Consensus       111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCC
T ss_pred             cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccc
Confidence            887 67766   57888888888888876 345788888888888888888875   345555555  8888888888  


Q ss_pred             CCCCCcccccCC-CccEEEccCCcCcccCcc-cccCCcccceeeccccc-----ccccCCCCCcCCcccccccccccccc
Q 035998          242 SGKLSPSIADLS-NLVRLDVSSNNFSGNIPD-VFAGLGEFQYLVAHSNR-----FTGRIPHSLSNSPTLNLLNLRNNSLD  314 (1020)
Q Consensus       242 ~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~p~~~~~l~~L~~L~L~~N~l~  314 (1020)
                      ++..|..+..+. ..-.+++++|.+.+.+++ .+..+++|+.|++++|+     +.+.+ ..+..+++|+.|+++++.+.
T Consensus       184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~l~  262 (562)
T 3a79_B          184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIETT  262 (562)
T ss_dssp             CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEEEC
T ss_pred             cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCcCc
Confidence            777787877765 222567888888775554 45677888888888874     22222 24566777777777777665


Q ss_pred             cccccC---CCCCCCcCEEEcCCCccCCCCCCCC-----CCCCCCCeEecCCCcccccCc-ccccC---CCCCCeeeCCC
Q 035998          315 GSLLLN---CPALTNLTSLDLGTNKFNGPLPTNL-----PRCRKLKNINLARNNFSGQIP-ETYKN---FESLSYLSLSN  382 (1020)
Q Consensus       315 ~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~p-~~~~~---l~~L~~L~l~~  382 (1020)
                      +.....   ....++|++|++++|+++|.+|..+     ..++.|+.++++.|.+  .+| ..+..   ..+|++|++++
T Consensus       263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~  340 (562)
T 3a79_B          263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD  340 (562)
T ss_dssp             HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred             HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence            321110   1123478888888888887777776     5666666666666665  333 22222   24577777777


Q ss_pred             CCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccc
Q 035998          383 SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSG  462 (1020)
Q Consensus       383 N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  462 (1020)
                      |.+..++                             ....+++|+.|++++|.+.+.+|..++++++|+.|+|++|++++
T Consensus       341 n~~~~~~-----------------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  391 (562)
T 3a79_B          341 TPFIHMV-----------------------------CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN  391 (562)
T ss_dssp             SCCCCCC-----------------------------CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCB
T ss_pred             CCccccc-----------------------------CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCC
Confidence            6653321                             11356789999999999999999999999999999999999996


Q ss_pred             --cccccccCcCcCcEEeCCCCcccccCCC-CCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeec
Q 035998          463 --TIPVWFGGFQDLFYLDLSNNTFTGEIPK-NLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDL  539 (1020)
Q Consensus       463 --~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~L  539 (1020)
                        .+|..|+++++|++|+|++|++++.+|. .+..+++|                                    +.|+|
T Consensus       392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L------------------------------------~~L~l  435 (562)
T 3a79_B          392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI------------------------------------LVLNL  435 (562)
T ss_dssp             TTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC------------------------------------CEEEC
T ss_pred             cccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC------------------------------------CEEEC
Confidence              4467899999999999999999985665 47777766                                    46788


Q ss_pred             ccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcc-ccccccccccccccccccc
Q 035998          540 SLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS-LEKLSFLSKFSVANNHLTG  618 (1020)
Q Consensus       540 s~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-l~~l~~L~~l~ls~N~l~g  618 (1020)
                      ++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|++|||++|+|+ .+|.. +..+++|+.|++++|++++
T Consensus       436 ~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             CSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             CCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCC
Confidence            89999887776665  78999999999998 79998889999999999999999 67776 9999999999999999998


Q ss_pred             cCCC
Q 035998          619 RIPS  622 (1020)
Q Consensus       619 ~~p~  622 (1020)
                      ..|.
T Consensus       512 ~c~~  515 (562)
T 3a79_B          512 TCPG  515 (562)
T ss_dssp             CHHH
T ss_pred             Ccch
Confidence            7663

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-44  Score=397.67  Aligned_cols=286  Identities=40%  Similarity=0.654  Sum_probs=248.4

Q ss_pred             cccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc
Q 035998          731 EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK  810 (1020)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  810 (1020)
                      .+++.++...+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34445556678999999999999999999999888999999998876655667899999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      +..++||||+++|+|.+++.........+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999976544445789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +++...............||+.|+|||++.+..++.++||||+|+++|||++|+.||....+.+......|.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99875433333334445689999999999888999999999999999999999999987777666677777666666666


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .....++.......+.....+.+++.+||+.||++|||++|+++.|+.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            6666777666677788889999999999999999999999999999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.7e-43  Score=431.86  Aligned_cols=502  Identities=19%  Similarity=0.221  Sum_probs=402.7

Q ss_pred             ecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccC
Q 035998           91 FLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLN  169 (1020)
Q Consensus        91 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~  169 (1020)
                      +=++.+++ .+|..+.  +++++|||++|+|++..|.+|.++++|++|||++|+|++++|.++ ++++|++|+|++|+|+
T Consensus        37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            33444555 4666553  579999999999997777889999999999999999999999888 8999999999999998


Q ss_pred             CCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCCcc
Q 035998          170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSPS  248 (1020)
Q Consensus       170 ~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  248 (1020)
                       .+|...|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ ..|..+..+++|++|+|++|++++..+..
T Consensus       114 -~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  192 (635)
T 4g8a_A          114 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD  192 (635)
T ss_dssp             -EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred             -CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence             7888888999999999999999998888889999999999999999976 46888999999999999999999888888


Q ss_pred             cccCCCc----cEEEccCCcCcccCcccccCCcccceeeccccccccc-CCCCCcCCccccccccccccc------cccc
Q 035998          249 IADLSNL----VRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR-IPHSLSNSPTLNLLNLRNNSL------DGSL  317 (1020)
Q Consensus       249 ~~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l------~~~~  317 (1020)
                      +..+.++    ..++++.|.++...+..+.. ..+..+++.+|..... .+..+..+..++...+..+..      ....
T Consensus       193 l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  271 (635)
T 4g8a_A          193 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  271 (635)
T ss_dssp             GHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             ccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence            8877654    47999999999776666654 4677888888866532 233455666666666544432      2223


Q ss_pred             ccCCCCCCCcCEEEcCCCccC---CCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHH
Q 035998          318 LLNCPALTNLTSLDLGTNKFN---GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQV  394 (1020)
Q Consensus       318 ~~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~  394 (1020)
                      ...+..+..+..+++..+...   ...+..+..+.+++.+++.+|.+....  .+....+|+.|++++|.+..++.    
T Consensus       272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~----  345 (635)
T 4g8a_A          272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT----  345 (635)
T ss_dssp             TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC----
T ss_pred             ccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc----
Confidence            334445556666666555433   234556677788999999998887543  35667789999999998877654    


Q ss_pred             HhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccc--cccchhhhcCCCCcEEecccccccccccccccCcC
Q 035998          395 LQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLR--GSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQ  472 (1020)
Q Consensus       395 l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  472 (1020)
                       ..+..|+.+.+..|.......   ...+++|+.+++..|.+.  +..+..+..+.+|+.|+++.|.+. .++..+..++
T Consensus       346 -~~l~~L~~l~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~  420 (635)
T 4g8a_A          346 -LKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLE  420 (635)
T ss_dssp             -CBCTTCCEEEEESCCSCCBCC---CCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCT
T ss_pred             -ccchhhhhcccccccCCCCcc---cccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccc
Confidence             245677777777775544322   346789999999999885  456778889999999999999998 5677899999


Q ss_pred             cCcEEeCCCCcccccCC-CCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCcc
Q 035998          473 DLFYLDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPE  551 (1020)
Q Consensus       473 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~  551 (1020)
                      +|+.+++++|+.....+ ..+.+++++                                    ..++++.|++.+..+..
T Consensus       421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l------------------------------------~~l~ls~n~l~~~~~~~  464 (635)
T 4g8a_A          421 QLEHLDFQHSNLKQMSEFSVFLSLRNL------------------------------------IYLDISHTHTRVAFNGI  464 (635)
T ss_dssp             TCCEEECTTSEEESTTSSCTTTTCTTC------------------------------------CEEECTTSCCEECCTTT
T ss_pred             cccchhhhhcccccccccccccccccc------------------------------------ccccccccccccccccc
Confidence            99999999998876654 345555544                                    36789999999999999


Q ss_pred             ccCCCcceEEEecCCcc-eeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccCCC-CCCCCCc
Q 035998          552 FGNLKKLHVFDLKHNNL-SGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS-GGQFQTF  629 (1020)
Q Consensus       552 ~~~L~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~  629 (1020)
                      +..+++|+.|+|++|++ .+.+|..|..+++|++|||++|+|++.+|..|.++++|+.|+|++|+|++.+|. ...+.++
T Consensus       465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  544 (635)
T 4g8a_A          465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  544 (635)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred             cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence            99999999999999985 446889999999999999999999999999999999999999999999998875 3456778


Q ss_pred             CCccccCCCCCCCCC
Q 035998          630 PNSSFDGNNLCGEHR  644 (1020)
Q Consensus       630 ~~~~~~~n~l~~~~~  644 (1020)
                      ..+.+.+|.+.+..+
T Consensus       545 ~~L~Ls~N~l~~~~~  559 (635)
T 4g8a_A          545 QVLDYSLNHIMTSKK  559 (635)
T ss_dssp             CEEECTTSCCCBCCS
T ss_pred             CEEECCCCcCCCCCH
Confidence            888999999887644

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=406.32  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec------cC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH------KN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  811 (1020)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999864 79999999997543  2334678899999999999999999998764      35


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..|+|||||+ |+|.+++...    ..+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            7899999996 6788888653    5799999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCC--CcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          892 ARLILSPY--DTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       892 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+...   .+...........
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~  281 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGT  281 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence            98764321  12234557899999999987764 679999999999999999999999975332   1222222111111


Q ss_pred             cccccc--------------c---CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 NRESEV--------------L---DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~~~~~~--------------~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......              .   .+.......+.....+.+|+.+||+.||++|||++|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000              0   000000000111235789999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-43  Score=395.52  Aligned_cols=202  Identities=27%  Similarity=0.354  Sum_probs=171.7

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      ++....++|++.+.||+|+||+||+|+.+    +++.||||++.....  ...+.+|+++++.+ +|||||++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            33445678999999999999999999753    467899999876532  45678999999998 699999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeec
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADF  889 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  889 (1020)
                      +..|+||||+++|+|.+++.       .+++.++..++.|++.||+|||++   +||||||||+|||++.+ +.+||+||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999999884       378999999999999999999999   99999999999999876 79999999


Q ss_pred             cccccccCCCC--------------------------cccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHc
Q 035998          890 GLARLILSPYD--------------------------THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLT  942 (1020)
Q Consensus       890 g~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt  942 (1020)
                      |+|+...+...                          .......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99986543211                          0112345799999999988765 58999999999999999999


Q ss_pred             CCCCCCC
Q 035998          943 GKRPMDM  949 (1020)
Q Consensus       943 g~~pf~~  949 (1020)
                      |+.||..
T Consensus       243 G~~Pf~~  249 (361)
T 4f9c_A          243 GRYPFYK  249 (361)
T ss_dssp             TCSSSSC
T ss_pred             CCCCCCC
Confidence            9999964

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=8.6e-43  Score=419.80  Aligned_cols=453  Identities=20%  Similarity=0.231  Sum_probs=340.4

Q ss_pred             CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCC
Q 035998           65 WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSND  144 (1020)
Q Consensus        65 w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  144 (1020)
                      .+-+.|+....+.+|.+.+ .+++.|+|++|.+++..+.+|+++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus        33 ~~~l~ls~~~L~~ip~~~~-~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  111 (562)
T 3a79_B           33 ESMVDYSNRNLTHVPKDLP-PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR  111 (562)
T ss_dssp             CCEEECTTSCCCSCCTTSC-TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CcEEEcCCCCCccCCCCCC-CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc
Confidence            4679999999999998776 799999999999999888999999999999999999998889999999999999999999


Q ss_pred             CCCCCCCccCCCCcceeeeccCccCCCCC-ccccccCCcccEEEccCCCCCCCCCCcccccccc--cccccccccc--cc
Q 035998          145 LSGPLPQTINLPSIQVLDISSNSLNGSVP-TSICKNSSRIRVINLSVNYFSGTLSPGLGNCASL--EHLCLGMNDL--TG  219 (1020)
Q Consensus       145 l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip-~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~N~l--~~  219 (1020)
                      |+.. |.. .+++|++|+|++|++++ +| ...+..+++|++|+|++|++++.   .+..+++|  ++|+|++|.+  ++
T Consensus       112 l~~l-p~~-~l~~L~~L~Ls~N~l~~-l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~  185 (562)
T 3a79_B          112 LQNI-SCC-PMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKG  185 (562)
T ss_dssp             CCEE-CSC-CCTTCSEEECCSSCCSB-CCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCS
T ss_pred             CCcc-Ccc-ccccCCEEECCCCCccc-cCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccc
Confidence            9954 444 89999999999999984 43 24557899999999999999863   45555666  9999999999  88


Q ss_pred             ccchhhhhhc-ccccccccccccCCCCCc-ccccCCCccEEEccCCc-----CcccCcccccCCcccceeeccccccccc
Q 035998          220 GIADDIFQLQ-KLRLLGLQDNQLSGKLSP-SIADLSNLVRLDVSSNN-----FSGNIPDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       220 ~~~~~~~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      ..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|+     +.+. ...|.++++|+.|++.++.+++.
T Consensus       186 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~~~  264 (562)
T 3a79_B          186 GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETTWK  264 (562)
T ss_dssp             SSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEECHH
T ss_pred             cCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCcHH
Confidence            8888887764 222568888988876654 56678889999999885     2222 23456667777777666655432


Q ss_pred             C----CCCCcCCcccccccccccccccccccCC-----CCCCCcCEEEcCCCccCCCCC-CCCCC---CCCCCeEecCCC
Q 035998          293 I----PHSLSNSPTLNLLNLRNNSLDGSLLLNC-----PALTNLTSLDLGTNKFNGPLP-TNLPR---CRKLKNINLARN  359 (1020)
Q Consensus       293 ~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~---l~~L~~L~L~~N  359 (1020)
                      .    +..+ ..++|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+| ..+..   ..+|+.|++++|
T Consensus       265 ~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n  341 (562)
T 3a79_B          265 CSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDT  341 (562)
T ss_dssp             HHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred             HHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCC
Confidence            1    1111 12367777777777776666655     5556666666666655  233 11111   145677777777


Q ss_pred             cccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccc-
Q 035998          360 NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG-  438 (1020)
Q Consensus       360 ~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-  438 (1020)
                      .+....  ....+++|++|++++|+++....                           ..+..+++|+.|++++|.+.+ 
T Consensus       342 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~---------------------------~~~~~l~~L~~L~L~~N~l~~~  392 (562)
T 3a79_B          342 PFIHMV--CPPSPSSFTFLNFTQNVFTDSVF---------------------------QGCSTLKRLQTLILQRNGLKNF  392 (562)
T ss_dssp             CCCCCC--CCSSCCCCCEEECCSSCCCTTTT---------------------------TTCCSCSSCCEEECCSSCCCBT
T ss_pred             Cccccc--CccCCCCceEEECCCCccccchh---------------------------hhhcccCCCCEEECCCCCcCCc
Confidence            664321  12556677777777776654211                           112234556666666666665 


Q ss_pred             -ccchhhhcCCCCcEEecccccccccccc-cccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccce
Q 035998          439 -SIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFM  516 (1020)
Q Consensus       439 -~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~  516 (1020)
                       .+|..+.++++|+.|++++|++++.+|. .|..+++|++|+|++|++++.+|..+.  ++|                  
T Consensus       393 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L------------------  452 (562)
T 3a79_B          393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKV------------------  452 (562)
T ss_dssp             THHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTC------------------
T ss_pred             ccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcC------------------
Confidence             3456788999999999999999985554 588999999999999999988777653  333                  


Q ss_pred             eecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCcc-ccCCCcccEEEccCCccccc
Q 035998          517 RRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSE-LTGMTSLETLDLSYNNLSGA  595 (1020)
Q Consensus       517 ~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~  595 (1020)
                                        +.|+|++|+|+ .+|+.+..+++|++|+|++|+|+ .+|.. +..+++|+.|+|++|++++.
T Consensus       453 ------------------~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          453 ------------------KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             ------------------SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             ------------------CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence                              36788899888 57777779999999999999999 57776 99999999999999999987


Q ss_pred             CC
Q 035998          596 IP  597 (1020)
Q Consensus       596 ip  597 (1020)
                      .|
T Consensus       513 c~  514 (562)
T 3a79_B          513 CP  514 (562)
T ss_dssp             HH
T ss_pred             cc
Confidence            65

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.6e-42  Score=404.97  Aligned_cols=387  Identities=18%  Similarity=0.225  Sum_probs=300.7

Q ss_pred             CCCcCce--EEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCC-CccccCCCCCCe
Q 035998           61 DCCHWVG--ITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTV-PVSLVNLPNLEV  137 (1020)
Q Consensus        61 ~~C~w~g--v~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~  137 (1020)
                      +.|.|.+  |.|+..+.+.+|. .+ .+++.|+|++|.+++..|..++++++|++|+|++|.+.+.+ |..|.++++|++
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~-l~-~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~   83 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPE-LP-AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII   83 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCC-CC-TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred             ceeEEEccccCcCCCCcccCCC-CC-CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCE
Confidence            4455544  9999999999988 33 68999999999999988999999999999999999998766 567999999999


Q ss_pred             eeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCc-cccccCCcccEEEccCCCCCCCCCCc-cccccccccccccc
Q 035998          138 LDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPT-SICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGM  214 (1020)
Q Consensus       138 L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~-~~~~~~~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~  214 (1020)
                      |+|++|++++.+|..+ ++++|++|+|++|++++.+|. ..+..+++|++|+|++|++++..|.. ++++++|++|+|++
T Consensus        84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  163 (455)
T 3v47_A           84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF  163 (455)
T ss_dssp             EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred             EeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence            9999999999988888 899999999999999875544 44678899999999999999887876 88999999999999


Q ss_pred             cccccccchhhhhh--cccccccccccccCCCCCcc--------cccCCCccEEEccCCcCcccCcccccCC---cccce
Q 035998          215 NDLTGGIADDIFQL--QKLRLLGLQDNQLSGKLSPS--------IADLSNLVRLDVSSNNFSGNIPDVFAGL---GEFQY  281 (1020)
Q Consensus       215 N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~--------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~  281 (1020)
                      |++++..+..+..+  .+|+.|++++|.+++..+..        +..+++|++|++++|++++..|..+...   ++|+.
T Consensus       164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  243 (455)
T 3v47_A          164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS  243 (455)
T ss_dssp             CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred             CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence            99999889888887  78999999999998655443        3356889999999999998888877665   78899


Q ss_pred             eecccccccccCCCCCcCCcccccccccccccccccccCCCC--CCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCC
Q 035998          282 LVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA--LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARN  359 (1020)
Q Consensus       282 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  359 (1020)
                      |++++|.+.+....              .+.+.+..+..+..  .++|++|++++|++++.+|..+..+++|++|+|++|
T Consensus       244 L~l~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  309 (455)
T 3v47_A          244 LILSNSYNMGSSFG--------------HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN  309 (455)
T ss_dssp             EECTTCTTTSCCTT--------------CCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             Eeeccccccccccc--------------hhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCC
Confidence            99998876543211              11111111111211  246666666666666666666666666666666666


Q ss_pred             cccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccc
Q 035998          360 NFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGS  439 (1020)
Q Consensus       360 ~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  439 (1020)
                      ++++..|..|..+++|++|++++|.++.++..                           .+..+++|+.|++++|.+.+.
T Consensus       310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------------~~~~l~~L~~L~Ls~N~l~~~  362 (455)
T 3v47_A          310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR---------------------------MFENLDKLEVLDLSYNHIRAL  362 (455)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECGG---------------------------GGTTCTTCCEEECCSSCCCEE
T ss_pred             cccccChhHhcCcccCCEEECCCCccCCcChh---------------------------HhcCcccCCEEECCCCccccc
Confidence            66666666666666666666666666554321                           112334555666666667777


Q ss_pred             cchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCC
Q 035998          440 IPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPK  490 (1020)
Q Consensus       440 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  490 (1020)
                      .|..+.++++|++|+|++|+|++..+..|..+++|++|+|++|++++..|.
T Consensus       363 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence            788899999999999999999977777889999999999999999987763

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=9.4e-43  Score=408.70  Aligned_cols=383  Identities=22%  Similarity=0.242  Sum_probs=263.0

Q ss_pred             eeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccccc-chhhhhhcccccccccc
Q 035998          160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGI-ADDIFQLQKLRLLGLQD  238 (1020)
Q Consensus       160 ~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~  238 (1020)
                      .++.+++.++ .+|. +   .++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus        14 ~~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~   88 (455)
T 3v47_A           14 NAICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY   88 (455)
T ss_dssp             EEECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred             ccCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence            3444444444 4444 2   245566666666666555666666666666666666665333 44566666666666666


Q ss_pred             cccCCCCCcccccCCCccEEEccCCcCcccCccc--ccCCcccceeecccccccccCCCC-CcCCccccccccccccccc
Q 035998          239 NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDV--FAGLGEFQYLVAHSNRFTGRIPHS-LSNSPTLNLLNLRNNSLDG  315 (1020)
Q Consensus       239 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~  315 (1020)
                      |++++..|..|.++++|++|+|++|++++..|..  |..+++|++|++++|++++..|.. +.++++|++|++++|.+++
T Consensus        89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            6666555666666666666666666666543333  666666666666666666655554 5666666666666666666


Q ss_pred             ccccCCCCC--CCcCEEEcCCCccCCCCCCCC--------CCCCCCCeEecCCCcccccCcccccCC---CCCCeeeCCC
Q 035998          316 SLLLNCPAL--TNLTSLDLGTNKFNGPLPTNL--------PRCRKLKNINLARNNFSGQIPETYKNF---ESLSYLSLSN  382 (1020)
Q Consensus       316 ~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~l--------~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~l~~  382 (1020)
                      ..+..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++++..|..+...   .+|+.|++++
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~  248 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN  248 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence            555555444  567777777777765444332        245667777777777776666655443   6666777766


Q ss_pred             CCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcC--CCCcEEecccccc
Q 035998          383 SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGC--SKLQLVDLSWNQL  460 (1020)
Q Consensus       383 N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l--~~L~~L~Ls~N~l  460 (1020)
                      |.+.....                                         ..+.+.+..+..+.++  ++|+.|++++|++
T Consensus       249 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l  287 (455)
T 3v47_A          249 SYNMGSSF-----------------------------------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKI  287 (455)
T ss_dssp             CTTTSCCT-----------------------------------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCC
T ss_pred             cccccccc-----------------------------------------chhhhccCcccccccccccCceEEEecCccc
Confidence            65332110                                         0111222222233333  5788889999988


Q ss_pred             cccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecc
Q 035998          461 SGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLS  540 (1020)
Q Consensus       461 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls  540 (1020)
                      ++.+|.+|+.+++|++|+|++|++++..|..++++++|                                    +.|+|+
T Consensus       288 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L------------------------------------~~L~Ls  331 (455)
T 3v47_A          288 FALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL------------------------------------LKLNLS  331 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC------------------------------------CEEECC
T ss_pred             cccchhhcccCCCCCEEECCCCcccccChhHhcCcccC------------------------------------CEEECC
Confidence            88888888888889999999998888888888888777                                    357788


Q ss_pred             cCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccC
Q 035998          541 LNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRI  620 (1020)
Q Consensus       541 ~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~  620 (1020)
                      +|++++..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++++.+
T Consensus       332 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  411 (455)
T 3v47_A          332 QNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  411 (455)
T ss_dssp             SSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence            88888888888999999999999999999888999999999999999999999776677899999999999999999999


Q ss_pred             CCCC
Q 035998          621 PSGG  624 (1020)
Q Consensus       621 p~~~  624 (1020)
                      |...
T Consensus       412 ~~~~  415 (455)
T 3v47_A          412 PRID  415 (455)
T ss_dssp             TTTH
T ss_pred             Ccch
Confidence            8653

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.5e-42  Score=403.61  Aligned_cols=262  Identities=22%  Similarity=0.255  Sum_probs=111.1

Q ss_pred             CCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeee
Q 035998           84 SGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDI  163 (1020)
Q Consensus        84 ~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~L  163 (1020)
                      ..++++++++++.+ |.+|++++++++|++|++++|.++|.+|.+++++++|+.+++++|..          .+|++|++
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~----------~~l~~L~l   78 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----------RQAHELEL   78 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH----------HTCSEEEC
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc----------cCCCEEEe
Confidence            34566677777777 66777777777777777777777777777777666653333322211          12344444


Q ss_pred             ccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCC
Q 035998          164 SSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG  243 (1020)
Q Consensus       164 s~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  243 (1020)
                      ++|.++ .+|..    .++|+.|++++|++++ +|..   +++|++|++++|++++ ++..   .++|++|++++|++++
T Consensus        79 ~~~~l~-~lp~~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           79 NNLGLS-SLPEL----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             TTSCCS-CCCSC----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS
T ss_pred             cCCccc-cCCCC----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC
Confidence            444444 22321    2344444444444443 3322   2344444555554443 1110   1345555555555543


Q ss_pred             CCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCC
Q 035998          244 KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA  323 (1020)
Q Consensus       244 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  323 (1020)
                       +| .++++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .++++++|+.|++++|++++. |..   
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~---  213 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL---  213 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC---
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC---
Confidence             33 35555555555555555543 23222   244555555555544 23 344555555555555555432 111   


Q ss_pred             CCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          324 LTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       324 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      .++|++|++++|+++ .+| .+..+++|++|++++|++++ +|..   +++|++|++++|+++.
T Consensus       214 ~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~  271 (454)
T 1jl5_A          214 PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD  271 (454)
T ss_dssp             CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC
T ss_pred             cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc
Confidence            134555555555555 344 25555555555555555553 2221   2445555555555443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-42  Score=386.83  Aligned_cols=290  Identities=42%  Similarity=0.757  Sum_probs=245.9

Q ss_pred             CCccccHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh-hHHHHHHHHHHHHHcCCCccceEeeE
Q 035998          728 KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHPNLVHLQGY  806 (1020)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  806 (1020)
                      ..+.++..++....++|++.+.||+|+||.||+|+.++++.||||++...... ....+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34668889999999999999999999999999999888999999998765322 22368899999999999999999999


Q ss_pred             EeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       807 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      +.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            99999999999999999999999887666677999999999999999999999987778999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CCCcccHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK--PKGSRDLISWVIR  964 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--~~~~~~~~~~~~~  964 (1020)
                      +|||+++..... .........||+.|+|||++.+..++.++||||+|+++|||++|+.||....  .........+...
T Consensus       176 ~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999876432 2233344569999999999988889999999999999999999999996321  2223344555555


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ...........+..............+.+++.+||+.||.+|||++|+++.|++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            445555566666666667788888999999999999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.4e-42  Score=404.52  Aligned_cols=248  Identities=27%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHH---HHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAE---VEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.++||+|+||+||+|+.+ +|+.||||++.+..   ......+.+|   +++++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999865 68999999996532   1122233344   55566678999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||++||+|.+++.+.    ..+++..+..++.||+.||+|||++   +||||||||+|||++.+|++||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999875    4689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ....    .....+||+.|||||++. +..|+.++||||+||++|||++|+.||.........   .......... . .
T Consensus       342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~~-~-~  412 (689)
T 3v5w_A          342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMA-V-E  412 (689)
T ss_dssp             CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHCC-C-C
T ss_pred             cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCCC-C-C
Confidence            6432    234568999999999986 468999999999999999999999999754333221   1111111111 0 0


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                           +...    ...++.+++.+||+.||.+|++     ++||++
T Consensus       413 -----~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 -----LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 0011    1235789999999999999998     688765

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.4e-42  Score=398.85  Aligned_cols=391  Identities=24%  Similarity=0.297  Sum_probs=180.2

Q ss_pred             CCCCCCC-CCceEEEecCCCcccccccccccCCCCC-------------cEEecCCCCCCCCCCccccCCCCCCeeeccC
Q 035998           77 GLNDSIG-SGRVTGLFLYKRRLKGKLSESLGNLVQL-------------RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSS  142 (1020)
Q Consensus        77 ~~~~~~~-~~~v~~l~l~~~~l~~~~~~~l~~l~~L-------------~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~  142 (1020)
                      .+|...+ -.+++.|++++|.+.|.+|.+++++++|             ++|++++|.+++ +|..   .++|++|++++
T Consensus        25 ~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~  100 (454)
T 1jl5_A           25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASC  100 (454)
T ss_dssp             ---------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCS
T ss_pred             hCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccC
Confidence            3454332 2466778899999999999999999987             666666666663 3431   25666666666


Q ss_pred             CCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccc
Q 035998          143 NDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA  222 (1020)
Q Consensus       143 n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  222 (1020)
                      |.+++ +|..  .++|++|++++|+++ .+|..    .++|++|++++|++++ +| .|+++++|++|++++|++++ +|
T Consensus       101 n~l~~-lp~~--~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp  169 (454)
T 1jl5_A          101 NSLTE-LPEL--PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LP  169 (454)
T ss_dssp             SCCSS-CCCC--CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CC
T ss_pred             CcCCc-cccc--cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cC
Confidence            66665 3332  256666666666665 23321    1456666666666654 44 35566666666666666553 33


Q ss_pred             hhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcc
Q 035998          223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT  302 (1020)
Q Consensus       223 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  302 (1020)
                      ..+   .+|++|++++|++++ +| .+.++++|++|++++|++++ +|...   ++|++|++++|+++ .+| .++.+++
T Consensus       170 ~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~  238 (454)
T 1jl5_A          170 DLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPF  238 (454)
T ss_dssp             CCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTT
T ss_pred             CCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCC
Confidence            322   355555555555554 33 35555555555555555553 22221   24455555555554 233 2444444


Q ss_pred             cccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCC
Q 035998          303 LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN  382 (1020)
Q Consensus       303 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  382 (1020)
                      |++|++++|++++                         +|..   +++|+.|++++|++++ +|..   .++|++|++++
T Consensus       239 L~~L~l~~N~l~~-------------------------l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~  286 (454)
T 1jl5_A          239 LTTIYADNNLLKT-------------------------LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSE  286 (454)
T ss_dssp             CCEEECCSSCCSS-------------------------CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred             CCEEECCCCcCCc-------------------------cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcC
Confidence            5555555444443                         2221   1344555555555443 2322   24445555555


Q ss_pred             CCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcC-CCCcEEeccccccc
Q 035998          383 SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGC-SKLQLVDLSWNQLS  461 (1020)
Q Consensus       383 N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~  461 (1020)
                      |+++.++..                               .++|+.|++++|.+.+ ++    .+ ++|+.|++++|+++
T Consensus       287 N~l~~l~~~-------------------------------~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~  330 (454)
T 1jl5_A          287 NIFSGLSEL-------------------------------PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLI  330 (454)
T ss_dssp             SCCSEESCC-------------------------------CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCS
T ss_pred             CccCcccCc-------------------------------CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCccc
Confidence            544432210                               0233344444444432 11    12 36777777777777


Q ss_pred             ccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeeccc
Q 035998          462 GTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSL  541 (1020)
Q Consensus       462 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~  541 (1020)
                      + +|..   +++|++|+|++|+++ .+|.   .+++|                                    +.|++++
T Consensus       331 ~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L------------------------------------~~L~L~~  366 (454)
T 1jl5_A          331 E-LPAL---PPRLERLIASFNHLA-EVPE---LPQNL------------------------------------KQLHVEY  366 (454)
T ss_dssp             C-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTC------------------------------------CEEECCS
T ss_pred             c-cccc---CCcCCEEECCCCccc-cccc---hhhhc------------------------------------cEEECCC
Confidence            4 5543   466777777777776 3444   12333                                    3466666


Q ss_pred             Ccccc--CCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccc--cCCcccccccccccccccccccc
Q 035998          542 NRLDG--SIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG--AIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       542 N~l~~--~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      |++++  .+|..++.        |+.|++.|.+|..   +++|++|||++|+++|  .+|.+      |+.|.+.+|.+.
T Consensus       367 N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~  429 (454)
T 1jl5_A          367 NPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVV  429 (454)
T ss_dssp             SCCSSCCCCCTTCCE--------EECCC----------------------------------------------------
T ss_pred             CCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccC
Confidence            77766  56665543        3356777777763   4789999999999997  77754      455678888888


Q ss_pred             ccCCC
Q 035998          618 GRIPS  622 (1020)
Q Consensus       618 g~~p~  622 (1020)
                      +.+|.
T Consensus       430 ~~~~~  434 (454)
T 1jl5_A          430 DPYEF  434 (454)
T ss_dssp             -----
T ss_pred             Ccccc
Confidence            87764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.3e-42  Score=384.95  Aligned_cols=295  Identities=28%  Similarity=0.487  Sum_probs=205.8

Q ss_pred             CCCHHHHHHHHHHHHHhccCC--CCCCCCCCCCCCCc--CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccc--cccc
Q 035998           30 TCNPNDLAALEDFMKNFESGI--DGWGTNASSSDCCH--WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKG--KLSE  103 (1020)
Q Consensus        30 ~~~~~~~~aL~~~k~~~~~~~--~~~~~~~~~~~~C~--w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~--~~~~  103 (1020)
                      .|.++|++||++||+++.++.  .+|   ..++|||.  |.||+|+..+        ..++|+.|+|+++.++|  .+|.
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W---~~~~~~C~~~w~gv~C~~~~--------~~~~l~~L~L~~~~l~~~~~~~~   70 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSW---LPTTDCCNRTWLGVLCDTDT--------QTYRVNNLDLSGLNLPKPYPIPS   70 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTC---CTTSCTTTTCSTTEEECCSS--------SCCCEEEEEEECCCCSSCEECCG
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCC---CCCCCCCcCCCcceEeCCCC--------CCceEEEEECCCCCccCCcccCh
Confidence            599999999999999997542  344   34678998  9999998642        13689999999999999  8999


Q ss_pred             cccCCCCCcEEecCC-CCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCC
Q 035998          104 SLGNLVQLRFLNLSH-NLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSS  181 (1020)
Q Consensus       104 ~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~  181 (1020)
                      .++++++|++|+|++ |++++.+|..|+++++|++|+|++|++++.+|..+ ++++|++|+|++|++++.+|..+ ..++
T Consensus        71 ~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~  149 (313)
T 1ogq_A           71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLP  149 (313)
T ss_dssp             GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-GGCT
T ss_pred             hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHH-hcCC
Confidence            999999999999995 99999999999999999999999999998888777 78888888888888776666554 3455


Q ss_pred             cccEEEccCCCCCCCCCCcccccc-ccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEc
Q 035998          182 RIRVINLSVNYFSGTLSPGLGNCA-SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV  260 (1020)
Q Consensus       182 ~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  260 (1020)
                      +|++|+|++|++++.+|..+++++ +|++|+|++|++++.+|..+..++                         |++|++
T Consensus       150 ~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-------------------------L~~L~L  204 (313)
T 1ogq_A          150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------------------LAFVDL  204 (313)
T ss_dssp             TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-------------------------CSEEEC
T ss_pred             CCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-------------------------ccEEEC
Confidence            566666666665555555555554 555555555555555555444443                         555555


Q ss_pred             cCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCC
Q 035998          261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP  340 (1020)
Q Consensus       261 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  340 (1020)
                      ++|++++.+|..|..+++|+.|++++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.
T Consensus       205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  283 (313)
T 1ogq_A          205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence            55555444445555555555555555555444433 44555666666666666655666666666666666666666666


Q ss_pred             CCCCCCCCCCCCeEecCCCc-ccc
Q 035998          341 LPTNLPRCRKLKNINLARNN-FSG  363 (1020)
Q Consensus       341 ~p~~l~~l~~L~~L~L~~N~-l~~  363 (1020)
                      +|.. ..+++|+.|++++|+ +.|
T Consensus       284 ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          284 IPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             CCCC-ccccccChHHhcCCCCccC
Confidence            6664 666777777777776 443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-42  Score=412.13  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=208.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+....|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999865 69999999998766555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC--CCeEEeeccccccccCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN--FGAHLADFGLARLILSP  898 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~  898 (1020)
                      +||+|.+++...   ...+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+.. 
T Consensus       237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-  309 (573)
T 3uto_A          237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-  309 (573)
T ss_dssp             CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-
T ss_pred             CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC-
Confidence            999999988643   24689999999999999999999999   99999999999999854  8999999999998743 


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                        .......+||+.|||||++.+..|+.++||||+||++|||++|+.||......      .....+.....   .+.+.
T Consensus       310 --~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~---~~~~~  378 (573)
T 3uto_A          310 --KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW---NMDDS  378 (573)
T ss_dssp             --TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC---CCCSG
T ss_pred             --CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCC---CCCcc
Confidence              22334568999999999999999999999999999999999999999753321      11122211111   01111


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    ...+.+|+.+||+.||.+|||++|+++
T Consensus       379 ~~~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111    235789999999999999999999987

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.1e-41  Score=379.09  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=212.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|++.+.||+|+||.||+|++.        ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467899999999999999999852        34579999997654 33446789999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      +..++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||++   +|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999986532            124589999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence            9999999999999987654433333444567889999999999999999999999999999999 99999754322   2


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ....   ...... ..         .+......+.+++.+||+.||++||+++|+++.|++++
T Consensus       314 ~~~~---~~~~~~-~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 LFKL---LKEGHR-MD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHH---HHTTCC-CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH---HhcCCC-CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2211   111111 00         11122246889999999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=363.79  Aligned_cols=259  Identities=26%  Similarity=0.410  Sum_probs=211.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357889999999999999999875 6899999998776666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999864   34689999999999999999999999   99999999999999999999999999998764322


Q ss_pred             Ccc------------cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh
Q 035998          900 DTH------------VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ  967 (1020)
Q Consensus       900 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  967 (1020)
                      ...            ......||+.|+|||++.+..++.++||||+|+++|||++|..||....................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            111            11145789999999999999999999999999999999999999875443322111111111111


Q ss_pred             hcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          968 ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       968 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      . . .            ......+.+++.+||+.||++|||+++++++|+++
T Consensus       243 ~-~-~------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          243 Y-C-P------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             T-C-C------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c-C-C------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0 0 0            01112478999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-39  Score=358.93  Aligned_cols=281  Identities=36%  Similarity=0.595  Sum_probs=229.6

Q ss_pred             ccccHHHHHHhccCCCcC------CeeeccCCeEEEEEEeCCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHcCCCc
Q 035998          730 KEISIDDILESTNNFDQA------NIIGCGGFGLVYRATLPDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPN  799 (1020)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~n  799 (1020)
                      ..++++++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            567899999999998877      9999999999999987 58899999987532    234567899999999999999


Q ss_pred             cceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          800 LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       800 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      |+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            9999999999999999999999999999987542 235689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH
Q 035998          880 GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       880 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  959 (1020)
                      .++.+||+|||+++...............|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            999999999999987654333333445678999999998765 4789999999999999999999999865443322222


Q ss_pred             HHHHHHHhh-cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          960 SWVIRMRQE-NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       960 ~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ....... .......++.. ..........+.+++.+||+.||.+||+++++++.|+++
T Consensus       247 --~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          247 --KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             --HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence              1121111 11222223222 234566777899999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-39  Score=358.32  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=207.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999985 47899999999766555567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999764     589999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||......      ........... .....+  
T Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~-~~~~~~--  239 (297)
T 3fxz_A          171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT-PELQNP--  239 (297)
T ss_dssp             --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS-CCCSCG--
T ss_pred             --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-CCCCCc--
Confidence              2234567999999999999999999999999999999999999999643211      11111111111 111111  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ......+.+++.+||+.||++|||++|+++
T Consensus       240 -----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          240 -----EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 112235789999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.1e-40  Score=369.43  Aligned_cols=267  Identities=28%  Similarity=0.370  Sum_probs=209.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc----eEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND----RLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv  816 (1020)
                      .++|++.++||+|+||.||+|++. ++.||||++..... ......+|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357899999999999999999985 78999999975532 23456678999999999999999999987654    5899


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-------CCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-------EPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      |||+++|+|.+++...     .+++..++.++.|++.||+|||+.+       .++|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999764     4899999999999999999999751       238999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHH-----
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI-----  959 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-----  959 (1020)
                      |+++...............||+.|+|||++.+     ..++.++|||||||++|||+||+.||............     
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            99987754433333444679999999999876     35667899999999999999999999765433222111     


Q ss_pred             -----HHHHHHHhhcccccccCccccC-ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          960 -----SWVIRMRQENRESEVLDPFIYD-KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       960 -----~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           ..........     ..+.... .........+.+++.+||+.||++|||++|+++.|+++
T Consensus       256 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          256 HPSLEDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             SCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 1111111111     1111111 11234556799999999999999999999999999875

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.4e-39  Score=378.98  Aligned_cols=364  Identities=18%  Similarity=0.207  Sum_probs=212.1

Q ss_pred             ccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccc
Q 035998           97 LKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSI  176 (1020)
Q Consensus        97 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~  176 (1020)
                      ..+..+.+++++++|++|++++|.+++ +| .++.+++|++|+|++|++++. | ...+++|++|+|++|++++ +|   
T Consensus        30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~-~~---  101 (457)
T 3bz5_A           30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN-LD---  101 (457)
T ss_dssp             CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC---
T ss_pred             cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce-ee---
Confidence            344445566667777777777777764 34 566677777777777777664 2 2256666666666666653 22   


Q ss_pred             cccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCcc
Q 035998          177 CKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLV  256 (1020)
Q Consensus       177 ~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  256 (1020)
                      +..+++|++|++++|++++. |  ++++                        ++|++|++++|++++.   .++.+++|+
T Consensus       102 ~~~l~~L~~L~L~~N~l~~l-~--~~~l------------------------~~L~~L~l~~N~l~~l---~l~~l~~L~  151 (457)
T 3bz5_A          102 VTPLTKLTYLNCDTNKLTKL-D--VSQN------------------------PLLTYLNCARNTLTEI---DVSHNTQLT  151 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSCC-C--CTTC------------------------TTCCEEECTTSCCSCC---CCTTCTTCC
T ss_pred             cCCCCcCCEEECCCCcCCee-c--CCCC------------------------CcCCEEECCCCcccee---ccccCCcCC
Confidence            23444455555555544432 2  4444                        4444444444444432   144455555


Q ss_pred             EEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCc
Q 035998          257 RLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNK  336 (1020)
Q Consensus       257 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  336 (1020)
                      +|++++|+..+.+  .+..+++|+.|++++|++++. |  ++.+++|+.|++++|++++.   .+..+++|++|++++|+
T Consensus       152 ~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~  223 (457)
T 3bz5_A          152 ELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNK  223 (457)
T ss_dssp             EEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSC
T ss_pred             EEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCc
Confidence            5555555333333  244455555555555555542 2  45555556666666655543   25556666666666666


Q ss_pred             cCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCC
Q 035998          337 FNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLP  416 (1020)
Q Consensus       337 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~  416 (1020)
                      +++ +|  +..+++|+.|++++|++++..   +..+++|+.|++++|+++                              
T Consensus       224 l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L~------------------------------  267 (457)
T 3bz5_A          224 LTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDLL------------------------------  267 (457)
T ss_dssp             CSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCCS------------------------------
T ss_pred             ccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCCC------------------------------
Confidence            665 44  566666777777777666542   344556666666554321                              


Q ss_pred             CCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCc
Q 035998          417 TDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLP  496 (1020)
Q Consensus       417 ~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  496 (1020)
                                 .|++++|.+.+.+|  ++.+++|+.|++++|++.+.+|.   ...+|+.|++++|             +
T Consensus       268 -----------~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~  318 (457)
T 3bz5_A          268 -----------EIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------P  318 (457)
T ss_dssp             -----------CCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------T
T ss_pred             -----------EEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------c
Confidence                       11222222333333  23444455555555544444442   2233334444433             1


Q ss_pred             ccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccc
Q 035998          497 SLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL  576 (1020)
Q Consensus       497 ~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~  576 (1020)
                      +|                                    +.|++++|+|++.   .++.+++|+.|++++|+|++      
T Consensus       319 ~L------------------------------------~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~------  353 (457)
T 3bz5_A          319 KL------------------------------------VYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD------  353 (457)
T ss_dssp             TC------------------------------------CEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB------
T ss_pred             cC------------------------------------CEEECCCCccccc---ccccCCcCcEEECCCCCCCC------
Confidence            11                                    4688899999884   38899999999999999986      


Q ss_pred             cCCCcccEEEccCCcccccCCccccccccccccccccccccccCCCC
Q 035998          577 TGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG  623 (1020)
Q Consensus       577 ~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~p~~  623 (1020)
                        ++.|+.|++++|+++|.     .++..|..+++++|+|+|.||..
T Consensus       354 --l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 --FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             --CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             --ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence              24677788999999986     46778899999999999999963

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.8e-40  Score=363.76  Aligned_cols=261  Identities=30%  Similarity=0.472  Sum_probs=203.0

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      +....++|++.+.||+|+||.||+|+. +++.||||++....  ....+.+.+|++++++++||||+++++++.+....+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            334457899999999999999999987 58899999987654  233467889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||++
T Consensus       111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            9999999999999997531 112489999999999999999999999   8  999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      +.....  ........||+.|+|||++.+..++.++||||+|+++|||++|+.||......   ...   ..........
T Consensus       187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~---~~~~~~~~~~  258 (309)
T 3p86_A          187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVV---AAVGFKCKRL  258 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHH---HHHHHSCCCC
T ss_pred             cccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhcCCCC
Confidence            765332  12234467899999999999999999999999999999999999999754321   111   1111111111


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..         +......+.+++.+||+.||++|||++++++.|+.+
T Consensus       259 ~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          259 EI---------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10         111223588999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.1e-39  Score=361.04  Aligned_cols=247  Identities=25%  Similarity=0.317  Sum_probs=205.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++....  ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999987 579999999987543  334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999765    4689999999999999999999999   999999999999999999999999999987633


Q ss_pred             CCCcccccccccccCccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVAT-YKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .   .......||+.|+|||++.+..+. .++||||+||++|||++|+.||.....      .............    .
T Consensus       167 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~----~  233 (328)
T 3fe3_A          167 G---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYR----I  233 (328)
T ss_dssp             S---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----C
T ss_pred             C---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC----C
Confidence            2   234456899999999998887764 899999999999999999999975321      1111122111110    0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      |       ......+.+++.+||+.||.+|||++|+++
T Consensus       234 p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          234 P-------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             C-------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             C-------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1       011235789999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-40  Score=379.97  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=208.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ..++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3467889999999999999999986 789999999876532 33456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.++++..   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       192 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999764   23588999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...........+++.|+|||++.++.++.++|||||||++|||++ |..||......   ...   .........   ..
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~---~~~~~~~~~---~~  336 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR---EFVEKGGRL---PC  336 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH---HHHHTTCCC---CC
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCCC---CC
Confidence            211111122345678999999988899999999999999999999 99999754321   111   111111111   00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                             +......+.+++.+||+.||++|||++++++.|+++
T Consensus       337 -------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          337 -------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                   111224688999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=367.88  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=207.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|++.    .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357899999999999999999874    34469999998653 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999653   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          896 LSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       896 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ...... .......+|+.|+|||++.+..++.++||||+|+++|||++ |..||......   +.   ........... 
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~---~~~~~~~~~~~-  274 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV---ISSVEEGYRLP-  274 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH---HHHHHTTCCCC-
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH---HHHHHcCCCCC-
Confidence            543221 12233456778999999998899999999999999999999 99999653221   11   11111111110 


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                               .+......+.+++.+||+.||++||+++++++.|+++
T Consensus       275 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          275 ---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     0111224688999999999999999999999999876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-40  Score=356.62  Aligned_cols=255  Identities=29%  Similarity=0.463  Sum_probs=210.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|+..+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357899999999999999999998889999999986543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  160 (269)
T 4hcu_A           88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  160 (269)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence            999999999754   34689999999999999999999999   99999999999999999999999999998653321 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||......      ...........   ...+. 
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~~~---~~~~~-  230 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFR---LYKPR-  230 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC---CCCCT-
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcCcc---CCCCC-
Confidence            122233456778999999998999999999999999999999 99999743221      11112211111   01111 


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                            .....+.+++.+||+.||++||+++|+++.|+++
T Consensus       231 ------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          231 ------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                  1123588999999999999999999999999876

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9e-39  Score=355.71  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=212.3

Q ss_pred             ccccHHHHHHhccC----------CCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCC
Q 035998          730 KEISIDDILESTNN----------FDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP  798 (1020)
Q Consensus       730 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  798 (1020)
                      ..++.+++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34566777666653          677789999999999999976 7999999999866555567789999999999999


Q ss_pred             ccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          799 NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       799 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      ||+++++++...+..++||||+++++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            9999999999999999999999999999988643     589999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                      +.++.+||+|||+++......  .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....      
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------  246 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------  246 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------
T ss_pred             CCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence            999999999999998764321  223456799999999999999999999999999999999999999964321      


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........... ......       .......+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~-~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 VQAMKRLRDSP-PPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHHHHHSS-CCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhcCC-CCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111121111 111000       0111235789999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-39  Score=369.39  Aligned_cols=271  Identities=27%  Similarity=0.416  Sum_probs=215.8

Q ss_pred             ccHHHHHHhccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceE
Q 035998          732 ISIDDILESTNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHL  803 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  803 (1020)
                      +...++....++|++.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455556678999999999999999999973      2467899999986543 3346789999999999 79999999


Q ss_pred             eeEEeccCc-eEEEEEeccCCChhhhhhhcCCC-----------------------------------------------
Q 035998          804 QGYCMHKND-RLLIYSFMENGSLDYWLHEKLDG-----------------------------------------------  835 (1020)
Q Consensus       804 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  835 (1020)
                      ++++.+.+. .++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 89999999999999999765321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          836 ---------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       836 ---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                                     ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           12289999999999999999999999   999999999999999999999999999987654444


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........||+.|+|||++.+..++.++||||+|+++|||+| |+.||.......  ....   ....... ..  .+  
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~---~~~~~~~-~~--~~--  318 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR---RLKEGTR-MR--AP--  318 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH---HHHHTCC-CC--CC--
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH---HHHcCCC-CC--CC--
Confidence            444455678899999999989999999999999999999999 999997543321  1111   1111111 11  01  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                           ......+.+++.+||+.||++|||++|+++.|++++
T Consensus       319 -----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          319 -----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                 111235889999999999999999999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=5.5e-39  Score=373.90  Aligned_cols=311  Identities=19%  Similarity=0.205  Sum_probs=245.1

Q ss_pred             CceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeec
Q 035998           85 GRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDIS  164 (1020)
Q Consensus        85 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls  164 (1020)
                      .+++.|+++++.+++. | .++.+++|++|+|++|++++ +|  ++.+++|++|+|++|+|++. + ..++++|++|+|+
T Consensus        42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~  114 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCD  114 (457)
T ss_dssp             TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECC
T ss_pred             CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECC
Confidence            5789999999999975 5 79999999999999999996 44  89999999999999999986 3 3389999999999


Q ss_pred             cCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCC
Q 035998          165 SNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGK  244 (1020)
Q Consensus       165 ~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  244 (1020)
                      +|++++ +|   +..+++|++|++++|++++.   .++++++|++|++++|+..+.+  .+..+++|++|++++|++++ 
T Consensus       115 ~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-  184 (457)
T 3bz5_A          115 TNKLTK-LD---VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-  184 (457)
T ss_dssp             SSCCSC-CC---CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-
T ss_pred             CCcCCe-ec---CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-
Confidence            999995 55   57899999999999999974   3889999999999999665555  47888999999999999996 


Q ss_pred             CCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCC
Q 035998          245 LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPAL  324 (1020)
Q Consensus       245 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  324 (1020)
                      +|  +..+++|++|++++|++++.   .++.+++|++|++++|++++ +|  ++.+++|+.|++++|++++..   +..+
T Consensus       185 l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l  253 (457)
T 3bz5_A          185 LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTL  253 (457)
T ss_dssp             CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTC
T ss_pred             ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHC
Confidence            44  78889999999999999875   37888899999999999987 45  778888888899988888764   4456


Q ss_pred             CCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc-hhhHHHHHhhhcccch
Q 035998          325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN-LSSALQVLQQCRNLTT  403 (1020)
Q Consensus       325 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~-l~~~~~~l~~l~~L~~  403 (1020)
                      ++|+.|++++|              +|+.|++++|++.+.+|  ++.+++|+.|++++|+... +|.             
T Consensus       254 ~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~-------------  304 (457)
T 3bz5_A          254 SKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC-------------  304 (457)
T ss_dssp             TTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC-------------
T ss_pred             CCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc-------------
Confidence            77888888776              35677888888887776  4677888888888886321 110             


Q ss_pred             hhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCc
Q 035998          404 LVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNT  483 (1020)
Q Consensus       404 L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  483 (1020)
                                        ..++|+.|+             ++++++|+.|++++|+|++. +  ++.+++|+.|++++|+
T Consensus       305 ------------------~~~~L~~L~-------------l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~  350 (457)
T 3bz5_A          305 ------------------QAAGITELD-------------LSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAH  350 (457)
T ss_dssp             ------------------TTCCCSCCC-------------CTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred             ------------------CCCcceEec-------------hhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCC
Confidence                              011222222             23335677777777777753 2  6677777777777777


Q ss_pred             ccc
Q 035998          484 FTG  486 (1020)
Q Consensus       484 l~~  486 (1020)
                      +++
T Consensus       351 l~~  353 (457)
T 3bz5_A          351 IQD  353 (457)
T ss_dssp             CCB
T ss_pred             CCC
Confidence            664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.9e-40  Score=354.46  Aligned_cols=255  Identities=25%  Similarity=0.464  Sum_probs=210.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|+.+++..||||++..... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467899999999999999999998888999999976543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        86 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  158 (268)
T 3sxs_A           86 SNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-  158 (268)
T ss_dssp             TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-
T ss_pred             CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh-
Confidence            999999999764   23589999999999999999999999   99999999999999999999999999998764432 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......      ...........   ...+..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~---~~~~~~  229 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHR---LYRPHL  229 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---CCCCTT
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCC---CCCCCc
Confidence            222233456778999999988889999999999999999999 99999643321      11111111111   111111


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                             ....+.+++.+||+.||++|||++|+++.|+++
T Consensus       230 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          230 -------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             -------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             -------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                   123588999999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=371.64  Aligned_cols=260  Identities=27%  Similarity=0.370  Sum_probs=212.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|.+.+.||+|+||.||+|+..        .+..||||++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467899999999999999999852        235799999976543 3446789999999999 999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      +..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999987532            124689999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654433334445667889999999999999999999999999999999 9999964321     


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       ............ ...         +......+.+++.+||+.||++||+++|+++.|+++
T Consensus       300 -~~~~~~~~~~~~-~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          300 -EELFKLLKEGHR-MDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             -HHHHHHHHTTCC-CCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHcCCC-CCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             111112211111 110         011223688999999999999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-39  Score=356.57  Aligned_cols=266  Identities=26%  Similarity=0.346  Sum_probs=205.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            467999999999999999999998899999999975432  234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++ ++.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....+
T Consensus       100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9985 777777653   34689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc---cccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR---ESEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~  974 (1020)
                      .  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+..   ...........   ....
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGG
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhh
Confidence            2  22334578999999998876 56899999999999999999999999765443322   22211111110   0000


Q ss_pred             c-------------CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          975 L-------------DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       975 ~-------------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                      .             +........+....++.+++.+||+.||++|||++|+++  +|++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence            0             000000001112246789999999999999999999987  5543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=372.97  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=209.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357899999999999999999853      46689999997553 34456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC---CeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  887 (1020)
                      ++||||+++|+|.+++.....   ....+++.+++.++.||+.||+|||++   +|+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987532   234689999999999999999999999   999999999999999555   59999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....      ........
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence            9999986543322333344667899999999988999999999999999999998 9999975322      11111221


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..... .         .+......+.+++.+||+.||++||+++++++.|+.+
T Consensus       301 ~~~~~-~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGGRM-D---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCCC-C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC-C---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11110 0         0111223588999999999999999999999999764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.5e-40  Score=363.11  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=212.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|.+.+.||+|+||.||+|+.      .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56789999999999999999975      245789999997654 33456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 035998          814 LLIYSFMENGSLDYWLHEKLD--------------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKS  873 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  873 (1020)
                      ++||||+++++|.+++.....                    ....+++.+++.++.|++.||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999987532                    123488999999999999999999999   999999999


Q ss_pred             CCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 035998          874 SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKP  952 (1020)
Q Consensus       874 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  952 (1020)
                      +||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654333333344567889999999988899999999999999999999 9999975433


Q ss_pred             CCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          953 KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ..   ....   ...... ..         .+......+.+++.+||+.||++||+++|+++.|++++
T Consensus       259 ~~---~~~~---~~~~~~-~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 ER---LFNL---LKTGHR-ME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             GG---HHHH---HHTTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH---HHHH---hhcCCc-CC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            21   1111   111110 00         01112246889999999999999999999999999863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-40  Score=368.08  Aligned_cols=264  Identities=28%  Similarity=0.443  Sum_probs=212.9

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK  810 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  810 (1020)
                      ....++|++.+.||+|+||.||+|+..      +++.||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999864      34789999998654 33456789999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecC
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDG--------------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRD  870 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  870 (1020)
                      +..++||||+++|+|.+++......                    ...+++.+++.++.||++||+|||++   +|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            9999999999999999999864221                    25789999999999999999999999   999999


Q ss_pred             CCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 035998          871 IKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDM  949 (1020)
Q Consensus       871 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~  949 (1020)
                      |||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987643322223344567889999999988899999999999999999999 9999974


Q ss_pred             CCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          950 CKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       950 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ...      .......... .....         +......+.+++.+||+.||++||+++++++.|+++.
T Consensus       280 ~~~------~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          280 MAH------EEVIYYVRDG-NILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             SCH------HHHHHHHHTT-CCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCh------HHHHHHHhCC-CcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            321      1111112111 11110         1112236889999999999999999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.7e-40  Score=366.42  Aligned_cols=263  Identities=27%  Similarity=0.432  Sum_probs=195.4

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeCCC----CEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLPDG----RNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      ...++|++.+.||+|+||.||+|+....    ..||||++....  ....+.+.+|++++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3457899999999999999999986533    279999987652  3345678999999999999999999999987765


Q ss_pred             e------EEEEEeccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          813 R------LLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       813 ~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      .      ++||||+++|+|.+++....  .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      89999999999999997543  2233689999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++...............+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+   ....  
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~--  251 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY--  251 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH--
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH--
Confidence            9999999987654333333334566789999999999999999999999999999999 999997543322   1111  


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                       ....... .         .+......+.+++.+||+.||++|||++++++.|++++
T Consensus       252 -~~~~~~~-~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          252 -LIGGNRL-K---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             -HHTTCCC-C---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HhcCCCC-C---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             1111110 0         01112246889999999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.8e-39  Score=353.41  Aligned_cols=262  Identities=27%  Similarity=0.371  Sum_probs=204.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHH--cCCCccceEeeEEecc----CceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR--AQHPNLVHLQGYCMHK----NDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  814 (1020)
                      .++|++.+.||+|+||.||+|++ +++.||||++...   ....+.+|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999998 6899999998754   34556677777777  7999999999987653    4578


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH--------QSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      +||||+++|+|.++++.     ..+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++.+||
T Consensus        83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred             EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence            99999999999999964     36899999999999999999999        77   9999999999999999999999


Q ss_pred             eeccccccccCCCCcc--cccccccccCccCccccCCC------CCCchhhHHHHHHHHHHHHcC----------CCCCC
Q 035998          887 ADFGLARLILSPYDTH--VTTDLVGTLGYIPPEYGQAS------VATYKGDVYSFGVVLLELLTG----------KRPMD  948 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~~pf~  948 (1020)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++||||+|+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765432221  12335789999999998776      455799999999999999999          88886


Q ss_pred             CCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          949 MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ........ .................    ............+.+++.+||+.||++|||++|+++.|+++
T Consensus       235 ~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPS-FEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCC-HHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcc-hhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            54433221 11111111111111111    11112334567899999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8.4e-40  Score=371.36  Aligned_cols=257  Identities=27%  Similarity=0.448  Sum_probs=197.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999864    57789999997653 3345679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...   ...+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999754   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          896 LSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       896 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ...... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......   ..   ........... 
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~---~~~i~~~~~~~-  270 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DV---IKAVDEGYRLP-  270 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HH---HHHHHTTEECC-
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcCCCCC-
Confidence            433211 11222345778999999999999999999999999999998 99999653221   11   11111111100 


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                               .+......+.+++.+||+.||++||+++++++.|+++
T Consensus       271 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          271 ---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                     0112234688999999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.6e-39  Score=358.26  Aligned_cols=260  Identities=17%  Similarity=0.218  Sum_probs=212.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999986 4788999999875432  24578999999999 99999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC-----eEEeeccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-----AHLADFGLAR  893 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~~~  893 (1020)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 99999999864   34789999999999999999999999   9999999999999998887     9999999998


Q ss_pred             cccCCCCcc-----cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          894 LILSPYDTH-----VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       894 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      .........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            765433221     124568999999999999999999999999999999999999999876544433333333222222


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......      ....   . .+.+++..||+.||.+||+++++++.|+++
T Consensus       239 ~~~~~~------~~~~---p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          239 TPIEVL------CENF---P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             SCHHHH------TTTC---H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCHHHH------hccC---h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            111100      0011   1 688999999999999999999999999865

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.3e-39  Score=352.52  Aligned_cols=264  Identities=26%  Similarity=0.402  Sum_probs=205.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46789999999999999999984     2678999999987766666789999999999999999999999865  3568


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            9999999999999999764   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CCcccHHHHHH
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP---------KGSRDLISWVI  963 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~---------~~~~~~~~~~~  963 (1020)
                      ........ .......++..|+|||.+.+..++.++||||+|+++|||++|..||.....         ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76433221 222334567789999999999999999999999999999999999863210         00000000111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .........         ..+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       243 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          243 ELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111111100         01112234688999999999999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7e-39  Score=352.09  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999864 68999999985432   33446789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999999865    4689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ... ........||+.|+|||++.+..++.++||||+|+++|||++|+.||.....      ........... ...   
T Consensus       163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~---  231 (294)
T 4eqm_A          163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPN---  231 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCC---
T ss_pred             ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCC---
Confidence            321 1223345789999999999999999999999999999999999999975321      11111111111 000   


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhcC
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-TTQQLVSWLDSII 1020 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~il 1020 (1020)
                        ............+.+++.+|++.||++|| +++++.+.|++++
T Consensus       232 --~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 --VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             --HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             --cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence              00011112234688999999999999999 8999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-38  Score=355.03  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=204.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357899999999999999999875 68999999997542   22345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999998764    4689999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....  .  -
T Consensus       157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~--~--~  224 (337)
T 1o6l_A          157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI--R--F  224 (337)
T ss_dssp             CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--C--C
T ss_pred             cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC--C--C
Confidence            22  2233456799999999999999999999999999999999999999964321      111111111110  0  0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      |   .    .....+.+++.+||+.||++||     +++|+++
T Consensus       225 p---~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 P---R----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C---T----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C---C----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            1   1    1123578999999999999999     8999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-38  Score=350.54  Aligned_cols=261  Identities=16%  Similarity=0.225  Sum_probs=212.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+++++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999985 5789999999865432  34578899999999 79999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC-----eEEeeccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-----AHLADFGLAR  893 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~~~  893 (1020)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+++
T Consensus        87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99 99999999864   24589999999999999999999999   9999999999999987776     9999999998


Q ss_pred             cccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          894 LILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       894 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      ........     .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            77543221     1234567899999999999999999999999999999999999999875544433333322222221


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......     ..    .....+.+++.+||+.||++||+++++++.|+++
T Consensus       240 ~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          240 TPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             SCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccHHHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            111111     01    1124688999999999999999999999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=352.64  Aligned_cols=271  Identities=22%  Similarity=0.230  Sum_probs=212.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC--ceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN--DRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357899999999999999999875 58999999997543 233566789999999999999999999998765  67999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE----cCCCCeEEeecccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGAHLADFGLA  892 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~  892 (1020)
                      |||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999986532 23489999999999999999999999   99999999999999    77888999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccC--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHHH
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQ--------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-DLISWVI  963 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~  963 (1020)
                      +......   ......||+.|+|||++.        +..++.++||||+||++|||++|+.||......... ..+....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            8764322   223457899999999875        578899999999999999999999999754433222 2222221


Q ss_pred             HHHhhcccccccC-----------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          964 RMRQENRESEVLD-----------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       964 ~~~~~~~~~~~~d-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      .............           ..............+.+++.+||+.||++|||++|+++..++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            1111111110000           001112345667788999999999999999999999997765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-39  Score=364.46  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh------hHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ------MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++......      ..+.+.+|++++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999875 6899999999764321      346789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeec
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADF  889 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  889 (1020)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999998753    4689999999999999999999999   999999999999998776    7999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      |+++.....   .......||+.|+|||++.+..++.++||||+||++|+|++|..||......   .   ....+....
T Consensus       164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~---~~~~i~~~~  234 (361)
T 2yab_A          164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E---TLANITAVS  234 (361)
T ss_dssp             SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---H---HHHHHHTTC
T ss_pred             CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHHHhcC
Confidence            999876432   2234467999999999999999999999999999999999999999753211   1   111111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ...++......    ...+.+++.+||+.||++|||++|+++
T Consensus       235 ---~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 ---YDFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ---CCCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CCCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00111111111    235789999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-39  Score=362.32  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=200.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||.||+|++. +++    +||+|.+.... ....+.+.+|++++++++||||+++++++.+. ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            56899999999999999999864 444    36888876443 23456799999999999999999999999875 4789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      |+||+.+|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999864   34689999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........   ...   ........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~---~~~~~~~~--  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI---LEKGERLP--  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH---HHTTCCCC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHH---HHcCCCCC--
Confidence            55443333444567889999999999999999999999999999999 9999975433221   111   11111100  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                              .+......+.+++.+||+.||++||+++|+++.|+++
T Consensus       240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    0111224688999999999999999999999999865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-39  Score=355.94  Aligned_cols=256  Identities=26%  Similarity=0.411  Sum_probs=207.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|++.++..||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            467899999999999999999998888999999986543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A          102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            999999999763   23589999999999999999999999   99999999999999999999999999998763321 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......      ...........   ...+  
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~---~~~~--  243 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLR---LYRP--  243 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC---CCCC--
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcccC---CCCC--
Confidence            112223456778999999988899999999999999999998 99999754321      11111211111   0011  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                       .    .....+.+++.+||+.||++|||++++++.|++++
T Consensus       244 -~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          244 -H----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             -T----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -C----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence             0    11235889999999999999999999999998763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.2e-39  Score=357.16  Aligned_cols=253  Identities=25%  Similarity=0.343  Sum_probs=203.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999875 789999999865432 234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            99999999888653    4689999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..........||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ....    ......   ...+
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~----~~~~~~---~~~~  230 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKKT---YLNP  230 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHH----HHTTCT---TSTT
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH----Hhcccc---cCCc
Confidence            33333445689999999999877665 7899999999999999999999975433211 1111    111110   0011


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        .    ......+.+++.+||+.||++|||++|+++
T Consensus       231 --~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          231 --W----KKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --G----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --c----ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence              0    111235789999999999999999999976

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=358.77  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=205.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999875 57889999987553 3355688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC--CCCeEEeeccccccccC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG--NFGAHLADFGLARLILS  897 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~  897 (1020)
                      +++|+|.+++...   ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||+++....
T Consensus        83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999998653   34689999999999999999999999   9999999999999987  78999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .   .......||+.|+|||++.+..++.++||||+||++|+|++|..||......   ..   ...+.....   ..++
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~---~~~~  224 (321)
T 1tki_A          157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI---IENIMNAEY---TFDE  224 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHTCC---CCCH
T ss_pred             C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HH---HHHHHcCCC---CCCh
Confidence            2   2234467899999999999988999999999999999999999999753221   11   111111111   0111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    ....+.+++.+||+.||.+|||++|+++
T Consensus       225 ~~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 EAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhcc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11111    1235789999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.5e-39  Score=373.66  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=206.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC-ceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN-DRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  818 (1020)
                      ..++|++.+.||+|+||.||+|.+. ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467889999999999999999985 7899999998654  3467899999999999999999999987765 7899999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999865  223478999999999999999999999   9999999999999999999999999999864221


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                           .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.   ..   ........ .    
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~---~i~~~~~~-~----  406 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---RVEKGYKM-D----  406 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH---HHHTTCCC-C----
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHcCCCC-C----
Confidence                 122356889999999999999999999999999999999 9999986544332   11   11111110 0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           .+......+.+++.+||+.||++|||++++++.|+++
T Consensus       407 -----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          407 -----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 1112234688999999999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.4e-39  Score=370.71  Aligned_cols=263  Identities=22%  Similarity=0.243  Sum_probs=208.5

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh---hHHHHHHHHHHHHHcCCCccceEeeEEe
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPNLVHLQGYCM  808 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~  808 (1020)
                      .+.++....++|++.++||+|+||+||+|+.+ +++.||||++.+....   ....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34555667789999999999999999999976 4788999999753211   1223788999999999999999999999


Q ss_pred             ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       809 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      +.+..++||||+++|+|.+++...   ...+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999763   24689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+++...... .......+||+.|+|||++.     .+.++.++||||+||++|||++|+.||......   +......
T Consensus       219 FGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~  294 (437)
T 4aw2_A          219 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIM  294 (437)
T ss_dssp             CTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH
T ss_pred             hhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhh
Confidence            99998764322 22334468999999999876     567899999999999999999999999753221   1111111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      ........+.     ....    ....+.+++.+|++.+|++  ||+++|+++
T Consensus       295 ~~~~~~~~p~-----~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          295 NHKERFQFPT-----QVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             THHHHCCCCS-----SCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hccccccCCc-----cccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            1111111111     0011    1235789999999998888  999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-38  Score=352.65  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=212.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999984      3567899999986543 3356789999999999 99999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          813 RLLIYSFMENGSLDYWLHEKLD--------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      .++||||+++|+|.+++.....              ....+++..++.++.|++.||+|||++   +|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            9999999999999999986532              123589999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |+.||.......  .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence            9999999999999987755433333445567889999999988999999999999999999999 999997543221  1


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...   ....... ..  .       +......+.+++.+||+.||.+|||++|+++.|+++
T Consensus       257 ~~~---~~~~~~~-~~--~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 FYK---MIKEGFR-ML--S-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HHH---HHHHTCC-CC--C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH---HhccCCC-CC--C-------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            111   1111110 00  0       011124688999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-39  Score=359.72  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|++.+.||+|+||.||+|+..        ++..||||++.... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467999999999999999999863        46789999997654 23456788999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDG------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      +..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||+.   +|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            9999999999999999999865321            23489999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||.....   ..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence            9999999999999987654333233344567889999999988889999999999999999999 9999975321   11


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..   ........ ..         .+......+.+++.+||+.||.+||+++|+++.|+++
T Consensus       268 ~~---~~~~~~~~-~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 LF---KLLKEGHR-MD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HH---HHHHHTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH---HHHhcCCC-CC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11   11111111 00         0111224688999999999999999999999999876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-38  Score=360.02  Aligned_cols=255  Identities=22%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.++||+|+||.||+|+.+ +++.||||++++...   ...+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457999999999999999999875 578899999976432   2223577899999887 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999998865    4689999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc--cHHHHHHHHHhhccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR--DLISWVIRMRQENRESE  973 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  973 (1020)
                      ...  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..  ............... .
T Consensus       204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~  280 (396)
T 4dc2_A          204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R  280 (396)
T ss_dssp             CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-C
T ss_pred             ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-C
Confidence            322  22344568999999999999999999999999999999999999999754322211  111111111111111 0


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT------QQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1014 (1020)
                        -|       ......+.+++.+||+.||.+||++      +|+++
T Consensus       281 --~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          281 --IP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             --CC-------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             --CC-------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence              00       1112357899999999999999995      56655

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=357.13  Aligned_cols=250  Identities=26%  Similarity=0.355  Sum_probs=204.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch------hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....      ...+.+.+|++++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46899999999999999999875 689999999875432      13567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeecc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADFG  890 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  890 (1020)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999998753    4689999999999999999999999   999999999999999887    79999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +++.....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......   ...   ........
T Consensus       164 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~~~~~~~  234 (326)
T 2y0a_A          164 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL---ANVSAVNY  234 (326)
T ss_dssp             TCEECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH---HHHHHTCC
T ss_pred             CCeECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHH---HHHHhcCC
Confidence            99876422   1233457999999999999999999999999999999999999999643211   111   11111110


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ...+.....    ....+.+++.+||+.||++|||++|+++
T Consensus       235 ---~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 ---EFEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ---CCCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CcCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               001111111    1235789999999999999999999987

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-39  Score=378.79  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=209.1

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..++|++.+.||+|+||.||+|+++++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            356788999999999999999999888999999998654 33578999999999999999999999986 6678999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.++++...  ...+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++..... 
T Consensus       264 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-  337 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-  337 (454)
T ss_dssp             CTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-
T ss_pred             cCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-
Confidence            99999999997541  13578899999999999999999999   9999999999999999999999999999876321 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .........+++.|+|||++....++.++|||||||++|||+| |+.||......   +..   ..........   .  
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~---~~i~~~~~~~---~--  406 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI---RALERGYRMP---R--  406 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH---HHHHHTCCCC---C--
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCCCC---C--
Confidence            1111223456778999999988899999999999999999999 99999754321   111   1111111110   0  


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                           +......+.+++.+||+.||++|||++++++.|+++.
T Consensus       407 -----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          407 -----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                 1112346889999999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=357.77  Aligned_cols=263  Identities=25%  Similarity=0.396  Sum_probs=210.2

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccC
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  811 (1020)
                      ..++|++.+.||+|+||.||+|+.      .++..||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999985      245689999997543 22346789999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDG-------------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIK  872 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  872 (1020)
                      ..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||++   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999764321                   13479999999999999999999999   99999999


Q ss_pred             CCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 035998          873 SSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCK  951 (1020)
Q Consensus       873 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~  951 (1020)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333445667889999999988899999999999999999998 999997543


Q ss_pred             CCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          952 PKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       952 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ...  ...   ........ ..         .+......+.+++.+||+.||.+||+++|+++.|+.++
T Consensus       280 ~~~--~~~---~~~~~~~~-~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDA--NFY---KLIQNGFK-MD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSH--HHH---HHHHTTCC-CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHH--HHH---HHHhcCCC-CC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            321  111   11111111 00         01111246889999999999999999999999998764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-38  Score=357.95  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=205.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||||++....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46899999999999999999864 68999999986421     1135678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEeecccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLADFGLA  892 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~  892 (1020)
                      ||||+++++|.+++.........+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            9999999999988876544455689999999999999999999999   9999999999999986654   999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      +.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....    ....   ........  
T Consensus       181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~---~~i~~~~~--  249 (351)
T 3c0i_A          181 IQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---EGIIKGKY--  249 (351)
T ss_dssp             EECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH---HHHHHTCC--
T ss_pred             eEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH---HHHHcCCC--
Confidence            876432  222344679999999999999999999999999999999999999997421    1111   11111110  


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ...+.....    ....+.+++.+||+.||++|||+.|+++
T Consensus       250 -~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 -KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             011111111    1236789999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.6e-39  Score=361.10  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCE----EEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRN----VAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57899999999999999999864 4443    8888875443 222345778999999999999999999986 567899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence            99999999999998754   24678899999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............++..|+|||++.+..++.++||||+|+++|||++ |+.||......+....      .......   
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------~~~~~~~---  236 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL------LEKGERL---  236 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH------HHTTCBC---
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH------HHcCCCC---
Confidence            55443344455677889999999998999999999999999999999 9999976543322111      1111110   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..+..       ....+.+++.+||+.||.+||+++++++.|+++
T Consensus       237 ~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          237 AQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             CCCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             CCCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            01100       112467899999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=357.72  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=199.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+.+|.++++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999865 68999999997542   22345678899999988 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999765    4689999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...  .......+||+.|+|||++.+..++.++||||+||++|||++|+.||......   +   ....+.....    .
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~---~~~~i~~~~~----~  242 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---D---LFEAILNDEV----V  242 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCCC----C
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---H---HHHHHHcCCC----C
Confidence            322  22334567999999999998889999999999999999999999999753221   1   1112211110    0


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT------QQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1014 (1020)
                      .|       ......+.+++.+|++.||++||++      +|+++
T Consensus       243 ~p-------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 YP-------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CC-------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CC-------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            01       1112357899999999999999998      77765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-39  Score=379.45  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=211.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+++. +..||||++..... ..+.+.+|++++++++||||++++++|.+....++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3568889999999999999999764 78999999986543 356799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.++++..  ....+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999864  234689999999999999999999999   99999999999999999999999999998764321


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                       ........+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ....   .......       
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~---~~~~~~~-------  438 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL---LEKDYRM-------  438 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---HHTTCCC-------
T ss_pred             -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHcCCCC-------
Confidence             122233456788999999988899999999999999999999 999997544321   1111   1111110       


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                         ..+......+.+++.+||+.||++|||++++++.|++++
T Consensus       439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence               011122246889999999999999999999999999864

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.1e-37  Score=366.13  Aligned_cols=347  Identities=27%  Similarity=0.386  Sum_probs=211.1

Q ss_pred             cCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          106 GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                      ..+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++.++ ..++++|++|+|++|++++..|   +..+++|++
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~  116 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP---LANLTNLTG  116 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG---GTTCTTCCE
T ss_pred             hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh---hcCCCCCCE
Confidence            34567778888888777 455 36777888888888888877655 3367778888888887774333   456777777


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcC
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF  265 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  265 (1020)
                      |++++|.+++..+  ++++++|++|++++|.+++ ++ .+..+++|++|+++ |.+.+..  .+.++++|++|++++|.+
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l  189 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV  189 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence            7777777765432  6777777777777777774 23 36677777777775 4454332  366777777777777777


Q ss_pred             cccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC
Q 035998          266 SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL  345 (1020)
Q Consensus       266 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  345 (1020)
                      ++.  ..+..+++|++|++++|++++..|  ++.+++|+.|++++|.+++.  ..+..+++|++|++++|++++..|  +
T Consensus       190 ~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  261 (466)
T 1o6v_A          190 SDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L  261 (466)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred             CCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence            643  235666666666666666665443  44555555555555555532  134445555555555555553333  4


Q ss_pred             CCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       346 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                      ..+++|++|++++|++++..+  +..+++|+.|++++|++..+                                     
T Consensus       262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-------------------------------------  302 (466)
T 1o6v_A          262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-------------------------------------  302 (466)
T ss_dssp             TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-------------------------------------
T ss_pred             hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-------------------------------------
Confidence            445555555555555543322  44444444444444443221                                     


Q ss_pred             ceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcC
Q 035998          426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISL  505 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~  505 (1020)
                                    .|  +..+++|+.|++++|++++..|  +..+++|++|++++|++++                   
T Consensus       303 --------------~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-------------------  345 (466)
T 1o6v_A          303 --------------SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-------------------  345 (466)
T ss_dssp             --------------GG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-------------------
T ss_pred             --------------hh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC-------------------
Confidence                          11  4455566666666666665444  4555666666666665552                   


Q ss_pred             CCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEE
Q 035998          506 EEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETL  585 (1020)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  585 (1020)
                                                               .  +.++.+++|+.|++++|++++..|  +..+++|+.|
T Consensus       346 -----------------------------------------~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  380 (466)
T 1o6v_A          346 -----------------------------------------V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL  380 (466)
T ss_dssp             -----------------------------------------C--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEE
T ss_pred             -----------------------------------------c--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEE
Confidence                                                     1  235556677777777777776555  6777777777


Q ss_pred             EccCCcccc
Q 035998          586 DLSYNNLSG  594 (1020)
Q Consensus       586 ~Ls~N~l~g  594 (1020)
                      ++++|++++
T Consensus       381 ~l~~n~~~~  389 (466)
T 1o6v_A          381 GLNDQAWTN  389 (466)
T ss_dssp             ECCCEEEEC
T ss_pred             eccCCcccC
Confidence            777777775

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.7e-39  Score=356.15  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....   .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999996 5789999999865321   1235688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+ +|+|.+++...    ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 67888888764    4689999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ..   .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...........+            ... 
T Consensus       160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------~~~-  223 (336)
T 3h4j_B          160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------NSC-  223 (336)
T ss_dssp             TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------------CSS-
T ss_pred             CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------------HcC-
Confidence            32   23345679999999999988776 78999999999999999999999754332211110            000 


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..    ..+......+.+++.+||+.||.+|||++|+++
T Consensus       224 ~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 VY----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CC----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CC----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            00    001112235789999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.3e-39  Score=350.66  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=200.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|+..+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47899999999999999999988899999999975532  2236788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....+.
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            986 888888653   24689999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc-----
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE-----  973 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  973 (1020)
                        .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+................     
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhh
Confidence              22234578999999998865 4689999999999999999999999975322   122221111111100000     


Q ss_pred             ---ccCcc-------ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 ---VLDPF-------IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ---~~d~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ..++.       ............+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               00000       000111122346789999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=359.75  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=203.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57899999999999999999865 58899999986542   123457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+.+|+|..++...    ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999998764    4689999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCcccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .   .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.............   .......  . 
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~~~~--~-  238 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFETTVV--T-  238 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHHCCC--C-
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhhccc--C-
Confidence            2   23345689999999998864   468999999999999999999999997544333222221   1111110  0 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-TQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1014 (1020)
                       .       +......+.+++.+||+.||.+||+ ++++.+
T Consensus       239 -~-------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 -Y-------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -C-------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -C-------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence             0       1111236889999999999999998 777664

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.4e-38  Score=342.61  Aligned_cols=251  Identities=31%  Similarity=0.468  Sum_probs=194.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch----hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG----QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|.+. ++.||||++.....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357899999999999999999985 88999999875432    2246788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC---eEecCCCCCCEEEcC--------CCCeE
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH---ILHRDIKSSNILLDG--------NFGAH  885 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlkp~NIll~~--------~~~~k  885 (1020)
                      |||+++++|.+++..     ..+++..++.++.|++.||+|||++   +   |+||||||+||+++.        ++.+|
T Consensus        85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence            999999999998864     3689999999999999999999999   7   999999999999986        77899


Q ss_pred             EeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          886 LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       886 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      |+|||+++.....    ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....      .......
T Consensus       157 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~  226 (271)
T 3dtc_A          157 ITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGV  226 (271)
T ss_dssp             ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHH
T ss_pred             EccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhh
Confidence            9999999865432    12245789999999999999999999999999999999999999974321      1111111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ........         .+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       227 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNKLALP---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCCCCCC---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111111         1111224688999999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=368.15  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            457999999999999999999864 68899999987654  233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~  894 (1020)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++   .++.+||+|||+++.
T Consensus        90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999988764    4689999999999999999999999   999999999999998   568899999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .....  .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....      ......+.....  ..
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~--~~  232 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAY--DF  232 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC--CC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCC--CC
Confidence            64322  223446799999999999999999999999999999999999999964321      111112211111  00


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..+ ...    .....+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 PSP-EWD----TVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CTT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Ccc-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            011 011    11235889999999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-38  Score=360.85  Aligned_cols=251  Identities=24%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999865 68999999997543  233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC---CCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~  894 (1020)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.+   +.+||+|||+++.
T Consensus       108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999888754    4689999999999999999999999   99999999999999865   4599999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....      ......+.....  ..
T Consensus       181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~--~~  249 (362)
T 2bdw_A          181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAY--DY  249 (362)
T ss_dssp             CTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC--CC
T ss_pred             ecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC--CC
Confidence            6432   223346799999999999999999999999999999999999999964321      111111211111  00


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..+ ...    .....+.+++.+||+.||++||+++|+++
T Consensus       250 ~~~-~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          250 PSP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CTT-GGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Ccc-ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000 011    11235789999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.7e-38  Score=351.46  Aligned_cols=254  Identities=22%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56899999999999999999975 58899999997543   23345678899999988 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999764    4689999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc--cHHHHHHHHHhhcccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR--DLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~  974 (1020)
                      ...  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........  ............... ..
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~  238 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI  238 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-CC
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-CC
Confidence            222  2334568999999999999999999999999999999999999999753322111  111111111111111 00


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT------QQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1014 (1020)
                        |       ......+.+++.+||+.||.+||++      +|+++
T Consensus       239 --p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          239 --P-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             --C-------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             --C-------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence              1       1112357899999999999999995      56654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=361.89  Aligned_cols=252  Identities=21%  Similarity=0.328  Sum_probs=206.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999865 6889999999876655566789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC--CCCeEEeeccccccccC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG--NFGAHLADFGLARLILS  897 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~  897 (1020)
                      +++|+|.+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999988753   34689999999999999999999999   9999999999999974  57899999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....   ..++
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~---~~~~  271 (387)
T 1kob_A          204 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW---EFDE  271 (387)
T ss_dssp             T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC---CCCS
T ss_pred             C---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC---CCCc
Confidence            2   223345789999999999999999999999999999999999999975321      111122211111   0111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    ....+.+++.+||+.||++|||++|+++
T Consensus       272 ~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 DAFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             STTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            11111    2236889999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7.8e-39  Score=349.58  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=196.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|....    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678999999999999999998643    4569999987643 334567899999999999999999999984 567899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999764   24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .... ........+++.|+|||++.+..++.++||||+|+++|||++ |..||......   +....   +...... . 
T Consensus       167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~---i~~~~~~-~-  237 (281)
T 1mp8_A          167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---IENGERL-P-  237 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---HHTTCCC-C-
T ss_pred             Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH---HHcCCCC-C-
Confidence            4322 122233456789999999988899999999999999999997 99999754332   22211   1111110 0 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                              .+......+.+++.+||+.||++||+++|+++.|+++
T Consensus       238 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          238 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    0111224688999999999999999999999999876

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-38  Score=347.38  Aligned_cols=244  Identities=26%  Similarity=0.349  Sum_probs=202.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57899999999999999999875 689999999975421   23456788999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999864    4689999999999999999999999   999999999999999999999999999987532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                           ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....  .  -|
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~--~--~p  223 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAEL--R--FP  223 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCC--C--CC
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--C--CC
Confidence                 22346799999999999999999999999999999999999999964321      111112211110  0  01


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                             ......+.+++.+|++.||++||     +++|+++
T Consensus       224 -------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 -------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   11123578999999999999999     8898875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-38  Score=346.38  Aligned_cols=253  Identities=32%  Similarity=0.513  Sum_probs=203.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhh-------HHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQM-------EREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467899999999999999999874 78999999986543211       157889999999999999999999986554 


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEcCCCC-----eE
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLDGNFG-----AH  885 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k  885 (1020)
                       ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             7999999999998888653   34689999999999999999999999   8  999999999999988776     99


Q ss_pred             EeeccccccccCCCCcccccccccccCccCcccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          886 LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG--QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       886 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      |+|||+++....     ......||+.|+|||++  ....++.++||||+|+++|||++|+.||.......    .....
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~  240 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFIN  240 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHH
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHH
Confidence            999999975422     23446789999999998  45567899999999999999999999997543321    11122


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..........     .    +......+.+++.+||+.||++|||++|+++.|+++
T Consensus       241 ~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 MIREEGLRPT-----I----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHSCCCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHhccCCCCC-----C----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            2222111111     1    111224688999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.6e-39  Score=346.88  Aligned_cols=255  Identities=29%  Similarity=0.459  Sum_probs=209.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            457889999999999999999998888999999986543 3467899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++++|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++..... .
T Consensus        86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~  158 (267)
T 3t9t_A           86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-Q  158 (267)
T ss_dssp             TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-H
T ss_pred             CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc-c
Confidence            999999999764   24689999999999999999999999   9999999999999999999999999999875321 1


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI  979 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  979 (1020)
                      ........+++.|+|||+..+..++.++||||+|+++|||++ |+.||.....      ............   ...+  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~~~---~~~~--  227 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR---LYKP--  227 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC---CCCC--
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcCCc---CCCC--
Confidence            112223456788999999988899999999999999999999 8999974321      111112211111   0011  


Q ss_pred             cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          980 YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       980 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           ......+.+++.+||+.||++||+++++++.|+++
T Consensus       228 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          228 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 11123588999999999999999999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-38  Score=347.00  Aligned_cols=251  Identities=20%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-C-------CEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-G-------RNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|+... +       ..||+|++........+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578899999999999999998642 3       4799999977666667789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC--------e
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--------A  884 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~  884 (1020)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999864   23489999999999999999999999   9999999999999998887        9


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++....      .....|++.|+|||++.+ ..++.++||||+|+++|||++|..|+.....     ......
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~  229 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKLQ  229 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHHH
Confidence            9999999875422      123457889999998877 7799999999999999999996554432111     111111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ............            ...+.+++.+||+.||++|||++|+++.|++++
T Consensus       230 ~~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          230 FYEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HHHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             HhhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            111111111100            124789999999999999999999999999874

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-38  Score=353.93  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      ...++|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999975 68899999997542   12345677899999877 999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999864    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      .....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ..   ....+.....   
T Consensus       167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~---~~~~i~~~~~---  235 (345)
T 1xjd_A          167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EE---LFHSIRMDNP---  235 (345)
T ss_dssp             CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---HHHHHHHCCC---
T ss_pred             hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HH---HHHHHHhCCC---
Confidence            64321  1223456899999999999999999999999999999999999999974321   11   1111211110   


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ-QLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1014 (1020)
                          .....    ....+.+++.+||+.||++||++. ++++
T Consensus       236 ----~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          236 ----FYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----CCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                00011    123578999999999999999987 6653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.5e-38  Score=354.93  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999875 7899999999765332 35688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC--eEEeeccccccccC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--AHLADFGLARLILS  897 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~  897 (1020)
                      +++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999998764    4689999999999999999999999   9999999999999987765  99999999975422


Q ss_pred             CCCcccccccccccCccCccccCCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYK-GDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                         ........||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........  .............  ...+
T Consensus       171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~--~~~~  243 (361)
T 3uc3_A          171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKY--SIPD  243 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCC--CCCT
T ss_pred             ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCC--CCCC
Confidence               122344579999999999887777655 9999999999999999999975443322  2222222221111  0000


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .       ......+.+++.+||+.||++|||++|+++
T Consensus       244 ~-------~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          244 D-------IRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             T-------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             c-------CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0       011235789999999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.2e-39  Score=366.09  Aligned_cols=259  Identities=22%  Similarity=0.252  Sum_probs=206.2

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      +.++....++|++.+.||+|+||.||+|+.+ +++.||+|++.+...   ...+.+.+|+++++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455556789999999999999999999875 588999999865321   112347889999999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      .+..|+||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++++||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999998753     589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV----ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      |+++...... .......+||+.|+|||++.+..    ++.++||||+||++|||++|+.||......   .........
T Consensus       213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~  288 (410)
T 3v8s_A          213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNH  288 (410)
T ss_dssp             TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTH
T ss_pred             ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhc
Confidence            9998764321 22234568999999999887655    789999999999999999999999743221   111111111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKV--RPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1014 (1020)
                      ......+.   .   .    .....+.+++.+|++.+|.+  ||+++||++
T Consensus       289 ~~~~~~p~---~---~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          289 KNSLTFPD---D---N----DISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHCCCCT---T---C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cccccCCC---c---c----cccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            11111110   0   0    11235789999999999988  999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-38  Score=346.38  Aligned_cols=260  Identities=28%  Similarity=0.481  Sum_probs=195.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+..  ..||||++....  ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            467999999999999999999864  469999987553  33456789999999999999999999965 5567899999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999998653   35689999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ..........||+.|+|||++.   +..++.++||||+|+++|||++|+.||......  .....   .... .......
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~-~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIE---MVGR-GSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHH---HHHH-TSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHH---Hhcc-cccCcch
Confidence            3333334567899999999876   667899999999999999999999999754321  11111   1111 1111100


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .     .........+.+++.+||+.||.+||+++++++.|+++.
T Consensus       248 ~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          248 S-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             T-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             h-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            0     011122346889999999999999999999999999873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.8e-38  Score=350.54  Aligned_cols=270  Identities=27%  Similarity=0.416  Sum_probs=215.0

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEe
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQ  804 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  804 (1020)
                      ...++....++|++.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444555678899999999999999999974      3567899999986543 3346789999999999 799999999


Q ss_pred             eEEeccC-ceEEEEEeccCCChhhhhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 035998          805 GYCMHKN-DRLLIYSFMENGSLDYWLHEKLDG------------PSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI  871 (1020)
Q Consensus       805 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  871 (1020)
                      +++...+ ..++||||+++++|.+++......            ...+++..++.++.|++.||+|||+.   +|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence            9988755 489999999999999999865321            22378999999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 035998          872 KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMC  950 (1020)
Q Consensus       872 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~  950 (1020)
                      ||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||+| |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987654433333445667889999999988999999999999999999998 99999754


Q ss_pred             CCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          951 KPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       951 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ....  ...   ........ ...  +   .    .....+.+++.+||+.||.+|||++|+++.|++++
T Consensus       255 ~~~~--~~~---~~~~~~~~-~~~--~---~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDE--EFC---RRLKEGTR-MRA--P---D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSH--HHH---HHHHHTCC-CCC--C---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhH--HHH---HHhccCcc-CCC--C---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3221  111   11111111 000  0   1    11235889999999999999999999999998763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-38  Score=358.09  Aligned_cols=266  Identities=18%  Similarity=0.198  Sum_probs=202.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC------CCEEEEEEecCCchhhH-----------HHHHHHHHHHHHcCCCccceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDCGQME-----------REFRAEVEALSRAQHPNLVHL  803 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l  803 (1020)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4679999999999999999998754      47899999876643211           123345556667789999999


Q ss_pred             eeEEecc----CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc
Q 035998          804 QGYCMHK----NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD  879 (1020)
Q Consensus       804 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  879 (1020)
                      ++++...    ...++||||+ +++|.+++...   ...+++..++.++.||+.||+|||++   +|+||||||+||+++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9999865    4478999999 99999999763   34689999999999999999999999   999999999999999


Q ss_pred             --CCCCeEEeeccccccccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 035998          880 --GNFGAHLADFGLARLILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKP  952 (1020)
Q Consensus       880 --~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~  952 (1020)
                        .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876432111     111335599999999999999999999999999999999999999975332


Q ss_pred             CCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          953 KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..  ........... .......++......   ....+.+++..||+.||.+||+++++++.|+++
T Consensus       267 ~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DP--KYVRDSKIRYR-ENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CH--HHHHHHHHHHH-HCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CH--HHHHHHHHHhh-hhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            21  22211111111 111122222111111   123688999999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=355.46  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=198.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCE----EEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRN----VAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+.... ....+.+.+|++++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999864 4443    5778775432 344678899999999999999999999998654 78


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +|+||+.+|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            999999999999999864   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ..............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.......   ....   ........ 
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~---~~~~~~~~-  239 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---LEKGERLP-  239 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTCCCC-
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHcCCCCC-
Confidence            654433333344567889999999999999999999999999999999 999997543322   1111   11111100 


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                               .+......+.+++.+||+.||.+||+++|+++.|+++
T Consensus       240 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          240 ---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     0111223588999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.1e-39  Score=374.11  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=204.2

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..++|++.+.||+|+||.||+|.++++..||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3467888999999999999999998888899999986542 35678999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       260 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999997531  23588999999999999999999999   99999999999999999999999999998764321


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                       ........+++.|+|||++.+..++.++||||||+++|||++ |+.||......   +.   ...........      
T Consensus       335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~---~~~i~~~~~~~------  401 (452)
T 1fmk_A          335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV---LDQVERGYRMP------  401 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHHHHTTCCCC------
T ss_pred             -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcCCCCC------
Confidence             122233456789999999988899999999999999999999 99999754321   11   11111111110      


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                          .+......+.+++.+||+.||++|||++++++.|++++
T Consensus       402 ----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          402 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                11122346889999999999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.1e-38  Score=343.16  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999875 68999999997543  2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++ ++.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....+
T Consensus        82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9986 455544432   24689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc--
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASV-ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL--  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  975 (1020)
                      .  .......||+.|+|||++.+.. ++.++||||+||++|||++|..||....  ...+..................  
T Consensus       155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhh
Confidence            2  2234467899999999887665 8999999999999999999888864321  1222222222221111100000  


Q ss_pred             ----C----c-----cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 ----D----P-----FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 ----d----~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          +    +     .......+.....+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                0    0     0000111123346789999999999999999999987

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=360.79  Aligned_cols=273  Identities=23%  Similarity=0.245  Sum_probs=212.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC--ceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN--DRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999875 58999999997543 233466789999999999999999999998765  67999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE----cCCCCeEEeecccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGAHLADFGLA  892 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~  892 (1020)
                      |||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999986532 23489999999999999999999999   99999999999999    77788999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHHH
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQA--------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-DLISWVI  963 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~  963 (1020)
                      +.....   .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... ..+....
T Consensus       164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            876332   22334679999999998754        56788999999999999999999999754433222 2221111


Q ss_pred             HHHhhccccccc-----------CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          964 RMRQENRESEVL-----------DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       964 ~~~~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ............           +..............+.+++.+||+.||++||+++|+++.+++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            111111100000           000111234566778899999999999999999999999988763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.1e-39  Score=355.39  Aligned_cols=264  Identities=27%  Similarity=0.413  Sum_probs=198.9

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK  810 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  810 (1020)
                      +....++|++.+.||+|+||.||+|+..    +++.||||++....  ....+.+.+|++++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3345678999999999999999999753    34589999987543  33346789999999999999999999999875


Q ss_pred             Cc-----eEEEEEeccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          811 ND-----RLLIYSFMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       811 ~~-----~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      +.     .++||||+++++|.+++....  .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            53     489999999999999985432  3345789999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  962 (1020)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.......   .... 
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~-  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY-  261 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH-
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH-
Confidence            99999999987654332233334567889999999999999999999999999999999 889997543321   1111 


Q ss_pred             HHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          963 IRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       963 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ....... .     .    +......+.+++.+||+.||.+||+++++++.|+++
T Consensus       262 --~~~~~~~-~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 --LLHGHRL-K-----Q----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             --HHTTCCC-C-----C----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHcCCCC-C-----C----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              1111110 0     0    111223688999999999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.9e-38  Score=346.57  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=206.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--Cce
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  813 (1020)
                      ++|++.+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999984     368899999997543 23346789999999999999999999999876  668


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999999654   24589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CCCcc-cHHHHHH
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK--------PKGSR-DLISWVI  963 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~--------~~~~~-~~~~~~~  963 (1020)
                      ........ .......||..|+|||++.+..++.++||||+|+++|||++|..|+....        +.... .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76543221 22334567888999999988899999999999999999999999864210        01111 1111111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ........          ..+......+.+++.+||+.||.+|||++++++.|++++
T Consensus       255 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111110          011122346889999999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=342.99  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh--------------------------hHHHHHHHHHHHH
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ--------------------------MEREFRAEVEALS  793 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  793 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999864 6889999998654311                          1245889999999


Q ss_pred             HcCCCccceEeeEEec--cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 035998          794 RAQHPNLVHLQGYCMH--KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI  871 (1020)
Q Consensus       794 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  871 (1020)
                      +++||||+++++++.+  .+..++||||+++++|.++...     ..+++..+..++.|++.||+|||++   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  5678999999999998776432     4689999999999999999999999   9999999


Q ss_pred             CCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCC
Q 035998          872 KSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASV---ATYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       872 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      ||+||+++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++||||+||++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999998764322  2234467999999999987765   4789999999999999999999996


Q ss_pred             CCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          949 MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...      .............  ...+       .+.....+.+++.+||+.||++||+++|+++
T Consensus       242 ~~~------~~~~~~~~~~~~~--~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          242 DER------IMCLHSKIKSQAL--EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSS------HHHHHHHHHHCCC--CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             Ccc------HHHHHHHHhcccC--CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            432      1111122211111  0000       0111235889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=363.71  Aligned_cols=262  Identities=21%  Similarity=0.243  Sum_probs=206.4

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEe
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCM  808 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  808 (1020)
                      .+.+.....++|++.+.||+|+||.||+|+.+ +|+.||||++.+...   ...+.+.+|++++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34555566789999999999999999999975 689999999975321   11234788999999999999999999999


Q ss_pred             ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEee
Q 035998          809 HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       809 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      +.+..|+||||+++|+|.+++.+.   +..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999864   23689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccCCCCcccccccccccCccCccccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  961 (1020)
                      ||+++...... .......+||+.|+|||++.       ...++.++||||+||++|||++|+.||......   .....
T Consensus       206 FGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~  281 (412)
T 2vd5_A          206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGK  281 (412)
T ss_dssp             CTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHH
T ss_pred             chhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence            99998764322 22233468999999999876       467899999999999999999999999753221   11111


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR---PTTQQLVS 1014 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 1014 (1020)
                      ..........     |.....    ...++.+++.+||+ +|++|   |+++|+++
T Consensus       282 i~~~~~~~~~-----p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          282 IVHYKEHLSL-----PLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHTHHHHCCC-----C----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHhcccCcCC-----CccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            1111111111     111011    12368899999999 99998   58999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-37  Score=342.84  Aligned_cols=262  Identities=19%  Similarity=0.252  Sum_probs=206.6

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEE-eccCceEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC-MHKNDRLLIY  817 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  817 (1020)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++.....  ...+.+|+++++.++|++++..+.++ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            357899999999999999999986 5788999998765432  23578899999999988877766666 5566779999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~  894 (1020)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999 99999998753   24689999999999999999999999   99999999999999   7889999999999987


Q ss_pred             ccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          895 ILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       895 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      .......     .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6543221     12234678999999999999999999999999999999999999998766555444444333332222


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......     ...    ...+.+++.+||+.||++||+++++++.|+++
T Consensus       238 ~~~~~~-----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          238 PIEVLC-----KGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CHHHHT-----TTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhh-----ccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            111100     111    23688999999999999999999999999876

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-38  Score=368.77  Aligned_cols=329  Identities=19%  Similarity=0.176  Sum_probs=294.1

Q ss_pred             CCCCCCC--cCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCC
Q 035998           57 ASSSDCC--HWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPN  134 (1020)
Q Consensus        57 ~~~~~~C--~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~  134 (1020)
                      ++..+.|  .|..|.|+....+.+|...+ ..++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++
T Consensus         3 Cp~~C~C~~~~~~v~c~~~~l~~ip~~~~-~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~   81 (477)
T 2id5_A            3 CPPRCECSAQDRAVLCHRKRFVAVPEGIP-TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN   81 (477)
T ss_dssp             CSTTCEEETTTTEEECCSCCCSSCCSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ccCCCeECCCCCEEEeCCCCcCcCCCCCC-CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc
Confidence            4555557  48899999999999998775 58999999999999988899999999999999999999888999999999


Q ss_pred             CCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccc
Q 035998          135 LEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       135 L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      |++|+|++|++++.++..+ ++++|++|+|++|++++ ++...+..+++|+.|+|++|.+.+..+..|.++++|++|+|+
T Consensus        82 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A           82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             CCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred             CCEEECCCCcCCccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence            9999999999998888777 89999999999999984 444455789999999999999998888899999999999999


Q ss_pred             ccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC
Q 035998          214 MNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI  293 (1020)
Q Consensus       214 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  293 (1020)
                      +|++++..+..+..+++|+.|+|++|++++..+..|..+++|++|++++|.+.+.+|..+....+|+.|++++|++++..
T Consensus       161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  240 (477)
T 2id5_A          161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP  240 (477)
T ss_dssp             SCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCC
T ss_pred             CCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccC
Confidence            99999877788999999999999999999888888999999999999999888777777766779999999999999766


Q ss_pred             CCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCC
Q 035998          294 PHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFE  373 (1020)
Q Consensus       294 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  373 (1020)
                      +..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..++
T Consensus       241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  320 (477)
T 2id5_A          241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG  320 (477)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred             HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence            67788999999999999999988888899999999999999999988899999999999999999999988788889999


Q ss_pred             CCCeeeCCCCCCcc
Q 035998          374 SLSYLSLSNSSIYN  387 (1020)
Q Consensus       374 ~L~~L~l~~N~i~~  387 (1020)
                      +|++|++++|++..
T Consensus       321 ~L~~L~l~~N~l~c  334 (477)
T 2id5_A          321 NLETLILDSNPLAC  334 (477)
T ss_dssp             GCCEEECCSSCEEC
T ss_pred             ccCEEEccCCCccC
Confidence            99999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.8e-39  Score=352.01  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=211.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++..+.. ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567899999999999999999876 478899999986543 35678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999764  235689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      . ........+++.|+|||++.+..++.++||||+|+++|+|++ |..||.......   ....   ....... .    
T Consensus       165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~---~~~~~~~-~----  232 (288)
T 3kfa_A          165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL---LEKDYRM-E----  232 (288)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---HHTTCCC-C----
T ss_pred             c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HhccCCC-C----
Confidence            2 223334566789999999988899999999999999999999 999997543221   1111   1111110 0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           .+......+.+++.+|++.||.+||+++++++.|+++
T Consensus       233 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          233 -----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                 0111224688999999999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.5e-38  Score=351.67  Aligned_cols=265  Identities=24%  Similarity=0.367  Sum_probs=190.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999865 689999999875532 233568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          819 FMENGSLDYWLHEKL--DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |++ |+|.+++....  .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999887542  2234689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc---cc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR---ES  972 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~  972 (1020)
                      .+.  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......   +.............   ..
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhh
Confidence            322  12234578999999998876 46899999999999999999999999754321   22222211111000   00


Q ss_pred             cc-----cCccc------------cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EV-----LDPFI------------YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~-----~d~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..     ..+..            ...........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00     00000            00000012236889999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.9e-39  Score=357.54  Aligned_cols=266  Identities=23%  Similarity=0.350  Sum_probs=213.0

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEe
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCM  808 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  808 (1020)
                      ++....++|++.+.||+|+||.||+|++.      +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999754      367899999976542 33456889999999999999999999999


Q ss_pred             ccCceEEEEEeccCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC
Q 035998          809 HKNDRLLIYSFMENGSLDYWLHEKL------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       809 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                      +.+..++||||+++|+|.+++....      .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999987532      1124578999999999999999999999   999999999999999999


Q ss_pred             CeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHH
Q 035998          883 GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  961 (1020)
                      .+||+|||+++...............+++.|+|||++.+..++.++||||+|+++|||++ |..||.....      ...
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~  249 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV  249 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHH
Confidence            999999999987643322233344567889999999988899999999999999999999 8999965321      111


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ........ ....         +......+.+++.+||+.||++||++.|+++.|++++
T Consensus       250 ~~~~~~~~-~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          250 LRFVMEGG-LLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHHTTC-CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHHcCC-cCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            11111111 1110         1112245889999999999999999999999998763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-38  Score=354.48  Aligned_cols=263  Identities=28%  Similarity=0.429  Sum_probs=211.2

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeCC------CCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLPD------GRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      ...++|++.+.||+|+||.||+|....      ...||+|.+..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999998642      24799999976542 3456789999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD----------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG  880 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  880 (1020)
                      +..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||++   +|+||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence            999999999999999999875421          134679999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHH
Q 035998          881 NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLI  959 (1020)
Q Consensus       881 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  959 (1020)
                      ++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||+| |..||........  ..
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~  277 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FY  277 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HH
Confidence            99999999999987654333333444567889999999988899999999999999999999 9999975432211  11


Q ss_pred             HHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          960 SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       960 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          .........  ..+       ......+.+++.+||+.||.+|||++|+++.|+++
T Consensus       278 ----~~~~~~~~~--~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          278 ----KLVKDGYQM--AQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ----HHHHHTCCC--CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHhcCCCC--CCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                111111100  001       11123688999999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.8e-37  Score=340.07  Aligned_cols=261  Identities=19%  Similarity=0.255  Sum_probs=208.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEE-eccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYC-MHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....  .+.+.+|+++++.++|++++..+.++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999986 5789999999876533  24588999999999988877666665 45666789999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~  895 (1020)
                      |+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++..
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99 89999999753   24689999999999999999999999   99999999999999   48899999999999876


Q ss_pred             cCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          896 LSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       896 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ......     .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543221     112456789999999999999999999999999999999999999987655444444333332222111


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....     ...    ....+.+++.+||+.||++||+++++++.|+++
T Consensus       239 ~~~~-----~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          239 IEVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHH-----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hHHH-----Hhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            1100     011    123588999999999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-37  Score=346.42  Aligned_cols=248  Identities=24%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe----CCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++....    ......+.+|++++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999986    478999999997653    1233457889999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+++++|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999764    4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      +.....  ........||+.|+|||++.+..++.++||||+|+++|||++|+.||.....   ....   ..+.....  
T Consensus       169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---~~i~~~~~--  238 (327)
T 3a62_A          169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTI---DKILKCKL--  238 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHTCC--
T ss_pred             cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHhCCC--
Confidence            764322  1223446789999999999999999999999999999999999999974321   1111   11111110  


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      . .        ++.....+.+++.+||+.||++||     ++.|+++
T Consensus       239 ~-~--------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 N-L--------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             C-C--------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C-C--------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            0 0        011123688999999999999999     7788876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=350.69  Aligned_cols=251  Identities=27%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCC--CccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQH--PNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++|  |||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999998889999999987543  3334678999999999976  9999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      || +.+++|.+++...    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++...
T Consensus        88 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             Ee-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            99 5678999999864    4689999999999999999999999   999999999999997 6789999999998765


Q ss_pred             CCCCcccccccccccCccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQA-----------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      ............||+.|+|||++.+           ..++.++||||+||++|||++|+.||....     .........
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~  233 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAI  233 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHH
Confidence            4333333445689999999998754           678999999999999999999999996432     122222222


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .........         +......+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~---------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          234 IDPNHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HCTTSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcCCcccCC---------cccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            111111110         1111135789999999999999999999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.6e-37  Score=362.89  Aligned_cols=347  Identities=24%  Similarity=0.338  Sum_probs=217.7

Q ss_pred             CCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccc
Q 035998          155 LPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLL  234 (1020)
Q Consensus       155 l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  234 (1020)
                      +++|+.|++++|.+. .+|.  +..+++|++|+|++|.+++..+  ++++++|++|++++|.+++..+            
T Consensus        45 l~~l~~L~l~~~~i~-~l~~--~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~------------  107 (466)
T 1o6v_A           45 LDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP------------  107 (466)
T ss_dssp             HHTCCEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG------------
T ss_pred             hccccEEecCCCCCc-cCcc--hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh------------
Confidence            455666666666655 3442  2344555555555555543322  4444555555555554443322            


Q ss_pred             cccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccc
Q 035998          235 GLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD  314 (1020)
Q Consensus       235 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  314 (1020)
                                    +.++++|++|++++|.+++..+  +..+++|++|++++|++++. + .+..+++|+.|+++ |.+.
T Consensus       108 --------------~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~  168 (466)
T 1o6v_A          108 --------------LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVT  168 (466)
T ss_dssp             --------------GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCC
T ss_pred             --------------hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Cccc
Confidence                          4444555555555555443322  44455555555555554432 1 24555555555554 3333


Q ss_pred             cccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHH
Q 035998          315 GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQV  394 (1020)
Q Consensus       315 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~  394 (1020)
                      +..+  +..+++|++|++++|++++.  ..+..+++|++|++++|++++..|  ++.+++|++|++++|+++.++.    
T Consensus       169 ~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~----  238 (466)
T 1o6v_A          169 DLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----  238 (466)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG----
T ss_pred             Cchh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccchh----
Confidence            2222  55566666666666666532  235566666666666666665444  5556666666666666554421    


Q ss_pred             HhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcC
Q 035998          395 LQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDL  474 (1020)
Q Consensus       395 l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  474 (1020)
                      +                         ..+++|+.|++++|.+.+..|  +..+++|+.|++++|++++..+  +..+++|
T Consensus       239 l-------------------------~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L  289 (466)
T 1o6v_A          239 L-------------------------ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL  289 (466)
T ss_dssp             G-------------------------GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred             h-------------------------hcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc
Confidence            1                         123445555555555555444  6778888888888888885544  7788888


Q ss_pred             cEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccC
Q 035998          475 FYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN  554 (1020)
Q Consensus       475 ~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~  554 (1020)
                      ++|+|++|++++..|  +..+++|                                    +.|+|++|++++..|  ++.
T Consensus       290 ~~L~L~~n~l~~~~~--~~~l~~L------------------------------------~~L~L~~n~l~~~~~--~~~  329 (466)
T 1o6v_A          290 TNLELNENQLEDISP--ISNLKNL------------------------------------TYLTLYFNNISDISP--VSS  329 (466)
T ss_dssp             SEEECCSSCCSCCGG--GGGCTTC------------------------------------SEEECCSSCCSCCGG--GGG
T ss_pred             CeEEcCCCcccCchh--hcCCCCC------------------------------------CEEECcCCcCCCchh--hcc
Confidence            888888888876544  5555555                                    357777888877655  788


Q ss_pred             CCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccccccC
Q 035998          555 LKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRI  620 (1020)
Q Consensus       555 L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g~~  620 (1020)
                      +++|+.|++++|++++.  +.+..+++|++|++++|++++.+|  +..+++|+.|++++|++++.+
T Consensus       330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred             CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence            99999999999999864  579999999999999999998877  899999999999999999843

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-37  Score=349.85  Aligned_cols=244  Identities=21%  Similarity=0.269  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999875 68999999986542   123456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999865    4589999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....  ..  |
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~--~~--p  258 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV--RF--P  258 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--CC--C
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC--CC--C
Confidence            1     2345789999999999999999999999999999999999999974321      111112211110  00  1


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                             ......+.+++.+||+.||.+||+     ++|+++
T Consensus       259 -------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 -------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                   111235889999999999999998     888875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.4e-38  Score=357.80  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=204.8

Q ss_pred             ccCCCcCCeeecc--CCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCG--GFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|  +||.||+|+.. +++.||||++....  ....+.+.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 68999999997553  3344678889999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++....  ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999997642  24589999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCCC-----cccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          896 LSPYD-----THVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       896 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      .....     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||.........  ..........
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCc
Confidence            32211     112223478899999999887  67999999999999999999999999764433211  1000000000


Q ss_pred             ---------cc-------------cccc---cCcc------ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 ---------NR-------------ESEV---LDPF------IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ---------~~-------------~~~~---~d~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                               ..             ....   ..+.      ............+.+++.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                     00             0000   0000      000011222346889999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=354.28  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=188.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999976 57899999997653  345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeecccccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLIL  896 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~~  896 (1020)
                      +++++|.+++...    ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++...
T Consensus       130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999988754    4689999999999999999999999   9999999999999975   8899999999998653


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..  ....+.....  ....
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~--~~~~i~~~~~--~~~~  272 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QF--MFRRILNCEY--YFIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HH--HHHHHHTTCC--CCCT
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HH--HHHHHHhCCC--ccCC
Confidence            22   2233467899999999999999999999999999999999999999643221   10  1111111110  0011


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      + .    .......+.+++.+||+.||++|||+.|+++
T Consensus       273 ~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 P-W----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             T-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c-h----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1 1    1112246889999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-38  Score=347.94  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=207.4

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..++|++.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            3467899999999999999999988888999999976532 3567899999999999999999999986 4568999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++......
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99999999987531  12589999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                       ........+++.|+|||+..+..++.++||||+|+++|||++ |+.||......   ..   ..........   ..  
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~---~~~~~~~~~~---~~--  231 (279)
T 1qpc_A          164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EV---IQNLERGYRM---VR--  231 (279)
T ss_dssp             -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHHHHTTCCC---CC--
T ss_pred             -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HH---HHHHhcccCC---CC--
Confidence             122233456789999999988889999999999999999999 99999753221   11   1111111110   00  


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           +......+.+++.+||+.||++|||++++++.|+++
T Consensus       232 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                 111224688999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.9e-38  Score=350.67  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=209.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEe--ccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM--HKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5789999999999999999984     367899999998776666678999999999999999999999987  445688


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999997642   3589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC--------CcccHHHHHHHH
Q 035998          895 ILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK--------GSRDLISWVIRM  965 (1020)
Q Consensus       895 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~--------~~~~~~~~~~~~  965 (1020)
                      ....... .......+++.|+|||++.+..++.++||||+|+++|+|++|+.||......        ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6443222 1223456788899999998889999999999999999999999998532110        000011111111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......         ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       257 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          257 LEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             hhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111110         011122234688999999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-38  Score=343.28  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|++..    +..||||.+.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678999999999999999998542    3359999998653 3345678999999999999999999999765 45789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999764   24589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .... ........+++.|+|||+..+..++.++||||+|+++|||++ |+.||......   +.....   .......  
T Consensus       164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~---~~~~~~~--  234 (281)
T 3cc6_A          164 EDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL---EKGDRLP--  234 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH---HHTCCCC--
T ss_pred             cccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH---hcCCCCC--
Confidence            4322 122234556889999999988899999999999999999998 99999754332   222111   1111100  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       .+       ......+.+++.+||+.||++||+++|+++.|+++
T Consensus       235 -~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 -KP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             -CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence             01       11123588999999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=358.45  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=198.2

Q ss_pred             CCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccCCCh
Q 035998          747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      .+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            578999999999999864 6899999999877655667899999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE--cCCCCeEEeeccccccccCCCCccc
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--DGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      .+++...   ...+++..++.++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||+++......   .
T Consensus       174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9888653   23589999999999999999999999   99999999999999  567889999999998764322   2


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCcc
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQ  983 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  983 (1020)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ..   ...+......   ..+..... 
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~---~~~i~~~~~~---~~~~~~~~-  314 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ET---LNNILACRWD---LEDEEFQD-  314 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHTCCC---SCSGGGTT-
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhccCC---CChhhhcc-
Confidence            33457999999999999999999999999999999999999999753221   11   1111111110   01111111 


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          984 HDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       984 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                         ....+.+++.+||+.||.+||+++|+++  +++
T Consensus       315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          315 ---ISEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ---CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence               1236889999999999999999999997  554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.9e-38  Score=350.10  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-------
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-------  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  812 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56899999999999999999976 79999999997543 3345779999999999999999999999865432       


Q ss_pred             --------------------------------------------------eEEEEEeccCCChhhhhhhcCCCCCCCCHH
Q 035998          813 --------------------------------------------------RLLIYSFMENGSLDYWLHEKLDGPSSLDWD  842 (1020)
Q Consensus       813 --------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  842 (1020)
                                                                        .++||||+++++|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                              7899999999999999987532 2345777


Q ss_pred             HHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc----------ccccccccccC
Q 035998          843 SRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT----------HVTTDLVGTLG  912 (1020)
Q Consensus       843 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~  912 (1020)
                      .++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            8999999999999999999   9999999999999999999999999999877543211          12234578999


Q ss_pred             ccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHH
Q 035998          913 YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVL  992 (1020)
Q Consensus       913 y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  992 (1020)
                      |+|||++.+..++.++||||+|+++|||++|..|+.        ............ ..     +    .........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~~-~~-----~----~~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRNL-KF-----P----LLFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHTT-CC-----C----HHHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhcc-CC-----C----cccccCChhHH
Confidence            999999999999999999999999999999877642        111111111111 00     1    01122234578


Q ss_pred             HHHhhccCCCCCCCCCHHHHHH
Q 035998          993 DIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       993 ~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +++.+||+.||++|||++|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            9999999999999999999997

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-38  Score=344.73  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             cCCCcCC-eeeccCCeEEEEEEeC---CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQAN-IIGCGGFGLVYRATLP---DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999853   57789999998753 33456789999999999999999999999 55678999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999998743   34689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ..... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||......   ...   ........ .. 
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~---~~i~~~~~-~~-  233 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM---AFIEQGKR-ME-  233 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH---HHHHTTCC-CC-
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHH---HHHhcCCc-CC-
Confidence            33221 12233456889999999988889999999999999999999 99999754321   111   11111111 00 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                              .+......+.+++.+||+.||++||+++++++.|+++
T Consensus       234 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          234 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             --------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    1112224688999999999999999999999999876

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=350.04  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=206.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            35789999999999999999986 5789999999876655666789999999999999999999999873    346789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999987655567899999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCCCc-------ccccccccccCccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          896 LSPYDT-------HVTTDLVGTLGYIPPEYGQASV---ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       896 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      ......       .......||+.|+|||++.+..   ++.++||||||+++|||++|+.||........ ....   ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~  260 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL---AV  260 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH---HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH---Hh
Confidence            321110       0112345789999999987654   68899999999999999999999953211111 1110   01


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ......   .       ........+.+++.+||+.||.+||+++++++.|+++
T Consensus       261 ~~~~~~---~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          261 QNQLSI---P-------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HCC--C---C-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hccCCC---C-------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            110000   0       0111224688999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-37  Score=342.09  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999986 478999999997532   33456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++.........+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999976544456789999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  .......|++.|+|||++.+..++.++||||||+++|||++|+.||.....    .............. ...  
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-~~~--  258 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY-PPL--  258 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCS-CCC--
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccC-CCC--
Confidence            321  222345789999999999999999999999999999999999999964322    11122222221111 110  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ....    ....+.+++.+||+.||++||+++++++.|+++
T Consensus       259 --~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          259 --PSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             --CTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0011    123588999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-37  Score=337.37  Aligned_cols=250  Identities=23%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+++ ++.||||++....  ....+.+.+|++++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57899999999999999999985 8899999997653  33456789999999999999999999999887  7789999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.++++|||++...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999864  223689999999999999999999998   7  999999999999999999999999987543


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATY---KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ..       ....||+.|+|||.+.+..++.   ++||||+|+++|||++|+.||.....      ..............
T Consensus       164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~  230 (271)
T 3kmu_A          164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRP  230 (271)
T ss_dssp             SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCC
T ss_pred             cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCC
Confidence            21       2346789999999987765444   89999999999999999999974322      11111111111111


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .     ...    .....+.+++.+||+.||++|||++|+++.|+++
T Consensus       231 ~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          231 T-----IPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             C-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            1     111    1223588999999999999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.4e-38  Score=367.51  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=206.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999875 68999999986532   12345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||++||+|.+++...  ....+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+++...
T Consensus       263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999998764  234589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+..  .... ... .   
T Consensus       338 ~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~--~i~~-~~~-~---  407 (576)
T 2acx_A          338 EG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKE-VPE-E---  407 (576)
T ss_dssp             TT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--HHHH-CCC-C---
T ss_pred             cC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--Hhhc-ccc-c---
Confidence            32   223345899999999999999999999999999999999999999976543322222211  1111 100 0   


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                        +    +......+.+++.+||+.||.+||     +++|+++
T Consensus       408 --~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 --Y----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --C----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --C----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence              0    011123688999999999999999     7888875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-38  Score=349.09  Aligned_cols=256  Identities=22%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             hccCCCcCC-eeeccCCeEEEEEEe---CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          740 STNNFDQAN-IIGCGGFGLVYRATL---PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       740 ~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      ..++|++.+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|++++++++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788887 999999999999964   246789999997653  22356789999999999999999999998 56778


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            9999999999999999864    4589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ........ .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......   ..   ......... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~---~~~~~~~~~-  238 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV---TAMLEKGER-  238 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHHHHTTCC-
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH---HHHHHcCCC-
Confidence            76443222 11223456788999999988889999999999999999999 99999753321   11   111111111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..         .+......+.+++.+||+.||.+||+++++++.|+++
T Consensus       239 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          239 MG---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CC---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            10         0111224688999999999999999999999999876

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.6e-37  Score=352.95  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=191.3

Q ss_pred             cCCCcC-CeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHH-cCCCccceEeeEEec----cCceE
Q 035998          742 NNFDQA-NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       742 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  814 (1020)
                      ++|.+. +.||+|+||.||+|+.. +++.||||++...     ..+.+|++++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999865 6889999999643     346678888744 589999999999875    56689


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  891 (1020)
                      +||||+++|+|.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            999999999999999864  234689999999999999999999999   9999999999999987   78999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...............  +..... 
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--i~~~~~-  284 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--IRMGQY-  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH--HHHTCC-
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH--HHcCcc-
Confidence            9875322   2234567899999999999999999999999999999999999999765443322111111  111110 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ....+ ..    ......+.+++.+||+.||++|||++|+++
T Consensus       285 -~~~~~-~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 -EFPNP-EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             -CCCTT-TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCCc-cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             00000 00    112235889999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=359.41  Aligned_cols=255  Identities=28%  Similarity=0.452  Sum_probs=193.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC--CC--CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEec-cCceEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP--DG--RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMH-KNDRLLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  816 (1020)
                      .|++.+.||+|+||.||+|++.  ++  ..||||.+.... ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677889999999999999863  22  368999987543 3445678999999999999999999999765 4578999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...   ...+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999753   34678999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc--ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          897 SPYDT--HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       897 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      .....  .......+++.|+|||++.+..++.++||||||+++|||+| |.+||......+.   ...   ......   
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~---~~~~~~---  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY---LLQGRR---  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH---HHTTCC---
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH---HHcCCC---
Confidence            32211  12233567789999999999999999999999999999999 7778865443322   111   111111   


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...|       ......+.+++.+||+.||++||+++|+++.|+++
T Consensus       315 ~~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          315 LLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0111       11223688999999999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=348.02  Aligned_cols=261  Identities=24%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999875 589999999865542  334668899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999998887653    4689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh----------
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ----------  967 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------  967 (1020)
                      .  .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+   ..........          
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          156 S--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHH
T ss_pred             c--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhccccccccccc
Confidence            2  22334578999999998865 678999999999999999999999997543221   1111111100          


Q ss_pred             --hccc--ccccCccccCc---cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 --ENRE--SEVLDPFIYDK---QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 --~~~~--~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        ....  ....++.....   ..+.....+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              0000  00011100000   00122345889999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=343.86  Aligned_cols=253  Identities=27%  Similarity=0.473  Sum_probs=196.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||.||+|++. ++.||||++...  ...+.+.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56888999999999999999985 788999999754  33567899999999999999999999876  45799999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC-eEEeeccccccccCCCC
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYD  900 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~  900 (1020)
                      +++|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....  
T Consensus        83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            999999997642 2235788999999999999999999932239999999999999998887 799999999765321  


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ............ ..     ..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~-~~-----~~  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHNGTR-PP-----LI  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHTTCC-CC-----CB
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhcCCC-CC-----cc
Confidence               223468999999999999999999999999999999999999997543221    111111111111 11     11


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..    ....+.+++.+||+.||++|||++++++.|+++
T Consensus       227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11    123588999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-38  Score=351.70  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=200.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      .++|+..+.||+|+||.||+|....     +..||||++.... ......+.+|++++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3568888999999999999998642     2359999997653 334457889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999764   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          895 ILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       895 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ....... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||......   .   ....+.......
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~---~~~~~~~~~~~~  270 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E---VMKAINDGFRLP  270 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H---HHHHHHTTCCCC
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---H---HHHHHHCCCcCC
Confidence            6432211 11223456788999999999999999999999999999999 99999643221   1   111111111110


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                         .       +......+.+++.+||+.||++||+++++++.|+++
T Consensus       271 ---~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          271 ---T-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ---C-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---C-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0       111224688999999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-37  Score=347.31  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=180.2

Q ss_pred             CCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEeccCCC
Q 035998          747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGS  824 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  824 (1020)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|+++++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999875 6899999999753   3456788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC---CeEEeeccccccccCCCCc
Q 035998          825 LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       825 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      |.+++...    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++.....  .
T Consensus        93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~  163 (325)
T 3kn6_A           93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N  163 (325)
T ss_dssp             HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence            99999864    4689999999999999999999999   999999999999998765   7999999999865332  2


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc-cHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR-DLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ........+..... .  ..+.. 
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~--~~~~~-  239 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-S--FEGEA-  239 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-C--CCSHH-
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-C--CCccc-
Confidence            2234457899999999999999999999999999999999999999764432211 12222222221111 0  01000 


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         .......+.+++.+||+.||.+|||++|+++
T Consensus       240 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 ---WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               0112346889999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.9e-38  Score=352.94  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             CCcCCeeeccCCeEEEEEEeC-----CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEecc--CceEE
Q 035998          744 FDQANIIGCGGFGLVYRATLP-----DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--NDRLL  815 (1020)
Q Consensus       744 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  815 (1020)
                      |++.+.||+|+||.||++.+.     +++.||||++..... ...+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998653     678899999986643 3456789999999999999999999999874  56789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...     .+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999764     489999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------CcccHHHHHHHH
Q 035998          896 LSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK---------GSRDLISWVIRM  965 (1020)
Q Consensus       896 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~---------~~~~~~~~~~~~  965 (1020)
                      ...... .......++..|+|||++.+..++.++||||+|+++|||++|+.||......         ............
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543221 2233456788899999999889999999999999999999999998642110         000000111111


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .....          ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       265 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          265 ERGER----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcccC----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11100          011112234688999999999999999999999999876

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=348.22  Aligned_cols=262  Identities=26%  Similarity=0.354  Sum_probs=198.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcC---CCccceEeeEEeccC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQ---HPNLVHLQGYCMHKN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  811 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....     ......+.+|++++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            57899999999999999999996 478999999986332     112345667787777764   999999999998755


Q ss_pred             -----ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          812 -----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       812 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                           ..++||||++ ++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence                 4789999997 59999987642  23489999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      +|||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   .+.........
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHH
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence            999999866322   223456789999999999889999999999999999999999999975332   12222221111


Q ss_pred             hhcccccccC----c-ccc--------CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVLD----P-FIY--------DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d----~-~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..........    + ...        ....++....+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1110000000    0 000        0001122346789999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.9e-38  Score=345.85  Aligned_cols=257  Identities=28%  Similarity=0.448  Sum_probs=201.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEe-ccCceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCM-HKNDRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  814 (1020)
                      ..+|++.+.||+|+||.||+|+..+    ...||+|.+..... ...+.+.+|++++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568889999999999999998642    23589999876443 34467899999999999999999999965 456789


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999753   34678999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC--cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          895 ILSPYD--THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       895 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ......  ........+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||......+.   ...   ...... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~---~~~~~~-  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY---LLQGRR-  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH---HHTTCC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH---HhcCCC-
Confidence            643221  122234567789999999999999999999999999999999 5666654433221   111   111111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ...+       ......+.+++.+||+.||++||+++|+++.|+++
T Consensus       251 --~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          251 --LLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             --CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0011       01123588999999999999999999999999886

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-37  Score=341.00  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999865 68999999986543  233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~  894 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||.+..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999998888765    4689999999999999999999999   9999999999999986655   99999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....   .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....      .............  .
T Consensus       158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~--~  226 (284)
T 3kk8_A          158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD--Y  226 (284)
T ss_dssp             CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC--C
T ss_pred             cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhcccc--C
Confidence            6432   223346789999999999999999999999999999999999999964321      1111111111110  0


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..+ ...    .....+.+++.+||+.||++|||++|+++
T Consensus       227 ~~~-~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PSP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CTT-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cch-hhc----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000 001    11235789999999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-37  Score=348.32  Aligned_cols=248  Identities=22%  Similarity=0.313  Sum_probs=202.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+.+|.+++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999976 47889999997542   12345678899999887 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++++||+|||+++..
T Consensus        99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999865    4689999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.....  .. 
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~--~~-  240 (353)
T 2i0e_A          172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV--AY-  240 (353)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--CC-
T ss_pred             ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC--CC-
Confidence            322  2233456899999999999999999999999999999999999999974321      111111211110  00 


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                       |       ......+.+++.+||+.||.+||+     ++|+++
T Consensus       241 -p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          241 -P-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -C-------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -C-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             0       111236889999999999999995     577764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.6e-38  Score=342.06  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356899999999999999999875 5778999999766555567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeecccccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999988764    4589999999999999999999999   99999999999999   788999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..   .......||+.|+|||++.+. ++.++||||+|+++|||++|+.||......   .   ...........   ..
T Consensus       161 ~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~~~---~~  227 (277)
T 3f3z_A          161 PG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---E---VMLKIREGTFT---FP  227 (277)
T ss_dssp             TT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCCCC---CC
T ss_pred             Cc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---H---HHHHHHhCCCC---CC
Confidence            32   223445789999999988664 899999999999999999999999753221   1   11111111100   00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                      +.....    ....+.+++.+|++.||++||++.++++  +++
T Consensus       228 ~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          228 EKDWLN----VSPQAESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             HHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             chhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            000001    1236889999999999999999999986  444

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-37  Score=352.77  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=197.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcC--CCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQ--HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999986543  334567899999999996  599999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      | +.+++|.+++...    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++ ++.+||+|||+++....
T Consensus       136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            9 5688999999865    3678899999999999999999999   999999999999995 58899999999987644


Q ss_pred             CCCcccccccccccCccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQA-----------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .........
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~  281 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence            332233445679999999998754           4789999999999999999999999964321     122222222


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........  +    ..   ....+.+++.+||+.||.+||+++|+++
T Consensus       282 ~~~~~~~~--~----~~---~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEF--P----DI---PEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCC--C----CC---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCC--C----cc---chHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            11111110  0    01   1235789999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-38  Score=346.22  Aligned_cols=244  Identities=25%  Similarity=0.283  Sum_probs=192.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.++||+|+||+||+|+.. +++.||||++....  .........|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46999999999999999999876 79999999986543  22233455566666555 8999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 66898888765   24689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .   .......||+.|+|||++.+ .++.++||||+||++|||++|..||...      ...   .......     ..+
T Consensus       210 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~---~~~~~~~-----~~~  271 (311)
T 3p1a_A          210 A---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGW---QQLRQGY-----LPP  271 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHH---HHHTTTC-----CCH
T ss_pred             C---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHH---HHHhccC-----CCc
Confidence            2   22344568999999998876 7899999999999999999997766421      000   1111110     111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    ....+.+++.+||+.||++|||++|+++
T Consensus       272 ~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 EFTAG----LSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111    1246889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-37  Score=364.26  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=207.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++.....   ...+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367899999999999999999975 689999999965421   2245688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||++||+|.+++.........+++..++.++.||+.||+|||++   +|+||||||+||+++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999987654456799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  .......||+.|+|||++.+..++.++||||+||++|||++|+.||..........  .....+.....  ..  
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~~~~--~~--  412 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLEQAV--TY--  412 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHHCCC--CC--
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhhccc--CC--
Confidence            322  22334589999999999999999999999999999999999999997654322211  11111111110  00  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT-----QQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1014 (1020)
                             +......+.+++.+||+.||++||++     +++++
T Consensus       413 -------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          413 -------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                   11112367899999999999999965     66654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-38  Score=355.84  Aligned_cols=265  Identities=24%  Similarity=0.279  Sum_probs=202.8

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-----hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-----GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  811 (1020)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....     ....+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            344678999999999999999999864 68899999986432     233467899999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDG------------------------------------PSSLDWDSRLHIAQGAARGL  855 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~L  855 (1020)
                      ..++||||+++|+|.+++......                                    ...+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998632111                                    11235677889999999999


Q ss_pred             HHhHhcCCCCeEecCCCCCCEEEcCCC--CeEEeeccccccccCCCCc--ccccccccccCccCccccCC--CCCCchhh
Q 035998          856 AYLHQSCEPHILHRDIKSSNILLDGNF--GAHLADFGLARLILSPYDT--HVTTDLVGTLGYIPPEYGQA--SVATYKGD  929 (1020)
Q Consensus       856 ~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  929 (1020)
                      +|||+.   +|+||||||+||+++.++  .+||+|||+++........  .......||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999   999999999999998776  8999999999876432211  22345678999999998865  67899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          930 VYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       930 vwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                      |||+|+++|||++|+.||......   +   ...........  ...+. .    ......+.+++.+||+.||.+||++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~---~---~~~~~~~~~~~--~~~~~-~----~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDA---D---TISQVLNKKLC--FENPN-Y----NVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHCCCC--TTSGG-G----GGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcccc--cCCcc-c----ccCCHHHHHHHHHHcCCChhHCCCH
Confidence            999999999999999999743321   1   11111111110  01110 0    1112368899999999999999999


Q ss_pred             HHHHH--HHHh
Q 035998         1010 QQLVS--WLDS 1018 (1020)
Q Consensus      1010 ~evl~--~L~~ 1018 (1020)
                      .|+++  ++++
T Consensus       326 ~~~l~hp~~~~  336 (345)
T 3hko_A          326 MRALQHPWISQ  336 (345)
T ss_dssp             HHHHHSHHHHT
T ss_pred             HHHhcChhhcc
Confidence            99988  5554

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-38  Score=353.02  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=194.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce---
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR---  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  813 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....   ......+.+|++++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999986 578899999997653   23345788999999999999999999998876544   


Q ss_pred             -EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          814 -LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       814 -~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                       ++||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             9999999999999999765    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          893 RLILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       893 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      +........ .......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....      .............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCC
Confidence            876433221 223345789999999999999999999999999999999999999964322      1111111111111


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .    +...   .......+.+++.+||+.||++||++.++++
T Consensus       238 ~----~~~~---~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          238 P----PSAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             C----HHHH---STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             C----cccc---cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            0    0000   0112235889999999999999998776654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.7e-37  Score=336.96  Aligned_cols=246  Identities=30%  Similarity=0.416  Sum_probs=200.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999865 57799999986532   12346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999998765    4589999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .    .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....      ............  ..  
T Consensus       161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~--~~--  226 (279)
T 3fdn_A          161 S----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEF--TF--  226 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC--CC--
T ss_pred             c----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhCCC--CC--
Confidence            2    223345789999999999999999999999999999999999999974321      111111111110  00  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                             +......+.+++.+||+.||++||+++|+++
T Consensus       227 -------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          227 -------PDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -------CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   0111235789999999999999999999997

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-37  Score=359.64  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57899999999999999999875 799999999975421   23457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999998753    4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......   ..   ...+.....    ..
T Consensus       169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~---~~~i~~~~~----~~  235 (476)
T 2y94_A          169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TL---FKKICDGIF----YT  235 (476)
T ss_dssp             T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HH---HHHHHTTCC----CC
T ss_pred             c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HH---HHHHhcCCc----CC
Confidence            2   22344679999999999888765 78999999999999999999999753321   11   111111110    00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      |       ......+.+++.+||+.||++|||++|+++
T Consensus       236 p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          236 P-------QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             C-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            1       011135789999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-37  Score=339.16  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=198.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46889999999999999999864 68899999987654 23356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeecccccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +++|+|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999876544446789999999999999999999999   99999999999999   456889999999998654


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..   .......|++.|+|||++. +.++.++||||+|+++|||++|+.||......   ..   ............ ..
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~---~~~~~~~~~~~~-~~  247 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EV---QQKATYKEPNYA-VE  247 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCCCC-C-
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HH---HhhhccCCcccc-cc
Confidence            32   2234457899999999876 56899999999999999999999999753211   11   111111111000 00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ....    ...+.+++.+||+.||++|||++|+++
T Consensus       248 ---~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 ---CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0011    235789999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.7e-38  Score=357.40  Aligned_cols=266  Identities=23%  Similarity=0.278  Sum_probs=205.9

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-----CCccceEeeEE
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-----HPNLVHLQGYC  807 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~  807 (1020)
                      +.+.....++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+..|++++++++     ||||+++++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            333344567899999999999999999987 46889999999754 333556788999999996     99999999999


Q ss_pred             eccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-------
Q 035998          808 MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-------  880 (1020)
Q Consensus       808 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------  880 (1020)
                      ...+..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.       
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence            9999999999999 899999998652  23589999999999999999999999   9999999999999975       


Q ss_pred             ------------------CCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 035998          881 ------------------NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT  942 (1020)
Q Consensus       881 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  942 (1020)
                                        ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                              789999999999864322     234578999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcccHHHHHHHHHhhccc-----------ccccC------ccccCccCHH---------------HHHH
Q 035998          943 GKRPMDMCKPKGSRDLISWVIRMRQENRE-----------SEVLD------PFIYDKQHDK---------------EMLR  990 (1020)
Q Consensus       943 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~d------~~~~~~~~~~---------------~~~~  990 (1020)
                      |+.||......   +..............           ....+      ..........               ....
T Consensus       255 g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          255 GSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             SSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             CCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            99999753321   222211111110000           00000      0000000000               0145


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHH
Q 035998          991 VLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       991 l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +.+++.+||+.||++|||++|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            779999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.8e-37  Score=341.55  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=204.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch------hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46899999999999999999875 689999999875432      13567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeecc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADFG  890 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  890 (1020)
                      +||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999753    4689999999999999999999999   999999999999999887    79999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +++......   ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....   ..   ......... 
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~---~~~~i~~~~-  234 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE---TLANITSVS-  234 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HH---HHHHHHTTC-
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HH---HHHHHHhcc-
Confidence            998764322   22345789999999999999999999999999999999999999964321   11   111111110 


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        ...++......    ...+.+++.+||+.||++|||++|+++
T Consensus       235 --~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 --YDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --CCCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --cccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              00111111111    235789999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.7e-38  Score=351.44  Aligned_cols=260  Identities=29%  Similarity=0.427  Sum_probs=204.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|++      .+++.||||++.... ......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46799999999999999999984      257789999997543 34456789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  887 (1020)
                      ++||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999987532   224589999999999999999999999   9999999999999984   4569999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++...............+++.|+|||++.+..++.++||||||+++|||+| |+.||.....   ...   .....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~---~~~~~  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEV---LEFVT  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH---HHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHH---HHHHh
Confidence            9999986644333333344567889999999988899999999999999999998 9999964321   111   11111


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..... .     .    +......+.+++.+||+.||.+||+++++++.|+.+
T Consensus       260 ~~~~~-~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          260 SGGRM-D-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             TTCCC-C-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCC-C-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11110 0     0    111223688999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-37  Score=344.80  Aligned_cols=266  Identities=27%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc--CCCccceEeeEEecc----Cc
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA--QHPNLVHLQGYCMHK----ND  812 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~  812 (1020)
                      ...++|++.+.||+|+||.||+|+.. ++.||||++....   ...+.+|.+++...  +||||+++++++.+.    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            34568999999999999999999985 8999999986442   33445566666554  899999999999877    67


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-----EPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                      .++||||+++|+|.++++..     .+++..++.++.|++.||+|||++.     .++|+||||||+||+++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            89999999999999999763     5899999999999999999999752     3389999999999999999999999


Q ss_pred             eccccccccCCCCcc--cccccccccCccCccccCCCCCCch------hhHHHHHHHHHHHHcC----------CCCCCC
Q 035998          888 DFGLARLILSPYDTH--VTTDLVGTLGYIPPEYGQASVATYK------GDVYSFGVVLLELLTG----------KRPMDM  949 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltg----------~~pf~~  949 (1020)
                      |||+++.........  ......||+.|+|||++.+...+.+      +|||||||++|||+||          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999998764332211  1224578999999999887766654      9999999999999999          666654


Q ss_pred             CCCCCcccHHHHHHHHHhhcccccccCcccc-CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          950 CKPKGSRDLISWVIRMRQENRESEVLDPFIY-DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       950 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...... ......... .....    .+... ..........+.+++.+||+.||++|||++|+++.|+++
T Consensus       265 ~~~~~~-~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          265 LVPSDP-SYEDMREIV-CIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TSCSSC-CHHHHHHHH-TTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCC-chhhhHHHH-hhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            333222 111111111 11111    11111 111235667799999999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-37  Score=339.91  Aligned_cols=258  Identities=24%  Similarity=0.303  Sum_probs=198.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|++++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999875 688999999875532   2346788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999865    4689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ... ........|++.|+|||++.+..++.++||||+|+++|||++|+.||.....    .  ................ 
T Consensus       186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~--~~~~~~~~~~~~~~~~-  257 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S--VMGAHINQAIPRPSTV-  257 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H--HHHHHHHSCCCCGGGT-
T ss_pred             ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H--HHHHHhccCCCCcccc-
Confidence            321 1223345789999999999999999999999999999999999999974221    1  1111111111100000 


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhcC
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-TTQQLVSWLDSII 1020 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~il 1020 (1020)
                             .+.....+.+++.+||+.||++|| +++++++.|++++
T Consensus       258 -------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          258 -------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             -------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             -------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence                   111123588999999999999999 9999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=343.55  Aligned_cols=256  Identities=29%  Similarity=0.394  Sum_probs=201.5

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CC---CEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEeccCce-EEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DG---RNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR-LLI  816 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  816 (1020)
                      .|+..++||+|+||.||+|++. ++   ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999853 22   3799999976443 3456789999999999999999999999876665 999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+.+++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999763   35679999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC--CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPY--DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ...  .........+++.|+|||...+..++.++||||+|+++|+|++|..|+.....  ..+....   ........  
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~---~~~~~~~~--  248 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF---LAQGRRLP--  248 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH---HHTTCCCC--
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH---hhcCCCCC--
Confidence            321  11222345678899999999999999999999999999999996555432211  1122211   11111100  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                       .+       ......+.+++.+||+.||.+|||++++++.|+++
T Consensus       249 -~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          249 -QP-------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             -CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CC-------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             00       11123588999999999999999999999999876

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=365.72  Aligned_cols=302  Identities=22%  Similarity=0.173  Sum_probs=147.2

Q ss_pred             ccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecc
Q 035998          206 SLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAH  285 (1020)
Q Consensus       206 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  285 (1020)
                      ++++|+|++|++++..+..|.++++|++|+|++|++++..|.+|.++++|++|+|++|++++..+..|.++++|++|+++
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  112 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS  112 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence            33344444444443333334444444444444444443334444444444444444444443333334444444444444


Q ss_pred             cccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccC
Q 035998          286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQI  365 (1020)
Q Consensus       286 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  365 (1020)
                      +|++++..|..|.++++|+.|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~  192 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIR  192 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEEC
T ss_pred             CCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeC
Confidence            44444444444444444444444444444444444444444444444444444333333444444555555555444444


Q ss_pred             cccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhh
Q 035998          366 PETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLR  445 (1020)
Q Consensus       366 p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~  445 (1020)
                      +..|..+++|++|++++|+                                                   ..+.+|....
T Consensus       193 ~~~~~~l~~L~~L~l~~~~---------------------------------------------------~~~~~~~~~~  221 (477)
T 2id5_A          193 DYSFKRLYRLKVLEISHWP---------------------------------------------------YLDTMTPNCL  221 (477)
T ss_dssp             TTCSCSCTTCCEEEEECCT---------------------------------------------------TCCEECTTTT
T ss_pred             hhhcccCcccceeeCCCCc---------------------------------------------------cccccCcccc
Confidence            4444444444444444443                                                   2222333333


Q ss_pred             cCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeeccccccc
Q 035998          446 GCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGL  525 (1020)
Q Consensus       446 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l  525 (1020)
                      ...+|+.|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|                           
T Consensus       222 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L---------------------------  274 (477)
T 2id5_A          222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL---------------------------  274 (477)
T ss_dssp             TTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTC---------------------------
T ss_pred             cCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccC---------------------------
Confidence            33466666666666664444566666667777777766665544444444433                           


Q ss_pred             ccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccc
Q 035998          526 QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG  594 (1020)
Q Consensus       526 ~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g  594 (1020)
                               +.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+++.
T Consensus       275 ---------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          275 ---------QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             ---------CEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             ---------CEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence                     133444444444444555556666666666666665444456666666666666666664

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-38  Score=376.98  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=208.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..++|++.+.||+|+||.||+|+++++..||||+++.... ..+++.+|++++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3567889999999999999999998888899999986543 34679999999999999999999999876 678999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.++++...  ...+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       343 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  416 (535)
T 2h8h_A          343 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-  416 (535)
T ss_dssp             CTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred             hcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence            99999999997531  23588999999999999999999999   9999999999999999999999999999875321 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .........++..|+|||++.+..++.++|||||||++|||++ |+.||......   +..   ..+.......      
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~---~~i~~~~~~~------  484 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQVERGYRMP------  484 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH---HHHHTTCCCC------
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCCCC------
Confidence            1111223456788999999988899999999999999999999 99999754321   111   1111111110      


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                          .+......+.++|.+||+.||++|||++++++.|++++
T Consensus       485 ----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          485 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                01122346889999999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-37  Score=351.02  Aligned_cols=246  Identities=24%  Similarity=0.300  Sum_probs=192.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHH-HHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEA-LSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++.+...   ...+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999875 588999999976532   223445667666 466799999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.+|++||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            99999999999999764    4688999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....      ......+.... . . .
T Consensus       190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~-~-~-~  258 (373)
T 2r5t_A          190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP-L-Q-L  258 (373)
T ss_dssp             BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSC-C-C-C
T ss_pred             ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcc-c-C-C
Confidence            332  2233456899999999999999999999999999999999999999964321      11111111111 0 0 0


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1012 (1020)
                      .    ..    ....+.+++.+||+.||.+||++.+.
T Consensus       259 ~----~~----~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          259 K----PN----ITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             C----SS----SCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             C----CC----CCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            0    11    12357899999999999999998543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.5e-38  Score=347.67  Aligned_cols=259  Identities=22%  Similarity=0.285  Sum_probs=198.4

Q ss_pred             cCCCcC-CeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQA-NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 78999999999999854 7899999999876555567889999999985 79999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~  895 (1020)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||+++..
T Consensus        92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999865    4689999999999999999999999   9999999999999998776   999999999765


Q ss_pred             cCCCC-----cccccccccccCccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCccc--------
Q 035998          896 LSPYD-----THVTTDLVGTLGYIPPEYGQA-----SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD--------  957 (1020)
Q Consensus       896 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~--------  957 (1020)
                      .....     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||..........        
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223568999999998764     568899999999999999999999997654322100        


Q ss_pred             -HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          958 -LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       958 -~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .......+.... . .. ......    .....+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~i~~~~-~-~~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGK-Y-EF-PDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCC-C-CC-CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccC-c-cc-Cchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             001111111111 0 00 000000    11236889999999999999999999987

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4e-37  Score=335.10  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56899999999999999999875 68999999986443 23456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||.+.......
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999888643    4689999999999999999999999   99999999999999999999999999998654332


Q ss_pred             CcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .........|++.|+|||+..+..+ +.++||||+|+++|||++|+.||........ ...    ........   ..+ 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~~~~~---~~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKKTY---LNP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH----HHHTTCTT---STT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH----Hhhhcccc---cCc-
Confidence            2223345678999999999887665 7899999999999999999999975433211 111    11111100   000 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .    ......+.+++.+||+.||++|||++|+++
T Consensus       231 -~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 -W----KKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -G----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -h----hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             0    111235789999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=8.1e-38  Score=350.34  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|..+ +++.||||++.....    ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            356999999999999999999875 688999999976533    234688888888 79999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC----CCeEEeecccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN----FGAHLADFGLARL  894 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~~~~  894 (1020)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||++.++    +.+||+|||+++.
T Consensus        97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999988754    4689999999999999999999999   99999999999998533    3599999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||............   ..+..... .  
T Consensus       170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~~~-~--  241 (342)
T 2qr7_A          170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSGKF-S--  241 (342)
T ss_dssp             CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHCCC-C--
T ss_pred             CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccCCc-c--
Confidence            64322  2234467899999999998888999999999999999999999999754332222222   22221111 0  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    .......+.+++.+||+.||++||+++|+++
T Consensus       242 ~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 LSGGY----WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCSTT----TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00101    1112236789999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=349.04  Aligned_cols=265  Identities=17%  Similarity=0.220  Sum_probs=198.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCchhh-----------HHHHHHHHHHHHHcCCCccceEee
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDCGQM-----------EREFRAEVEALSRAQHPNLVHLQG  805 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  805 (1020)
                      .++|++.+.||+|+||.||+|+..    ++..||||++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    57889999987654221           123567888899999999999999


Q ss_pred             EEec----cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC
Q 035998          806 YCMH----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN  881 (1020)
Q Consensus       806 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  881 (1020)
                      ++..    ....++||||+ +++|.+++...    ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9987    67789999999 99999998765    2689999999999999999999999   99999999999999987


Q ss_pred             C--CeEEeeccccccccCCCC-----cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 035998          882 F--GAHLADFGLARLILSPYD-----THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG  954 (1020)
Q Consensus       882 ~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  954 (1020)
                      +  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999987642211     112244678999999999999999999999999999999999999996432211


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        ............. ...........   ......+.+++.+||+.||++||+++++++.|+++
T Consensus       268 --~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 --VAVQTAKTNLLDE-LPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             --HHHHHHHHHHHHT-TTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             --HHHHHHHHhhccc-ccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence              1111111111111 00000000000   01223688999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-37  Score=352.03  Aligned_cols=201  Identities=28%  Similarity=0.423  Sum_probs=162.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcC-CCccceEeeEEeccC--ceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKN--DRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~  814 (1020)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++++. ||||+++++++...+  ..|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            468999999999999999999864 68999999986542  334456789999999997 999999999997544  689


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||++ ++|..++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        88 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            9999998 5898888753     688999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCC-------------------CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          895 ILSPY-------------------DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       895 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      .....                   ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            53311                   1122344689999999998876 67899999999999999999999999753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8e-37  Score=343.91  Aligned_cols=265  Identities=28%  Similarity=0.348  Sum_probs=209.7

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHH--cCCCccceEeeEEeccC---
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSR--AQHPNLVHLQGYCMHKN---  811 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  811 (1020)
                      -....++|++.+.||+|+||.||+|+. +++.||||++...   ..+.+.+|++++..  ++||||+++++++....   
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            344567899999999999999999998 4899999999643   34567889999988  68999999999998776   


Q ss_pred             -ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeEecCCCCCCEEEcCCC
Q 035998          812 -DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH--------QSCEPHILHRDIKSSNILLDGNF  882 (1020)
Q Consensus       812 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~  882 (1020)
                       ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.   +|+||||||+||+++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             789999999999999999763     5899999999999999999999        77   999999999999999999


Q ss_pred             CeEEeeccccccccCCCCcc--cccccccccCccCccccCCC------CCCchhhHHHHHHHHHHHHcC----------C
Q 035998          883 GAHLADFGLARLILSPYDTH--VTTDLVGTLGYIPPEYGQAS------VATYKGDVYSFGVVLLELLTG----------K  944 (1020)
Q Consensus       883 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltg----------~  944 (1020)
                      .+||+|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          .
T Consensus       185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~  264 (342)
T 1b6c_B          185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  264 (342)
T ss_dssp             CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence            99999999998765432211  23445789999999988765      234789999999999999999          7


Q ss_pred             CCCCCCCCCCcccHHHHHHHHHhhcccccccCccccC-ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          945 RPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD-KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       945 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .||........ ....+........     ..+.+.. .........+.+++.+||+.||++|||++|+++.|+++
T Consensus       265 ~p~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          265 LPYYDLVPSDP-SVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CTTTTTSCSSC-CHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccccCcCcc-cHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            78865433221 1111111111111     1111111 12345667899999999999999999999999999876

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-37  Score=360.98  Aligned_cols=258  Identities=23%  Similarity=0.272  Sum_probs=193.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|+++++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999864 68899999997642  334567889999999999999999999997553      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||++++ +.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            469999999875 5555432      378999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc--
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN--  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--  969 (1020)
                      ++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+...   .+............  
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCH
T ss_pred             eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            9876432   233456899999999999999999999999999999999999999975321   11111111110000  


Q ss_pred             ------------------ccc-----cccCccccCcc---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 ------------------RES-----EVLDPFIYDKQ---HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ------------------~~~-----~~~d~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                        ...     ...........   .......+.+++.+||+.||++|||++|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                              000     00000000000   1112456899999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.9e-37  Score=355.31  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=209.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC-CccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH-PNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  ..++.+|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999986 5789999998875432  2357889999999976 556666666677788899999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~  895 (1020)
                      |+ +++|.+++...   ...+++..++.++.||+.||+|||++   +||||||||+|||+   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 99999999753   24689999999999999999999999   99999999999999   68899999999999887


Q ss_pred             cCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          896 LSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       896 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543321     122356799999999999999999999999999999999999999987655444333333332222211


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .....     ...    ..++.+++.+||+.||++||+++++++.|+++
T Consensus       237 ~~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 IEALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111     111    23688999999999999999999999999876

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=349.95  Aligned_cols=253  Identities=16%  Similarity=0.165  Sum_probs=205.2

Q ss_pred             hccCCCcCCeeeccCCeEEEEEE------eCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC---CCccceEeeEEecc
Q 035998          740 STNNFDQANIIGCGGFGLVYRAT------LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ---HPNLVHLQGYCMHK  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  810 (1020)
                      ..++|++.+.||+|+||.||+|.      ..+++.||||++....   ..++.+|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45679999999999999999994      4468899999997653   456788888888886   99999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---------
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD-GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---------  880 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------  880 (1020)
                      +..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++   +||||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999976432 245799999999999999999999999   9999999999999998         


Q ss_pred             --CCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH
Q 035998          881 --NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL  958 (1020)
Q Consensus       881 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~  958 (1020)
                        ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999765433334445567899999999999999999999999999999999999999964322110   


Q ss_pred             HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHhc
Q 035998          959 ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVR-PTTQQLVSWLDSI 1019 (1020)
Q Consensus       959 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i 1019 (1020)
                                 .....    ......   ...+.+++..|++.+|.+| |+++++.+.|+++
T Consensus       294 -----------~~~~~----~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 -----------KPEGL----FRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -----------EECSC----CTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -----------eechh----ccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                       00000    001111   2346688999999999988 5688888877764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=351.20  Aligned_cols=262  Identities=19%  Similarity=0.262  Sum_probs=204.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC---------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccce---------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD---------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH---------  802 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  802 (1020)
                      .++|++.+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999998753         789999998754     35788999999999999987         


Q ss_pred             ------EeeEEec-cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          803 ------LQGYCMH-KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       803 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                            +++++.. ....++||||+ +++|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  5677765 67789999999 999999998642  24689999999999999999999999   99999999999


Q ss_pred             EEEcCCC--CeEEeeccccccccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 035998          876 ILLDGNF--GAHLADFGLARLILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       876 Ill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      |+++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876432111     11234578999999999999999999999999999999999999997


Q ss_pred             CCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          949 MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...... ............  ......++......   ....+.+++.+||+.||++||+++++++.|+++
T Consensus       270 ~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          270 NCLPNT-EDIMKQKQKFVD--KPGPFVGPCGHWIR---PSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GGTTCH-HHHHHHHHHHHH--SCCCEECTTSCEEC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCcCH-HHHHHHHHhccC--ChhhhhhhccccCC---CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            543221 111111111111  11111111110001   124688999999999999999999999999876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=376.34  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=200.1

Q ss_pred             CCCcCC-eeeccCCeEEEEEEeC---CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          743 NFDQAN-IIGCGGFGLVYRATLP---DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       743 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++.+.+ .||+|+||.||+|.++   ++..||||+++... ....+++.+|++++++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999764   45679999997653 2346789999999999999999999999976 5689999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...   ...+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999998753   35689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          898 PYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       898 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      .... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+   ..   ..+...... .  
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~---~~i~~~~~~-~--  559 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---AFIEQGKRM-E--  559 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH---HHHHTTCCC-C--
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH---HHHHcCCCC-C--
Confidence            2211 11223445689999999998999999999999999999998 999997644321   11   111111111 0  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                             .+......+.+++.+||+.||++||+++++++.|+.+
T Consensus       560 -------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          560 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   1112234688999999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.2e-38  Score=341.58  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=204.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999875 68999999997543  3345678999999999999999999998854  567899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-----eEecCCCCCCEEEcCCCCeEEeecc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH-----ILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999987544455689999999999999999999998   7     9999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      .++.....  ........|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....   ...   ...+... .
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~i~~~-~  232 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL---AGKIREG-K  232 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHT-C
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH---HHHHhhc-c
Confidence            99876432  1222345789999999999888999999999999999999999999975421   111   1111111 1


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1016 (1020)
                      ....         +......+.+++.+||+.||++||+++|+++.+
T Consensus       233 ~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          233 FRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cccC---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1111         011224688999999999999999999999754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.5e-38  Score=351.62  Aligned_cols=256  Identities=31%  Similarity=0.453  Sum_probs=202.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCE--EEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRN--VAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||.||+|+.. ++..  ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57899999999999999999864 4554  4999887543 23345688999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          817 YSFMENGSLDYWLHEKL------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      |||+++++|.+++....            .....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997642            2235789999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++....   ........+++.|+|||++.+..++.++||||+|+++|||++ |+.||.....      .....
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHH
Confidence            9999999974321   112233456889999999988889999999999999999998 9999965321      11111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ........      .    .+......+.+++.+||+.||.+||+++|+++.|+++
T Consensus       253 ~~~~~~~~------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 KLPQGYRL------E----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             HGGGTCCC------C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhcCCCC------C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111100      0    0111224688999999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.8e-37  Score=335.97  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=202.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec----------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH----------  809 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  809 (1020)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|++....    ..+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            356899999999999999999976 78999999997653    346789999999999999999998864          


Q ss_pred             ------cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          810 ------KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       810 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                            ....++||||+++++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                  345789999999999999997642  24689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      +||+|||+++......   ......|++.|+|||++.+..++.++||||+|+++|||++|..||...        .....
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFT  229 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHH
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHH
Confidence            9999999998764322   223456899999999999999999999999999999999999887411        11111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ... ......        ..+    ..+.+++.+||+.||++||+++|+++.|+.+
T Consensus       230 ~~~-~~~~~~--------~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          230 DLR-DGIISD--------IFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHH-TTCCCT--------TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hhh-cccccc--------cCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111 111111        111    3578999999999999999999999998764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.7e-37  Score=343.97  Aligned_cols=245  Identities=29%  Similarity=0.420  Sum_probs=198.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|+..+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999986 578899999997543   223457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++ |++.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 5777777543   24689999999999999999999999   999999999999999999999999999976532


Q ss_pred             CCCcccccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                            .....||+.|+|||++   ..+.++.++|||||||++|||++|+.||.....      ............ .. 
T Consensus       207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~-~~-  272 (348)
T 1u5q_A          207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PA-  272 (348)
T ss_dssp             ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CC-
T ss_pred             ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-CC-
Confidence                  2345789999999987   367889999999999999999999999964321      111122221111 11 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ....   .....+.+++.+||+.||++|||++++++
T Consensus       273 ----~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          273 ----LQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             ----CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                1011   11235789999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-37  Score=360.96  Aligned_cols=248  Identities=22%  Similarity=0.320  Sum_probs=194.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999864 68999999987532   22234577899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..
T Consensus       227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999998765    468999999999999999999998 7   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ...   ...+.....  .  
T Consensus       300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~---~~~i~~~~~--~--  367 (446)
T 4ejn_A          300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKL---FELILMEEI--R--  367 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHCCC--C--
T ss_pred             cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHH---HHHHHhCCC--C--
Confidence            322  2233456899999999999999999999999999999999999999964321   111   111111110  0  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                      -|       ......+.+++.+||+.||.+||     +++|+++
T Consensus       368 ~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC-------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            00       11123578999999999999999     9999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-37  Score=338.76  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch------hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....      ...+.+.+|++++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999876 689999999875431      13567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeecc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADFG  890 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg  890 (1020)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999764    4689999999999999999999999   999999999999998877    89999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      .++.....   .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......   .   ......... 
T Consensus       158 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~~~~-  227 (283)
T 3bhy_A          158 IAHKIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---E---TLTNISAVN-  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---H---HHHHHHTTC-
T ss_pred             cceeccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---H---HHHHhHhcc-
Confidence            99876432   1223456899999999999999999999999999999999999999753211   1   111111110 


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                        ....+.....    ....+.+++.+||+.||++||+++|+++  ++++
T Consensus       228 --~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          228 --YDFDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             --CCCCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             --cCCcchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence              0011111111    1235789999999999999999999997  5543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=342.31  Aligned_cols=264  Identities=26%  Similarity=0.398  Sum_probs=207.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-----CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC--ce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-----PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN--DR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  813 (1020)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45689999999999999999984     368899999998766666678999999999999999999999987654  67


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999999864   24589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------CCCcccHHHHHH
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK---------PKGSRDLISWVI  963 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~---------~~~~~~~~~~~~  963 (1020)
                      ........ .......++..|+|||.+.+..++.++||||+|+++|||+||..||....         ............
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76443221 11223456778999999988889999999999999999999999985321         000000000111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .........         ..+......+.+++.+||+.||++||+++|+++.|+++
T Consensus       274 ~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          274 ELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111000         01112234688999999999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-37  Score=342.38  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357899999999999999999875 7899999999866544456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeecccccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~  896 (1020)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++...
T Consensus        88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            9999999998764    4689999999999999999999999   99999999999999   788999999999987542


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .    .......|++.|+|||++.+..++.++||||+|+++|||++|+.||.....   ...   ...+.....  . ..
T Consensus       161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~i~~~~~--~-~~  227 (304)
T 2jam_A          161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL---FEKIKEGYY--E-FE  227 (304)
T ss_dssp             C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHCCC--C-CC
T ss_pred             C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHcCCC--C-CC
Confidence            2    222345689999999999999999999999999999999999999964321   111   111111111  0 00


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +...    ......+.+++.+||+.||++||+++|+++
T Consensus       228 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 SPFW----DDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTT----TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0011    112246889999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.5e-38  Score=342.31  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=197.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc-CceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-NDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.+ |+.||||++....  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467899999999999999999884 8899999997653  346789999999999999999999997654 478999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++....  ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            99999999997641  12378899999999999999999999   9999999999999999999999999999765322 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                          .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......   +...   .......      +.
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~~~~~~~------~~  234 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---RVEKGYK------MD  234 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH---HHTTTCC------CC
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHhcCCC------CC
Confidence                123457889999999988899999999999999999998 99999754322   1111   1111100      00


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .    +......+.+++.+||+.||++||+++|+++.|+++
T Consensus       235 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          235 A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            1    111224688999999999999999999999999875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=350.50  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhh-HHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQM-EREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999875 78999999987543221 12355799999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....+ 
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  153 (324)
T 3mtl_A           82 LDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-  153 (324)
T ss_dssp             CSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence            984 888888764   34689999999999999999999999   9999999999999999999999999999865332 


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc---ccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR---ESEVL  975 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  975 (1020)
                       ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+.............   .....
T Consensus       154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhh
Confidence             122334578999999998876 6789999999999999999999999975432   222222222211111   00000


Q ss_pred             Cc---------cccC----ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DP---------FIYD----KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~---------~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..         ....    ...+.....+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00         0000    001112245789999999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=336.40  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=183.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35789999999999999999986 4789999999864321   2236788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999998754   34689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      .+.  .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..........      .    ......  
T Consensus       164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~----~~~~~~--  229 (278)
T 3cok_A          164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------K----VVLADY--  229 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSSCC--
T ss_pred             CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------H----Hhhccc--
Confidence            322  12234578999999999999999999999999999999999999997543321110      0    000000  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..    +......+.+++.+||+.||++||+++++++
T Consensus       230 -~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 -EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             00    1112235789999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=346.86  Aligned_cols=268  Identities=24%  Similarity=0.384  Sum_probs=197.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHH--HHHcCCCccceEeeEEec-----cCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEA--LSRAQHPNLVHLQGYCMH-----KNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999987 68999999997543   2334444444  445799999999986543     2246


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC------EPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                      ++||||+++|+|.+++...     ..++..++.++.|++.||+|||+..      .++|+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            8999999999999999764     3488999999999999999999763      2389999999999999999999999


Q ss_pred             eccccccccCCCC------cccccccccccCccCccccCC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 035998          888 DFGLARLILSPYD------THVTTDLVGTLGYIPPEYGQA-------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG  954 (1020)
Q Consensus       888 Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~  954 (1020)
                      |||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            9999987643211      122234579999999999877       456789999999999999999977764332211


Q ss_pred             c-ccH-----------HHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          955 S-RDL-----------ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       955 ~-~~~-----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      . ...           .................+.   ..........+.+++.+||+.||++|||++|+++.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1 111           0111111111111111110   1112345567999999999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-36  Score=333.92  Aligned_cols=248  Identities=21%  Similarity=0.348  Sum_probs=204.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467899999999999999999875 57899999986542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++...
T Consensus        94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999988764    4689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||......      ...........  .  .
T Consensus       167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~--~  234 (294)
T 2rku_A          167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY--S--I  234 (294)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC--C--C
T ss_pred             cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccC--C--C
Confidence            322  2233457899999999999999999999999999999999999999743211      11111111110  0  0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +   .    .....+.+++.+||+.||++||+++|+++
T Consensus       235 ~---~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 P---K----HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             C---T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c---c----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0   1    11235789999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.7e-37  Score=348.25  Aligned_cols=199  Identities=25%  Similarity=0.462  Sum_probs=175.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999875 68999999997653 3445678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||+ +   +|+||||||+||+++.++.+||+|||+++....
T Consensus       112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999865    468999999999999999999998 5   799999999999999999999999999976532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                          .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus       185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                1223457899999999999999999999999999999999999999743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=347.70  Aligned_cols=241  Identities=23%  Similarity=0.353  Sum_probs=199.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--------hhHHHHHHHHHHHHHcCCCccceEeeEEeccC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  811 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....        ...+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46799999999999999999985 4688999999976531        12235678999999999999999999999999


Q ss_pred             ceEEEEEeccCC-ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          812 DRLLIYSFMENG-SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       812 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      ..++||||+.+| +|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            999999999777 999988764    4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      +++.....   .......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||......                
T Consensus       176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            99876432   22334578999999999888776 88999999999999999999999642110                


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .......+.   .    ....+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~---~----~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          237 VEAAIHPPY---L----VSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TTTCCCCSS---C----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhhccCCCc---c----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000010   0    1235889999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4e-37  Score=355.03  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=191.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--------hhHHHHHHHHHHHHHcCCCccceEeeEEecc
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--------QMEREFRAEVEALSRAQHPNLVHLQGYCMHK  810 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  810 (1020)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3578999999999999999999864 689999999875321        11224789999999999999999999975 4


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC---CeEEe
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---GAHLA  887 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~  887 (1020)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            5579999999999998887653    5689999999999999999999999   999999999999997544   59999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      |||+++....   ........||+.|+|||++.   ...++.++||||+||++|||++|+.||........  .....  
T Consensus       285 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i--  357 (419)
T 3i6u_A          285 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--  357 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH--
T ss_pred             ecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH--
Confidence            9999987643   22334567999999999875   36788999999999999999999999975432221  11111  


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .. ....  ..+.....    ....+.+++.+||+.||++||+++|+++
T Consensus       358 -~~-~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 -TS-GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -HT-TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -hc-CCCC--CCchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             11 1000  01111111    1235889999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-37  Score=347.76  Aligned_cols=258  Identities=25%  Similarity=0.387  Sum_probs=205.8

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--------hhHHHHHHHHHHHHHc-CCCccceE
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--------QMEREFRAEVEALSRA-QHPNLVHL  803 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l  803 (1020)
                      +.......++|++.+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3334445578999999999999999999975 799999999875431        1235678899999999 79999999


Q ss_pred             eeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC
Q 035998          804 QGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG  883 (1020)
Q Consensus       804 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  883 (1020)
                      ++++......++||||+++++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            99999999999999999999999999864    4689999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCccc
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD  957 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~  957 (1020)
                      +||+|||++......   .......||+.|+|||++.      ...++.++||||+||++|||++|+.||.....   ..
T Consensus       239 ikl~DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---IL  312 (365)
T ss_dssp             EEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred             EEEEecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HH
Confidence            999999999876432   2234467899999999875      34688999999999999999999999964321   11


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .   ...+......   ........    ....+.+++.+||+.||++||+++|+++
T Consensus       313 ~---~~~i~~~~~~---~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 M---LRMIMEGQYQ---FSSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             H---HHHHHHTCCC---CCHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H---HHHHHhCCCC---CCCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1   1111111100   00000011    1235889999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-37  Score=347.46  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=199.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357899999999999999999875 58999999986543  233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|..+....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            999999998876543    4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH-----------
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM-----------  965 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~-----------  965 (1020)
                      ..  .......|++.|+|||++.+. .++.++||||+|+++|||++|+.||......   +........           
T Consensus       177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHH
T ss_pred             Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhhhH
Confidence            22  223345789999999988775 7899999999999999999999999754321   111111110           


Q ss_pred             -HhhcccccccCccccCcc-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 -RQENRESEVLDPFIYDKQ-----HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 -~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ...........+......     .+.....+.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             000000111111111111     1122346889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-37  Score=347.97  Aligned_cols=262  Identities=24%  Similarity=0.298  Sum_probs=193.5

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4568999999999999999999854 788999999975532  2235677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-----CCCCeEEeeccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-----GNFGAHLADFGL  891 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfg~  891 (1020)
                      |||+++ +|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++     .++.+||+|||+
T Consensus       112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999985 999988764    4589999999999999999999999   999999999999994     455699999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ++......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....   .+.............
T Consensus       184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCc
Confidence            98764322  223345789999999988764 589999999999999999999999974322   111111111110000


Q ss_pred             ccccc---------C--ccccCcc-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVL---------D--PFIYDKQ-----HDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~---------d--~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....         .  +......     .......+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000         0  0000000     0012246789999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-37  Score=348.33  Aligned_cols=252  Identities=27%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe----CCCCEEEEEEecCCc----hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          742 NNFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLSGDC----GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      ++|++.+.||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+++++++ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999987    378999999986532    12234567899999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+++++|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999865    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........  ..........
T Consensus       207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSEP  283 (355)
T ss_dssp             EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHCCC
T ss_pred             eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH--HHHHHhccCC
Confidence            8653221 222334679999999999875  4578999999999999999999999975443322221  1112111110


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                        .     .    +......+.+++.+||+.||.+||     +++|+++
T Consensus       284 --~-----~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          284 --P-----Y----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             --C-----C----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --C-----C----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence              0     0    111223578999999999999999     9999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-36  Score=340.55  Aligned_cols=248  Identities=21%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            457899999999999999999875 57899999987542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999988764    4689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ...  .......|++.|+|||++.+..++.++||||||+++|||++|+.||......   +   ..........  ..  
T Consensus       193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---~~~~~~~~~~--~~--  260 (335)
T 2owb_A          193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---E---TYLRIKKNEY--SI--  260 (335)
T ss_dssp             STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---H---HHHHHHHTCC--CC--
T ss_pred             cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---H---HHHHHhcCCC--CC--
Confidence            322  2233467899999999999999999999999999999999999999643211   1   1111111110  00  


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +   ..    ....+.+++.+||+.||++||+++|+++
T Consensus       261 ~---~~----~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 P---KH----INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C---TT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C---cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   11    1135789999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.1e-36  Score=350.69  Aligned_cols=200  Identities=27%  Similarity=0.342  Sum_probs=167.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----ND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  812 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999865 57889999997543  33456788999999999999999999999766     56


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .|+||||++ ++|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999997 5999888753    5689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc--------------------ccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 035998          893 RLILSPYDT--------------------HVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       893 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      +........                    ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876433211                    123557899999999975 66779999999999999999998655553

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-37  Score=374.51  Aligned_cols=248  Identities=23%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             CeeeccCCeEEEEEEeC---CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP---DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999653   46789999997643  234578999999999999999999999986 4568899999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc-
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT-  901 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  901 (1020)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +||||||||+||+++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999754    4689999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   ..   ...+..... ..       
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~---~~~i~~~~~-~~-------  592 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV---TAMLEKGER-MG-------  592 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHHHHTTCC-CC-------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcCCC-CC-------
Confidence            22233456788999999999999999999999999999998 99999754321   11   111111111 11       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .+......+.+++.+||+.||++||+++++++.|+++
T Consensus       593 --~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          593 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              0111224688999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=346.13  Aligned_cols=255  Identities=25%  Similarity=0.304  Sum_probs=187.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEe--------cc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCM--------HK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  810 (1020)
                      ..+|++.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357899999999999999999864 78999999987666666678899999999996 999999999994        23


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEcCCCCeEEee
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLDGNFGAHLAD  888 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D  888 (1020)
                      ...++||||++ |+|.+++..... ...+++..++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            34789999996 689888876422 34689999999999999999999998   8  99999999999999999999999


Q ss_pred             ccccccccCCCCcc----------cccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 035998          889 FGLARLILSPYDTH----------VTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS  955 (1020)
Q Consensus       889 fg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  955 (1020)
                      ||+++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998764322111          11134689999999988   56778999999999999999999999996432211 


Q ss_pred             ccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          956 RDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       956 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           .....   ...   ..   ...    ....+.+++.+||+.||++||+++|+++.|+++
T Consensus       261 -----~~~~~---~~~---~~---~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          261 -----IVNGK---YSI---PP---HDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             -------------CCC---CT---TCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hhcCc---ccC---Cc---ccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 00000   000   00   001    112377899999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-37  Score=348.51  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=194.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999986 478999999986542  233467889999999999999999999997653      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 7899999875     3589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      ++.....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+............ 
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC
Confidence            9875322     234578999999998776 7899999999999999999999999975322   11111111110000 


Q ss_pred             -----------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 -----------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 -----------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                       ...... +.......+.....+.+++.+|++.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCC-CCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                             000000 00001111122346889999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-37  Score=358.13  Aligned_cols=195  Identities=26%  Similarity=0.347  Sum_probs=154.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----ND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  812 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999865 78999999987543  33446788999999999999999999998543     56


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .|+||||++ ++|.+++...    ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            899999985 6888888653    5689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc-------------------------ccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcC
Q 035998          893 RLILSPYDT-------------------------HVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTG  943 (1020)
Q Consensus       893 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg  943 (1020)
                      +....+...                         ......+||+.|+|||++ ....++.++||||+||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            876432211                         123446789999999975 567799999999999999999993

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-36  Score=331.93  Aligned_cols=245  Identities=26%  Similarity=0.355  Sum_probs=202.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999875 57789999986432   123467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999865    3589999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .    ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....      ............       
T Consensus       167 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-------  229 (284)
T 2vgo_A          167 L----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDL-------  229 (284)
T ss_dssp             S----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------
T ss_pred             c----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcccc-------
Confidence            2    22345789999999999999999999999999999999999999974321      111111111110       


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..    +......+.+++.+|++.||.+||+++|+++
T Consensus       230 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            00    0111235789999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-37  Score=353.54  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc-------
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-------  810 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  810 (1020)
                      ...++|++.+.||+|+||.||+|+. .+|+.||||++..+..    ...+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999986 5789999999876532    234799999999999999999998543       


Q ss_pred             -------------------------------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH
Q 035998          811 -------------------------------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH  859 (1020)
Q Consensus       811 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH  859 (1020)
                                                     ...++||||++ |+|.+.+.........+++..+..++.|++.||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           23789999998 4888887765555568999999999999999999999


Q ss_pred             hcCCCCeEecCCCCCCEEEc-CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHH
Q 035998          860 QSCEPHILHRDIKSSNILLD-GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVL  937 (1020)
Q Consensus       860 ~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil  937 (1020)
                      +.   +|+||||||+||+++ .++.+||+|||+++.....   .......+|+.|+|||++.+. .++.++||||+||++
T Consensus       159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            99   999999999999998 6889999999999876432   223345789999999987764 589999999999999


Q ss_pred             HHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc----------ccccccCccccC-----ccCHHHHHHHHHHHhhccCCC
Q 035998          938 LELLTGKRPMDMCKPKGSRDLISWVIRMRQEN----------RESEVLDPFIYD-----KQHDKEMLRVLDIACLCLSES 1002 (1020)
Q Consensus       938 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~d 1002 (1020)
                      |||++|+.||......   +............          ......-+....     ..+......+.+++.+||+.|
T Consensus       233 ~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            9999999999753221   2111111110000          000000000000     011122345889999999999


Q ss_pred             CCCCCCHHHHHH
Q 035998         1003 PKVRPTTQQLVS 1014 (1020)
Q Consensus      1003 P~~RPs~~evl~ 1014 (1020)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-37  Score=346.02  Aligned_cols=263  Identities=27%  Similarity=0.333  Sum_probs=196.9

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh-----hHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ-----MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++......     ..+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999975 6899999998753221     124678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++ +|..++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            999999986 788877653   34678889999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ......  .......||+.|+|||++.+ ..++.++||||+||++|||++|..||.....   .+...............
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChh
Confidence            764332  22344678999999998865 4589999999999999999999999865322   12222111111111000


Q ss_pred             cccC------ccc---cCccC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLD------PFI---YDKQH-----DKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d------~~~---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...+      ...   ....+     ......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000      000   00000     122346889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.1e-37  Score=338.01  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=204.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356899999999999999999864 68999999997553 3345778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999864     3689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .  .......|++.|+|||++.+..++.++||||||+++|||++|+.||......      ......... ..     +.
T Consensus       173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~-----~~  238 (303)
T 3a7i_A          173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIPKN-NP-----PT  238 (303)
T ss_dssp             B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CC-----CC
T ss_pred             c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhhcC-CC-----CC
Confidence            1  2233457899999999999999999999999999999999999999743221      111111111 11     11


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....    ...+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Ccccc----CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111    235889999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-36  Score=332.02  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=197.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  814 (1020)
                      +.|++.+.||+|+||.||+|... ++..||+|++....  ....+.+.+|++++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45778889999999999999864 67899999987543  3345678899999999999999999999875    34578


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEc-CCCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLD-GNFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~  891 (1020)
                      +||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|||+
T Consensus       106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            999999999999999865    4689999999999999999999998   7  99999999999998 789999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      +.....    .......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||.....     ............. 
T Consensus       179 ~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~-  247 (290)
T 1t4h_A          179 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK-  247 (290)
T ss_dssp             GGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC-
T ss_pred             cccccc----cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhccCC-
Confidence            976432    22334578999999998764 589999999999999999999999964322     1111111111111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..    .....    ....+.+++.+||+.||.+|||++|+++
T Consensus       248 ~~----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PA----SFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CG----GGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc----ccCCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            10    00011    1135889999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.5e-36  Score=328.82  Aligned_cols=247  Identities=23%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999975 78999999986532   12345788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            9999999999999765    4589999999999999999999999   99999999999999999999999999998763


Q ss_pred             CCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ..   .......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.....   ..   ..........  .  
T Consensus       163 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~---~~~~~~~~~~--~--  229 (276)
T 2h6d_A          163 DG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PT---LFKKIRGGVF--Y--  229 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---HHHHHHHCCC--C--
T ss_pred             CC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HH---HHHHhhcCcc--c--
Confidence            32   22234568999999999887765 6899999999999999999999964321   11   1111111110  0  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+   .    .....+.+++.+||+.||.+|||++|+++
T Consensus       230 ~~---~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 IP---E----YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cc---h----hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            01   0    11235789999999999999999999997

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-36  Score=334.17  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=199.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            357899999999999999999875 78999999987643  33456788999999999 999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC---------------
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN---------------  881 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---------------  881 (1020)
                      |||+++++|.+++.........+++..++.++.|++.||+|||++   +|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999987543345689999999999999999999999   99999999999999844               


Q ss_pred             ----CCeEEeeccccccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc
Q 035998          882 ----FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR  956 (1020)
Q Consensus       882 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~  956 (1020)
                          ..+|++|||.++.....      ....||+.|+|||++.+. .++.++||||+|+++|||++|.+|+...      
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence                47999999999876432      223589999999998766 6678999999999999999998876421      


Q ss_pred             cHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          957 DLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +...   .... .....     ....    ....+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~---~~~~-~~~~~-----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 DQWH---EIRQ-GRLPR-----IPQV----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHH---HHHT-TCCCC-----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHH---HHHc-CCCCC-----CCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            1111   1111 11111     1111    1236889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=331.11  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             CCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          743 NFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      +|....+||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455567999999999999986 4688999999987655556789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeeccccccccCCCC
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      +++|.+++.... ....+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||+++.....  
T Consensus       103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--  176 (295)
T 2clq_A          103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--  176 (295)
T ss_dssp             EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC--
Confidence            999999998642 334567899999999999999999999   9999999999999987 899999999999876432  


Q ss_pred             cccccccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          901 THVTTDLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ........|++.|+|||++.+.  .++.++||||||+++|||++|+.||.......  ... .  .......     .+.
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-~--~~~~~~~-----~~~  246 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAM-F--KVGMFKV-----HPE  246 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHH-H--HHHHHCC-----CCC
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHH-H--hhccccc-----ccc
Confidence            1223345789999999988654  37899999999999999999999996432211  111 1  1111110     111


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    .....+.+++.+||+.||++||+++|+++
T Consensus       247 ~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPE----SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111    12236789999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-37  Score=355.72  Aligned_cols=247  Identities=18%  Similarity=0.204  Sum_probs=191.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCC---chhhHHHHHHHHH---HHHHcCCCccceEe-------eE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGD---CGQMEREFRAEVE---ALSRAQHPNLVHLQ-------GY  806 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  806 (1020)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|++   .+++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46789999999999999999996 46999999998743   2344577899995   45555899999998       66


Q ss_pred             EeccC-----------------ceEEEEEeccCCChhhhhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 035998          807 CMHKN-----------------DRLLIYSFMENGSLDYWLHEKLD---GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI  866 (1020)
Q Consensus       807 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  866 (1020)
                      +.+.+                 ..++||||+ +|+|.+++.....   ....+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            65543                 278999999 6799999986411   112344688889999999999999999   99


Q ss_pred             EecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCC-----------CCCchhhHHHHHH
Q 035998          867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-----------VATYKGDVYSFGV  935 (1020)
Q Consensus       867 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv  935 (1020)
                      +||||||+||+++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986421     2334567 999999998877           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH-
Q 035998          936 VLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS- 1014 (1020)
Q Consensus       936 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~- 1014 (1020)
                      ++|||++|+.||...........+               ...  ...    ....+.+++.+||+.||++||++.|+++ 
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI---------------FRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG---------------GSS--CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccchhhh---------------hhh--ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999999654322211110               000  011    1235889999999999999999999986 


Q ss_pred             -HHHh
Q 035998         1015 -WLDS 1018 (1020)
Q Consensus      1015 -~L~~ 1018 (1020)
                       ++++
T Consensus       361 p~f~~  365 (377)
T 3byv_A          361 PEYEQ  365 (377)
T ss_dssp             HHHHH
T ss_pred             hHHHH
Confidence             5443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.2e-37  Score=361.91  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46999999999999999999875 78999999986432  2235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~  895 (1020)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||+++..
T Consensus       102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999888765    4689999999999999999999999   999999999999995   5667999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....   .+..   ..+.......   
T Consensus       175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~---~~i~~~~~~~---  241 (486)
T 3mwu_A          175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDIL---KRVETGKYAF---  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCCCS---
T ss_pred             CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCCCCC---
Confidence            432   22344679999999999876 589999999999999999999999975322   1111   1221111100   


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +....    ......+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          242 DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00001    111235789999999999999999999997

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.4e-37  Score=346.49  Aligned_cols=263  Identities=25%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEecc--------
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHK--------  810 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  810 (1020)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.....  .....+.+|++++++++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999987 4789999999865432  2235678999999999999999999999873        


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      +..++||||+++ ++...+...   ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            457899999986 666666543   24589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCC--cccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh
Q 035998          891 LARLILSPYD--THVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ  967 (1020)
Q Consensus       891 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  967 (1020)
                      +++.......  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......   ...........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence            9987643221  122344678999999998876 56899999999999999999999999753321   22222222111


Q ss_pred             hcccc---cccCcccc--------CccC-HHH------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          968 ENRES---EVLDPFIY--------DKQH-DKE------MLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       968 ~~~~~---~~~d~~~~--------~~~~-~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....   ........        .... .+.      ...+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11100   00000000        0000 011      234789999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-37  Score=348.95  Aligned_cols=269  Identities=22%  Similarity=0.273  Sum_probs=199.1

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch-----------hhHHHHHHHHHHHHHcCCCccc
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG-----------QMEREFRAEVEALSRAQHPNLV  801 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv  801 (1020)
                      .+.++....++|++.+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            46677888999999999999999999999988899999999854321           1236789999999999999999


Q ss_pred             eEeeEEecc-----CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCE
Q 035998          802 HLQGYCMHK-----NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNI  876 (1020)
Q Consensus       802 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  876 (1020)
                      ++++++...     ...++||||++ |+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999998543     35799999998 5787777643   34689999999999999999999999   999999999999


Q ss_pred             EEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 035998          877 LLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS  955 (1020)
Q Consensus       877 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~  955 (1020)
                      +++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  240 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--  240 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence            9999999999999999754322   22334578899999998876 77899999999999999999999999753321  


Q ss_pred             ccHHHHHHHHHhhcccc---------------ccc---CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          956 RDLISWVIRMRQENRES---------------EVL---DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       956 ~~~~~~~~~~~~~~~~~---------------~~~---d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ................               ...   .+.......+.....+.+++.+||+.||++|||++|+++
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence             1111111110000000               000   000000111122345889999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-36  Score=334.31  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=188.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch-h-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG-Q-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++..... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46799999999999999999986 4788999999976532 2 2233445555577789999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++ +|.+++.........+++..++.++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99975 888888765555568999999999999999999999853  899999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYG----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      .   .......||+.|+|||++    .+..++.++||||+|+++|||++|+.||.....    . ............ ..
T Consensus       163 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~-~~  233 (290)
T 3fme_A          163 D---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----P-FQQLKQVVEEPS-PQ  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----H-HHHHHHHHHSCC-CC
T ss_pred             c---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----h-HHHHHHHhccCC-CC
Confidence            2   222334789999999985    566789999999999999999999999964321    1 111111111111 11


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    .    .....+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 LPA----D----KFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCT----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccc----c----cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            000    1    11235889999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-37  Score=343.43  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=200.7

Q ss_pred             HhccCCCcC-CeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCce
Q 035998          739 ESTNNFDQA-NIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       739 ~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  813 (1020)
                      ...++|.+. +.||+|+||.||+|+.. +++.||||++....  ......+.+|+.+++++ +||||+++++++.+.+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            334567777 88999999999999865 68999999987643  22356788999999999 569999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeecc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFG  890 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  890 (1020)
                      ++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||
T Consensus       105 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            9999999999999988653  235689999999999999999999999   9999999999999987   7899999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +++.....   .......||+.|+|||++.+..++.++||||+|+++|||++|+.||......   ..   .........
T Consensus       180 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~  250 (327)
T 3lm5_A          180 MSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ET---YLNISQVNV  250 (327)
T ss_dssp             GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHTCC
T ss_pred             cccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HH---HHHHHhccc
Confidence            99876432   2223457899999999999999999999999999999999999999643221   11   111111110


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        . ..+    .........+.+++.+||+.||++|||++|+++
T Consensus       251 --~-~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          251 --D-YSE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --C-CCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --c-cCc----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence              0 000    001112245889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-36  Score=334.32  Aligned_cols=252  Identities=25%  Similarity=0.447  Sum_probs=198.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999975 5899999999766555567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...... 
T Consensus        98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            9999999998764   24589999999999999999999999   9999999999999999999999999997643211 


Q ss_pred             CcccccccccccCccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          900 DTHVTTDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                       ........|++.|+|||++     .+..++.++||||+|+++|+|++|+.||.....      ............ ...
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~  242 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP-PTL  242 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-ccc
Confidence             1112335689999999987     467889999999999999999999999975322      111111111111 111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..+       ......+.+++.+||+.||++|||++++++
T Consensus       243 ~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 LTP-------SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SSG-------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CCc-------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111       111235889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.2e-37  Score=361.27  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=197.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||.||+|+.. ++..||||++....  ......+.+|+++++.++||||+++++++.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999875 68899999987543  2234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~~~~~  895 (1020)
                      |+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++..
T Consensus       117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999888765    4689999999999999999999999   9999999999999976   455999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...   .......||+.|+|||++. +.++.++||||+||++|+|++|+.||......   ..   ...+......   .
T Consensus       190 ~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~~i~~~~~~---~  256 (494)
T 3lij_A          190 ENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EI---LRKVEKGKYT---F  256 (494)
T ss_dssp             BTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHTCCC---C
T ss_pred             CCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCCC---C
Confidence            432   2234467999999999876 46899999999999999999999999753321   11   1112111110   1


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +...+..    ....+.+++.+||+.||.+|||++|+++
T Consensus       257 ~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          257 DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1111111    1235789999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=328.56  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc----hhhHHHHHHHHHHHHHcCCCccceEeeEEe--ccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQHPNLVHLQGYCM--HKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|... +++.||+|++....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999874 68899999997542    223567899999999999999999999984  45678


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||++++ +.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999887 666666542  34689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASV--ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ...............|++.|+|||+..+..  ++.++||||+|+++|||++|+.||.....      ............ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~-  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGSY-  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCC-
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCCC-
Confidence            765433333344567899999999887644  47899999999999999999999974321      111111111110 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .     ...    .....+.+++.+||+.||.+||+++|+++
T Consensus       231 -~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          231 -A-----IPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             -C-----CCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -C-----CCC----ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0     001    11235789999999999999999999996

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-36  Score=360.48  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-------------hhHHHHHHHHHHHHHcCCCccceEeeE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-------------QMEREFRAEVEALSRAQHPNLVHLQGY  806 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~  806 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999875 578999999875431             234678899999999999999999999


Q ss_pred             EeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC---C
Q 035998          807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF---G  883 (1020)
Q Consensus       807 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~  883 (1020)
                      +.+....++||||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            99999999999999999999988765    4689999999999999999999999   999999999999998776   6


Q ss_pred             eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          884 AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       884 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      +||+|||+++.....   .......||+.|+|||++. +.++.++||||+||++|+|++|..||......   ..   ..
T Consensus       188 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~---~~  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DI---IK  257 (504)
T ss_dssp             EEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH
T ss_pred             EEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH---HH
Confidence            999999999876432   2234467999999999977 46899999999999999999999999753321   11   11


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+......   .+......    ....+.+++.+||+.||.+|||++|+++
T Consensus       258 ~i~~~~~~---~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYY---FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCC---CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCC---CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            12111110   01001111    1235889999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.2e-37  Score=348.48  Aligned_cols=254  Identities=11%  Similarity=0.042  Sum_probs=182.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHc--CCCccceEe-------eEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRA--QHPNLVHLQ-------GYC  807 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  807 (1020)
                      ..+|++.+.||+|+||.||+|++. +++.||||++.....   ...+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345889999999999999999965 788999999987542   3345677886655555  599987754       444


Q ss_pred             ecc-----------------CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHhHhcCCC
Q 035998          808 MHK-----------------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSR------LHIAQGAARGLAYLHQSCEP  864 (1020)
Q Consensus       808 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~  864 (1020)
                      ...                 ...++||||++ |+|.+++....   ..+++..+      ..++.||+.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            433                 23799999999 89999998641   22344555      78889999999999999   


Q ss_pred             CeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHc
Q 035998          865 HILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLT  942 (1020)
Q Consensus       865 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt  942 (1020)
                      +|+||||||+||+++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++||||+||++|||++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            999999999999999999999999999987532     1223456799999999987  789999999999999999999


Q ss_pred             CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          943 GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       943 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      |+.||....+.......        .......................+.+++.+||+.||++|||++|+++
T Consensus       289 g~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999865432211100        00000000000000111122346889999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.8e-37  Score=363.25  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=203.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46999999999999999999875 78999999986542   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE---cCCCCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL---DGNFGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~  894 (1020)
                      ||+.+|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++.
T Consensus       106 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          106 EVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             CCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            999999999988754    4689999999999999999999999   99999999999999   5678999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....   ....   ..+........ 
T Consensus       179 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~---~~i~~~~~~~~-  247 (484)
T 3nyv_A          179 FEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDIL---KKVEKGKYTFE-  247 (484)
T ss_dssp             BCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHCCCCCC-
T ss_pred             cccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHH---HHHHcCCCCCC-
Confidence            6432   22344579999999998866 689999999999999999999999975322   1111   12211111100 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       .+ ..    ......+.+++.+||+.||.+|||++|+++
T Consensus       248 -~~-~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -LP-QW----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -SG-GG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -Cc-cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence             00 00    112235789999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.1e-36  Score=336.31  Aligned_cols=261  Identities=19%  Similarity=0.302  Sum_probs=201.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEec--cCceEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMH--KNDRLLI  816 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  816 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....   .+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            35799999999999999999985 578999999997543   467889999999997 9999999999987  5678999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeeccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARLI  895 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~  895 (1020)
                      |||+++++|.+++..       +++..+..++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||+++..
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            999999999988753       68899999999999999999999   999999999999999776 8999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc----
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR----  970 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  970 (1020)
                      ....   ......|+..|+|||++.+ ..++.++||||+||++|||++|+.||.....  ..+.............    
T Consensus       182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~  256 (330)
T 3nsz_A          182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDY  256 (330)
T ss_dssp             CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHH
T ss_pred             CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhH
Confidence            4322   2334578999999998876 6799999999999999999999999954322  1111111111000000    


Q ss_pred             ---cccccCc----------------cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhc
Q 035998          971 ---ESEVLDP----------------FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019 (1020)
Q Consensus       971 ---~~~~~d~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1019 (1020)
                         .....++                .............+.+++.+||+.||++|||++|+++  +|.++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence               0000000                0000111112346889999999999999999999997  55443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-36  Score=332.22  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=196.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--CCC--EEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--DGR--NVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|++.  +++  .||||++....   ....+.+.+|++++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999853  333  68999987542   234567899999999999999999999988654 8


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            8999999999999999764   23588999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ........ .......++..|+|||+..+..++.++||||+|+++|||++ |+.||.....      .............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~  243 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGER  243 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCC
Confidence            76443222 12234567788999999988889999999999999999999 9999975322      1111122111110


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..         ........+.+++.+||+.||++||+++++++.|+++
T Consensus       244 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          244 LP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence            00         0111224688999999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-36  Score=348.27  Aligned_cols=259  Identities=24%  Similarity=0.301  Sum_probs=193.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc------eEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND------RLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l  815 (1020)
                      .+|++.+.||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46899999999999999999987777799998865432    23469999999999999999999965443      789


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-CCCCeEEeecccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGAHLADFGLARL  894 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~  894 (1020)
                      ||||++++.+.. +.........+++..++.++.|++.||+|||++   +|+||||||+||+++ .++.+||+|||+++.
T Consensus       116 v~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          116 VLEYVPETVYRA-SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEECCSEEHHHH-HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeeccCccHHHH-HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            999998754443 332222345789999999999999999999999   999999999999999 799999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh-----
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE-----  968 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  968 (1020)
                      .....   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......   +...........     
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence            63322   22346789999999988664 5899999999999999999999999753321   111111111000     


Q ss_pred             -----cccccccCcccc-----CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 -----NRESEVLDPFIY-----DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 -----~~~~~~~d~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           .......-+...     ..........+.+++.+||+.||.+|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                 000000000000     0011112346889999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-36  Score=337.00  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=196.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch--------hhHHHHHHHHHHHHHcCCCccceEeeEEeccC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG--------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  811 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....        .....+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999865 578999999875421        12235789999999999999999999987654


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEee
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLAD  888 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  888 (1020)
                       .++||||+++++|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             89999999999999888653    4689999999999999999999999   9999999999999987654   99999


Q ss_pred             ccccccccCCCCcccccccccccCccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH
Q 035998          889 FGLARLILSPYDTHVTTDLVGTLGYIPPEYG---QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM  965 (1020)
Q Consensus       889 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  965 (1020)
                      ||+++....   ........||+.|+|||++   ....++.++||||+|+++|+|++|..||........  ......  
T Consensus       161 fg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~--  233 (322)
T 2ycf_A          161 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT--  233 (322)
T ss_dssp             CTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH--
T ss_pred             Cccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH--
Confidence            999987632   2223345789999999986   356789999999999999999999999975443221  111111  


Q ss_pred             HhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       . ....  ..+.....    ....+.+++.+||+.||++||+++|+++
T Consensus       234 -~-~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 -S-GKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -H-TCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -h-Cccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence             1 1000  01111111    1236889999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.9e-36  Score=339.12  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=190.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999864 68899999997543  334467889999999999999999999997654      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            67999999975 67777752      478999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHH------
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM------  965 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~------  965 (1020)
                      ++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||......   +........      
T Consensus       174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP  247 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCH
T ss_pred             ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCH
Confidence            9865322   2233467899999999999999999999999999999999999999753221   111110000      


Q ss_pred             -------------Hhhccc-c-----cccCccccCc---cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          966 -------------RQENRE-S-----EVLDPFIYDK---QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       966 -------------~~~~~~-~-----~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   ...... .     ..........   ........+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                         000000 0     0000000000   01123457899999999999999999999987

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-36  Score=343.65  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=200.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----NDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  813 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999865 67889999997543 33346788999999999999999999999754     367


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||+++ +|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            999999975 898888753     589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCc-ccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          894 LILSPYDT-HVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       894 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ........ .......||+.|+|||++. +..++.++||||+||++|||++|+.||......+   ..............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence            76432111 1224457899999999754 5568999999999999999999999997544322   22211111100000


Q ss_pred             c---------------cccCc--cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 S---------------EVLDP--FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~---------------~~~d~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .               ....+  .......+.....+.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0               00000  0000001112245889999999999999999999987

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-36  Score=333.12  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=202.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---------hhhHHHHHHHHHHHHHcC-CCccceEeeEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---------GQMEREFRAEVEALSRAQ-HPNLVHLQGYCMH  809 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  809 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999875 68899999987542         122356789999999995 9999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      ....++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999864    4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQ------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      |+++.....   .......|++.|+|||++.      ...++.++||||+|+++|||++|+.||.....      .....
T Consensus       169 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~  239 (298)
T 1phk_A          169 GFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLR  239 (298)
T ss_dssp             TTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred             cchhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHH
Confidence            999876432   2233457899999999874      56789999999999999999999999964321      11111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ........  ...+     ........+.+++.+||+.||++||+++|+++
T Consensus       240 ~~~~~~~~--~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQ--FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCC--CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcc--cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111110  0000     00112246889999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.9e-36  Score=348.73  Aligned_cols=198  Identities=22%  Similarity=0.289  Sum_probs=172.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHc------CCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRA------QHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  813 (1020)
                      ..+|++.+.||+|+||.||+|... +++.||||++.... ...+++.+|+++++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 58899999997653 3346778899988887      577999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC--eEEeeccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG--AHLADFGL  891 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~  891 (1020)
                      ++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.  +||+|||+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            99999996 58988887642  24589999999999999999999999   9999999999999999887  99999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      ++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            976432     123457899999999999999999999999999999999999999754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-36  Score=349.62  Aligned_cols=260  Identities=25%  Similarity=0.284  Sum_probs=194.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc------CceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------NDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  814 (1020)
                      .+|++.+.||+|+||.||+|++. +++.||||++..+..    ...+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 689999999875432    234799999999999999999998542      1256


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-CCeEEeeccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLAR  893 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~  893 (1020)
                      +||||+++ ++.+.+.........+++..+..++.||++||+|||++   +|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 66666654433456789999999999999999999999   99999999999999965 568999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH------
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR------  966 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~------  966 (1020)
                      ......   ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......  ...........      
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence            764321   22346789999999988664 7999999999999999999999999753221  11111111100      


Q ss_pred             --h-hcccccccCccccCc-----cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 --Q-ENRESEVLDPFIYDK-----QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 --~-~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        . .....+...+.+...     ..+.....+.+++.+||+.||++||++.|+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              0 000001111111000     11122346889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=330.25  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=200.0

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....  ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567999999999999999999875 58999999997653  23568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+......
T Consensus       105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998743   24689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .  .......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....      ......... ........+ 
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~~-  248 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPT-NPPPTFRKP-  248 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCSSG-
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhc-CCCcccCCc-
Confidence            1  223345789999999999999999999999999999999999999974321      111111111 111111111 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                            ......+.+++.+||+.||.+|||+.++++
T Consensus       249 ------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  111236889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.2e-37  Score=337.98  Aligned_cols=264  Identities=27%  Similarity=0.461  Sum_probs=187.3

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34678999999999999999999864 68999999986543 23345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcC----CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          817 YSFMENGSLDYWLHEKL----DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      |||+++++|.+++....    .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999987521    1234689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCC---cccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          893 RLILSPYD---THVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       893 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      +.......   ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||.......   ...  ......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~--~~~~~~  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM--LTLQND  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH--HHHTSS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH--HHhccC
Confidence            87643211   112234578999999998765 568999999999999999999999997543221   111  111110


Q ss_pred             c--ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          969 N--RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       969 ~--~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .  ......++......    ...+.+++.+||+.||.+||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0  00011111111122    235789999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6e-37  Score=346.80  Aligned_cols=257  Identities=24%  Similarity=0.316  Sum_probs=182.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------C
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------N  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  811 (1020)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999985 468899999987542  23456788999999999999999999998754      5


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++|+||+ +++|.+++..     ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 6788888764     3689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+.............
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPG  250 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCC
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence            9865321     234678999999998876 6889999999999999999999999975332   122221111110000


Q ss_pred             ---cccccC--------------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ---ESEVLD--------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ---~~~~~d--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                         ...+..              +.......+.....+.+++.+||+.||.+|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence               000000              00000000111245789999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=337.96  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=198.1

Q ss_pred             HHHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEec---
Q 035998          735 DDILESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMH---  809 (1020)
Q Consensus       735 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  809 (1020)
                      .++....++|++.+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+++++++ +||||+++++++..   
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            34445678899999999999999999987 4789999999875533 346788999999999 89999999999986   


Q ss_pred             ---cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          810 ---KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       810 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                         ....++||||+++++|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence               457899999999999999998642  24688999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW  961 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  961 (1020)
                      +|||++.......  .......|++.|+|||++.     +..++.++||||+|+++|+|++|+.||.....      ...
T Consensus       171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~  242 (326)
T 2x7f_A          171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRA  242 (326)
T ss_dssp             CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHH
T ss_pred             eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHH
Confidence            9999998653321  1223457899999999876     56789999999999999999999999964321      111


Q ss_pred             HHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          962 VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       962 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....... .......    ..    ....+.+++.+||+.||.+||+++++++
T Consensus       243 ~~~~~~~-~~~~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          243 LFLIPRN-PAPRLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHS-CCCCCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhcC-ccccCCc----cc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111 1111100    11    1236889999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.6e-36  Score=364.32  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=203.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+..|.+++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999865 68899999997542   12235677899998887 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +||||||||+|||++.++++||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999875    4689999999999999999999999   9999999999999999999999999999864


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....  .  
T Consensus       493 ~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~--~--  560 (674)
T 3pfq_A          493 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV--A--  560 (674)
T ss_dssp             CCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC--C--
T ss_pred             ccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC--C--
Confidence            322  2234457899999999999999999999999999999999999999975322      111122211110  0  


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTT-----QQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1014 (1020)
                             .+.....++.+++.+||+.||++||++     +||++
T Consensus       561 -------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 -------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                   011122368899999999999999997     77764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-36  Score=344.23  Aligned_cols=268  Identities=19%  Similarity=0.257  Sum_probs=191.0

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc--
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND--  812 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  812 (1020)
                      ......++|++.+.||+|+||.||+|+.. +++.||||++..+... .....+|++.++.++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34556789999999999999999999874 6899999998655322 2345678888889999999999999976443  


Q ss_pred             -----eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH--hcCCCCeEecCCCCCCEEEcC-CCCe
Q 035998          813 -----RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH--QSCEPHILHRDIKSSNILLDG-NFGA  884 (1020)
Q Consensus       813 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~  884 (1020)
                           .++||||+++ ++...+.........+++..+..++.|++.|++|||  +.   +|+||||||+||+++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence                 7899999986 555555544444567899999999999999999999  77   9999999999999996 8999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++.....   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......   .......
T Consensus       172 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~  245 (360)
T 3e3p_A          172 KLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIV  245 (360)
T ss_dssp             EECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHH
Confidence            99999999876432   223345789999999988654 4899999999999999999999999753321   1111111


Q ss_pred             HHHhh------------cccccccC------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          964 RMRQE------------NRESEVLD------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       964 ~~~~~------------~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....            .......+      ..............+.+++.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11000            00000000      00001111123457899999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-35  Score=329.63  Aligned_cols=252  Identities=27%  Similarity=0.368  Sum_probs=195.8

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcC--CCccceEeeEEeccCceEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQ--HPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  815 (1020)
                      ..++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++  ||||+++++++.+.+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            356799999999999999999998889999999986543  334567899999999997  5999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||++++ +.+||+|||+++..
T Consensus       106 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            999 5688999999864    4689999999999999999999999   9999999999999964 89999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQA-----------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      .............|++.|+|||++.+           ..++.++||||+|+++|||++|+.||.....     .......
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~  251 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA  251 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHH
Confidence            44332223344578999999998765           5788999999999999999999999964321     1111122


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..........         +......+.+++.+||+.||.+||+++|+++
T Consensus       252 ~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          252 IIDPNHEIEF---------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHCTTSCCCC---------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcccccCC---------cccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2111111110         0011235889999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.1e-36  Score=338.94  Aligned_cols=259  Identities=22%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchh-----------------hHHHHHHHHHHHHHcCCCccceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQ-----------------MEREFRAEVEALSRAQHPNLVHL  803 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l  803 (1020)
                      .++|++.+.||+|+||.||+|+. +++.||||++......                 ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998643211                 11678999999999999999999


Q ss_pred             eeEEeccCceEEEEEeccCCChhhh------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCE
Q 035998          804 QGYCMHKNDRLLIYSFMENGSLDYW------LHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNI  876 (1020)
Q Consensus       804 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI  876 (1020)
                      ++++.+.+..++||||+++++|.++      +...  ....+++..++.++.|++.||+|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      4331  24678999999999999999999998 8   999999999999


Q ss_pred             EEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 035998          877 LLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATY-KGDVYSFGVVLLELLTGKRPMDMCKPKG  954 (1020)
Q Consensus       877 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltg~~pf~~~~~~~  954 (1020)
                      +++.++.+||+|||.++.....    ......|++.|+|||+..+. .++. ++||||+|+++|||++|+.||...... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            9999999999999999876332    33456789999999998877 6666 999999999999999999999754331 


Q ss_pred             cccHHHHHHHHHhhcc-cccc----cCcccc---CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          955 SRDLISWVIRMRQENR-ESEV----LDPFIY---DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~-~~~~----~d~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ....   ..+..... ....    ..+...   ..........+.+++.+||+.||.+||+++|+++
T Consensus       259 -~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -VELF---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -HHHH---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHHH---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111   11111110 0000    000000   0000122346889999999999999999999987

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.3e-36  Score=336.68  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe--CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCC------ccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL--PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP------NLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|..  .+++.||||++... ....+.+.+|+++++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999986  36789999999754 33356788999999998765      49999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC------------
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG------------  880 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------  880 (1020)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 88999998764  224688999999999999999999999   9999999999999987            


Q ss_pred             -------CCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 035998          881 -------NFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK  953 (1020)
Q Consensus       881 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  953 (1020)
                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   678999999999864321     23457899999999999999999999999999999999999999754322


Q ss_pred             CcccHHHHHHHHHhhccc--------ccc---------------------cCc-cccCccCHHHHHHHHHHHhhccCCCC
Q 035998          954 GSRDLISWVIRMRQENRE--------SEV---------------------LDP-FIYDKQHDKEMLRVLDIACLCLSESP 1003 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~--------~~~---------------------~d~-~~~~~~~~~~~~~l~~li~~cl~~dP 1003 (1020)
                         +..............        ...                     ..+ .............+.+++.+||+.||
T Consensus       241 ---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          241 ---EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             ---HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ---HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence               111111111110000        000                     000 00011133456678999999999999


Q ss_pred             CCCCCHHHHHH
Q 035998         1004 KVRPTTQQLVS 1014 (1020)
Q Consensus      1004 ~~RPs~~evl~ 1014 (1020)
                      ++|||++|+++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.5e-36  Score=342.54  Aligned_cols=263  Identities=21%  Similarity=0.245  Sum_probs=202.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC--------CCccceEeeEEe---
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ--------HPNLVHLQGYCM---  808 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  808 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            368999999999999999999864 6889999999755 334567889999999985        788999999987   


Q ss_pred             -ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-----
Q 035998          809 -HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-----  882 (1020)
Q Consensus       809 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----  882 (1020)
                       .....++||||+ ++++.+++...  ....+++..++.++.||+.||+|||+++  +|+||||||+||+++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence             556789999999 55665555543  2246899999999999999999999853  799999999999999775     


Q ss_pred             --------------------------------------------CeEEeeccccccccCCCCcccccccccccCccCccc
Q 035998          883 --------------------------------------------GAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY  918 (1020)
Q Consensus       883 --------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  918 (1020)
                                                                  .+||+|||.++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999875322     234578999999999


Q ss_pred             cCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccH---HHHHHHHHhhcc---------cccccCc---------
Q 035998          919 GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL---ISWVIRMRQENR---------ESEVLDP---------  977 (1020)
Q Consensus       919 ~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~d~---------  977 (1020)
                      +.+..++.++|||||||++|||++|+.||...........   ............         .......         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999986554433211   111111111000         0000000         


Q ss_pred             -cc---------cCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 -FI---------YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 -~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..         ...........+.+++.+||+.||++|||++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence             00         01224566678999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-36  Score=338.89  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe--CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHc---CCCccceEeeEEe---
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL--PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRA---QHPNLVHLQGYCM---  808 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  808 (1020)
                      ...++|++.+.||+|+||.||+|+.  .+++.||||++.....  .....+.+|+++++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999987  3678899999864321  1123456777777766   8999999999987   


Q ss_pred             --ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          809 --HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       809 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                        .....++||||++ |+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence              4567889999998 59999987652  23589999999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      +|||+++....   ........|++.|+|||++.+..++.++||||+|+++|||++|+.||.....   .+.........
T Consensus       162 ~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~  235 (326)
T 1blx_A          162 ADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVI  235 (326)
T ss_dssp             CSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH
T ss_pred             ecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHc
Confidence            99999976532   2233456789999999999999999999999999999999999999975332   12222111111


Q ss_pred             hhccccccc----Cc---------cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVL----DP---------FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~----d~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .........    .+         .............+.+++.+||+.||++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            100000000    00         0000111122346789999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-36  Score=366.95  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=203.8

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ..++|++.+.||+|+||.||+|.+..    +..||||++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            45678999999999999999998642    4579999987643 334467899999999999999999999985 45689


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999999754   24689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ..... ........+++.|+|||++.+..++.++||||||+++|||++ |..||......   +..   ..+....... 
T Consensus       541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~---~~i~~~~~~~-  612 (656)
T 2j0j_A          541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI---GRIENGERLP-  612 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHHTCCCC-
T ss_pred             cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH---HHHHcCCCCC-
Confidence            64322 122233456789999999988899999999999999999997 99999753321   111   1121111110 


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                               .+......+.+++.+||+.||++||+++|+++.|++++
T Consensus       613 ---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                     01112246889999999999999999999999998763

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1e-35  Score=341.05  Aligned_cols=311  Identities=20%  Similarity=0.194  Sum_probs=183.2

Q ss_pred             CCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                      .++++++|++++|.++...+..|..+++|++|+|++|.+++..+..+ .+++|++|+|++|+++ .+|...+..+++|++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCE
Confidence            46778888888888773333346778888888888888877766666 6777777777777776 344444455666666


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcC
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF  265 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  265 (1020)
                      |+|++|+++...+..|+++++|++|+|++|++++..+..+..+++|++|++++|++++.   .+..+++|++|++++|.+
T Consensus       122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l  198 (390)
T 3o6n_A          122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL  198 (390)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred             EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence            66666666643333456666666666666666655555555566666666666665533   234455566666666655


Q ss_pred             cccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC
Q 035998          266 SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL  345 (1020)
Q Consensus       266 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  345 (1020)
                      ++.     ....+|+.|++++|+++..                        ...   ..++|++|++++|++++.  ..+
T Consensus       199 ~~~-----~~~~~L~~L~l~~n~l~~~------------------------~~~---~~~~L~~L~l~~n~l~~~--~~l  244 (390)
T 3o6n_A          199 STL-----AIPIAVEELDASHNSINVV------------------------RGP---VNVELTILKLQHNNLTDT--AWL  244 (390)
T ss_dssp             SEE-----ECCSSCSEEECCSSCCCEE------------------------ECC---CCSSCCEEECCSSCCCCC--GGG
T ss_pred             ccc-----CCCCcceEEECCCCeeeec------------------------ccc---ccccccEEECCCCCCccc--HHH
Confidence            431     1223444444444444432                        111   124455555555555432  244


Q ss_pred             CCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccC
Q 035998          346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFAN  425 (1020)
Q Consensus       346 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~  425 (1020)
                      ..+++|++|+|++|++++..|..|..+++|++|++++|+++.++..                            ...+++
T Consensus       245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----------------------------~~~l~~  296 (390)
T 3o6n_A          245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLY----------------------------GQPIPT  296 (390)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECS----------------------------SSCCTT
T ss_pred             cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcc----------------------------cCCCCC
Confidence            4555555555555555555555555555555555555554443321                            012334


Q ss_pred             ceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCccccc
Q 035998          426 LKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGE  487 (1020)
Q Consensus       426 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  487 (1020)
                      |+.|++++|.+. .+|..+..+++|+.|+|++|+|++. |  +..+++|++|+|++|++++.
T Consensus       297 L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred             CCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccch
Confidence            455555555554 3455567778888888888888743 3  67788888999999988753

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.1e-36  Score=361.38  Aligned_cols=334  Identities=22%  Similarity=0.227  Sum_probs=255.4

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      .+++++.|++++|.++...+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            46788999999999997777778889999999999999998888899999999999999999998888889999999999


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      +|++|++++..+..|+++++|++|+|++|.+++..+..|..+++|++|+|++|++++..   +..+++|+.|++++|.++
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence            99999999777777888899999999999998888888888889999999999888642   556778888888888887


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccch
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQ  442 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~  442 (1020)
                      +.     ....+|+.|++++|.+..++..                              ..++|+.|++++|.+++  +.
T Consensus       206 ~l-----~~~~~L~~L~ls~n~l~~~~~~------------------------------~~~~L~~L~L~~n~l~~--~~  248 (597)
T 3oja_B          206 TL-----AIPIAVEELDASHNSINVVRGP------------------------------VNVELTILKLQHNNLTD--TA  248 (597)
T ss_dssp             EE-----ECCTTCSEEECCSSCCCEEECS------------------------------CCSCCCEEECCSSCCCC--CG
T ss_pred             cc-----cCCchhheeeccCCcccccccc------------------------------cCCCCCEEECCCCCCCC--Ch
Confidence            52     3456788888888887655421                              11345555555555554  24


Q ss_pred             hhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccc
Q 035998          443 WLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSA  522 (1020)
Q Consensus       443 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~  522 (1020)
                      ++..+++|+.|+|++|++++.+|..|+.+++|++|+|++|+++                                     
T Consensus       249 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------------------------  291 (597)
T 3oja_B          249 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-------------------------------------  291 (597)
T ss_dssp             GGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-------------------------------------
T ss_pred             hhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-------------------------------------
Confidence            5555666666666666666555555666666666666665554                                     


Q ss_pred             cccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccc
Q 035998          523 RGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEK  602 (1020)
Q Consensus       523 ~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~  602 (1020)
                                             + +|..++.+++|+.|+|++|+++ .+|..++.+++|+.|+|++|+|++. |  +..
T Consensus       292 -----------------------~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~  343 (597)
T 3oja_B          292 -----------------------A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LST  343 (597)
T ss_dssp             -----------------------E-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred             -----------------------C-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhh
Confidence                                   3 2334556778889999999998 6888888899999999999999854 3  677


Q ss_pred             cccccccccccccccccCCCCCCCCCcCCccccCCC-CCCC
Q 035998          603 LSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCGE  642 (1020)
Q Consensus       603 l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~-l~~~  642 (1020)
                      +++|+.|++++|++++..+. ..+..+....+.++. .|+.
T Consensus       344 ~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~  383 (597)
T 3oja_B          344 HHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI  383 (597)
T ss_dssp             TCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCT
T ss_pred             cCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCc
Confidence            88999999999999875432 234556666677775 7775

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.9e-36  Score=342.69  Aligned_cols=266  Identities=24%  Similarity=0.329  Sum_probs=182.1

Q ss_pred             CCCc-CCeeeccCCeEEEEEEeC---CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEE
Q 035998          743 NFDQ-ANIIGCGGFGLVYRATLP---DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLI  816 (1020)
Q Consensus       743 ~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  816 (1020)
                      .|++ .++||+|+||.||+|+++   +++.||||++.....  ...+.+|++++++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3555 568999999999999965   578899999976532  3467899999999999999999999954  6678999


Q ss_pred             EEeccCCChhhhhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE----cCCCCeEEe
Q 035998          817 YSFMENGSLDYWLHEKL-----DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL----DGNFGAHLA  887 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~  887 (1020)
                      |||+++ +|.+++....     .....+++..++.++.||+.||+|||+.   +|+||||||+||++    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 7777765321     1223589999999999999999999999   99999999999999    678899999


Q ss_pred             eccccccccCCCCc-ccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCC------cccHH
Q 035998          888 DFGLARLILSPYDT-HVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG------SRDLI  959 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~------~~~~~  959 (1020)
                      |||+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......      ..+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876433211 22344678999999998877 458999999999999999999999997543311      01111


Q ss_pred             HHHHHHHhhcccccccC---------------ccccCccCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          960 SWVIRMRQENRESEVLD---------------PFIYDKQHD---------KEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       960 ~~~~~~~~~~~~~~~~d---------------~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ................+               .........         .....+.+|+.+||+.||.+|||++|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111000000000               000000000         00235789999999999999999999987

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-35  Score=340.77  Aligned_cols=331  Identities=22%  Similarity=0.244  Sum_probs=194.4

Q ss_pred             cccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeec
Q 035998          205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA  284 (1020)
Q Consensus       205 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  284 (1020)
                      ++++.|++++|.++...+..+..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|++
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            44444555555554333333445555555555555555444445555555555555555555555555555555555555


Q ss_pred             ccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc
Q 035998          285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ  364 (1020)
Q Consensus       285 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  364 (1020)
                      ++|+++...+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++.   .+..+++|+.|++++|.+++.
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~  201 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL  201 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc
Confidence            55555544444445555555566665555555555555566666666666666533   244455666666666665532


Q ss_pred             CcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhh
Q 035998          365 IPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL  444 (1020)
Q Consensus       365 ~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l  444 (1020)
                           ...++|+.|++++|.+..++..                              .+++|+.|++++|.+.+.  .++
T Consensus       202 -----~~~~~L~~L~l~~n~l~~~~~~------------------------------~~~~L~~L~l~~n~l~~~--~~l  244 (390)
T 3o6n_A          202 -----AIPIAVEELDASHNSINVVRGP------------------------------VNVELTILKLQHNNLTDT--AWL  244 (390)
T ss_dssp             -----ECCSSCSEEECCSSCCCEEECC------------------------------CCSSCCEEECCSSCCCCC--GGG
T ss_pred             -----CCCCcceEEECCCCeeeecccc------------------------------ccccccEEECCCCCCccc--HHH
Confidence                 2334566666666665544321                              113444555555555432  356


Q ss_pred             hcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccc
Q 035998          445 RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARG  524 (1020)
Q Consensus       445 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~  524 (1020)
                      ..+++|++|+|++|++++..|..|..+++|++|+|++|++++ +                                    
T Consensus       245 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~------------------------------------  287 (390)
T 3o6n_A          245 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-L------------------------------------  287 (390)
T ss_dssp             GGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-E------------------------------------
T ss_pred             cCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-c------------------------------------
Confidence            666777777777777776666777777777777777776653 2                                    


Q ss_pred             cccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccc
Q 035998          525 LQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLS  604 (1020)
Q Consensus       525 l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~  604 (1020)
                                              |..++.+++|++|+|++|+++ .+|..++.+++|++|+|++|+|++ +|  +..++
T Consensus       288 ------------------------~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~  339 (390)
T 3o6n_A          288 ------------------------NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LK--LSTHH  339 (390)
T ss_dssp             ------------------------ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CC--CCTTC
T ss_pred             ------------------------CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccce-eC--chhhc
Confidence                                    223445667888888888887 577778888888888888888874 44  67778


Q ss_pred             cccccccccccccccCCCCCCCCCcCCccccCCC-CCC
Q 035998          605 FLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNN-LCG  641 (1020)
Q Consensus       605 ~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~-l~~  641 (1020)
                      +|+.|++++|++++.-.. ..+..+....+.++. .|+
T Consensus       340 ~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~  376 (390)
T 3o6n_A          340 TLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCK  376 (390)
T ss_dssp             CCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCC
T ss_pred             cCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceec
Confidence            888888888888763221 223444445555554 454

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-35  Score=332.13  Aligned_cols=255  Identities=22%  Similarity=0.320  Sum_probs=173.9

Q ss_pred             ccCCCcCC-eeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceE
Q 035998          741 TNNFDQAN-IIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       741 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  814 (1020)
                      .++|.+.+ +||+|+||.||+|+.. +++.||||++....    ....+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788854 6999999999999876 68999999997642    112222334566799999999999876    44578


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  891 (1020)
                      +||||+++|+|.+++...  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||+
T Consensus       103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            999999999999999864  234689999999999999999999999   9999999999999976   45599999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ++.....    ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..............  ......  
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~--  249 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RIRLGQ--  249 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--hhhccc--
Confidence            9865322    22345789999999999888999999999999999999999999975433221111100  000000  


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                      .....+ .    .......+.+++.+||+.||.+|||++|+++  +++
T Consensus       250 ~~~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          250 YGFPNP-E----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             -CCCTT-T----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             cccCch-h----hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            000000 0    0112246889999999999999999999998  554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.8e-36  Score=340.85  Aligned_cols=255  Identities=22%  Similarity=0.297  Sum_probs=194.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce----
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR----  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  813 (1020)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999865 68899999997643  23356788999999999999999999999877654    


Q ss_pred             --EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          814 --LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       814 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                        ++||||++ ++|.+++..      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 577776642      489999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....   .+.............
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPG  262 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCC
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCc
Confidence            9865322     234578999999998877 7899999999999999999999999975322   111111111100000


Q ss_pred             ------------------cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          971 ------------------ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       971 ------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                        ........ .....+.....+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCC-HHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchh-HHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                              00000000 00001112346889999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-35  Score=337.92  Aligned_cols=200  Identities=25%  Similarity=0.318  Sum_probs=170.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CC-----ccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HP-----NLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....++.+|+++++.++ |+     +|+++++++...+..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            468999999999999999999865 67889999997542 33566788999988885 55     499999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc--CCCCeEEeeccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD--GNFGAHLADFGL  891 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~  891 (1020)
                      ++||||++ ++|.+++....  ...+++..+..++.|++.||+|||.+ +.+|+||||||+||+++  .++.+||+|||+
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            99999996 49999987642  24589999999999999999999953 23899999999999995  578899999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMC  950 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~  950 (1020)
                      ++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9876332     23457899999999999999999999999999999999999999754

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.9e-35  Score=357.59  Aligned_cols=268  Identities=19%  Similarity=0.203  Sum_probs=153.0

Q ss_pred             CCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEE
Q 035998          108 LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI  186 (1020)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L  186 (1020)
                      +++++.|++++|.++...+..|.++++|++|+|++|.|++.+|..+ .+++|++|+|++|.++ .+|...+..+++|++|
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCEE
Confidence            4455555555555553333334555555555555555555555444 4555555555555555 2333333455555555


Q ss_pred             EccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCc
Q 035998          187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       187 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                      +|++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|++++.   .+..+++|+.|++++|.++
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc
Confidence            5555555544444445555555555555555555555555555566666666655543   1344555666666666555


Q ss_pred             ccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCC
Q 035998          267 GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP  346 (1020)
Q Consensus       267 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~  346 (1020)
                      +.     ....+|+.|++++|.++...+...   ++|+.|+|++|.+++.  ..+..+++|++|+|++|.+++.+|..|.
T Consensus       206 ~l-----~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          206 TL-----AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             EE-----ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             cc-----cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhc
Confidence            32     223456666666666654433222   4566666666666642  4455666777777777777766666677


Q ss_pred             CCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhh
Q 035998          347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSS  390 (1020)
Q Consensus       347 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~  390 (1020)
                      .+++|+.|+|++|++++ +|..+..+++|++|+|++|.++.+|.
T Consensus       276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~  318 (597)
T 3oja_B          276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVER  318 (597)
T ss_dssp             TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGG
T ss_pred             CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCc
Confidence            77777777777777765 45555667777777777777665554

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=330.65  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=194.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEe-----------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM-----------  808 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  808 (1020)
                      .++|++.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999876 48899999998766666678899999999999999999999874           


Q ss_pred             ---ccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-CCCCe
Q 035998          809 ---HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGA  884 (1020)
Q Consensus       809 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  884 (1020)
                         +....++||||++ |+|.+++..     ..+++..++.++.|++.||+|||++   +|+||||||+||+++ .++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3356789999998 599988864     3588999999999999999999999   999999999999997 56799


Q ss_pred             EEeeccccccccCCCC-cccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHH
Q 035998          885 HLADFGLARLILSPYD-THVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWV  962 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  962 (1020)
                      ||+|||+++....... ........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......   ......
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~  237 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLI  237 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence            9999999987643211 112234567889999997754 78899999999999999999999999754321   111111


Q ss_pred             HHHHhh----------ccccc-----ccCcc-ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          963 IRMRQE----------NRESE-----VLDPF-IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       963 ~~~~~~----------~~~~~-----~~d~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                      ......          .....     ...+. ......+.....+.+++.+||+.||++|||++|+++  +++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            100000          00000     00000 000001112346889999999999999999999987  444

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=335.06  Aligned_cols=258  Identities=25%  Similarity=0.360  Sum_probs=199.5

Q ss_pred             HHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          738 LESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       738 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ....++|++.+.||+|+||.||+|+.+.  .||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3346789999999999999999998753  599999875431  223457789999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             ECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999998753   34688999999999999999999999   999999999999998 679999999998765


Q ss_pred             cCCC---CcccccccccccCccCccccCC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHH
Q 035998          896 LSPY---DTHVTTDLVGTLGYIPPEYGQA---------SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       896 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ....   .........|++.|+|||++.+         ..++.++||||||+++|||++|+.||......      ....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~  253 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIW  253 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence            3211   1122234568899999998764         45789999999999999999999999743211      1111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....... ......    ..    ...+.+++.+||+.||++|||++++++.|+++
T Consensus       254 ~~~~~~~-~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          254 QMGTGMK-PNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             HHHTTCC-CCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             HhccCCC-CCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111111 111100    11    12478999999999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-35  Score=322.12  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=202.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            467999999999999999999875 68999999986543  234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC---CCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN---FGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~  894 (1020)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.+   +.+||+|||+++.
T Consensus       101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999888764    3689999999999999999999999   99999999999999754   4699999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .....   ......+++.|+|||.+.+. ++.++||||+|+++|+|++|+.||.....   .+   ............  
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~---~~~~~~~~~~~~--  241 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE---YD---ILKRVETGKYAF--  241 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---HHHHHHHCCCCC--
T ss_pred             ecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHcCCCCC--
Confidence            64322   22334578999999988764 88999999999999999999999975321   11   111121111100  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                       +......    ....+.+++.+||+.||++|||++|+++  ++++
T Consensus       242 -~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          242 -DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             -CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             -Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence             0000011    1235889999999999999999999998  5554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-35  Score=332.02  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=198.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----NDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  813 (1020)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999875 68899999997543 33445788999999999999999999988754     678


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ++||||++ ++|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 5898888753     589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCcc--------cccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          894 LILSPYDTH--------VTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       894 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      .........        ......||+.|+|||++. +..++.++||||+||++|||++|+.||......   +.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHH
Confidence            764321111        122357899999999765 478999999999999999999999999753311   11111111


Q ss_pred             HHhhccccc----ccC-------------c-cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          965 MRQENRESE----VLD-------------P-FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       965 ~~~~~~~~~----~~d-------------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .........    ...             + .......+.....+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            110000000    000             0 0000001122346789999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=335.55  Aligned_cols=255  Identities=22%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-----
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-----  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  812 (1020)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999864 68899999997543  2334678899999999999999999999987654     


Q ss_pred             -eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          813 -RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       813 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                       .++||||++ ++|.+++..      .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 587776642      489999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      ++.....     .....+|+.|+|||++.+ ..++.++||||+|+++|||++|+.||......   +............ 
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~  244 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPG  244 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCC
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC
Confidence            9865321     234578999999998876 68899999999999999999999999754321   1111111110000 


Q ss_pred             -----------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 -----------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 -----------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                       .......+. .....+.....+.+++.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                             000000000 01111223346889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.6e-35  Score=323.39  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=192.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec----------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH----------  809 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  809 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            357899999999999999999864 7899999999654 3345678899999999999999999998865          


Q ss_pred             ---cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          810 ---KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       810 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                         ....++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence               34678999999999999999753   24578899999999999999999999   9999999999999999999999


Q ss_pred             eeccccccccCCCC------------cccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 035998          887 ADFGLARLILSPYD------------THVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPK  953 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~  953 (1020)
                      +|||+++.......            ........|++.|+|||++.+. .++.++||||+|+++|||++   ||..    
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----  230 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----  230 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS----
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC----
Confidence            99999987543211            1122345789999999998764 78999999999999999998   5431    


Q ss_pred             CcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          954 GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..+............   ....+    .........+.+++.+||+.||.+|||++++++
T Consensus       231 -~~~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 -GMERVNILKKLRSVS---IEFPP----DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHHHHHHHHHHHSTT---CCCCT----TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -chhHHHHHHhccccc---cccCc----cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             111111222221111   00111    112223345789999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.7e-35  Score=331.24  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=200.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CC-CEEEEEEecCCchhhHHHHHHHHHHHHHcCCCc------cceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DG-RNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN------LVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  812 (1020)
                      .++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999864 34 68999999754 334567888999999997665      8999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE--------------
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL--------------  878 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--------------  878 (1020)
                      .++||||+ ++++.+++...  ....+++.+++.++.||+.||+|||++   +|+||||||+||++              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 56676666653  224689999999999999999999999   99999999999999              


Q ss_pred             -----cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 035998          879 -----DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPK  953 (1020)
Q Consensus       879 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~  953 (1020)
                           +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999864322     23457899999999999999999999999999999999999999753321


Q ss_pred             CcccHHHHHHHHHhhccc---------ccccC--------------------c-cccCccCHHHHHHHHHHHhhccCCCC
Q 035998          954 GSRDLISWVIRMRQENRE---------SEVLD--------------------P-FIYDKQHDKEMLRVLDIACLCLSESP 1003 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~---------~~~~d--------------------~-~~~~~~~~~~~~~l~~li~~cl~~dP 1003 (1020)
                         ...............         .....                    + .........+...+.+++.+||+.||
T Consensus       246 ---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          246 ---EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             ---HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ---HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence               112111111110000         00000                    0 00011123445578999999999999


Q ss_pred             CCCCCHHHHHH
Q 035998         1004 KVRPTTQQLVS 1014 (1020)
Q Consensus      1004 ~~RPs~~evl~ 1014 (1020)
                      ++|||++|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.6e-35  Score=333.09  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=199.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-----------CCccceEeeEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-----------HPNLVHLQGYCM  808 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  808 (1020)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999986 468899999997653 33466888999999886           899999999998


Q ss_pred             ccC----ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-----
Q 035998          809 HKN----DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-----  879 (1020)
Q Consensus       809 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----  879 (1020)
                      ...    ..++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+++  +|+||||||+||+++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            654    678999999 889999988642  235899999999999999999999853  899999999999994     


Q ss_pred             -CCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcc--
Q 035998          880 -GNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSR--  956 (1020)
Q Consensus       880 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~--  956 (1020)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4457999999999875322     23457899999999999999999999999999999999999999754432211  


Q ss_pred             -cHHHHHHHHHhhccc-------------------ccccCcc---------ccCccCHHHHHHHHHHHhhccCCCCCCCC
Q 035998          957 -DLISWVIRMRQENRE-------------------SEVLDPF---------IYDKQHDKEMLRVLDIACLCLSESPKVRP 1007 (1020)
Q Consensus       957 -~~~~~~~~~~~~~~~-------------------~~~~d~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1007 (1020)
                       +..............                   .......         .....+......+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence             111111111000000                   0000000         00123456677899999999999999999


Q ss_pred             CHHHHHH
Q 035998         1008 TTQQLVS 1014 (1020)
Q Consensus      1008 s~~evl~ 1014 (1020)
                      |++|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-35  Score=328.55  Aligned_cols=257  Identities=23%  Similarity=0.369  Sum_probs=178.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHH-HHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVE-ALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467899999999999999999875 68899999997653 233345556665 666779999999999999999999999


Q ss_pred             EeccCCChhhhhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          818 SFMENGSLDYWLHEKL-DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      ||+++ +|.+++.... .....+++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 7777765321 12357899999999999999999999852  89999999999999999999999999998764


Q ss_pred             CCCCcccccccccccCccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYG----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ..   .......|++.|+|||++    .+..++.++||||||+++|||++|+.||.......  +.      ...   ..
T Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~------~~~---~~  243 (327)
T 3aln_A          178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQ------LTQ---VV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------CC---CC
T ss_pred             cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HH------HHH---Hh
Confidence            32   122334789999999998    56678999999999999999999999997532110  00      000   00


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....+.+...........+.+++.+||+.||++||+++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000011111111112346889999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5e-35  Score=339.17  Aligned_cols=254  Identities=23%  Similarity=0.285  Sum_probs=187.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +.|...+.||+|+||+||.+...+|+.||||++..+.   .+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455568899999999987766789999999987542   34678899999886 8999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC-------------CCe
Q 035998          821 ENGSLDYWLHEKLDGPSS---LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN-------------FGA  884 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~  884 (1020)
                      + |+|.+++.........   .++..++.++.||+.||+|||++   +|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999999865322211   13335678999999999999999   99999999999999754             489


Q ss_pred             EEeeccccccccCCCCc--ccccccccccCccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 035998          885 HLADFGLARLILSPYDT--HVTTDLVGTLGYIPPEYGQA-------SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKG  954 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~  954 (1020)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543211  12234579999999998865       678999999999999999999 999996432211


Q ss_pred             cccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          955 SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       955 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ..   .........     .............+.+++.+||+.||.+|||+.|+++
T Consensus       248 ----~~---i~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SN---IIRGIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HH---HHHTCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HH---HhcCCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                11   111111111     1111123445567899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=324.53  Aligned_cols=242  Identities=24%  Similarity=0.363  Sum_probs=190.4

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchh------hHHHHHHHHHHHHHc----CCCccceEeeEE
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ------MEREFRAEVEALSRA----QHPNLVHLQGYC  807 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~  807 (1020)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++......      ....+.+|+++++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999986 46889999999755321      123456799999998    899999999999


Q ss_pred             eccCceEEEEEe-ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-CCCCeE
Q 035998          808 MHKNDRLLIYSF-MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGAH  885 (1020)
Q Consensus       808 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  885 (1020)
                      .+.+..++|||| +.+++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+|
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            999999999999 7899999999874    4689999999999999999999999   999999999999999 889999


Q ss_pred             EeeccccccccCCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          886 LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       886 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      |+|||+++.....    ......|+..|+|||++.+..+ +.++||||+|+++|||++|+.||....     .      .
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------~  245 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------I  245 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------H
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------H
Confidence            9999999876432    2334568999999998876665 459999999999999999999996310     0      0


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .......            .......+.+++.+||+.||++||+++|+++
T Consensus       246 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAELHF------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTCCCC------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhccCC------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0110000            0111235789999999999999999999987

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2e-35  Score=327.11  Aligned_cols=257  Identities=31%  Similarity=0.519  Sum_probs=185.1

Q ss_pred             cccccccccccccc--ccccCCCCCCCcCEEEcCC-CccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCee
Q 035998          302 TLNLLNLRNNSLDG--SLLLNCPALTNLTSLDLGT-NKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYL  378 (1020)
Q Consensus       302 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  378 (1020)
                      +++.|+|++|.+++  .+|..+..+++|++|+|++ |++.+.+|..|..+++|++|+|++|++++.+|..|.++++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            44555555555554  4444555555555555553 55555555555555555555555555555555555555555555


Q ss_pred             eCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccc
Q 035998          379 SLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN  458 (1020)
Q Consensus       379 ~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N  458 (1020)
                      ++++|.                                                   +.+.+|..+..+++|++|+|++|
T Consensus       131 ~Ls~N~---------------------------------------------------l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A          131 DFSYNA---------------------------------------------------LSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             ECCSSE---------------------------------------------------EESCCCGGGGGCTTCCEEECCSS
T ss_pred             eCCCCc---------------------------------------------------cCCcCChHHhcCCCCCeEECcCC
Confidence            555554                                                   33455666666777777777777


Q ss_pred             cccccccccccCcC-cCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCee
Q 035998          459 QLSGTIPVWFGGFQ-DLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI  537 (1020)
Q Consensus       459 ~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l  537 (1020)
                      ++++.+|..+..++ +|++|+|++|++++.+|..+..++ |                                    +.|
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L------------------------------------~~L  202 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-L------------------------------------AFV  202 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-C------------------------------------SEE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-c------------------------------------cEE
Confidence            77767777777776 777777777777777776665543 3                                    356


Q ss_pred             ecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       538 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      +|++|++++..|..|+.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|+|.+|..+.++++|+.|++++|+++
T Consensus       203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  281 (313)
T 1ogq_A          203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC  281 (313)
T ss_dssp             ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred             ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence            6777777777777888888999999999999876665 888999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCcCCccccCCC-CCCCCCCCC
Q 035998          618 GRIPSGGQFQTFPNSSFDGNN-LCGEHRYSC  647 (1020)
Q Consensus       618 g~~p~~~~~~~~~~~~~~~n~-l~~~~~~~c  647 (1020)
                      |.+|..+.+.++....+.+|+ +||.+.++|
T Consensus       282 ~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C  312 (313)
T 1ogq_A          282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPAC  312 (313)
T ss_dssp             EECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred             ccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence            999998888889999999998 999877677

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-35  Score=328.01  Aligned_cols=242  Identities=25%  Similarity=0.376  Sum_probs=197.7

Q ss_pred             HhccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchh------hHHHHHHHHHHHHHcC--CCccceEeeEEec
Q 035998          739 ESTNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQ------MEREFRAEVEALSRAQ--HPNLVHLQGYCMH  809 (1020)
Q Consensus       739 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  809 (1020)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++......      ..+.+.+|++++++++  ||||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999985 46889999998754311      1234677999999996  5999999999999


Q ss_pred             cCceEEEEEeccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc-CCCCeEEe
Q 035998          810 KNDRLLIYSFMEN-GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD-GNFGAHLA  887 (1020)
Q Consensus       810 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~  887 (1020)
                      .+..++||||+.+ ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++ .++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999986 8999998864    4689999999999999999999999   999999999999999 78999999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++.....    ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....     .      ...
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~------~~~  257 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E------IIR  257 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------HHH
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h------hhc
Confidence            99999876432    2234578999999998876665 688999999999999999999996311     0      001


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....        ....    ....+.+++.+||+.||++||+++|+++
T Consensus       258 ~~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQVF--------FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CCCC--------CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1000        0011    1235789999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=319.62  Aligned_cols=251  Identities=22%  Similarity=0.361  Sum_probs=178.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-h-hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-Q-MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356889999999999999999875 789999999976532 2 2233445556678889999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      ||+ ++.+..+....   ...+++..++.++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++...
T Consensus       104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 45555554432   2468999999999999999999998 6   89999999999999999999999999997653


Q ss_pred             CCCCcccccccccccCccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQ-----ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ..   .......|++.|+|||++.     ...++.++||||+|+++|||++|+.||.....  .   ............ 
T Consensus       177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~---~~~~~~~~~~~~-  247 (318)
T 2dyl_A          177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--D---FEVLTKVLQEEP-  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHHHHHHHHSCC-
T ss_pred             CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--c---HHHHHHHhccCC-
Confidence            32   2223456899999999884     56788999999999999999999999974321  1   111111111111 


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....       .......+.+++.+||+.||.+||+++|+++
T Consensus       248 ~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11000       0011235889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=332.73  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=186.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ..+|++.++||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +|||||++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346888899999999997665556899999999975432   2356799999999 799999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-----CCCeEEeecccccc
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-----NFGAHLADFGLARL  894 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~~~~  894 (1020)
                      ++ |+|.+++....   ...+...++.++.||+.||+|||++   +|+||||||+||+++.     ...+||+|||+++.
T Consensus       100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            96 59999987642   2334445678999999999999999   9999999999999943     33588999999987


Q ss_pred             ccCCCCc-ccccccccccCccCccccC---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          895 ILSPYDT-HVTTDLVGTLGYIPPEYGQ---ASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       895 ~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      ....... .......||+.|+|||++.   ...++.++||||+||++|||++ |..||.....    ...   ..... .
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----~~~---~~~~~-~  244 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQA---NILLG-A  244 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----HHH---HHHTT-C
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----HHH---HHHhc-c
Confidence            6432211 2234467999999999987   4677889999999999999999 9999953221    111   11111 1


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .......      ........+.+++.+||+.||.+|||++|+++
T Consensus       245 ~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111111      11233445789999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.5e-35  Score=347.57  Aligned_cols=260  Identities=25%  Similarity=0.338  Sum_probs=197.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEec------cCce
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMH------KNDR  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  813 (1020)
                      ++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999864 68999999987653 3445678999999999999999999998765      6677


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCC---eEEeecc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFG---AHLADFG  890 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  890 (1020)
                      ++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999998643 233588899999999999999999999   9999999999999997765   8999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      .++.....   .......||+.|+|||++.+..++.++||||+|+++|||++|..||.....     ...|........ 
T Consensus       170 ~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred             cccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence            99876432   223446789999999999999999999999999999999999999964311     011100000000 


Q ss_pred             ---cccccc------Cc--cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 035998          970 ---RESEVL------DP--FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013 (1020)
Q Consensus       970 ---~~~~~~------d~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1013 (1020)
                         ......      ..  .............+.+++.+||++||++|||++|++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence               000000      00  001112334556789999999999999999998843

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=7e-35  Score=324.69  Aligned_cols=289  Identities=19%  Similarity=0.253  Sum_probs=212.1

Q ss_pred             ccCCCCHHHHHHHHHHHHHhccCCCCCCCCC-----CCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccc
Q 035998           27 QDLTCNPNDLAALEDFMKNFESGIDGWGTNA-----SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKL  101 (1020)
Q Consensus        27 ~~~~~~~~~~~aL~~~k~~~~~~~~~~~~~~-----~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~  101 (1020)
                      +...+.++|++||++||+++..+..+|...|     .+.++|.|.||.|+.... .+ ......+|+.|+|+++.++ .+
T Consensus        20 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~-~l-~~~~~~~l~~L~L~~n~l~-~l   96 (328)
T 4fcg_A           20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD-LL-EDATQPGRVALELRSVPLP-QF   96 (328)
T ss_dssp             C--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHH-HH-HHHTSTTCCEEEEESSCCS-SC
T ss_pred             eccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHH-HH-hcccccceeEEEccCCCch-hc
Confidence            3455778999999999999987776775545     267899999999953100 00 0011368899999999998 78


Q ss_pred             cccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccC
Q 035998          102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNS  180 (1020)
Q Consensus       102 ~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~  180 (1020)
                      |..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..+ ++++|++|+|++|++.+.+|..+... 
T Consensus        97 p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~-  173 (328)
T 4fcg_A           97 PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-  173 (328)
T ss_dssp             CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-
T ss_pred             ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-
Confidence            888999999999999999999 89999999999999999999998 556556 88999999999988888888766420 


Q ss_pred             CcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEc
Q 035998          181 SRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDV  260 (1020)
Q Consensus       181 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  260 (1020)
                                     ..+..|+++++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +|..+..+++|++|+|
T Consensus       174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL  236 (328)
T ss_dssp             ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred             ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence                           12233455666777777777766 566666677777777777777763 4556667777777777


Q ss_pred             cCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccC
Q 035998          261 SSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       261 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      ++|++.+.+|..|+++++|++|++++|.+.+.+|..+.++++|+.|+|++|.+.+.+|..+..+++|+.+++..|.+.
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            777777777777777777777777777777777777777777777777777777777777777777777777766554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.4e-33  Score=318.00  Aligned_cols=307  Identities=23%  Similarity=0.355  Sum_probs=174.9

Q ss_pred             ccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCccc
Q 035998          105 LGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIR  184 (1020)
Q Consensus       105 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~  184 (1020)
                      +..+++|++|++++|.++ .+| .+..+++|++|++++|++++..+ ...+++|++|+|++|.++ .+|  .+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKIT-DIS--ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG--GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCccc-Cch--HHcCCCcCC
Confidence            345667777777777776 344 36667777777777777765544 226667777777777665 233  134555566


Q ss_pred             EEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCc
Q 035998          185 VINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       185 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      +|++++|.+++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+  +..+++|++|++++|.
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            66666665553322  5555666666666664432222 25555555555555555553322  5555555666665555


Q ss_pred             CcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCC
Q 035998          265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN  344 (1020)
Q Consensus       265 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  344 (1020)
                      +++..+  +..+++|+.|++++|++++..+  +..                        +++|++|++++|++++..+  
T Consensus       189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~------------------------~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          189 IEDISP--LASLTSLHYFTAYVNQITDITP--VAN------------------------MTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGG------------------------CTTCCEEECCSSCCCCCGG--
T ss_pred             cccccc--ccCCCccceeecccCCCCCCch--hhc------------------------CCcCCEEEccCCccCCCcc--
Confidence            553322  4445555555555555443322  344                        4444444444444443222  


Q ss_pred             CCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCcccccc
Q 035998          345 LPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA  424 (1020)
Q Consensus       345 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~  424 (1020)
                      +..+++|++|++++|++++.  ..+..+++|++|++++|+++.++.                             ...++
T Consensus       239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~-----------------------------~~~l~  287 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV-----------------------------LNNLS  287 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-----------------------------GGGCT
T ss_pred             hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCChh-----------------------------hcCCC
Confidence            44445555555555555432  234555555555555555444321                             11233


Q ss_pred             CceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCccc
Q 035998          425 NLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       425 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      +|+.|++++|.+.+..|..+.++++|+.|++++|++++..|  +..+++|++|++++|.|+
T Consensus       288 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            44555555555666677788889999999999999997666  888999999999999886

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-33  Score=314.26  Aligned_cols=302  Identities=21%  Similarity=0.210  Sum_probs=177.4

Q ss_pred             CCCCCCCCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccc
Q 035998           50 IDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL  129 (1020)
Q Consensus        50 ~~~~~~~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l  129 (1020)
                      +..|...++..+.|+|+.+.|+......+|.... .+++.|++++|.+++..+.+++++++|++|+|++|.+++..|..|
T Consensus        20 p~~~~~~cp~~c~c~l~~l~~~~~~l~~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~   98 (332)
T 2ft3_A           20 PPTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEIS-PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF   98 (332)
T ss_dssp             -----CCCCSSCEEETTEEECCSSCCSSCCSCCC-TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGS
T ss_pred             CCcccCCCCCCCcccCCEEECCCCCccccCCCCC-CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHh
Confidence            3445555555566899999998877666666553 466667777777766666667777777777777777766566667


Q ss_pred             cCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCC--CCCCCcccccccc
Q 035998          130 VNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFS--GTLSPGLGNCASL  207 (1020)
Q Consensus       130 ~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~--~~~~~~l~~l~~L  207 (1020)
                      +++++|++|+|++|+++..++...  ++|++|++++|+++ .+|...+..+++|+.|++++|.++  +..+..+..+ +|
T Consensus        99 ~~l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L  174 (332)
T 2ft3_A           99 SPLRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KL  174 (332)
T ss_dssp             TTCTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CC
T ss_pred             hCcCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-cc
Confidence            777777777777776664333332  56666666666665 445544455566666666666654  2444455554 55


Q ss_pred             ccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccc
Q 035998          208 EHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN  287 (1020)
Q Consensus       208 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  287 (1020)
                      ++|++++|++++ +|..+.  +                        +|++|++++|.+++..+..|..+++|+.|++++|
T Consensus       175 ~~L~l~~n~l~~-l~~~~~--~------------------------~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N  227 (332)
T 2ft3_A          175 NYLRISEAKLTG-IPKDLP--E------------------------TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN  227 (332)
T ss_dssp             SCCBCCSSBCSS-CCSSSC--S------------------------SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSS
T ss_pred             CEEECcCCCCCc-cCcccc--C------------------------CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence            555555555553 333222  3                        4445555555555444444555555555555555


Q ss_pred             cccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCC------CCCCCeEecCCCcc
Q 035998          288 RFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR------CRKLKNINLARNNF  361 (1020)
Q Consensus       288 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~L~~N~l  361 (1020)
                      ++++..+..+..+++|+.|++++|+++ .+|..+..+++|++|++++|+|++..+..|..      ..+|+.|++++|++
T Consensus       228 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~  306 (332)
T 2ft3_A          228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV  306 (332)
T ss_dssp             CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred             cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence            555544445555555555555555555 34444555666666666666666555555443      35677788888877


Q ss_pred             c--ccCcccccCCCCCCeeeCCCCC
Q 035998          362 S--GQIPETYKNFESLSYLSLSNSS  384 (1020)
Q Consensus       362 ~--~~~p~~~~~l~~L~~L~l~~N~  384 (1020)
                      .  +..|..|..+++|+.+++++|+
T Consensus       307 ~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          307 PYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccCcccccccchhhhhhccccc
Confidence            6  5667777788888888887774

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.8e-33  Score=315.54  Aligned_cols=307  Identities=22%  Similarity=0.336  Sum_probs=212.0

Q ss_pred             hhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccc
Q 035998          225 IFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLN  304 (1020)
Q Consensus       225 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  304 (1020)
                      +..+++|++|++++|.++. ++ .+..+++|++|++++|++++..+  +..+++|++|++++|++++.  +.+.++++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence            4556666777777766663 33 36666777777777777764433  66677777777777766643  2466677777


Q ss_pred             cccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCC
Q 035998          305 LLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS  384 (1020)
Q Consensus       305 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  384 (1020)
                      +|++++|.+++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|++|++++|.
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            77777777765443  6667777777777775543333 36677777777777777765433  6677777777777777


Q ss_pred             CcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccc
Q 035998          385 IYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTI  464 (1020)
Q Consensus       385 i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  464 (1020)
                      +..++.    +.                         .+++|+.+++.+|.+.+..+  +..+++|+.|++++|++++..
T Consensus       189 l~~~~~----~~-------------------------~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~  237 (347)
T 4fmz_A          189 IEDISP----LA-------------------------SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS  237 (347)
T ss_dssp             CCCCGG----GG-------------------------GCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred             cccccc----cc-------------------------CCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc
Confidence            665543    22                         33445555555665655444  677778888888888887544


Q ss_pred             cccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCcc
Q 035998          465 PVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRL  544 (1020)
Q Consensus       465 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l  544 (1020)
                      +  +..+++|++|+|++|.+++.  +.+..+++|                                    +.|++++|++
T Consensus       238 ~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L------------------------------------~~L~l~~n~l  277 (347)
T 4fmz_A          238 P--LANLSQLTWLEIGTNQISDI--NAVKDLTKL------------------------------------KMLNVGSNQI  277 (347)
T ss_dssp             G--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC------------------------------------CEEECCSSCC
T ss_pred             c--hhcCCCCCEEECCCCccCCC--hhHhcCCCc------------------------------------CEEEccCCcc
Confidence            4  77788888888888887742  235555544                                    3566777777


Q ss_pred             ccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          545 DGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       545 ~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      ++.  +.+..+++|+.|+|++|++++..|..++.+++|++|+|++|++++..|  +..+++|+.|++++|+++
T Consensus       278 ~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          278 SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            664  468888999999999999998888889999999999999999997665  888999999999999886

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=5.7e-33  Score=310.58  Aligned_cols=302  Identities=19%  Similarity=0.225  Sum_probs=208.0

Q ss_pred             CCCCCCCCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccc
Q 035998           50 IDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSL  129 (1020)
Q Consensus        50 ~~~~~~~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l  129 (1020)
                      ...|...++..+.|+|+.+.|+....+.+|...+                         ++|++|+|++|++++..+..|
T Consensus        18 i~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~-------------------------~~l~~L~L~~n~i~~~~~~~~   72 (330)
T 1xku_A           18 IEPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLP-------------------------PDTALLDLQNNKITEIKDGDF   72 (330)
T ss_dssp             ----CCCCCTTCEEETTEEECTTSCCCSCCCSCC-------------------------TTCCEEECCSSCCCCBCTTTT
T ss_pred             cccccCCCCCCCcCCCeEEEecCCCccccCccCC-------------------------CCCeEEECCCCcCCEeChhhh
Confidence            3456666676777999999998765444443322                         355666666666665444456


Q ss_pred             cCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccc
Q 035998          130 VNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLE  208 (1020)
Q Consensus       130 ~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~  208 (1020)
                      +++++|++|+|++|++++..|..+ ++++|++|+|++|+++ .+|..++   ++|+.|++++|.+++..+..|.++++|+
T Consensus        73 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~  148 (330)
T 1xku_A           73 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMI  148 (330)
T ss_dssp             TTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCC
T ss_pred             ccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCcccc
Confidence            666666666666666666555555 5666666666666665 5555543   4666777777777666556667777777


Q ss_pred             ccccccccccc--ccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccc
Q 035998          209 HLCLGMNDLTG--GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS  286 (1020)
Q Consensus       209 ~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  286 (1020)
                      +|++++|.++.  ..+..+.++++|++|++++|+++. +|..+.  ++|++|++++|++++..|..|..+++|+.|++++
T Consensus       149 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  225 (330)
T 1xku_A          149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF  225 (330)
T ss_dssp             EEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS
T ss_pred             EEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            77777777753  566677777778888888887773 444443  6788888888888877778888888888888888


Q ss_pred             ccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCC------CCCCCeEecCCCc
Q 035998          287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR------CRKLKNINLARNN  360 (1020)
Q Consensus       287 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~L~~N~  360 (1020)
                      |++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..      ...|+.|++++|+
T Consensus       226 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~  304 (330)
T 1xku_A          226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP  304 (330)
T ss_dssp             SCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred             CcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCc
Confidence            8888777777888888888888888887 55666777888888888888888766666643      3677888888888


Q ss_pred             ccc--cCcccccCCCCCCeeeCCCCC
Q 035998          361 FSG--QIPETYKNFESLSYLSLSNSS  384 (1020)
Q Consensus       361 l~~--~~p~~~~~l~~L~~L~l~~N~  384 (1020)
                      +..  ..|..|..+.+++.++|++|+
T Consensus       305 ~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          305 VQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ccccccCccccccccceeEEEecccC
Confidence            753  556778888888888888774

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.8e-34  Score=309.46  Aligned_cols=229  Identities=14%  Similarity=0.140  Sum_probs=181.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.....   ...+.+.+|++.+++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999875 589999999976532   23467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++++|.+++...      ....++..++.|++.||+|||++   +|+||||||+||+++.++.+||++++       
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999998542      35567889999999999999999   99999999999999999999997443       


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                                     |++       .++.++|||||||++|||+||+.||.............       .........+
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~  225 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEP  225 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-------BCTTSCBCCH
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-------HHhccCCCCh
Confidence                           333       36889999999999999999999998654322110000       0000000000


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .   .........+.+++.+||+.||++| |++|+++.|+++
T Consensus       226 ~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          226 A---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             H---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             h---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            0   0011122458899999999999999 999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.1e-34  Score=348.56  Aligned_cols=237  Identities=23%  Similarity=0.307  Sum_probs=191.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC--CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc-----e
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP--DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND-----R  813 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  813 (1020)
                      ++|++.+.||+|+||.||+|.+.  +++.||||++.... ......+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999875  58899999986543 3445678899999999999999999999987766     6


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      |+||||+++++|.+++..      .+++.+++.++.||+.||+|||++   +||||||||+||+++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            999999999999877643      589999999999999999999999   99999999999999986 89999999998


Q ss_pred             cccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          894 LILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       894 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      .....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.........                 
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-----------------  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-----------------  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence            76332      3457999999999887654 89999999999999999999988642211110                 


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHHh
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-TQQLVSWLDS 1018 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~ 1018 (1020)
                        .    ..........+.+++.+||+.||++||+ ++++.+.|.+
T Consensus       286 --~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 --E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             --T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence              0    0000112245889999999999999995 5556666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.6e-33  Score=305.97  Aligned_cols=228  Identities=21%  Similarity=0.288  Sum_probs=177.1

Q ss_pred             cCCCcC-CeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHH-HHcCCCccceEeeEEec----cCceE
Q 035998          742 NNFDQA-NIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEAL-SRAQHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       742 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  814 (1020)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|++...     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            457776 7899999999999986 46899999999753     3567788887 55699999999999876    66789


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  891 (1020)
                      +||||+++|+|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            999999999999999874  234689999999999999999999999   9999999999999998   78899999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      ++...                        +..++.++||||+||++|||++|+.||.........           ....
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHH
Confidence            86542                        234677999999999999999999999643321100           0000


Q ss_pred             ccccCccccCc--cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDK--QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...........  ........+.+++.+||+.||++|||++|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000000000  00112346889999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-33  Score=316.87  Aligned_cols=241  Identities=16%  Similarity=0.142  Sum_probs=183.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--------hhhHHHHHHHHHHHHHcC---------CCccceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--------GQMEREFRAEVEALSRAQ---------HPNLVHL  803 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  803 (1020)
                      .++|++.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|++++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45689999999999999999998 68999999997542        122367889999999886         6666666


Q ss_pred             eeEE-----------------ec-------------cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHH
Q 035998          804 QGYC-----------------MH-------------KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR  853 (1020)
Q Consensus       804 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  853 (1020)
                      .+++                 .+             .+..++||||+++|++.+.+.+     ..+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            6554                 32             6788999999999976655543     35799999999999999


Q ss_pred             HHHHhH-hcCCCCeEecCCCCCCEEEcCCC--------------------CeEEeeccccccccCCCCcccccccccccC
Q 035998          854 GLAYLH-QSCEPHILHRDIKSSNILLDGNF--------------------GAHLADFGLARLILSPYDTHVTTDLVGTLG  912 (1020)
Q Consensus       854 ~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  912 (1020)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+....       ....||+.
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV  242 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence            999999 89   999999999999999887                    899999999987643       13479999


Q ss_pred             ccCccccCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCCCcccHHHHHH-HHHhhcccccccCccccCccCHHHHHH
Q 035998          913 YIPPEYGQASVATYKGDVYSFGVV-LLELLTGKRPMDMCKPKGSRDLISWVI-RMRQENRESEVLDPFIYDKQHDKEMLR  990 (1020)
Q Consensus       913 y~aPE~~~~~~~~~~~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~  990 (1020)
                      |+|||++.+.. +.++||||+|++ .+++++|..||..      ........ .........    .............+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence            99999998776 899999998776 7888889999842      00101111 111111111    11111123345667


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHH
Q 035998          991 VLDIACLCLSESPKVRPTTQQLV 1013 (1020)
Q Consensus       991 l~~li~~cl~~dP~~RPs~~evl 1013 (1020)
                      +.+++.+||+.|     |++|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     999998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-33  Score=324.63  Aligned_cols=243  Identities=17%  Similarity=0.184  Sum_probs=180.5

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch---hhHHHHHHHHHHHHHcCC-CccceE------------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQH-PNLVHL------------  803 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l------------  803 (1020)
                      ..+|...++||+|+||.||+|++ .+|+.||||++.....   ...+.+.+|+.+++.++| +|...+            
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577789999999999999995 4799999999884332   224678899999999977 322111            


Q ss_pred             ---------eeEEec-----cCceEEEEEeccCCChhhhhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 035998          804 ---------QGYCMH-----KNDRLLIYSFMENGSLDYWLHEK---LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHI  866 (1020)
Q Consensus       804 ---------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  866 (1020)
                               ..++..     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                     111111     12346677755 67998888522   22334678889999999999999999999   99


Q ss_pred             EecCCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCcccc----------CCCCCCchhhHHHHHHH
Q 035998          867 LHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG----------QASVATYKGDVYSFGVV  936 (1020)
Q Consensus       867 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGvi  936 (1020)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865321     344567 999999988          66678999999999999


Q ss_pred             HHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          937 LLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       937 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      +|||++|+.||...........               .+...  ...    ...+.+++.+||+.||++||++.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEW---------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGG---------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhhHHH---------------HHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999975432221111               00000  011    246889999999999999999888865

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.9e-32  Score=301.93  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=125.1

Q ss_pred             cccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEcc
Q 035998          182 RIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVS  261 (1020)
Q Consensus       182 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  261 (1020)
                      +|+.|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..+.  ++|++|+++
T Consensus        55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~  131 (332)
T 2ft3_A           55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH  131 (332)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred             CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence            3444444444444333444444444444444444444444444444444444444444444 2232222  444455555


Q ss_pred             CCcCcccCcccccCCcccceeeccccccc--ccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCC
Q 035998          262 SNNFSGNIPDVFAGLGEFQYLVAHSNRFT--GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG  339 (1020)
Q Consensus       262 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  339 (1020)
                      +|++++..+..|.++++|+.|++++|+++  +..|..+..+ +|+.|++++|++++. |..+.  ++|++|++++|++++
T Consensus       132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~  207 (332)
T 2ft3_A          132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI-PKDLP--ETLNELHLDHNKIQA  207 (332)
T ss_dssp             SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC-CSSSC--SSCSCCBCCSSCCCC
T ss_pred             CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc-Ccccc--CCCCEEECCCCcCCc
Confidence            55444444444444444555555554443  2344444444 455555555554432 22221  345555555555554


Q ss_pred             CCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCc
Q 035998          340 PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDP  419 (1020)
Q Consensus       340 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~  419 (1020)
                      ..+..+..+++|+.|+|++|++++..+..+..+++|++|++++|+++.+|..   +.                       
T Consensus       208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~---l~-----------------------  261 (332)
T 2ft3_A          208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAG---LP-----------------------  261 (332)
T ss_dssp             CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTT---GG-----------------------
T ss_pred             cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChh---hh-----------------------
Confidence            4444455555555555555555544444455555555555555544433321   11                       


Q ss_pred             cccccCceEEEecccccccccchhhhc------CCCCcEEeccccccc--ccccccccCcCcCcEEeCCCCc
Q 035998          420 RLHFANLKVLVIASCGLRGSIPQWLRG------CSKLQLVDLSWNQLS--GTIPVWFGGFQDLFYLDLSNNT  483 (1020)
Q Consensus       420 ~~~~~~L~~L~l~~n~l~~~~p~~l~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~  483 (1020)
                        .+++|+.|++++|.+++..+..|..      ..+|+.|++++|.+.  +..|.+|..+++|+.|+|++|+
T Consensus       262 --~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          262 --DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             --GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             --cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence              1122223333333333333333322      356777788888776  5667777778888888887774

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=4.1e-36  Score=352.93  Aligned_cols=231  Identities=21%  Similarity=0.217  Sum_probs=119.7

Q ss_pred             CcceeeeccCccCCCCCccccccCCcccEEEccCCCCCC----CCCCccccccccccccccccccccccchhhhh-hc--
Q 035998          157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG----TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-LQ--  229 (1020)
Q Consensus       157 ~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-l~--  229 (1020)
                      +|++|+|++|+++......++..+++|++|+|++|.++.    .++..+..+++|++|+|++|.+++..+..+.. ++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            445555555554422222333444555555555555543    23444555666666666666666444444432 33  


Q ss_pred             --ccccccccccccCC----CCCcccccCCCccEEEccCCcCcccCcccccC-----CcccceeecccccccccC----C
Q 035998          230 --KLRLLGLQDNQLSG----KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAG-----LGEFQYLVAHSNRFTGRI----P  294 (1020)
Q Consensus       230 --~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----p  294 (1020)
                        +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+..     .++|++|++++|++++..    +
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  163 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  163 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence              46666666666663    33556666667777777777666443333322     345666666666665432    3


Q ss_pred             CCCcCCcccccccccccccccccccCCC-----CCCCcCEEEcCCCccCCC----CCCCCCCCCCCCeEecCCCcccccC
Q 035998          295 HSLSNSPTLNLLNLRNNSLDGSLLLNCP-----ALTNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLARNNFSGQI  365 (1020)
Q Consensus       295 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~  365 (1020)
                      ..+..+++|+.|++++|.+++..+..+.     ..++|++|+|++|++++.    ++..+..+++|++|++++|++++..
T Consensus       164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  243 (461)
T 1z7x_W          164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  243 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence            3344455666666666665543332221     134566666666665542    2444445555666666665554322


Q ss_pred             -----cccccCCCCCCeeeCCCCCCcc
Q 035998          366 -----PETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       366 -----p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                           +..+..+++|++|++++|.++.
T Consensus       244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~  270 (461)
T 1z7x_W          244 MAELCPGLLHPSSRLRTLWIWECGITA  270 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HHHHHHHHhcCCCCceEEECcCCCCCH
Confidence                 1122235555555555555543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=2.6e-31  Score=297.11  Aligned_cols=267  Identities=22%  Similarity=0.257  Sum_probs=200.6

Q ss_pred             CCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEE
Q 035998          108 LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI  186 (1020)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L  186 (1020)
                      ..+++.++++++.++ .+|..+.  ++|++|+|++|++++.++..+ ++++|++|+|++|++++..|..+ ..+++|++|
T Consensus        30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L  105 (330)
T 1xku_A           30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-APLVKLERL  105 (330)
T ss_dssp             EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-TTCTTCCEE
T ss_pred             cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHh-cCCCCCCEE
Confidence            346889999999998 6787664  689999999999998888777 79999999999999985445544 678888888


Q ss_pred             EccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCC--CCCcccccCCCccEEEccCCc
Q 035998          187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG--KLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       187 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      +|++|+++ .+|..+.  ++|++|++++|++++..+..+.++++|++|++++|+++.  ..+..+.++++|++|++++|.
T Consensus       106 ~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          106 YLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             ECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             ECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            88888888 4565554  688888888888887777778888888888888888853  566778888888888888888


Q ss_pred             CcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCC
Q 035998          265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN  344 (1020)
Q Consensus       265 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  344 (1020)
                      ++. +|..+.  ++|++|++++|++++..|..|..+++|+.|++++|.+++..+..+..+++|++|+|++|+++ .+|..
T Consensus       183 l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~  258 (330)
T 1xku_A          183 ITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG  258 (330)
T ss_dssp             CCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred             ccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence            874 344332  67777777777777777777777777777777777777766666777777777777777777 66667


Q ss_pred             CCCCCCCCeEecCCCcccccCcccccCC------CCCCeeeCCCCCC
Q 035998          345 LPRCRKLKNINLARNNFSGQIPETYKNF------ESLSYLSLSNSSI  385 (1020)
Q Consensus       345 l~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~l~~N~i  385 (1020)
                      +..+++|++|++++|++++..+..|...      .+|+.|++++|++
T Consensus       259 l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~  305 (330)
T 1xku_A          259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  305 (330)
T ss_dssp             TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             hccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcc
Confidence            7777777777777777776655555432      4556666666654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=8.7e-35  Score=341.56  Aligned_cols=370  Identities=22%  Similarity=0.148  Sum_probs=199.3

Q ss_pred             ceEEEecCCCccccccccc-ccCCCCCcEEecCCCCCCC----CCCccccCCCCCCeeeccCCCCCCCCCCcc--CCC--
Q 035998           86 RVTGLFLYKRRLKGKLSES-LGNLVQLRFLNLSHNLLKG----TVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--NLP--  156 (1020)
Q Consensus        86 ~v~~l~l~~~~l~~~~~~~-l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~--~l~--  156 (1020)
                      +++.|+|+++.++...... +..+++|++|+|++|.+++    .++..+..+++|++|+|++|.++...+..+  .++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            5666666666665543332 5566666666666666663    245556666666666666666654333222  233  


Q ss_pred             --CcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhh-----hc
Q 035998          157 --SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-----LQ  229 (1020)
Q Consensus       157 --~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~  229 (1020)
                        +|++|+|++|+++..--                     ..++..+..+++|++|+|++|.+++..+..+..     .+
T Consensus        84 ~~~L~~L~L~~n~i~~~~~---------------------~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  142 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGC---------------------GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  142 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGH---------------------HHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCceeEEEccCCCCCHHHH---------------------HHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCC
Confidence              45555555555542100                     123444555555555555555555433333332     23


Q ss_pred             ccccccccccccCCCC----CcccccCCCccEEEccCCcCcccCcccccC-----Ccccceeeccccccccc----CCCC
Q 035998          230 KLRLLGLQDNQLSGKL----SPSIADLSNLVRLDVSSNNFSGNIPDVFAG-----LGEFQYLVAHSNRFTGR----IPHS  296 (1020)
Q Consensus       230 ~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~~  296 (1020)
                      +|++|+|++|++++..    +..+..+++|++|++++|.+++..+..+..     .++|++|++++|++++.    ++..
T Consensus       143 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~  222 (461)
T 1z7x_W          143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI  222 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH
T ss_pred             cceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH
Confidence            4555555555555422    334444556666666666655433333321     34566666666655542    3444


Q ss_pred             CcCCccccccccccccccccc-----ccCCCCCCCcCEEEcCCCccCCC----CCCCCCCCCCCCeEecCCCcccccCcc
Q 035998          297 LSNSPTLNLLNLRNNSLDGSL-----LLNCPALTNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLARNNFSGQIPE  367 (1020)
Q Consensus       297 ~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~  367 (1020)
                      +..+++|+.|++++|.+++..     +..+..+++|++|+|++|++++.    ++..+..+++|++|++++|++++..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            555566666666666655432     22223456666666666666642    444555566666777776666554433


Q ss_pred             cccC-----CCCCCeeeCCCCCCcchhh--HHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccccc
Q 035998          368 TYKN-----FESLSYLSLSNSSIYNLSS--ALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI  440 (1020)
Q Consensus       368 ~~~~-----l~~L~~L~l~~N~i~~l~~--~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  440 (1020)
                      .+..     .++|++|++++|.++....  ....+..                         +++|+.|++++|.+.+..
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~-------------------------~~~L~~L~Ls~n~i~~~~  357 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ-------------------------NRFLLELQISNNRLEDAG  357 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHH-------------------------CSSCCEEECCSSBCHHHH
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhh-------------------------CCCccEEEccCCcccccc
Confidence            3332     2566777777766654321  1111222                         234445555555555444


Q ss_pred             chhhhc-----CCCCcEEecccccccc----cccccccCcCcCcEEeCCCCccccc--------CCCCCCCCcccccc
Q 035998          441 PQWLRG-----CSKLQLVDLSWNQLSG----TIPVWFGGFQDLFYLDLSNNTFTGE--------IPKNLTGLPSLITR  501 (1020)
Q Consensus       441 p~~l~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~--------~p~~~~~l~~L~~l  501 (1020)
                      +..+..     .++|+.|+|++|++++    .+|..+..+++|++|+|++|++++.        +|.....++.|..+
T Consensus       358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~  435 (461)
T 1z7x_W          358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY  435 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeec
Confidence            443432     5677788888887775    6677777777788888888877643        44444455554433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2.1e-31  Score=294.50  Aligned_cols=289  Identities=21%  Similarity=0.206  Sum_probs=173.7

Q ss_pred             CCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCC--CCCccccCCCCC
Q 035998           58 SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKG--TVPVSLVNLPNL  135 (1020)
Q Consensus        58 ~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L  135 (1020)
                      +..+.|.|.+|.|+..+.+.+|...+ ..++.|+|++|.++...+..++++++|++|+|++|.++.  .+|..+..+++|
T Consensus         2 P~~C~C~~~~l~c~~~~l~~ip~~~~-~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L   80 (306)
T 2z66_A            2 PSRCSCSGTEIRCNSKGLTSVPTGIP-SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSL   80 (306)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSCCC-TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCC
T ss_pred             cCCCeeCCCEEEcCCCCcccCCCCCC-CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCccccccccccc
Confidence            44566999999999877766666543 355556665555553333335555555555555555552  224444555555


Q ss_pred             CeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCC-Cccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLS-PGLGNCASLEHLCLGM  214 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~  214 (1020)
                      ++|+|++|.++..++....+++|++|+|++|+++                         +..+ ..+.++++|++|++++
T Consensus        81 ~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~~l~~L~~L~l~~  135 (306)
T 2z66_A           81 KYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-------------------------QMSEFSVFLSLRNLIYLDISH  135 (306)
T ss_dssp             CEEECCSCSEEEEEEEEETCTTCCEEECTTSEEE-------------------------SSTTTTTTTTCTTCCEEECTT
T ss_pred             CEEECCCCccccChhhcCCCCCCCEEECCCCccc-------------------------ccccchhhhhccCCCEEECCC
Confidence            5555555555532222224555555555555554                         3332 3445555555555555


Q ss_pred             cccccccchhhhhhcccccccccccccCC-CCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC
Q 035998          215 NDLTGGIADDIFQLQKLRLLGLQDNQLSG-KLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI  293 (1020)
Q Consensus       215 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  293 (1020)
                      |.+++..+..+..+++|++|++++|++++ ..|..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..
T Consensus       136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  215 (306)
T 2z66_A          136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD  215 (306)
T ss_dssp             SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred             CcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccC
Confidence            55555555555555555566666665554 35556666666666666666666666666666666666666666666666


Q ss_pred             CCCCcCCcccccccccccccccccccCCCCCC-CcCEEEcCCCccCCCCCC--CCCCCCCCCeEecCCCcccccCccccc
Q 035998          294 PHSLSNSPTLNLLNLRNNSLDGSLLLNCPALT-NLTSLDLGTNKFNGPLPT--NLPRCRKLKNINLARNNFSGQIPETYK  370 (1020)
Q Consensus       294 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~  370 (1020)
                      +..+..+++|+.|++++|++++..+..+..++ +|++|+|++|.+++..+.  ....+.+++.+.+..+.+....|..+.
T Consensus       216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~  295 (306)
T 2z66_A          216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ  295 (306)
T ss_dssp             SGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred             hhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence            65666677777777777777777776676663 788888888877753221  112234555666777788877787766


Q ss_pred             CC
Q 035998          371 NF  372 (1020)
Q Consensus       371 ~l  372 (1020)
                      +.
T Consensus       296 g~  297 (306)
T 2z66_A          296 GM  297 (306)
T ss_dssp             TC
T ss_pred             Cc
Confidence            54

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=7.9e-31  Score=296.03  Aligned_cols=286  Identities=20%  Similarity=0.209  Sum_probs=168.1

Q ss_pred             CCCCCCcCceE-EcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCC
Q 035998           58 SSSDCCHWVGI-TCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLE  136 (1020)
Q Consensus        58 ~~~~~C~w~gv-~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  136 (1020)
                      ...++|.|.|+ .|+....+.+|.... .+++.|++++|.+++..+..++++++|++|+|++|++++..|..|+++++|+
T Consensus        25 ~~~~~C~~~~~c~~~~~~l~~iP~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           25 QASLSCDRNGICKGSSGSLNSIPSGLT-EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             --CCEECTTSEEECCSTTCSSCCTTCC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ccCCCCCCCeEeeCCCCCccccccccc-ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            34578999997 333444555555443 3566666666666655455566666666666666666655555566666666


Q ss_pred             eeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCc-cccccCCcccEEEccCC-CCCCCCCCcccccccccccccc
Q 035998          137 VLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPT-SICKNSSRIRVINLSVN-YFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~-~~~~~~~~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      +|+|++|++++.++..+ ++++|++|+|++|+++ .+|. ..+..+++|++|++++| .+.+..+..|+++++|++|+++
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  182 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID  182 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence            66666666665544434 5666666666666665 4444 44455555555555555 3444444455555555555555


Q ss_pred             ccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC
Q 035998          214 MNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI  293 (1020)
Q Consensus       214 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  293 (1020)
                      +|++++..|..+..+++|++|++++|+++...+..+..+++|++|++++|.+++..+..+..                  
T Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------------  244 (353)
T 2z80_A          183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------------  244 (353)
T ss_dssp             ETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----------------------
T ss_pred             CCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc------------------
Confidence            55555555555555555555555555554222222333455555555555555433322211                  


Q ss_pred             CCCCcCCccccccccccccccc----ccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc
Q 035998          294 PHSLSNSPTLNLLNLRNNSLDG----SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP  366 (1020)
Q Consensus       294 p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  366 (1020)
                         ....+.++.++|++|.+++    .+|..+..+++|++|+|++|+++...+..|..+++|++|+|++|++++..|
T Consensus       245 ---~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          245 ---GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ---ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence               1123445556666665554    345667788999999999999994444446899999999999999997655

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.8e-33  Score=338.57  Aligned_cols=430  Identities=13%  Similarity=0.084  Sum_probs=211.7

Q ss_pred             cccccccCCCCCcEEecCCCCC---CCCCCcccc------------CCCCCCeeeccCCCCCCCCCCcc-C-CCC-ccee
Q 035998          100 KLSESLGNLVQLRFLNLSHNLL---KGTVPVSLV------------NLPNLEVLDLSSNDLSGPLPQTI-N-LPS-IQVL  161 (1020)
Q Consensus       100 ~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~p~~~-~-l~~-L~~L  161 (1020)
                      ..+..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..+ . +++ |++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            3445567788899999987532   134554443            56677777777776665444433 2 233 6666


Q ss_pred             eeccCc-cCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccc
Q 035998          162 DISSNS-LNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQ  240 (1020)
Q Consensus       162 ~Ls~N~-l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  240 (1020)
                      +|++|. ++......+...+++|++|+|++|.+++....+                    ++..+..+++|++|++++|.
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~--------------------l~~~~~~~~~L~~L~L~~n~  203 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKW--------------------LHELAQHNTSLEVLNFYMTE  203 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHH--------------------HHHHHHHCCCCCEEECTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhH--------------------HHHHHhcCCCccEEEeeccC
Confidence            666664 110000111223445555555555444331110                    22233344455555555555


Q ss_pred             cCCC----CCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccc---ccCCCCCcCCccccccccccccc
Q 035998          241 LSGK----LSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT---GRIPHSLSNSPTLNLLNLRNNSL  313 (1020)
Q Consensus       241 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l  313 (1020)
                      +++.    ++..+.++++|++|++++|.+.+ +|..+..+++|+.|+++.+...   +..+..+..+++|+.|+++++..
T Consensus       204 ~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~  282 (592)
T 3ogk_B          204 FAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP  282 (592)
T ss_dssp             CSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT
T ss_pred             CCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch
Confidence            4421    12223344555555555555543 3444555555555555432211   22334455566666666665432


Q ss_pred             ccccccCCCCCCCcCEEEcCCCccCCCCC-CCCCCCCCCCeEecCCCccc-ccCcccccCCCCCCeeeCCC---------
Q 035998          314 DGSLLLNCPALTNLTSLDLGTNKFNGPLP-TNLPRCRKLKNINLARNNFS-GQIPETYKNFESLSYLSLSN---------  382 (1020)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~---------  382 (1020)
                       ..++..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+. +.++..+..+++|++|++++         
T Consensus       283 -~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~  360 (592)
T 3ogk_B          283 -NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMED  360 (592)
T ss_dssp             -TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSS
T ss_pred             -hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccccccc
Confidence             2344455556677777777776553322 224566777777777 3333 23333445667777777772         


Q ss_pred             --CCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhc-CCCCcEEecc---
Q 035998          383 --SSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRG-CSKLQLVDLS---  456 (1020)
Q Consensus       383 --N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~-l~~L~~L~Ls---  456 (1020)
                        |.++.... .....                         .+++|+.|++..|++++..+..+.. +++|+.|+++   
T Consensus       361 ~~~~~~~~~~-~~l~~-------------------------~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~  414 (592)
T 3ogk_B          361 EEGLVSQRGL-IALAQ-------------------------GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD  414 (592)
T ss_dssp             TTCCCCHHHH-HHHHH-------------------------HCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECS
T ss_pred             ccCccCHHHH-HHHHh-------------------------hCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecC
Confidence              44432210 00111                         1234444455445555554445544 6666666664   


Q ss_pred             -ccccccc-----ccccccCcCcCcEEeCCCCc--ccccCCCCCCC-CcccccccCcCCCCCCCcccceeeccccccccc
Q 035998          457 -WNQLSGT-----IPVWFGGFQDLFYLDLSNNT--FTGEIPKNLTG-LPSLITRNISLEEPSPDFPFFMRRNVSARGLQY  527 (1020)
Q Consensus       457 -~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~-l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~  527 (1020)
                       .|++++.     ++..+.++++|++|+|++|.  +++..+..+.. +++|                             
T Consensus       415 ~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L-----------------------------  465 (592)
T 3ogk_B          415 REERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNV-----------------------------  465 (592)
T ss_dssp             CCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTC-----------------------------
T ss_pred             CCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccc-----------------------------
Confidence             5556542     33345556666666665432  33222211110 1111                             


Q ss_pred             ccccCCCCeeecccCccccC-CCccccCCCcceEEEecCCcceec-cCccccCCCcccEEEccCCcccccCCccc-cccc
Q 035998          528 NQIWSFPPTIDLSLNRLDGS-IWPEFGNLKKLHVFDLKHNNLSGP-IPSELTGMTSLETLDLSYNNLSGAIPISL-EKLS  604 (1020)
Q Consensus       528 n~~~~~~~~l~Ls~N~l~~~-~~~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l-~~l~  604 (1020)
                             +.|++++|++++. ++..+.++++|+.|+|++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++
T Consensus       466 -------~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p  538 (592)
T 3ogk_B          466 -------RWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARP  538 (592)
T ss_dssp             -------CEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCT
T ss_pred             -------eEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCC
Confidence                   2334444444432 222335566677777777776543 33344556677777777777664422222 2344


Q ss_pred             cccccccccc
Q 035998          605 FLSKFSVANN  614 (1020)
Q Consensus       605 ~L~~l~ls~N  614 (1020)
                      .+....+..+
T Consensus       539 ~l~~~~~~~~  548 (592)
T 3ogk_B          539 YWNIELIPSR  548 (592)
T ss_dssp             TEEEEEECCC
T ss_pred             CcEEEEecCc
Confidence            4544444443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=4e-29  Score=290.91  Aligned_cols=254  Identities=24%  Similarity=0.256  Sum_probs=175.1

Q ss_pred             CCCCCCCc--CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCC
Q 035998           57 ASSSDCCH--WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPN  134 (1020)
Q Consensus        57 ~~~~~~C~--w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~  134 (1020)
                      ++..+.|.  |..|.|.....+.+|...+ ..++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++
T Consensus        35 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~  113 (440)
T 3zyj_A           35 CPSVCSCSNQFSKVICVRKNLREVPDGIS-TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN  113 (440)
T ss_dssp             CCSSSEECTTSCEEECCSCCCSSCCSCCC-TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSS
T ss_pred             CCCCCEeCCCCCEEEeCCCCcCcCCCCCC-CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCcc
Confidence            44445564  7789999887777776654 35566666666666655566666666666666666666555555666666


Q ss_pred             CCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccc
Q 035998          135 LEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       135 L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      |++|+|++|+|++.++..+ .+++|++|+|++|+++                         ...+..|.++++|++|+|+
T Consensus       114 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-------------------------~~~~~~~~~l~~L~~L~l~  168 (440)
T 3zyj_A          114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-------------------------SIPSYAFNRIPSLRRLDLG  168 (440)
T ss_dssp             CCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC-------------------------EECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc-------------------------ccCHHHhhhCcccCEeCCC
Confidence            6666666666665555444 4555555555555554                         3334445555555555555


Q ss_pred             cc-ccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccccc
Q 035998          214 MN-DLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       214 ~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      +| .++...+..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|++++|++++.
T Consensus       169 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  246 (440)
T 3zyj_A          169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI  246 (440)
T ss_dssp             CCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             CCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEE
Confidence            53 333333335566666666667777666 333 467778888888888888888888888888888888888888888


Q ss_pred             CCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccC
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      .+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       247 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            8888888888888999988888888888888899999999999886

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.8e-29  Score=292.17  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=174.3

Q ss_pred             CCCCCCCc--CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCC
Q 035998           57 ASSSDCCH--WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPN  134 (1020)
Q Consensus        57 ~~~~~~C~--w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~  134 (1020)
                      ++..+.|.  |..|.|+..+.+.+|.+.+ .+++.|+|++|++++..+..|+++++|++|+|++|++++..|..|.++++
T Consensus        46 Cp~~C~C~~~~~~v~c~~~~l~~iP~~~~-~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  124 (452)
T 3zyi_A           46 CPSVCSCSNQFSKVVCTRRGLSEVPQGIP-SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLAS  124 (452)
T ss_dssp             CCTTSEECSSSCEEECCSSCCSSCCSCCC-TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCCCCEECCCCcEEEECCCCcCccCCCCC-CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCccc
Confidence            45555575  6899999887777766554 35555666666665555555566666666666666655555555555555


Q ss_pred             CCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccc
Q 035998          135 LEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLG  213 (1020)
Q Consensus       135 L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  213 (1020)
                      |++|+|++|+|++.++..+ .+++|++|+|++|++                         +...+..|.++++|++|+|+
T Consensus       125 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------~~~~~~~~~~l~~L~~L~l~  179 (452)
T 3zyi_A          125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-------------------------ESIPSYAFNRVPSLMRLDLG  179 (452)
T ss_dssp             CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCC-------------------------CEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCcCCccChhhhcccCCCCEEECCCCCc-------------------------ceeCHhHHhcCCcccEEeCC
Confidence            6666665555555544444 455555555555555                         43444455555666666666


Q ss_pred             c-cccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccccc
Q 035998          214 M-NDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       214 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      + |.++...+..|.++++|++|+|++|++++. | .+..+++|++|+|++|++++..|..|.++++|+.|++++|++++.
T Consensus       180 ~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  257 (452)
T 3zyi_A          180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI  257 (452)
T ss_dssp             CCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred             CCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence            5 333333334566667777777777777643 3 467788888888888888888888888888888888888888888


Q ss_pred             CCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccC
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      .|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            8888888889999999999998888888888999999999999886

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=5.1e-30  Score=289.41  Aligned_cols=278  Identities=22%  Similarity=0.228  Sum_probs=139.1

Q ss_pred             eeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccccccccc
Q 035998          160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDN  239 (1020)
Q Consensus       160 ~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  239 (1020)
                      ..++++|.++ .+|..++   ++|++|++++|++++..+..|+++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        35 ~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  110 (353)
T 2z80_A           35 ICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN  110 (353)
T ss_dssp             EEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence            3444444444 4444332   24444555555544433334555555555555555555444444555555555555555


Q ss_pred             ccCCCCCcccccCCCccEEEccCCcCcccCc-ccccCCcccceeecccc-cccccCCCCCcCCccccccccccccccccc
Q 035998          240 QLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSN-RFTGRIPHSLSNSPTLNLLNLRNNSLDGSL  317 (1020)
Q Consensus       240 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  317 (1020)
                      ++++..+..|.++++|++|++++|++++..+ ..|..+++|++|++++| .+++..+..|.++++|+.|++++|++++..
T Consensus       111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  190 (353)
T 2z80_A          111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE  190 (353)
T ss_dssp             CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred             cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccC
Confidence            5553333334455555555555555543322 24444444444444444 234333444444444444444444444444


Q ss_pred             ccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCccccc---CCCCCCeeeCCCCCCcchhhHHHH
Q 035998          318 LLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYK---NFESLSYLSLSNSSIYNLSSALQV  394 (1020)
Q Consensus       318 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~l~~N~i~~l~~~~~~  394 (1020)
                      +..+..+++|++|++++|+++...+..+..+++|+.|++++|++++..+..+.   ....++.++++++.+..       
T Consensus       191 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~-------  263 (353)
T 2z80_A          191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD-------  263 (353)
T ss_dssp             TTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH-------
T ss_pred             HHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC-------
Confidence            44444444444444444444321111122234444444444444433222211   12233334443333221       


Q ss_pred             HhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccccccccccc-ccCcCc
Q 035998          395 LQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW-FGGFQD  473 (1020)
Q Consensus       395 l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~  473 (1020)
                                                             +.+. .+|.++..+++|+.|+|++|+|+ .+|.. |..+++
T Consensus       264 ---------------------------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~  302 (353)
T 2z80_A          264 ---------------------------------------ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS  302 (353)
T ss_dssp             ---------------------------------------HHHH-HHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTT
T ss_pred             ---------------------------------------cchh-hhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCC
Confidence                                                   1111 46778889999999999999999 55555 689999


Q ss_pred             CcEEeCCCCcccccCC
Q 035998          474 LFYLDLSNNTFTGEIP  489 (1020)
Q Consensus       474 L~~L~Ls~N~l~~~~p  489 (1020)
                      |++|+|++|++++..|
T Consensus       303 L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          303 LQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CCEEECCSSCBCCCHH
T ss_pred             CCEEEeeCCCccCcCC
Confidence            9999999999986554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=3.4e-29  Score=276.74  Aligned_cols=221  Identities=26%  Similarity=0.283  Sum_probs=127.2

Q ss_pred             eeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccc--ccchhhhhhccccccccc
Q 035998          160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG--GIADDIFQLQKLRLLGLQ  237 (1020)
Q Consensus       160 ~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~  237 (1020)
                      .++++++.++ .+|..+.   ++|+.|+|++|+++...+..|+++++|++|+|++|+++.  ..+..+..+++|++|+|+
T Consensus        11 ~l~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             EEEcCCCCcc-cCCCCCC---CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            3444444444 4444332   345555555555553333345556666666666666552  224555566666666666


Q ss_pred             ccccCCCCCcccccCCCccEEEccCCcCcccCc-ccccCCcccceeecccccccccCCCCCcCCccccccccccccccc-
Q 035998          238 DNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDG-  315 (1020)
Q Consensus       238 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-  315 (1020)
                      +|+++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++++..+..+.++++|++|++++|.+++ 
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            66665 345556666666666666666665443 456666666666666666666666666666666666666666654 


Q ss_pred             ccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCC
Q 035998          316 SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       316 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i  385 (1020)
                      ..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++|++|++++|++
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  235 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI  235 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence            4455556666666666666666655555666666666666666666655555555555555555555553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=3.3e-28  Score=291.03  Aligned_cols=289  Identities=23%  Similarity=0.276  Sum_probs=233.8

Q ss_pred             CCCCCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCC
Q 035998           53 WGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNL  132 (1020)
Q Consensus        53 ~~~~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l  132 (1020)
                      |..|..+.+||.|.|..|.-...    .......++.|++++++++ .+|..+.  ++|++|+|++|+|+ .+|.   .+
T Consensus        12 w~~W~~~~~~~~~~~r~~~~~~~----~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l   80 (622)
T 3g06_A           12 WSAWRRAAPAEESRGRAAVVQKM----RACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP   80 (622)
T ss_dssp             HHHHHHTCCGGGHHHHHHHHHHH----HHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred             HHHHHhcCCcchhccccccCccc----ccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence            43333456899997743210000    0000135889999999998 7787776  89999999999999 6776   57


Q ss_pred             CCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccc
Q 035998          133 PNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCL  212 (1020)
Q Consensus       133 ~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  212 (1020)
                      ++|++|+|++|+|++.++   .+++|++|+|++|+++ .+|.    .+++|+.|++++|++++ +|..   +++|++|+|
T Consensus        81 ~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~L  148 (622)
T 3g06_A           81 PELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSV  148 (622)
T ss_dssp             TTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEEC
Confidence            999999999999996544   7899999999999998 5666    46889999999999995 5654   489999999


Q ss_pred             cccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccccc
Q 035998          213 GMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       213 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      ++|++++ +|.   .+.+|+.|++++|+|++ +|   ..+++|+.|++++|+|++ +|..   +++|+.|++++|+++. 
T Consensus       149 s~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-  215 (622)
T 3g06_A          149 SDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-  215 (622)
T ss_dssp             CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-
T ss_pred             cCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-
Confidence            9999995 444   35789999999999995 55   457899999999999996 4443   4789999999999995 


Q ss_pred             CCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCC
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNF  372 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  372 (1020)
                      +|..   +++|+.|+|++|++++..    ..+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+.++
T Consensus       216 l~~~---~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l  283 (622)
T 3g06_A          216 LPAL---PSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL  283 (622)
T ss_dssp             CCCC---CTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred             cCCC---CCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence            4443   478999999999999743    45689999999999999 5665   5689999999999999 778999999


Q ss_pred             CCCCeeeCCCCCCcchh
Q 035998          373 ESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       373 ~~L~~L~l~~N~i~~l~  389 (1020)
                      ++|+.|+|++|+++...
T Consensus       284 ~~L~~L~L~~N~l~~~~  300 (622)
T 3g06_A          284 SSETTVNLEGNPLSERT  300 (622)
T ss_dssp             CTTCEEECCSCCCCHHH
T ss_pred             cccCEEEecCCCCCCcC
Confidence            99999999999998654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.5e-28  Score=266.76  Aligned_cols=225  Identities=24%  Similarity=0.263  Sum_probs=179.9

Q ss_pred             ceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccc
Q 035998          159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQD  238 (1020)
Q Consensus       159 ~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  238 (1020)
                      ++++.+++.++ .+|..+   .++|+.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            45555555555 555543   35677777777777766666777788888888888888777777788888888888888


Q ss_pred             cc-cCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccccc
Q 035998          239 NQ-LSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL  317 (1020)
Q Consensus       239 N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  317 (1020)
                      |+ ++...|..+..+++|++|++++|.+++..|..|.++++|++|++++|++++..+..|..+++|+.|++++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            86 77666778888888888888888888777888888888888888888888777777888888888888888888777


Q ss_pred             ccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          318 LLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       318 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      +..+..+++|++|+|++|++++..|..+..+++|+.|++++|++++..+..+..+++|++|++++|++..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            7778888889999999999888888888888999999999999988777778888899999999888754

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.7e-29  Score=277.93  Aligned_cols=165  Identities=18%  Similarity=0.200  Sum_probs=99.5

Q ss_pred             cccccccccccccccccccccchhhhhhcccccccccccccC-CCCCcccc-------cCCCccEEEccCCcCcccCccc
Q 035998          201 LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLS-GKLSPSIA-------DLSNLVRLDVSSNNFSGNIPDV  272 (1020)
Q Consensus       201 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~  272 (1020)
                      ++..++|++|++++|.+  .+|..+...  |+.|+|++|+++ +.+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45566777777777777  566666554  777777777773 34454444       5666666666666666655554


Q ss_pred             c--cCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCC
Q 035998          273 F--AGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRK  350 (1020)
Q Consensus       273 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  350 (1020)
                      +  ..+++|++|++++|++++. |..++.+..                   ..+++|++|+|++|++++..|..|..+++
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~-------------------~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQ-------------------WLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHT-------------------TCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHH-------------------hhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            4  5555555555555555544 333322210                   01266777777777777666677777777


Q ss_pred             CCeEecCCCccccc--Ccccc--cCCCCCCeeeCCCCCCcchh
Q 035998          351 LKNINLARNNFSGQ--IPETY--KNFESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       351 L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~i~~l~  389 (1020)
                      |++|+|++|++.+.  .|..+  ..+++|++|++++|+|+.++
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  217 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS  217 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHH
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchH
Confidence            77777777776654  23333  56666777777776665443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=4.2e-28  Score=269.90  Aligned_cols=238  Identities=17%  Similarity=0.207  Sum_probs=179.9

Q ss_pred             CCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccc
Q 035998          132 LPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC  211 (1020)
Q Consensus       132 l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  211 (1020)
                      .+++++|+|++|.++..++...++++|++|+|++|.++ .+|..+ ..+++|++|+|++|+++ .+|..++++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~-~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM-QQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCG-GGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHH-hccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            57889999999999855444447888888888888887 677655 45666777777777666 5566666666666666


Q ss_pred             ccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccc
Q 035998          212 LGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG  291 (1020)
Q Consensus       212 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  291 (1020)
                      |++|++.+.+|..+...               ..+..+.++++|++|+|++|+++ .+|..++.+++|++|++++|++++
T Consensus       157 L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             EEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred             CCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence            66666666666544330               11123445777888888888777 667777777788888888888775


Q ss_pred             cCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccC
Q 035998          292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKN  371 (1020)
Q Consensus       292 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  371 (1020)
                       +|..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..+++
T Consensus       221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence             4556788888888888888888888888888899999999999888899989999999999999999999999999999


Q ss_pred             CCCCCeeeCCCCCCcchh
Q 035998          372 FESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       372 l~~L~~L~l~~N~i~~l~  389 (1020)
                      +++|+.+++..|.+..++
T Consensus       300 L~~L~~l~l~~~~~~~l~  317 (328)
T 4fcg_A          300 LPANCIILVPPHLQAQLD  317 (328)
T ss_dssp             SCTTCEEECCGGGSCC--
T ss_pred             ccCceEEeCCHHHHHHHh
Confidence            999999999888765544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.9e-28  Score=267.66  Aligned_cols=262  Identities=21%  Similarity=0.230  Sum_probs=192.4

Q ss_pred             CCCCCCCcC---ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCC
Q 035998           57 ASSSDCCHW---VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLP  133 (1020)
Q Consensus        57 ~~~~~~C~w---~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  133 (1020)
                      ++..+.|..   ..|.|+..+.+.+|...+ ..++.|+++++.+++..+..++++++|++|+|++|.+++..|..|.+++
T Consensus         2 CP~~C~C~~~~~~~~~c~~~~l~~ip~~~~-~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~   80 (285)
T 1ozn_A            2 CPGACVCYNEPKVTTSCPQQGLQAVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA   80 (285)
T ss_dssp             CCTTCEEECSSSCEEECCSSCCSSCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred             cCCCceECCCCCeEEEcCcCCcccCCcCCC-CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence            344555754   458999888888887654 5788888888888887777888888888888888888877788888888


Q ss_pred             CCCeeeccCCC-CCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccc
Q 035998          134 NLEVLDLSSND-LSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC  211 (1020)
Q Consensus       134 ~L~~L~L~~n~-l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  211 (1020)
                      +|++|+|++|. ++...|..+ .+++|++|+|++|++++ ++...+..+++|++|++++|++++..+..|+++++|++|+
T Consensus        81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  159 (285)
T 1ozn_A           81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (285)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE-ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence            88888888887 777767776 78888888888888874 4444456778888888888888876666777888888888


Q ss_pred             ccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccc
Q 035998          212 LGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG  291 (1020)
Q Consensus       212 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  291 (1020)
                      |++|++++..+..+..+++|++|+|++|++++..|..|..+++|++|++++|++++..+..|..+++|++|++++|.+..
T Consensus       160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            88888876666667777788888888888877777777777788888888888877666677777777777777777764


Q ss_pred             cCCCCCcCCcccccccccccccccccccCC
Q 035998          292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNC  321 (1020)
Q Consensus       292 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  321 (1020)
                      ..+.. .-...++.+..+.+.+....|..+
T Consensus       240 ~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          240 DCRAR-PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             SGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             CCCcH-HHHHHHHhcccccCccccCCchHh
Confidence            32211 111234444455555554444433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=1.4e-27  Score=278.74  Aligned_cols=248  Identities=22%  Similarity=0.255  Sum_probs=169.7

Q ss_pred             CcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccc
Q 035998          157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGL  236 (1020)
Q Consensus       157 ~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  236 (1020)
                      ....++.+++.++ .+|..+.   ++++.|+|++|++++..+..|++++                        +|++|+|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~------------------------~L~~L~L  106 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLH------------------------HLEVLQL  106 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCT------------------------TCCEEEC
T ss_pred             CCcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCC------------------------CCCEEEC
Confidence            3456667666666 5555442   3455555555555544444444444                        4444445


Q ss_pred             cccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccc-ccccc
Q 035998          237 QDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN-NSLDG  315 (1020)
Q Consensus       237 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~  315 (1020)
                      ++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|++++|+++...+..|.++++|+.|++++ |.+..
T Consensus       107 s~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~  186 (452)
T 3zyi_A          107 GRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEY  186 (452)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred             CCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccc
Confidence            55555444445555555555555555555555555555566666666666666655555666666677777766 44444


Q ss_pred             ccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHH
Q 035998          316 SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVL  395 (1020)
Q Consensus       316 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l  395 (1020)
                      ..+..|..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..|..|.++++|+.|++++|+++.        
T Consensus       187 i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--------  256 (452)
T 3zyi_A          187 ISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL--------  256 (452)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCE--------
T ss_pred             cChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCce--------
Confidence            445567778888888888888874 34 47788889999999999888888888888888888888887543        


Q ss_pred             hhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCc
Q 035998          396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF  475 (1020)
Q Consensus       396 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  475 (1020)
                                                                 ..|..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus       257 -------------------------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  293 (452)
T 3zyi_A          257 -------------------------------------------IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV  293 (452)
T ss_dssp             -------------------------------------------ECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred             -------------------------------------------ECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence                                                       4456678888999999999999977778889999999


Q ss_pred             EEeCCCCccc
Q 035998          476 YLDLSNNTFT  485 (1020)
Q Consensus       476 ~L~Ls~N~l~  485 (1020)
                      .|+|++|.+.
T Consensus       294 ~L~L~~Np~~  303 (452)
T 3zyi_A          294 ELHLHHNPWN  303 (452)
T ss_dssp             EEECCSSCEE
T ss_pred             EEEccCCCcC
Confidence            9999999887

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=3.3e-30  Score=285.37  Aligned_cols=202  Identities=21%  Similarity=0.259  Sum_probs=130.4

Q ss_pred             CCcccEEEccCCCCCCCCCCcc--ccccccccccccccccccccchhhhhh-----cccccccccccccCCCCCcccccC
Q 035998          180 SSRIRVINLSVNYFSGTLSPGL--GNCASLEHLCLGMNDLTGGIADDIFQL-----QKLRLLGLQDNQLSGKLSPSIADL  252 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l  252 (1020)
                      +++|++|+|++|++++.+|..+  +.+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|+++
T Consensus        94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  172 (312)
T 1wwl_A           94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF  172 (312)
T ss_dssp             TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred             cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence            3444444444444444444443  5556666666666666654 5556655     666777777777766666667777


Q ss_pred             CCccEEEccCCcCccc--Ccccc--cCCcccceeecccccccc---cCCCCCcCCcccccccccccccccccc-cCCCCC
Q 035998          253 SNLVRLDVSSNNFSGN--IPDVF--AGLGEFQYLVAHSNRFTG---RIPHSLSNSPTLNLLNLRNNSLDGSLL-LNCPAL  324 (1020)
Q Consensus       253 ~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l  324 (1020)
                      ++|++|+|++|++.+.  .|..+  ..+++|++|++++|++++   .....+.++++|++|+|++|++++..+ ..+..+
T Consensus       173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l  252 (312)
T 1wwl_A          173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP  252 (312)
T ss_dssp             SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred             CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence            7777777777766554  22233  666777777777777662   112233456777777777777776654 345567


Q ss_pred             CCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       325 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      ++|++|+|++|+|+ .+|..+.  ++|++|+|++|++++. |. +..+++|++|++++|+++.
T Consensus       253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            77888888888887 6666665  7788888888888765 55 7778888888888887754

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=277.46  Aligned_cols=248  Identities=21%  Similarity=0.238  Sum_probs=158.7

Q ss_pred             CcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccc
Q 035998          157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGL  236 (1020)
Q Consensus       157 ~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  236 (1020)
                      ..+.++.+++.++ .+|..+.   ++++.|+|++|++++..+..|.++++|++|+|++|++++..+              
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~--------------  105 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI--------------  105 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECG--------------
T ss_pred             CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccCh--------------
Confidence            3456666666666 5665442   345555555555555555555555555555555555554444              


Q ss_pred             cccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccc-ccccc
Q 035998          237 QDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN-NSLDG  315 (1020)
Q Consensus       237 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~  315 (1020)
                                ..|.++++|++|+|++|+|++..+..|..+++|++|++++|+++...+..|.++++|+.|+|++ |.+..
T Consensus       106 ----------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~  175 (440)
T 3zyj_A          106 ----------GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY  175 (440)
T ss_dssp             ----------GGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE
T ss_pred             ----------hhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce
Confidence                      4444455555555555555544444455555555555555555545555555566666666665 33444


Q ss_pred             ccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHH
Q 035998          316 SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVL  395 (1020)
Q Consensus       316 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l  395 (1020)
                      ..+..|..+++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|+.        
T Consensus       176 i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--------  245 (440)
T 3zyj_A          176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV--------  245 (440)
T ss_dssp             ECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE--------
T ss_pred             eCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE--------
Confidence            44445667777777777777777 444 36777788888888888887777778888888888887777543        


Q ss_pred             hhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCc
Q 035998          396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF  475 (1020)
Q Consensus       396 ~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  475 (1020)
                                                                 ..|..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus       246 -------------------------------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  282 (440)
T 3zyj_A          246 -------------------------------------------IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE  282 (440)
T ss_dssp             -------------------------------------------ECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred             -------------------------------------------EChhhhcCCCCCCEEECCCCCCCccChhHhccccCCC
Confidence                                                       3345677788888888888888877777888888999


Q ss_pred             EEeCCCCccc
Q 035998          476 YLDLSNNTFT  485 (1020)
Q Consensus       476 ~L~Ls~N~l~  485 (1020)
                      .|+|++|.+.
T Consensus       283 ~L~L~~Np~~  292 (440)
T 3zyj_A          283 RIHLHHNPWN  292 (440)
T ss_dssp             EEECCSSCEE
T ss_pred             EEEcCCCCcc
Confidence            9999999886

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=3.7e-29  Score=277.56  Aligned_cols=269  Identities=22%  Similarity=0.182  Sum_probs=185.7

Q ss_pred             CccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcC
Q 035998          254 NLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLG  333 (1020)
Q Consensus       254 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  333 (1020)
                      +++.++++.+.+...++..+..+++|++|++++|++++..|..|..+++|++|+|++|.+++..+  +..+++|++|+|+
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            34555666666655555555555566666666666665555556666666666666666554443  5555555555555


Q ss_pred             CCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCC
Q 035998          334 TNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNE  413 (1020)
Q Consensus       334 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~  413 (1020)
                      +|++++..     ..++|++|++++|++++..+..   ++                                        
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~----------------------------------------  120 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQ----------------------------------------  120 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CS----------------------------------------
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCccc---cC----------------------------------------
Confidence            55555321     1245555555555554433222   23                                        


Q ss_pred             CCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccc-cCcCcCcEEeCCCCcccccCCCCC
Q 035998          414 KLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWF-GGFQDLFYLDLSNNTFTGEIPKNL  492 (1020)
Q Consensus       414 ~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~  492 (1020)
                                 +|+.|++++|.+.+..|..+..+++|++|+|++|++++..|..+ ..+++|++|+|++|++++. |.. 
T Consensus       121 -----------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-  187 (317)
T 3o53_A          121 -----------GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-  187 (317)
T ss_dssp             -----------SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-
T ss_pred             -----------CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc-
Confidence                       44455555555555556677788889999999999987777766 4788899999999988854 222 


Q ss_pred             CCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceecc
Q 035998          493 TGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPI  572 (1020)
Q Consensus       493 ~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~  572 (1020)
                      ..+++|                                    +.|+|++|+|++. |+.|..+++|+.|+|++|+|+ .+
T Consensus       188 ~~l~~L------------------------------------~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l  229 (317)
T 3o53_A          188 VVFAKL------------------------------------KTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LI  229 (317)
T ss_dssp             CCCTTC------------------------------------CEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EE
T ss_pred             cccccC------------------------------------CEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-ch
Confidence            224444                                    4678888888864 455999999999999999998 58


Q ss_pred             CccccCCCcccEEEccCCccc-ccCCccccccccccccccc-cccccccCCCC
Q 035998          573 PSELTGMTSLETLDLSYNNLS-GAIPISLEKLSFLSKFSVA-NNHLTGRIPSG  623 (1020)
Q Consensus       573 p~~~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l~~L~~l~ls-~N~l~g~~p~~  623 (1020)
                      |..+..+++|+.|+|++|+++ +.+|..+..++.|+.|+++ .+.++|..|..
T Consensus       230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            999999999999999999999 8899999999999999999 66788877753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.6e-29  Score=278.76  Aligned_cols=268  Identities=19%  Similarity=0.208  Sum_probs=189.3

Q ss_pred             cccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccc
Q 035998          207 LEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS  286 (1020)
Q Consensus       207 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  286 (1020)
                      ++..+++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+  |..+++|++|++++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            4445566666654445555566678888888888877666778888888888888888876554  77777778888887


Q ss_pred             ccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc
Q 035998          287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP  366 (1020)
Q Consensus       287 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  366 (1020)
                      |++++..     ..++|+.|++++|++++..+..   +++|++|++++|++++..+..+..+++|++|+|++|++++..+
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence            7777543     2367777777777777665543   4667778888888777667677777777777777777777666


Q ss_pred             cccc-CCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhh
Q 035998          367 ETYK-NFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLR  445 (1020)
Q Consensus       367 ~~~~-~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~  445 (1020)
                      ..+. .+++|++|++++|.|+.++.                                                     ..
T Consensus       162 ~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------------------------------------~~  188 (317)
T 3o53_A          162 AELAASSDTLEHLNLQYNFIYDVKG-----------------------------------------------------QV  188 (317)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEEEC-----------------------------------------------------CC
T ss_pred             HHHhhccCcCCEEECCCCcCccccc-----------------------------------------------------cc
Confidence            6553 56777777777777554321                                                     12


Q ss_pred             cCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeeccccccc
Q 035998          446 GCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGL  525 (1020)
Q Consensus       446 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l  525 (1020)
                      .+++|++|+|++|+|++ +|..|..+++|++|+|++|+++ .+|.                                   
T Consensus       189 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~-----------------------------------  231 (317)
T 3o53_A          189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK-----------------------------------  231 (317)
T ss_dssp             CCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECT-----------------------------------
T ss_pred             ccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhh-----------------------------------
Confidence            35677788888888874 4445777778888888887776 2333                                   


Q ss_pred             ccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcce-eccCccccCCCcccEEEcc-CCcccccCCcc
Q 035998          526 QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLS-GPIPSELTGMTSLETLDLS-YNNLSGAIPIS  599 (1020)
Q Consensus       526 ~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~g~ip~~  599 (1020)
                                               .+..+++|+.|+|++|.++ +.+|..++.+++|+.|+++ .+.++|..|..
T Consensus       232 -------------------------~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          232 -------------------------ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             -------------------------TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             -------------------------HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence                                     3455667888888888888 6788888888899999888 45677766644

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=1.5e-30  Score=315.86  Aligned_cols=401  Identities=16%  Similarity=0.165  Sum_probs=253.2

Q ss_pred             CCCCcceeeeccCcc---CCCCCcccc-----------ccCCcccEEEccCCCCCCCCCCccccc--cccccccccccc-
Q 035998          154 NLPSIQVLDISSNSL---NGSVPTSIC-----------KNSSRIRVINLSVNYFSGTLSPGLGNC--ASLEHLCLGMND-  216 (1020)
Q Consensus       154 ~l~~L~~L~Ls~N~l---~~~ip~~~~-----------~~~~~L~~L~L~~N~l~~~~~~~l~~l--~~L~~L~L~~N~-  216 (1020)
                      .+++|++|+|+++..   .+.+|..+.           ..+++|++|+|++|.+++..+..++..  .+|++|+|++|. 
T Consensus        71 ~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~  150 (592)
T 3ogk_B           71 RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSG  150 (592)
T ss_dssp             HCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEE
T ss_pred             hCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCC
Confidence            688999999988642   123443221           256677777777777766555555543  347777777765 


Q ss_pred             ccc-ccchhhhhhcccccccccccccCCC----CCcccccCCCccEEEccCCcCcc----cCcccccCCcccceeecccc
Q 035998          217 LTG-GIADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFSG----NIPDVFAGLGEFQYLVAHSN  287 (1020)
Q Consensus       217 l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N  287 (1020)
                      ++. .++.....+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++    .++..+.++++|+.|++++|
T Consensus       151 ~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~  230 (592)
T 3ogk_B          151 FTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDF  230 (592)
T ss_dssp             EEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSC
T ss_pred             cCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCc
Confidence            221 1222233567777777777776654    23344556777777777777762    33444556667777777777


Q ss_pred             cccccCCCCCcCCcccccccccccccc---cccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc
Q 035998          288 RFTGRIPHSLSNSPTLNLLNLRNNSLD---GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ  364 (1020)
Q Consensus       288 ~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  364 (1020)
                      .+.+ +|..+.++++|+.|+++++...   ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++.
T Consensus       231 ~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~  308 (592)
T 3ogk_B          231 EILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETE  308 (592)
T ss_dssp             BGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHH
T ss_pred             cHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHH
Confidence            7665 4456666677777777653222   222334555666666666665332 4555556666666666666665543


Q ss_pred             Cc-ccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecc----------
Q 035998          365 IP-ETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS----------  433 (1020)
Q Consensus       365 ~p-~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~----------  433 (1020)
                      .. ..+..+++|++|+++ |.+..  ..+..+                        ...+++|+.|++.+          
T Consensus       309 ~~~~~~~~~~~L~~L~L~-~~~~~--~~l~~~------------------------~~~~~~L~~L~L~~g~~~~~~~~~  361 (592)
T 3ogk_B          309 DHCTLIQKCPNLEVLETR-NVIGD--RGLEVL------------------------AQYCKQLKRLRIERGADEQGMEDE  361 (592)
T ss_dssp             HHHHHHTTCTTCCEEEEE-GGGHH--HHHHHH------------------------HHHCTTCCEEEEECCCCSSTTSST
T ss_pred             HHHHHHHhCcCCCEEecc-CccCH--HHHHHH------------------------HHhCCCCCEEEeecCccccccccc
Confidence            33 234566666666666 32221  111111                        11345566666662          


Q ss_pred             -cccccc-cchhhhcCCCCcEEecccccccccccccccC-cCcCcEEeCC----CCccccc-----CCCCCCCCcccccc
Q 035998          434 -CGLRGS-IPQWLRGCSKLQLVDLSWNQLSGTIPVWFGG-FQDLFYLDLS----NNTFTGE-----IPKNLTGLPSLITR  501 (1020)
Q Consensus       434 -n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~l  501 (1020)
                       +.+++. ++....++++|++|+++.|++++..+..+.. +++|+.|+|+    .|.+++.     ++..+.++++|+  
T Consensus       362 ~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~--  439 (592)
T 3ogk_B          362 EGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR--  439 (592)
T ss_dssp             TCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCC--
T ss_pred             cCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCC--
Confidence             344433 3334567899999999999999887777766 8899999996    6777753     222244445443  


Q ss_pred             cCcCCCCCCCcccceeecccccccccccccCCCCeeeccc--CccccCCCccccC-CCcceEEEecCCccee-ccCcccc
Q 035998          502 NISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSL--NRLDGSIWPEFGN-LKKLHVFDLKHNNLSG-PIPSELT  577 (1020)
Q Consensus       502 ~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~--N~l~~~~~~~~~~-L~~L~~L~Ls~N~l~~-~~p~~~~  577 (1020)
                                                        .|++++  +.+++..+..++. +++|+.|+|++|++++ .++..+.
T Consensus       440 ----------------------------------~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~  485 (592)
T 3ogk_B          440 ----------------------------------RFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSR  485 (592)
T ss_dssp             ----------------------------------EEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHT
T ss_pred             ----------------------------------EEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHh
Confidence                                              455543  2355554555543 8899999999999986 4566678


Q ss_pred             CCCcccEEEccCCccccc-CCcccccccccccccccccccccc
Q 035998          578 GMTSLETLDLSYNNLSGA-IPISLEKLSFLSKFSVANNHLTGR  619 (1020)
Q Consensus       578 ~l~~L~~L~Ls~N~l~g~-ip~~l~~l~~L~~l~ls~N~l~g~  619 (1020)
                      .+++|++|+|++|++++. ++..+..+++|+.|++++|++++.
T Consensus       486 ~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          486 GCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             cCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            899999999999999865 455567899999999999998763

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=9.5e-27  Score=278.43  Aligned_cols=137  Identities=21%  Similarity=0.294  Sum_probs=100.2

Q ss_pred             cccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccc
Q 035998          229 QKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNL  308 (1020)
Q Consensus       229 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  308 (1020)
                      .+++.|++++|.++ .+|..+.  ++|++|+|++|+|++ +|.   .+++|++|++++|+|++ +|.   .+++|++|+|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  108 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI  108 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence            46889999999998 6676665  789999999999984 444   46788888888888885 443   5677888888


Q ss_pred             cccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcch
Q 035998          309 RNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       309 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                      ++|.+++...    .+++|+.|++++|+|++ +|..   +++|++|+|++|++++ +|.   .+.+|+.|++++|.|+.+
T Consensus       109 s~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l  176 (622)
T 3g06_A          109 FSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSL  176 (622)
T ss_dssp             CSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC
T ss_pred             cCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCC
Confidence            8888876443    45778888888888874 5543   3678888888888774 343   345677777777776544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2.4e-27  Score=278.37  Aligned_cols=236  Identities=22%  Similarity=0.188  Sum_probs=170.3

Q ss_pred             CcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeee
Q 035998          300 SPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLS  379 (1020)
Q Consensus       300 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  379 (1020)
                      +++|+.|+|++|.+++..|..|..+++|++|+|++|.+++.+|  +..+++|++|+|++|.+++..+     .++|++|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            3455555555555555555555556666666666666654444  5566666666666666654322     25666666


Q ss_pred             CCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccc
Q 035998          380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ  459 (1020)
Q Consensus       380 l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  459 (1020)
                      +++|.|+.++.                              ..+++|+.|++++|.+++..|..++.+++|+.|+|++|+
T Consensus       106 L~~N~l~~~~~------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  155 (487)
T 3oja_A          106 AANNNISRVSC------------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE  155 (487)
T ss_dssp             CCSSCCCCEEE------------------------------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred             CcCCcCCCCCc------------------------------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence            66666554432                              123566777777777777778888889999999999999


Q ss_pred             cccccccccc-CcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeee
Q 035998          460 LSGTIPVWFG-GFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTID  538 (1020)
Q Consensus       460 l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~  538 (1020)
                      |++.+|..|. .+++|++|+|++|.+++..+.  ..+++|                                    ..|+
T Consensus       156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~--~~l~~L------------------------------------~~L~  197 (487)
T 3oja_A          156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ--VVFAKL------------------------------------KTLD  197 (487)
T ss_dssp             CCEEEGGGGGGGTTTCCEEECTTSCCCEEECC--CCCTTC------------------------------------CEEE
T ss_pred             CCCcChHHHhhhCCcccEEecCCCcccccccc--ccCCCC------------------------------------CEEE
Confidence            9988888886 789999999999999866332  234444                                    3678


Q ss_pred             cccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCccc-ccCCccccccccccccccc
Q 035998          539 LSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLS-GAIPISLEKLSFLSKFSVA  612 (1020)
Q Consensus       539 Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~l~~l~~L~~l~ls  612 (1020)
                      |++|+|++. |+.|+.+++|+.|+|++|+|++ +|..++.+++|+.|+|++|.++ +.+|..+..++.|+.++++
T Consensus       198 Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          198 LSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            888888874 4458889999999999999985 7888999999999999999998 7888888888888888886

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.6e-26  Score=248.39  Aligned_cols=217  Identities=19%  Similarity=0.272  Sum_probs=167.2

Q ss_pred             CCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeee
Q 035998           60 SDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLD  139 (1020)
Q Consensus        60 ~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  139 (1020)
                      .|+|.|.|+.|+-.           +.++.+++++++++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+
T Consensus         2 ~~~C~~~~~~C~c~-----------~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~   67 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-----------NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLY   67 (270)
T ss_dssp             CCCBGGGTCSBEEE-----------TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEE
T ss_pred             CccCCCCCCCCEeC-----------CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEE
Confidence            48999999999642           346678899998884 676555  6899999999999976667899999999999


Q ss_pred             ccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccc
Q 035998          140 LSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       140 L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      |++|+++..++..+ ++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..|+++++|++|+|++|+++
T Consensus        68 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  146 (270)
T 2o6q_A           68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ  146 (270)
T ss_dssp             CCSSCCSCCCTTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCccCeeChhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC
Confidence            99999988777776 6888999999988887 666666677788888888888888777777777777777777777777


Q ss_pred             cccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccc
Q 035998          219 GGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG  291 (1020)
Q Consensus       219 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  291 (1020)
                      +..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+..
T Consensus       147 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            6655566777777777777777776666667777777777777777776666666667777777777776653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=1.8e-27  Score=283.08  Aligned_cols=184  Identities=18%  Similarity=0.125  Sum_probs=130.2

Q ss_pred             eeccCCeEEEEEE-eCCCCEEEEEEecCCc----------hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEEE
Q 035998          750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDC----------GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       750 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .+.|+.|.+..++ .-.|+.||||++..+.          ....+++.+|+++|+++ .|+||+++++++.++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666665554 2358889999997652          12235699999999999 7999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++|++|.+++.+.    ..++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999864    345553   5899999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRP  946 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p  946 (1020)
                      ..  ......+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            22  233456899999999998764 56789999999998887665444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=9.3e-27  Score=273.28  Aligned_cols=235  Identities=20%  Similarity=0.206  Sum_probs=187.3

Q ss_pred             hcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccc
Q 035998          228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN  307 (1020)
Q Consensus       228 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  307 (1020)
                      +++|++|+|++|++++..|..|..+++|++|+|++|.+++.+|  |..+++|++|++++|+|++..+     .++|+.|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            3477788888888877777778888888888888888876655  7778888888888888876543     27788888


Q ss_pred             ccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCccccc-CCCCCCeeeCCCCCCc
Q 035998          308 LRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYK-NFESLSYLSLSNSSIY  386 (1020)
Q Consensus       308 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~i~  386 (1020)
                      +++|.+++..+..   +++|++|+|++|++++..|..+..+++|+.|+|++|.+++.+|..+. .+++|++|+|++|.|+
T Consensus       106 L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            8888888766643   47788888888888888888888888888888888888888887776 7888888888888877


Q ss_pred             chhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccc
Q 035998          387 NLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV  466 (1020)
Q Consensus       387 ~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~  466 (1020)
                      .++..                             ..+++|+.|++++|.+++..| .+..+++|+.|+|++|+|+ .+|.
T Consensus       183 ~~~~~-----------------------------~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~-~lp~  231 (487)
T 3oja_A          183 DVKGQ-----------------------------VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEK  231 (487)
T ss_dssp             EEECC-----------------------------CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECT
T ss_pred             ccccc-----------------------------ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCc-ccch
Confidence            65421                             135678888888888887554 4889999999999999999 5888


Q ss_pred             cccCcCcCcEEeCCCCccc-ccCCCCCCCCcccccccC
Q 035998          467 WFGGFQDLFYLDLSNNTFT-GEIPKNLTGLPSLITRNI  503 (1020)
Q Consensus       467 ~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~l~~  503 (1020)
                      ++..+++|+.|+|++|.++ +.+|..+..++.|..+++
T Consensus       232 ~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             TCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred             hhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence            8999999999999999998 777888888887765443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=4.2e-25  Score=239.88  Aligned_cols=223  Identities=20%  Similarity=0.200  Sum_probs=178.3

Q ss_pred             ceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCC
Q 035998           66 VGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDL  145 (1020)
Q Consensus        66 ~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  145 (1020)
                      ..|.|.+...+.+|...+ ..++.|++++|.+++..+..++++++|++|+|++|++++..+..|.++++|++|+|++|++
T Consensus        10 ~~~~c~~~~l~~ip~~l~-~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l   88 (276)
T 2z62_A           10 ITYQCMELNFYKIPDNLP-FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (276)
T ss_dssp             TEEECTTSCCSSCCSSSC-TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             ceEEecCCCccccCCCCC-CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence            369999988888888775 5789999999999987777899999999999999999876777899999999999999999


Q ss_pred             CCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCC-CCCccccccccccccccccccccccch
Q 035998          146 SGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT-LSPGLGNCASLEHLCLGMNDLTGGIAD  223 (1020)
Q Consensus       146 ~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~  223 (1020)
                      ++..+..+ ++++|++|++++|+++ .++...+..+++|++|++++|.+++. +|..|+++++|++|+|++|++++..+.
T Consensus        89 ~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             CccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            98887777 7899999999999888 44444456788888888888888764 578888888888888888888877777


Q ss_pred             hhhhhcccc----cccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccc
Q 035998          224 DIFQLQKLR----LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG  291 (1020)
Q Consensus       224 ~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  291 (1020)
                      .+..+++|+    .|++++|++++..+..+. ..+|++|+|++|++++..+..|..+++|+.|++++|.+++
T Consensus       168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             GGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             HhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            787777777    677777777755444443 3467777777777776666667777777777777777764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=3.1e-28  Score=295.47  Aligned_cols=235  Identities=15%  Similarity=0.160  Sum_probs=113.7

Q ss_pred             cccCCCCCCeeeccCCCCCC---CCCCc------------c-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCC
Q 035998          128 SLVNLPNLEVLDLSSNDLSG---PLPQT------------I-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN  191 (1020)
Q Consensus       128 ~l~~l~~L~~L~L~~n~l~~---~~p~~------------~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N  191 (1020)
                      .+.++++|++|+|+++....   ..|..            . .+++|++|+|++|.+++..+..+...+++|+.|+|++|
T Consensus        61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~  140 (594)
T 2p1m_B           61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC  140 (594)
T ss_dssp             HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred             HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence            46678899999999875321   11111            1 35677777777776665544444434556666666665


Q ss_pred             -CCCCC-CCCccccccccccccccccccccccchhhh----hhcccccccccccccCCCCCccc----ccCCCccEEEcc
Q 035998          192 -YFSGT-LSPGLGNCASLEHLCLGMNDLTGGIADDIF----QLQKLRLLGLQDNQLSGKLSPSI----ADLSNLVRLDVS  261 (1020)
Q Consensus       192 -~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls  261 (1020)
                       .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+.|++++|. .......+    ..+++|++|+++
T Consensus       141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~  219 (594)
T 2p1m_B          141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLN  219 (594)
T ss_dssp             EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECC
T ss_pred             CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecC
Confidence             33321 222233455566666666555544333333    23355555555554 11111111    223555555555


Q ss_pred             CC-cCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEE-EcCCCccCC
Q 035998          262 SN-NFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSL-DLGTNKFNG  339 (1020)
Q Consensus       262 ~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~  339 (1020)
                      +| .+++ +|..+..+++|+.|+++.+..                 +++.|.+.+.. ..+.++++|+.| .+.+... +
T Consensus       220 ~~~~~~~-l~~~~~~~~~L~~L~l~~~~~-----------------~~~~~~~~~l~-~~l~~~~~L~~Ls~~~~~~~-~  279 (594)
T 2p1m_B          220 RAVPLEK-LATLLQRAPQLEELGTGGYTA-----------------EVRPDVYSGLS-VALSGCKELRCLSGFWDAVP-A  279 (594)
T ss_dssp             TTSCHHH-HHHHHHHCTTCSEEECSBCCC-----------------CCCHHHHHHHH-HHHHTCTTCCEEECCBTCCG-G
T ss_pred             CCCcHHH-HHHHHhcCCcceEcccccccC-----------------ccchhhHHHHH-HHHhcCCCcccccCCcccch-h
Confidence            55 2222 444444555555554322210                 02233333322 234455555555 2332222 1


Q ss_pred             CCCCCCCCCCCCCeEecCCCcccccCcc-cccCCCCCCeeeCCCC
Q 035998          340 PLPTNLPRCRKLKNINLARNNFSGQIPE-TYKNFESLSYLSLSNS  383 (1020)
Q Consensus       340 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N  383 (1020)
                      .++..+..+++|++|+|++|.+++.... .+..+++|++|++++|
T Consensus       280 ~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~  324 (594)
T 2p1m_B          280 YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY  324 (594)
T ss_dssp             GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred             hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence            2333333456666666666665543222 2445666666666655

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=1.3e-24  Score=236.03  Aligned_cols=211  Identities=23%  Similarity=0.235  Sum_probs=115.2

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEE
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN  187 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~  187 (1020)
                      ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+ ++++|++|+|++|++                   
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l-------------------   88 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-------------------   88 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC-------------------
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc-------------------
Confidence            345556666555554444455555555555555555554444333 344444444444443                   


Q ss_pred             ccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCC-CCcccccCCCccEEEccCCcCc
Q 035998          188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGK-LSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       188 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                            ++..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++. +|..+.++++|++|++++|+++
T Consensus        89 ------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~  162 (276)
T 2z62_A           89 ------QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  162 (276)
T ss_dssp             ------CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             ------CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence                  333334444555555555555555544343444455555555555555432 3555555566666666666655


Q ss_pred             ccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCC
Q 035998          267 GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP  346 (1020)
Q Consensus       267 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~  346 (1020)
                      +..+..|..+.+|+.+.+                    .|++++|.+++..+..+.. .+|++|+|++|++++..+..|.
T Consensus       163 ~~~~~~~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~  221 (276)
T 2z62_A          163 SIYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFD  221 (276)
T ss_dssp             EECGGGGHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTT
T ss_pred             cCCHHHhhhhhhccccce--------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhc
Confidence            555444444444431110                    4556666665544444433 3677777777777766666677


Q ss_pred             CCCCCCeEecCCCcccccC
Q 035998          347 RCRKLKNINLARNNFSGQI  365 (1020)
Q Consensus       347 ~l~~L~~L~L~~N~l~~~~  365 (1020)
                      .+++|+.|+|++|++++..
T Consensus       222 ~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          222 RLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             TCCSCCEEECCSSCBCCCT
T ss_pred             ccccccEEEccCCcccccC
Confidence            7888888888888877543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.6e-24  Score=234.57  Aligned_cols=231  Identities=18%  Similarity=0.179  Sum_probs=175.7

Q ss_pred             ccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceee
Q 035998          204 CASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV  283 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  283 (1020)
                      +..+..+++..+.+...  .....+++|+.|++++|.++. + ..+..+++|++|++++|.+++.  ..+..+++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            45666777777777643  335677888888888888773 2 3577788888888888888753  3677788888888


Q ss_pred             cccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc
Q 035998          284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       284 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +++|++++..+..|.++++|++|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            88888887777777888888888888888887777777778888888888888887767777788888888888888887


Q ss_pred             cCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchh
Q 035998          364 QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW  443 (1020)
Q Consensus       364 ~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~  443 (1020)
                      ..+..|..+++|++|++++|+++                                                   +..|..
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~---------------------------------------------------~~~~~~  200 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLK---------------------------------------------------SVPDGV  200 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCS---------------------------------------------------CCCTTT
T ss_pred             cCHHHhcCCccCCEEECCCCcCC---------------------------------------------------ccCHHH
Confidence            76667777777777777777644                                                   344455


Q ss_pred             hhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCccc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL  498 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  498 (1020)
                      +..+++|+.|+|++|.+.+.       +++|++|+++.|.++|.+|.+++.+...
T Consensus       201 ~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          201 FDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             TTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             HhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence            67788888888888887744       4468888888888888888888877654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=5.7e-24  Score=229.99  Aligned_cols=202  Identities=23%  Similarity=0.258  Sum_probs=128.7

Q ss_pred             ccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccC
Q 035998          183 IRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS  262 (1020)
Q Consensus       183 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  262 (1020)
                      .+.+++++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            344444444444 2333332  3455555555555544444555555555555555555544444556666666666666


Q ss_pred             CcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCC
Q 035998          263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP  342 (1020)
Q Consensus       263 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  342 (1020)
                      |++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  174 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE  174 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence            66665555666666666666666666666666666677777777777777776666667777777777777777776666


Q ss_pred             CCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       343 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      ..|..+++|++|+|++|++++..+..|..+++|+.|++++|++..
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            667777777777777777776666667777778888888877643

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.7e-24  Score=234.37  Aligned_cols=212  Identities=23%  Similarity=0.289  Sum_probs=167.0

Q ss_pred             cccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccc
Q 035998          201 LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ  280 (1020)
Q Consensus       201 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  280 (1020)
                      +..+++|++|++++|.++.  ...+..+++|++|++++|++++.  ..+..+++|++|++++|.+++..+..|..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  112 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK  112 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccccceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence            3456666667777766663  23466677777777777777752  4677778888888888888877777778888888


Q ss_pred             eeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCc
Q 035998          281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNN  360 (1020)
Q Consensus       281 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  360 (1020)
                      +|++++|++++..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|+
T Consensus       113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            88888888887777778888888888888888887777778888999999999999998778788899999999999999


Q ss_pred             ccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccccc
Q 035998          361 FSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI  440 (1020)
Q Consensus       361 l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  440 (1020)
                      +++..|..+..+++|++|++++|++.                                                      
T Consensus       193 l~~~~~~~~~~l~~L~~L~l~~N~~~------------------------------------------------------  218 (272)
T 3rfs_A          193 LKSVPDGVFDRLTSLQYIWLHDNPWD------------------------------------------------------  218 (272)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBC------------------------------------------------------
T ss_pred             CCccCHHHHhCCcCCCEEEccCCCcc------------------------------------------------------
Confidence            99888888889999999999988742                                                      


Q ss_pred             chhhhcCCCCcEEecccccccccccccccCcCcC
Q 035998          441 PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDL  474 (1020)
Q Consensus       441 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  474 (1020)
                          +.+++|+.|+++.|+++|.+|.+++.+...
T Consensus       219 ----~~~~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          219 ----CTCPGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             ----CCTTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             ----ccCcHHHHHHHHHHhCCCcccCcccccCCC
Confidence                123457778888888888888888776653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=1.8e-27  Score=288.73  Aligned_cols=373  Identities=18%  Similarity=0.219  Sum_probs=218.9

Q ss_pred             cccccccccccccccccccchhhh-hhccccccccccc-ccCCC-CCcccccCCCccEEEccCCcCcccCccccc----C
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIF-QLQKLRLLGLQDN-QLSGK-LSPSIADLSNLVRLDVSSNNFSGNIPDVFA----G  275 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~  275 (1020)
                      .+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            344555555555555544444443 4555555555555 33321 222233455555555555555543333332    3


Q ss_pred             Ccccceeeccccc--cccc-CCCCCcCCccccccccccc-ccccccccCCCCCCCcCEEEcCC-------CccCCCCCCC
Q 035998          276 LGEFQYLVAHSNR--FTGR-IPHSLSNSPTLNLLNLRNN-SLDGSLLLNCPALTNLTSLDLGT-------NKFNGPLPTN  344 (1020)
Q Consensus       276 l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-------N~l~~~~p~~  344 (1020)
                      +++|+.|++++|.  ++.. ++..+.++++|+.|++++| .+++ ++..+..+++|+.|+++.       |.+.+ ++..
T Consensus       183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~  260 (594)
T 2p1m_B          183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVA  260 (594)
T ss_dssp             CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHH
T ss_pred             CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHH
Confidence            4455666665554  1110 1111233566777777766 3333 445555667777777543       44443 3346


Q ss_pred             CCCCCCCCeE-ecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccc
Q 035998          345 LPRCRKLKNI-NLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF  423 (1020)
Q Consensus       345 l~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~  423 (1020)
                      +.++++|+.| .+.+... +.++..+..+++|++|++++|.++... ....+..+++|+.|+++.|.....+. .....+
T Consensus       261 l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~-l~~~~~~~~~L~~L~l~~~~~~~~l~-~l~~~~  337 (594)
T 2p1m_B          261 LSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYD-LVKLLCQCPKLQRLWVLDYIEDAGLE-VLASTC  337 (594)
T ss_dssp             HHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHH-HHHHHTTCTTCCEEEEEGGGHHHHHH-HHHHHC
T ss_pred             HhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHH-HHHHHhcCCCcCEEeCcCccCHHHHH-HHHHhC
Confidence            7888999999 4554433 345666667899999999999966422 12335678888888888762211110 011246


Q ss_pred             cCceEEEecc---------cccccccchhhh-cCCCCcEEeccccccccccccccc-CcCcCcEEeCC--C----Ccccc
Q 035998          424 ANLKVLVIAS---------CGLRGSIPQWLR-GCSKLQLVDLSWNQLSGTIPVWFG-GFQDLFYLDLS--N----NTFTG  486 (1020)
Q Consensus       424 ~~L~~L~l~~---------n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~  486 (1020)
                      ++|+.|++.+         +.+++.....+. ++++|+.|+++.|++++..+..+. .+++|+.|+|+  +    |.+++
T Consensus       338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~  417 (594)
T 2p1m_B          338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL  417 (594)
T ss_dssp             TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred             CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence            7788888833         344433333333 478888888888888766665554 57888888888  3    44442


Q ss_pred             cCC-----CCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccC-CCcceE
Q 035998          487 EIP-----KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN-LKKLHV  560 (1020)
Q Consensus       487 ~~p-----~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~-L~~L~~  560 (1020)
                      ...     ..+.++++|                                    +.|+|++ .+++..+..++. +++|+.
T Consensus       418 ~~~~~~~~~l~~~~~~L------------------------------------~~L~L~~-~l~~~~~~~l~~~~~~L~~  460 (594)
T 2p1m_B          418 EPLDIGFGAIVEHCKDL------------------------------------RRLSLSG-LLTDKVFEYIGTYAKKMEM  460 (594)
T ss_dssp             CCTHHHHHHHHHHCTTC------------------------------------CEEECCS-SCCHHHHHHHHHHCTTCCE
T ss_pred             CchhhHHHHHHhhCCCc------------------------------------cEEeecC-cccHHHHHHHHHhchhccE
Confidence            110     112223333                                    3566655 555554555555 788999


Q ss_pred             EEecCCcceeccCccc-cCCCcccEEEccCCcccccCCc-ccccccccccccccccccc
Q 035998          561 FDLKHNNLSGPIPSEL-TGMTSLETLDLSYNNLSGAIPI-SLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       561 L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~g~ip~-~l~~l~~L~~l~ls~N~l~  617 (1020)
                      |+|++|.+++..+..+ ..+++|++|+|++|.+++..+. .+..+++|+.|++++|+++
T Consensus       461 L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             EEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             eeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            9999998876555555 6688899999999988755444 3455888999999998874

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=1.1e-23  Score=229.75  Aligned_cols=177  Identities=21%  Similarity=0.170  Sum_probs=104.0

Q ss_pred             cccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccc
Q 035998          207 LEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS  286 (1020)
Q Consensus       207 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  286 (1020)
                      ++.|+|++|++++..+..|..+++|++|+|++|+|++..+  ...+++|++|+|++|+++ .+|..+.++++|++|++++
T Consensus        33 l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~  109 (290)
T 1p9a_G           33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF  109 (290)
T ss_dssp             CCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCS
T ss_pred             CCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCC
Confidence            3333333333333333334444444444444444432211  134455555555555555 4445555555566666666


Q ss_pred             ccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc
Q 035998          287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP  366 (1020)
Q Consensus       287 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  366 (1020)
                      |++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|
T Consensus       110 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip  188 (290)
T 1p9a_G          110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP  188 (290)
T ss_dssp             SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCC
T ss_pred             CcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccC
Confidence            6665555556666666666666666666665666666777777777777777555556677777777777777777 566


Q ss_pred             ccccCCCCCCeeeCCCCCCcc
Q 035998          367 ETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       367 ~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      ..+..+.+|+.|+|++|++..
T Consensus       189 ~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          189 KGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             TTTTTTCCCSEEECCSCCBCC
T ss_pred             hhhcccccCCeEEeCCCCccC
Confidence            666667777788888777653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.90  E-value=1.6e-23  Score=228.36  Aligned_cols=202  Identities=27%  Similarity=0.255  Sum_probs=187.0

Q ss_pred             CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccc
Q 035998          154 NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRL  233 (1020)
Q Consensus       154 ~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  233 (1020)
                      ++++|+++++++|.++ .+|..++   ++++.|+|++|.+++..+..|.++++|++|+|++|.+++..+.  ..+++|++
T Consensus         8 ~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~   81 (290)
T 1p9a_G            8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT   81 (290)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred             ccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence            6889999999999998 8888774   6899999999999998889999999999999999999965443  78999999


Q ss_pred             ccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccc
Q 035998          234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL  313 (1020)
Q Consensus       234 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  313 (1020)
                      |+|++|+++ .+|..+..+++|++|+|++|+|++..|..|.++++|++|++++|++++..+..|..+++|+.|+|++|++
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            999999999 6788899999999999999999988889999999999999999999998888899999999999999999


Q ss_pred             ccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc
Q 035998          314 DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +...+..|..+++|++|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus       161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            9888888899999999999999999 788888889999999999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.2e-24  Score=257.40  Aligned_cols=186  Identities=16%  Similarity=0.146  Sum_probs=146.7

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--------hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--------QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ...++||+|+||.||+|.. .++.+|+|+......        ...+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 578899998654321        1134588999999999999999777777778888999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++++|.+++..            +..++.|+++||+|||++   +|+||||||+||+++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999875            458999999999999999   9999999999999998  99999999999874


Q ss_pred             CCCCcc-----cccccccccCccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 035998          897 SPYDTH-----VTTDLVGTLGYIPPEYGQA--SVATYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       897 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      ......     ......||+.|||||++..  ..|+.++|+|+..+-..+.+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            322111     1235689999999999876  668888999999998888888777663

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=1.8e-23  Score=223.41  Aligned_cols=190  Identities=22%  Similarity=0.272  Sum_probs=138.1

Q ss_pred             CCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeec
Q 035998           61 DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDL  140 (1020)
Q Consensus        61 ~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  140 (1020)
                      +||.|.|.+|..             ..+.+++.+++++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|
T Consensus         3 ~Cp~~~gC~C~~-------------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   66 (251)
T 3m19_A            3 TCETVTGCTCNE-------------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNL   66 (251)
T ss_dssp             -CHHHHSSEEEG-------------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCCCceEcCC-------------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEEC
Confidence            688999999953             3446788888887 4666555  68999999999999888888999999999999


Q ss_pred             cCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccc
Q 035998          141 SSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG  219 (1020)
Q Consensus       141 ~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  219 (1020)
                      ++|.|++..+..+ ++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..|..+++|++|+|++|++++
T Consensus        67 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  145 (251)
T 3m19_A           67 DYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS  145 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence            9999998888777 7888888888888887 5565555667777777777777776555556666666666666666665


Q ss_pred             ccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcc
Q 035998          220 GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG  267 (1020)
Q Consensus       220 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  267 (1020)
                      ..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++
T Consensus       146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            555556666666666666666665555556666666666666666553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=2.4e-25  Score=249.45  Aligned_cols=267  Identities=15%  Similarity=0.187  Sum_probs=151.3

Q ss_pred             CCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCC--CCCcEEecCCCCCCCCCCccccCCCCCCe
Q 035998           60 SDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNL--VQLRFLNLSHNLLKGTVPVSLVNLPNLEV  137 (1020)
Q Consensus        60 ~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  137 (1020)
                      .-|.+|+++.|+..            .++.++++++.+.   +..+..+  ++++.|++++|.+++..+. +..+++|++
T Consensus        34 ~vc~~W~~~~~~~~------------~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~   97 (336)
T 2ast_B           34 GVCKRWYRLASDES------------LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQH   97 (336)
T ss_dssp             SSCHHHHHHHTCST------------TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCE
T ss_pred             HHHHHHHHHhcCch------------hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCE
Confidence            34667999998642            3556777766655   3445555  6667777777766654443 445666666


Q ss_pred             eeccCCCCCCC-CCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          138 LDLSSNDLSGP-LPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       138 L~L~~n~l~~~-~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      |+|++|.+++. +|..+ .+++|++|+|++|.+++                         ..+..++.+++|++|+|++|
T Consensus        98 L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~-------------------------~~~~~l~~~~~L~~L~L~~~  152 (336)
T 2ast_B           98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSD-------------------------PIVNTLAKNSNLVRLNLSGC  152 (336)
T ss_dssp             EECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCH-------------------------HHHHHHTTCTTCSEEECTTC
T ss_pred             EEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCH-------------------------HHHHHHhcCCCCCEEECCCC
Confidence            66666666543 34333 45555555555555543                         33444444555555555555


Q ss_pred             -cccc-ccchhhhhhccccccccccc-ccCCC-CCcccccCC-CccEEEccCC--cCc-ccCcccccCCcccceeecccc
Q 035998          216 -DLTG-GIADDIFQLQKLRLLGLQDN-QLSGK-LSPSIADLS-NLVRLDVSSN--NFS-GNIPDVFAGLGEFQYLVAHSN  287 (1020)
Q Consensus       216 -~l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~L~~N  287 (1020)
                       .+++ .++..+..+++|++|++++| ++++. ++..+..++ +|++|++++|  .++ +.+|..+..+++|++|++++|
T Consensus       153 ~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~  232 (336)
T 2ast_B          153 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS  232 (336)
T ss_dssp             BSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTC
T ss_pred             CCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCC
Confidence             3443 24444555555555555555 55532 344455555 6666666666  333 334455555666666666666


Q ss_pred             c-ccccCCCCCcCCcccccccccccc-cccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCC-CCCCeEecCCCccccc
Q 035998          288 R-FTGRIPHSLSNSPTLNLLNLRNNS-LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRC-RKLKNINLARNNFSGQ  364 (1020)
Q Consensus       288 ~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~  364 (1020)
                      . +++..+..+..+++|+.|++++|. +.......+..+++|++|++++| ++   ...+..+ .+|+.|++++|++++.
T Consensus       233 ~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~  308 (336)
T 2ast_B          233 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTI  308 (336)
T ss_dssp             TTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCT
T ss_pred             CcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccc
Confidence            5 555555556666666666666663 32222224556777777777777 32   2233333 2366667777777777


Q ss_pred             CcccccC
Q 035998          365 IPETYKN  371 (1020)
Q Consensus       365 ~p~~~~~  371 (1020)
                      .|..++.
T Consensus       309 ~~~~~~~  315 (336)
T 2ast_B          309 ARPTIGN  315 (336)
T ss_dssp             TCSSCSS
T ss_pred             cCCcccc
Confidence            7766554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=7.9e-25  Score=247.53  Aligned_cols=251  Identities=21%  Similarity=0.222  Sum_probs=182.3

Q ss_pred             EecCCCcccccccccccCCCCCcEEecCCCCCCCCCC----ccccCCC-CCCeeeccCCCCCCCCCCcc-CC-----CCc
Q 035998           90 LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVP----VSLVNLP-NLEVLDLSSNDLSGPLPQTI-NL-----PSI  158 (1020)
Q Consensus        90 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~~-~l-----~~L  158 (1020)
                      ..++.++++|.+|..+...++|++|+|++|.+++..+    ..|.+++ +|++|+|++|+|++..+..+ .+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4677888898888888888889999999999986666    7788888 89999999999988777665 43     889


Q ss_pred             ceeeeccCccCCCCCccccc---cC-CcccEEEccCCCCCCCCCCcccc-----ccccccccccccccccccchhh----
Q 035998          159 QVLDISSNSLNGSVPTSICK---NS-SRIRVINLSVNYFSGTLSPGLGN-----CASLEHLCLGMNDLTGGIADDI----  225 (1020)
Q Consensus       159 ~~L~Ls~N~l~~~ip~~~~~---~~-~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~~~~~----  225 (1020)
                      ++|+|++|++++..+..++.   .. ++|+.|+|++|.+++..+..++.     .++|++|+|++|.+++..+..+    
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            99999999988655554432   23 78888999988888766554433     2588888888888885444443    


Q ss_pred             hhhc-ccccccccccccCCCCCccccc----C-CCccEEEccCCcCccc----CcccccC-CcccceeecccccccccCC
Q 035998          226 FQLQ-KLRLLGLQDNQLSGKLSPSIAD----L-SNLVRLDVSSNNFSGN----IPDVFAG-LGEFQYLVAHSNRFTGRIP  294 (1020)
Q Consensus       226 ~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~p  294 (1020)
                      ..++ +|++|+|++|++++..+..+..    . ++|++|+|++|.|++.    ++..+.. .++|++|++++|++++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            4444 8888888888888766655443    3 5888888888888763    3444544 3478888888888876543


Q ss_pred             ----CCCcCCcccccccccccccccc-------cccCCCCCCCcCEEEcCCCccCCC
Q 035998          295 ----HSLSNSPTLNLLNLRNNSLDGS-------LLLNCPALTNLTSLDLGTNKFNGP  340 (1020)
Q Consensus       295 ----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l~~~  340 (1020)
                          ..+..+++|+.|+|++|.+.+.       ++..+..+++|+.||+++|++.+.
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence                3456667788888888874432       233566677777777777777654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=2.5e-23  Score=220.57  Aligned_cols=220  Identities=20%  Similarity=0.230  Sum_probs=119.7

Q ss_pred             CCCCCCCcC-ce--EEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCC-CCCCCCccccCC
Q 035998           57 ASSSDCCHW-VG--ITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNL-LKGTVPVSLVNL  132 (1020)
Q Consensus        57 ~~~~~~C~w-~g--v~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l  132 (1020)
                      ++..+.|.+ .+  |.|..  .+.+|. .+ ..++.|++++|++++..+..++++++|++|+|++|. +++..+..|.++
T Consensus         4 cp~~C~C~~~~~~~v~c~~--l~~ip~-~~-~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l   79 (239)
T 2xwt_C            4 SSPPCECHQEEDFRVTCKD--IQRIPS-LP-PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL   79 (239)
T ss_dssp             CSSSCSEEECSTTEEEECS--CSSCCC-CC-TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESC
T ss_pred             CCCCCeeCCCCcceeEccC--ccccCC-CC-CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCC
Confidence            344444643 54  55975  444554 22 355555555555555444455555555555555554 543333345555


Q ss_pred             CCCCeeeccC-CCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccc--
Q 035998          133 PNLEVLDLSS-NDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLE--  208 (1020)
Q Consensus       133 ~~L~~L~L~~-n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~--  208 (1020)
                      ++|++|+|++ |++++..+..+ ++++|++|+|++|++++ +|.                          |+.+++|+  
T Consensus        80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~--------------------------~~~l~~L~~L  132 (239)
T 2xwt_C           80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD--------------------------LTKVYSTDIF  132 (239)
T ss_dssp             TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC--------------------------CTTCCBCCSE
T ss_pred             cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc--------------------------cccccccccc
Confidence            5555555555 55555444444 45555555555555542 333                          44444444  


Q ss_pred             -ccccccc-ccccccchhhhhhcccc-cccccccccCCCCCcccccCCCccEEEccCCc-CcccCcccccCC-cccceee
Q 035998          209 -HLCLGMN-DLTGGIADDIFQLQKLR-LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN-FSGNIPDVFAGL-GEFQYLV  283 (1020)
Q Consensus       209 -~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~  283 (1020)
                       +|++++| ++++..+..|.++++|+ +|++++|+++...+..+.. ++|++|++++|+ +++..+..|.++ ++|+.|+
T Consensus       133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~  211 (239)
T 2xwt_C          133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD  211 (239)
T ss_dssp             EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred             cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence             5566655 55544445555566666 6666666665322233333 566666666663 665556666666 6677777


Q ss_pred             cccccccccCCCCCcCCccccccccccc
Q 035998          284 AHSNRFTGRIPHSLSNSPTLNLLNLRNN  311 (1020)
Q Consensus       284 L~~N~l~~~~p~~~~~l~~L~~L~L~~N  311 (1020)
                      +++|++++..+.   .+++|+.|+++++
T Consensus       212 l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          212 VSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCCccccCChh---HhccCceeeccCc
Confidence            777766644333   3456666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2.8e-23  Score=229.42  Aligned_cols=225  Identities=16%  Similarity=0.177  Sum_probs=165.8

Q ss_pred             CCCcEEecCCCCCCCCCCc---cccCCCCCCeeeccCCCCCCCCCCcc---CCCCcceeeeccCccCCCCCc---ccccc
Q 035998          109 VQLRFLNLSHNLLKGTVPV---SLVNLPNLEVLDLSSNDLSGPLPQTI---NLPSIQVLDISSNSLNGSVPT---SICKN  179 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~---~l~~l~~L~~L~L~~n~l~~~~p~~~---~l~~L~~L~Ls~N~l~~~ip~---~~~~~  179 (1020)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+   .+++|++|+|++|++++..|.   ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            3467777777776522110   12234668888888888887777663   578888888888888765551   22236


Q ss_pred             CCcccEEEccCCCCCCCCCCccccccccccccccccccccc--c--chhhhhhcccccccccccccCCCCCc----cccc
Q 035998          180 SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGG--I--ADDIFQLQKLRLLGLQDNQLSGKLSP----SIAD  251 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~  251 (1020)
                      +++|++|+|++|++.+..+..|+++++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++ .++.    .+.+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence            77888888888888877778888888888888888887642  2  122357788888888888887 3333    2567


Q ss_pred             CCCccEEEccCCcCcccCcccccCC---cccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcC
Q 035998          252 LSNLVRLDVSSNNFSGNIPDVFAGL---GEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLT  328 (1020)
Q Consensus       252 l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  328 (1020)
                      +++|++|+|++|++++..|..+..+   ++|++|++++|+|+ .+|..+.  ++|+.|+|++|++++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            7888888888888888777777766   58899999999988 5566664  7899999999999865 22 67789999


Q ss_pred             EEEcCCCccCC
Q 035998          329 SLDLGTNKFNG  339 (1020)
Q Consensus       329 ~L~L~~N~l~~  339 (1020)
                      .|+|++|+|+.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            99999999874

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.89  E-value=3.9e-23  Score=219.16  Aligned_cols=196  Identities=15%  Similarity=0.171  Sum_probs=131.9

Q ss_pred             cccEEEccCCCCCCCCCCccccccccccccccccc-cccccchhhhhhcccccccccc-cccCCCCCcccccCCCccEEE
Q 035998          182 RIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMND-LTGGIADDIFQLQKLRLLGLQD-NQLSGKLSPSIADLSNLVRLD  259 (1020)
Q Consensus       182 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  259 (1020)
                      +|+.|++++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            56666666666665555566666677777777775 6655555666667777777776 677655556677777777777


Q ss_pred             ccCCcCcccCcccccCCcccc---eeecccc-cccccCCCCCcCCcccc-cccccccccccccccCCCCCCCcCEEEcCC
Q 035998          260 VSSNNFSGNIPDVFAGLGEFQ---YLVAHSN-RFTGRIPHSLSNSPTLN-LLNLRNNSLDGSLLLNCPALTNLTSLDLGT  334 (1020)
Q Consensus       260 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  334 (1020)
                      +++|++++ +|. |..+++|+   +|++++| ++++..+..|.++++|+ .|++++|+++...+..+.. ++|++|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            77777765 444 66666666   7777777 77766666677777777 7777777777444444544 6777777777


Q ss_pred             Cc-cCCCCCCCCCCC-CCCCeEecCCCcccccCcccccCCCCCCeeeCCCC
Q 035998          335 NK-FNGPLPTNLPRC-RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS  383 (1020)
Q Consensus       335 N~-l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  383 (1020)
                      |+ +++..+..|..+ ++|+.|++++|++++. |..  .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence            74 776666677777 7777777777777743 332  5667777777765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=5.1e-25  Score=251.69  Aligned_cols=258  Identities=20%  Similarity=0.254  Sum_probs=160.9

Q ss_pred             CCCCCcCCccccccccccccccccc----ccCCCCCCCcCEEEcCCC---ccCCCCCCCC-------CCCCCCCeEecCC
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSL----LLNCPALTNLTSLDLGTN---KFNGPLPTNL-------PRCRKLKNINLAR  358 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N---~l~~~~p~~l-------~~l~~L~~L~L~~  358 (1020)
                      ++..+..+++|+.|+|++|.++...    +..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            3444555566666666666666542    234666777778877775   3444455444       5778888888888


Q ss_pred             Ccccc----cCcccccCCCCCCeeeCCCCCCcchhhHHHHHhh-hcccchhhhhccccCCCCCCCccccccCceEEEecc
Q 035998          359 NNFSG----QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQ-CRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIAS  433 (1020)
Q Consensus       359 N~l~~----~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~-l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~  433 (1020)
                      |++++    .+|..+..+++|++|+|++|.++.....  .+.. +..+....+...             .++|+.|++++
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~l~~~~~~~~-------------~~~L~~L~L~~  168 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA--KIARALQELAVNKKAKN-------------APPLRSIICGR  168 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHH--HHHHHHHHHHHHHHHHT-------------CCCCCEEECCS
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHH--HHHHHHHHHhhhhhccc-------------CCCCcEEECCC
Confidence            88886    4677788888888888888887643221  1111 111111111000             03455555555


Q ss_pred             cccc-cccc---hhhhcCCCCcEEeccccccc--c---cccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCc
Q 035998          434 CGLR-GSIP---QWLRGCSKLQLVDLSWNQLS--G---TIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS  504 (1020)
Q Consensus       434 n~l~-~~~p---~~l~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s  504 (1020)
                      |.+. +.+|   ..+..+++|+.|+|++|+|+  |   ..|..+..+++|++|+|++|.++..-                
T Consensus       169 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g----------------  232 (386)
T 2ca6_A          169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG----------------  232 (386)
T ss_dssp             SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH----------------
T ss_pred             CCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH----------------
Confidence            5554 2333   34455556666666666555  2   23335555555666666555554100                


Q ss_pred             CCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceec----cCccc--cC
Q 035998          505 LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP----IPSEL--TG  578 (1020)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~----~p~~~--~~  578 (1020)
                                                              .+.+|..+..+++|+.|+|++|++++.    +|..+  +.
T Consensus       233 ----------------------------------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~  272 (386)
T 2ca6_A          233 ----------------------------------------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE  272 (386)
T ss_dssp             ----------------------------------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCS
T ss_pred             ----------------------------------------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhcc
Confidence                                                    023445667778889999999998765    56666  44


Q ss_pred             CCcccEEEccCCcccc----cCCccc-cccccccccccccccccccCC
Q 035998          579 MTSLETLDLSYNNLSG----AIPISL-EKLSFLSKFSVANNHLTGRIP  621 (1020)
Q Consensus       579 l~~L~~L~Ls~N~l~g----~ip~~l-~~l~~L~~l~ls~N~l~g~~p  621 (1020)
                      +++|++|+|++|++++    .+|..+ .++++|+.|++++|++++..|
T Consensus       273 ~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          273 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             SCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            8899999999999987    488888 668999999999999987554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=5.1e-25  Score=249.09  Aligned_cols=47  Identities=15%  Similarity=0.204  Sum_probs=32.2

Q ss_pred             hhhcCCCCcEEeccccccccc-------ccccccCcCcCcEEeCCCCcccccCC
Q 035998          443 WLRGCSKLQLVDLSWNQLSGT-------IPVWFGGFQDLFYLDLSNNTFTGEIP  489 (1020)
Q Consensus       443 ~l~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p  489 (1020)
                      .+..+++|+.|+|++|++.+.       ++..+..+++|+.|||++|++.+..+
T Consensus       248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          248 LKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             TTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            345567788888888874432       34466777888888888888775533

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=2.2e-23  Score=230.32  Aligned_cols=202  Identities=20%  Similarity=0.266  Sum_probs=150.7

Q ss_pred             CcccEEEccCCCCCCCCCCcc--ccccccccccccccccccccc----hhhhhhcccccccccccccCCCCCcccccCCC
Q 035998          181 SRIRVINLSVNYFSGTLSPGL--GNCASLEHLCLGMNDLTGGIA----DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSN  254 (1020)
Q Consensus       181 ~~L~~L~L~~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  254 (1020)
                      ++|++|++++|.+++..|..+  +.+++|++|+|++|.+++..+    ..+..+++|++|+|++|++++..+..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            345555555555555666665  677777777777777776444    34456788888888888888777788888888


Q ss_pred             ccEEEccCCcCccc---C-cccccCCcccceeecccccccccCC--C-CCcCCcccccccccccccccccccCCCCC---
Q 035998          255 LVRLDVSSNNFSGN---I-PDVFAGLGEFQYLVAHSNRFTGRIP--H-SLSNSPTLNLLNLRNNSLDGSLLLNCPAL---  324 (1020)
Q Consensus       255 L~~L~Ls~N~l~~~---~-p~~~~~l~~L~~L~L~~N~l~~~~p--~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l---  324 (1020)
                      |++|+|++|++.+.   . +..+..+++|++|++++|+++...+  . .++++++|++|+|++|++++..|..+..+   
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            88888888887652   2 2334678888888888888863221  1 24677888889999998888777666655   


Q ss_pred             CCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       325 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      ++|++|+|++|+|+ .+|..+.  ++|++|+|++|++++. |. +..+++|+.|++++|+|+.
T Consensus       251 ~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          251 SALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            68999999999998 6677765  7899999999999864 33 6778899999999998754

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=8e-23  Score=229.81  Aligned_cols=216  Identities=19%  Similarity=0.193  Sum_probs=137.5

Q ss_pred             CCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCc-cccCCCCCCe-e
Q 035998           61 DCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV-SLVNLPNLEV-L  138 (1020)
Q Consensus        61 ~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~-L  138 (1020)
                      +.|+|..|.|++...+.||.+++ .+++.|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. .|.++++|++ +
T Consensus         7 C~C~~~~v~C~~~~Lt~iP~~l~-~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l   85 (350)
T 4ay9_X            7 CHCSNRVFLCQESKVTEIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   85 (350)
T ss_dssp             SEEETTEEEEESTTCCSCCTTCC-TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred             cEeeCCEEEecCCCCCccCcCcC-CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence            45899999999888888887764 4677888888888765556678888888888888887665654 5677777665 5


Q ss_pred             eccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccC-CCCCCCCCCcccccc-cccccccccc
Q 035998          139 DLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSV-NYFSGTLSPGLGNCA-SLEHLCLGMN  215 (1020)
Q Consensus       139 ~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~-N~l~~~~~~~l~~l~-~L~~L~L~~N  215 (1020)
                      ++++|+|+...|..+ .+++|++|++++|+++ .+|...+....++..+++.+ |++....+..|..+. .++.|+|++|
T Consensus        86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X           86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             EEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             cccCCcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            556678877777776 6778888888888777 44444444455566666654 455544444555543 4566666666


Q ss_pred             ccccccchhhhhhcccccccccc-cccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccc
Q 035998          216 DLTGGIADDIFQLQKLRLLGLQD-NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEF  279 (1020)
Q Consensus       216 ~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  279 (1020)
                      +|+ .++...+...+|+.|++++ |.++...+.+|.++++|++|||++|+|+...+..|.++++|
T Consensus       165 ~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L  228 (350)
T 4ay9_X          165 GIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL  228 (350)
T ss_dssp             CCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred             ccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHh
Confidence            666 3444444445556666553 44443333455555666666666666554444444433333

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2.1e-22  Score=208.49  Aligned_cols=186  Identities=22%  Similarity=0.246  Sum_probs=112.6

Q ss_pred             CCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCe
Q 035998           58 SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEV  137 (1020)
Q Consensus        58 ~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  137 (1020)
                      +..+.|.|.+|.|+..+.+.+|.... .+++.|++++|.+++..+..++++++|++|+|++|++++..+..|..+++|++
T Consensus         2 p~~C~C~~~~v~c~~~~l~~~p~~~~-~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   80 (208)
T 2o6s_A            2 PSRCSCSGTTVECYSQGRTSVPTGIP-AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY   80 (208)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCEECCCEEEecCCCccCCCCCCC-CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCE
Confidence            44567999999999877766665553 36666666666666555555666666666666666666544445566666666


Q ss_pred             eeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccc
Q 035998          138 LDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMND  216 (1020)
Q Consensus       138 L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  216 (1020)
                      |+|++|++++.++..+ ++++|++|+|++|+++ .+|...+..+++|+.|+|++|++++..+..|..+++|++|+|++|.
T Consensus        81 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  159 (208)
T 2o6s_A           81 LNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  159 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred             EECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence            6666666666555554 5666666666666665 4444444555556666666666655444445555555555555555


Q ss_pred             cccccchhhhhhcccccccccccccCCCCCcccccC
Q 035998          217 LTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADL  252 (1020)
Q Consensus       217 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  252 (1020)
                      +.+.       +++|++|+++.|+++|.+|..++.+
T Consensus       160 ~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l  188 (208)
T 2o6s_A          160 WDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  188 (208)
T ss_dssp             BCCC-------TTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred             eecC-------CCCHHHHHHHHHhCCceeeccCccc
Confidence            5432       2345555555555555555544443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=8.8e-25  Score=249.72  Aligned_cols=192  Identities=22%  Similarity=0.335  Sum_probs=116.0

Q ss_pred             ccCCCccEEEccCCcCcc----cCcccccCCcccceeecccccccccCCCCCc----CC---------cccccccccccc
Q 035998          250 ADLSNLVRLDVSSNNFSG----NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS----NS---------PTLNLLNLRNNS  312 (1020)
Q Consensus       250 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~L~~N~  312 (1020)
                      ..+++|++|+|++|.+++    .+|..+..+++|++|+|++|++++..+..+.    .+         ++|++|+|++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            344555555555555554    2444455555555555555555433222222    12         566666666666


Q ss_pred             cc-cccc---cCCCCCCCcCEEEcCCCccC--C---CCCCCCCCCCCCCeEecCCCccc----ccCcccccCCCCCCeee
Q 035998          313 LD-GSLL---LNCPALTNLTSLDLGTNKFN--G---PLPTNLPRCRKLKNINLARNNFS----GQIPETYKNFESLSYLS  379 (1020)
Q Consensus       313 l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~  379 (1020)
                      ++ +..+   ..+..+++|++|+|++|+|+  |   ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            65 2222   23445566777777777666  2   33446666777777777777775    45666666777777777


Q ss_pred             CCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhh--cCCCCcEEeccc
Q 035998          380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLR--GCSKLQLVDLSW  457 (1020)
Q Consensus       380 l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~--~l~~L~~L~Ls~  457 (1020)
                      |++|.|+.....                                               .+|..+.  .+++|+.|+|++
T Consensus       251 L~~n~i~~~~~~-----------------------------------------------~l~~~l~~~~~~~L~~L~L~~  283 (386)
T 2ca6_A          251 LNDCLLSARGAA-----------------------------------------------AVVDAFSKLENIGLQTLRLQY  283 (386)
T ss_dssp             CTTCCCCHHHHH-----------------------------------------------HHHHHHHTCSSCCCCEEECCS
T ss_pred             CCCCCCchhhHH-----------------------------------------------HHHHHHhhccCCCeEEEECcC
Confidence            777766543211                                               1344553  378888888888


Q ss_pred             ccccc----cccccc-cCcCcCcEEeCCCCcccccC
Q 035998          458 NQLSG----TIPVWF-GGFQDLFYLDLSNNTFTGEI  488 (1020)
Q Consensus       458 N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~  488 (1020)
                      |++++    .+|..+ .++++|++|+|++|++++..
T Consensus       284 n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             SCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            88886    477777 66888999999999888554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=7.9e-22  Score=210.62  Aligned_cols=178  Identities=22%  Similarity=0.242  Sum_probs=88.6

Q ss_pred             ccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccC
Q 035998          183 IRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS  262 (1020)
Q Consensus       183 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  262 (1020)
                      .+.++++++.++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~   92 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN   92 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence            344444444444 3333332  3444555555555444444444444444444444444444444444455555555555


Q ss_pred             CcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCC
Q 035998          263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP  342 (1020)
Q Consensus       263 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  342 (1020)
                      |++++..+..|..++                        +|++|+|++|++++..+..|..+++|++|+|++|+|++..+
T Consensus        93 n~l~~~~~~~~~~l~------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A           93 NQLASLPLGVFDHLT------------------------QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             SCCCCCCTTTTTTCT------------------------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CcccccChhHhcccC------------------------CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence            555444444444444                        44444444444444444444455555555555555554444


Q ss_pred             CCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          343 TNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       343 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      ..|..+++|++|+|++|++++..+..|..+++|++|++++|++..
T Consensus       149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            455555555555555555555555555555566666666665543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.87  E-value=1.9e-22  Score=226.69  Aligned_cols=201  Identities=13%  Similarity=0.097  Sum_probs=102.3

Q ss_pred             EEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccE-EEccC
Q 035998          113 FLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRV-INLSV  190 (1020)
Q Consensus       113 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~-L~L~~  190 (1020)
                      +++-++++++ .+|..+  .+++++|+|++|+|+.+++..+ ++++|++|+|++|++.+.+|...|.++++++. +.++.
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            3444555555 455444  2355566666666655544444 45566666666665554555555555554443 44445


Q ss_pred             CCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccc-cccCCCCCcccccCC-CccEEEccCCcCccc
Q 035998          191 NYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQD-NQLSGKLSPSIADLS-NLVRLDVSSNNFSGN  268 (1020)
Q Consensus       191 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~  268 (1020)
                      |+++...|..|.++++|++|++++|++++..+..+....++..|++.+ |+++...+..|..+. .++.|+|++|+|+.+
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i  169 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  169 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCC
Confidence            555555555566666666666666666544444444444455555533 344433334444442 455555555555543


Q ss_pred             CcccccCCcccceeecc-cccccccCCCCCcCCccccccccccccccccc
Q 035998          269 IPDVFAGLGEFQYLVAH-SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL  317 (1020)
Q Consensus       269 ~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  317 (1020)
                      .+..|. ..+|+.|++. +|.++.+.+..|.++++|++|+|++|+|+..+
T Consensus       170 ~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp  218 (350)
T 4ay9_X          170 HNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP  218 (350)
T ss_dssp             CTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred             Chhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence            333332 2345555554 24444333344555555555555555555433

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=5.2e-22  Score=218.71  Aligned_cols=214  Identities=22%  Similarity=0.344  Sum_probs=152.1

Q ss_pred             ccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceee
Q 035998          204 CASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV  283 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  283 (1020)
                      +..+..+.+..+.+++.+  .+..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+
T Consensus        18 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            445566667777766433  34567888888888888874 44 57788888888888888886544  77888888888


Q ss_pred             cccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc
Q 035998          284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       284 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +++|++++.  ..+..+++|+.|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|+|++|++++
T Consensus        92 L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             ccCCcCCCc--hhhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence            888887754  256777777777777777775432  6677777777777777775433  6677777777777777775


Q ss_pred             cCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchh
Q 035998          364 QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW  443 (1020)
Q Consensus       364 ~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~  443 (1020)
                      ..+  +..+++|+.|++++|+++.++                                                   +  
T Consensus       166 ~~~--l~~l~~L~~L~l~~n~l~~~~---------------------------------------------------~--  190 (308)
T 1h6u_A          166 LTP--LANLSKLTTLKADDNKISDIS---------------------------------------------------P--  190 (308)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCCG---------------------------------------------------G--
T ss_pred             Chh--hcCCCCCCEEECCCCccCcCh---------------------------------------------------h--
Confidence            333  667777777777777654432                                                   1  


Q ss_pred             hhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTG  486 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  486 (1020)
                      +..+++|+.|+|++|++++..|  +..+++|++|+|++|++++
T Consensus       191 l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            5667788888888888885543  7788888888888888874

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=1.9e-23  Score=234.04  Aligned_cols=250  Identities=20%  Similarity=0.232  Sum_probs=142.9

Q ss_pred             ccEEEccCCcCcccCcccccCC--cccceeecccccccccCCCCCcCCcccccccccccccccc-cccCCCCCCCcCEEE
Q 035998          255 LVRLDVSSNNFSGNIPDVFAGL--GEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGS-LLLNCPALTNLTSLD  331 (1020)
Q Consensus       255 L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~  331 (1020)
                      ++.+++++|.+.   +..+..+  ++++.|++++|.+++..+. +..+++|+.|++++|.+++. .+..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            566777777665   3445554  5666666666666655443 33455555555555555543 444444555555555


Q ss_pred             cCCCccCCCCCCCCCCCCCCCeEecCCC-ccccc-CcccccCCCCCCeeeCCCC-CCcchhhHHHHHhhhcccchhhhhc
Q 035998          332 LGTNKFNGPLPTNLPRCRKLKNINLARN-NFSGQ-IPETYKNFESLSYLSLSNS-SIYNLSSALQVLQQCRNLTTLVLTL  408 (1020)
Q Consensus       332 L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~i~~l~~~~~~l~~l~~L~~L~l~~  408 (1020)
                      |++|++++..+..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .++..                    
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~--------------------  184 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK--------------------  184 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH--------------------
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH--------------------
Confidence            5555555444444444555555555555 34431 3333444444555555444 33211                    


Q ss_pred             cccCCCCCCCccccccCceEEEecccccccccchhhhcCC-CCcEEecccc--ccc-ccccccccCcCcCcEEeCCCCc-
Q 035998          409 NFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCS-KLQLVDLSWN--QLS-GTIPVWFGGFQDLFYLDLSNNT-  483 (1020)
Q Consensus       409 n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-  483 (1020)
                                                    .++..+..++ +|++|++++|  .++ +.+|..+..+++|++|+|++|. 
T Consensus       185 ------------------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~  234 (336)
T 2ast_B          185 ------------------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM  234 (336)
T ss_dssp             ------------------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred             ------------------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence                                          1334455566 6667777766  343 3455566666666666666666 


Q ss_pred             ccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEe
Q 035998          484 FTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDL  563 (1020)
Q Consensus       484 l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~L  563 (1020)
                      +++.                                                            .+..++.+++|+.|+|
T Consensus       235 l~~~------------------------------------------------------------~~~~l~~l~~L~~L~l  254 (336)
T 2ast_B          235 LKND------------------------------------------------------------CFQEFFQLNYLQHLSL  254 (336)
T ss_dssp             CCGG------------------------------------------------------------GGGGGGGCTTCCEEEC
T ss_pred             CCHH------------------------------------------------------------HHHHHhCCCCCCEeeC
Confidence            4322                                                            2334556677888888


Q ss_pred             cCCc-ceeccCccccCCCcccEEEccCCcccccCCccccccc-cccccccccccccccCCC
Q 035998          564 KHNN-LSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLS-FLSKFSVANNHLTGRIPS  622 (1020)
Q Consensus       564 s~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~-~L~~l~ls~N~l~g~~p~  622 (1020)
                      ++|. ++......++++++|+.|+|++| ++.   ..+..+. .|..|++++|+++|..|.
T Consensus       255 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          255 SRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             CCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence            8885 32222235778888888888888 332   2455553 488888999999988875

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=1.1e-21  Score=216.25  Aligned_cols=194  Identities=25%  Similarity=0.354  Sum_probs=107.9

Q ss_pred             ccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCccc
Q 035998          105 LGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIR  184 (1020)
Q Consensus       105 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~  184 (1020)
                      +.++++|++|++++|.++ .+| .+..+++|++|+|++|.+++..+ ...+++|++|+|++|++++ +|  .+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~-~~--~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN-VS--AIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC-CG--GGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCC-ch--hhcCCCCCC
Confidence            345677777777777777 344 57777777777777777776555 3367777777777777663 33  234455555


Q ss_pred             EEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCc
Q 035998          185 VINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       185 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      .|+|++|++++. + .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++. +. +..+++|++|++++|+
T Consensus       111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCc
Confidence            555555555542 2 25555555555555555553322  44445555555555555432 21 4444555555555555


Q ss_pred             CcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccC
Q 035998          265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       265 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      ++                        +..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|+++
T Consensus       185 l~------------------------~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          185 IS------------------------DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CC------------------------CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             cC------------------------cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence            44                        3322  4445555555555555554432  455556666666666665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=2.1e-22  Score=237.75  Aligned_cols=203  Identities=26%  Similarity=0.325  Sum_probs=158.6

Q ss_pred             CCCCC-----cCceE-EcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCC
Q 035998           59 SSDCC-----HWVGI-TCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNL  132 (1020)
Q Consensus        59 ~~~~C-----~w~gv-~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l  132 (1020)
                      +.++|     .|.|+ .|..            ++++.|+|+++++++ +|..+.  ++|++|+|++|+|+ .+|   ..+
T Consensus        39 ~~~~~~~~~~~~~~l~~C~~------------~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l   99 (571)
T 3cvr_A           39 QALPGENRNEAVSLLKECLI------------NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELP   99 (571)
T ss_dssp             TCCTTCCHHHHHHHHHHHHH------------TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCC
T ss_pred             cCCccccccchhhhcccccc------------CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---ccc
Confidence            34566     79999 7853            478899999999987 777664  88999999999999 788   557


Q ss_pred             CCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccc
Q 035998          133 PNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCL  212 (1020)
Q Consensus       133 ~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  212 (1020)
                      ++|++|+|++|+|++ +|...+  +|++|+|++|+|++ +|.    .+++|+.|+|++|+|++ +|.   .+++|++|+|
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  167 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSV  167 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence            899999999999998 455224  89999999999985 776    47889999999999986 555   5678888899


Q ss_pred             cccccccccchhhhhhcccccccccccccCCCCCcccccCCCc-------cEEEccCCcCcccCcccccCCcccceeecc
Q 035998          213 GMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNL-------VRLDVSSNNFSGNIPDVFAGLGEFQYLVAH  285 (1020)
Q Consensus       213 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  285 (1020)
                      ++|+|++ +|. |.  ++|+.|+|++|+|+ .+|. +..  +|       ++|+|++|+|+ .+|..+..+++|+.|+++
T Consensus       168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~  238 (571)
T 3cvr_A          168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILE  238 (571)
T ss_dssp             CSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECC
T ss_pred             CCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEee
Confidence            9998886 666 55  78888888888888 5555 554  66       88888888888 466666668888888888


Q ss_pred             cccccccCCCCCcCCc
Q 035998          286 SNRFTGRIPHSLSNSP  301 (1020)
Q Consensus       286 ~N~l~~~~p~~~~~l~  301 (1020)
                      +|++++.+|..+..++
T Consensus       239 ~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          239 DNPLSSRIRESLSQQT  254 (571)
T ss_dssp             SSSCCHHHHHHHHHHH
T ss_pred             CCcCCCcCHHHHHHhh
Confidence            8888877777665543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=1.4e-21  Score=211.66  Aligned_cols=154  Identities=15%  Similarity=0.121  Sum_probs=124.0

Q ss_pred             cHHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch------------------hhHHHHHHHHHHHHH
Q 035998          733 SIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG------------------QMEREFRAEVEALSR  794 (1020)
Q Consensus       733 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~  794 (1020)
                      .+..+......|.+.+.||+|+||.||+|+..+|+.||||++.....                  .....+.+|++++++
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            34555666777888899999999999999997799999999964321                  134568899999999


Q ss_pred             cCCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCC
Q 035998          795 AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSS  874 (1020)
Q Consensus       795 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  874 (1020)
                      ++  | +++.+++. .+..++||||++|++|.+ +..          .....++.|++.||+|||+.   +|+||||||+
T Consensus       161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~  222 (282)
T 1zar_A          161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQY  222 (282)
T ss_dssp             TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence            99  5 67777554 356699999999999987 321          12457999999999999999   9999999999


Q ss_pred             CEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccC
Q 035998          875 NILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ  920 (1020)
Q Consensus       875 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  920 (1020)
                      ||+++ ++.+||+|||+++..               ..++|||++.
T Consensus       223 NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          223 NVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             SEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             HEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence            99999 999999999998743               3567888753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.4e-20  Score=222.18  Aligned_cols=197  Identities=25%  Similarity=0.381  Sum_probs=129.3

Q ss_pred             ccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecC
Q 035998          278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA  357 (1020)
Q Consensus       278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  357 (1020)
                      +|+.|++++|++++ +|..+.  ++|+.|+|++|+|+. +|   ..+++|++|+|++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            67777777777775 444442  566666666666663 33   335666666666666664 444 443  66666666


Q ss_pred             CCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccc
Q 035998          358 RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLR  437 (1020)
Q Consensus       358 ~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~  437 (1020)
                      +|+|++ +|.   .+++|++|++++|.|+.                                                  
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--------------------------------------------------  154 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM--------------------------------------------------  154 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC--------------------------------------------------
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc--------------------------------------------------
Confidence            666665 343   45556666666555432                                                  


Q ss_pred             cccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCccccee
Q 035998          438 GSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMR  517 (1020)
Q Consensus       438 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~  517 (1020)
                        +|.   .+++|+.|+|++|+|++ +|. |.  ++|++|+|++|+|+ .+|. +..  +|                   
T Consensus       155 --lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-------------------  202 (571)
T 3cvr_A          155 --LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-------------------  202 (571)
T ss_dssp             --CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC------------------------
T ss_pred             --CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh-------------------
Confidence              222   34677788888888875 666 55  77888888888777 4444 322  11                   


Q ss_pred             ecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCC
Q 035998          518 RNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIP  597 (1020)
Q Consensus       518 ~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip  597 (1020)
                                                        +.....|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus       203 ----------------------------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          203 ----------------------------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             ---------------------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ----------------------------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence                                              112234699999999998 689999999999999999999999999


Q ss_pred             ccccccccc
Q 035998          598 ISLEKLSFL  606 (1020)
Q Consensus       598 ~~l~~l~~L  606 (1020)
                      ..+.+++..
T Consensus       248 ~~l~~l~~~  256 (571)
T 3cvr_A          248 ESLSQQTAQ  256 (571)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHhhcC
Confidence            998887653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.3e-20  Score=194.95  Aligned_cols=150  Identities=20%  Similarity=0.245  Sum_probs=102.0

Q ss_pred             cccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccc
Q 035998          233 LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS  312 (1020)
Q Consensus       233 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  312 (1020)
                      .++++++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|+
T Consensus        11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~   87 (208)
T 2o6s_A           11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ   87 (208)
T ss_dssp             EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCc
Confidence            4555555555 334333  2467777777777776666666677777777777777776666666677777777777777


Q ss_pred             cccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCC
Q 035998          313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       313 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i  385 (1020)
                      +++..+..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++
T Consensus        88 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A           88 LQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             CCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            7766666667777777777777777766666677777777777777777766666677777777777777753

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1.3e-19  Score=190.29  Aligned_cols=159  Identities=21%  Similarity=0.261  Sum_probs=91.3

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLE  136 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  136 (1020)
                      +.+.+.|+|.+|.|+......+|...+ ..++.|+|++|.+++..|..+.++++|++|+|++|++++..+..|..+++|+
T Consensus        13 ~~~~~~Cs~~~v~c~~~~l~~ip~~~~-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~   91 (229)
T 3e6j_A           13 CPSQCSCSGTTVDCRSKRHASVPAGIP-TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT   91 (229)
T ss_dssp             CCTTCEEETTEEECTTSCCSSCCSCCC-TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CCCCCEEeCCEeEccCCCcCccCCCCC-CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence            456789999999999877666666544 4555556666655555555555555666666666555533334455555555


Q ss_pred             eeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          137 VLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      +|+|++|+|++.++..+ .+++|++|+|++|+|+ .+|..+ ..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  169 (229)
T 3e6j_A           92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN  169 (229)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence            56655555555555544 4555555555555555 444443 34455555555555555444444444555555555555


Q ss_pred             ccc
Q 035998          216 DLT  218 (1020)
Q Consensus       216 ~l~  218 (1020)
                      .+.
T Consensus       170 ~~~  172 (229)
T 3e6j_A          170 PWD  172 (229)
T ss_dssp             CBC
T ss_pred             Ccc
Confidence            444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=3e-19  Score=186.09  Aligned_cols=160  Identities=16%  Similarity=0.234  Sum_probs=110.0

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLE  136 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  136 (1020)
                      ++..+-|.|..|.|+....+.+|...+ ..++.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|+
T Consensus         5 CP~~C~C~~~~v~c~~~~l~~iP~~l~-~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~   83 (220)
T 2v9t_B            5 CPAACTCSNNIVDCRGKGLTEIPTNLP-ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN   83 (220)
T ss_dssp             SCTTSEEETTEEECTTSCCSSCCSSCC-TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCC
T ss_pred             CCCCCEECCCEEEcCCCCcCcCCCccC-cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCC
Confidence            556667999999999888777777655 4677777777777766666777777777777777777766677777777777


Q ss_pred             eeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          137 VLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      +|+|++|+|+..++..+ ++++|++|+|++|+++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        84 ~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  162 (220)
T 2v9t_B           84 SLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN  162 (220)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECCCCcCCccCHhHccCCCCCCEEECCCCCCC-EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence            77777777776666555 5677777777777666 333334455666666666666666555555666666666666666


Q ss_pred             ccc
Q 035998          216 DLT  218 (1020)
Q Consensus       216 ~l~  218 (1020)
                      .+.
T Consensus       163 ~~~  165 (220)
T 2v9t_B          163 PFI  165 (220)
T ss_dssp             CEE
T ss_pred             CcC
Confidence            654

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=2e-19  Score=214.85  Aligned_cols=172  Identities=24%  Similarity=0.334  Sum_probs=118.5

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      .+..+..+.+..+.++...+  +..+++|+.|++++|.++. ++ .+..+++|+.|+|++|+|++..|  +..+++|+.|
T Consensus        19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L   92 (605)
T 1m9s_A           19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWL   92 (605)
T ss_dssp             HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEE
T ss_pred             HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEE
Confidence            34556666777777765433  4677777777887777774 33 57777788888888887776554  7777777777


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      +|++|++++.  ..+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+++
T Consensus        93 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             ECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             ECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            7777777752  2567777777777777777653  2466677777777777777754  45667777777777777777


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcch
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                      +..|  +..+++|+.|+|++|+|..+
T Consensus       167 ~~~~--l~~l~~L~~L~Ls~N~i~~l  190 (605)
T 1m9s_A          167 DIVP--LAGLTKLQNLYLSKNHISDL  190 (605)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             Cchh--hccCCCCCEEECcCCCCCCC
Confidence            6555  67777777777777776554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=1.1e-20  Score=231.80  Aligned_cols=271  Identities=15%  Similarity=0.126  Sum_probs=98.6

Q ss_pred             CCHHHHHHHHHHHHHhccC----CCCCCCCCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCccccccccccc
Q 035998           31 CNPNDLAALEDFMKNFESG----IDGWGTNASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLG  106 (1020)
Q Consensus        31 ~~~~~~~aL~~~k~~~~~~----~~~~~~~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~  106 (1020)
                      ....++++|.++..+....    ...|.  ...+..+.|.++.++.            ++++.|+|.++.+... +.   
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~------------~~~~~l~L~~n~~~~~-~~---  190 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPT--GDSTPSGTATNSAVST------------PLTPKIELFANGKDEA-NQ---  190 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCc--CCCCccccCCCceecC------------CccceEEeeCCCCCcc-hh---
Confidence            4567889999999887532    22232  2345567898888864            5788999988888763 33   


Q ss_pred             CCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       107 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                        ..|+.++|+.|.|.+.              +++.|++. .+|..+ .+++|+.|+|++|.+. .+|..++ .+++|++
T Consensus       191 --~~l~~l~Ls~~~i~~~--------------~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~L~~  251 (727)
T 4b8c_D          191 --ALLQHKKLSQYSIDED--------------DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDFLTR  251 (727)
T ss_dssp             ------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGG-GCCSCSC
T ss_pred             --hHhhcCccCcccccCc--------------ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCCCCE
Confidence              2345555655555421              23333333 233333 4555555555555554 4444443 3444445


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcC
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF  265 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  265 (1020)
                      |+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|
T Consensus       252 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l  328 (727)
T 4b8c_D          252 LYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL  328 (727)
T ss_dssp             CBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred             EEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence            555555554 45555666666666666666666 55666667777777777777776 5566677777777777777777


Q ss_pred             cccCcccccCCcc-cceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCC
Q 035998          266 SGNIPDVFAGLGE-FQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN  344 (1020)
Q Consensus       266 ~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  344 (1020)
                      ++.+|..+..+.. +..++|++|.+++.+|..      |+.|++++|...   .             ...+.+.+..+..
T Consensus       329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---~-------------~~~~~l~~~~~~~  386 (727)
T 4b8c_D          329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---Q-------------REYDSLQQSTEHL  386 (727)
T ss_dssp             CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------------------------------------------------
T ss_pred             CCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccc---c-------------cccCCccccccch
Confidence            7777766654422 223566666666655543      334444444110   0             0011333344445


Q ss_pred             CCCCCCCCeEecCCCcccc
Q 035998          345 LPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       345 l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +..+.++....+++|-+.+
T Consensus       387 ~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          387 ATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             ---------------CCCG
T ss_pred             hhcccccceeeeecccccc
Confidence            5566666777777777653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=3.5e-19  Score=212.87  Aligned_cols=174  Identities=24%  Similarity=0.349  Sum_probs=94.0

Q ss_pred             cCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          106 GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                      ..|++|+.|++++|.++ .+| .|..+++|++|+|++|+|++.+| ...+++|++|+|++|.++                
T Consensus        40 ~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~----------------  100 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIK----------------  100 (605)
T ss_dssp             HHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCC----------------
T ss_pred             hcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCC----------------
Confidence            44555555555555554 233 35555555555555555554443 224555555555555544                


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcC
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF  265 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  265 (1020)
                               + + +.+..+++|++|+|++|++++.  ..+..+++|+.|+|++|+|++.  ..+..+++|++|+|++|+|
T Consensus       101 ---------~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l  165 (605)
T 1m9s_A          101 ---------D-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  165 (605)
T ss_dssp             ---------C-C-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCC
T ss_pred             ---------C-C-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcC
Confidence                     2 1 2455555555555555555532  2355555666666666666543  4555666666666666666


Q ss_pred             cccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccccc
Q 035998          266 SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL  317 (1020)
Q Consensus       266 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  317 (1020)
                      ++..|  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+.+..
T Consensus       166 ~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          166 SDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred             CCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence            65444  55666666666666666543  24556666666666666665443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.79  E-value=2e-19  Score=196.10  Aligned_cols=168  Identities=25%  Similarity=0.328  Sum_probs=92.3

Q ss_pred             ccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceee
Q 035998          204 CASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV  283 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  283 (1020)
                      +..+..+.+..+.+++..  .+..+++|+.|++++|.++.. + .+..+++|++|++++|++++..+  +..+++|++|+
T Consensus        23 l~~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            445556666666666432  245677777777777777643 3 46777777777777777775444  66666777777


Q ss_pred             cccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc
Q 035998          284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       284 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++
T Consensus        97 l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A           97 LDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             CCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence            776666642  1245555555555555555432  2334444555555555554432  234444444444444444443


Q ss_pred             cCcccccCCCCCCeeeCCCCCC
Q 035998          364 QIPETYKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       364 ~~p~~~~~l~~L~~L~l~~N~i  385 (1020)
                      ..|  +..+++|++|++++|.|
T Consensus       171 ~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          171 IVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             CGG--GTTCTTCCEEECCSSCC
T ss_pred             chh--hcCCCccCEEECCCCcC
Confidence            322  44444444444444443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=4.2e-19  Score=193.60  Aligned_cols=172  Identities=23%  Similarity=0.346  Sum_probs=94.1

Q ss_pred             cCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccE
Q 035998          106 GNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRV  185 (1020)
Q Consensus       106 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~  185 (1020)
                      ..+++|++|++++|.++. +| .+..+++|++|+|++|++++..+ ..++++|++|+|++|++++ +|.  +..+++|++
T Consensus        43 ~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~--l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LSS--LKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GGG--GTTCTTCCE
T ss_pred             hhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Chh--hccCCCCCE
Confidence            456667777777776663 33 36666777777777777766554 2256666666666666652 222  234444444


Q ss_pred             EEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcC
Q 035998          186 INLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNF  265 (1020)
Q Consensus       186 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  265 (1020)
                      |+|++|++++.                          ..+..+++|++|++++|++++.  ..+..+++|++|++++|++
T Consensus       117 L~L~~n~i~~~--------------------------~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l  168 (291)
T 1h6t_A          117 LSLEHNGISDI--------------------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI  168 (291)
T ss_dssp             EECTTSCCCCC--------------------------GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             EECCCCcCCCC--------------------------hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence            44444444432                          2344445555555555555432  3455555555555555555


Q ss_pred             cccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccc
Q 035998          266 SGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDG  315 (1020)
Q Consensus       266 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  315 (1020)
                      ++..|  +..+++|+.|++++|++++. + .+..+++|+.|++++|.++.
T Consensus       169 ~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          169 SDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            54333  55555555555555555543 2 25556666666666666654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.78  E-value=1.1e-18  Score=181.90  Aligned_cols=153  Identities=15%  Similarity=0.219  Sum_probs=122.7

Q ss_pred             ccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccc
Q 035998          232 RLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN  311 (1020)
Q Consensus       232 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  311 (1020)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            35566666666 4454443  57788888888888777777888888888888888888777888888888888888888


Q ss_pred             ccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          312 SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       312 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      +|+...+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            8887777778888888888888888888888888888889999999999888777788888899999999998754

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=1.3e-18  Score=181.31  Aligned_cols=161  Identities=19%  Similarity=0.183  Sum_probs=100.4

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCccccccc-ccccCCCCCcEEecCCCCCCCCCCccccCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLS-ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNL  135 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  135 (1020)
                      ++..+-|.|..|.|+....+.+|...+ ..++.|+|++|.+++..+ ..|.++++|++|+|++|.+++..|..|.++++|
T Consensus         5 CP~~C~C~~~~l~~s~n~l~~iP~~~~-~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L   83 (220)
T 2v70_A            5 CPEKCRCEGTTVDCSNQKLNKIPEHIP-QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV   83 (220)
T ss_dssp             CCTTCEEETTEEECCSSCCSSCCSCCC-TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCCCCEECCCEeEeCCCCcccCccCCC-CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC
Confidence            455667999999998877766666553 345666677666666544 345666666666666666665555566666666


Q ss_pred             CeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGM  214 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  214 (1020)
                      ++|+|++|+|++.++..+ ++++|++|+|++|++++..|. .+..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus        84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  162 (220)
T 2v70_A           84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGND-SFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA  162 (220)
T ss_dssp             CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTT-SSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHh-HcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecC
Confidence            666666666666666555 566666666666666633232 234455555555555555555555555555555555555


Q ss_pred             ccccc
Q 035998          215 NDLTG  219 (1020)
Q Consensus       215 N~l~~  219 (1020)
                      |.+.+
T Consensus       163 N~l~c  167 (220)
T 2v70_A          163 NPFNC  167 (220)
T ss_dssp             CCEEC
T ss_pred             cCCcC
Confidence            55553

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=8.5e-19  Score=197.70  Aligned_cols=184  Identities=24%  Similarity=0.255  Sum_probs=114.8

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCcccc-CCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLV-NLPNL  135 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L  135 (1020)
                      ++..+-|.|..|.|+......+|...+                         ..++.|+|++|+|++..+..|. ++++|
T Consensus        12 Cp~~C~C~~~~l~c~~~~l~~iP~~~~-------------------------~~l~~L~Ls~N~l~~l~~~~~~~~l~~L   66 (361)
T 2xot_A           12 CPANCLCASNILSCSKQQLPNVPQSLP-------------------------SYTALLDLSHNNLSRLRAEWTPTRLTNL   66 (361)
T ss_dssp             CCTTCEEETTEEECCSSCCSSCCSSCC-------------------------TTCSEEECCSSCCCEECTTSSSSCCTTC
T ss_pred             CCCCCEECCCEEEeCCCCcCccCccCC-------------------------CCCCEEECCCCCCCccChhhhhhccccc
Confidence            556666899999998766555554332                         2345555555555544444444 55555


Q ss_pred             CeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGM  214 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  214 (1020)
                      ++|+|++|+|++..+..+ ++++|++|+|++|+|+ .+|...+..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        67 ~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  145 (361)
T 2xot_A           67 HSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ  145 (361)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCC
Confidence            555555555555555544 4555555555555555 44444455566666666666666666666677777777777777


Q ss_pred             cccccccchhh---hhhcccccccccccccCCCCCcccccCCC--ccEEEccCCcCc
Q 035998          215 NDLTGGIADDI---FQLQKLRLLGLQDNQLSGKLSPSIADLSN--LVRLDVSSNNFS  266 (1020)
Q Consensus       215 N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~  266 (1020)
                      |+|++..+..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|.+.
T Consensus       146 N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             SCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            77775444434   45777778888888877655566777776  477888888776

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.77  E-value=1.6e-18  Score=180.65  Aligned_cols=153  Identities=18%  Similarity=0.236  Sum_probs=117.7

Q ss_pred             ccccccccccCCCCCcccccCCCccEEEccCCcCcccCc-ccccCCcccceeecccccccccCCCCCcCCcccccccccc
Q 035998          232 RLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIP-DVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN  310 (1020)
Q Consensus       232 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  310 (1020)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..| ..|..+++|++|++++|+|++..+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35666666666 3454443  345677777777776644 4577777778888888877777777788888888888888


Q ss_pred             cccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          311 NSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       311 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      |++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++..
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            88887777778888888888888888888778888888888888888888888778888888888888888888764

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.3e-20  Score=223.96  Aligned_cols=203  Identities=15%  Similarity=0.112  Sum_probs=160.2

Q ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccce
Q 035998          202 GNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQY  281 (1020)
Q Consensus       202 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  281 (1020)
                      ..+++|+.|+|++|+++ .+|+.++.+++|+.|++++|......|..           +..+.+.+.+|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence            56789999999999998 78999999999999999777531111111           1223455678888899999999


Q ss_pred             ee-cccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCc
Q 035998          282 LV-AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNN  360 (1020)
Q Consensus       282 L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  360 (1020)
                      |+ ++.|.+.           .|+.+.+++|.++...+.      .|+.|+|++|+|++ +|. ++.+++|+.|+|++|+
T Consensus       414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhcccc-----------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence            98 7777653           578888999998865542      48999999999995 676 9999999999999999


Q ss_pred             ccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccccc
Q 035998          361 FSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI  440 (1020)
Q Consensus       361 l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  440 (1020)
                      |+ .+|..|+.+++|++|+|++|+|+.+                                                    
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~l----------------------------------------------------  501 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALENV----------------------------------------------------  501 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCCC----------------------------------------------------
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCCC----------------------------------------------------
Confidence            99 7899999999999999999986543                                                    


Q ss_pred             chhhhcCCCCcEEecccccccccc-cccccCcCcCcEEeCCCCcccccCC
Q 035998          441 PQWLRGCSKLQLVDLSWNQLSGTI-PVWFGGFQDLFYLDLSNNTFTGEIP  489 (1020)
Q Consensus       441 p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p  489 (1020)
                      | .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|++++.+|
T Consensus       502 p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            3 4666777888888888887665 7788888888888888888876554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.76  E-value=4.7e-19  Score=199.84  Aligned_cols=157  Identities=22%  Similarity=0.179  Sum_probs=100.3

Q ss_pred             cccccccccccCCCCCcccc-cCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccc
Q 035998          231 LRLLGLQDNQLSGKLSPSIA-DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLR  309 (1020)
Q Consensus       231 L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  309 (1020)
                      ++.|+|++|+|++..+..+. ++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44555555555544444454 55666666666666665555566666666666666666666555666666666666666


Q ss_pred             ccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC---CCCCCCCeEecCCCcccccCcccccCCCC--CCeeeCCCCC
Q 035998          310 NNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL---PRCRKLKNINLARNNFSGQIPETYKNFES--LSYLSLSNSS  384 (1020)
Q Consensus       310 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~l~~N~  384 (1020)
                      +|+|++..+..|..+++|++|+|++|+|++..+..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|+
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence            666666666666777777777777777775444444   45777778888888777665566777766  3778888887


Q ss_pred             Ccc
Q 035998          385 IYN  387 (1020)
Q Consensus       385 i~~  387 (1020)
                      +..
T Consensus       201 ~~C  203 (361)
T 2xot_A          201 LEC  203 (361)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=2.8e-20  Score=221.10  Aligned_cols=174  Identities=19%  Similarity=0.172  Sum_probs=103.2

Q ss_pred             ccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccE
Q 035998          178 KNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVR  257 (1020)
Q Consensus       178 ~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  257 (1020)
                      ...+.|+.|+|++|+++ .+|..++++++|++|++++|......|..           +..+.+.+..|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhccc
Confidence            45788999999999998 78999999999999999887521111100           0111122233444444444444


Q ss_pred             EE-ccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCc
Q 035998          258 LD-VSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNK  336 (1020)
Q Consensus       258 L~-Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  336 (1020)
                      |+ ++.|.+           .+|..+.+++|.++...+.      .|+.|+|++|.|++. |. +..+++|+.|+|++|+
T Consensus       414 L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~  474 (567)
T 1dce_A          414 VDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNR  474 (567)
T ss_dssp             HCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSC
T ss_pred             Ccchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCCC-cC-ccccccCcEeecCccc
Confidence            44 333332           2334444455555433221      255566666666542 33 5566666666666666


Q ss_pred             cCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCC
Q 035998          337 FNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSI  385 (1020)
Q Consensus       337 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i  385 (1020)
                      |+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|++|+|++|+|
T Consensus       475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l  520 (567)
T 1dce_A          475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRL  520 (567)
T ss_dssp             CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCC
T ss_pred             cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCC
Confidence            66 556666666666666666666664 44 566666666666666654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=6.1e-18  Score=177.43  Aligned_cols=154  Identities=19%  Similarity=0.203  Sum_probs=120.2

Q ss_pred             cccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccc
Q 035998          231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN  310 (1020)
Q Consensus       231 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  310 (1020)
                      -+.++.++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            345666666665 4444443  6777777777777777777777777777788877777766667777888888888888


Q ss_pred             cccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcch
Q 035998          311 NSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       311 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                      |+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++..+..|..+++|+.|++++|++..-
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            8888777777788888888888888888 7788888888999999999998877777788888999999999987643

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=4.2e-18  Score=182.61  Aligned_cols=167  Identities=20%  Similarity=0.249  Sum_probs=101.5

Q ss_pred             eEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccC
Q 035998           87 VTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN  166 (1020)
Q Consensus        87 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N  166 (1020)
                      ++.+++.++.+++..  .+..+++|++|++++|.++ .+| .+..+++|++|+|++|+|++..+ ...+++|++|+|++|
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N   95 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRN   95 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCC
Confidence            344555666665433  4666777777777777776 455 56677777777777777776555 336677777777777


Q ss_pred             ccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCC
Q 035998          167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS  246 (1020)
Q Consensus       167 ~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  246 (1020)
                      +++ .+|....   ++|+.|+|++|++++.  +.++.+++|++|+|++|++++. + .+..+++|++|+|++|++++.  
T Consensus        96 ~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--  165 (263)
T 1xeu_A           96 RLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--  165 (263)
T ss_dssp             CCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--
T ss_pred             ccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--
Confidence            776 3443221   5666666666666642  2456666666666666666643 2 455666666666666666644  


Q ss_pred             cccccCCCccEEEccCCcCccc
Q 035998          247 PSIADLSNLVRLDVSSNNFSGN  268 (1020)
Q Consensus       247 ~~~~~l~~L~~L~Ls~N~l~~~  268 (1020)
                      ..+..+++|++|++++|.+++.
T Consensus       166 ~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          166 GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTSTTCCCCCEEEEEEEEEECC
T ss_pred             HHhccCCCCCEEeCCCCcccCC
Confidence            4555566666666666666544

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=3.5e-18  Score=183.27  Aligned_cols=172  Identities=21%  Similarity=0.251  Sum_probs=138.3

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      ++.++..+++++|.+++. + .+..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            567788888888888854 3 57888899999999998884 44 68888999999999999986655  8888899999


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      ++++|++++..+ . .. ++|+.|++++|++++.  ..+..+++|++|+|++|+|++. + .+..+++|+.|+|++|+++
T Consensus        91 ~L~~N~l~~l~~-~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKNLNG-I-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSCCTT-C-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCcCc-c-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            999999886433 2 22 8888999999988864  2477888899999999998854 3 6888889999999999988


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcchh
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l~  389 (1020)
                      +.  ..+..+++|+.|++++|++...|
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccCCc
Confidence            66  67888888889998888876554

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=6.6e-18  Score=180.55  Aligned_cols=144  Identities=19%  Similarity=0.185  Sum_probs=110.3

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEe-CCCCE--EEEEEecCCchh------------------------hHHHHHHH
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATL-PDGRN--VAIKRLSGDCGQ------------------------MEREFRAE  788 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E  788 (1020)
                      .+.....-|++.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|
T Consensus        41 ~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  120 (258)
T 1zth_A           41 KLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKE  120 (258)
T ss_dssp             HHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHH
T ss_pred             HHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHH
Confidence            3333444467889999999999999987 67888  999987543211                        12357889


Q ss_pred             HHHHHHcCCCcc--ceEeeEEeccCceEEEEEeccC-C----ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhH-h
Q 035998          789 VEALSRAQHPNL--VHLQGYCMHKNDRLLIYSFMEN-G----SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH-Q  860 (1020)
Q Consensus       789 ~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~  860 (1020)
                      ++.++++.|+++  +.++++    ...++||||+.+ |    +|.++...       .++..+..++.|++.|++||| +
T Consensus       121 ~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          121 FRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH
Confidence            999999988864  333332    367899999953 4    66655432       123457889999999999999 8


Q ss_pred             cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          861 SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       861 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      .   +|+||||||+|||++.  .++|+|||+|...
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            8   9999999999999998  9999999999765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.72  E-value=1.1e-17  Score=171.10  Aligned_cols=156  Identities=19%  Similarity=0.314  Sum_probs=134.0

Q ss_pred             ccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCccc
Q 035998          419 PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL  498 (1020)
Q Consensus       419 ~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  498 (1020)
                      ....+++|+.|++++|.+. .+| .+..+++|++|++++|.++ . +..+..+++|++|+|++|++++..|..++.+++|
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            4467788999999999998 556 6999999999999999876 3 3478999999999999999998889999988877


Q ss_pred             ccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCc-ceeccCcccc
Q 035998          499 ITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNN-LSGPIPSELT  577 (1020)
Q Consensus       499 ~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~-l~~~~p~~~~  577 (1020)
                                                          +.|+|++|++++..|..|+.+++|++|+|++|+ ++ .+| .+.
T Consensus       115 ------------------------------------~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~  156 (197)
T 4ezg_A          115 ------------------------------------TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLK  156 (197)
T ss_dssp             ------------------------------------CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGG
T ss_pred             ------------------------------------CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhc
Confidence                                                367889999998888999999999999999998 65 666 799


Q ss_pred             CCCcccEEEccCCcccccCCccccccccccccccccccccc
Q 035998          578 GMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTG  618 (1020)
Q Consensus       578 ~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~g  618 (1020)
                      .+++|++|+|++|++++ +| .+..+++|+.|++++|++.+
T Consensus       157 ~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          157 TLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             GCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            99999999999999995 55 79999999999999999865

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=1.4e-18  Score=212.99  Aligned_cols=231  Identities=18%  Similarity=0.192  Sum_probs=101.9

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEc
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINL  188 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L  188 (1020)
                      +.++.|+|.+|.+.. +|.     ..|+.++|+.|.|.+             ++++.|.+.  +|...+..++.|+.|+|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~-------------~~~~~n~~~--~~~~~~~~l~~L~~L~L  231 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE-------------DDDIENRMV--MPKDSKYDDQLWHALDL  231 (727)
T ss_dssp             ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred             CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC-------------cccccccee--cChhhhccCCCCcEEEC
Confidence            456777777777774 332     235666676666653             455566664  45555567777888888


Q ss_pred             cCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCccc
Q 035998          189 SVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGN  268 (1020)
Q Consensus       189 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  268 (1020)
                      ++|.+. .+|..+.++++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .
T Consensus       232 s~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~  307 (727)
T 4b8c_D          232 SNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-T  307 (727)
T ss_dssp             TTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-C
T ss_pred             CCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-c
Confidence            888877 66666667788888888888877 67777777788888888888877 66777777778888888888776 5


Q ss_pred             CcccccCCcccceeecccccccccCCCCCcCCcc-cccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCC
Q 035998          269 IPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT-LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR  347 (1020)
Q Consensus       269 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  347 (1020)
                      +|..|+.+++|+.|+|++|+|++.+|..+..+.. +..|+|++|.+++.+|.      .|+.|+++.|...   -..+  
T Consensus       308 lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~---~~~~--  376 (727)
T 4b8c_D          308 LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEP---QREY--  376 (727)
T ss_dssp             CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------------------
T ss_pred             cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeeccccc---cccc--
Confidence            5666777777777777777777777766654422 23466777776655443      3445555555111   0111  


Q ss_pred             CCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc
Q 035998          348 CRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       348 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~  386 (1020)
                                 +.+.+..+..+..+..++...++.|-+.
T Consensus       377 -----------~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          377 -----------DSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------------------------------CCC
T ss_pred             -----------CCccccccchhhcccccceeeeeccccc
Confidence                       1333344445556666677777777664

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.72  E-value=1.9e-18  Score=192.31  Aligned_cols=262  Identities=13%  Similarity=0.100  Sum_probs=140.4

Q ss_pred             CCCCcEEecCCCCCCCCCCccccC-CCCCCeeeccCCCCC--CCCCCccCCCCcceeeeccCccCCCCCcccccc-----
Q 035998          108 LVQLRFLNLSHNLLKGTVPVSLVN-LPNLEVLDLSSNDLS--GPLPQTINLPSIQVLDISSNSLNGSVPTSICKN-----  179 (1020)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~--~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~-----  179 (1020)
                      +.+++.|.++++ +.+..-..+.. +++|++|||++|+|.  ...+.  .++.+..+.+..|    .+|...|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~--~~~~~~~~~~~~~----~I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG--TYPNGKFYIYMAN----FVPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS--SSGGGCCEEECTT----EECTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc--ccccccccccccc----ccCHHHhccccccc
Confidence            667777777754 22111122333 677888888888877  22222  2233455555555    456666666     


Q ss_pred             ---CCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccccccccc----ccCCCCCcccccC
Q 035998          180 ---SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDN----QLSGKLSPSIADL  252 (1020)
Q Consensus       180 ---~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N----~l~~~~~~~~~~l  252 (1020)
                         +++|+.++|.+ .++.+.+.+|.++++|++|++++|.++...+.+|.++.++..+.+..+    ........+|.++
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~  175 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG  175 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence               77777777777 777666667777778888888777777666677777666666666553    2233334556566


Q ss_pred             CCcc-EEEccCCcC------------------------cccCcccc-cCCcccceeecccccccccCCCCCcCCcccccc
Q 035998          253 SNLV-RLDVSSNNF------------------------SGNIPDVF-AGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLL  306 (1020)
Q Consensus       253 ~~L~-~L~Ls~N~l------------------------~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  306 (1020)
                      .+|+ .+++....-                        .......+ ..+++|+.+++++|+++.+.+.+|.++++|+.|
T Consensus       176 ~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l  255 (329)
T 3sb4_A          176 EPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI  255 (329)
T ss_dssp             CCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred             cccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence            6665 444432210                        00000000 113445555555555554444445555555555


Q ss_pred             cccccccccccccCCCCCCCcC-EEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeee
Q 035998          307 NLRNNSLDGSLLLNCPALTNLT-SLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLS  379 (1020)
Q Consensus       307 ~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  379 (1020)
                      +|.+| ++.+....|.++++|+ .+++.+ +++...+.+|.++++|+.|++++|+++...+.+|.++++|+.++
T Consensus       256 ~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          256 KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             ECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            55544 4444444455555555 555544 44434444555555555555555555544444555555555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.70  E-value=2.5e-17  Score=168.50  Aligned_cols=154  Identities=21%  Similarity=0.287  Sum_probs=120.8

Q ss_pred             hhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccc
Q 035998          225 IFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLN  304 (1020)
Q Consensus       225 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  304 (1020)
                      ...+++|+.|++++|+++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..++.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            366778888888888887 455 67788888888888886652  34677888888888888888877788888888888


Q ss_pred             cccccccccccccccCCCCCCCcCEEEcCCCc-cCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCC
Q 035998          305 LLNLRNNSLDGSLLLNCPALTNLTSLDLGTNK-FNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNS  383 (1020)
Q Consensus       305 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  383 (1020)
                      +|++++|.+++..+..+..+++|++|+|++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence            88888888887777778888888888888887 55 455 58888888889998888885 33 6788888888888888


Q ss_pred             CCc
Q 035998          384 SIY  386 (1020)
Q Consensus       384 ~i~  386 (1020)
                      +|.
T Consensus       192 ~i~  194 (197)
T 4ezg_A          192 TIG  194 (197)
T ss_dssp             ---
T ss_pred             ccC
Confidence            864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=1.6e-17  Score=168.97  Aligned_cols=132  Identities=23%  Similarity=0.334  Sum_probs=87.0

Q ss_pred             eEEEecccccccccchhhhcCCCCcEEecccccccccccc-cccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcC
Q 035998          427 KVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISL  505 (1020)
Q Consensus       427 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~  505 (1020)
                      +.+++++|++. .+|..+..  +|+.|+|++|+|++..+. .|+.+++|++|+|++|++++..|..|.++++|       
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------   80 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI-------   80 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-------
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccC-------
Confidence            56677777664 44544432  677777777777655443 46777777777777777776666666666655       


Q ss_pred             CCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEE
Q 035998          506 EEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETL  585 (1020)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  585 (1020)
                                                   +.|+|++|+|++..+..|+++++|+.|+|++|+|++..|..|..+++|++|
T Consensus        81 -----------------------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  131 (192)
T 1w8a_A           81 -----------------------------QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL  131 (192)
T ss_dssp             -----------------------------CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred             -----------------------------CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEE
Confidence                                         245666666666666666667777777777777766666667777777777


Q ss_pred             EccCCcccccCC
Q 035998          586 DLSYNNLSGAIP  597 (1020)
Q Consensus       586 ~Ls~N~l~g~ip  597 (1020)
                      +|++|.+++..+
T Consensus       132 ~L~~N~l~c~c~  143 (192)
T 1w8a_A          132 NLASNPFNCNCH  143 (192)
T ss_dssp             ECTTCCBCCSGG
T ss_pred             EeCCCCccCcCc
Confidence            777777766544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.68  E-value=1.2e-16  Score=177.59  Aligned_cols=213  Identities=15%  Similarity=0.098  Sum_probs=117.0

Q ss_pred             CCCccEEEccCCcCc--ccCcccccCCcccceeecccccccccCCCCCcC--------CcccccccccccccccccccCC
Q 035998          252 LSNLVRLDVSSNNFS--GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSN--------SPTLNLLNLRNNSLDGSLLLNC  321 (1020)
Q Consensus       252 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L~~L~L~~N~l~~~~~~~~  321 (1020)
                      +++|++|||++|+++  ...+..+   +.+..+.+..|.   +.+.+|.+        +++|+.|+|.+ .++.+....|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            456666666666665  2222222   123333444442   23345555        77777777777 7776667777


Q ss_pred             CCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcc----cccCcccccCCCCCC-eeeCCCCCCcchhhHHHHHh
Q 035998          322 PALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF----SGQIPETYKNFESLS-YLSLSNSSIYNLSSALQVLQ  396 (1020)
Q Consensus       322 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~p~~~~~l~~L~-~L~l~~N~i~~l~~~~~~l~  396 (1020)
                      .++++|+.|++++|.+....+.+|..+.++..+.+..+..    ......+|.++..|+ .+.+...  ..++..+..  
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~--~~l~~~~~~--  196 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAM--GKLEDEIMK--  196 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTT--CCHHHHHHH--
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCC--CcHHHHHhh--
Confidence            7778888888888877766677777777676666655322    222334455555555 4444332  123221100  


Q ss_pred             hhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcE
Q 035998          397 QCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFY  476 (1020)
Q Consensus       397 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  476 (1020)
                      .                      .....++..+.+.++-...........+++|+.|+|++|+++...+..|.++.+|+.
T Consensus       197 ~----------------------~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~  254 (329)
T 3sb4_A          197 A----------------------GLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK  254 (329)
T ss_dssp             T----------------------TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred             c----------------------ccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence            0                      001223444444433111111111123678888888888888555667888888888


Q ss_pred             EeCCCCcccccCCCCCCCCccc
Q 035998          477 LDLSNNTFTGEIPKNLTGLPSL  498 (1020)
Q Consensus       477 L~Ls~N~l~~~~p~~~~~l~~L  498 (1020)
                      |+|++| ++...+..|.++++|
T Consensus       255 l~l~~n-i~~I~~~aF~~~~~L  275 (329)
T 3sb4_A          255 IKLPHN-LKTIGQRVFSNCGRL  275 (329)
T ss_dssp             EECCTT-CCEECTTTTTTCTTC
T ss_pred             EECCcc-cceehHHHhhCChhc
Confidence            888877 554444445555444

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.67  E-value=2.4e-16  Score=160.35  Aligned_cols=140  Identities=21%  Similarity=0.270  Sum_probs=78.5

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCc-cccCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV-SLVNLPNL  135 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L  135 (1020)
                      ++..+.|.|+.|.|+....+.+|...+.                         +|++|+|++|++++..+. .|+.+++|
T Consensus         2 CP~~C~C~~~~l~~s~~~l~~ip~~~~~-------------------------~l~~L~l~~n~i~~~~~~~~~~~l~~L   56 (192)
T 1w8a_A            2 CPAMCHCEGTTVDCTGRGLKEIPRDIPL-------------------------HTTELLLNDNELGRISSDGLFGRLPHL   56 (192)
T ss_dssp             CCTTSEEETTEEECTTSCCSSCCSCCCT-------------------------TCSEEECCSCCCCSBCCSCSGGGCTTC
T ss_pred             cCCCCEECCCEEEcCCCCcCcCccCCCC-------------------------CCCEEECCCCcCCccCCccccccCCCC
Confidence            3455668999999987665555544332                         445555555555433332 24555555


Q ss_pred             CeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGM  214 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  214 (1020)
                      ++|+|++|+|++.+|..+ ++++|++|+|++|+|+ .++...+..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus        57 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (192)
T 1w8a_A           57 VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS  135 (192)
T ss_dssp             CEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTT
T ss_pred             CEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCC-ccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCC
Confidence            555555555555544444 4555555555555554 23333334455566666666666656666666667777777777


Q ss_pred             cccccccc
Q 035998          215 NDLTGGIA  222 (1020)
Q Consensus       215 N~l~~~~~  222 (1020)
                      |.+++..+
T Consensus       136 N~l~c~c~  143 (192)
T 1w8a_A          136 NPFNCNCH  143 (192)
T ss_dssp             CCBCCSGG
T ss_pred             CCccCcCc
Confidence            77665443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=6.7e-16  Score=154.94  Aligned_cols=139  Identities=21%  Similarity=0.273  Sum_probs=87.4

Q ss_pred             CCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCe
Q 035998           58 SSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEV  137 (1020)
Q Consensus        58 ~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  137 (1020)
                      +..+.|+|++|.|+....+.+|....                         ++|++|++++|++++..+..|+.+++|++
T Consensus         2 p~~C~C~~~~l~~~~~~l~~~p~~~~-------------------------~~l~~L~l~~n~l~~~~~~~~~~l~~L~~   56 (177)
T 2o6r_A            2 PSRCSCSGTEIRCNSKGLTSVPTGIP-------------------------SSATRLELESNKLQSLPHGVFDKLTQLTK   56 (177)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCTTCC-------------------------TTCSEEECCSSCCCCCCTTTTTTCTTCSE
T ss_pred             cCCCEeCCCEEEecCCCCccCCCCCC-------------------------CCCcEEEeCCCcccEeCHHHhcCcccccE
Confidence            34566899999998765444443222                         45666666666666544445566666666


Q ss_pred             eeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccc
Q 035998          138 LDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMND  216 (1020)
Q Consensus       138 L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  216 (1020)
                      |+|++|+|++.++..+ .+++|++|+|++|+++ .+|...+..+++|+.|+|++|++++..+..+..+++|++|+|++|.
T Consensus        57 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           57 LSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcceEeChhHccCCCccCEEECCCCCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence            6666666665555554 5666666666666666 4444444556666666666666665555556677777777777777


Q ss_pred             cccccc
Q 035998          217 LTGGIA  222 (1020)
Q Consensus       217 l~~~~~  222 (1020)
                      +++..+
T Consensus       136 ~~~~~~  141 (177)
T 2o6r_A          136 WDCSCP  141 (177)
T ss_dssp             BCCCHH
T ss_pred             eeccCc
Confidence            775443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.62  E-value=6.2e-16  Score=153.72  Aligned_cols=135  Identities=22%  Similarity=0.220  Sum_probs=106.9

Q ss_pred             CCCcEEeccccccc-ccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccc
Q 035998          448 SKLQLVDLSWNQLS-GTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQ  526 (1020)
Q Consensus       448 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~  526 (1020)
                      ++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|                            
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L----------------------------   73 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKL----------------------------   73 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSC----------------------------
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCC----------------------------
Confidence            56778888888877 67777777788888888888887754  556666655                            


Q ss_pred             cccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceec-cCccccCCCcccEEEccCCcccccCC---ccccc
Q 035998          527 YNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP-IPSELTGMTSLETLDLSYNNLSGAIP---ISLEK  602 (1020)
Q Consensus       527 ~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~ip---~~l~~  602 (1020)
                              +.|+|++|++++.+|..++.+++|+.|+|++|++++. .+..++.+++|++|+|++|++++..+   ..+..
T Consensus        74 --------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  145 (168)
T 2ell_A           74 --------KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKL  145 (168)
T ss_dssp             --------CEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTT
T ss_pred             --------CEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHh
Confidence                    3567777777777777778899999999999999853 22789999999999999999996554   48999


Q ss_pred             cccccccccccccccccC
Q 035998          603 LSFLSKFSVANNHLTGRI  620 (1020)
Q Consensus       603 l~~L~~l~ls~N~l~g~~  620 (1020)
                      +++|++|++++|.+...+
T Consensus       146 l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A          146 LPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             CSSCCEETTEETTSCBCC
T ss_pred             CccCcEecCCCCChhhcc
Confidence            999999999999987543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=2e-15  Score=153.52  Aligned_cols=136  Identities=25%  Similarity=0.334  Sum_probs=85.4

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLE  136 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  136 (1020)
                      ++..+.|.|..|.|+....+.+|...+                         ++|++|+|++|+|+ .+|..|.++++|+
T Consensus         4 CP~~C~C~~~~l~~~~~~l~~ip~~~~-------------------------~~l~~L~L~~n~i~-~ip~~~~~l~~L~   57 (193)
T 2wfh_A            4 CPTECTCLDTVVRCSNKGLKVLPKGIP-------------------------RDVTELYLDGNQFT-LVPKELSNYKHLT   57 (193)
T ss_dssp             CCTTCEEETTEEECTTSCCSSCCSCCC-------------------------TTCCEEECCSSCCC-SCCGGGGGCTTCC
T ss_pred             CCCCCEeCCCEEEcCCCCCCcCCCCCC-------------------------CCCCEEECCCCcCc-hhHHHhhcccCCC
Confidence            556677899999998765544443322                         34566666666665 5555666666666


Q ss_pred             eeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          137 VLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      +|+|++|+|++..+..+ ++++|++|+|++|+|+ .+|...+..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        58 ~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  136 (193)
T 2wfh_A           58 LIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN  136 (193)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECCCCcCCEeCHhHccCCCCCCEEECCCCccC-EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC
Confidence            66666666666555555 5666666666666665 444444455666666666666666555556677777777777777


Q ss_pred             cccc
Q 035998          216 DLTG  219 (1020)
Q Consensus       216 ~l~~  219 (1020)
                      .+..
T Consensus       137 ~~~C  140 (193)
T 2wfh_A          137 PLYC  140 (193)
T ss_dssp             CEEC
T ss_pred             Ceec
Confidence            7763

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=5.2e-16  Score=150.88  Aligned_cols=128  Identities=21%  Similarity=0.231  Sum_probs=102.9

Q ss_pred             CCCcEEeccccccc-ccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccc
Q 035998          448 SKLQLVDLSWNQLS-GTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQ  526 (1020)
Q Consensus       448 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~  526 (1020)
                      ++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..++++++|                            
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L----------------------------   66 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKL----------------------------   66 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTC----------------------------
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCC----------------------------
Confidence            56788888888887 67777778888888888888888754  556666655                            


Q ss_pred             cccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceec-cCccccCCCcccEEEccCCcccccCC---ccccc
Q 035998          527 YNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGP-IPSELTGMTSLETLDLSYNNLSGAIP---ISLEK  602 (1020)
Q Consensus       527 ~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~g~ip---~~l~~  602 (1020)
                              +.|+|++|++++.+|..++.+++|++|+|++|++++. .|..++.+++|++|++++|++++..+   ..+..
T Consensus        67 --------~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  138 (149)
T 2je0_A           67 --------KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKL  138 (149)
T ss_dssp             --------CEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHH
T ss_pred             --------CEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHH
Confidence                    3567777777777777788899999999999999863 45889999999999999999997665   57999


Q ss_pred             ccccccccccc
Q 035998          603 LSFLSKFSVAN  613 (1020)
Q Consensus       603 l~~L~~l~ls~  613 (1020)
                      +++|+.|++++
T Consensus       139 l~~L~~L~l~d  149 (149)
T 2je0_A          139 LPQLTYLDGYD  149 (149)
T ss_dssp             CTTCCEETTBC
T ss_pred             CCCcccccCCC
Confidence            99999999874

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.61  E-value=4.9e-16  Score=154.48  Aligned_cols=136  Identities=21%  Similarity=0.264  Sum_probs=86.2

Q ss_pred             CCccEEEccCCcCc-ccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEE
Q 035998          253 SNLVRLDVSSNNFS-GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLD  331 (1020)
Q Consensus       253 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  331 (1020)
                      ++|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555555 44555555555555555555555544  4555666666666666666655555555566777777


Q ss_pred             cCCCccCCCC-CCCCCCCCCCCeEecCCCcccccCc---ccccCCCCCCeeeCCCCCCcchhh
Q 035998          332 LGTNKFNGPL-PTNLPRCRKLKNINLARNNFSGQIP---ETYKNFESLSYLSLSNSSIYNLSS  390 (1020)
Q Consensus       332 L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~N~i~~l~~  390 (1020)
                      |++|+|++.. +..+..+++|+.|++++|++++..+   ..+..+++|++|++++|.+..+|.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~  164 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD  164 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence            7777776432 2566777777777777777775544   467777788888887777766654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=2.1e-15  Score=166.63  Aligned_cols=150  Identities=10%  Similarity=0.059  Sum_probs=107.9

Q ss_pred             HHHHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--------------h--------hHHHHHHHHHH
Q 035998          734 IDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--------------Q--------MEREFRAEVEA  791 (1020)
Q Consensus       734 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~--------~~~~~~~E~~~  791 (1020)
                      +..+.....-|++.+.||+|++|.||+|...+|+.||||+++....              .        ......+|...
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            3444444556999999999999999999998999999998753210              0        00112456777


Q ss_pred             HHHcCCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 035998          792 LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDI  871 (1020)
Q Consensus       792 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  871 (1020)
                      +.++.+.++....-+..  ...++||||++|+.+..+...          +....++.|++.+|.|||+.   |||||||
T Consensus       167 L~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDL  231 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDF  231 (397)
T ss_dssp             HHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             HHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence            77775554432222211  234799999999887554321          13457889999999999999   9999999


Q ss_pred             CCCCEEEcCCCC----------eEEeeccccccccCC
Q 035998          872 KSSNILLDGNFG----------AHLADFGLARLILSP  898 (1020)
Q Consensus       872 kp~NIll~~~~~----------~kl~Dfg~~~~~~~~  898 (1020)
                      ||.|||+++++.          +.|+||+-+.....+
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence            999999987763          899999988765443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=9.7e-15  Score=165.78  Aligned_cols=267  Identities=13%  Similarity=0.135  Sum_probs=206.3

Q ss_pred             CCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEE
Q 035998          108 LVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN  187 (1020)
Q Consensus       108 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~  187 (1020)
                      ...++.+.+.+ .++..-..+|.++ +|+.+++..| ++.+....|.-.+|+.+.|.. .++ .|+...|.++++|+.++
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNSTVQEIVFPS-TLE-QLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTCCCCEEECCT-TCC-EECSSTTTTCTTCCEEE
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCCCceEEEeCC-Ccc-EehHHHhhCcccCCeee
Confidence            46677777754 4554555667775 7888888766 776667777435788888875 565 67777788888888888


Q ss_pred             ccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcc
Q 035998          188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSG  267 (1020)
Q Consensus       188 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  267 (1020)
                      |+.|+++......|. .++|+.+.|.++ ++.....+|.++++|+.+++.+| ++.+...+|.+ .+|+.+++ .|.++.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~  261 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN  261 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence            888888866666666 588888888744 77667778888888888888875 55566677777 78888888 456776


Q ss_pred             cCcccccCCcccceeeccccccc-----ccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCC
Q 035998          268 NIPDVFAGLGEFQYLVAHSNRFT-----GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP  342 (1020)
Q Consensus       268 ~~p~~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  342 (1020)
                      +...+|.++++|+.+.+.+|.+.     .+.+.+|.++++|+.++|. +.++.+....|.++++|+.++|..| ++...+
T Consensus       262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~  339 (401)
T 4fdw_A          262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF  339 (401)
T ss_dssp             ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred             EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence            77888888899999988887765     5667788999999999998 4577777888989999999999655 766777


Q ss_pred             CCCCCCCCCCeEecCCCcccccCcccccCCC-CCCeeeCCCCCCcc
Q 035998          343 TNLPRCRKLKNINLARNNFSGQIPETYKNFE-SLSYLSLSNSSIYN  387 (1020)
Q Consensus       343 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~l~~N~i~~  387 (1020)
                      .+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+..
T Consensus       340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~  384 (401)
T 4fdw_A          340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK  384 (401)
T ss_dssp             TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred             HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence            889888 999999999988877777888874 78888888776443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=1e-14  Score=165.53  Aligned_cols=254  Identities=12%  Similarity=0.101  Sum_probs=214.7

Q ss_pred             cccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCc
Q 035998           96 RLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPT  174 (1020)
Q Consensus        96 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~  174 (1020)
                      .++..-..+|.+. +|+.+.|..+ ++..-..+|.++ +|+.+++.. .++.+.+..| ++++|+.++|++|+++ .+|.
T Consensus       123 ~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~  197 (401)
T 4fdw_A          123 SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPA  197 (401)
T ss_dssp             TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECT
T ss_pred             ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-Eech
Confidence            4444445677774 7999999876 775566678884 799999986 7887778888 8999999999999998 8888


Q ss_pred             cccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCC
Q 035998          175 SICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSN  254 (1020)
Q Consensus       175 ~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  254 (1020)
                      ..|. .++|+.+.|..+ +......+|.++++|+.++|.+| ++.....+|.+ .+|+.+.+ .|.++.+...+|.++++
T Consensus       198 ~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~  272 (401)
T 4fdw_A          198 STFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPE  272 (401)
T ss_dssp             TTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTT
T ss_pred             hhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCC
Confidence            8887 589999999854 77778889999999999999985 66555666766 89999999 56677677889999999


Q ss_pred             ccEEEccCCcCc-----ccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCE
Q 035998          255 LVRLDVSSNNFS-----GNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTS  329 (1020)
Q Consensus       255 L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  329 (1020)
                      |+.+++.+|.+.     .+.+.+|.++++|+.+.+. +.++.+...+|.++++|+.++|.+| ++.+....|.++ +|+.
T Consensus       273 L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~  349 (401)
T 4fdw_A          273 LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKE  349 (401)
T ss_dssp             CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred             CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCE
Confidence            999999998876     5677899999999999999 5588888899999999999999665 777788899999 9999


Q ss_pred             EEcCCCccCCCCCCCCCCCC-CCCeEecCCCccc
Q 035998          330 LDLGTNKFNGPLPTNLPRCR-KLKNINLARNNFS  362 (1020)
Q Consensus       330 L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~  362 (1020)
                      +++++|.+....+..|.+++ +++.|++..+.+.
T Consensus       350 l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          350 VKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            99999999877788888884 7899999888764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.58  E-value=5.5e-15  Score=150.21  Aligned_cols=126  Identities=20%  Similarity=0.341  Sum_probs=61.7

Q ss_pred             cccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccc
Q 035998          233 LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS  312 (1020)
Q Consensus       233 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  312 (1020)
                      ++++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.              
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~--------------   75 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFS--------------   75 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTT--------------
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHcc--------------
Confidence            3445555554 3333332  35555555555555 3344455454455554444444444444444              


Q ss_pred             cccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc
Q 035998          313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       313 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~  386 (1020)
                                .+++|++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|..+++|++|+|++|++.
T Consensus        76 ----------~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           76 ----------NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             ----------TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ----------CCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence                      4444444444444444444444555555555555555555444444555555555555555543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=3.9e-15  Score=144.65  Aligned_cols=129  Identities=26%  Similarity=0.271  Sum_probs=82.4

Q ss_pred             cccccccccccccc-cccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeee
Q 035998          301 PTLNLLNLRNNSLD-GSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLS  379 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  379 (1020)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45566666666665 45555556666666666666666644  5566666677777777776665666666666666666


Q ss_pred             CCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccc
Q 035998          380 LSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ  459 (1020)
Q Consensus       380 l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  459 (1020)
                      +++|+++.++.                                                  |..++.+++|++|++++|+
T Consensus        95 ls~N~i~~~~~--------------------------------------------------~~~~~~l~~L~~L~l~~N~  124 (149)
T 2je0_A           95 LSGNKIKDLST--------------------------------------------------IEPLKKLENLKSLDLFNCE  124 (149)
T ss_dssp             CTTSCCCSHHH--------------------------------------------------HGGGGGCTTCCEEECTTCG
T ss_pred             CCCCcCCChHH--------------------------------------------------HHHHhhCCCCCEEeCcCCc
Confidence            66666554321                                                  2345667777777777777


Q ss_pred             cccccc---ccccCcCcCcEEeCCC
Q 035998          460 LSGTIP---VWFGGFQDLFYLDLSN  481 (1020)
Q Consensus       460 l~~~~p---~~~~~l~~L~~L~Ls~  481 (1020)
                      +++..+   ..+..+++|++||+++
T Consensus       125 l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          125 VTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             GGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ccchHHHHHHHHHHCCCcccccCCC
Confidence            775544   4677777777777763

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.57  E-value=1.8e-14  Score=144.47  Aligned_cols=114  Identities=19%  Similarity=0.145  Sum_probs=73.7

Q ss_pred             ccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecC
Q 035998          278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLA  357 (1020)
Q Consensus       278 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  357 (1020)
                      +|+.|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|+|++..+..+..+++|++|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            44555555555554444455555666666666666665555556666777777777777776666666777777777777


Q ss_pred             CCcccccCcccccCCCCCCeeeCCCCCCcchhhH
Q 035998          358 RNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSA  391 (1020)
Q Consensus       358 ~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~  391 (1020)
                      +|++++..+..|..+++|++|++++|++......
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            7777765555667777777777777777654443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.53  E-value=1.1e-14  Score=145.76  Aligned_cols=135  Identities=19%  Similarity=0.138  Sum_probs=105.6

Q ss_pred             hhcCCCCcEEecccccccccccccccCcC-cCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccc
Q 035998          444 LRGCSKLQLVDLSWNQLSGTIPVWFGGFQ-DLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSA  522 (1020)
Q Consensus       444 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~  522 (1020)
                      +..+.+|+.|++++|+++ .+|. +..+. +|++|+|++|.+++.  ..++.+++|                        
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L------------------------   66 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRL------------------------   66 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSC------------------------
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCC------------------------
Confidence            455677888888888887 4454 44444 888888888888754  456666655                        


Q ss_pred             cccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCc--cccCCCcccEEEccCCcccccCCcc-
Q 035998          523 RGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPS--ELTGMTSLETLDLSYNNLSGAIPIS-  599 (1020)
Q Consensus       523 ~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~g~ip~~-  599 (1020)
                                  +.|+|++|+|++..+..|+.+++|+.|+|++|+|+ .+|.  .++.+++|+.|+|++|+++ .+|.. 
T Consensus        67 ------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~  132 (176)
T 1a9n_A           67 ------------KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYR  132 (176)
T ss_dssp             ------------CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHH
T ss_pred             ------------CEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHH
Confidence                        35677778877655555689999999999999996 6776  8999999999999999998 67775 


Q ss_pred             ---ccccccccccccccccccccC
Q 035998          600 ---LEKLSFLSKFSVANNHLTGRI  620 (1020)
Q Consensus       600 ---l~~l~~L~~l~ls~N~l~g~~  620 (1020)
                         +..+++|+.|++++|......
T Consensus       133 ~~~~~~l~~L~~Ld~~~n~~~~~~  156 (176)
T 1a9n_A          133 LYVIYKVPQVRVLDFQKVKLKERQ  156 (176)
T ss_dssp             HHHHHHCTTCSEETTEECCHHHHH
T ss_pred             HHHHHHCCccceeCCCcCCHHHHH
Confidence               999999999999999987533

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.51  E-value=2.7e-16  Score=160.98  Aligned_cols=154  Identities=21%  Similarity=0.220  Sum_probs=81.2

Q ss_pred             cccccccccccccccccccch------hhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCC
Q 035998          203 NCASLEHLCLGMNDLTGGIAD------DIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGL  276 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  276 (1020)
                      ....++.++++.|.+++.+|.      .+..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            344555555666665555554      56666666666666666654 44 5556666666666666665 344455555


Q ss_pred             cccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEec
Q 035998          277 GEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINL  356 (1020)
Q Consensus       277 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  356 (1020)
                      ++|++|++++|++++. | .+..+++|++|++++|++++..+                       ...+..+++|++|++
T Consensus        93 ~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~-----------------------~~~l~~l~~L~~L~l  147 (198)
T 1ds9_A           93 DTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGE-----------------------IDKLAALDKLEDLLL  147 (198)
T ss_dssp             HHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHH-----------------------HHHHTTTTTCSEEEE
T ss_pred             CcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhH-----------------------HHHHhcCCCCCEEEe
Confidence            5555555555555542 2 34444444444444444443221                       023444555555555


Q ss_pred             CCCcccccCcc----------cccCCCCCCeeeCCCCCCc
Q 035998          357 ARNNFSGQIPE----------TYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       357 ~~N~l~~~~p~----------~~~~l~~L~~L~l~~N~i~  386 (1020)
                      ++|++++..|.          .+..+++|++||  +|.++
T Consensus       148 ~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             CSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             cCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            55555444333          256666666665  55544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.50  E-value=2.2e-16  Score=161.57  Aligned_cols=152  Identities=18%  Similarity=0.297  Sum_probs=107.5

Q ss_pred             hhhhcccccccccccccCCCCCc------ccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCc
Q 035998          225 IFQLQKLRLLGLQDNQLSGKLSP------SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS  298 (1020)
Q Consensus       225 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  298 (1020)
                      +.....++.++++.|.++|..|.      .+..+++|++|++++|++++ +| .+..+++|++|++++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            55667888889999998887776      77777788888888877775 44 6666666666666666666 3344343


Q ss_pred             CCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCc-ccccCCCCCCe
Q 035998          299 NSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP-ETYKNFESLSY  377 (1020)
Q Consensus       299 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~  377 (1020)
                      .+                        ++|++|+|++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++
T Consensus        91 ~~------------------------~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~  144 (198)
T 1ds9_A           91 VA------------------------DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLED  144 (198)
T ss_dssp             HH------------------------HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSE
T ss_pred             cC------------------------CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCE
Confidence            33                        455555555555553 33 46677788888888888875433 57899999999


Q ss_pred             eeCCCCCCcchhhH--------HHHHhhhcccchhh
Q 035998          378 LSLSNSSIYNLSSA--------LQVLQQCRNLTTLV  405 (1020)
Q Consensus       378 L~l~~N~i~~l~~~--------~~~l~~l~~L~~L~  405 (1020)
                      |++++|++...+..        ...+..+++|+.|+
T Consensus       145 L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld  180 (198)
T 1ds9_A          145 LLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             EEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred             EEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence            99999998765321        23477888888886

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.49  E-value=1.3e-14  Score=145.31  Aligned_cols=138  Identities=17%  Similarity=0.132  Sum_probs=97.8

Q ss_pred             ccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCc
Q 035998          248 SIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNL  327 (1020)
Q Consensus       248 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  327 (1020)
                      .+.++++|++|++++|+++. +|......++|++|++++|++++.  ..+..+++|++|++++|.+++..+..+..+++|
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            45556677777777777763 343222233677777777777754  567777777778888887776555555777888


Q ss_pred             CEEEcCCCccCCCCCC--CCCCCCCCCeEecCCCcccccCcc----cccCCCCCCeeeCCCCCCcchhh
Q 035998          328 TSLDLGTNKFNGPLPT--NLPRCRKLKNINLARNNFSGQIPE----TYKNFESLSYLSLSNSSIYNLSS  390 (1020)
Q Consensus       328 ~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~l~~N~i~~l~~  390 (1020)
                      ++|+|++|+|+ .+|.  .+..+++|+.|++++|+++. +|.    .+..+++|++|++++|.+.+...
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~~~~  157 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKERQE  157 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHHHHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHHHHH
Confidence            88888888886 4554  67788888888888888874 455    38888899999999888665443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=3.8e-13  Score=153.37  Aligned_cols=269  Identities=13%  Similarity=0.089  Sum_probs=160.2

Q ss_pred             ccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCcc
Q 035998           97 LKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTS  175 (1020)
Q Consensus        97 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~  175 (1020)
                      ++.....+|.++++|+.+.|.. .++..-..+|.++++|+.++|.++ ++.+....+ ++.+|+.+.+..+ +. .+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecce
Confidence            3334456788899999999974 476455667999999999999754 665556666 7888888777654 33 45555


Q ss_pred             ccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCc
Q 035998          176 ICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNL  255 (1020)
Q Consensus       176 ~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  255 (1020)
                      .|.+...+........  ......+|.++++|+.+.+.++. +......|.++.+|+.+++..| ++.+...+|.++..|
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            5555544433333222  22334567777777777776553 3244556667777777777665 443455667777777


Q ss_pred             cEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCC
Q 035998          256 VRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTN  335 (1020)
Q Consensus       256 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  335 (1020)
                      +.+.+..+...  +.+.+....+|+.+.+..+ ++......|.++..|+.+.+..+... .....|.....++.+.+..+
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~  286 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV  286 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred             ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence            77766655432  1222233345566555432 23344455666666666666555333 44455566666666666555


Q ss_pred             ccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCC
Q 035998          336 KFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLS  381 (1020)
Q Consensus       336 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  381 (1020)
                      .+.   ...|..+.+|+.+.+.++ ++.....+|.++.+|+.+++.
T Consensus       287 ~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp  328 (394)
T 4fs7_A          287 IVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP  328 (394)
T ss_dssp             EEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred             eec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence            432   234556666666666543 444445556666666666664

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.47  E-value=1.6e-12  Score=148.18  Aligned_cols=219  Identities=11%  Similarity=0.085  Sum_probs=104.5

Q ss_pred             CccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccc
Q 035998          126 PVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNC  204 (1020)
Q Consensus       126 p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l  204 (1020)
                      ..+|.++.+|+.+.|.. .++.+...+| ++++|+.++|..+ ++ .|+.                        .+|.++
T Consensus        64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~------------------------~aF~~c  116 (394)
T 4fs7_A           64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGR------------------------CTFSGC  116 (394)
T ss_dssp             TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECT------------------------TTTTTC
T ss_pred             HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-Eccc------------------------hhhccc
Confidence            34566666666666653 2444444444 4555555555433 22 2333                        344445


Q ss_pred             cccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeec
Q 035998          205 ASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVA  284 (1020)
Q Consensus       205 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  284 (1020)
                      ++|+.+.+..+ ++.....+|.+...+........  ......+|.++++|+.+.+..+. ..+....|.++.+|+.+.+
T Consensus       117 ~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l  192 (394)
T 4fs7_A          117 YALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKL  192 (394)
T ss_dssp             TTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCC
T ss_pred             ccchhhcccCc-eeeecceeeecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEc
Confidence            55555444332 22233333443332222222211  11234566777777777776543 3355566666666776666


Q ss_pred             ccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccccc
Q 035998          285 HSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ  364 (1020)
Q Consensus       285 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  364 (1020)
                      ..| ++.....+|.++..|+.+.+.++...  +...+....+|+.+.+..+. +......+..+.+|+.+.+..+... .
T Consensus       193 ~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i  267 (394)
T 4fs7_A          193 PRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-I  267 (394)
T ss_dssp             CTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-E
T ss_pred             CCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-e
Confidence            555 44455556666666666666554332  11122233455555554332 2233344555555555555544332 3


Q ss_pred             CcccccCCCCCCeeeC
Q 035998          365 IPETYKNFESLSYLSL  380 (1020)
Q Consensus       365 ~p~~~~~l~~L~~L~l  380 (1020)
                      ....|.....++.+.+
T Consensus       268 ~~~~F~~~~~l~~~~~  283 (394)
T 4fs7_A          268 GGSLFYNCSGLKKVIY  283 (394)
T ss_dssp             CSCTTTTCTTCCEEEE
T ss_pred             eccccccccccceecc
Confidence            3344444444444433

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.41  E-value=7.1e-13  Score=131.57  Aligned_cols=113  Identities=22%  Similarity=0.293  Sum_probs=75.9

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLE  136 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  136 (1020)
                      ++..+-|+|+.|.|+....+.+                       |..+.  ++|++|+|++|+|++..|..|.++++|+
T Consensus         3 CP~~C~C~~~~l~~s~n~l~~i-----------------------p~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~   57 (170)
T 3g39_A            3 CPSQCSCSGTTVDCSGKSLASV-----------------------PTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLT   57 (170)
T ss_dssp             CC-CCEEETTEEECTTSCCSSC-----------------------CSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCS
T ss_pred             CcCcCCcCCCEEEeCCCCcCcc-----------------------CccCC--CCCcEEEcCCCcCCccChhhhcCcccCC
Confidence            4555668899888876544333                       33332  5667777777777766666677777777


Q ss_pred             eeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCC
Q 035998          137 VLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG  195 (1020)
Q Consensus       137 ~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~  195 (1020)
                      +|+|++|+|++.++..+ ++++|++|+|++|+|+ .+|...+..+++|+.|+|++|.+..
T Consensus        58 ~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           58 RLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             EEECCCCCcCccChhhccCCCCCCEEECCCCccC-EeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            77777777776666665 6777777777777776 5555555667777777777777763

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.40  E-value=6.9e-13  Score=132.11  Aligned_cols=104  Identities=25%  Similarity=0.260  Sum_probs=59.8

Q ss_pred             cEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccc
Q 035998          451 QLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQI  530 (1020)
Q Consensus       451 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~  530 (1020)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++.+|..|.++++|                                
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L--------------------------------   59 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNL--------------------------------   59 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTC--------------------------------
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCC--------------------------------
Confidence            56677777765 5555443  566666666666665555555555544                                


Q ss_pred             cCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCccc
Q 035998          531 WSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLS  593 (1020)
Q Consensus       531 ~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  593 (1020)
                          +.|+|++|+|++..+..|+.+++|+.|+|++|+|++..|..|..+++|++|+|++|+++
T Consensus        60 ----~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           60 ----QQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             ----CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ----CEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence                23444555555444444555666666666666665433334666666666666666665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.39  E-value=1.4e-12  Score=129.38  Aligned_cols=90  Identities=23%  Similarity=0.227  Sum_probs=58.1

Q ss_pred             cccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeC
Q 035998          301 PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL  380 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  380 (1020)
                      ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            45555566666666555556666666666666666666555556666677777777777776655556677777777777


Q ss_pred             CCCCCcchhh
Q 035998          381 SNSSIYNLSS  390 (1020)
Q Consensus       381 ~~N~i~~l~~  390 (1020)
                      ++|++.....
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            7777664443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.38  E-value=1.8e-12  Score=129.10  Aligned_cols=92  Identities=20%  Similarity=0.190  Sum_probs=62.3

Q ss_pred             cccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeC
Q 035998          301 PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSL  380 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  380 (1020)
                      ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            45566666666666665666666677777777777777655555677777777777777777655556777777777777


Q ss_pred             CCCCCcchhhHH
Q 035998          381 SNSSIYNLSSAL  392 (1020)
Q Consensus       381 ~~N~i~~l~~~~  392 (1020)
                      ++|++...+..+
T Consensus       113 ~~N~~~c~~~~~  124 (174)
T 2r9u_A          113 YNNPWDCECRDI  124 (174)
T ss_dssp             CSSCBCTTBGGG
T ss_pred             CCCCcccccccH
Confidence            777776655433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.26  E-value=1.5e-10  Score=131.87  Aligned_cols=331  Identities=10%  Similarity=0.110  Sum_probs=185.3

Q ss_pred             ccccccCCC-CCcEEecCCCCCCCCCCccccCCCCCCeeeccCCC---CCCCCCCcc-CCCCcceeeeccCccCCCCCcc
Q 035998          101 LSESLGNLV-QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSND---LSGPLPQTI-NLPSIQVLDISSNSLNGSVPTS  175 (1020)
Q Consensus       101 ~~~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~  175 (1020)
                      ...+|.+.+ .|+.+.+..+ ++..-..+|.++++|+.+.++.|.   ++.+....| ++.+|+.+.+..+ ++ .++..
T Consensus        55 g~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~  131 (394)
T 4gt6_A           55 GDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSE  131 (394)
T ss_dssp             CTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTT
T ss_pred             CHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhh
Confidence            345677764 5889988754 665566779999999999998764   555556666 6788888877655 44 67777


Q ss_pred             ccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCc
Q 035998          176 ICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNL  255 (1020)
Q Consensus       176 ~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  255 (1020)
                      .|..+.+|+.+.+..+ +.......|.++.+|+.+.+.++ ++.....+| ...+|+.+.+..+-.. ....+|.++.++
T Consensus       132 aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF-~~~~l~~i~ip~~~~~-i~~~af~~c~~l  207 (394)
T 4gt6_A          132 AFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAF-TGTALTQIHIPAKVTR-IGTNAFSECFAL  207 (394)
T ss_dssp             TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTT-TTCCCSEEEECTTCCE-ECTTTTTTCTTC
T ss_pred             hhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccc-cccceeEEEECCcccc-cccchhhhcccc
Confidence            7778888888888644 34355667778888888887655 442333333 3456777777655333 445667777777


Q ss_pred             cEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCC
Q 035998          256 VRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTN  335 (1020)
Q Consensus       256 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  335 (1020)
                      +......+......-..+...........           .+.....+..+.+. +.++......|..+.+|+.+.+.++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~  275 (394)
T 4gt6_A          208 STITSDSESYPAIDNVLYEKSANGDYALI-----------RYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDS  275 (394)
T ss_dssp             CEEEECCSSSCBSSSCEEEECTTSCEEEE-----------ECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTT
T ss_pred             ceecccccccccccceeeccccccccccc-----------ccccccccceEEcC-CcceEcccceeeecccccEEecccc
Confidence            77776665544221111111100000000           00111122222222 2233344556666777777777655


Q ss_pred             ccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCC
Q 035998          336 KFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKL  415 (1020)
Q Consensus       336 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~  415 (1020)
                      ..+ ....+|.++.+|+.+.+. +.++.....+|.++.+|+.+++..+ ++.+..                         
T Consensus       276 ~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~-------------------------  327 (394)
T 4gt6_A          276 VVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILD-------------------------  327 (394)
T ss_dssp             CCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECT-------------------------
T ss_pred             cce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehH-------------------------
Confidence            443 555667777777777775 4455455567777777777777543 333322                         


Q ss_pred             CCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcc
Q 035998          416 PTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTF  484 (1020)
Q Consensus       416 ~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  484 (1020)
                        ..+....+|+.+.+..+ +..+-..+|.++++|+.+++.+|....   ..|....+|+.+.+..|.+
T Consensus       328 --~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          328 --DAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             --TTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             --hHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence              12222233333333222 333445566777777777777665431   3455566666666655543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.26  E-value=5e-14  Score=158.30  Aligned_cols=186  Identities=17%  Similarity=0.197  Sum_probs=89.8

Q ss_pred             CCcccEEEccCCCCCCCCCCccccc-----cccccccccccccccccchhhh-hhcccccccccccccCCCCCcccc---
Q 035998          180 SSRIRVINLSVNYFSGTLSPGLGNC-----ASLEHLCLGMNDLTGGIADDIF-QLQKLRLLGLQDNQLSGKLSPSIA---  250 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~---  250 (1020)
                      .+.|+.|+|++|.++......+...     ++|++|+|++|.++......+. .+++|+.|+|++|+|+......+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3456677777777664333332222     4666666666666543333332 345555566666555432222221   


Q ss_pred             --cCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccccc----ccCCCCC
Q 035998          251 --DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSL----LLNCPAL  324 (1020)
Q Consensus       251 --~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l  324 (1020)
                        ..++|++|+|++|.|+......                    ++..+..+++|++|+|++|.|++..    ...+...
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~--------------------l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~  210 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAV--------------------LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN  210 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHH--------------------HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred             HhcCCccceeeCCCCCCChHHHHH--------------------HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence              2344555555555554311111                    1122233444555555555554321    2334445


Q ss_pred             CCcCEEEcCCCccCCC----CCCCCCCCCCCCeEecCCCcccccCcccccCCCC-----CCeee--CCCCCC
Q 035998          325 TNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLARNNFSGQIPETYKNFES-----LSYLS--LSNSSI  385 (1020)
Q Consensus       325 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-----L~~L~--l~~N~i  385 (1020)
                      ++|++|+|++|.|++.    ++..+...++|++|+|++|.|+......+..+..     |+.+.  +..|.+
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~  282 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV  282 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----C
T ss_pred             CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCcc
Confidence            5677777777766532    2233344567777777777776554444433321     55555  555544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.26  E-value=1e-13  Score=155.74  Aligned_cols=44  Identities=16%  Similarity=0.135  Sum_probs=21.8

Q ss_pred             hhhhcCCCCcEEecccccccccccccccCcC-----cCcEEe--CCCCccc
Q 035998          442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQ-----DLFYLD--LSNNTFT  485 (1020)
Q Consensus       442 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-----~L~~L~--Ls~N~l~  485 (1020)
                      ..+...++|++|+|++|.|++.-...+..+.     .|+.+.  +..|.++
T Consensus       233 ~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          233 RAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            3444556677777777777654444443321     155555  5555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.20  E-value=2.8e-11  Score=135.45  Aligned_cols=137  Identities=19%  Similarity=0.137  Sum_probs=99.2

Q ss_pred             CCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCC-CCCCCCCCccccCCCCCCeeec
Q 035998           62 CCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSH-NLLKGTVPVSLVNLPNLEVLDL  140 (1020)
Q Consensus        62 ~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L  140 (1020)
                      -|.|.+|.|++.                     |+++ .+|. |..+++|++|+|++ |.|++..|..|++|++|++|+|
T Consensus         7 ~C~~~~v~~~~~---------------------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l   63 (347)
T 2ifg_A            7 PHGSSGLRCTRD---------------------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI   63 (347)
T ss_dssp             CSSSSCEECCSS---------------------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEEC
T ss_pred             cccCCEEEcCCC---------------------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEEC
Confidence            399999999753                     1343 3666 88888899999986 8888777788899999999999


Q ss_pred             cCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCC-Cccccccccccccccccccc
Q 035998          141 SSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLS-PGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       141 ~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      ++|+|++.+|..+ ++++|++|+|++|+|+ .+|...+..++ |+.|+|++|.+...-. .+|..........+..+.++
T Consensus        64 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~  141 (347)
T 2ifg_A           64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ  141 (347)
T ss_dssp             CSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCC
T ss_pred             CCCccceeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCC
Confidence            9999998888887 7899999999999998 67777776666 9999999998874321 12222222233344455555


Q ss_pred             cccch
Q 035998          219 GGIAD  223 (1020)
Q Consensus       219 ~~~~~  223 (1020)
                      -..|.
T Consensus       142 C~~~~  146 (347)
T 2ifg_A          142 CHGQG  146 (347)
T ss_dssp             CSSSS
T ss_pred             CCCCh
Confidence            44444

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=8.1e-11  Score=125.97  Aligned_cols=143  Identities=14%  Similarity=0.069  Sum_probs=112.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      -..|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+||||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            356888888898999999999864 6899999987532122345889999999984 67788999999888889999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-------------------------------------
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-------------------------------------  862 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  862 (1020)
                      ++|.++.+....         ......++.+++++++.||+..                                     
T Consensus        92 i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           92 ADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             cCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999998765321         1223478889999999999810                                     


Q ss_pred             -------------------CCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          863 -------------------EPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       863 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                                         .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               1369999999999999876556799999764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.16  E-value=9.6e-10  Score=125.09  Aligned_cols=322  Identities=14%  Similarity=0.102  Sum_probs=166.8

Q ss_pred             cccccccccccCCCCCcccccCCCccEEEccCCc---CcccCcccccCCcccceeecccccccccCCCCCcCCccccccc
Q 035998          231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN---FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN  307 (1020)
Q Consensus       231 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  307 (1020)
                      |+.+.+.++ ++.+-..+|.++++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.....+|.++.+|+.+.
T Consensus        66 L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~  143 (394)
T 4gt6_A           66 LTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT  143 (394)
T ss_dssp             CCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred             CEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence            555555433 443445566666666666665553   44444556666666666555443 4434455566666666666


Q ss_pred             ccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          308 LRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       308 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      +..+ +.......|....+|+.+.+..+ ++.....+|.. .+|+.+.+..+-.. ....+|....+++......+....
T Consensus       144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~  219 (394)
T 4gt6_A          144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA  219 (394)
T ss_dssp             CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred             ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence            6533 33344455666666666666554 33233444433 45666666544322 444556666666666555444332


Q ss_pred             hhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccccccccccc
Q 035998          388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW  467 (1020)
Q Consensus       388 l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  467 (1020)
                      +...+  +..... ....+           ........+....+. +.+...-..+|.++.+|+.+.+..+..+ .-...
T Consensus       220 ~~~~~--~~~~~~-~~~~~-----------~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a  283 (394)
T 4gt6_A          220 IDNVL--YEKSAN-GDYAL-----------IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGA  283 (394)
T ss_dssp             SSSCE--EEECTT-SCEEE-----------EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred             cccee--eccccc-ccccc-----------cccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcc
Confidence            22110  000000 00000           000001112222221 2233344567778888888888766544 55667


Q ss_pred             ccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccC
Q 035998          468 FGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGS  547 (1020)
Q Consensus       468 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~  547 (1020)
                      |.++.+|+.+.+. +.++......|.++.+|+.+++                                    .. .++..
T Consensus       284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~l------------------------------------p~-~v~~I  325 (394)
T 4gt6_A          284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDI------------------------------------PE-GITQI  325 (394)
T ss_dssp             TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEEC------------------------------------CT-TCCEE
T ss_pred             cccccccccccCC-CcccccCceeecCCCCcCEEEe------------------------------------CC-cccEe
Confidence            7888888888885 3455344556766666644332                                    11 12223


Q ss_pred             CCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccccccccccccccccccc
Q 035998          548 IWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHL  616 (1020)
Q Consensus       548 ~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l  616 (1020)
                      ...+|.++.+|+.+.|..+ ++..-...|.++++|+.+++++|....   ..+....+|+.+.+..|.+
T Consensus       326 ~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          326 LDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             hHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            3456778888888888654 653344678888888888888776542   3566667777777665544

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.12  E-value=7.5e-11  Score=131.92  Aligned_cols=90  Identities=14%  Similarity=0.092  Sum_probs=45.7

Q ss_pred             ccCCcccceeeccc-ccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCC
Q 035998          273 FAGLGEFQYLVAHS-NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKL  351 (1020)
Q Consensus       273 ~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  351 (1020)
                      +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..++ |
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L  105 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L  105 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence            33333444444432 444433334444444444444444444444444455555566666666666544444444444 6


Q ss_pred             CeEecCCCcccc
Q 035998          352 KNINLARNNFSG  363 (1020)
Q Consensus       352 ~~L~L~~N~l~~  363 (1020)
                      +.|+|++|++..
T Consensus       106 ~~l~l~~N~~~c  117 (347)
T 2ifg_A          106 QELVLSGNPLHC  117 (347)
T ss_dssp             CEEECCSSCCCC
T ss_pred             eEEEeeCCCccC
Confidence            777777776653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.04  E-value=3.2e-10  Score=121.16  Aligned_cols=137  Identities=15%  Similarity=0.086  Sum_probs=100.8

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCc--cceEeeEEeccCceEEEEEec
Q 035998          743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN--LVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .|.+..+.+.|..+.||++...+|+.+++|.....   ....+.+|+++++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333466679999998877888999997654   1245778999999986544  456888888777889999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC--------------------------------------  862 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  862 (1020)
                      +|.++.  ...       .+   ...++.++++.++.||+..                                      
T Consensus        98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            998874  111       11   2356778888888888642                                      


Q ss_pred             -----------------CCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          863 -----------------EPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       863 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                                       ...++|||++|.||++++++.+.++||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             11399999999999998776677999998753

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.95  E-value=1.2e-10  Score=129.53  Aligned_cols=180  Identities=15%  Similarity=0.199  Sum_probs=105.3

Q ss_pred             CceEEEecCCCcccc-c-------ccccccCCCCCcEEecCCCCCC---------CCCCccccCCCCCCeeeccCCCCCC
Q 035998           85 GRVTGLFLYKRRLKG-K-------LSESLGNLVQLRFLNLSHNLLK---------GTVPVSLVNLPNLEVLDLSSNDLSG  147 (1020)
Q Consensus        85 ~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~l~~l~~L~~L~L~~n~l~~  147 (1020)
                      .+|++|.+......| .       +.+++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-..
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~  186 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS  186 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence            467888877655543 1       2445667889999999765431         2355556778999999998873111


Q ss_pred             CCCCccCCCCcceeeeccCccCCCCCcccc-ccCCcccEEEccC--CCCCCC-----CCCcc--cccccccccccccccc
Q 035998          148 PLPQTINLPSIQVLDISSNSLNGSVPTSIC-KNSSRIRVINLSV--NYFSGT-----LSPGL--GNCASLEHLCLGMNDL  217 (1020)
Q Consensus       148 ~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~-~~~~~L~~L~L~~--N~l~~~-----~~~~l--~~l~~L~~L~L~~N~l  217 (1020)
                       .+. +.+++|++|+|..|.++......++ ..+++|+.|+|+.  |...+.     +...+  ..+++|++|+|.+|.+
T Consensus       187 -l~~-~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i  264 (362)
T 2ra8_A          187 -IGK-KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE  264 (362)
T ss_dssp             -CCS-CBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred             -ecc-ccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence             222 3578899999988877533323333 2577888888753  221111     01112  2356777777777776


Q ss_pred             ccccchhhh---hhcccccccccccccCCC----CCcccccCCCccEEEccCCcCc
Q 035998          218 TGGIADDIF---QLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       218 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                      ++..+..+.   .+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.|+
T Consensus       265 ~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             HHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             chHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            644444443   255666666666665532    2222334556666666666555

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.90  E-value=3.4e-08  Score=111.64  Aligned_cols=283  Identities=13%  Similarity=0.127  Sum_probs=139.3

Q ss_pred             ceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeecc
Q 035998           86 RVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISS  165 (1020)
Q Consensus        86 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~  165 (1020)
                      .++++.+. .+++.....+|.++++|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++.+....+...+|+.+.+..
T Consensus        47 ~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~~L~~i~lp~  122 (379)
T 4h09_A           47 RISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGTDLDDFEFPG  122 (379)
T ss_dssp             GCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTCCCSEEECCT
T ss_pred             CCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccCCcccccCCC
Confidence            45555554 3455444566777777888777643 553444556665 5666666533 444444555445677777765


Q ss_pred             CccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccccccccc------------chhhhhhccccc
Q 035998          166 NSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGI------------ADDIFQLQKLRL  233 (1020)
Q Consensus       166 N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~------------~~~~~~l~~L~~  233 (1020)
                      +- + .+....|.+. .|+.+.+..+ ++......|.++.+++.+.+..+......            ...+.....+..
T Consensus       123 ~~-~-~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (379)
T 4h09_A          123 AT-T-EIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE  198 (379)
T ss_dssp             TC-C-EECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred             cc-c-cccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence            42 2 3444444443 3444444332 33344455666666666655544332111            111112222222


Q ss_pred             ccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccc
Q 035998          234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSL  313 (1020)
Q Consensus       234 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  313 (1020)
                      +.+..+. .......+....+|+.+.+..+ ++......|.+...|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +
T Consensus       199 ~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i  274 (379)
T 4h09_A          199 FTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-V  274 (379)
T ss_dssp             EECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-C
T ss_pred             cccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-c
Confidence            2222211 1122334444555555555433 33344445555555555555443 44444445555555555555432 3


Q ss_pred             ccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCC
Q 035998          314 DGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLS  381 (1020)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  381 (1020)
                      .......|..+++|+.+.+.++.++.....+|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+.
T Consensus       275 ~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          275 KTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             SEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             eeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            3344445555555555555555555444455555555555555433 443444455555555555554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.86  E-value=6.6e-08  Score=109.30  Aligned_cols=261  Identities=10%  Similarity=0.046  Sum_probs=134.1

Q ss_pred             ccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCccc
Q 035998          105 LGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIR  184 (1020)
Q Consensus       105 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~  184 (1020)
                      +....+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++.+...++.-.+|+.+.+..+ ++ .++...|... +|+
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~-l~-~I~~~aF~~~-~L~  116 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMER-VK-KFGDYVFQGT-DLD  116 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTT-CC-EECTTTTTTC-CCS
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCce-ee-EeccceeccC-Ccc
Confidence            44556788888864 455444567888888888888654 6656666663336777776543 33 4555555443 566


Q ss_pred             EEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCc
Q 035998          185 VINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNN  264 (1020)
Q Consensus       185 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  264 (1020)
                      .+.+..+ +.......|.+. +|+.+.+..+ ++......|.....++.+.+..+.........+.           .+.
T Consensus       117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-----------~~~  182 (379)
T 4h09_A          117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-----------YNK  182 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-----------EET
T ss_pred             cccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccccee-----------ccc
Confidence            6666544 222223333332 3443333322 2223333344444444444333222100000000           000


Q ss_pred             CcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCC
Q 035998          265 FSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTN  344 (1020)
Q Consensus       265 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  344 (1020)
                       .......+.....+..+.+..+ .+......+....+|+.+.+..+ +.......|.....|+.+.+..+ ++.....+
T Consensus       183 -~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~a  258 (379)
T 4h09_A          183 -NKTILESYPAAKTGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFL  258 (379)
T ss_dssp             -TSSEEEECCTTCCCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTT
T ss_pred             -ccceeccccccccccccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccc
Confidence             0011122233333333333222 12233445556666666666544 33344556666777777777655 55455666


Q ss_pred             CCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchh
Q 035998          345 LPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       345 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~  389 (1020)
                      |.++.+|+.+.+..+ +......+|.++.+|+.+.+.++.++.++
T Consensus       259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~  302 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLE  302 (379)
T ss_dssp             TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEEC
T ss_pred             cceeehhcccccccc-ceeccccccccccccccccccccccceeh
Confidence            777777777777543 44455566777777777777666655443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.86  E-value=5e-09  Score=117.53  Aligned_cols=142  Identities=14%  Similarity=0.183  Sum_probs=106.7

Q ss_pred             cCCeeeccCCeEEEEEEeCCCCEEEEEEec--CCc-hhhHHHHHHHHHHHHHcC--CCccceEeeEEecc---CceEEEE
Q 035998          746 QANIIGCGGFGLVYRATLPDGRNVAIKRLS--GDC-GQMEREFRAEVEALSRAQ--HPNLVHLQGYCMHK---NDRLLIY  817 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  817 (1020)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|+++++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567899999999999875 4688899876  322 122356888999999997  45578888888766   3479999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----------------------------------
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-----------------------------------  862 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  862 (1020)
                      ||++|..+.+..      ...++..++..++.+++++|+.||+..                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999998764311      124677888999999999999999721                                   


Q ss_pred             --------------------CCCeEecCCCCCCEEEcCCCC--eEEeecccccc
Q 035998          863 --------------------EPHILHRDIKSSNILLDGNFG--AHLADFGLARL  894 (1020)
Q Consensus       863 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~  894 (1020)
                                          .+.++|||+++.||+++.++.  +.++||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                247999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.78  E-value=3.5e-09  Score=115.83  Aligned_cols=186  Identities=22%  Similarity=0.216  Sum_probs=121.5

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCc--cceEeeEEeccC---ceEEEEEec
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPN--LVHLQGYCMHKN---DRLLIYSFM  820 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  820 (1020)
                      .+.++.|....||++.    ..+++|+....  .....+.+|+++++.+. +..  +.+++.+.....   ..|+||||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4679999999999864    56899986533  33467889999999884 333  334444332222   347899999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhc---------------------------------------
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS---------------------------------------  861 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  861 (1020)
                      +|.++......      .++.+++..++.++++.++.||+.                                       
T Consensus        99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99887653321      356777888888888888888861                                       


Q ss_pred             ----------------CCCCeEecCCCCCCEEEcC--CCCeEEeeccccccccCCCCccc-cccc---cc---------c
Q 035998          862 ----------------CEPHILHRDIKSSNILLDG--NFGAHLADFGLARLILSPYDTHV-TTDL---VG---------T  910 (1020)
Q Consensus       862 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~-~~~~---~g---------t  910 (1020)
                                      ..+.++|+|++|.||++++  +..+.++||+.+..- ++...-. ....   .+         .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~-~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS-DPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE-CTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC-ChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                            0136899999999999998  456789999998653 2211100 0000   00         0


Q ss_pred             cCccC-ccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 035998          911 LGYIP-PEYGQASVATYKGDVYSFGVVLLELLTGKRPM  947 (1020)
Q Consensus       911 ~~y~a-PE~~~~~~~~~~~DvwSlGvil~elltg~~pf  947 (1020)
                      .++.. |+...  ......+.|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            01111 12110  1122368999999999999998775

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.77  E-value=9e-10  Score=122.47  Aligned_cols=60  Identities=18%  Similarity=0.231  Sum_probs=31.3

Q ss_pred             chhhhhhcccccccccccc-cCCCCCcccccCCCccEEEccCCcCcccCccccc--CCcccceeecc
Q 035998          222 ADDIFQLQKLRLLGLQDNQ-LSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFA--GLGEFQYLVAH  285 (1020)
Q Consensus       222 ~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~  285 (1020)
                      ...+..+++|+.|+|++|. ++  ++. +. +++|++|+|..|.++......+.  .+++|+.|+|+
T Consensus       165 ~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          165 SPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             HHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred             HHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence            3444555666666666652 21  222 22 56677777766666543333332  45666666553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.62  E-value=3.2e-10  Score=119.38  Aligned_cols=12  Identities=0%  Similarity=-0.438  Sum_probs=10.1

Q ss_pred             CCcCceEEcCCC
Q 035998           62 CCHWVGITCNSS   73 (1020)
Q Consensus        62 ~C~w~gv~C~~~   73 (1020)
                      -|.|.|+.|+..
T Consensus        77 l~~~~g~i~~~~   88 (267)
T 3rw6_A           77 LKAVNYKILDRE   88 (267)
T ss_dssp             HHHTTSSCBCTT
T ss_pred             HHhcCcEEECCC
Confidence            489999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=5.6e-06  Score=90.10  Aligned_cols=136  Identities=16%  Similarity=0.112  Sum_probs=94.7

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCC---ccceEeeEEe-ccCceEEEEEeccC
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP---NLVHLQGYCM-HKNDRLLIYSFMEN  822 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  822 (1020)
                      .+.++.|....||+.    ++.+++|+...  ......+.+|+++++.+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456889999999988    56788898532  23456788999999999653   3556666664 34567899999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhc-----------------------------------------
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS-----------------------------------------  861 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  861 (1020)
                      ..+......      .++..+...++.++++.|+.||+.                                         
T Consensus        98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            887653211      123444455555555555555532                                         


Q ss_pred             ----------------CCCCeEecCCCCCCEEEcC---CCCe-EEeecccccc
Q 035998          862 ----------------CEPHILHRDIKSSNILLDG---NFGA-HLADFGLARL  894 (1020)
Q Consensus       862 ----------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfg~~~~  894 (1020)
                                      ..+.++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            2336799999999999987   4554 7999998764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.25  E-value=2e-07  Score=97.96  Aligned_cols=92  Identities=17%  Similarity=0.193  Sum_probs=51.1

Q ss_pred             ccccccccc--ccccccccc---cccchhhhhhcccccccccccccCC--CCCcccccCCCccEEEccCCcCcccCcccc
Q 035998          201 LGNCASLEH--LCLGMNDLT---GGIADDIFQLQKLRLLGLQDNQLSG--KLSPSIADLSNLVRLDVSSNNFSGNIPDVF  273 (1020)
Q Consensus       201 l~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  273 (1020)
                      |...+.|..  ++++.|...   ..++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            344455555  556666433   1122222346677777777777776  3345566777777777777777654  223


Q ss_pred             cCCc--ccceeecccccccccCC
Q 035998          274 AGLG--EFQYLVAHSNRFTGRIP  294 (1020)
Q Consensus       274 ~~l~--~L~~L~L~~N~l~~~~p  294 (1020)
                      ..+.  +|+.|+|++|.+.+.+|
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhcccCCcceEEccCCcCccccC
Confidence            3332  55666666666554433

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.24  E-value=1.9e-07  Score=93.51  Aligned_cols=43  Identities=12%  Similarity=0.049  Sum_probs=27.0

Q ss_pred             hhhcCCCCcEEec--cccccccc----ccccccCcCcCcEEeCCCCccc
Q 035998          443 WLRGCSKLQLVDL--SWNQLSGT----IPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       443 ~l~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      .+...+.|++|+|  ++|.|+..    +...+...+.|++|+|++|.+.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            3445566777777  66777643    2334445567777777777765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=7.8e-06  Score=87.32  Aligned_cols=135  Identities=19%  Similarity=0.176  Sum_probs=97.8

Q ss_pred             CeeeccCCe-EEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEEEeccCCC
Q 035998          748 NIIGCGGFG-LVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGS  824 (1020)
Q Consensus       748 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  824 (1020)
                      +.+..|..| .||+.... ++..+++|+-..   .....+.+|++.++.+. +-.+.++++++.+.+..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345566666 68988764 466799998653   23457888999999884 3346788888888889999999999988


Q ss_pred             hhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------------------
Q 035998          825 LDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC------------------------------------------  862 (1020)
Q Consensus       825 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------  862 (1020)
                      +.+.....        ......++.+++..++.||...                                          
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            76654321        1223455666667777777421                                          


Q ss_pred             -------------CCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          863 -------------EPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       863 -------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                                   .+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         1238999999999999987777799999875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.13  E-value=2.5e-07  Score=92.61  Aligned_cols=65  Identities=15%  Similarity=0.250  Sum_probs=31.2

Q ss_pred             ccccccccccccccccccc----chhhhhhcccccccccccccCCC----CCcccccCCCccEEEc--cCCcCcc
Q 035998          203 NCASLEHLCLGMNDLTGGI----ADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDV--SSNNFSG  267 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--s~N~l~~  267 (1020)
                      ..++|++|+|++|.|+...    ...+...++|++|+|++|+|+..    +..++...++|++|+|  ++|.|+.
T Consensus        63 ~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A           63 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            3445555555555554322    22223334555555555555432    2334444455666666  5555553

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=4.5e-06  Score=93.23  Aligned_cols=80  Identities=5%  Similarity=-0.042  Sum_probs=56.0

Q ss_pred             CCee-eccCCeEEEEEEeC-------CCCEEEEEEecCCch--h-hHHHHHHHHHHHHHcC-C--CccceEeeEEecc--
Q 035998          747 ANII-GCGGFGLVYRATLP-------DGRNVAIKRLSGDCG--Q-MEREFRAEVEALSRAQ-H--PNLVHLQGYCMHK--  810 (1020)
Q Consensus       747 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~-~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  810 (1020)
                      .+.| +.|....+|+....       +++.+++|+......  . ....+.+|+++++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88999999998754       267899998654320  0 1245778899988884 3  3467788777654  


Q ss_pred             -CceEEEEEeccCCChh
Q 035998          811 -NDRLLIYSFMENGSLD  826 (1020)
Q Consensus       811 -~~~~lv~e~~~~g~L~  826 (1020)
                       ...++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.82  E-value=7.4e-05  Score=82.68  Aligned_cols=141  Identities=21%  Similarity=0.294  Sum_probs=80.8

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC--CccceEee------EEeccCceEEEEEe
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH--PNLVHLQG------YCMHKNDRLLIYSF  819 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  819 (1020)
                      +.++.|..+.||++...+| .+++|+....    ...+..|+++++.+..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566678899999987654 5899998763    2334455666655531  12333332      12235567899999


Q ss_pred             ccCCChh--------------hhhhhcCCC---C-------CCCCHHHH-------------------------------
Q 035998          820 MENGSLD--------------YWLHEKLDG---P-------SSLDWDSR-------------------------------  844 (1020)
Q Consensus       820 ~~~g~L~--------------~~l~~~~~~---~-------~~l~~~~~-------------------------------  844 (1020)
                      ++|..+.              ..++.....   +       ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              011111110   1       01123211                               


Q ss_pred             HHHHHHHHHHHHHhHh----------cCCCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          845 LHIAQGAARGLAYLHQ----------SCEPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       845 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                      ..+..++..++++|++          ...+.++|||+++.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111224446666763          124589999999999999888889999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=8.9e-05  Score=79.79  Aligned_cols=79  Identities=23%  Similarity=0.352  Sum_probs=58.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCC---ccceEeeEEeccCceEEEEEe
Q 035998          743 NFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP---NLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .....+.+|.|..+.||+.+..||+.|++|+...........+.+|++.|+.+...   .+++++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            34456779999999999999999999999987655444445688999999988432   23444443    234789999


Q ss_pred             ccCCCh
Q 035998          820 MENGSL  825 (1020)
Q Consensus       820 ~~~g~L  825 (1020)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00018  Score=77.78  Aligned_cols=140  Identities=15%  Similarity=0.170  Sum_probs=93.1

Q ss_pred             cCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC---CCccceEeeEEeccCceEEEEEeccC
Q 035998          746 QANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ---HPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ..+.|+.|....+|+... +++.+++|+....   ....+.+|++.++.+.   ...+++++.++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999986 4778999987643   2456889999998884   35688888888877889999999998


Q ss_pred             CChhh-----------hhhhcCC-C-----------------CCCCCHHHHH---HHH----------------HHHHHH
Q 035998          823 GSLDY-----------WLHEKLD-G-----------------PSSLDWDSRL---HIA----------------QGAARG  854 (1020)
Q Consensus       823 g~L~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~i~~~  854 (1020)
                      ..+..           .++.... .                 ...-+|....   ++.                ..+...
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1222111 0                 0012454321   011                111111


Q ss_pred             -HHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          855 -LAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       855 -L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                       ...|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223321 2246899999999999999887 8899974

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.67  E-value=0.00014  Score=82.21  Aligned_cols=75  Identities=17%  Similarity=0.146  Sum_probs=49.6

Q ss_pred             CCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch-------hhHHHHHHHHHHHHHcCC--Cc-cceEeeEEeccCceEE
Q 035998          747 ANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG-------QMEREFRAEVEALSRAQH--PN-LVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  815 (1020)
                      .+.+|.|..+.||++... +++.|+||.......       .....+..|+++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 468899998653221       112346778999888742  33 3455543  4456789


Q ss_pred             EEEeccCC
Q 035998          816 IYSFMENG  823 (1020)
Q Consensus       816 v~e~~~~g  823 (1020)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.41  E-value=2.2e-05  Score=76.29  Aligned_cols=88  Identities=10%  Similarity=0.151  Sum_probs=58.3

Q ss_pred             cccccccccccccccccccCCCCCCCcCEEEcCCCc-cCCCCCCCCCCC----CCCCeEecCCCc-ccccCcccccCCCC
Q 035998          301 PTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNK-FNGPLPTNLPRC----RKLKNINLARNN-FSGQIPETYKNFES  374 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~  374 (1020)
                      ..|+.||++++.++......+..+++|++|+|+++. |++..-..++.+    ++|++|+|++|. ++...-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356777777777665555556677777777777774 554333334443    368888888874 77655566777888


Q ss_pred             CCeeeCCCCC-Ccch
Q 035998          375 LSYLSLSNSS-IYNL  388 (1020)
Q Consensus       375 L~~L~l~~N~-i~~l  388 (1020)
                      |++|++++++ ++..
T Consensus       141 L~~L~L~~c~~Itd~  155 (176)
T 3e4g_A          141 LKYLFLSDLPGVKEK  155 (176)
T ss_dssp             CCEEEEESCTTCCCH
T ss_pred             CCEEECCCCCCCCch
Confidence            8888888874 5543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.39  E-value=0.00061  Score=77.57  Aligned_cols=77  Identities=10%  Similarity=0.117  Sum_probs=47.7

Q ss_pred             CCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccccccccc--ccCccCccccCCC---CCCchhhHHHHHHHH
Q 035998          863 EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG--TLGYIPPEYGQAS---VATYKGDVYSFGVVL  937 (1020)
Q Consensus       863 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGvil  937 (1020)
                      .+.++|||++|.||+++.++ ++++||+.+..- ++...-  .....  ...|.+|+.....   ......++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G-~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG-PMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE-CHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC-chHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            34899999999999999876 999999988642 111000  00010  1345666544311   223345566788888


Q ss_pred             HHHHcC
Q 035998          938 LELLTG  943 (1020)
Q Consensus       938 ~elltg  943 (1020)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887765

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.30  E-value=3.3e-05  Score=75.15  Aligned_cols=35  Identities=11%  Similarity=0.047  Sum_probs=19.2

Q ss_pred             CCccEEEccCCcCcccCcccccCCcccceeecccc
Q 035998          253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSN  287 (1020)
Q Consensus       253 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  287 (1020)
                      .+|++||++++.++..--..+.++++|+.|+|++|
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            35666666666665444344445555555555554

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.27  E-value=0.00073  Score=73.08  Aligned_cols=71  Identities=11%  Similarity=0.098  Sum_probs=46.0

Q ss_pred             CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCcc-ceEeeEEeccCceEEEEEec-cCCC
Q 035998          747 ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL-VHLQGYCMHKNDRLLIYSFM-ENGS  824 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~  824 (1020)
                      .+.|+.|....+|++     +.+++|+....... .....+|+++++.+...++ .+++++  +.+..++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     56889988653211 1123568888877743333 355543  444567899999 6654


Q ss_pred             h
Q 035998          825 L  825 (1020)
Q Consensus       825 L  825 (1020)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.17  E-value=0.0012  Score=75.09  Aligned_cols=73  Identities=15%  Similarity=0.171  Sum_probs=50.6

Q ss_pred             CCeeeccCCeEEEEEEeCC--------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCcc-ceEeeEEeccCceEEEE
Q 035998          747 ANIIGCGGFGLVYRATLPD--------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL-VHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  817 (1020)
                      .+.|+.|....||++...+        ++.+++|+....  .....+.+|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568889999999998753        578999998542  112345579999988853333 566665542    3899


Q ss_pred             EeccCCCh
Q 035998          818 SFMENGSL  825 (1020)
Q Consensus       818 e~~~~g~L  825 (1020)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.14  E-value=0.0025  Score=69.55  Aligned_cols=160  Identities=14%  Similarity=0.117  Sum_probs=88.0

Q ss_pred             ccHHHHHHhccCCCc-----CCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCc--cceEe
Q 035998          732 ISIDDILESTNNFDQ-----ANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN--LVHLQ  804 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  804 (1020)
                      ++.+++...-.+|..     .+.|+.|....+|+....+| .+++|......  ....+..|+++++.+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            444555555455654     24567788899999987655 68899887531  1234566788877774222  23333


Q ss_pred             eE------EeccCceEEEEEeccCCChhh--------------hhhhcC---CCCC--CC---CHHHHHH----------
Q 035998          805 GY------CMHKNDRLLIYSFMENGSLDY--------------WLHEKL---DGPS--SL---DWDSRLH----------  846 (1020)
Q Consensus       805 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~---~~~~--~l---~~~~~~~----------  846 (1020)
                      ..      ....+..+++|+|++|..+..              .++...   ....  ..   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      112345689999999865321              011110   0010  01   1222110          


Q ss_pred             --HHHHHHHHHHHhHhc----CCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          847 --IAQGAARGLAYLHQS----CEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       847 --i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                        +...+...++++++.    .+.+++|+|+.+.||++++++.+.++||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011234455555532    134799999999999999876668999997753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.13  E-value=0.0014  Score=72.81  Aligned_cols=143  Identities=17%  Similarity=0.169  Sum_probs=84.3

Q ss_pred             CCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEE
Q 035998          747 ANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .+.+..|-...+|++...        +++.|++|+..... .....+.+|.++++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            356777888999999874        25789999864321 22455678999998884 3333566666543    2899


Q ss_pred             EeccCCChhhh--------------h---hhc-CCCCCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 035998          818 SFMENGSLDYW--------------L---HEK-LDGPSSLD--WDSRLHIAQGAAR-------------------GLAYL  858 (1020)
Q Consensus       818 e~~~~g~L~~~--------------l---~~~-~~~~~~l~--~~~~~~i~~~i~~-------------------~L~~L  858 (1020)
                      ||++|..+..-              +   +.. ........  +.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998655311              1   111 01111222  3455555544322                   12333


Q ss_pred             H----hc-CCCCeEecCCCCCCEEEcCC----CCeEEeecccccc
Q 035998          859 H----QS-CEPHILHRDIKSSNILLDGN----FGAHLADFGLARL  894 (1020)
Q Consensus       859 H----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~~~~  894 (1020)
                      .    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    11 13478999999999999876    7899999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.05  E-value=0.0012  Score=72.62  Aligned_cols=142  Identities=14%  Similarity=0.122  Sum_probs=74.1

Q ss_pred             CeeeccCCeE-EEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCC--ccceEeeEEeccCceEEEEEeccCCC
Q 035998          748 NIIGCGGFGL-VYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHP--NLVHLQGYCMHKNDRLLIYSFMENGS  824 (1020)
Q Consensus       748 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~  824 (1020)
                      +.++.|+... +|+....+++.+++|.......   ..+..|+++++.+...  .+.+++.+..  +..+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence            4566665554 6677654477888886544321   2345677777776422  3455666533  23378999998766


Q ss_pred             hhhhhhhc---------------------CC-CCCCCCHHHHH-------H-H------------HHHHHHHHHHhHh--
Q 035998          825 LDYWLHEK---------------------LD-GPSSLDWDSRL-------H-I------------AQGAARGLAYLHQ--  860 (1020)
Q Consensus       825 L~~~l~~~---------------------~~-~~~~l~~~~~~-------~-i------------~~~i~~~L~~LH~--  860 (1020)
                      +.+++...                     .. ....++.....       . +            ...+...++.+.+  
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            65433210                     00 00112211100       0 0            0111122222211  


Q ss_pred             -cCCCCeEecCCCCCCEEEcCC----CCeEEeecccccc
Q 035998          861 -SCEPHILHRDIKSSNILLDGN----FGAHLADFGLARL  894 (1020)
Q Consensus       861 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~~~~  894 (1020)
                       ...+.++|||+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             123489999999999999875    6789999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.91  E-value=0.0057  Score=66.81  Aligned_cols=143  Identities=13%  Similarity=0.147  Sum_probs=82.4

Q ss_pred             CeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCc--cceEeeE-----EeccCceEEEEEec
Q 035998          748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN--LVHLQGY-----CMHKNDRLLIYSFM  820 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~  820 (1020)
                      +.++ |....||++...+|+.+++|....... ....+..|.++++.+....  +++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 888899998877777899999864321 2346677888888774222  3444432     11234557899999


Q ss_pred             cCCChhh-----------h---hhhcCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHhHhc-
Q 035998          821 ENGSLDY-----------W---LHEKLD-----GPSSLDWDSR----LHI---------------AQGAARGLAYLHQS-  861 (1020)
Q Consensus       821 ~~g~L~~-----------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~i~~~L~~LH~~-  861 (1020)
                      +|..+..           .   ++....     .....++...    ..+               ...+...++.+.+. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8854320           1   111100     0111222211    000               11111223333221 


Q ss_pred             ---CCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          862 ---CEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       862 ---~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                         ....++|||+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234689999999999999 4 899999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.88  E-value=0.0032  Score=71.89  Aligned_cols=74  Identities=15%  Similarity=0.103  Sum_probs=48.6

Q ss_pred             CCeeeccCCeEEEEEEeCC-CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCcc-ceEeeEEeccCceEEEEEeccCCC
Q 035998          747 ANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL-VHLQGYCMHKNDRLLIYSFMENGS  824 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  824 (1020)
                      .+.|+.|....+|++...+ +..+++|+........ ....+|..+++.+...++ .++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4568889999999998765 4788999875432111 112578999998865444 56666653  2  35999999755


Q ss_pred             h
Q 035998          825 L  825 (1020)
Q Consensus       825 L  825 (1020)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.79  E-value=0.0023  Score=71.45  Aligned_cols=73  Identities=12%  Similarity=0.095  Sum_probs=45.4

Q ss_pred             CeeeccCCeEEEEEEeCC---------CCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCc-cceEeeEEeccCceEEEE
Q 035998          748 NIIGCGGFGLVYRATLPD---------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPN-LVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  817 (1020)
                      +.++.|....+|++...+         ++.+++|+........ .....|.++++.+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            457788889999998754         2789999876543221 12467888888875333 44666543    237899


Q ss_pred             EeccCCCh
Q 035998          818 SFMENGSL  825 (1020)
Q Consensus       818 e~~~~g~L  825 (1020)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988643

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.65  E-value=0.00036  Score=69.15  Aligned_cols=61  Identities=10%  Similarity=0.167  Sum_probs=26.2

Q ss_pred             CCCCcCEEEcCCCccCCCCCCC----CCCCCCCCeEecCCCcccccC----cccccCCCCCCeeeCCCC
Q 035998          323 ALTNLTSLDLGTNKFNGPLPTN----LPRCRKLKNINLARNNFSGQI----PETYKNFESLSYLSLSNS  383 (1020)
Q Consensus       323 ~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~l~~N  383 (1020)
                      .-+.|+.|+|++|+|.......    +..-+.|+.|+|++|.|....    -+++..-+.|++|+|++|
T Consensus        68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            3345555555555554322222    223344555555555554321    122333344555555443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.51  E-value=0.004  Score=57.52  Aligned_cols=56  Identities=21%  Similarity=0.333  Sum_probs=39.3

Q ss_pred             EEEcCCCccC-CCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc
Q 035998          329 SLDLGTNKFN-GPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       329 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~  386 (1020)
                      .++.+++.++ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|++|+|++|++.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5667777765 34555443  45777888888887666677777888888888888765

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.50  E-value=0.00044  Score=68.50  Aligned_cols=59  Identities=19%  Similarity=0.249  Sum_probs=25.3

Q ss_pred             ccccccccccccccccc----chhhhhhcccccccccccccCCC----CCcccccCCCccEEEccCC
Q 035998          205 ASLEHLCLGMNDLTGGI----ADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSN  263 (1020)
Q Consensus       205 ~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N  263 (1020)
                      +.|++|+|++|+|+...    .+.+..-+.|++|+|+.|+|+..    +..++..-+.|++|+|++|
T Consensus        70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            44555555555544222    22222334455555555555421    1122233344556666543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.44  E-value=0.0092  Score=65.49  Aligned_cols=68  Identities=13%  Similarity=0.142  Sum_probs=43.6

Q ss_pred             eccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC---CCccceEeeE------EeccCceEEEEEecc
Q 035998          751 GCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ---HPNLVHLQGY------CMHKNDRLLIYSFME  821 (1020)
Q Consensus       751 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~  821 (1020)
                      |.|....||+....+| .+++|+......      .+|+++++.+.   -|.+++++..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344689999987766 899998876432      34566665552   2324444432      223456789999999


Q ss_pred             CCCh
Q 035998          822 NGSL  825 (1020)
Q Consensus       822 ~g~L  825 (1020)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.31  E-value=0.045  Score=54.37  Aligned_cols=101  Identities=15%  Similarity=0.100  Sum_probs=66.9

Q ss_pred             ChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCccc
Q 035998          824 SLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV  903 (1020)
Q Consensus       824 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  903 (1020)
                      +|.+.|..+   +.+++++++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence            788888765   4689999999999999999877632111 1 1333457899999999998764 1110          


Q ss_pred             ccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 035998          904 TTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKR  945 (1020)
Q Consensus       904 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~  945 (1020)
                          .....+.|||... ...+.+.-|||+|+++|.-+--..
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                1122567888753 456789999999999999887333

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.92  E-value=0.0091  Score=55.10  Aligned_cols=37  Identities=30%  Similarity=0.266  Sum_probs=29.2

Q ss_pred             CCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCC
Q 035998          110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLS  146 (1020)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  146 (1020)
                      +|++|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5778888888888555566788888888888888775

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.19  E-value=0.047  Score=61.37  Aligned_cols=142  Identities=11%  Similarity=0.131  Sum_probs=85.4

Q ss_pred             CCeeeccCCeEEEEEEeCC--------CCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEE
Q 035998          747 ANIIGCGGFGLVYRATLPD--------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      .+.+..|-...+|+....+        ++.|++|+....... ..+..+|.++++.+. +.-..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567788899999998753        578999987543211 123457888888884 333445555332    37899


Q ss_pred             EeccCCChhh--------------hh---hhc-C-----C---CCCCCCHHHHHHHHHHHH-------------------
Q 035998          818 SFMENGSLDY--------------WL---HEK-L-----D---GPSSLDWDSRLHIAQGAA-------------------  852 (1020)
Q Consensus       818 e~~~~g~L~~--------------~l---~~~-~-----~---~~~~l~~~~~~~i~~~i~-------------------  852 (1020)
                      ||++|..+..              .+   +.. .     .   ...+.-+.++.++..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999876421              00   000 0     1   111222444444433321                   


Q ss_pred             HHHHHhHh---------------------cCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          853 RGLAYLHQ---------------------SCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       853 ~~L~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ..+..|.+                     ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            12233221                     11236899999999999 8888999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.82  E-value=0.52  Score=52.66  Aligned_cols=30  Identities=30%  Similarity=0.386  Sum_probs=25.2

Q ss_pred             CeEecCCCCCCEEE------cCCCCeEEeecccccc
Q 035998          865 HILHRDIKSSNILL------DGNFGAHLADFGLARL  894 (1020)
Q Consensus       865 ~ivH~Dlkp~NIll------~~~~~~kl~Dfg~~~~  894 (1020)
                      .++|+|+.+.||++      +.+..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      3466799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.54  E-value=4.2  Score=40.30  Aligned_cols=116  Identities=8%  Similarity=0.079  Sum_probs=77.3

Q ss_pred             CCCccceEeeEEeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCC
Q 035998          796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSN  875 (1020)
Q Consensus       796 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  875 (1020)
                      .||+.++. .+-.+++...+.++.-+  +...|-.-     ...+...+++++.+|+...++++..     +|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            58888866 45555665555555433  22222221     2457889999999999988776644     888999999


Q ss_pred             EEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 035998          876 ILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD  948 (1020)
Q Consensus       876 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~  948 (1020)
                      |+++.++.+++.=.|+-..                   ++|.     ..+...=.-.+=+++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999976665322                   2222     12222233447788889999999885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1020
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-33
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-10
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	4e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 3e-69
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 21/281 (7%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
                    IG G FG VY+        V +  ++    Q  + F+ EV  L + +H N++
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
               GY        ++  + E  SL + LH      +  +    + IA+  A+G+ YLH  
Sbjct: 68   LFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA- 122

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY--- 918
                I+HRD+KS+NI L  +    + DFGLA +      +H    L G++ ++ PE    
Sbjct: 123  --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
               +  +++ DVY+FG+VL EL+TG+ P        + +    +I M      S  L   
Sbjct: 181  QDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKV 234

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                        +  +   CL +    RP   Q+++ ++ +
Sbjct: 235  -----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 4e-64
 Identities = 73/278 (26%), Positives = 112/278 (40%), Gaps = 23/278 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
                    +G G FG V+         VA+K L          F AE   + + QH  LV
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L      +    +I  +MENGSL  +L         L  +  L +A   A G+A++   
Sbjct: 72   RLYAVV-TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
             E + +HRD++++NIL+       +ADFGLARLI    +          + +  PE    
Sbjct: 127  -ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINY 184

Query: 922  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
               T K DV+SFG++L E++T  R         + ++I  + R  +  R     +     
Sbjct: 185  GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGYRMVRPDNCPEELY-- 240

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                        +  LC  E P+ RPT   L S L+  
Sbjct: 241  -----------QLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 4e-62
 Identities = 75/292 (25%), Positives = 116/292 (39%), Gaps = 29/292 (9%)

Query: 750  IGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH 809
            IG G FG V+R     G  VA+K  S    +      AE+      +H N++        
Sbjct: 11   IGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 810  KNDRL----LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC--- 862
             N       L+  + E+GSL  +L+       ++  +  + +A   A GLA+LH      
Sbjct: 69   DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 863  --EPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT--HVTTDLVGTLGYIPPEY 918
              +P I HRD+KS NIL+  N    +AD GLA    S  DT        VGT  Y+ PE 
Sbjct: 124  QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 919  GQASV------ATYKGDVYSFGVVLLELLTGKRPM----DMCKPKGSRDLISWVIRMRQE 968
               S+      +  + D+Y+ G+V  E+           D   P          +   ++
Sbjct: 184  LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 969  NRESEVLDPFIYDKQHDKEMLRVL-DIACLCLSESPKVRPTTQQLVSWLDSI 1019
                + L P I ++    E LRV+  I   C   +   R T  ++   L  +
Sbjct: 244  VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 8e-62
 Identities = 74/280 (26%), Positives = 117/280 (41%), Gaps = 25/280 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            +       IG G FGLV+     +   VAIK +       E +F  E E + +  HP LV
Sbjct: 5    SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L G C+ +    L++ FME+G L  +L  +         ++ L +      G+AYL   
Sbjct: 64   QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL--- 117

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
             E  ++HRD+ + N L+  N    ++DFG+ R  +       +T     + +  PE    
Sbjct: 118  EEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSF 176

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
            S  + K DV+SFGV++ E+ + GK P +        + IS   R+ +    S        
Sbjct: 177  SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------- 229

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                      V  I   C  E P+ RP   +L+  L  I 
Sbjct: 230  ---------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-61
 Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 25/276 (9%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
             +      +G G FG+V         +VAIK +  +    E EF  E + +    H  LV
Sbjct: 4    KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L G C  +    +I  +M NG L  +L E             L + +     + YL   
Sbjct: 63   QLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES- 118

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
                 LHRD+ + N L++      ++DFGL+R +L   +   +      + + PPE    
Sbjct: 119  --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMY 175

Query: 922  SVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY 980
            S  + K D+++FGV++ E+ + GK P +      + + I+  +R+ + +  SE       
Sbjct: 176  SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------- 228

Query: 981  DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                     +V  I   C  E    RPT + L+S +
Sbjct: 229  ---------KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  207 bits (528), Expect = 8e-61
 Identities = 78/306 (25%), Positives = 129/306 (42%), Gaps = 40/306 (13%)

Query: 733  SIDDILESTNNFDQA---------NIIGCGGFGLVYRATLP----DGRNVAIKRL-SGDC 778
            + +D  E+   F +           +IG G FG V    L         VAIK L SG  
Sbjct: 8    TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 779  GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSS 838
             +  R+F +E   + +  HPN++HL+G        ++I  FMENGSLD +L +       
Sbjct: 68   EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQ 124

Query: 839  LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP 898
                  + + +G A G+ YL      + +HRD+ + NIL++ N    ++DFGL+R +   
Sbjct: 125  FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 899  YDTHVTTDLVG---TLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKG 954
                  T  +G    + +  PE  Q    T   DV+S+G+V+ E+++ G+RP      + 
Sbjct: 182  TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
              + I    R+                         +  +   C  +    RP   Q+V+
Sbjct: 242  VINAIEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 1015 WLDSII 1020
             LD +I
Sbjct: 286  TLDKMI 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 9e-61
 Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 23/279 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
             +      +G G FG V+  T      VAIK L          F  E + + + +H  LV
Sbjct: 17   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L           ++  +M  GSL  +L  +      L     + +A   A G+AY+ + 
Sbjct: 76   QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER- 131

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQA 921
               + +HRD++++NIL+  N    +ADFGLARLI    +          + +  PE    
Sbjct: 132  --MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALY 188

Query: 922  SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYD 981
               T K DV+SFG++L EL T  R         +R+++  V R  +     E  +     
Sbjct: 189  GRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGYRMPCPPECPESLH-- 244

Query: 982  KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                       D+ C C  + P+ RPT + L ++L+   
Sbjct: 245  -----------DLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (527), Expect = 1e-60
 Identities = 75/305 (24%), Positives = 123/305 (40%), Gaps = 45/305 (14%)

Query: 742  NNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSR 794
            NN +    IG G FG V++A  P          VA+K L  +    M+ +F+ E   ++ 
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK--------------------LD 834
              +PN+V L G C       L++ +M  G L+ +L                         
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 835  GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL 894
            GP  L    +L IA+  A G+AYL    E   +HRD+ + N L+  N    +ADFGL+R 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 895  ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKG 954
            I S        +    + ++PPE    +  T + DV+++GVVL E+ +            
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248

Query: 955  SRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
              ++I +V                      +   L + ++  LC S+ P  RP+   +  
Sbjct: 249  -EEVIYYVRDGN-------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 1015 WLDSI 1019
             L  +
Sbjct: 295  ILQRM 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 2e-60
 Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 39/301 (12%)

Query: 741  TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ-MEREFRAEVEALSRAQHP 798
             ++F++ + +G G  G+V++ +  P G  +A K +  +    +  +   E++ L     P
Sbjct: 5    DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
             +V   G      +  +    M+ GSLD  L +       +       ++    +GL YL
Sbjct: 65   YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYL 120

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
             +     I+HRD+K SNIL++      L DFG++  +       +    VGT  Y+ PE 
Sbjct: 121  REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMD---------MCKPKGSRDLISWVIRMRQEN 969
             Q +  + + D++S G+ L+E+  G+ P+          M   +   D      R R   
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 970  RESEVLDPFIYDKQHDKEMLR------------------VLDIACLCLSESPKVRPTTQQ 1011
            R                E+L                     D    CL ++P  R   +Q
Sbjct: 235  RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 1012 L 1012
            L
Sbjct: 295  L 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-60
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 36/290 (12%)

Query: 731  EISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVE 790
             +++ +             IG G FG V       G  VA+K +  D     + F AE  
Sbjct: 3    ALNMKE-------LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEAS 52

Query: 791  ALSRAQHPNLVHLQGYCMHKNDRL-LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQ 849
             +++ +H NLV L G  + +   L ++  +M  GSL  +L  +  G S L  D  L  + 
Sbjct: 53   VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSL 110

Query: 850  GAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVG 909
                 + YL      + +HRD+ + N+L+  +  A ++DFGL +   S  DT        
Sbjct: 111  DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----L 162

Query: 910  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN 969
             + +  PE  +    + K DV+SFG++L E+ +  R      P   +D++  V +  + +
Sbjct: 163  PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKMD 220

Query: 970  RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                                   ++   C      +RP+  QL   L+ I
Sbjct: 221  APDGCPPAVY-------------EVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 1e-59
 Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 46/319 (14%)

Query: 724  LFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGD 777
            L ++ + E   +              +G G FG V  AT            VA+K L   
Sbjct: 12   LPYDHKWEFPRNR-------LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64

Query: 778  CGQMERE-FRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDG 835
                ERE   +E++ LS    H N+V+L G C      L+I  +   G L  +L  K D 
Sbjct: 65   AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 836  PSS--------------LDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN 881
                             LD +  L  +   A+G+A+L      + +HRD+ + NILL   
Sbjct: 125  FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHG 181

Query: 882  FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELL 941
                + DFGLAR I +  +  V  +    + ++ PE     V T++ DV+S+G+ L EL 
Sbjct: 182  RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

Query: 942  TGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSE 1001
            +         P               +++  +++         +     + DI   C   
Sbjct: 242  SLGSSPYPGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287

Query: 1002 SPKVRPTTQQLVSWLDSII 1020
             P  RPT +Q+V  ++  I
Sbjct: 288  DPLKRPTFKQIVQLIEKQI 306

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 2e-59
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 25/281 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
             +    + +G G +G VY          VA+K L  D  ++E EF  E   +   +HPNL
Sbjct: 17   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            V L G C  +    +I  FM  G+L  +L E       +     L++A   +  + YL +
Sbjct: 76   VQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 861  SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQ 920
                + +HRD+ + N L+  N    +ADFGL+RL ++             + +  PE   
Sbjct: 134  ---KNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS-RDLISWVIRMRQENRESEVLDPFI 979
             +  + K DV++FGV+L E+ T               +L+    RM +     E      
Sbjct: 190  YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE------ 243

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                      +V ++   C   +P  RP+  ++    +++ 
Sbjct: 244  ----------KVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 4e-58
 Identities = 59/298 (19%), Positives = 119/298 (39%), Gaps = 42/298 (14%)

Query: 729  EKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD---GRNVAIKRLSGDC--GQMER 783
             K ++++D             +G G FG V +         + VA+K L  +     ++ 
Sbjct: 5    RKLLTLED-----------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 53

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
            E  AE   + +  +P +V + G C  ++  +L+    E G L+ +L +       +   +
Sbjct: 54   ELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQN----RHVKDKN 108

Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
             + +    + G+ YL +S   + +HRD+ + N+LL     A ++DFGL++ + +  + + 
Sbjct: 109  IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165

Query: 904  TTD-LVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISW 961
                    + +  PE       + K DV+SFGV++ E  + G++P    K      ++  
Sbjct: 166  AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

Query: 962  VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
              RM                         + D+  LC +   + RP    +   L + 
Sbjct: 226  GERMGCPAGCPR----------------EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-58
 Identities = 69/320 (21%), Positives = 128/320 (40%), Gaps = 51/320 (15%)

Query: 726  HNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN------VAIKRLSGDCG 779
            ++ + E   ++        +   ++G G FG V  AT            VA+K L     
Sbjct: 28   YDLKWEFPREN-------LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80

Query: 780  QMERE-FRAEVEALSR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK----- 832
              ERE   +E++ +++   H N+V+L G C       LI+ +   G L  +L  K     
Sbjct: 81   SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140

Query: 833  --------------LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL 878
                           +  + L ++  L  A   A+G+ +L        +HRD+ + N+L+
Sbjct: 141  EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLV 197

Query: 879  DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLL 938
                   + DFGLAR I+S  +  V  +    + ++ PE     + T K DV+S+G++L 
Sbjct: 198  THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

Query: 939  ELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLC 998
            E+ +         P     + +   ++ Q   + +   PF   ++       +  I   C
Sbjct: 258  EIFSLGVN-----PYPGIPVDANFYKLIQNGFKMD--QPFYATEE-------IYIIMQSC 303

Query: 999  LSESPKVRPTTQQLVSWLDS 1018
             +   + RP+   L S+L  
Sbjct: 304  WAFDSRKRPSFPNLTSFLGC 323

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 7e-58
 Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 28/288 (9%)

Query: 740  STNNFDQANIIGCGGFGLVYRATLPDG-----RNVAIKRLSGDCGQMER-EFRAEVEALS 793
              +   +  +IG G FG VY+  L          VAIK L     + +R +F  E   + 
Sbjct: 5    HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 794  RAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAAR 853
            +  H N++ L+G        ++I  +MENG+LD +L EK            + + +G A 
Sbjct: 65   QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 121

Query: 854  GLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS-PYDTHVTTDLVGTLG 912
            G+ YL      + +HRD+ + NIL++ N    ++DFGL+R++   P  T+ T+     + 
Sbjct: 122  GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 913  YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            +  PE       T   DV+SFG+V+ E++T              +++  +    +     
Sbjct: 179  WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLPTPM 236

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            +                 +  +   C  +    RP    +VS LD +I
Sbjct: 237  DCPS-------------AIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 8e-58
 Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 27/283 (9%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPN 799
            +++    IG G +G   +     DG+ +  K L         ++   +EV  L   +HPN
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 800  LVHLQGYCMHKNDRLL--IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            +V      + + +  L  +  + E G L   + +       LD +  L +       L  
Sbjct: 65   IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 858  LHQ--SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
             H+       +LHRD+K +N+ LDG     L DFGLAR++    DT      VGT  Y+ 
Sbjct: 125  CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMS 182

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            PE         K D++S G +L EL     P      K     I      R   R S+ L
Sbjct: 183  PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WL 1016
                             +I    L+     RP+ ++++    +
Sbjct: 243  ----------------NEIITRMLNLKDYHRPSVEEILENPLI 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 5e-57
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 34/301 (11%)

Query: 728  KEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQME- 782
            +   I    +     +F+   +IG G FG VY  TL D        A+K L+      E 
Sbjct: 18   QHVVIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV 72

Query: 783  REFRAEVEALSRAQHPNLVHLQGYCMHKNDR-LLIYSFMENGSLDYWLHEKLDGPSSLDW 841
             +F  E   +    HPN++ L G C+      L++  +M++G L  ++  +     +   
Sbjct: 73   SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTV 129

Query: 842  DSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP--Y 899
               +      A+G+           +HRD+ + N +LD  F   +ADFGLAR +      
Sbjct: 130  KDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI 959
              H  T     + ++  E  Q    T K DV+SFGV+L EL+T   P     P    +  
Sbjct: 187  SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTF 241

Query: 960  SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
               + + Q  R   +L P             + ++   C     ++RP+  +LVS + +I
Sbjct: 242  DITVYLLQGRR---LLQPEYCPDP-------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

Query: 1020 I 1020
             
Sbjct: 292  F 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (497), Expect = 2e-56
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 35/278 (12%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQHPN 799
            F     IG G FG VY A  + +   VAIK++S    Q     ++   EV  L + +HPN
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
             +  +G  + ++   L+  +    + D     K      L       +  GA +GLAYLH
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH 132

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY- 918
                 +++HRD+K+ NILL       L DFG A ++            VGT  ++ PE  
Sbjct: 133  ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVI 183

Query: 919  --GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
                      K DV+S G+  +EL   K P+           +  + +            
Sbjct: 184  LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNE---------S 231

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
            P +      +      +    CL + P+ RPT++ L+ 
Sbjct: 232  PALQSGHWSEYF---RNFVDSCLQKIPQDRPTSEVLLK 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 7e-56
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 38/296 (12%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDG---RNVAIKRLSGD-CGQMEREFRAEVEALSR-AQ 796
            N+    ++IG G FG V +A +       + AIKR+         R+F  E+E L +   
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------LDGPSSLDWDSR 844
            HPN+++L G C H+    L   +  +G+L  +L +                 S+L     
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 845  LHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT 904
            LH A   ARG+ YL    +   +HRD+ + NIL+  N+ A +ADFGL+R           
Sbjct: 130  LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 905  TDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR 964
            T     + ++  E    SV T   DV+S+GV+L E+++         P           +
Sbjct: 184  TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238

Query: 965  MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            + Q  R      P   D +       V D+   C  E P  RP+  Q++  L+ ++
Sbjct: 239  LPQGYRLE---KPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 7e-56
 Identities = 59/286 (20%), Positives = 107/286 (37%), Gaps = 30/286 (10%)

Query: 741  TNNFDQANI-IGCGGFGLVYRATL---PDGRNVAIKRLSGDCGQMERE-FRAEVEALSRA 795
             +N   A+I +GCG FG V +          +VAIK L     + + E    E + + + 
Sbjct: 7    RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66

Query: 796  QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             +P +V L G C      +L+      G L  +L  K      +   +   +    + G+
Sbjct: 67   DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGM 122

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP-YDTHVTTDLVGTLGYI 914
             YL +    + +HRD+ + N+LL     A ++DFGL++ + +        +     L + 
Sbjct: 123  KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 915  PPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
             PE       + + DV+S+GV + E L+ G++P    K       I    RM        
Sbjct: 180  APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
                             +  +   C     + RP    +   + + 
Sbjct: 240  ----------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 8e-56
 Identities = 64/294 (21%), Positives = 117/294 (39%), Gaps = 34/294 (11%)

Query: 725  FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMER 783
            + +  ++++ +D       ++    +G G FG VY+A   +     A K +     +   
Sbjct: 1    YEHVTRDLNPED------FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 54

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
            ++  E++ L+   HPN+V L     ++N+  ++  F   G++D  + E       L    
Sbjct: 55   DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQ 111

Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV 903
               + +     L YLH +    I+HRD+K+ NIL   +    LADFG++           
Sbjct: 112  IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-- 166

Query: 904  TTDLVGTLGYIPPEY-----GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDL 958
                +GT  ++ PE       +     YK DV+S G+ L+E+   + P     P      
Sbjct: 167  RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---- 222

Query: 959  ISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               V+    ++    +  P  +            D    CL ++   R TT QL
Sbjct: 223  ---VLLKIAKSEPPTLAQPSRWSSN-------FKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-55
 Identities = 65/279 (23%), Positives = 108/279 (38%), Gaps = 34/279 (12%)

Query: 748  NIIGCGGFGLVYRATLPD-GRNVAIKRLS--GDCGQMEREFRAEVEALSRAQHPNLVHLQ 804
              IG G F  VY+    +    VA   L          + F+ E E L   QHPN+V   
Sbjct: 15   IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 805  GYCM----HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
                     K   +L+   M +G+L  +L         +         +   +GL +LH 
Sbjct: 75   DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 130

Query: 861  SCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
               P I+HRD+K  NI + G  G   + D GLA L            ++GT  ++ PE  
Sbjct: 131  RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY 185

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
            +        DVY+FG+ +LE+ T + P         ++      R+    +      P  
Sbjct: 186  EEKY-DESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRRVTSGVK------PAS 233

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WL 1016
            +DK    E+    +I   C+ ++   R + + L++  + 
Sbjct: 234  FDKVAIPEV---KEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 7e-55
 Identities = 62/276 (22%), Positives = 95/276 (34%), Gaps = 24/276 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLS-GDCGQMEREFRAEVEALSRAQHPN 799
             ++D    +G G +G V  A        VA+K +            + E+       H N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +V   G+    N + L   +   G L   +         +              G+ YLH
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY- 918
                  I HRDIK  N+LLD      ++DFGLA +        +   + GTL Y+ PE  
Sbjct: 121  ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
             +        DV+S G+VL  +L G+ P D      S    S     +      + +D  
Sbjct: 178  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNPWKKIDS- 234

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014
                         L +    L E+P  R T   +  
Sbjct: 235  -----------APLALLHKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-54
 Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 25/285 (8%)

Query: 729  EKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRA 787
            EK  SI  + +    + +   IG G  G VY A  +  G+ VAI++++      +     
Sbjct: 7    EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 788  EVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHI 847
            E+  +   ++PN+V+     +  ++  ++  ++  GSL   + E       +D      +
Sbjct: 67   EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAV 121

Query: 848  AQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDL 907
             +   + L +LH +    ++HRDIKS NILL  +    L DFG    I    +    + +
Sbjct: 122  CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTM 176

Query: 908  VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ 967
            VGT  ++ PE         K D++S G++ +E++ G+ P     P          + +  
Sbjct: 177  VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIA 229

Query: 968  ENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
             N   E+ +P               D    CL    + R + ++L
Sbjct: 230  TNGTPELQNPEKLSAI-------FRDFLNRCLDMDVEKRGSAKEL 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-54
 Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 30/284 (10%)

Query: 744  FDQANIIGCGGFGLVYRAT-LPDGRN----VAIKRLS-GDCGQMEREFRAEVEALSRAQH 797
            F +  ++G G FG VY+   +P+G      VAIK L      +  +E   E   ++   +
Sbjct: 11   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 798  PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
            P++  L G C+  +   LI   M  G L  ++ E  D          L+     A+G+ Y
Sbjct: 71   PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNY 126

Query: 858  LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
            L       ++HRD+ + N+L+       + DFGLA+L+ +    +        + ++  E
Sbjct: 127  LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 918  YGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
                 + T++ DV+S+GV + EL+T G +P D         ++    R+ Q    +    
Sbjct: 184  SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI--- 240

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                          V  I   C       RP  ++L+     + 
Sbjct: 241  -------------DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-54
 Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 41/295 (13%)

Query: 730  KEISIDDILESTNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLS---GDCGQMEREF 785
            ++ +++D       F+    +G G FG VY A        +A+K L     +   +E + 
Sbjct: 1    RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 786  RAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
            R EVE  S  +HPN++ L GY        LI  +   G++   L +     S  D     
Sbjct: 54   RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTA 109

Query: 846  HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
                  A  L+Y H      ++HRDIK  N+LL       +ADFG +        +   T
Sbjct: 110  TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRT 162

Query: 906  DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
             L GTL Y+PPE  +  +   K D++S GV+  E L GK P +    + +   I      
Sbjct: 163  TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----S 217

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018
            R E    + +                 D+    L  +P  RP  ++++   W+ +
Sbjct: 218  RVEFTFPDFVTE------------GARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-53
 Identities = 70/285 (24%), Positives = 105/285 (36%), Gaps = 30/285 (10%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRN----VAIKRLSGDCGQMERE-FRAEVEALSRAQ 796
               +    IG G FG V++       N    VAIK          RE F  E   + +  
Sbjct: 7    ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            HP++V L G    +N   +I      G L  +L  +     SLD  S +  A   +  LA
Sbjct: 67   HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 122

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            YL        +HRDI + N+L+  N    L DFGL+R  +     +  +     + ++ P
Sbjct: 123  YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 178

Query: 917  EYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            E       T   DV+ FGV + E+L  G +P    K       I    R+         L
Sbjct: 179  ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
                              +   C +  P  RP   +L + L +I+
Sbjct: 239  Y----------------SLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-53
 Identities = 62/292 (21%), Positives = 111/292 (38%), Gaps = 31/292 (10%)

Query: 742  NNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCGQMER-EFRAEVEALSR 794
                 +  +G G FG+VY               VAIK ++      ER EF  E   +  
Sbjct: 20   EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLH------EKLDGPSSLDWDSRLHIA 848
                ++V L G        L+I   M  G L  +L             +       + +A
Sbjct: 80   FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLV 908
               A G+AYL+ +     +HRD+ + N ++  +F   + DFG+ R I            +
Sbjct: 140  GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 909  GTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
              + ++ PE  +  V T   DV+SFGVVL E+ T            +  ++ +V+     
Sbjct: 197  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVMEGGLL 254

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
            ++     D                ++  +C   +PK+RP+  +++S +   +
Sbjct: 255  DKPDNCPDMLF-------------ELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  184 bits (469), Expect = 3e-52
 Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 28/291 (9%)

Query: 725  FHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMER 783
            ++ +  EI  D +L   +++D    +G G FG+V+R T    G N A K +       + 
Sbjct: 12   YYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 68

Query: 784  EFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDS 843
              R E++ +S  +HP LV+L       N+ ++IY FM  G L   + ++    + +  D 
Sbjct: 69   TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDE 125

Query: 844  RLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LADFGLARLILSPYDT 901
             +   +   +GL ++H   E + +H D+K  NI+          L DFGL   +      
Sbjct: 126  AVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182

Query: 902  HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISW 961
             VTT   GT  +  PE  +     Y  D++S GV+   LL+G  P        +   +  
Sbjct: 183  KVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239

Query: 962  VIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                  ++  S + +                D     L   P  R T  Q 
Sbjct: 240  CDWNMDDSAFSGISEDGK-------------DFIRKLLLADPNTRMTIHQA 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-51
 Identities = 59/283 (20%), Positives = 100/283 (35%), Gaps = 29/283 (10%)

Query: 742  NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC---GQMEREFRAEVEALSR 794
             +      +G G FG+V R           +VA+K L  D     +   +F  EV A+  
Sbjct: 8    KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
              H NL+ L G  +      ++      GSL   L +           +    A   A G
Sbjct: 68   LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 123

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHV-TTDLVGTLGY 913
            + YL        +HRD+ + N+LL       + DFGL R +    D +V          +
Sbjct: 124  MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 914  IPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE 973
              PE  +    ++  D + FGV L E+ T  +   +        ++  + +  +     E
Sbjct: 181  CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKIDKEGERLPRPE 238

Query: 974  VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWL 1016
                             + ++   C +  P+ RPT   L  +L
Sbjct: 239  DCPQ------------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-51
 Identities = 72/300 (24%), Positives = 111/300 (37%), Gaps = 38/300 (12%)

Query: 742  NNFDQANIIGCGGFGLVYRAT------LPDGRNVAIKRLSGDCGQME-REFRAEVEALSR 794
            +       +G G FG V  A           R VA+K L       E R   +E++ L  
Sbjct: 13   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 795  -AQHPNLVHLQGYCMHKNDRLLI-YSFMENGSLDYWLHEKLDGPSS------------LD 840
               H N+V+L G C      L++   F + G+L  +L  K +                L 
Sbjct: 73   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 841  WDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD 900
             +  +  +   A+G+ +L        +HRD+ + NILL       + DFGLAR I    D
Sbjct: 133  LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 901  THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLIS 960
                 D    L ++ PE     V T + DV+SFGV+L E+ +         P     +  
Sbjct: 190  YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244

Query: 961  WVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
               R  +E       D    +         +      C    P  RPT  +LV  L +++
Sbjct: 245  EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-50
 Identities = 62/279 (22%), Positives = 95/279 (34%), Gaps = 28/279 (10%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG---QMEREFRAEVEALSRAQHP 798
            +F    I+G G F  V  A  L   R  AIK L                E + +SR  HP
Sbjct: 9    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
              V L              S+ +NG L  ++ +      S D              L YL
Sbjct: 69   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
            H      I+HRD+K  NILL+ +    + DFG A+++            VGT  Y+ PE 
Sbjct: 125  H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF 978
                 A    D+++ G ++ +L+ G  P            I     ++ E    E   P 
Sbjct: 182  LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----IKLEYDFPEKFFP- 235

Query: 979  IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLD 1017
                       +  D+    L      R   +++  +  
Sbjct: 236  -----------KARDLVEKLLVLDATKRLGCEEMEGYGP 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-50
 Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 40/301 (13%)

Query: 742  NNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDCGQME-REFRAEVEAL 792
            +       +G G FG V  A               VA+K L  D  + +  +  +E+E +
Sbjct: 13   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 793  SR-AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEK------------LDGPSSL 839
                +H N+++L G C       +I  +   G+L  +L  +             +    L
Sbjct: 73   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 840  DWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY 899
                 +  A   ARG+ YL        +HRD+ + N+L+  +    +ADFGLAR I    
Sbjct: 133  SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 900  DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLI 959
                TT+    + ++ PE     + T++ DV+SFGV+L E+ T         P    +L 
Sbjct: 190  YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELF 247

Query: 960  SWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019
              +    + ++ S   +                 +   C    P  RPT +QLV  LD I
Sbjct: 248  KLLKEGHRMDKPSNCTNELY-------------MMMRDCWHAVPSQRPTFKQLVEDLDRI 294

Query: 1020 I 1020
            +
Sbjct: 295  V 295

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 4e-48
 Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 32/305 (10%)

Query: 711  DKDLEELGSKLVVLFHNKEKEISIDDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNV 769
            DK  E++  K V     +  E+    + +    +D    +G G FG+V+R      GR  
Sbjct: 5    DKFYEDIWKKYV----PQPVEVKQGSVYD---YYDILEELGSGAFGVVHRCVEKATGRVF 57

Query: 770  AIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWL 829
              K ++      +   + E+  +++  HP L++L      K + +LI  F+  G L   +
Sbjct: 58   VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117

Query: 830  HEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAH--LA 887
              +      +     ++  + A  GL ++H   E  I+H DIK  NI+ +    +   + 
Sbjct: 118  AAE---DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 171

Query: 888  DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPM 947
            DFGLA  +       +      T  +  PE        +  D+++ GV+   LL+G  P 
Sbjct: 172  DFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 228

Query: 948  DMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP 1007
                   +   +        E+  S V                  D     L + P+ R 
Sbjct: 229  AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK-------------DFIKNLLQKEPRKRL 275

Query: 1008 TTQQL 1012
            T    
Sbjct: 276  TVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (423), Expect = 6e-47
 Identities = 62/282 (21%), Positives = 118/282 (41%), Gaps = 29/282 (10%)

Query: 741  TNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ---MEREFRAEVEALSRAQ 796
            ++ ++   I+G GG   V+ A  L   R+VA+K L  D  +       FR E +  +   
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 797  HPNLVHLQGYCMHKNDRL----LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            HP +V +      +        ++  +++  +L   +H        +     + +   A 
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121

Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT-HVTTDLVGTL 911
            + L +     +  I+HRD+K +NI++       + DFG+AR I    ++   T  ++GT 
Sbjct: 122  QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
             Y+ PE  +      + DVYS G VL E+LTG+ P     P     +    +R       
Sbjct: 179  QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVR------- 228

Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013
             + + P    +    ++  V+      L+++P+ R  T   +
Sbjct: 229  EDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEM 267

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-46
 Identities = 52/288 (18%), Positives = 87/288 (30%), Gaps = 26/288 (9%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
            N +     IG G FG +Y  T +  G  VAIK           +   E +     Q    
Sbjct: 7    NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            +    +C  + D  ++   +   SL+   +            + L +A      + Y+H 
Sbjct: 65   IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS 121

Query: 861  SCEPHILHRDIKSSNIL---LDGNFGAHLADFGLARLI-----LSPYDTHVTTDLVGTLG 912
                + +HRD+K  N L          ++ DFGLA+                 +L GT  
Sbjct: 122  K---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 913  YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            Y           + + D+ S G VL+    G  P    K    R     +   +      
Sbjct: 179  YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
             +   +        E          C S     +P    L     ++ 
Sbjct: 239  VLCKGY------PSEF---ATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (422), Expect = 1e-45
 Identities = 67/280 (23%), Positives = 99/280 (35%), Gaps = 33/280 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQME------REFRAEVEAL 792
            + N+F    IIG GGFG VY     D G+  A+K L     +M+         R  +  +
Sbjct: 2    TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 793  SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
            S    P +V +       +    I   M  G L Y L +                A    
Sbjct: 62   STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEII 117

Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
             GL ++H      +++RD+K +NILLD +    ++D GLA      +        VGT G
Sbjct: 118  LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHG 170

Query: 913  YIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE 971
            Y+ PE  Q  VA     D +S G +L +LL G  P    K K   ++    + M      
Sbjct: 171  YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224

Query: 972  SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
                           E   +  +    L      R     
Sbjct: 225  -----AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLG 256

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 1e-45
 Identities = 57/280 (20%), Positives = 98/280 (35%), Gaps = 25/280 (8%)

Query: 735  DDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQ-MEREFRAEVEAL 792
            +DI    + +D  +++G G F  V  A      + VAIK ++    +  E     E+  L
Sbjct: 5    EDI---RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 793  SRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAA 852
             + +HPN+V L           LI   +  G L   + EK              +     
Sbjct: 62   HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVL 117

Query: 853  RGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLG 912
              + YLH     H   +        LD +    ++DFGL+++        V +   GT G
Sbjct: 118  DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPG 174

Query: 913  YIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
            Y+ PE       +   D +S GV+   LL G  P                 ++ ++  ++
Sbjct: 175  YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----------KLFEQILKA 224

Query: 973  EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            E      Y           +      + + P+ R T +Q 
Sbjct: 225  EYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQA 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-45
 Identities = 53/266 (19%), Positives = 96/266 (36%), Gaps = 26/266 (9%)

Query: 750  IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
            +G G FG+V+R       +    K +    G  +   + E+  L+ A+H N++HL     
Sbjct: 13   LGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 809  HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILH 868
               + ++I+ F+    +   ++        L+    +         L +LH     +I H
Sbjct: 72   SMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNIGH 125

Query: 869  RDIKSSNILLDGNFGAH--LADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATY 926
             DI+  NI+      +   + +FG AR +           L     Y  PE  Q  V + 
Sbjct: 126  FDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 927  KGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDK 986
              D++S G ++  LL+G  P      +   + I            +E        K+   
Sbjct: 183  ATDMWSLGTLVYVLLSGINPFLAETNQQIIENI----------MNAEYTFDEEAFKEISI 232

Query: 987  EMLRVLDIACLCLSESPKVRPTTQQL 1012
            E    +D     L +  K R T  + 
Sbjct: 233  E---AMDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 63/287 (21%), Positives = 108/287 (37%), Gaps = 40/287 (13%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCG---------QMEREFRAEVEAL 792
            N++   I+G G   +V R    P  +  A+K +    G         ++      EV+ L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 793  SRAQ-HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
             +   HPN++ L+          L++  M+ G L  +L EK     +L       I +  
Sbjct: 64   RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRAL 119

Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
               +  LH   + +I+HRD+K  NILLD +    L DFG +  +          ++ GT 
Sbjct: 120  LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173

Query: 912  GYIPPEYGQASVA------TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
             Y+ PE  + S+         + D++S GV++  LL G  P    K      +I      
Sbjct: 174  SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
                              +   +    D+    L   P+ R T ++ 
Sbjct: 228  ----MSGNYQFGSPEWDDYSDTV---KDLVSRFLVVQPQKRYTAEEA 267

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-45
 Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 24/301 (7%)

Query: 737  ILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE-FRAEVEALSR 794
            + +    +   + IG G +G+V  A    +   VAIK++S    Q   +    E++ L R
Sbjct: 3    VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             +H N++ +           +   ++    +   L++ L     L  D   +      RG
Sbjct: 63   FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRG 121

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT-TDLVGTLGY 913
            L Y+H +   ++LHRD+K SN+LL+      + DFGLAR+    +D     T+ V T  Y
Sbjct: 122  LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 914  IPPEY-GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES 972
              PE    +   T   D++S G +L E+L+ +            + I  ++    +   +
Sbjct: 179  RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 973  EVLDPFIYDKQHDKEMLR--------------VLDIACLCLSESPKVRPTTQQLVS--WL 1016
             +++    +                        LD+    L+ +P  R   +Q ++  +L
Sbjct: 239  CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 1017 D 1017
            +
Sbjct: 299  E 299

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-44
 Identities = 68/286 (23%), Positives = 105/286 (36%), Gaps = 34/286 (11%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE---FRAEVEALSRA-Q 796
             +F    ++G G FG V+ A      +  AIK L  D   M+ +      E   LS A +
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 797  HPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
            HP L H+      K +   +  ++  G L Y +          D       A     GL 
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQ 117

Query: 857  YLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPP 916
            +L       I++RD+K  NILLD +    +ADFG+ +  +            GT  YI P
Sbjct: 118  FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172

Query: 917  EYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD 976
            E        +  D +SFGV+L E+L G+ P      +   +L   +             D
Sbjct: 173  EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM-----------D 218

Query: 977  PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV---SWLDSI 1019
               Y +  +KE     D+        P+ R   +  +        I
Sbjct: 219  NPFYPRWLEKEA---KDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 4e-44
 Identities = 74/283 (26%), Positives = 111/283 (39%), Gaps = 27/283 (9%)

Query: 748  NIIGCGGFGLVYRAT-LPDGRNVAIKRL-----SGDCGQMEREFRAEVEALSRAQHPNLV 801
            + +G G F  VY+A      + VAIK++     S     + R    E++ L    HPN++
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 802  HLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQS 861
             L     HK++  L++ FME           L     L             +GL YLH  
Sbjct: 64   GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLH-- 117

Query: 862  CEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-YGQ 920
             +  ILHRD+K +N+LLD N    LADFGLA+   SP   +  T  V T  Y  PE    
Sbjct: 118  -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFG 174

Query: 921  ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM--RQENRESEVLDPF 978
            A +     D+++ G +L ELL     +           I   +     ++  +   L  +
Sbjct: 175  ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 979  IYDKQHDKEMLR---------VLDIACLCLSESPKVRPTTQQL 1012
            +  K      L          +LD+       +P  R T  Q 
Sbjct: 235  VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-44
 Identities = 70/301 (23%), Positives = 114/301 (37%), Gaps = 27/301 (8%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT--LPDGRNVAIKRLSGDCGQ--MEREFRAEVE---AL 792
            +   ++    IG G +G V++A      GR VA+KR+    G+  M      EV     L
Sbjct: 5    ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 793  SRAQHPNLVHLQGYCM--HKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
               +HPN+V L   C     +    +    E+   D   +        +  ++   +   
Sbjct: 65   ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
              RGL +LH      ++HRD+K  NIL+  +    LADFGLAR+          T +V T
Sbjct: 125  LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM-RQEN 969
            L Y  PE    S      D++S G +  E+   K              I  VI +  +E+
Sbjct: 179  LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 970  RESEVLDPFIYDKQHDKEMLR---------VLDIACLCLSESPKVRPTTQQLVS--WLDS 1018
               +V  P         + +            D+   CL+ +P  R +    +S  +   
Sbjct: 239  WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

Query: 1019 I 1019
            +
Sbjct: 299  L 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 46/290 (15%), Positives = 92/290 (31%), Gaps = 28/290 (9%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL 800
             ++     IG G FG+++  T L + + VAIK           + R E            
Sbjct: 5    VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 801  VHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ 860
            +    Y   +    ++   +   SL+  L             +    A+     +  +H+
Sbjct: 63   IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 861  SCEPHILHRDIKSSNILLDGNFGAH-----LADFGLARLILSP-----YDTHVTTDLVGT 910
                 +++RDIK  N L+      +     + DFG+ +    P            +L GT
Sbjct: 120  K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              Y+          + + D+ + G V +  L G  P    K   ++     +   +Q   
Sbjct: 177  ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020
              E+   F       +E  + +       + +    P    L      ++
Sbjct: 237  LRELCAGF------PEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVL 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 61/286 (21%), Positives = 111/286 (38%), Gaps = 24/286 (8%)

Query: 742  NNFDQANIIGCGGFGLVYRATLPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHPN 799
              +     IG G +G+VY+A    G   A+K  RL  +   +      E+  L   +H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +V L      K   +L++  ++          +      L+  +          G+AY H
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH 117

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE-Y 918
               +  +LHRD+K  N+L++      +ADFGLAR    P   +     + TL Y  P+  
Sbjct: 118  ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVL 172

Query: 919  GQASVATYKGDVYSFGVVLLELLTGKRP----------MDMCKPKGSRDLISW--VIRMR 966
              +   +   D++S G +  E++ G             M + +  G+ +  +W  V  + 
Sbjct: 173  MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 967  QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
            + +    V +P  ++          +D+    L   P  R T +Q 
Sbjct: 233  KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-43
 Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 24/294 (8%)

Query: 743  NFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPN 799
            NF +   IG G +G+VY+A     G  VA+K++  D     +      E+  L    HPN
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            +V L      +N   L++ F+      +     L G   +             +GLA+  
Sbjct: 63   IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC- 118

Query: 860  QSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
                  +LHRD+K  N+L++      LADFGLAR    P     T ++V      P    
Sbjct: 119  --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILL 175

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                 +   D++S G +  E++T +              I   +    E     V     
Sbjct: 176  GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 980  YDKQHDKEMLRVL------------DIACLCLSESPKVRPTTQQLVS--WLDSI 1019
            Y     K   +               +    L   P  R + +  ++  +   +
Sbjct: 236  YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 1e-42
 Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 33/276 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC---GQMEREFRAEVEALSRA 795
            S  +F     +G G FG V+      +GR  A+K L  +     +       E   LS  
Sbjct: 2    SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61

Query: 796  QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             HP ++ + G         +I  ++E G L   L +    P   +  ++ + A+      
Sbjct: 62   THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCL--- 115

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
              L       I++RD+K  NILLD N    + DFG A+ +     T     L GT  YI 
Sbjct: 116  -ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIA 169

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL 975
            PE           D +SFG+++ E+L G  P                ++  ++   +E+ 
Sbjct: 170  PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----------MKTYEKILNAELR 219

Query: 976  DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
             P  +++        V D+    ++     R    Q
Sbjct: 220  FPPFFNED-------VKDLLSRLITRDLSQRLGNLQ 248

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-42
 Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 32/299 (10%)

Query: 743  NFDQANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLV 801
            ++    +IG G FG+VY+A L D G  VAIK++  D    +R    E++ + +  H N+V
Sbjct: 21   SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76

Query: 802  HLQGYCMHKNDR------LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
             L+ +     ++       L+  ++         H       +L             R L
Sbjct: 77   RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAH-LADFGLARLILSPYDTHVTTDLVGTLGYI 914
            AY+H      I HRDIK  N+LLD +     L DFG A+ ++        + +       
Sbjct: 136  AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRA 190

Query: 915  PPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV 974
            P     A+  T   DV+S G VL ELL G+              I  V+      +  E+
Sbjct: 191  PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 975  LDPFIYDKQHDKEMLR------------VLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019
               +   K    +                + +    L  +P  R T  +  +  + D +
Sbjct: 251  NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 3e-42
 Identities = 63/285 (22%), Positives = 106/285 (37%), Gaps = 46/285 (16%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE------FRAEVEALSRAQ--HPN 799
            ++G GGFG VY    + D   VAIK +  D      E         EV  L +       
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 800  LVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLH 859
            ++ L  +    +  +LI    E     +    +     +L  +            + +  
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHC- 126

Query: 860  QSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEY 918
                  +LHRDIK  NIL+D N G   L DFG   L+       V TD  GT  Y PPE+
Sbjct: 127  --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 180

Query: 919  -GQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP 977
                        V+S G++L +++ G  P +                      + E++  
Sbjct: 181  IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE---------------------HDEEIIRG 219

Query: 978  FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSII 1020
             ++ +Q      +   +   CL+  P  RPT +++ +  W+  ++
Sbjct: 220  QVFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 6e-41
 Identities = 66/291 (22%), Positives = 104/291 (35%), Gaps = 36/291 (12%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRL------SGDCGQMEREFRAEVEALSR 794
            + +D    +G G F +V +      G   A K +      S   G    +   EV  L  
Sbjct: 10   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 795  AQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             QHPN++ L     +K D +LI   +  G L  +L EK     SL  +      +    G
Sbjct: 70   IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNG 125

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFGA----HLADFGLARLILSPYDTHVTTDLVGT 910
               ++      I H D+K  NI+L           + DFGLA  I      +   ++ GT
Sbjct: 126  ---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGT 179

Query: 911  LGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR 970
              ++ PE         + D++S GV+   LL+G  P      + +   +S V    ++  
Sbjct: 180  PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239

Query: 971  ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019
             S                    D     L + PK R T Q  +   W+   
Sbjct: 240  FSNTSALAK-------------DFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-40
 Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 31/273 (11%)

Query: 749  IIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGY 806
            ++G G  G V +          A+K L     Q   + R EVE   RA Q P++V +   
Sbjct: 19   VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 807  CMH----KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC 862
              +    +   L++   ++ G L   + ++  G  +        I +     + YLH   
Sbjct: 74   YENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI- 130

Query: 863  EPHILHRDIKSSNILLDGNFG---AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYG 919
              +I HRD+K  N+L           L DFG A+   + +++  T     T  Y+ PE  
Sbjct: 131  --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPC--YTPYYVAPEVL 185

Query: 920  QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFI 979
                     D++S GV++  LL G  P        S   ++    M+   R  +   P  
Sbjct: 186  GPEKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPNP 239

Query: 980  YDKQHDKEMLRVLDIACLCLSESPKVRPTTQQL 1012
               +  +E+  ++      L   P  R T  + 
Sbjct: 240  EWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-39
 Identities = 66/302 (21%), Positives = 111/302 (36%), Gaps = 36/302 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRL--SGDCGQMEREFRAEVEALSRAQ 796
              + +++   IG G FG V++A     G+ VA+K++    +          E++ L   +
Sbjct: 8    EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67

Query: 797  HPNLVHLQGYC--------MHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIA 848
            H N+V+L   C          K    L++ F E+       +                + 
Sbjct: 68   HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVM 123

Query: 849  QGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVT--TD 906
            Q    GL Y+       ILHRD+K++N+L+  +    LADFGLAR      ++     T+
Sbjct: 124  QMLLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 907  LVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
             V TL Y PPE            D++  G ++ E+ T    M     +    LIS +   
Sbjct: 181  RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRV---------------LDIACLCLSESPKVRPTTQ 1010
                    V +  +Y+K    +  +                LD+    L   P  R  + 
Sbjct: 241  ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 1011 QL 1012
              
Sbjct: 301  DA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-39
 Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 13/211 (6%)

Query: 740 STNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE---FRAEVEALSRA 795
           + N+FD   ++G G FG V        GR  A+K L  +    + E      E   L   
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 796 QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
           +HP L  L+      +    +  +   G L + L  +          +        A  +
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIV 115

Query: 856 AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           + L       +++RDIK  N++LD +    + DFGL +  +S   T       GT  Y+ 
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLA 173

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRP 946
           PE  + +      D +  GVV+ E++ G+ P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-39
 Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 26/300 (8%)

Query: 739  ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRA 795
            E    +     +G G +G V  A     G  VAIK+L          +    E+  L   
Sbjct: 15   EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 796  QHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGL 855
            +H N++ L               F            KL     L  D    +     +GL
Sbjct: 75   RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 856  AYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
             Y+H      I+HRD+K  N+ ++ +    + DFGLAR      D+ +T  +V      P
Sbjct: 135  RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAP 187

Query: 916  PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVI-----RMRQENR 970
                     T   D++S G ++ E++TGK              I  V         Q  +
Sbjct: 188  EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247

Query: 971  ESEVLDPFIYDKQHDKEMLR---------VLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019
              E  +      + +K+             +++    L    + R T  + ++  + +S+
Sbjct: 248  SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 26/288 (9%)

Query: 742  NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIK--RLSGDCGQMEREFRAEVEALSRAQHP 798
              +++   IG G +G V++A        VA+K  RL  D   +      E+  L   +H 
Sbjct: 2    QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 799  NLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYL 858
            N+V L           L++ F +     Y+                  +     + L  L
Sbjct: 62   NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGL 114

Query: 859  HQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE- 917
                  ++LHRD+K  N+L++ N    LA+FGLAR    P   +  +  V TL Y PP+ 
Sbjct: 115  GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDV 172

Query: 918  YGQASVATYKGDVYSFGVVLLELLTGKRP-----------MDMCKPKGSRDLISWVIRMR 966
               A + +   D++S G +  EL    RP             + +  G+     W    +
Sbjct: 173  LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 967  QENRESEVLDPFIYDKQHDKEMLR--VLDIACLCLSESPKVRPTTQQL 1012
              + +   + P      +    L     D+    L  +P  R + ++ 
Sbjct: 233  LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 2e-37
 Identities = 45/209 (21%), Positives = 76/209 (36%), Gaps = 16/209 (7%)

Query: 742 NNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMERE---FRAEVEALSRAQH 797
           + FD+   +G G FG V        G + A+K L        ++      E   L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
           P LV L+      ++  ++  ++  G +   L                  A        Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEY 156

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPE 917
           LH      +++RD+K  N+L+D      + DFG A+ +     T     L GT   + PE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPE 208

Query: 918 YGQASVATYKGDVYSFGVVLLELLTGKRP 946
              +       D ++ GV++ E+  G  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-35
 Identities = 68/283 (24%), Positives = 105/283 (37%), Gaps = 32/283 (11%)

Query: 740  STNNFDQANIIGCGGFGLVYRATL----PDGRNVAIKRLS----GDCGQMEREFRAEVEA 791
               NF+   ++G G +G V+          G+  A+K L         +     R E + 
Sbjct: 22   GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 792  LSRAQH-PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQG 850
            L   +  P LV L      +    LI  ++  G L   L ++       +  +   +   
Sbjct: 82   LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIY 134

Query: 851  AARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGT 910
                +  L    +  I++RDIK  NILLD N    L DFGL++      +T    D  GT
Sbjct: 135  VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGT 193

Query: 911  LGYIPPE--YGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE 968
            + Y+ P+   G  S      D +S GV++ ELLTG  P  +   K S+  IS  I   + 
Sbjct: 194  IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253

Query: 969  NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
                E+                  D+    L + PK R     
Sbjct: 254  PYPQEMSALAK-------------DLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  134 bits (339), Expect = 3e-35
 Identities = 52/311 (16%), Positives = 108/311 (34%), Gaps = 45/311 (14%)

Query: 739  ESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSR-AQ 796
             + +++     +G G +  V+ A  + +   V +K L       +++ + E++ L     
Sbjct: 32   GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRG 88

Query: 797  HPNLVHLQGYCMHKNDRL--LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARG 854
             PN++ L         R   L++  + N               +L             + 
Sbjct: 89   GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKA 141

Query: 855  LAYLHQSCEPHILHRDIKSSNILLDGNFG-AHLADFGLARLILSPYDTHVTTDLVGTLGY 913
            L Y H      I+HRD+K  N+++D       L D+GLA      +        V +  +
Sbjct: 142  LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYF 195

Query: 914  IPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMD-----------MCKPKGSRDLISW 961
              PE      +  Y  D++S G +L  ++  K P             + K  G+ DL  +
Sbjct: 196  KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 962  VIRMRQE----------NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQ 1011
            + +   E              +  + F++ +         LD     L    + R T ++
Sbjct: 256  IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 1012 LVS--WLDSII 1020
             +   +  +++
Sbjct: 316  AMEHPYFYTVV 326

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-33
 Identities = 57/295 (19%), Positives = 93/295 (31%), Gaps = 24/295 (8%)

Query: 735  DDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEA 791
              I E    +   + +G G +G V  A     G  VA+K+LS         +    E+  
Sbjct: 11   KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 792  LSRAQHPNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGA 851
            L   +H N++ L                     L       +     L  D    +    
Sbjct: 71   LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 852  ARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTL 911
             RGL Y+H      I+HRD+K SN+ ++ +    + DFGLAR      D  +T  +    
Sbjct: 131  LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183

Query: 912  GYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMD----------MCKPKGSRDLISW 961
               P             D++S G ++ ELLTG+              + +  G+      
Sbjct: 184  YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243

Query: 962  VIRMRQENRESEVLDPFIYDKQHDKEMLRV----LDIACLCLSESPKVRPTTQQL 1012
                 +  R        +         +      +D+    L      R T  Q 
Sbjct: 244  KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-31
 Identities = 56/312 (17%), Positives = 98/312 (31%), Gaps = 47/312 (15%)

Query: 735  DDILESTNNFDQANIIGCGGFGLVYRAT-LPDGRNVAIKRLSGDC--GQMEREFRAEVEA 791
            D        +     IG G  G+V  A      RNVAIK+LS         +    E+  
Sbjct: 10   DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 792  LSRAQHPNLVHLQGYCMHK------NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRL 845
            +    H N++ L      +       D  L+   M+         E        D +   
Sbjct: 70   MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMS 122

Query: 846  HIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTT 905
            ++      G+ +LH      I+HRD+K SNI++  +    + DFGLAR   +   + + T
Sbjct: 123  YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 176

Query: 906  DLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
              V T  Y  PE           D++S G ++ E++  K            + +   +  
Sbjct: 177  PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 966  RQENRESEVLDPFIYDKQHDKEMLRV-------------------------LDIACLCLS 1000
                   ++        ++  +   +                          D+    L 
Sbjct: 237  PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 1001 ESPKVRPTTQQL 1012
              P  R +    
Sbjct: 297  IDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (303), Expect = 3e-30
 Identities = 44/230 (19%), Positives = 83/230 (36%), Gaps = 17/230 (7%)

Query: 750 IGCGGFGLVYRAT-LPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCM 808
           +G G F  V+ A  + +  +VA+K + GD    E     E++ L R    +         
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMGA 79

Query: 809 HKNDRLLIYS------------FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLA 856
           +   +LL +               E    +     K      +       I++    GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 857 YLHQSCEPHILHRDIKSSNILLDGN-FGAHLADFGLARLILSPYDTHVTTDLVGTLGYIP 915
           Y+H      I+H DIK  N+L++      +L    +A L  + +     T+ + T  Y  
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 916 PEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRM 965
           PE    +      D++S   ++ EL+TG    +  +          + ++
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 29/203 (14%), Positives = 61/203 (30%), Gaps = 28/203 (13%)

Query: 748 NIIGCGGFGLVYRATLPDGRNVAIKRLSGD----------CGQMEREFRAEVEALSRAQH 797
            ++G G    V+           +K                   +  F       +R + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 798 PNLVHLQGYCMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAY 857
             L  LQG  + K      Y++  N  L   +         +  ++   +       +A 
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDA--KELYRVRVENPDEVLDMILEEVAK 118

Query: 858 LHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP-YDTHVTTDLVGTLGYIPP 916
            +      I+H D+   N+L+    G  + DF  +  +    +   +  D+   + Y   
Sbjct: 119 FYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 917 EYGQASVATYKGDVYSFGVVLLE 939
            Y        + D+ S    +L+
Sbjct: 175 TYR------TEKDINSAIDRILQ 191

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 98.9 bits (245), Expect = 1e-22
 Identities = 68/384 (17%), Positives = 112/384 (29%), Gaps = 38/384 (9%)

Query: 250 ADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLR 309
             L+  ++  +   N +  +      L +   L A            +     L  +N  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 310 NNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETY 369
           NN L          L NLT L       N                    NN    I    
Sbjct: 75  NNQLTDI-----TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCR-------------NLTTLVLTLNFRNEKLP 416
                      SN+     + +     Q               NLTTL       N+   
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189

Query: 417 TDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFY 476
                   NL+ L+  +  +    P  +   + L  + L+ NQL            +L  
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTD 245

Query: 477 LDLSNNTFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPP 535
           LDL+NN  +   P   LT L  L      +   SP        N+     Q   I     
Sbjct: 246 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 536 -----TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
                 + L  N +         +L KL      +N +S    S L  +T++  L   +N
Sbjct: 306 LKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHN 361

Query: 591 NLSGAIPISLEKLSFLSKFSVANN 614
            +S   P++   L+ +++  + + 
Sbjct: 362 QISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.5 bits (218), Expect = 4e-19
 Identities = 71/398 (17%), Positives = 126/398 (31%), Gaps = 36/398 (9%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN 166
            L +     L    +  TV  +  +L  +  L      +   +     L ++  ++ S+N
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNN 76

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF 226
            L    P    KN +++  I ++ N  +           +   L          + +   
Sbjct: 77  QLTDITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHS 286
             +         N +       I+ LS L  L   S           A L   + L   S
Sbjct: 134 LNRLEL----SSNTI-----SDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 287 NRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP 346
           N+ +       +    L  L   NN +    +     LTNL  L L  N+        L 
Sbjct: 185 NKVSDISVL--AKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLA 238

Query: 347 RCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVL 406
               L +++LA N  S   P        L+ L L  + I N+S           LT L  
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-------LAGLTALTN 289

Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
                N+     P  +  NL  L +    +    P  +   +KLQ +  + N++S     
Sbjct: 290 LELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VS 345

Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS 504
                 ++ +L   +N  +   P  L  L  +    ++
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.7 bits (216), Expect = 7e-19
 Identities = 82/391 (20%), Positives = 142/391 (36%), Gaps = 36/391 (9%)

Query: 92  LYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQ 151
           L K  +   +S++  +L Q+  L      +K      +  L NL  ++ S+N L+   P 
Sbjct: 29  LGKTNVTDTVSQT--DLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDITPL 84

Query: 152 TINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLC 211
             NL  +  + +++N +    P +   N + + + N  +       +    N   L    
Sbjct: 85  K-NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNT 143

Query: 212 LGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPD 271
           +            I  L  L  L              +A+L+ L RLD+SSN    +   
Sbjct: 144 ISD----------ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV--SDIS 191

Query: 272 VFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLD 331
           V A L   + L+A +N+ +   P  +  +  L+ L+L  N L    +    +LTNLT LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 332 LGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSA 391
           L  N+ +   P  L    KL  + L  N  S   P       +            N    
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN------LELNENQLED 299

Query: 392 LQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQ 451
           +  +   +NLT L L  N  ++  P         L+ L  A+  +       L   + + 
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQRLFFANNKVSD--VSSLANLTNIN 354

Query: 452 LVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
            +    NQ+S   P        +  L L++ 
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 76.6 bits (187), Expect = 3e-15
 Identities = 74/461 (16%), Positives = 138/461 (29%), Gaps = 98/461 (21%)

Query: 131 NLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSV 190
            L       L   +++  + QT +L  +  L      +      SI              
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT-DLDQVTTLQADRLGI-----KSI-------------- 59

Query: 191 NYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIA 250
                    G+    +L  +    N LT      +  L KL  + + +NQ          
Sbjct: 60  --------DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ---------- 99

Query: 251 DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
                +    +  N +G                  +        +++S+   L+ L    
Sbjct: 100 --IADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157

Query: 311 NSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLP-RCRKLKNINLARNNFSGQIPETY 369
               G+ + +   L NLT+L+      N     ++  +   L+++    N  S   P   
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--L 215

Query: 370 KNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVL 429
               +L  LSL+ + + ++ +    L    NLT L L  N  +   P         L  L
Sbjct: 216 GILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLAPLS---GLTKLTEL 268

Query: 430 VIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIP 489
            + +  +    P    G + L  ++L+ NQ            ++L YL L  N  +   P
Sbjct: 269 KLGANQISNISPLA--GLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP 324

Query: 490 KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIW 549
             ++ L  L                                      +  + N++  S  
Sbjct: 325 --VSSLTKLQ------------------------------------RLFFANNKV--SDV 344

Query: 550 PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYN 590
               NL  ++     HN +S   P  L  +T +  L L+  
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.9 bits (141), Expect = 1e-09
 Identities = 20/77 (25%), Positives = 32/77 (41%), Gaps = 5/77 (6%)

Query: 90  LFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPL 149
           L LY   +       + +L +L+ L  ++N +      SL NL N+  L    N +S   
Sbjct: 312 LTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367

Query: 150 PQTINLPSIQVLDISSN 166
           P   NL  I  L ++  
Sbjct: 368 PLA-NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 2e-04
 Identities = 41/253 (16%), Positives = 79/253 (31%), Gaps = 33/253 (13%)

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ 459
            L   + T+  +     T  +     +  L     G++ SI   +   + L  ++ S NQ
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQ 77

Query: 460 LSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITR------------------ 501
           L+   P        L  + ++NN      P       + +T                   
Sbjct: 78  LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 502 -------NISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN 554
                   IS            + +   +      + +      L ++    S       
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 555 LKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
           L  L      +N +S   P  +  +T+L+ L L+ N L      +L  L+ L+   +ANN
Sbjct: 196 LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 615 HLTGRIPSGGQFQ 627
            ++   P  G  +
Sbjct: 252 QISNLAPLSGLTK 264

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 91.4 bits (225), Expect = 2e-20
 Identities = 69/326 (21%), Positives = 114/326 (34%), Gaps = 24/326 (7%)

Query: 31  CNPNDLAALEDFMKNFE--SGIDGWGTNASSSDCCH--WVGITCNSSSSLGLNDSIGSGR 86
           CNP D  AL    K+    + +  W     ++DCC+  W+G+ C++ +         + R
Sbjct: 3   CNPQDKQALLQIKKDLGNPTTLSSWL---PTTDCCNRTWLGVLCDTDT--------QTYR 51

Query: 87  VTGLFLYKRRLKGK--LSESLGNLVQLRFLNLSHNL-LKGTVPVSLVNLPNLEVLDLSSN 143
           V  L L    L     +  SL NL  L FL +     L G +P ++  L  L  L ++  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 144 DLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGN 203
           ++SG +P  ++     V    S +           +   +  I    N  SG +    G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 204 CASLEHLCLGM-NDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS 262
            + L        N LTG I      L    +   ++           +D +        +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCP 322
           +          +       L   +NR  G +P  L+    L+ LN+  N+L G  +    
Sbjct: 232 SLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE-IPQGG 288

Query: 323 ALTNLTSLDLGTNKFNGPLPTNLPRC 348
            L          NK     P  LP C
Sbjct: 289 NLQRFDVSAYANNKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 84.4 bits (207), Expect = 3e-18
 Identities = 60/275 (21%), Positives = 89/275 (32%), Gaps = 14/275 (5%)

Query: 375 LSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASC 434
           ++ L LS  ++         L     L  L +                   L  L I   
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 435 GLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTG 494
            + G+IP +L     L  +D S+N LSGT+P       +L  +    N  +G IP +   
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 495 LPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGN 554
              L             F           G       +           +          
Sbjct: 172 FSKL-------------FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 555 LKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANN 614
             K         N       ++    +L  LDL  N + G +P  L +L FL   +V+ N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 615 HLTGRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCT 648
           +L G IP GG  Q F  S++  N  LCG    +CT
Sbjct: 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.8 bits (203), Expect = 1e-17
 Identities = 56/326 (17%), Positives = 100/326 (30%), Gaps = 38/326 (11%)

Query: 63  CHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLK 122
           CH   + C+      +   +       L L   ++         NL  L  L L +N + 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPP-DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 123 GTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSR 182
              P +   L  LE L LS N L   LP+ +   ++Q L +  N +     +        
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLKE-LPEKMP-KTLQELRVHENEITKVRKSVFNGL--- 123

Query: 183 IRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLS 242
                               N   +  L       +G        ++KL  + + D  ++
Sbjct: 124 --------------------NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163

Query: 243 GKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPT 302
             +   +    +L  L +  N  +        GL     L    N  +     SL+N+P 
Sbjct: 164 -TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220

Query: 303 LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG------PLPTNLPRCRKLKNINL 356
           L  L+L NN L             +  + L  N  +         P    +      ++L
Sbjct: 221 LRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

Query: 357 ARN--NFSGQIPETYKNFESLSYLSL 380
             N   +    P T++     + + L
Sbjct: 280 FSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 80.5 bits (197), Expect = 7e-17
 Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 9/255 (3%)

Query: 253 SNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
            +   LD+ +N  +      F  L     L+  +N+ +   P + +    L  L L  N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNF 372
           L          L  L   +    K    +   L +   ++         SG     ++  
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGM 149

Query: 373 ESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIA 432
           + LSY+ +++++I  +   L       +LT L L  N   +      +    NL  L ++
Sbjct: 150 KKLSYIRIADTNITTIPQGL-----PPSLTELHLDGNKITKVDAASLK-GLNNLAKLGLS 203

Query: 433 SCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNL 492
              +       L     L+ + L+ N+L   +P      + +  + L NN  +  I  N 
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSND 261

Query: 493 TGLPSLITRNISLEE 507
              P   T+  S   
Sbjct: 262 FCPPGYNTKKASYSG 276

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 1e-15
 Identities = 57/314 (18%), Positives = 95/314 (30%), Gaps = 52/314 (16%)

Query: 286 SNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL 345
           S+    ++P  L   P   LL+L+NN +      +   L NL +L L  NK +   P   
Sbjct: 18  SDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 346 PRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLV 405
               KL+ + L++N       +  K  + L       + +                    
Sbjct: 76  APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRK------------------ 117

Query: 406 LTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIP 465
                          L+   +  L        G      +G  KL  + ++   ++ TIP
Sbjct: 118 ----------SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 166

Query: 466 VWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGL 525
                   L  L L  N  T     +L GL +L    +S    S      +         
Sbjct: 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL--------- 215

Query: 526 QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSG------PIPSELTGM 579
                      + L+ N+L         + K + V  L +NN+S         P   T  
Sbjct: 216 ---ANTPHLRELHLNNNKLVKVPG-GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 580 TSLETLDLSYNNLS 593
            S   + L  N + 
Sbjct: 272 ASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 1e-14
 Identities = 54/309 (17%), Positives = 89/309 (28%), Gaps = 50/309 (16%)

Query: 325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS 384
            +   LDL  NK       +    + L  + L  N  S   P  +     L  L LS + 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 385 IYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL 444
           +  L   +   +  + L      +     +      L+   +  L        G      
Sbjct: 91  LKELPEKMP--KTLQELRVHENEIT--KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 445 RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNIS 504
           +G  KL  + ++   ++ TIP        L  L L  N  T     +L GL +L      
Sbjct: 147 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL------ 197

Query: 505 LEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLK 564
                                           + LS N +         N   L    L 
Sbjct: 198 ------------------------------AKLGLSFNSISAVDNGSLANTPHLRELHLN 227

Query: 565 HNNLSGPIPSELTGMTSLETLDLSYNNLSG------AIPISLEKLSFLSKFSVANNHLTG 618
           +N L   +P  L     ++ + L  NN+S         P    K +  S  S+ +N +  
Sbjct: 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286

Query: 619 RIPSGGQFQ 627
                  F+
Sbjct: 287 WEIQPSTFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.5 bits (179), Expect = 1e-14
 Identities = 52/258 (20%), Positives = 90/258 (34%), Gaps = 14/258 (5%)

Query: 231 LRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFT 290
             LL LQ+N+++        +L NL  L + +N  S   P  FA L + + L    N+  
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 291 GRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRK 350
                       L +       +  S+      +  +  L     K +G         +K
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGMKK 151

Query: 351 LKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNF 410
           L  I +A  N +  IP+      SL+ L L  + I  + +    L+   NL  L L+   
Sbjct: 152 LSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDA--ASLKGLNNLAKLGLS-FN 205

Query: 411 RNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGG 470
               +      +  +L+ L + +  L   +P  L     +Q+V L  N +S      F  
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 471 FQ------DLFYLDLSNN 482
                       + L +N
Sbjct: 265 PGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 69.7 bits (169), Expect = 2e-13
 Identities = 43/241 (17%), Positives = 78/241 (32%), Gaps = 16/241 (6%)

Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
            +   +  L   P+    +  +L + +  +        +    L  + L  N++S   P 
Sbjct: 14  VVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQ 526
            F     L  L LS N         L  LP  + + +       +    +R++V     Q
Sbjct: 74  AFAPLVKLERLYLSKN--------QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125

Query: 527 YNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLD 586
              +      +  S     G     F  +KKL    +   N++  IP  L    SL  L 
Sbjct: 126 MIVVELGTNPLKSS-----GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELH 177

Query: 587 LSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCGEHRYS 646
           L  N ++     SL+ L+ L+K  ++ N ++                   NN   +    
Sbjct: 178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG 237

Query: 647 C 647
            
Sbjct: 238 L 238

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 28/196 (14%), Positives = 48/196 (24%), Gaps = 40/196 (20%)

Query: 445 RGCS-KLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNI 503
             C   L++V  S   L   +P       D   LDL NN  T     +   L +L T   
Sbjct: 6   FRCQCHLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT--- 59

Query: 504 SLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDL 563
                                            + L  N++       F  L KL    L
Sbjct: 60  ---------------------------------LILINNKISKISPGAFAPLVKLERLYL 86

Query: 564 KHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPSG 623
             N L          +  L   +     +  ++   L ++  +   +           + 
Sbjct: 87  SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 624 GQFQTFPNSSFDGNNL 639
              +          N+
Sbjct: 147 QGMKKLSYIRIADTNI 162

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (188), Expect = 7e-16
 Identities = 54/254 (21%), Positives = 85/254 (33%), Gaps = 5/254 (1%)

Query: 111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLD-LSSNDLSGPLPQTINLPSIQVLDISSNSLN 169
            + + L  N +      S     NL +L   S+            L  ++ LD+S N+  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 170 GSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQ 229
            SV  +      R+  ++L                A+L++L L  N L     D    L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 230 KLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRF 289
            L  L L  N++S     +   L +L RL +  N  +   P  F  LG    L   +N  
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 290 TGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCR 349
           +     +L+    L  L L +N          P    L      +++    LP  L    
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL---A 269

Query: 350 KLKNINLARNNFSG 363
                 LA N+  G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (177), Expect = 2e-14
 Identities = 54/272 (19%), Positives = 84/272 (30%), Gaps = 7/272 (2%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSV 172
            +     L+  VPV +      + + L  N +S     +     ++ +L + SN L    
Sbjct: 16  TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 173 PTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLR 232
             +    +   ++                     L  L L    L          L  L+
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 233 LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR 292
            L LQDN L      +  DL NL  L +  N  S      F GL     L+ H NR    
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 293 IPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLK 352
            PH+  +   L  L L  N+L          L  L  L L  N +        P    L+
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQ 251

Query: 353 NINLARNNFSGQIPETYKN--FESLSYLSLSN 382
               + +     +P+       + L+   L  
Sbjct: 252 KFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.0 bits (172), Expect = 7e-14
 Identities = 53/278 (19%), Positives = 87/278 (31%), Gaps = 20/278 (7%)

Query: 341 LPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRN 400
           +P  +P     + I L  N  S     +++   +L+ L L ++ +  + +A         
Sbjct: 26  VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 401 LTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQL 460
              L      R+    T   L    L  L +  CGL+   P   RG + LQ + L  N L
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGR--LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 461 SGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV 520
                  F    +L +L L  N  +    +   GL SL    +     +   P       
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF---- 197

Query: 521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMT 580
                   +      T+ L  N L          L+ L    L  N       +      
Sbjct: 198 --------RDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWA 248

Query: 581 SLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTG 618
            L+    S + +  ++P  L          +A N L G
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 50/283 (17%), Positives = 84/283 (29%), Gaps = 40/283 (14%)

Query: 396 QQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDL 455
             C       +T +   + L   P    A  + + +    +        R C  L ++ L
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWL 63

Query: 456 SWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEI-PKNLTGLPSLITRNISLEEPSPDFP- 513
             N L+      F G   L  LDLS+N     + P    GL  L T ++         P 
Sbjct: 64  HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG 123

Query: 514 -FFMRRNVSARGLQYNQIWSFPP----------TIDLSLNRLDGSIWPEFGNLKKLHVFD 562
            F     +    LQ N + + P            + L  NR+       F  L  L    
Sbjct: 124 LFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 563 LKHNNLSGPIPSEL------------------------TGMTSLETLDLSYNNLSGAIPI 598
           L  N ++   P                             + +L+ L L+ N        
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243

Query: 599 SLEKLSFLSKFSVANNHLTGRIPSGGQFQTFPNSSFDGNNLCG 641
                ++L KF  +++ +   +P     +         N+L G
Sbjct: 244 -RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL--KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.6 bits (132), Expect = 9e-09
 Identities = 26/208 (12%), Positives = 46/208 (22%), Gaps = 16/208 (7%)

Query: 453 VDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDF 512
                  L   +PV          + L  N  +     +     +L    +     +   
Sbjct: 16  TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 513 PFFMRRNVSARGLQYNQIWSFPP-------------TIDLSLNRLDGSIWPEFGNLKKLH 559
                       L  +                    T+ L    L       F  L  L 
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 560 VFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGR 619
              L+ N L          + +L  L L  N +S     +   L  L +  +  N +   
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 620 IPSGGQFQTFPNSSFDGNNLCGEHRYSC 647
            P   +      + +   N         
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEA 220

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (117), Expect = 7e-07
 Identities = 25/153 (16%), Positives = 51/153 (33%), Gaps = 4/153 (2%)

Query: 91  FLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLP 150
           +L    L+    ++  +L  L  L L  N +      +   L +L+ L L  N ++   P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 151 QTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHL 210
                    +      +   ++PT        ++ + L+ N +           A L+  
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKF 253

Query: 211 CLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSG 243
               +++   +     +L    L  L  N L G
Sbjct: 254 RGSSSEVPCSLPQ---RLAGRDLKRLAANDLQG 283

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 41/273 (15%), Positives = 85/273 (31%), Gaps = 14/273 (5%)

Query: 114 LNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVP 173
           L+L+   L   V   L++   +       + +  PL +  +   +Q +D+S++ +  S  
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63

Query: 174 TSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRL 233
             I    S+++ ++L     S  +   L   ++L  L L         A         RL
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123

Query: 234 LGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE---------FQYLVA 284
             L  +         +      V   ++  N SG   ++                   ++
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183

Query: 285 HSNRFTGRIPHSLSNSPTLNLLNLRN-NSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPT 343
            S                L  L+L     +    LL    +  L +L +     +G L  
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243

Query: 344 NLPRCRKLKNINLARNNFSGQIPETYKNFESLS 376
                  L+   +  ++F+     T  N ++  
Sbjct: 244 LKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 7e-09
 Identities = 44/295 (14%), Positives = 79/295 (26%), Gaps = 35/295 (11%)

Query: 328 TSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN 387
            +LDL     +  +   L   + +      R+     + E +  F  + ++ LSNS I  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVI-E 59

Query: 388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGC 447
           +S+   +L QC  L  L                          +    L   I   L   
Sbjct: 60  VSTLHGILSQCSKLQNLS-------------------------LEGLRLSDPIVNTLAKN 94

Query: 448 SKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEE 507
           S L  ++LS          +           L     +         +   +        
Sbjct: 95  SNLVRLNLSGCSG---FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT 151

Query: 508 PSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKH-N 566
                 +      S       +  +           L    + EF  L  L    L    
Sbjct: 152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 211

Query: 567 NLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP 621
           ++      EL  + +L+TL +      G + +  E L  L    +  +H T    
Sbjct: 212 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 38/262 (14%), Positives = 85/262 (32%), Gaps = 19/262 (7%)

Query: 159 QVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLT 218
           Q LD++  +L+  V   +      +       ++    L     +   ++H+ L  + + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIE 59

Query: 219 GGIADDIFQ-LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLG 277
                 I     KL+ L L+  +LS  +  ++A  SNLVRL++S  +             
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 278 EFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPA---------LTNLT 328
             +    + +         +  +       +   +L G       +            + 
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 329 SLDLGTNKFNGPLPTNLPRCRKLKNINLAR-NNFSGQIPETYKNFESLSYLSLSN----S 383
                +            +   L++++L+R  +   +         +L  L +       
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 384 SIYNLSSALQVLQ-QCRNLTTL 404
           ++  L  AL  LQ  C + TT+
Sbjct: 240 TLQLLKEALPHLQINCSHFTTI 261

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 6e-05
 Identities = 40/251 (15%), Positives = 74/251 (29%), Gaps = 14/251 (5%)

Query: 70  CNSSSSLGLNDSIGSGRVTGLFLYKRRLKGK-LSESLGNLVQLRFLNLSHNLLKGTVPVS 128
             S     L +     RV  + L    ++   L   L    +L+ L+L    L   +  +
Sbjct: 31  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

Query: 129 LVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINL 188
           L    NL  L+LS             L S   LD  + S          + +       +
Sbjct: 91  LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150

Query: 189 SVNYFSG---------TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQD- 238
           +    SG           +        +         L      + FQL  L+ L L   
Sbjct: 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210

Query: 239 NQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLS 298
             +  +    + ++  L  L V      G +  +   L    +L  + + FT     ++ 
Sbjct: 211 YDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL---PHLQINCSHFTTIARPTIG 267

Query: 299 NSPTLNLLNLR 309
           N     +  ++
Sbjct: 268 NKKNQEIWGIK 278

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 60.3 bits (144), Expect = 4e-10
 Identities = 38/319 (11%), Positives = 80/319 (25%), Gaps = 19/319 (5%)

Query: 303 LNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLAR 358
           L L  +       S+        ++  + L  N         L  N+   + L+    + 
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 359 NNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTD 418
                   E  +    L    L    ++ +  +            +         +    
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 419 PRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLS-GTIPVWFGGFQDLFYL 477
                       IA      ++ +  +    L+ +    N+L  G++  W   FQ    L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 478 DLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI 537
                   G  P+ +  L           +             S+      + W     +
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 538 DLSLNRLDGSIWPEFGN------LKKLHVFDLKHNNLSGPIPSEL-----TGMTSLETLD 586
            L+   L         +         L    L++N +       L       M  L  L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 587 LSYNNLS--GAIPISLEKL 603
           L+ N  S    +   + ++
Sbjct: 309 LNGNRFSEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 55.7 bits (132), Expect = 1e-08
 Identities = 39/327 (11%), Positives = 86/327 (26%), Gaps = 20/327 (6%)

Query: 329 SLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ----IPETYKNFESLSYLSLSNSS 384
            LD  T +    +   L     +K I L+ N    +    + E   + + L     S+  
Sbjct: 11  KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70

Query: 385 IYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWL 444
              +    ++ +  R L   +L     +    +D        + L+            +L
Sbjct: 71  TGRVKD--EIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 445 --RGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRN 502
              G        ++       +         L  +    N       K            
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 503 ISLEEPSPDFPFFMRRNVSARGL-QYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVF 561
            +++            ++   GL    ++       +   +    ++     +   L   
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 562 DLKHNNLSGPIPSELTGM------TSLETLDLSYNNLSGAIPISL-----EKLSFLSKFS 610
            L    LS    + +           L+TL L YN +      +L     EK+  L    
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 611 VANNHLTGRIPSGGQFQTFPNSSFDGN 637
           +  N  +       + +   ++   G 
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 8/87 (9%), Positives = 24/87 (27%), Gaps = 5/87 (5%)

Query: 556 KKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSG----AIPISLEKLSFLSKFSV 611
           K L +  +   +    + + L    S++ + LS N +       +  ++     L     
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 612 ANNHLTGRIPSGGQFQTFPNSSFDGNN 638
           ++           +       +     
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCP 93

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 37/212 (17%), Positives = 66/212 (31%), Gaps = 9/212 (4%)

Query: 104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLD 162
            +  +     +N     L   +P  L    +  +L LS N L      T+     +  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIA 222
           +    L              + + +  +               +L  L +  N LT    
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSL----PLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 223 DDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL 282
             +  L +L+ L L+ N+L       +     L +L +++NN +     +  GL     L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD 314
           +   N     IP     S  L    L  N   
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 38/207 (18%), Positives = 65/207 (31%), Gaps = 14/207 (6%)

Query: 419 PRLHFANLKVLVIASCGLRG--SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFY 476
           P    + +   +  +C  R   ++P  L       ++ LS N L          +  L  
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 477 LDLSN-NTFTGEIPKNLTGLPSLITRNISLEEPSP--------DFPFFMRRNVSARGLQY 527
           L+L        ++   L  L +L   +  L+                     +++  L  
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 528 NQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDL 587
            +       + L  N L            KL    L +NNL+      L G+ +L+TL L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 588 SYNNLSGAIPISLEKLSFLSKFSVANN 614
             N+L   IP        L    +  N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 9e-08
 Identities = 26/205 (12%), Positives = 49/205 (23%), Gaps = 11/205 (5%)

Query: 397 QCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLS 456
           +   + +  L +N     L   P     +  +L ++   L       L   ++L  ++L 
Sbjct: 5   EVSKVASH-LEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 457 ---------WNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEE 507
                       L     +     Q      L        +        + +        
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 508 PSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNN 567
                 +     +                + L+ N L          L+ L    L+ N+
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183

Query: 568 LSGPIPSELTGMTSLETLDLSYNNL 592
           L   IP    G   L    L  N  
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 43/209 (20%), Positives = 71/209 (33%), Gaps = 10/209 (4%)

Query: 296 SLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNIN 355
            +S   +   +N    +L  +L  + P   + T L L  N         L    +L  +N
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 356 LARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKL 415
           L             +   +L  L  +    +N   +L +L Q     T++     R   L
Sbjct: 62  L-----DRAELTKLQVDGTLPVLG-TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 416 PTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLF 475
           P         L+ L +    L+   P  L    KL+ + L+ N L+        G ++L 
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 476 YLDLSNNTFTGEIPKNLTGLPSLITRNIS 504
            L L  N+    IPK   G   L    + 
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLH 203

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 45/202 (22%), Positives = 61/202 (30%), Gaps = 12/202 (5%)

Query: 447 CSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLE 506
            +    V+     L+  +P      +D   L LS N         L     L   N+   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 507 EPSPDFPFFMRRNVSARGLQYNQIWSFPPTID---------LSLNRLDGSIWPEFGNLKK 557
           E +          +    L +NQ+ S P             +S NRL          L +
Sbjct: 66  ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 558 LHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT 617
           L    LK N L    P  LT    LE L L+ NNL+      L  L  L    +  N L 
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

Query: 618 GRIPSGGQFQTFPNSSFDGNNL 639
                       P +   GN  
Sbjct: 186 TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 48/198 (24%), Positives = 69/198 (34%), Gaps = 5/198 (2%)

Query: 68  ITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPV 127
           + C+  +   L   +     T L L +  L      +L    +L  LNL     + T   
Sbjct: 15  VNCDKRNLTALPPDLPK-DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQ 71

Query: 128 SLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVIN 187
               LP L  LDLS N L         LP++ VLD+S N L      ++        +  
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131

Query: 188 LSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSP 247
              N         L     LE L L  N+LT   A  +  L+ L  L LQ+N L   +  
Sbjct: 132 -KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 248 SIADLSNLVRLDVSSNNF 265
                  L    +  N +
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 54.3 bits (129), Expect = 1e-08
 Identities = 38/240 (15%), Positives = 68/240 (28%), Gaps = 33/240 (13%)

Query: 349 RKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTL 408
                I   ++N +  + +   + + ++ LS   + +  +      +Q   NL  L L  
Sbjct: 19  ANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTIEG----VQYLNNLIGLELKD 72

Query: 409 NFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWF 468
           N              A LK L   +       P              + +  S  I    
Sbjct: 73  NQIT---------DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 469 GGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYN 528
                     L  +         L GL +L   +I   + S   P      ++      N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 529 QIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLS 588
           +I    P                  +L  L    LK+N +S   P  L   ++L  + L+
Sbjct: 184 KISDISP----------------LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 30/211 (14%), Positives = 64/211 (30%), Gaps = 7/211 (3%)

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQ 459
            L   +     ++    T  +     +  L     G+  +I   ++  + L  ++L  NQ
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 460 LSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMR-- 517
           ++   P+          L  +       I    +     +T     +         ++  
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 518 RNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELT 577
                +    + +        LS+     S      NL KL       N +S   P  L 
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 578 GMTSLETLDLSYNNLSGAIPIS-LEKLSFLS 607
            + +L  + L  N +S   P++    L  ++
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 31/217 (14%), Positives = 64/217 (29%), Gaps = 20/217 (9%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN 166
            L     +    + +     V+  +L  +  L      ++  +     L ++  L++  N
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGN------CASLEHLCLGMNDLTGG 220
            +    P       + + +    +   S                   +   L        
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 221 IADDIFQLQKLRLLG-------LQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVF 273
           +  D+ Q+  +  L        L            +A+LS L  L    N  S   P   
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 274 AGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
           A L     +   +N+ +   P  L+N+  L ++ L N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 37/233 (15%), Positives = 60/233 (25%), Gaps = 27/233 (11%)

Query: 252 LSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNN 311
           L+N +++    +N +  +    A L     L A     T       +      L NL   
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-------TIEGVQYLNNLIGL 68

Query: 312 SLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKN 371
            L  + + +   L NLT +       N     +     +        +     +      
Sbjct: 69  ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 372 FESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFA---NLKV 428
                        +  L   L  +     L  L                   A    L  
Sbjct: 129 SN-----------LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177

Query: 429 LVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSN 481
           L      +    P  L     L  V L  NQ+S   P       +LF + L+N
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 6e-05
 Identities = 29/252 (11%), Positives = 65/252 (25%), Gaps = 42/252 (16%)

Query: 131 NLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSV 190
            L N   +    ++++  + Q  +L  I  L      +     T+I              
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGV-----TTI-------------- 56

Query: 191 NYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIA 250
                    G+    +L  L L  N +T               L     +    ++   +
Sbjct: 57  --------EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQS 108

Query: 251 DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRN 310
             +  +     ++            L      + + +   G       +     + +L  
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168

Query: 311 NSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYK 370
            +    L         ++ +              L     L  ++L  N  S   P    
Sbjct: 169 LANLSKLTTLKADDNKISDIS------------PLASLPNLIEVHLKNNQISDVSP--LA 214

Query: 371 NFESLSYLSLSN 382
           N  +L  ++L+N
Sbjct: 215 NTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 16/60 (26%), Positives = 30/60 (50%), Gaps = 3/60 (5%)

Query: 105 LGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDIS 164
           L NL +L  L    N +    P++  +LPNL  + L +N +S   P   N  ++ ++ ++
Sbjct: 169 LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSPLA-NTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 11/39 (28%), Positives = 19/39 (48%), Gaps = 2/39 (5%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLS 141
             L +L  L  ++L +N +    P  L N  NL ++ L+
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 7e-04
 Identities = 34/205 (16%), Positives = 69/205 (33%), Gaps = 22/205 (10%)

Query: 92  LYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG---- 147
             K  +   ++++  +L  +  L+     +     V    L NL  L+L  N ++     
Sbjct: 26  AGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQITDLAPL 81

Query: 148 ---PLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNC 204
                   + L    + ++S+ +   S+ T    ++    V  L+       L   L   
Sbjct: 82  KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQI 141

Query: 205 ASLEHLCLG-------MNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVR 257
            ++  L          + +        +  L KL  L   DN++S      +A L NL+ 
Sbjct: 142 TNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIE 199

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYL 282
           + + +N  S   P   A       +
Sbjct: 200 VHLKNNQISDVSP--LANTSNLFIV 222

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.5 bits (120), Expect = 5e-08
 Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)

Query: 112 RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGS 171
           R L+L+H  L  TV   L  L  +  LDLS N L    P    L +++ L++   S N  
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNAL 55

Query: 172 VPTSICKNSSRIRVINLSVNYFSGTLSPG-LGNCASLEHLCLGMNDLTG 219
                  N  R++ + L  N    + +   L +C  L  L L  N L  
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 9e-06
 Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 6/109 (5%)

Query: 137 VLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGT 196
           VL L+  DL+  L     L  +  LD+S N L    P      ++   +  L  +  +  
Sbjct: 2   VLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNALE 56

Query: 197 LSPGLGNCASLEHLCLGMNDLTGGIADDIF-QLQKLRLLGLQDNQLSGK 244
              G+ N   L+ L L  N L    A        +L LL LQ N L  +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 6/109 (5%)

Query: 232 RLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTG 291
           R+L L    L+      +  L  +  LD+S N      P +          V  ++    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALA---ALRCLEVLQASDNAL 55

Query: 292 RIPHSLSNSPTLNLLNLRNNSL-DGSLLLNCPALTNLTSLDLGTNKFNG 339
                ++N P L  L L NN L   + +    +   L  L+L  N    
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 2/93 (2%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLD 162
             L  L+ +  L+LSHN L+   P +L  L  LEVL  S N     +    NLP +Q L 
Sbjct: 14  CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA-LENVDGVANLPRLQELL 71

Query: 163 ISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG 195
           + +N L  S       +  R+ ++NL  N    
Sbjct: 72  LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 2e-04
 Identities = 25/156 (16%), Positives = 36/156 (23%), Gaps = 40/156 (25%)

Query: 451 QLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSP 510
           +++ L+   L  T+         + +LDLS+N      P  L  L  L     S      
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 511 DFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSG 570
                                     + L  NRL                          
Sbjct: 58  VDGVAN--------------LPRLQELLLCNNRLQ-----------------------QS 80

Query: 571 PIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFL 606
                L     L  L+L  N+L     I       L
Sbjct: 81  AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.8 bits (87), Expect = 0.001
 Identities = 26/126 (20%), Positives = 46/126 (36%), Gaps = 12/126 (9%)

Query: 377 YLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGL 436
            L L++  +  L      L+Q   +T L L+ N    +L   P    A   + V+ +   
Sbjct: 2   VLHLAHKDLTVLCH----LEQLLLVTHLDLSHN----RLRALPPALAALRCLEVLQASDN 53

Query: 437 RGSIPQWLRGCSKLQLVDLSWNQLSGTIPV-WFGGFQDLFYLDLSNNTFTGE---IPKNL 492
                  +    +LQ + L  N+L  +  +        L  L+L  N+   E     +  
Sbjct: 54  ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113

Query: 493 TGLPSL 498
             LPS+
Sbjct: 114 EMLPSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 22/103 (21%), Positives = 33/103 (32%), Gaps = 12/103 (11%)

Query: 525 LQYNQIWSFPP--------TIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSEL 576
           L +  +              +DLS NRL   + P    L+ L V     N         +
Sbjct: 5   LAHKDLTVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA--LENVDGV 61

Query: 577 TGMTSLETLDLSYNNLSGAIPI-SLEKLSFLSKFSVANNHLTG 618
             +  L+ L L  N L  +  I  L     L   ++  N L  
Sbjct: 62  ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 8e-08
 Identities = 53/327 (16%), Positives = 80/327 (24%), Gaps = 19/327 (5%)

Query: 292 RIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKL 351
           R+   L      + L L N  L  SL        +L SL    N     LP      + L
Sbjct: 31  RLRDCLDRQ--AHELELNNLGL-SSL---PELPPHLESLVASCNSLT-ELPELPQSLKSL 83

Query: 352 KNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFR 411
              N      S   P       S + L        +    +  +          L  +  
Sbjct: 84  LVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143

Query: 412 NEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGF 471
                 +       L+ L   +     +          L L  +                
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203

Query: 472 QDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIW 531
             L  +   NN             PSL   N+     +                      
Sbjct: 204 PFLTTIYADNNLLKTLPDLP----PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259

Query: 532 SFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNN 591
           S  P     LN     I         L   ++ +N L   +P+       LE L  S+N+
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNH 315

Query: 592 LSGAIPISLEKLSFLSKFSVANNHLTG 618
           L+  +P   + L  L    V  N L  
Sbjct: 316 LA-EVPELPQNLKQL---HVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 9e-06
 Identities = 46/301 (15%), Positives = 86/301 (28%), Gaps = 20/301 (6%)

Query: 325 TNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSS 384
                L+L     +  LP   P    L     + N+ + ++PE  ++ +SL   + +  +
Sbjct: 38  RQAHELELNNLGLSS-LPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 385 IYNLSSALQVLQQ---CRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIP 441
           + +L   L+ L            +   +F       +  L         +       +  
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 442 QWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITR 501
           + L     L  +   +   +    +          +  +N        +NL  L ++   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 502 NISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVF 561
           N  L+      P                 +                    F  L +L   
Sbjct: 213 NNLLKTLPDLPPSLEAL-------NVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265

Query: 562 DLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIP 621
               N  S  I S      SLE L++S N L   +P    +L  L     + NHL   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320

Query: 622 S 622
            
Sbjct: 321 E 321

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 12/98 (12%)

Query: 115 NLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPT 174
               N     +       P+LE L++S+N L   LP     P ++ L  S N L      
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA--LPPRLERLIASFNHL-----A 317

Query: 175 SICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCL 212
            + +    ++ +++  N              S+E L +
Sbjct: 318 EVPELPQNLKQLHVEYNPLR-EFPDIPE---SVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 17/93 (18%), Positives = 37/93 (39%), Gaps = 8/93 (8%)

Query: 307 NLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIP 366
               N+    +   C    +L  L++  NK    LP   PR   L+ +  + N+ + ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320

Query: 367 ETYKNFESLSYLSLSNSSIYNLSSALQVLQQCR 399
           E     ++L  L +  + +       + ++  R
Sbjct: 321 EL---PQNLKQLHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 9/94 (9%)

Query: 187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS 246
              +N  S  +        SLE L +  N L   +     +L++L       N L+ ++ 
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLIA---SFNHLA-EVP 320

Query: 247 PSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ 280
                  NL +L V  N      PD+   + + +
Sbjct: 321 EL---PQNLKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 6e-07
 Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 5/70 (7%)

Query: 536 TIDLSLNRLDGSIWPE-FGNLKKLHVFDLKHNNLSG----PIPSELTGMTSLETLDLSYN 590
           ++D+    L  + W E    L++  V  L    L+      I S L    +L  L+L  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 591 NLSGAIPISL 600
            L       +
Sbjct: 66  ELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 4/91 (4%)

Query: 157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG----TLSPGLGNCASLEHLCL 212
            IQ LDI    L+ +    +     + +V+ L     +      +S  L    +L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 213 GMNDLTGGIADDIFQLQKLRLLGLQDNQLSG 243
             N+L       + Q  +     +Q   L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 14/92 (15%), Positives = 30/92 (32%), Gaps = 10/92 (10%)

Query: 134 NLEVLDLSSNDLSGPLPQTI--NLPSIQVLDISSNSLNGSVPTSIC---KNSSRIRVINL 188
           +++ LD+   +LS      +   L   QV+ +    L  +    I    + +  +  +NL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 189 SVNYFSGTLSPGLG-----NCASLEHLCLGMN 215
             N         +          ++ L L   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 16/93 (17%), Positives = 27/93 (29%), Gaps = 12/93 (12%)

Query: 302 TLNL--LNLRNNSL-DGSLLLNCPALTNLTSLDLGTNKFNG----PLPTNLPRCRKLKNI 354
           +L++  L+++   L D       P L     + L            + + L     L  +
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 355 NLARNNFSGQIPET-----YKNFESLSYLSLSN 382
           NL  N                    +  LSL N
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 16/80 (20%), Positives = 31/80 (38%), Gaps = 9/80 (11%)

Query: 131 NLPNLEVLDLSSNDLSGPLPQTI-----NLPSIQVLDISSNSLNGSVPTSICK----NSS 181
               L VL L+  D+S     ++        S++ LD+S+N L  +    + +       
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 182 RIRVINLSVNYFSGTLSPGL 201
            +  + L   Y+S  +   L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 6e-05
 Identities = 19/83 (22%), Positives = 32/83 (38%), Gaps = 9/83 (10%)

Query: 422 HFANLKVLVIASCGLRG----SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFG-GFQD--- 473
             + L+VL +A C +      S+   L     L+ +DLS N L     +      +    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 474 -LFYLDLSNNTFTGEIPKNLTGL 495
            L  L L +  ++ E+   L  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 17/90 (18%), Positives = 35/90 (38%), Gaps = 13/90 (14%)

Query: 110 QLRFLNLSHNLLKGT----VPVSLVNLPNLEVLDLSSNDLSGPLPQTI------NLPSIQ 159
            LR L L+   +  +    +  +L+   +L  LDLS+N L       +          ++
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 160 VLDISSNSLNGSVP---TSICKNSSRIRVI 186
            L +     +  +     ++ K+   +RVI
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 13/74 (17%), Positives = 30/74 (40%), Gaps = 5/74 (6%)

Query: 206 SLEHLCLGMNDLT-GGIADDIFQLQKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDV 260
            ++ L +   +L+    A+ +  LQ+ +++ L D  L+      +S ++     L  L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 261 SSNNFSGNIPDVFA 274
            SN           
Sbjct: 63  RSNELGDVGVHCVL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 9/80 (11%)

Query: 552 FGNLKKLHVFDLKHNNLSG----PIPSELTGMTSLETLDLSYNNLSGAIPISL-----EK 602
                 L V  L   ++S      + + L    SL  LDLS N L  A  + L     + 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 603 LSFLSKFSVANNHLTGRIPS 622
              L +  + + + +  +  
Sbjct: 425 GCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 5/70 (7%)

Query: 558 LHVFDLKHNNLSGPIPSEL-TGMTSLETLDLSYNNLSG----AIPISLEKLSFLSKFSVA 612
           +   D++   LS    +EL   +   + + L    L+      I  +L     L++ ++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 613 NNHLTGRIPS 622
           +N L      
Sbjct: 64  SNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 3e-04
 Identities = 17/76 (22%), Positives = 27/76 (35%), Gaps = 10/76 (13%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKG----TVPVSLVNLPNLEVLDLSSNDLSGPLPQTI--- 153
            +E L  L Q + + L    L       +  +L   P L  L+L SN+L       +   
Sbjct: 19  WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78

Query: 154 ---NLPSIQVLDISSN 166
                  IQ L + + 
Sbjct: 79  LQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 10/71 (14%)

Query: 101 LSESLGNLVQLRFLNLSHNLLKGTVPVSLV-----NLPNLEVLDLSSNDLSGPLPQTI-- 153
           L+ +L     LR L+LS+N L     + LV         LE L L     S  +   +  
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448

Query: 154 ---NLPSIQVL 161
              + PS++V+
Sbjct: 449 LEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 9/87 (10%)

Query: 175 SICKNSSRIRVINLSVNYFSGT----LSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQK 230
            + +  S +RV+ L+    S +    L+  L    SL  L L  N L       + +  +
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 231 -----LRLLGLQDNQLSGKLSPSIADL 252
                L  L L D   S ++   +  L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 5e-04
 Identities = 15/77 (19%), Positives = 23/77 (29%), Gaps = 9/77 (11%)

Query: 536 TIDLSLNRLDG----SIWPEFGNLKKLHVFDLKHNNLSGPIPSELTG-----MTSLETLD 586
            + L+   +      S+         L   DL +N L      +L          LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 587 LSYNNLSGAIPISLEKL 603
           L     S  +   L+ L
Sbjct: 433 LYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 14/112 (12%), Positives = 34/112 (30%), Gaps = 21/112 (18%)

Query: 254 NLVRLDVSSNNFSGN-IPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNS 312
           ++  LD+     S     ++   L + Q +       T      +S++       LR N 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA-------LRVN- 54

Query: 313 LDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQ 364
                         L  L+L +N+        + +  +  +  + + +    
Sbjct: 55  ------------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 13/99 (13%)

Query: 294 PHSLSNSPTLNLLNLRNNSLDG----SLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR-- 347
                    L +L L +  +      SL     A  +L  LDL  N         L    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 348 ---CRKLKNINLARNNFSGQIPET----YKNFESLSYLS 379
                 L+ + L    +S ++ +      K+  SL  +S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 15/92 (16%), Positives = 29/92 (31%), Gaps = 9/92 (9%)

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRG----SIPQWLRGCSKLQLVDL 455
           ++ +L +     ++    +        +V+ +  CGL       I   LR    L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 456 SWNQLSGTIPVWFGGF-----QDLFYLDLSNN 482
             N+L                  +  L L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 13/76 (17%), Positives = 28/76 (36%), Gaps = 2/76 (2%)

Query: 102 SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVL 161
           +    N V+ R L+L    +   +      L   + +D S N++   L     L  ++ L
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTL 68

Query: 162 DISSNSLNGSVPTSIC 177
            +++N +         
Sbjct: 69  LVNNNRICRIGEGLDQ 84

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 8e-05
 Identities = 13/82 (15%), Positives = 24/82 (29%), Gaps = 3/82 (3%)

Query: 550 PEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKF 609
            ++ N  +    DL+   +   I +    +   + +D S N +          L  L   
Sbjct: 12  AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68

Query: 610 SVANNHLTGRIPSGGQFQTFPN 631
            V NN +        Q      
Sbjct: 69  LVNNNRICRIGEGLDQALPDLT 90

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 23/148 (15%), Positives = 37/148 (25%), Gaps = 9/148 (6%)

Query: 116 LSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTS 175
           L+  L++        N      LDL    +         L     +D S N +       
Sbjct: 3   LTAELIEQ--AAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR---KLD 57

Query: 176 ICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLR--- 232
                 R++ + ++ N               L  L L  N L      D     K     
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 233 -LLGLQDNQLSGKLSPSIADLSNLVRLD 259
            +L              I  +  +  LD
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLD 145

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 34/191 (17%), Positives = 67/191 (35%), Gaps = 7/191 (3%)

Query: 423 FANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN 482
           FA      +    +  ++ Q     + +  +  + + +     + +    ++  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGN 78

Query: 483 TFTGEIP-KNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSL 541
             T   P  NL  L  L      +++ S        +++S      + I        L  
Sbjct: 79  KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138

Query: 542 NRLDGSIWPEFGNLKKLHVFDLK-HNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS- 599
             L  +   +   L +L   D     +        L G+T L+ L LS N++S    ++ 
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAG 198

Query: 600 LEKLSFLSKFS 610
           L+ L  L  FS
Sbjct: 199 LKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 6e-05
 Identities = 35/185 (18%), Positives = 70/185 (37%), Gaps = 20/185 (10%)

Query: 92  LYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSG---- 147
           L K+ +   ++++   L  +  +  +++ +K    +    LPN+  L L+ N L+     
Sbjct: 31  LKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDIKPL 86

Query: 148 ---PLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNC 204
                   + L   +V D+SS      + +   +++    +  L       +L  G    
Sbjct: 87  ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKI 146

Query: 205 ASLEHLCLGMNDLTGGIAD-------DIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVR 257
             +  L       T  + D        +  L KL+ L L  N +S     ++A L NL  
Sbjct: 147 TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDV 204

Query: 258 LDVSS 262
           L++ S
Sbjct: 205 LELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 33/204 (16%), Positives = 64/204 (31%), Gaps = 18/204 (8%)

Query: 203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS 262
             A      L    +T  +  +  +L  +  +   ++ +       I  L N+ +L ++ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCP 322
           N  +   P   A L    +L    N+                    ++ SL+ + + +  
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKL-------KSLSLEHNGISDIN 128

Query: 323 ALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSN 382
            L +L  L+      N      +       +     +N    I         L  L LS 
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSK 187

Query: 383 SSIYNLSSALQVLQQCRNLTTLVL 406
           + I +L +    L   +NL  L L
Sbjct: 188 NHISDLRA----LAGLKNLDVLEL 207

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 3e-05
 Identities = 29/232 (12%), Positives = 54/232 (23%), Gaps = 19/232 (8%)

Query: 407 TLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPV 466
               +  K+   P     N   L      LR        G   L+ +++S N +   I  
Sbjct: 12  VFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71

Query: 467 WFGGFQDLFYLDLSNNTFTGEIPKNLTGLPS----------------LITRNISLEEPSP 510
                    +                                          I   +   
Sbjct: 72  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131

Query: 511 DFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSG 570
                     +     +  +      + L+ N +       F   +   +    +NNL  
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191

Query: 571 PIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLTGRIPS 622
                  G +    LD+S   +       LE L  L   S    +L  ++P+
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS--TYNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 7e-04
 Identities = 27/220 (12%), Positives = 58/220 (26%), Gaps = 11/220 (5%)

Query: 280 QYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG 339
             L     +       + S    L  + +  N +   +  +  +              N 
Sbjct: 32  IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 91

Query: 340 PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCR 399
                           L  +N   +         SL  + L      N+ +  +      
Sbjct: 92  LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151

Query: 400 NLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQW-LRGCSKLQLVDLSWN 458
           +  +++L LN    +   +   +   L  L ++       +P     G S   ++D+S  
Sbjct: 152 SFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211

Query: 459 QLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSL 498
           ++           + L                NL  LP+L
Sbjct: 212 RIHSLPSYGLENLKKLRARSTY----------NLKKLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 6/41 (14%), Positives = 11/41 (26%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSN 143
           +          L++S   +       L NL  L      + 
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.3 bits (100), Expect = 4e-05
 Identities = 30/171 (17%), Positives = 57/171 (33%), Gaps = 18/171 (10%)

Query: 399 RNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN 458
            + T L+L  N               +L  L +    L G  P    G S +Q + L  N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 459 QLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFP-FFMR 517
           ++       F G   L  L+L +N  +  +P +   L SL + N++    + +    +  
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148

Query: 518 RNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNL 568
             +  + L         P+                  ++ + + DL H+  
Sbjct: 149 EWLRKKSLNGGAARCGAPS-----------------KVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.9 bits (94), Expect = 3e-04
 Identities = 32/177 (18%), Positives = 66/177 (37%), Gaps = 6/177 (3%)

Query: 138 LDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTL 197
           +D +   L   +P+ I       L ++ N L       +      +  + L  N  +G  
Sbjct: 13  VDCTGRGLKE-IPRDIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70

Query: 198 SPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVR 257
                  + ++ L LG N +          L +L+ L L DNQ+S  +  S   L++L  
Sbjct: 71  PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS 130

Query: 258 LDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLD 314
           L+++SN F+ N    +      +    +        P  + +   + + +L ++   
Sbjct: 131 LNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFK 183

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 29/189 (15%), Positives = 56/189 (29%), Gaps = 18/189 (9%)

Query: 107 NLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSN 166
            L +     L    +  TV  +  +L  +  L      +   +     L ++  ++ S+N
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNN 72

Query: 167 SLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIF 226
            L    P         I + N  +   +   +       +L +  +   D    + +   
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 227 QLQKLRLLGLQDNQLSGKLS-------------PSIADLSNLVRLDVSSNNFSGNIPDVF 273
                  +                           +A+L+ L RLD+SSN  S     V 
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190

Query: 274 AGLGEFQYL 282
           A L   + L
Sbjct: 191 AKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 31/188 (16%), Positives = 56/188 (29%), Gaps = 9/188 (4%)

Query: 423 FANLKVLVIASCGLRGSIPQW-LRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSN 481
            A     V+    +  ++ Q  L   + LQ   L    + G          +L  ++ SN
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 71

Query: 482 NTFTGE--IPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDL 539
           N  T    +      +  L+  N   +         +           +       T   
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 540 SLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPIS 599
            L     +I           +  L  ++        L  +T+LE LD+S N +S    ++
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVLA 191

Query: 600 -LEKLSFL 606
            L  L  L
Sbjct: 192 KLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 7e-04
 Identities = 21/145 (14%), Positives = 44/145 (30%), Gaps = 8/145 (5%)

Query: 364 QIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHF 423
           Q+          S  +L    + +       L        L    +     L      + 
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSDPD----LVAQNIDVVLNR-RSSMAATLRIIEE-NI 64

Query: 424 ANLKVLVIASCGLRG--SIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSN 481
             L  L +++  L     +   ++    L++++LS N+L     +       L  L L  
Sbjct: 65  PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124

Query: 482 NTFTGEIPKNLTGLPSLITRNISLE 506
           N+ +       T + ++  R   L 
Sbjct: 125 NSLSDTFRDQSTYISAIRERFPKLL 149

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.003
 Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 5/99 (5%)

Query: 103 ESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI---NLPSIQ 159
             L        LN   ++   T+ +   N+P L  L+LS+N L      +      P+++
Sbjct: 36  PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94

Query: 160 VLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLS 198
           +L++S N L  S          ++  + L  N  S T  
Sbjct: 95  ILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1020
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.45
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.45
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.43
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.27
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.23
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.2
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.39
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.34
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.9
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.43
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.27
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.2
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.59
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.39
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=418.09  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=202.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||+||+|+++  ..||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            568999999999999999999874  469999986543  3445789999999999999999999998754 56899999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...   ...+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999754   24689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ..........||+.|||||++.+   ..++.++|||||||++|||+||+.||......   ..+.  .........+.. 
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~--~~~~~~~~~p~~-  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQII--FMVGRGYLSPDL-  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHH--HHHHHTSCCCCG-
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHH--HHHhcCCCCCcc-
Confidence            33344456789999999998864   35899999999999999999999999754321   1111  111111111110 


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           ..........+.+++.+||+.||++||||+|+++.|+.+
T Consensus       232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 011112234688999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=414.64  Aligned_cols=254  Identities=28%  Similarity=0.470  Sum_probs=200.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.+.||+|+||+||+|++.+++.||||++.... ...+++.+|++++++++|||||+++++|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888899999997653 335679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +|+|.+++...   ...+++..+..++.|||+||+|||++   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~  156 (263)
T d1sm2a_          84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  156 (263)
T ss_dssp             TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC-c
Confidence            99999998754   35689999999999999999999999   99999999999999999999999999998764432 2


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG-KRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||....   .....   ..+.....   ...|.  
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~---~~i~~~~~---~~~p~--  225 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVV---EDISTGFR---LYKPR--  225 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHH---HHHHHTCC---CCCCT--
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHH---HHHHhcCC---CCCcc--
Confidence            223346789999999999999999999999999999999995 55554221   11111   12221111   11111  


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           ....++.+++.+||+.||++|||++|+++.|++|
T Consensus       226 -----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         226 -----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 1124688999999999999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=411.66  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999875 68999999987653 23345689999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.+++...    ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999988653    4689999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      ........+||+.|||||++.+..+ +.++||||+||++|||+||+.||........ ..    .........   ..+ 
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~----~~~~~~~~~---~~~-  228 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY----SDWKEKKTY---LNP-  228 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HH----HHHHTTCTT---STT-
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HH----HHHhcCCCC---CCc-
Confidence            3344456789999999999887775 6789999999999999999999975433211 11    111111110   000 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                       ..    ....++.+++.+||+.||++|||++|+++
T Consensus       229 -~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 -WK----KIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -GG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01    11235779999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-47  Score=407.92  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=207.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999986 479999999997655445677999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++.+.     .+++.++..++.||+.||+|||++   +||||||||+|||++.++++||+|||+|+.....  
T Consensus       100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--  169 (293)
T d1yhwa1         100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--  169 (293)
T ss_dssp             TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred             CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence            999999987653     589999999999999999999999   9999999999999999999999999999876432  


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ........||+.|+|||++.++.++.++||||+||++|||+||+.||.....   .+.   ......... .....+   
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~---~~~~~~~~~-~~~~~~---  239 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRA---LYLIATNGT-PELQNP---  239 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHHCS-CCCSSG---
T ss_pred             cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHH---HHHHHhCCC-CCCCCc---
Confidence            2234456899999999999999999999999999999999999999964321   111   111111111 111111   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                          ......+.+++.+||+.||++|||++|+++
T Consensus       240 ----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 ----EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                112246889999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=404.49  Aligned_cols=248  Identities=30%  Similarity=0.448  Sum_probs=206.9

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.+ +++.||||++....   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999875 68899999986432   233567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999865    4689999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ...   ...+.....  .  -|
T Consensus       159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~---~~~i~~~~~--~--~p  224 (263)
T d2j4za1         159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QET---YKRISRVEF--T--FP  224 (263)
T ss_dssp             C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHHHHTTCC--C--CC
T ss_pred             C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---HHH---HHHHHcCCC--C--CC
Confidence            2    23456799999999999999999999999999999999999999964321   111   111111110  0  00


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                             .....++.+++.+||+.||++|||++|+++  +|.
T Consensus       225 -------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         225 -------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             -------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence                   111236789999999999999999999997  554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=406.19  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFME  821 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  821 (1020)
                      ++|++.++||+|+||+||+|++++++.||||+++.... ..+++.+|++++++++||||++++++|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999998888999999986543 35689999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc
Q 035998          822 NGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT  901 (1020)
Q Consensus       822 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  901 (1020)
                      +|++.+++...   ...+++..+.+++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus        83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~  155 (258)
T d1k2pa_          83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EY  155 (258)
T ss_dssp             TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SC
T ss_pred             CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC-Cc
Confidence            99999987654   24688999999999999999999999   9999999999999999999999999999876543 22


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......   +.   ...+.....   ...|   
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~---~~~i~~~~~---~~~p---  223 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ET---AEHIAQGLR---LYRP---  223 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH---HHHHHTTCC---CCCC---
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HH---HHHHHhCCC---CCCc---
Confidence            23344678999999999999999999999999999999998 89999754322   11   111221111   1111   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          ......+.+++.+||+.||++|||++|+++.|.+|
T Consensus       224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                11224688999999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=412.49  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=195.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec--cCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH--KNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  816 (1020)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....  ....+.+.+|++++++++|||||++++++.+  ....|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999864 68999999987653  2334568899999999999999999999865  4567999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC--EPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      |||+++|+|.+++.+.......+++..++.++.|++.||+|||++.  ..+||||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999999765444567999999999999999999999871  11399999999999999999999999999988


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ....  ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....   .+..   ..+... .....
T Consensus       164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~---~~i~~~-~~~~~  234 (269)
T d2java1         164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GKIREG-KFRRI  234 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHT-CCCCC
T ss_pred             cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH---HHHHcC-CCCCC
Confidence            6432  2233457899999999999999999999999999999999999999974322   1111   112111 11111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ....    ..++.+++.+||+.||.+|||++|+++
T Consensus       235 -----~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 -----PYRY----SDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 1111    235889999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-47  Score=416.96  Aligned_cols=257  Identities=29%  Similarity=0.453  Sum_probs=198.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-C---CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-G---RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.++||+|+||+||+|+++. +   ..||||++.... ....+.|.+|++++++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457788999999999999998752 3   258999887653 34456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...   ...+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999988753   34689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcc---cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          897 SPYDTH---VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       897 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ......   ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......   +..   ..+......+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~---~~i~~~~~~~  253 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI---NAIEQDYRLP  253 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTTCCCC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCCCCC
Confidence            432211   1123467899999999999999999999999999999998 89999754321   111   1222211111


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                                .+......+.+++.+||+.||++|||++||++.|++++
T Consensus       254 ----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         254 ----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                      11122346889999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-47  Score=412.53  Aligned_cols=259  Identities=25%  Similarity=0.356  Sum_probs=211.3

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ..++|++.+.||+|+||+||+|+++ +++.||||+++.+.. ..+++.+|++++++++|||||+++++|.+.+..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            4567889999999999999999875 588899999976543 35679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|+|.+++...  ....+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999998764  235789999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      . ........|++.|+|||++.++.++.++|||||||++|||++|..||.....     ............. ..     
T Consensus       169 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~~~~~i~~~~~-~~-----  236 (287)
T d1opja_         169 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKDYR-ME-----  236 (287)
T ss_dssp             S-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTTCC-CC-----
T ss_pred             C-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHHHHHHHhcCCC-CC-----
Confidence            2 2233345688999999999999999999999999999999997776643221     1111111111111 11     


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                          .+.....++.+++.+||+.||++|||++|++++|+.+.
T Consensus       237 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         237 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                11112246889999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=413.68  Aligned_cols=256  Identities=29%  Similarity=0.425  Sum_probs=206.9

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||+||+|++++++.||||++..... ..+++.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            457889999999999999999998888999999976543 35679999999999999999999998754 5679999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++....  ...+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+|+...+. .
T Consensus        90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~  163 (272)
T d1qpca_          90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-E  163 (272)
T ss_dssp             TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-C
T ss_pred             CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC-c
Confidence            9999998876542  23589999999999999999999999   9999999999999999999999999999876432 2


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ........||+.|+|||++.++.++.++|||||||++|||+||..|+.....  ..+..   .........   ..|   
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~---~~i~~~~~~---~~p---  232 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVI---QNLERGYRM---VRP---  232 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHH---HHHHTTCCC---CCC---
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHH---HHHHhcCCC---CCc---
Confidence            2333456789999999999989999999999999999999996665532211  11111   112111110   111   


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                          .....++.+++.+||+.||++||||+||++.|+++
T Consensus       233 ----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         233 ----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                11223688999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=408.28  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             cCCCcCCe-eeccCCeEEEEEEeC---CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANI-IGCGGFGLVYRATLP---DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666664 999999999999764   34579999997654 3345679999999999999999999999864 568999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...   ...+++..+..++.||++||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999987643   35689999999999999999999999   99999999999999999999999999999875


Q ss_pred             CCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          897 SPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       897 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......   +...   .+..... .+.
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~---~i~~~~~-~~~  233 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA---FIEQGKR-MEC  233 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH---HHHTTCC-CCC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH---HHHcCCC-CCC
Confidence            43322 22334568899999999999999999999999999999998 99999754332   1111   1211111 111


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                               ++....++.+++.+||+.||++||||.+|++.|+.+
T Consensus       234 ---------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                     111224688999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-47  Score=407.29  Aligned_cols=251  Identities=25%  Similarity=0.397  Sum_probs=206.2

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      +.|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999875 68999999998765555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++.+.   ...+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.....  
T Consensus        92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--  163 (288)
T d2jfla1          92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--  163 (288)
T ss_dssp             TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence            999999988754   24689999999999999999999999   9999999999999999999999999999765321  


Q ss_pred             cccccccccccCccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          901 THVTTDLVGTLGYIPPEYG-----QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ........||+.|+|||++     ....|+.++||||+||++|||+||+.||......+   ...   .+.... .....
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~~~~-~~~~~  236 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIAKSE-PPTLA  236 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHHSC-CCCCS
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCC-CCCCC
Confidence            1223456899999999987     35568999999999999999999999997543322   111   111111 11111


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+       .....++.+++.+||+.||++|||++|+++
T Consensus       237 ~~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 QP-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc-------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11       112246889999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=402.95  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=202.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999874 78999999986432   223457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   +||||||||+||++++++.+||+|||+|+....
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999988765    4689999999999999999999999   999999999999999999999999999988754


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ...........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ...   ...+.....  .    
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~---~~~i~~~~~--~----  228 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLI---FQKIIKLEY--D----  228 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHTTCC--C----
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHH---HHHHHcCCC--C----
Confidence            4333444557899999999999999999999999999999999999999974321   111   111111110  0    


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLV 1013 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1013 (1020)
                       +...    ....+.+++.+||+.||++|||++|++
T Consensus       229 -~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 -FPEK----FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -CCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence             0011    123578999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=414.76  Aligned_cols=200  Identities=25%  Similarity=0.460  Sum_probs=178.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|++++++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999864 68899999997653 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      |+++|+|.+++.+.    ..+++..+..++.|++.||+|||+ +   +|+||||||+|||++.++.+||+|||+|+...+
T Consensus        85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999865    468999999999999999999996 6   899999999999999999999999999987632


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCK  951 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~  951 (1020)
                          ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus       158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                22345689999999999999999999999999999999999999997543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=402.86  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=198.0

Q ss_pred             CeeeccCCeEEEEEEeC---CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEeccC
Q 035998          748 NIIGCGGFGLVYRATLP---DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFMEN  822 (1020)
Q Consensus       748 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  822 (1020)
                      ++||+|+||+||+|.++   .++.||||+++...  ....+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   34679999997543  2335679999999999999999999999864 567899999999


Q ss_pred             CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCCc-
Q 035998          823 GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYDT-  901 (1020)
Q Consensus       823 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-  901 (1020)
                      |+|.++++..    ..+++..+..++.||+.||+|||++   +||||||||+||+++.++.+|++|||+++........ 
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999998864    4689999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          902 HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       902 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......   +.   ...+...... .       
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~---~~~i~~~~~~-~-------  230 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV---TAMLEKGERM-G-------  230 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH---HHHHHTTCCC-C-------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH---HHHHHcCCCC-C-------
Confidence            22334678999999999999999999999999999999998 89999754321   11   1112111111 1       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .+.....++.+++.+||+.||++|||+++|++.|+..
T Consensus       231 --~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         231 --CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              0111224688999999999999999999999888753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-46  Score=408.51  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=208.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC-C-----CEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD-G-----RNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.++||+|+||+||+|++.. +     ..||||++.... ......+.+|+++++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4678999999999999999998642 2     369999986543 23345788999999998 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 035998          813 RLLIYSFMENGSLDYWLHEKLD-------------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKS  873 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  873 (1020)
                      .++||||+++|+|.++++....                   ....+++..++.++.||++||+|||++   +||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            9999999999999999976432                   124589999999999999999999999   999999999


Q ss_pred             CCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 035998          874 SNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKP  952 (1020)
Q Consensus       874 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~  952 (1020)
                      +||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755444444455678999999999999999999999999999999998 8999975443


Q ss_pred             CCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 035998          953 KGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDS 1018 (1020)
Q Consensus       953 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1018 (1020)
                      ...  ...   ........ .         .+.....++.+++.+||+.||++|||++||++.|..
T Consensus       273 ~~~--~~~---~~~~~~~~-~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DAN--FYK---LIQNGFKM-D---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SHH--HHH---HHHTTCCC-C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH--HHH---HHhcCCCC-C---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            211  111   11111110 0         111122468899999999999999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=403.01  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=199.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCC-----CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDG-----RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ..|+..++||+|+||+||+|.++..     ..||||++.... .....+|.+|++++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4578889999999999999986532     369999997654 3334578999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+.++++.+++...   ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999887654   35689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCc-ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDT-HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.....  ....   ...+......   
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~---~~~i~~~~~~---  232 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV---MKAINDGFRL---  232 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH---HHHHHTTCCC---
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHH---HHHHhccCCC---
Confidence            443222 223345689999999999999999999999999999999997666543221  1111   1112111111   


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                             ..+......+.+++.+||+.||++||||+||++.|+++
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence                   11112234688999999999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=393.65  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=195.2

Q ss_pred             CcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec----cCceEEEE
Q 035998          745 DQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH----KNDRLLIY  817 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  817 (1020)
                      +..+.||+|+||+||+|+.. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999875 68899999986542  3334678999999999999999999999875    34578999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCCEEEc-CCCCeEEeecccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPH--ILHRDIKSSNILLD-GNFGAHLADFGLARL  894 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~  894 (1020)
                      ||+++|+|.+++.+.    ..+++..++.++.||++||+|||++   +  |+||||||+|||++ .++.+||+|||+|+.
T Consensus        92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999999999999865    4689999999999999999999998   6  99999999999996 578999999999986


Q ss_pred             ccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ...    ......+||+.|||||++.+ .++.++||||+||++|||++|+.||.....     .......+..... .  
T Consensus       165 ~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~~~~-~--  231 (270)
T d1t4ha_         165 KRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVK-P--  231 (270)
T ss_dssp             CCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCC-C--
T ss_pred             ccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHcCCC-C--
Confidence            422    22345689999999999865 599999999999999999999999964322     1111111211111 0  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                        +......    ..++.+++.+||+.||++|||++|+++
T Consensus       232 --~~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 --ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --cccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              1111111    235789999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-46  Score=404.86  Aligned_cols=251  Identities=25%  Similarity=0.326  Sum_probs=190.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .+.|++.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            456999999999999999999875 68999999997654 2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~  895 (1020)
                      |++||+|.+++.+.    ..+++..+..++.||+.||+|||++   +||||||||+||++.   +++.+||+|||+|+..
T Consensus        88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999764    5799999999999999999999999   999999999999994   5789999999999865


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                      ..   .......+||+.|||||++.++.++.++||||+||++|||++|+.||......   ..   ...+......   .
T Consensus       161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~~~~~---~  228 (307)
T d1a06a_         161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL---FEQILKAEYE---F  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHTTCCC---C
T ss_pred             cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHhccCCC---C
Confidence            32   22334567999999999999999999999999999999999999999743211   11   1111111110   0


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .+..    .+.....+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111    1112235889999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.6e-46  Score=410.21  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=207.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999864 68999999998776666678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc--CCCCeEEeeccccccccCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD--GNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ++|+|.+++...   ...+++..+..++.||+.||+|||++   +||||||||+|||++  .++.+||+|||+++.....
T Consensus       106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999988643   34689999999999999999999999   999999999999995  4688999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                         .......||+.|||||++.+..++.++||||+||++|||++|+.||.....   .+..   ..+......   ..+.
T Consensus       180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~---~~i~~~~~~---~~~~  247 (350)
T d1koaa2         180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETL---RNVKSCDWN---MDDS  247 (350)
T ss_dssp             ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTCCC---SCCG
T ss_pred             ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HHHH---HHHHhCCCC---CCcc
Confidence               233456899999999999999999999999999999999999999964321   1111   122111110   1111


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    .....+.+++.+||+.||++|||++|+++
T Consensus       248 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         248 AFS----GISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111    11235789999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-46  Score=407.07  Aligned_cols=265  Identities=29%  Similarity=0.462  Sum_probs=212.9

Q ss_pred             HHHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHcCCCccceEeeEEec
Q 035998          737 ILESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRAQHPNLVHLQGYCMH  809 (1020)
Q Consensus       737 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  809 (1020)
                      ++...++|++.+.||+|+||+||+|+++      +++.||||++..... ...+++.+|++++++++||||++++++|.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3335678999999999999999999863      457899999976543 345679999999999999999999999999


Q ss_pred             cCceEEEEEeccCCChhhhhhhcC--------------------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKL--------------------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHR  869 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  869 (1020)
                      ....++||||+++|+|.++++...                    .....+++..++.++.|++.||+|||++   +||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            999999999999999999997532                    1233589999999999999999999999   99999


Q ss_pred             CCCCCCEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCC
Q 035998          870 DIKSSNILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK-RPMD  948 (1020)
Q Consensus       870 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~  948 (1020)
                      ||||+||+++.++.+||+|||+|+...+.......+...|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765443334445567889999999999999999999999999999999985 5675


Q ss_pred             CCCCCCcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          949 MCKPKGSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       949 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .....   +..   ..+.... ....         +...+.++.+++.+||+.||++||||.||+++|++|.
T Consensus       245 ~~~~~---e~~---~~v~~~~-~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHE---EVI---YYVRDGN-ILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHH---HHH---HHHHTTC-CCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHH---HHH---HHHHcCC-CCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43221   111   1222111 1111         1112246889999999999999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=402.55  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|++++++++|||||+++++|.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            35789999999999999999999888899999997553 335679999999999999999999999854 5689999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|++..++....  ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...+.. 
T Consensus        94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-  167 (285)
T d1fmka3          94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  167 (285)
T ss_dssp             TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence            9999998887642  24689999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcccc
Q 035998          901 THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPFIY  980 (1020)
Q Consensus       901 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  980 (1020)
                      ........||+.|+|||++..+.++.++|||||||++|||+||..||.....  ....   ...+...... .       
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~---~~~i~~~~~~-~-------  234 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREV---LDQVERGYRM-P-------  234 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH---HHHHHTTCCC-C-------
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHH---HHHHHhcCCC-C-------
Confidence            2333446789999999999999999999999999999999997666543211  1111   2222211111 1       


Q ss_pred             CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          981 DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       981 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                        .+.....++.+++.+||+.||++||++++|+++|++.
T Consensus       235 --~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         235 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             --CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence              1112234688999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-45  Score=398.57  Aligned_cols=244  Identities=29%  Similarity=0.412  Sum_probs=199.9

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .|+..+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4889999999999999999864 68889999987553   2334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+++|++..+....    ..+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.... 
T Consensus        96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999998766543    4689999999999999999999999   999999999999999999999999999986532 


Q ss_pred             CCcccccccccccCccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQA---SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  975 (1020)
                           .....||+.|||||++.+   +.|+.++||||+||++|||++|+.||.....      ............ ....
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~-~~~~  235 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PALQ  235 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCCS
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC-CCCC
Confidence                 234579999999998754   4689999999999999999999999964321      111111111111 1111


Q ss_pred             CccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          976 DPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       976 d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .     .   .....+.+++.+||+.||++|||++|+++
T Consensus       236 ~-----~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S-----G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C-----T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C-----C---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1     1   11236889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-45  Score=407.46  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=207.5

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSFM  820 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  820 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46999999999999999999864 79999999998776555677899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc--CCCCeEEeeccccccccCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD--GNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ++|+|.+++...   ...+++.+++.++.||+.||+|||++   +||||||||+|||++  .++.+||+|||+|+.....
T Consensus       109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999998877643   34689999999999999999999999   999999999999997  6789999999999876432


Q ss_pred             CCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                         .......||+.|+|||++.+..++.++||||+||++|||+||+.||.....   .+.   ...+......   ..+.
T Consensus       183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~---~~~i~~~~~~---~~~~  250 (352)
T d1koba_         183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LET---LQNVKRCDWE---FDED  250 (352)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH---HHHHHHCCCC---CCSS
T ss_pred             ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHHHhCCCC---CCcc
Confidence               233456789999999999999999999999999999999999999964322   111   1122111110   0111


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ...    ....++.+++.+||+.||.+|||++|+++
T Consensus       251 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111    12235789999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=397.76  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=205.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc------hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC------GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||++....      ....+.+.+|++++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999974 78999999986432      12356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC----CeEEeec
Q 035998          814 LLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF----GAHLADF  889 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df  889 (1020)
                      |+||||+++|+|.+++.+.    ..+++..++.++.|++.||+|||++   +||||||||+||+++.++    .+|++||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999865    4689999999999999999999999   999999999999998776    4999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN  969 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  969 (1020)
                      |+++.....   .......||+.|+|||++.++.++.++||||+||++|||++|+.||......   +.   ...+....
T Consensus       162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~~~  232 (293)
T d1jksa_         162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANVSAVN  232 (293)
T ss_dssp             TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHTTC
T ss_pred             hhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HH---HHHHHhcC
Confidence            999876432   2334567899999999999999999999999999999999999999753221   11   11111111


Q ss_pred             ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          970 RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       970 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ..   ..+....    .....+.+++.+||+.||++|||++|+++
T Consensus       233 ~~---~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 YE---FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC---CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC---CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   0011111    11235789999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-45  Score=402.01  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCC----EEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGR----NVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      ++|++.++||+|+||+||+|++. +|+    +||+|++.... ....+++.+|++++++++|||||+++++|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999864 444    58999886543 34467899999999999999999999999864 5778


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ++||+.+|+|.+++...   ...+++..++.++.|||.||+|||++   +||||||||+||+++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            89999999999888764   35789999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      .............||+.|+|||++.++.++.++|||||||++|||+| |..||......+   .....   .......  
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i---~~~~~~~--  233 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL---EKGERLP--  233 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH---HHTCCCC--
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH---HcCCCCC--
Confidence            55443334445678999999999999999999999999999999999 888987544322   22111   1111110  


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                              .++.....+.+++.+||+.||++|||++|+++.|+.+
T Consensus       234 --------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         234 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                    1111224688999999999999999999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=393.28  Aligned_cols=250  Identities=27%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEec-cCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMH-KNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||.||+|+++ |+.||||+++.+.  ..+.+.+|++++++++||||++++++|.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356788999999999999999985 7899999997653  34679999999999999999999999965 4568999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +++|+|.+++....  ...+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++..... 
T Consensus        83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            99999999997541  23589999999999999999999999   9999999999999999999999999999865322 


Q ss_pred             CcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                          .....+++.|+|||++.++.++.++|||||||++|||+| |+.||......   +.....   .. ....+.    
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i---~~-~~~~~~----  221 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV---EK-GYKMDA----  221 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH---TT-TCCCCC----
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH---Hc-CCCCCC----
Confidence                233467889999999999999999999999999999998 78887654322   222221   11 111111    


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                           +.....++.+++.+||+.||.+||||+|++++|++|
T Consensus       222 -----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         222 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                 111224688999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=395.97  Aligned_cols=256  Identities=26%  Similarity=0.373  Sum_probs=197.2

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeCC----CCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLPD----GRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  815 (1020)
                      .++|++.+.||+|+||.||+|++..    +..||||+++... ....+.+.+|++++++++|||||++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4578999999999999999998642    3468999986543 333567999999999999999999999986 467899


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLI  895 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  895 (1020)
                      ||||+++|++.+++...   ...+++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            99999999999987654   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccccc
Q 035998          896 LSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRESEV  974 (1020)
Q Consensus       896 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  974 (1020)
                      ... .........||+.|+|||++.+..++.++|||||||++|||+| |.+||......+   ....   +...... . 
T Consensus       159 ~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~---i~~~~~~-~-  229 (273)
T d1mp8a_         159 EDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR---IENGERL-P-  229 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTCCC-C-
T ss_pred             cCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCCCC-C-
Confidence            432 2233345678999999999999999999999999999999998 899997654332   2211   1111111 1 


Q ss_pred             cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          975 LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       975 ~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                              .++.....+.+++.+||+.||++|||++||++.|++++
T Consensus       230 --------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         230 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                    11122346889999999999999999999999998763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=395.52  Aligned_cols=267  Identities=27%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEE
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYC  807 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  807 (1020)
                      .+....++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|.+.+.++ +|+||+.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            33334568999999999999999999853      34689999987544 33345677888888777 689999999998


Q ss_pred             ecc-CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCC
Q 035998          808 MHK-NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSS  874 (1020)
Q Consensus       808 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  874 (1020)
                      .+. ...++||||+++|+|.++++....            ....+++.++..++.||++||+|||++   +||||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            765 467999999999999999975422            134589999999999999999999999   9999999999


Q ss_pred             CEEEcCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCC
Q 035998          875 NILLDGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG-KRPMDMCKPK  953 (1020)
Q Consensus       875 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~pf~~~~~~  953 (1020)
                      |||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+|| ..||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876554444445567899999999999999999999999999999999996 5577543322


Q ss_pred             CcccHHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          954 GSRDLISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       954 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .  ....   ..... ......         .....++.+++.+||+.||++|||++|+++.|++++
T Consensus       244 ~--~~~~---~~~~~-~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 E--EFCR---RLKEG-TRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             H--HHHH---HHHHT-CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHH---HHhcC-CCCCCC---------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1  1111   11111 111111         111235889999999999999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-44  Score=391.98  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=205.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.+..   ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999986 479999999997542   223466889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999998875    4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      ..  ......+||+.|+|||++.++.|+.++||||+||++|||++|+.||.....   ...   ...+.... . ..  |
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~---~~~i~~~~-~-~~--p  225 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERL---FELILMEE-I-RF--P  225 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHHHHHCC-C-CC--C
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HHH---HHHHhcCC-C-CC--C
Confidence            22  234457899999999999999999999999999999999999999975332   111   11111111 0 00  1


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                         ..    ...++.+++.+||+.||++||+     ++|+++
T Consensus       226 ---~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 ---RT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---TT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---cc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               11    1235789999999999999995     888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=396.50  Aligned_cols=261  Identities=28%  Similarity=0.396  Sum_probs=208.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC--------CCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEecc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP--------DGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHK  810 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  810 (1020)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.+.. ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            467899999999999999999753        234799999977653 3346788899999888 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLD------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      +..++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||++   +||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999976532            234689999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||......   .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence            9999999999999998765544445556788999999999999999999999999999999998 78888643321   1


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      ..   ..+. .+.....  |   .    .....+.+++.+||+.||.+|||++||++.|++|+
T Consensus       246 ~~---~~i~-~~~~~~~--p---~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         246 LF---KLLK-EGHRMDK--P---S----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HH---HHHH-TTCCCCC--C---S----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH---HHHH-cCCCCCC--C---c----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            11   1111 1111111  1   1    12235889999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-43  Score=382.39  Aligned_cols=259  Identities=25%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCc----
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKND----  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  812 (1020)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++...   ....+.+.+|++++++++|||||++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999986 478999999997653   2334578999999999999999999999987543    


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .|+||||++|++|.+++...    ..+++.+++.++.||+.||+|||++   +||||||||+||+++.++.++++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            78999999999999988765    4689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCC-cccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          893 RLILSPYD-THVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       893 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      +....... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....      .............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence            76543222 2234456899999999999999999999999999999999999999974321      1111122111111


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhc
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-TTQQLVSWLDSI 1019 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 1019 (1020)
                      .    +...   .+.....+.+++.+||+.||.+|| |++++++.|.++
T Consensus       233 ~----~~~~---~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 P----PSAR---HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             C----GGGT---SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C----Cchh---ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            1    1010   111123688999999999999999 899999988765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-43  Score=388.43  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=203.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||++....   ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46899999999999999999974 68999999987532   223467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||++||++..++...    ..+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999988765    4678899999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-ccccccC
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-RESEVLD  976 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d  976 (1020)
                      .     .....||+.|+|||++.+..++.++||||+||++|||+||+.||.....      ......+.... ..+.   
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~~p~---  222 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELRFPP---  222 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCCCCT---
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCCCCC---
Confidence            2     2346899999999999999999999999999999999999999974321      11111221111 1111   


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                               .....+.+++.+||+.||.+||     |++|+++
T Consensus       223 ---------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         223 ---------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                     1123578999999999999996     8999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-44  Score=389.75  Aligned_cols=262  Identities=29%  Similarity=0.421  Sum_probs=212.1

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe------CCCCEEEEEEecCCch-hhHHHHHHHHHHHHHc-CCCccceEeeEEeccCc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL------PDGRNVAIKRLSGDCG-QMEREFRAEVEALSRA-QHPNLVHLQGYCMHKND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  812 (1020)
                      .++|++.++||+|+||.||+|++      .+++.||||+++.... ....++.+|+.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46788999999999999999975      2456899999976543 3445789999999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEE
Q 035998          813 RLLIYSFMENGSLDYWLHEKLD--------------GPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILL  878 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  878 (1020)
                      .++||||+++|+|.++++....              ....+++..+..++.||++||+|||++   ++|||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            9999999999999999986532              234689999999999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCccc
Q 035998          879 DGNFGAHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRD  957 (1020)
Q Consensus       879 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  957 (1020)
                      +.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||......   .
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~---~  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---S  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---H
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---H
Confidence            9999999999999998765544455556788999999999999999999999999999999999 55555443322   1


Q ss_pred             HHHHHHHHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          958 LISWVIRMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       958 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .+.   ..........  .       +......+.+++.+||+.||++||||++|+++|++++
T Consensus       256 ~~~---~~i~~~~~~~--~-------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         256 KFY---KMIKEGFRML--S-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHH---HHHHHTCCCC--C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH---HHHhcCCCCC--C-------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            111   1111111000  0       1112246889999999999999999999999998753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-44  Score=383.55  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC--CC--CEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP--DG--RNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++..+.   ....++|.+|++++++++|||||+++++|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56899999999999999999853  23  368999987543   3345679999999999999999999999965 4678


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++|++.+++...   ...+++..++.++.|||.||+|||++   +|+||||||+||+++.++.+|++|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            999999999999887764   24589999999999999999999999   999999999999999999999999999998


Q ss_pred             ccCCCCcc-cccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          895 ILSPYDTH-VTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLT-GKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       895 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ........ ......|+..|+|||++.+..++.++|||||||++|||+| |+.||......      .....+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~  234 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL  234 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCC
Confidence            75443322 2334567889999999999999999999999999999998 89999643221      1122222221111


Q ss_pred             cccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          973 EVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       973 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      +.         +......+.+++.+||+.||++||||+||++.|++.
T Consensus       235 ~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 PR---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11         111224688999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3e-43  Score=377.48  Aligned_cols=255  Identities=25%  Similarity=0.393  Sum_probs=205.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch---------hhHHHHHHHHHHHHHcC-CCccceEeeEEecc
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG---------QMEREFRAEVEALSRAQ-HPNLVHLQGYCMHK  810 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  810 (1020)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....         ...+.+.+|++++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5799999999999999999986 4788999999875431         12345789999999997 99999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecc
Q 035998          811 NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFG  890 (1020)
Q Consensus       811 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  890 (1020)
                      +..|+||||+++|+|.++++..    ..+++.+++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999765    4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHH
Q 035998          891 LARLILSPYDTHVTTDLVGTLGYIPPEYGQ------ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIR  964 (1020)
Q Consensus       891 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  964 (1020)
                      +++.....   .......||+.|+|||++.      ...++.++||||+||++|||++|+.||.....   ...   ...
T Consensus       156 ~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~---~~~  226 (277)
T d1phka_         156 FSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLM---LRM  226 (277)
T ss_dssp             TCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH---HHH
T ss_pred             heeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHH---HHH
Confidence            99876432   2234567999999999764      34578899999999999999999999975321   111   111


Q ss_pred             HHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhc
Q 035998          965 MRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019 (1020)
Q Consensus       965 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1019 (1020)
                      +..... . ...+     .......++.+++.+||+.||++|||++|+++  +|++.
T Consensus       227 i~~~~~-~-~~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         227 IMSGNY-Q-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHTCC-C-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHhCCC-C-CCCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            111111 0 0000     11112246889999999999999999999987  45543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=387.73  Aligned_cols=267  Identities=27%  Similarity=0.320  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccC----ceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN----DRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  817 (1020)
                      ++|...+.||+|+||.||+|++ +|+.||||++...... ....+.|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4577788999999999999997 5889999999754221 122334555556789999999999998754    478999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC-----EPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      ||+++|+|.+++++.     .+++..++.++.|+|.||+|+|+..     .++||||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999864     5899999999999999999999631     249999999999999999999999999999


Q ss_pred             ccccCCCCcc--cccccccccCccCccccCCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCc--------c
Q 035998          893 RLILSPYDTH--VTTDLVGTLGYIPPEYGQASV------ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGS--------R  956 (1020)
Q Consensus       893 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~pf~~~~~~~~--------~  956 (1020)
                      +.........  ......||+.|+|||++.+..      ++.++|||||||++|||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8875433221  234568999999999877643      57799999999999999999988754332211        0


Q ss_pred             cHHHHHHHHHhhcccccccCcccc-CccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          957 DLISWVIRMRQENRESEVLDPFIY-DKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       957 ~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ..............    ..|.+. .....+....+.+++.+||+.||++|||+.||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         236 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            11112222211111    122211 112335566799999999999999999999999999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=394.21  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=211.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC------CCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCce
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP------DGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDR  813 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  813 (1020)
                      .++|++.+.||+|+||+||+|.++      +++.||||+++... ......+.+|++++++++|||||++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467889999999999999999763      35789999997654 33345689999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          814 LLIYSFMENGSLDYWLHEKL------DGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       814 ~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                      ++||||+++|+|.+++....      .....+++..+.+++.|+|+||+|||++   +|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886431      2234578999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCcccHHHHHHHHH
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK-RPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. .||......      +....+.
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~~~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence            999998775544444445567899999999999999999999999999999999985 677543221      1122222


Q ss_pred             hhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhcC
Q 035998          967 QENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSII 1020 (1020)
Q Consensus       967 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~il 1020 (1020)
                      .... ...         +......+.+++.+||+.||.+|||+++|++.|++.+
T Consensus       250 ~~~~-~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         250 EGGL-LDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TTCC-CCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             hCCC-CCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2111 111         1112246899999999999999999999999998753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=390.05  Aligned_cols=251  Identities=20%  Similarity=0.291  Sum_probs=205.0

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .++|++.+.||+|+||+||+|+.+ +++.||||++..... ....+.+|++++++++|||||++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999875 688999999987643 345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCC--CCeEEeeccccccccC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGN--FGAHLADFGLARLILS  897 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~~~~~~~  897 (1020)
                      ++||+|.+++.+.   +..+++.+++.++.||+.||+|||++   +|+||||||+||+++.+  +.+|++|||+++....
T Consensus        83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999998754   34689999999999999999999999   99999999999999854  5799999999987633


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .   .......+|+.|+|||...+..++.++||||+||++|+|++|+.||......   +.   ...+.....   ..+.
T Consensus       157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~---~~~i~~~~~---~~~~  224 (321)
T d1tkia_         157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI---IENIMNAEY---TFDE  224 (321)
T ss_dssp             T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHHTCC---CCCH
T ss_pred             C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC---CCCh
Confidence            2   2334467899999999999999999999999999999999999999753221   11   111111110   0111


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ......    ..++.+++.+|++.||.+|||++|+++
T Consensus       225 ~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111111    235789999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-43  Score=389.14  Aligned_cols=244  Identities=21%  Similarity=0.263  Sum_probs=203.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++|++++.||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999874 79999999986432   123456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccC
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILS  897 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  897 (1020)
                      ||+.+|+|..++...    ..+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999998765    4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc
Q 035998          898 PYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP  977 (1020)
Q Consensus       898 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  977 (1020)
                      .     .....||+.|||||++.+..++.++||||+||++|||+||+.||.....      ......+.....  .  .|
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~--~--~p  258 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV--R--FP  258 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--C--CC
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCC--C--CC
Confidence            2     2346799999999999999999999999999999999999999964321      111112211111  0  00


Q ss_pred             cccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          978 FIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       978 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                         ..    ...++.+++.+||+.||.+|+     |++|+++
T Consensus       259 ---~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 ---SH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---TT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---cc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               11    123578999999999999994     8999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-43  Score=392.61  Aligned_cols=248  Identities=27%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHH---HHHHHHcCCCccceEeeEEeccCceE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAE---VEALSRAQHPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~  814 (1020)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|   +++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999875 68999999986432   1122334444   55666668999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      +||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999865    4678999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccc
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQ-ASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESE  973 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  973 (1020)
                      ....    ......||+.|+|||++. +..++.++||||+||++|||+||+.||........   ... ........   
T Consensus       157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-~~~~~~~~---  225 (364)
T d1omwa3         157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEI-DRMTLTMA---  225 (364)
T ss_dssp             CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHH-HHHSSSCC---
T ss_pred             cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHhcccCC---
Confidence            6432    234467999999999886 45789999999999999999999999976443322   111 11111100   


Q ss_pred             ccCccccCccCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 035998          974 VLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPT-----TQQLVS 1014 (1020)
Q Consensus       974 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1014 (1020)
                         +......    ..++.+++.+||+.||++|||     ++|+++
T Consensus       226 ---~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ---VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence               0011111    235789999999999999999     688875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=387.28  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=197.6

Q ss_pred             cCCCcCC-eeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHc-CCCccceEeeEEec----cCceE
Q 035998          742 NNFDQAN-IIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRA-QHPNLVHLQGYCMH----KNDRL  814 (1020)
Q Consensus       742 ~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  814 (1020)
                      ++|++.+ .||+|+||.||+|+. .+++.||||+++..     ..+.+|++++.++ +|||||+++++|.+    +...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788775 699999999999986 57899999999753     4567899987655 89999999999875    45679


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC---CCCeEEeeccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG---NFGAHLADFGL  891 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~  891 (1020)
                      +|||||+||+|.+++.+.  +...+++.+++.++.||+.||+|||++   +|+||||||+||+++.   ++.+||+|||+
T Consensus        86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence            999999999999999764  235689999999999999999999999   9999999999999975   56799999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE  971 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  971 (1020)
                      |+.....   .......||+.|+|||++.+..|+.++||||+||++|+|+||+.||...........+.      .....
T Consensus       161 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~------~~i~~  231 (335)
T d2ozaa1         161 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------TRIRM  231 (335)
T ss_dssp             CEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------CCCS
T ss_pred             eeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH------HHHhc
Confidence            9876432   22345689999999999999999999999999999999999999997544332211110      00000


Q ss_pred             ccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          972 SEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       972 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      ....-|   .........++.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQYEFP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSSSCC---TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCC---CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000000   0111122346889999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=392.88  Aligned_cols=256  Identities=30%  Similarity=0.429  Sum_probs=202.1

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCC-CC--EEEEEEecCCc-hhhHHHHHHHHHHHHHc-CCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPD-GR--NVAIKRLSGDC-GQMEREFRAEVEALSRA-QHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.++||+|+||+||+|++++ |.  .||||++.... ....+.+.+|+++++++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            568889999999999999998753 33  47888876443 33455799999999998 799999999999999999999


Q ss_pred             EEeccCCChhhhhhhc------------CCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCe
Q 035998          817 YSFMENGSLDYWLHEK------------LDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGA  884 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  884 (1020)
                      |||+++|+|.++++..            ......+++..+.+++.|||.||+|+|++   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999754            12346789999999999999999999999   99999999999999999999


Q ss_pred             EEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCCCcccHHHHHH
Q 035998          885 HLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGK-RPMDMCKPKGSRDLISWVI  963 (1020)
Q Consensus       885 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~  963 (1020)
                      ||+|||+++.....   .......||..|+|||.+.++.++.++|||||||++|||++|. +||.....      .+...
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE  237 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHH
Confidence            99999999865322   2223456899999999999999999999999999999999976 46653321      11111


Q ss_pred             HHHhhcccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          964 RMRQENRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       964 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      .+.....      +..    +.....++.+++.+||+.||++||||+||++.|+++
T Consensus       238 ~i~~~~~------~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 KLPQGYR------LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HGGGTCC------CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCC------CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1111111      111    111224688999999999999999999999999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-43  Score=381.44  Aligned_cols=252  Identities=28%  Similarity=0.437  Sum_probs=200.3

Q ss_pred             CCeeeccCCeEEEEEEeCCC----CEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-CceEEEEEec
Q 035998          747 ANIIGCGGFGLVYRATLPDG----RNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-NDRLLIYSFM  820 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  820 (1020)
                      .++||+|+||+||+|++.++    ..||||+++... ....++|.+|++++++++||||+++++++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            47899999999999987532    258999997543 34457799999999999999999999998764 5789999999


Q ss_pred             cCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCCC
Q 035998          821 ENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPYD  900 (1020)
Q Consensus       821 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  900 (1020)
                      ++|+|.+++...   ...+++..++.++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999988754   34678889999999999999999999   999999999999999999999999999987643322


Q ss_pred             c--ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCcc
Q 035998          901 T--HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDPF  978 (1020)
Q Consensus       901 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  978 (1020)
                      .  .......||+.|+|||.+....++.++||||||+++|||+||..||......  .+....   .......   ..| 
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~---i~~g~~~---~~p-  256 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVY---LLQGRRL---LQP-  256 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTTCCC---CCC-
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHH---HHcCCCC---CCc-
Confidence            1  2233467899999999999999999999999999999999988887543211  111211   1111111   111 


Q ss_pred             ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          979 IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       979 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                            ......+.+++.+||+.||++||+|+||++.|+++
T Consensus       257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                  11223688999999999999999999999999876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-43  Score=382.68  Aligned_cols=247  Identities=27%  Similarity=0.378  Sum_probs=200.3

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc---hhhHHHHHHHHHHHH-HcCCCccceEeeEEeccCceEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC---GQMEREFRAEVEALS-RAQHPNLVHLQGYCMHKNDRLLI  816 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  816 (1020)
                      ++|++.+.||+|+||+||+|+.+ +++.||||++.+..   ....+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999875 68899999997532   122344566666654 68999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccccc
Q 035998          817 YSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLIL  896 (1020)
Q Consensus       817 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  896 (1020)
                      |||+++|+|.+++...    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999865    4688999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccC
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLD  976 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  976 (1020)
                      ..  ........||+.|+|||++.+..++.++||||+||++|||+||+.||.+....   ...   ..+.....  .  -
T Consensus       155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~---~~i~~~~~--~--~  222 (320)
T d1xjda_         155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF---HSIRMDNP--F--Y  222 (320)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCC--C--C
T ss_pred             cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCCC--C--C
Confidence            32  23334568999999999999999999999999999999999999999753221   111   11111110  0  0


Q ss_pred             ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 035998          977 PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQ-QLVS 1014 (1020)
Q Consensus       977 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1014 (1020)
                      |   ..    ...++.+++.+||+.||++||++. |+++
T Consensus       223 p---~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 P---RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C---TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C---cc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1   11    123588999999999999999985 6754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=383.22  Aligned_cols=257  Identities=28%  Similarity=0.301  Sum_probs=195.1

Q ss_pred             cCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchh-----hHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          746 QANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQ-----MEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       746 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      .+++||+|+||+||+|+.+ +|+.||||++......     ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999964 6899999998654321     124688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      ++++++..+...    ...+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            999877655443    35688899999999999999999999   99999999999999999999999999998764432


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccccCc-
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVLDP-  977 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-  977 (1020)
                        ......+||+.|+|||++.. ..++.++||||+||++|||+||+.||.....   .+..................+. 
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccchh
Confidence              22334679999999998764 5689999999999999999999999964322   2222222221111110000000 


Q ss_pred             -----cc---cCccC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          978 -----FI---YDKQH-----DKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       978 -----~~---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                           ..   ....+     ......+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                 00   00000     112346889999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=378.51  Aligned_cols=266  Identities=24%  Similarity=0.327  Sum_probs=200.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999986 4789999999965432  234678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      |+.++.+. ++...  ....+++..+..++.|++.||+|||++   +||||||||+|||++.++.+|++|||.|+....+
T Consensus        82 ~~~~~~~~-~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHH-HHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhh-hhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99765444 44332  235689999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccccccCccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccc---ccc
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQASV-ATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRE---SEV  974 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  974 (1020)
                      .  .......||+.|+|||...... ++.++||||+||++|+|++|+.||.....   .+..............   ...
T Consensus       156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTG
T ss_pred             c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhcccc
Confidence            2  2344567999999999866654 58899999999999999999999974321   1111111111110000   000


Q ss_pred             -cCcccc------Cc-----cCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          975 -LDPFIY------DK-----QHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       975 -~d~~~~------~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                       ..+...      ..     ..+.....+.+++.+|++.||++|||++|+++  +|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence             000000      00     01112246789999999999999999999987  4554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-42  Score=376.75  Aligned_cols=261  Identities=22%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch--hhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEEe
Q 035998          742 NNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG--QMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYSF  819 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  819 (1020)
                      ++|++.++||+|+||+||+|++++|+.||||++.....  ...+.+.+|+.++++++|||||++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999999999999999976532  2346789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCCC
Q 035998          820 MENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSPY  899 (1020)
Q Consensus       820 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  899 (1020)
                      +.++.+..+....    ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.+.....+.
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            9887776665533    5799999999999999999999999   99999999999999999999999999998865432


Q ss_pred             CcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccccc----
Q 035998          900 DTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEV----  974 (1020)
Q Consensus       900 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  974 (1020)
                        .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.....   .+.................    
T Consensus       155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchh
Confidence              22334568999999998765 4678999999999999999999999975432   1222211111111000000    


Q ss_pred             -----------cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          975 -----------LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       975 -----------~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                 ..+.......+.....+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       0000001111122346789999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=373.73  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=197.6

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCch------hhHHHHHHHHHHHHHcC--CCccceEeeEEeccC
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCG------QMEREFRAEVEALSRAQ--HPNLVHLQGYCMHKN  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  811 (1020)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.....      .....+.+|++++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999864 789999999865321      11233668999999996  899999999999999


Q ss_pred             ceEEEEEeccC-CChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-CCCeEEeec
Q 035998          812 DRLLIYSFMEN-GSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-NFGAHLADF  889 (1020)
Q Consensus       812 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Df  889 (1020)
                      ..++||||+.+ +++.+++...    ..+++.+++.++.||+.||+|||++   +|+||||||+||+++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 5777777654    4689999999999999999999999   9999999999999985 478999999


Q ss_pred             cccccccCCCCcccccccccccCccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          890 GLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVA-TYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       890 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      |+|+....    .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...      ..     .....
T Consensus       156 G~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~-----i~~~~  220 (273)
T d1xwsa_         156 GSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE-----IIRGQ  220 (273)
T ss_dssp             TTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH-----HHHCC
T ss_pred             ccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hH-----Hhhcc
Confidence            99986532    22345689999999999877655 67799999999999999999999631      10     01111


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhc
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1019 (1020)
                      ...    .    ...    ..++.+++.+||+.||++|||++|+++  +|+++
T Consensus       221 ~~~----~----~~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         221 VFF----R----QRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCC----S----SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cCC----C----CCC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            111    1    111    235789999999999999999999987  55543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=379.29  Aligned_cols=267  Identities=25%  Similarity=0.333  Sum_probs=198.7

Q ss_pred             hccCCCcCCeeeccCCeEEEEEEeC-C-CCEEEEEEecCCch--hhHHHHHHHHHHHHHc---CCCccceEeeEEec---
Q 035998          740 STNNFDQANIIGCGGFGLVYRATLP-D-GRNVAIKRLSGDCG--QMEREFRAEVEALSRA---QHPNLVHLQGYCMH---  809 (1020)
Q Consensus       740 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  809 (1020)
                      +.++|++++.||+|+||+||+|+.. + ++.||||++.....  .....+.+|+++++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3478999999999999999999863 4 56799999864321  1223456777777666   79999999999863   


Q ss_pred             --cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEe
Q 035998          810 --KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLA  887 (1020)
Q Consensus       810 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  887 (1020)
                        ....+++|||++++++......   ....+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeec
Confidence              3467899999998876554433   235689999999999999999999999   99999999999999999999999


Q ss_pred             eccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHh
Q 035998          888 DFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQ  967 (1020)
Q Consensus       888 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  967 (1020)
                      |||+++...   .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....   .+..........
T Consensus       159 dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~  232 (305)
T d1blxa_         159 DFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIG  232 (305)
T ss_dssp             SCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred             chhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhC
Confidence            999987642   23344567899999999999999999999999999999999999999975432   122221111111


Q ss_pred             hcccccccC-------------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          968 ENRESEVLD-------------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       968 ~~~~~~~~d-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                      .........             +.............+.+|+.+||+.||++|||++|+++  +|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence            000000000             00000111122345789999999999999999999987  4543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5.8e-42  Score=377.81  Aligned_cols=294  Identities=29%  Similarity=0.469  Sum_probs=200.6

Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCCCCCCCCc--CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccc--cccccc
Q 035998           30 TCNPNDLAALEDFMKNFESGIDGWGTNASSSDCCH--WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKG--KLSESL  105 (1020)
Q Consensus        30 ~~~~~~~~aL~~~k~~~~~~~~~~~~~~~~~~~C~--w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~--~~~~~l  105 (1020)
                      -|+|+|++||++||++++++. .+.+|+.++|||.  |+||+|++.+        +.+||++|+|.++++.|  .+|+++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~--------~~~~v~~L~L~~~~l~g~~~lp~~l   72 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT--------QTYRVNNLDLSGLNLPKPYPIPSSL   72 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS--------SCCCEEEEEEECCCCSSCEECCGGG
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCC--------CcEEEEEEECCCCCCCCCCCCChHH
Confidence            399999999999999998653 2333346789994  9999998753        24699999999999998  578999


Q ss_pred             cCCCCCcEEecCC-CCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcc
Q 035998          106 GNLVQLRFLNLSH-NLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRI  183 (1020)
Q Consensus       106 ~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L  183 (1020)
                      ++|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+.++..+ .+.+|+++++++|.+.+.+|..+ ..++.|
T Consensus        73 ~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l-~~l~~L  151 (313)
T d1ogqa_          73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNL  151 (313)
T ss_dssp             GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-GGCTTC
T ss_pred             hcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhh-ccCccc
Confidence            9999999999987 89999999999999999999999999998877766 67778888877777766665554 345555


Q ss_pred             cEEEccCCCCCCCCCCcccccccc-ccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccC
Q 035998          184 RVINLSVNYFSGTLSPGLGNCASL-EHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSS  262 (1020)
Q Consensus       184 ~~L~L~~N~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  262 (1020)
                      +.+++++|.+.+.+|..+..+.++ +.+++++|+++                        +..|..+..+..+ .+++++
T Consensus       152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~------------------------~~~~~~~~~l~~~-~l~l~~  206 (313)
T d1ogqa_         152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT------------------------GKIPPTFANLNLA-FVDLSR  206 (313)
T ss_dssp             CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE------------------------EECCGGGGGCCCS-EEECCS
T ss_pred             ceeecccccccccccccccccccccccccccccccc------------------------ccccccccccccc-cccccc
Confidence            555555555555555555444443 44444555554                        4444444444322 455555


Q ss_pred             CcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCC
Q 035998          263 NNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLP  342 (1020)
Q Consensus       263 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  342 (1020)
                      |.+.+.+|..+..+++++.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|..+..+++|++|+|++|+|+|.+|
T Consensus       207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             cccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            55555555555555555555555555554433 34555556666666666665566556666666666666666666665


Q ss_pred             CCCCCCCCCCeEecCCCc
Q 035998          343 TNLPRCRKLKNINLARNN  360 (1020)
Q Consensus       343 ~~l~~l~~L~~L~L~~N~  360 (1020)
                      . ++++++|+.+++++|+
T Consensus       286 ~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         286 Q-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             C-STTGGGSCGGGTCSSS
T ss_pred             C-cccCCCCCHHHhCCCc
Confidence            3 4566666666666665

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-40  Score=359.07  Aligned_cols=261  Identities=16%  Similarity=0.224  Sum_probs=208.7

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC-CccceEeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH-PNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....  ...+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999965 688999999865432  2457789999999965 899999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcC-----CCCeEEeeccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDG-----NFGAHLADFGLAR  893 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~~~  893 (1020)
                      |+ +++|.+++...   ...+++.++..++.|++.||+|||++   +|+||||||+||+++.     ++.+|++|||+|+
T Consensus        82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 68998888654   24689999999999999999999999   9999999999999974     5789999999998


Q ss_pred             cccCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhh
Q 035998          894 LILSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQE  968 (1020)
Q Consensus       894 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  968 (1020)
                      ........     .......||+.|||||++.+..++.++||||+||++|||+||+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            87543222     1233467999999999999999999999999999999999999999865544433333222222221


Q ss_pred             cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          969 NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       969 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ....+.     ....    +.++.+++..|++.+|++||+++.+.+.|+++
T Consensus       235 ~~~~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChHHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            111111     1111    23588999999999999999999999988765

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-40  Score=361.04  Aligned_cols=261  Identities=19%  Similarity=0.237  Sum_probs=198.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccce-EeeEEeccCceEEEEE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVH-LQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e  818 (1020)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++.....  ..++.+|+++++.++|++++. +.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999986 4688999999876532  245788999999998776555 4555567778889999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEc---CCCCeEEeeccccccc
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLD---GNFGAHLADFGLARLI  895 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~  895 (1020)
                      |+. +++...+...   ...+++..+..++.|++.||+|||++   +||||||||+||+++   .+..+|++|||+|+..
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EcC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            995 5565555433   34689999999999999999999999   999999999999986   4557999999999987


Q ss_pred             cCCCCc-----ccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          896 LSPYDT-----HVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       896 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            543221     223456899999999999999999999999999999999999999976554433333222222211111


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhc
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVSWLDSI 1019 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1019 (1020)
                      ...     ....    ...++.+++.+||+.+|++||+++++.+.|+.+
T Consensus       237 ~~~-----~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 IEV-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHH-----HTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hhH-----hccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            111     1111    123588999999999999999999999988764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=367.99  Aligned_cols=264  Identities=24%  Similarity=0.309  Sum_probs=195.8

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEec--------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMH--------  809 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  809 (1020)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....  ....+++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999996 479999999986442  2234678899999999999999999999865        


Q ss_pred             cCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeec
Q 035998          810 KNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADF  889 (1020)
Q Consensus       810 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  889 (1020)
                      ....++||||++++++..+...    ...++...++.++.|++.||+|||+.   +|+||||||+||+++.++.+|++||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            3457899999998876655433    35688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCCCCc--ccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH
Q 035998          890 GLARLILSPYDT--HVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR  966 (1020)
Q Consensus       890 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  966 (1020)
                      |+++........  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+   ...........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~  238 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLC  238 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhc
Confidence            999876432211  222345799999999988655 689999999999999999999999974322   12222222221


Q ss_pred             hhccc---ccccCccc--------cCccCH-H------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 QENRE---SEVLDPFI--------YDKQHD-K------EMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 ~~~~~---~~~~d~~~--------~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .....   ........        ...... .      ....+.+++.+||++||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11100   00000000        000011 1      1224678999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-41  Score=372.74  Aligned_cols=262  Identities=24%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             CCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCccceEeeEEecc------CceEE
Q 035998          743 NFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------NDRLL  815 (1020)
Q Consensus       743 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  815 (1020)
                      +|+..++||+|+||+||+|+.. +|+.||||++..+..    ...+|++++++++||||++++++|...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999975 689999999976532    234799999999999999999998543      24689


Q ss_pred             EEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeecccccc
Q 035998          816 IYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARL  894 (1020)
Q Consensus       816 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~  894 (1020)
                      ||||++++.+.. +.........+++.+++.++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998764443 333333446799999999999999999999999   999999999999999775 899999999987


Q ss_pred             ccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH-------
Q 035998          895 ILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR-------  966 (1020)
Q Consensus       895 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-------  966 (1020)
                      ....   .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......   +.........       
T Consensus       173 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~  246 (350)
T d1q5ka_         173 LVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQ  246 (350)
T ss_dssp             CCTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHHH
T ss_pred             ccCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHHh
Confidence            6432   22344679999999997664 57899999999999999999999999754321   1111111100       


Q ss_pred             --h--h----cccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          967 --Q--E----NRESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       967 --~--~----~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                        .  .    ................+.....+.+|+.+||+.||++|||++|+++  +|++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence              0  0    0000000000000011122335789999999999999999999986  4544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=367.60  Aligned_cols=263  Identities=24%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc-hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC----ceE
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC-GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN----DRL  814 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  814 (1020)
                      +.+|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999986 479999999997543 334567889999999999999999999997543    335


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ++++|+.+|+|.+++...     .+++..++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||+++.
T Consensus        87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            566777899999999753     589999999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC-cccccccccccCccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcccc
Q 035998          895 ILSPYD-THVTTDLVGTLGYIPPEYG-QASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRES  972 (1020)
Q Consensus       895 ~~~~~~-~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  972 (1020)
                      ...... .......+||+.|+|||++ .+..++.++||||+||++|||++|+.||......   +...............
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCChh
Confidence            543211 1223456789999999987 4556789999999999999999999999754321   1111111110000000


Q ss_pred             c---------------c--cCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          973 E---------------V--LDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       973 ~---------------~--~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                      .               .  ..+.......+....++.+++.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0               0  0000000000111235789999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=369.01  Aligned_cols=260  Identities=23%  Similarity=0.313  Sum_probs=194.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccC------
Q 035998          741 TNNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKN------  811 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  811 (1020)
                      .++|++++.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999864 69999999997543  233467889999999999999999999998654      


Q ss_pred             ceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccc
Q 035998          812 DRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGL  891 (1020)
Q Consensus       812 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  891 (1020)
                      ..++||||+ +.+|..+.+.     ..+++..++.++.||+.||+|||++   +||||||||+|||++.++.+|++|||.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            469999999 5677777654     3689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhc-
Q 035998          892 ARLILSPYDTHVTTDLVGTLGYIPPEYGQA-SVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQEN-  969 (1020)
Q Consensus       892 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  969 (1020)
                      |+.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......   +............ 
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPP  239 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCCCc
Confidence            9876332     345679999999998765 56789999999999999999999999754221   1111111110000 


Q ss_pred             -----------------ccccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHh
Q 035998          970 -----------------RESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDS 1018 (1020)
Q Consensus       970 -----------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~ 1018 (1020)
                                       ...... ..............+.+|+.+||+.||.+|||++|+++  +|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHHhhhcchhhhhhhccCCccc-ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence                             000000 00000111112235789999999999999999999997  4543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=355.75  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=207.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEeccCceEEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHKNDRLLIYS  818 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  818 (1020)
                      ++|++++.||+|+||+||+|+. .+++.||||+++...  ......+.+|++++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999986 478999999986543  2345778999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeeccccccccCC
Q 035998          819 FMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLARLILSP  898 (1020)
Q Consensus       819 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  898 (1020)
                      ++.++++..+....    ..+++..++.++.|++.||+|||++   +||||||||+||+++.++.+|++|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999988877643    5678999999999999999999999   9999999999999999999999999999876443


Q ss_pred             CCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhccccccc--
Q 035998          899 YDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENRESEVL--  975 (1020)
Q Consensus       899 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  975 (1020)
                      .  .......+++.|+|||.+... .++.++||||+||++|||++|+.||....  ...+..................  
T Consensus       155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhh
Confidence            2  223345677889999987665 46899999999999999999999974322  2222222222221111100000  


Q ss_pred             ----C----cc-----ccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhc
Q 035998          976 ----D----PF-----IYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019 (1020)
Q Consensus       976 ----d----~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1019 (1020)
                          +    +.     ............+.+++.+|++.||.+|||++|+++  +|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                0    00     000111222346789999999999999999999987  56543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-40  Score=361.25  Aligned_cols=252  Identities=27%  Similarity=0.362  Sum_probs=201.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC----CCCEEEEEEecCCc----hhhHHHHHHHHHHHHHcCC-CccceEeeEEeccCc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP----DGRNVAIKRLSGDC----GQMEREFRAEVEALSRAQH-PNLVHLQGYCMHKND  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  812 (1020)
                      ++|++.+.||+|+||+||+|+..    +|+.||||++....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999752    57899999986432    1234567889999999976 899999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .++||||+.+|+|.+++...    ..+++..+..++.|++.|++|+|+.   +||||||||+||+++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999998876    4567889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQAS--VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR  970 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  970 (1020)
                      +..... .........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||...........+...... ....
T Consensus       177 ~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-~~~~  254 (322)
T d1vzoa_         177 KEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPP  254 (322)
T ss_dssp             EECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCC
T ss_pred             hhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc-CCCC
Confidence            876432 22334456789999999987654  5788999999999999999999999866544433332211111 1000


Q ss_pred             cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 035998          971 ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRP-----TTQQLVS 1014 (1020)
Q Consensus       971 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1014 (1020)
                                  .+.....++.+++.+||++||++||     |++|+++
T Consensus       255 ------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         255 ------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                        0111224688999999999999999     5889886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-39  Score=357.17  Aligned_cols=260  Identities=18%  Similarity=0.301  Sum_probs=197.7

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEec--cCceEEEE
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMH--KNDRLLIY  817 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  817 (1020)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++...   .+.+.+|++++++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999987 468999999997543   456889999999995 9999999999974  45689999


Q ss_pred             EeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCC-CeEEeecccccccc
Q 035998          818 SFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNF-GAHLADFGLARLIL  896 (1020)
Q Consensus       818 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  896 (1020)
                      ||+++++|..+.       ..+++..+..++.||+.||+|||++   +||||||||+|||++.++ .+|++|||+|+...
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence            999999987653       2589999999999999999999999   999999999999998755 59999999998764


Q ss_pred             CCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH---------
Q 035998          897 SPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR---------  966 (1020)
Q Consensus       897 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~---------  966 (1020)
                      ..   .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......  +.........         
T Consensus       182 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         182 PG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             TT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHH
T ss_pred             CC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhh
Confidence            32   223456789999999987664 57999999999999999999999996543211  1111111100         


Q ss_pred             hhccc------ccccC--------ccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhc
Q 035998          967 QENRE------SEVLD--------PFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLDSI 1019 (1020)
Q Consensus       967 ~~~~~------~~~~d--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 1019 (1020)
                      .....      .....        .............++.+|+.+|++.||++|||++|+++  +|+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            00000      00000        00000011112245789999999999999999999997  55543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-39  Score=360.26  Aligned_cols=257  Identities=23%  Similarity=0.277  Sum_probs=189.0

Q ss_pred             cCCCcCCeeeccCCeEEEEEEeC-CCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc------Cc
Q 035998          742 NNFDQANIIGCGGFGLVYRATLP-DGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK------ND  812 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  812 (1020)
                      ++|++.++||+|+||+||+|++. +|+.||||++....  ......+.+|+.++++++|||||+++++|...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999875 69999999997553  23345688999999999999999999999643      57


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .|+||||+.++.+..+ .      ..+++..++.++.||+.||+|||+.   ||+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHHHhh-h------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            7999999987655443 2      2478999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHH------
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMR------  966 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~------  966 (1020)
                      +....   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....   ..........      
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred             hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCHH
Confidence            86533   23334567899999999999999999999999999999999999999643211   1111110000      


Q ss_pred             -------------hhc-cccc-----ccCccccC---ccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 035998          967 -------------QEN-RESE-----VLDPFIYD---KQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS 1014 (1020)
Q Consensus       967 -------------~~~-~~~~-----~~d~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1014 (1020)
                                   ... ....     ........   .........+.+|+.+|++.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                         000 0000     00000000   112234557899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=357.35  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=195.3

Q ss_pred             ccCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCc--hhhHHHHHHHHHHHHHcCCCccceEeeEEecc-----Cc
Q 035998          741 TNNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDC--GQMEREFRAEVEALSRAQHPNLVHLQGYCMHK-----ND  812 (1020)
Q Consensus       741 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  812 (1020)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|++++++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999986 479999999997553  23345688999999999999999999998643     34


Q ss_pred             eEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEEeecccc
Q 035998          813 RLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHLADFGLA  892 (1020)
Q Consensus       813 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~  892 (1020)
                      .+++++|+.+|+|.+++..     ..+++.+++.++.||+.||+|||++   +|+||||||+||+++.++.+|++|||.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            5677888899999998864     3589999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCcccccccccccCccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCcccHHHHHHHHHhhcc-
Q 035998          893 RLILSPYDTHVTTDLVGTLGYIPPEYGQAS-VATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRDLISWVIRMRQENR-  970 (1020)
Q Consensus       893 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  970 (1020)
                      ....     .......|++.|+|||...+. .++.++||||+||++|+|++|+.||......   .............. 
T Consensus       169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGA  240 (348)
T ss_dssp             -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCH
T ss_pred             cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCh
Confidence            7542     233456789999999976554 5689999999999999999999999743221   11111111100000 


Q ss_pred             -----------------cccccCccccCccCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHH
Q 035998          971 -----------------ESEVLDPFIYDKQHDKEMLRVLDIACLCLSESPKVRPTTQQLVS--WLD 1017 (1020)
Q Consensus       971 -----------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~ 1017 (1020)
                                       ......... ..........+.+++.+|++.||++|||++|+++  +|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                             000000000 0000111235789999999999999999999997  554

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.6e-34  Score=321.96  Aligned_cols=263  Identities=22%  Similarity=0.254  Sum_probs=189.8

Q ss_pred             cCCCcCCeeeccCCeEEEEEEe-CCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-----------CCccceEeeEEec
Q 035998          742 NNFDQANIIGCGGFGLVYRATL-PDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-----------HPNLVHLQGYCMH  809 (1020)
Q Consensus       742 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  809 (1020)
                      .+|+++++||+|+||+||+|+. .+|+.||||+++.+.. ..+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999986 4789999999987643 2456788999888775           5789999998865


Q ss_pred             c--CceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCC---
Q 035998          810 K--NDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFG---  883 (1020)
Q Consensus       810 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---  883 (1020)
                      .  ...+++++++..+......... .....+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence            3  4556777776555433222222 234567899999999999999999998 6   8999999999999986553   


Q ss_pred             ---eEEeeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCCccc---
Q 035998          884 ---AHLADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGKRPMDMCKPKGSRD---  957 (1020)
Q Consensus       884 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~pf~~~~~~~~~~---  957 (1020)
                         ++++|||.+.....     .....+||+.|+|||++.+..++.++||||+||++++|++|+.||..........   
T Consensus       168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               99999999986532     2234679999999999999999999999999999999999999997543322111   


Q ss_pred             HHHHHHHHHhh---------cccccccC---------cc----------ccCccCHHHHHHHHHHHhhccCCCCCCCCCH
Q 035998          958 LISWVIRMRQE---------NRESEVLD---------PF----------IYDKQHDKEMLRVLDIACLCLSESPKVRPTT 1009 (1020)
Q Consensus       958 ~~~~~~~~~~~---------~~~~~~~d---------~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1009 (1020)
                      ...........         .......+         ..          ............+.+++.+|+++||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            11111111000         00000000         00          0112235566789999999999999999999


Q ss_pred             HHHHH
Q 035998         1010 QQLVS 1014 (1020)
Q Consensus      1010 ~evl~ 1014 (1020)
                      +|+++
T Consensus       323 ~e~L~  327 (362)
T d1q8ya_         323 GGLVN  327 (362)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99987

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-33  Score=310.49  Aligned_cols=258  Identities=31%  Similarity=0.520  Sum_probs=202.3

Q ss_pred             cccccccccccccc--ccccCCCCCCCcCEEEcCC-CccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCee
Q 035998          302 TLNLLNLRNNSLDG--SLLLNCPALTNLTSLDLGT-NKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYL  378 (1020)
Q Consensus       302 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  378 (1020)
                      +++.|+|++|.+++  .+|..+.++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            34455555555544  2344555555555555554 55555555555555555555555555555555555555555555


Q ss_pred             eCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccc
Q 035998          379 SLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWN  458 (1020)
Q Consensus       379 ~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N  458 (1020)
                      ++++|.                                                   +.+.+|..+..++.|+.+++++|
T Consensus       131 ~l~~N~---------------------------------------------------~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_         131 DFSYNA---------------------------------------------------LSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             ECCSSE---------------------------------------------------EESCCCGGGGGCTTCCEEECCSS
T ss_pred             cccccc---------------------------------------------------ccccCchhhccCcccceeecccc
Confidence            555443                                                   55677888999999999999999


Q ss_pred             cccccccccccCcCcC-cEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCee
Q 035998          459 QLSGTIPVWFGGFQDL-FYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTI  537 (1020)
Q Consensus       459 ~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l  537 (1020)
                      ++++.+|..+..+..+ +.+++++|++++..|..++++..+                                     .+
T Consensus       160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-------------------------------------~l  202 (313)
T d1ogqa_         160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-------------------------------------FV  202 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-------------------------------------EE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-------------------------------------cc
Confidence            9999999999888876 889999999999888777655422                                     57


Q ss_pred             ecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          538 DLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       538 ~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      ++++|.+.|.+|..++.+++|+.|++++|++++.+| .++.+++|+.|||++|+|+|.+|.+|+++++|++|+|++|+|+
T Consensus       203 ~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~  281 (313)
T d1ogqa_         203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC  281 (313)
T ss_dssp             ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence            888999999999999999999999999999997654 7999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCcCCccccCCC-CCCCCCCCCc
Q 035998          618 GRIPSGGQFQTFPNSSFDGNN-LCGEHRYSCT  648 (1020)
Q Consensus       618 g~~p~~~~~~~~~~~~~~~n~-l~~~~~~~c~  648 (1020)
                      |.||+.+.+.++..+++.||+ +||.|.++|.
T Consensus       282 g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         282 GEIPQGGNLQRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             EECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred             ccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence            999999899999999999998 9999888884

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2.1e-28  Score=277.05  Aligned_cols=322  Identities=24%  Similarity=0.314  Sum_probs=183.6

Q ss_pred             cccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccc
Q 035998          201 LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQ  280 (1020)
Q Consensus       201 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  280 (1020)
                      +..+++|++|+|++|+|++..  .+.++++|++|++++|++++..  .++++++|+.|++++|.+++..+  ......+.
T Consensus        62 l~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~  135 (384)
T d2omza2          62 VEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLN  135 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             cccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccc
Confidence            444555555555555555322  1555555555555555555321  24555555555555555553322  22233444


Q ss_pred             eeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCc
Q 035998          281 YLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNN  360 (1020)
Q Consensus       281 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  360 (1020)
                      .+....|.+....+.................     ....+...+.........|...  .+..+..+++++.+++++|.
T Consensus       136 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~  208 (384)
T d2omza2         136 RLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQ  208 (384)
T ss_dssp             EEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSC
T ss_pred             ccccccccccccccccccccccccccccccc-----hhhhhccccccccccccccccc--cccccccccccceeeccCCc
Confidence            4444444444332222211111111111111     1112233344444455554443  23344556666666666666


Q ss_pred             ccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEeccccccccc
Q 035998          361 FSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSI  440 (1020)
Q Consensus       361 l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  440 (1020)
                      +++..|  +...++|++|++++|+++.++.    +.                         .+++|+.+++.+|.+.+..
T Consensus       209 i~~~~~--~~~~~~L~~L~l~~n~l~~~~~----l~-------------------------~l~~L~~L~l~~n~l~~~~  257 (384)
T d2omza2         209 ISDITP--LGILTNLDELSLNGNQLKDIGT----LA-------------------------SLTNLTDLDLANNQISNLA  257 (384)
T ss_dssp             CCCCGG--GGGCTTCCEEECCSSCCCCCGG----GG-------------------------GCTTCSEEECCSSCCCCCG
T ss_pred             cCCCCc--ccccCCCCEEECCCCCCCCcch----hh-------------------------cccccchhccccCccCCCC
Confidence            665433  3445566666666666555432    11                         2234444455555555433


Q ss_pred             chhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccccccCcCCCCCCCcccceeecc
Q 035998          441 PQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNV  520 (1020)
Q Consensus       441 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~  520 (1020)
                      +  +..+++|+.|++++|++++..+  +..+..++.+++++|.+++.  ..+..++++                      
T Consensus       258 ~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l----------------------  309 (384)
T d2omza2         258 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNL----------------------  309 (384)
T ss_dssp             G--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTC----------------------
T ss_pred             c--ccccccCCEeeccCcccCCCCc--cccccccccccccccccccc--cccchhccc----------------------
Confidence            2  6667778888888888874433  66777788888888877642  123333332                      


Q ss_pred             cccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCcceeccCccccCCCcccEEEccCCcccccCCccc
Q 035998          521 SARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISL  600 (1020)
Q Consensus       521 ~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l  600 (1020)
                                    ..+++++|++++..  .+..+++|++|+|++|+|++ +| .|+++++|++|||++|+|++.+|  +
T Consensus       310 --------------~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l  369 (384)
T d2omza2         310 --------------TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--L  369 (384)
T ss_dssp             --------------SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred             --------------CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--h
Confidence                          35777888887643  37889999999999999984 44 69999999999999999997654  8


Q ss_pred             cccccccccccccc
Q 035998          601 EKLSFLSKFSVANN  614 (1020)
Q Consensus       601 ~~l~~L~~l~ls~N  614 (1020)
                      .++++|+.|+|++|
T Consensus       370 ~~l~~L~~L~L~~N  383 (384)
T d2omza2         370 ANLTRITQLGLNDQ  383 (384)
T ss_dssp             TTCTTCSEEECCCE
T ss_pred             ccCCCCCEeeCCCC
Confidence            99999999999988

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=4.2e-28  Score=274.51  Aligned_cols=356  Identities=24%  Similarity=0.292  Sum_probs=188.8

Q ss_pred             ecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCC
Q 035998           91 FLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNG  170 (1020)
Q Consensus        91 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~  170 (1020)
                      .+....+++.++  ...+.+|++|++++|+|+. + +.+..|++|++|+|++|+|++..| ..++++|++|++++|++.+
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~  102 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD  102 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCccccccccccccccc
Confidence            344555555443  2456677778887777773 3 356777778888888777776543 3367777777777777763


Q ss_pred             CCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccc
Q 035998          171 SVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIA  250 (1020)
Q Consensus       171 ~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  250 (1020)
                       ++.  +..+++|+.|++++|.+++..+  ......+..+....|.+....+...............     ......+.
T Consensus       103 -i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  172 (384)
T d2omza2         103 -ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQ-----VTDLKPLA  172 (384)
T ss_dssp             -CGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEES-----CCCCGGGT
T ss_pred             -ccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc-----cchhhhhc
Confidence             322  2456666666666666654322  2233445555555555543222211111111111100     01112223


Q ss_pred             cCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEE
Q 035998          251 DLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSL  330 (1020)
Q Consensus       251 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  330 (1020)
                      ..+.........|...                          ....+..+++++.+++++|.+++..+  +...++|++|
T Consensus       173 ~~~~~~~~~~~~~~~~--------------------------~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L  224 (384)
T d2omza2         173 NLTTLERLDISSNKVS--------------------------DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL  224 (384)
T ss_dssp             TCTTCCEEECCSSCCC--------------------------CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             cccccccccccccccc--------------------------cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence            3333333333333332                          12233344444555555555544333  2234555556


Q ss_pred             EcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccc
Q 035998          331 DLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNF  410 (1020)
Q Consensus       331 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~  410 (1020)
                      ++++|+++. + ..+..+++|+.|++++|++++..+  +..+++|++|++++|+++.++.    +               
T Consensus       225 ~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~----~---------------  281 (384)
T d2omza2         225 SLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP----L---------------  281 (384)
T ss_dssp             ECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG----G---------------
T ss_pred             ECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc----c---------------
Confidence            666665552 2 235555666666666666654332  5555666666666665544332    0               


Q ss_pred             cCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCC
Q 035998          411 RNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPK  490 (1020)
Q Consensus       411 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  490 (1020)
                                ..+..++.+.+..|.+.+  +..+..+++++.|++++|++++..|  +..+++|++|+|++|++++    
T Consensus       282 ----------~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~----  343 (384)
T d2omza2         282 ----------AGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD----  343 (384)
T ss_dssp             ----------TTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC----
T ss_pred             ----------cccccccccccccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC----
Confidence                      011122233333333332  1234555666666666666664332  5666666666666666552    


Q ss_pred             CCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEEecCCccee
Q 035998          491 NLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFDLKHNNLSG  570 (1020)
Q Consensus       491 ~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~Ls~N~l~~  570 (1020)
                                                                                ++.|+++++|++|+|++|+|++
T Consensus       344 ----------------------------------------------------------l~~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         344 ----------------------------------------------------------VSSLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             ----------------------------------------------------------CGGGGGCTTCCEEECCSSCCCB
T ss_pred             ----------------------------------------------------------ChhHcCCCCCCEEECCCCcCCC
Confidence                                                                      1245677788999999999986


Q ss_pred             ccCccccCCCcccEEEccCC
Q 035998          571 PIPSELTGMTSLETLDLSYN  590 (1020)
Q Consensus       571 ~~p~~~~~l~~L~~L~Ls~N  590 (1020)
                      ..|  +.++++|++|+|++|
T Consensus       366 l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         366 LTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CGG--GTTCTTCSEEECCCE
T ss_pred             Chh--hccCCCCCEeeCCCC
Confidence            543  888999999999887

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.6e-27  Score=257.67  Aligned_cols=288  Identities=18%  Similarity=0.222  Sum_probs=181.9

Q ss_pred             CCCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCCC
Q 035998           56 NASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNL  135 (1020)
Q Consensus        56 ~~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  135 (1020)
                      .++..+-|.|.+|.|++.+.+.+|.+++ ..++.|+|++|+|+...+.+|.++++|++|++++|.++...|..|.++++|
T Consensus         3 ~~p~~c~c~~~~~~C~~~~L~~lP~~l~-~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L   81 (305)
T d1xkua_           3 VCPFRCQCHLRVVQCSDLGLEKVPKDLP-PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL   81 (305)
T ss_dssp             CCCTTCEEETTEEECTTSCCCSCCCSCC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             CCCCCCEecCCEEEecCCCCCccCCCCC-CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence            3677778999999999877666665543 244455555554443333344445555555555555444344444445555


Q ss_pred             CeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      ++|++++|+++                        .+|...   ...++.|+++.|.+.+..+..+.....+..++...|
T Consensus        82 ~~L~l~~n~l~------------------------~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n  134 (305)
T d1xkua_          82 ERLYLSKNQLK------------------------ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN  134 (305)
T ss_dssp             CEEECCSSCCS------------------------BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred             CEecccCCccC------------------------cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccc
Confidence            55555554444                        344332   233445555555555444444444455555555555


Q ss_pred             cc--ccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccC
Q 035998          216 DL--TGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRI  293 (1020)
Q Consensus       216 ~l--~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  293 (1020)
                      ..  ....+..+..+++|+.+++++|+++ .+|..+  .++|++|++++|.+++..+..|.+++.++.|++++|++++..
T Consensus       135 ~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~  211 (305)
T d1xkua_         135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD  211 (305)
T ss_dssp             CCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred             cccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence            33  2334555667777778888888777 344433  467888888888888888888888888888888888888888


Q ss_pred             CCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCC------CCCCCCCeEecCCCccc--ccC
Q 035998          294 PHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNL------PRCRKLKNINLARNNFS--GQI  365 (1020)
Q Consensus       294 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l------~~l~~L~~L~L~~N~l~--~~~  365 (1020)
                      +..+.++++|++|+|++|+|+. +|..+..+++|++|+|++|+|+......|      ..+.+|+.|+|++|+++  ...
T Consensus       212 ~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~  290 (305)
T d1xkua_         212 NGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ  290 (305)
T ss_dssp             TTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred             cccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCC
Confidence            8888888888888888888874 46678888888888888888885433333      34566777777777664  234


Q ss_pred             cccccCCCCC
Q 035998          366 PETYKNFESL  375 (1020)
Q Consensus       366 p~~~~~l~~L  375 (1020)
                      |.+|.-+...
T Consensus       291 ~~~f~~~~~~  300 (305)
T d1xkua_         291 PSTFRCVYVR  300 (305)
T ss_dssp             GGGGTTCCCG
T ss_pred             HhHhcccccC
Confidence            4444444333

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=4.5e-25  Score=240.81  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=215.3

Q ss_pred             CcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEcc
Q 035998          111 LRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS  189 (1020)
Q Consensus       111 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~  189 (1020)
                      ++.+|=++++++ .+|..+.  +++++|+|++|+|+..++..+ ++++|++|++++|.+. .++...+..+++|+.|+++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEeccc
Confidence            445555555666 5666553  467777777777776666555 6777777777777776 4555556788899999999


Q ss_pred             CCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccC--CCCCcccccCCCccEEEccCCcCcc
Q 035998          190 VNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLS--GKLSPSIADLSNLVRLDVSSNNFSG  267 (1020)
Q Consensus       190 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~  267 (1020)
                      +|+++. +|..+  ...++.|++.+|.+.+..+..+.....+..++...|...  ...+..+..+++|+++++++|.++.
T Consensus        88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          88 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             SSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence            999984 55543  357899999999999877777778888888998888544  3456678899999999999999984


Q ss_pred             cCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCC
Q 035998          268 NIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPR  347 (1020)
Q Consensus       268 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  347 (1020)
                       +|..+  .++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+..+++|++|+|++|+|+ .+|.+|..
T Consensus       165 -l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~  240 (305)
T d1xkua_         165 -IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD  240 (305)
T ss_dssp             -CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred             -cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence             44433  578999999999999999999999999999999999999998999999999999999999998 67889999


Q ss_pred             CCCCCeEecCCCcccccCcccc------cCCCCCCeeeCCCCCCcchhh
Q 035998          348 CRKLKNINLARNNFSGQIPETY------KNFESLSYLSLSNSSIYNLSS  390 (1020)
Q Consensus       348 l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~L~l~~N~i~~l~~  390 (1020)
                      +++|++|+|++|+|+......|      ..+.+|+.|+|++|+++..+-
T Consensus       241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~  289 (305)
T d1xkua_         241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  289 (305)
T ss_dssp             CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence            9999999999999996544444      457889999999999875443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.7e-25  Score=241.37  Aligned_cols=261  Identities=21%  Similarity=0.229  Sum_probs=197.1

Q ss_pred             CCCCCCc---CceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCCccccCCCC
Q 035998           58 SSSDCCH---WVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPN  134 (1020)
Q Consensus        58 ~~~~~C~---w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~  134 (1020)
                      +..+.|.   |.-|.|++.+.+.+|..++ ..++.|+|++|+|+...+.+|.++++|++|++++|++.+..+..+..++.
T Consensus         3 p~~C~C~~~~~~~v~c~~~~L~~iP~~ip-~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~   81 (284)
T d1ozna_           3 PGACVCYNEPKVTTSCPQQGLQAVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL   81 (284)
T ss_dssp             CTTCEEECSSSCEEECCSSCCSSCCTTCC-TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCCCEEcCCCCeEEEcCCCCCCccCCCCC-CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccc
Confidence            3445563   6679999988888888776 46788899998888766677888889999999988888777777888888


Q ss_pred             CCeeecc-CCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccc
Q 035998          135 LEVLDLS-SNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCL  212 (1020)
Q Consensus       135 L~~L~L~-~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  212 (1020)
                      ++.++.. .|.++...+..+ ++++|++|++++|.+. .++...+....+|+.+++++|++++..+..|..+++|++|+|
T Consensus        82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l  160 (284)
T d1ozna_          82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL  160 (284)
T ss_dssp             CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccccccccccccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhccc
Confidence            8888765 567777777777 7888888888888886 556666677788888888888888777777888888888888


Q ss_pred             cccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeeccccccccc
Q 035998          213 GMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGR  292 (1020)
Q Consensus       213 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  292 (1020)
                      ++|++++..+..|.++++|+++++++|++++..|..|.++++|++|++++|.+++..+..|.++.+|++|++++|.+...
T Consensus       161 ~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             ccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            88888877777788888888888888888877788888888888888888888877778888888888888888887743


Q ss_pred             CCCCCcCCcccccccccccccccccccCC
Q 035998          293 IPHSLSNSPTLNLLNLRNNSLDGSLLLNC  321 (1020)
Q Consensus       293 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  321 (1020)
                      -+ ...-...++.+....+.+....|..+
T Consensus       241 C~-~~~l~~~l~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         241 CR-ARPLWAWLQKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             GG-GHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             cc-chHHHHHHHhCcCCCCceEeCCchHH
Confidence            21 00011234444445455544444433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=4.1e-25  Score=238.31  Aligned_cols=223  Identities=23%  Similarity=0.257  Sum_probs=183.1

Q ss_pred             eeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhccccccccc-cc
Q 035998          161 LDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQ-DN  239 (1020)
Q Consensus       161 L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N  239 (1020)
                      ++.++++++ .+|..+.   +.+++|+|++|+|+...+..|.++++|++|++++|++++..+..+..+..++.+... .|
T Consensus        16 v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~   91 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA   91 (284)
T ss_dssp             EECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred             EEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence            455555565 6666553   456777777777776666678888888888888888887777777777777777654 56


Q ss_pred             ccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccccccccccccccc
Q 035998          240 QLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLL  319 (1020)
Q Consensus       240 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  319 (1020)
                      .++...+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+.
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~  171 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence            77767778888888899999999888877777888888888899999988887788888888899999999999888888


Q ss_pred             CCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          320 NCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       320 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      .|..+++|+++++++|++++..|..|..+++|++|++++|++.+..+..|..+++|++|++++|++..
T Consensus       172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            88889999999999999998889999999999999999999998888889999999999999998753

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=3.5e-23  Score=220.49  Aligned_cols=201  Identities=25%  Similarity=0.258  Sum_probs=124.7

Q ss_pred             CCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccc
Q 035998          323 ALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLT  402 (1020)
Q Consensus       323 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~  402 (1020)
                      ....+.+++.++++|+ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.++.            
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~------------   72 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV------------   72 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC------------
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc------------
Confidence            4455666788888887 5676664  578888888888887666778888888888888887665432            


Q ss_pred             hhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCC
Q 035998          403 TLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNN  482 (1020)
Q Consensus       403 ~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  482 (1020)
                                                               ++.+++|++|+|++|+++ ..+..+.++++|++|++++|
T Consensus        73 -----------------------------------------~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~  110 (266)
T d1p9ag_          73 -----------------------------------------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN  110 (266)
T ss_dssp             -----------------------------------------CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSS
T ss_pred             -----------------------------------------cccccccccccccccccc-cccccccccccccccccccc
Confidence                                                     223445555555555555 33445555555555555555


Q ss_pred             cccccCCCCCCCCcccccccCcCCCCCCCcccceeecccccccccccccCCCCeeecccCccccCCCccccCCCcceEEE
Q 035998          483 TFTGEIPKNLTGLPSLITRNISLEEPSPDFPFFMRRNVSARGLQYNQIWSFPPTIDLSLNRLDGSIWPEFGNLKKLHVFD  562 (1020)
Q Consensus       483 ~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~~~~~~~~~~l~~n~~~~~~~~l~Ls~N~l~~~~~~~~~~L~~L~~L~  562 (1020)
                      .+.+..+..+..+.++                                    ..+++++|.+++..+..+..+++|+.|+
T Consensus       111 ~~~~~~~~~~~~l~~l------------------------------------~~L~l~~n~l~~l~~~~~~~l~~l~~l~  154 (266)
T d1p9ag_         111 RLTSLPLGALRGLGEL------------------------------------QELYLKGNELKTLPPGLLTPTPKLEKLS  154 (266)
T ss_dssp             CCCCCCSSTTTTCTTC------------------------------------CEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             ccceeecccccccccc------------------------------------ccccccccccceeccccccccccchhcc
Confidence            5554444444444333                                    2344555555554455555666666666


Q ss_pred             ecCCcceeccCccccCCCcccEEEccCCcccccCCcccccccccccccccccccc
Q 035998          563 LKHNNLSGPIPSELTGMTSLETLDLSYNNLSGAIPISLEKLSFLSKFSVANNHLT  617 (1020)
Q Consensus       563 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~L~~l~ls~N~l~  617 (1020)
                      +++|+|++..|..|+.+++|++|||++|+|+ .+|+++..+++|+.|+|++|++.
T Consensus       155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            6666666555555666666666666666666 56666666666666666666553

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=9.7e-23  Score=216.98  Aligned_cols=200  Identities=22%  Similarity=0.192  Sum_probs=146.8

Q ss_pred             CCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEE
Q 035998          180 SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLD  259 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  259 (1020)
                      .+.+..++.++++++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+
T Consensus         9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~   83 (266)
T d1p9ag_           9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLD   83 (266)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEE
T ss_pred             cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccc
Confidence            334444555555555 3454443  456666666666665555666666777777777777663 22 345677777777


Q ss_pred             ccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCC
Q 035998          260 VSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG  339 (1020)
Q Consensus       260 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  339 (1020)
                      |++|++++ .+..+.++++|+.|++++|++.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++
T Consensus        84 Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          84 LSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             CCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             cccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            77777773 45667777778888888887777777777788888888888888887777777888888888888888887


Q ss_pred             CCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCc
Q 035998          340 PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       340 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~  386 (1020)
                      ..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++.
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            77788888888888888888888 67877888888999999998865

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=1e-21  Score=197.55  Aligned_cols=169  Identities=14%  Similarity=0.107  Sum_probs=120.8

Q ss_pred             CcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCch------------------hhHHHHHHHHHHHHHcCCCccceEeeE
Q 035998          745 DQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCG------------------QMEREFRAEVEALSRAQHPNLVHLQGY  806 (1020)
Q Consensus       745 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  806 (1020)
                      .+.++||+|+||.||+|+..+|+.||||+++....                  .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988899999998753210                  012335678899999999999988765


Q ss_pred             EeccCceEEEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCCEEEcCCCCeEE
Q 035998          807 CMHKNDRLLIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSCEPHILHRDIKSSNILLDGNFGAHL  886 (1020)
Q Consensus       807 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  886 (1020)
                      .    ..+++|||+++..+..           ++...+..++.|++.|++|||++   +|+||||||+|||++++ .+++
T Consensus        83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            3    2479999998865432           23344568999999999999999   99999999999999965 4899


Q ss_pred             eeccccccccCCCCcccccccccccCccCccccCCCCCCchhhHHHHHHHH
Q 035998          887 ADFGLARLILSPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVL  937 (1020)
Q Consensus       887 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGvil  937 (1020)
                      +|||.|+....+.........+..    ..|. ..+.|+.++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHHH
Confidence            999999876433211100000000    0011 135677889999986443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=2.9e-19  Score=198.30  Aligned_cols=53  Identities=26%  Similarity=0.407  Sum_probs=34.4

Q ss_pred             CCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCC
Q 035998          134 NLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFS  194 (1020)
Q Consensus       134 ~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~  194 (1020)
                      +|++|||++|.++. +|+.  .++|++|+|++|+|+ .+|..    ..+|+.|++++|+++
T Consensus        39 ~l~~LdLs~~~L~~-lp~~--~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~   91 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL--PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK   91 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC--CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS
T ss_pred             CCCEEEeCCCCCCC-CCCC--CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc
Confidence            57778888888774 3432  456777777777776 56643    245666666666655

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=5.3e-19  Score=196.19  Aligned_cols=312  Identities=26%  Similarity=0.304  Sum_probs=168.4

Q ss_pred             CCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEcc
Q 035998          110 QLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLS  189 (1020)
Q Consensus       110 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~  189 (1020)
                      ++++|||++|.++ .+|+.   +++|++|+|++|+|+. +|..  ..+|+.|++++|+++ .++.    ..+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPEL--PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCC--CTTCCEEECCSSCCS-CCCS----CCTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccc--hhhhhhhhhhhcccc-hhhh----hcccccccccc
Confidence            4555555555555 45532   3455556666665552 2332  245555566666555 3332    12346666666


Q ss_pred             CCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccC
Q 035998          190 VNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNI  269 (1020)
Q Consensus       190 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  269 (1020)
                      +|.+. .+|. ++.+++|++|++++|.++.. +..   ...+..+.+..+...  .+..+..++.++.|++++|.+....
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~  178 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLP  178 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCC
T ss_pred             ccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceecccccccccccc
Confidence            66665 3332 45566666666666666532 221   233444555444443  2344556667777777777665322


Q ss_pred             cccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCC
Q 035998          270 PDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCR  349 (1020)
Q Consensus       270 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  349 (1020)
                       ...   ...+.+...++.+. .++ .+..++.|+.+++++|..... +   ....++..+.+.+|++.. .+..   ..
T Consensus       179 -~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~-~~~~---~~  244 (353)
T d1jl5a_         179 -DLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTD-LPEL---PQ  244 (353)
T ss_dssp             -CCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSC-CCCC---CT
T ss_pred             -ccc---cccccccccccccc-ccc-ccccccccccccccccccccc-c---cccccccccccccccccc-cccc---cc
Confidence             111   12334444444443 122 244556666666666655422 1   123455666666666552 2221   23


Q ss_pred             CCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEE
Q 035998          350 KLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVL  429 (1020)
Q Consensus       350 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L  429 (1020)
                      .+...++..|.+.+.. .   -.......++..|.+..++                               ..+++|++|
T Consensus       245 ~l~~~~~~~~~~~~l~-~---l~~~~~~~~~~~~~~~~~~-------------------------------~~~~~L~~L  289 (353)
T d1jl5a_         245 SLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRSLC-------------------------------DLPPSLEEL  289 (353)
T ss_dssp             TCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSEEC-------------------------------CCCTTCCEE
T ss_pred             cccccccccccccccc-c---ccchhcccccccCcccccc-------------------------------ccCCCCCEE
Confidence            4455555555444211 0   0123344445444443322                               124567788


Q ss_pred             EecccccccccchhhhcCCCCcEEecccccccccccccccCcCcCcEEeCCCCcccccCCCCCCCCcccc
Q 035998          430 VIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFTGEIPKNLTGLPSLI  499 (1020)
Q Consensus       430 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  499 (1020)
                      ++++|++. .+|.   .+++|+.|+|++|+|+ .+|..   +++|++|+|++|+++ .+|....++..|+
T Consensus       290 ~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~~L~~L~  350 (353)
T d1jl5a_         290 NVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLR  350 (353)
T ss_dssp             ECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCTTCCEEE
T ss_pred             ECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccccccCeeE
Confidence            88888777 4554   3578999999999998 67753   568999999999998 7787776666553

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=8.8e-20  Score=191.14  Aligned_cols=218  Identities=17%  Similarity=0.134  Sum_probs=121.7

Q ss_pred             CCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCCCCCCCCC-ccccCCCCCCeeec
Q 035998           62 CCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHNLLKGTVP-VSLVNLPNLEVLDL  140 (1020)
Q Consensus        62 ~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L  140 (1020)
                      -|+++.|.|...+.+.+|.... ..++.|+|++|.++...+.+|.++++|++|+|++|.+...+| ..|.+++++++|++
T Consensus         7 ~C~~~~i~c~~~~l~~iP~~l~-~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1           7 HCSNRVFLCQESKVTEIPSDLP-RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             EECSSEEEEESCSCSSCCSCSC-SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CCcCCEEEEeCCCCCCcCCCCC-CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            3889999999887777776654 357777777777765445567777777777777777765443 35667777777776


Q ss_pred             cC-CCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccc-cccccccccccc
Q 035998          141 SS-NDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCA-SLEHLCLGMNDL  217 (1020)
Q Consensus       141 ~~-n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l  217 (1020)
                      .. |.+....+..+ ++++|++|++++|++....+...+..+..+..+...++.+....+..|..++ .++.|++++|++
T Consensus        86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l  165 (242)
T d1xwdc1          86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  165 (242)
T ss_dssp             ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence            53 56666666665 6777777777777765332333334445555555555555544444444433 455555555555


Q ss_pred             ccccchhhhhhcccc-cccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccce
Q 035998          218 TGGIADDIFQLQKLR-LLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQY  281 (1020)
Q Consensus       218 ~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  281 (1020)
                      +...+ ..+...+++ .+.+++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.
T Consensus       166 ~~i~~-~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  229 (242)
T d1xwdc1         166 QEIHN-CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  229 (242)
T ss_dssp             CEECT-TTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred             ccccc-ccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccccc
Confidence            53222 222222222 2234444444333333444444444444444444333333333333333

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.4e-18  Score=179.85  Aligned_cols=209  Identities=20%  Similarity=0.288  Sum_probs=131.9

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      .+.++..++++.+++++.+  .+..+.+|+.|++.+|+|+. + ..+..+++|++|++++|++++..|  +..+++|+++
T Consensus        17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            4455566777777777543  45677888888888888874 3 357788888888888888875443  6777777777


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      ++++|.++..  ..+..+++|+.+++++|...+..+  +...+.++.+.++++.+....  .+..+++|+.|++++|.++
T Consensus        91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~  164 (227)
T d1h6ua2          91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVS  164 (227)
T ss_dssp             ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCC
T ss_pred             cccccccccc--ccccccccccccccccccccccch--hccccchhhhhchhhhhchhh--hhccccccccccccccccc
Confidence            7777777632  245566666666666666554322  344566666666666665322  2455566666666666665


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccch
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQ  442 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~  442 (1020)
                      +..  .+.++++|+.|++++|+++.++                                                     
T Consensus       165 ~~~--~l~~l~~L~~L~Ls~n~l~~l~-----------------------------------------------------  189 (227)
T d1h6ua2         165 DLT--PLANLSKLTTLKADDNKISDIS-----------------------------------------------------  189 (227)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCCCCG-----------------------------------------------------
T ss_pred             cch--hhcccccceecccCCCccCCCh-----------------------------------------------------
Confidence            322  2555666666666666544322                                                     


Q ss_pred             hhhcCCCCcEEecccccccccccccccCcCcCcEEeCC
Q 035998          443 WLRGCSKLQLVDLSWNQLSGTIPVWFGGFQDLFYLDLS  480 (1020)
Q Consensus       443 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  480 (1020)
                      .++++++|++|+|++|+|++..|  +.++++|++|+|+
T Consensus       190 ~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            24556667777777777764322  6667777777765

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=5.4e-19  Score=185.03  Aligned_cols=50  Identities=16%  Similarity=0.097  Sum_probs=26.0

Q ss_pred             cccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEec
Q 035998          307 NLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINL  356 (1020)
Q Consensus       307 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  356 (1020)
                      ++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus       183 ~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             CTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            34455555444444555556666666666665443444555555555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.1e-18  Score=175.30  Aligned_cols=181  Identities=18%  Similarity=0.217  Sum_probs=97.8

Q ss_pred             CCCCCCCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccc-cccccCCCCCcEEecCCCCCCCCCCccccCCCCC
Q 035998           57 ASSSDCCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKL-SESLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNL  135 (1020)
Q Consensus        57 ~~~~~~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  135 (1020)
                      +|..+-|.|..|.|++.+.+.||.+++ ..++.|+|++|.|++.+ +..|+++++|++|+|++|++++..+..|..+++|
T Consensus         2 CP~~C~C~~~~v~Cs~~~L~~iP~~lp-~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L   80 (192)
T d1w8aa_           2 CPAMCHCEGTTVDCTGRGLKEIPRDIP-LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI   80 (192)
T ss_dssp             CCTTSEEETTEEECTTSCCSSCCSCCC-TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             cCCCCEEcCCEEEEeCCCcCccCCCCC-CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc
Confidence            455566899999999887777776554 35555555555555433 2334555555555555555555555555555555


Q ss_pred             CeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccccccccccccccc
Q 035998          136 EVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMN  215 (1020)
Q Consensus       136 ~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  215 (1020)
                      ++|+|++|+|++.+|..|                        .++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        81 ~~L~Ls~N~l~~l~~~~F------------------------~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N  136 (192)
T d1w8aa_          81 QELQLGENKIKEISNKMF------------------------LGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN  136 (192)
T ss_dssp             CEEECCSCCCCEECSSSS------------------------TTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred             ceeeeccccccccCHHHH------------------------hCCCcccccccCCccccccCHHHhcCCccccccccccc
Confidence            555555555555444444                        44444444444444444444445555555555555555


Q ss_pred             ccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCc
Q 035998          216 DLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       216 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                      .+..... ...-...++.+.+..|.++...|..+   ..++.++|+.|.++
T Consensus       137 ~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         137 PFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             CBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCC
T ss_pred             ccccccc-hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCc
Confidence            5553221 11112334555555666554444433   34445566666654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.4e-21  Score=223.66  Aligned_cols=231  Identities=20%  Similarity=0.218  Sum_probs=105.3

Q ss_pred             cceeeeccCccCCCCCccccccCCcccEEEccCCCCCC----CCCCccccccccccccccccccccccchhhhh-----h
Q 035998          158 IQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSG----TLSPGLGNCASLEHLCLGMNDLTGGIADDIFQ-----L  228 (1020)
Q Consensus       158 L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l  228 (1020)
                      |++||+++|++++..-..++..++++++|+|++|.++.    .+...+..+++|++|+|++|.|+......+..     .
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence            44444444444422112223334444555555554441    22334455666777777776665322222221     2


Q ss_pred             cccccccccccccCCC----CCcccccCCCccEEEccCCcCcccCcccccC-----Ccccceeeccccccccc----CCC
Q 035998          229 QKLRLLGLQDNQLSGK----LSPSIADLSNLVRLDVSSNNFSGNIPDVFAG-----LGEFQYLVAHSNRFTGR----IPH  295 (1020)
Q Consensus       229 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~----~p~  295 (1020)
                      .+|++|+|++|+++..    ++..+..+++|++|+|++|.++......+..     .............+...    ...
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS  163 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccc
Confidence            3577777777776632    2345566677777777777776432222211     11111222222111100    001


Q ss_pred             CCcCCccccccccccccccccccc----CC-CCCCCcCEEEcCCCccCCC----CCCCCCCCCCCCeEecCCCcccc---
Q 035998          296 SLSNSPTLNLLNLRNNSLDGSLLL----NC-PALTNLTSLDLGTNKFNGP----LPTNLPRCRKLKNINLARNNFSG---  363 (1020)
Q Consensus       296 ~~~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~---  363 (1020)
                      .+.....++.++++++........    .+ ........+++..+.+...    ....+...+.++.+++++|++..   
T Consensus       164 ~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~  243 (460)
T d1z7xw1         164 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM  243 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccccc
Confidence            122334555566665554321100    00 1123445566666655421    11122345566677777766532   


Q ss_pred             --cCcccccCCCCCCeeeCCCCCCcch
Q 035998          364 --QIPETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       364 --~~p~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                        ..+..+.....++.+++++|.+...
T Consensus       244 ~~~~~~~~~~~~~l~~l~l~~n~i~~~  270 (460)
T d1z7xw1         244 AELCPGLLHPSSRLRTLWIWECGITAK  270 (460)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             chhhccccccccccccccccccccccc
Confidence              1223344456677777777766543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.7e-21  Score=223.22  Aligned_cols=61  Identities=26%  Similarity=0.262  Sum_probs=39.9

Q ss_pred             ceEEEecCCCcccccc-cccccCCCCCcEEecCCCCCCC----CCCccccCCCCCCeeeccCCCCC
Q 035998           86 RVTGLFLYKRRLKGKL-SESLGNLVQLRFLNLSHNLLKG----TVPVSLVNLPNLEVLDLSSNDLS  146 (1020)
Q Consensus        86 ~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~  146 (1020)
                      ++++||++.+++++.. .+-+..++++++|+|++|+++.    .++..+..+++|++|||++|.|+
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            5677777777776532 3345566777777777777762    34455667777777777777664

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=1.5e-18  Score=179.48  Aligned_cols=186  Identities=24%  Similarity=0.285  Sum_probs=101.0

Q ss_pred             CCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEE
Q 035998          180 SSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLD  259 (1020)
Q Consensus       180 ~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  259 (1020)
                      +.+|+.|++.+|.|+. + +.+.++++|++|++++|++++..|  +..+++|+++++++|.++. + ..+.++++|+.++
T Consensus        40 l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~  113 (227)
T d1h6ua2          40 LDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLD  113 (227)
T ss_dssp             HHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEE
T ss_pred             cCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-ccccccccccccc
Confidence            3444555555555442 2 235556666666666666654322  5555666666666666552 2 2455666666666


Q ss_pred             ccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCC
Q 035998          260 VSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNG  339 (1020)
Q Consensus       260 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  339 (1020)
                      +++|...+..  .+...+.+..+.++.+.+....  .+.+.++|+.|++++|.+++..+  +..+++|++|+|++|++++
T Consensus       114 l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~  187 (227)
T d1h6ua2         114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (227)
T ss_dssp             CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchh--hcccccceecccCCCccCC
Confidence            6666555322  2444555555666555554322  24455556666666665553322  4556666666666666653


Q ss_pred             CCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCC
Q 035998          340 PLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLS  381 (1020)
Q Consensus       340 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  381 (1020)
                       ++ .++++++|++|+|++|++++..  .+.++++|++|+++
T Consensus       188 -l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         188 -IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             -CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             -Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence             22 2556666666666666666432  25566666666654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=5.4e-18  Score=170.06  Aligned_cols=110  Identities=23%  Similarity=0.324  Sum_probs=58.6

Q ss_pred             CcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCccccccccccccccccccccccchhhhhhcccccccc
Q 035998          157 SIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGL  236 (1020)
Q Consensus       157 ~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  236 (1020)
                      ++++|+|++|+|++.++...|..+++|+.|+|++|++.+..+..|..+++|++|+|++|+|+...+..|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            34444444444443344444444455555555555555455555555555555555555555555555555555555555


Q ss_pred             cccccCCCCCcccccCCCccEEEccCCcCc
Q 035998          237 QDNQLSGKLSPSIADLSNLVRLDVSSNNFS  266 (1020)
Q Consensus       237 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (1020)
                      ++|+|++..+.+|..+++|++|+|++|.+.
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CCccccccCHHHhcCCcccccccccccccc
Confidence            555555555555555666666666666554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=1.3e-17  Score=168.29  Aligned_cols=183  Identities=22%  Similarity=0.336  Sum_probs=141.1

Q ss_pred             cccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCccccee
Q 035998          203 NCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYL  282 (1020)
Q Consensus       203 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  282 (1020)
                      ++.++..+.++.+.+++.+.  ...+.++++|++++|.++. + +.+..+++|++|++++|++++..|  ++++++|++|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            34556667777787776543  3567888888888888874 3 357788889999999998886543  8888889999


Q ss_pred             ecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCccc
Q 035998          283 VAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       283 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      ++++|.+....  .+++++.|+.|++++|.+....  .+..+++|+.|++++|++.. ++ .+..+++|++|++++|+++
T Consensus        90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~~--~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2          90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC
T ss_pred             ccccccccccc--cccccccccccccccccccccc--ccchhhhhHHhhhhhhhhcc-cc-ccccccccccccccccccc
Confidence            99988887543  4788889999999988887543  46778999999999999873 33 5788899999999999998


Q ss_pred             ccCcccccCCCCCCeeeCCCCCCcchhhHHHHHhhhcccch
Q 035998          363 GQIPETYKNFESLSYLSLSNSSIYNLSSALQVLQQCRNLTT  403 (1020)
Q Consensus       363 ~~~p~~~~~l~~L~~L~l~~N~i~~l~~~~~~l~~l~~L~~  403 (1020)
                      +..  .++++++|++|++++|+|++++.    +.++++|+.
T Consensus       164 ~l~--~l~~l~~L~~L~ls~N~i~~i~~----l~~L~~L~~  198 (199)
T d2omxa2         164 DLK--PLANLTTLERLDISSNKVSDISV----LAKLTNLES  198 (199)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCCCCGG----GGGCTTCSE
T ss_pred             CCc--cccCCCCCCEEECCCCCCCCCcc----ccCCCCCCc
Confidence            642  48889999999999999988763    455555554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=2.7e-17  Score=167.36  Aligned_cols=172  Identities=24%  Similarity=0.294  Sum_probs=117.0

Q ss_pred             ccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceee
Q 035998          204 CASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLV  283 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  283 (1020)
                      +.++...++..+.+++.++.  ..+.+|++|++++|+++.. + .+..+++|++|+|++|+|++..  .++.+++|++|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence            34455556777777765543  4567788888888888743 2 4677888888888888887543  256777888888


Q ss_pred             cccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccc
Q 035998          284 AHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSG  363 (1020)
Q Consensus       284 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  363 (1020)
                      +++|++++. | .+.++++|+.|++++|.+...  ..+..+++++.+++++|.+++  +..+..+++|+.+++++|++++
T Consensus        97 l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2          97 LDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred             ccccccccc-c-ccccccccccccccccccccc--ccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            888877753 2 466777777777777776532  245667777777777777763  2345667777777777777764


Q ss_pred             cCcccccCCCCCCeeeCCCCCCcchh
Q 035998          364 QIPETYKNFESLSYLSLSNSSIYNLS  389 (1020)
Q Consensus       364 ~~p~~~~~l~~L~~L~l~~N~i~~l~  389 (1020)
                      . + .+.++++|+.|++++|+|+.++
T Consensus       171 i-~-~l~~l~~L~~L~Ls~N~i~~l~  194 (210)
T d1h6ta2         171 I-V-PLAGLTKLQNLYLSKNHISDLR  194 (210)
T ss_dssp             C-G-GGTTCTTCCEEECCSSCCCBCG
T ss_pred             c-c-cccCCCCCCEEECCCCCCCCCh
Confidence            3 2 3677777777777777765543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=2.4e-17  Score=167.76  Aligned_cols=187  Identities=21%  Similarity=0.267  Sum_probs=110.8

Q ss_pred             hcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCccccccc
Q 035998          228 LQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLN  307 (1020)
Q Consensus       228 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  307 (1020)
                      +.+....+++.+.+++.++.  ..+.+|++|++++|.+++..  .+..+++|++|++++|+|++..  .++++++|++|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence            34455567777877765543  35678888888888887533  3566777777777777776533  245566666666


Q ss_pred             ccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcccccCcccccCCCCCCeeeCCCCCCcc
Q 035998          308 LRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNFSGQIPETYKNFESLSYLSLSNSSIYN  387 (1020)
Q Consensus       308 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~i~~  387 (1020)
                      +++|++++..  .+..+++|+.|++++|.+.. + ..+..+++|+.+++++|.+++  +..+..+++|+++++++|++  
T Consensus        97 l~~n~i~~l~--~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l--  168 (210)
T d1h6ta2          97 LDENKVKDLS--SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--  168 (210)
T ss_dssp             CCSSCCCCGG--GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC--
T ss_pred             cccccccccc--cccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccc--
Confidence            6666665422  24555556666665555542 2 234455555555555555542  22344445555555555443  


Q ss_pred             hhhHHHHHhhhcccchhhhhccccCCCCCCCccccccCceEEEecccccccccchhhhcCCCCcEEeccccccccccccc
Q 035998          388 LSSALQVLQQCRNLTTLVLTLNFRNEKLPTDPRLHFANLKVLVIASCGLRGSIPQWLRGCSKLQLVDLSWNQLSGTIPVW  467 (1020)
Q Consensus       388 l~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  467 (1020)
                                                                       .+. + .++++++|+.|+|++|+|+ .+| .
T Consensus       169 -------------------------------------------------~~i-~-~l~~l~~L~~L~Ls~N~i~-~l~-~  195 (210)
T d1h6ta2         169 -------------------------------------------------SDI-V-PLAGLTKLQNLYLSKNHIS-DLR-A  195 (210)
T ss_dssp             -------------------------------------------------CCC-G-GGTTCTTCCEEECCSSCCC-BCG-G
T ss_pred             -------------------------------------------------ccc-c-cccCCCCCCEEECCCCCCC-CCh-h
Confidence                                                             321 1 2566777777777777777 344 4


Q ss_pred             ccCcCcCcEEeCCC
Q 035998          468 FGGFQDLFYLDLSN  481 (1020)
Q Consensus       468 ~~~l~~L~~L~Ls~  481 (1020)
                      |.++++|++|+|++
T Consensus       196 l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         196 LAGLKNLDVLELFS  209 (210)
T ss_dssp             GTTCTTCSEEEEEE
T ss_pred             hcCCCCCCEEEccC
Confidence            77777777777754

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=3.9e-17  Score=164.72  Aligned_cols=125  Identities=22%  Similarity=0.247  Sum_probs=66.5

Q ss_pred             hhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccc
Q 035998          227 QLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLL  306 (1020)
Q Consensus       227 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  306 (1020)
                      .+.++..+.++.+.+++.++  ...+.++++|++++|.++..  +.+..+++|++|++++|++++..|  ++++++|+.|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            45555667788888876443  35678888888888888742  235556666666666666654322  4455555555


Q ss_pred             cccccccccccccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCCcc
Q 035998          307 NLRNNSLDGSLLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARNNF  361 (1020)
Q Consensus       307 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  361 (1020)
                      ++++|.+....  .+..+++|+.|++++|.+...  ..+..+++|+.|++++|++
T Consensus        90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l  140 (199)
T d2omxa2          90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTI  140 (199)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC
T ss_pred             ccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhh
Confidence            55555444222  133444444444444444321  1233344444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=2.8e-16  Score=167.74  Aligned_cols=223  Identities=16%  Similarity=0.161  Sum_probs=129.2

Q ss_pred             cEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCC
Q 035998          112 RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN  191 (1020)
Q Consensus       112 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N  191 (1020)
                      ++|||+++.+.......+.. ..+..+.++.+.+...........+|++|||++|.+++.....++..+++|++|+|++|
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            35666666654222222111 13445555555555444444456677777777777765444555666777777777777


Q ss_pred             CCCCCCCCcccccccccccccccc-cccccc-chhhhhhccccccccccc-ccCCC-CCccccc-CCCccEEEccCC--c
Q 035998          192 YFSGTLSPGLGNCASLEHLCLGMN-DLTGGI-ADDIFQLQKLRLLGLQDN-QLSGK-LSPSIAD-LSNLVRLDVSSN--N  264 (1020)
Q Consensus       192 ~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~Ls~N--~  264 (1020)
                      .++...+..++.+++|++|+|+++ .++... ..-+.++++|++|+++++ .++.. +...+.. .++|+.|+++++  .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~  161 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN  161 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred             CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence            776666666777777888888774 555322 222345677778877775 34321 1122333 357777777754  3


Q ss_pred             Cccc-CcccccCCcccceeecccc-cccccCCCCCcCCccccccccccc-ccccccccCCCCCCCcCEEEcCCC
Q 035998          265 FSGN-IPDVFAGLGEFQYLVAHSN-RFTGRIPHSLSNSPTLNLLNLRNN-SLDGSLLLNCPALTNLTSLDLGTN  335 (1020)
Q Consensus       265 l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N  335 (1020)
                      ++.. +...+.++++|++|++++| .+++.....+.++++|++|++++| .+++.....++.+++|++|+++++
T Consensus       162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            4322 2223345666777777664 455555556666666666666663 455544445556666666666665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=2.7e-14  Score=137.62  Aligned_cols=112  Identities=19%  Similarity=0.196  Sum_probs=78.1

Q ss_pred             cccCCCCCcEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcc
Q 035998          104 SLGNLVQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRI  183 (1020)
Q Consensus       104 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L  183 (1020)
                      .+.+...|++|+|++|+|+ .+|..+..+++|++|||++|+|+.. +....+++|++|+|++|+++ .+|..++..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCcccccccccc
Confidence            3567778888888888888 5676667788888888888888754 33336788888888888887 5666666666777


Q ss_pred             cEEEccCCCCCCCCC-Cccccccccccccccccccc
Q 035998          184 RVINLSVNYFSGTLS-PGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       184 ~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      +.|++++|+++.... ..+..+++|++|++++|.++
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccc
Confidence            777777777663211 34555566666666666555

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.4e-14  Score=138.08  Aligned_cols=111  Identities=20%  Similarity=0.125  Sum_probs=55.7

Q ss_pred             cccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCCcccccccccccccccccccCCCCCCCcC
Q 035998          249 IADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTLNLLNLRNNSLDGSLLLNCPALTNLT  328 (1020)
Q Consensus       249 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  328 (1020)
                      +.+..+|++|||++|+|+. ++..+..+++|+.|++++|+|+..  +.|..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            4455566666666666663 344455555555555555555533  2244455555555555555543333334445555


Q ss_pred             EEEcCCCccCCCCC-CCCCCCCCCCeEecCCCccc
Q 035998          329 SLDLGTNKFNGPLP-TNLPRCRKLKNINLARNNFS  362 (1020)
Q Consensus       329 ~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~  362 (1020)
                      +|++++|+|+.... ..+..+++|++|++++|+++
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cceeccccccccccccccccccccchhhcCCCccc
Confidence            55555555542111 23444455555555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.45  E-value=8.2e-14  Score=127.53  Aligned_cols=33  Identities=21%  Similarity=0.319  Sum_probs=18.7

Q ss_pred             cEEecccccccccccccccCcCcCcEEeCCCCccc
Q 035998          451 QLVDLSWNQLSGTIPVWFGGFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       451 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  485 (1020)
                      |.|+|++|+|+ .++ .+..+++|++|||++|+|+
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~   33 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR   33 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC
Confidence            35666666665 333 2555666666666666655

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=7.8e-15  Score=156.40  Aligned_cols=83  Identities=22%  Similarity=0.252  Sum_probs=41.7

Q ss_pred             cccccccccccccccc-cccCCCCCCCcCEEEcCCCccCCCCCCCCCCCCCCCeEecCCC-cccccC-cccccCCCCCCe
Q 035998          301 PTLNLLNLRNNSLDGS-LLLNCPALTNLTSLDLGTNKFNGPLPTNLPRCRKLKNINLARN-NFSGQI-PETYKNFESLSY  377 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~-p~~~~~l~~L~~  377 (1020)
                      .+|++||+++|.++.. +...+..+++|++|+|+++.+++..+..++.+++|++|+++++ .++... ......+++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            4555555555555432 2223445555666666666555544455555556666666553 343211 112234556666


Q ss_pred             eeCCCC
Q 035998          378 LSLSNS  383 (1020)
Q Consensus       378 L~l~~N  383 (1020)
                      |+++++
T Consensus       126 L~ls~c  131 (284)
T d2astb2         126 LNLSWC  131 (284)
T ss_dssp             EECCCC
T ss_pred             cccccc
Confidence            666653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=9.3e-16  Score=169.11  Aligned_cols=265  Identities=17%  Similarity=0.179  Sum_probs=140.9

Q ss_pred             cccccCCCCCcEEecCCCCCCCC----CCccccCCCCCCeeeccCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccc
Q 035998          102 SESLGNLVQLRFLNLSHNLLKGT----VPVSLVNLPNLEVLDLSSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSI  176 (1020)
Q Consensus       102 ~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~  176 (1020)
                      ...+.+.+.|+.|+|++|.+...    +...+...++|+.|+++++.+........ ...              .+. ..
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~--------------~l~-~~   88 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR--------------LLL-QA   88 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH--------------HHH-HH
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHH--------------HHH-HH
Confidence            34566677788888888777532    34456667777777777765542211100 000              000 00


Q ss_pred             cccCCcccEEEccCCCCCCC----CCCccccccccccccccccccccccchhhhhhcccccccccccccCCCCCcccccC
Q 035998          177 CKNSSRIRVINLSVNYFSGT----LSPGLGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLSPSIADL  252 (1020)
Q Consensus       177 ~~~~~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  252 (1020)
                      ....++|+.|+|++|.+...    +...+...++|++|++++|.++......+..  .+..+....         .....
T Consensus        89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~---------~~~~~  157 (344)
T d2ca6a1          89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNK---------KAKNA  157 (344)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHH---------HHHTC
T ss_pred             HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccc--ccccccccc---------ccccC
Confidence            11223344444444444332    2223445677888888888775322222211  011111000         11223


Q ss_pred             CCccEEEccCCcCccc----CcccccCCcccceeecccccccc-----cCCCCCcCCcccccccccccccccc----ccc
Q 035998          253 SNLVRLDVSSNNFSGN----IPDVFAGLGEFQYLVAHSNRFTG-----RIPHSLSNSPTLNLLNLRNNSLDGS----LLL  319 (1020)
Q Consensus       253 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~  319 (1020)
                      +.|+.|++++|.++..    +...+...+.|+.|++++|+++.     .+...+..+++|+.|+|++|.++..    +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            4555555555555422    12223344556666666665542     1234456667777777777776532    223


Q ss_pred             CCCCCCCcCEEEcCCCccCCCCCCC----CC--CCCCCCeEecCCCcccccC----ccccc-CCCCCCeeeCCCCCCcch
Q 035998          320 NCPALTNLTSLDLGTNKFNGPLPTN----LP--RCRKLKNINLARNNFSGQI----PETYK-NFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       320 ~~~~l~~L~~L~L~~N~l~~~~p~~----l~--~l~~L~~L~L~~N~l~~~~----p~~~~-~l~~L~~L~l~~N~i~~l  388 (1020)
                      .+...++|++|+|++|.|++.....    +.  ..+.|++|++++|+|+...    ...+. +.++|++|+|++|++..-
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence            4556778888888888876432222    21  2367888999998886532    23332 567899999999998765


Q ss_pred             hhHH
Q 035998          389 SSAL  392 (1020)
Q Consensus       389 ~~~~  392 (1020)
                      ...+
T Consensus       318 ~~~~  321 (344)
T d2ca6a1         318 DDVV  321 (344)
T ss_dssp             SHHH
T ss_pred             chHH
Confidence            5443

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.43  E-value=3.8e-15  Score=164.10  Aligned_cols=38  Identities=26%  Similarity=0.503  Sum_probs=27.9

Q ss_pred             CCCcEEeccccccccc----cccccc-CcCcCcEEeCCCCccc
Q 035998          448 SKLQLVDLSWNQLSGT----IPVWFG-GFQDLFYLDLSNNTFT  485 (1020)
Q Consensus       448 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~  485 (1020)
                      ..|++|++++|+|+..    +...+. ++++|++|+|++|++.
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            5688899999988743    233332 5678999999999886

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.40  E-value=3.6e-13  Score=123.16  Aligned_cols=102  Identities=31%  Similarity=0.364  Sum_probs=52.8

Q ss_pred             cEEecCCCCCCCCCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCC
Q 035998          112 RFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVN  191 (1020)
Q Consensus       112 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N  191 (1020)
                      |.|+|++|+++ .++ .++++++|++|++++|+|+..++....+++|++|++++|+|+ .+|.  +..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCC
Confidence            45666666666 344 366666666666666666643332225666666666666665 3332  234444555555555


Q ss_pred             CCCCCCC-Cccccccccccccccccccc
Q 035998          192 YFSGTLS-PGLGNCASLEHLCLGMNDLT  218 (1020)
Q Consensus       192 ~l~~~~~-~~l~~l~~L~~L~L~~N~l~  218 (1020)
                      +++.... ..++.+++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            4443211 23444455555555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.27  E-value=5.7e-14  Score=140.41  Aligned_cols=113  Identities=21%  Similarity=0.239  Sum_probs=65.0

Q ss_pred             cchhhhhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccCcccccCCcccceeecccccccccCCCCCcCC
Q 035998          221 IADDIFQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGEFQYLVAHSNRFTGRIPHSLSNS  300 (1020)
Q Consensus       221 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  300 (1020)
                      ++..+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+++..  +.+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            44556666677777777777663 33 4666677777777777766 3344444455566666666666543  224555


Q ss_pred             cccccccccccccccccc-cCCCCCCCcCEEEcCCCccC
Q 035998          301 PTLNLLNLRNNSLDGSLL-LNCPALTNLTSLDLGTNKFN  338 (1020)
Q Consensus       301 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  338 (1020)
                      ++|+.|++++|+++.... ..+..+++|++|+|++|.+.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            566666666666553322 23445555555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.27  E-value=1.2e-13  Score=137.98  Aligned_cols=116  Identities=20%  Similarity=0.310  Sum_probs=66.4

Q ss_pred             CCCccccCCCCCCeeeccCCCCCCCCCCccCCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCCCCCCCcccc
Q 035998          124 TVPVSLVNLPNLEVLDLSSNDLSGPLPQTINLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFSGTLSPGLGN  203 (1020)
Q Consensus       124 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~~~~~~~l~~  203 (1020)
                      .+|.++..+++|++|+|++|+|+.. +...++++|++|+|++|+++ .+|                         ..+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~-------------------------~~~~~   91 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIE-------------------------NLDAV   91 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCS-------------------------SHHHH
T ss_pred             hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccc-ccc-------------------------ccccc
Confidence            3445566666666666666666533 22224555555555555554 222                         22233


Q ss_pred             ccccccccccccccccccchhhhhhcccccccccccccCCCCC-cccccCCCccEEEccCCcCccc
Q 035998          204 CASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKLS-PSIADLSNLVRLDVSSNNFSGN  268 (1020)
Q Consensus       204 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~  268 (1020)
                      +++|++|++++|+++. + +.+..+++|++|++++|+|+.... ..+..+++|++|+|++|.+...
T Consensus        92 ~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_          92 ADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             cccccccccccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            4456666666666663 2 346667777777777777763221 3566777777777777776643

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=1.1e-11  Score=118.13  Aligned_cols=108  Identities=20%  Similarity=0.209  Sum_probs=72.7

Q ss_pred             CCcCceEEcCCCCCCCCCCCCCCCceEEEecCCCcccccccccccCCCCCcEEecCCC-CCCCCCCccccCCCCCCeeec
Q 035998           62 CCHWVGITCNSSSSLGLNDSIGSGRVTGLFLYKRRLKGKLSESLGNLVQLRFLNLSHN-LLKGTVPVSLVNLPNLEVLDL  140 (1020)
Q Consensus        62 ~C~w~gv~C~~~~~~~~~~~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L  140 (1020)
                      ||.+.+|+|+....+.+                       |..+..+++|++|++++| .++..-+.+|.++++|+.|+|
T Consensus         7 c~~~~~l~c~~~~~~~~-----------------------p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~L   63 (156)
T d2ifga3           7 PHGSSGLRCTRDGALDS-----------------------LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI   63 (156)
T ss_dssp             CSSSSCEECCSSCCCTT-----------------------TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEEC
T ss_pred             cCCCCeEEecCCCCccC-----------------------cccccCccccCeeecCCCccccccCchhhccccccCccee
Confidence            44589999987554333                       344555667777777655 366444556777777777777


Q ss_pred             cCCCCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEEEccCCCCC
Q 035998          141 SSNDLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVINLSVNYFS  194 (1020)
Q Consensus       141 ~~n~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L~L~~N~l~  194 (1020)
                      ++|+|+.+.|..+ .+++|++|+|++|+|+ .+|..++... .|+.|+|++|.+.
T Consensus        64 s~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             eccccCCcccccccccccccceeccCCCCc-ccChhhhccc-cccccccCCCccc
Confidence            7777777666666 6777777777777776 6666666544 5777777777764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.20  E-value=3.8e-11  Score=114.41  Aligned_cols=141  Identities=18%  Similarity=0.130  Sum_probs=101.4

Q ss_pred             CCCcEEecCCCCCCCCCCccccCCCCCCeeeccCC-CCCCCCCCcc-CCCCcceeeeccCccCCCCCccccccCCcccEE
Q 035998          109 VQLRFLNLSHNLLKGTVPVSLVNLPNLEVLDLSSN-DLSGPLPQTI-NLPSIQVLDISSNSLNGSVPTSICKNSSRIRVI  186 (1020)
Q Consensus       109 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~L~~L  186 (1020)
                      .....++.+++++. .+|..+..+++|++|++++| .|+.+.+..+ ++++|++|+|++|+|+ .++...|..+++|++|
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Ccccccccccccccce
Confidence            44556888888888 67888999999999999766 5888777777 7999999999999998 7777788889999999


Q ss_pred             EccCCCCCCCCCCcccccccccccccccccccc-ccchhhhhhcccccccccccccCCCCCcccccC
Q 035998          187 NLSVNYFSGTLSPGLGNCASLEHLCLGMNDLTG-GIADDIFQLQKLRLLGLQDNQLSGKLSPSIADL  252 (1020)
Q Consensus       187 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  252 (1020)
                      +|++|+|+...+..|.. .+|++|+|++|.+.- -...++..+.......+..++++-..|..+.++
T Consensus        86 ~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~  151 (156)
T d2ifga3          86 NLSFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM  151 (156)
T ss_dssp             ECCSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCC
T ss_pred             eccCCCCcccChhhhcc-ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcC
Confidence            99999998554445544 479999999998862 112223333333344444555554445444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=2.7e-08  Score=94.82  Aligned_cols=90  Identities=17%  Similarity=-0.007  Sum_probs=55.1

Q ss_pred             cccccccccccccccccccccchhhhhhcccccccccccccCCCC--CcccccCCCccEEEccCCcCcccCcccccCCcc
Q 035998          201 LGNCASLEHLCLGMNDLTGGIADDIFQLQKLRLLGLQDNQLSGKL--SPSIADLSNLVRLDVSSNNFSGNIPDVFAGLGE  278 (1020)
Q Consensus       201 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  278 (1020)
                      +..+..+..++..+|..+ .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|+...+-.+....+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            334445555666555544 44555566788888888888887532  344666777888888888777544333333445


Q ss_pred             cceeecccccccc
Q 035998          279 FQYLVAHSNRFTG  291 (1020)
Q Consensus       279 L~~L~L~~N~l~~  291 (1020)
                      |+.|++++|.++.
T Consensus       117 L~~L~L~~Npl~~  129 (162)
T d1koha1         117 LEELWLDGNSLSD  129 (162)
T ss_dssp             CSSCCCTTSTTSS
T ss_pred             cceeecCCCCcCc
Confidence            6666666666553

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.34  E-value=8.1e-07  Score=92.00  Aligned_cols=148  Identities=14%  Similarity=0.092  Sum_probs=101.2

Q ss_pred             HHHHhccCCCcCCeeeccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceE
Q 035998          736 DILESTNNFDQANIIGCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRL  814 (1020)
Q Consensus       736 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  814 (1020)
                      ++.+--..|+..+..+.++.+.||+... +++.+++|+...........+.+|.+.++.+. +--+.+++.+..+.+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3444445666666555555678999875 56778889886554333445778888888774 434677888888888889


Q ss_pred             EEEEeccCCChhhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------
Q 035998          815 LIYSFMENGSLDYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQSC--------------------------------  862 (1020)
Q Consensus       815 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------  862 (1020)
                      +||++++|.++.......         .....++.++++.++.||+..                                
T Consensus        87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999998775443211         112334555666666666421                                


Q ss_pred             ------------------------CCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          863 ------------------------EPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       863 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                                              ...++|+|+.|.||++++++.+-++||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    0238999999999999987667799999875

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=2.3e-08  Score=95.42  Aligned_cols=88  Identities=16%  Similarity=0.125  Sum_probs=41.0

Q ss_pred             hhhcccccccccccccCCCCCcccccCCCccEEEccCCcCcccC--cccccCCcccceeecccccccccCCCCCcCCccc
Q 035998          226 FQLQKLRLLGLQDNQLSGKLSPSIADLSNLVRLDVSSNNFSGNI--PDVFAGLGEFQYLVAHSNRFTGRIPHSLSNSPTL  303 (1020)
Q Consensus       226 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  303 (1020)
                      ..+..+..++..+|... .++..+..+++|++|+|++|+|+...  +..+..+++|+.|++++|+|+...+-.+....+|
T Consensus        39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L  117 (162)
T d1koha1          39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL  117 (162)
T ss_dssp             TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC
T ss_pred             hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccc
Confidence            33344444554444433 33334455666666666666666432  2334445555555555555553322122222334


Q ss_pred             ccccccccccc
Q 035998          304 NLLNLRNNSLD  314 (1020)
Q Consensus       304 ~~L~L~~N~l~  314 (1020)
                      +.|++++|.+.
T Consensus       118 ~~L~L~~Npl~  128 (162)
T d1koha1         118 EELWLDGNSLS  128 (162)
T ss_dssp             SSCCCTTSTTS
T ss_pred             ceeecCCCCcC
Confidence            44444444443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.90  E-value=1.5e-05  Score=81.52  Aligned_cols=130  Identities=15%  Similarity=0.065  Sum_probs=86.3

Q ss_pred             eeeccCC-eEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCC--CccceEeeEEeccCceEEEEEeccCCCh
Q 035998          749 IIGCGGF-GLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQH--PNLVHLQGYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       749 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      .+..|.. +.||+...+++..+++|.......   ..+..|++.++.+..  -.+.+++.+..+.+..++||||++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 678999988888899998765432   346778888887743  3356778887888888999999988765


Q ss_pred             hhhhhhcCCCCCCCCHHHHHHHHHHHHHHHHHhHh---------------------------------------------
Q 035998          826 DYWLHEKLDGPSSLDWDSRLHIAQGAARGLAYLHQ---------------------------------------------  860 (1020)
Q Consensus       826 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~---------------------------------------------  860 (1020)
                      ...-         ...   ...+.++++.++-||+                                             
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            3210         010   1112233333333332                                             


Q ss_pred             ------cC----CCCeEecCCCCCCEEEcCCCCeEEeeccccc
Q 035998          861 ------SC----EPHILHRDIKSSNILLDGNFGAHLADFGLAR  893 (1020)
Q Consensus       861 ------~~----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  893 (1020)
                            ..    .+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  10    1248999999999999987767899999774

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.43  E-value=0.00027  Score=76.88  Aligned_cols=76  Identities=17%  Similarity=0.121  Sum_probs=48.6

Q ss_pred             CCeeeccCCeEEEEEEeCC-CCEEEEEEecCCc-------hhhHHHHHHHHHHHHHcC-C--CccceEeeEEeccCceEE
Q 035998          747 ANIIGCGGFGLVYRATLPD-GRNVAIKRLSGDC-------GQMEREFRAEVEALSRAQ-H--PNLVHLQGYCMHKNDRLL  815 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  815 (1020)
                      .+.||.|....||++...+ ++.|+||.-....       +........|+++++.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998654 6789999754311       111223456888887763 3  234555543  5566789


Q ss_pred             EEEeccCCC
Q 035998          816 IYSFMENGS  824 (1020)
Q Consensus       816 v~e~~~~g~  824 (1020)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997653

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.27  E-value=2.5e-05  Score=73.98  Aligned_cols=89  Identities=12%  Similarity=0.151  Sum_probs=47.5

Q ss_pred             Cccccccccccc-ccccc----cccCCCCCCCcCEEEcCCCccCCCCCC----CCCCCCCCCeEecCCCcccccC----c
Q 035998          300 SPTLNLLNLRNN-SLDGS----LLLNCPALTNLTSLDLGTNKFNGPLPT----NLPRCRKLKNINLARNNFSGQI----P  366 (1020)
Q Consensus       300 l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~----p  366 (1020)
                      .++|+.|+|+++ .++..    +...+...+.|++|+|++|.++.....    .+...+.|++|+|++|.++...    -
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            345555555542 34321    122344456666777777666532222    2334566777777777765432    2


Q ss_pred             ccccCCCCCCeeeCCCCCCcch
Q 035998          367 ETYKNFESLSYLSLSNSSIYNL  388 (1020)
Q Consensus       367 ~~~~~l~~L~~L~l~~N~i~~l  388 (1020)
                      .++...++|++|++++|.+..+
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHhCCcCCEEECCCCcCCCc
Confidence            2445556677777777765544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.20  E-value=5.7e-05  Score=71.48  Aligned_cols=63  Identities=16%  Similarity=0.210  Sum_probs=33.5

Q ss_pred             CCCcCEEEcCCC-ccCCC----CCCCCCCCCCCCeEecCCCcccccCc----ccccCCCCCCeeeCCCCCCc
Q 035998          324 LTNLTSLDLGTN-KFNGP----LPTNLPRCRKLKNINLARNNFSGQIP----ETYKNFESLSYLSLSNSSIY  386 (1020)
Q Consensus       324 l~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l~~N~i~  386 (1020)
                      .++|++|+|+++ .++..    +-..+...+.|++|+|++|.+.....    +.+...+.|+.|+|++|.|.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            466777777653 34421    22234455666666666666653222    23334455666666666554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.94  E-value=0.00084  Score=70.79  Aligned_cols=139  Identities=14%  Similarity=0.123  Sum_probs=79.4

Q ss_pred             cCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCcc--ceEe-----eEEeccCceEEEEEeccCCCh
Q 035998          753 GGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL--VHLQ-----GYCMHKNDRLLIYSFMENGSL  825 (1020)
Q Consensus       753 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L  825 (1020)
                      +.--.||+++.++|+.|++|+..... ...+++..|.+.+..+....+  +...     ..+......+.+++|++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            33468999999999999999987542 235667889988888743222  1111     122234556789999987533


Q ss_pred             hh-----------hh---hhc-----CCCCCCCCH-------------------HHHHHHHHHHHHHHHHhHh----cCC
Q 035998          826 DY-----------WL---HEK-----LDGPSSLDW-------------------DSRLHIAQGAARGLAYLHQ----SCE  863 (1020)
Q Consensus       826 ~~-----------~l---~~~-----~~~~~~l~~-------------------~~~~~i~~~i~~~L~~LH~----~~~  863 (1020)
                      ..           .+   +..     .......+.                   ..+..+...+...++.+..    ..+
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            20           00   000     000111111                   1111122222333333322    224


Q ss_pred             CCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          864 PHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       864 ~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      .++||+|+.+.||+++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            579999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.59  E-value=0.0041  Score=67.27  Aligned_cols=73  Identities=14%  Similarity=0.092  Sum_probs=50.9

Q ss_pred             CCeeeccCCeEEEEEEeCC--------CCEEEEEEecCCchhhHHHHHHHHHHHHHcC-CCccceEeeEEeccCceEEEE
Q 035998          747 ANIIGCGGFGLVYRATLPD--------GRNVAIKRLSGDCGQMEREFRAEVEALSRAQ-HPNLVHLQGYCMHKNDRLLIY  817 (1020)
Q Consensus       747 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  817 (1020)
                      ++.|+.|-.-.+|++..++        .+.|++++.....  ......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578889999999998653        3567777765332  2345668999998884 4434577777643    6899


Q ss_pred             EeccCCCh
Q 035998          818 SFMENGSL  825 (1020)
Q Consensus       818 e~~~~g~L  825 (1020)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987644

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.39  E-value=0.00037  Score=65.53  Aligned_cols=42  Identities=14%  Similarity=0.048  Sum_probs=22.3

Q ss_pred             hhhcCCCCcEE--ecccccccc----cccccccCcCcCcEEeCCCCcc
Q 035998          443 WLRGCSKLQLV--DLSWNQLSG----TIPVWFGGFQDLFYLDLSNNTF  484 (1020)
Q Consensus       443 ~l~~l~~L~~L--~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l  484 (1020)
                      .+...++|+.+  ++++|++..    .+...+...+.|+.|+++.|..
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            34445556543  334555543    2334455566777777766543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.33  E-value=0.00012  Score=69.00  Aligned_cols=65  Identities=14%  Similarity=0.168  Sum_probs=35.2

Q ss_pred             ccCCCCCcEEecCC-CCCCCC----CCccccCCCCCCeeeccCCCCCCCCCCcc-----CCCCcceeeeccCccC
Q 035998          105 LGNLVQLRFLNLSH-NLLKGT----VPVSLVNLPNLEVLDLSSNDLSGPLPQTI-----NLPSIQVLDISSNSLN  169 (1020)
Q Consensus       105 l~~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~p~~~-----~l~~L~~L~Ls~N~l~  169 (1020)
                      ..+.+.|++|+|++ +.++..    +-.++...++|++|+|++|.++......+     ..++|+.|++++|.+.
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            34556777777776 445421    33445566777777777776653221111     2445555555555443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.11  E-value=0.016  Score=60.19  Aligned_cols=160  Identities=13%  Similarity=0.081  Sum_probs=83.9

Q ss_pred             ccHHHHHHhccCCCcCCee-----eccCCeEEEEEEeCCCCEEEEEEecCCchhhHHHHHHHHHHHHHcCCCcc--ceEe
Q 035998          732 ISIDDILESTNNFDQANII-----GCGGFGLVYRATLPDGRNVAIKRLSGDCGQMEREFRAEVEALSRAQHPNL--VHLQ  804 (1020)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  804 (1020)
                      ++.+++...-.+|.+.++.     ..|---+.|+.+..+| .+++|++.....  .+++..|++++..+...++  ....
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            4566777777788775543     4666688899987655 589999865322  2345567777777743222  1111


Q ss_pred             e------EEeccCceEEEEEeccCCChhh--------------hhhhc---CCCC--CCCCH------------------
Q 035998          805 G------YCMHKNDRLLIYSFMENGSLDY--------------WLHEK---LDGP--SSLDW------------------  841 (1020)
Q Consensus       805 ~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~---~~~~--~~l~~------------------  841 (1020)
                      .      +.........++.++.+.....              .++..   ....  .....                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1112334556677666542210              00000   0000  00000                  


Q ss_pred             HHHHHHHHHHHHHHHHhHh-cCCCCeEecCCCCCCEEEcCCCCeEEeecccccc
Q 035998          842 DSRLHIAQGAARGLAYLHQ-SCEPHILHRDIKSSNILLDGNFGAHLADFGLARL  894 (1020)
Q Consensus       842 ~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  894 (1020)
                      ......+..+...+...+. ..+.++||+|+.++||+++++...-+.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            0111122222222222221 1234899999999999999887778999998753